PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Lu, B; Li, JG; Suzuki, TS; Tanaka, H; Sun, XD; Sakka, Y				Lu, Bin; Li, Ji-Guang; Suzuki, Tohru S.; Tanaka, Hidehiko; Sun, Xudong; Sakka, Yoshio			Effects of Gd Substitution on Sintering and Optical Properties of Highly Transparent (Y0.95-xGdxEu0.05)(2)O-3 Ceramics	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							LUMINESCENT PROPERTIES; YTTRIA CERAMICS; SC2O3 CERAMICS; POWDER COMPACTS; FABRICATION; PHOTOLUMINESCENCE; SCINTILLATORS; HYDROXIDE; Y2O3; EU	Highly transparent (Y0.95-xGdxEu0.05)(2)O-3 (x=0.15-0.55) ceramics have been fabricated by vacuum sintering at the relatively low temperature of 1700 degrees C for 4h with the in-line transmittances of 73.6%-79.5% at the Eu3+ emission wavelength of 613nm (similar to 91.9%-99.3% of the theoretical transmittance of Y1.34Gd0.6Eu0.06O3 single crystal), whereas the x=0.65 ceramic undergoes a phase transformation at 1650 degrees C and has a transparency of 53.4% at the lower sintering temperature of 1625 degrees C. The effects of Gd3+ substitution for Y3+ on the particle characteristics, sintering kinetics, and optical performances of the materials were systematically studied. The results show that (1) calcining the layered rare-earth hydroxide precursors of the ternary Y-Gd-Eu system yielded rounded oxide particles with greatly reduced hard agglomeration and the particle/crystallite size slightly decreases along with increasing Gd3+ incorporation; (2) in the temperature range 1100 degrees C-1480 degrees C, the sintering kinetics of (Y0.95-xGdxEu0.05)(2)O-3 is mainly controlled by grain-boundary diffusion with similar activation energies of similar to 230kJ/mol; (3) Gd3+ addition promotes grain growth and densification in the temperature range 1100 degrees C-1400 degrees C; (4) the bandgap energies of the (Y0.95-xGdxEu0.05)(2)O-3 ceramics generally decrease with increasing x; however, they are much lower than those of the oxide powders; (5) both the oxide powders and the transparent ceramics exhibit the typical red emission of Eu3+ at similar to 613nm (the (D0F2)-D-5-F-7 transition) under charge transfer (CT) excitation. Gd3+ incorporation enhances the photoluminescence and shortens the fluorescence lifetime of Eu3+.	[Lu, Bin; Sakka, Yoshio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Mat Sci & Engn, Tsukuba, Ibaraki 3058571, Japan; [Lu, Bin; Li, Ji-Guang; Suzuki, Tohru S.; Sakka, Yoshio] Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan; [Li, Ji-Guang; Sun, Xudong] Northeastern Univ, Sch Met & Mat, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Liaoning, Peoples R China; [Tanaka, Hidehiko] Natl Inst Mat Sci, World Premier Int Ctr Mat Nanoarchitecton WPI MAN, Tsukuba, Ibaraki 3050044, Japan	Li, JG (reprint author), Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan.	LI.Jiguang@nims.go.jp; SAKKA.Yoshio@nims.go.jp			China Scholar Council (CSC); National Natural Science Foundation of China [51172038];  [26420686]	Bin Lu gratefully acknowledges the China Scholar Council (CSC) for financial support. Special thanks are due to World Premier International Center for Materials Nanoarchitectonics (WPI-MANA) of National Institute for Materials Science (NIMS) for allowing to access analysis facilities. The authors express their strong appreciation to Mr. Kento Imai of Shibaura Institute of Technology, and Mr. Hideo Okuyama and Ms. Keiko Suzuta of NIMS for technical support. The work is supported in part by the National Natural Science Foundation of China (grant no. 51172038) and Grants-in-Aid for Scientific Research (KAKENHI, grant no. 26420686).	Lu B, 2015, J AM CERAM SOC, V98, P1413, DOI 10.1111/jace.13488; Chen QW, 2006, J AM CERAM SOC, V89, P2038, DOI 10.1111/j.1551-2916.2006.01016.x; Chen PL, 1996, J AM CERAM SOC, V79, P1801, DOI 10.1111/j.1151-2916.1996.tb07998.x; Geng FX, 2008, J AM CHEM SOC, V130, P16344, DOI 10.1021/ja807050e; Ikegami T, 2002, J AM CERAM SOC, V85, P1725; Serivalsatit K, 2010, J AM CERAM SOC, V93, P1320, DOI 10.1111/j.1551-2916.2010.03601.x; Fu ZL, 2007, J LUMIN, V124, P213, DOI 10.1016/j.jlumin.2006.02.020; Wu XL, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015006; Hu LF, 2009, ANGEW CHEM INT EDIT, V48, P3846, DOI 10.1002/anie.200806206; Zeng SY, 2007, J COLLOID INTERF SCI, V316, P921, DOI 10.1016/j.jcis.2007.08.034; Lu SZ, 2013, OPT MATER, V35, P718, DOI 10.1016/j.optmat.2012.09.014; Huang YH, 2009, J AM CERAM SOC, V92, P2883, DOI 10.1111/j.1551-2916.2009.03312.x; Wu XL, 2015, J MATER CHEM C, V3, P3428, DOI 10.1039/c4tc02681k; Zorenko Y, 2002, NUCL INSTRUM METH A, V486, P309, DOI 10.1016/S0168-9002(02)00725-8; Wu XL, 2012, DALTON T, V41, P1854, DOI 10.1039/c1dt11332a; Li JG, 2008, J PHYS CHEM C, V112, P11707, DOI 10.1021/jp802383a; Ningthoujam RS, 2009, J APPL PHYS, V105, DOI 10.1063/1.3098253; McIntyre LJ, 2008, CHEM MATER, V20, P335, DOI 10.1021/cm7019284; Zhu Q, 2010, CHEM MATER, V22, P4204, DOI 10.1021/cm1011586; Poudret L, 2008, CHEM MATER, V20, P7447, DOI 10.1021/cm802301a; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Boulesteix R, 2014, SCRIPTA MATER, V75, P54, DOI 10.1016/j.scriptamat.2013.11.016; Packiyaraj P, 2014, J LUMIN, V145, P997, DOI 10.1016/j.jlumin.2013.07.074; Zhu Q, 2009, ACTA MATER, V57, P5975, DOI 10.1016/j.actamat.2009.08.026; GRESKOVICH CD, 1992, AM CERAM SOC BULL, V71, P1120; Greskovich C, 1997, ANNU REV MATER SCI, V27, P69, DOI 10.1146/annurev.matsci.27.1.69; Li JG, 2005, J AM CERAM SOC, V88, P817, DOI 10.1111/j.1551-2916.2005.00162.x; Brown EE, 2014, J AM CERAM SOC, V97, P2105, DOI 10.1111/jace.12898; CARNALL E, 1972, MATER RES BULL, V7, P647, DOI 10.1016/0025-5408(72)90052-9; Cho G, 2005, IEEE NUCL SCI CONF R, P1314; Concas G., 2005, J PHYS CONDENS MATT, V17, P2594; Ganjkhanlou Y, 2010, NANO, V5, P111, DOI 10.1142/S1793292010001998; HEBER J, 1970, Z PHYS, V237, P189, DOI 10.1007/BF01398633; JOHNSON DL, 1963, J AM CERAM SOC, V46, P541, DOI 10.1111/j.1151-2916.1963.tb14606.x; Jorgen J. F., 2014, ACTA MAT, V69, P187; Kim YK, 2004, J MATER RES, V19, P413, DOI 10.1557/jmr.2004.19.2.413; Li J. -G., 2000, ACTA MAT, V59, P3688; Li JG, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/1/014902; Li JK, 2012, J AM CERAM SOC, V95, P931, DOI 10.1111/j.1551-2916.2011.04991.x; Li XD, 2010, INT J APPL CERAM TEC, V7, pE1, DOI 10.1111/j.1744-7402.2008.02351.x; Li YH, 2007, J LUMIN, V124, P297, DOI 10.1016/j.jlumin.2006.03.016; Lim LC, 2000, ACTA MATER, V48, P2263, DOI 10.1016/S1359-6454(00)00031-8; Lu B, 2012, ADV APPL CERAM, V111, P389, DOI 10.1179/1743676112Y.0000000010; Lu B, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/6/064202; Lu SZ, 2013, IEEE J QUANTUM ELECT, V49, P293, DOI 10.1109/JQE.2012.2226235; Retot H, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/23/235101; Rhodes W. H., 1995, PHASE CHEM DEV TRANS, P2; Schwarz SM, 2003, ACTA MATER, V51, P2765, DOI 10.1016/S1359-6454(03)00082-X; Wang Y, 2011, ADV APPL CERAM, V110, P95, DOI 10.1179/1743676110Y.0000000006; Wei GC, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/14/144014; Xu J, 2013, J AM CERAM SOC, V96, P1930, DOI 10.1111/jace.12231; Young W. S., 1970, Journal of the American Ceramic Society, V53, DOI 10.1111/j.1151-2916.1970.tb12036.x	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	AUG	2015	98	8					2480	2487		10.1111/jace.13627		8	Materials Science, Ceramics	Materials Science	CN8UI	WOS:000358719400025		
J	Inoue, H; Sato, H; Ikeda, H; Onimaru, M; Sato, C; Minami, H; Yokomichi, H; Kobayashi, Y; Grimes, KL; Kudo, S				Inoue, Haruhiro; Sato, Hiroki; Ikeda, Haruo; Onimaru, Manabu; Sato, Chiaki; Minami, Hitomi; Yokomichi, Hiroshi; Kobayashi, Yasutoshi; Grimes, Kevin L.; Kudo, Shin-ei			Per-Oral Endoscopic Myotomy: A Series of 500 Patients	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LAPAROSCOPIC HELLER MYOTOMY; LONG-TERM OUTCOMES; ESOPHAGEAL ACHALASIA; BOTULINUM TOXIN; PNEUMATIC DILATION; BALLOON DILATATION; MOTOR DISORDERS; SINGLE-CENTER; POEM; CLASSIFICATION	BACKGROUND: After the first case of per-oral endoscopic myotomy (POEM) at our institution in 2008, the procedure was quickly accepted as an alternative to surgical myotomy and is now established as an excellent treatment option for achalasia. This study aimed to examine the safety and outcomes of POEM at our institution. STUDY DESIGN: Per-oral endoscopic myotomy was performed on 500 consecutive achalasia patients at our institution between September 2008 and November 2013. A review of prospectively collected data was conducted, including procedure time, myotomy location and length, adverse events, and patient data with short- (2 months) and long-term (1 and 3 years) follow-up. RESULTS: Per-oral endoscopic myotomy was successfully completed in all patients, with adverse events observed in 3.2%. Two months post-POEM, significant reductions in symptom scores (Eckardt score 6.0 +/- 3.0 vs 1.0 +/- 2.0, p < 0.0001) and lower esophageal sphincter (LES) pressures (25.4 +/- 17.1 vs 13.4 +/- 5.9 mmHg, p < 0.0001) were achieved, and this persisted at 3 years post-POEM. Gastroesophageal reflux was seen in 16.8% of patients at 2 months and 21.3% at 3-year follow-up. CONCLUSIONS: Per-oral endoscopic myotomy was successfully completed in all cases, even when extended indications (extremes of age, previous interventions, or sigmoid esophagus) were used. Adverse events were rare (3.2%), and there were no mortalities. Significant improvements in Eckardt scores and LES pressures were seen at 2 months, 1 year, and 3 years post-POEM. Based on our large series, POEM is a safe and effective treatment for achalasia; there are relatively few contraindications, and the procedure may be used as either first-or second-line therapy. (C) 2015 by the American College of Surgeons	[Inoue, Haruhiro; Sato, Hiroki; Ikeda, Haruo; Onimaru, Manabu; Sato, Chiaki; Minami, Hitomi; Kudo, Shin-ei] Showa Univ, Northern Yokohama Hosp, Digest Dis Ctr, Yokohama, Kanagawa 2248503, Japan; [Yokomichi, Hiroshi] Univ Yamanashi, Grad Sch, Dept Interdisciplinary Res, Div Med, Yamanashi, Japan; [Kobayashi, Yasutoshi] Kobayashi Internal Med Clin, Kobe, Hyogo, Japan; [Grimes, Kevin L.] Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Tokyo, Japan	Inoue, H (reprint author), Showa Univ, Northern Yokohama Hosp, Digest Dis Ctr, Tsuzuki Ku, 35-1 Chigasakichuo, Yokohama, Kanagawa 2248503, Japan.	haruinoue@yahoo.co.jp					Swanstrom LL, 2012, ANN SURG, V256, P659, DOI 10.1097/SLA.0b013e31826b5212; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Lundell LR, 1999, GUT, V45, P172; Francis DL, 2010, GASTROENTEROLOGY, V139, P369, DOI 10.1053/j.gastro.2010.06.024; Richter JE, 2011, GUT, V60, P869, DOI 10.1136/gut.2010.212423; Burton A, 2004, BRIT J CANCER, V91, P4, DOI 10.1038/sj.bjc.6601907; Alderliesten J, 2011, GUT, V60, P10, DOI 10.1136/gut.2010.211409; Zaninotto G, 2008, ANN SURG, V248, P986, DOI 10.1097/SLA.0b013e3181907bdd; Mayberry J F, 2001, Gastrointest Endosc Clin N Am, V11, P235; Boeckxstaens GE, 2011, NEW ENGL J MED, V364, P1807, DOI 10.1056/NEJMoa1010502; Weber CE, 2012, SURG LAPARO ENDO PER, V22, P289, DOI 10.1097/SLE.0b013e31825a2478; Maselli R, 2012, ENDOSCOPY, V44, pE285, DOI 10.1055/s-0032-1309924; Zaninotto G, 2004, ANN SURG, V239, P364, DOI 10.1097/01.sla.0000114217.52941.e5; Park W, 2005, AM J GASTROENTEROL, V100, P1404, DOI 10.1111/j.1572-0241.2005.41775.x; Zhou PH, 2013, ENDOSCOPY, V45, P161, DOI 10.1055/s-0032-1326203; Costamagna G, 2012, DIGEST LIVER DIS, V44, P827, DOI 10.1016/j.dld.2012.04.003; CASTELL DO, 1990, GASTROENTEROL CLIN N, V19, P235; COHEN S, 1979, NEW ENGL J MED, V301, P184, DOI 10.1056/NEJM197907263010404; Dagli U, 2009, DIGEST DIS SCI, V54, P1237, DOI 10.1007/s10620-008-0493-6; Diseases JSoE, 2012, DIS JSOE DESCRIPTIVE, V4th; Eckardt V F, 2001, Gastrointest Endosc Clin N Am, V11, P281; Gockel I, 2007, AM SURGEON, V73, P327; Neubrand M, 2002, ENDOSCOPY, V34, P519, DOI 10.1055/s-2002-33225; SCHLUCHTER MD, 1988, STAT MED, V7, P317, DOI 10.1002/sim.4780070132; Schuchert MJ, 2008, ANN THORAC SURG, V85, P1729, DOI 10.1016/j.athoracsur.2007.11.017; Van Buuren S, 2012, FLEXIBLE IMPUTATION; VANTRAPPEN G, 1980, GASTROENTEROLOGY, V79, P144; Vela MF, 2004, AM J GASTROENTEROL, V99, P1029; Wood Angela M, 2004, Clin Trials, V1, P368, DOI 10.1191/1740774504cn032oa	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					256	264		10.1016/j.jamcollsurg.2015.03.057		9	Surgery	Surgery	CN4EZ	WOS:000358384400009		
J	Honda, M; Hiki, N; Nunobe, S; Ohashi, M; Kumagai, K; Hashimoto, Y; Mine, S; Kamiya, S; Sano, T; Yamaguchi, T				Honda, Michitaka; Hiki, Naoki; Nunobe, Souya; Ohashi, Manabu; Kumagai, Koshi; Hashimoto, Yoshikazu; Mine, Shinji; Kamiya, Satoshi; Sano, Takeshi; Yamaguchi, Toshiharu			Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							ENDOSCOPIC RESECTION; PARTIAL GASTRECTOMY; DISTAL GASTRECTOMY; OPEN-LABEL; INFECTION; MANAGEMENT; THERAPY; STOMACH; SURGERY; REFLUX	BACKGROUND: The Maastricht, Asia-Pacific consensus guidelines strongly recommend eradication of Helicobacter pylori in patients who have a history of gastric cancer. This open-label, single-center, randomized controlled trial was conducted to investigate the appropriate timing of eradication for patients undergoing gastrectomy. STUDY DESIGN: One hundred and fifty patients scheduled to undergo gastrectomy were allocated to either a preoperative or a postoperative group. The eradication regimen was a common triple therapy: lansoprazole, amoxicillin, and clarithromycin. Patients in the preoperative group were treated with the regimen, followed by surgery, and patients in the postoperative group were treated after postoperative day 8. The primary end point was the proportion of patients achieving successful eradication in the remnant stomach. The definition of successful eradication was negativity in both the C13 urea breath test and for the antigen in feces at 6 months after surgery. RESULTS: Eight patients were excluded, and the remaining one hundred and forty-two, 70 in the preoperative group and 72 in the postoperative group, were included on an intention to treat basis. The procedures used were gastrectomy with Billroth I, Roux-en-Y, and pylorus-preserving gastrectomy in 18, 70, and 57 patients, respectively. The proportion of patients showing successful eradication hardly differed between the 2 groups, 68.6% vs 69.4%( p = 1.000) in the pre- and postoperative groups, respectively. Subgroup analysis also demonstrated no significant difference among the reconstruction methods used. CONCLUSIONS: Preoperative H pylori eradication therapy for gastric cancer patients scheduled for gastrectomy is not necessary, regardless of the planned reconstruction procedure. (C) 2015 by the American College of Surgeons	[Honda, Michitaka; Hiki, Naoki; Nunobe, Souya; Ohashi, Manabu; Kumagai, Koshi; Mine, Shinji; Kamiya, Satoshi; Sano, Takeshi; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Surg Gastroenterol, Tokyo 1358550, Japan; [Hashimoto, Yoshikazu] Kyorin Univ, Sch Med, Dept Surg, Tokyo, Japan	Hiki, N (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Surg Gastroenterol,Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	naoki.hiki@jfcr.or.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Nunobe S, 2007, GASTRIC CANCER, V10, P167, DOI 10.1007/s10120-007-0434-7; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Nunobe S, 2007, INT J CLIN ONCOL, V12, P433, DOI 10.1007/s10147-007-0706-6; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Lin YS, 2014, WORLD J GASTROENTERO, V20, P5274, DOI 10.3748/wjg.v20.i18.5274; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mamori S, 2010, WORLD J GASTROENTERO, V16, P4176, DOI 10.3748/wjg.v16.i33.4176; Danesh J, 1998, BRIT MED J, V316, P746; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Morgan DR, 2013, JAMA-J AM MED ASSOC, V309, P578, DOI 10.1001/jama.2013.311; Asaka M, 2010, INTERNAL MED, V49, P633, DOI 10.2169/internalmedicine.49.3470; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Bae SE, 2014, AM J GASTROENTEROL, V109, P60, DOI 10.1038/ajg.2013.404; Kubota K, 2002, DIGESTION, V65, P82, DOI 10.1159/000057709; Takiguchi S, 2013, WORLD J SURG, V37, P2379, DOI 10.1007/s00268-013-2121-7; BECHI P, 1987, GASTROENTEROLOGY, V93, P335; Fukuhara K, 2004, HEPATO-GASTROENTEROL, V51, P1241; Giuliani A, 2010, ARCH SURG-CHICAGO, V145, P962, DOI 10.1001/archsurg.2010.211; Guadagni S, 1996, J SURG ONCOL, V63, P226, DOI 10.1002/(SICI)1096-9098(199612)63:4<226::AID-JSO3>3.0.CO;2-E; Katsube T, 2002, HEPATO-GASTROENTEROL, V49, P128; Kim CG, 2008, AM J GASTROENTEROL, V103, P48, DOI 10.1111/j.1572-0241.2007.01482.x; Kim JE, 2014, J MICROBIOL, V52, P955, DOI 10.1007/s12275-014-4355-y; Marcus EA, 2013, HELICOBACTER, V18, P363, DOI 10.1111/hel.12055; McNicholl AG, 2014, GUT, V63, P244, DOI 10.1136/gutjnl-2013-304820; Pan XL, 2010, CLIN THER, V32, P2003, DOI 10.1016/j.clinthera.2010.11.005; Tomtitchong P, 1998, J CLIN GASTROENTEROL, V27, pS154, DOI 10.1097/00004836-199800001-00025; Wu W, 2012, GASTROENT RES PRACT, V2012, DOI DOI 10.1155/2012/723183]	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					273	279		10.1016/j.jamcollsurg.2015.03.052		7	Surgery	Surgery	CN4EZ	WOS:000358384400011		
J	Kawanaka, H; Akahoshi, T; Kinjo, N; Harimoto, N; Itoh, S; Tsutsumi, N; Matsumoto, Y; Yoshizumi, T; Shirabe, K; Maehara, Y				Kawanaka, Hirofumi; Akahoshi, Tomohiko; Kinjo, Nao; Harimoto, Norifumi; Itoh, Shinji; Tsutsumi, Norifumi; Matsumoto, Yoshihiro; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko			Laparoscopic Splenectomy with Technical Standardization and Selection Criteria for Standard or Hand-Assisted Approach in 390 Patients with Liver Cirrhosis and Portal Hypertension	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							CHRONIC HEPATITIS-C; SPLENIC ARTERY EMBOLIZATION; RISK-FACTORS; ADVANCED FIBROSIS; VEIN THROMBOSIS; THERAPY; COMPLICATIONS; HYPERSPLENISM; SURGERY; THROMBOCYTOPENIA	BACKGROUND: Laparoscopic splenectomy (LS) is still challenging in patients with liver cirrhosis and portal hypertension. This study was designed to establish safe and less invasive LS in patients with liver cirrhosis and portal hypertension. STUDY DESIGN: We analyzed 390 patients with liver cirrhosis and portal hypertension, who underwent LS between 1993 and 2013. Patients were divided into 3 time periods; early (1993 to 2004, n = 106); middle (2005 to 2008, n = 159); and late (2008 to 2013, n = 125). During the middle time period, standardized technique for LS and selection criteria for hand-assisted LS were adopted. Patients with spleen volume >= 1,000 mL by CT volumetry, large perisplenic collateral vessels, and/or Child-Pugh score >= 9, underwent hand- assisted LS. During the late time period, the selection criteria were refined and patients with spleen volume >= 600 mL underwent hand- assisted LS. ESULTS: Conversion to open splenectomy decreased (10.4% in the early time period, 1.9% in the middle time period, and 3.2% in the late time period, p = 0.004), median blood loss decreased (300g, 87g, and 98g, respectively, p < 0.001), and the success rate of pure LS tended to improve (87.2%, 89.5%, and 98.0%, respectively, p = 0.110). Mortality was 0% in each time period, Clavien-Dindo grade IIIb or more complications tended to decrease (5.7%, 2.5%, and 0.8%, respectively, p = 0.081), and technique-related complications decreased significantly (10.4%, 3.8%, and 2.4%, respectively, p = 0.014). CONCLUSIONS: Laparoscopic splenectomy is now a safe and less invasive approach, even in patients with liver cirrhosis and portal hypertension, because of its technical standardization with the refined selection criteria for pure or hand- assisted LS. (C) 2015 by the American College of Surgeons	[Kawanaka, Hirofumi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Multidisciplinary Treatment, Fukuoka 8128582, Japan; [Kawanaka, Hirofumi; Akahoshi, Tomohiko; Kinjo, Nao; Harimoto, Norifumi; Itoh, Shinji; Tsutsumi, Norifumi; Matsumoto, Yoshihiro; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Kawanaka, Hirofumi] Natl Hosp Org, Beppu Med Ctr, Clin Res Inst, Beppu, Oita, Japan	Kawanaka, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Multidisciplinary Treatment, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	harrykw@v102.vaio.ne.jp			Japan Society for the Promotion of Science [25893166]	Partly supported by a Grant-in-Aid for Scientific Research (Grant 25893166) from the Japan Society for the Promotion of Science.	Aizawa N, 2014, J GASTROENTEROL, V49, P1253, DOI 10.1007/s00535-013-0884-0; Akahoshi T, 2012, J GASTROEN HEPATOL, V27, P286, DOI 10.1111/j.1440-1746.2011.06870.x; Anegawa G, 2009, J GASTROEN HEPATOL, V24, P1554, DOI 10.1111/j.1440-1746.2009.05906.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Kawanaka H, 2014, J AM COLL SURGEONS, V219, P865, DOI 10.1016/j.jamcollsurg.2014.07.939; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Habermalz B, 2008, SURG ENDOSC, V22, P821, DOI 10.1007/s00464-007-9735-5; Kawanaka H, 2010, ANN SURG, V251, P76, DOI 10.1097/SLA.0b013e3181bdf8ad; Chand B, 2001, SURG ENDOSC-ULTRAS, V15, P1273, DOI 10.1007/s004640080054; Kinjo N, 2010, BRIT J SURG, V97, P910, DOI 10.1002/bjs.7002; Kawanaka H, 2009, J HEPATO-BILIARY-PAN, V16, P749, DOI 10.1007/s00534-009-0149-8; Rincon D, 2006, AM J GASTROENTEROL, V101, P2269, DOI 10.1111/j.1572-0241.2006.00743.x; Wang X, 2013, SURG ENDOSC, V27, P3564, DOI 10.1007/s00464-013-2978-4; Cai YQ, 2011, SURG ENDOSC, V25, P3791, DOI 10.1007/s00464-011-1790-2; Casaccia M, 2006, SURG ENDOSC, V20, P1214, DOI 10.1007/s00464-005-0527-5; Grahn SW, 2006, ARCH SURG-CHICAGO, V141, p761e762; Grahn SW, 2006, ARCH SURG-CHICAGO, V141, P755, DOI 10.1001/archsurg.141.8.755; Heniford BT, 2001, AM SURGEON, V67, P854; Heniford BT, 2001, AM SURGEON, V67, p857e858; Ikegami T, 2008, HEPATOL RES, V38, P1159, DOI 10.1111/j.1872-034X.2008.00384.x; Kaban GK, 2004, SURG ENDOSC, V18, P1340, DOI 10.1007/s00464-003-9175-9; Kawanaka H, 2014, BRIT J SURG, V101, P1585, DOI 10.1002/bjs.9622; Lisman T, 2013, J HEPATOL, V59, P358, DOI 10.1016/j.jhep.2013.03.027; Mahon D, 2003, ANN ROY COLL SURG, V85, P248, DOI 10.1308/003588403766274953; Nagaoki Y, 2013, J GASTROENTEROL, V48, P847, DOI 10.1007/s00535-012-0679-8; Naoum JJ, 2007, AM J SURG, V193, P713, DOI 10.1016/j.amjsurg.2006.09.043; Ogawa E, 2014, J GASTROEN HEPATOL, V29, P1728, DOI 10.1111/jgh.12619; Ohta M, 2005, J HEPATO-BILIARY-PAN, V12, P433, DOI 10.1007/s00534-005-1027-7; Patel AG, 2003, ANN SURG, V238, P235, DOI 10.1097/01.sla.0000080826.97026.d8; Rosen M, 2002, ARCH SURG-CHICAGO, V137, P1348, DOI 10.1001/archsurg.137.12.1348; SOPER NJ, 1982, AM J SURG, V144, P700, DOI 10.1016/0002-9610(82)90554-2; Tan M, 2003, WORLD J GASTROENTERO, V9, P1086; Targarona EM, 2000, ARCH SURG-CHICAGO, V135, P1137, DOI 10.1001/archsurg.135.10.1137; Targarona EM, 1999, SURG ENDOSC-ULTRAS, V13, P559; Targarona EM, 2011, SAUDI J GASTROENTERO, V17, P4, DOI 10.4103/1319-3767.74428; Targarona EM, 2002, SURG ENDOSC, V16, P426, DOI 10.1007/s00464-001-8104-z; Tomikawa M, 2000, J AM COLL SURGEONS, V191, P498, DOI 10.1016/S1072-7515(00)00735-3; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Wu Z, 2012, SURG ENDOSC, V26, P2758, DOI 10.1007/s00464-012-2270-z	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					354	366		10.1016/j.jamcollsurg.2015.04.011		13	Surgery	Surgery	CN4EZ	WOS:000358384400020		
J	Yoshikawa, K; Shimada, M; Wakabayashi, G; Ishida, K; Kaiho, T; Kitagawa, Y; Sakamoto, J; Shiraishi, N; Koeda, K; Mochiki, E; Saikawa, Y; Yamaguchi, K; Watanabe, M; Morita, S; Kitano, S; Saji, S; Kanematsu, T; Kitajima, M				Yoshikawa, Kozo; Shimada, Mitsuo; Wakabayashi, Go; Ishida, Koichiro; Kaiho, Takashi; Kitagawa, Yuko; Sakamoto, Junichi; Shiraishi, Norio; Koeda, Keisuke; Mochiki, Erito; Saikawa, Yoshiro; Yamaguchi, Kazuya; Watanabe, Masayuki; Morita, Satoshi; Kitano, Seigo; Saji, Shigetoyo; Kanematsu, Takashi; Kitajima, Masaki			Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							DAI-KENCHU-TO; HUMAN PLASMA; CONSTIPATION; PEPTIDES; CHILDREN; DISEASE; TRANSIT; HUMANS; RATS	BACKGROUND: Daikenchuto (DKT) has widely been used to improve abdominal symptoms by being expected to accelerate bowel motility. The purpose of this study is to examine the efficacy and safety of DKT for prevention of ileus and associated gastrointestinal symptoms after total gastrectomy. STUDY DESIGN: Two hundred and forty-five gastric cancer patients who underwent total gastrectomy were enrolled. Patients received either DKT (15.0 g/d) or matching placebo from postoperative days 1 to 12. Primary end points were time to first flatus, time to first bowel movement (BM), and frequency of BM. Secondary end points included quality of life, C-reactive protein level, symptoms indicative of a severe gastrointestinal disorder, and incidence of postoperative ileus. RESULTS: A total of 195 patients (DKT, n = 96; placebo, n = 99) were included in the per-protocol set analysis. There were no significant differences between the groups in terms of patient background characteristics. Median time to first BM was shorter in the DKT group than in the placebo group (94.7 hours vs 113.9 hours; p = 0.051). In patients with high medication adherence, median time to first BM was significantly shorter in the DKT group than in the placebo group (93.8 hours vs 115.1 hours; p = 0.014). Significantly fewer patients in the DKT group had >= 2 symptoms of gastrointestinal dysfunction than those in the placebo group on postoperative day 12 (p = 0.026). CONCLUSIONS: Administration of DKT during the immediate postoperative period after total gastrectomy appears to promote early recovery of postoperative bowel function. (C) 2015 by the American College of Surgeons	[Yoshikawa, Kozo; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Tokushima 7708503, Japan; [Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Ishida, Koichiro] Natl Hosp Org, Osaka Minami Med Ctr, Dept Surg, Osaka, Japan; [Kaiho, Takashi] Kimitsu Hosp, Chiba, Japan; [Kitagawa, Yuko; Saikawa, Yoshiro] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Watanabe, Masayuki] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Surg Gastroenterol, Tokyo, Japan; [Saji, Shigetoyo] Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan; [Kitajima, Masaki] Int Univ Hlth & Welf, Tokyo, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Kakamigahara, Japan; [Shiraishi, Norio] Oita Univ, Fac Med, Ctr Community Med, Dept Surg, Oita 87011, Japan; [Koeda, Keisuke; Kitano, Seigo] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Mochiki, Erito] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Saitama, Japan; [Yamaguchi, Kazuya] Gifu Univ, Sch Med, Dept Surg Oncol, Gifu 500, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Kanematsu, Takashi] Nagasaki City Hosp Org, Nagasaki, Japan	Yoshikawa, K (reprint author), Univ Tokushima, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yoshikawa.kozo@tokushima-u.ac.jp			Japanese Foundation for Multidisciplinary Treatment of Cancer	This work was supported by the Japanese Foundation for Multidisciplinary Treatment of Cancer.	Yoshikawa K, 2012, SURG TODAY, V42, P646, DOI 10.1007/s00595-011-0094-4; Iwai N, 2007, EUR J PEDIATR SURG, V17, P115, DOI 10.1055/s-2007-965016; Itoh T, 2002, J INT MED RES, V30, P428; Endo S, 2006, AM J SURG, V192, P9, DOI 10.1016/j.amjsurg.2006.01.022; Kono T, 2009, SURGERY, V146, P837, DOI 10.1016/j.surg.2009.06.012; Nagano T, 1999, BIOL PHARM BULL, V22, P1131; Chikakiyo M, 2012, SURG TODAY, V42, P60, DOI 10.1007/s00595-011-0014-7; Hayakawa Terumasa, 1999, Journal of Smooth Muscle Research, V35, P47; Kaiho T, 2005, HEPATO-GASTROENTEROL, V52, P161; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Nagano T, 2000, BIOL PHARM BULL, V23, P352; Nakamura T, 2002, JPN J PHARMACOL, V88, P217, DOI 10.1254/jjp.88.217; Ohya T, 2003, AM J CHINESE MED, V31, P129, DOI 10.1142/S0192415X03000710; Sakakibara R, 2005, MOVEMENT DISORD, V20, P261, DOI 10.1002/mds.20352; Sato Y, 2004, BIOL PHARM BULL, V27, P1875, DOI 10.1248/bpb.27.1875; Sato Y, 2006, BIOL PHARM BULL, V29, P166, DOI 10.1248/bpb.29.166; Satoh K, 2001, DIGEST DIS SCI, V46, P250, DOI 10.1023/A:1005636412287; Satoh K, 2003, J ETHNOPHARMACOL, V86, P37, DOI 10.1016/S0378-8741(03)00038-2; Shibata C, 1999, SURGERY, V126, P918; Suehiro T, 2005, HEPATO-GASTROENTEROL, V52, P97; Yoshikawa K, 2008, DIGEST DIS SCI, V53, P1824, DOI 10.1007/s10620-008-0281-3	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					571	578		10.1016/j.jamcollsurg.2015.03.004		8	Surgery	Surgery	CN4EZ	WOS:000358384400044		
J	Aoki, T; Murakami, M; Koizumi, T; Fujimori, A; Gareer, H; Enami, Y; Koike, R; Watanabe, M; Otsuka, K				Aoki, Takeshi; Murakami, Masahiko; Koizumi, Tomotake; Fujimori, Akira; Gareer, Haytham; Enami, Yuta; Koike, Reiko; Watanabe, Makoto; Otsuka, Koji			Three-Dimensional Virtual Endoscopy for Laparoscopic and Thoracoscopic Liver Resection	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							ULTRASONOGRAPHY; HEPATECTOMY; SURGERY		[Aoki, Takeshi; Murakami, Masahiko; Koizumi, Tomotake; Fujimori, Akira; Gareer, Haytham; Enami, Yuta; Koike, Reiko; Watanabe, Makoto; Otsuka, Koji] Showa Univ, Sch Med, Dept Gastroenterol & Gen Surg, Tokyo 1428666, Japan	Aoki, T (reprint author), Showa Univ, Sch Med, Dept Gastroenterol & Gen Surg, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	takejp@wb4.so-net.ne.jp					Beller S, 2007, ANN SURG, V246, P288, DOI 10.1097/01.sla.0000264233.48306.99; Marescaux J, 1998, ANN SURG, V228, P627, DOI 10.1097/00000658-199811000-00001; Vapenstad C, 2010, SURG ENDOSC, V24, P2944, DOI 10.1007/s00464-010-1135-6; Kawaguchi Y, 2014, J HEPATO-BIL-PAN SCI, V21, P78, DOI 10.1002/jhbp.33; Harms J, 2001, SURG ENDOSC-ULTRAS, V15, P1459, DOI 10.1007/s004640090071; Mise Y, 2013, J HEPATO-BIL-PAN SCI, V20, P157, DOI 10.1007/s00534-012-0574-y; Cash DM, 2007, J GASTROINTEST SURG, V11, P844, DOI 10.1007/s11605-007-0090-6; Lamata P, 2010, SURG ENDOSC, V24, P2327, DOI 10.1007/s00464-010-0915-3; Lamadé Wolfram, 2002, J Hepatobiliary Pancreat Surg, V9, P592, DOI 10.1007/s005340200079; Murakami M, 2011, WORLD J SURG, V35, P1050, DOI 10.1007/s00268-011-0999-5; Schwaiger J, 2001, INT J COMPUT ASSIST, V6, P785; Yamanaka J, 2009, J HEPATO-BILIARY-PAN, V16, P808, DOI 10.1007/s00534-009-0112-8	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					E21	E26		10.1016/j.jamcollsurg.2015.04.012		6	Surgery	Surgery	CN4EZ	WOS:000358384400003		
J	Miyata, A; Ishizawa, T; Tani, K; Shimizu, A; Kaneko, J; Aoki, T; Sakamoto, Y; Sugawara, Y; Hasegawa, K; Kokudo, N				Miyata, Akinori; Ishizawa, Takeaki; Tani, Keigo; Shimizu, Atsushi; Kaneko, Junichi; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Hasegawa, Kiyoshi; Kokudo, Norihiro			Reappraisal of a Dye-Staining Technique for Anatomic Hepatectomy by the Concomitant Use of Indocyanine Green Fluorescence Imaging	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER CANCERS; HEPATOBILIARY SURGERY; HEPATIC RESECTION; SUBSEGMENTECTOMY; IDENTIFICATION; COMPRESSION; NAVIGATION; SYSTEM		[Miyata, Akinori; Ishizawa, Takeaki; Tani, Keigo; Shimizu, Atsushi; Kaneko, Junichi; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo 1138655, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp			Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	This work was supported by grants from the Takeda Science Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Ministry of Health, Labour, and Welfare of Japan.	Liu Y, 2013, TRANSL RES, V162, P324, DOI 10.1016/j.trsl.2013.05.002; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Mitsuhashi N, 2008, J HEPATO-BILIARY-PAN, V15, P508, DOI 10.1007/s00534-007-1307-5; Shindoh J, 2013, HPB, V15, P31, DOI 10.1111/j.1477-2574.2012.00552.x; Motomura K, 1999, JPN J CLIN ONCOL, V29, P604, DOI 10.1093/jjco/29.12.604; Shindoh J, 2010, ANN SURG, V251, P917, DOI 10.1097/SLA.0b013e3181d773ae; Inoue Yosuke, 2015, Ann Surg, V262, P105, DOI 10.1097/SLA.0000000000000775; Ishizawa T, 2012, ARCH SURG-CHICAGO, V147, P393, DOI 10.1001/archsurg.2012.59; Shindoh J, 2015, ANN SURG, V261, pE145, DOI 10.1097/SLA.0000000000000531; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Ishizawa T, 2014, ANN SURG ONCOL, V21, P440, DOI 10.1245/s10434-013-3360-4; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575; SPEICH R, 1988, ANN INTERN MED, V109, P345; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Ahn KS, 2013, ANN SURG, V258, P1014, DOI 10.1097/SLA.0b013e318281eda3; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Kawaguchi Y, 2013, J HEPATOL, V58, P247, DOI 10.1016/j.jhep.2012.09.028; Ishizawa T, 2010, BRIT J SURG, V97, P1369, DOI 10.1002/bjs.7125; Kawaguchi Y, 2011, J AM COLL SURGEONS, V212, pE33, DOI 10.1016/j.jamcollsurg.2011.03.006; Aoki T, 2008, WORLD J SURG, V32, P1763, DOI 10.1007/s00268-008-9620-y; Ishizawa Takeaki, 2009, J Am Coll Surg, V208, pe1, DOI 10.1016/j.jamcollsurg.2008.09.024; LETHCO EJ, 1966, J PHARMACOL EXP THER, V154, P384; Miyata A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112667; Rodrigues EB, 2007, RETINA-J RET VIT DIS, V27, P958; TAKASAKI K, 1990, INT SURG, V75, P73; Takasaki K, 1998, J Hepatobiliary Pancreat Surg, V5, P286, DOI 10.1007/s005340050047; TAKAYAMA T, 1991, SURGERY, V109, P226; Torzilli G, 2004, SURG ENDOSC, V18, P136, DOI 10.1007/s00464-003-9024-x; Torzilli G, 2010, ANN SURG, V251, P229, DOI 10.1097/SLA.0b013e3181b7fdcd	31	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					E27	E36		10.1016/j.jamcollsurg.2015.05.005		10	Surgery	Surgery	CN4EZ	WOS:000358384400004		
J	Sho, M; Akahori, T; Nagai, M; Satoi, S; Yanagimoto, H; Kinoshita, S; Yamamoto, T; Ikeda, N; Kwon, AH; Nakajima, Y				Sho, Masayuki; Akahori, Takahiro; Nagai, Minako; Satoi, Sohei; Yanagimoto, Hiroaki; Kinoshita, Shoichi; Yamamoto, Tomohisa; Ikeda, Naoya; Kwon, A-Hon; Nakajima, Yoshiyuki			Central Pancreatectomy with Double Pancreaticojejunostomy	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							HAND-SEWN CLOSURE; DISTAL PANCREATECTOMY; CLINICAL-TRIAL; FISTULA; STUMP		[Sho, Masayuki; Akahori, Takahiro; Nagai, Minako; Kinoshita, Shoichi; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Satoi, Sohei; Yanagimoto, Hiroaki; Yamamoto, Tomohisa; Kwon, A-Hon] Kansai Med Univ, Hirakata, Osaka, Japan; [Ikeda, Naoya] Nara Prefecture Western Med Ctr, Ikoma, Nara, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp					Song KB, 2015, SURG ENDOSC, V29, P937, DOI 10.1007/s00464-014-3756-7; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Olah A, 2009, BRIT J SURG, V96, P602, DOI 10.1002/bjs.6620; Kang CM, 2014, J HEPATO-BIL-PAN SCI, V21, P831, DOI 10.1002/jhbp.143; Frozanpor F, 2012, ANN SURG, V255, P1032, DOI 10.1097/SLA.0b013e318251610f; Goudard Y, 2014, JAMA SURG, V149, P356, DOI 10.1001/jamasurg.2013.4146; Wagner M, 2007, J GASTROINTEST SURG, V11, P303, DOI 10.1007/s11605-007-0094-2; Iacono C, 2013, BRIT J SURG, V100, P873, DOI 10.1002/bjs.9136; Goldstein MJ, 2004, J AM COLL SURGEONS, V198, P871, DOI 10.1016/j.jamcollsurg.2004.02.026; Kleeff J, 2007, ANN SURG, V245, P573, DOI 10.1097/01.sla.0000251438.43135.fb; Crippa S, 2007, ANN SURG, V246, P69, DOI 10.1097/01.sla.0000262790.51512.57; Zhou YM, 2014, HEPATOB PANCREAT DIS, V13, P203, DOI 10.1016/S1499-3872(14)60032-1; Hashimoto Y, 2012, J GASTROINTEST SURG, V16, P993, DOI 10.1007/s11605-012-1849-y; Iacono C, 2014, WORLD J GASTROENTERO, V20, P15674, DOI 10.3748/wjg.v20.i42.15674; Meniconi RL, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-23; Renou C, 2000, INT J PANCREATOL, V27, P143, DOI 10.1385/IJGC:27:2:143; Zureikat AH, 2013, ANN SURG, V258, P554, DOI 10.1097/SLA.0b013e3182a4e87c	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					E15	E19		10.1016/j.jamcollsurg.2015.05.004		5	Surgery	Surgery	CN4EZ	WOS:000358384400002		
J	Yukaya, T; Saeki, H; Kasagi, Y; Nakashima, Y; Ando, K; Imamura, Y; Ohgaki, K; Oki, E; Morita, M; Maehara, Y				Yukaya, Takafumi; Saeki, Hiroshi; Kasagi, Yuta; Nakashima, Yuichiro; Ando, Koji; Imamura, Yu; Ohgaki, Kippei; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko			Indocyanine Green Fluorescence Angiography for Quantitative Evaluation of Gastric Tube Perfusion in Patients Undergoing Esophagectomy	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LEAK FOLLOWING ESOPHAGECTOMY; ANASTOMOTIC LEAK; POSTOPERATIVE COMPLICATIONS; SURGERY; RECONSTRUCTION; CANCER; SUPERDRAINAGE; CARCINOMA; RESECTION; VEIN		[Yukaya, Takafumi; Saeki, Hiroshi; Kasagi, Yuta; Nakashima, Yuichiro; Ando, Koji; Imamura, Yu; Ohgaki, Kippei; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Yukaya, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	t-yukaya@surg2.med.kyushu-u.ac.jp					Pacheco PE, 2013, AM J SURG, V205, P349, DOI 10.1016/j.amjsurg.2012.11.005; Lucas DJ, 2014, SURGERY, V155, P593, DOI 10.1016/j.surg.2013.12.001; Walther B, 2003, ANN SURG, V238, P803, DOI 10.1097/01.sla.0000098624.04100.b1; Gawad KA, 1999, AM J GASTROENTEROL, V94, P1490; Nozoe T, 2002, EUR J SURG ONCOL, V28, P396, DOI 10.1053/ejso.2002.1257; Bhat MA, 2006, ANN THORAC SURG, V82, P1857, DOI 10.1016/j.athoracsur.2006.05.101; van der Schaaf M, 2012, BRIT J SURG, V99, P95, DOI 10.1002/bjs.7750; Kassis ES, 2013, ANN THORAC SURG, V96, P1919, DOI 10.1016/j.athoracsur.2013.07.119; Jafari MD, 2013, SURG ENDOSC, V27, P3003, DOI 10.1007/s00464-013-2832-8; van Lanschot JJB, 1999, BRIT J SURG, V86, P102; Tabatabai A, 2009, ANN THORAC MED, V4, P197, DOI 10.4103/1817-1737.56012; Kawaguchi Y, 2011, J AM COLL SURGEONS, V212, pE33, DOI 10.1016/j.jamcollsurg.2011.03.006; Fernandez Felix G, 2004, Semin Thorac Cardiovasc Surg, V16, P152, DOI 10.1053/j.semtcvs.2004.03.008; Fukuda K, 2015, WORLD NEUROSURG, V83, P203, DOI 10.1016/j.wneu.2014.07.012; Kono K, 2007, WORLD J SURG, V31, P780, DOI 10.1007/s00268-006-0285-0; Reavis KM, 2009, J GASTROINTEST SURG, V13, P1558, DOI 10.1007/s11605-009-0906-7; Reuthebuch O, 2004, CHEST, V125, P418, DOI 10.1378/chest.125.2.418; Saeki H, 2010, SURG TODAY, V40, P626, DOI 10.1007/s00595-009-4135-1; Saeki H, 2013, DIS ESOPHAGUS, V26, P50, DOI 10.1111/j.1442-2050.2012.01327.x; Schaheen L, 2014, AM J SURG, V208, P536, DOI 10.1016/j.amjsurg.2014.05.011; Schuchert MJ, 2010, SURGERY, V148, P831, DOI 10.1016/j.surg.2010.07.034; SUGIMACHI K, 1982, J SURG RES, V33, P463, DOI 10.1016/0022-4804(82)90063-4; Uchiyama H, 2010, SURG TODAY, V40, P578, DOI 10.1007/s00595-009-4081-y; Urschel JD, 2001, DIS ESOPHAGUS, V14, P212, DOI 10.1046/j.1442-2050.2001.00187.x; Zehetner J, 2014, ANN SURG, p1e5	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	AUG	2015	221	2					E37	E42		10.1016/j.jamcollsurg.2015.04.022		6	Surgery	Surgery	CN4EZ	WOS:000358384400005		
J	Yamada, M; Nishiguchi, S; Fukutani, N; Aoyama, T; Arai, H				Yamada, Minoru; Nishiguchi, Shu; Fukutani, Naoto; Aoyama, Tomoki; Arai, Hidenori			Mail-Based Intervention for Sarcopenia Prevention Increased Anabolic Hormone and Skeletal Muscle Mass in Community-Dwelling Japanese Older Adults: The INE (Intervention by Nutrition and Exercise) Study	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Sarcopenia; frailty; walking; nutrition; older adults	RANDOMIZED CONTROLLED-TRIAL; LOWER-LIMB MUSCLE; GROWTH-FACTOR-I; BODY-COMPOSITION; PHYSICAL-ACTIVITY; PROTEIN-INTAKE; ELDERLY-PEOPLE; WHEY-PROTEIN; DOUBLE-BLIND; LEAN MASS	Objective: The aim of the Intervention by Nutrition and Exercise (INE) study was to investigate the effects of a mail-based intervention for sarcopenia prevention on muscle mass and anabolic hormones in community-dwelling older adults. Design: A cluster-randomized controlled trial. Setting and Participants: This trial recruited community-dwelling adults aged 65 years and older in Japan. The 227 participants were cluster randomized into a walking and nutrition (W/N) group (n = 79), a walking (W) group (n = 71), and a control (C) group (n = 77). We analyzed the physical and biochemical measurements in this substudy. Intervention: Six months of mail-based intervention (a pedometer-based walking program and nutritional supplementation). Measurements: The skeletal muscle mass index (SMI) using the bioelectrical impedance data acquisition system, biochemical measurements, such as those of insulin like growth factor (IGF-1), dehydroepiandrosterone sulfate (DHEA-S), and 25-hydroxy vitamin D (25[OH]D), as well as frailty, were assessed by the Cardiovascular Health Study criteria. Results: Participants in the W/N and W groups had significantly greater improvements in SMI, IGF-1, and 25(OH)D (P < .05) than those in the C group. Participants in the W/N group had significantly greater improvements in DHEA-S (P < .05) than in the other groups. These effects were more pronounced in frail, older adults. Conclusion: These results suggest that the mail-based walking intervention of the remote monitoring type for sarcopenia prevention can increase anabolic hormone levels and SMI in community-dwelling older adults, particularly in those who are frail. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Yamada, Minoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Lifespan Dev Sci, Tokyo 1120012, Japan; [Nishiguchi, Shu; Fukutani, Naoto; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan	Yamada, M (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Bunkyo Ku, 3-29-1 Otsuka, Tokyo 1120012, Japan.	m-yamada@human.tsukuba.ac.jp			Ministry of Health, Labor, and Welfare, Japan [H24-Tyojyu-001]	This study was funded by Grants-in-Aid for Comprehensive Research on Aging and Health, from the Ministry of Health, Labor, and Welfare, Japan (H24-Tyojyu-001).	Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Kubo K, 2008, SCAND J MED SCI SPOR, V18, P31, DOI 10.1111/j.600-0838.2007.00654.x; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Paddon-Jones D, 2006, EXP GERONTOL, V41, P215, DOI 10.1016/j.exger.2005.10.006; Houston DK, 2008, AM J CLIN NUTR, V87, P150; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Hays NP, 2009, J AM DIET ASSOC, V109, P1082, DOI 10.1016/j.jada.2009.03.003; Kemmler W, 2010, AM J PREV MED, V38, P279, DOI 10.1016/j.amepre.2009.10.042; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Sattler FR, 2009, J CLIN ENDOCR METAB, V94, P1991, DOI 10.1210/jc.2008-2338; Moreira-Pfrimer LDF, 2009, ANN NUTR METAB, V54, P291, DOI 10.1159/000235874; Franz JR, 2013, GAIT POSTURE, V37, P378, DOI 10.1016/j.gaitpost.2012.08.004; Wolfe RR, 2008, CLIN NUTR, V27, P675, DOI 10.1016/j.clnu.2008.06.008; Cesari M, 2015, J GERONTOL A-BIOL, V70, P216, DOI 10.1093/gerona/glu099; Vukovich MD, 2001, J NUTR, V131, P2049; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Akishita M, 2005, J AM GERIATR SOC, V53, P1076, DOI 10.1111/j.1532-5415.2005.53338_4.x; Ardawi MSM, 2012, J CLIN ENDOCR METAB, V97, P3691, DOI 10.1210/jc.2011-3361; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Chale A, 2013, J GERONTOL A-BIOL, V68, P682, DOI 10.1093/gerona/gls221; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Wang CY, 2012, GERIATR GERONTOL INT, V12, P388, DOI 10.1111/j.1447-0594.2012.00851.x; Rockwood K, 1999, LANCET, V353, P205, DOI 10.1016/S0140-6736(98)04402-X; Morley JE, 2012, FAM PRACT, V29, pi44, DOI 10.1093/fampra/cmr063; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Houston DK, 2007, J GERONTOL A-BIOL, V62, P440; Vellas BJ, 1997, NUTRITION, V13, P515, DOI 10.1016/S0899-9007(97)00029-4; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Daly RM, 2014, AM J CLIN NUTR, V99, P899, DOI 10.3945/ajcn.113.064154; de Gonzalo-Calvo D, 2012, AGE, V34, P761, DOI 10.1007/s11357-011-9266-9; Farmer Bonnie Cashin, 2006, Home Healthc Nurse, V24, P449, DOI 10.1097/00004045-200607000-00009; Fulgoni VL, 2008, AM J CLIN NUTR, V87, p1554S; Hirani V, 2005, AGE AGEING, V34, P485, DOI 10.1093/ageing/afi153; Jung HW, 2014, J AM GERIATR SOC, V62, P2110, DOI 10.1111/jgs.13107; Kasayama S, 2007, CLIN ENDOCRINOL, V66, P797, DOI 10.1111/j.1365-2265.2007.02815.x; Lesourd B., 1996, European Journal of Clinical Nutrition, V50, pS16; Morley JE, 2011, J AM MED DIR ASSOC, V11, P391; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231; Sato K, 2014, FASEB J, V28, P1891, DOI 10.1096/fj.13-245480; Snyder A, 2011, J AM MED DIR ASSOC, V12, P590, DOI 10.1016/j.jamda.2010.06.007	43	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	AUG 1	2015	16	8					654	660		10.1016/j.jamda.2015.02.017		7	Geriatrics & Gerontology	Geriatrics & Gerontology	CN4TP	WOS:000358423400006		
J	Shimada, H; Makizako, H; Doi, T; Tsutsumimoto, K; Suzuki, T				Shimada, Hiroyuki; Makizako, Hyuma; Doi, Takehiko; Tsutsumimoto, Kota; Suzuki, Takao			Incidence of Disability in Frail Older Persons With or Without Slow Walking Speed	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Frailty; physical performance; gait; activities of daily living; aged	PHYSICAL PERFORMANCE-MEASURES; GERIATRIC DEPRESSION SCALE; LOWER-EXTREMITY FUNCTION; TERM-CARE INSURANCE; BODY-COMPOSITION; GAIT SPEED; ELDERLY-PEOPLE; SUBSEQUENT DISABILITY; COGNITIVE IMPAIRMENT; FUNCTIONAL DECLINE	Objective: To identify the differences of incidence of disability between frail older persons with and without slow walking speed. Design: Prospective cohort study. Setting: Japanese community. Participants: A total of 14,081 older adults aged >= 65 years living in the community, participated in a baseline assessment and were followed for incidence of disability for 29.5 months. Measurements: Care-needs certification in the national long-term care insurance system of Japan, physical frailty (slow walking speed, muscle weakness, exhaustion, low activity, weight loss), adjusted for several potential confounders such as demographic characteristics; Kaplan-Meier survival curves for incident disability by physical frailty with and without slow walking speed. Results: During the follow-up period, 198 participants (4.9%) were certified as requiring long-term care insurance in accordance with incident disability. Participants who had prefrailty without slow walking speed (hazard ratio 1.86, 95% confidence interval 1.19-2.92), prefrailty with slow walking speed (3.62, 2.19-5.96), frailty without slow walking speed (4.33, 2.00-9.39), and frailty with slow walking speed (4.68, 2.72-8.05) at the baseline assessment had an increased risk of incident disability compared with nonfrail participants. In stratified analyses, frail older men and frail participants with low cognitive performance had the highest risk of incidence of disability. Conclusion: The presence of frailty or even prefrailty when older adults showed slow walking speed increased the risk of future disability in community-dwelling older adults. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Shimada, Hiroyuki; Makizako, Hyuma; Doi, Takehiko; Tsutsumimoto, Kota] Natl Ctr Geriatr & Gerontol, Dept Prevent Gerontol, Ctr Gerontol & Social Sci, Obu, Aichi 4748511, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Obu, Aichi 4748511, Japan	Shimada, H (reprint author), Natl Ctr Geriatr & Gerontol, Dept Prevent Gerontol, Ctr Gerontol & Social Sci, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan.	shimada@ncgg.go.jp			Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health) [H24-Choju-Ippan-004]; Scientific Research (B) [23300205]; National Center for Geriatrics and Gerontology, Japan [22-16]	This work received financial support from Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health, grant number H24-Choju-Ippan-004), a Grant-in-Aid for Scientific Research (B) (grant number 23300205), and Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology (grant number 22-16), Japan. No support was received from industry. The funding source played no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Afilalo J., 2011, CURR CARDIOVASC RISK, V5, P467, DOI DOI 10.1007/S12170-011-0186-0; Al Snih S, 2009, J REHABIL MED, V41, P892, DOI 10.2340/16501977-0424; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Avila-Funes JA, 2008, J GERONTOL A-BIOL, V63, P1089; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424; Syddall H, 2010, AGE AGEING, V39, P197, DOI 10.1093/ageing/afp204; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744; Boyd CM, 2005, AM J MED, V118, P1225, DOI 10.1016/j.amjmed.2005.01.062; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221; Friedman B, 2005, J AM GERIATR SOC, V53, P1570, DOI 10.1111/j.1532-5415.2005.53461.x; van Kan GA, 2012, J GERONTOL A-BIOL, V67, P425, DOI 10.1093/gerona/glr177; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Cesari M, 2006, AM J CLIN NUTR, V83, P1142; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Onder G, 2005, J GERONTOL A-BIOL, V60, P74; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Fukutomi E, 2015, GERIATR GERONTOL INT, V15, P864, DOI 10.1111/ggi.12360; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Ensrud KE, 2009, J AM GERIATR SOC, V57, P492, DOI 10.1111/j.1532-5415.2009.02137.x; Shimada H, 2009, GERONTOLOGY, V55, P532, DOI 10.1159/000236364; Garcia-Garcia FJ, 2011, J NUTR HEALTH AGING, V15, P852, DOI 10.1007/s12603-011-0075-8; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Barba C, 2004, LANCET, V363, P157; Castell MV, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-86; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; Dodge HH, 2005, GERONTOLOGIST, V45, P222; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 1995, NIH PUB; HOSSACK KF, 1982, J APPL PHYSIOL, V53, P799; Kempen GIJM, 1998, INT J GERIATR PSYCH, V13, P480, DOI 10.1002/(SICI)1099-1166(199807)13:7<480::AID-GPS805>3.0.CO;2-S; Markides KS, 2001, J GERONTOL A-BIOL, V56, pM243; Shimada H, 2013, BMJ OPEN, V3; Simonsick EM, 2008, J GERONTOL A-BIOL, V63, P841; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483; TOTH MJ, 1994, J APPL PHYSIOL, V77, P647; Weiss EP, 2006, J APPL PHYSIOL, V101, P938, DOI 10.1152/japplphysiol.01398.2005	48	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	AUG 1	2015	16	8					690	696		10.1016/j.jamda.2015.03.019		7	Geriatrics & Gerontology	Geriatrics & Gerontology	CN4TP	WOS:000358423400011		
J	Jin, LH; Takei, A; Hutchinson, JW				Jin, Lihua; Takei, Atsushi; Hutchinson, John W.			Mechanics of wrinkle/ridge transitions in thin film/substrate systems	JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS			English	Article						Wrinkling; Thin films; Elastic substrates; Ridge instabilities; Soft materials	ELASTIC MEMBRANES; PRE-STRETCH; SUBSTRATE; FILMS; PATTERNS; BIFURCATIONS; STRESS	The mechanics of the formation and propagation of ridges on compressed stiff film/compliant substrate systems is studied theoretically and experimentally. Ridges form on bilayer systems where the elastomeric substrate is subject to a significant pre-stretch prior to attachment of the film. When the bilayer is then subject to increasing overall compressive strain, sinusoidal wrinkles first form and subsequently become unstable giving way to localized ridges with relatively large amplitudes. Two-dimensional plane strain simulations for neo-Hookean film/substrate systems reveal the transition from wrinkles to ridges under increasing compression and the reverse transition from ridges to wrinkles when the overall compression is subsequently reduced. For a significant range of pre-stretch, the two transition strains differ, and a significant hysteresis response is observed in a complete cycle of loading and unloading. The Maxwell equal-energy condition has been identified associated with co-existence of wrinkles and ridges and with the three-dimensional steady-state propagation condition for the ridges. Experiments conducted with a specially designed film/substrate loading system have been performed that confirm the essential features of ridge formation and the hysteretic behavior in loading/unloading cycles that span the two transitions. (C) 2015 Elsevier Ltd. All rights reserved.	[Jin, Lihua; Hutchinson, John W.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jin, Lihua] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Takei, Atsushi] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Hutchinson, JW (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jhutchin@fas.harvard.edu					Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Holmes DP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.038303; Lee SG, 2010, ADV MATER, V22, P5013, DOI 10.1002/adma.201002320; Brau F, 2011, NAT PHYS, V7, P56, DOI [10.1038/nphys1806, 10.1038/NPHYS1806]; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Bowden N, 1998, NATURE, V393, P146; Chen YC, 2014, ADV MATER, V26, P5626, DOI 10.1002/adma.201401444; Kim P, 2013, ADV OPT MATER, V1, P381, DOI 10.1002/adom.201300034; Cao CY, 2014, ADV MATER, V26, P1763, DOI 10.1002/adma.201304589; Lin PC, 2008, SOFT MATTER, V4, P1830, DOI 10.1039/b802848f; Audoly B, 2008, J MECH PHYS SOLIDS, V56, P2401, DOI 10.1016/j.jmps.2008.03.003; Zang JF, 2012, J MECH PHYS SOLIDS, V60, P1265, DOI 10.1016/j.jmps.2012.03.009; Lin PC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743939; Cai S, 2011, J MECH PHYS SOLIDS, V59, P1094, DOI 10.1016/j.jmps.2011.02.001; Schweikart A, 2009, MICROCHIM ACTA, V165, P249, DOI 10.1007/s00604-009-0153-3; Zhang ZY, 2009, ACTA MATER, V57, P4332, DOI 10.1016/j.actamat.2009.05.034; Takei A, 2014, ADV MATER, V26, P4061, DOI 10.1002/adma.201306162; Kim P, 2011, NAT MATER, V10, P952, DOI [10.1038/nmat3144, 10.1038/NMAT3144]; Chan EP, 2008, ADV MATER, V20, P711, DOI 10.1002/adma.200701530; Auguste A, 2014, SOFT MATTER, V10, P6520, DOI 10.1039/c4sm01038h; Pocivavsek L, 2008, SCIENCE, V320, P912, DOI 10.1126/science.1154069; Sun JY, 2012, P ROY SOC A-MATH PHY, V468, P932, DOI 10.1098/rspa.2011.0567; Wang QM, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4025828; Lin PC, 2009, SOFT MATTER, V5, P1011, DOI 10.1039/b814145b; Lu CH, 2007, SOFT MATTER, V3, P1530, DOI 10.1039/b712706e; Brau F, 2013, SOFT MATTER, V9, P8177, DOI 10.1039/c3sm50655j; Chung JY, 2007, SOFT MATTER, V3, P1163, DOI 10.1039/b705112c; Cao YP, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005960; Breid D, 2011, SOFT MATTER, V7, P4490, DOI 10.1039/c1sm05152k; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; Balluffi RW, 2005, KINETICS OF MATERIALS, P1; Budiansky B, 1974, ADV APPL MECH, V14, P1, DOI 10.1016/S0065-2156(08)70030-9; NOWINSKI JL, 1969, J FRANKLIN I, V288, P367, DOI 10.1016/0016-0032(69)90017-9; Porter D.A., 1981, PHASE TRANSFORMATION; van der Heijden A. M. A., 2009, ELASTIC STABILITY SO; Yin J, 2012, ADV MATER, V24, P5441, DOI 10.1002/adma.201201937	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-5096	1873-4782		J MECH PHYS SOLIDS	J. Mech. Phys. Solids	AUG	2015	81						22	40		10.1016/j.jmps.2015.04.016		19	Materials Science, Multidisciplinary; Mechanics; Physics, Condensed Matter	Materials Science; Mechanics; Physics	CN5LH	WOS:000358470300002		
J	Kondo, T; Ura, S; Magnusson, R				Kondo, Tomohiro; Ura, Shogo; Magnusson, Robert			Design of guided-mode resonance mirrors for short laser cavities	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							GRATING MIRROR; FILTER; SILICON; REFLECTIVITY; BANDWIDTH	A guided-mode resonance mirror (GMRM) consists of a waveguide grating integrated on an optical buffer layer on a high-reflection substrate. An incident free-space wave at the resonance wavelength is once coupled by the grating to a guided mode and coupled again by the same grating back to free space. The reflection characteristics of a GMRM are numerically calculated and theoretically analyzed. It is predicted that notch filtering or flat reflection spectra are obtained depending on the optical buffer layer thickness. Design of short cavities using a GMRM is discussed for potential application in surface-mount packaging of diode lasers onto a photonic circuit board. (C) 2015 Optical Society of America	[Kondo, Tomohiro; Ura, Shogo] Kyoto Inst Technol, Dept Elect, Sakyo Ku, Kyoto 6068585, Japan; [Magnusson, Robert] Univ Texas Arlington, Dept Elect Engn, Arlington, TX 76019 USA	Ura, S (reprint author), Kyoto Inst Technol, Dept Elect, Sakyo Ku, Kyoto 6068585, Japan.	ura@kit.ac.jp					Magnusson R, 2010, OPT LETT, V35, P2472, DOI 10.1364/OL.35.002472; Yoon YT, 2008, OPT EXPRESS, V16, P2374, DOI 10.1364/OE.16.002374; Mehta AA, 2007, IEEE PHOTONIC TECH L, V19, P2030, DOI 10.1109/LPT.2007.908776; MASHEV L, 1985, OPT COMMUN, V55, P377, DOI 10.1016/0030-4018(85)90134-8; Block S, 2005, IEEE J QUANTUM ELECT, V41, P1049, DOI 10.1109/JQE.2005.851248; Avrutsky I, 2001, OPT LETT, V26, P989, DOI 10.1364/OL.26.000989; WANG SS, 1993, APPL OPTICS, V32, P2606, DOI 10.1364/AO.32.002606; Kanamori Y, 2006, IEEE PHOTONIC TECH L, V18, P2126, DOI 10.1109/LPT.2006.883208; Kintaka K, 2012, OPT LETT, V37, P3264, DOI 10.1364/OL.37.003264; Kintaka K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.102203; Mazulquim DB, 2014, OPT EXPRESS, V22, P30843, DOI 10.1364/OE.22.030843; Lee KJ, 2008, IEEE PHOTONIC TECH L, V20, P1857, DOI 10.1109/LPT.2008.2004777; Rosenblatt D, 1997, IEEE J QUANTUM ELECT, V33, P2038, DOI 10.1109/3.641320; Buet X, 2012, OPT EXPRESS, V20, P9322, DOI 10.1364/OE.20.009322; Rassem N, 2015, J OPT SOC AM A, V32, P420, DOI 10.1364/JOSAA.32.000420; Cho EH, 2009, OPT EXPRESS, V17, P8621, DOI 10.1364/OE.17.008621; Vartiainen I, 2009, OPT LETT, V34, P1648, DOI 10.1364/OL.34.001648; Biener G, 2003, OPT LETT, V28, P1400, DOI 10.1364/OL.28.001400; Kintaka K, 2012, OPT EXPRESS, V20, P1444, DOI 10.1364/OE.20.001444; Tibuleac S, 1997, J OPT SOC AM A, V14, P1617, DOI 10.1364/JOSAA.14.001617; Buet X, 2012, ELECTRON LETT, V48, DOI 10.1049/el.2012.3058; Byrd MJ, 2014, IEEE PHOTONIC TECH L, V26, P2311, DOI 10.1109/LPT.2014.2351351; Golubenko G. A., 1985, Soviet Journal of Quantum Electronics, V15, DOI 10.1070/QE1985v015n07ABEH007275; Hatanaka K, 2012, ELECTRON LETT, V48, P717, DOI 10.1049/el.2012.1521; Inoue J, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.022201; Inoue J, 2014, OPT LETT, V39, P1893, DOI 10.1364/OL.39.001893; Inoue J, 2013, IEICE ELECTRON EXPR, V10, DOI 10.1587/elex.10.20130444; Magnusson R., 2000, U.S. patent, Patent No. [6,154,480, 6154480]; Magnusson R, 2003, P SOC PHOTO-OPT INS, V5225, P20, DOI 10.1117/12.504425; Norton SM, 1997, J OPT SOC AM A, V14, P629, DOI 10.1364/JOSAA.14.000629; Ura S, 2013, 2013 IEEE 63RD ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE (ECTC), P1874, DOI 10.1109/ECTC.2013.6575833	31	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	AUG 1	2015	32	8					1454	1458		10.1364/JOSAA.32.001454		5	Optics	Optics	CN9TQ	WOS:000358792400006		
J	Yashiki, S				Yashiki, Satoshi			Analytical solution for Gamo entropy under spatially partial coherent illumination	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							INTENSITY MATRIX; PUPIL	We present a methodology for obtaining the analytical solution of the Gamo entropy, defined by the intensity matrix proposed by Gamo [J. Opt. Soc. Am. 47, 976 (1957)]. The matrix, which consists of numerous image amplitudes at all the sampling points of the entire imaging plane, is generally infinite-dimensional. The essence of our theory is that the computational difficulties arising because of the infinite-dimensionality are avoided by introducing the inner products of two image amplitudes. The integral in continuous space plays the role of a buffer against the infinite-dimensionality. The validity of the approach is confirmed by comparing our analytical solution and Yamazoe's numerical simulations [J. Opt. Soc. Am. A 28, 448 (2011)]. (C) 2015 Optical Society of America	Nikon Inc, Core Technol Div, Opt Res Lab, Saitama 3300845, Japan	Yashiki, S (reprint author), Nikon Inc, Core Technol Div, Opt Res Lab, Saitama 3300845, Japan.	Satoshi.Yashiki@nikon.com					Yamazoe K, 2008, J OPT SOC AM A, V25, P3111, DOI 10.1364/JOSAA.25.003111; HOPKINS HH, 1957, J OPT SOC AM, V47, P508, DOI 10.1364/JOSA.47.000508; Aoyama H, 2014, PROC SPIE, V9052, DOI 10.1117/12.2046547; Gamo H., 1968, JPN J APPL PHYS, V25, P431; Gamo H., 1957, JPN J APPL PHYS, V26, P102; Gamo H., 1957, JPN J APPL PHYS, V26, P577; Gamo H., 1964, PROGR OPTICS, VIII; GAMO H, 1957, J OPT SOC AM, V47, P976, DOI 10.1364/JOSA.47.000976; GAMO H, 1958, J OPT SOC AM, V48, P136, DOI 10.1364/JOSA.48.000136; Gamo H., 1957, JPN J APPL PHYS, V26, P414; Goodman J. W., 2005, INTRO FOURIER OPTICS; Griffiths D. J., 2004, INTRO QUANTUM MECH; Hirayanagi N, 2013, PROC SPIE, V8683, DOI 10.1117/12.2011077; HOPKINS HH, 1953, PROC R SOC LON SER-A, V217, P408, DOI 10.1098/rspa.1953.0071; HOPKINS HH, 1950, P PHYS SOC LOND B, V63, P737, DOI 10.1088/0370-1301/63/10/301; kit Wong AK, 2005, OPTICAL IMAGING PROJ; Matsui R, 2013, PROC SPIE, V8683, DOI 10.1117/12.2008267; Matsuyama T, 2012, PROC SPIE, V8326, DOI 10.1117/12.916594; Matsuyama T, 2011, PROC SPIE, V7973, DOI 10.1117/12.879395; O'Neill E. L., 2003, INTRO STAT OPTICS, P8; Perina J., 1985, COHERENCE OF LIGHT, V2nd; Sakurai J. J., 2010, MODERN QUANTUM MECH; Wolf E., 2007, INTRO THEORY COHEREN; Yamazoe K, 2011, J OPT SOC AM A, V28, P448, DOI 10.1364/JOSAA.28.000448; Yamazoe K, 2012, J OPT SOC AM A, V29, P1529, DOI 10.1364/JOSAA.29.001529; Yashiki S, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064701; Yashiki S, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.093707; Yashiki S, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.084717	28	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	AUG 1	2015	32	8					1502	1512		10.1364/JOSAA.32.001502		11	Optics	Optics	CN9TQ	WOS:000358792400012		
J	Yamaguchi, J; Tanaka, T; Eto, N; Nangaku, M				Yamaguchi, Junna; Tanaka, Tetsuhiro; Eto, Nobuaki; Nangaku, Masaomi			Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein delta	KIDNEY INTERNATIONAL			English	Article						cell signaling; hypoxia; inflammation; proximal tubule	INDUCIBLE FACTOR 1-ALPHA; REMNANT KIDNEY MODEL; 3 C/EBP ISOFORMS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; TUBULOINTERSTITIAL INJURY; PATHWAY; HIF-1-ALPHA; INDUCTION; CANCER	Tubulointerstitial hypoxia plays a critical role in the pathogenesis of kidney injury, and hypoxia-inducible factor (HIF)-1 is a master regulator of cellular adaptation to hypoxia. Aside from oxygen molecules, factors that modify HIF-1 expression and functional operation remain obscure. Therefore, we sought to identify novel HIF-1-regulating genes in kidney. A short-hairpin RNA library consisting of 150 hypoxia-inducible genes was derived from a microarray analysis of the rat renal artery stenosis model screened for the effect on HIF-1 response. We report that CCAAT/enhancer-binding protein delta (CEBPD), a transcription factor and inflammatory response gene, is a novel HIF-1 regulator in kidney. CEBPD was induced in the nuclei of tubular epithelial cells in both acute and chronic hypoxic kidneys. In turn, CEBPD induction augmented HIF-1 alpha expression and its transcriptional activity. Mechanistically, CEBPD directly bound to the HIF-1 alpha promoter and enhanced its transcription. Notably, CEBPD was rapidly induced by inflammatory cytokines, such as IL-1 beta in a nuclear factor-kappa B-dependent manner, which not only increased HIF-1 alpha expression during hypoxia, but was also indispensable for the non-hypoxic induction of HIF-1 alpha. Thus our study provides novel insight into HIF-1 regulation in tubular epithelial cells and offers a potential hypoxia and inflammation link relevant in both acute and chronic kidney diseases.	[Yamaguchi, Junna; Tanaka, Tetsuhiro; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo 1138655, Japan; [Eto, Nobuaki] Kyowa Hakko Kirin, Tokyo, Japan	Nangaku, M (reprint author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mnangaku-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390213, 22790781]; Naito Kinen Foundation; Kyowa Hakko Kirin, Tokyo, Japan	This work was supported by Grant-in-Aids for Scientific Research 24390213 (to MN) and 22790781 (to TT) from the Japan Society for the Promotion of Science, the Naito Kinen Foundation (to JY) and Kyowa Hakko Kirin, Tokyo, Japan. We thank Dr Makiko Koike (Kyowa Hakko Kirin) for the helpful discussions.	ALAM T, 1992, J BIOL CHEM, V267, P5021; Kobayashi H, 2012, J IMMUNOL, V188, P5106, DOI 10.4049/jimmunol.1103377; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Min Y, 2011, ONCOGENE, V30, P4901, DOI 10.1038/onc.2011.187; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Zhong H, 2000, CANCER RES, V60, P1541; [Anonymous], 2011, J MED, DOI DOI 10.1056/NEJMRA0910283; Ramji DP, 2002, BIOCHEM J, V365, P561; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCl200421086; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Bohle A, 1996, KIDNEY BLOOD PRESS R, V19, P191, DOI 10.1159/000174072; DIEHL JA, 1994, MOL CELL BIOL, V14, P6635; Eto N, 2009, AM J PATHOL, V174, P1553, DOI 10.2353/ajpath.2009.080190; Fine L G, 2000, Kidney Int Suppl, V75, pS22; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kojima I, 2009, KIDNEY INT, V75, P268, DOI 10.1038/ki.2008.488; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEE YH, 1994, MOL CELL BIOL, V14, P1383; Mink S, 1997, MOL CELL BIOL, V17, P6609; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854; Osada S, 1996, J BIOL CHEM, V271, P3891; RAY A, 1995, J BIOL CHEM, V270, P7365; Semenza GL, 2011, NEW ENGL J MED, V365, P537, DOI 10.1056/NEJMra1011165; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; Tanaka T, 2005, AM J PHYSIOL-RENAL, V289, pF1123, DOI 10.1152/ajprenal.00081.2005; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Tanaka T, 2012, J BIOL CHEM, V287, P34866, DOI 10.1074/jbc.M112.374587; Tanaka T, 2013, FASEB J, V27, P4059, DOI 10.1096/fj.13-231837; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Yamanaka S, 2014, PLOS ONE, V9, P1	56	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	AUG	2015	88	2					262	275		10.1038/ki.2015.21		14	Urology & Nephrology	Urology & Nephrology	CN9QD	WOS:000358783000010		
J	Lefebvre, J; Clarkson, M; Massa, F; Bradford, ST; Charlet, A; Buske, F; Lacas-Gervais, S; Schulz, H; Gimpel, C; Hata, Y; Schaefer, F; Schedl, A				Lefebvre, Jonathan; Clarkson, Michael; Massa, Filippo; Bradford, Stephen T.; Charlet, Aurelie; Buske, Fabian; Lacas-Gervais, Sandra; Schulz, Herbert; Gimpel, Charlotte; Hata, Yutaka; Schaefer, Franz; Schedl, Andreas			Alternatively spliced isoforms of WT1 control podocyte-specific gene expression	KIDNEY INTERNATIONAL			English	Article						glomerular disease; kidney development; nephrin; podocyte differentiation; slit diaphragm; WT1	GLOMERULAR-FILTRATION BARRIER; SYNAPTIC-SCAFFOLDING-MOLECULE; D-ASPARTATE RECEPTORS; DENYS-DRASH SYNDROME; WILMS-TUMOR GENE; NEPHROTIC-SYNDROME; UROGENITAL DEVELOPMENT; SEX DETERMINATION; FRASIER-SYNDROME; IN-VIVO	The Wilms' tumor suppressor WT1 is a key regulator of podocyte function that is mutated in Denys-Drash and Frasier syndromes. Here we have used an integrative approach employing ChIP, exon array, and genetic analyses in mice to address general and isoform-specific functions of WT1 in podocyte differentiation. Analysis of ChIP-Seq data showed that almost half of the podocyte-specific genes are direct targets of WT1. Bioinformatic analysis further identified coactivator FOXC1-binding sites in proximity to WT1-bound regions, thus supporting coordinated action of these transcription factors in regulating podocyte-specific genes. Transcriptional profiling of mice lacking the WT1 alternative splice isoform (+KTS) had a more restrictive set of genes whose expression depends on these alternatively spliced isoforms. One of these genes encodes the membraneassociated guanylate kinase MAGI2, a protein that localizes to the base of the slit diaphragm. Using functional analysis in mice, we further show that MAGI2 alpha is essential for proper localization of nephrin and the assembly of the slit diaphragm complex. Finally, a dramatic reduction of MAGI2 was found in an LPS mouse model of glomerular injury and in genetic cases of human disease. Thus, our study highlights the central role of WT1 in podocyte differentiation, identifies that WT1 has a central role in podocyte differentiation, and identifies MAGI2a as the crucial isoform in slit diaphragm assembly, suggesting a causative role of this gene in the etiology of glomerular disorders.	[Lefebvre, Jonathan; Clarkson, Michael; Massa, Filippo; Bradford, Stephen T.; Charlet, Aurelie; Schedl, Andreas] Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06189 Nice, France; [Lefebvre, Jonathan; Clarkson, Michael; Massa, Filippo; Bradford, Stephen T.; Charlet, Aurelie; Schedl, Andreas] Fac Med Nice, INSERM, UMR1091, F-06034 Nice, France; [Lefebvre, Jonathan; Clarkson, Michael; Massa, Filippo; Bradford, Stephen T.; Charlet, Aurelie; Schedl, Andreas] CNRS, UMR7277, F-06034 Nice, France; [Bradford, Stephen T.; Buske, Fabian] CSIRO, Food & Nutr Flagship, N Ryde, NSW 2113, Australia; [Bradford, Stephen T.; Buske, Fabian] St Vincents Hosp, Garvan Inst Med Res, Canc Program, Epigenet Grp, Darlinghurst, NSW 2010, Australia; [Lacas-Gervais, Sandra] Univ Nice, CCMA, Nice, France; [Schulz, Herbert] MDC Mol Med, Berlin, Germany; [Gimpel, Charlotte] Univ Childrens Hosp, Freiburg, Germany; [Hata, Yutaka] Tokyo Med & Dent Univ, Tokyo, Japan; [Schaefer, Franz] Univ Childrens Hosp, Heidelberg, Germany	Schedl, A (reprint author), Ctr Biochim, Inserm UMR1091, Parc Valrose, F-06108 Nice, France.	Schedl@unice.fr			FRM (Fondation pour la Recherche Medicale) [DEQ20090515425]; ANR [ANR-08-GENOPAT-017, ANR-11-LABX-0028-01]; Fondation du Rein; E-Rare (German Ministry of Education and Research); EU [2012-305608]; Association Francaise contre les myopathies (AFM); ARC [SL22020605297]	We thank members of the animal facility at the iBV for technical assistance and Norbert Hubner and Sabine Schmidt (MDC Berlin) for help with Exon-Array analysis. We are grateful to Christoph Englert (Jena) for the kind gift of the WT1-C8 antibody. This work was supported by grants from the FRM (Fondation pour la Recherche Medicale, DEQ20090515425), ANR (ANR-08-GENOPAT-017 and ANR-11-LABX-0028-01), Fondation du Rein and ARC (SL22020605297), E-Rare (German Ministry of Education and Research), and the EU 7th framework Programme (EURenOmics, grant 2012-305608); STB was financed by the Association Francaise contre les myopathies (AFM).	Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Wagner N, 2004, J AM SOC NEPHROL, V15, P3044, DOI 10.1097/01.ASN.0000146687.99058.25; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Brunskill EW, 2011, J AM SOC NEPHROL, V22, P2213, DOI 10.1681/ASN.2011040401; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Boute N, 2000, NAT GENET, V24, P349; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guo G, 2004, J AM SOC NEPHROL, V15, P2851, DOI 10.1097/01.ASN.0000143474.91362.C4; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Ristola M, 2012, NEPHROL DIAL TRANSPL, V27, P1737, DOI 10.1093/ndt/gfr576; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Balbas MD, 2014, P NATL ACAD SCI USA, V111, P14876, DOI 10.1073/pnas.1417297111; BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Cui SY, 2005, J AM SOC NEPHROL, V16, P3247, DOI 10.1681/ASN.2005030278; Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; Graham JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074094; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Ihara K, 2012, GENE EXPR PATTERNS, V12, P95, DOI 10.1016/j.gep.2012.01.006; Ihara KI, 2014, AM J PATHOL, V184, P2699, DOI 10.1016/j.ajpath.2014.06.019; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Lefebvre J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.377; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/01.wnr.0000111329.38420.bf; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; O'Brien LL, 2011, DEV BIOL, V358, P318, DOI 10.1016/j.ydbio.2011.08.005; Ratelade J, 2010, HUM MOL GENET, V19, P1, DOI 10.1093/hmg/ddp462; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Shi ZZ, 2001, MOL CELL BIOL, V21, P5389, DOI 10.1128/MCB.21.16.5389-5395.2001; Sun Xiujun, 1999, Proceedings of the National Academy of Sciences of the United States of America, V96, P628, DOI 10.1073/pnas.96.2.628; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; Yabuta Y, 2011, J CELL BIOL, V192, P781, DOI 10.1083/jcb.201009043	57	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	AUG	2015	88	2					321	331		10.1038/ki.2015.140		11	Urology & Nephrology	Urology & Nephrology	CN9QD	WOS:000358783000015		
J	Komaba, H; Taniguchi, M; Wada, A; Iseki, K; Tsubakihara, Y; Fukagawa, M				Komaba, Hirotaka; Taniguchi, Masatomo; Wada, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Fukagawa, Masafumi			Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism	KIDNEY INTERNATIONAL			English	Article						hemodialysis; hyperparathyroidism; parathyroid hormone; survival	STAGE RENAL-DISEASE; CHRONIC DIALYSIS PATIENTS; LEFT-VENTRICULAR FUNCTION; SUBTOTAL PARATHYROIDECTOMY; PRACTICE PATTERNS; UNITED-STATES; MORTALITY; CALCIUM; AUTOTRANSPLANTATION; CALCIFICATION	Parathyroidectomy (PTx) drastically improves biochemical parameters and clinical symptoms related to severe secondary hyperparathyroidism (SHPT) but the effect of PTx on survival has not been adequately investigated. Here we analyzed data on 114,064 maintenance hemodialysis patients from a nationwide registry of the Japanese Society for Dialysis Therapy to evaluate the associations of severity of SHPT and history of PTx with 1-year all-cause and cardiovascular mortality. We then compared the mortality rate between 4428 patients who had undergone PTx and 4428 propensity score-matched patients who had not despite severe SHPT. During a 1-year follow-up, 7926 patients of the entire study population died, of whom 3607 died from cardiovascular disease. Among patients without a history of PTx, severe SHPT was associated with an increased risk for all-cause and cardiovascular mortality. However, such an increased risk of mortality was not observed among patients with a history of PTx. In the propensity score-matched analysis, patients who had undergone PTx had a 34% and 41% lower risk for all-cause and cardiovascular mortality, respectively, compared to the matched controls. The survival benefit associated with PTx was robust in several sensitivity analyses and consistent across subgroups, except for those who had persistent postoperative SHPT. Thus, successful PTx may reduce the risk for all-cause and cardiovascular mortality in hemodialysis patients with severe, uncontrolled SHPT.	[Komaba, Hirotaka; Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 2591193, Japan; [Taniguchi, Masatomo; Wada, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Komaba, H (reprint author), Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, 143 Shimo Kasuya, Isehara, Kanagawa 2591193, Japan.	hkomaba@tokai-u.jp	Komaba, Hirotaka/C-9199-2011	Komaba, Hirotaka/0000-0002-1704-4507	Bayer Yakuhin; Kyowa Hakko Kirin; Astellas Pharma; Chugai Pharmaceutical; Daiichi Sankyo; Merck Sharp Dohme Corp.; Mochida Pharmaceutical; Teijin Pharma; Torii Pharmaceutical; Asahi Kasei Medical; Baxter; Fuso Pharmaceutical Industries; GlaxoSmithKline K.K.; Kissei Pharmaceutical; Mitsubishi Tanabe Pharma; Nippon Boehringer Ingelheim; Otsuka Pharmaceutical; Shionogi Pharmaceutical; Taisho Pharmaceutical; Takeda Pharmaceutical; Ono Pharmaceutical	HK has received honoraria and/or consulting fees from Bayer Yakuhin and Kyowa Hakko Kirin. MT has received consulting fees from Kyowa Hakko Kirin. KI has received honoraria and/or consulting fees from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Hakko Kirin, Merck Sharp & Dohme Corp., Mochida Pharmaceutical, Teijin Pharma, and Torii Pharmaceutical. YT has received honoraria, consulting fees, and/or grant/research support from Asahi Kasei Medical, Astellas Pharma, Baxter, Bayer Yakuhin, Chugai Pharmaceutical, Fuso Pharmaceutical Industries, GlaxoSmithKline K.K., Kissei Pharmaceutical, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, Otsuka Pharmaceutical, Shionogi Pharmaceutical, Taisho Pharmaceutical, Takeda Pharmaceutical, Teijin Pharma, and Torii Pharmaceutical. MF has received honoraria, consulting fees, and/or grant/research support from Astellas Pharma, Bayer Yakuhin, Kyowa Hakko Kirin, Ono Pharmaceutical, and Torii Pharmaceutical. AW declared no competing interests.	Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1202, DOI 10.1002/pds.1673; FUKUDA N, 1993, J CLIN INVEST, V92, P1436, DOI 10.1172/JCI116720; Kifor O, 1996, J CLIN ENDOCR METAB, V81, P1598, DOI 10.1210/jc.81.4.1598; Kestenbaum B, 2004, KIDNEY INT, V66, P2010, DOI 10.1111/j.1523-1755.2004.00972.x; Rashid G, 2007, AM J PHYSIOL-RENAL, V292, pF1215, DOI 10.1152/ajprenal.00406.2006; Takahashi H, 2014, J CLIN ENDOCR METAB, V99, pE652, DOI 10.1210/jc.2013-4050; Bleyer AJ, 2005, AM J KIDNEY DIS, V46, P464, DOI 10.1053/j.ajkd.2005.04.035; Rudser KD, 2007, J AM SOC NEPHROL, V18, P2401, DOI 10.1681/ASN.2007010022; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Iwamoto N, 2012, J NEPHROL, V25, P755, DOI 10.5301/jn.5000056; Trombetti A, 2007, WORLD J SURG, V31, P1014, DOI 10.1007/s00268-006-0693-1; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Zhang J, 2013, CLIN J AM SOC NEPHRO, V8, P1378, DOI 10.2215/CJN.10381012; PUNCH JD, 1995, ARCH SURG-CHICAGO, V130, P538; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Tominaga Y, 2001, AM J KIDNEY DIS, V38, pS168, DOI 10.1053/ajkd.2001.27432; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Gasparri G, 2001, ANN SURG, V233, P65, DOI 10.1097/00000658-200101000-00011; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; Stracke S, 1999, AM J KIDNEY DIS, V33, P304, DOI 10.1016/S0272-6386(99)70305-7; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Chou FF, 2000, J AM COLL SURGEONS, V190, P65, DOI 10.1016/S1072-7515(99)00212-4; GAGNE ER, 1992, J AM SOC NEPHROL, V3, P1008; Costa-Hong V, 2007, SURGERY, V142, P699, DOI 10.1016/j.surg.2007.06.015; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; Lin HC, 2014, CLIN ENDOCRINOL, V80, P508, DOI 10.1111/cen.12333; Chou FF, 1999, WORLD J SURG, V23, P452; DRUEKE T, 1980, LANCET, V1, P112; Goldsmith DJA, 1996, AM J KIDNEY DIS, V27, P819, DOI 10.1016/S0272-6386(96)90519-3; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Kidney Disease, 2009, KIDNEY INT S113, V76, pS1; Lafrance JP, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-100; Nagashima M, 2003, CIRC J, V67, P269; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Trunzo JA, 2008, SURGERY, V144, P915, DOI 10.1016/j.surg.2008.07.026; Yasunaga C, 1999, AM J SURG, V178, P332, DOI 10.1016/S0002-9610(99)00194-4	40	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	AUG	2015	88	2					350	359		10.1038/ki.2015.72		10	Urology & Nephrology	Urology & Nephrology	CN9QD	WOS:000358783000018		
J	Tamaki, M; Miyashita, K				Tamaki, Masanori; Miyashita, Kazutoshi			Changes in skeletal muscle fiber types induced by chronic kidney disease Reply	KIDNEY INTERNATIONAL			English	Letter									[Tamaki, Masanori; Miyashita, Kazutoshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan; [Tamaki, Masanori] Tokushima Univ Hosp, Dept Nephrol, Tokushima, Japan	Miyashita, K (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	miyakaz@z6.keio.jp					Dursun B, 2008, NEPHROL DIAL TRANSPL, V23, P1697, DOI 10.1093/ndt/gfm906; Nakatani T, 1999, ARCH HISTOL CYTOL, V62, P393, DOI 10.1679/aohc.62.393; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Schiaffino S, 2015, KIDNEY INT, V88, P412, DOI 10.1038/ki.2015.168	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	AUG	2015	88	2					412	413		10.1038/ki.2015.169		3	Urology & Nephrology	Urology & Nephrology	CN9QD	WOS:000358783000026		
J	Urushiyama, H; Terasaki, Y; Nagasaka, S; Terasaki, M; Kunugi, S; Nagase, T; Fukuda, Y; Shimizu, A				Urushiyama, Hirokazu; Terasaki, Yasuhiro; Nagasaka, Shinya; Terasaki, Mika; Kunugi, Shinobu; Nagase, Takahide; Fukuda, Yuh; Shimizu, Akira			Role of alpha 1 and alpha 2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts	LABORATORY INVESTIGATION			English	Article							BASEMENT-MEMBRANE PROTEINS; PULMONARY-FIBROSIS; TISSUE INHIBITOR; DIABETIC-NEPHROPATHY; LIVER-DISEASE; TUMOR-GROWTH; IN-VITRO; CELLS; METALLOPROTEINASES; ANGIOGENESIS	Early fibrotic lesions are thought to be the initial findings of fibrogenesis in idiopathic interstitial pneumonias, but little is known about their properties. Type IV collagen comprises six gene products, alpha 1-alpha 6, and although it is known as a major basement membrane component, its abnormal deposition is seen in fibrotic lesions of certain organs. We studied the expression of type I and III collagen and all a chains of type IV collagen in lung specimens from patients with usual interstitial pneumonia (UIP) or organizing pneumonia (OP) via immunohistochemistry. With cultured lung fibroblasts, we analyzed the expression and function of all a chains of type IV collagen via immunohistochemistry, western blotting, real-time quantitative PCR, and a Boyden chamber migration assay after the knockdown of alpha 1 and alpha 2 chains. Although we observed type I and III collagens in early fibrotic lesions of both UIP and OP, we found type IV collagen, especially alpha 1 and alpha 2 chains, in early fibrotic lesions of UIP but not OP. Fibroblasts enhanced the expression of alpha 1 and alpha 2 chains of type IV collagen after transforming growth factor-beta 1 stimulation. Small interfering RNA against alpha 1 and alpha 2 chains increased fibroblast migration, with upregulated phosphorylation of focal adhesion kinase (FAK), and adding medium containing fibroblast-produced alpha 1 and alpha 2 chains reduced the increased levels of fibroblast migration and phosphorylation of FAK. Fibroblasts in OP were positive for phosphorylated FAK but fibroblasts in UIP were not. These results suggest that fibroblasts in UIP with type IV collagen deposition, especially alpha 1 and alpha 2 chains, have less ability to migrate from early fibrotic lesions than fibroblasts in OP without type IV collagen deposition. Thus, type IV collagen deposition in early fibrotic lesions of UIP may be implicated in refractory pathophysiology including migration of lesion fibroblasts via a FAK pathway.	[Urushiyama, Hirokazu; Terasaki, Yasuhiro; Nagasaka, Shinya; Terasaki, Mika; Kunugi, Shinobu; Fukuda, Yuh; Shimizu, Akira] Nippon Med Sch, Grad Sch Med, Dept Analyt Human Pathol, Tokyo 1138602, Japan; [Nagase, Takahide] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan	Terasaki, Y (reprint author), Nippon Med Sch, Grad Sch Med, Dept Analyt Human Pathol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	terasaki@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Diffuse Lung Diseases Research Group from Ministry of Health, Labor and Welfare of Japan	We are grateful to Dr Yoshikazu Sado, director of immunological research at Shigei Medical Research Institute, for the generous donation of antibodies against a chains of type IV collagen, and Ms Judith B Gandy for her excellent editing of the manuscript. This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and in part by a grant from the Diffuse Lung Diseases Research Group from the Ministry of Health, Labor and Welfare of Japan.	Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Sieg DJ, 1999, J CELL SCI, V112, P2677; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; Colorado PC, 2000, CANCER RES, V60, P2520; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Watanabe H, 2000, NEPHRON, V86, P27, DOI 10.1159/000045709; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Fukuda Y, 1998, LAB INVEST, V78, P687; Ramos C, 2001, AM J RESP CELL MOL, V24, P591; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Lagares D, 2012, ARTHRITIS RHEUM-US, V64, P1653, DOI 10.1002/art.33482; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; HAHN E, 1980, GUT, V21, P63, DOI 10.1136/gut.21.1.63; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Panka DJ, 2003, J BIOL CHEM, V278, P37632, DOI 10.1074/jbc.M307339200; Baba Y, 2007, J GASTROENTEROL, V42, P874, DOI 10.1007/s00535-007-2112-2; Chen YX, 2001, PATHOL RES PRACT, V197, P585, DOI 10.1016/S0344-0338(04)70132-6; Dhanabal M, 1999, CANCER RES, V59, P189; El-Zammar O, 2009, HUM PATHOL, V40, P1182, DOI 10.1016/j.humpath.2009.01.006; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; Kang D, 2009, HUM PATHOL, V40, P1618, DOI 10.1016/j.humpath.2009.04.019; Kasuga I, 1996, Respirology, V1, P277, DOI 10.1111/j.1440-1843.1996.tb00043.x; Khalil N, 1996, AM J RESP CELL MOL, V14, P131; MURAWAKI Y, 1994, HEPATOLOGY, V20, P780, DOI 10.1002/hep.1840200403; Nakano K, 2001, J PATHOL, V194, P420, DOI 10.1002/path.928; Paine R, 1999, AM J MED, V107, P268, DOI 10.1016/S0002-9343(99)00226-0; Poduval P, 2009, ARTHRITIS RHEUM, V60, P938, DOI 10.1002/art.24388; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Schaefer C J, 2011, Eur Respir Rev, V20, P85, DOI 10.1183/09059180.00001111; Society AT, 2002, AM J RESP CRIT CARE, V165, P277; Tomino Y, 2001, J CLIN LAB ANAL, V15, P188, DOI 10.1002/jcla.1026; TSUTSUMI M, 1993, HEPATOLOGY, V17, P820, DOI 10.1016/0270-9139(93)90158-J; VANDERREST M, 1991, FASEB J, V5, P2814; Yokozeki M, 1997, EXP CELL RES, V231, P328, DOI 10.1006/excr.1997.3473; YOSHIOKA K, 1994, AM J PATHOL, V144, P986	54	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	AUG	2015	95	8					872	885		10.1038/labinvest.2015.66		14	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CN8KH	WOS:000358688600003		
J	Suzuki, E; Kajita, S; Takahashi, H; Matsumoto, T; Tsuruta, T; Saegusa, M				Suzuki, Erina; Kajita, Sabine; Takahashi, Hiroyuki; Matsumoto, Toshihide; Tsuruta, Tomoko; Saegusa, Makoto			Transcriptional upregulation of HNF-1 beta by NF-kappa B in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression	LABORATORY INVESTIGATION			English	Article							OXIDATIVE STRESS; POOR-PROGNOSIS; CANCER; PATHWAY; IDENTIFICATION; ENDOMETRIOSIS; PATHOGENESIS; HIF-1-ALPHA; SURVIVIN-2B; MECHANISMS	Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a transcriptional factor that has an important role in endometriosis-ovarian clear cell carcinoma (OCCC) sequence by modulating cell kinetics and glucose metabolism. However, little is known about the detailed molecular mechanisms that govern its regulation and function. Herein, we focus on upstream and downstream regulatory factors of HNF-1 beta in OCCCs. In clinical samples, HNF-1 beta expression was positively correlated with the active form of NF-kappa B/p65 in OCCCs, and closely linked with a low nuclear grade and non-solid architecture. In cell lines, transfection of p65 resulted in increased HNF-1 beta mRNA and protein expression in TOV-21G cells (OCCC cell line with endogenous HNF-1 beta expression), in line with activation of the promoter, probably through interacting with the basic transcriptional machinery. Suppression of endogenous HNF-1 beta expression by siRNA increased apoptosis in TOV-21G cells, while treatment of Hec251 cells (endometrial carcinoma cell line with extremely low endogenous HNF-1 beta expression) stably overexpressing exogenous HNF-1 beta with doxorubicin abrogated apoptosis of the cells, along with increased ratio of bcl-2 relative to bax. Moreover, overexpression of HNF-1 beta led to upregulation of bcl-2 expression at the transcriptional level in TOV-21G cells, which provided evidence for a positive correlation between HNF-1 beta and bcl-2 expression in OCCCs. These data, therefore, suggest that association between HNF-1 beta and NF-kappa B signaling may participate in cell survival by alteration of apoptotic events, particularly in mitochondria-mediated pathways, through upregulation of bcl-2 expression in OCCCs.	[Suzuki, Erina; Kajita, Sabine; Takahashi, Hiroyuki; Matsumoto, Toshihide; Tsuruta, Tomoko; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Saegusa, M (reprint author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	msaegusa@med.kitasato-u.ac.jp			JSPS KAKENHI [25670179]	This study was supported by a grant from JSPS KAKENHI Grand Number 25670179.	Tanaka T, 2004, NUCLEIC ACIDS RES, V32, P2740, DOI 10.1093/nar/gkh597; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Lee YH, 1998, MOL CELL BIOL, V18, P3059; BACH I, 1991, NUCLEIC ACIDS RES, V19, P3553, DOI 10.1093/nar/19.13.3553; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Terasawa K, 2006, BRIT J CANCER, V94, P914, DOI 10.1038/sj.bjc.6602984; Kobayashi H, 2007, INT J GYNECOL CANCER, V17, P37, DOI 10.1111/j.1525-1438.2006.00754.x; Kato N, 2008, VIRCHOWS ARCH, V452, P175, DOI 10.1007/s00428-007-0543-z; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Tazo Y, 2014, J CANCER RES CLIN, V140, P2027, DOI 10.1007/s00432-014-1762-8; Somigliana E, 2006, GYNECOL ONCOL, V101, P331, DOI 10.1016/j.ygyno.2005.11.033; Veras E, 2009, AM J SURG PATHOL, V33, P844, DOI 10.1097/PAS.0b013e31819c4271; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Yamada Y, 2011, INT J GYNECOL CANCER, V21, P1200, DOI 10.1097/IGC.0b013e318222cfdd; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Kajihara H, 2010, ONCOL REP, V23, P1193, DOI 10.3892/or_00000750; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Miura K., 2012, Experimental Oncology, V34, P212; Skirnisdottir I, 2005, INT J ONCOL, V26, P177; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Yoshida T, 2013, LAB INVEST, V93, P1184, DOI 10.1038/labinvest.2013.111; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Ling X, 2007, J BIOL CHEM, V282, P27204, DOI 10.1074/jbc.M705161200; KERR JFR, 1994, CANCER, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Kelly RJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-35; Okamoto T, 2013, MOL CARCINOG, V54, P35; Saegusa M, 2012, AM J PATHOL, V181, P684, DOI 10.1016/j.ajpath.2012.05.008; Shigetomi H, 2012, GYNECOL ENDOCRINOL, V28, P897, DOI 10.3109/09513590.2012.683071	34	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	AUG	2015	95	8					962	972		10.1038/labinvest.2015.73		11	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CN8KH	WOS:000358688600010		
J	Jayatilleke, AC; Jayatilleke, AU; Yasuoka, J; Jimba, M				Jayatilleke, Achini Chinthika; Jayatilleke, Achala Upendra; Yasuoka, Junko; Jimba, Masamine			Prevention of violence against women and girls at the community level	LANCET			English	Letter									[Jayatilleke, Achini Chinthika; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo 1130033, Japan; [Jayatilleke, Achala Upendra] Univ Colombo, Postgrad Inst Med, Colombo, Sri Lanka	Jayatilleke, AC (reprint author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo 1130033, Japan.	achi_cj@yahoo.com					Guedes A, 2002, INT J GYNECOL OBSTET, V78, pS57, DOI 10.1016/S0020-7292(02)00045-0; Michau L, 2015, LANCET, V385, P1672, DOI 10.1016/S0140-6736(14)61797-9; Jayatilleke AC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1674-9; WHO Lshtm, 2010, PREV INT PARTN VIOL	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					427	428				2	Medicine, General & Internal	General & Internal Medicine	CN9IY	WOS:000358761700016		
J	Kamiya, K; Ozasa, K; Akiba, S; Niwa, O; Kodama, K; Takamura, N; Zaharieva, EK; Kimura, Y; Wakeford, R				Kamiya, Kenji; Ozasa, Kotaro; Akiba, Suminori; Niwa, Ohstura; Kodama, Kazunori; Takamura, Noboru; Zaharieva, Elena K.; Kimura, Yuko; Wakeford, Richard			Long-term effects of radiation exposure on health	LANCET			English	Article							ATOMIC-BOMB SURVIVORS; SOLID CANCER INCIDENCE; THYROID-CANCER; IN-UTERO; IONIZING-RADIATION; CHILDHOOD LEUKEMIA; CHERNOBYL ACCIDENT; YOUNG-CHILDREN; CT SCANS; RISK	Late-onset effects of exposure to ionising radiation on the human body have been identified by long-term, large-scale epidemiological studies. The cohort study of Japanese survivors of the atomic bombings of Hiroshima and Nagasaki (the Life Span Study) is thought to be the most reliable source of information about these health effects because of the size of the cohort, the exposure of a general population of both sexes and all ages, and the wide range of individually assessed doses. For this reason, the Life Span Study has become fundamental to risk assessment in the radiation protection system of the International Commission on Radiological Protection and other authorities. Radiation exposure increases the risk of cancer throughout life, so continued follow-up of survivors is essential. Overall, survivors have a clear radiation-related excess risk of cancer, and people exposed as children have a higher risk of radiation-induced cancer than those exposed at older ages. At high doses, and possibly at low doses, radiation might increase the risk of cardiovascular disease and some other non-cancer diseases. Hereditary effects in the children of atomic bomb survivors have not been detected. The dose-response relation for cancer at low doses is assumed, for purposes of radiological protection, to be linear without a threshold, but has not been shown definitively. This outstanding issue is not only a problem when dealing appropriately with potential health effects of nuclear accidents, such as at Fukushima and Chernobyl, but is of growing concern in occupational and medical exposure. Therefore, the appropriate dose-response relation for effects of low doses of radiation needs to be established.	[Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Hiroshima 7348553, Japan; [Zaharieva, Elena K.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Ozasa, Kotaro] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan; [Kodama, Kazunori] Radiat Effects Res Fdn, Hiroshima, Japan; [Akiba, Suminori] Kagoshima Univ, Grad Sch Med & Dent Sci, Epidemiol & Prevent Med, Kagoshima 890, Japan; [Niwa, Ohstura] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima, Japan; [Takamura, Noboru; Kimura, Yuko] Nagasaki Univ, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Wakeford, Richard] Univ Manchester, Inst Populat Hlth, Ctr Occupat & Environm Hlth, Manchester, Lancs, England	Kamiya, K (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	kkamiya@hiroshima-u.ac.jp			Japanese Ministry of Health, Labour and Welfare; US Department of Energy; RERF [1-75, 2-75, 2-61, 4-75, 4-10]	The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, are a public interest foundation funded by the Japanese Ministry of Health, Labour and Welfare and the US Department of Energy. This publication was supported by RERF Research Protocols 1-75, 2-75, 2-61, 4-75, and 4-10. The views of the authors do not necessarily reflect those of the two governments. We thank Fumie Okubo for her valuable assistance with technical and administrative matters.	Adams MJ, 2012, RADIAT RES, V177, P220, DOI 10.1667/RR2746.1; Pernot E, 2012, MUTAT RES-REV MUTAT, V751, P258, DOI 10.1016/j.mrrev.2012.05.003; NEEL JV, 1990, AM J HUM GENET, V46, P1053; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; SCHULL WJ, 1966, AM J HUM GENET, V18, P328; Sera N, 2013, RADIAT RES, V179, P46, DOI 10.1667/RR2863.1; Nakano M, 2007, RADIAT RES, V167, P693, DOI 10.1667/RR0718.1; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Otake M, 1998, INT J RADIAT BIOL, V74, P159, DOI 10.1080/095530098141555; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Leeman-Neill RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/cncr.28484; Furukawa K, 2010, RADIAT RES, V174, P72, DOI 10.1667/RR2083.1; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Richardson D, 2009, RADIAT RES, V172, P368, DOI 10.1667/RR1801.1; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Izumi S, 2003, INT J CANCER, V107, P292, DOI 10.1002/ijc.11400; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; Wakeford R, 2008, RADIAT PROT DOSIM, V132, P166, DOI 10.1093/rpd/ncn272; Kesminiene A, 2012, RADIAT RES, V178, P425, DOI 10.1667/RR2975.1; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Hayashi T, 2012, FASEB J, V26, P4765, DOI 10.1096/fj.12-215228; Preston DL, 2008, J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Leeman-Neill RJ, 2013, CANCER-AM CANCER SOC, V119, P1792, DOI 10.1002/cncr.27893; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; FOLLEY JH, 1952, AM J MED, V13, P311, DOI 10.1016/0002-9343(52)90285-4; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Izumi S, 2003, BRIT J CANCER, V89, P1709, DOI 10.1038/sj.bjc.6601322; [Anonymous], 2007, ANN ICRP, V37, P1, DOI 10.1016/j.icrp.2007.09.001; Zablotska LB, 2013, ENVIRON HEALTH PERSP, V121, P59, DOI 10.1289/ehp.1204996; Kodaira M, 2010, RADIAT RES, V173, P205, DOI 10.1667/RR1991.1; Walsh L, 2014, J RADIOL PROT, V34, pE1, DOI 10.1088/0952-4746/34/1/E1; Pukkala E, 2006, INT J CANCER, V119, P651, DOI 10.1002/ijc.21885; Wakeford R, 2003, INT J RADIAT BIOL, V79, P293, DOI 10.1080/0955300031000114729; Kendall GM, 2013, LEUKEMIA, V27, P3, DOI 10.1038/leu.2012.151; Tatsukawa Y, 2013, J RADIOL PROT, V33, P281, DOI 10.1088/0952-4746/33/2/281; Atomic Bomb Survivors Support Division Hiroshima Prefectural Government, 2014, AT BOMB SURV SUPP DI, P1; Atomic Bomb Survivors Support Division Nagasaki Prefectural Government, 2014, AT BOMB SURV SUPP DI, P8; Codman E., 1902, PHILADELPHIA M J, V9, P438; Daniel J, 1896, Science, V3, P562, DOI 10.1126/science.3.67.562; Delongchamp RR, 1997, RADIAT RES, V147, P385, DOI 10.2307/3579348; Doll R, 1997, BRIT J RADIOL, V70, P130; Drozdovitch V, 2013, RADIAT RES, V179, P597, DOI 10.1667/RR3153.1; Egawa H, 2012, RADIAT RES, V178, P191, DOI 10.1667/RR2819.1; Francis T, 1955, 3359 AT BOMB CAS COM; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Hayashi T, 2013, RADIAT RES, V180, P60, DOI 10.1667/RR3183.1; Honda S, 2002, PSYCHIAT CLIN NEUROS, V56, P575, DOI 10.1046/j.1440-1819.2002.01057.x; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; ICRP, 2003, ANN ICRP, V33, P126; Ishida M, 1959, 459 AT BOMB CAS COMM; Kusunoki Y, 2010, RADIAT RES, V174, P870, DOI 10.1667/RR1847.1; Li CI, 2010, CANCER RES, V70, P7187, DOI 10.1158/0008-5472.CAN-10-0276; Little MP, 2002, INT J RADIAT BIOL, V78, P1001, DOI 10.1080/0955300021000013803; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Ministry of Health, AT BOMB SURV COMPR M; Muller HJ, 1928, GENETICS, V13, P279; NAKASHIMA E, 1994, RADIAT RES, V138, P121, DOI 10.2307/3578855; NEEL JV, 1988, AM J HUM GENET, V42, P663; Ohtaki K, 2004, RADIAT RES, V161, P373, DOI 10.1667/3147; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Pham TM, 2013, RADIAT RES, V180, P539, DOI 10.1667/RR13421.1; Preston RJ, 2015, HEALTH PHYS, V108, P125, DOI 10.1097/HP.0000000000000224; RERF, 2008, BRIEF DESCR; Shibata Y, 2001, LANCET, V358, P1965, DOI 10.1016/S0140-6736(01)06971-9; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Stewart AM, 2000, INT J EPIDEMIOL, V29, P708, DOI 10.1093/ije/29.4.708; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; The Committee for the Compilation of Materials on the Damage by the Atomic Bombs in Hiroshima and Nagasak, 1979, DAM AT BOMB HIR NAG, P241; UNSCEAR, 2013, SCI ANN B EFF ION RA; UNSCEAR, 2008, SCI ANN EP STUD RAD; UNSCEAR, 2008, SCI ANN D HLTH EFF D; UNSCEAR, 2013, SCI ANN A LEV EFF RA; UNSCEAR, 2008, SCI ANN B EP EV CARD; US National Academy of Sciences National Research Council Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L, P13; Weinberg R, 2013, BIOL CANC; Yamada M, 2002, SOC PSYCH PSYCH EPID, V37, P409, DOI 10.1007/s00127-002-0572-5; Yamada M, 1991, MED BASIS RAD ACCIDE, P155	85	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					469	478				10	Medicine, General & Internal	General & Internal Medicine	CN9IY	WOS:000358761700027		
J	Hasegawa, A; Tanigawa, K; Ohtsuru, A; Yabe, H; Maeda, M; Shigemura, J; Ohira, T; Tominaga, T; Akashi, M; Hirohashi, N; Ishikawa, T; Kamiya, K; Shibuya, K; Yamashita, S; Chhem, RK				Hasegawa, Arifumi; Tanigawa, Koichi; Ohtsuru, Akira; Yabe, Hirooki; Maeda, Masaharu; Shigemura, Jun; Ohira, Tetsuya; Tominaga, Takako; Akashi, Makoto; Hirohashi, Nobuyuki; Ishikawa, Tetsuo; Kamiya, Kenji; Shibuya, Kenji; Yamashita, Shunichi; Chhem, Rethy K.			Health effects of radiation and other health problems in the aftermath of nuclear accidents, with an emphasis on Fukushima	LANCET			English	Article							POWER-PLANT ACCIDENT; ACADEMIC-MEDICAL-CENTER; WHOLE-BODY-COUNTER; MENTAL-HEALTH; NPP ACCIDENT; DISASTER; JAPAN; EXPOSURE; RESIDENTS; WORKERS	437 nuclear power plants are in operation at present around the world to meet increasing energy demands. Unfortunately, five major nuclear accidents have occurred in the past-ie, at Kyshtym (Russia [ then USSR], 1957), Windscale Piles (UK, 1957), Three Mile Island (USA, 1979), Chernobyl (Ukraine [ then USSR], 1986), and Fukushima (Japan, 2011). The effects of these accidents on individuals and societies are diverse and enduring. Accumulated evidence about radiation health effects on atomic bomb survivors and other radiation-exposed people has formed the basis for national and international regulations about radiation protection. However, past experiences suggest that common issues were not necessarily physical health problems directly attributable to radiation exposure, but rather psychological and social effects. Additionally, evacuation and long-term displacement created severe health-care problems for the most vulnerable people, such as hospital inpatients and elderly people.	[Hasegawa, Arifumi] Fukushima Med Univ, Dept Radiat Disaster Med, Fukushima 9601295, Japan; [Tanigawa, Koichi] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima 9601295, Japan; [Ohtsuru, Akira] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima 9601295, Japan; [Yabe, Hirooki] Fukushima Med Univ, Dept Neuropsychiat, Fukushima 9601295, Japan; [Maeda, Masaharu] Fukushima Med Univ, Dept Disaster Psychiat, Fukushima 9601295, Japan; [Ohira, Tetsuya] Fukushima Med Univ, Dept Epidemiol, Fukushima 9601295, Japan; [Ishikawa, Tetsuo] Fukushima Med Univ, Dept Radiat Phys & Chem, Fukushima 9601295, Japan; [Shigemura, Jun] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Tominaga, Takako] Natl Inst Radiol Sci, Dept Radiat Emergency Med Assistance Team Med Sec, Chiba 260, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Hirohashi, Nobuyuki] Hiroshima Univ, Dept Emergency & Crit Care Med, Hiroshima, Japan; [Kamiya, Kenji] Hiroshima Univ, Dept Expt Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Yamashita, Shunichi] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Chhem, Rethy K.] Cambodia Dev Resource Inst, Phnom Penh, Cambodia	Tanigawa, K (reprint author), Fukushima Med Univ, Fukushima Global Med Sci Ctr, 1 Hikariga Oka, Fukushima 9601295, Japan.	tanigawa@fmu.ac.jp			Fukushima Medical University; Hiroshima University; Nagasaki University	We thank Kenneth Nollet (Fukushima Medical University) for English proofreading. This work was supported by Fukushima Medical University, Hiroshima University, and Nagasaki University. The views expressed in this report are solely those of the authors.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Akashi M, 2010, HEALTH PHYS, V98, P804, DOI 10.1097/HP.0b013e3181ac924a; CUTTER S, 1982, DISASTERS, V6, P116, DOI 10.1111/j.1467-7717.1982.tb00765.x; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Bromet EJ, 2011, SOC PSYCH PSYCH EPID, V46, P393, DOI 10.1007/s00127-010-0203-5; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Nagataki S, 2008, THYROID, V18, P667, DOI 10.1089/thy.2007.0379; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Wakeford R, 2007, J RADIOL PROT, V27, P211, DOI 10.1088/0952-4746/27/3/E02; Tominaga T, 2014, HEALTH PHYS, V106, P630, DOI 10.1097/HP.0000000000000093; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Sugimoto A, 2014, ENVIRON HEALTH PERSP, V122, P587, DOI 10.1289/ehp.1306848; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019; Bromet E. J., 2012, J RADIOL PROTECT, V32, pN71; Brumfiel G, 2013, NATURE, V493, P290, DOI 10.1038/493290a; Butler Declan, 2011, Nature, V472, P400, DOI 10.1038/472400a; Cuttler JM, 2012, DOSE-RESPONSE, V10, P473, DOI 10.2203/dose-response.12-013.Cuttler; Etherington G, 2014, INT J RADIAT BIOL, V90, P1088, DOI 10.3109/09553002.2014.942920; Fukushima Health Survey Examination Committee, 2014, BAS SURV RAD DOS EST, V24; Fukushima Prefectural Government, RES GLASS BADG MEAS; Glionna JM, 2012, LOS ANGELES TIMES; Gonzalez AJ, 2007, HEALTH PHYS, V93, P571; Gordon HS, 1996, MED CARE, V34, P295, DOI 10.1097/00005650-199604000-00002; Guey LT, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-27; Harasawa K, 2012, LANCET, V379, P2240, DOI 10.1016/S0140-6736(12)60978-7; Havenaar JM, 2002, TOXIC TURMOIL PSYCHO; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P196, DOI 10.2183/pjab.89.196; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Ichiseki H, 2013, LANCET, V381, P204, DOI 10.1016/S0140-6736(13)60091-4; International Atomic Energy Agency, INT NUCL RAD EV SCAL; International Atomic Energy Agency, 2010, EN EL NUCL POW EST P; International Atomic Energy Agency, OP LONG TERM SHUTD R; International Atomic Energy Agency, 2013, 60 YEARS AT PEAC; International Commission on Radiological Protection, 1991, REC INT COMM RAD PRO, V1st; International Commission on Radiological Protection, 2009, APPL COMM REC PROT P; Kawakami N, NATL SURVEY MENTAL H; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Maeda M, 2013, RAD DISASTER MED, P79; Maekawa K, 2011, J CLIN EXP MED, V239, P1056; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; MAXWELL C, 1982, AM J PUBLIC HEALTH, V77, P275; McCurry J, 2013, LANCET, V381, P791, DOI 10.1016/S0140-6736(13)60611-X; Ministry of Health, EXP DOS DISTR WORK F; Ministry of Health, 2012, EST INT EXP MEAS RAD; Morita N, 2013, RADIAT RES, V180, P299, DOI 10.1667/RR3372.1; Naoi Yutaka, 2013, Am J Disaster Med, V8, P87, DOI 10.5055/ajdm.2013.0114; National Diet of Japan, 2012, OFF REP FUK NUCL ACC; National Police Agency, 2011, DAM SIT POL MEAS REL; Nikepelov BV, 1989, INFCIRC368 IAEA; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ohira Tetsuya, 2014, Fukushima J Med Sci, V60, P211, DOI 10.5387/fms.2014-25; Murakami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112791; Radiation Emergency Assistance Center, 1944, MAJOR RAD ACC WORLDW; Radiation Medical Science Center for Fukushima Health Management Survey, 2013, P 11 PREF OV COMM M; Radiation Medical Science Center for Fukushima Health Management Survey, 2013, P 12 PREF OV COMM M; Rahu K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004516; Reconstruction Agency, 2014, EARTHQ REL DEATH GRE; Satoh H, 2015, J DIABETES, V2015, DOI 10.1155/2015/627390; Save the Children, 2012, FUK FAM CHILDR FAM A; Sawada A, 2004, PSYCHIATRY, V67, P43, DOI 10.1521/psyc.67.1.43.31249; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shigemura J, 2012, AM J PSYCHIAT, V169, P784, DOI 10.1176/appi.ajp.2012.12030387; Shigemura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087516; SMITH JS, 1981, JAMA-J AM MED ASSOC, V245, P1656; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Sugimoto A, 2012, B WORLD HEALTH ORGAN, V90, P629, DOI 10.2471/BLT.11.094474; Sugimoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106377; Tanaka S I, 2001, J Radiat Res, V42 Suppl, pS1; Tanigawa K, 2013, RAD DISASTER MED PER, P30; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; UN Scientific Committee on the Effects of Atomic Radiation, 2010, SOURC EFF ION RAD UN; UN Scientific Committee on the Effects of Atomic Radiation, 2013, UNSCEAR 1993 REP GEN; United Nations Scientific Committee on the Eff ects of Atomic Radiation, 2013, UNSCEAR 2013 REP, V1; United States President's Commission on the Accident at Three Mile Island, 1979, REP PRES COMM ACC 3; Valentin J, 2007, 2007 RECOMMENDATIONS; Walsh L, 2014, RADIAT RES, V182, P556, DOI 10.1667/RR13779.1; WHO, 2014, HLTH RISK ASS NUCL A; Wilson R, 2012, DOSE-RESPONSE, V10, P480, DOI 10.2203/dose-response.11-058.Wilson; Yasumura Seiji, 2014, Fukushima J Med Sci, V60, P192, DOI 10.5387/fms.2014-13; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019	92	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					479	488				10	Medicine, General & Internal	General & Internal Medicine	CN9IY	WOS:000358761700028		
J	Ohtsuru, A; Tanigawa, K; Kumagai, A; Niwa, O; Takamura, N; Midorikawa, S; Nollet, K; Yamashita, S; Ohto, H; Chhem, RK; Clarke, M				Ohtsuru, Akira; Tanigawa, Koichi; Kumagai, Atsushi; Niwa, Ohtsura; Takamura, Noboru; Midorikawa, Sanae; Nollet, Kenneth; Yamashita, Shunichi; Ohto, Hitoshi; Chhem, Rethy K.; Clarke, Mike			Nuclear disasters and health: lessons learned, challenges, and proposals	LANCET			English	Article							EAST JAPAN EARTHQUAKE; POWER-PLANT; RISK COMMUNICATION; HURRICANE SANDY; FUKUSHIMA CITY; NEW-YORK; ACCIDENT; EVACUATION; MANAGEMENT; PREPAREDNESS	Past nuclear disasters, such as the atomic bombings in 1945 and major accidents at nuclear power plants, have highlighted similarities in potential public health effects of radiation in both circumstances, including health issues unrelated to radiation exposure. Although the rarity of nuclear disasters limits opportunities to undertake rigorous research of evidence-based interventions and strategies, identification of lessons learned and development of an effective plan to protect the public, minimise negative effects, and protect emergency workers from exposure to high-dose radiation is important. Additionally, research is needed to help decision makers to avoid premature deaths among patients already in hospitals and other vulnerable groups during evacuation. Since nuclear disasters can affect hundreds of thousands of people, a substantial number of people are at risk of physical and mental harm in each disaster. During the recovery period after a nuclear disaster, physicians might need to screen for psychological burdens and provide general physical and mental health care for many affected residents who might experience long-term displacement. Reliable communication of personalised risks has emerged as a challenge for health-care professionals beyond the need to explain radiation protection. To overcome difficulties of risk communication and provide decision aids to protect workers, vulnerable people, and residents after a nuclear disaster, physicians should receive training in nuclear disaster response. This training should include evidence-based interventions, support decisions to balance potential harms and benefits, and take account of scientific uncertainty in provision of community health care. An open and joint learning process is essential to prepare for, and minimise the effects of, future nuclear disasters.	[Ohtsuru, Akira; Midorikawa, Sanae] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima 9601295, Japan; [Tanigawa, Koichi; Niwa, Ohtsura; Nollet, Kenneth] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima 9601295, Japan; [Kumagai, Atsushi] Fukushima Med Univ, Educ Ctr Disaster Med, Fukushima 9601295, Japan; [Ohto, Hitoshi] Fukushima Med Univ, Radiat Med Sci Ctr, Fukushima 9601295, Japan; [Yamashita, Shunichi] Nagasaki Univ, Dept Radiat Med Sci, Nagasaki 852, Japan; [Takamura, Noboru] Nagasaki Univ, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Chhem, Rethy K.] Cambodia Dev Resource Inst, Phnom Penh, Cambodia; [Clarke, Mike] Queens Univ Belfast, Royal Hosp, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Ohtsuru, A (reprint author), Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima 9601295, Japan.	ohtsuru@fmc.ac.jp			Fukushima Medical University; Hiroshima University; Nagasaki University	We thank Fukushima Medical University, Hiroshima University, and Nagasaki University for generous support. The views expressed in this report are solely those of the authors. We thank Masafumi Abe, Shin-ichi Suzuki, Satoru Suzuki, and Seiji Yasumura (Fukushima Medical University, Fukushima, Japan) for their academic support. We thank Mitsuko Fujino, Akira Sakai, Makoto Miyazaki, Hisashi Sato, Naohiro Tsuyama, Takashi Ohba, Koji Yoshida, and Kiyotaka Yasui (Fukushima Medical University, Fukushima city, Japan), and Tomoyoshi Oikawa (Minamisoma Municipal General Hospital, Minamisoma city, Japan) for nuclear disaster medical education and training.	Allen Claire, 2014, J Evid Based Med, V7, P234, DOI 10.1111/jebm.12127; Gonzalez AJ, 2013, J RADIOL PROT, V33, P497, DOI 10.1088/0952-4746/33/3/497; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Chan TC, 2004, ACAD EMERG MED, V11, P1229, DOI 10.1197/j.aem.2004.08.018; [Anonymous], ACT DEV CRIS MAN SYS; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295; CUTTER S, 1982, DISASTERS, V6, P116, DOI 10.1111/j.1467-7717.1982.tb00765.x; O'Malley P, 2009, B WORLD HEALTH ORGAN, V87, P614, DOI 10.2471/BLT.08.056689; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Koido Y., 2011, Journal of the National Institute of Public Health, V60, P495; Ito Y, 2013, NAT REV ENDOCRINOL, V9, P178, DOI 10.1038/nrendo.2012.257; Yamashita S, 2014, HEALTH PHYS, V106, P166, DOI 10.1097/HP.0000000000000007; Tominaga T, 2014, HEALTH PHYS, V106, P630, DOI 10.1097/HP.0000000000000093; Neria Y, 2011, AM PSYCHOL, V66, P429, DOI [10.1037/a0024791, 10.1037/0024791]; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kim Y, 2011, BRIT J PSYCHIAT, V199, P411, DOI 10.1192/bjp.bp.110.085472; Bromet E. J., 2012, J RADIOL PROTECT, V32, pN71; Butler Declan, 2011, Nature, V472, P400, DOI 10.1038/472400a; Covello VT, 2011, HEALTH PHYS, V101, P511, DOI 10.1097/HP.0b013e3182299549; Davies E, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7357; Evidence Aid Priority Setting Group, 2013, PLOS CURR, V5; Fukushima Prefectural Government, 2014, RES SURV INT EV; Fukushima Radiation and Health, P 17 PREF OV COMM M; Gerdin M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001632; Goto A, 2014, DISASTERS, V38, ps179, DOI 10.1111/disa.12070; Goto A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-129; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P196, DOI 10.2183/pjab.89.196; Health Physics Society, IS POT IOD MAG BULL; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Ichiseki H, 2013, LANCET, V381, P204, DOI 10.1016/S0140-6736(13)60091-4; International Commission on Radiological Protection, 1991, ICRP PUBL, V60; KASPERSON RE, 1992, SOCIAL THEORIES OF RISK, P153; Klein Kelly R, 2007, Disaster Manag Response, V5, P56, DOI 10.1016/j.dmr.2007.03.001; Kondo Hisayoshi, 2009, Prehosp Disaster Med, V24, P556; Kudo D, 2013, DISASTER MED PUBLIC, V7, P461, DOI 10.1017/dmp.2013.77; Maekawa K, 2011, J CLIN EXP MED, V239, P1056; Malilay J, 2014, AM J PUBLIC HEALTH, V104, P2092, DOI 10.2105/AJPH.2014.302010; MAXWELL C, 1982, AM J PUBLIC HEALTH, V77, P275; Ministry of Health Labour and Welfare, EM MED INF SYST HOSP; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ochi S, 2014, PLOS CURR, V6, P6; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Pfenninger Ernst G, 2010, Int J Emerg Med, V3, P9, DOI 10.1007/s12245-009-0140-9; Prylyko V, 2011, HLTH EFFECTS CHERNOB, P533; Radiation Emergency Medicine Network, LOC RAD EM MED FAC; Save the Children, 2012, FUK FAM CHILDR FAM A; Schmemann S, 1986, NY TIMES; Sekiya Naoya, 2011, Fukushima J Med Sci, V57, P93; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shlyakhter A, 1992, PUBLIC UNDERST SCI, V1, P251, DOI 10.1088/0963-6625/1/3/002; SMITH JS, 1981, JAMA-J AM MED ASSOC, V245, P1656; Sources and Effects of Ionizing Radiation, 2010, SOURC EFF ION RAD; Staudenherz A, 2011, Int J Occup Environ Med, V2, P133; Tanigawa K, 2013, RAD DISASTER MED PER; Tanigawa K, 2011, JAPANESE ASS ACUTE M, V22, P782; The Fukushima Nuclear Accident Independent Investigation Commission, 2012, NAT DIET JAPAN; The Joint US-Japan Aerial Measuring Systems Data, RAD ASS EFF FUK DAII; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Tokyo Electric Power Company, DISTR WORK EXP DOS; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF RISKS ION; United States President's Commission on the Accident at Three Mile Island, 1979, REP PRES COMM ACC 3; VanDevanter N, 2014, J URBAN HEALTH, V91, P603, DOI 10.1007/s11524-014-9889-0; Wells KB, 2013, PSYCHIAT CLIN N AM, V36, P451, DOI 10.1016/j.psc.2013.05.002; WHO, 1999, GUID IOD PROPH FOLL; Wilson R, 2012, DOSE-RESPONSE, V10, P480, DOI 10.2203/dose-response.11-058.Wilson; Wisner B, 2014, BIOSECUR BIOTERROR; Yamashita Shunichi, 2013, Respir Investig, V51, P128, DOI 10.1016/j.resinv.2013.05.007; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019	72	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					489	497				9	Medicine, General & Internal	General & Internal Medicine	CN9IY	WOS:000358761700029		
J	Reich, MR; Goto, A				Reich, Michael R.; Goto, Aya			Towards long-term responses in Fukushima	LANCET			English	Editorial Material									[Reich, Michael R.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Goto, Aya] Fukushima Med Univ, Dept Publ Hlth, Fukushima, Japan	Reich, MR (reprint author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	michael_reich@harvard.edu					Aldrich DP, 2012, ASIA PACIFIC ISSUES, V103, P1; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Aoki M, 2014, JAPAN TIMES TOK 0922; Bricker MK, 2014, FUKUSHIMA DAIICHI NU; Bromet EJ, 2011, WORLD PSYCHIATRY, V10, P83; Fackler M, 2013, NY TIMES; FAIRDO, 2013, 20131 FAIRDO I GLOB; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Kemeny JG, 1979, REPORT PRESIDENTS CO; Kurokawa K, 2015, ROLE NATION STATE AD, P18; Leflar R., 2012, J ENV LAW LITIG, V27, P107; Lifton R, 1968, DEATH LIFE SURVIVORS; Lochard J, 2009, Ann ICRP, V39, P1, DOI 10.1016/j.icrp.2009.09.008; Nakayachi K, 2010, RISK ANAL, V30, P143, DOI 10.1111/j.1539-6924.2009.01306.x; National Diet of Japan Fukushima Nuclear Accident Independent Investigation Commission, 2012, OFF REP EX SUMM; Nollet Kenneth E, 2011, Fukushima J Med Sci, V57, P86; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; Pilling D, 2014, BENDING ADVERSITY JA, P257; Reich Michael R., 1991, TOXIC POLITICS RESPO; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, V1406112 UNSCEAR; Weitzdorfer J, 2014, ASIA PACIFIC DISASTE, P119; Yasutaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075308	23	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					498	500				3	Medicine, General & Internal	General & Internal Medicine	CN9IY	WOS:000358761700030		
J	Tabernero, J; Lenz, HJ; Siena, S; Sobrero, A; Falcone, A; Ychou, M; Humblet, Y; Bouche, O; Mineur, L; Barone, C; Adenis, A; Yoshino, T; Goldberg, RM; Sargent, DJ; Wagner, A; Laurent, D; Teufel, M; Jeffers, M; Grothey, A; Van Cutsem, E				Tabernero, Josep; Lenz, Heinz-Josef; Siena, Salvatore; Sobrero, Alberto; Falcone, Alfredo; Ychou, Marc; Humblet, Yves; Bouche, Olivier; Mineur, Laurent; Barone, Carlo; Adenis, Antoine; Yoshino, Takayuki; Goldberg, Richard M.; Sargent, Daniel J.; Wagner, Andrea; Laurent, Dirk; Teufel, Michael; Jeffers, Michael; Grothey, Axel; Van Cutsem, Eric			Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial	LANCET ONCOLOGY			English	Article							RANDOMIZED PHASE-III; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; PLUS IRINOTECAN; INHIBITS GROWTH; KRAS MUTATIONS; PLACEBO PLUS; TUMOR-GROWTH; FLUOROURACIL; LEUCOVORIN	Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the genotype of the tissue obtained at the time of diagnosis might not accurately represent tumour genotype after multiple lines of treatment. This retrospective exploratory analysis investigated the clinical activity of regorafenib in biomarker subgroups of the CORRECT study population defined by tumour mutational status or plasma protein levels. Methods We used BEAMing technology to identify KRAS, PIK3CA, and BRAF mutations in DNA obtained from the plasma of 503 patients with metastatic colorectal cancer who enrolled in the CORRECT trial. We quantified total human genomic DNA isolated from plasma samples for 503 patients using a modified version of human long interspersed nuclear element-1 (LINE-1) quantitive real-time PCR. We also measured the concentration of 15 proteins of interest-angiopoietin 2, interleukin 6, interleukin 8, placental growth factor, soluble TIE-1, soluble VEGFR1, VEGF-A, VEGF-C, VEGF-D, VEGF-A isoform 121, bone morphogenetic protein 7, macrophage colony-stimulating factor, stromal cell-derived factor-1, tissue inhibitor of metalloproteinase 2, and von Willebrand factor-in plasma samples from 611 patients. We did correlative analyses of overall survival and progression-free survival in patient subgroups based on mutational status, circulating DNA concentration, and protein concentrations. The CORRECT trial was registered with ClinicalTrials.gov, number NCT01103323. Findings Tumour-associated mutations were readily detected with BEAMing of plasma DNA, with KRAS mutations identified in 349 (69%) of 503 patients, PIK3CA mutations in 84 (17%) of 503 patients, and BRAF mutations in 17 (3%) of 502 patients. We did not do correlative analysis based on BRAF genotype because of the low mutational frequency detected for this gene. Some of the most prevalent individual hot-spot mutations we identified included: KRAS (KRAS G12D, 116 [28%] of 413 mutations; G12V, 72 [17%]; and G13D, 67 [16%]) and PIK3CA (PIK3CA E542K, 27 [30%] of 89 mutations; E545K, 37 [42%]; and H1047R, 12 [14%]). 41 (48%) of 86 patients who had received anti-EGFR therapy and whose archival tumour tissue DNA was KRAS wild-type in BEAMing analysis were identified as having KRAS mutations in BEAMing analysis of fresh plasma DNA. Correlative analyses suggest a clinical benefit favouring regorafenib across patient subgroups defined by KRAS and PIK3CA mutational status (progression-free survival with regorafenib vs placebo: hazard ratio [HR] 0.52, 95% CI 0.35-0.76 for KRAS wildtype; HR 0.51, 95% CI 0.40-0.65 for KRAS mutant [KRAS wild type vs mutant, p(interaction) = 0.74]; HR 0.50, 95% CI 0.40-0.63 for PIK3CA wild-type; HR 0.54, 95% CI 0.32-0.89 for PIK3CA mutant [PIK3CA wild-type vs mutant, p(interaction) = 0.85]) or circulating DNA concentration (progression-free survival with regorafenib vs placebo: HR 0.53, 95% CI 0.40-0.71, for low circulating DNA concentrations; HR 0.52, 95% CI 0.40-0.70, for high circulating DNA concentrations; low vs high circulating DNA, p(interaction) = 0.601). With the exception of von Willebrand factor, assessed with the median cutoff method, plasma protein concentrations were also not associated with regorafenib activity in terms of progression-free survival. In univariable analyses, the only plasma protein that was associated with overall survival was TIE-1, high concentrations of which were associated with longer overall survival compared with low TIE-1 concentrations. This association was not significant in multivariable analyses. Interpretation BEAMing of circulating DNA could be a viable approach for non-invasive analysis of tumour genotype in real time and for the identification of potentially clinically relevant mutations that are not detected in archival tissue. Additionally, the results show that regorafenib seems to be consistently associated with a clinical benefit in a range of patient subgroups based on mutational status and protein biomarker concentrations.	[Tabernero, Josep] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Tabernero, Josep] Univ Autonoma Barcelona, Inst Oncol, Barcelona 08035, Spain; [Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Siena, Salvatore] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy; [Siena, Salvatore] Univ Milan, Milan, Italy; [Sobrero, Alberto] IRCCS San Martino IST, Genoa, Italy; [Falcone, Alfredo] Univ Hosp, Pisa, Italy; [Ychou, Marc] ICM Val Aurelle, Montpellier, France; [Humblet, Yves] Catholic Univ Louvain, St Luc Univ Hosp, B-1200 Brussels, Belgium; [Bouche, Olivier] Hop Robert Debre, Ctr Hosp Univ Reims, Reims, France; [Mineur, Laurent] Inst St Catherine, Gastrointestinal & Liver Oncol Unit, Avignon, France; [Barone, Carlo] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; [Adenis, Antoine] Ctr Oscar Lambret, F-59020 Lille, France; [Yoshino, Takayuki] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Goldberg, Richard M.] Ohio State Univ, James Canc Hosp, Sch Med, Columbus, OH 43210 USA; [Goldberg, Richard M.] Solove Res Inst, Columbus, OH USA; [Sargent, Daniel J.; Grothey, Axel] Mayo Clin, Rochester, MN USA; [Wagner, Andrea; Laurent, Dirk] Bayer Pharma AG, Berlin, Germany; [Teufel, Michael; Jeffers, Michael] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Van Cutsem, Eric] Univ Hosp Gasthuisberg, Leuven, Belgium; [Van Cutsem, Eric] Katholieke Univ Leuven, Leuven, Belgium	Tabernero, J (reprint author), Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Barcelona 08035, Spain.	jtabernero@vhio.net		SIENA, SALVATORE/0000-0002-2681-2846	Bayer HealthCare AG	The CORRECT trial was sponsored by Bayer HealthCare AG. We thank the patients, their families, and the study investigators. We also thank Lei Xu and Frank Cihon of Bayer HealthCare for data analysis support; Robert Gerwien for data analysis support; Scott Wilhelm of Bayer HealthCare and Chetan Lathia for input on the biomarker study design; Bernard Kerr of Succinct Medical Communications for editorial assistance in the preparation of this manuscript, with financial support from Bayer HealthCare AG. The authors retained editorial control over the content.	Frattini M, 2006, ANN NY ACAD SCI, V1075, P185, DOI 10.1196/annals.1368.025; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Groblewska M, 2014, TUMOR BIOL, V35, P3793, DOI 10.1007/s13277-013-1502-8; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Eisen T, 2012, LANCET ONCOL, V13, P1055, DOI 10.1016/S1470-2045(12)70364-9; Ning Y, 2012, EXPERT OPIN THER TAR, V16, P491, DOI 10.1517/14728222.2012.677440; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Joulain F, 2013, BRIT J CANCER, V109, P1735, DOI 10.1038/bjc.2013.523; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Rees KA, 2007, INT J ONCOL, V31, P893; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Li J, 2015, LANCET ONCOL, V16, P619, DOI 10.1016/S1470-2045(15)70156-7; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; D'Amico G, 2014, J CLIN INVEST, V124, P824, DOI 10.1172/JCI68897; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Australian Government Department of Health, 2014, AUSTR PUBL ASS REP R; Dewerchin M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011056; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Motoyama Kazuo, 2008, Ann Surg Oncol, V15, P1530, DOI 10.1245/s10434-007-9746-4; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Pare-Brunet L, 2015, PHARMACOGENOMICS J, V15, P397, DOI 10.1038/tpj.2015.1; Schellerer VS, 2011, AM J TRANSL RES, V3, P445; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stintzing S, 2015, HEMATOL ONCOL CLIN N, V29, P43, DOI 10.1016/j.hoc.2014.09.009; Sung Chan Yong, 2012, J Korean Soc Coloproctol, V28, P315, DOI 10.3393/jksc.2012.28.6.315; Tung SY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-91	48	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	AUG	2015	16	8					937	948		10.1016/S1470-2045(15)00138-2		12	Oncology	Oncology	CN6OS	WOS:000358554700046		
J	Soria, JC; Wu, YL; Nakagawa, K; Kim, SW; Yang, JJ; Ahn, MJ; Wang, J; Yang, JCH; Lu, Y; Atagi, S; Ponce, S; Lee, DH; Liu, YP; Yoh, K; Zhou, JY; Shi, XJ; Webster, A; Jiang, HY; Mok, TSK				Soria, Jean-Charles; Wu, Yi-Long; Nakagawa, Kazuhiko; Kim, Sang-We; Yang, Jin-Ji; Ahn, Myung-Ju; Wang, Jie; Yang, James Chih-Hsin; Lu, You; Atagi, Shinji; Ponce, Santiago; Lee, Dae Ho; Liu, Yunpeng; Yoh, Kiyotaka; Zhou, Jian-Ying; Shi, Xiaojin; Webster, Alan; Jiang, Haiyi; Mok, Tony S. K.			Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation- positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial	LANCET ONCOLOGY			English	Article							TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; OPEN-LABEL; ERLOTINIB; ADENOCARCINOMA; MULTICENTER; GEMCITABINE; AFATINIB	Background Optimum management strategies for patients with advanced non-small-cell lung cancer (NSCLC) with acquired resistance to EGFR tyrosine-kinase inhibitors are undefined. We aimed to assess the efficacy and safety of continuing gefitinib combined with chemotherapy versus chemotherapy alone in patients with EGFR-mutation-positive advanced NSCLC with acquired resistance to first-line gefitinib. Methods The randomised, phase 3, multicentre IMPRESS study was done in 71 centres in 11 countries in Europe and the Asia-Pacific region. Eligible patients were aged at least 18 years with histologically confirmed, chemotherapynaive, stage IIIB-IV EGFR-mutation-positive advanced NSCLC with previous disease control with first-line gefitinib and recent disease progression (Response Evaluation Criteria in Solid Tumors version 1.1). Participants were randomly assigned (1: 1) by central block randomisation to oral gefitinib 250 mg or placebo once daily in tablet form; randomisation did not include stratification factors. All patients also received the platinum-based doublet chemotherapy cisplatin 75 mg/m(2) plus pemetrexed 500 mg/m(2) on the first day of each cycle. After completion of a maximum of six chemotherapy cycles, patients continued their randomly assigned treatment until disease progression or another discontinuation criterion was met. All study investigators and participants were masked to treatment allocation. The primary endpoint was progression-free survival in the intention-to-treat population. Safety was assessed in patients who received at least one dose of study treatment. The study has completed enrolment, but patients are still in follow-up for overall survival. This trial is registered with ClinicalTrials.gov, number NCT01544179. Findings Between March 29, 2012, and Dec 20, 2013, 265 patients were randomly assigned: 133 to the gefitinib group and 132 to the placebo group. At the time of data cutoff (May 5, 2014), 98 (74%) patients had disease progression in the gefitinib group compared with 107 (81%) in the placebo group (hazard ratio 0 . 86, 95% CI 0 . 65-1 . 13; p=0 . 27; median progression-free survival 5 . 4 months in both groups [95% CI 4 . 5-5 . 7 in the gefitinib group and 4 . 6-5 . 5 in the placebo group]). The most common adverse events of any grade were nausea (85 [64%] of 132 patients in the gefitinib group and 81 [61%] of 132 patients in the placebo group) and decreased appetite (65 [49%] and 45 [34%]). The most common adverse events of grade 3 or worse were anaemia (11 [8%] of 132 patients in the gefitinib group and five [4%] of 132 patients in the placebo group) and neutropenia (nine [7%] and seven [5%]). 37 (28%) of 132 patients in the gefitinib group and 28 (21%) of 132 patients in the placebo group reported serious adverse events. Interpretation Continuation of gefitinib after radiological disease progression on first-line gefitinib did not prolong progression-free survival in patients who received platinum-based doublet chemotherapy as subsequent line of treatment. Platinum-based doublet chemotherapy remains the standard of care in this setting.	[Soria, Jean-Charles] Dept Med, Villejuif, France; [Soria, Jean-Charles] Univ Paris 11, Villejuif, France; [Wu, Yi-Long; Yang, Jin-Ji] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long; Yang, Jin-Ji] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osakasayama City, Osaka, Japan; [Kim, Sang-We; Lee, Dae Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Wang, Jie] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Thorac Med Oncol, Beijing 100871, Peoples R China; [Yang, James Chih-Hsin] Natl Taiwan Univ Hosp, Coll Med, Dept Oncol, Taipei, Taiwan; [Lu, You] Sichuan Univ, Dept Thorac Canc, Ctr Canc, West China Hosp,West China Med Sch, Chengdu, Sichuan, Peoples R China; [Atagi, Shinji] Kinki Chuo Chest Med Ctr, Dept Thorac Oncol, Osaka, Japan; [Ponce, Santiago] Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain; [Liu, Yunpeng] China Med Univ, Dept Med Oncol, Hosp 1, Shengyang City, Peoples R China; [Yoh, Kiyotaka] Natl Canc Ctr Hosp East, Div Thorac Oncol, Chiba, Japan; [Zhou, Jian-Ying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China; [Shi, Xiaojin; Jiang, Haiyi] AstraZeneca, Shanghai, Peoples R China; [Webster, Alan] AstraZeneca, Macclesfield, England; [Mok, Tony S. K.] Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab South China, Hong Kong Canc Inst,Dept Clin Oncol, Sha Tin, Hong Kong, Peoples R China	Mok, TSK (reprint author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Sha Tin, Hong Kong, Peoples R China.	tony@clo.cuhk.edu.hk			AstraZeneca	This study was funded by AstraZeneca. We thank the patients and investigators for their participation in this study. We thank the independent data and safety committee members for their critical review: M Reck, S Lu, and M Buyse. We thank L Brown, from Complete Medical Communications, who provided medical writing support funded by AstraZeneca.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; [Anonymous], 2014, ANN ONCOL         S4, DOI DOI 10.1093/ANN0NC/MDU349.2; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Park SJ, 2012, LUNG CANCER, V77, P556, DOI 10.1016/j.lungcan.2012.05.092; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Douillard JY, 2014, BRIT J CANCER, V110, P55, DOI 10.1038/bjc.2013.721; Mok T, 2013, J CLIN ONCOL, V31, P1081, DOI 10.1200/JCO.2012.43.0652; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Hirsh V, 2011, CURR ONCOL, V18, P126; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gandara DR, 2014, CLIN LUNG CANCER, V15, P1, DOI 10.1016/j.cllc.2013.10.001; Goldberg SB, 2013, ONCOLOGIST, V18, P1214, DOI 10.1634/theoncologist.2013-0168; Yang JJ, 2013, LUNG CANCER, V79, P33, DOI 10.1016/j.lungcan.2012.09.016; Mitsudomi T, 2012, J CLIN ONCOL, V30; National Cancer Institute, 2010, NAT CANC I COMM TERM; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JCH, 2012, P AM SOC CLIN ONCO S, V30	28	6	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	AUG	2015	16	8					990	998		10.1016/S1470-2045(15)00121-7		9	Oncology	Oncology	CN6OS	WOS:000358554700051		
J	Hamaji, M; Groth, SS; Sugarbaker, DJ; Burt, BM				Hamaji, Masatsugu; Groth, Shawn S.; Sugarbaker, David J.; Burt, Bryan M.			Surgery versus SABR for resectable non-small-cell lung cancer	LANCET ONCOLOGY			English	Letter							LOBECTOMY		[Hamaji, Masatsugu] Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan; [Groth, Shawn S.; Sugarbaker, David J.; Burt, Bryan M.] Baylor Coll Med, Dept Surg, Div Thorac Surg, Houston, TX 77030 USA	Hamaji, M (reprint author), Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan.	bryan.burt@bcm.edu					Nwogu CE, 2015, ANN THORAC SURG, V99, P399, DOI 10.1016/j.athoracsur.2014.09.018; Burt BM, 2014, J THORAC CARDIOV SUR, V148, P19, DOI 10.1016/j.jtcvs.2014.03.007; Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3; Falcoz PE, 2015, EUR J CARDIO-THORAC, DOI [10.1093/ejcts/ezv154, DOI 10.1093/EJCTS/EZV154]; Paul S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5575	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	AUG	2015	16	8					E372	E372				1	Oncology	Oncology	CN6OS	WOS:000358554700003		
J	Tsutsumi, A; Izutsu, T; Ito, A; Thornicroft, G; Patel, V; Minas, H				Tsutsumi, Atsuro; Izutsu, Takashi; Ito, Akiko; Thornicroft, Graham; Patel, Vikram; Minas, Harry			Mental health mainstreamed in new UN disaster framework	LANCET PSYCHIATRY			English	Editorial Material									[Tsutsumi, Atsuro] UKMMC, United Nations Univ, Int Inst Global Hlth, Kuala Lumpur 56000, Malaysia; [Izutsu, Takashi] World Bank, Tokyo Dev Learning Ctr, Tokyo, Japan; [Ito, Akiko] UN, Secretariat Convent Rights Persons Disabil, Div Social Policy & Dev, Dept Econ & Social Affairs, New York, NY 10017 USA; [Thornicroft, Graham] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London WC2R 2LS, England; [Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Minas, Harry] Univ Melbourne, Ctr Mental Hlth, Global & Cultural Mental Hlth Unit, Melbourne, Vic, Australia	Tsutsumi, A (reprint author), UKMMC, United Nations Univ, Int Inst Global Hlth, Kuala Lumpur 56000, Malaysia.	tsutsumi@gakushikai.jp	Thornicroft, Graham/B-4027-2010				[Anonymous], 2013, BUILD BACK BETT SUST; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Minas H, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/s13033-015-0003-0; Semrau Maya, 2012, Am J Public Health, V102, pe55, DOI 10.2105/AJPH.2012.300720; UN, 2015, SEND FRAM DIS RISK R; UNISDR, 2009, UNISDR TERM DIS RISK; United Nations, 2005, HYOG FRAM ACT 2005 2; United Nations United Nations University, 2015, UN EXP GROUP M MENT; WHO, 2010, MHGAP INT GUID MENT; World Health Organization & King's College London, 2011, HUM EM SETT PERC NEE	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	AUG	2015	2	8					679	680				3	Psychiatry	Psychiatry	CN9CH	WOS:000358743200011		
J	Soyama, A; Takatsuki, M; Hidaka, M; Imamura, H; Kuroki, T; Eguchi, S				Soyama, Akihiko; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Imamura, Hajime; Kuroki, Tamotsu; Eguchi, Susumu			Acute and chronic postsurgical pain after living liver donation: Incidence and predictors	LIVER TRANSPLANTATION			English	Letter							DONOR HEPATECTOMY; TRANSPLANTATION		[Soyama, Akihiko; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Imamura, Hajime; Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, Nagasaki 8528501, Japan	Eguchi, S (reprint author), Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp					Holtzman S, 2014, LIVER TRANSPLANT, V20, P1336, DOI 10.1002/lt.23949; Koffron AJ, 2006, AM J TRANSPLANT, V6, P2522, DOI 10.1111/j.1600-6143.2006.01498.x; Imamura H, 2013, CLIN TRANSPLANT, V27, pE605, DOI 10.1111/ctr.12226; Jain A, 2009, LIVER TRANSPLANT, V15, P1488, DOI 10.1002/lt.21850; Soyama A, 2014, SURG ENDOSC, V28, P203, DOI 10.1007/s00464-013-3159-1; Suh SW, 2015, LIVER TRANSPLANT, V21, P72, DOI 10.1002/lt.24033	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	AUG	2015	21	8					1109	1109		10.1002/lt.24125		1	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	CN8KP	WOS:000358689500017		
J	Yasukochi, Y; Naka, I; Patarapotikul, J; Hananantachai, H; Ohashi, J				Yasukochi, Yoshiki; Naka, Izumi; Patarapotikul, Jintana; Hananantachai, Hathairad; Ohashi, Jun			Genetic evidence for contribution of human dispersal to the genetic diversity of EBA-175 in Plasmodium falciparum	MALARIA JOURNAL			English	Article						Diversifying selection; EBA-175; Human evolution; Out-of-Africa; Plasmodium falciparum	ERYTHROCYTE BINDING ANTIGEN; MALARIA PARASITES; MAXIMUM-LIKELIHOOD; PHYLOGENETIC NETWORKS; PROTEIN EVOLUTION; DNA POLYMORPHISM; SEQUENCES; SELECTION; INVASION; ORIGINS	Background: The 175-kDa erythrocyte binding antigen (EBA-175) of Plasmodium falciparum plays a crucial role in merozoite invasion into human erythrocytes. EBA-175 is believed to have been under diversifying selection; however, there have been no studies investigating the effect of dispersal of humans out of Africa on the genetic variation of EBA-175 in P. falciparum. Methods: The PCR-direct sequencing was performed for a part of the eba-175 gene (regions II and III) using DNA samples obtained from Thai patients infected with P. falciparum. The divergence times for the P. falciparum eba-175 alleles were estimated assuming that P. falciparum/Plasmodium reichenowi divergence occurred 6 million years ago (MYA). To examine the possibility of diversifying selection, nonsynonymous and synonymous substitution rates for Plasmodium species were also estimated. Results: A total of 32 eba-175 alleles were identified from 131 Thai P. falciparum isolates. Their estimated divergence time was 0.13-0.14 MYA, before the exodus of humans from Africa. A phylogenetic tree for a large sequence dataset of P. falciparum eba-175 alleles from across the world showed the presence of a basal Asian-specific cluster for all P. falciparum sequences. A markedly more nonsynonymous substitutions than synonymous substitutions in region II in P. falciparum was also detected, but not within Plasmodium species parasitizing African apes, suggesting that diversifying selection has acted specifically on P. falciparum eba-175. Conclusions: Plasmodium falciparum eba-175 genetic diversity appeared to increase following the exodus of Asian ancestors from Africa. Diversifying selection may have played an important role in the diversification of eba-175 allelic lineages. The present results suggest that the dispersals of humans out of Africa influenced significantly the molecular evolution of P. falciparum EBA-175.	[Yasukochi, Yoshiki; Naka, Izumi; Ohashi, Jun] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Naka, Izumi; Ohashi, Jun] Univ Tokyo, Grad Sch Sci, Dept Human Genet, Tokyo 1130033, Japan; [Patarapotikul, Jintana] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10700, Thailand; [Hananantachai, Hathairad] Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok 10700, Thailand	Yasukochi, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hyasukou@proof.ocn.ne.jp			KAKENHI [25650125, 26305015, 26-1601]; Takeda Science Foundation	The authors deeply thank all the subjects for their participation in the study. This study was partly supported by KAKENHI (25650125) Grant-in-Aid for Challenging Exploratory Research and KAKENHI (26305015) Grant-in-Aid for Scientific Research (B), the Takeda Science Foundation, and KAKENHI (26-1601) Grant-in-Aid for JSPS Fellows.	Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Baum J, 2003, GENETICS, V163, P1327; Whelan S, 2001, MOL BIOL EVOL, V18, P691; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; TAJIMA F, 1989, GENETICS, V123, P585; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Escalante AA, 1998, GENETICS, V149, P189; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JUKES T H, 1969, P21; Matsui Atsushi, 2012, P243; NEI M, 1986, MOL BIOL EVOL, V3, P418; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Rich SM, 2006, EMERG INF DIS 21ST C, P125; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Satta Y, 2004, J MOL EVOL, V59, P478, DOI 10.1007/s00239-004-2639-2; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Stringer C, 2003, NATURE, V423, P692, DOI 10.1038/423692a; Vargas-Serrato E, 2003, INFECT GENET EVOL, V3, P67, DOI 10.1016/S1567-1348(03)00007-8; Verra F, 2006, MOL BIOCHEM PARASIT, V149, P182, DOI 10.1016/j.molbiopara.2006.05.010; WARE LA, 1993, MOL BIOCHEM PARASIT, V60, P105, DOI 10.1016/0166-6851(93)90033-T	38	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 1	2015	14								293	10.1186/s12936-015-0820-2		9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CN9NV	WOS:000358776800001		
J	Sugiyama, Y				Sugiyama, Yukimaru			Influence of provisioning on primate behavior and primate studies	MAMMALIA			English	Review						environment; free-ranging; habituation; individual recognition; Japanese macaque; long-term study	MACAQUES MACACA-FUSCATA; STONE-HANDLING BEHAVIOR; WILD JAPANESE MACAQUES; POPULATION-DYNAMICS; SOCIAL-ORGANIZATION; PRESBYTIS-ENTELLUS; NATURAL HABITATS; HANUMAN LANGURS; RHESUS-MONKEYS; NATIONAL-PARK	After World War II, primate studies began on Japanese macaques and artificial provisioning facilitated short-distance observation. During these early stages of primate field research, this method allowed for individual recognition and long-term studies whereby individual and social behaviors could be described in detail and, ultimately, social structure. Owing primarily to provisioning, monkeys and apes were able to innovate some cultural behaviors. However, provisioning influences the behavior of animals. Artificially fed primate populations in Japan grew rapidly and social relationships among individuals changed. After the 1980s, scientific reports tended to not mention the incidence of provisioning in descriptions of the environment. Such omissions could inadvertently lead to misleading interpretations of the data. Therefore, authors must describe the provisioning situation as an important element of the environment. Even in the early stages of the primate studies, it should have been noted that provisioning was an experimental method and was partly an artificial living condition applied to wild populations of animals, which could have both positive and negative outcomes. In this paper I defined the terms wild, provisioning, free-ranging and habituation in appropriate words.	Primate Res Stn, Inuyama, Aichi 4840081, Japan	Sugiyama, Y (reprint author), Primate Res Stn, Kitabesso 23-3, Inuyama, Aichi 4840081, Japan.	hqvg62yd@qc.commufa.jp					Altmann S.A., 1965, JAPANESE MONKEYS COL, P151; Sinha A, 2005, CURR SCI INDIA, V89, P1166; SUGIYAMA Y, 1976, J HUM EVOL, V5, P249, DOI 10.1016/0047-2484(76)90029-4; Zhang P, 2007, AM J PRIMATOL, V69, P1425, DOI 10.1002/ajp.20454; Galdikas BM, 2013, PRIMATES, V54, P61, DOI 10.1007/s10329-012-0331-5; Yamagiwa J, 1998, PRIMATES, V39, P257, DOI 10.1007/BF02573076; SUGIYAMA Y, 1987, PRIMATES, V28, P133, DOI 10.1007/BF02382192; Nakamichi M, 1998, FOLIA PRIMATOL, V69, P35; CHENEY DL, 1983, AM NAT, V122, P392, DOI 10.1086/284142; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; WICKINGS EJ, 1992, J REPROD FERTIL, V95, P129; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Turner SE, 2008, PRIMATES, V49, P223, DOI 10.1007/s10329-008-0083-4; Sueur C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1875, DOI 10.1007/s00265-010-0999-8; Asquith P.J., 1986, P61; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; Asquith P.J., 1996, NAKED SCI ANTHR INQU, P239; Carpenter CR, 1942, J COMP PSYCHOL, V33, P113, DOI 10.1037/h0058655; CCPSJ (Conservation Committee of Primate Society of Japan), 1997, CCPSJ NEWS LETTER, V7, P6; DeVore I., 1965, PRIMATE BEHAV, P654; Dittus V., 1975, SOCIOECOLOGY PSYCHOL, P125; Fedigan L.M., 1991, P54; Furuichi T., 1982, IDEN GENETICS, V37, P51; Furuya Y., 1957, Primates, V1, P47, DOI 10.1007/BF01667198; FUSHIMI T, 1991, PRIMATOLOGY TODAY, P695; Goodall J. M., 1963, National Geographic Magazine, V124, P272; Goodall JvL, 1968, ANIM BEHAV MONOGR, V1, P161; GREEN S, 1975, Zeitschrift fuer Tierpsychologie, V38, P304; Hasegawa M., 1992, DOBUTSU NI OKERU KYO, P185; HILL DA, 1995, BEHAVIOUR, V132, P367, DOI 10.1163/156853995X00612; Hockings KJ, 2011, PRIMATOL MONOGR, P211, DOI 10.1007/978-4-431-53921-6_23; Hsu MJ, 2000, FOLIA PRIMATOL, V71, P154, DOI 10.1159/000021745; Huffman M.A., 2009, INTEGRATIVE APPROACH, P287; HUFFMAN MA, 1984, J HUM EVOL, V13, P725, DOI 10.1016/S0047-2484(84)80022-6; Huffman MA, 2010, JAPANESE MACAQUES, P191, DOI 10.1007/978-4-431-53886-8_9; Huffman Michael A., 1996, P267, DOI 10.1016/B978-012273965-1/50014-5; Huffman Michael A., 2003, P267, DOI 10.1017/CBO9780511584022.011; Ingmanson Ellen J., 1996, P190; Itani J., 1991, SARU HITO AFRICA, P213; Itani J., 1985, PRIMATE RES, V1, P5; Itani J., 1996, EDO TO AFRICA NO TAI; Itani J., 1954, JPN J ECOL, V4, P22; Itani J., 1954, TAKASAKIYAMA NO SARU, P284; Itani J., 1958, PRIMATES, V1, P84, DOI DOI 10.1007/BF01813697; Iwamoto T., 1988, ECOLOGY BEHAV FOOD E, P79; JMAP (Japanese Monkey Malformation Research Group), 1979, KIK YAEN KOEN KAR HO; Kawai M, 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Kawai M., 1960, Primates, V2, P181, DOI 10.1007/BF01659168; Kawamura S., 1958, PRIMATES, V1, P149, DOI DOI 10.1007/BF01813701; KOYAMA N, 1970, Primates, V11, P335, DOI 10.1007/BF01730638; KUDO H, 1984, J ANTHROPOL SOC NIP, V92, P253; Kurita H, 2008, INT J PRIMATOL, V29, P1189, DOI 10.1007/s10764-008-9296-z; Leca JB, 2010, PRIMATES, V51, P13, DOI 10.1007/s10329-009-0159-9; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; MILLER MH, 1973, AM J PHYS ANTHROPOL, V38, P605, DOI 10.1002/ajpa.1330380275; Mizuhara H., 1971, SARU NO KUNI NO REKI, P251; Mizuhara H., 1957, NIHONZARU, P220; MOHNOT S M, 1971, Mammalia, V35, P175, DOI 10.1515/mamm.1971.35.2.175; Nahallage CAD, 2008, AM J PRIMATOL, V70, P1124, DOI 10.1002/ajp.20610; Nahallage CAD, 2008, INT J PRIMATOL, V29, P795, DOI 10.1007/s10764-008-9268-3; Nakagawa Naofumi, 2011, Primate Research, V27, P111; NEWTON PN, 1986, ANIM BEHAV, V34, P785, DOI 10.1016/S0003-3472(86)80062-8; Newton Paul N., 1994, P311; Nishida T., 1990, P3; Nissen H.W., 1931, COMP PSYCHOL MONOGR, V8, P1; PRUDHOMME J, 1993, INT J PRIMATOL, V14, P405, DOI 10.1007/BF02192774; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; Radhakrishna S., 2013, MACAQUE CONNECTION, P286; Ripley S., 1967, SOCIAL COMMUNICATION, P237; SOMMER V, 1989, INT J PRIMATOL, V10, P293, DOI 10.1007/BF02737419; Sueur C, 2011, CURR ZOOL, V57, P8; Sueur C, 2011, P ROY SOC B-BIOL SCI, V278, P1697, DOI 10.1098/rspb.2010.2084; Sugiyama Y., 1966, Primates, V7, P41, DOI 10.1007/BF01730557; Sugiyama Yukimaru, 2011, Primate Research, V27, P51; SUGIYAMA Y, 1993, PRIMATES, V34, P151, DOI 10.1007/BF02381386; Sugiyama Y., 1960, PRIMATES, V7, P381; Sugiyama Y., 2013, PRIMATES, V55, P63; SUGIYAMA Y, 1982, FOLIA PRIMATOL, V39, P238, DOI 10.1159/000156080; Sugiyama Y, 2011, PRIMATES, V52, P19, DOI 10.1007/s10329-010-0220-8; Sugiyama Y., 2009, ANTHROPOL SCI, V119, P113; Sugiyama Yukimru, 2013, Primate Research, V29, P63; Sugiyama Y, 1977, RES REPORT TAKASAKIY, P92; Sugiyama Yukimaru, 2012, P34; Sugiyama Y., 1965, Primates, V6, P381, DOI 10.1007/BF01730356; Suzuki A., 1965, Primates, V6, P31, DOI 10.1007/BF01794458; Watanabe K, 2007, AM J PRIMATOL, V69, P940, DOI 10.1002/ajp.20403; Westergaard GC, 2003, NEUROPSYCHOPHARMACOL, V28, P1045, DOI 10.1038/sj.npp.1300171; WRANGHAM RW, 1974, ANIM BEHAV, V22, P83, DOI 10.1016/S0003-3472(74)80056-4; Yamada M., 1957, Primates, V1, P30, DOI 10.1007/BF01667197; Yamagiwa J, 2010, JAPANESE MACAQUES, P3, DOI 10.1007/978-4-431-53886-8_1; Yamagiwa J, 1998, PRIMATES, V39, P255, DOI 10.1007/BF02573075; Yasugi R., 1996, DICT BIOL, P818; Yokota N., 1998, WILDLIFE FORUM, V3, P163; YOSHIHIRO S, 1979, ECOTOX ENVIRON SAFE, V3, P458, DOI 10.1016/0147-6513(79)90036-8	94	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0025-1461	1864-1547		MAMMALIA	Mammalia	AUG	2015	79	3					255	265		10.1515/mammalia-2014-0028		11	Zoology	Zoology	CN4SN	WOS:000358420600001		
J	Vincenot, CE; Koyama, L; Russo, D				Vincenot, Christian Ernest; Koyama, Lina; Russo, Danilo			Near threatened? First report of unsuspected human-driven decline factors in the Ryukyu flying fox (Pteropus dasymallus) in Japan	MAMMALIAN BIOLOGY			English	Article						Agriculture; Culling; Fruit bat; Megabat; Poisoning; Wildlife conflict	FRUIT BATS; CONSERVATION; ISLAND; CATS	Japan hosts the largest population of the threatened Ryukyu flying fox (Pteropus dasymallus), which, in Taiwan, suffered a drastic decline leading to local extinctions and, in the Philippines, remains only on three small islands. Conservation of the species in Japan is therefore crucial. National and international assessments have been based only on local anthropogenic factors, such as habitat degradation, electrocution on power lines, and accidental entanglements. Using face-to-face interviews of farmers of the Yaeyama islands (southwestern part of the Ryukyu archipelago), we discovered that other significant human-driven causes of decline were overlooked in assessments. Most importantly, we report here for the first time on the illegal killing of this species by farmers because it feeds on crops. The bat has been killed by intense poisoning, beating, and netting. Other cases of illegal infringement of animal welfare principles by the general population were also encountered (i.e. confinement and mistreatment) but could not be quantified. Furthermore, we also determined the historical use of flying fox meat as a food source, which has also never been documented before. Finally, we identified emerging threats that were previously neglected in the assessments of the species' conservation status, namely predation by feral or semi-feral cats and dogs, whose populations have been booming in recent years. These unexpected factors, especially the ongoing killing of P.d. yayeyamae, call into question the IUCN downlisting (EN -> NT) decided in 2008, when poisoning campaigns were actually culminating, and lead us to recommend the initiation of conservation actions (particularly population monitoring), education campaigns, as well as the provision of technical assistance to farmers in need of it. (C) 2015 Deutsche Gesellschaft fur Saugetierkunde. Published by Elsevier GmbH. All rights reserved.	[Vincenot, Christian Ernest; Koyama, Lina] Kyoto Univ, Grad Sch Informat, Dept Social Informat, Kyoto, Japan; [Russo, Danilo] Univ Naples Federico II, Wildlife Res Unit, Sez Biol & Protez Sistemi Agr & Forestali, Lab Ecol Appl,Dipartimento Agr, I-80055 Portici, Italy; [Russo, Danilo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Russo, D (reprint author), Univ Naples Federico II, Wildlife Res Unit, Sez Biol & Protez Sistemi Agr & Forestali, Lab Ecol Appl,Dipartimento Agr, Via Univ 100, I-80055 Naples, Italy.	danrusso@unina.it			JSPS Post-Doctoral Fellowship LISPS KAKENHI [24-02084]	The authors hereby declare no conflict of interest. This work was performed with personal funds mainly, and travel costs to CEV were partly covered by a JSPS Post-Doctoral Fellowship LISPS KAKENHI Ref. 24-02084). All sources who contributed to this study are protected by anonymity. The authors would like to thank the people of the Yaeyama islands for their precious help in conducting this research, and more particularly the farmers, who have kindly agreed to disclose the information reported here. We sincerely hope that this study will benefit both the conservation of the beautiful fauna of the Ryukyu archipelago and the quality of life of the local human community. Finally, the authors wish to thank Karen Haysom and a second anonymous reviewer for their insightful comments on this manuscript.	[Anonymous], 2012, 11 WILDL PROT PLAN; Scheffers BR, 2012, TROP CONSERV SCI, V5, P133; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Ancillotto L, 2013, MAMM BIOL, V78, P369, DOI 10.1016/j.mambio.2013.01.003; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Chavez A, 2012, THE JAPAN TIMES 1124; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; CRAIG P, 1994, BIOL CONSERV, V69, P261, DOI 10.1016/0006-3207(94)90425-1; DoD, 2010, JAP ENV GOV STAND; Don't Shoot Bats (DSB), 2014, ENV THREATS SHOOT EL; Esselstyn JA, 2006, PAC SCI, V60, P531, DOI 10.1353/psc.2006.0027; Heaney L., 2008, IUCN RED LIST THREAT; Isa N, 2013, RYUKYU SHIMPO   0113; Mainichi Yaeyama, 2012, YAEYAMA DAILY   0920; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Okinawa Prefecture, 2012, REV ED OK RED DAT BO; Okinawa Prefecture, 2014, STAT AGR YAEYAM REG; Palmeirim JM, 2007, ORYX, V41, P509, DOI 10.1017/S0030605307004036; RDB, 2012, JAP RED DAT BOOK JAP; Threatened Species Scientific Committee (TSSC), 2014, COMM CONS ADV PTER M; TIDEMANN CR, 1994, WILDLIFE RES, V21, P279, DOI 10.1071/WR9940279; Vincenot C.E., 2015, GLOB ECOL CONSERV, V3, P526	22	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1616-5047	1618-1476		MAMM BIOL	Mamm. Biol.	AUG	2015	80	4					273	277		10.1016/j.mambio.2015.03.003		5	Zoology	Zoology	CN5KU	WOS:000358469000005		
J	Okada, A; Ito, TY; Buuveibaatar, B; Lhagvasuren, B; Tsunekawa, A				Okada, Ayumi; Ito, Takehiko Y.; Buuveibaatar, Bayarbaatar; Lhagvasuren, Badamjav; Tsunekawa, Atsushi			Genetic structure in Mongolian gazelles based on mitochondrial and micro satellite markers	MAMMALIAN BIOLOGY			English	Article							EFFECTIVE POPULATION-SIZE; PROCAPRA-GUTTUROSA; MAXIMUM-LIKELIHOOD; LANDSCAPE GENETICS; COMPUTER-PROGRAM; LINKAGE MAP; PHYLOGEOGRAPHY; PHYLOGENIES; INFERENCE; RAILROAD		[Okada, Ayumi] Kitasato Univ, Sch Vet Med, Towada, Aomori 0348628, Japan; [Ito, Takehiko Y.; Tsunekawa, Atsushi] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Buuveibaatar, Bayarbaatar] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar 15141, Mongol Peo Rep; [Lhagvasuren, Badamjav] Mongolian Acad Sci, Inst Biol, Ulaanbaatar 51, Mongol Peo Rep	Okada, A (reprint author), Kitasato Univ, Sch Vet Med, 23-35-1 Higashi, Towada, Aomori 0348628, Japan.	okada@vmas.kitasato-u.ac.jp	Ito, Takehiko/M-7221-2015; Tsunekawa, Atsushi/L-8526-2013	Tsunekawa, Atsushi/0000-0002-7690-0633			AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; AREVALO E, 1994, ANIM GENET, V25, P202; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Olson KA, 2011, CONSERV LETT, V4, P304, DOI 10.1111/j.1755-263X.2011.00180.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Ito TY, 2005, CONSERV BIOL, V19, P945, DOI 10.1111/j.1523-1739.2005.004364.x; Pritchard JK, 2000, GENETICS, V155, P945; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; CRAWFORD AM, 1995, GENETICS, V140, P703; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; MOORE SS, 1994, MAMM GENOME, V5, P84, DOI 10.1007/BF00292333; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj/hdy/6800060; Milner-Gulland EJ, 1998, J APPL ECOL, V35, P240; HOLM S, 1979, SCAND J STAT, V6, P65; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Zhang FF, 2006, MOL PHYLOGENET EVOL, V41, P313, DOI 10.1016/j.ympev.2006.05.024; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; BISHOP MD, 1994, GENETICS, V136, P619; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BANNIKOV A G, 1951, Biull Mosk Ova Ispyt Prir (Biol), V56, P20; Buchanan F. C., 1993, Animal Genetics, V24, P145; BUCHANAN FC, 1992, ANIM GENET, V23, P185; Chen J, 2012, INT J MOL SCI, V13, P8805, DOI 10.3390/ijms13078805; Comuet JM, 1996, GENETICS, V144, P2001; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fleming CH, 2014, AM NAT, V183, pE154, DOI 10.1086/675504; Freeland JR, 2011, MOL ECOLOGY; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heptner V.G., 1988, MAMMALS SOVIET UNION, V1; Huebinger RM, 2006, MOL ECOL NOTES, V6, P1150, DOI 10.1111/j.1471-8286.2006.01467.x; International Union for Conservation of Nature (IUCN), 2013, IUCN RED LIST THREAT; Ito TY, 2013, J ARID ENVIRON, V91, P61, DOI 10.1016/j.jaridenv.2012.12.008; Ito TY, 2008, J WILDLIFE MANAGE, V72, P940, DOI 10.2193/2007-188; Ito TY, 2006, J ZOOL, V269, P291, DOI 10.1111/j.1469-7998.2006.00077.x; Ito TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056995; Jiang Zhaowen, 1998, Mammal Study, V23, P63, DOI 10.3106/mammalstudy.23.63; Lei RH, 2003, ANIM CONSERV, V6, P361, DOI 10.1017/S136794300300433; Leimgruber P, 2001, BIOL CONSERV, V102, P205, DOI 10.1016/S0006-3207(01)00041-6; Leslie David M. Jr., 2010, Mammalian Species, P138, DOI 10.1644/861.1; Lhagvasuren B, 1997, ORYX, V31, P127, DOI 10.1046/j.1365-3008.1997.d01-6.x; Lushchekina A.A., 1985, ARCH NATURSCHUTZ LAN, V25, P57; Nei M., 2000, MOL EVOLUTION PHYLOG; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, 1981, GENETICS, V98, P625; Okada Ayumi, 2012, Mongolian Journal of Biological Sciences, V10, P59; Olson K.A., 2010, MONGOLIAN J BIOL SCI, V8, P15; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Olson KA, 2009, ORYX, V43, P149, DOI 10.1017/S0030605307002293; Peakall R, 1996, BACK FROM THE BRINK: REFINING THE THREATENED SPECIES RECOVERY PROCESS, P119; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; RAYMOND M, 1995, J HERED, V86, P248; Rousset F, 2004, GENETIC STRUCTURE SE; Sambrook J., 1989, MOL CLONING LAB MANU; Sorokin P.A., 2006, DOKL AKAD NAUK, V409, P311, DOI 10.1134/S0012496606040120; [Сорокин П.А. Sorokin P.A.], 2005, [Генетика, Russian Journal of Genetics, Genetika], V41, P1345; TAJIMA F, 1983, GENETICS, V105, P437; Wang XM, 1997, ORYX, V31, P120, DOI 10.1046/j.1365-3008.1997.d01-100.x; Waples RS, 2002, POPULATION VIABILITY ANALYSIS, P147; Wright S, 1969, EVOLUTION GENETICS P, V2; YANG J, 2011, PLOS ONE, V0006; Zhang FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060712	90	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1616-5047	1618-1476		MAMM BIOL	Mamm. Biol.	AUG	2015	80	4					303	311				9	Zoology	Zoology	CN5KU	WOS:000358469000010		
J	Rivals, F; Takatsuki, S				Rivals, Florent; Takatsuki, Seiki			Within-island local variations in tooth wear of sika deer (Cervus nippon centralis) in northern Japan	MAMMALIAN BIOLOGY			English	Article						Cervidae; Kinkazan Island; Diet; Mesowear; Microwear	KINKAZAN ISLAND; DENTAL MICROWEAR; PERISSODACTYLA	Geographical variations in feeding habits of mammals are usually known from field observation. However, using proxies such as tooth wear (mesowear and microwear), other studies also permitted to indirectly infer dietary traits of populations. Tooth mesowear which indicates the diet over a long temporal scale (the last weeks or months) and tooth microwear which reflects the diet over a short temporal scale (the last days or weeks) were employed to identify differences in diets at large scales. The objective of this study is to test for local variations in diet by comparing populations of sika deer (Cervus nippon centralis) from five small areas on Kinkazan Island, northern Japan. Results indicate that tooth mesowear averages the feeding habits over long periods of time and consequently is not appropriate to identify local differences. On the contrary, tooth microwear permitted to distinguish significant differences in wear patterns. Tooth microwear analysis has shown that even on a small island like Kinkazan, local variations in feeding habits of sika deer could be identified. Therefore microwear is a proxy suitable to the study of feeding habits of ungulates at small geographical scale. (C) 2015 Deutsche Gesellschaft fur Saugetierkunde. Published by Elsevier GmbH. All rights reserved.	[Rivals, Florent] ICREA Catalan Inst Res & Adv Studies, Barcelona, Spain; [Rivals, Florent] IPHES, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43007, Spain; [Rivals, Florent] Univ Rovira & Virgili, Area Prehist, Tarragona 43002, Spain; [Takatsuki, Seiki] Azabu Univ, Lab Wildlife Ecol & Conservat, Sagamihara, Kanagawa 229850, Japan	Rivals, F (reprint author), IPHES, Inst Catala Paleoecol Humana & Evolucio Social, C Marcelli Domingo S-N,Campus Sescelades URV, Tarragona 43007, Spain.	florent.rivals@gmail.com	Rivals, Florent/B-7962-2014	Rivals, Florent/0000-0001-8074-9254	Agencia de Gestio d'Ajuts Universitaris i de Recerca [AGAUR 2012-BE-DGR-93]; Ministerio de Economia y Competitividad [HAR2010-19957, HAR2013-48784-C3-1-P]; Azabu University; Nature Conservation Branch of Miyagi Prefecture	This research received the financial support of the grants from the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR 2012-BE-DGR-93) and the Ministerio de Economia y Competitividad (HAR2010-19957 and HAR2013-48784-C3-1-P) to FR, and a research project grant awarded by the Azabu University to ST. The Nature Conservation Branch of Miyagi Prefecture also financially supported this study. We acknowledge Mr. K. Suzuki, Tohoku University, for supporting sample collection.	Semprebon GM, 2011, J MAMM EVOL, V18, P33, DOI 10.1007/s10914-010-9149-3; Rivals F, 2007, J VERTEBR PALEONTOL, V27, P763, DOI 10.1671/0272-4634(2007)27[763:EOODIF]2.0.CO;2; Rivals F, 2009, J HUM EVOL, V56, P329, DOI 10.1016/j.jhevol.2008.11.005; TAKATSUKI S, 1994, ECOL RES, V9, P115, DOI 10.1007/BF02347486; Rivals F, 2014, J MAMMAL, V95, P1043, DOI 10.1644/14-MAMM-A-097; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Ito TY, 2005, ECOL RES, V20, P573, DOI 10.1007/s11284-005-0073-6; Kubo MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090745; Mainland I.L., 2000, INT J OSTEOARCHAEOL, V10, P97; Mainland I.L., 1998, ENV ARCHAEOLOGY, V1, P55; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Schulz E, 2013, MAMMAL REV, V43, P111, DOI 10.1111/j.1365-2907.2012.00210.x; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Takatsuki Seiki, 2009, P231, DOI 10.1007/978-4-431-09429-6_17; TAKATSUKI S, 1980, Science Reports of the Tohoku University Fourth Series (Biology), V38, P7; Takatsuki Seiki, 2007, Mammal Study, V32, P115, DOI 10.3106/1348-6160(2007)32[115:MVIWFC]2.0.CO;2; TAKATSUKI S, 1991, Journal of the Mammalogical Society of Japan, V15, P91; Takatsulki Seiki, 2009, P113, DOI 10.1007/978-4-431-09429-6_8; TAKATSUKI S, 1994, ECOL RES, V9, P215, DOI 10.1007/BF02347497; Takatsuki Seiki, 2009, P125, DOI 10.1007/978-4-431-09429-6_9; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Yamada E, 2012, MAMM STUDY, V37, P93	26	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1616-5047	1618-1476		MAMM BIOL	Mamm. Biol.	AUG	2015	80	4					333	339		10.1016/j.mambio.2015.02.001		7	Zoology	Zoology	CN5KU	WOS:000358469000014		
J	Biswas, G; Kinoshita, S; Kono, T; Hikima, J; Sakai, M				Biswas, Gouranga; Kinoshita, Shunsuke; Kono, Tomoya; Hikima, Jun-ichi; Sakai, Masahiro			Evolutionary evidence of tumor necrosis factor super family members in the Japanese pufferfish (Takifugu rubripes): Comprehensive genomic identification and expression analysis	MARINE GENOMICS			English	Article						Tumor necrosis factor superfamily; Genomic location; TNFSF evolution; TNFSF10; Japanese pufferfish	NF-KAPPA-B; CARP CTENOPHARYNGODON-IDELLA; TROUT ONCORHYNCHUS-MYKISS; DOUBLE-STRANDED-RNA; FUNCTIONAL-CHARACTERIZATION; TNF SUPERFAMILY; RAINBOW-TROUT; FUGU-RUBRIPES; FACTOR-ALPHA; LIGAND TRAIL	Tumor necrosis factor (TNF) and its superfamily (TNFSF) members are important inflammatory cytokines. Although fish have fourteen TNFSF genes, their genomic location and existence are yet to be described and confirmed in the Japanese pufferfish (Fugu) (Takifugu rubripes). Therefore, we conducted in silico identification, synteny analysis of TNFSF genes from Fugu with that of zebrafish and human TNFSF loci and their expression analysis in various tissues. We identified ten novel TNFSF genes, viz. TNFSF5 (CD4OL), TNFSF6 (FasL), three TNFSF10 (TRAIL) (-1,2 and 3), TNFSF11 (RANKlg), TNESF12 (TWEAK), two TNESF13B (BAFF) (1 and 2) and TNFSF14 (LIGHT) belonging to seven TNFSFs in Fugu. Several features such as existence of TNF family signature, conservation of genes in TNF loci with human and zebrafish chromosomes and phylogenetic clustering with other teleost TNFSF orthologs confirmed their identity. Fugu TNFSF genes were constitutively expressed in all eight different tissues with most of them expressed highly in liver. Fugu TNFSF10 gene has three homologs present on chromosomes 10 (TNFSF10-1), 8 (TNFSF10-2) and 2 (TNFSF10-3). Moreover, a phylogenetic analysis containing all available vertebrate (mammals, birds, reptiles, amphibians and fish) TNFSF10 oithologs showed that Fugu TNFSF10-1 and 10-3 are present in all vertebrates, whereas TNFSF10-2 was not related to any mammalian and avian orthologs. Viral double-stranded RNA mimic poly (I:C) caused an elevated expression of three Fugu TNFSF10 genes in head kidney cells at 4 h indicating probable role of these genes to induce apoptosis in virus-infected cells. In conclusion, Fugu possesses genes belonging to nine TNFSFs including the newly identified seven and previously reported two, TNFSF New (TNF-N) and TNFSF2 (TNF-alpha). Our findings would add up information to TNFSF evolution among vertebrates. (C) 2015 Elsevier B.V. All rights reserved.	[Biswas, Gouranga] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Kinoshita, Shunsuke; Kono, Tomoya; Hikima, Jun-ichi; Sakai, Masahiro] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892192, Japan	Sakai, M (reprint author), Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, 1-1 Gakuenkibanadai Nishi, Miyazaki 8892192, Japan.	m.sakai@cc.miyazaki-u.ac.jp			JSPS Asian CORE Program and Scientific Research; MEXT (Monbukagakusho), Japan	This work was supported by the JSPS Asian CORE Program and Scientific Research. GB received a scholarship from the MEXT (Monbukagakusho), Japan during this study.	AbdallA SA, 2004, J VET MED SCI, V66, P643, DOI 10.1292/jvms.66.643; Tamada K, 2000, J IMMUNOL, V164, P4105; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Laing KJ, 2001, EUR J BIOCHEM, V268, P1315, DOI 10.1046/j.1432-1327.2001.01996.x; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Mackay F, 2002, TRENDS IMMUNOL, V23, P113, DOI 10.1016/S1471-4906(01)02159-7; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Edwards YJK, 1998, J MOL BIOL, V278, P843, DOI 10.1006/jmbi.1998.1752; Glenney GW, 2007, J IMMUNOL, V178, P7955; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Kono T, 2006, MOL IMMUNOL, V43, P1390, DOI 10.1016/j.molimm.2005.07.037; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Zou J, 2003, DEV COMP IMMUNOL, V27, P813, DOI 10.1016/S0145-305X(03)00077-6; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P29, DOI 10.1016/S0145-305X(02)00064-2; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Biswas G, 2013, FISH SHELLFISH IMMUN, V34, P1170, DOI 10.1016/j.fsi.2013.01.024; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Grayfer L, 2008, DEV COMP IMMUNOL, V32, P532, DOI 10.1016/i.dci.2007.09.009; Zhang AY, 2012, FISH SHELLFISH IMMUN, V33, P1123, DOI 10.1016/j.fsi.2012.08.029; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Collette Y, 2003, TRENDS IMMUNOL, V24, P387, DOI 10.1016/S1471-4906(03)00166-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Chang MX, 2006, VET IMMUNOL IMMUNOP, V110, P51, DOI 10.1016/j.vetimm.2005.09.003; Clarice P., 2000, J VIROL, V74, P8134; Clark MS, 2001, MAR BIOTECHNOL, V3, pS130, DOI 10.1007/s10126-001-0034-1; Crispe IN, 1996, IMMUNOL TODAY, V17, P522, DOI 10.1016/S0167-5699(96)80906-6; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hirono I, 2000, J IMMUNOL, V165, P4423; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Kinoshita S, 2014, MAR GENOM, V13, P1, DOI 10.1016/j.margen.2013.10.004; Laing KJ, 2000, FISH SHELLFISH IMMUN, V10, P261, DOI 10.1006/fsim.1999.0255; Liu DW, 2015, AQUACULTURE, V436, P65, DOI 10.1016/j.aquaculture.2014.10.030; Mohi M.M., 2010, J FISH DIS, V33, P833; Nakayama M., 2003, INFLAMM REGEN, V23, P144; Pandit NP, 2013, DEV COMP IMMUNOL, V39, P460, DOI 10.1016/j.dci.2013.01.004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Savan R, 2006, COMP BIOCHEM PHYS D, V1, P89, DOI 10.1016/j.cbd.2005.08.005; Sayan R, 2004, FISH SHELLFISH IMMUN, V17, P87; Sayan R., 2005, IMMUNOGENETICS, V57, P140; Watabe Shugo, 2008, Bulletin of Fisheries Research Agency, P83; Weins G. D., 2011, DEV COMP IMMUNOL, V35, P1324; Zou J, 2003, DEV COMP IMMUNOL, V27, P845, DOI 10.1016/S0145-305X(03)00085-5	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-7787	1876-7478		MAR GENOM	Mar. Genom.	AUG	2015	22						25	36		10.1016/j.margen.2015.03.003		12	Genetics & Heredity; Marine & Freshwater Biology	Genetics & Heredity; Marine & Freshwater Biology	CN7PY	WOS:000358627700006		
J	Otsuka-Kanazawa, S; Ichii, O; Kon, Y				Otsuka-Kanazawa, Saori; Ichii, Osamu; Kon, Yasuhiro			Testicular oocytes in MRL/MpJ mice possess similar morphological, genetic, and functional characteristics to ovarian oocytes	MECHANISMS OF DEVELOPMENT			English	Article						DNA methylation; H3K9me2; Meiosis; MRL/MpJ mouse; Oogenesis; Testicular oocytes	GERM-CELLS; MOUSE; FERTILIZATION; TESTES; SEX; DIFFERENTIATION; METHYLATION; PROGRESSION; KNOCKOUT; GENOME	In general, mammalian males produce only spermatozoa in their testes and females produce only oocytes in their ovaries. However, newborn MRL/MpJ male mice produce oocytes within their testes. In this study, we examined the initiation and progression of oogenesis in fetal and neonatal MRL/MpJ mouse testes and evaluated the characteristics of testicular oocytes. Germ cells with positive reactions to oogenesis markers such as NOBOX oogenesis homeobox and synaptonemal complex protein 3 were observed in the MRL/MpJ fetal testes on embryonic day 18.5. These fetal testicular oocytes possessed maternal-specific methylation patterns of histone and DNA. The level of DNA methylation was still low in postnatal testicular oocytes at day 14 after birth. Additionally, the postnatal testicular oocytes contained both X and Y chromosomes and had the ability to fuse with sperm. These results suggest that some XY germ cells in fetal testes of MRL/MpJ mice enter meiosis prematurely, undergo oogenesis, and differentiate into oocytes. In addition, MRL/MpJ testicular oocytes have the ability to carry on oogenesis before and shortly after birth until they obtain some of the morphological, epigenetic, and functional characteristics of oocytes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Otsuka-Kanazawa, Saori; Ichii, Osamu; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Anat Lab, Sapporo, Hokkaido 0600818, Japan	Otsuka-Kanazawa, S (reprint author), Hokkaido Univ, Grad Sch Vet Med, Anat Lab, Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	saori-o@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24780278, 26450439]; Kurata Memorial Hitachi Science and Technology Foundation; Takeda Science Foundation; Hayashi Memorial Foundation for Female Natural Scientists	We thank Dr. M. Tsuji (Chromosome Science Labo Inc.) for technical support on FISH experiments. Financial support for this study was provided by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (no. 24780278 and no. 26450439), The Kurata Memorial Hitachi Science and Technology Foundation, Takeda Science Foundation, and Hayashi Memorial Foundation for Female Natural Scientists.	Abe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023848; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; CONOVER JC, 1988, J REPROD FERTIL, V82, P681; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193; Otsuka S, 2008, BIOL REPROD, V79, P9, DOI 10.1095/biolreprod.107.064519; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Alfieri JA, 2003, J CELL SCI, V116, P2149, DOI 10.1242/jcs.00430; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Deguchi K, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103572; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Isotani A, 2005, P NATL ACAD SCI USA, V102, P4039, DOI 10.1073/pnas.0406769102; McLaren A, 1995, PHILOS T ROY SOC B, V350, P229, DOI 10.1098/rstb.1995.0156; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Otsuka S, 2008, JPN J VET RES, V56, P129; Otsuka S, 2012, MAMM GENOME, V23, P741, DOI 10.1007/s00335-012-9405-3; Zuccotti Maurizio, 1994, Zygote, V2, P333	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	AUG	2015	137						23	32		10.1016/j.mod.2015.04.002		10	Developmental Biology	Developmental Biology	CN9VZ	WOS:000358799800003		
J	Sakai, H; Sakaguchi, H; Aoki, F; Suzuki, MG				Sakai, Hiroki; Sakaguchi, Honami; Aoki, Fugaku; Suzuki, Masataka G.			Functional analysis of sex-determination genes by gene silencing with LNA-DNA gapmers in the silkworm, Bombyx mori	MECHANISMS OF DEVELOPMENT			English	Article						Sex determination; Fem; Masc; Imp; Bmdsx; Bombyx mori	X-CHROMOSOME INACTIVATION; RNAI-MEDIATED KNOCKDOWN; PRE-MESSENGER-RNA; DROSOPHILA-MELANOGASTER; DETERMINING REGION; DOUBLESEX GENE; IDENTIFICATION; MECHANISM; SEQUENCE; IMP	The sexual fate of B. mori is determined genetically; ZW, female and ZZ, male. Recently, we successfully identified a strong candidate gene at the top of the sex determination cascade in B. mori. This gene was termed Feminizer (Fem) and revealed to be a source of Fem-piRNA. Further, we found that B. mori doublesex (Bmdsx) splicing was markedly altered to produce the male-type isoform when a Fem-piRNA inhibitor was injected into ZW embryos. Moreover, knockdown of Masculinizer (Masc), a Fem-piRNA target gene, altered to produce the female-type isoform of Bmdsx in male embryos. However, it remains unclear as to whether Masc directly regulates the sex-specific expression of Bmdsx. In previous studies, we determined that the male-specific isoform of the Bombyx homolog of IGF-II mRNA-binding protein (Imp(M)) was involved in the male-specific splicing of Bmdsx. In an attempt to clarify the genetic relationship between Fem, Masc, Imp(M), and Bmdsx, knockdown experiments were performed. Knockdown of Fem shifted into male-type Bmdsx, Imp(M) and Masc in female embryos. Knockdown of Masc led to the production of the female-type Bmdsx and a dramatic reduction in Imp(M) expression in male embryos. Knockdown of ImpM shifted Bmdsx splice mode from the male-type into the female-type. Our results suggest that: (1) Fem reduces Masc expression, (2) Masc dramatically induces Imp(M) expression, and (3) Imp(M) shifting Bmdsx splice mode from the female-type into the male-type. Based on these findings, we propose a possible genetic cascade regulating sex determination in B. mori. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sakai, Hiroki; Sakaguchi, Honami; Aoki, Fugaku; Suzuki, Masataka G.] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Suzuki, MG (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	gakyo@k.u-tokyo.ac.jp			 [26292172]	We would like to thank Dr. Takashi Kiuchi for providing the siRNAs. This work was supported by a Grant-in-Aid for Scientific Research (B), 26292172, 2014.	Alló M, 2010, Cold Spring Harb Symp Quant Biol, V75, P103, DOI 10.1101/sqb.2010.75.023; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Suzuki MG, 2010, MOL CELL BIOL, V30, P5776, DOI 10.1128/MCB.00444-10; Suzuki MG, 2014, INT J MOL SCI, V15, P6772, DOI 10.3390/ijms15046772; Gendrel AV, 2014, ANNU REV CELL DEV BI, V30, P561, DOI 10.1146/annurev-cellbio-101512-122415; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; BEDO DG, 1985, CHROMOSOMA, V92, P344, DOI 10.1007/BF00327465; Willhoeft U, 1996, GENETICS, V144, P737; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Nagaraju J, 2014, SEX DEV, V8, P104, DOI 10.1159/000357483; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; BAKER RH, 1976, J HERED, V67, P289; BEUKEBOOM LW, 1995, BIOESSAYS, V17, P813, DOI 10.1002/bies.950170911; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; HASIMOTO HARUO, 1933, JAP JOUR GENETICS, V8, P245; Koike Y, 2003, MOL GENET GENOMICS, V269, P137, DOI 10.1007/s00438-003-0822-6; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; Sahara K, 2012, CHROMOSOME RES, V20, P83, DOI 10.1007/s10577-011-9262-z; Sakai H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00235; Sakai H, 2014, DEV GENES EVOL, V224, P119, DOI 10.1007/s00427-013-0461-9; Suzuki MG, 2012, INT J DEV BIOL, V56, P693, DOI 10.1387/ijdb.120049ms; Suzuki MG, 2014, MECH DEVELOP, V131, P47, DOI 10.1016/j.mod.2013.10.004; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Tanaka N, 2000, HEREDITAS, V133, P95, DOI 10.1111/j.1601-5223.2000.t01-1-00095.x; TRAUT W, 1994, J HERED, V85, P218	31	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	AUG	2015	137						45	52		10.1016/j.mod.2015.03.002		8	Developmental Biology	Developmental Biology	CN9VZ	WOS:000358799800005		
J	Ahammad, AKS; Asaduzzaman, M; Asakawa, S; Watabe, S; Kinoshita, S				Ahammad, A. K. Shakur; Asaduzzaman, Md; Asakawa, Shuichi; Watabe, Shugo; Kinoshita, Shigeharu			Regulation of gene expression mediating indeterminate muscle growth in teleosts	MECHANISMS OF DEVELOPMENT			English	Article						Indeterminate muscle growth; Muscle hyperplasia; Teleost; Myosin heavy chain; Promoter analysis	HEAVY-CHAIN GENES; FISH SPARUS-AURATA; SKELETAL-MUSCLE; TAKIFUGU-RUBRIPES; HYPERTROPHIC GROWTH; MYOSIN; SARCOPENIA; ZEBRAFISH; HEDGEHOG; FIBERS	Teleosts are unique among vertebrates due to their indeterminate muscle growth, i.e., continued production of neonatalmuscle fibers until death. However, the molecular mechanism(s) underlying this property is unknown. Here, we focused on the torafugu (Takifugu rubripes) myosin heavy chain gene, MYHM2528-1, which is specifically expressed in neonatalmuscle fibers produced by indeterminate muscle growth. We examined the flanking region of MYHM2528-1 through an in vivo reporter assay using zebrafish (Danio rerio) and identified a 2100 bp 5'-flanking sequence that contained sufficient promoter activity to allow specific gene expression. The effects of enhanced promoter activity were observed at the outer region of the fast muscle and the dorsal edge of slow muscle in zebrafish larvae. At the juvenile stage, the promoter was specifically activated in small diameter muscle fibers scattered throughout fast muscle and in slow muscle near the septum separating slow and fast muscles. This spatiotemporal promoter activity overlapped with known myogenic zones involved in teleost indeterminate muscle growth. A deletion mutant analysis revealed that the -2100 to -600 bp 5'flanking sequence of MYHM2528-1 is essential for promoter activity. This region contains putative binding sites for several representative myogenesis-related transcription factors and nuclear factor of activated T-cell (NFAT), a transcription activator involved in regeneration of mammalian adult skeletal muscle. A significant reduction in the promoter activity of the MYHM2528-1 deletion constructs was observed in accordance with a reduction in the number of these binding sites, suggesting the involvement of specific transcription factors in indeterminate muscle growth. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ahammad, A. K. Shakur; Asakawa, Shuichi; Kinoshita, Shigeharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1138657, Japan; [Asaduzzaman, Md] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu 21030, Terengganu, Malaysia; [Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Kinoshita, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan.	akino@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [14498637]	This study was partially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (14498637). The authors thank Dr. Koichi Kawakami, National Institute of Genetics, Japan, for providing the pT2AL200R150G and pCS-TP vectors used in this study. The authors also thank Mr. Koda, Oshima Fisheries Hatchery, Nagasaki, Japan, and Mr. Toshitaka Mochiduki, Kawaku Co., Ltd., Yamaguchi, Japan, for supplying the torafugu samples.	WHALEN RG, 1981, NATURE, V292, P805, DOI 10.1038/292805a0; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Demontis F, 2013, AGING CELL, V12, P943, DOI 10.1111/acel.12126; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Akolkar DB, 2010, J EXP BIOL, V213, P137, DOI 10.1242/jeb.030759; ROWLERSON A, 1995, J MUSCLE RES CELL M, V16, P223, DOI 10.1007/BF00121131; Berg JS, 2001, MOL BIOL CELL, V12, P780; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Asaduzzaman M, 2013, GENE, V515, P144, DOI 10.1016/j.gene.2012.10.089; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Froehlich JM, 2013, IN VITRO CELL DEV-AN, V49, P371, DOI 10.1007/s11626-013-9616-2; Johnston IA, 2009, J EXP BIOL, V212, P1781, DOI 10.1242/jeb.029918; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; ROWE RWD, 1969, J ANAT, V104, P519; Clark BC, 2010, CURR OPIN CLIN NUTR, V13, P271, DOI 10.1097/MCO.0b013e328337819e; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Bone Q, 1978, FISH PHYSIOL, P361; Chanoine C, 2004, DEV DYNAM, V231, P662, DOI 10.1002/dvdy.20174; Daou N, 2013, DEVELOPMENT, V140, P4914, DOI 10.1242/dev.097428; ENNION S, 1995, J EXP BIOL, V198, P1603; Fernandes JMO, 2005, PHYSIOL GENOMICS, V22, P327, DOI 10.1152/physiolgenomics.00087.2005; Froehlich Jacob M., 2013, Frontiers in Genetics, V4, P159, DOI 10.3389/fgene.2013.00159; Johnston IA, 2001, EXPTL BIOL REV, P99; Johnston Ian A., 2001, Fish Physiology, V18, P141; Lee H.-T., 2010, THESIS U ST ANDREWS; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Rowlerson A., 2001, Fish Physiology, V18, P103; Rowlerson A, 1997, CELL TISSUE RES, V289, P311, DOI 10.1007/s004410050878; Westerfield M, 1995, ZEBRAFISH BOOK	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	AUG	2015	137						53	65		10.1016/j.mod.2015.02.006		13	Developmental Biology	Developmental Biology	CN9VZ	WOS:000358799800006		
J	Nagasao, T; Hamamoto, Y; Tamai, M; Kudo, H; Ensako, T; Kogure, T; Takano, N; Tanaka, Y				Nagasao, Tomohisa; Hamamoto, Yusuke; Tamai, Motoki; Kudo, Hiroo; Ensako, Toshiya; Kogure, Tetsukuni; Takano, Naoki; Tanaka, Yoshio			The "Sea" should not be operated on in scar revision for "Island-Like" scars	MEDICAL HYPOTHESES			English	Article							STRESS; FIBROBLASTS; CHANNELS; SUTURE; HEART	Scars developing on body surfaces not only restrict body movement, but are also problematic from a cosmetic standpoint. Hence, revision is conducted by removing the scar and re-suturing the resultant defects. In performing scar revision, care should be taken to prevent the re-sutured wounds from developing hypertrophy again. Scars often present a pattern where hard, red parts are separated by soft parts in between. As the hard and soft parts may be analogized as islands and seas respectively, we call this the "Island-Like" scar. Two strategies can be taken to treat scars of this type. The first is to remove the entire scar including both hard and soft parts; the second is to remove only the hard parts and leave the soft parts untouched. The authors conducted a biomechanical study using finite element analyses and found that as a body moves, greater stresses occur in the pen-wound regions with the first strategy than with the second strategy. A wound's likelihood to develop hypertrophy increases as the stresses working on it increase. Hence, it is hypothesized that the second strategy carries less risk of the operated wounds developing re-hypertrophy than the first strategy. Based on this logic, in performing scar revision for scars consisting of hard and soft parts, it is recommended only to remove only hard parts and not to operate on soft parts in between. (C) 2015 Elsevier Ltd. All rights reserved.	[Nagasao, Tomohisa; Hamamoto, Yusuke; Tamai, Motoki; Kudo, Hiroo; Ensako, Toshiya; Kogure, Tetsukuni; Tanaka, Yoshio] Kagawa Univ, Grad Sch Med, Fac Med, Dept Plast & Reconstruct Surg, Miki, Kagawa, Japan; [Takano, Naoki] Keio Univ, Dept Mech Engn, Tokyo 108, Japan	Nagasao, T (reprint author), Kagawa Univ, Sch Med, Dept Plast Surg, Ikenobe 1750-1, Miki, Kagawa, Japan.	nagasao@med.kagawa-u.ac.jp					Abramochkin DV, 2014, J MOL CELL CARDIOL, V70, P27, DOI 10.1016/j.yjmcc.2013.12.020; Nagasao T, 2010, J THORAC CARDIOV SUR, V140, P1294, DOI 10.1016/j.jtcvs.2010.06.025; ELLIOT D, 1985, ANN ROY COLL SURG, V67, P238; Junker JPE, 2008, BURNS, V34, P942, DOI 10.1016/j.burns.2008.01.010; Li JQ, 2013, BURNS, V39, P89, DOI 10.1016/j.burns.2012.05.009; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Garg Shilpa, 2014, J Cutan Aesthet Surg, V7, P3, DOI 10.4103/0974-2077.129959; BOWMAN CL, 1992, BRAIN RES, V584, P272, DOI 10.1016/0006-8993(92)90906-P; Durkaya S, 2005, TEX HEART I J, V32, P544; Furuya K, 2005, J CELL SCI, V118, P3289, DOI 10.1242/jcs.02453; Hu H, 1996, J MEMBRANE BIOL, V154, P205, DOI 10.1007/s002329900145; Mizunuma M, 2000, PLAST RECONSTR SURG, V106, P845, DOI 10.1097/00006534-200009040-00015; Mizunuma M, 2000, PLAST RECONSTR SURG, V106, P849; Nagasao T, 2013, MED HYPOTHESES, V81, P136, DOI 10.1016/j.mehy.2013.04.016; Nagasao T, 2013, J PLAST SURG HAND SU, V47, P484, DOI 10.3109/2000656X.2012.738422; Nagasao T, 2011, CLEFT PALATE-CRAN J, V48, P190, DOI 10.1597/09-027; Ogawa R, 2012, WOUND REPAIR REGEN, V20, P149, DOI 10.1111/j.1524-475X.2012.00766.x; Sachs F, 1990, Neurosci Res Suppl, V12, pS1, DOI 10.1016/0921-8696(90)90003-L; Sasamoto A, 2005, AM J PHYSIOL-CELL PH, V288, P1012; SIMPSON JEP, 1979, BRIT J SURG, V66, P281, DOI 10.1002/bjs.1800660421; Yamada H., 1970, STRENGTH BIOL MAT; Yoshida H, 2000, MED ENG PHYS, V22, P481, DOI 10.1016/S1350-4533(00)00064-3; Yoshimura K, 2008, P NATL ACAD SCI USA, V105, P4033, DOI 10.1073/pnas.0709436105; ZHANG LQ, 1995, ARCH DERMATOL RES, V287, P534, DOI 10.1007/BF00374072	24	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	AUG	2015	85	2					215	218		10.1016/j.mehy.2015.04.026		4	Medicine, Research & Experimental	Research & Experimental Medicine	CN5KQ	WOS:000358468600022		
J	McCluggage, WG; Judge, MJ; Clarke, BA; Davidson, B; Gilks, CB; Hollema, H; Ledermann, JA; Matias-Guiu, X; Mikami, Y; Stewart, CJR; Vang, R; Hirschowitz, L				McCluggage, W. Glenn; Judge, Meagan J.; Clarke, Blaise A.; Davidson, Ben; Gilks, C. Blake; Hollema, Harry; Ledermann, Jonathan A.; Matias-Guiu, Xavier; Mikami, Yoshiki; Stewart, Colin J. R.; Vang, Russell; Hirschowitz, Lynn			Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)	MODERN PATHOLOGY			English	Article								A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the 'required' and 'recommended' elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management.	[McCluggage, W. Glenn] Belfast Hlth & Social Care Trust, Dept Pathol, Belfast, Antrim, North Ireland; [Judge, Meagan J.] Royal Coll Pathologists Australasia, Sydney, NSW, Australia; [Clarke, Blaise A.] Univ Toronto, Dept Pathol & Lab Med, Univ Hlth Network, Toronto, ON, Canada; [Davidson, Ben] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Davidson, Ben] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Gilks, C. Blake] Univ British Columbia, Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Hollema, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Ledermann, Jonathan A.] UCL Canc Inst, Dept Oncol, London, England; [Matias-Guiu, Xavier] Univ Lleida, IRBLleida, Hosp Univ Arnau de Vilanova, Dept Pathol, Lleida, Spain; [Matias-Guiu, Xavier] Univ Lleida, IRBLleida, Hosp Univ Arnau de Vilanova, Mol Genet & Res Lab, Lleida, Spain; [Mikami, Yoshiki] Kumamoto Univ Hosp, Dept Diagnost Pathol, Kumamoto, Japan; [Stewart, Colin J. R.] King Edward Mem Hosp, Dept Histopathol, Perth, WA, Australia; [Stewart, Colin J. R.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Vang, Russell] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Gynecol Pathol, Baltimore, MD USA; [Hirschowitz, Lynn] Birmingham Womens Hosp, Dept Cellular Pathol, Birmingham, W Midlands, England	McCluggage, WG (reprint author), Royal Grp Hosp Trust, Dept Pathol, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland.	glenn.mccluggage@belfasttrust.hscni.net	matias-guiu, xavier/C-3039-2009	matias-guiu, xavier/0000-0002-7201-6605				0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	AUG	2015	28	8					1101	1122		10.1038/modpathol.2015.77		22	Pathology	Pathology	CO0LD	WOS:000358841800009		
J	Choudhary, MK; Nomura, Y; Wang, L; Nakagami, H; Somers, DE				Choudhary, Mani Kant; Nomura, Yuko; Wang, Lei; Nakagami, Hirofumi; Somers, David E.			Quantitative Circadian Phosphoproteomic Analysis of Arabidopsis Reveals Extensive Clock Control of Key Components in Physiological, Metabolic, and Signaling Pathways	MOLECULAR & CELLULAR PROTEOMICS			English	Article							SUCROSE-PHOSPHATE SYNTHASE; NITRATE REDUCTASE-ACTIVITY; PROTEIN-KINASE CK2; MASS-SPECTROMETRY; POSTTRANSLATIONAL REGULATION; PHOSPHORYLATION MOTIFS; TRANSDUCTION PATHWAY; BIOLOGICAL NETWORKS; RESPONSIVE GENES; FLOWERING TIME	The circadian clock provides adaptive advantages to an organism, resulting in increased fitness and survival. The phosphorylation events that regulate circadian-dependent signaling and the processes which post-translationally respond to clock-gated signals are largely unknown. To better elucidate post-translational events tied to the circadian system we carried out a survey of circadian-regulated protein phosphorylation events in Arabidopsis seedlings. A large-scale mass spectrometry-based quantitative phosphoproteomics approach employing TiO2-based phosphopeptide enrichment techniques identified and quantified 1586 phosphopeptides on 1080 protein groups. A total of 102 phosphopeptides displayed significant changes in abundance, enabling the identification of specific patterns of response to circadian rhythms. Our approach was sensitive enough to quantitate oscillations in the phosphorylation of low abundance clock proteins (EARLY FLOWERING4; ELF4 and PSEUDORESPONSE REGULATOR3; PRR3) as well as other transcription factors and kinases. During constant light, extensive cyclic changes in phosphorylation status occurred in critical regulators, implicating direct or indirect regulation by the circadian system. These included proteins influencing transcriptional regulation, translation, metabolism, stress and phytohormones-mediated responses. We validated our analysis using the elf4-211 allele, in which an S45L transition removes the phosphorylation herein identified. We show that removal of this phosphorylatable site diminishes interaction with EARLY FLOWERING3 (ELF3), a key partner in a tripartite evening complex required for circadian cycling. elf4-211 lengthens period, which increases with increasing temperature, relative to the wild type, resulting in a more stable temperature compensation of circadian period over a wider temperature range.	[Choudhary, Mani Kant; Wang, Lei; Somers, David E.] POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, Kyungbuk, South Korea; [Wang, Lei; Somers, David E.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Nomura, Yuko; Nakagami, Hirofumi] RIKEN Ctr Sustainable Resource Sci CSRS, Plant Prote Res Unit, Yokohama, Kanagawa 2300045, Japan; [Wang, Lei] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Phys, Beijing 100093, Peoples R China	Somers, DE (reprint author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	somers.24@osu.edu	Nakagami, Hirofumi/A-4122-2011		National Institutes of Health [R01GM093285]; World Class University Program of South Korea [R31-2008-000-10105-0]; NRF; MEST; JSPS KAKENHI [24688007, 26650106]	This work was supported by National Institutes of Health Grant R01GM093285 (to D.E.S.) and the World Class University Program of South Korea (No. R31-2008-000-10105-0), NRF, MEST (to D.E.S.) and by JSPS KAKENHI Grant Numbers 24688007 and 26650106 to H.N.	Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Prado K, 2013, PLANT CELL, V25, P1029, DOI 10.1105/tpc.112.108456; van Wijk KJ, 2014, PLANT CELL, V26, P2367, DOI 10.1105/tpc.114.125815; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Takase T, 2011, PLANT CELL PHYSIOL, V52, P373, DOI 10.1093/pcp/pcq198; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Ozkaya O, 2012, ADV GENET, V77, P79, DOI 10.1016/B978-0-12-387687-4.00004-0; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Hansson M, 2003, MOL CELL PROTEOMICS, V2, P550, DOI 10.1074/mcp.M300050-MCP200; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Barbier-Brygoo H, 2011, ANNU REV PLANT BIOL, V62, P25, DOI 10.1146/annurev-arplant-042110-103741; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Ravichandran A, 2009, PROTEOMICS, V9, P2764, DOI 10.1002/pmic.200800655; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Michael TP, 2003, PLANT PHYSIOL, V132, P629, DOI 10.1104/pp.021006; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P499, DOI 10.1016/j.tplants.2010.05.011; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Kolmos E, 2009, HFSP J, V3, P350, DOI 10.2976/1.3218766; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Pesaresi P, 2011, BBA-BIOENERGETICS, V1807, P887, DOI 10.1016/j.bbabio.2010.08.002; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Crane BR, 2014, ANNU REV BIOCHEM, V83, P191, DOI 10.1146/annurev-biochem-060713-035644; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Vener AV, 2007, BBA-BIOENERGETICS, V1767, P449, DOI 10.1016/j.bbabio.2007.11.007; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Johansson I, 1998, PLANT CELL, V10, P451; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Lakin-Thomas PL, 2011, ADV GENET, V74, P55, DOI 10.1016/B978-0-12-387690-4.00003-9; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Romijn EP, 2005, MOL CELL PROTEOMICS, V4, P1297, DOI 10.1074/mcp.M500123-MCP200; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Deery MJ, 2009, CURR BIOL, V19, P2031, DOI 10.1016/j.cub.2009.10.024; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Takeuchi T, 2014, J EXP BOT, V65, P6003, DOI 10.1093/jxb/eru339; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; MacKintosh C, 2001, CELL MOL LIFE SCI, V58, P205, DOI 10.1007/PL00000848; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Kim Y, 2013, CELL REP, V3, P671, DOI 10.1016/j.celrep.2013.02.021; McClung CR, 2011, ADV GENET, V74, P105, DOI 10.1016/B978-0-12-387690-4.00004-0; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Kusakina J, 2012, TRENDS PLANT SCI, V17, P575, DOI 10.1016/j.tplants.2012.06.008; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; ELICH TD, 1993, EMBO J, V12, P4857; Beltran-Pena E, 2002, PHYSIOL PLANTARUM, V115, P291, DOI 10.1034/j.1399-3054.2002.1150216.x; Booij-James IS, 2002, PLANT PHYSIOL, V130, P2069, DOI 10.1104/pp.013441; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; CHENG CL, 1991, PLANT PHYSIOL, V96, P275, DOI 10.1104/pp.96.1.275; Chow Brenda Y, 2012, Plant Signal Behav, V7, P170, DOI 10.4161/psb.18766; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; DENG MD, 1990, PLANTA, V180, P257, DOI 10.1007/BF00194005; DOEHLERT DC, 1983, PLANT PHYSIOL, V73, P989, DOI 10.1104/pp.73.4.989; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Dorn KV, 2010, BIOCHEM J, V427, P205, DOI 10.1042/BJ20091412; Elich TD, 1997, FEBS LETT, V411, P236, DOI 10.1016/S0014-5793(97)00698-4; Hazen SP, 2009, GENOME BIOL, V10, P17; HUBER JLA, 1989, ARCH BIOCHEM BIOPHYS, V270, P681, DOI 10.1016/0003-9861(89)90551-1; Jones TL, 1997, PLANT PHYSIOL, V113, P1167; Jones TL, 1998, PLANT PHYSIOL, V118, P149, DOI 10.1104/pp.118.1.149; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Khandal D, 2009, P NATL ACAD SCI USA, V106, P13112, DOI 10.1073/pnas.0903522106; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; LILLO C, 1984, PHYSIOL PLANTARUM, V61, P219, DOI 10.1111/j.1399-3054.1984.tb05900.x; Mauvoisin D., 2014, PROTEOMICS, V15, P310; MCMICHAEL RW, 1993, ARCH BIOCHEM BIOPHYS, V307, P248, DOI 10.1006/abbi.1993.1586; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Muller LM, 2014, J EXP BOT, V65, P2915, DOI 10.1093/jxb/eru117; Murakami M, 2004, PLANT CELL PHYSIOL, V45, P645, DOI 10.1093/pcp/pch065; Nakagami H, 2012, PLANT CELL PHYSIOL, V53, P118, DOI 10.1093/pcp/pcr148; Nakagami H, 2014, METHODS MOL BIOL, V1072, P595, DOI 10.1007/978-1-62703-631-3_40; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Ouyang Yan, 1998, Proceedings of the National Academy of Sciences of the United States of America, V95, P8660, DOI 10.1073/pnas.95.15.8660; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; PILGRIM ML, 1993, PLANT MOL BIOL, V23, P349, DOI 10.1007/BF00029010; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Portoles S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001201; RAMALHO CB, 1995, PLANT PHYSIOL, V107, P225, DOI 10.1104/pp.107.1.225; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; REIMHOLZ R, 1994, PLANTA, V192, P480; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Seo PJ, 2014, PLANT CELL, V26, P79, DOI 10.1105/tpc.113.119842; Somers DE, 2001, PHILOS T ROY SOC B, V356, P1745, DOI 10.1098/rstb.2001.0965; Somers DE, 2007, COLD SPRING HARB SYM, V72, P193, DOI 10.1101/sqb.2007.72.035; Su WP, 1996, PLANT CELL, V8, P519; Tchorzewski M., 2002, CELL BIOL, V34, P911; Toroser D, 1997, PLANT PHYSIOL, V114, P947, DOI 10.1104/pp.114.3.947; Turkina MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029307; von der Fecht-Bartenbach J, 2010, PLANT CELL PHYSIOL, V51, P960, DOI 10.1093/pcp/pcq062; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76	146	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	AUG	2015	14	8					2243	2260		10.1074/mcp.M114.047183		18	Biochemical Research Methods	Biochemistry & Molecular Biology	CO0JR	WOS:000358837400015		
J	Niino, M; Sato, S; Fukazawa, T; Yoshimura, S; Hisahara, S; Matsushita, T; Isobe, N; Yoshida, K; Houzen, H; Miyazaki, Y; Shimohama, S; Kikuchi, S; Kira, Ji				Niino, Masaaki; Sato, Shinya; Fukazawa, Toshiyuki; Yoshimura, Satoshi; Hisahara, Shin; Matsushita, Takuya; Isobe, Noriko; Yoshida, Kazuto; Houzen, Hideki; Miyazaki, Yusei; Shimohama, Shun; Kikuchi, Seiji; Kira, Jun-ichi			y Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis	MULTIPLE SCLEROSIS JOURNAL			English	Article						Multiple sclerosis; oligoclonal IgG band; IgG index; cerebrospinal fluid; human leukocyte antigen; MRI	OLIGOCLONAL BANDS; NEUROMYELITIS-OPTICA; PREDICT CONVERSION; JAPANESE PATIENTS; ASSOCIATION; CRITERIA; ELECTROPHORESIS; IMMUNOFIXATION; DISABILITY; DISORDERS	Background: It is unclear whether the prevalence of oligoclonal IgG bands (OCBs) in multiple sclerosis (MS) is different between northern and southern regions of Asia. Objective: This study aimed to compare the prevalence of OCBs and positive cerebrospinal fluid (CSF) findings between northern and southern regions of Japan and to investigate the association of these CSF findings with HLA-DRB1 alleles. Methods: The study included 180 MS patients from Hokkaido (northern Japan) and 184 patients from Kyushu (southern Japan). The IgG index was defined as increased if it was >0.658. Presence of CSF OCBs and/or increased IgG index was defined as positive CSF findings. Results: Positive CSF findings and OCB positivity were significantly higher in MS patients from Hokkaido than in those from Kyushu (p < 0.0001 for both). Logistic regression analysis revealed that after adjusting for covariates that can be related to abnormal CSF IgG production, the geographic region (Hokkaido) showed odds ratios (ORs) of 4.08 and 2.57, whereas the HLA-DRB1*04:05 allele showed ORs of 0.36 and 0.30 for positive CSF findings and OCB positivity, respectively. Conclusions: The results indicate that latitude and HLA-DRB1 alleles independently affect the emergence of CSF IgG abnormalities in Japanese patients with MS.	[Niino, Masaaki; Miyazaki, Yusei] Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido 0630005, Japan; [Sato, Shinya; Yoshimura, Satoshi; Matsushita, Takuya; Isobe, Noriko; Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Fukazawa, Toshiyuki] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan; [Hisahara, Shin; Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Yoshida, Kazuto] Asahikawa Red Cross Hosp, Dept Neurol, Asahikawa, Hokkaido, Japan; [Houzen, Hideki] Obihiro Kosei Gen Hosp, Dept Neurol, Obihiro, Hokkaido, Japan; [Miyazaki, Yusei; Kikuchi, Seiji] Hokkaido Med Ctr, Dept Neurol, Sapporo, Hokkaido, Japan	Niino, M (reprint author), Hokkaido Med Ctr, Dept Clin Res, Nishi Ku, Yamanote 5-jo 7-chome, Sapporo, Hokkaido 0630005, Japan.	niino@hok-mc.hosp.go.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390178]	This work was supported in part by a Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan, and a grant-in-aid (B; no. 22390178) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Siritho S, 2009, J NEUROL SCI, V279, P21, DOI 10.1016/j.jns.2008.12.029; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; KURTZKE JF, 1983, NEUROLOGY, V33, P1444; Houzen H, 2012, J NEUROL SCI, V323, P117, DOI 10.1016/j.jns.2012.08.032; Melcon MO, 2014, J NEUROL SCI, V344, P171, DOI 10.1016/j.jns.2014.06.051; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Kikuchi S, 2003, NEUROLOGY, V60, P647; Wu JS, 2010, J NEUROL SCI, V288, P63, DOI 10.1016/j.jns.2009.10.005; Avasarala JR, 2001, ARCH NEUROL-CHICAGO, V58, P2044, DOI 10.1001/archneur.58.12.2044; Matsushita T, 2009, TISSUE ANTIGENS, V73, P171, DOI 10.1111/j.1399-0039.2008.01172.x; Lechner-Scott J, 2012, MULT SCLER J, V18, P974, DOI 10.1177/1352458511431729; Bankoti J, 2014, ANN NEUROL, V75, P266, DOI 10.1002/ana.24088; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Tintore M, 2000, AM J NEURORADIOL, V21, P702; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Osoegawa M, 2009, MULT SCLER, V15, P159, DOI 10.1177/1352458508098372; Petzold A, 2013, J NEUROIMMUNOL, V262, P1, DOI 10.1016/j.jneuroim.2013.06.014; Obermeier B, 2011, J NEUROIMMUNOL, V233, P245, DOI 10.1016/j.jneuroim.2011.01.010; Cavuoti D, 1998, AM J CLIN PATHOL, V109, P585; Chang KH, 2006, MULT SCLER J, V12, P501, DOI 10.1191/1352458506ms1297oa; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Fukazawa T, 1998, J NEUROL SCI, V158, P209, DOI 10.1016/S0022-510X(98)00127-0; Kira J, 1996, ANN NEUROL, V40, P569; Li B, 2007, ACTA NEUROL SCAND, V115, P319, DOI 10.1111/j.1600-0404.2006.00753.x; Nakashima I, 2005, J NEUROIMMUNOL, V159, P133, DOI 10.1016/j.jneuroim.2004.09.011; Sellebjerg F, 2000, TISSUE ANTIGENS, V55, P312, DOI 10.1034/j.1399-0039.2000.550404.x; Yoshimura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048592; Yoshimura S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095367	37	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	AUG	2015	21	9					1112	1120		10.1177/1352458514560924		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN6IF	WOS:000358537400004		
J	Uzawa, A; Mori, M; Muto, M; Uchida, T; Masuda, H; Masuda, S; Kuwabara, S				Uzawa, Akiyuki; Mori, Masahiro; Muto, Mayumi; Uchida, Tomohiko; Masuda, Hiroki; Masuda, Saeko; Kuwabara, Satoshi			y Benign neuromyelitis optica is rare in Japanese patients	MULTIPLE SCLEROSIS JOURNAL			English	Article						Benign; Expanded Disability Status Scale; good outcome; neuromyelitis optica	MULTIPLE-SCLEROSIS	Good-outcome neuromyelitis optica (NMO) is defined as an Expanded Disability Status Scale (EDSS) score of 3.0 at 10 years after onset. The clinical courses of 80 consecutive patients with NMO were analyzed to identify the frequency and features of Japanese patients with good-outcome NMO. Of the 80 patients, 37 had a disease duration of >10 years; of these, eight (21.6%) presented a good outcome. These cases presented lower EDSS scores during the early phase of disease compared with those with conventional NMO. However, half of these patients developed severe disabilities later on, indicating that truly benign NMO is rare.	[Uzawa, Akiyuki; Mori, Masahiro; Muto, Mayumi; Uchida, Tomohiko; Masuda, Hiroki; Masuda, Saeko; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan	Uzawa, A (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	auzawa@chiba-u.jp					KURTZKE JF, 1983, NEUROLOGY, V33, P1444; Collongues N, 2011, ARCH NEUROL-CHICAGO, V68, P918, DOI 10.1001/archneurol.2011.127; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Uzawa A, 2012, J NEUROL, V259, P1600, DOI 10.1007/s00415-011-6384-3; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Mandler RN, 2006, AUTOIMMUN REV, V5, P537, DOI 10.1016/j.autrev.2006.02.008; Cabre P, 2009, J NEUROL NEUROSUR PS, V80, P1162, DOI 10.1136/jnnp.2007.143529; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Uzawa A, 2014, J CLIN NEUROSCI, V21, P12, DOI 10.1016/j.jocn.2012.12.022	11	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	AUG	2015	21	9					1204	1208		10.1177/1352458514560927		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN6IF	WOS:000358537400014		
J	Lu, WY; Bird, TG; Boulter, L; Tsuchiya, A; Cole, AM; Hay, T; Guest, RV; Wojtacha, D; Man, TY; Mackinnon, A; Ridgway, RA; Kendall, T; Williams, MJ; Jamieson, T; Raven, A; Hay, DC; Iredale, JP; Clarke, AR; Sansom, OJ; Forbes, SJ				Lu, Wei-Yu; Bird, Thomas G.; Boulter, Luke; Tsuchiya, Atsunori; Cole, Alicia M.; Hay, Trevor; Guest, Rachel V.; Wojtacha, Davina; Man, Tak Yung; Mackinnon, Alison; Ridgway, Rachel A.; Kendall, Timothy; Williams, Michael J.; Jamieson, Thomas; Raven, Alex; Hay, David C.; Iredale, John P.; Clarke, Alan R.; Sansom, Owen J.; Forbes, Stuart J.			Hepatic progenitor cells of biliary origin with liver repopulation capacity	NATURE CELL BIOLOGY			English	Article							ETHIONINE-SUPPLEMENTED DIET; ADULT-MOUSE LIVER; STEM-CELLS; DUCTULAR REACTIONS; OVAL CELLS; HEPATOCYTE TRANSPLANTATION; MATURE HEPATOCYTES; CHOLINE-DEFICIENT; INJURY; REGENERATION	Hepatocytes and cholangiocytes self-renew following liver injury. Following severe injury hepatocytes are increasingly senescent, but whether hepatic progenitor cells (HPCs) then contribute to liver regeneration is unclear. Here, we describe a mouse model where the E3 ubiquitin ligase Mdm2 is inducibly deleted in more than 98% of hepatocytes, causing apoptosis, necrosis and senescence with nearly all hepatocytes expressing p21. This results in florid HPC activation, which is necessary for survival, followed by complete, functional liver reconstitution. HPCs isolated from genetically normal mice, using cell surface markers, were highly expandable and phenotypically stable in vitro. These HPCs were transplanted into adult mouse livers where hepatocyte Mdm2 was repeatedly deleted, creating a non-competitive repopulation assay. Transplanted HPCs contributed significantly to restoration of liver parenchyma, regenerating hepatocytes and biliary epithelia, highlighting their in vivo lineage potency. HPCs are therefore a potential future alternative to hepatocyte or liver transplantation for liver disease.	[Lu, Wei-Yu; Bird, Thomas G.; Guest, Rachel V.; Wojtacha, Davina; Man, Tak Yung; Mackinnon, Alison; Williams, Michael J.; Raven, Alex; Hay, David C.; Forbes, Stuart J.] MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Boulter, Luke; Kendall, Timothy] MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Tsuchiya, Atsunori] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata 9518510, Japan; [Cole, Alicia M.; Ridgway, Rachel A.; Jamieson, Thomas; Sansom, Owen J.] CRUK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hay, Trevor; Clarke, Alan R.] European Canc Stem Cell Res Inst, Cardiff Sch Biosci, London CF24 4HQ, England; [Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	Forbes, SJ (reprint author), MRC, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	stuart.forbes@ed.ac.uk		Clarke, Alan/0000-0002-4281-426X; Kendall, Timothy/0000-0002-4174-2786; Sansom, Owen J./0000-0001-9540-3010; Bird, Thomas/0000-0002-6120-1581	Wellcome Trust; Academy of Medical Sciences; University of Edinburgh; Charles Darwin Scholarship; Edinburgh Overseas Research Scholarship; UK Regenerative Medicine Platform; MRC; Cancer Research UK; European Research Council; Sir Jules Thorn Charitable Trust; Medical Research Council	The authors would like to thank Biogen Idec for supplying the Fn14<SUP>KO</SUP> mouse line. We would also like to thank V. Factor for kindly supplying the A6 antibody, and M. Alison for proofreading the manuscript. We would like to thank F. Rossi, C. Cryer, O. Rodrigues and S. Monard for assistance with flow cytometry. T.G.B. is financially supported by the Wellcome Trust and the Academy of Medical Sciences. W.Y.L. was supported by the University of Edinburgh, Charles Darwin Scholarship, Edinburgh Overseas Research Scholarship, and the UK Regenerative Medicine Platform. J.P.I is supported by the MRC. O.J.S. is financially supported by Cancer Research UK and the European Research Council. S.J.F. is supported by the Sir Jules Thorn Charitable Trust, the Medical Research Council, and the UK Regenerative Medicine Platform.	Overturf K, 1997, AM J PATHOL, V151, P1273; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Erker L, 2010, GASTROENTEROLOGY, V139, P1019, DOI 10.1053/j.gastro.2010.05.082; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Jors S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; GOLDING M, 1995, HEPATOLOGY, V22, P1243, DOI 10.1016/0270-9139(95)90635-5; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904; Eischen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046148; Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Grier JD, 2002, GENESIS, V32, P145, DOI 10.1002/gene.10066; Hay DC, 2010, GASTROENTEROLOGY, V139, P729, DOI 10.1053/j.gastro.2010.07.013; Horslen SP, 2004, TRANSPLANTATION, V77, P1481, DOI 10.1097/01.TP.0000113809.53415.C2; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Lu W. Y., 2015, PROTOC EXCH; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245	54	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					971	U43		10.1038/ncb3203		25	Cell Biology	Cell Biology	CO0NE	WOS:000358847700005		
J	Noguchi, TK; Ninomiya, N; Sekine, M; Komazaki, S; Wang, PC; Asashima, M; Kurisaki, A				Noguchi, Taka-aki K.; Ninomiya, Naoto; Sekine, Mari; Komazaki, Shinji; Wang, Pi-Chao; Asashima, Makoto; Kurisaki, Akira			Generation of stomach tissue from mouse embryonic stem cells	NATURE CELL BIOLOGY			English	Article							IN-VITRO; GROUND-STATE; SELF-RENEWAL; ENDODERM; DIFFERENTIATION; DISEASE; NAIVE; PLURIPOTENCY; DERIVATION; EXPRESSION	Successful pluripotent stem cell differentiation methods have been developed for several endoderm-derived cells, including hepatocytes, beta-cells and intestinal cells. However, stomach lineage commitment from pluripotent stem cells has remained a challenge, and only antrum specification has been demonstrated. We established a method for stomach differentiation from embryonic stem cells by inducing mesenchymal Barx1, an essential gene for in vivo stomach specification from gut endoderm. Barx1-inducing culture conditions generated stomach primordium-like spheroids, which differentiated into mature stomach tissue cells in both the corpus and antrum by three-dimensional culture. This embryonic stem cell-derived stomach tissue (e-ST) shared a similar gene expression profile with adult stomach, and secreted pepsinogen as well as gastric acid. Furthermore, TGFA overexpression in e-ST caused hypertrophic mucus and gastric anacidity, which mimicked Menetrier disease in vitro. Thus, in vitro stomach tissue derived from pluripotent stem cells mimics in vivo development and can be used for stomach disease models.	[Noguchi, Taka-aki K.; Sekine, Mari; Wang, Pi-Chao; Kurisaki, Akira] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058577, Japan; [Ninomiya, Naoto; Asashima, Makoto; Kurisaki, Akira] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Ibaraki 3058562, Japan; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan; [Asashima, Makoto] Univ Tsukuba, Life Sci Ctr Tsukuba Adv Res Alliance, Ibaraki 3058577, Japan	Noguchi, TK (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058577, Japan.	taka.noguchi@aist.go.jp; a-kurisaki@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [21241048]	We thank E. Kobayashi for kindly providing technical help with electron microscopy. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS; No. 21241048, M.A. and A.K.) and for JSPS Fellows (T.-a.K.N.).	D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Kunisato A, 2010, STEM CELLS DEV, V19, P229, DOI 10.1089/scd.2009.0149; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; HAYASHI K, 1988, DEVELOPMENT, V103, P725; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/i.devcel.2005.01.015; Speer AL, 2011, J SURG RES, V171, P6, DOI 10.1016/j.jss.2011.03.062; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Vivas Y, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-86; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Piazuelo MB, 2013, COLOMB MEDICA, V44, P192; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; TAKAGI H, 1992, J CLIN INVEST, V90, P1161, DOI 10.1172/JCI115936; Nishimura Y, 2010, BIOCHEM BIOPH RES CO, V401, P1, DOI 10.1016/j.bbrc.2010.08.099; Fukuda K, 2005, DEV GROWTH DIFFER, V47, P375; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Brafman DA, 2013, STEM CELL REP, V1, P464, DOI 10.1016/j.stemcr.2013.09.005; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Antherieu S, 2014, TOXICOL APPL PHARM, V276, P63, DOI 10.1016/j.taap.2014.01.019; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; Hoffmann W., 2008, CURR MED CHEM, V15, P133; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kearns NA, 2013, STEM CELL RES, V11, P1003, DOI 10.1016/j.scr.2013.06.007; LAWSON HH, 1977, S AFR J SURG, V15, P179; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Ninomiya N, 2013, IN VITRO CELL DEV-AN, V49, P230, DOI 10.1007/s11626-013-9589-1; Noguchi T. K., 2015, NAT PROTOC EXCH; Noguchi TK, 2012, GENE EXPR PATTERNS, V12, P154, DOI 10.1016/j.gep.2012.01.001; Ochi Y, 2005, LIFE SCI, V77, P2040, DOI 10.1016/j.lfs.2005.04.006; Stringer EJ, 2008, FEBS LETT, V582, P2555, DOI 10.1016/j.febslet.2008.06.024; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; TAKIGUCHI K, 1986, ROUX ARCH DEV BIOL, V195, P475, DOI 10.1007/BF00375887; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Torihashi S, 2006, STEM CELLS, V24, P2618, DOI 10.1634/stemcells.2006-0148; Udager A, 2010, PROG MOL BIOL TRANSL, V96, P35, DOI [10.1016/B978-0-12-381280-3.00002-6, 10.1016/S1877-1173(10)96002-X]; Zorn A. M., 2009, ANNU REV CELL DEV BI, V25, P29	49	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					984	U62		10.1038/ncb3200		19	Cell Biology	Cell Biology	CO0NE	WOS:000358847700006		
J	Shintomi, K; Takahashi, TS; Hirano, T				Shintomi, Keishi; Takahashi, Tatsuro S.; Hirano, Tatsuya			Reconstitution of mitotic chromatids with a minimum set of purified factors	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; NUCLEOSOME ASSEMBLY PROTEIN-1; CHROMOSOME CONDENSATION; TOPOISOMERASE-II; CRYSTAL-STRUCTURE; 13S CONDENSIN; IN-VITRO; AURORA-B; HISTONE; DNA	The assembly of mitotic chromosomes, each composed of a pair of rod-shaped chromatids, is an essential prerequisite for accurate transmission of the genome during cell division. It remains poorly understood, however, how this fundamental process might be achieved and regulated in the cell. Here we report an in vitro system in which mitotic chromatids can be reconstituted by mixing a simple substrate with only six purified factors: core histones, three histone chaperones (nucleoplasmin, Nap1 and FACT), topoisomerase II (topo II) and condensin I. We find that octameric nucleosomes containing the embryonic variant H2A.X-F are highly susceptible to FACT and function as the most productive substrate for subsequent actions of topo II and condensin I. Cdk1 phosphorylation of condensin I is the sole mitosis-specific modification required for chromatid reconstitution. This experimental system will enhance our understanding of the mechanisms of action of individual factors and their cooperation during this process.	[Shintomi, Keishi; Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan; [Takahashi, Tatsuro S.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Hirano, T (reprint author), RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan.	hiranot@riken.jp					Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Isaacs RJ, 1998, BBA-GENE STRUCT EXPR, V1400, P121, DOI 10.1016/S0167-4781(98)00131-6; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Loisel TP, 1999, NATURE, V401, P613; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Luger K, 1997, NATURE, V389, P251; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Flemming W., 1882, ZELLSUBSTANTZ KERN Z; Formosa Tim, 2013, Biochim Biophys Acta, V1819, P247; Hancock R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036045; Hirano T, 2014, TRENDS CELL BIOL, V24, P727, DOI 10.1016/j.tcb.2014.06.007; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Lindsley JE, 1999, METH MOL B, V94, P187; Maeshima K, 2010, Cold Spring Harb Symp Quant Biol, V75, P439, DOI 10.1101/sqb.2010.75.034; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; OHSUMI K, 1991, DEV BIOL, V148, P295, DOI 10.1016/0012-1606(91)90338-4; Okumura E, 1996, J CELL BIOL, V132, P125, DOI 10.1083/jcb.132.1.125; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pepenella S, 2014, CHROMOSOMA, V123, P3, DOI 10.1007/s00412-013-0435-8; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Shintomi K, 2005, P NATL ACAD SCI USA, V102, P8210, DOI 10.1073/pnas.0500822102; Wang WL, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-22; Wühr Martin, 2014, Curr Biol, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236	49	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1014	U336		10.1038/ncb3187		16	Cell Biology	Cell Biology	CO0NE	WOS:000358847700009		
J	Hanafusa, H; Kedashiro, S; Tezuka, M; Funatsu, M; Usami, S; Toyoshima, F; Matsumoto, K				Hanafusa, Hiroshi; Kedashiro, Shin; Tezuka, Motohiro; Funatsu, Motoki; Usami, Satoshi; Toyoshima, Fumiko; Matsumoto, Kunihiro			PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; POLO-LIKE KINASE-1; ASYMMETRIC CELL-DIVISION; TUBULIN RING COMPLEX; GAMMA-TUBULIN; MICROTUBULE NUCLEATION; ENDOSOMAL TRAFFICKING; MITOTIC PROGRESSION; ADHERENT CELLS; BOX DOMAIN	Correct formation of the cell division axis requires the initial precise orientation of the mitotic spindle. Proper spindle orientation depends on centrosome maturation, and Polo-like kinase 1 (PLK1) is known to play a crucial role in this process. However, the molecular mechanisms that function downstream of PLK1 are not well understood. Here we show that LRRK1 is a PLK1 substrate that is phosphorylated on Ser 1790. PLK1 phosphorylation is required for CDK1-mediated activation of LRRK1 at the centrosomes, and this in turn regulates mitotic spindle orientation by nucleating the growth of astral microtubules from the centrosomes. Interestingly, LRRK1 in turn phosphorylates CDK5RAP2(Cep215), a human homologue of Drosophila Centrosomin (Cnn), in its gamma-tubulin-binding motif, thus promoting the interaction of CDK5RAP2 with gamma-tubulin. LRRK1 phosphorylation of CDK5RAP2 Ser 140 is necessary for CDK5RAP2-dependent microtubule nucleation. Thus, our findings provide evidence that LRRK1 regulates mitotic spindle orientation downstream of PLK1 through CDK5RAP2-dependent centrosome maturation.	[Hanafusa, Hiroshi; Kedashiro, Shin; Tezuka, Motohiro; Funatsu, Motoki; Usami, Satoshi; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Toyoshima, Fumiko] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan	Hanafusa, H (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	q47371a@nucc.cc.nagoya-u.ac.jp; g44177a@nucc.cc.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Daiichi Sankyo Foundation of Life Science	We thank N. Hisamoto for helpful discussion, K. Ishikawa for virus infections and G. Goshima for U2OS cells. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.M. and H.H.), as well as from the Takeda Science Foundation and the Daiichi Sankyo Foundation of Life Science (to H.H.).	Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Paisan-Ruiz C, 2004, NEURON, V44, P595; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2005.12.046; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Conduit PT, 2014, DEV CELL, V28, P659, DOI 10.1016/j.devcel.2014.02.013; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Matsumura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1634; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Ishikawa K, 2012, MOL BIOL CELL, V23, P1294, DOI 10.1091/mbc.E11-09-0780; Kedashiro S, 2015, J CELL SCI, V128, P385, DOI 10.1242/jcs.161547; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Yang YH, 2010, P NATL ACAD SCI USA, V107, P3499, DOI 10.1073/pnas.0914307107	47	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1024	U360		10.1038/ncb3204		24	Cell Biology	Cell Biology	CO0NE	WOS:000358847700010		
J	Pusterla, I; Bode, JW				Pusterla, Ivano; Bode, Jeffrey W.			An oxazetidine amino acid for chemical protein synthesis by rapid, serine-forming ligations	NATURE CHEMISTRY			English	Article							KETOACID-HYDROXYLAMINE LIGATION; ALPHA-KETOACIDS; REARRANGEMENT; 5-OXAPROLINE	Amide-forming ligation reactions allow the chemical synthesis of proteins by the union of unprotected peptide segments, and enable the preparation of protein derivatives not accessible by expression or bioengineering approaches. The native chemical ligation (NCL) of thioesters and N-terminal cysteines is unquestionably the most successful approach, but is not ideal for all synthetic targets. Here we describe the synthesis of an Fmoc-protected oxazetidine amino acid for use in the alpha-ketoacid-hydroxylamine (KAHA) amide ligation. When incorporated at the N-terminus of a peptide segment, this fourmembered cyclic hydroxylamine can be used for rapid serine-forming ligations with peptide alpha-ketoacids. This ligation operates at low concentration (100 mu M-5 mM) and mild temperatures (20-25 degrees C). The utility of the reaction was demonstrated by the synthesis of S100A4, a 12 kDa calcium-binding protein not easily accessible by NCL or other amideforming reactions due to its primary sequence and properties.	[Pusterla, Ivano; Bode, Jeffrey W.] ETH, Organ Chem Lab, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Bode, Jeffrey W.] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Pusterla, I (reprint author), ETH, Organ Chem Lab, Dept Chem & Appl Biosci, Vladimir Prelog Weg 3, CH-8093 Zurich, Switzerland.	bode@org.chem.ethz.ch			Swiss National Science Foundation [200020_150073]; ETH Zurich	This work was supported by the Swiss National Science Foundation (200020_150073) and ETH Zurich. F. Thuaud, S. Baldauf and M. Dao are thanked for contributions to the synthesis of compound 1, V. Pattabiraman for discussions, F. Saito for advice on kinetics and C. Wolfrum for biological evaluation.	Kent SBH, 2013, ANGEW CHEM INT EDIT, V52, P11988, DOI 10.1002/anie.201304116; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; Li XC, 2010, ORG LETT, V12, P1724, DOI 10.1021/ol1003109; CASADEI MA, 1984, J AM CHEM SOC, V106, P1051, DOI 10.1021/ja00316a039; Nilsson BL, 2005, ANNU REV BIOPH BIOM, V34, P91, DOI 10.1146/annurev.biophys.34.040204.144700; Wucherpfennig TG, 2014, ANGEW CHEM INT EDIT, V53, P12248, DOI 10.1002/anie.201407014; Pattabiraman VR, 2012, ANGEW CHEM INT EDIT, V51, P5114, DOI 10.1002/anie.201200907; Kalia J, 2010, CURR ORG CHEM, V14, P138; Wucherpfennig TG, 2014, ANGEW CHEM INT EDIT, V53, P12244, DOI 10.1002/anie.201406097; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Bode JW, 2006, ANGEW CHEM INT EDIT, V45, P1248, DOI 10.1002/anie.200503991; Avital-Shmilovici M, 2013, J AM CHEM SOC, V135, P3173, DOI 10.1021/ja311408y; Baldwin J. E, 1976, CHEM COMMUN, P734; Davies SG, 1998, CHEM COMMUN, P2235, DOI 10.1039/a806200e; DENICOLA A, 1994, J CHEM SOC CHEM COMM, P879, DOI 10.1039/c39940000879; Florio S., 2008, COMP HETEROCYCL CHEM, V2, P689; Gilmore K., 2013, CHEM COMMUN, V49, P1124; Hackenberger C. P. R., 2010, AMINO ACIDS PEPTIDES, V3, P445; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Magers D. H., 1999, THEOCHEM, V487, DOI 10.1016/S0166-1280(99)00155-4; Medjahdi M, 2009, J ORG CHEM, V74, P7859, DOI 10.1021/jo9016666; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Snider BB, 2003, TETRAHEDRON LETT, V44, P3067, DOI 10.1016/S0040-4039(03)00542-2; Tanino K, 2011, NAT CHEM, V3, P484, DOI [10.1038/nchem.1044, 10.1038/NCHEM.1044]; Wuts P G, 2006, GREENES PROTECTIVE G; Zhang Y., 2012, P NATL ACAD SCI USA, V110, P6657	27	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	AUG	2015	7	8					668	672		10.1038/NCHEM.2282		5	Chemistry, Multidisciplinary	Chemistry	CN6FM	WOS:000358529600013		
J	Ueno-Yokohata, H; Okita, H; Nakasato, K; Akimoto, S; Hata, J; Koshinaga, T; Fukuzawa, M; Kiyokawa, N				Ueno-Yokohata, Hitomi; Okita, Hajime; Nakasato, Keiko; Akimoto, Shingo; Hata, Jun-ichi; Koshinaga, Tsugumichi; Fukuzawa, Masahiro; Kiyokawa, Nobutaka			Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney	NATURE GENETICS			English	Article							TUMOR STUDY-GROUP; POLYCOMB GROUP; WILMS-TUMOR; SOMATIC MUTATIONS; COMPLEX; DURATION; THERAPY; REVEALS; SUBTYPE; SOCIETY	Clear cell sarcoma of the kidney (CCSK) is one of the major pediatric renal neoplasms, but its associated genetic abnormalities are largely unknown. We identified internal tandem duplications in the BCOR gene (BCL6 corepressor) affecting the C terminus in 100% (20/20) of CCSK tumors but in none (0/193) of the other pediatric renal tumors. CCSK tumors expressed only an aberrant BCOR allele, indicating a close correlation between BCOR aberration and CCSK tumorigenesis.	[Ueno-Yokohata, Hitomi; Okita, Hajime; Nakasato, Keiko; Akimoto, Shingo; Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Hata, Jun-ichi] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Koshinaga, Tsugumichi] Nihon Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Fukuzawa, Masahiro] Osaka Med Ctr, Osaka, Japan; [Fukuzawa, Masahiro] Res Inst Maternal & Child Hlth, Osaka, Japan	Okita, H (reprint author), Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan.	okita-h@keio.jp			National Center for Child Health and Development [24-4, 26-20]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) [10-41, 10-42, 10-43, 10-44, 10-45]; research program of the Project for Development of Innovative Research on Cancer Therapeutics [11035153]; Tailor-Made Medical Treatment Program (BioBankJapan), Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by the Grant from the National Center for Child Health and Development (24-4, 26-20), grants from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO; 10-41, 10-42, 10-43, 10-44, 10-45), and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (11035153) and Tailor-Made Medical Treatment Program (BioBankJapan), Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Seibel NL, 2004, J CLIN ONCOL, V22, P468; O'Meara E, 2012, J PATHOL, V227, P72, DOI 10.1002/path.3985; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Argani P, 2000, AM J SURG PATHOL, V24, P4, DOI 10.1097/00000478-200001000-00002; Oue T, 2009, PEDIATR SURG INT, V25, P923, DOI 10.1007/s00383-009-2449-0; Junco SE, 2013, STRUCTURE, V21, P665, DOI 10.1016/j.str.2013.02.013; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Furtwangler R, 2013, EUR J CANCER, V49, P3497, DOI 10.1016/j.ejca.2013.06.036; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Pierron G, 2012, NAT GENET, V44, P461, DOI 10.1038/ng.1107; Gadd S, 2010, LAB INVEST, V90, P724, DOI 10.1038/labinvest.2010.66; Perlman EJ, 2005, PEDIATR DEVEL PATHOL, V8, P320, DOI 10.1007/s10024-005-1156-7; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Tournade MF, 2001, J CLIN ONCOL, V19, P488; Ueno H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062233	20	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					861	+		10.1038/ng.3338		4	Genetics & Heredity	Genetics & Heredity	CN8FG	WOS:000358674100007		
J	Kelemen, LE; Lawrenson, K; Tyrer, J; Li, Q; Lee, JM; Seo, JH; Phelan, CM; Beesley, J; Chen, XQ; Spindler, TJ; Aben, KKH; Anton-Culver, H; Antonenkova, N; Baker, H; Bandera, EV; Bean, Y; Beckmann, MW; Bisogna, M; Bjorge, L; Bogdanova, N; Brinton, LA; Brooks-Wilson, A; Bruinsma, F; Butzow, R; Campbell, IG; Carty, K; Chang-Claude, J; Chen, YA; Chen, ZH; Cook, LS; Cramer, DW; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; Dennis, J; Dicks, E; Doherty, JA; Dicks, E; Doherty, JA; Dork, T; du Bois, A; Durst, M; Eccles, D; Easton, DT; Edwards, RP; Eilber, U; Ekici, AB; Engelholm, SA; Fasching, PA; Fridley, BL; Gao, YT; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goode, EL; Goodman, MT; Grownwald, J; Harrington, P; Harter, P; Hasmad, HN; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, E; Hogdall, C; Hosono, S; Iversen, ES; Jakubowska, A; Jensen, A; Ji, BT; Karlan, BY; Kellar, M; Kelley, JL; Kiemeney, LA; Krakstad, C; Kjaer, SK; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, AW; Lele, S; Leminen, A; Lester, J; Levine, DA; Liang, D; Lissowska, J; Lu, KR; Lubinski, J; Lundvall, L; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, I; Menon, U; Modugno, F; Moes-Sosnowska, J; Moysich, KB; Narod, SA; Nedergaard, L; Ness, RB; Nevanlinna, H; Adenan, NAM; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Weber, RP; Paul, J; Pearce, CL; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rosen, B; Rossing, MA; Rothstein, JH; Rudolph, A; Runnebaum, IB; Rzepecka, IK; Salvesen, HB; Schildkraut, JM; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, HL; Southey, MC; Sucheston, L; Tangen, IL; Teo, SH; Terry, KL; Thompson, PJ; Tworoger, SS; van Altena, AM; Van Nieuwenhuysen, E; Vergote, I; Vierkant, RA; Wang-Gohrke, S; Walsh, C; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Sawicki, W; Woo, YL; Wu, XF; Wu, AH; Yang, H; Zheng, W; Ziogas, A; Sellers, TA; Freedman, ML; Chenevix-Trench, G; Pharoah, PDP; Gayther, SA; Berchuck, A				Kelemen, Linda E.; Lawrenson, Kate; Tyrer, Jonathan; Li, Qiyuan; Lee, Janet M.; Seo, Ji-Heui; Phelan, Catherine M.; Beesley, Jonathan; Chen, Xiaoqing; Spindler, Tassja J.; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Baker, Helen; Bandera, Elisa V.; Bean, Yukie; Beckmann, Matthias W.; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise A.; Brooks-Wilson, Angela; Bruinsma, Fiona; Butzow, Ralf; Campbell, Ian G.; Carty, Karen; Chang-Claude, Jenny; Chen, Y. Ann; Chen, Zhihua; Cook, Linda S.; Cramer, Daniel W.; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Dennis, Joe; Dicks, Ed; Doherty, Jennifer A.; Dicks, Ed; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Eccles, Diana; Easton, Douglas T.; Edwards, Robert P.; Eilber, Ursula; Ekici, Arif B.; Engelholm, Svend Aage; Fasching, Peter A.; Fridley, Brooke L.; Gao, Yu-Tang; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goode, Ellen L.; Goodman, Marc T.; Grownwald, Jacek; Harrington, Patricia; Harter, Philipp; Hasmad, Hanis Nazihah; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Estrid; Hogdall, Claus; Hosono, Satoyo; Iversen, Edwin S.; Jakubowska, Anna; Jensen, Allan; Ji, Bu-Tian; Karlan, Beth Y.; Kellar, Melissa; Kelley, Joseph L.; Kiemeney, Lambertus A.; Krakstad, Camilla; Kjaer, Susanne K.; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Alice W.; Lele, Shashi; Leminen, Arto; Lester, Jenny; Levine, Douglas A.; Liang, Dong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Iain; Menon, Usha; Modugno, Francesmary; Moes-Sosnowska, Joanna; Moysich, Kirsten B.; Narod, Steven A.; Nedergaard, Lotte; Ness, Roberta B.; Nevanlinna, Heli; Adenan, Noor Azmi Mat; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Weber, Rachel Palmieri; Paul, James; Pearce, Celeste Leigh; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jennifer; Pike, Malcolm C.; Poole, Elizabeth M.; Ramus, Susan J.; Risch, Harvey A.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Rudolph, Anja; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Salvesen, Helga B.; Schildkraut, Joellen M.; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Sucheston, Lara; Tangen, Ingvild L.; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Tworoger, Shelley S.; van Altena, Anne M.; Van Nieuwenhuysen, Els; Vergote, Ignace; Vierkant, Robert A.; Wang-Gohrke, Shan; Walsh, Christine; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Sawicki, Wlodzimierz; Woo, Yin-Ling; Wu, Xifeng; Wu, Anna H.; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Sellers, Thomas A.; Freedman, Matthew L.; Chenevix-Trench, Georgia; Pharoah, Paul D. P.; Gayther, Simon A.; Berchuck, Andrew		Australian Canc Study; Australian Ovarian Canc Study Grp; Ovarian Canc Assoc Consortium	Genome-wide significant risk associations for mucinous ovarian carcinoma	NATURE GENETICS			English	Article							IDENTIFIES SUSCEPTIBILITY LOCI; BREAST-CANCER RISK; COLORECTAL-CANCER; MOLECULAR CHARACTERIZATION; ANALYSES REVEAL; FALLOPIAN-TUBE; HEPATITIS-C; CELL-TYPE; TUMORS; GENES	Genome-wide association studies have identified several risk associations for ovarian carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC cases and 21,693 controls with imputation identified 3 new risk associations: rs752590 at 2q13 (P = 3.3 x 10(-8)), rs711830 at 2q31.1 (P = 7.5 x 10(-12)) and rs688187 at 19q13.2 (P = 6.8 x 10(-13)). We identified significant expression quantitative trait locus (eQTL) associations for HOXD9 at 2q31.1 in ovarian (P = 4.95 x 10(-4), false discovery rate (FDR) = 0.003) and colorectal (P = 0.01, FDR = 0.09) tumors and for PAX8 at 2q13 in colorectal tumors (P = 0.03, FDR = 0.09). Chromosome conformation capture analysis identified interactions between the HOXD9 promoter and risk-associated SNPs at 2q31.1. Overexpressing HOXD9 in MOC cells augmented the neoplastic phenotype. These findings provide the first evidence for MOC susceptibility variants and insights into the underlying biology of the disease.	[Kelemen, Linda E.] Med Univ S Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Lawrenson, Kate; Lee, Janet M.; Spindler, Tassja J.; Lee, Alice W.; Pearce, Celeste Leigh; Pike, Malcolm C.; Ramus, Susan J.; Wu, Anna H.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Tyrer, Jonathan; Harrington, Patricia; Song, Honglin; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Li, Qiyuan] Xiamen Univ, Coll Med, Xiamen, Peoples R China; [Li, Qiyuan; Seo, Ji-Heui; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Boston, MA 02115 USA; [Phelan, Catherine M.; Permuth-Wey, Jennifer; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Beesley, Jonathan; Chen, Xiaoqing; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Canc Genet, Brisbane, Qld, Australia; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Genet Epidemiol Res Inst, Dept Epidemiol, Irvine, CA 92717 USA; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, Byelarus; [Baker, Helen; Dennis, Joe; Dicks, Ed; Easton, Douglas T.; Song, Honglin; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Bandera, Elisa V.] Rutgers State Univ, Canc Inst New Jersey, Canc Prevent & Control Program, New Brunswick, NJ 08903 USA; [Bean, Yukie; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, D-91054 Erlangen, Germany; [Bisogna, Maria; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brinton, Louise A.; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Bruinsma, Fiona; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Australia; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Helsinki Univ Hosp, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Campbell, Ian G.] Peter MacCallum Canc Ctr, Div Res, Canc Genet Lab, East Melbourne, Vic, Australia; [Campbell, Ian G.; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Carty, Karen; Glasspool, Rosalind; Paul, James] Beatson West Scotland Canc Ctr, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Eilber, Ursula; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chen, Y. Ann; Chen, Zhihua] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Cramer, Daniel W.; Poole, Elizabeth M.; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.] Brigham & Womens Hosp, Obstetr & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN USA; [Cybulski, Cezary; Grownwald, Jacek; Jakubowska, Anna; Lubinski, Jan] West Pomeranian Univ Technol, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70310 Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Moes-Sosnowska, Joanna; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland; [Doherty, Jennifer A.] Geisel Sch Med, Dept Epidemiol, Lebanon, NH USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte Evang Huyssens Stiftung Knap, Dept Gynecol & Gynecol Oncol, Essen, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [Duerst, Matthias; Runnebaum, Ingo B.] Univ Jena, Jena Univ Hospital, Dept Gynecol, Jena, Germany; [Eccles, Diana] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Edwards, Robert P.; Kelley, Joseph L.; Modugno, Francesmary] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, Pittsburgh, PA USA; [Edwards, Robert P.; Kelley, Joseph L.; Modugno, Francesmary] Univ Pittsburgh, Ovarian Canc Ctr Excellence, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Ctr Comprehens Canc, Inst Human Genet, D-91054 Erlangen, Germany; [Engelholm, Svend Aage] Univ Copenhagen, Rigshosp, Dept Radiat Oncol, DK-2100 Copenhagen, Denmark; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Shanghai, Peoples R China; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Inst Womens Hlth, Gynaecol Canc Res Ctr, Dept Womens Canc, London, England; [Giles, Graham G.] Univ Melbourne, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Giles, Graham G.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Canc Prevent & Control, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Community & Populat Hlth Res Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Hasmad, Hanis Nazihah; Teo, Soo-Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hillemanns, Peter] Hannover Med Sch, Clin Obstet & Gynaecol, Hannover, Germany; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Copenhagen, Denmark; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc Res Ctr, Dept Virus Lifestyle & Genes, Copenhagen, Denmark; [Hogdall, Claus; Kjaer, Susanne K.; Lundvall, Lene; Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Gynaecol, DK-2100 Copenhagen, Denmark; [Hosono, Satoyo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace] Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Gynecol Oncol, Leuven, Belgium; [Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; [Le, Nhu D.] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC V5Z 4E6, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston, Lara] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Matsuo, Keitaro; Rothstein, Joseph H.] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Nagoya, Aichi, Japan; [McGuire, Valerie; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [McLaughlin, John R.] Publ Hlth Ontario, Toronto, ON, Canada; [McNeish, Iain] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Beatson Inst Canc Res, Inst Canc Sci, Glasgow, Lanark, Scotland; [Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res Program, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Adenan, Noor Azmi Mat; Woo, Yin-Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Weber, Rachel Palmieri; Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC USA; [Pearce, Celeste Leigh] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Med, Boston, MA USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rosen, Barry] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Rossing, Mary Anne; Wicklund, Kristine G.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Schildkraut, Joellen M.] Duke Canc Inst, Durham, NC USA; [Schwaab, Ira] Praxis Humangenet, Wiesbaden, Germany; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Shvetsov, Yurii B.; Wilkens, Lynne R.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Teo, Soo-Hwang; Woo, Yin-Ling] Univ Malaya, Fac Med, Med Ctr, Canc Res Inst, Kuala Lumpur, Malaysia; [Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, D-89069 Ulm, Germany; [Sawicki, Wlodzimierz] Med Univ Warsaw, Fac Med 2, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Gayther, SA (reprint author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA.	simon.gayther@med.usc.edu	Hein, Alexander/F-6999-2010; Woo, Yin Ling/B-5198-2010; Massuger, Leon/H-8072-2014; Kiemeney, Lambertus/D-3357-2009; Dork, Thilo/J-8620-2012; 	Hein, Alexander/0000-0003-2601-3398; Woo, Yin Ling/0000-0003-1742-1066; Kiemeney, Lambertus/0000-0002-2368-1326; McNeish, Iain/0000-0002-9387-7586; Kjaer, Susanne/0000-0002-8347-1398	European Commission [223175-HEALTH-F2-2009-223175]; Ovarian Cancer Research Fund [PPD/RPCI.07]; Genetic Associations and Mechanisms in Oncology (GAME-ON); National Cancer Institute Cancer Post-GWAS Initiative [U19-CA148112]; Wellcome Trust [076113]	We thank all the individuals who took part in this study and all the researchers, clinicians, and technical and administrative staff who made possible the many studies contributing to this work (a full list is provided in the Supplementary Note). The COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement 223175-HEALTH-F2-2009-223175). The Ovarian Cancer Association Consortium (OCAC) is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were supported in part by Genetic Associations and Mechanisms in Oncology (GAME-ON) and a National Cancer Institute Cancer Post-GWAS Initiative (U19-CA148112). Details of the funding of individual investigators and studies are provided in the Supplementary Note. This study made use of data generated by the Wellcome Trust Case Control Consortium; funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the consortium website (see URLs). The results published here are based in part on data generated by The Cancer Genome Atlas (TCGA) Pilot Project established by the National Cancer Institute and National Human Genome Research Institute; information about TCGA and the investigators and institutions who constitute the TCGA research network can be found on the project website (see URLs).	Coetzee SG, 2015, HUM MOL GENET, V24, P3595, DOI 10.1093/hmg/ddv101; Kelemen LE, 2011, LANCET ONCOL, V12, P1071, DOI 10.1016/S1470-2045(11)70058-4; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; RONNETT BM, 1995, AM J SURG PATHOL, V19, P1390, DOI 10.1097/00000478-199512000-00006; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Risch HA, 2006, J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/nmeth.1785, 10.1038/NMETH.1785]; Seidman JD, 2003, AM J SURG PATHOL, V27, P985, DOI 10.1097/00000478-200307000-00014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Risch HA, 1996, AM J EPIDEMIOL, V144, P363; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Pieretti M, 2002, CANCER INVEST, V20, P11, DOI 10.1081/CNV-120000361; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Ochi H, 2011, J GEN VIROL, V92, P1071, DOI 10.1099/vir.0.029124-0; Lee KR, 2003, AM J SURG PATHOL, V27, P281, DOI 10.1097/00000478-200303000-00001; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Li H, 2002, GYNECOL ONCOL, V84, P216, DOI 10.1006/gyno.2001.6498; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Laury AR, 2010, AM J SURG PATHOL, V34, P627, DOI 10.1097/PAS.0b013e3181da7687; LYNCH HT, 1991, CANCER GENET CYTOGEN, V53, P161, DOI 10.1016/0165-4608(91)90094-B; Ronnett BM, 2004, HUM PATHOL, V35, P949, DOI 10.1016/j.humpath.2004.03.006; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Hart WR, 2005, INT J GYNECOL PATHOL, V24, P4, DOI 10.1097/01.pgp.0000148335.39146.a7; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Boyd J, 1997, GYNECOL ONCOL, V64, P196, DOI 10.1006/gyno.1996.4572; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; LYNCH HT, 1985, CANCER, V56, P939, DOI 10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T; Gilks CB, 2008, HUM PATHOL, V39, P1239, DOI 10.1016/j.humpath.2008.01.003; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x; Laury AR, 2011, AM J SURG PATHOL, V35, P816, DOI 10.1097/PAS.0b013e318216c112; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Yemelyanova AV, 2008, AM J SURG PATHOL, V32, P128; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Faber MT, 2013, CANCER CAUSE CONTROL, V24, P989, DOI 10.1007/s10552-013-0174-4; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Chen KX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5682; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cuatrecasas M, 1997, CANCER, V79, P1581, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T; Di Palma T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-292; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Heinzelmann-Schwarz VA, 2006, BRIT J CANCER, V94, P904, DOI 10.1038/sj.bjc.6603003; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; ICHIKAWA Y, 1994, CANCER RES, V54, P33; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; KUNZMANN R, 1987, CANCER GENET CYTOGEN, V28, P201, DOI 10.1016/0165-4608(87)90206-8; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; PEJOVIC T, 1995, ANN MED, V27, P73, DOI 10.3109/07853899509031940; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Tabuse M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-60; Tavassoulu F.A., 2003, WHO CLASSIFICATION T	71	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					888	+		10.1038/ng.3336		12	Genetics & Heredity	Genetics & Heredity	CN8FG	WOS:000358674100012		
J	Miyata, Y; Nakayama, K; Sugawara, K; Sato, T; Takahashi, T				Miyata, Y.; Nakayama, K.; Sugawara, K.; Sato, T.; Takahashi, T.			High-temperature superconductivity in potassium-coated multilayer FeSe thin films	NATURE MATERIALS			English	Article							SINGLE-LAYER FESE; SRTIO3; ORIGIN	The recent discovery of possible high-temperature (T-c) superconductivity over 65 K in a monolayer FeSe film on SrTiO3 (refs 1-6) triggered a fierce debate on how superconductivity evolves from bulk to film, because bulk FeSe crystal exhibits a T-c of no higher than 10 K (ref. 7). However, the difficulty in controlling the carrier density and the number of FeSe layers has hindered elucidation of this problem(4,8). Here, we demonstrate that deposition of potassium onto FeSe films markedly expands the accessible doping range towards the heavily electron-doped region. Intriguingly, we have succeeded in converting non-superconducting films with various thicknesses into superconductors with T-c as high as 48 K. We also found a marked increase in the magnitude of the superconducting gap on decreasing the FeSe film thickness, indicating that the interface plays a crucial role in realizing the high-temperature superconductivity. The results presented provide a new strategy to enhance and optimize T-c in ultrathin films of iron-based superconductors.	[Miyata, Y.; Nakayama, K.; Sato, T.; Takahashi, T.] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Sugawara, K.; Takahashi, T.] Tohoku Univ, Adv Inst Mat Res, WPI Res Ctr, Sendai, Miyagi 9808577, Japan	Miyata, Y (reprint author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.	k.nakayama@arpes.phys.tohoku.ac.jp	Takahashi, Takashi/E-5080-2010; Sato, Takafumi/E-5094-2010; Sugawara, Katsuaki/A-4857-2010		Japan Society for the Promotion Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	We thank Q. Xue, X. Ma, L. Wang, F. Li and W. Zhang for their advice in thin-film growth. We also thank E. Ieki, G. N. Phan, S. Kanayama and E. Noguchi for their assistance in thin-film growth and ARPES measurements. This work was supported by grants from the Japan Society for the Promotion Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Xiang YY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.134508; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; Maletz J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220506; Peng R, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.107001; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee JJ, 2014, NATURE, V515, P245, DOI 10.1038/nature13894; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Tan SY, 2013, NAT MATER, V12, P634, DOI [10.1038/nmat3654, 10.1038/NMAT3654]; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; He SL, 2013, NAT MATER, V12, P605, DOI [10.1038/nmat3648, 10.1038/NMAT3648]; Wang QY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/037402; Bozovic I, 2014, NAT PHYS, V10, P892; Cao HY, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.014501; Ge G-F., 2015, NAT MATER, V14, P285; Hao NN, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031053; Liu DF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1946; Liu X., 2014, NATURE COMMUN, V5, P5047; Matsui H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217002; Nakayama K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.237001; Norman M. R., 1998, PHYS REV B, V57; Peng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6044; Song CL, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020503; Sun Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06040	23	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	AUG	2015	14	8					775	+		10.1038/NMAT4302		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CN6FQ	WOS:000358530100017		
J	Comin, R; Sutarto, R; He, F; Neto, EHD; Chauviere, L; Frano, A; Liang, R; Hardy, WN; Bonn, DA; Yoshida, Y; Eisaki, H; Achkar, AJ; Hawthorn, DG; Keimer, B; Sawatzky, GA; Damascelli, A				Comin, R.; Sutarto, R.; He, F.; da Silva Neto, E. H.; Chauviere, L.; Frano, A.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Yoshida, Y.; Eisaki, H.; Achkar, A. J.; Hawthorn, D. G.; Keimer, B.; Sawatzky, G. A.; Damascelli, A.			Symmetry of charge order in cuprates	NATURE MATERIALS			English	Article							QUASI-PARTICLE STATES; STRIPE ORDER; DENSITY-WAVE; SUPERCONDUCTIVITY; BI2SR2CACU2O8+DELTA; NEMATICITY; MAGNETISM; MODEL	Charge-ordered ground states permeate the phenomenology of 3d-based transition metal oxides, and more generally represent a distinctive hallmark of strongly correlated states of matter. The recent discovery of charge order in various cuprate families has fuelled new interest into the role played by this incipient broken symmetry within the complex phase diagram of high-T-c superconductors. Here, we use resonant X-ray scattering to resolve the main characteristics of the charge-modulated state in two cuprate families: Bi2Sr2-xLaxCuO6C6+delta (Bi2201) and YBa2Cu3O6+y (YBCO). We detect no signatures of spatial modulations along the nodal direction in Bi2201, thus clarifying the inter-unit-cell momentum structure of charge order. We also resolve the intra-unit-cell symmetry of the charge-ordered state, which is revealed to be best represented by a bond order with modulated charges on the O-2p orbitals and a prominent d-wave character. These results provide insights into the origin and microscopic description of charge order in cuprates, and its interplay with superconductivity.	[Comin, R.; da Silva Neto, E. H.; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Comin, R.; da Silva Neto, E. H.; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [Sutarto, R.; He, F.] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [da Silva Neto, E. H.; Chauviere, L.; Frano, A.; Keimer, B.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [da Silva Neto, E. H.] Canadian Inst Adv Res, Quantum Mat Program, Toronto, ON M5G 1Z8, Canada; [Frano, A.] Helmholtz Zentrum Berlin Mat & Energie, D-12489 Berlin, Germany; [Yoshida, Y.; Eisaki, H.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Achkar, A. J.; Hawthorn, D. G.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	Comin, R (reprint author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	r.comin@utoronto.ca; damascelli@physics.ubc.ca	Hawthorn, David/I-6491-2012; He, Feizhou/G-8493-2015	Hawthorn, David/0000-0002-7002-0416; He, Feizhou/0000-0002-3125-1406	Max Planck-UBC Centre for Quantum Materials; Killam Fellowship; A. von Humboldt Fellowship; NSERC's Steacie Memorial Fellowship; Canada Research Chairs Program; NSERC; CFI; CIFAR Quantum Materials; NRC; CIHR; Government of Saskatchewan; University of Saskatchewan; CLS Graduate Student Travel Support Program; CIFAR Global Academy; A. P. Sloan Fellowship; WD Canada	We are grateful to J. E. Hoffman, Y. He and M. Yee for sharing their STM data and for fruitful discussions. We also acknowledge M. Le Tacon, S. Sachdev, M. Norman, S. Kivelson, C. Pepin, E. D. Torre and E. Demler for insightful discussions. This work was supported by the Max Planck-UBC Centre for Quantum Materials, the Killam, A. P. Sloan, A. von Humboldt, and NSERC's Steacie Memorial Fellowships (A. D.), the Canada Research Chairs Program (A. D., G. A. S.), NSERC, CFI and CIFAR Quantum Materials. Part of the research described in this paper was performed at the Canadian Light Source, which is funded by the CFI, NSERC, NRC, CIHR, the Government of Saskatchewan, WD Canada and the University of Saskatchewan. R.C. acknowledges the receipt of support from the CLS Graduate Student Travel Support Program. E.H.d.S.N. acknowledges support from the CIFAR Global Academy.	Achkar A. J., 2014, PREPRINT; Ando Y., 2000, PHYS REV B, V61; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Achkar AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167001; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Lee PA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031017; EMERY VJ, 1990, PHYS REV LETT, V64, P475, DOI 10.1103/PhysRevLett.64.475; da Silva Neto Eduardo H, 2015, Science, V347, P282, DOI [10.1126/science.1256441, 10.1126/science.aaa2148]; Sachdev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027202; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Seibold G, 2012, PHYSICA C, V481, P132, DOI 10.1016/j.physc.2012.03.072; Nie LM, 2014, P NATL ACAD SCI USA, V111, P7980, DOI 10.1073/pnas.1406019111; Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Fujita K, 2014, P NATL ACAD SCI USA, V111, pE3026, DOI 10.1073/pnas.1406297111; Bulut S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.155132; Efetov KB, 2013, NAT PHYS, V9, P442, DOI [10.1038/nphys2641, 10.1038/NPHYS2641]; Wang YX, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035149; Metlitski MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075128; Cwik M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057201; Achkar AJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.017001; Melikyan A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024507; Chang J, 2012, NAT PHYS, V8, P871, DOI [10.1038/nphys2456, 10.1038/NPHYS2456]; Davis JCS, 2013, P NATL ACAD SCI USA, V110, P17623, DOI 10.1073/pnas.1316512110; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Dalla Torre E. G., 2015, NEW J PHYS, V111; EMERY VJ, 1990, PHYS REV B, V41, P7247, DOI 10.1103/PhysRevB.41.7247; Fink Jn, 2009, PHYS REV A, V79; He Y, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064516; Kivelson SA, 2003, REV MOD PHYS, V75, P1201, DOI 10.1103/RevModPhys.75.1201; Le Tacon M., 2014, NATURE PHYS, V10, P52; MACHIDA K, 1989, PHYSICA C, V158, P192, DOI 10.1016/0921-4534(89)90316-X; Matteo S. D., 2012, J PHYS D, V45; Meier H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020506; POILBLANC D, 1989, PHYS REV B, V39, P9749, DOI 10.1103/PhysRevB.39.9749; Schussler-Langeheine C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.156402; Tranquada JM, 1996, PHYS REV B, V54, P12318, DOI 10.1103/PhysRevB.54.12318; Vojta M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094504; Von Zimmermann M, 1998, EUROPHYS LETT, V41, P629, DOI 10.1209/epl/i1998-00204-2; Yoshizawa H., 1995, PHYS REV B, V52; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	50	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	AUG	2015	14	8					796	+		10.1038/NMAT4295		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CN6FQ	WOS:000358530100021		
J	Kiuchi, T; Higuchi, M; Takamura, A; Maruoka, M; Watanabe, N				Kiuchi, Tai; Higuchi, Makio; Takamura, Akihiro; Maruoka, Masahiro; Watanabe, Naoki			Multitarget super-resolution microscopy with high-density labeling by exchangeable probes	NATURE METHODS			English	Article							LOCALIZATION MICROSCOPY; FLUORESCENCE MICROSCOPY; ACTIN POLYMERIZATION; ROTATIONAL MOVEMENT; CELLULAR STRUCTURES; OPTICAL NANOSCOPY; ADHESIONS; CELLS; MDIA1; MICROTUBULES	We have developed a multitarget super-resolution microscopy technique called image reconstruction by integrating exchangeable single-molecule localization (IRIS). IRIS uses protein fragment-based probes that directly associate with and dissociate from their targets over durations on the order of tens of milliseconds. By integrating single-molecule localization and sequential labeling, IRIS enables unprecedented labeling density along multiple cellular structures. IRIS can be used to discern the area-specific proximity between cytoskeletal components and focal adhesions within a single cell.	[Kiuchi, Tai; Higuchi, Makio; Watanabe, Naoki] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Takamura, Akihiro; Maruoka, Masahiro] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Sendai, Miyagi 980, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Single Mol Cell Biol, Kyoto 606, Japan	Kiuchi, T (reprint author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	kiuchi.tai.6z@kyoto-u.ac.jp; watanabe.naoki.4v@kyoto-u.ac.jp			Cabinet Office of the Government of Japan [LS013]; Uehara Memorial Foundation; Japan Society for the Promotion of Science (JSPS) [26440091, 15H01635]	We thank H. Mizuno and S. Yamashiro (Kyoto University) for rabbit muscle actin and Y. Mimori-Kiyosue (RIKEN) for providing cDNAs encoding EB1, CLIP-170, CLASP2 gamma and APC. This work was supported by the Cabinet Office of the Government of Japan through the Funding Program for Next Generation World-Leading Researchers (LS013), by the Uehara Memorial Foundation (N.W.) and by the Uehara Memorial Foundation (N.W.), by Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers 26440091 and 15H01635 (T.K.).	Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Schoen I, 2011, NANO LETT, V11, P4008, DOI 10.1021/nl2025954; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Sauer M, 2013, J CELL SCI, V126, P3505, DOI 10.1242/jcs.123612; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/nmeth.1991, 10.1038/NMETH.1991]; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Gell C, 2009, J MICROSC-OXFORD, V234, P38, DOI 10.1111/j.1365-2818.2009.03147.x; Huda S, 2012, J CELL SCI, V125, P5790, DOI 10.1242/jcs.110494; Kanchanawong P, 2013, METHODS MOL BIOL, V1046, P59, DOI 10.1007/978-1-62703-538-5_4; Mizuno H, 2011, SCIENCE, V331, P80, DOI 10.1126/science.1197692; Mizuno H, 2014, METHOD ENZYMOL, V540, P73, DOI 10.1016/B978-0-12-397924-7.00005-4; Tanji M, 2010, MOL CELL BIOL, V30, P4604, DOI 10.1128/MCB.00197-10; Vale RD, 2008, CELL, V135, P779, DOI 10.1016/j.cell.2008.11.009; Yamashiro S, 2014, MOL BIOL CELL, V25, P1010, DOI 10.1091/mbc.E13-03-0162	31	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	AUG	2015	12	8					743	U69		10.1038/NMETH.3466		7	Biochemical Research Methods	Biochemistry & Molecular Biology	CN8ZW	WOS:000358736100017		
J	Plattner, F; Hayashi, K; Hernandez, A; Benavides, DR; Tassin, TC; Tan, CF; Day, J; Fina, MW; Yuen, EY; Yan, Z; Goldberg, MS; Nairn, AC; Greengard, P; Nestler, EJ; Taussig, R; Nishi, A; Houslay, MD; Bibb, JA				Plattner, Florian; Hayashi, Kanehiro; Hernandez, Adan; Benavides, David R.; Tassin, Tara C.; Tan, Chunfeng; Day, Jonathan; Fina, Maggy W.; Yuen, Eunice Y.; Yan, Zhen; Goldberg, Matthew S.; Nairn, Angus C.; Greengard, Paul; Nestler, Eric J.; Taussig, Ronald; Nishi, Akinori; Houslay, Miles D.; Bibb, James A.			The role of ventral striatal cAMP signaling in stress-induced behaviors	NATURE NEUROSCIENCE			English	Article							CYCLIN-DEPENDENT KINASE-5; MAJOR DEPRESSIVE DISORDER; AMP PHOSPHODIESTERASE; SYNAPTIC PLASTICITY; PROTEIN-KINASE; CDK5; BRAIN; PHOSPHORYLATION; ANTIDEPRESSANT; DOPAMINE	The cAMP and cAMP-dependent protein kinase A (PKA) signaling cascade is a ubiquitous pathway acting downstream of multiple neuromodulators. We found that the phosphorylation of phosphodiesterase-4 (PDE4) by cyclin-dependent protein kinase 5 (Cdk5) facilitated cAMP degradation and homeostasis of cAMP/PKA signaling. In mice, loss of Cdk5 throughout the forebrain elevated cAMP levels and increased PKA activity in striatal neurons, and altered behavioral responses to acute or chronic stressors. Ventral striatum- or D1 dopamine receptor-specific conditional knockout of Cdk5, or ventral striatum infusion of a small interfering peptide that selectively targeted the regulation of PDE4 by Cdk5, produced analogous effects on stress-induced behavioral responses. Together, our results demonstrate that altering cAMP signaling in medium spiny neurons of the ventral striatum can effectively modulate stress-induced behavioral states. We propose that targeting the Cdk5 regulation of PDE4 could be a new therapeutic approach for clinical conditions associated with stress, such as depression.	[Plattner, Florian; Hayashi, Kanehiro; Hernandez, Adan; Benavides, David R.; Tassin, Tara C.; Tan, Chunfeng; Goldberg, Matthew S.; Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Day, Jonathan] Univ Glasgow, Inst Biomed & Life Sci, Div Neurosci & Mol Pharmacol, Glasgow, Lanark, Scotland; [Fina, Maggy W.; Taussig, Ronald] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Goldberg, Matthew S.; Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Nairn, Angus C.; Greengard, Paul] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10021 USA; [Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, Fukuoka, Japan; [Houslay, Miles D.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Bibb, JA (reprint author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu		Plattner, Florian/0000-0002-3150-1866	UTSW Depression Center; Brain and Behavior Research Foundation NARSAD Young Investigator Award; pre-doctoral National Research Service Award from the National Institute on Drug Abuse; Darrell K Royal Research Fund for Alzheimer's Research; California Metabolic Research Foundation; US National Institutes of Health grants [MH090963, DA10044, MH51399, GM084249, MH79710, MH083711, DA016672, DA018343, DA033485, NS073855]	We thank N. Heintz (Rockefeller University) and GenSat for D1R-Cre mice, K. Deisseroth (Stanford University) for the Dio-Cre vector, C. Burger (University of Wisconsin-Madison) for AAV vectors, H. Ball and Y. Li (University of Texas Southwestern (UTSW) Protein Technology Center) for peptides, the UTSW Animal Resource Center for help with phosphorylation state-specific antibody generation, D.M. Dietz, M. Lutter, M. Kouser and J. Kumar for help with the social defeat procedure, and T. Singh and G. Mettlach for technical assistance. We thank M. Trivedi and the UTSW Depression Center for support. This work was supported by a Brain and Behavior Research Foundation NARSAD Young Investigator Award (K.H.), a pre-doctoral National Research Service Award from the National Institute on Drug Abuse (D.R.B.), a grant from the Darrell K Royal Research Fund for Alzheimer's Research (F.P.) and the California Metabolic Research Foundation (M.D.H.), as well as by US National Institutes of Health grants to A.C.N. and P.G. (MH090963, DA10044), E.J.N. (MH51399), R.T. (GM084249) and J.A.B. (MH79710, MH083711, DA016672, DA018343, DA033485, NS073855).	Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Barnett DGS, 2011, BRAIN RES BULL, V85, P9, DOI 10.1016/j.brainresbull.2010.11.016; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Fujita M, 2012, BIOL PSYCHIAT, V72, P548, DOI 10.1016/j.biopsych.2012.04.030; Mathews DC, 2012, DRUGS, V72, P1313, DOI 10.2165/11633130-000000000-00000; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Meyer DA, 2014, J NEUROSCI, V34, P8259, DOI 10.1523/JNEUROSCI.4368-13.2014; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; CARLSON JN, 1991, BRAIN RES, V550, P313, DOI 10.1016/0006-8993(91)91333-V; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Fischer A, 2002, J NEUROSCI, V22, P3700; Johansson EM, 2012, NEUROSCI LETT, V525, P1, DOI 10.1016/j.neulet.2012.07.050; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Kleppisch Thomas, 2009, V191, P71; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Bibb JA, 1999, NATURE, V402, P669; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Sette C, 1996, J BIOL CHEM, V271, P16526; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Chrapusta SJ, 1997, J NEUROCHEM, V68, P2024; Song GG, 2013, J MOL NEUROSCI, V51, P428, DOI 10.1007/s12031-013-0047-z; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Nishi A, 1997, J NEUROSCI, V17, P8147; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Halene TB, 2007, DRUG DISCOV TODAY, V12, P870, DOI 10.1016/j.drudis.2007.07.023; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Bignante EA, 2010, EUR NEUROPSYCHOPHARM, V20, P388, DOI 10.1016/j.euroneuro.2010.02.007; Bignante EA, 2008, EUR NEUROPSYCHOPHARM, V18, P578, DOI 10.1016/j.euroneuro.2008.02.007; Castagne V., 2011, CURRENT PROTOCOLS NE, V8, p10A; CZERNIK AJ, 1997, NEUROMETH, V30, P219; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; LOBBAN M, 1994, BIOCHEM J, V304, P399; Mungenast AE, 2012, NEURODEGENER DIS, V10, P191, DOI 10.1159/000334602; O'Donnell JM, 2012, BIOL PSYCHIAT, V72, P524, DOI 10.1016/j.biopsych.2012.07.017; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; ZELLER E, 1984, PHARMACOPSYCHIATRY, V17, P188, DOI 10.1055/s-2007-1017435; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m; Zhong P, 2014, J NEUROSCI, V34, P6352, DOI 10.1523/JNEUROSCI.3673-13.2014; Zhu WL, 2012, INT J NEUROPSYCHOPH, V15, P795, DOI 10.1017/S1461145711000915	62	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1094	+		10.1038/nn.4066		9	Neurosciences	Neurosciences & Neurology	CN7HO	WOS:000358605400009		
J	Tatebayashi, J; Kako, S; Ho, JF; Ota, Y; Iwamoto, S; Arakawa, Y				Tatebayashi, Jun; Kako, Satoshi; Ho, Jinfa; Ota, Yasutomo; Iwamoto, Satoshi; Arakawa, Yasuhiko			Room-temperature lasing in a single nanowire with quantum dots	NATURE PHOTONICS			English	Article							LASERS; NANOLASERS; SILICON; GROWTH; PHOTOLUMINESCENCE; HETEROSTRUCTURE; EFFICIENCY; ARRAY	Semiconductor nanowire lasers are promising as ultrasmall, highly efficient coherent light emitters in the fields of nano-photonics, nano-optics and nanobiotechnology(1,2). Although there have been several demonstrations of nanowire lasers using homogeneous bulk gainmaterials(3-14) or multi-quantum-wells/disks(15-17), it is crucial to incorporate lower-dimensional quantum nano-structures into the nanowire to achieve superior device performance in relation to threshold current, differential gain, modulation bandwidth and temperature sensitivity. The quantum dot is a useful and essential that can meet these requirements(18). However, difficulties in forming stacks of quantum dots in a single nanowire hamper the realization of lasing operation. Here, we demonstrate room-temperature lasing of a single nanowire containing 50 quantum dots by properly designing the nanowire cavity and tailoring the emission energy of each dot to enhance the optical gain. Our demonstration paves the way toward ultrasmall lasers with extremely low power consumption for integrated photonic systems.	[Tatebayashi, Jun; Kako, Satoshi; Ho, Jinfa; Ota, Yasutomo; Iwamoto, Satoshi; Arakawa, Yasuhiko] Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Ho, Jinfa; Iwamoto, Satoshi; Arakawa, Yasuhiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Tatebayashi, J (reprint author), Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	tatebaya@iis.u-tokyo.ac.jp; arakawa@iis.u-tokyo.ac.jp			Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program); New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by the Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program) and the New Energy and Industrial Technology Development Organization (NEDO). The authors thank M. Arita, M. Holmes, M. Nishioka and S. Ishida for discussions and technical support.	Buckley S, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126503; Yang L, 2009, OPT EXPRESS, V17, P9337, DOI 10.1364/OE.17.009337; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; Ding JX, 2004, APPL PHYS LETT, V85, P2361, DOI 10.1063/1.1791326; Wu YY, 2002, NANO LETT, V2, P83, DOI 10.1021/nl0156888; Liu ZC, 2013, NANO LETT, V13, P4945, DOI 10.1021/nl4029686; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Ertekin E, 2005, J APPL PHYS, V97, DOI 10.1063/1.1903106; Saxena D, 2013, NAT PHOTONICS, V7, P963, DOI [10.1038/nphoton.2013.303, 10.1038/NPHOTON.2013.303]; Qian F, 2008, NAT MATER, V7, P701, DOI 10.1038/nmat2253; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Bjork MT, 2002, NANO LETT, V2, P87, DOI 10.1021/nl010099n; Makhonin MN, 2013, NANO LETT, V13, P861, DOI 10.1021/nl303075q; Xu HW, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4751862; Chen R, 2011, NAT PHOTONICS, V5, P170, DOI [10.1038/nphoton.2010.315, 10.1038/NPHOTON.2010.315]; Tatebayashi J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895597; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Otsubo K, 2004, JPN J APPL PHYS 2, V43, pL1124, DOI 10.1143/JJAP.43.L1124; Glas F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121302; Frost T, 2014, NANO LETT, V14, P4535, DOI 10.1021/nl5015603; Tateno K, 2012, NANO LETT, V12, P2888, DOI 10.1021/nl300482n; Hua B, 2009, NANO LETT, V9, P112, DOI 10.1021/nl802636b; Johnson JC, 2002, NAT MATER, V1, P106, DOI 10.1038/nmat728; Gao Q, 2014, NANO LETT, V14, P5206, DOI 10.1021/nl5021409; Tatebayashi J, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4731208; Chin AH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198017; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Li KH, 2015, NAT NANOTECHNOL, V10, P140, DOI [10.1038/nnano.2014.308, 10.1038/NNANO.2014.308]; Lu FL, 2012, OPT EXPRESS, V20, P12171, DOI 10.1364/OE.20.012171; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Mayer B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3931; Mi ZT, 2005, J APPL PHYS, V98, DOI 10.1063/1.1985969; Nilsson HA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362594	34	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	AUG	2015	9	8					501	+		10.1038/NPHOTON.2015.111		6	Optics; Physics, Applied	Optics; Physics	CN9AF	WOS:000358737200010		
J	Shi, ZW; Hong, XP; Bechtel, HA; Zeng, B; Martin, MC; Watanabe, K; Taniguchi, T; Shen, YR; Wang, F				Shi, Zhiwen; Hong, Xiaoping; Bechtel, Hans A.; Zeng, Bo; Martin, Michael C.; Watanabe, Kenji; Taniguchi, Takashi; Shen, Yuen-Ron; Wang, Feng			Observation of a Luttinger-liquid plasmon in metallic single-walled carbon nanotubes	NATURE PHOTONICS			English	Article							GRAPHENE PLASMONS; SCATTERING; RESONANCES; JUNCTIONS; OPTICS; LIGHT	Surface plasmons(1), collective oscillations of conduction electrons, hold great promise for the nanoscale integration of photonics and electronics(1-4). However, nanophotonic circuits based on plasmons have been significantly hampered by the difficulty in achieving broadband plasmonic waveguides that simultaneously exhibit strong spatial confinement, a high quality factor and low dispersion. Quantum plasmons, where the quantum mechanical effects of electrons play a dominant role, such as plasmons in very small metal nanoparticles(5,6) and plasmons affected by tunnelling effects(7), can lead to novel plasmonic phenomena in nanostructures. Here, we show that a Luttinger liquid(8,9) of one-dimensional Dirac electrons in carbon nanotubes(10-13) exhibits quantum plasmons that behave qualitatively differently from classical plasmon excitations. The Luttinger-liquid plasmons propagate at 'quantized' velocities that are independent of carrier concentration or excitation wavelength, and simultaneously exhibit extraordinary spatial confinement and high quality factor. Such Luttinger-liquid plasmons could enable novel low-loss plasmonic circuits for the subwavelength manipulation of light.	[Shi, Zhiwen; Hong, Xiaoping; Zeng, Bo; Shen, Yuen-Ron; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bechtel, Hans A.; Martin, Michael C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source Div, Berkeley, CA 94720 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; [Shen, Yuen-Ron; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Wang, Feng] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Shi, ZW (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	zhiwen22@gmail.com; fengwang76@berkeley.edu	wang, Feng/I-5727-2015; Shi, Zhiwen/C-4945-2013	Shi, Zhiwen/0000-0002-3928-2960	Office of Basic Energy Science, Department of Energy [DE-AC02-05CH11231, DE-SC0003949]; National Science Foundation [DMR-1404865]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; David and Lucile Packard fellowship	The authors thank M. Raschke for discussions. H.B. and M.M., in particular, thank M. Raschke and his group for the years of pioneering research on infrared near-field techniques and key collaborations that led to the development of a near-field infrared instrument at the Advanced Light Source (ALS). The authors also thank K. Liu, Y. Sun, S. Shi, C. Jin and H. Chang for their help with sample preparation and discussions. This work was primarily supported by the Office of Basic Energy Science, Department of Energy (contract no. DE-AC02-05CH11231, Sub-Wavelength Metamaterial Program; contract no. DE-SC0003949, Early Career Award). Spectroscopy of nanotubes in the visible range was supported by the National Science Foundation (grant no. DMR-1404865). The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy (contract no. DE-AC02-05CH11231). F.W. acknowledges support from a David and Lucile Packard fellowship.	Ando T, 1998, J PHYS SOC JPN, V67, P2857, DOI 10.1143/JPSJ.67.2857; Park JY, 2004, NANO LETT, V4, P517, DOI 10.1021/nl035258c; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Pendry JB, 2012, SCIENCE, V337, P549, DOI 10.1126/science.1220600; Bechtel HA, 2014, P NATL ACAD SCI USA, V111, P7191, DOI 10.1073/pnas.1400502111; Bockrath M, 1999, NATURE, V397, P598; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/nmat2630, 10.1038/NMAT2630]; Ishii H, 2003, NATURE, V426, P540, DOI 10.1038/nature02074; Tan SF, 2014, SCIENCE, V343, P1496, DOI 10.1126/science.1248797; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Egger R, 1997, PHYS REV LETT, V79, P5082, DOI 10.1103/PhysRevLett.79.5082; Kane C, 1997, PHYS REV LETT, V79, P5086, DOI 10.1103/PhysRevLett.79.5086; LUTTINGER JM, 1963, J MATH PHYS, V4, P1154, DOI 10.1063/1.1704046; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; McEuen PL, 1999, PHYS REV LETT, V83, P5098, DOI 10.1103/PhysRevLett.83.5098; Liu KH, 2013, NAT NANOTECHNOL, V8, P917, DOI [10.1038/nnano.2013.227, 10.1038/NNANO.2013.227]; VOIT J, 1995, REP PROG PHYS, V58, P977, DOI 10.1088/0034-4885/58/9/002; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Scholl JA, 2012, NATURE, V483, P421, DOI 10.1038/nature10904; Hillenbrand R, 2001, J MICROSC-OXFORD, V202, P77, DOI 10.1046/j.1365-2818.2001.00794.x; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Liu KH, 2012, NAT NANOTECHNOL, V7, P325, DOI [10.1038/nnano.2012.52, 10.1038/NNANO.2012.52]; HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Purewal MS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186808; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Yao Z, 1999, NATURE, V402, P273; Gerber JA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.055502; Palik E. D., 1997, HDB OPTICAL CONSTANT; Suzuura H, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235412	30	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	AUG	2015	9	8					515	519		10.1038/NPHOTON.2015.123		5	Optics; Physics, Applied	Optics; Physics	CN9AF	WOS:000358737200013		
J	Akashi, YJ; Lyononly, AR				Akashi, Yoshihiro J.; Lyononly, Alexander R.			Microcirculatory dysfunction and autonomic disturbance in Takotsubo syndrome REPLY	NATURE REVIEWS CARDIOLOGY			English	Letter							CARDIOMYOPATHY		[Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Div Cardiol, Dept Internal Med,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Lyononly, Alexander R.] Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Lyononly, Alexander R.] Univ London Imperial Coll Sci Technol & Med, London SW3 6NP, England	Akashi, YJ (reprint author), St Marianna Univ, Sch Med, Div Cardiol, Dept Internal Med,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	yoakashi-circ@umin.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Akashi Y. J., 2015, NAT REV CARDIOL; Deshmukh A, 2012, AM HEART J, V164, P66, DOI 10.1016/j.ahj.2012.03.020; Szardien S, 2013, INT J CARDIOL, V168, P1685, DOI 10.1016/j.ijcard.2013.03.075; Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050; KHALID, NAT REV CARDIOL, DOI DOI 10.1038/NRCARDIO.2015.88; Khalid N., 2015, NAT REV CARDIOL; MADIAS, NAT REV CARDIOL, DOI DOI 10.1038/NRCARDIO.2015.89; MADIAS J, 2015, NAT REV CARDIOL, DOI DOI 10.1016/J.AHJ.2012.03.020; Redfors B, 2014, EUR HEART J-CARD IMG, V15, P152, DOI 10.1093/ehjci/jet079; NAT REV CARDIOL, DOI DOI 10.1038/NRCARDIO.2015.39	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5002	1759-5010		NAT REV CARDIOL	Nat. Rev. Cardiol.	AUG	2015	12	8								10.1038/nrcardio.2015.90		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN5EG	WOS:000358452000010		
J	Takebe, N; Miele, L; Harris, PJ; Jeong, W; Bando, H; Kahn, M; Yang, S; Ivy, SP				Takebe, Naoko; Miele, Lucio; Harris, Pamela Jo; Jeong, Woondong; Bando, Hideaki; Kahn, Michael; Yang, SherryX.; Ivy, S. Percy			Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update	NATURE REVIEWS CLINICAL ONCOLOGY			English	Review							GAMMA-SECRETASE INHIBITOR; TUMOR-INITIATING CELLS; ADVANCED SOLID TUMORS; METASTATIC COLORECTAL-CANCER; ACUTE LYMPHOBLASTIC-LEUKEMIA; TO-MESENCHYMAL TRANSITION; NEGATIVE BREAST-CANCER; PHASE-II TRIAL; BETA-CATENIN; SIGNALING PATHWAY	During the past decade, cancer stem cells (CSCs) have been increasingly identified in many malignancies. Although the origin and plasticity of these cells remain controversial, tumour heterogeneity and the presence of small populations of cells with stem-like characteristics is established in most malignancies. CSCs display many features of embryonic or tissue stem cells, and typically demonstrate persistent activation of one or more highly conserved signal transduction pathways involved in development and tissue homeostasis, including the Notch, Hedgehog (HH), and Wnt pathways. CSCs generally have slow growth rates and are resistant to chemotherapy and/or radiotherapy. Thus, new treatment strategies targeting these pathways to control stem-cell replication, survival and differentiation are under development. Herein, we provide an update on the latest advances in the clinical development of such approaches, and discuss strategies for overcoming CSC-associated primary or acquired resistance to cancer treatment. Given the crosstalk between the different embryonic developmental signalling pathways, as well as other pathways, designing clinical trials that target CSCs with rational combinations of agents to inhibit possible compensatory escape mechanisms could be of particular importance. We also share our views on the future directions for targeting CSCs to advance the clinical development of these classes of agents.	[Takebe, Naoko; Harris, Pamela Jo; Ivy, S. Percy] NCI, Invest Drug Branch, Canc Therapy Evaluat Program, Div Canc Treatment & Diag,NIH, Bethesda, MD 20892 USA; [Miele, Lucio] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, Baton Rouge, LA 70803 USA; [Miele, Lucio] Louisiana Canc Res Consortium, New Orleans, LA USA; [Jeong, Woondong] Univ Texas, Canc Therapy & Res Ctr, Austin, TX USA; [Bando, Hideaki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Tokyo, Japan; [Kahn, Michael] Univ So Calif, Norris Comprehens Canc Res Ctr, San Francisco, CA USA; [Yang, SherryX.] NCI, Natl Clin Target Validat Lab, Div Canc Treatment & Diag, Bethesda, MD 20892 USA	Ivy, SP (reprint author), NCI, Invest Drug Branch, Canc Therapy Evaluat Program, Div Canc Treatment & Diag,NIH, 9609 Med Ctr Dr MSC9739, Bethesda, MD 20892 USA.	Takeben@mail.nih.gov; ivyp@ctep.nci.nih.gov					Abel EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091983; Albain K., 2011, CANC RES S, V71; Albain K, 2010, CANC RES S, V70, p113s; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Dirix L, 2014, J CLIN ONCOL, V32, P720, DOI 10.1200/JCO.2013.53.7118; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Graham RA, 2011, CLIN CANCER RES, V17, P2512, DOI 10.1158/1078-0432.CCR-10-2736; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Kim DJ, 2014, J CLIN ONCOL, V32, P745, DOI 10.1200/JCO.2013.49.9525; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Mohammed TA, 2011, ONCOLOGIST, V16, P835, DOI 10.1634/theoncologist.2011-0031; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Espinoza I, 2013, CANCER LETT, V341, P41, DOI 10.1016/j.canlet.2013.08.027; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Lehmann C, 2012, INT J ONCOL, V41, P1932, DOI 10.3892/ijo.2012.1654; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Strosberg JR, 2012, EUR J CANCER, V48, P997, DOI 10.1016/j.ejca.2012.02.056; Lee KS, 2013, GENE DEV, V27, P2642, DOI 10.1101/gad.225169.113; Roderick JE, 2013, J EXP MED, V210, P1311, DOI 10.1084/jem.20112615; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Zahreddine HA, 2014, NATURE, V511, P90, DOI 10.1038/nature13283; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Sahebjam S, 2013, BRIT J CANCER, V109, P943, DOI 10.1038/bjc.2013.380; Escobar C, 2012, ANN ONCOL, V23, P562, DOI 10.1093/annonc/mdr386; Chau WK, 2013, ONCOGENE, V32, P2767, DOI 10.1038/onc.2012.290; Real PJ, 2009, LEUKEMIA, V23, P1374, DOI 10.1038/leu.2009.75; Zhang CC, 2013, STEM CELL TRANSL MED, V2, P233, DOI 10.5966/sctm.2012-0096; Yoon JW, 2013, MOL CANCER RES, V11, P604, DOI 10.1158/1541-7786.MCR-12-0441; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Rabadan MA, 2012, CELL DEATH DIFFER, V19, P209, DOI 10.1038/cdd.2011.84; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Yoshizumi T, 2004, INT J ONCOL, V25, P631; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee HJ, 2009, ANGEW CHEM INT EDIT, V48, P6448, DOI 10.1002/anie.200902981; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Arcaroli JJ, 2013, BRIT J CANCER, V109, P667, DOI 10.1038/bjc.2013.361; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Raafat A, 2009, ONCOGENE, V28, P219, DOI 10.1038/onc.2008.379; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Carothers AM, 2012, CANCER RES, V72, P346, DOI 10.1158/0008-5472.CAN-11-2819; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Belani C. P., 2013, J CLIN ONCOL S, V31, pa7508; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Catenacci D. V. T., 2013, J CLIN ONCOL S, V31, pa4012; Cohen D. J., 2013, J CLIN ONCOL S, V31, pa4011; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; De Jesus-Acosta A., 2014, J CLIN ONCOL S3, V32, pa257; Deangelo D. J., 2006, J CLIN ONCOL S, V24, pa6585; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; El-Khoueiry AB, 2013, J CLIN ONCOL S, V31, p2501a; Espinoza I, 2013, ONCOTARGETS THER, V6, P1249, DOI 10.2147/OTT.S36162; Fogelstrand L, 2014, PEDIATR BLOOD CANCER, V61, P424, DOI 10.1002/pbc.24803; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gomez-del Arco P, 2010, IMMUNITY, V33, P685; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Gu Jian-Wei, 2012, Vasc Cell, V4, P7, DOI 10.1186/2045-824X-4-7; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Hao L, 2010, ONCOGENE, V29, P201, DOI 10.1038/onc.2009.323; Hollingshead Melinda G, 2008, J Natl Cancer Inst, V100, P1500, DOI 10.1093/jnci/djn351; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Jimeno A., 2013, J CLIN ONCOL S, V31, pa2502; Jimeno A, 2014, J CLIN ONCOL S, V32, p2505a; Karsten U, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-301; Lewis K. D., 2014, J CLIN ONCOL S, V32, pa9012; Madden J. I., 2012, INFINITY REPORTS UPD; Means-Powell J., 2012, CANCER RES, V72, p280s; Messersmiths WA, 2012, EUR J CANCER, V48, P180; Messersmith WA, 2015, CLIN CANCER RES, V21, P60, DOI 10.1158/1078-0432.CCR-14-0607; Migden M. R., 2014, J CLIN ONCOL S, V32; Mortier L., 2014, J CLIN ONCOL, V32; Nguyen D, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0104-2; Paryan M, 2013, MOL BIOL REP, V40, P5531, DOI 10.1007/s11033-013-2654-8; Perumalsamy LR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002859; Pietanza M. C., 2014, J CLIN ONCOL S, V32, pa7602; Rajguru S, 2012, J CLIN ONCOL, V30; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Roma J, 2012, SARCOMA, V2012; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shou Y, 2015, CLIN CANCER RES, V21, P585, DOI 10.1158/1078-0432.CCR-13-1711; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Sloan AE, 2014, J CLIN ONCOL S15, V32, P2026; Smith DC, 2013, J CLIN ONCOL S, V31, p2540a; Smith DC, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-B79; Smith ML, 2000, EUR J CANCER, V36, P664, DOI 10.1016/S0959-8049(99)00333-0; Stoeck A, 2014, CANCER DISCOV, V4, P1154, DOI 10.1158/2159-8290.CD-13-0830; Su YY, 2003, P NATL ACAD SCI USA, V100, P12729, DOI 10.1073/pnas.2133261100; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Takebe N, 2014, PHARMACOL THERAPEUT, V141, P140, DOI 10.1016/j.pharmthera.2013.09.005; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Sagert J, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-C158; Von Hoff D. E., 2012, J CLIN ONCOL S34, V30; Xie M, 2013, J CLIN ONCOL, V31; Yan Minhong, 2011, Vasc Cell, V3, P17, DOI 10.1186/2045-824X-3-17; Yao H, 2011, Blood Cancer J, V1, pe43, DOI 10.1038/bcj.2011.41; Yun J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.26; Zhang SB, 2014, CANCER BIOL THER, V15, P633, DOI 10.4161/cbt.28180	175	11	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4774	1759-4782		NAT REV CLIN ONCOL	Nat. Rev. Clin. Oncol.	AUG	2015	12	8					445	464		10.1038/nrclinonc.2015.61		20	Oncology	Oncology	CN8FO	WOS:000358675100005		
J	Matsui, T; Kawahara, N; Kimoto, A; Yoshida, Y				Matsui, Tomohiro; Kawahara, Natsumi; Kimoto, Arisa; Yoshida, Yusuke			Hypothermia Reduces but Hyperthermia Augments T Cell-Derived Release of Interleukin-17 and Granzyme B that Mediate Neuronal Cell Death	NEUROCRITICAL CARE			English	Article						T cells; Hypothermia; Interleukin-17; Granzyme B; Neuronal cell death; Hyperthermia; Brain endothelial cells; Adhesion molecules; Chemokines	CEREBRAL-ARTERY OCCLUSION; MESSENGER-RNA EXPRESSION; NEUTROPHIL RECRUITMENT; ISCHEMIC-STROKE; LYMPHOCYTE TRAFFICKING; RAT MICROGLIA; BRAIN-INJURY; INFLAMMATION; IL-17; TEMPERATURE	T cells infiltrate into the infarcted brain within days after cerebral ischemia and play essential roles in exacerbating the delayed phase of the brain injury by producing pro-inflammatory factors. However, the involvement of these factors in brain damage is also demonstrated systemically. Such periphery-brain abnormalities are interesting because they may constitute a pathway to the central nervous system (CNS), which may be a target of therapeutic hypothermia. Although this therapy protects neurons after severe brain damage, the underlying mechanisms are partly understood. We examined the effects of hypothermic and hyperthermic cultures on peripheral T cell-derived release of interleukin (IL)-17 and granzyme B (GrB) and evaluated whether and how these factors induced neurotoxicity and activated brain endothelial cells. We determined levels of IL-17 and GrB produced by several activated, IL-1 beta/IL-23-treated activated T cells (na < ve CD4(+), CD4(+), CD8(+), and gamma delta T cells obtained from healthy humans) under hypothermia, normothermia, and hyperthermia. The viability of neuronal SH-SY5Y cells treated with IL-17 or GrB and mRNA expression of adhesion molecules/chemokines by brain endothelial bEND.3 cells treated with IL-17 were also measured. Compared with normothermia, IL-17 and GrB release in these T cells was reduced by hypothermia but augmented by hyperthermia. IL-17 and GrB caused the death of neuronal SH-SY5Y cells, and IL-17 upregulated mRNA expression of several adhesion molecules/chemokines in bEND.3 cells; both effects were concentration-dependent. Hypothermia reduced but hyperthermia augmented T cell-derived release of IL-17 and GrB that mediate neuronal cell death, suggesting that the attenuation of T cell-derived release of these factors by therapeutic hypothermia leads to the inhibition of neuronal cell death in the delayed phase of brain injury. Moreover, hypothermia may suppress but hyperthermia may promote the recruitment of inflammatory cells to CNS by regulating brain endothelial activation of IL-17.	[Matsui, Tomohiro; Kawahara, Natsumi; Kimoto, Arisa] Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan; [Yoshida, Yusuke] ACEL Inc, Dept Res & Dev, Midori Ku, Sagamihara, Kanagawa 2520131, Japan	Matsui, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25462403]	This research was supported in part by Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Scientific Research (C), No. 25462403 to T. M.	Murugaiyan G, 2008, J IMMUNOL, V181, P7480; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Li HL, 2001, J NEUROIMMUNOL, V116, P5, DOI 10.1016/S0165-5728(01)00264-8; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Dufour JH, 2002, J IMMUNOL, V168, P3195; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; DIETRICH WD, 1990, STROKE, V21, P1318; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Penido C, 2003, J IMMUNOL, V171, P6788; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Giuliani F, 2003, J IMMUNOL, V171, P368; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Wang DD, 2009, J NEUROIMMUNOL, V212, P17, DOI 10.1016/j.jneuroim.2009.04.007; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Matsumoto T, 1997, LAB INVEST, V77, P119; Kostulas N, 1999, STROKE, V30, P2174; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Chaitanya GV, 2011, BRAIN PATHOL, V21, P16, DOI 10.1111/j.1750-3639.2010.00426.x; Chaitanya GV, 2010, NEUROSCIENCE, V165, P1203, DOI 10.1016/j.neuroscience.2009.10.067; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Haile Y, 2011, J LEUKOCYTE BIOL, V89, P927, DOI 10.1189/jlb.1210654; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/01.CCM.0000038358.78744.15; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; Matsui T, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/436263; Matsui T, 2013, NEUROCRIT CARE, V20, P301; Matsui T, 2012, NEUROCRIT CARE, V17, P293, DOI 10.1007/s12028-011-9639-z; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Strecker JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025863; Wang T, 2006, FASEB J, V20, P1209, DOI 10.1096/fj.05-5022fje	49	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2015	23	1					116	126		10.1007/s12028-014-0094-5		11	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CN8FJ	WOS:000358674600018		
J	Nagaoka, U; Shimizu, T; Uchihara, T				Nagaoka, Utako; Shimizu, Toshio; Uchihara, Toshiki			Leptin upregulation in advanced multiple system atrophy with hypocholesterolemia and unexpected fat accumulation	NEUROLOGICAL SCIENCES			English	Article						Multiple system atrophy; Fat accumulation; Hypocholesterolemia; Leptin; Autonomic dysfunction	ADIPOSE-TISSUE; INVOLVEMENT; GHRELIN; NEURONS	Advanced multiple system atrophy (MSA) patients exhibit malnutrition with hypocholesterolemia and hypoalbuminemia, similar to patients with other neurodegenerative disorders, but also display unexpected fat accumulation. To understand this paradox, we herein examined the relationship between fat accumulation, measured by triceps skinfold thickness (TSF), and plasma leptin in 29 MSA patients at three clinical stages: activities of daily living (ADL) 1: ambulatory with/without wheelchair; ADL2: bedridden/communicable; and ADL3: bedridden/non-communicable. TSF and leptin were higher while cholesterol and albumin were lower in advanced stage ADL3 than in ADL1 or ADL2. Although a correlation was observed between leptin and TSF, a stepwise regression analysis identified the first significant positive predictor of leptin as the duration of autonomic symptoms (p < 0.005) rather than TSF. Leptin/TSF strongly correlated with the duration of autonomic symptoms (p < 0.001). These results implicate leptin resistance through autonomic dysfunction in the paradoxical fat accumulation observed in patients with advanced MSA, but not to be seen in the cholesterol metabolism.	[Nagaoka, Utako; Shimizu, Toshio] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan; [Uchihara, Toshiki] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Tokyo 113, Japan	Nagaoka, U (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	utako_nagaoka@tmhp.jp					Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Paz G, 2010, INT J CLIN PRACT, V64, P1808, DOI 10.1111/j.1742-1241.2010.02536.x; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Martins I, 2013, NEUROSCIENCE, V241, P41, DOI 10.1016/j.neuroscience.2013.02.062; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; WENNING GK, 1994, BRAIN, V117, P835, DOI 10.1093/brain/117.4.835; Benarroch EE, 2007, ACTA NEUROPATHOL, V113, P75, DOI 10.1007/s00401-006-0150-0; Benarroch EE, 2006, BRAIN, V129, P2688, DOI 10.1093/brain/awl109; de Timary P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038682; Johnston J.M., 2011, THERAPY, V8, P481, DOI DOI 10.2217/THY.11.57; Kasarskis EJ, 1997, MUSCLE NERVE, V20, P330, DOI 10.1002/(SICI)1097-4598(199703)20:3<330::AID-MUS10>3.0.CO;2-4; Kohara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024633; Nagaoka Utako, 2010, Rinsho Shinkeigaku, V50, P141; Ozawa T, 2014, J NEUROL SCI, V347, P349, DOI 10.1016/j.jns.2014.09.045; Pellecchia MT, 2010, MOVEMENT DISORD, V25, P2621, DOI 10.1002/mds.23320; Sakuma K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/204164; Simonds S. E., 2012, ADIPOCYTE, V1, P177; Sun YM, 2010, PEPTIDES, V31, P1205, DOI 10.1016/j.peptides.2010.03.023	23	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2015	36	8					1471	1477		10.1007/s10072-015-2189-y		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN7AX	WOS:000358587000022		
J	Sakamoto, Y; Okubo, S; Kanamaru, T; Suzuki, K; Kimura, K				Sakamoto, Yuki; Okubo, Seiji; Kanamaru, Takuya; Suzuki, Kentaro; Kimura, Kazumi			A case report of bilateral paramedian thalamic and occult midbrain infarctions without disturbance of consciousness	NEUROLOGICAL SCIENCES			English	Letter							VERTICAL GAZE PALSIES		[Sakamoto, Yuki; Okubo, Seiji; Kanamaru, Takuya; Suzuki, Kentaro; Kimura, Kazumi] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, Tokyo 1138603, Japan	Sakamoto, Y (reprint author), Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	ysakamoto02@gmail.com					CLARK JM, 1995, STROKE, V26, P1467; Caballero P. E. J., 2010, J STROKE CEREBROVASC, V19, P283; Jodar M, 2011, NEUROCASE, V17, P345, DOI 10.1080/13554794.2010.509324; Kumral E, 2001, ACTA NEUROL SCAND, V103, P35, DOI 10.1034/j.1600-0404.2001.00141.x; PERCHERO.G, 1973, Z NEUROL, V205, P1, DOI 10.1007/BF00315956; Perren F, 2005, ARCH NEUROL-CHICAGO, V62, P1212, DOI 10.1001/archneur.62.8.1212; SIATKOWSKI RM, 1993, J CLIN NEURO-OPHTHAL, V13, P190	7	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2015	36	8					1511	1513		10.1007/s10072-015-2128-y		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN7AX	WOS:000358587000033		
J	Kanbayashi, T; Hokkoku, K; Hatanaka, Y; Nishiyama, K; Sonoo, M				Kanbayashi, Takamichi; Hokkoku, Keiichi; Hatanaka, Yuki; Nishiyama, Kyohei; Sonoo, Masahiro			Isolated shoulder palsy diagnosed from needle EMG and an associated movement	NEUROLOGICAL SCIENCES			English	Letter						Isolated shoulder palsy; Cerebral infarction; Electromyography; Coordination synkinesis	SMALL CORTICAL INFARCTION; INDEX FINGER		[Kanbayashi, Takamichi; Hokkoku, Keiichi; Hatanaka, Yuki; Sonoo, Masahiro] Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Tokyo 1738605, Japan; [Nishiyama, Kyohei] Teikyo Univ, Sch Med, Dept Neurosurg, Itabashi Ku, Tokyo 1738605, Japan	Kanbayashi, T (reprint author), Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	ta_kanba@yahoo.co.jp; k1-hokkoku@hotmail.co.jp; y-hata@med.teikyo-u.ac.jp; kyohein@gmail.com; sonoom@med.teikyo-u.ac.jp					KEEGAN JJ, 1965, J NEUROSURG, V23, P528, DOI 10.3171/jns.1965.23.5.0528; Kim JS, 2002, NEUROLOGY, V58, P985; Kobayashi M, 2004, J NEUROL NEUROSUR PS, V75, P507, DOI 10.1136/jnnp.2003.015685; Komatsu K, 2003, NEUROLOGY, V61, P1457; Tsuda H, 2011, INTERNAL MED, V50, P947, DOI 10.2169/internalmedicine.50.4928	5	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2015	36	8					1527	1529		10.1007/s10072-015-2213-2		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN7AX	WOS:000358587000038		
J	Takahama, T; Nishimura, K; Ninomiya, S; Matsumoto, Y; Harada, Y				Takahama, Tsunemichi; Nishimura, Kazuma; Ninomiya, Seiichiro; Matsumoto, Yoshihiro; Harada, Yutaka			Pipe stress analysis	NUCLEAR ENGINEERING INTERNATIONAL			English	Editorial Material									[Takahama, Tsunemichi; Nishimura, Kazuma; Ninomiya, Seiichiro; Matsumoto, Yoshihiro; Harada, Yutaka] Nucl Engn Ltd, Nishi Ku, Osaka, Japan	Takahama, T (reprint author), Nucl Engn Ltd, Nishi Ku, 1-3-7,Tosabori, Osaka, Japan.							0	0	0	WILMINGTON PUBL	SIDCUP	WILMINGTON HOUSE, MAIDSTONE RD, FOOTS CRAY, SIDCUP DA14 SHZ, KENT, ENGLAND	0029-5507			NUCL ENG INT	Nucl. Eng. Int.	AUG	2015	60	733					26	27				2	Nuclear Science & Technology	Nuclear Science & Technology	CO3YQ	WOS:000359097600010		
J	Nishiyama, Y				Nishiyama, Yoshihiro			Critical behavior of the Higgs- and Goldstone-mass gaps for the two-dimensional S=1 XY model	NUCLEAR PHYSICS B			English	Article							DYNAMICS; ANTIFERROMAGNETS; FLUCTUATIONS; TRANSITION; SYMMETRY	Spectral properties for the two-dimensional quantum S = 1 XY model were investigated with the exact diagonalization method. In the symmetry-broken phase, there appear the massive Higgs and massless Golds-tone excitations, which correspond to the longitudinal and transverse modes of the spontaneous magnetic moment, respectively. The former excitation branch is embedded in the continuum of the latter, and little attention has been paid to the details, particularly, in proximity to the critical point. The finite-size-scaling behavior is improved by extending the interaction parameters. An analysis of the critical amplitude ratio for these mass gaps is made. (C) 2015 The Author. Published by Elsevier B.V.	Okayama Univ, Fac Sci, Dept Phys, Okayama 7008530, Japan	Nishiyama, Y (reprint author), Okayama Univ, Fac Sci, Dept Phys, Okayama 7008530, Japan.	nisiyama@science.okayama-u.ac.jp			Japan Society for the Promotion of Science [25400402]	This work was supported by a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (Grant No. 25400402).	Campostrini M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144506; CHUBUKOV AV, 1994, PHYS REV B, V49, P11919, DOI 10.1103/PhysRevB.49.11919; Podolsky D, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.054508; Podolsky D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174522; Chen K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.030402; Endres M, 2012, NATURE, V487, P454, DOI 10.1038/nature11255; Lindner NH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054512; Chen K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.170403; Demsar J, 1999, PHYS REV LETT, V83, P800, DOI 10.1103/PhysRevLett.83.800; Yusupov R, 2010, NAT PHYS, V6, P681, DOI 10.1038/NPHYS1738; SHASTRY BS, 1990, PHYS REV LETT, V65, P1068, DOI 10.1103/PhysRevLett.65.1068; Sachdev S, 1999, PHYS REV B, V59, P14054, DOI 10.1103/PhysRevB.59.14054; Huber SD, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085106; Pollet L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.010401; Pekker D, 2015, ANNU REV CONDEN MA P, V6, P269, DOI 10.1146/annurev-conmatphys-031214-014350; Zwerger W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.027203; Gazit S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.235108; Rancon A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.180501; Burovski E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.132502; Bissbort U, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.205303; Dupuis N, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043627; Dusuel S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.064412; ELLIOTT RJ, 1969, J PHYS PART C SOLID, V2, P1630, DOI 10.1088/0022-3719/2/9/312; FLEURY PA, 1970, PHYS REV LETT, V24, P1346, DOI 10.1103/PhysRevLett.24.1346; Gazit S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140401; Huber SD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050404; Katan YT, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.075132; LYONS KB, 1988, PHYS REV B, V37, P2353, DOI 10.1103/PhysRevB.37.2353; Nishiyama Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021135; NOVOTNY MA, 1990, J APPL PHYS, V67, P5448, DOI 10.1063/1.345839; PARKINSO.JB, 1969, J PHYS PART C SOLID, V2, P2003, DOI 10.1088/0022-3719/2/11/315; Rose F, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.224501; Ruegg Ch., 2008, PHYS REV LETT, V100	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	AUG	2015	897						555	562		10.1016/j.nuclphysb.2015.06.006		8	Physics, Particles & Fields	Physics	CN7OJ	WOS:000358623600021		
J	Hamada, Y; Kobayashi, T; Uemura, S				Hamada, Yuta; Kobayashi, Tatsuo; Uemura, Shohei			Standard model-like D-brane models and gauge couplings	NUCLEAR PHYSICS B			English	Article							MINIMAL STRING UNIFICATION; DISCRETE FLAVOR SYMMETRIES; THRESHOLD CORRECTIONS; LOOP CORRECTIONS; ORIENTIFOLDS; COMPACTIFICATIONS; D6-BRANES; ORBIFOLD; ANGLES; Z(6)'	We systematically search intersecting D-brane models, which just realize the Standard Model chiral matter contents and gauge symmetry. We construct new classes of non-supersymmetric Standard Model-like models. We also study the gauge coupling constants of these models. The tree level gauge coupling is a function of the compactification moduli, the string scale, the string coupling and the winding numbers of D-branes. By tuning them, we examine whether the models can explain the experimental values of gauge couplings. As a result, we find that the string scale should be greater than 10(14-15) GeV if the compactification scale and the string scale are of the same order. (C) 2015 The Authors. Published by Elsevier B.V.	[Hamada, Yuta; Uemura, Shohei] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Kobayashi, Tatsuo] Hokkaido Univ, Dept Phys, Sapporo, Hokkaido 0600810, Japan	Uemura, S (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	uemura@gauge.scphys.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25.1107]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25400252]	The authors would like to thank Jahn Alexander for his kind comments and advice. The work of Y.H. is supported in part by the Grant-in-Aid of Japan Society for the Promotion of Science (JSPS) Fellows No. 25.1107. The work of T.K. is supported in part by the Grant-in-Aid for Scientific Research No. 25400252 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe H, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.126006; Abe H, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.126003; Abe H, 2009, NUCL PHYS B, V820, P317, DOI [10.1016/j.nuclphysb.2009.05.024, 10.1010/j.nuclphysb.2009.05.024]; Abe H., 2014, J HIGH ENERGY PHYS, V1406; Akerblom N., 2007, JHEP, V0708; Aldazabal G, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/02/047; Altendorfer R, 1996, INT J MOD PHYS A, V11, P903, DOI 10.1142/S0217751X96000419; Cvetic M, 2001, NUCL PHYS B, V615, P3, DOI 10.1016/S0550-3213(01)00427-8; Honecker G, 2012, FORTSCHR PHYS, V60, P243, DOI 10.1002/prop.201100087; Angelantonj C, 2000, PHYS LETT B, V489, P223, DOI 10.1016/S0370-2693(00)00907-2; KAPLUNOVSKY VS, 1988, NUCL PHYS B, V307, P145, DOI 10.1016/0550-3213(88)90526-3; Blumenhagen R, 2000, NUCL PHYS B, V569, P209, DOI 10.1016/S0550-3213(99)00795-6; Kobayashi T, 2007, NUCL PHYS B, V768, P135, DOI 10.1016/j.nuclphysb.2007.01.018; Berkooz M, 1996, NUCL PHYS B, V480, P265, DOI 10.1016/S0550-3213(96)00452-X; Blumenhagen R, 2007, NUCL PHYS B, V771, P113, DOI 10.1016/j.nuclphysb.2007.02.016; Blumenhagen R, 2007, PHYS REP, V445, P1, DOI 10.1016/j.physrep.2007.04.003; Gmeiner F, 2010, NUCL PHYS B, V829, P225, DOI 10.1016/j.nuclphysb.2009.12.011; KAPLUNOVSKY VS, 1992, NUCL PHYS B, V382, P436; Honecker G, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.126010; Aldazabal G, 2001, J MATH PHYS, V42, P3103, DOI 10.1063/1.1376157; DERENDINGER JP, 1992, NUCL PHYS B, V372, P145, DOI 10.1016/0550-3213(92)90315-3; Honecker G, 2013, NUCL PHYS B, V868, P156, DOI 10.1016/j.nuclphysb.2012.11.011; DIXON LJ, 1991, NUCL PHYS B, V355, P649, DOI 10.1016/0550-3213(91)90490-O; ANTONIADIS I, 1991, PHYS LETT B, V267, P37, DOI 10.1016/0370-2693(91)90521-Q; Antusch S., 2007, JHEP, V0709; Berasaluce-Gonzalez M., 2012, J HIGH ENERGY PHYS, V1209, P059, DOI DOI 10.1007/JHEP09(2012)059; Beye F., ARXIV14064660HEPTH; Blumenhagen R., 2007, J HIGH ENERGY PHYS, V0712; Blumenhagen R, 2000, J HIGH ENERGY PHYS; Blumenhagen R., 2003, JHEP, V0307; Cremades D., ARXIVHEPPH0212048; GINSPARG P, 1987, PHYS LETT B, V197, P139, DOI 10.1016/0370-2693(87)90357-1; Hamada Y., 2014, J HIGH ENERGY PHYS, V1405, P116; Higaki T, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.086003; Honecker G, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.069902; Ibanez L. E., 2001, JHEP, V0111, P002; Ibanez L.E., 2007, JHEP, V0706; Ibanez L.E., 2007, JHEP, V0703; IBANEZ LE, 1991, PHYS LETT B, V272, P251, DOI 10.1016/0370-2693(91)91828-J; IBANEZ LE, 1992, NUCL PHYS B, V382, P305, DOI 10.1016/0550-3213(92)90189-I; Ibanez L.E., 2012, STRING THEORY PARTIC; KAWABE H, 1995, NUCL PHYS B, V434, P210, DOI 10.1016/0550-3213(94)00465-Q; Klebanov IR, 2003, NUCL PHYS B, V664, P3, DOI 10.1016/S0550-3213(03)00410-3; Ko P, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.059901; Ko P, 2007, PHYS REV D, V76, DOI 10.1106/PhysRevE.76.035005; Kobayashi T, 2005, NUCL PHYS B, V704, P3, DOI 10.1016/j.nuclphysb.2004.10.035; KOBAYASHI T, 1995, INT J MOD PHYS A, V10, P1393, DOI 10.1142/S0217751X9500067X; Lust D, 2007, FORTSCHR PHYS, V55, P427, DOI 10.1002/prop.200310335; Marchesano F., 2013, J HIGH ENERGY PHYS, V1309, P028; Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020; Chatrchyan S, 2012, PHYS LETT B, V716, P30, DOI 10.1016/j.physletb.2012.08.021	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	AUG	2015	897						563	582		10.1016/j.nuclphysb.2015.06.005		20	Physics, Particles & Fields	Physics	CN7OJ	WOS:000358623600022		
J	Yamashita, T; Kimura, K; Yamamoto, Y				Yamashita, Takumi; Kimura, Kinji; Yamamoto, Yusaku			A new subtraction-free formula for lower bounds of the minimal singular value of an upper bidiagonal matrix	NUMERICAL ALGORITHMS			English	Article						Singular value; Lower bound; Trace	COMPUTATION; PRECISION; ALGORITHM	Traces of inverse powers of a positive definite symmetric tridiagonal matrix give lower bounds of the minimal singular value of an upper bidiagonal matrix. In a preceding work, a formula for the traces which gives the diagonal entries of the inverse powers is presented. In this paper, we present another formula which gives the traces based on a quite different idea from the one in the preceding work. An efficient implementation of the formula for practice is also presented.	[Kimura, Kinji] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Yusaku] Univ Electrocommun, Grad Sch Informat & Engn, Chofu, Tokyo 1828585, Japan	Yamashita, T (reprint author), 28-20 Kojogaoka, Otsu, Shiga 5200821, Japan.	t-yamashita@kke.biglobe.ne.jp; kkimur@amp.i.kyoto-u.ac.jp; yusaku.yamamoto@uec.ac.jp					Bai ZJ, 1996, J COMPUT APPL MATH, V74, P71, DOI 10.1016/0377-0427(96)00018-0; DEKKER TJ, 1971, NUMER MATH, V18, P224, DOI 10.1007/BF01397083; Bailey DH, 2005, COMPUT SCI ENG, V7, P54, DOI 10.1109/MCSE.2005.52; Brezinski C, 2012, ELECTRON T NUMER ANA, V39, P144; FERNANDO KV, 1994, NUMER MATH, V67, P191, DOI 10.1007/s002110050024; Golub GH, 2010, PRINC SER APPL MATH, P1; HONG YP, 1992, LINEAR ALGEBRA APPL, V172, P27, DOI 10.1016/0024-3795(92)90016-4; Iwasaki M, 2006, JPN J IND APPL MATH, V23, P239; JOHNSON CR, 1989, LINEAR ALGEBRA APPL, V112, P1, DOI 10.1016/0024-3795(89)90583-1; Johnson CR, 1998, LINEAR ALGEBRA APPL, V272, P169, DOI 10.1016/S0024-3795(97)00330-3; Kimura K., 2011, J PHYS A, V44, P12; Knuth D.E., 1969, ART COMPUTER PROGRAM, VII; Li LL, 2001, COMPUT MATH APPL, V41, P483, DOI 10.1016/S0898-1221(00)00289-3; Nagata M, 2012, NUMER ALGORITHMS, V61, P261, DOI 10.1007/s11075-012-9607-5; Rojo O, 1999, COMPUT MATH APPL, V38, P215, DOI 10.1016/S0898-1221(99)00252-7; vonMatt U, 1997, SIAM J SCI COMPUT, V18, P1163, DOI 10.1137/S1064827594274887; Wilkinson J. H., 1965, ALGEBRAIC EIGENVALUE; Yamashita T., 2013, JSIAM LETT, V5, P21; Yamashita T., 2012, J MATH FOR IND, V4, P55; Yu YS, 1997, LINEAR ALGEBRA APPL, V253, P25	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1017-1398	1572-9265		NUMER ALGORITHMS	Numer. Algorithms	AUG	2015	69	4					893	912		10.1007/s11075-014-9931-z		20	Mathematics, Applied	Mathematics	CN7GV	WOS:000358603300012		
J	Liao, Y; Pan, WJ; Cui, Y; Qiao, LL; Bellouard, Y; Sugioka, K; Cheng, Y				Liao, Yang; Pan, Wangjun; Cui, Yun; Qiao, Lingling; Bellouard, Yves; Sugioka, Koji; Cheng, Ya			Formation of in-volume nanogratings with sub-100-nm periods in glass by femtosecond laser irradiation	OPTICS LETTERS			English	Article							POROUS-GLASS; PULSES; SILICON	We present direct experimental observation of the morphological evolution during the formation of nanogratings with sub-100-nm periods with the increasing number of pulses. Theoretical simulation shows that the constructive interference of the scattering light from original nanoplanes will create an intensity maximum located between the two adjacent nanoplanes, resulting in shortening the nanograting period by half. The proposed mechanism explains the formation of nanogratings with periods beyond those predicted by the nanoplasmonic model. (C) 2015 Optical Society of America	[Liao, Yang; Pan, Wangjun; Qiao, Lingling; Cheng, Ya] Chinese Acad Sci, Shanghai Inst Opt & Fine Mech, State Key Lab High Field Laser Phys, Shanghai 201800, Peoples R China; [Cui, Yun] Chinese Acad Sci, Shanghai Inst Opt & Fine Mech, Key Lab Mat High Power Laser, Shanghai 201800, Peoples R China; [Bellouard, Yves] EPFL, STI IMT, Galatea Lab, CH-2002 Neuchatel, Switzerland; [Sugioka, Koji] RIKEN, SIOM Joint Res Unit, Adv Sci Inst, Ctr Adv Photon, Wako, Saitama 3510198, Japan	Cheng, Y (reprint author), Chinese Acad Sci, Shanghai Inst Opt & Fine Mech, State Key Lab High Field Laser Phys, Shanghai 201800, Peoples R China.	ya.cheng@siom.ac.cn			National Basic Research Program of China [2014CB921300]; National Natural Science Foundation of China (NSFC) [61275205, 11174305]; Youth Innovation Promotion Association of Chinese Academy of Sciences	National Basic Research Program of China (2014CB921300); National Natural Science Foundation of China (NSFC) (61275205, 11174305); Youth Innovation Promotion Association of Chinese Academy of Sciences.	Cheng Y, 2003, OPT LETT, V28, P55, DOI 10.1364/OL.28.000055; Bellouard Y, 2008, OPT EXPRESS, V16, P19520, DOI 10.1364/OE.16.019520; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Taylor R, 2008, LASER PHOTONICS REV, V2, P26, DOI 10.1002/lpor.200710031; Richter S, 2011, APPL PHYS A-MATER, V104, P503, DOI 10.1007/s00339-011-6489-7; Richter S, 2012, J LASER APPL, V24, DOI 10.2351/1.4718561; Liao Y, 2015, OPTICA, V2, P329, DOI 10.1364/OPTICA.2.000329; Liao Y, 2013, OPT LETT, V38, P187, DOI 10.1364/OL.38.000187; Buschlinger R, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184306; Joglekar AP, 2004, P NATL ACAD SCI USA, V101, P5856, DOI 10.1073/pnas.0307470101; Sugioka K, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4904320; SHANK CV, 1983, PHYS REV LETT, V50, P454, DOI 10.1103/PhysRevLett.50.454; Buividas R, 2014, PROG QUANT ELECTRON, V38, P119, DOI 10.1016/j.pquantelec.2014.03.002; Umran FA, 2013, OPT EXPRESS, V21, P15259, DOI 10.1364/OE.21.015259; Chen F, 2014, LASER PHOTONICS REV, V8, P251, DOI 10.1002/lpor.201300025; Bellouard Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2363957; Beresna M, 2014, ADV OPT PHOTONICS, V6, P293, DOI 10.1364/AOP.6.000293; Bhardwaj VR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057404; Elmer T. H., 1992, ENG MAT HDB, P427; Obara G, 2013, OPT EXPRESS, V21, P26323, DOI 10.1364/OE.21.026323; Sokolowski-Tinten K, 2000, PHYS REV B, V61, P2643, DOI 10.1103/PhysRevB.61.2643	21	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	AUG 1	2015	40	15					3623	3626		10.1364/OL.40.003623		4	Optics	Optics	CN9XC	WOS:000358802800048		
J	Chiba, A; Akamatsu, Y; Takada, K				Chiba, Akito; Akamatsu, Yosuke; Takada, Kazumasa			Optical two-tone signal generation without use of optical filter for photonics-assisted radio-frequency quadrupling	OPTICS LETTERS			English	Article							MILLIMETER-WAVE SIGNAL; MODULATION	Optical two-tone (OTT) signal generation is demonstrated without optical wavelength filtering for wavelength-free operation in radio-frequency (RF) upconversion assisted by photonics. This principle is based on selective polarization manipulation for the optical carrier; the optical carrier's polarization is first tilted, and the carrier is then suppressed using a polarizer. Owing to optimized conditions obtained from theoretical calculation and the high polarization extinction ratio achieving a 25.7-dB carrier suppression, a 40-GHz separated OTT signal is successfully generated by an optical intensity modulator driven by a 10-GHz sinusoidal RF signal. Conversion into a frequency-quadrupled RF signal is also demonstrated experimentally. (C) 2015 Optical Society of America	[Chiba, Akito; Akamatsu, Yosuke; Takada, Kazumasa] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gumma 3768515, Japan	Chiba, A (reprint author), Gunma Univ, Grad Sch Sci & Technol, 4-2-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	akito.chiba@osamember.org			Japan Society for the Promotion of Science (JSPS) [15K06050]; Ministry of Internal Affairs and Communications, Japan (SCOPE) [142103013]	Japan Society for the Promotion of Science (JSPS) (15K06050); Ministry of Internal Affairs and Communications, Japan (SCOPE, 142103013).	Akamatsu Y., 2015, OPTICAL FIBER COMMUN; Enokihara A, 2011, INT J MICROW WIREL T, V3, P295, DOI 10.1017/S175907871100047X; Ghelfi P, 2014, NATURE, V507, P341, DOI 10.1038/nature13078; Wang WT, 2014, OPT COMMUN, V318, P162, DOI 10.1016/j.optcom.2013.12.044; Qi GH, 2005, IEEE T MICROW THEORY, V53, P3090, DOI 10.1109/TMTT.2005.855123; OREILLY JJ, 1992, ELECTRON LETT, V28, P2309; Liu WL, 2013, J LIGHTWAVE TECHNOL, V31, P1636, DOI 10.1109/JLT.2013.2254699; Mohamed M, 2008, OPT EXPRESS, V16, P10786, DOI 10.1364/OE.16.010786; Chiba A, 2010, ELECTRON LETT, V46, P220, DOI 10.1049/el.2010.3141; Kiuchi H, 2008, IEEE T MICROW THEORY, V56, P1493, DOI 10.1109/TMTT.2008.923887; Kawanishi T, 2001, IEEE PHOTONIC TECH L, V13, P854, DOI 10.1109/68.935826; Chiba A, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2263121; IZUTSU M, 1978, IEEE J QUANTUM ELECT, V14, P394, DOI 10.1109/JQE.1978.1069819; Kawanishi T., 2005, P INT TOP M MICR PHO, P29; Lin C.-T., 2009, IEEE T MICROW THEORY, V57, P909; Shih PT, 2009, OPT EXPRESS, V17, P19501, DOI 10.1364/OE.17.019501; Yamazaki H., 2011, P 9 AS NETW QUAL C, P1	17	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	AUG 1	2015	40	15					3651	3654		10.1364/OL.40.003651		4	Optics	Optics	CN9XC	WOS:000358802800055		
J	Onishi, Y; Minoura, Y; Chiba, Y; Onuki, T; Ito, H; Adachi, T; Asano, T; Kobayashi, Y				Onishi, Yoshimi; Minoura, Yoshino; Chiba, Yuta; Onuki, Tatsuya; Ito, Hiroyuki; Adachi, Taro; Asano, Taku; Kobayashi, Youichi			Daily Dysfunction of Autonomic Regulation Based on Ambulatory Blood Pressure Monitoring in Patients with Neurally Mediated Reflex Syncope	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						syncope; autonomic dysfunction; hemodynamics; ambulatory blood pressure monitoring	HEAD-UP TILT; SYMPATHETIC-NERVE ACTIVITY; POWER SPECTRAL-ANALYSIS; UNEXPLAINED SYNCOPE; VASOVAGAL SYNCOPE; RATE-VARIABILITY; UPRIGHT TILT; ISOPROTERENOL; HYPOTENSION; MECHANISMS	BackgroundThe onset of neurally mediated reflex syncope (NMRS) is associated with dysfunction of the autonomic regulatory system. Yet relatively little is known about the daily conditions of the autonomic regulation system in patients with NMRS. This study elucidated characteristics of daily autonomic function using ambulatory blood pressure monitoring (ABPM) and evaluated the utility of ABPM for NMRS diagnosis. MethodsPatients with syncope underwent the head-up tilt test (HUT) (80 degrees, 30 minutes). If no syncope occurred, the HUT was repeated with drug loading. ABPM was performed on a different day. ResultsThe enrolled subjects were 152 consecutive patients with syncope and 12 controls. Sixty-four patients with other diseases related to autonomic dysfunction were excluded. HUT with/without drug loading was positive in 40 patients (Group P) and negative in 48 patients (Group N). The average systolic blood pressure (SBP) in daytime was lower in Groups P and N than in the control group (Group C) (P < 0.05). The average diastolic blood pressure in daytime was also lower in Group P than in Group C (P < 0.05). The average standard deviation-SBP at nighttime was higher in Groups P and N than in Group C (P < 0.05). In heart rate variability analysis, Group P had higher high frequency normalized unit in daytime than Groups C and N (P < 0.05, P < 0.1). Low frequency/high frequency was lower in Group P than in Group N in both daytime and nighttime (P < 0.1, P < 0.05). ConclusionThis study suggests that patients with NMRS present with daily vagal hyperactivity and sympathetic dysfunction. ABPM may support the diagnosis of NMRS.	[Onishi, Yoshimi; Minoura, Yoshino; Chiba, Yuta; Onuki, Tatsuya; Ito, Hiroyuki; Adachi, Taro; Asano, Taku; Kobayashi, Youichi] Showa Univ, Div Cardiol, Dept Med, Sch Med, Tokyo 1428666, Japan	Minoura, Y (reprint author), Showa Univ, Div Cardiol, Dept Med, Sch Med, 1-5-8 Hatanodai Shinagawaku, Tokyo 1428666, Japan.	yoshinomm@med.showa-u.ac.jp					AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Kouakam C, 1999, HEART, V82, P312; Baharav A, 1993, Clin Auton Res, V3, P261, DOI 10.1007/BF01829016; SAYERS BM, 1973, ERGONOMICS, V16, P17; LIPSITZ LA, 1990, CIRCULATION, V81, P1803; Burklow TR, 1999, J AM COLL CARDIOL, V33, P2059, DOI 10.1016/S0735-1097(99)00133-3; MORILLO CA, 1994, AM J CARDIOL, V74, P1258, DOI 10.1016/0002-9149(94)90559-2; PAGANI M, 1986, CIRC RES, V59, P178; Morillo CA, 1997, CIRCULATION, V96, P2509; ALMQUIST A, 1989, NEW ENGL J MED, V320, P346, DOI 10.1056/NEJM198902093200603; Narkiewicz K, 2002, HYPERTENSION, V39, P168, DOI 10.1161/hy1201.097302; BENDITT DG, 1991, PACE, V14, P1528, DOI 10.1111/j.1540-8159.1991.tb04074.x; KENNY RA, 1986, LANCET, V1, P1352; Bartoletti A, 2000, EUROPACE, V2, P339, DOI 10.1053/eupc.2000.0125; SRA JS, 1994, AM J CARDIOL, V73, P33, DOI 10.1016/0002-9149(94)90723-4; Carlioz R, 1997, AM HEART J, V133, P346, DOI 10.1016/S0002-8703(97)70231-X; FITZPATRICK A, 1989, LANCET, V1, P658; GOLDSTEIN DS, 1982, AM HEART J, V104, P1071, DOI 10.1016/0002-8703(82)90442-2; Hosaka H, 2003, BIOMED PHARMACOTHER, V57, p77S, DOI 10.1016/j.biopha.2003.08.009; Kamiya A, 2005, AM J PHYSIOL-HEART C, V289, pH1758, DOI 10.1152/ajpheart.01027.2004; KAPOOR WN, 1992, ANN INTERN MED, V116, P358; Lagi Alfonso, 1996, Clinical Science (London), V91, P62; Minoura Y, 2008, PACE, V31, P1130, DOI 10.1111/j.1540-8159.2008.01153.x; Moya A, 2001, CIRCULATION, V104, P1261, DOI 10.1161/hc3601.095708; NATALE A, 1995, CIRCULATION, V92, P54; Olgunturk R, 2003, PACE, V26, P1926, DOI 10.1046/j.1460-9592.2003.00297.x; Ono T, 1998, AM J CARDIOL, V82, P438, DOI 10.1016/S0002-9149(98)00358-0; Piccirillo G, 2006, INT J CARDIOL, V111, P59, DOI 10.1016/j.ijcard.2005.07.003; RAVIELE A, 1994, AM HEART J, V127, P103, DOI 10.1016/0002-8703(94)90515-0; RUBIN AM, 1993, AM HEART J, V125, P476, DOI 10.1016/0002-8703(93)90029-9; SANDERJENSEN K, 1986, AM J PHYSIOL, V251, pR742; SHELDON R, 1992, J AM COLL CARDIOL, V19, P773; SNEDDON JF, 1993, AM J CARDIOL, V72, P1314, DOI 10.1016/0002-9149(93)90304-U; Takei A, 2001, JPN CIRC J, V65, P320, DOI 10.1253/jcj.65.320; van Dijk N, 2007, EUROPACE, V9, P823, DOI 10.1093/europace/eum104; WALLIN BG, 1982, J AUTONOM NERV SYST, V6, P287; Wieling W, CLIN AUTON RES, V21, P405	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	AUG	2015	38	8					997	1004		10.1111/pace.12661		8	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	CN8NE	WOS:000358697100012		
J	Ito, A				Ito, A.			Beyond our conceived concepts	PARASITE IMMUNOLOGY			English	Letter							TAENIA		Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan	Ito, A (reprint author), Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan.	akiraito@asahikawa-med.ac.jp					Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Asada J, 1963, PROGR PARASITOLOGY R, V3, P251; Ito A, 2015, PARASITE IMMUNOL, V37, P53, DOI 10.1111/pim.12167; Ito A, 1987, IMMUNE RESPONSES PAR, P117; Wandra Toni, 2015, Parasit Vectors, V8, P755, DOI 10.1186/s13071-015-0755-z	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9838	1365-3024		PARASITE IMMUNOL	Parasite Immunol.	AUG	2015	37	8					430	431		10.1111/pim.12205		2	Immunology; Parasitology	Immunology; Parasitology	CN8SY	WOS:000358714500008		
J	Iwasaki, T; Matsushita, M; Nonaka, D; Kato, M; Nagata, K; Murakami, I; Hayashi, K				Iwasaki, Takeshi; Matsushita, Michiko; Nonaka, Daisuke; Kato, Masako; Nagata, Keiko; Murakami, Ichiro; Hayashi, Kazuhiko			Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices	PATHOLOGY INTERNATIONAL			English	Article						Ki-67; Merkel cell carcinoma; Merkel cell polyomavirus; mitotic index; PHH3; phosphohistone-H3	ASSOCIATION; INFECTION	Merkel cell carcinomas (MCCs) associated with Merkel cell polyomavirus (MCPyV) have better prognosis than those without MCPyV. The relationship between mitotic index (MI) and MCC outcome has remained elusive because of the difficulty in differentiating mitotic cells from apoptotic ones. We evaluated the role of phosphohistone-H3 (PHH3) (Ser10), a new mitotic count biomarker, in MCPyV-positive or -negative MCC patients, and assessed its prognostic value in comparison to Ki-67 labeling index or MI using hematoxylin and eosin (HE) staining. We compared the prognostic value of PHH3 mitotic index with that of MI by HE in 19 MCPyV-positive and 9 MCPyV-negative MCC patients. PHH3-positive immunoreactivity was mostly observed in mitotic figures. Multivariate analysis significantly showed that MCPyV status (HR, 0.004; 95% CI 0.0003-0.058) and the American Joint Committee of Cancer (AJCC) stage (HR, 5.02; 95% CI 1.23-20.51) were observed as significantly independent prognostic factors for OS. PHH3-positive cell counts/10 HPF was a slightly significant independent prognostic factor for OS (HR, 4.96; 95% CI 0.93-26.55). PHH3-positive MI and MCPyV status in MCC patients are useful in prognostication, although MCPyV-infection is a more powerful prognostic factor in MCCs than the AJCC scheme on proliferation or mitotic indices.	[Iwasaki, Takeshi; Matsushita, Michiko; Kato, Masako; Nagata, Keiko; Murakami, Ichiro; Hayashi, Kazuhiko] Tottori Univ, Div Mol Pathol, Dept Pathol, Fac Med, Yonago, Tottori 6838503, Japan; [Matsushita, Michiko] Tottori Univ, Dept Pathobiol Sci & Technol, Sch Hlth Sci, Fac Med, Yonago, Tottori 6838503, Japan; [Nonaka, Daisuke] Christie NHS Fdn Trust, Dept Histopathol, Manchester, Lancs, England	Hayashi, K (reprint author), Tottori Univ, Div Mol Pathol, Dept Pathol, Fac Med, Nishi Cho 86, Yonago, Tottori 6838503, Japan.	iwasakit-path@umin.ac.jp			Japan Society for the Promotion of Science [26460433]	This study was supported in part by grants from Japan Society for the Promotion of Science (No. 26460433).	Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; Fukushima S, 2009, BRAIN TUMOR PATHOL, V26, P51, DOI 10.1007/s10014-009-0249-9; Brunner A, 2012, BRIT J CANCER, V107, P84, DOI 10.1038/bjc.2012.198; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Nowak M, 2014, WORLD J UROL, V32, P703, DOI 10.1007/s00345-013-1135-y; Fleming KE, 2014, HUM PATHOL, V45, P952, DOI 10.1016/j.humpath.2013.12.008; Higaki-Mori H, 2012, HUM PATHOL, V43, P2282, DOI 10.1016/j.humpath.2012.04.002; Iwasaki T, 2013, HUM PATHOL, V44, P1912, DOI 10.1016/j.humpath.2013.01.026; Matsushita M, 2014, VIRUS GENES, V48, P233, DOI 10.1007/s11262-013-1023-y; Vujic I, 2015, J EUR ACAD DERMATOL, V29, P542, DOI 10.1111/jdv.12626	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					404	409		10.1111/pin.12305		6	Pathology	Pathology	CN7GZ	WOS:000358603700002		
J	Shibayama, T; Okamoto, T; Nakashima, Y; Kato, T; Sakurai, T; Minamiguchi, S; Kataoka, TR; Shibuya, S; Yoshizawa, A; Toguchida, J; Haga, H				Shibayama, Takahiro; Okamoto, Takeshi; Nakashima, Yasuaki; Kato, Takaaki; Sakurai, Takaki; Minamiguchi, Sachiko; Kataoka, Tatsuki R.; Shibuya, Shinsuke; Yoshizawa, Akihiko; Toguchida, Junya; Haga, Hironori			Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases	PATHOLOGY INTERNATIONAL			English	Article						BCOR-CCNB3; Ewing sarcoma; Ewing-like sarcoma	EWING-SARCOMA; CHILDHOOD; FUSION	BCOR-CCNB3 sarcoma is a recently recognized tumor morphologically and clinically simulating Ewing sarcoma. We herein retrospectively collected clinicopathologic data on BCOR-CCNB3 sarcoma in the Kyoto University Hospital over the last 10 years. Three (20%) bone sarcomas were revealed to be diffusely positive for CCNB3 immunohistochemistry among 15 pediatric cases of undifferentiated sarcoma morphologically similar to Ewing sarcoma, while the other cases showed completely negative staining. The three patients with immunohistochemically CCNB3-positive tumors were all male, aged between 11 and 17, and confirmed to have the BCOR-CCNB3 fusion transcript by RT-PCR. Radiologically, all cases had well-demarcated solid masses with bone destruction. Although the tumors were basically small round cell tumors, less monomorphic histological patterns such as short spindle cells, a myxoid matrix, and hemangiopericytoma-like pattern were also observed in both biopsy and resected specimens. Two patients achieved a complete response after chemotherapy for Ewing sarcoma and osteosarcoma, respectively. These results demonstrated that the application of CCNB3 immunostaining was useful for differentiating BCOR-CCNB3 from a group of Ewing-like sarcomas' and may contribute to the evaluation of treatment strategies for bone sarcomas.	[Shibayama, Takahiro; Nakashima, Yasuaki; Kato, Takaaki; Sakurai, Takaki; Minamiguchi, Sachiko; Kataoka, Tatsuki R.; Shibuya, Shinsuke; Yoshizawa, Akihiko; Haga, Hironori] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto 6068507, Japan; [Okamoto, Takeshi] Kyoto Univ, Grad Sch Med, Orthoped Surg, Kyoto 6068507, Japan; [Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto 6068507, Japan	Haga, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	haga@kuhp.kyoto-u.ac.jp					Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Puls F, 2014, AM J SURG PATHOL, V38, P1307, DOI 10.1097/PAS.0000000000000223; Pierron G, 2012, NAT GENET, V44, P461, DOI 10.1038/ng.1107; Graham C, 2012, HUM PATHOL, V43, P180, DOI 10.1016/j.humpath.2011.04.023; Brecht IB, 2014, PEDIATR BLOOD CANCER, V61, P1202, DOI [10.1002/pbc.24997, 10.1002/pbc.24996]; Linabery AM, 2008, CANCER, V113, P2575, DOI 10.1002/cncr.23866; Peters TL, 2015, MODERN PATHOL, V28, P575, DOI 10.1038/modpathol.2014.139; TB1 N, 2002, J BIOL CHEM, V277, P41960	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					410	414		10.1111/pin.12319		5	Pathology	Pathology	CN7GZ	WOS:000358603700003		
J	Toyokuni, S; Jiang, L; Wang, SQ; Hirao, A; Wada, T; Soh, C; Toyama, K; Kawada, A				Toyokuni, Shinya; Jiang, Li; Wang, Shenqi; Hirao, Ayaka; Wada, Tamae; Soh, Chieko; Toyama, Kazumi; Kawada, Akira			Aging rather than sun exposure is a major determining factor for the density of miR-125b-positive epidermal stem cells in human skin	PATHOLOGY INTERNATIONAL			English	Article						biomarker; epidermal stem cell; miRNA; skin aging; UV	HAIRLESS MICE; 8-HYDROXY-2-DEOXYGUANOSINE; DIFFERENTIATION; PROLIFERATION; MICRORNAS; AGE; UV	Sunlight exposure and aging are two major factors in the deterioration of skin function. In the present study, we used eighty formalin-fixed human skin samples from sun-exposed and unexposed areas from old and young individuals to evaluate the presence of miR-125b-positive epidermal stem cells (ESCs) by in situ hybridization. miR-125b-positive ESCs were detected in the basal layer of the epidermis. The density of miR-125b-positive ESCs was significantly associated with age rather than sun exposure, whereas the density of miR-125b-positive ESCs tended to decrease in the sun-exposed area. These data suggest the potential use of miR-125b as a surrogate marker for the quality of epidermal cells.	[Toyokuni, Shinya; Jiang, Li; Wang, Shenqi] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan; [Hirao, Ayaka; Wada, Tamae; Kawada, Akira] Kinki Univ, Sch Med, Dept Dermatol, Osaka 589, Japan; [Soh, Chieko; Toyama, Kazumi] Procter & Gamble Co, Kobe Tech Ctr, Kobe, Hyogo, Japan	Toyokuni, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	toyokuni@med.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010	Toyokuni, Shinya/0000-0002-5757-1109	Procter Gamble Company; National Cancer Center Research and Development Fund [25-A-5]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24390094, 221S0001-04, 24108001]	This study was supported in part by the Procter & Gamble Company, the National Cancer Center Research and Development Fund (25-A-5), and by a grant-in-aid for research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24390094; 221S0001-04; 24108001).	Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Michel M, 1996, J CELL SCI, V109, P1017; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Hattori Y, 1996, J INVEST DERMATOL, V107, P733, DOI 10.1111/1523-1747.ep12365625; HATTORINAKAKUKI Y, 1994, BIOCHEM BIOPH RES CO, V201, P1132, DOI 10.1006/bbrc.1994.1823; Ning MS, 2015, STEM CELLS, V33, P1047, DOI 10.1002/stem.1922; Toyokuni S, 2007, PATHOL INT, V57, P461, DOI 10.1111/j.1440-1827.2007.02127.x; Toyokuni S, 2011, J CLIN BIOCHEM NUTR, V49, P121, DOI 10.3164/jcbn.11-05; Zhang L, 2014, GENE DEV, V28, P2532, DOI 10.1101/gad.248377.114	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					415	419		10.1111/pin.12320		5	Pathology	Pathology	CN7GZ	WOS:000358603700004		
J	Tajima, S; Takanashi, Y; Takahashi, T; Neyatani, H				Tajima, Shogo; Takanashi, Yusuke; Takahashi, Tsuyoshi; Neyatani, Hiroshi			Intimal sarcoma of the abdominal aorta with platelet-derived growth factor receptor overexpression and amplification in mural invasive cells and pulmonary metastatic cells but not in intimal spreading cells	PATHOLOGY INTERNATIONAL			English	Article						aorta; fluorescence in situ hybridization; immunohistochemistry; intimal sarcoma; platelet-derived growth factor receptor	OF-THE-LITERATURE; PDGFR-ALPHA; FREQUENT; TARGETS; TUMORS; ARTERY; MDM2	Intimal sarcoma (IS) is the most common sarcoma of the aorta. The platelet-derived growth factor receptor (PDGFRA), murine double minute 2 (MDM2), and cyclin-dependent kinase 4 (CDK4) genes are often simultaneously amplified in IS. While immunohistochemical analysis of IS tissue has demonstrated frequent overexpression of the MDM2 and CDK4 proteins, the expression pattern of PDGFRA has not been well characterized, particularly in terms of intratumoral heterogeneity. Here, we present the case of a 46-year-old man who presented with a backache and was subsequently diagnosed with IS. Intratumoral heterogeneity of PDGFRA gene amplification was observed using fluorescence in situ hybridization and was positively correlated with PDGFRA protein expression using immunohistochemistry (IHC). The expression of PDGFRA was also correlated with cytological atypia: PDGFRA was not overexpressed in intimal spreading cells that displayed the lowest degree of atypia while PDGFRA overexpression and amplification were observed in invasive cells of progressive areas such as the aortic wall and a pulmonary metastatic site, which showed increased cytological atypia. Although PDGFRA has not been well examined on IHC, IHC of PDGFRA could be useful to diagnose IS. However, the areas within the tumor from which specimens are derived are important given potential intratumoral heterogeneity.	[Tajima, Shogo] Shizuoka Saiseikai Gen Hosp, Dept Pathol, Shizuoka 4228021, Japan; [Takanashi, Yusuke; Takahashi, Tsuyoshi; Neyatani, Hiroshi] Fujieda Municipal Gen Hosp, Dept Chest Surg, Shizuoka, Japan	Tajima, S (reprint author), Shizuoka Saiseikai Gen Hosp, Dept Pathol, Suruga Ku, 1-1-1 Oshika, Shizuoka 4228021, Japan.	stajima-tky@umin.ac.jp					Bode-Lesniewska B, 2001, VIRCHOWS ARCH, V438, P57, DOI 10.1007/s004280000313; Sebenik M, 2005, AM J SURG PATHOL, V29, P1184, DOI 10.1097/01.pas.0000159774.70288.7d; Dewaele B, 2010, CANCER RES, V70, P7304, DOI 10.1158/0008-5472.CAN-10-1543; Binh MBN, 2005, AM J SURG PATHOL, V29, P1340, DOI 10.1097/01.pas.0000170343.09562.39; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Chiche L, 2003, ANN VASC SURG, V17, P354, DOI 10.1007/s10016-003-0018-x; Bode-Lesniewska B, 2013, WHO CLASSIFICATION T, P232; Neuville A, 2014, AM J SURG PATHOL, V38, P461, DOI 10.1097/PAS.0000000000000184; Nishida N, 2000, PATHOL INT, V50, P923, DOI 10.1046/j.1440-1827.2000.01144.x; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495; Tamborini E, 2007, J PATHOL, V212, P227, DOI 10.1002/path.2177; WRIGHT EP, 1985, AM J SURG PATHOL, V9, P890, DOI 10.1097/00000478-198512000-00005; Zhao JM, 2002, GENE CHROMOSOME CANC, V34, P48, DOI 10.1002/gcc.10035	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					426	431		10.1111/pin.12308		6	Pathology	Pathology	CN7GZ	WOS:000358603700006		
J	Iwafuchi, H; Tsuzuki, T; Ito, R; Miyake, H; Okita, H; Hamazaki, M				Iwafuchi, Hideto; Tsuzuki, Toyonori; Ito, Rieko; Miyake, Hiromu; Okita, Hajime; Hamazaki, Minoru			Generalized infantile myofibromatosis with a monophasic primitive pattern	PATHOLOGY INTERNATIONAL			English	Article						CD105; electron microscopy; immunohistochemistry; infantile myofibroma; myofibromatosis; PDGFR beta; placenta	GENE; FIBROSARCOMA; FUSION; MARKER; TUMORS	Infantile myofibromatosis (IM) is a rare disorder present at birth or in early infancy with a biphasic histological pattern. We present a neonatal-onset case of generalized IM with visceral (central nervous system, heart, lungs, liver, spleen, small intestine, kidneys and bones) and placental involvement, showing a monophasic histological pattern through the lesions during the course of disease. Histologically, the tumor was composed of a solid proliferation of cytologically uniform, primitive' mesenchymal cells associated with a hemangiopericytoma-like vascular pattern. Immunohistochemical analysis and ultrastructural study revealed that the tumor cells exhibited primitive features without mature myofibroblastic differentiation. Neither ETV6-NTRK3 nor ACTB-GLI fusion gene was identified. The patient died of cerebral hemorrhage and respiratory failure at four months of age despite intensive therapy. Generalized IM characterized by monophasic primitive pattern could be related to poor clinical outcome.	[Iwafuchi, Hideto; Okita, Hajime] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo 1578535, Japan; [Okita, Hajime] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Tsuzuki, Toyonori] Nagoya Daini Red Cross Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Iwafuchi, Hideto; Hamazaki, Minoru] Shizuoka Childrens Hosp, Dept Pathol, Shizuoka, Japan; [Miyake, Hiromu] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka, Japan; [Ito, Rieko] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan	Iwafuchi, H (reprint author), Natl Ctr Child Hlth & Dev, Dept Pathol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	iwafuchi-h@ncchd.go.jp			National Center for Child Health and Development, Japan [24-4]	We appreciate Dr. Kentaro Matsuoka and Dr. Atsuko Nakazawa for critical review and discussion of the manuscript. We also thank Ms. Kaoru Inaba and Ms. Hiromi Ono for technical assistance, and Dr. Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for proofreading and editing this manuscript. This work was supported in part by the Grant of National Center for Child Health and Development, Japan (24-4).	Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P42, DOI 10.3748/wjg.v19.i1.42; Miettinen M, 2011, AM J SURG PATHOL, V35, P432, DOI 10.1097/PAS.0b013e318206b67b; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; CHUNG EB, 1981, CANCER, V48, P1807, DOI 10.1002/1097-0142(19811015)48:8<1807::AID-CNCR2820480818>3.0.CO;2-G; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Hogeling M, 2011, PEDIATRICS, V128, pE259, DOI 10.1542/peds.2010-0029; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Alaggio R, 2008, PEDIATR DEVEL PATHOL, V11, P355, DOI 10.2350/07-09-0355.1; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Dahlen A, 2004, AM J PATHOL, V164, P1645, DOI 10.1016/S0002-9440(10)63723-6; desTar M, 2006, PEDIAT DEV PATHOL, V9, P161; Fisher C, 2004, ULTRASTRUCT PATHOL, V28, P291, DOI 10.1080/019131290882187; Fletcher CDM, 2013, WHO CLASSIFICATION S; Goldblum JR, 2014, ENZINGER WEISS SOFT, P188; Hatzidaki E, 2001, J DERMATOL, V28, P379; Homsi Jade, 2007, Cancer Control, V14, P285; Levine E, 2012, PEDIATR BLOOD CANCER, V59, P115, DOI 10.1002/pbc.23387; Martin JM, 2008, J EUR ACAD DERMATOL, V22, P236, DOI 10.1111/j.1468-3083.2007.02292.x; Oudijk L, 2012, HISTOPATHOLOGY, V60, pE1, DOI 10.1111/j.1365-2559.2012.04221.x; Wiswell T E, 1988, J Pediatr Surg, V23, P315; ZELGER BWH, 1995, AM J DERMATOPATH, V17, P131, DOI 10.1097/00000372-199504000-00004	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					432	437		10.1111/pin.12312		6	Pathology	Pathology	CN7GZ	WOS:000358603700007		
J	Kobayashi, Y; Miyoshi, T; Matsuyama, T; Miyauchi, J; Miyashita, T; Ishibashi-Ueda, H; Yoshimatsu, J				Kobayashi, Yoshinari; Miyoshi, Takekazu; Matsuyama, Taka-aki; Miyauchi, Jun; Miyashita, Toshiyuki; Ishibashi-Ueda, Hatsue; Yoshimatsu, Jun			Mirror syndrome associated with fetal transient abnormal myelopoiesis in Down syndrome	PATHOLOGY INTERNATIONAL			English	Letter							MYELOPROLIFERATIVE DISORDER		[Kobayashi, Yoshinari; Miyoshi, Takekazu; Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka, Japan; [Matsuyama, Taka-aki; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan; [Miyauchi, Jun] Ichikawa Gen Hosp, Dept Pathol & Lab Med, Tokyo Dent Coll, Ichikawa, Japan; [Miyashita, Toshiyuki] Kitasato Univ, Sch Med, Dept Mol Genet, Sagamihara, Kanagawa 228, Japan	Kobayashi, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka, Japan.						Braun T, 2010, FETAL DIAGN THER, V27, P191, DOI 10.1159/000305096; Bae JS, 2014, AM J RESP CRIT CARE, V189, P779, DOI 10.1164/rccm.201311-2033OC; Ballantyne JW., 1892, DIS DEFORMITIES FOET; BECROFT D M O, 1990, Pediatric Pathology, V10, P397; Insuasti-Beltran G, 2012, HISTOPATHOLOGY, V61, P694, DOI 10.1111/j.1365-2559.2012.04259.x; Ishigaki H, 2011, HUM PATHOL, V42, P141, DOI 10.1016/j.humpath.2010.06.012; MIYAUCHI J, 1992, BLOOD, V80, P1521; Roy A, 2012, SEMIN FETAL NEONAT M, V17, P196, DOI 10.1016/j.siny.2012.02.010; RUCHELLI ED, 1991, HUM PATHOL, V22, P1274, DOI 10.1016/0046-8177(91)90111-2; Shimadaa A, 2004, BIOL NEONATE, V85, P167, DOI 10.1159/000075376	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					443	445		10.1111/pin.12291		3	Pathology	Pathology	CN7GZ	WOS:000358603700009		
J	Maruyama, H; Torii, Y; Enomoto, Y; Nonomura, A; Ohbayashi, C				Maruyama, Hiroshi; Torii, Yoshio; Enomoto, Yasunori; Nonomura, Akitaka; Ohbayashi, Chiho			A case of colonic solitary polypoid ganglioneuroma with a feature of inverted hyperplastic polyp	PATHOLOGY INTERNATIONAL			English	Letter							TUMOR		[Maruyama, Hiroshi] JCHO, Hoshigaoka Med Ctr, Dept Pathol, Hirakata, Osaka, Japan; [Torii, Yoshio] JCHO, Hoshigaoka Med Ctr, Digest Med, Hirakata, Osaka, Japan; [Enomoto, Yasunori] Toho Univ, Med Ctr, Ohashi Hosp, Dept Diagnost Pathol, Tokyo, Japan; [Nonomura, Akitaka; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 634, Japan	Maruyama, H (reprint author), JCHO, Hoshigaoka Med Ctr, Dept Pathol, Hirakata, Osaka, Japan.						Al-Daraji WI, 2005, J GASTROEN HEPATOL, V20, P961, DOI 10.1111/j.1400-1746.2005.03790.x; ALLEN MS, 1966, CANCER, V19, P257, DOI 10.1002/1097-0142(196602)19:2<257::AID-CNCR2820190218>3.0.CO;2-H; SHEKITKA KM, 1994, AM J SURG PATHOL, V18, P250, DOI 10.1097/00000478-199403000-00004; Riddell RH, 2003, TUMORS INTESTINES, P49; SOBIN LH, 1985, AM J SURG PATHOL, V9, P265, DOI 10.1097/00000478-198504000-00002; Tanaka S, 2007, DIGEST ENDOSC, V19, P40, DOI 10.1111/j.1443-1661.2007.00674.x; Yantiss RK, 2001, MODERN PATHOL, V14, P869, DOI 10.1038/modpathol.3880403	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	AUG	2015	65	8					446	449		10.1111/pin.12289		4	Pathology	Pathology	CN7GZ	WOS:000358603700010		
J	Tanaka, Y; Manabe, A; Fukushima, H; Suzuki, R; Nakadate, H; Kondoh, K; Nakamura, K; Koh, K; Fukushima, T; Tsuchida, M; Koike, K; Kiyokawa, N; Noguchi, E; Sumazaki, R; Komiyama, T				Tanaka, Y.; Manabe, A.; Fukushima, H.; Suzuki, R.; Nakadate, H.; Kondoh, K.; Nakamura, K.; Koh, K.; Fukushima, T.; Tsuchida, M.; Koike, K.; Kiyokawa, N.; Noguchi, E.; Sumazaki, R.; Komiyama, T.			Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia	PHARMACOGENOMICS JOURNAL			English	Article							ORGANIC ANION TRANSPORTER; INOSINE TRIPHOSPHATE PYROPHOSPHATASE; GENE LOCUS; TOXICITY; ABCC4; EXPRESSION; CHILDREN; CELLS; HETEROZYGOSITY; DRUGS	Multidrug resistance protein 4 (MRP4) is involved in the efflux of nucleoside derivatives and has a role in the determination of drug sensitivity. We investigated the relationship between MRP4 genetic polymorphisms and doses of the 6-mercaptopurine (6-MP) and methotrexate. Further, we evaluated the frequency of therapeutic interruption during maintenance therapy in Japanese children with acute lymphoblastic leukemia (ALL). Ninety-four patients received an initial 6-MP dose in the range of 30-50 mg m(-2) in this analysis. Patients with homozygous variant allele in any of MRP4 G2269A, C912A and G559T required high frequency of 6-MP dose reduction compared with non-homozygous individuals. Average 6-MP dose for patients with homozygous variant allele on either MRP4 or inosine triphosphate pyrophosphatase was significantly lower than that for patients with non-homozygous variant allele during maintenance therapy (30.5 versus 40.0 mg m(-2), P = 0.024). Therefore, MRP4 genotyping may be useful for personalizing the therapeutic dose of 6-MP during the ALL maintenance therapy in Japanese.	[Tanaka, Y.; Komiyama, T.] Kitasato Univ, Sch Pharm, Ctr Clin Pharm & Sci, Dept Clin Pharm, Tokyo 1088641, Japan; [Manabe, A.] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Fukushima, H.; Suzuki, R.; Fukushima, T.; Sumazaki, R.] Univ Tsukuba Hosp, Dept Pediat, Ibaraki, Japan; [Nakadate, H.] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Tokyo, Japan; [Kondoh, K.] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Nakamura, K.] Teikyo Univ Hosp, Dept Pediat, Tokyo, Japan; [Koh, K.] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Tsuchida, M.; Koike, K.] Ibaraki Childrens Hosp, Dept Hematol Oncol, Ibaraki, Japan; [Kiyokawa, N.] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Noguchi, E.] Univ Tsukuba, Dept Epidemiol, Fac Med, Ibaraki, Japan	Tanaka, Y (reprint author), Kitasato Univ, Sch Pharm, Ctr Clin Pharm & Sci, Dept Clin Pharm,Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tanakay@pharm.kitasato-u.ac.jp			National Center for Child Health and Development [25-2];  [22790170]	This study was supported by the Grant-in-Aid for Young Scientists (B) (22790170) and the Grant of National Center for Child Health and Development (25-2).	Karas-Kuzelicki N, 2009, LEUKEMIA, V23, P971, DOI 10.1038/leu.2008.317; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Janke D, 2008, HUM MUTAT, V29, P659, DOI 10.1002/humu.20694; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Kool M, 1997, CANCER RES, V57, P3537; de Beaumais TA, 2011, BRIT J CLIN PHARMACO, V71, P575, DOI 10.1111/j.1365-2125.2010.03867.x; Relling MV, 1999, J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Lee K, 2000, J NATL CANCER I, V92, P1934, DOI 10.1093/jnci/92.23.1934; Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; El-Sheikh AAK, 2013, TRANSL RES, V162, P398, DOI 10.1016/j.trsl.2013.08.003; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Pozler O, 2010, J CROHNS COLITIS, V4, P623, DOI 10.1016/j.crohns.2010.06.005; Lee K, 1998, CANCER RES, V58, P2741; Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; Chen ZS, 2002, CANCER RES, V62, P3144; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; Errasti-Murugarren E, 2010, PHARMACOGENOMICS, V11, P809, DOI [10.2217/pgs.10.70, 10.2217/PGS.10.70]; Gradhand U, 2008, PHARMACOGENOMICS J, V8, P42, DOI 10.1038/sj.tpj.6500451; Lopez-Lopez Elixabet, 2013, Pharmacogenet Genomics, V23, P53, DOI 10.1097/FPC.0b013e32835c3b24; Peng XX, 2008, LEUKEMIA RES, V32, P799, DOI 10.1016/j.leukres.2007.09.015; Peregud-Pogorzelski J, 2011, PEDIATR BLOOD CANCER, V57, P578, DOI 10.1002/pbc.23013; Tanaka Y, 2012, LEUKEMIA RES, V36, P560, DOI 10.1016/j.leukres.2011.11.015; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13	26	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1470-269X	1473-1150		PHARMACOGENOMICS J	Pharmacogenomics J.	AUG	2015	15	4					380	384		10.1038/tpj.2014.74		5	Genetics & Heredity; Pharmacology & Pharmacy	Genetics & Heredity; Pharmacology & Pharmacy	CN5CY	WOS:000358448500013		
J	Makita, N; Kawamura, A; Osawa, A				Makita, Naoki; Kawamura, Ayumi; Osawa, Akira			Size-dependent morphological and chemical property of fine root litter decomposition	PLANT AND SOIL			English	Article						Degradation; Mass loss; Nitrogen; Root tissue density; Specific root area; Substrate quality	ECONOMICS SPECTRUM; TERM DECOMPOSITION; INDIVIDUAL ROOTS; GLOBAL PATTERNS; LEAF TRAITS; MASS-LOSS; FOREST; RATES; CLIMATE; DECOMPOSABILITY	To estimate cause-and-effect relationships of decomposition rates of fine root litter up to 2 mm in diameter, we explored the relationships between mass loss rates and substrate litter properties with respect to chemical and morphological dynamics. Mass loss, nitrogen (N) concentration, specific root area (SRA), root tissue density (RTD), and their remaining proportions were measured for initial and residual fine roots of two diameter classes (< 0.5 and 0.5-2 mm) of Quercus serrata and Ilex pedunculosa in a temperate forest. Litterbags were sequentially collected after 1 month of decomposition and then every 3 months for 27 months. N concentration dynamics during decomposition showed a significant interaction between species and diameter, and there was a greater convergence between diameter classes for Q. serrata than for I. pedunculosa. The remaining area and volume of the two diameters changed during decomposition in both species, but the degree of change was somewhat different between the species. The remaining surface area and volume in I. pedunculosa roots showed greater differences between diameter classes compared with Q. serrata roots. Remaining mass was positively correlated with the remaining C concentration and surface area and was negatively correlated with the remaining tissue volume and N concentration, according to principal component analysis analysis. Differences in morphological and chemical properties between diameter sizes of two species could indicate differences in decomposition processes. Estimates of fine root decomposition rates are best obtained by a combination of biological and physicochemical species-specific processes.	[Makita, Naoki] Kansai Res Ctr, Forestry & Forest Prod Res Inst, Kyoto 6120855, Japan; [Makita, Naoki; Kawamura, Ayumi; Osawa, Akira] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Osawa, Akira] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto 6068502, Japan	Makita, N (reprint author), Kansai Res Ctr, Forestry & Forest Prod Res Inst, Kyoto 6120855, Japan.	makita701@gmail.com			Japan Science Society;  [PD13J09602]	The authors acknowledge K. Hattori, R. Shintani, M. Katsuyama, S. Fujii, and T. Tanikawa for helpful supports in field and laboratory experiments and Y. Kosugi, M. Tani, M. Dannoura, Y. Kominami, and T. Miyaura for constructive suggestions on this study. Support by the Satoyama-Gaku Research Center of Ryukoku University is acknowledged. The authors also gratefully acknowledge the suggestions by the editor and three anonymous reviewers. This work was funded by Grant-in Aid for Japan Society for the Promotion of Science fellows (PD13J09602) to N.M. and the Sasakawa Scientific Research Grant from the Japan Science Society to A.K.	Angers DA, 1997, PLANT SOIL, V189, P197, DOI 10.1023/A:1004207219678; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; FAHEY TJ, 1988, FOREST SCI, V34, P744; Ruess RW, 2003, ECOL MONOGR, V73, P643, DOI 10.1890/02-4032; Hishi T, 2007, J FOREST RES-JPN, V12, P126, DOI 10.1007/s10310-006-0260-5; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Brunner I, 2013, PLANT SOIL, V362, P357, DOI 10.1007/s11104-012-1313-5; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Harmon ME, 2009, GLOBAL CHANGE BIOL, V15, P1320, DOI 10.1111/j.1365-2486.2008.01837.x; Osawa A, 2012, PLANT SOIL, V355, P167, DOI 10.1007/s11104-011-1090-6; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; BERG B, 1984, SOIL BIOL BIOCHEM, V16, P609, DOI 10.1016/0038-0717(84)90081-6; Goebel M, 2011, ECOL MONOGR, V81, P89, DOI 10.1890/09-2390.1; Lin CF, 2011, PLANT SOIL, V338, P311, DOI 10.1007/s11104-010-0547-3; Freschet GT, 2013, J ECOL, V101, P943, DOI 10.1111/1365-2745.12092; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Makita N, 2011, ECOL RES, V26, P95, DOI 10.1007/s11284-010-0764-5; Smith SW, 2014, NEW PHYTOL, V203, P851, DOI 10.1111/nph.12845; Yang YS, 2004, ANN FOREST SCI, V61, P65, DOI 10.1051/forest:2003085; Talbot JM, 2012, BIOGEOCHEMISTRY, V108, P279, DOI 10.1007/s10533-011-9599-6; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Silver WL, 2001, OECOLOGIA, V129, P407; Freschet GT, 2012, FUNCT ECOL, V26, P56, DOI 10.1111/j.1365-2435.2011.01913.x; Fan PP, 2010, OECOLOGIA, V163, P509, DOI 10.1007/s00442-009-1541-4; Bouma TJ, 2000, PLANT SOIL, V218, P185, DOI 10.1023/A:1014905104017; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; de Graaff MA, 2013, SOIL BIOL BIOCHEM, V58, P198, DOI 10.1016/j.soilbio.2012.11.015; Kazakou E, 2009, ANN BOT-LONDON, V104, P1151, DOI 10.1093/aob/mcp202; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; Birouste M, 2012, ANN BOT-LONDON, V109, P463, DOI 10.1093/aob/mcr297; Evert R., 2006, ESAUS PLANT ANATOMY; Fan PP, 2010, J PLANT RES, V123, P433, DOI 10.1007/s10265-009-0303-z; FOSTER JR, 1982, CAN J FOREST RES, V12, P617, DOI 10.1139/x82-094; Heal O. W., 1997, P3; Hishi T, 2005, J FOR RES-JPN, V10, P181, DOI 10.1007/s10310-004-0120-0; Kawamura A., 2013, Plant Root, V7, P77, DOI 10.3117/plantroot.7.77; KING HGC, 1967, PEDOBIOLOGIA, V7, P192; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Makita N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117694; McClaugherty C., 2007, PLANT LITTER DECOMPO; Pohl M, 2011, ANN BOT-LONDON, V108, P537, DOI 10.1093/aob/mcr169; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P1; Swift M.J., 1979, DECOMPOSITION TERRES; Valenzuela-Estrada LR, 2008, AM J BOT, V95, P1506, DOI 10.3732/ajb.0800092; Wang H, 2010, PLANT SOIL, V335, P289, DOI 10.1007/s11104-010-0415-1; Xiong Y, 2012, PLANT SOIL, V363, P19, DOI DOI 10.1007/S11104-012-1290-8	52	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	AUG	2015	393	1-2					283	295		10.1007/s11104-015-2491-8		13	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CN8CY	WOS:000358666600022		
J	Maslow, S				Maslow, Sebastian			The Struggle for Order: Hegemony, Hierarchy and Transition in Post-Cold War East Asia	POLITICAL STUDIES REVIEW			English	Book Review									[Maslow, Sebastian] German Inst Japan Studies DIJ, Tokyo, Japan	Maslow, S (reprint author), German Inst Japan Studies DIJ, Tokyo, Japan.						Goh Evelyn, 2013, STRUGGLE ORDER HEGEM	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-9299	1478-9302		POLIT STUD REV	Polit. Stud. Rev.	AUG	2015	13	3					459	459		10.1111/1478-9302.12100_106		1	Political Science	Government & Law	CM6NP	WOS:000357805800113		
J	Nakade, M; Takagi, D; Suzuki, K; Aida, J; Ojima, T; Kondo, K; Hirai, H; Kondo, N				Nakade, Miyo; Takagi, Daisuke; Suzuki, Kayo; Aida, Jun; Ojima, Toshiyuki; Kondo, Katsunori; Hirai, Hiroshi; Kondo, Naoki			Influence of socioeconomic status on the association between body mass index and cause-specific mortality among older Japanese adults: The AGES Cohort Study	PREVENTIVE MEDICINE			English	Article						Socioeconomic status; Japan; Aged; Mortality; Overweight; Underweight	SELF-REPORTED HEIGHT; ALL-CAUSE MORTALITY; EDUCATIONAL-DIFFERENCES; METABOLIC SYNDROME; HEALTH LITERACY; PUBLIC-HEALTH; FOLLOW-UP; OBESITY; POPULATION; GENDER	Objective. Many studies have suggested a U-shaped curve for the association between body size and mortality risks, i.e., mortality risks increase in those who are both overweight and underweight. The strength of the associations may vary according to socioeconomic statuses (SES), as they determine levels of access to healthcare and psychosocial stresses. We investigated the modifying effects of SES on the relationship between body mass index (BMI) and mortality. Method. We used prospective cohort data of participants in the Aichi Gerontological Evaluation Study in 2003 (n = 14,931), who were 65 years or older and physically and cognitively independent at baseline, and residing in eight municipalities in Japan. Data on all-causes mortality and mortality from cancer, cardiovascular disease, and respiratory disease was obtained from municipal government registries. Results. Proportional hazard regression analyses showed that, among men, the associations between overweight (BMI >= 25 kg/m(2)) and higher mortality risks by any cause were stronger among lower income groups. Even adjusting for multiple confounding factors, hazard ratios (95% confidence intervals) for mortality by all causes among low income group (household income <15 million yen) were 1.96 (1.02-3.73) for overweight compared with BMIs between 23.0 and 24.9, whereas they were 0.94 (0.57-138) among men in high income group (income > 3 million yen). The modifying effects of income were not marked among women. Conclusion. Household income, which may directly reflect accessibility to healthcare and psychosocial stress among older Japanese men, may be an important modifying factor in the health risks attributable to overweight. (C) 2015 Elsevier Inc. All rights reserved.	[Nakade, Miyo] Tokaigakuen Univ, Dept Hlth & Nutr, Tempaku Ku, Nagoya, Aichi 4680014, Japan; [Takagi, Daisuke; Kondo, Naoki] Univ Tokyo, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Kayo] Aichi Gakuin Univ, Dept Policy Studies, Nisshin, Aichi 4700131, Japan; [Aida, Jun] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Ojima, Toshiyuki] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Naka Ku, Nagoya, Aichi 4600012, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Chiba 2608670, Japan; [Hirai, Hiroshi] Iwate Univ, Dept Civil & Environm Engn, Morioka, Iwate 0208551, Japan	Kondo, N (reprint author), Univ Tokyo, Dept Hlth & Social Behav, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	naoki-kondo@umin.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities [23243070, 25253052, 15H01972]; Ministry of Health, Labour and Welfare [H25-chouju-ipppan-003, H26-chouju-ippan-006, H25-kenki-wakate-015]; AXA CR Fixed Income Fund	This study used data from the Aichi Gerontological Evaluation Study (AGES), conducted by the Center for Well-being and Society, Nihon Fukushi University as one of their research projects. This study was supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013, Grant-in-Aid for Scientific Research (23243070, 25253052, and 15H01972), and the Ministry of Health, Labour and Welfare (H25-chouju-ipppan-003, H26-chouju-ippan-006, and H25-kenki-wakate-015). NK was also supported by AXA CR Fixed Income Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Strazdins L, 2004, J FAM ISSUES, V25, P356, DOI 10.1177/0192513X03257413; Makela P, 1997, BRIT MED J, V315, P211; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Peeters A, 2003, ANN INTERN MED, V138, P24; Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; HYMOWITZ N, 1991, PREV MED, V20, P590, DOI 10.1016/0091-7435(91)90057-B; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Stommel M, 2010, OBESITY, V18, P1821, DOI 10.1038/oby.2009.472; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Abell JE, 2007, PUBLIC HEALTH REP, V122, P507; Kastarinen MJ, 2000, J HYPERTENS, V18, P255, DOI 10.1097/00004872-200018030-00003; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Matsuo T, 2008, OBESITY, V16, P2348, DOI 10.1038/oby.2008.342; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Sasazuki S, 2011, J EPIDEMIOL, V21, P417, DOI 10.2188/jea.JE20100180; Barba C, 2004, LANCET, V363, P157; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Droomers M, 1999, PREV MED, V29, P1, DOI 10.1006/pmed.1999.0496; Ichien M., 2000, INT REV PUBLIC ADM, V5, P23; Ikeda A, 2011, J EPIDEMIOL COMMUN H, V65, P71, DOI 10.1136/jech.2009.090613; Inoue M, 2004, CANCER CAUSE CONTROL, V15, P671, DOI 10.1023/B:CACO.0000036177.77953.47; Japan Society for the Study of Obesity, 1999, 20 M TOK JAP; Kondo K., 2010, HLTH INEQUALITIES JA; Ministry of Health Labour and Welfare, 2002, ANN REP NAT NUTR SUR; Miyazaki Motonobu, 2002, J Epidemiol, V12, P40; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Takeda Y, 2006, PUBLIC HEALTH, V120, P966, DOI 10.1016/j.puhe.2006.06.006; Toyokawa T., 2012, IRYOU TO SHAKAI, V22, P69; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj/ijo/801961; Vainio H., 2002, INT AG CANC HDB CANC, V6; Wannamethee SG, 1998, J HUM HYPERTENS, V12, P735, DOI 10.1038/sj.jhh.1000714; World Health Organization, 2000, OB PREV MAN GLOB END	46	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	AUG	2015	77						112	118		10.1016/j.ypmed.2015.05.015		7	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	CN4HQ	WOS:000358391600016		
J	Sano, T; Magoshi, R; Shinohara, T; Yoshimine, C; Nishioka, T; Tochitani, N; Sumi, Y				Sano, T.; Magoshi, R.; Shinohara, T.; Yoshimine, C.; Nishioka, T.; Tochitani, N.; Sumi, Y.			Confirmation of performance and reliability of direct lubricated tilting two pads bearing	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART J-JOURNAL OF ENGINEERING TRIBOLOGY			English	Article						Direct lubrication; tilting pad; two pads bearing; high specific load; full scale	JOURNAL BEARING	Direct lubricated tilting two pads bearing with 890mm diameter for large steam turbine was developed. Its performance, both static and dynamic characteristics, and reliability were tested with full scale test, after confirmation by thermo-hydrodynamic calculation coupled with finite element method deformation analysis, to evaluate deformations of the bearing pads. As a result of full scale test, it was confirmed that all of the target values were satisfied. In the same manner, robustness tests, changing the tilt angle of the shaft and supply oil condition were also conducted, and sufficient safety operations of the test bearing were also confirmed. Compared to the conventional bearings, the friction loss of the developed bearing was less than half of other types, such as flooded type, or direct lubricated four pads bearing.	[Sano, T.; Shinohara, T.; Yoshimine, C.; Nishioka, T.] Mitsubishi Heavy Ind Co Ltd, Technol & Innovat Headquarters, Takasago, Hyogo 6768686, Japan; [Magoshi, R.; Tochitani, N.] Mitsubishi Hitachi Power Syst Ltd, Steam Turbine Prod Headquarters, Yokohama, Kanagawa, Japan; [Sumi, Y.] L&T MHPS Turbine Generators Prv Ltd, Surat, Gujarat, India	Sano, T (reprint author), Mitsubishi Heavy Ind Co Ltd, Technol & Innovat Headquarters, 2-1-1 Shinhama,Arai Cho, Takasago, Hyogo 6768686, Japan.	takeshi_sano@mhi.co.jp					[Anonymous], 1990, T ASME J TRIBOL; DESBORDES H, 1995, J TRIBOL-T ASME, V117, P379, DOI 10.1115/1.2831262; HESHMAT H, 1986, J TRIBOL-T ASME, V108, P231; Monmousseau P, 2000, TRIBOL INT, V33, P225, DOI 10.1016/S0301-679X(00)00035-9; Filion M., 1992, ASME, V114, P579; Gaudin M, 2010, 9 EDF LMS POIT WORKS; Hagemann T, 2013, P ASME TURB EXP 2013; He M, 2005, P 34 TURB S TURB LAB, P155; MIKULA AM, 1983, J LUBRIC TECH-T ASME, V105, P39; New NH, 1974, T ASME, V96, P22; Sumi Y, 2014, P ASME TURB EXP 2014; SZERI A. Z., 2011, FLUID FILM LUBRICATI; Taniguchi S, 1998, J TRIBOL-T ASME, V120, P214, DOI 10.1115/1.2834412; Uhkoetter S, 2012, P ASME TURB EXP 2012; Uhkoetter S., 2013, P ASME TURB EXP 2013; Uhkoetter S, 2014, P ASME TURB EXP 2014, P542; Wodtke M, 2013, T ASME J TRIBOL, V135	17	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1350-6501	2041-305X		P I MECH ENG J-J ENG	Proc. Inst. Mech. Eng. Part J.-J. Eng. Tribol.	AUG	2015	229	8			SI		1011	1021		10.1177/1350650115579945		11	Engineering, Mechanical	Engineering	CN8ZR	WOS:000358735600012		
J	Nosaka, M; Mifune, A; Kawaguchi, M; Shiiba, T; Kato, T				Nosaka, Masataka; Mifune, Akira; Kawaguchi, Masahiro; Shiiba, Takashi; Kato, Takahisa			Friction fade-out at polymer-like carbon films slid by ZrO2 pins under hydrogen environment	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART J-JOURNAL OF ENGINEERING TRIBOLOGY			English	Article						Polymer-like carbon; diamond-like carbon; zirconia; H-2 gas environment; catalysis; friction fade-out; friction free	DIAMOND-LIKE-CARBON; SUPERLOW FRICTION; AMORPHOUS-CARBON; BEHAVIOR; COATINGS; SURFACE; WEAR	Friction tests using ceramic pins against fully hydrogenated diamond-like carbon (polymer-like carbon, PLC) film under H-2/He mixed gas or pure H-2 gas environment were conducted. The test results of ZrO2 (YSZ: yttria-stabilized zirconia) pin slid against PLC film with an applied load of 4.9N showed that the friction coefficient dropped to the tribometer noise level (friction fade-out, FFO) as low as 0.0002. In another experiment with the same materials and with an applied load of 30.4N, the friction coefficient dropped to 0.0001-0.0005, which continued more than 4h. Optical microscope and scanning electron microscopic observations, nano-indentation, surface profiler, X-ray photoelectron spectroscopy, Raman, and time-of-flight secondary ion mass spectrometry measurements were conducted and the mechanism for inviting FFO is investigated. It is found by an optical microscopic observation that the transfer film has small blisters, indicating some gaseous substance is generated at the ZrO2 surface. It is discussed based on the measurements that ZrO2 catalysis plays very important roles for gaseous substances generation and for H-passivation on both PLC and transfer film surfaces, which are closely relating to FFO through gas-lubrication effect, and through reducing adhesive force, respectively.	[Nosaka, Masataka; Mifune, Akira; Shiiba, Takashi; Kato, Takahisa] Univ Tokyo, Dept Mech Engn, Tokyo 1138656, Japan; [Kawaguchi, Masahiro] Tokyo Metropolitan Ind Technol Res Inst, Tokyo, Japan	Kato, T (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	katox@mech.t.u-tokyo.ac.jp					Erdemir A, 2001, SURF COAT TECH, V146, P292, DOI 10.1016/S0257-8972(01)01417-7; Pastewka L, 2011, NAT MATER, V10, P34, DOI [10.1038/nmat2902, 10.1038/NMAT2902]; Konicek AR, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155448; Liu Y, 1996, SURF COAT TECH, V86-7, P564, DOI 10.1016/S0257-8972(96)03057-5; Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5; Zhao F, 2009, SURF COAT TECH, V203, P981, DOI 10.1016/j.surfcoat.2008.09.025; Sanchez-Lopez JC, 2003, SURF COAT TECH, V163, P444, DOI 10.1016/S0257-8972(02)00641-2; Konicek AR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.235502; Merkle AP, 2010, CARBON, V48, P587, DOI 10.1016/j.carbon.2009.08.036; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Pei YT, 2005, ACTA MATER, V53, P4505, DOI 10.1016/j.actamat.2005.05.045; Erdemir A, 2004, TRIBOL INT, V37, P1005, DOI 10.1016/j.triboint.2004.07.018; Casiraghi C, 2005, DIAM RELAT MATER, V14, P1098, DOI 10.1016/j.diamond.2004.10.030; Braca E, 2001, THIN SOLID FILMS, V394, P29, DOI 10.1016/S0040-6090(01)01016-1; Chen X, 2014, J APPL PHYS, V115; Chen X, 2013, J PHYS D, V46; Chen XC, 2014, ACS APPL MATER INTER, V6, P13389, DOI 10.1021/am502416w; Donnet C, 2000, TRIBOL LETT, V9, P137; Erdemir A, 2000, DIAM RELAT MATER, V9, P632, DOI 10.1016/S0925-9635(99)00361-1; Eryilmaz OL, 2007, TRIBOL LETT, V28, P241, DOI 10.1007/s11249-007-9268-z; Goswami R, 2008, J PHYS D, V41; Heinz T, 1998, RR B, V58, P13957; Hofmann A, 2002, PHYS CHEM CHEM PHYS, V4, P3500, DOI 10.1039/b202330j; Ji L, 2010, J PHYS D, V43; Jiang J, 2010, J APPL PHYS, V108; KONDO J, 1990, J CHEM SOC FARADAY T, V86, P397, DOI 10.1039/ft9908600397; Kumar N, 2013, J PHYS D, V46; Martin JM, 2010, J PHYS CHEM C, V114, P5003, DOI 10.1021/jp909940j; NAKATSUJI H, 1994, J PHYS CHEM-US, V98, P11840, DOI 10.1021/j100097a008; NAKATSUJI H, 1987, SURF SCI, V185, P319, DOI 10.1016/S0039-6028(87)80629-5; Radhika R, 2013, J PHYS D, V46; Sankaran KJ, 2013, SCI ADV MATER, V5, P687, DOI 10.1166/sam.2013.1504; Wang CS, 2008, NANOTECHNOLOGY, V19; Yoshimoto M, 1998, J CATAL, V173, P53, DOI 10.1006/jcat.1997.1889	34	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1350-6501	2041-305X		P I MECH ENG J-J ENG	Proc. Inst. Mech. Eng. Part J.-J. Eng. Tribol.	AUG	2015	229	8			SI		1030	1038		10.1177/1350650115569857		9	Engineering, Mechanical	Engineering	CN8ZR	WOS:000358735600014		
J	Ozaki, T; Hibiki, T				Ozaki, Tetsuhiro; Hibiki, Takashi			Drift-flux model for rod bundle geometry	PROGRESS IN NUCLEAR ENERGY			English	Article						Drift-flux model; Rod bundle; Sub channel; Void fraction; Two-phase flow	INTERFACIAL AREA CONCENTRATION; BUBBLY FLOW SYSTEMS; LARGE-DIAMETER PIPE; 2-PHASE FLOW; VOID FRACTION	In view of an important role of a one-dimensional drift-flux correlation in nuclear thermal-hydraulic system analysis codes, several drift-flux correlations such as Lellouche-Zolotar, Chexal-Lellouche, TRAC-BF1 and Ozaki correlations have been reevaluated by rod bundle test data taken in FRIGG and NUPEC test facilities. The mean absolute error of void fraction representing a correlation bias of the Lellouche-Zolotar, Chexal-Lellouche, TRAC-BF1 and Ozaki correlations are, respectively, -1.0, 0.5, -6.3 and -3.3% for the FRIGG test data and 2.0, 2.3, -0.4 and -0.7% for the NUPEC test data. The effects of unheated rods, axial and radial power distributions, large unheated center rod and geometry of a shroud or casing on void fraction are identified. The presence of unheated rods with similar size of other heated rods tends to increase a distribution parameter in a drift-flux correlation, whereas the presence of a large unheated center rod tends to decrease the distribution parameter. The axial and radial power distributions do not have significant effect on void fraction within the tested axial and radial power distribution range. The Ozaki correlation is recommended for predicting void fraction in a BWR core but it is suggested to reduce the distribution parameter in the Ozaki correlation if a large unheated center rod exists in the core. It is indicated that drift-flux correlations developed based on bounded rod bundle test facility data may overestimate the distribution parameter for a PWR core. (C) 2015 Elsevier Ltd. All rights reserved.	[Ozaki, Tetsuhiro] Nucl Fuel Ind Ltd, Tokai Works, Tokai, Ibaraki 3191196, Japan; [Hibiki, Takashi] Purdue Univ, Sch Nucl Engn, W Lafayette, IN 47907 USA	Ozaki, T (reprint author), Nucl Fuel Ind Ltd, Tokai Works, 3135-41 Muramatsu, Tokai, Ibaraki 3191196, Japan.	te-ozaki@nfi.co.jp					Hibiki T, 2006, CHEM ENG SCI, V61, P7979, DOI 10.1016/j.ces.2006.09.009; Ozar B, 2012, INT J HEAT FLUID FL, V38, P168, DOI 10.1016/j.ijheatfluidflow.2012.08.006; Atomic Energy Society of Japan (AESJ), 1993, THERM HYDR DIV THD N; Atomic Energy Society of Japan (AESJ), 2008, STAND METH EV US BES; BESTION D, 1990, NUCL ENG DES, V124, P229, DOI 10.1016/0029-5493(90)90294-8; Borkowski J.A., 1992, NUREGCR4391EGG2680R4; Boyack B., 1989, NUREGCR5249EGG2552R4; Brooks CS, 2012, PROG NUCL ENERG, V61, P57, DOI 10.1016/j.pnucene.2012.07.001; Chen SW, 2012, INT J MULTIPHAS FLOW, V40, P166, DOI 10.1016/j.ijmultiphaseflow.2011.11.004; Chexal B., 1991, NSAC139; Clark C, 2014, INT J HEAT FLUID FL, V48, P1, DOI 10.1016/j.ijheatfluidflow.2014.03.008; Coddington P, 2002, NUCL ENG DES, V215, P199, DOI 10.1016/S0029-5493(01)00503-9; Goda H, 2003, INT J HEAT MASS TRAN, V46, P4835, DOI 10.1016/S0017-9310(03)00309-0; Griffiths MJ, 2014, PROG NUCL ENERG, V73, P51, DOI 10.1016/j.pnucene.2014.01.008; Hibiki T, 2002, CHEM ENG SCI, V57, P3967, DOI 10.1016/S0009-2509(02)00263-4; Hibiki T, 2003, INT J HEAT MASS TRAN, V46, P1409, DOI 10.1016/S0017-9310(02)00418-0; Hibiki T, 2006, AIAA J, V44, P1635, DOI 10.2514/1.13159; Hibiki T, 2003, INT J HEAT MASS TRAN, V46, P1773, DOI 10.1016/S0017-9310(02)00473-8; Hibiki T, 2002, INT J HEAT MASS TRAN, V45, P707, DOI 10.1016/S0017-9310(01)00195-8; Information System Laboratories (ISL), 2001, NUREGCR5535REV1 ISL, VIV; Ishii M, 2011, THERMO-FLUID DYNAMICS OF TWO-PHASE FLOW, SECOND EDITION, P1, DOI 10.1007/978-1-4419-7985-8; Ishii M., 1977, ANL7747; Julia JE, 2009, INT J HEAT MASS TRAN, V52, P3032, DOI 10.1016/j.ijheatmasstransfer.2009.02.012; KATAOKA I, 1987, INT J HEAT MASS TRAN, V30, P1927; Kondo M., 1993, 93200 JAERIM; Lellouche G.S., 1982, NP2246SR EPRI; Lellouche G.S, 1974, RP1036 BNR; Morooka S., 1991, P ICONE 1 TOK JAP; Neykov B., 2005, NUPEC BWR FULL SIZE, VI; Nuclear Power Engineering Corporation (NUPEC), 1993, REP PROV TEST REL BW; Nuclear Power Engineering Test Center, 1992, REP PROV TEST REL BW; Nylund O., 1970, FRIGG4 ASEA AB AT; Nylund O., 1969, ASEA RES, V10, P63; Nylund O., 1969, FRIGG3 ASEA AB AT; Nylund O., 1967, FRIGG1 ASEA AB AT; Nylund O., 1968, FRIGG2 ASEA AB AT; Nylund O., 1960, ASEA RES, V7, P305; Ozaki T, 2013, J NUCL SCI TECHNOL, V50, P563, DOI 10.1080/00223131.2013.785277; Ozar B, 2008, CHEM ENG SCI, V63, P3998, DOI 10.1016/j.ces.2008.04.042; Rouhani S.Z., 1969, 841 AERTV AB AT; U.S. NRC, 2008, TRAC V5 0 THEOR MAN; Yang X, 2012, INT J HEAT FLUID FL, V34, P85, DOI 10.1016/j.ijheatfluidflow.2012.02.001; ZUBER N, 1965, J HEAT TRANSF, V87, P453	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	AUG	2015	83						229	247		10.1016/j.pnucene.2015.03.015		19	Nuclear Science & Technology	Nuclear Science & Technology	CN5KN	WOS:000358468300025		
J	Zeng, QY; Cal, JJ; Yin, HQ; Yang, XT; Watanabe, T				Zeng, Qingyun; Cal, Jiejin; Yin, Huaqiang; Yang, Xingtuan; Watanabe, Tadashi			Numerical simulation of single bubble condensation in subcooled flow using OpenFOAM	PROGRESS IN NUCLEAR ENERGY			English	Article						Bubble behavior; Condensation; OpenFOAM; CLSVOF method	PARTICLE SEMIIMPLICIT METHOD; DIRECT-CONTACT CONDENSATION; OF-FLUID METHOD; HEAT-TRANSFER; VAPOR BUBBLE; SURFACE-TENSION; LEVEL SET; BEHAVIOR; REACTOR; LIQUID	The single condensing bubble behavior in subcooled flow has been numerical investigated using the open source code OpenFOAM. A coupled Level Set (LS) and Volume of Fluid (VOF) method (CLSVOF) model with a phase change model for condensation was developed and implemented in the code. The simulated results were firstly compared with the experimental results, they were in great agreements, and thus the simulation model was validated. The validated numerical model was then used to analyze the condensing bubble deformation, bubble lifetime, bubble size history, condensate Nusselt number and other interesting parameters with different variables in subcooled flow. The numerical results indicated that the initial bubble size, subcooling of liquid and system pressure play an important role to influence the condensing bubble behaviors significantly and bubble will be pierced when the subcooling and initial diameter reach a certain value at the later condensing stage. The bubble diameter history and condensate Nusselt number were found in good agreement with the empirical correlation. The drag force coefficient was predicted well by introducing a reduced drag coefficient. (C) 2015 Elsevier Ltd. All rights reserved.	[Zeng, Qingyun; Cal, Jiejin] Sun Yat Sen Univ, Sino French Inst Nucl Engn & Technol, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Huaqiang; Yang, Xingtuan] Tsinghua Univ, Inst Nucl & New Energy Technol, Minist Educ, Key Lab Adv Reactor Engn & Safety, Beijing 100084, Peoples R China; [Watanabe, Tadashi] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan	Cal, JJ (reprint author), Sun Yat Sen Univ, Sino French Inst Nucl Engn & Technol, Xiangzhou 519082, Zhuhai, Peoples R China.	chiven77@hotmail.com		Zeng, Qingyun/0000-0003-1369-8236	Open Research Fund Program of Key Laboratory of Advanced Reactor Engineering and Safety, Ministry of Education of China [ARES-200401]; Program for New CenturyExcellent Talents in University [NCET-10-0846]	This work is partially supported by Open Research Fund Program of Key Laboratory of Advanced Reactor Engineering and Safety, Ministry of Education of China (Grant No. ARES-200401), and the Program for New CenturyExcellent Talents in University (Grant No. NCET-10-0846). Appreciation is also due to the OpenFOAM team for the contribution to the wonderful open-source CFD tool OpenFOAM.	Chen RH, 2010, NUCL ENG DES, V240, P3830, DOI 10.1016/j.nucengdes.2010.08.008; ISENBERG J, 1970, INT J HEAT MASS TRAN, V13, P997, DOI 10.1016/0017-9310(70)90166-3; Ju SH, 2000, NUCL ENG DES, V199, P75; Sussman M, 2000, J COMPUT PHYS, V162, P301, DOI 10.1006/jcph.2000.6537; Hardt S, 2008, J COMPUT PHYS, V227, P5871, DOI 10.1016/j.jcp.2008.02.020; Kalman H, 2002, CHEM ENG J, V85, P197, DOI 10.1016/S1385-8947(01)00150-4; Albadawi A, 2013, INT J MULTIPHAS FLOW, V53, P11, DOI 10.1016/j.ijmultiphaseflow.2013.01.005; Tian WX, 2010, ANN NUCL ENERGY, V37, P5, DOI 10.1016/j.anucene.2009.10.011; Pan LM, 2012, NUCL ENG DES, V248, P126, DOI 10.1016/j.nucengdes.2012.04.001; Chen RH, 2011, CHEM ENG SCI, V66, P5055, DOI 10.1016/j.ces.2011.06.058; Kunkelmann C, 2009, NUMER HEAT TR A-APPL, V56, P631, DOI 10.1080/10407780903423908; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; CHEN YM, 1992, INT J MULTIPHAS FLOW, V18, P877, DOI 10.1016/0301-9322(92)90065-O; Warrier GR, 2002, INT J HEAT MASS TRAN, V45, P3947, DOI 10.1016/S0017-9310(02)00102-3; Kalman H, 2003, INT J HEAT MASS TRAN, V46, P3451, DOI 10.1016/S0017-9310(03)00128-5; Aufiero M, 2014, ANN NUCL ENERGY, V65, P78, DOI 10.1016/j.anucene.2013.10.015; Cai J.J., 2010, 2010 ANN M AT EN SOC; Cai J.J., 2011, PROG NUCL SCI TECHNO, V2, P107; Cai J.J., 2013, THERM POWER GENER, V42, P28; Clift R, 1978, BUBBLES DROPS PARTIC; Deshpande Suraj S., 2012, Computational Science and Discovery, V5, DOI 10.1088/1749-4699/5/1/014016; Hadamard J.S., 1911, CR HEBD ACAD SCI, V152, P1735; Harada T, 2010, NUCL ENG DES, V240, P3949, DOI 10.1016/j.nucengdes.2010.03.016; Jareteg K, 2014, ANN NUCL ENERGY, V68, P247, DOI 10.1016/j.anucene.2013.12.019; Kamei S., 1986, JSME INT J B-FLUID T, P464; Kamei S, 1990, EXP HEAT TRANSFER, V3, P173, DOI 10.1080/08916159008946385; Lin M, 2012, ANN NUCL ENERGY, V49, P23, DOI 10.1016/j.anucene.2012.06.001; Morita K, 2008, NUCL ENG DES, V238, P49, DOI 10.1016/j.nucengdes.2007.04.013; Nath D, 2014, ANN NUCL ENERGY, V63, P51, DOI 10.1016/j.anucene.2013.07.021; OpenFOAM, 2014, OPENFOAM US GUID; Patel G, 2014, ANN NUCL ENERGY, V71, P376, DOI 10.1016/j.anucene.2014.04.009; BEARD KV, 1969, J ATMOS SCI, V26, P1066, DOI 10.1175/1520-0469(1969)026<1066:ADOTTV>2.0.CO;2; Robin T.T., 1970, INT J HEAT MASS TRAN, V53, P11; Rusche H., 2002, THESIS U LONDON UK; Schrage R.W., 1953, THEORETICAL STUDY IN; Sudhoff B., 1982, GER CHEM ENG, V5, P24; Wanchoo RK, 1997, AICHE J, V43, P1955, DOI 10.1002/aic.690430805; Zeng QY, 2014, ANN NUCL ENERGY, V63, P680, DOI 10.1016/j.anucene.2013.09.020; Zeng QY., 2013, P 21 INT C NUCL ENG; Zeng Q.Y., 2013, 13 ANN M REACT THERM; Zuo JL, 2013, PROG NUCL ENERG, V64, P31, DOI 10.1016/j.pnucene.2012.12.003	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	AUG	2015	83						336	346		10.1016/j.pnucene.2015.04.011		11	Nuclear Science & Technology	Nuclear Science & Technology	CN5KN	WOS:000358468300035		
J	Inada, T; Inagaki, A				Inada, Toshiya; Inagaki, Ataru			Psychotropic dose equivalence in Japan	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						antidepressant; antiparkinsonian drugs; antipsychotic; anxiolytic; dose equivalence; hypnotic	RESEARCH-TEAM PORT; TREATMENT RECOMMENDATIONS; EXTRAPYRAMIDAL SYMPTOMS; SCHIZOPHRENIA; DRUGS	Psychotropic dose equivalence is an important concept when estimating the approximate psychotropic doses patients receive, and deciding on the approximate titration dose when switching from one psychotropic agent to another. It is also useful from a research viewpoint when defining and extracting specific subgroups of subjects. Unification of various agents into a single standard agent facilitates easier analytical comparisons. On the basis of differences in psychopharmacological prescription features, those of available psychotropic agents and their approved doses, and racial differences between Japan and other countries, psychotropic dose equivalency tables designed specifically for Japanese patients have been widely used in Japan since 1998. Here we introduce dose equivalency tables for: (i) antipsychotics; (ii) antiparkinsonian agents; (iii) antidepressants; and (iv) anxiolytics, sedatives and hypnotics available in Japan. Equivalent doses for the therapeutic effects of individual psychotropic compounds were determined principally on the basis of randomized controlled trials conducted in Japan and consensus among dose equivalency tables reported previously by psychopharmacological experts. As these tables are intended to merely suggest approximate standard values, physicians should use them with discretion. Updated information of psychotropic dose equivalence in Japan is available at . [Correction added on 8 July 2015, after first online publication: A link to the updated information has been added.]	[Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Tokyo 1620851, Japan; [Inagaki, Ataru] Aoyama Gakuin Univ, Sch Int Polit Econ & Commun, Tokyo, Japan; [Inagaki, Ataru] Aoyama Gakuin Univ, Hlth Adm Ctr, Tokyo, Japan	Inada, T (reprint author), Seiwa Hosp, Inst Neuropsychiat, Shinjuku Ku, 91 Benten Cho, Tokyo 1620851, Japan.	toshiya.inada@gmail.com			Japan Pharmaceutical Manufacturer Association	Dr Inagaki has received grants from the Japan Pharmaceutical Manufacturer Association and honoraria for lectures for 3 years recently from Janssen pharmaceutical companies. Dr Inada has received honoraria for lectures and/or royalties for 3 years recently from Otsuka, Dainippon Sumitomo, Astellas, Tanabe Mitsubishi, Takeda, Pfizer, Eli Lilly, Janssen, and GlaxoSmithKline pharmaceutical companies. These grants and honoraria had no role in the preparation, the intervention in the contents, or the publication of this review article. The authors do not have any other conflicts of interest to declare.	Akimoto T, 2005, RINSYO SEISHIN YAKUR, V8, P1199; Ali IM, 1998, PSYCHIAT B, V22, P15, DOI 10.1192/pb.22.1.15; Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5; Lehman AF, 2004, SCHIZOPHRENIA BULL, V30, P193; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Humberstone V, 2004, AUST NZ J PSYCHIAT, V38, P240, DOI 10.1080/j.1440-1614.2004.01340.x; DAVIS JM, 1974, J PSYCHIAT RES, V11, P65, DOI 10.1016/0022-3956(74)90071-5; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; BEZCHLIBNYKBUTLER KZ, 1994, CAN J PSYCHIAT, V39, P74; BINDER RL, 1987, AM J PSYCHIAT, V144, P1494; Centorrino F, 2002, AM J PSYCHIAT, V159, P1932, DOI 10.1176/appi.ajp.159.11.1932; desLeon J, 1994, HOSP COMMUNITY PSYCH, V45, P606; Furukawa Toshi A, 2002, BMC Med Res Methodol, V2, P6, DOI 10.1186/1471-2288-2-6; Gelder MG, 2000, NEW OXFORD TXB PSYCH; Inada T, 2008, JPN J CLIN PSYCHOPHA, V11, P887; Inada T, 2003, HUM PSYCHOPHARM CLIN, V18, P483, DOI 10.1002/hup.510; Inagaki A, 1999, RINSYO SEISHIN YAKUR, V2, P297; Inagaki A, 2006, JPN J CLIN PSYCHOPHA, V9, P249; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P215; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P335; Inagaki A, 1999, DOSE EQUIVALENCE PSY; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P969; INAGAKI A, 2007, JAPANESE J CLIN PSYC, V10, P2373; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P887; Inagaki A, 2001, RINSYO SEISHIN YAKUR, V4, P869; Inagaki A, 1998, RINSYO SEISIN YAKURI, V1, P557; Inagaki A, 1999, RINSYO SEISHIN YAKUR, V2, P411; Inagaki A, 2001, RINSYO SEISHIN YAKUR, V4, P997; Inagaki A, 2001, RINSYO SEISHIN YAKUR, V4, P681; Inagaki A., 2006, JPN J CLIN PSYCHOPHA, V9, P1443; Inagaki A, 2006, JPN J CLIN PSYCHOPHA, V9, P1859; Inagaki A, 2012, RINSYO SEISHIN YAKUR, V15, P1403; Inagaki A, 1998, RINSYO SEISIN YAKURI, V1, P443; Inagaki A, 2010, JPN J CLIN PSYCHOPHA, V13, P1349; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P1209; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P1087; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P101; Inagaki A, 1998, RINSYO SEISHIN YAKUR, V1, P663; Inagaki A, 2012, JPN J CLIN PSYCHOPHA, V15, P397; Kamijima K, 2004, RINSYO SEISHIN YAKUR, V7, P1385; KLETT CJ, 1972, ARCH GEN PSYCHIAT, V26, P374; Kubota T, 2001, XENOBIO METAB DISPOS, V16, P69; Marangell LB, 2004, ESSENTIALS CLIN PSYC, V2nd, P783; Meltzer HY, 2000, CURRENT DIAGNOSIS TR, P260; Sadock BJ, 2001, KAPLAN SADOCKS POCKE, V3rd; Tran PV, 1997, J CLIN PSYCHIAT, V58, P205, DOI 10.4088/JCP.v58n0505	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					440	447		10.1111/pcn.12275		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400001		
J	Wang, CY; Aleksic, B; Ozaki, N				Wang, Chenyao; Aleksic, Branko; Ozaki, Norio			Glia-related genes and their contribution to schizophrenia	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						gene; glial; schizophrenia	AMINO-ACID OXIDASE; DORSOLATERAL PREFRONTAL CORTEX; FAMILY-BASED ASSOCIATION; 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ANTERIOR CINGULATE CORTEX; MYELINATION-RELATED GENES; GENOME-WIDE ASSOCIATION; CHINESE-HAN POPULATION; CASE-CONTROL SAMPLE; JAPANESE POPULATION	Schizophrenia, a debilitating disease with 1% prevalence in the general population, is characterized by major neuropsychiatric symptoms, including delusions, hallucinations, and deficits in emotional and social behavior. Previous studies have directed their investigations on the mechanism of schizophrenia towards neuronal dysfunction and have defined schizophrenia as a neuron-centric' disorder. However, along with the development of genetics and systematic biology approaches in recent years, the crucial role of glial cells in the brain has also been shown to contribute to the etiopathology of schizophrenia. Here, we summarize comprehensive data that support the involvement of glial cells (including oligodendrocytes, astrocytes, and microglial cells) in schizophrenia and list several acknowledged glia-related genes or molecules associated with schizophrenia. Instead of purely an abnormality of neurons in schizophrenia, an additional glial perspective' provides us a novel and promising insight into the causal mechanisms and treatment for this disease.	[Wang, Chenyao; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan	Aleksic, B (reprint author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	branko@med.nagoya-u.ac.jp	Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014	Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	The authors declare that they have no competing financial or other interests that might be perceived to influence the results and discussion reported in this paper. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; a Grant-in-Aid for 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant-in-Aid for Scientific Research on Innovative Areas, 'Glial assembly: A new regulatory machinery of brain function and disorders'.	Agim ZS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053042; Aleksovska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106342; Roussos P, 2012, ARCH GEN PSYCHIAT, V69, P7, DOI 10.1001/archgenpsychiatry.2011.110; Mondelli V, 2011, J CLIN PSYCHIAT, V72, P1677, DOI 10.4088/JCP.10m06745; Qin W, 2005, NEUROSCI LETT, V375, P207, DOI 10.1016/j.neulet.2004.11.013; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Walterfang M, 2005, AUST NZ J PSYCHIAT, V39, P746, DOI 10.1080/j.1440-1614.2005.01678.x; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Aoyama N, 2006, GENES BRAIN BEHAV, V5, P364, DOI 10.1111/j.1601-183X.2006.00231.x; Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Holtze M, 2012, J PSYCHIATR NEUROSCI, V37, P53, DOI 10.1503/jpn.100175; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Huang K, 2008, HUM GENET, V122, P659, DOI 10.1007/s00439-007-0434-z; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Cruz DA, 2009, NEUROPSYCHOPHARMACOL, V34, P2112, DOI 10.1038/npp.2009.36; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Chen MS, 2000, NATURE, V403, P434; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Ratta-apha W, 2013, NEUROSCI RES, V77, P222, DOI 10.1016/j.neures.2013.08.010; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Katsel P, 2011, NEUROPSYCHOPHARMACOL, V36, P1171, DOI 10.1038/npp.2010.252; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Tan W, 2007, J BIOL CHEM, V282, P24343, DOI 10.1074/jbc.M702953200; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; McIntosh AM, 2008, MOL PSYCHIATR, V13, P1054, DOI 10.1038/sj.mp.4002103; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Hall J, 2006, NAT NEUROSCI, V9, P1477, DOI 10.1038/nn1795; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Tanaka H, 2009, J NEUROSCI, V29, P8363, DOI 10.1523/JNEUROSCI.3216-08.2009; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; de Jong S, 2012, EUR J HUM GENET, V20, P1004, DOI 10.1038/ejhg.2012.38; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; Ikeda M, 2013, MOL PSYCHIATR, V18, P636, DOI 10.1038/mp.2012.74; Martins-de-Souza D, 2009, J NEURAL TRANSM, V116, P275, DOI 10.1007/s00702-008-0156-y; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; Rastogi A, 2009, SCHIZOPHR RES, V114, P39, DOI 10.1016/j.schres.2009.06.019; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Dracheva S, 2006, NEUROBIOL DIS, V21, P531, DOI 10.1016/j.nbd.2005.08.012; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Roussos P, 2011, BIOL PSYCHIAT, V69, P479, DOI 10.1016/j.biopsych.2010.09.009; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Tan EC, 2005, MOL BRAIN RES, V139, P212, DOI 10.1016/j.molbrainres.2005.05.010; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257; Roussos P, 2012, ARCH GEN PSYCHIAT, V69, P1205, DOI 10.1001/archgenpsychiatry.2012.704; Usui H, 2006, SCHIZOPHR RES, V88, P245, DOI 10.1016/j.schres.2006.07.019; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Kubicki M, 2005, CURR OPIN PSYCHIATR, V18, P121, DOI 10.1097/00001504-200503000-00004; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Yuan AH, 2012, AM J MED GENET B, V159B, P997, DOI 10.1002/ajmg.b.32112; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45; Meisenzahl EM, 2001, AM J PSYCHIAT, V158, P1316, DOI 10.1176/appi.ajp.158.8.1316; Sainz J, 2013, MOL PSYCHIATR, V18, P1056, DOI 10.1038/mp.2012.165; Chaudhry IB, 2012, J PSYCHOPHARMACOL, V26, P1185, DOI 10.1177/0269881112444941; Kapoor R, 2006, BRAIN RES, V1106, P205, DOI 10.1016/j.brainres.2006.05.082; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; Fatemi SH, 2004, SCHIZOPHR RES, V69, P317, DOI 10.1016/j.schres.2003.08.014; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Kato TA, 2011, SCHIZOPHR RES, V129, P172, DOI 10.1016/j.schres.2011.03.019; Peirce TR, 2006, ARCH GEN PSYCHIAT, V63, P18, DOI 10.1001/archpsyc.63.1.18; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Takano A, 2010, INT J NEUROPSYCHOPH, V13, P943, DOI 10.1017/S1461145710000313; Martins-De-Souza D, 2009, J PSYCHIATR RES, V43, P978, DOI 10.1016/j.jpsychires.2008.11.006; Foster R, 2006, EUR J NEUROSCI, V24, P3561, DOI 10.1111/j.1460-9568.2006.05219.x; Morita Y, 2007, BIOL PSYCHIAT, V61, P1200, DOI 10.1016/j.biopsych.2006.07.025; Voineskos AN, 2008, PSYCHIAT GENET, V18, P143, DOI 10.1097/YPG.0b013e3282fa1874; Sugai T, 2004, ANN NY ACAD SCI, V1025, P84, DOI 10.1196/annals.1316.011; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Steiner J, 2006, ACTA NEUROPATHOL, V112, P305, DOI 10.1007/s00401-006-0090-8; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Bernstein HG, 2015, SCHIZOPHR RES, V161, P4, DOI 10.1016/j.schres.2014.03.035; Chen WY, 2004, NEUROSCI LETT, V365, P23, DOI 10.1016/j.neulet.2004.04.021; Deng XD, 2007, AM J MED GENET B, V144B, P271, DOI 10.1002/ajmg.b.30351; Denier C, 2007, NEUROLOGY, V68, P1538, DOI 10.1212/01.wnl.0000260701.76868.44; Duncan LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089441; Goudriaan A, 2014, SCHIZOPHRENIA BULL, V40, P925, DOI 10.1093/schbul/sbt109; Hagiwara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062438; Hsu R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001234; Jitoku D, 2011, AM J MED GENET B, V156B, P581, DOI 10.1002/ajmg.b.31199; Kalkman HO, 2011, MED HYPOTHESES, V76, P905, DOI 10.1016/j.mehy.2011.03.005; Kano S, 2011, NEUROSCI RES, V71, P289, DOI 10.1016/j.neures.2011.07.1818; Kato TA, 2013, FRONT PSYCHIAT, V4, P1; Kim S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.42; Lazar NL, 2011, BEHAV BRAIN RES, V224, P73, DOI 10.1016/j.bbr.2011.05.020; Li DW, 2009, WORLD J BIOL PSYCHIA, V10, P595, DOI [10.1080/15622970903304442, 10.3109/15622970903304442]; Liu JX, 2005, BIOCHEM BIOPH RES CO, V328, P335, DOI 10.1016/j.bbrc.2004.12.175; Liu XM, 2005, SCHIZOPHR RES, V73, P275, DOI 10.1016/j.schres.2004.07.018; Maeno N, 2007, PSYCHIAT GENET, V17, P227, DOI 10.1097/YPG.0b013e3280ae6cd8; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Matthews PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038211; Paul-Samojedny M, 2011, J MOL NEUROSCI, V43, P309, DOI 10.1007/s12031-010-9442-x; Reshef R, 2014, BRAIN BEHAV IMMUN, V41, P239, DOI 10.1016/j.bbi.2014.04.009; Roussos P, 2011, NEUROPSYCHOPHARMACOL, V36, P1677, DOI 10.1038/npp.2011.49; ROUSSOS P, 2014, FRONT CELL NEUROSCI, V8, P1; Saetre P, 2008, SCHIZOPHR RES, V106, P237, DOI 10.1016/j.schres.2008.08.024; Seki Y, 2013, SCHIZOPHR RES, V151, P20, DOI 10.1016/j.schres.2013.09.011; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Somkuwar SS, 2014, FRONT PHARMACOL, V5, P1; Takahashi N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.8; Takahashi N, 2011, BIOL PSYCHIAT, V70, P626, DOI 10.1016/j.biopsych.2011.06.016; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Weickert CS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.25; Williams M, 2014, EUR ARCH PSY CLIN N, V264, P357, DOI 10.1007/s00406-013-0482-4; Xing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112531; Xu JZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S2; Yuan AH, 2012, NEUROSCI LETT, V521, P93, DOI 10.1016/j.neulet.2012.05.040; Zalcman S, 1999, BRAIN RES, V847, P276, DOI 10.1016/S0006-8993(99)02063-6; Zhai JG, 2012, SCHIZOPHR RES, V134, P89, DOI 10.1016/j.schres.2011.09.029; Zhang M, 2011, BEHAV BRAIN RES, V217, P81, DOI 10.1016/j.bbr.2010.09.030	148	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					448	461		10.1111/pcn.12290		14	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400002		
J	Inoue, E; Watanabe, Y; Egawa, J; Sugimoto, A; Nunokawa, A; Shibuya, M; Igeta, H; Someya, T				Inoue, Emiko; Watanabe, Yuichiro; Egawa, Jun; Sugimoto, Atsunori; Nunokawa, Ayako; Shibuya, Masako; Igeta, Hirofumi; Someya, Toshiyuki			Rare heterozygous truncating variations and risk of autism spectrum disorder: Whole-exome sequencing of a multiplex family and follow-up study in a Japanese population	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						autism spectrum disorder; Japanese; multiplex family; truncating variation; whole-exome sequencing	DIAMOND-BLACKFAN ANEMIA; DE-NOVO MUTATIONS; ASSOCIATION ANALYSIS; GENE; SCHIZOPHRENIA; PATTERNS	AimsRare heterozygous truncating variations in multiplex families with autism spectrum disorder (ASD) are suggested to play a major role in the genetic etiology of ASD. To further investigate the role of rare heterozygous truncating variations, we performed whole-exome sequencing (WES) in a multiplex ASD family with four affected individuals (two siblings and two maternal cousins), and a follow-up case-control study in a Japanese population. MethodsWES was performed in four individuals (a proband, his affected and unaffected siblings, and their putative carrier mother) from the multiplex ASD family. Rare heterozygous truncating variations prioritized in WES were genotyped in 243 patients and 667 controls. ResultsBy WES of the multiplex family, we prioritized two rare heterozygous truncating variations, RPS24Q191X and CD300LFP261fsX266. However, we did not identify these variations in patients or controls in the follow-up study. ConclusionsOur findings suggest that two rare heterozygous truncating variations (RPS24Q191X and CD300LFP261fsX266) are risk candidates for ASD.	[Inoue, Emiko; Watanabe, Yuichiro; Egawa, Jun; Sugimoto, Atsunori; Nunokawa, Ayako; Shibuya, Masako; Igeta, Hirofumi; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518510, Japan; [Watanabe, Yuichiro] Niigata Univ, Sch Med, Div Med Educ, Comprehens Med Educ Ctr,Fac Med, Niigata 9518510, Japan; [Egawa, Jun] Niigata Univ, Dept Pediat Psychiat, Ctr Transdisciplinary Res, Niigata 9518510, Japan; [Shibuya, Masako] Niigata Univ, Hlth Adm Ctr, Headquarters Hlth Adm, Niigata 9518510, Japan; [Nunokawa, Ayako] Oojima Hosp, Niigata, Japan	Egawa, J (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Chuo Ku, 757 Asahimachidori Ichibancho, Niigata 9518510, Japan.	jeg5414@med.niigata-u.ac.jp			 [26860917]	The authors thank the patients, their families, and the healthy volunteers for participation, and Ms Yamazaki for excellent technical assistance. This work was supported by a Grant-in-Aid for Scientific Research (No. 26860917). The authors have no conflicts of interest to declare.	Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Toma C, 2014, MOL PSYCHIATR, V19, P784, DOI 10.1038/mp.2013.106; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Nunokawa A, 2010, SCHIZOPHR RES, V116, P61, DOI 10.1016/j.schres.2009.10.016; Watanabe Y, 2006, SCHIZOPHR RES, V84, P29, DOI 10.1016/j.schres.2006.03.011; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Depino AM, 2013, MOL CELL NEUROSCI, V53, P69, DOI 10.1016/j.mcn.2012.10.003; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Landowski M, 2013, HUM GENET, V132, P1265, DOI 10.1007/s00439-013-1326-z; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Birnbaum R, 2014, AM J PSYCHIAT, V171, P758, DOI 10.1176/appi.ajp.2014.13111452; Egawa J, 2015, PSYCHIAT CLIN NEUROS, V69, P131, DOI 10.1111/pcn.12205; Egawa J, 2013, PSYCHIAT CLIN NEUROS, V67, P277, DOI 10.1111/pcn.12047; Gauglerl T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Peluffo H, 2012, BRAIN PATHOL, V22, P318, DOI 10.1111/j.1750-3639.2011.00537.x; Xi H, 2010, J EXP MED, V207, P7, DOI 10.1084/jem.20091508	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					472	476		10.1111/pcn.12274		5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400004		
J	Nomura, T; Inoue, Y; Kagimura, T; Kusumi, M; Nakashima, K				Nomura, Takashi; Inoue, Yuichi; Kagimura, Tatsuo; Kusumi, Masayoshi; Nakashima, Kenji			Validity of the Japanese version of the REM Sleep Behavior Disorder (RBD) Screening Questionnaire for detecting probable RBD in the general population	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						general population; item response theory; probable REM sleep behavior disorder; REM Sleep Behavior Disorder Screening Questionnaire; receiver-operator curve	RESTLESS LEGS SYNDROME	AimsIn order to evaluate the validity of the REM Sleep Behavior Disorder (RBD) Screening Questionnaire (RBDSQ) as a screening tool for RBD in a general population setting, we conducted a validation study using residents of a rural community. MethodsWe sent questionnaires that included the RBDSQ to 2631 eligible adult residents in the town of Daisen, Japan. ResultsOf those residents, 1572 participants (59.7%) gave complete answers to the RBDSQ. Among them, 179 participants (11.4%) scored 5 points on the questionnaire; an additional 149 participants scoring 4 points were randomly selected for further telephone interview. Based on obtained results, nine participants (0.57%) were judged as having probable RBD. Receiver-operator curve analysis revealed that a total score of 6 points on the RBDSQ represented the best cut-off value for detecting probable RBD (sensitivity: 100%; specificity: 73.0%). Analysis based on the item response theory revealed that items 1, 4, 6-1, 7, and 8 had lower difficulty than the remaining items, suggesting that these items are more essential in the screening for probable RBD. ConclusionsThe present study revealed that a score of 6 points on the RBDSQ could be used as a cut-off value for the screening of probable RBD in the general population. Evaluation of the distribution of positive items might be helpful for identifying the intensity of a person's RBD symptoms.	[Nomura, Takashi; Kusumi, Masayoshi; Nakashima, Kenji] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, Yonago, Tottori 6838504, Japan; [Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Kagimura, Tatsuo] Translat Res Informat Ctr, Kobe, Hyogo, Japan	Nomura, T (reprint author), Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	ntnomura@med.tottori-u.ac.jp			Philips Respironics GK; Takeda Pharmaceutical Co., Ltd; GlaxoSmithKline K.K.; Astellas Pharma Inc.; Sanofi-Aventis K.K.; Yoshitomiyakuhin Co.; Otsuka Pharmaceutical Co., Ltd; Eisai Co., Ltd	Yuichi Inoue has the following conflicts of interest: consultancy (Hisamitsu Pharmaceutical Co., Inc.); expert testimony (Nippon BoehringerIngelheim Co., Ltd, Philips Respironics GK, Alfresa Pharma Corporation, Takeda Pharmaceutical Co., Ltd, MSD K.K., Pacific Medico Co., Ltd., Otsuka Pharmaceutical Co. Ltd, Eisai Co., Ltd., and Mitsubishi Tanabe Pharma Corporation); payment for lectures, including service on speakers' bureaus (Philips Respironics GK, Takeda Pharmaceutical Co., Ltd, GlaxoSmithKline K.K., Astellas Pharma Inc., Sanofi-Aventis K.K., Yoshitomiyakuhin Co., Otsuka Pharmaceutical Co., Ltd, and Eisai Co., Ltd); and payment for manuscript preparation (Takeda Pharmaceutical Co., Ltd and Eisai Co., Ltd) (all less than $10 000). The other authors have no conflicts of interest pertaining to this study.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P148; American Sleep Disorders Association, 1990, INT CLASS SLEEP DIS; Miyamoto T, 2009, SLEEP MED, V10, P1151, DOI 10.1016/j.sleep.2009.05.007; Frauscher B, 2007, MOVEMENT DISORD, V22, P1464, DOI 10.1002/mds.21561; Chiu HFK, 2000, SLEEP, V23, P513; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Ohayon MM, 2010, SLEEP MED, V11, P941, DOI 10.1016/j.sleep.2010.02.016; Kagimura T, 2011, SLEEP MED, V12, P821, DOI 10.1016/j.sleep.2011.04.012; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Gelhorn H, 2008, J AM ACAD CHILD PSY, V47, P1329, DOI 10.1097/CHI.0b013e318184ff2e; Boeve Bradley F, 2013, J Clin Sleep Med, V9, P475, DOI 10.5664/jcsm.2670; Ohayon MM, 1997, J CLIN PSYCHIAT, V58, P369; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					477	482		10.1111/pcn.12286		6	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400005		
J	Xiang, YT; Ungvari, GS; Correll, CU; Chiu, HFK; Lai, KYC; Wang, CY; Si, TM; Lee, EHM; He, YL; Yang, SY; Chong, MY; Kua, EH; Fujii, S; Sim, K; Yong, MKH; Trivedi, JK; Chung, EK; Udomratn, P; Chee, KY; Sartorius, N; Tan, CH; Shinfuku, N				Xiang, Yu-Tao; Ungvari, Gabor S.; Correll, Christoph U.; Chiu, Helen F. K.; Lai, Kelly Y. C.; Wang, Chuan-Yue; Si, Tian-Mei; Lee, Edwin H. M.; He, Yan-Ling; Yang, Shu-Yu; Chong, Mian-Yoon; Kua, Ee-Heok; Fujii, Senta; Sim, Kang; Yong, Michael K. H.; Trivedi, Jitendra K.; Chung, Eun-Kee; Udomratn, Pichet; Chee, Kok-Yoon; Sartorius, Norman; Tan, Chay-Hoon; Shinfuku, Naotaka			Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): Trends and correlates	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						Asia; electroconvulsive therapy; inpatients; schizophrenia	HONG-KONG; CHINA; PERSPECTIVE; HOSPITALS; EFFICACY; ECT	AimsLittle is known about electroconvulsive therapy (ECT) use in Asian inpatients with schizophrenia. This study examined trends of ECT use for schizophrenia patients in Asia between 2001 and 2009 and its independent demographic and clinical correlates. MethodsData on 6761 hospitalized schizophrenia patients (2001=2399, 2004=2136, and 2009=2226) in nine Asian countries and territories were collected by either chart review or interviews during a 1-month period. Patients' sociodemographic and clinical characteristics, prescriptions of psychotropic drugs and ECT use were recorded using a standardized protocol and data-collection procedure. ResultsThe frequency of ECT was 3.3% in the whole sample; rising from 1.8% in 2001 to 3.3% in 2004 and 4.9% in 2009 (P<0.0001). However, this increased trend was driven solely by increased ECT use in China (P<0.0001), and the inclusion of India in the 2009 survey. There were wide inter-country variations: 2001, 0% (Hong Kong, Korea) to 5.9% (China); 2004, 0% (Singapore) to 11.1% (China); 2009, 0% (Hong Kong) to 13.8% (India) and 15.2% (China). Multiple logistic regression analysis of the whole sample revealed that patients receiving ECT were less likely in the 35-64-year age group, had shorter length of current hospitalization and fewer negative symptoms, and were more likely to receive second-generation antipsychotic medications compared to those who were not treated with ECT (R-2=0.264, P<0.001). ConclusionsECT use for schizophrenia has increased over the past decade in China, being low/relatively stable in other Asian countries/regions. Reasons for substantial variations in ECT frequency in Asia require further study.	[Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Xiang, Yu-Tao; Chiu, Helen F. K.; Lai, Kelly Y. C.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Lee, Edwin H. M.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Wang, Chuan-Yue] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Si, Tian-Mei] Minist Mental Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Si, Tian-Mei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [He, Yan-Ling] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ungvari, Gabor S.] Univ Notre Dame Australia, Perth, WA, Australia; [Correll, Christoph U.] North Shore Long Isl Jewish Hlth Syst, Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA; [Yang, Shu-Yu] Taipei City Hosp, Taipei, Taiwan; [Chong, Mian-Yoon] Kaohsiung Chang Gung Mem Hosp, Chang Gung, Taiwan; [Chong, Mian-Yoon] Chang Gung Univ, Sch Med, Chang Gung, Taiwan; [Kua, Ee-Heok] Natl Univ Singapore, Dept Med Pharmacol, Singapore 117548, Singapore; [Sim, Kang] Natl Univ Singapore, Inst Mental Hlth, Buangkok View, Singapore 117548, Singapore; [Tan, Chay-Hoon] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Fujii, Senta] Fukushima Med Univ, Fukushima, Japan; [Shinfuku, Naotaka] Seinan Gakuin Univ, Sch Human Sci, Fukuoka, Japan; [Trivedi, Jitendra K.] CSM Med Univ UP, Dept Psychiat, Lucknow, Uttar Pradesh, India; [Chung, Eun-Kee] Natl Seoul Hosp, Dept Psychiat, Seoul, South Korea; [Udomratn, Pichet] Prince Songkla Univ, Fac Med, Dept Psychiat, Hat Yai, Thailand; [Chee, Kok-Yoon] Kuala Lumpur Hosp, Tunku Abdul Rahman Inst Neurosci, Dept Psychiat & Mental Hlth, Kuala Lumpur, Malaysia; [Sartorius, Norman] Assoc Improvement Mental Hlth Programs, Geneva, Switzerland	Xiang, YT (reprint author), Univ Macau, Fac Hlth Sci, 3-F,Bldg E12,Ave Univ, Taipa, Macau, Peoples R China.	xyutly@gmail.com	王, 传跃/C-9369-2015	王, 传跃/0000-0001-6549-3713	National Natural Science Foundation of China [81171270, 30800367, 30770776]; Beijing Municipal Science and Technology Commission [2008B59]; Chinese University of Hong Kong [2041454]; Institute of Mental Health in Singapore [CRC 249/2008]; Taiwan Bureau of National Health Insurance [DOH92-NH-1025]; Chang Gung Memorial Hospital [CMRPG83043]; Taipei City Government in Taiwan [97001-62-010]; Bristol-Myers Squibb; Novo Nordisk A/S; Otsuka	This study was supported in part by grants from the National Natural Science Foundation of China (81171270; 30800367; 30770776), the Beijing Nova Program of the Beijing Municipal Science and Technology Commission (2008B59), the Chinese University of Hong Kong (Direct Grant for Research; Project 2041454), the Institute of Mental Health Research Grant (CRC 249/2008) in Singapore, and the Taiwan Bureau of National Health Insurance (DOH92-NH-1025), Chang Gung Memorial Hospital (CMRPG83043) and the Taipei City Government (97001-62-010) in Taiwan. Dr Correll has been a consultant and/or advisor to or has received honoraria from: Bristol-Myers Squibb, Eli Lilly, Genentech, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, Lundbeck, MedAvante, Medscape, Otsuka, Pfizer, ProPhase, Roche, Sunovion, Supernus, and Takeda. He has received grant support from Bristol-Myers Squibb, Novo Nordisk A/S, and Otsuka. Other authors do not report any conflicts of interest specifically related to the topic of this article. The authors are grateful to the following clinicians involved in the data collection: Hong Deng and Wei Hao in China; Ajit Avasthi, Dipesh Bhagabati, Roy Abraham Kallivayalil, Shubhangi R. Parkar, and YC Janardhan Reddy in India; Tateno Masaru, Masamune Yayoi, Akiyama Tsuyoshi, Sato Soichirou, Nakagome Kazuyuki, Nakamura Jun, and Kuroki Toshihide in Japan; Tae-Yeon Hwang, Seok Hyeon Kim, Yo Wang Lee, and Jong- Il Lee in Korea; Tung-ping Su, Shih-ku Lin, Tzu-ting Chen, Chieh-hsin Chang, Hong-chieh Hsu, Chi-Fa Hung, and Cheng-chung Chen in Taiwan; Krisakorn Sukavatvibul, Jittima Kleawtanong, Tantawan Suradechasakul, Manote Lotrakul, Usaree Srisutudsanavong in Thailand; and Norharlina Bahar in Malaysia.	Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; American Psychiatric Association, 1997, PRACT GUID TREATM PA; An FR, 2010, INT J CLIN PHARM TH, V48, P270; Trevino K, 2010, J ECT, V26, P186, DOI 10.1097/YCT.0b013e3181efa1b2; Kane JM, 1998, EUR NEUROPSYCHOPHARM, V8, P55, DOI 10.1016/S0924-977X(97)00045-X; Siris SG, 2000, AM J PSYCHIAT, V157, P1379, DOI 10.1176/appi.ajp.157.9.1379; Payne NA, 2009, J PSYCHIATR PRACT, V15, P346, DOI 10.1097/01.pra.0000361277.65468.ef; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; Patkar AA, 2013, CNS DRUGS, V27, pS29, DOI 10.1007/s40263-012-0031-0; Case BG, 2013, BIOL PSYCHIAT, V73, P119, DOI 10.1016/j.biopsych.2012.09.005; Chanpattana W, 2010, J ECT, V26, P11, DOI 10.1097/YCT.0b013e3181c185f9; Chanpattana W, 2005, J ECT, V21, P100, DOI 10.1097/01.yct.0000166634.73555.e6; Chung KF, 2003, J ECT, V19, P98, DOI 10.1097/00124509-200306000-00008; Congs WD, 2006, J CLIN PSYCHOL MED C, V16, P56; Gazdag G, 2013, PSYCHIAT DANUB, V25, P366; Huangs J, 2010, J CLIN PSYCHOL MED C, V20, P57; [姜玮 Jiang Wei], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P835; Leung CM, 2009, J ECT, V25, P80, DOI 10.1097/YCT.0b013e31817b8135; Little JD, 2003, J ECT, V19, P93, DOI 10.1097/00124509-200306000-00007; Shinfuku N, 2008, INT REV PSYCHIATR, V20, P460, DOI 10.1080/09540260802397560; Tang YL, 2012, J ECT, V28, P206, DOI 10.1097/YCT.0b013e31825957b1; Trivedi J K, 2002, Indian J Psychiatry, V44, P313; Xiang YT, 2012, LANCET, V379, P780, DOI 10.1016/S0140-6736(11)61704-2	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					489	496		10.1111/pcn.12283		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400007		
J	Tesen, H; Hori, H; Atake, K; Beppu, H; Nakamura, J				Tesen, Hirofumi; Hori, Hikaru; Atake, Kiyokazu; Beppu, Hiroki; Nakamura, Jun			Electroconvulsive-therapy-associated neutropenia in treatment-resistant schizophrenia: Three case reports	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter							TUBEROUS SCLEROSIS		[Tesen, Hirofumi; Hori, Hikaru; Atake, Kiyokazu; Beppu, Hiroki; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan	Tesen, H (reprint author), Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan.	h-tesen@med.uoeh-u.ac.jp					Pisani F, 2002, DRUG SAFETY, V25, P91, DOI 10.2165/00002018-200225020-00004; Nicolini H, 2009, PSYCHIAT RES, V170, P7, DOI 10.1016/j.psychres.2008.10.011; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Baskin HJ, 2008, PEDIATR RADIOL, V38, P936, DOI 10.1007/s00247-008-0832-y; Dannaram Srinivas, 2012, Innov Clin Neurosci, V9, P10; Hassan IK, 2014, J CLIN NEUROSCI, V21, P867, DOI 10.1016/j.jocn.2013.08.005	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					504	504		10.1111/pcn.12302		1	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400009		
J	Oshikubo, G; Tochigi, M; Akahane, A; Hayashi, N; Ikebuchi, E				Oshikubo, Gaku; Tochigi, Mamoru; Akahane, Akihisa; Hayashi, Naoki; Ikebuchi, Emi			Graves' hyperthyroidism-induced psychosis in a patient with periventricular nodular heterotopia	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter							GRAY-MATTER; DISORDER		[Oshikubo, Gaku; Tochigi, Mamoru; Akahane, Akihisa; Hayashi, Naoki; Ikebuchi, Emi] Teikyo Univ, Sch Med, Dept Neuropsychiat, Tokyo 173, Japan	Oshikubo, G (reprint author), Teikyo Univ, Sch Med, Dept Neuropsychiat, Tokyo 173, Japan.	mtoc-tky@umin.ac.jp					BOURGEOIS JA, 1992, COMPR PSYCHIAT, V33, P407, DOI 10.1016/0010-440X(92)90063-V; Maruyama Y, 1998, PSYCHIAT CLIN NEUROS, V52, P361, DOI 10.1046/j.1440-1819.1998.00385.x; Nopoulos P, 1998, J NEUROPSYCH CLIN N, V10, P351	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					505	506		10.1111/pcn.12309		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400011		
J	Kurita, D; Wakuda, T; Takagai, S; Takahashi, Y; Iwata, Y; Suzuki, K; Mori, N				Kurita, Daisuke; Wakuda, Tomoyasu; Takagai, Shu; Takahashi, Yukitoshi; Iwata, Yasuhide; Suzuki, Katsuaki; Mori, Norio			Deterioration of clinical features of a patient with autism spectrum disorder after anti-N-methyl-D-aspartate receptor encephalitis	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Kurita, Daisuke; Wakuda, Tomoyasu; Iwata, Yasuhide; Suzuki, Katsuaki; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4313192, Japan; [Takagai, Shu; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan	Kurita, D (reprint author), Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4313192, Japan.	wakuda@hama-med.ac.jp					LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2015	69	8					507	507		10.1111/pcn.12323		1	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CN8XX	WOS:000358730400013		
J	Fukuyama, E; Hok, S				Fukuyama, Eiichi; Hok, Sebastien			Dynamic Overshoot Near Trench Caused by Large Asperity Break at Depth	PURE AND APPLIED GEOPHYSICS			English	Article						Earthquake rupture dynamics; non-planar fault; subduction earthquake; 2011 Tohoku-Oki earthquake	TOHOKU-OKI EARTHQUAKE; M-W 9.0; PACIFIC COAST; RUPTURE DYNAMICS; ELASTIC MEDIUM; FAULT; SLIP; DISPLACEMENT; SPACE; JAPAN	In an attempt to explain the large shallow slip that occurred near the trench during the 2011 Tohoku-Oki earthquake, numerical simulations of earthquake dynamic rupture were carried out using a fault model with a subduction interface containing a bump-shaped asperity, which might result from subduction of an old submarine volcano or seamount. It was assumed that during the interseismic period, slip only occurs outside the bump area and that stress accumulates inside the bump, creating a seismogenic asperity. We roughly evaluated the amount of slip outside the bump during the interseismic period, assuming a constant long-term subduction rate. Then we could estimate the accumulated stress inside the bump. We constructed the initial stress distribution based on the stress change caused by the slip-deficit distribution. A constitutive relation was constructed based on a slip-weakening friction law and was used to compute spontaneous ruptures. The results indicate that a large slip can occur between the trench and the bump, even though a very small amount of stress is accumulated there before the rupture. This is due to an interaction between the free surface and the fault that causes slip overshoot. On the region of the fault below the bump, such overshoot cannot occur because the fault is pinned by the deeper un-slipped zone. However, on the shallower side, the edge of the fault becomes free when the rupture approaches the free surface. In this region, such a large slip can occur without releasing a large amount of stress.	[Fukuyama, Eiichi] Natl Res Inst Earth Sci & Disaster Prevent NIED, Tsukuba, Ibaraki 3050006, Japan; [Hok, Sebastien] IRSN, PRP DGE, SCAN, BERSSIN, F-92260 Fontenay Aux Roses, France	Fukuyama, E (reprint author), Natl Res Inst Earth Sci & Disaster Prevent NIED, Tsukuba, Ibaraki 3050006, Japan.	fuku@bosai.go.jp; sebastien.hok@irsn.fr			NIED project "Development of Monitoring and Forecasting Technology for Crustal Activity"; NIED-JAMSTEC joint project "High Frequency Source Modeling"; JST J-Rapid/ANR Flash Japan DYNTOHOKU project [ANR-11-JAPN-0009]	We are grateful for the comments by two anonymous reviewers that helped improve the manuscript. This work was supported by the NIED project "Development of Monitoring and Forecasting Technology for Crustal Activity", the NIED-JAMSTEC joint project "High Frequency Source Modeling" and the JST J-Rapid/ANR Flash Japan DYNTOHOKU project (ANR-11-JAPN-0009).	Yao HJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049223; Maeda T, 2011, EARTH PLANETS SPACE, V63, P803, DOI 10.5047/eps.2011.06.005; Shao GF, 2011, EARTH PLANETS SPACE, V63, P559, DOI 10.5047/eps.2011.06.028; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; IDA Y, 1972, J GEOPHYS RES, V77, P3796, DOI 10.1029/JB077i020p03796; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Yoshida Y, 2011, EARTH PLANETS SPACE, V63, P565, DOI 10.5047/eps.2011.05.011; Koper KD, 2011, EARTH PLANETS SPACE, V63, P599, DOI 10.5047/eps.2011.05.026; Koketsu K, 2011, EARTH PLANET SC LETT, V310, P480, DOI 10.1016/j.epsl.2011.09.009; Madariaga R, 2000, PURE APPL GEOPHYS, V157, P1981, DOI 10.1007/PL00001071; Aochi H, 2000, PURE APPL GEOPHYS, V157, P2003, DOI 10.1007/PL00001072; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Miyazaki S, 2011, EARTH PLANETS SPACE, V63, P637, DOI 10.5047/eps.2011.07.001; Kido M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050057; Duan BC, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009124; Sagiya T, 2000, PURE APPL GEOPHYS, V157, P2303; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Oglesby DD, 1998, SCIENCE, V280, P1055, DOI 10.1126/science.280.5366.1055; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Asano Y, 2011, EARTH PLANETS SPACE, V63, P669, DOI 10.5047/eps.2011.06.016; Suzuki W, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049136; Saito T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049089; Fukuyama E, 1998, B SEISMOL SOC AM, V88, P1; Lee SJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049580; Ishii M, 2011, EARTH PLANETS SPACE, V63, P609, DOI 10.5047/eps.2011.07.009; FUKUYAMA E., 1996, REP NATL RES I EARTH, V57, P23; Hashimoto C, 2012, GEOPHYS J INT, V189, P1, DOI 10.1111/j.1365-246X.2011.05368.x; Hok S, 2011, GEOPHYS J INT, V184, P301, DOI 10.1111/j.1365-246X.2010.04835.x; Ito Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048355; Kinoshita S, 1998, SEISMOL RES LETT, V69, P309; Lay T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009133; MIKUMO T, 1987, TECTONOPHYSICS, V144, P19, DOI 10.1016/0040-1951(87)90006-0; WAN D., 2011, EARTH PLANETS SPACE, V63, P603; Yagi Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048701; Yoshida S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048902; Zhao DP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048408	41	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	AUG	2015	172	8			SI		2157	2165		10.1007/s00024-013-0745-z		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CN4QJ	WOS:000358414800005		
J	Kame, N; Fujita, S; Nakatani, M; Kusakabe, T				Kame, Nobuki; Fujita, Satoshi; Nakatani, Masao; Kusakabe, Tetsuya			Earthquake Nucleation on Faults with a Revised Rate- and State-Dependent Friction Law	PURE AND APPLIED GEOPHYSICS			English	Article						Earthquake; nucleation; rate- and state-dependent friction; preslip	ROCK FRICTION; STRENGTH; CONTACT; SLIP	Recently Nagata et al. (J Geophys Res 117:B02314, 2012) have proposed a new version of rate- and state-dependent friction law (RSF) that seems to have eventually resolved all the previously known discrepancies in the existing RSFs from laboratory observations. The values of a and b, empirical RSF parameters determined by fitting the same laboratory experiments, have been revised to be five times greater and a newly noticed weakening effect by shear stress with a coefficient c has been introduced. By using this revised RSF, we reinvestigated a problem of 2D quasi-static nucleation on faults. A crack-like nucleation-zone expansion known for the 'aging' version of RSF is not sustainable with the 'Nagata' law, which is understandable as the Nagata law does not produce a slip-weakening distance proportional to the involved strength reduction, an aging law's feature that contradicts laboratory observations. The later stage of Nagata-law nucleation shows localization of quasi-static slip within a limited spatial extent, but the localization is much milder than that predicted by the 'slip' version of RSF. With an appropriate c parameter of the Nagata law, the nucleation size seems to be reduced only by a factor from that of the aging law.	[Kame, Nobuki; Fujita, Satoshi; Nakatani, Masao; Kusakabe, Tetsuya] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Kame, N (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	kame@eri.u-tokyo.ac.jp			MEXT KAKENHI [21107007]; MEXT	The comments by two anonymous reviewers are greatly appreciated. Naoyuki Kato provided his numerical code. N.K. was supported by MEXT KAKENHI 21107007. This study was also supported by MEXT, under its Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions.	Ampuero JP, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005082; Nakatani M, 1996, GEOPHYS RES LETT, V23, P869, DOI 10.1029/96GL00726; Dieterich JH, 1996, TECTONOPHYSICS, V256, P219, DOI 10.1016/0040-1951(95)00165-4; Kato N, 2001, GEOPHYS RES LETT, V28, P1103, DOI 10.1029/2000GL012060; BEELER NM, 1994, GEOPHYS RES LETT, V21, P1987, DOI 10.1029/94GL01599; Nagata K, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008818; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; DIETERICH JH, 1992, TECTONOPHYSICS, V211, P115, DOI 10.1016/0040-1951(92)90055-B; HESLOT F, 1994, PHYS REV E, V49, P4973, DOI 10.1103/PhysRevE.49.4973; BHATTACHARYA P., 2012, 2012 FALL M; Fang ZJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006558; Kame N, 2013, TECTONOPHYSICS, V600, P187, DOI 10.1016/j.tecto.2012.11.028; Kame N, 2013, TECTONOPHYSICS, V600, P196, DOI 10.1016/j.tecto.2012.11.029; MARONE C, 1995, GEOPHYS RES LETT, V22, P723, DOI 10.1029/95GL00268; Nagata K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033146; Nakatani M, 2001, J GEOPHYS RES-SOL EA, V106, P13347, DOI 10.1029/2000JB900453; Press W. H., 1992, NUMERICAL RECIPES; Rubin AM, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003686; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359	19	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	AUG	2015	172	8			SI		2237	2246		10.1007/s00024-013-0744-0		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CN4QJ	WOS:000358414800011		
J	Thiel, C; Tsukamoto, S; Tokuyasu, K; Buylaert, JP; Murray, AS; Tanaka, K; Shirai, M				Thiel, Christine; Tsukamoto, Sumiko; Tokuyasu, Kayoko; Buylaert, Jan-Pieter; Murray, Andrew S.; Tanaka, Kazuhiro; Shirai, Masaaki			Testing the application of quartz and feldspar luminescence dating to MIS 5 Japanese marine deposits	QUATERNARY GEOCHRONOLOGY			English	Article						Quartz OSL; Slow OSL component; Post-IR IRSL; Internal dose rate; Japan	OGA PENINSULA; VOLCANIC QUARTZ; NORTHERN JAPAN; TOTTORI COAST; K-FELDSPARS; OSL; SEDIMENTS; IRSL; SEA; GRAINS	The applicability of both quartz and feldspar luminescence dating was tested on twenty-five samples from a marine succession now forming a coastal cliff at Oga Peninsula, Honshu Island, Japan. The quartz optically stimulated luminescence (OSL) signal shows thermal instability and linear modulated (LM)-OSL analysis revealed the dominance of a slow component. When compared with independent age control provided by two marker tephras, the quartz OSL ages grossly underestimate the depositional age. In contrast, potassium (K)-rich feldspar is a suitable dosimeter when measured using post-IR infrared stimulated luminescence (IRSL) at 225 degrees C (pIRIR(225)). Scanning electron microscope (SEM) analyses on the feldspar extracts revealed that the grains are amorphous with small crystalline inclusions; using standard internal dose rate parameters, this would result in a too large dose rate. Dose rates were calculated using the observed grain size of 40 +/- 20 gm with an assumed K concentration of 12.5 +/- 0.5%. The fading corrected pIRIR(225) ages agree well with independent age control, and the sediments of the Katanishi Formation were deposited between 82 +/- 6 and 170 +/- 16 ka. This study demonstrates that pIRIR dating of feldspar is a powerful chronological tool for the dating of sediments of volcanic origin. (C) 2015 Elsevier B.V. All rights reserved.	[Thiel, Christine; Buylaert, Jan-Pieter; Murray, Andrew S.] Aarhus Univ, Dept Geosci, Nord Lab Luminescence Dating, DK-4000 Roskilde, Denmark; [Thiel, Christine; Buylaert, Jan-Pieter] Tech Univ Denmark, Ctr Nucl Technol, DK-4000 Roskilde, Denmark; [Thiel, Christine; Tsukamoto, Sumiko] Leibniz Inst Appl Geophys, Sect Geochronol & Isotope Hydrol 3, D-30655 Hannover, Germany; [Tokuyasu, Kayoko] Japan Atom Energy Agcy, Geosci Res Dept, Neotecton Res Grp, Tono Geosci Ctr,Sect Decommissioning & Radioact W, Gifu 5095102, Japan; [Tanaka, Kazuhiro] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan; [Shirai, Masaaki] Tokyo Metropolitan Univ, Dept Geog, Hachioji, Tokyo 1920397, Japan	Tsukamoto, S (reprint author), Leibniz Inst Appl Geophys, Sect Geochronol & Isotope Hydrol 3, Stilleweg 2, D-30655 Hannover, Germany.	sumiko.tsukamoto@liag-hannover.de		Buylaert, Jan-Pieter/0000-0003-0587-8077	German Research Foundation (DFG) [TH1651/1-1]; Danish Research Council [11-104566]	We thank the reviewer Jakob Wallinga, an anonymous reviewer and the editor Frank Preusser for their valuable comments. We are grateful to Vicki Hansen, Mette Adrian and Anne Birgit Rasmussen for technical assistance, and to Reisuke Kondo, Masayuki Ooishi, and Sebastien Huot for their assistance in the field. Michael Kenzler is thanked for his valuable comments on the text. Ryuta Hataya and Takaomi Hamada (Central Research Institute of Electric Power Industry, Japan) are thanked for their help in the reflectance index measurements. Bodo Harazim (Federal Institute for Geosciences and Natural Resources, BGR, Hannover) is thanked for the ICP-OES analyses of the feldspar extracts. The help of Detlev Klosa (Geological Survey of Lower Saxony, LBEG, Hannover) with the SEM-EDX analyses is very much appreciated. Christine Thiel received funding from the German Research Foundation (DFG grant no. TH1651/1-1) and Jan-Pieter Buylaert thanks the Danish Research Council for financial support (Steno grant no. 11-104566).	Aitken M.J., 1998, INTRO OPTICAL DATING; Buylaert JP, 2009, RADIAT MEAS, V44, P560, DOI 10.1016/j.radmeas.2009.02.007; Jacobs Z, 2008, BOREAS, V37, P508, DOI 10.1111/j.1502-3885.2008.00054.x; Tanaka K, 1997, QUATERNARY SCI REV, V16, P257, DOI 10.1016/S0277-3791(96)00092-3; Buylaert JP, 2012, BOREAS, V41, P435, DOI 10.1111/j.1502-3885.2012.00248.x; Shirai M, 2000, J SEDIMENT RES, V70, P839, DOI 10.1306/2DC4093C-0E47-11D7-8643000102C1865D; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; Duller GAT, 2003, RADIAT MEAS, V37, P161, DOI 10.1016/S1350-4487(02)00170-1; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; MURRAY AS, 1987, J RADIOAN NUCL CH AR, V115, P263, DOI 10.1007/BF02037443; Jain M, 2003, RADIAT MEAS, V37, P441, DOI 10.1016/S1350-4487(03)00052-0; Thiel C, 2011, GEOMORPHOLOGY, V135, P295, DOI 10.1016/j.geomorph.2011.02.011; Jain M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/38/385402; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Tokuyasu K, 2010, GEOCHRONOMETRIA, V37, P13, DOI 10.2478/v10003-010-0020-6; Sohbati R, 2013, RADIAT MEAS, V51-52, P67, DOI 10.1016/j.radmeas.2012.12.011; Auclair M, 2003, RADIAT MEAS, V37, P487, DOI 10.1016/S1350-4487(03)00018-0; Sohbati R, 2012, BOREAS, V41, P250, DOI 10.1111/j.1502-3885.2011.00230.x; WINTLE AG, 1973, NATURE, V245, P143, DOI 10.1038/245143a0; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Bulur E, 1996, RADIAT MEAS, V26, P701, DOI 10.1016/S1350-4487(97)82884-3; Thiel C, 2010, QUATERN INT, V222, P36, DOI 10.1016/j.quaint.2009.12.020; Kars RH, 2012, QUAT GEOCHRONOL, V12, P74, DOI 10.1016/j.quageo.2012.05.001; Tsukamoto S, 2007, RADIAT MEAS, V42, P190, DOI 10.1016/j.radmeas.2006.07.008; BLOOM AL, 1974, QUATERNARY RES, V4, P185, DOI 10.1016/0033-5894(74)90007-6; Alappat L, 2010, GEOCHRONOMETRIA, V37, P37, DOI 10.2478/v10003-010-0025-1; Chiba T, 2014, QUATERNARY RES, V81, P21, DOI 10.1016/j.yqres.2013.10.015; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; Tsukamoto S, 2003, RADIAT MEAS, V37, P459, DOI 10.1016/S1350-4487(03)00054-4; Steffen D, 2009, QUAT GEOCHRONOL, V4, P353, DOI 10.1016/j.quageo.2009.05.015; Singarayer JS, 2003, RADIAT MEAS, V37, P451, DOI 10.1016/S1350-4487(03)00062-3; Wintle AG, 2006, RADIAT MEAS, V41, P369, DOI 10.1016/j.radmeas.2005.11.001; Kars RH, 2014, BOREAS, V43, P780, DOI 10.1111/bor.12082; Botter-Jensen L, 2003, RADIAT MEAS, V37, P535, DOI 10.1016/S1350-4487(03)00020-9; Watanuki T, 2005, EARTH PLANET SC LETT, V240, P774, DOI 10.1016/j.epsl.2005.09.027; Aoki K, 2008, QUATERN INT, V178, P100, DOI 10.1016/j.quaint.2007.02.005; Furusawa A, 1995, J GEOL SOC JAPAN, V101, P123; FURUTA T, 1986, MAR GEOL, V72, P125, DOI 10.1016/0025-3227(86)90103-9; Ganzawa Y., 2009, RADIAT MEAS, V43, P1; Guerin G, 2011, ANCIENT TL, V29, P5; Hataya Ryuta, 2003, Quaternary Research (Tokyo), V42, P347; Huntley D.J., 2001, ANCIENT TL, V19, P43; Huntley DJ, 1997, ANCIENT TL, V15, P11; Kato M., 1976, AKITA PREFECTURAL MU, V1, P56; Koike K., 2001, ATLAS QUATERNARY MAR; Kondo R, 2007, QUAT GEOCHRONOL, V2, P260, DOI 10.1016/j.quageo.2006.05.015; LAMOTHE M, 1994, RADIAT MEAS, V23, P555, DOI 10.1016/1350-4487(94)90099-X; Machida H., 2003, ATLAS TEPHRA JAPAN; MACHIDA H, 1983, J VOLCANOL GEOTH RES, V18, P151, DOI 10.1016/0377-0273(83)90007-0; Machida H., 1987, QUATERNARY RES, V26, P129; Matsu'ura T., 2013, QUAT GEOCHRONOL, V23, P63; MESOLELL.KJ, 1969, J GEOL, V77, P250; Oba T, 1991, CHIKYU MONTHLY EARTH, V13, P224; Shirai Masaaki, 1997, Quaternary Research (Tokyo), V36, P183; Shirai M., 1997, SEDIMENTOLOGICAL SOC, V44, P43; Shirai M, 2002, J SEDIMENT RES, V72, P386, DOI 10.1306/102501720386; Shiraishi T., 1992, QUATERNARY RES, V31, P17; Shiraishi T., 2008, J GEOLOGICAL SOC J S, P33; Smedley RK, 2012, RADIAT MEAS, V47, P790, DOI 10.1016/j.radmeas.2012.01.014; Tamura T, 2011, PALAEOGEOGR PALAEOCL, V308, P492, DOI 10.1016/j.palaeo.2011.05.054; Tamura T, 2011, GEOMORPHOLOGY, V132, P153, DOI 10.1016/j.geomorph.2011.05.005; Tsukamoto S, 2011, QUATERN INT, V234, P182, DOI 10.1016/j.quaint.2010.09.003	62	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-1014	1878-0350		QUAT GEOCHRONOL	Quat. Geochronol.	AUG	2015	29						16	29		10.1016/j.quageo.2015.05.008		14	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CN7QO	WOS:000358629300003		
J	Yoneshige, A; Hagiyama, M; Inoue, T; Mimae, T; Kato, T; Okada, M; Enoki, E; Ito, A				Yoneshige, Azusa; Hagiyama, Man; Inoue, Takao; Mimae, Takahiro; Kato, Takashi; Okada, Morihito; Enoki, Eisuke; Ito, Akihiko			Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia	RESPIRATORY RESEARCH			English	Article						alpha-shedding; Apoptosis; Emphysema; Nonspecific interstitial pneumonia; Paraffin section	ACUTE LUNG INJURY; PULMONARY-FIBROSIS; EXPRESSION; PATHOGENESIS; MARKERS; INVOLVEMENT; RECEPTORS; CARCINOMA; EMPHYSEMA; POLARITY	Background: Lung alveolar epithelial cell (AEC) apoptosis has attracted attention as an early pathogenic event in the development of idiopathic interstitial pneumonia (IIP); however, the causative mechanism remains unclear. Cell adhesion molecule 1 (CADM1) is an AEC adhesion molecule in the immunoglobulin superfamily. It generates a membrane-associated C-terminal fragment, alpha CTF, through protease-mediated ectodomain shedding, termed a-shedding. Increased CADM1 alpha-shedding contributes to AEC apoptosis in emphysematous lungs. Methods: Formalin-fixed, paraffin-embedded lung lobes (n = 39) from 36 autopsied patients with IIP were classified as acute IIP (n = 10), fibrosing-type nonspecific IIP (f-NSIP, n = 10), cryptogenic organizing IIP (n = 9), and usual IIP (n = 10). CADM1 expression in the lung sections was examined by western blotting and compared with control lungs (n = 10). The rate of CADM1 alpha-shedding was calculated as the relative amount of alpha CTF to full-length CADM1, and the full-length CADM1 level was estimated per epithelial cell by normalization to cytokeratin 7, a lung epithelial marker. Apoptotic AECs were detected by immunohistochemistry for single-stranded DNA (ssDNA). NCI-H441 and A549 human lung epithelial cells were transfected with small interfering RNA (siRNA) to silence CADM1 expression and analyzed by terminal nucleotide nick end labeling assays. Results: The rate of CADM1 alpha-shedding was higher in all IIP subtypes than in the control (P = 0.019), and the full-length CADM1 level was lower in f-NSIP (P = 0.007). The alpha-shedding rate and full-length CADM1 level were correlated with each other (P = 0.015) and with the proportion of ssDNA-positive AECs (P = 0.024). NCI-H441 cells transfected with siRNA exhibited a 61 % lower rate of expression of full-length CADM1 and a 17-fold increased proportion of apoptotic cells. Similar results were obtained with A549 cells. Conclusions: CADM1 alpha-shedding appeared to be increased in all four IIP subtypes and consequently contributed to AEC apoptosis by decreasing the full-length CADM1 level. This mechanism particularly impacted f-NSIP. The molecular mechanism causing AEC apoptosis may be similar between IIP and emphysema.	[Yoneshige, Azusa; Hagiyama, Man; Inoue, Takao; Kato, Takashi; Enoki, Eisuke; Ito, Akihiko] Kinki Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan; [Mimae, Takahiro; Okada, Morihito] Hiroshima Univ, Dept Surg Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan	Ito, A (reprint author), Kinki Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan.	aito@med.kindai.ac.jp			Japan Society for the Promotion of Science Kakenhi [26860267, 25860302, 24590492]; GSK Japan Research Grant; Takeda Science Foundation	The authors thank Yoshitaka Horiuchi and Yasumitsu Akahoshi (Kinki University Life Science Research Institute) for technical assistances. This study was supported by the Japan Society for the Promotion of Science Kakenhi (26860267 to AY, 25860302 to MH, and 24590492 to AI), GSK Japan Research Grant (to MH), and a grant from Takeda Science Foundation (to MH).	Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Kuwano K, 1999, AM J RESP CELL MOL, V20, P53; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Tanjore H, 2012, AM J PHYSIOL-LUNG C, V302, pL721, DOI 10.1152/ajplung.00410.2011; Bardales RH, 1996, AM J PATHOL, V149, P845; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Kuwano K, 2002, LAB INVEST, V82, P1695, DOI 10.1097/01.LAB.0000045084.81853.76; Masuda M, 2010, J BIOL CHEM, V285, P15511, DOI 10.1074/jbc.M109.076653; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Takahashi M, 2013, PATHOL INT, V63, P237, DOI 10.1111/pin.12058; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; Fogel AI, 2010, J BIOL CHEM, V285, P34864, DOI 10.1074/jbc.M110.120865; Frankfurt OS, 1997, CLIN CANCER RES, V3, P465; Inoue T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100988; Ito A, 2012, ISLETS, V4, DOI 10.4161/isl.18675; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Ito A, 2007, HEPATOLOGY, V45, P684, DOI 10.1002/hep.21501; Koma YI, 2008, GASTROENTEROLOGY, V134, P1544, DOI 10.1053/j.gastro.2008.01.081; Martin TR, 2003, CRIT CARE MED, V31, pS184, DOI 10.1097/01.CCM.0000057841.33876.B1; Mimae T, 2012, CLIN CANCER RES, V18, P945, DOI 10.1158/1078-0432.CCR-11-1946; Mimae T, 2014, THORAX, V69, P223, DOI 10.1136/thoraxjnl-2013-203867; Nagara Y, 2012, BIOCHEM BIOPH RES CO, V417, P462, DOI 10.1016/j.bbrc.2011.11.140; Nagata M, 2012, INT J CANCER, V130, P1329, DOI 10.1002/ijc.26160; Nakashima N, 2005, J CLIN PATHOL, V58, P583, DOI 10.1136/jcp.2004.022632; Psathakis K, 2006, EUR J CLIN INVEST, V36, P362, DOI 10.1111/j.1365-2362.2006.01636.x; Robledo O, 2003, EUR J IMMUNOL, V33, P1351, DOI 10.1002/eji.200323195; Rodriguez-Rigueiro T, 2011, PROTEOMICS, V11, P2555, DOI 10.1002/pmic.201000809; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; Schlage WK, 1998, TOXICOL PATHOL, V26, P324; Travis W, 2002, NONNEOPLASTIC DISORD; Uhal B.D., 2008, EUR RESPIR REV, V17, P138, DOI 10.1183/09059180.00010906	44	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-993X	1465-9921		RESP RES	Respir. Res.	AUG 1	2015	16								90	10.1186/s12931-015-0255-x		12	Respiratory System	Respiratory System	CN9KM	WOS:000358766500001		
J	Kambayashi, R; Kiyota, K				Kambayashi, Ryo; Kiyota, Kozo			Disemployment caused by foreign direct investment? Multinationals and Japanese employment	REVIEW OF WORLD ECONOMICS			English	Article						Foreign direct investment; Unemployment; Unconditional labor demand	IMPACT	Using parent-foreign affiliate matched data on Japan from 1995 to 2009, this paper examines the effects of foreign direct investment (FDI) on domestic employment, especially in manufacturing. One of the contributions of this paper is that we utilize the matched data for each country in which Japanese multinational firms operate, which enables us to identify the differences in the impact of FDI between destinations. Results indicate that the increases in the investment goods price in China but the decreases in it in the United States negatively affected the domestic labor demand of multinationals in Japan. This contrast may reflect a difference in specialization patterns across countries. We also found that disemployment in Japan was driven mainly by substitution between capital and labor, rather than by the reallocation of labor from Japan to overseas.	[Kambayashi, Ryo] Hitotsubashi Univ, Inst Econ Res, Kunitachi, Tokyo 1868603, Japan; [Kiyota, Kozo] Keio Univ, Keio Econ Observ, Minato Ku, Tokyo 1088345, Japan; [Kiyota, Kozo] RIETI, Tokyo, Japan	Kambayashi, R (reprint author), Hitotsubashi Univ, Inst Econ Res, 2-1 Naka, Kunitachi, Tokyo 1868603, Japan.	kambayas@ier.hit-u.ac.jp; kiyota@sanken.keio.ac.jp			Japan Society for the Promotion of Science [22243023, 26285058]	This research was conducted as a part of the Research Institute of Economy, Trade and Industry (RIETI) research project entitled "Competitiveness of Japanese Firms: Causes and Effects of the Productivity Dynamics". The authors acknowledge helpful comments on an earlier draft from Taro Akiyama, Masahisa Fujita, Kyoji Fukao, Toshiyuki Matsuura, Hoang Thi Anh Ngoc, Kazuo Ogawa, Yasuyuki Todo, Nobuaki Yamashita, Liu Yang, the seminar participants at the IDE-JETRO, Kobe University, Kyoto University, RIETI, the University of Tokyo, Yokohama National University, and participants at the SFU-NIESG workshop at Simon Fraser University, the EITI 2014 in Phuket, and the Spring 2014 Meeting of the Japanese Economic Association. Financial support received from the Japan Society for the Promotion of Science (Grant-in-aid A-22243023 and B-26285058) is also gratefully acknowledged.	Desai MA, 2009, AM ECON J-ECON POLIC, V1, P181, DOI 10.1257/pol.1.1.181; Kiyota K, 2008, WORLD DEV, V36, P1398, DOI 10.1016/j.worlddev.2007.08.006; Bernard AB, 2006, J INT ECON, V68, P219, DOI 10.1016/j.jinteco.2005.06.002; Muendler MA, 2010, AM ECON REV, V100, P1999, DOI 10.1257/aer.100.5.1999; Harrison A, 2011, REV ECON STAT, V93, P857, DOI 10.1162/REST_a_00085; Fukao K., 2007, 07E003 RIETI; Hayakawa K, 2013, JPN WORLD ECON, V27, P25, DOI 10.1016/j.japwor.2013.03.006; Kambayashi K., 2014, 14E051 RIETI; Matsuura T., 2011, JAPANESE J LABOUR ST, V609, P18; Research and Statistics Department Ministry of Economy Trade and Industry (METI), 1995, KIG KATS KIH CHOUS H; Research and Statistics Department Ministry of Economy Trade and Industry (METI), 1995, KAIG JIG KATS KIH CH; Tomiura E., 2012, JAPANESE J LABOUR ST, V623, P60; Tomiura E, 2003, J JPN INT ECON, V17, P118, DOI 10.1016/S0889-1583(03)00013-3; Yamashita N, 2010, JPN WORLD ECON, V22, P88, DOI 10.1016/j.japwor.2009.10.001	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1610-2878	1610-2886		REV WORLD ECON	Rev. World Econ.	AUG	2015	151	3			SI		433	460		10.1007/s10290-014-0205-6		28	Economics; International Relations	Business & Economics; International Relations	CN7BF	WOS:000358587800003		
J	Wu, HH; Xu, XK; Duan, CT; Li, TS; Cheng, WG				Wu HaoHao; Xu XingKai; Duan CunTao; Li TuanSheng; Cheng WeiGuo			Effect of vegetation type, wetting intensity, and nitrogen supply on external carbon stimulated heterotrophic respiration and microbial biomass carbon in forest soils	SCIENCE CHINA-EARTH SCIENCES			English	Article						dissolved organic carbon; forest soil; glucose; heterotrophic respiration; microbial biomass carbon; nitrogen supply; stimulating effect	ENVIRONMENTAL-FACTORS; ORGANIC-MATTER; LITTER DECOMPOSITION; HARVARD FOREST; PINE FOREST; MINERALIZATION; ADDITIONS; GLUCOSE; COMMUNITY; CO2	By using packed soil-core incubation experiments, we have studied stimulating effects of addition of external carbon (C) (glucose, 6.4 g C m(-2)) on heterotrophic respiration and microbial biomass C of a mature broadleaf and Korean pine mixed forest (BKPF) and an adjacent white birch forest (WBF) soil under different wetting intensities (55% and 80% WFPS, water-filled pore space) and nitrogen (N) supply (NH4Cl and KNO3, 4.5 g N m(-2)) conditions. The results showed that for the control, the cumulative carbon dioxide (CO2) flux from WBF soil during the 15-day incubation ranged from 5.44 to 5.82 g CO2-C m(-2), which was significantly larger than that from BKPF soil (2.86 to 3.36 g CO2-C m(-2)). With increasing wetting intensity, the cumulative CO2 flux from the control was decreased for the WBF soil, whereas an increase in the CO2 flux was observed in the BKPF soil (P < 0.05). The addition of NH4Cl or KNO3 alone significantly reduced the cumulative CO2 fluxes by 9.2%-21.6 % from the two soils, especially from WBF soil at low wetting intensity. The addition of glucose alone significantly increased soil heterotrophic respiration, microbial biomass C (MBC), and microbial metabolic quotient. The glucose-induced cumulative CO2 fluxes and soil MBC during the incubation ranged from 8.7 to 11.7 g CO2-C m(-2) and from 7.4 to 23.9 g C m(-2), which are larger than the dose of added C. Hence, the addition of external carbon can increase the decomposition of soil native organic C. The glucose-induced average and maximum rates of CO2 fluxes during the incubation were significantly influenced by wetting intensity (WI) and vegetation type (VT), and by WIxVT, NH(4)ClxVT and WIxVTxNH(4)Cl (P < 0.05). The addition of NH4Cl, instead of KNO3, significantly decreased the glucose-induced MBC of WBF soil (P < 0.05), whereas adding NH4Cl and KNO3 both significantly increased the glucose-induced MBC of BKPF soil at high moisture (P < 0.05). According to the differences in soil labile C pools, MBC and CO2 fluxes in the presence and absence of glucose, it can be concluded that the stimulating effects of glucose on soil heterotrophic respiration and MBC under temperate forests were dependent on vegetation type, soil moisture, and amount and type of the N added.	[Wu HaoHao; Xu XingKai; Duan CunTao] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Wu HaoHao] Univ Chinese Acad Sci, Coll Earth Sci, Beijing 100049, Peoples R China; [Li TuanSheng] Changan Univ, Coll Earth Sci & Resources, Xian 710054, Peoples R China; [Cheng WeiGuo] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan	Xu, XK (reprint author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China.	xingkai_xu@mail.iap.ac.cn			National Basic Research Program of China [2010CB950602]; National Natural Science Foundation of China [41175133, 21228701, 41275166, 41321064]	This work was financially supported jointly by the National Basic Research Program of China (Grant No. 2010CB950602) and the National Natural Science Foundation of China (Grant Nos. 41175133, 21228701, 41275166, and 41321064).	Zhao SC, 2014, AGR ECOSYST ENVIRON, V194, P29, DOI 10.1016/j.agee.2014.05.006; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Paterson E, 2013, GLOBAL CHANGE BIOL, V19, P1562, DOI 10.1111/gcb.12140; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; Bell JM, 2003, BIOL FERT SOILS, V37, P237, DOI 10.1007/s00374-003-0587-4; Dilly O, 2008, GEOMICROBIOL J, V25, P425, DOI 10.1080/01490450802403099; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Iqbal J, 2010, AGR ECOSYST ENVIRON, V137, P294, DOI 10.1016/j.agee.2010.02.015; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; Franzluebbers AJ, 1999, APPL SOIL ECOL, V11, P91, DOI 10.1016/S0929-1393(98)00128-0; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Banning NC, 2008, SOIL BIOL BIOCHEM, V40, P2021, DOI 10.1016/j.soilbio.2008.04.010; Wang YS, 2003, ADV ATMOS SCI, V20, P842; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; DALENBERG JW, 1989, SOIL BIOL BIOCHEM, V21, P443, DOI 10.1016/0038-0717(89)90157-0; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Conde E, 2005, SOIL BIOL BIOCHEM, V37, P681, DOI 10.1016/j.soilbio.2004.08.026; Schneckenberger K, 2008, SOIL BIOL BIOCHEM, V40, P1981, DOI 10.1016/j.soilbio.2008.02.020; JENKINSON DS, 1985, J SOIL SCI, V36, P425; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Blagodatskaya EV, 2007, APPL SOIL ECOL, V37, P95, DOI 10.1016/j.apsoil.2007.05.002; Wang QK, 2013, ANN FOREST SCI, V70, P579, DOI 10.1007/s13595-013-0294-8; Thirukkumaran CM, 2000, SOIL BIOL BIOCHEM, V32, P59, DOI 10.1016/S0038-0717(99)00129-7; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; ASMAR F, 1994, BIOL FERT SOILS, V17, P32, DOI 10.1007/BF00418669; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; [陈春梅 CHEN Chunmei], 2006, 土壤, V38, P359; Falchini L, 2003, SOIL BIOL BIOCHEM, V35, P775, DOI 10.1016/S0038-0717(03)00105-6; Huang W Z, 2007, CHINESE J SOIL SCI, V38, P149; Intergovernmental Panel on Climate Change (IPCC), 2013, AR5 IPCC, P475; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Jia F L, 2012, SCI AGR SIN, V11, P2199; Li YQ, 2006, PLANT SOIL, V281, P193, DOI 10.1007/s11104-005-4249-1; Liu HS, 2006, APPL SOIL ECOL, V32, P284, DOI 10.1016/j.apsoil.2005.08.001; Lv D Q, 2007, PLANT NUTR FERT SCI, V13, P423; Ma Qixiang, 2013, Chinese Journal of Applied and Environmental Biology, V19, P426, DOI 10.3724/SP.J.1145.2013.00426; Persson T, 2000, ECOL STU AN, V142, P257; Smith VR, 2005, SOIL BIOL BIOCHEM, V37, P81, DOI 10.1016/j.soilbio.2004.07.026; Tian DL, 2010, CHINESE SCI BULL, V55, P736, DOI 10.1007/s11434-009-0452-4; Wang Hong, 2008, Shengtaixue Zazhi, V27, P1469; Wang W, 2006, CHINESE SCI BULL, V38, P653; Wang Xu, 2007, Zhiwu Shengtai Xuebao, V31, P348; [吴浩浩 Wu Haohao], 2014, [科学通报, Chinese Science Bulletin], V59, P1337; Xu XK, 2007, SOIL SCI PLANT NUTR, V53, P430, DOI 10.1111/j.1747-0765.2007.00146.x; Yamasaki A, 2011, J FOREST RES-JPN, V16, P414, DOI 10.1007/s10310-011-0272-7; Yoshitake S, 2007, EUR J SOIL BIOL, V43, P1, DOI 10.1016/j.ejsobi.2006.01.003; Zhang TY, 2009, CHINESE SCI BULL, V54, P296, DOI 10.1007/s11434-008-0470-7	52	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7313	1869-1897		SCI CHINA EARTH SCI	Sci. China-Earth Sci.	AUG	2015	58	8					1446	1456		10.1007/s11430-015-5058-x		11	Geosciences, Multidisciplinary	Geology	CN6MV	WOS:000358549800017		
J	Yang, XH; Yan, HB; Wang, WB; Jin, LW; Lu, TJ; Ichimiya, K				Yang XiaoHu; Yan HongBin; Wang WenBin; Jin LiWen; Lu TianJian; Ichimiya, Koichi			Thermo-fluidic characteristics of natural convection in honeycombs: The role of chimney enhancement	SCIENCE CHINA-TECHNOLOGICAL SCIENCES			English	Article						natural convection; honeycomb; adiabatic chimney; inclination angle	HEAT-TRANSFER ENHANCEMENT; ENERGY-STORAGE; FIN ARRAYS; CHANNEL; DESIGN	The natural convective heat transfer performance and thermo-fluidic characteristics of honeycombs with/without chimney extensions are numerically investigated. The present numerical simulations are validated by the purposely-designed experimental measurements on honeycombs with/without chimney. Good agreement between numerical simulation and experimental measurement is obtained. The influences of inclination angle and geometric parameters such as cell shape, streamwise and spanwise length are also numerically quantified. With the increment in inclination angle, the overall heat transfer rate decreases for the honeycombs with/without chimney. For honeycombs with the same void volume fraction but different cell shapes, there is little difference on the overall heat transfer rate. To enhance the natural convective heat transfer of honeycombs, these techniques including increasing the length of honeycomb in the streamwise/spanwise direction, increasing the thermal conductivity of hon-eycomb structure or adding a chimney extension may be helpful.	[Yang XiaoHu; Jin LiWen] Xi An Jiao Tong Univ, Sch Human Settlements & Civil Engn, Dept Bldg Environm & Energy Engn, Xian 710049, Peoples R China; [Yang XiaoHu; Yan HongBin; Wang WenBin; Lu TianJian] Xi An Jiao Tong Univ, MOE Key Lab Multifunct Mat & Struct, Xian 710049, Peoples R China; [Yan HongBin] Xi An Jiao Tong Univ, Sch Energy & Power Engn, Xian 710049, Peoples R China; [Lu TianJian] Xi An Jiao Tong Univ, Sch Aerosp, State Key Lab Strength & Vibrat Mech Struct, Xian 710049, Peoples R China; [Ichimiya, Koichi] Univ Yamanashi, Dept Mech Engn, Kofu, Yamanashi 4008511, Japan	Lu, TJ (reprint author), Xi An Jiao Tong Univ, MOE Key Lab Multifunct Mat & Struct, Xian 710049, Peoples R China.	tjlu@mail.xjtu.edu.cn			National 111 Project of China [B06024]; National Basic Research Program of China ("973" Project) [2011CB610305]; National Natural Science Foundation of China [51206128]	This work was supported by the National 111 Project of China (Grant No. B06024), the National Basic Research Program of China ("973" Project) (Grant No. 2011CB610305), and the National Natural Science Foundation of China (Grant No. 51206128).	Abhat A, 1976, 11 THERM C AM I AER; Alawadhi E M, 2002, P 8 INT C THERM THER; Oztop HF, 2008, INT J HEAT FLUID FL, V29, P1326, DOI 10.1016/j.ijheatfluidflow.2008.04.009; ZOGRAFOS AI, 1990, EXP THERM FLUID SCI, V3, P440, DOI 10.1016/0894-1777(90)90042-6; Kim HY, 2004, INT J HEAT MASS TRAN, V47, P2831, DOI 10.1016/j.ijheatmasstransfer.2003.11.033; Feng HJ, 2013, SCI CHINA TECHNOL SC, V56, P299, DOI 10.1007/s11431-012-5097-x; Gu S, 2001, INT J HEAT MASS TRAN, V44, P2163, DOI 10.1016/S0017-9310(00)00234-9; Wang K, 2014, SCI CHINA TECHNOL SC, V57, P531, DOI 10.1007/s11431-013-5452-6; Kenisarin M, 2007, RENEW SUST ENERG REV, V11, P1913, DOI 10.1016/j.rser.2006.05.005; Ansys-CFX, 2011, ANSYS CFX REL 14 0 A; Asako Y, 1990, J HEAT TRANSF T ASME, V112, P15; Baskaya S, 2000, INT J THERM SCI, V39, P797, DOI 10.1016/S1290-0729(00)00271-4; Coleman H. W., 2009, EXPT VALIDATION UNCE; Farid MM, 2004, ENERG CONVERS MANAGE, V45, P1597, DOI 10.1016/j.enconman.2003.09.015; Gao XM, 2014, SCI CHINA TECHNOL SC, V57, P2177, DOI 10.1007/s11431-014-5668-0; Haaland S.E., 1983, NUMERICAL HEAT TRANS, V6, P155, DOI 10.1080/10407798308546980; Hasse C, 2011, ENERG BUILDINGS, V43, P232, DOI 10.1016/j.enbuild.2010.09.017; Liu ST, 2008, INT J HEAT MASS TRAN, V51, P6254, DOI 10.1016/j.ijheatmasstransfer.2007.07.055; Lu T J, 1998, INT J HEAT MASS TRAN, V42, P2031; Bhattacharya A, 2006, J ELECTRON PACKAGING, V128, P259, DOI 10.1115/1.2229225; STRAATMAN AG, 1993, J HEAT TRANS-T ASME, V115, P395, DOI 10.1115/1.2910691; Yang S.M., 2006, HEAT TRANSFER; Yang X H, 2014, THEOR APP MECH LETT, V4; Yang XH, 2013, TRANSPORT POROUS MED, V100, P211, DOI 10.1007/s11242-013-0212-4; Yao L S, 2006, INT J HEAT MASS TRAN, V49, P281; Yeh CL, 2003, EXP THERM FLUID SCI, V27, P271, DOI 10.1016/S0894-1777(02)00297-2; Zhang PG, 2014, SCI CHINA TECHNOL SC, V57, P2371, DOI 10.1007/s11431-014-5704-0	27	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7321	1869-1900		SCI CHINA TECHNOL SC	Sci. China-Technol. Sci.	AUG	2015	58	8					1318	1327		10.1007/s11431-015-5869-1		10	Engineering, Multidisciplinary; Materials Science, Multidisciplinary	Engineering; Materials Science	CN9DJ	WOS:000358746500002		
J	Yamada, N				Yamada, Noriyuki			Kinetic energy discrimination in collision/reaction cell ICP-MS: Theoretical review of principles and limitations	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Review						Inductively coupled plasma mass spectrometry; ICP-MS; Collision reaction cell; Kinetic energy discrimination; KED	PLASMA-MASS-SPECTROMETRY; DYNAMIC REACTION CELL; ION FLOW TUBE; ISOBARIC INTERFERENCES; DRC-MS; GAS	Kinetic energy discrimination (KED) is one of the means to control cell-formed interferences in collision/reaction cell ICP-MS, and also a technique to reduce polyatomic ion interferences derived from the plasma or vacuum interface in collision cell ICP-MS. The operation of KED is accurately described to explain how spectral interferences from polyatomic ions are reduced by this technique. The cell is operated under non-thermal conditions to implement KED, where the hard sphere collision model is aptly employed to portray the transmission of ions colliding with the cell gas that they don't chemically react with. It is theoretically explained that the analyte atomic ions surmount the energy barrier placed downstream of the cell and the interfering polyatomic ions do not due to their lower kinetic energy than the atomic ions, resulting in polyatomic interference reduction. The intrinsic limitations of this technique are shown to lie in the statistical nature of collision processes, which causes the broadening of ion kinetic energy distribution that hinders efficient MED. The reaction cell operation with KED, where plasma-derived interferences are reduced by the reactive cell gas while cell-formed interferences are suppressed by the energy barrier, is also described in a quantitative manner. This review paper provides an in-depth understanding of ICED in cell-based ICP-MS for analysts to make better use of it. (C) 2015 Elsevier B.V. All rights reserved.	Agilent Technol Int Japan, Tokyo, Japan	Yamada, N (reprint author), Agilent Technol Int Japan, Tokyo, Japan.	noriyuki.yamada@agilent.com					Anicich V.G., 2014, INDEX LIT BIOMOLECUL; Douglas DJ, 2009, MASS SPECTROM REV, V28, P937, DOI 10.1002/mas.20249; Tanner SD, 2002, SPECTROCHIM ACTA B, V57, P1361, DOI 10.1016/S0584-8547(02)00069-1; Alvarez S, 2013, DALTON T, V42, P8617, DOI 10.1039/c3dt50599e; Jackson BP, 2015, J ANAL ATOM SPECTROM, V30, P1179, DOI [10.1039/c4ja00310a, 10.1039/C4JA00310A]; ROWAN JT, 1989, APPL SPECTROSC, V43, P976, DOI 10.1366/0003702894204065; Koppenaal DW, 2004, J ANAL ATOM SPECTROM, V19, P561, DOI 10.1039/b403510k; Bandura DR, 2001, FRESEN J ANAL CHEM, V370, P454, DOI 10.1007/s002160100869; DOUGLAS DJ, 1992, J AM SOC MASS SPECTR, V3, P398, DOI 10.1016/1044-0305(92)87067-9; Baranov VI, 1999, J ANAL ATOM SPECTROM, V14, P1133, DOI 10.1039/a809889a; Eiden GC, 1997, RAPID COMMUN MASS SP, V11, P37, DOI 10.1002/(SICI)1097-0231(19970115)11:1<37::AID-RCM815>3.0.CO;2-C; ERVIN KM, 1985, J CHEM PHYS, V83, P166, DOI 10.1063/1.449799; Tanner SD, 1999, J AM SOC MASS SPECTR, V10, P1083, DOI 10.1016/S1044-0305(99)00081-1; Yamada N, 2002, J ANAL ATOM SPECTROM, V17, P1213, DOI 10.1039/b205416g; Koyanagi GK, 2000, J ANAL ATOM SPECTROM, V15, P1207, DOI 10.1039/b000989j; McCurdy E, 2004, J ANAL ATOM SPECTROM, V19, P607, DOI 10.1039/b312250f; Fernandez SD, 2012, ANAL CHEM, V84, P5851, DOI 10.1021/ac3009516; Bandura DR, 2002, ANAL CHEM, V74, P1497, DOI 10.1021/ac011031v; BEDFORD DK, 1990, INT J MASS SPECTROM, V98, P179, DOI 10.1016/0168-1176(90)85017-V; Deakyne C.A., 1992, J MOL STRUC-THEOCHEM, V260, P395, DOI 10.1016/0166-1280(92)87056-6; Quarles CD, 2014, J ANAL ATOM SPECTROM, V29, P297, DOI 10.1039/c3ja50272d; Douglas DJ, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P615; FULFORD JE, 1986, APPL SPECTROSC, V40, P971, DOI 10.1366/0003702864508160; Hattendorf B, 2004, J ANAL ATOM SPECTROM, V19, P600, DOI 10.1039/b312155k; McQuarrie D. A., 1997, PHYS CHEM MOL APPROA; McQuarrie D.A., 1997, KINETIC THEORY GASES, P1101; Takahashi J., 2010, 59906195EN	27	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	AUG 1	2015	110						31	44		10.1016/j.sab.2015.05.008		14	Spectroscopy	Spectroscopy	CN9YS	WOS:000358807700006		
J	Miyabe, M; Oba, M; Iimura, H; Akaoka, K; Khumaeni, A; Kato, M; Wakaida, I				Miyabe, M.; Oba, M.; Iimura, H.; Akaoka, K.; Khumaeni, A.; Kato, M.; Wakaida, I.			Ablation plume structure and dynamics in ambient gas observed by laser-induced fluorescence imaging spectroscopy	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Article						Laser ablation; Laser-induced fluorescence spectroscopy; Plume dynamics; Atomic absorption spectroscopy; LIBS	INDUCED BREAKDOWN SPECTROSCOPY; OPTICAL-EMISSION SPECTROSCOPY; INDUCED PLASMA; NUMBER DENSITY; RECOMBINATION PROCESSES; EXPANSION DYNAMICS; NEUTRAL ATOM; NUCLEAR-FUEL; YBA2CU3O7-X; PROPAGATION	The dynamic behavior of an ablation plume in ambient gas has been investigated by laser-induced fluorescence imaging spectroscopy. The second harmonic beam from an Nd:YAG laser (0.5-6 J/cm(2)) was focused on a sintered oxide pellet or a metal chip of gadolinium. The produced plume was subsequently intersected with a sheet-shaped UV beam from a dye laser so that time-resolved fluorescence images were acquired with an intensified CCD camera at various delay times. The obtained cross-sectional images of the plume indicate that the ablated ground state atoms and ions of gadolinium accumulate in a hemispherical contact layer between the plume and the ambient gas, and a cavity containing a smaller density of ablated species is formed near the center of the plume. At earlier expansion stage, another luminous component also expands in the cavity so that it coalesces into the hemispherical layer. The splitting and coalescence for atomic plume occur later than those for ionic plume. Furthermore, the hemispherical layer of neutral atoms appears later than that of ions; however, the locations of the layers are nearly identical. This coincidence of the appearance locations of the layers strongly suggests that the neutral atoms in the hemispherical layer are produced as a consequence of three-body recombination of ions through collisions with gas atoms. The obtained knowledge regarding plume expansion dynamics and detailed plume structure is useful for optimizing the experimental conditions for ablation-based spectroscopic analysis. (C) 2015 Elsevier B.V. All rights reserved.	[Miyabe, M.; Oba, M.; Iimura, H.; Akaoka, K.; Khumaeni, A.; Kato, M.; Wakaida, I.] Japan Atom Energy Agcy, CLADS, Fuel Debris Anal Grp, Tokai, Ibaraki 3191195, Japan	Miyabe, M (reprint author), Shirakata 2-4, Tokai, Ibaraki 3191195, Japan.						AHMAD SA, 1979, SPECTROCHIM ACTA B, V34, P221, DOI 10.1016/0584-8547(79)80010-5; Ali K., 2013, OPT EXPRESS, V21, P29755; Amoruso S, 2006, EUROPHYS LETT, V76, P436, DOI 10.1209/epl/i2006-10296-0; Bulgakova NM, 2000, PHYS REV E, V62, P5624, DOI 10.1103/PhysRevE.62.5624; Rifai K, 2013, J ANAL ATOM SPECTROM, V28, P388, DOI 10.1039/c3ja30308j; Rehse SJ, 2009, SPECTROCHIM ACTA B, V64, P974, DOI 10.1016/j.sab.2009.07.024; Ngom BD, 2011, J PHYS CHEM SOLIDS, V72, P1218, DOI 10.1016/j.jpcs.2011.07.006; Telle HH, 2001, SPECTROCHIM ACTA B, V56, P947, DOI 10.1016/S0584-8547(01)00190-2; Liu Y, 2012, SPECTROCHIM ACTA B, V73, P89, DOI 10.1016/j.sab.2012.06.041; Russo RE, 2002, TALANTA, V57, P425, DOI 10.1016/S0039-9140(02)00053-X; GEOHEGAN DB, 1992, APPL PHYS LETT, V60, P2732, DOI 10.1063/1.106859; Ma QL, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4829628; Amoruso S, 2008, APPL PHYS A-MATER, V92, P907, DOI 10.1007/s00339-008-4591-2; Aguilera JA, 2002, APPL SURF SCI, V197, P273, DOI 10.1016/S0169-4332(02)00382-3; Aragon C, 2008, SPECTROCHIM ACTA B, V63, P893, DOI 10.1016/j.sab.2008.05.010; Tampo M, 2014, J ANAL ATOM SPECTROM, V29, P886, DOI 10.1039/c3ja50259g; Hahn Y, 1997, REP PROG PHYS, V60, P691, DOI 10.1088/0034-4885/60/7/001; Itina TE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066406; Babushok VI, 2006, SPECTROCHIM ACTA B, V61, P999, DOI 10.1016/j.sab.2006.09.003; Bai XS, 2013, SPECTROCHIM ACTA B, V87, P27, DOI 10.1016/j.sab.2013.05.019; Wood RF, 1997, PHYS REV LETT, V79, P1571, DOI 10.1103/PhysRevLett.79.1571; Bulgakov AV, 1998, J PHYS D APPL PHYS, V31, P693, DOI 10.1088/0022-3727/31/6/017; Tognoni E, 2014, J ANAL ATOM SPECTROM, V29, P1318, DOI 10.1039/c4ja00033a; Lui SL, 2003, SPECTROCHIM ACTA B, V58, P1613, DOI 10.1016/S0584-8547(03)00139-3; KELLY R, 1988, SURF SCI, V198, P263, DOI 10.1016/0039-6028(88)90483-9; Dutouquet C, 2001, J PHYS D APPL PHYS, V34, P3356, DOI 10.1088/0022-3727/34/23/306; Grojo D, 2005, J APPL PHYS, V97, DOI [10.1063/1.1861519, 10.1063/1.1851519]; Harilal SS, 2003, J APPL PHYS, V93, P2380, DOI 10.1063/1.1544070; Shimada Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1856697; Aragon C, 2004, APPL PHYS A-MATER, V79, P1145, DOI 10.1007/s00339-004-2689-8; Arnold N, 1999, APPL PHYS A-MATER, V69, pS87, DOI 10.1007/s003399900183; Nassef OA, 2005, SPECTROCHIM ACTA B, V60, P1564, DOI 10.1016/j.sab.2005.10.010; Bogaerts A, 2006, J ANAL ATOM SPECTROM, V21, P384, DOI 10.1039/b514313f; Bulgakov AV, 1996, APPL SURF SCI, V96-8, P159, DOI 10.1016/0169-4332(95)00472-6; Bushaw BA, 2009, SPECTROCHIM ACTA B, V64, P1259, DOI 10.1016/j.sab.2009.10.002; CAPPELLI MA, 1990, APPL PHYS LETT, V56, P1715, DOI 10.1063/1.103124; Chrisey D.B., 1994, PULSED LASER DEPOSIT; Cremers D. A., 2006, HDB LASER INDUCED BR; De Giacomo A, 2008, SPECTROCHIM ACTA B, V63, P980, DOI 10.1016/j.sab.2008.06.010; De Giacomo A, 2003, SPECTROCHIM ACTA B, V58, P71, DOI 10.1016/S0584-8547(02)00234-3; Den Hartog E.A., 2011, J PHYS B ATOM MOL PH, V44; GILGENBACH RM, 1991, APPL PHYS LETT, V58, P1597, DOI 10.1063/1.105136; Gonzalo J, 1997, J APPL PHYS, V81, P951, DOI 10.1063/1.364188; Gornushkin IB, 1999, SPECTROCHIM ACTA B, V54, P1207, DOI 10.1016/S0584-8547(99)00064-6; Han M, 2002, PHYS LETT A, V302, P182, DOI 10.1016/S0375-9601(02)01116-7; Itina TE, 2003, APPL SURF SCI, V208, P27, DOI 10.1016/S0169-4332(02)01280-1; Kokai F, 2000, J PHYS CHEM B, V104, P6777, DOI 10.1021/jpc000359+; Kortenbruck F.H., 2001, SPECTROCHIM ACTA B, V56, P933; Liu H, 2002, SPECTROCHIM ACTA B, V57, P1611, DOI 10.1016/S0584-8547(02)00105-2; Martin GW, 1998, APPL SURF SCI, V127, P710, DOI 10.1016/S0169-4332(97)00730-7; Misra A, 1999, APPL PHYS LETT, V74, P929, DOI 10.1063/1.123412; Miyabe M, 1998, J PHYS B-AT MOL OPT, V31, P4559, DOI 10.1088/0953-4075/31/20/014; Miyabe M, 2013, APPL PHYS A-MATER, V112, P87, DOI 10.1007/s00339-012-7181-2; Miyabe M, 2012, J APPL PHYS, V112, DOI 10.1063/1.4771879; Miyabe M, 2010, APPL PHYS A-MATER, V101, P65, DOI 10.1007/s00339-010-5760-7; Nakata Y, 1996, J APPL PHYS, V80, P2458, DOI 10.1063/1.363082; Namba S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2190715; Odintsova N. K., 1976, Optics and Spectroscopy, V41; PREDTECHENSKY MR, 1993, APPL SUPERCOND, V1, P2011, DOI 10.1016/0964-1807(93)90349-7; SAPPEY AD, 1992, J APPL PHYS, V72, P5095, DOI 10.1063/1.352039; Sasaki K, 2002, J APPL PHYS, V92, P6471, DOI 10.1063/1.1518135; Schechter I, 2006, LASER-INDUCED BREAKDOWN SPECTROSCOPY (LIBS): FUNDAMENTALS AND APPLICATIONS, P40; Taylor N, 2008, J QUANT SPECTROSC RA, V109, P2561, DOI 10.1016/j.jqsrt.2008.05.007; Taylor NR, 2014, OPT LETT, V39, P594, DOI 10.1364/OL.39.000594; Yamagata Y, 1998, THIN SOLID FILMS, V316, P56, DOI 10.1016/S0040-6090(98)00388-5; Zhang ZG, 2001, EUR PHYS J D, V13, P301, DOI 10.1007/s100530170245	66	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	AUG 1	2015	110						101	117		10.1016/j.sab.2015.06.004		17	Spectroscopy	Spectroscopy	CN9YS	WOS:000358807700015		
J	Takemura, R				Takemura, Ryo			Counter-Example Construction with Euler Diagrams	STUDIA LOGICA			English	Article						Mathematical logic; Completeness; Euler diagrams	LOGIC	One of the traditional applications of Euler diagrams is as a representation or counterpart of the usual set-theoretical models of given sentences. However, Euler diagrams have recently been investigated as the counterparts of logical formulas, which constitute formal proofs. Euler diagrams are rigorously defined as syntactic objects, and their inference systems, which are equivalent to some symbolic logical systems, are formalized. Based on this observation, we investigate both counter-model construction and proof-construction in the framework of Euler diagrams. We introduce the notion of "counter-diagrammatic proof", which shows the invalidity of a given inference, and which is defined as a syntactic manipulation of diagrams of the same sort as inference rules to construct proofs. Thus, in our Euler diagrammatic framework, the completeness theorem can be formalized in terms of the existence of a diagrammatic proof or a counter-diagrammatic proof.	Nihon Univ, Coll Commerce, Setagaya Ku, Tokyo 1578570, Japan	Takemura, R (reprint author), Nihon Univ, Coll Commerce, Setagaya Ku, 5-2-1 Kinuta, Tokyo 1578570, Japan.	takemura@abelard.flet.keio.ac.jp					Allwein G., 1996, OXFORD STUDIES LOGIC; Cohn AG, 2001, FUND INFORM, V46, P1; Hammer E, 1998, HIST PHILOS LOGIC, V19, P1, DOI 10.1080/01445349808837293; Cohn AG, 2008, FOUND ARTIF INTELL, P551, DOI 10.1016/S1574-6526(07)03013-1; Barwise J., 1993, TARSKIS WORLD; Barwise J., LOGIC PROOF RE UNPUB; Barwise J., 1995, CTR STUDY LANGUAGE I, V42; Chen J., 2013, KNOWL ENG REV, P1, DOI DOI 10.1017/S0269888913000350; Howse J., 2005, LMS J COMPUT MATH, V8, P145; Mineshima Koji, 2012, Journal of Logic, Language and Information, V21, DOI 10.1007/s10849-012-9160-6; Mineshima K., 2009, CEUR SERIES, V510, P37; Peirce C. S., 1933, COLLECTED PAPERS CS, V4; RANDELL DA, 1992, PRINCIPLES OF KNOWLEDGE REPRESENTATION AND REASONING: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE (KR 92), P165; Shin S.-J., 1994, LOGICAL STATUS DIAGR; Takemura R, 2013, STUD LOGICA, V101, P157, DOI 10.1007/s11225-012-9370-6; Takemura R., 2013, J HUMANITIES SCI NIH, V19, P23	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0039-3215			STUD LOGICA	Stud. Log.	AUG	2015	103	4					669	696		10.1007/s11225-014-9584-x		28	Mathematics; Logic; Philosophy	Mathematics; Science & Technology - Other Topics; Philosophy	CN7BN	WOS:000358588600001		
J	Sakai, T; Seto, K; Tamaki, S				Sakai, Takayuki; Seto, Kazuhisa; Tamaki, Suguru			Solving Sparse Instances of Max SAT via Width Reduction and Greedy Restriction	THEORY OF COMPUTING SYSTEMS			English	Article						Exponential time algorithm; Polynomial space; Weight; Hard constraint; Counting	OPTIMAL 2-CONSTRAINT SATISFACTION; EXACT ALGORITHMS; CLAUSE DENSITY; UPPER-BOUNDS; SATISFIABILITY; FORMULAS; FASTER; COMPLEXITY; MAX-2-SAT; 2-CSP	We present a moderately exponential time and polynomial space algorithm for sparse instances of Max SAT. Our algorithms run in time of the form for instances with n variables and cn clauses. Our deterministic and randomized algorithm achieve and respectively. Previously, an exponential space deterministic algorithm with was shown by Dantsin and Wolpert [SAT 2006] and a polynomial space deterministic algorithm with was shown by Kulikov and Kutzkov [CSR [2007]]. Our algorithms have three new features. They can handle instances with (1) weights and (2) hard constraints, and also (3) they can solve counting versions of Max SAT. Our deterministic algorithm is based on the combination of two techniques, width reduction of Schuler and greedy restriction of Santhanam. Our randomized algorithm uses random restriction instead of greedy restriction.	[Sakai, Takayuki; Tamaki, Suguru] Kyoto Univ, Sakyo Ku, Kyoto 6068501, Japan; [Seto, Kazuhisa] Seikei Univ, Musashino, Tokyo 1808633, Japan	Seto, K (reprint author), Seikei Univ, Musashino, Tokyo 1808633, Japan.	tsakai@kuis.kyoto-u.ac.jp; seto@st.seikei.ac.jp; tamak@kuis.kyoto-u.ac.jp			MEXT KAKENHI [24106001, 24106003]; JSPS KAKENHI [26730007, 25240002, 26330011]	We would like to thank the anonymous referee for the helpful comments on an earlier version of this paper. KS was supported in part by MEXT KAKENHI (24106001, 24106003); JSPS KAKENHI (26730007). ST was supported in part by MEXT KAKENHI (24106003); JSPS KAKENHI (25240002, 26330011).	Koivisto M, 2006, INFORM PROCESS LETT, V98, P24, DOI 10.1016/j.ipl.2005.11.013; Santhanam R, 2010, ANN IEEE SYMP FOUND, P183, DOI 10.1109/FOCS.2010.25; Calabro C, 2009, LECT NOTES COMPUT SC, V5917, P75; Kulikov AS, 2007, LECT NOTES COMPUT SC, V4649, P194; Hirsch EA, 2000, LECT NOTES COMPUT SC, V1770, P65; Calabro C, 2006, ANN IEEE CONF COMPUT, P252; Impagliazzo R, 2013, ANN IEEE SYMP FOUND, P479, DOI 10.1109/FOCS.2013.58; Dantsin E, 2006, LECT NOTES COMPUT SC, V4121, P266; Gramm J, 2003, DISCRETE APPL MATH, V130, P139, DOI 10.1016/S0166-218X(02)00402-X; Chen JE, 2004, DISCRETE APPL MATH, V142, P17, DOI 10.1016/j.dam.2003.03.002; Mahajan M, 1999, J ALGORITHM, V31, P335, DOI 10.1006/jagm.1998.0996; Gaspers S, 2012, J COMPUT SYST SCI, V78, P305, DOI 10.1016/j.jcss.2011.05.010; HOROWITZ E, 1974, J ACM, V21, P277, DOI 10.1145/321812.321823; Williams R, 2005, THEOR COMPUT SCI, V348, P357, DOI 10.1016/j.tcs.2005.09.023; Scott AD, 2007, DISCRETE OPTIM, V4, P260, DOI 10.1016/j.disopt.2007.08.001; Schuler R, 2005, J ALGORITHMS, V54, P40, DOI 10.1016/j.jalgor.2004.04.012; BANSAL N, 1999, LECT NOTES COMPUTER, V1741, P247; Binkele-Raible Daniel, 2010, Journal of Discrete Algorithms, V8, DOI 10.1016/j.jda.2010.06.001; BLIZNETS I, 2012, LNCS, V7535, P37; Chen R., 2014, P 29 ANN IEEE C COMP, P262; Gramm J, 2000, LECT NOTES COMPUT SC, V1767, P174; GUTIN G, 2012, LNCS, V7370, P257; Hastad J., 1998, J COMPUT, V27, P48; Hirsch EA, 2003, DISCRETE APPL MATH, V130, P173, DOI 10.1016/S0166-218X(02)00404-3; Impagliazzo R., 2012, P 23 ANN ACM SIAM S, P961; Kneis J, 2005, LECT NOTES COMPUT SC, V3618, P568; Kneis J, 2009, SIAM J DISCRETE MATH, V23, P407, DOI 10.1137/080715482; Kojevnikov A, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P11, DOI 10.1145/1109557.1109559; Kulikov AS, 2005, LECT NOTES COMPUT SC, V3569, P430; Niedermeier R, 2000, J ALGORITHMS, V36, P63, DOI 10.1006/jagm.2000.1075; Scott AD, 2003, LECT NOTES COMPUT SC, V2764, P382; Seto K, 2013, COMPUT COMPLEX, V22, P245, DOI [10.1007/s00037-013-0067-7, 10.1007/s00037-013-0067-9]; Williams R., 2014, J ACM, V61, P1	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-4350	1433-0490		THEOR COMPUT SYST	Theor. Comput. Syst.	AUG	2015	57	2					426	443		10.1007/s00224-014-9600-6		18	Computer Science, Theory & Methods; Mathematics	Computer Science; Mathematics	CN9BM	WOS:000358740800006		
J	Ieda, N; Bui, QV; Nguyen, NTD; Lapar, L; Marshall, K				Ieda, Nahoko; Quang Van Bui; Nga Thi Duong Nguyen; Lapar, Lucy; Marshall, Karen			Characterization of smallholder pig breeding practices within a rural commune of North Central Vietnam	TROPICAL ANIMAL HEALTH AND PRODUCTION			English	Article						Smallhold pig production; North Central Vietnam; Mong Cai; Household survey; Animal-level survey	PRODUCTION SYSTEMS; MONG-CAI; PERFORMANCE	This case study focused on a pig production system in a rural area of North Central Vietnam, with a focus on describing household pig breeding practices and estimating herd demographic parameters, particularly on reproduction. One hundred five households undertaking small-scale piglet production were surveyed, with information gathered on 3268 individual pigs. Pig keeping contributed variably to the overall household livelihood portfolio, with female household members as the main decision makers, contributors to labor, and beneficiaries of income from the pig enterprise. All households kept between one and four young or adult sows, with 69 % of these sows of a local breed type (predominantly Mong Cai), 28 % a cross between a local sow and an exotic sow (predominantly Large White), and the remainder (3 %) as exotic sows. Eighty-eight percent of the piglets produced were cross-bred, while 12 % were local breed. No adult males were kept by the surveyed households, reflecting the common use of artificial insemination for mating purposes. The most common breeding system practiced-the keeping of Mong Cai females and production of cross-bred piglets-capitalizes on the small body size and high fecundity of the sows and the fast growth rate and leanness of the cross-bred piglets. The survey tool used, which was based on farmer recall of events over the preceding 12-month period, appeared to give reasonable results although some recall bias could be detected. This case study will serve as an entry point to planned broader scale characterization and development of pig breeding systems in North Central Vietnam.	[Ieda, Nahoko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Quang Van Bui; Nga Thi Duong Nguyen] Hanoi Univ Agr, Hanoi, Vietnam; [Lapar, Lucy; Marshall, Karen] Int Livestock Res Inst, Nairobi, Kenya	Marshall, K (reprint author), Int Livestock Res Inst, POB 30709-00100, Nairobi, Kenya.	k.marshall@cgiar.org					Roessler R, 2009, LIVEST SCI, V123, P241, DOI 10.1016/j.livsci.2008.11.022; Dang-Nguyen TQ, 2010, J REPROD DEVELOP, V56, P31; Duc N.V., 1997, P ASS ADV AN BREED G, V12, P185; Duyet H.N., 2003, EFFECT HIGH DIETARY, P15; FAO, 2005, LIV SECT BRIEF; Huyen L.T.T., 2005, C INT AGR RES DEV ST; ILRI CIAT ICARDA and Centre W, 2011, MOR MEAT MILK FISH P; Lapar M.L., 2012, P INT ASS AGR EC IAA; Lemke U, 2007, TROP ANIM HEALTH PRO, V39, P237, DOI 10.1007/s11250-007-9001-9; Lemke U, 2006, LIVEST SCI, V105, P229, DOI 10.1016/j.livsci.2006.06.012; Len NT, 2008, ASIAN AUSTRAL J ANIM, V21, P245; Lesnoff M., 2010, 12MO CROSS SECTIONAL; Ngoc TTB, 2013, ANIMAL, V7, P736, DOI 10.1017/S1751731112002169; Sivilai B., 2010, Livestock Research for Rural Development, V22, P79; Thuy L.T., 2012, STUDY MODEL EXPT BAN; Tu PK, 2010, ASIAN AUSTRAL J ANIM, V23, P385; Van V.T.K., 1999, P ASS ADVMT ANIM BRE, V13, P153	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-4747	1573-7438		TROP ANIM HEALTH PRO	Trop. Anim. Health Prod.	AUG	2015	47	6					1005	1016		10.1007/s11250-015-0817-4		12	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CN8BN	WOS:000358662100001		
J	Haji, IJ; Sugimoto, C; Kajino, K; Malele, I; Simukoko, H; Chitambo, H; Namangala, B				Haji, Isihaka Juma; Sugimoto, Chihiro; Kajino, Kiichi; Malele, Imna; Simukoko, Humphrey; Chitambo, Harrison; Namangala, Boniface			Determination of the prevalence of trypanosome species in cattle from Monduli district, northern Tanzania, by loop mediated isothermal amplification	TROPICAL ANIMAL HEALTH AND PRODUCTION			English	Article						BAT; HAT; Indigenous cattle; LAMP; Microscopy; Trypanosomes; Monduli district; Tanzania	HUMAN AFRICAN TRYPANOSOMIASIS; BRUCEI-RHODESIENSE; SLEEPING-SICKNESS; ZAMBEZI VALLEYS; RAPID DETECTION; EASTERN ZAMBIA; LAMP; DIAGNOSIS; UGANDA; RESISTANCE	Bovine African trypanosomosis (BAT) remains one of the major vector-borne diseases with serious impediment to cattle production and economic advancement in sub-Saharan Africa. The present study evaluated the performance of the trypanosome-species-specific loop-mediated isothermal amplification (LAMP), using parasite DNA obtained from 295 indigenous Tanzanian short horn Zebu (TSHZ) and Boran crosses in Monduli district within northern Tanzania, against routine microscopy on Giemsa-stained blood films. Compared to parasitological data in which the prevalence of BAT was estimated at 2.4 % (95 % CI 0.7-4.1 %), LAMP increased the prevalence to 27.8 % (95 % CI 22.3-32.5 %), of which 11.9 % (95 % CI 8.2-15.6 %) were monolytic infections with Trypanosoma vivax, while 13.6 % (95 % CI 9.7-17.5 %) were coinfections of either T. vivax and Trypanosoma brucei subspecies or T. vivax and Trypanosoma congolense, respectively. Among the T. brucei subspecies detected, 0.7 % (95 % CI 0-1.7 %) were human-infective Trypanosoma brucei rhodesiense. Our study is in concordance with previous reports and suggests that LAMP is a potential tool for routine diagnosis of trypanosomes in domestic animals in BAT endemic regions. According to LAMP, T. vivax seems to be the predominant trypanosome species circulating among the indigenous Monduli cattle. Importantly, the detection of T. b. rhodesiense in cattle in such wildlife-domestic-animal-human-interface areas poses a risk of contracting human African trypanosomiasis (HAT) by local communities and tourists. Continuous trypanosome surveillances in domestic animals, humans, and tsetse flies using sensitive and specific tests such as LAMP are recommended.	[Haji, Isihaka Juma] Reg Commissioners Off, Dept Econ & Prod Sect, Arusha, Tanzania; [Sugimoto, Chihiro; Kajino, Kiichi] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Malele, Imna] Tsetse & Trypanosomosis Res Inst, Tanga, Tanzania; [Simukoko, Humphrey] Univ Zambia, Sch Vet Med, Dept Biomed Studies, Lusaka, Zambia; [Chitambo, Harrison; Namangala, Boniface] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia	Namangala, B (reprint author), Univ Zambia, Sch Vet Med, Dept Paraclin Studies, POB 32379, Lusaka, Zambia.	boniface_1020@yahoo.com	Sugimoto, Chihiro/F-6583-2012	Sugimoto, Chihiro/0000-0002-8708-0140	Southern Africa Centre for Infectious Disease Surveillance (SACIDS)	This study received financial support from the Southern Africa Centre for Infectious Disease Surveillance (SACIDS). The authors would also like to thank the Monduli farmers, the Department of Livestock and Fisheries in Monduli district council, the technical staff at Tanzania veterinary laboratory agency (TVLA) Arusha center, and the University of Zambia, School of Veterinary Medicine, for their assistance and support.	Ahmed HA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-316; Taylor KA, 1998, INT J PARASITOL, V28, P219, DOI 10.1016/S0020-7519(97)00154-9; von Wissmann B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000941; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Thekisoe OMM, 2007, ACTA TROP, V102, P182, DOI 10.1016/j.actatropica.2007.05.004; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Laohasinnarong D, 2011, PARASITOL RES, V109, P1735, DOI 10.1007/s00436-011-2513-2; Namangala B, 2013, AM J TROP MED HYG, V89, P116, DOI 10.4269/ajtmh.13-0078; Simuunza M, 2011, VET PARASITOL, V175, P331, DOI 10.1016/j.vetpar.2010.09.027; Simukoko H, 2007, VET PARASITOL, V147, P231, DOI 10.1016/j.vetpar.2007.04.005; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; [Anonymous], 2013, PARASITE VECTOR; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; Coleman PG, 2004, TRENDS PARASITOL, V20, P311, DOI 10.1016/j.pt.2004.04.016; Haji IJ, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i1.843; Kibona S. N., 2002, TANZANIA HLTH RES B, V4, P27; Lisulo M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-19; Majekodunmi A. O., 2011, TRENDS PARASITOL, V27, P394; Matovu E, 2010, J CLIN MICROBIOL, V48, P2087, DOI 10.1128/JCM.00101-10; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Namangala B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-282; Njiru Z. K., 2011, VET PARASITOLOGY, DOI 10.1016; Njiru ZK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000147; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Selby R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-281; Swai E. S., 2012, Veterinary World, V5, P459; Van den Bossche P, 1999, ONDERSTEPOORT J VET, V66, P103; von Wissmann B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002931	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-4747	1573-7438		TROP ANIM HEALTH PRO	Trop. Anim. Health Prod.	AUG	2015	47	6					1139	1143		10.1007/s11250-015-0840-5		5	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CN8BN	WOS:000358662100019		
J	Wada, N; Tachibana, D; Kurihara, Y; Nakagawa, K; Nakano, A; Terada, H; Tanaka, K; Fukui, M; Koyama, M; Hecher, K				Wada, N.; Tachibana, D.; Kurihara, Y.; Nakagawa, K.; Nakano, A.; Terada, H.; Tanaka, K.; Fukui, M.; Koyama, M.; Hecher, K.			Alterations in time intervals of ductus venosus and atrioventricular flow velocity waveforms in growth-restricted fetuses	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article						cardiac cycle; Doppler; ductus venosus; intrauterine growth restriction; time-related analysis	TWIN TRANSFUSION SYNDROME; VEIN BLOOD-FLOW; REFERENCE RANGES; RETARDED FETUS; DOPPLER; RESISTANCE; ULTRASOUND	Objective To investigate time intervals of the ductus venosus (DV) flow velocity waveform (FVW) and those of the cardiac cycle that correspond with each DV-FVW component in fetuses with intrauterine growth restriction (IUGR) due to placental insufficiency. Methods Women with a pregnancy complicated by IUGR were recruited into the study, as was a normal control group. Time intervals for systolic (S) and diastolic (D) components were measured in DV-FVW as follows: SDV, from the nadir of the a-wave during atrial contraction to the nadir between the S-wave and D-wave; DDV, from the nadir between S-wave and D-wave to the nadir of the a-wave. Regarding cardiac cycles, the following variables were measured from ventricular inflow through the tricuspid valve (TV) and mitral valve (MV): STV and SMV, from the second peak of ventricular inflow caused by atrial contraction (A-wave) to the opening of the atrioventricular valve; DTV and DMV, from the opening of the atrioventricular valve to the peak of the A-wave. In the IUGR group, only the last examination performed within 1 week of delivery was used for analysis. All variables were analyzed statistically using Z-scores. Results Data were obtained from 249 normal fetuses and 26 fetuses with IUGR. Compared to normal fetuses, SDV showed a significant decrease (P < 0.001), while DDV showed a significant increase (P < 0.001) in the IUGR group. Regarding cardiac cycles, STV and SMV showed significant decreases (P = 0.014 and P < 0.001, respectively) and DTV and DMV showed significant increases (P = 0.008 and P = 0.002, respectively) in fetuses with IUGR. Conclusion Time-interval alterations of DV-FVW in growth-restricted fetuses reflect the hemodynamic events caused by placental insufficiency. Copyright (C) 2014 ISUOG. Published by John Wiley & Sons Ltd.	[Wada, N.; Tachibana, D.; Kurihara, Y.; Nakagawa, K.; Nakano, A.; Terada, H.; Koyama, M.] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka, Osaka 5458585, Japan; [Tanaka, K.] Osaka City Gen Hosp, Dept Obstet & Gynecol, Osaka, Japan; [Fukui, M.] Osaka City Univ, Grad Sch Med, Stat Lab, Osaka, Osaka 5458585, Japan; [Hecher, K.] Univ Med Ctr, Dept Obstet & Fetal Med, Hamburg, Germany	Tachibana, D (reprint author), Osaka City Univ, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka, Osaka 5458585, Japan.	dtachibana@med.osaka-cu.ac.jp					HECHER K, 1995, AM J OBSTET GYNECOL, V173, P10, DOI 10.1016/0002-9378(95)90161-2; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Tachibana D, 2015, ULTRASOUND OBST GYN, V45, P544, DOI 10.1002/uog.13449; Rigano S, 2001, AM J OBSTET GYNECOL, V185, P834, DOI 10.1067/mob.2001.117356; HECHER K, 1994, ULTRASOUND OBST GYN, V4, P381, DOI 10.1046/j.1469-0705.1994.04050381.x; Hecher K, 2001, ULTRASOUND OBST GYN, V18, P564, DOI 10.1046/j.0960-7692.2001.00590.x; Ferrazzi E, 2000, ULTRASOUND OBST GYN, V16, P432, DOI 10.1046/j.1469-0705.2000.00208.x; Nakagawa K, 2012, PRENATAL DIAG, V32, P803, DOI 10.1002/pd.3908; Baschat AA, 2004, AM J OBSTET GYNECOL, V191, P277, DOI 10.1016/j.ajog.2003.11.028; Bensouda B, 2007, ULTRASOUND OBST GYN, V30, P983, DOI 10.1002/uog.5161; Hecher K, 1996, ULTRASOUND OBST GYN, V7, P68, DOI 10.1046/j.1469-0705.1996.07010068.x; KISERUD T, 1991, LANCET, V338, P1412, DOI 10.1016/0140-6736(91)92720-M; KISERUD T, 1994, ULTRASOUND OBST GYN, V4, P109, DOI 10.1046/j.1469-0705.1994.04020109.x; KISERUD T, 1992, ULTRASOUND OBST GYN, V2, P389, DOI 10.1046/j.1469-0705.1992.02060389.x; SATOH S, 1989, EARLY HUM DEV, V20, P213, DOI 10.1016/0378-3782(89)90007-8; SHINOZUKA N, 1987, AM J OBSTET GYNECOL, V157, P1140; Turam OM, 2008, ULTRASOUND OBST GYN, V32, P160, DOI 10.1002/uog.5386	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	AUG	2015	46	2					221	226		10.1002/uog.14717		6	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CN8UY	WOS:000358721700015		
J	Sakae, C; Sato, Y; Taga, A; Satake, Y; Emoto, I; Maruyama, S; Kim, T				Sakae, C.; Sato, Y.; Taga, A.; Satake, Y.; Emoto, I.; Maruyama, S.; Kim, T.			Ultrasound-guided percutaneous aspiration of hyperreactio luteinalis avoids laparoscopic untwisting of ovarian torsion	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article						acute abdomen; detorsion; functional ovarian cyst; hydrops fetalis; laparoscopy	PREGNANCY	Hyperreactio luteinalis (HL) is characterized by multicystic bilateral enlargement of the ovaries and is a self-limiting benign condition associated with pregnancy or trophoblastic disease. Since HL regresses spontaneously over time, it should be managed conservatively as long as the patient's condition permits; torsion of the enlarged ovaries is believed to be the only exception that mandates surgical intervention. Here, we describe a case of HL complicated by ovarian torsion that was treated successfully without surgical intervention. A 33-year-old woman was admitted to our hospital owing to acute abdomen. Nine days previously, she had had a stillbirth caused by hydrops fetalis at 24 weeks' gestation. The characteristic findings observed on magnetic resonance imaging (MRI) led to the diagnosis of HL complicated by torsion of the enlarged left ovary. Emergency laparoscopic detorsion of the ischemic left ovary was planned. Aiming to reduce the risk of cystic injury and bleeding at the trocar insertion site, volume reduction of the left ovarian cyst was performed by percutaneous aspiration. The patient's pain diminished rapidly and laparoscopic surgery was deferred. Subsequent MRI revealed that gadolinium enhancement of the left ovarian tumor had been restored, indicating spontaneous detorsion of the left ovary. The patient remained asymptomatic and was discharged from the hospital 12 days after aspiration of the cyst. From this experience, we propose that, in cases of ovarian torsion occurring in large functional cysts, including HL, volume reduction by percutaneous cyst aspiration should be considered before performing emergency laparoscopic surgery. Copyright (C) 2015 ISUOG. Published by John Wiley & Sons Ltd.	[Sakae, C.; Sato, Y.; Taga, A.; Satake, Y.; Emoto, I.; Maruyama, S.; Kim, T.] Otsu Red Cross Hosp, Dept Obstet & Gynecol, Otsu, Shiga 5208511, Japan	Sato, Y (reprint author), Otsu Red Cross Hosp, Dept Obstet & Gynecol, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan.	yukiyasu@kuhp.kyoto-u.ac.jp					Oelsner G, 2006, CLIN OBSTET GYNECOL, V49, P459, DOI 10.1097/00003081-200609000-00006; Huchon C, 2010, EUR J OBSTET GYN R B, V150, P8, DOI 10.1016/j.ejogrb.2010.02.006; Cavoretto P, 2014, EUR J OBSTET GYN R B, V176, P10, DOI 10.1016/j.ejogrb.2014.02.017; Cohen Shlomo B, 2003, JSLS, V7, P295; Germeyer Ariane, 2009, Gynaekologisch-Geburtshilfliche Rundschau, V49, P331, DOI 10.1159/000301113; Grgic O, 2008, FERTIL STERIL, V90; Lynn KN, 2013, J ULTRAS MED, V32, P1285, DOI 10.7863/ultra.32.7.1285; McGovern P G, 1999, Obstet Gynecol Surv, V54, P601, DOI 10.1097/00006254-199909000-00025; Upadhyaya Geetika, 2004, Emerg Med Australas, V16, P476, DOI 10.1111/j.1742-6723.2004.00654.x; WAJDA KJ, 1989, ARCH PATHOL LAB MED, V113, P921	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	AUG	2015	46	2					243	246		10.1002/uog.14853		4	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CN8UY	WOS:000358721700019		
J	Hiono, T; Ohkawara, A; Ogasawara, K; Okamatsu, M; Tamura, T; Chu, DH; Suzuki, M; Kuribayashi, S; Shichinohe, S; Takada, A; Ogawa, H; Yoshida, R; Miyamoto, H; Nao, N; Furuyama, W; Maruyama, J; Eguchi, N; Ulziibat, G; Enkhbold, B; Shatar, M; Jargalsaikhan, T; Byambadorj, S; Damdinjav, B; Sakoda, Y; Kida, H				Hiono, Takahiro; Ohkawara, Ayako; Ogasawara, Kohei; Okamatsu, Masatoshi; Tamura, Tomokazu; Chu, Duc-Huy; Suzuki, Mizuho; Kuribayashi, Saya; Shichinohe, Shintaro; Takada, Ayato; Ogawa, Hirohito; Yoshida, Reiko; Miyamoto, Hiroko; Nao, Naganori; Furuyama, Wakako; Maruyama, Junki; Eguchi, Nao; Ulziibat, Gerelmaa; Enkhbold, Bazarragchaa; Shatar, Munkhduuren; Jargalsaikhan, Tserenjav; Byambadorj, Selenge; Damdinjav, Batchuluun; Sakoda, Yoshihiro; Kida, Hiroshi			Genetic and antigenic characterization of H5 and H7 influenza viruses isolated from migratory water birds in Hokkaido, Japan and Mongolia from 2010 to 2014	VIRUS GENES			English	Article						Antigenic analysis; Avian influenza; Migratory water birds; Phylogenetic analysis; Surveillance	A VIRUSES; NORTHERN-TERRITORY; DUCKS; POTENCY; CHINA; CHALLENGE; INFECTION; SIBERIA; ASIA	Migratory water birds are the natural reservoir of influenza A viruses. H5 and H7 influenza viruses are isolated over the world and also circulate among poultry in Asia. In 2010, two H5N1 highly pathogenic avian influenza viruses (HPAIVs) were isolated from fecal samples of water birds on the flyway of migration from Siberia, Russia to the south in Hokkaido, Japan. H7N9 viruses are sporadically isolated from humans and circulate in poultry in China. To monitor whether these viruses have spread in the wild bird population, we conducted virological surveillance of avian influenza in migratory water birds in autumn from 2010 to 2014. A total of 8103 fecal samples from migratory water birds were collected in Japan and Mongolia, and 350 influenza viruses including 13 H5 and 19 H7 influenza viruses were isolated. A phylogenetic analysis revealed that all isolates are genetically closely related to viruses circulating among wild water birds. The results of the antigenic analysis indicated that the antigenicity of viruses in wild water birds is highly stable despite their nucleotide sequence diversity but is distinct from that of HPAIVs recently isolated in Asia. The present results suggest that HPAIVs and Chinese H7N9 viruses were not predominantly circulating in migratory water birds; however, continued monitoring of H5 and H7 influenza viruses both in domestic and wild birds is recommended for the control of avian influenza.	[Hiono, Takahiro; Ohkawara, Ayako; Ogasawara, Kohei; Okamatsu, Masatoshi; Tamura, Tomokazu; Chu, Duc-Huy; Suzuki, Mizuho; Kuribayashi, Saya; Shichinohe, Shintaro; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Microbiol Lab, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan; [Takada, Ayato; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido 0600818, Japan; [Takada, Ayato; Ogawa, Hirohito; Yoshida, Reiko; Miyamoto, Hiroko; Nao, Naganori; Furuyama, Wakako; Maruyama, Junki; Eguchi, Nao; Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Ulziibat, Gerelmaa; Enkhbold, Bazarragchaa; Shatar, Munkhduuren; Jargalsaikhan, Tserenjav; Byambadorj, Selenge; Damdinjav, Batchuluun] State Cent Vet Lab, Zaisan 210153, Ulaanbaatar, Mongol Peo Rep	Kida, H (reprint author), Hokkaido Univ, Microbiol Lab, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan.	kida@vetmed.hokudai.ac.jp	Maruyama, Junki/H-7993-2013; Ogawa, Hirohito/F-6918-2012		Global Centers of Excellence Program; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Society for Promotion of Science (JSPS); JSPS [F01]; Strategic Funds for the Promotion of Science and Technology, Japan	We thank Ms. Chika Yamamoto for the kind help in the sampling in Mongolia. We greatly appreciate Dr. Takehiko Saito of the National Institute of Animal Health, Japan for kindly providing A/chicken/Ibaraki/1/2005 (H5N2), A/chicken/Yamaguchi/7/2004 (H5N1), and A/chicken/Kumamoto/1-7/2014 (H5N8). We also thank Dr. Masato Tashiro of the National Institute of Infectious Diseases, Japan for providing A/Anhui/1/2013 (H7N9). We appreciate Dr. Luk S.M. Geraldine of the University of Hong Kong for providing A/peregrine falcon/Hong Kong/810/2009 (H5N1). We also appreciate Dr. Paul Selleck of the Australian Animal Health Laboratory for providing A/chicken/North Korea/7916/2005 (H7N7) and A/chicken/New South Wales/327/1997 (H7N2). We also thank Dr. Ilaria Capua of the Istituto Zooprofilattico Sperimentale delle Venezie for kindly providing A/turkey/Italy/4580/1999 (H7N1). The present work was supported in part by the Global Centers of Excellence Program and Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Society for Promotion of Science (JSPS). The present work was partially supported by the Program for Leading Graduate Schools (F01) from JSPS. The present work was also partially supported by the Strategic Funds for the Promotion of Science and Technology (2011-2013), Japan.	Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Chu DH, 2014, VACCINE, V32, P3473, DOI 10.1016/j.vaccine.2014.04.060; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Shichinohe S, 2013, VET MICROBIOL, V164, P39, DOI 10.1016/j.vetmic.2013.01.041; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; KIDA H, 1980, INFECT IMMUN, V30, P547; Yang ZH, 2000, GENETICS, V155, P431; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Magor KE, 2011, DEV COMP IMMUNOL, V35, P1008, DOI 10.1016/j.dci.2011.02.011; Wu HB, 2014, EMERG INFECT DIS, V20, P1315, DOI 10.3201/eid2008.140339; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Okazaki K, 2000, ARCH VIROL, V145, P885, DOI 10.1007/s007050050681; Kajihara M, 2011, JPN J VET RES, V59, P89; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; KIDA H, 1987, VIROLOGY, V159, P109, DOI 10.1016/0042-6822(87)90353-9; Chaise C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105189; Chen ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107266; Hu TS, 2015, INFECT GENET EVOL, V33, P95, DOI 10.1016/j.meegid.2015.04.016; Isoda N, 2008, ARCH VIROL, V153, P1685, DOI 10.1007/s00705-008-0171-1; Kida Hiroshi, 2008, Global Environmental Research, V12, P9; KIDA H, 1982, VIROLOGY, V122, P38, DOI 10.1016/0042-6822(82)90375-0; KIDA H, 1979, ZBL BAKT-INT J MED M, V244, P135; Manzoor R, 2008, VIRUS GENES, V37, P144, DOI 10.1007/s11262-008-0248-7; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Samad RAA, 2011, JPN J VET RES, V59, P15; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5N1 Evolution Working Group, 2014, VIRUSES, V8, P384; World Organisation for Animal Health, 2015, UPD HIGHL PATH AV IN; Zhao ZM, 2008, J GEN VIROL, V89, P2182, DOI 10.1099/vir.0.2008/001875-0	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	AUG	2015	51	1					57	68		10.1007/s11262-015-1214-9		12	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CN6MI	WOS:000358548500008		
J	Ito, T; Sato, A; Suzaki, K				Ito, Takao; Sato, Akihiko; Suzaki, Koichi			An assemblage of divergent variants of a novel putative closterovirus from American persimmon	VIRUS GENES			English	Article						Closteroviridae; Deep-sequencing analysis; Variants; Persimmon; Phylogenetic analysis	STRAND RNA VIRUSES; JAPANESE PERSIMMON; RUGOSE WOOD; RT-PCR; GRAPEVINE; PROTEINS; ALIGNMENT; LEAFROLL; SEQUENCE; CONSERVATION	Deep-sequencing analysis of nucleic acids extracted from leaf tissue of an American persimmon (Diospyros virginiana L.) and subsequent-sequencing analyses uncovered at least four distinct closterovirus-like molecules. Two complete genomes of 18,569 and 18,030 nucleotides (nt) and partial genomes of 4,899 and 9,019 nt were determined. The two complete genomes encoded 11 potential open reading frames and the characteristic organization of closteroviruses. Among the four genomes, the putative heat shock protein 70 homolog (HSP70h), RNA-dependent RNA polymerase, and coat protein showed 82-85, 72-91, and 84-87 % amino acid sequence identities, respectively. These results suggested that the four identified viruses could be divergent variants in a single host plant. The phylogenetic tree based on HSP70h showed that their closest relative, although distant, is Olive leaf yellowing-associated virus, a putative unassigned member of the family Closteroviridae. The name Persimmon virus B was proposed for this new virus, representing another unassigned member of the family.	[Ito, Takao; Sato, Akihiko; Suzaki, Koichi] Natl Agr & Food Res Org NARO, Grape & Persimmon Res Stn, NARO Inst Fruit Tree Sci NIFTS, Akitsu, Hiroshima 7392494, Japan	Ito, T (reprint author), Natl Agr & Food Res Org NARO, Grape & Persimmon Res Stn, NARO Inst Fruit Tree Sci NIFTS, Akitsu, Hiroshima 7392494, Japan.	itotaka@affrc.go.jp					Dolja VV, 2006, VIRUS RES, V117, P38, DOI 10.1016/j.virusres.2006.02.002; Ito T, 2013, ARCH VIROL, V158, P2629, DOI 10.1007/s00705-013-1772-x; Peng CW, 2001, J VIROL, V75, P12153, DOI 10.1128/JVI.75.24.12153-12160.2001; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Prosser SW, 2007, VIRUS RES, V124, P151, DOI 10.1016/j.virusres.2006.10.014; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Dovas CI, 2003, J VIROL METHODS, V109, P217, DOI 10.1016/S0166-0934(03)00074-0; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; DOLJA VV, 1991, VIROLOGY, V184, P79, DOI 10.1016/0042-6822(91)90823-T; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Nakaune R, 2008, J GEN PLANT PATHOL, V74, P156, DOI 10.1007/s10327-008-0079-3; Martelli GP, 2012, J PLANT PATHOL, V94, P7; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; CANDRESSE T, 1990, RES VIROLOGY, V141, P315, DOI 10.1016/0923-2516(90)90003-2; COHEN Y, 1991, SCI HORTIC-AMSTERDAM, V48, P61, DOI 10.1016/0304-4238(91)90153-P; DIAZRUIZ JR, 1978, PREP BIOCHEM, V8, P1, DOI 10.1080/00327487808068215; El Beaino T, 2005, J PLANT PATHOL, V87, P223; Isogai M, 2013, J GEN PLANT PATHOL, V79, P123, DOI 10.1007/s10327-013-0431-0; Ito T, 2013, J GEN VIROL, V94, P1917, DOI 10.1099/vir.0.054445-0; Martelli G.P., 2012, VIRUS TAXONOMY, P987; Melzer MJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00039; Morelli M., 2012, 22 INT C VIR OTH TRA, P117; Nakaune R, 2008, ARCH VIROL, V153, P969, DOI 10.1007/s00705-008-0073-2; Nakaune R, 2006, J VIROL METHODS, V134, P244, DOI 10.1016/j.jviromet.2006.01.016; Seah YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-235; Sether DM, 2005, PLANT DIS, V89, P450, DOI 10.1094/PD-89-0450	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	AUG	2015	51	1					105	111		10.1007/s11262-015-1202-0		7	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CN6MI	WOS:000358548500013		
J	Sano, K; Okazaki, S; Taniguchi, S; Masangkay, JS; Puentespina, R; Eres, E; Cosico, E; Quibod, N; Kondo, T; Shimoda, H; Hatta, Y; Mitomo, S; Oba, M; Katayama, Y; Sassa, Y; Furuya, T; Nagai, M; Une, Y; Maeda, K; Kyuwa, S; Yoshikawa, Y; Akashi, H; Omatsu, T; Mizutani, T				Sano, Kaori; Okazaki, Sachiko; Taniguchi, Satoshi; Masangkay, Joseph S.; Puentespina, Roberto, Jr.; Eres, Eduardo; Cosico, Edison; Quibod, Nina; Kondo, Taisuke; Shimoda, Hiroshi; Hatta, Yuuki; Mitomo, Shumpei; Oba, Mami; Katayama, Yukie; Sassa, Yukiko; Furuya, Tetsuya; Nagai, Makoto; Une, Yumi; Maeda, Ken; Kyuwa, Shigeru; Yoshikawa, Yasuhiro; Akashi, Hiroomi; Omatsu, Tsutomu; Mizutani, Tetsuya			Detection of a novel herpesvirus from bats in the Philippines	VIRUS GENES			English	Article						Bats; The Philippines; Herpesvirus; Next generation sequencing	HOSTS	Bats are natural hosts of many zoonotic viruses. Monitoring bat viruses is important to detect novel bat-borne infectious diseases. In this study, next generation sequencing techniques and conventional PCR were used to analyze intestine, lung, and blood clot samples collected from wild bats captured at three locations in Davao region, in the Philippines in 2012. Different viral genes belonging to the Retroviridae and Herpesviridae families were identified using next generation sequencing. The existence of herpesvirus in the samples was confirmed by PCR using herpesvirus consensus primers. The nucleotide sequences of the resulting PCR amplicons were 166-bp. Further phylogenetic analysis identified that the virus from which this nucleotide sequence was obtained belonged to the Gammaherpesvirinae subfamily. PCR using primers specific to the nucleotide sequence obtained revealed that the infection rate among the captured bats was 30 %. In this study, we present the partial genome of a novel gammaherpesvirus detected from wild bats. Our observations also indicate that this herpesvirus may be widely distributed in bat populations in Davao region.	[Sano, Kaori; Okazaki, Sachiko; Hatta, Yuuki; Mitomo, Shumpei; Oba, Mami; Katayama, Yukie; Omatsu, Tsutomu; Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Saiwai Ku, Fuchu, Tokyo 1838509, Japan; [Taniguchi, Satoshi] Natl Inst Infect Dis, Dept Virol 1, Special Pathogens Lab, Tokyo 2080011, Japan; [Masangkay, Joseph S.] Univ Philippines Los Banos, Coll Vet Med, Los Banos 4031, Laguna, Philippines; [Puentespina, Roberto, Jr.] Univ Philippines Mindanao, Coll Sci, Bago Oshiro, Davao, Philippines; [Eres, Eduardo; Cosico, Edison; Quibod, Nina] Univ Philippines Los Banos, Museum Nat Hist, Los Banos 4031, Laguna, Philippines; [Kondo, Taisuke; Kyuwa, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Shimoda, Hiroshi; Maeda, Ken] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Microbiol, Yamaguchi 7538515, Japan; [Sassa, Yukiko; Nagai, Makoto] Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Med, Lab Epizootiol,Saiwai Ku, Fuchu, Tokyo 1838509, Japan; [Furuya, Tetsuya] Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Med, Microbiol Lab,Saiwai Ku, Fuchu, Tokyo 1838509, Japan; [Une, Yumi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa 2525201, Japan; [Yoshikawa, Yasuhiro] Chiba Inst Sci, Fac Risk & Crisis Management, Dept Anim Risk Management, Choshi, Chiba 2880025, Japan; [Akashi, Hiroomi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	Kyuwa, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akyuwa@mail.ecc.u-tokyo.ac.jp; tmizutan@cc.tuat.ac.jp		Une, Yumi/0000-0002-2112-1894	Ministry of Education, Science, Sports, and Culture, Japan (JSPS KAKENHI) [25304043]	This work was supported by a grant from the Ministry of Education, Science, Sports, and Culture, Japan (JSPS KAKENHI Grant Number 25304043).	Abdelgawad A, 2014, VET MICROBIOL, V169, P102, DOI 10.1016/j.vetmic.2013.12.011; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Troyer RM, 2014, J VIROL, V88, P3914, DOI 10.1128/JVI.03405-13; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Ehlers B, 2008, J VIROL, V82, P3509, DOI 10.1128/JVI.02646-07; Anthony S. J., 2013, MBIO, V4; Ehlers B, 2010, J GEN VIROL, V91, P630, DOI 10.1099/vir.0.017251-0	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	AUG	2015	51	1					136	139		10.1007/s11262-015-1197-6		4	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CN6MI	WOS:000358548500017		
J	Yamamoto, E; Ito, H; Kitamoto, E; Morinishi, K; Yano, A; Miyoshi, S; Ito, T				Yamamoto, Eiji; Ito, Hiroshi; Kitamoto, Eiji; Morinishi, Keiko; Yano, Atsushi; Miyoshi, Satomi; Ito, Toshihiro			Complete genome sequence of pigeon circovirus detected in racing pigeons in western Japan	VIRUS GENES			English	Article						Pigeon; Circovirus; Genome; Phylogenetic analysis	INFECTION; DISEASE; PCR	We report the genetic analysis of a pigeon circovirus (PiCV/Japan/2/2010) detected in a racing pigeon with diarrheal symptoms in western Japan. Sequencing revealed a genome size of 2,041 bp that contained 3 open reading frames (ORFs), designated V1, C1, and C2, a structure consistent with to those of other pigeon circoviruses. Phylogenetic analyses of the ORF C1 revealed that PiCV/Japan/2/2010 diverges from other Asian pigeon circoviruses, suggesting genetic diversity of pigeon circoviruses in Asia.	[Yamamoto, Eiji; Ito, Hiroshi; Ito, Toshihiro] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Yamamoto, Eiji; Kitamoto, Eiji; Morinishi, Keiko; Yano, Atsushi] Kagawa Prefectural Tobu Livestock Hyg Ctr, Kagawa, Japan; [Miyoshi, Satomi] Kagawa Prefectural Seibu Livestock Hyg Ctr, Kagawa, Japan; [Ito, Hiroshi; Ito, Toshihiro] Tottori Univ, Fac Agr, Dept Vet Publ Hlth, Tottori 6808553, Japan; [Ito, Hiroshi; Ito, Toshihiro] Tottori Univ, Avian Zoonosis Res Ctr, Fac Agr, Tottori 6808553, Japan	Ito, T (reprint author), Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan.	toshiito@muses.tottori-u.ac.jp					Gough RE, 1996, VET REC, V138, P167; Todd D, 2001, VIROLOGY, V286, P354, DOI 10.1006/viro.2001.0985; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Todd D, 2008, RES VET SCI, V84, P311, DOI 10.1016/j.rvsc.2007.03.007; Raue R, 2005, AVIAN PATHOL, V34, P418, DOI 10.1080/03079450500267825; Mase M, 2009, J VET MED SCI, V71, P1239, DOI 10.1292/jvms.71.1239; Abadie J, 2001, AVIAN PATHOL, V30, P149, DOI 10.1080/03079450124811; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666; Csagola A, 2012, VIRUS GENES, V44, P75, DOI 10.1007/s11262-011-0669-6; Franciosini MP, 2005, AVIAN DIS, V49, P340, DOI 10.1637/7334-012705R.1; Duchatel JP, 2005, VET REC, V157, P413; Lee, 2001, J VIROL METHODS, V97, P13; Mase M, 2009, J VET MED SCI, V71, P1101, DOI 10.1292/jvms.71.1101; Raidal SR, 1997, AVIAN PATHOL, V26, P829, DOI 10.1080/03079459708419256; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato Katsuya, 2000, Journal of the Japan Veterinary Medical Association, V53, P446; Woods L.W., 2003, DIS POULTRY, P202; WOODS LW, 1993, J VET DIAGN INVEST, V5, P609	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	AUG	2015	51	1					140	143		10.1007/s11262-015-1211-z		4	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CN6MI	WOS:000358548500018		
J	Sato, G; Kawashima, T; Kiuchi, M; Tohya, Y				Sato, Go; Kawashima, Taketo; Kiuchi, Masahiro; Tohya, Yukinobu			Novel cyclovirus detected in the intestinal contents of Taiwan squirrels (Callosciurus erythraeus thaiwanensis)	VIRUS GENES			English	Article						Cyclovirus; Taiwan squirrel; Alien species; Metagenomic analysis	STRANDED-DNA VIRUSES; PROCYONIS LARVA MIGRANS; GENETIC DIVERSITY; 1ST OUTBREAK; JAPAN; RABBITS; VIROME; FECES; FARM	A novel cyclovirus was identified in the intestinal contents of Taiwan squirrels (Callosciurus erythraeus thaiwanensis) collected in Kanagawa prefecture, Japan, by metagenomic analysis, and was named Taiwan squirrel cyclovirus-1 (TsCyV-1). Phylogenetic analysis showed that TsCyV-1 formed a branch separate from other representative cyclovirus strains. TsCyV-1 is considered to be a new species in the genus Cyclovirus because the criteria for demarcation of cyclovirus species is proposed as nucleotide identities <80 %.	[Sato, Go; Kawashima, Taketo; Kiuchi, Masahiro; Tohya, Yukinobu] Nihon Univ, Lab Vet Microbiol, Dept Vet Med, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Tohya, Y (reprint author), Nihon Univ, Lab Vet Microbiol, Dept Vet Med, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	tohya.yukinobu@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Nihon University	This study was supported in part by a Grant-in Aid for the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and a Grant-in-aid from Nihon University.	Phan TG, 2014, J GEN VIROL, V95, P922, DOI 10.1099/vir.0.061143-0; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Dayaram A, 2014, INFECT GENET EVOL, V22, P134, DOI 10.1016/j.meegid.2014.01.013; Dayaram A, 2012, VIRUS RES, V166, P130, DOI 10.1016/j.virusres.2012.03.009; Sukehiro N, 2013, JPN J INFECT DIS, V66, P189; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Zawar-Reza P, 2014, INFECT GENET EVOL, V26, P132, DOI 10.1016/j.meegid.2014.05.018; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; TAMURA N, 1989, OECOLOGIA, V79, P344, DOI 10.1007/BF00384313; Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Rosario K, 2011, J GEN VIROL, V92, P1302, DOI 10.1099/vir.0.030338-0; Biagini P., 2014, RESTRUCTURING EXPANS, p006a; Cheung AK, 2013, ARCH VIROL, V158, P2157, DOI 10.1007/s00705-013-1701-z; Dayaram A, 2013, J GEN VIROL, V94, P1827, DOI 10.1099/vir.0.052654-0; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Inoue S, 2004, JPN J INFECT DIS, V57, P110; Londono A, 2010, ARCH VIROL, V155, P1033, DOI 10.1007/s00705-010-0674-4; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Padilla-Rodriguez M, 2013, ARCH VIROL, V158, P1389, DOI 10.1007/s00705-013-1606-x; Rybicki EP, 2014, CURR TOP MICROBIOL, V375, P19, DOI 10.1007/82_2011_185; Sasaki M, 2015, J GEN VIROL, V96, P440, DOI 10.1099/vir.0.071209-0; Sato H, 2003, J VET MED SCI, V65, P453, DOI 10.1292/jvms.65.453; Sato H, 2002, PARASITOL INT, V51, P105, DOI 10.1016/S1383-5769(01)00101-5; Tan L.V., 2014, SCI REP, V4, P3967; Tan L.V., 2013, MBIO, V4	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	AUG	2015	51	1					148	151		10.1007/s11262-015-1217-6		4	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CN6MI	WOS:000358548500020		
J	Matsushima, M; Matsunaga, Y				Matsushima, Midori; Matsunaga, Yoshiho			Social Capital and Subjective Well-Being in Japan	VOLUNTAS			English	Article						Social capital; Subjective well-being; Japan	INDIVIDUAL HAPPINESS; LIFE; INCOME; PARTICIPATION; UNEMPLOYMENT; WELFARE; HEALTH; IMPACT; MONEY; HAPPY	This paper empirically examines how and what facets of social capital relate to one's subjective well-being in Japan by using data from the Japan General Survey 2010. It further scrutinises whether the relationship between well-being and volunteering changes throughout one's life course. The result reveals that social capital overall positively correlates with subjective well-being. It further suggests that trust and volunteering have a positive relation to one's subjective well-being, whereas membership did not. It also became apparent that volunteering is associated with one's subjective well-being differently depending on one's life stage measured by age category such that volunteers in their 1950s are less happy than volunteers in their 1960s. The results of analysis therefore suggest that the relationship between volunteering and well-being is not straightforward, and that this issue requires even further investigation.	[Matsushima, Midori; Matsunaga, Yoshiho] Osaka Univ Commerce, Fac Business Adm, Higashiosaka, Osaka, Japan	Matsushima, M (reprint author), Osaka Univ Commerce, Fac Business Adm, 4-1-10 Mikuriyasakae Machi, Higashiosaka, Osaka, Japan.	midori@daishodai.ac.jp					Alois Stutzer, 2002, HAPPINESS EC EC I AF; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Huang HF, 2012, J ECON PSYCHOL, V33, P776, DOI 10.1016/j.joep.2012.02.007; Winkelmann R, 2009, J HAPPINESS STUD, V10, P421, DOI 10.1007/s10902-008-9097-2; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Wollebaek D, 2002, NONPROF VOLUNT SEC Q, V31, P32, DOI 10.1177/0899764002311002; Kroll C, 2011, SOC INDIC RES, V104, P157, DOI 10.1007/s11205-010-9733-1; MENCHIK PL, 1987, J PUBLIC ECON, V32, P159, DOI 10.1016/0047-2727(87)90010-7; Bjornskov C, 2003, KYKLOS, V56, P3, DOI 10.1111/1467-6435.00207; Deaton A, 2008, J ECON PERSPECT, V22, P53, DOI 10.1257/jep.22.2.53; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Brown E, 2007, NONPROF VOLUNT SEC Q, V36, P85, DOI 10.1177/0899764006293178; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Hansen T, 2012, SOC INDIC RES, V108, P29, DOI 10.1007/s11205-011-9865-y; Stutzer A, 2004, J ECON BEHAV ORGAN, V54, P89, DOI 10.1016/j.jebo.2003.04.003; Shields MA, 2005, J ROY STAT SOC A STA, V168, P513, DOI 10.1111/j.1467-985X.2005.00361.x; Meier S, 2008, ECONOMICA, V75, P39, DOI 10.1111/j.1468-0335.2007.00597.x; Diekmann A, 2004, J CONFLICT RESOLUT, V48, P487, DOI 10.1177/0022002704265948; Di Tella R, 2001, AM ECON REV, V91, P335, DOI 10.1257/aer.91.1.335; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.007; Fahey T, 2004, EUR SOC, V6, P5, DOI 10.1080/1461669032000176297; Easterlin RA, 2006, J ECON PSYCHOL, V27, P463, DOI 10.1016/j.joep.2006.05.002; Di Tella R, 2005, REV ECON STUD, V72, P367, DOI 10.1111/j.1467-937X.2005.00336.x; Ram R, 2010, J HAPPINESS STUD, V11, P409, DOI 10.1007/s10902-009-9148-3; Haller M, 2006, SOC INDIC RES, V75, P169, DOI 10.1007/s11205-004-6297-y; Helliwell JF, 2003, ECON MODEL, V20, P331, DOI 10.1016/S0264-9993(02)00057-3; Becchetti L., 2009, SOEP PAPERS MULTIDIS, V209; Bjeirnskov C., 2008, APPL RES QUAL LIFE, V3, P43, DOI DOI 10.1007/S11482-008-9046-6; Blanchflower D. G., 2005, AUSTR EC REV, V38, P307, DOI 10.1111/j.1467-8462.2005.00377.x; Blanchflower DG, 2004, SCAND J ECON, V106, P393, DOI 10.1111/j.1467-9442.2004.00369.x; Brehm John, 1997, AM J POLIT SCI, V41, P888; Cabinet Office, 2012, PUBL OP POLL GEND EQ; Calvo R., 2012, PLOS ONE, V7, P1; Cramm JM, 2012, SOC INDIC RES, V105, P581, DOI 10.1007/s11205-011-9790-0; Durlauf Steven N., 2002, ECON J, V112, P459; Easterlin R. A., 1974, NATIONS HOUSEHOLDS E, P89; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Frey BS, 2000, ECON J, V110, P918, DOI 10.1111/1468-0297.00570; Gilbert Daniel, 2006, STUMBLING HAPPINESS; Helliwell J. F., 2011, INT J WELLBEING, V1, P42; Helliwell J. F., 2010, NBER WORKING PAPERS, V16025; Kahneman D., 2010, INT DIFFERENCES WELL; Kinder R., 1979, AM J POLIT SCI, V23, P495; Konow J, 2008, J PUBLIC ECON, V92, P1, DOI 10.1016/j.jpubeco.2007.04.006; Kuroki M, 2011, JPN ECON REV, V62, P444, DOI 10.1111/j.1468-5876.2011.00533.x; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1162/003355305774268255; Pichler F, 2006, SOC INDIC RES, V75, P419, DOI 10.1007/s11205-004-4337-2; Putnam R., 2000, BOWLING ALONE COLLAP; PUTNAM RD, 1995, J DEMOCRACY, V0006; Sarracino F., 2010, J SOCIO-ECON, V39, P482, DOI [10.1016/j.socec.2009.10.010, DOI 10.1016/J.SOCEC.2009.10.010]; Smith K, 2003, SOC INDIC RES, V64, P75, DOI 10.1023/A:1024728111718; Tsutui Y., 2005, J ECON, V58, P20; Uslaner E., 2002, MORAL FDN TRUST; Van Willigen M, 2000, J GERONTOL B-PSYCHOL, V55, pS308; VERBRUGGE LM, 1994, J HEALTH SOC BEHAV, V35, P97, DOI 10.2307/2137359; Wheeler A., 1998, INT J AGING HUM DEV, V47, P69; Wills-Herrera E., 2011, Journal of Socio-Economics, V40, P88, DOI 10.1016/j.socec.2010.08.002	57	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0957-8765	1573-7888		VOLUNTAS	Voluntas	AUG	2015	26	4					1016	1045		10.1007/s11266-015-9581-3		30	Social Issues	Social Issues	CN4TF	WOS:000358422400002		
J	Ishida, Y; Okuyama, N				Ishida, Yu; Okuyama, Naoko			Local Charitable Giving and Civil Society Organizations in Japan	VOLUNTAS			English	Article						Local public services; Charitable giving; Local civil society organizations; Neighborhood associations; Incorporated nonprofit organizations	INCOME-TAX; IMPACT; ASSOCIATIONS; NONPROFIT; BEHAVIOR; GENDER; RACE	This paper, using original survey data, examines the factors influencing individual giving behavior toward the organizations focusing on who gives what to which types of organizations, especially the local civil society organizations. The study finds that the variables regarding personal socio-demographic traits, experiences of local social participation, and an attachment to local society are statistically significant, but not the contextual effect such as size of city. In addition, it reveals various factors influencing giving behavior toward the neighborhood associations and incorporated NPOs. That is, it may denote there are different attributes between people who give to the neighborhood associations and people who give to the incorporated NPOs. Thus, further development of organizational forms may be considered for achieving better local governance and providing local public goods by the promotion of charitable giving from the enlightened residents.	[Ishida, Yu] Akashi Coll, Natl Inst Technol, Akashi, Hyogo, Japan; [Okuyama, Naoko] Kobe Univ, Kobe, Hyogo 657, Japan	Ishida, Y (reprint author), Akashi Coll, Natl Inst Technol, Akashi, Hyogo, Japan.	y-ishida@akashi.ac.jp			Foundation for Promoting Workers Welfare and Mutual aid Insurance in Tokyo, Japan; JSPS KAKENHI [25780198]	The authors appreciate the anonymous reviewers' instructive comments as well as the audience at the 7th Asia Pacific Conference of ISTR in Bali, Indonesia. The questionnaire survey conducted in this study was supported by a grant from the Foundation for Promoting Workers Welfare and Mutual aid Insurance in Tokyo, Japan, and a part of this work was supported by JSPS KAKENHI, Grant-in-Aid for Young Scientists (B), Grant Number 25780198.	Andreoni J, 2003, J HUM RESOUR, V38, P111, DOI 10.2307/1558758; Andreoni J., 1989, J POLITICAL EC, V97, P1444; Mesch DJ, 2006, NONPROF VOLUNT SEC Q, V35, P565, DOI 10.1177/0899764006288288; PILIAVIN JA, 1990, ANNU REV SOCIOL, V16, P27; FELDSTEIN M, 1976, ECONOMETRICA, V44, P1201, DOI 10.2307/1914255; BELL W, 1956, AM SOCIOL REV, V21, P25, DOI 10.2307/2089336; Hughes P, 2008, NONPROF VOLUNT SEC Q, V37, P264, DOI 10.1177/0899764007310416; RADLEY A, 1995, HUM RELAT, V48, P685, DOI 10.1177/001872679504800605; Sloan MF, 2009, NONPROF VOLUNT SEC Q, V38, P220, DOI 10.1177/0899764008316470; Bulcroft RA, 1996, J MARRIAGE FAM, V58, P866, DOI 10.2307/353976; Lee BA, 2003, URBAN AFF REV, V38, P299, DOI 10.1177/8087402238804; CLOTFELTER CT, 1982, NATL TAX J, V35, P171; Teets JC, 2009, CHINA QUART, P330, DOI 10.1017/S0305741009000332; TAUSSIG MK, 1967, NATL TAX J, V20, P1; James RN, 2007, NONPROF VOLUNT SEC Q, V36, P218, DOI 10.1177/0899764006295993; RANDOLPH WC, 1995, J POLIT ECON, V103, P709, DOI 10.1086/262000; FELDSTEIN M, 1975, NATL TAX J, V28, P209; Gittell R, 2006, NONPROF VOLUNT SEC Q, V35, P721, DOI 10.1177/0899764006289768; Sargeant A, 2006, J BUS RES, V59, P155, DOI 10.1016/j.jbusres.2005.04.006; [Anonymous], 2002, PUBLIC BUDGETTING FI, DOI 10.1111/1540-5850.223083; Wiepking P, 2009, SOC FORCES, V87, P1973; FEENBERG D, 1987, NATL TAX J, V40, P629; [Anonymous], 2004, PUBLIC FINANC REV, DOI 10.1177/1091142104266973; Auten GE, 2002, AM ECON REV, V92, P371, DOI 10.1257/000282802760015793; JONES A, 1991, APPL ECON, V23, P343, DOI 10.1080/00036849100000143; [Anonymous], 2002, NEW DIRECTIONS PHILA; [Anonymous], 2003, CONSUMER INTERESTS A; [Anonymous], 2004, NONPROFIT VOLUNTARY; FELDSTEIN M, 1975, NATL TAX J, V28, P81; Shieh S, 2011, CHINA J, V65, P181; Baba H., 2010, NONPROFIT REV, V10, P101; Banks J., 1999, VOLUNTAS, V10, P167, DOI 10.1023/A:1021477922789; Brooks Arthur, 2003, PUBLIC FINANC REV, V31, P166, DOI 10.1177/1091142102250328; Brown E., 1999, PHILANTHROPY NONPROF; Burgoyne CB, 2005, J COMMUNITY APPL SOC, V15, P383, DOI 10.1002/casp.832; Cabinet Office of Japan, 2014, NUMB CERT INC NONPR; Cabinet Office of Japan, 2012, NEW PUBL COMM ROUNDT; Central Committee of Community Chests in Japan, 2012, LONG TERM TREND FUND; Clotfelter C. T., 1990, NBER WORKING PAPERS, V3273; Gordon T. P., 1999, J ACCOUNTING LIT, V18, P31; Hodgkinson V., 1986, DIMENSION INDEPENDEN; Hughes O.E., 2012, PUBLIC MANAGEMENT AD; Ishida Y., 2008, NONPROFIT REV, V8, P49; Japan Center for International Exchange, 2007, CIVIL SOC MONITOR, V12, P2; Japan Center for International Exchange, 2004, CIVIL SOC MONITOR, V9, P1; Kansai Institute for Social and Economic Research [KISER] and Tohoku Development Research Center [TDRC], 2005, RES REV LOC COMM FOR; Kaplan A. E., 1993, NEW DIRECTIONS PHILA, V1993, P5, DOI 10.1002/pf.41219930203; Matsunaga Y., 2007, JAPANESE GEN SOCIAL, V6, P69; Ministry of Finance, 2012, STAT DAT LONG TERM D; Mori H., 2013, NONPROFIT REV, V13, P11; Nakata M., 2007, NEIGHBORHOOD ASS ERA; National Institute of Population and Social Security Research, 2012, POP PROJ JAP JAN 201; Ogawa N., 2009, INT HDB POPULATION A; Oizumi Y., 2005, COMMUNITY REGENERATI; Onishi T., 2007, INT J ED ADVANCEMENT, V7, P205, DOI 10.1057/palgrave.ijea.2150062; Pekkanen R., 2006, JAPANS DUAL CIVIL SO; Pekkanen RJ, 2014, NISSAN I ROUTL JPN S, P1; Pharoah C., 1997, FISCAL STUDIES, V18, P427, DOI 10.1111/j.1475-5890.1997.tb00272.x; Ringen S., 2011, KOREAN STATE SOCIAL; Rowland D, 2009, INT HDB POPULATION A; SCHIFF J, 1985, NATL TAX J, V38, P535; Simmon W. O, 2004, PUBLIC FINANC REV, V32, P498, DOI 10.1177/1091142104264364; Statistics Bureau Ministry of Internal Affairs and Communications, 2014, STAT DAT POP AG 15 Y; Statistics Bureau Ministry of Internal Affairs and Communications, 2014, REP INT MIGR JAP; Statistics Bureau Ministry of Internal Affairs and Communications, 2011, 2010 POP CENS; Statistics Bureau Ministry of Internal Affairs and Communications, 2010, FAM INC EXP SURV CLA; Statistics Bureau Ministry of Internal Affairs and Communications, 2014, FAM INC EXP SURV; Wang L., 2008, INT J VOLUNT NONPROF, V19, P23; Weisbrod B., 1975, ALTRUISM MORALITY EC; Yamauchi N., 2007, KOEKIHOJIN, V36, P4; Yamauchi N., 2008, HIEIRIHOJIN GAKKAISH, V10, P73; Yamauchi N., 2014, J INFORM SCI TECHNOL, V64, P294; Yamauchi N., 2010, NONPROFIT ALMANAC 20	73	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0957-8765	1573-7888		VOLUNTAS	Voluntas	AUG	2015	26	4					1164	1188		10.1007/s11266-015-9588-9		25	Social Issues	Social Issues	CN4TF	WOS:000358422400009		
J	Nishi, T; Takeuchi, H; Matsuda, S; Ogura, M; Kawakubo, H; Fukuda, K; Nakamura, R; Takahashi, T; Wada, N; Saikawa, Y; Omori, T; Kitagawa, Y				Nishi, Tomohiko; Takeuchi, Hiroya; Matsuda, Sachiko; Ogura, Masaharu; Kawakubo, Hirofumi; Fukuda, Kazumasa; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Saikawa, Yoshiro; Omori, Tai; Kitagawa, Yuko			CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer	WORLD JOURNAL OF SURGICAL ONCOLOGY			English	Article						CXCR2 protein; Postoperative complication; Esophagectomy	SQUAMOUS-CELL CARCINOMA; ANASTOMOTIC LEAKAGE; GASTROESOPHAGEAL JUNCTION; SURGICAL COMPLICATIONS; CURATIVE RESECTION; COLORECTAL-CANCER; SURGERY; OUTCOMES; THORACOTOMY; METASTASIS	Background: Esophagectomy is one of the most invasive surgical treatments for digestive tract cancer, and the blood levels of inflammatory cytokines such as interleukin-1, interleukin-6, and interleukin-8 are increased for several hours after surgery or in patients experiencing postoperative complications. CXCR2, an interleukin-8 receptor, is reportedly expressed in several carcinomas, and interleukin-8 signaling promotes cancer cell proliferation. The impact of postoperative complications following esophagectomy on long-term survival is controversial. In this study, we demonstrate the significance of CXCR2 expression and validate the effects of CXCR2 expression and postoperative complications on long-term prognosis of esophageal squamous cell carcinoma using resected specimens. Methods: Eighty-two specimens were sectioned from archived, paraffin-embedded tumor tissues obtained from patients with esophageal squamous cell carcinoma who underwent esophagectomy and extended lymphadenectomy for complete resection of cancer in our institute between 1997 and 2002. Immunohistochemistry was performed using a polyclonal antibody to CXCR2, and the correlation of stainability with clinicopathological factors and long-term survival was examined. Results: CXCR2 was expressed in 33 of 82 (40.2 %) specimens. In the CXCR2-positive group, the recurrence-free survival and overall survival rates of patients who developed postoperative complications were both significantly lower than those for patients who did not develop any complications. In contrast, in the CXCR2-negative group, there was no significant difference in long-term prognosis between patients with and without complications. CXCR2 positivity combined with postoperative complications was an independent risk factor for subsequent tumor recurrence, showing the highest hazard ratio. Conclusions: Our results suggest that the patients with CXCR2-positive esophageal cancer who develop postoperative complications have a poor prognosis and should be carefully followed.	[Nishi, Tomohiko; Takeuchi, Hiroya; Matsuda, Sachiko; Ogura, Masaharu; Kawakubo, Hirofumi; Fukuda, Kazumasa; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Saikawa, Yoshiro; Omori, Tai; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan	Takeuchi, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	htakeuchi@a6.keio.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [24591960, 21591712, 19591561]	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (Grant numbers: 24591960, 21591712, and 19591561).	Akamoto S, 2007, SURG TODAY, V37, P359, DOI 10.1007/s00595-006-3409-0; Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; Paats MS, 2013, EUR RESPIR J, V41, P1378, DOI 10.1183/09031936.00060112; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Takeuchi H, 2010, WORLD J SURG, V34, P277, DOI 10.1007/s00268-009-0331-9; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Ancona E, 2006, J AM COLL SURGEONS, V203, P661, DOI 10.1016/j.jamcollsurg.2006.07.017; Ogura M, 2013, SURGERY, V154, P512, DOI 10.1016/j.surg.2013.06.013; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Ferri LE, 2006, ANN SURG ONCOL, V13, P557, DOI 10.1245/ASO.2006.04.040; Branagan G, 2005, DIS COLON RECTUM, V48, P1021, DOI 10.1007/s10350-004-0869-4; Chaudhry H, 2013, IN VIVO, V27, P669; CHOLLETMARTIN S, 1993, INFECT IMMUN, V61, P4553; Frick VO, 2012, ONCOL REP, V27, P258, DOI 10.3892/or.2011.1493; Hirai T, 2014, SURG TODAY, V44, P804, DOI 10.1007/s00595-013-0627-0; Jorgren F, 2011, COLORECTAL DIS, V13, P272, DOI 10.1111/j.1463-1318.2009.02136.x; Kaburagi T, 2014, WORLD J SURG, V38, P410, DOI 10.1007/s00268-013-2258-4; Kim DY, 2014, CLIN EXP OTORHINOLAR, V7, P36, DOI 10.3342/ceo.2014.7.1.36; Lehnert T, 1999, BRIT J SURG, V86, P727, DOI 10.1046/j.1365-2168.1999.01152.x; Nakamura E, 2006, J SURG RES, V135, P364, DOI 10.1016/j.jss.2006.04.015; Raimondi Antônio Marcos, 2006, Sao Paulo Med J, V124, P112, DOI 10.1590/S1516-31802006000200013; Shimada H, 2000, SURGERY, V128, P791, DOI 10.1067/msy.2000.108614; Suda K, 2006, WORLD J SURG, V30, P1755, DOI 10.1007/s00268-005-0369-2; Xia BT, 2013, WORLD J SURG, V37, P408, DOI 10.1007/s00268-012-1823-6	34	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1477-7819			WORLD J SURG ONCOL	World J. Surg. Oncol.	AUG 1	2015	13								232	10.1186/s12957-015-0658-7		9	Oncology; Surgery	Oncology; Surgery	CO0KN	WOS:000358840000001		
J	Hanawa, T; Oguchi, T				Hanawa, Takehisa; Oguchi, Toshio			Hospital Preparations Supporting the Medication -Status Quo and Challenges in the Future-	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Hanawa, Takehisa] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Oguchi, Toshio] Yamanashi Univ, Univ Hosp, Dept Pharm, Chuo Ku, Nakakoma, Yamanashi 4093898, Japan	Hanawa, T (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	t-hanawa@rs.tus.ac.jp					Goto S., 2011, JPN J PHARM HLTH CAR, V37, P21; Japanese Society of Hospital Pharmacists, 2013, BYOIN YAKK SEIZ JIR	2	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					929	930				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500001		
J	Momo, K				Momo, Kenji			Indomethacin Spray Preparation for the Control of Pain Associated with Stomatitis Caused by Chemotherapy and Radiotherapy in Cancer Patients	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						stomatitis; mucositis; indomethacin	ORAL MUCOSITIS; NECK-CANCER; SEVERITY; HEAD	Severe stomatitis caused by chemotherapy and radiotherapy is accompanied by severe pain and results in a poor quality of life. We used a spray preparation of indomethacin (IM; 0.25% IM dissolved in phosphate buffer, pH 7.4), a nonsteroidal anti-inflammatory drug (NSAID) to control the pain associated with stomatitis at the University of Tsukuba Hospital. This review specifically aimed to collect information on the use of the IM spray preparation, from our previous studies, to facilitate its proper use in a hospital setting. On studying the stability of the IM spray preparation, we concluded that the preparation should be kept in the refrigerator for daily use, and that it can be stored for at least 2 months at 4 degrees C, and for 24 months at -20 degrees C. To evaluate the efficacy of the IM spray preparation, we retrospectively surveyed its analgesic effects. Using the 10-grade Visual Analogue Scale in 23 patients, we found that pain associated with stomatitis was reduced from 10 to 4.7 after application of the spray. In conclusion, our study results on the stability and efficacy of the IM spray preparation have led to the proper use of the spray in cancer patients with stomatitis caused by chemotherapy and radiotherapy.	Univ Tsukuba Hosp, Dept Pharm, Tsukuba, Ibaraki 3058576, Japan	Momo, K (reprint author), Univ Tsukuba Hosp, Dept Pharm, Amakubo 2-1-1, Tsukuba, Ibaraki 3058576, Japan.	kmomo@hosp.tsukuba.ac.jp					Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Watanabe T, 2010, INT J CANCER, V127, P1984, DOI 10.1002/ijc.25200; Yamagata K, 2012, BONE MARROW TRANSPL, V47, P725, DOI 10.1038/bmt.2011.171; [Anonymous], 2014, COMM TERM CRIT ADV E; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Chiba K., 1990, IAYKU, V26, P1173; Chiba K., 1992, JPN J HOSP PHARM, V18, P43; Coda BA, 1997, PAIN, V72, P333, DOI 10.1016/S0304-3959(97)00059-6; Ebina K., 2007, PALLATIVE CARE RES, V2, P301, DOI 10.2512/jspm.2.301; Momo K., 2014, J PHARM SCI TECH JPN, V74, P211; Momo K, 2005, YAKUGAKU ZASSHI, V125, P433, DOI 10.1248/yakushi.125.433; Momo K., 2012, IYAKU J, V48, P135	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					931	935				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500002		
J	Shinohara, A; Nakamura, M; Onikubo, T; Nakamura, K				Shinohara, Akiyoshi; Nakamura, Masato; Onikubo, Toshihide; Nakamura, Kumi			Efficacy of Rebamipide Gargle against Chemotherapy-induced Oral Mucositis	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						rebamipide; polyethylene oxide; carrageenan; oral mucositis; cancer chemotherapy		Chemotherapy-induced oral mucositis (CIOM) is a severe adverse event resulting from cancer chemotherapy. Toxic free radicals and pro-inflammatory cytokines produced by anticancer drugs have been reported to be associated with CIOM. Rebamipide has been shown to increase gastric endogenous prostaglandin E-2 and 12, to promote gastric epithelial mucin, and to behave as an oxygen free-radical scavenger in addition to other anti-inflammatory actions. We developed a gargle solution of rebamipide, adding ultrahydrogel for mucosal protection and to maintain rebamipide on the oral mucosa. A 300 mL rebamipide gargle solution combines 600 mg rebamipide, 3 g high molecular-weight polyethylene oxide, 1.2 g carrageenan, pineapple flavoring, and water. The efficacy of the rebamipide gargle was evaluated in 175 patients with CIOM from November 2009 to December 2012, each instructed to use the rebamipide gargle 5-6 times daily. The severity of CIOM was assessed according to the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE, version 4.0). Their CTCAE scores (3/2/1/0) changed from n=13/64/98/0 to 0/10/103/62, respectively, after initiation of the rebamipide gargle (p<0.01; paired t-test). The median duration to best response was 14 days (range: 1-49). CTCAE scores decreased in 132 patients (75.4%), including 62 (35.4%) who achieved grade 0. There were no unexpected safety events. Rebamipide gargle was well tolerated and demonstrated to have significant therapeutic efficacy against CIOM.	[Shinohara, Akiyoshi; Onikubo, Toshihide; Nakamura, Kumi] Aizawa Hosp, Med Management Informat Ctr, Matsumoto, Nagano 3908510, Japan; [Nakamura, Masato] Aizawa Hosp, Aizawa Comprehens Canc Ctr, Div Chemotherapy, Matsumoto, Nagano 3908510, Japan	Shinohara, A (reprint author), Aizawa Hosp, Med Management Informat Ctr, 2-5-1 Honjo, Matsumoto, Nagano 3908510, Japan.	yakuzaik@ai-hosp.or.jp					Hanawa T, 2000, YAKUGAKU ZASSHI, V120, P1209; Hanawa T., 2011, JPN J PHARM HLTH CAR, V37, P503; Hanawa T., 2008, PHARM MONTHLY, V50, P1717; Kawata K., 2001, J NEW REM CLIN, V50, P273; Matsuda T., 1994, J CLIN EXPT MED, V170, P773; Suzuki K., 2013, MANUAL SUPPORTIVE CA, P34; Tanaka H., 1997, PROG MED, V17, P1643; Yamazaki M., 2002, JPN J PHARM HLTH CAR, V28, P22; Yasuda T., 2008, JPN J CANC CHEMOTHER, V35, P1157	9	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					937	941				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500003		
J	Yonezawa, A; Kajiwara, M; Minami, I; Omura, T; Nakagawa, S; Matsubara, K				Yonezawa, Atsushi; Kajiwara, Moto; Minami, Ikuko; Omura, Tomohiro; Nakagawa, Shunsaku; Matsubara, Kazuo			The Contribution of GMP-grade Hospital Preparation to Translational Research	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						translational research; good manufacturing practice; hospital preparation; investigational new drug		Translational research is important for applying the outcomes of basic research studies to practical medical treatments. In exploratory early-phase clinical trials for an innovative therapy, researchers should generally manufacture investigational agents by themselves. To provide investigational agents with safety and high quality in clinical studies, appropriate production management and quality control are essential. In the Department of Pharmacy of Kyoto University Hospital, a manufacturing facility for sterile drugs was established, independent of existing manufacturing facilities. Manuals on production management and quality control were developed according to Good Manufacturing Practices (GMP) for Investigational New Drugs (INDs). Advanced clinical research has been carried out using investigational agents manufactured in our facility. These achievements contribute to both the safety of patients and the reliability of clinical studies. In addition, we are able to do licensing-out of our technique for the manufacture of investigational drugs. In this symposium, we will introduce our GMP grade manufacturing facility for sterile drugs and discuss the role of GMP grade hospital preparation in translational research.	[Yonezawa, Atsushi; Kajiwara, Moto; Minami, Ikuko; Omura, Tomohiro; Nakagawa, Shunsaku; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan	Yonezawa, A (reprint author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.	ayone@kuhp.kyoto-u.ac.jp					Ariyasu H, 2014, ENDOCR J, V61, P735, DOI 10.1507/endocrj.EJ14-0088; Nakagawa T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0219-x; Oka M., 2012, JPN J PHARM HLTH CAR, V38, P423	3	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					943	947				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500004		
J	Nakaya, M				Nakaya, Michio			Research on Molecular Mechanisms of Engulfment of Apoptotic Cells	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						engulfment; Rac1; Rab5; G protein-coupled receptor kinase 6	CLEARANCE; ELEGANS; PROTEIN; PHOSPHATIDYLSERINE; MACROPHAGES; MIGRATION; RECEPTOR; PATHWAY; KINASE	Apoptotic cells generated during development and immune responses in animals are rapidly engulfed by phagocytes, such as macrophages and dendritic cells. When the engulfment process malfunctions, the apoptotic cells undergo secondary necrosis, which results in the release of noxious cellular components into the extracellular space. Thus, the efficient clearance of apoptotic cells is indispensable for the maintenance of tissue homeostasis; however, the molecular mechanisms underlying the engulfment of apoptotic cells remain largely unknown. To identify the molecules that are involved in this process, we developed a functional screening strategy using a retrovirus cDNA library. Using this assay, we isolated cDNA clones encoding RhoG and Rab5 which enhanced the engulfment of apoptotic cells. In addition, we found that Rac1, which is very similar to RhoG, and Rab5 are necessary for engulfment; their activities were successfully visualized by a combination of fluorescence resonance energy transfer technology with time-lapse imaging techniques. We further determined that G protein-coupled receptor kinase 6 (GRK6), originally identified as a kinase responsible for the desensitization and downregulation of G-protein-coupled receptors, activates Rac1 independent of the two known intracellular engulfment pathways in phagocytes. GRK6-deficient macrophages exhibited impaired phagocytosis of apoptotic cells. Consequently, GRK6-deficient mice developed autoimmune phenotypes such as an increase in the amount of anti-dsDNA in serum and the deposition of immune complexes in the kidney. Thus, our findings contributed to the understanding of the molecular mechanisms that regulate apoptotic engulfment in phagocytes.	Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan	Nakaya, M (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nakaya@phar.kyushu-u.ac.jp					Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; FADOK VA, 1992, J IMMUNOL, V148, P2207; Reddien PW, 2000, NAT CELL BIOL, V2, P131; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nakaya M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2540; Watari Kenji, 2014, J Mol Signal, V9, P1, DOI 10.1186/1750-2187-9-1	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					949	954				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500005		
J	Tsunoda, M				Tsunoda, Makoto			Development of Efficient Separation and Sensitive Analytical Methods for Biological Compounds and Their Application	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						micro total analysis system; pillar array; thiol; hydrophilic interaction chromatography	HYDROPHILIC INTERACTION CHROMATOGRAPHY; LOW-DISPERSION TURNS; PILLAR ARRAY COLUMN; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; BIOTHIOLS; SAMPLES; PLASMA; BLOOD	Measurement of biological compounds is important for the clarification of biological phenomena. For the quantification of trace amounts of biological compounds, efficient separation and sensitive analytical methods are necessary. The present author developed HPLC-fluorescence and chemiluminescence detection methods for biological compounds such as catecholamines, amino acids, and thiols. In this review article, two studies are summarized: one on the development of an on-chip liquid chromatography method using pillar array columns with low-dispersion turns; and another on the development of simultaneous analytical method of biothiols by HPLC with fluorescence detection under hydrophilic interaction chromatography conditions.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Tsunoda, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makotot@mol.f.u-tokyo.ac.jp					He B, 1998, ANAL CHEM, V70, P3790, DOI 10.1021/ac980028h; Isokawa M, 2014, J CHROMATOGR B, V964, P103, DOI 10.1016/j.jchromb.2013.12.041; Isokawa M, 2013, ANALYST, V138, P3802, DOI 10.1039/c3an00527e; Aoyama C, 2010, ANAL CHEM, V82, P1420, DOI 10.1021/ac902491x; Isokawa M, 2014, BIOANALYSIS, V6, P2421, DOI 10.4155/bio.14.173; Griffiths SK, 2001, ANAL CHEM, V73, P272, DOI 10.1021/ac000936q; Song YT, 2013, ANAL BIOANAL CHEM, V405, P7993, DOI 10.1007/s00216-013-7034-7; Tsunoda M, 2008, YAKUGAKU ZASSHI, V128, P1589, DOI 10.1248/yakushi.128.1589	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					955	960				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500006		
J	Taguchi, K				Taguchi, Kumiko			The Role of GRK2 and Its Potential as a New Therapeutic Target in Diabetic Vascular Complications	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						endothelial dysfunction; G-protein coupled receptor kinase 2 (GRK2); diabetes	NITRIC-OXIDE SYNTHASE; RECEPTOR KINASE 2; ENDOTHELIUM-DEPENDENT RELAXATION; BETA-ARRESTIN 2; MOUSE AORTA; DYSFUNCTION; INSULIN; ACTIVATION; PATHWAY; MICE	A decrease in nitric oxide (NO) production may induce pathological conditions associated with endothelial dysfunction and diabetes. Although a decrease in NO production caused by impaired Akt/endothelial nitric oxide synthesis (eNOS) signaling has been demonstrated at the aorta in the presence of diabetic vascular complications, little is known regarding the details of the mechanism. We identified G-protein-coupled receptor kinase 2 (GRK2) as a critical factor in diabetic endothelial dysfunction. GRK2 plays a role in many physiological functions including regulation of G-protein-coupled receptors (GPCRs). We found that the vasculature affected by type 2 diabetes expresses high levels of GRK2, which may induce endothelial dysfunction caused by impaired Akt/eNOS signaling. GRK2 activation also induces changes in the subcellular localization of GRK2 and beta-arrestin 2, a downstream protein, from the cytosol to membrane. In mouse aorta GRK2 may be, on translocation, a key negative regulator and an important regulator of beta-arrestin 2/Akt /eNOS signaling, which has been implicated in diabetic endothelial dysfunction. Furthermore, in the aortic membrane of type 2 diabetic model mice under insulin stimulation, the impaired Akt/eNOS signaling was improved by a selective GRK2 inhibitor. These results suggest that in diabetes the GRK2 inhibitor ameliorates vascular endothelial dysfunction via Akt/eNOS signaling by inhibiting GRK2 activity and enhancing,beta-arrestin 2 translocation to the membrane under GPCR or non-GPCR stimulation, thereby contributing to blood pressure- and blood glucose-lowering effects. We propose that the GRK2 inhibitor may be a promising therapeutic target for cardiovascular complications in type 2 diabetes.	Hoshi Univ, Dept Physiol & Morphol, Inst Med Chem, Shinagawa Ku, Tokyo 1428501, Japan	Taguchi, K (reprint author), Hoshi Univ, Dept Physiol & Morphol, Inst Med Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	k-taguchi@hoshi.ac.jp					Taguchi K, 2013, ACTA PHYSIOL, V207, P142, DOI 10.1111/j.1748-1716.2012.02473.x; Taguchi K, 2012, DIABETES, V61, P1978, DOI 10.2337/db11-1729; Dimmeler S, 1999, NATURE, V399, P601; CaulinGlaser T, 1997, CIRC RES, V81, P885; Fulton D, 1999, NATURE, V399, P597; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Taguchi K, 2011, AM J PHYSIOL-HEART C, V301, pH571, DOI 10.1152/ajpheart.01189.2010; Taguchi K, 2012, PHARMACOL RES, V65, P56, DOI 10.1016/j.phrs.2011.08.009; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; Taguchi K, 2012, ENDOCRINOLOGY, V153, P2985, DOI 10.1210/en.2012-1101; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Taguchi K, 2011, PHARMACOL RES, V64, P535, DOI 10.1016/j.phrs.2011.05.001; Kobayashi T, 2004, HYPERTENSION, V44, P956, DOI 10.1161/01.HYP.0000147559.10261.a7; Landmesser U., 2004, CIRCULATION S1, V109, P1127; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					961	967				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500007		
J	Fujihara, H; Koinuma, M; Yumoto, T; Maeda, T; Kamite, M; Kawahara, E; Soeda, S; Takimoto, A; Tamura, K; Nakamura, M; Kaneta, M; Takao, Y; Saito, M; Kagaya, H; Murayama, J				Fujihara, Hisato; Koinuma, Masayoshi; Yumoto, Tetsuro; Maeda, Takuya; Kamite, Mariko; Kawahara, Eiko; Soeda, Shinji; Takimoto, Atsushi; Tamura, Kazuyoshi; Nakamura, Masatoshi; Kaneta, Mitsumasa; Takao, Yoshihiro; Saito, Masahisa; Kagaya, Hajime; Murayama, Jun-ichiro			Expected Duties of Pharmacists and Potential Needs of Physicians and Nurses on a Kaifukuki Rehabilitation Ward	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						kaifukuki rehabilitation ward; pharmacist; exploratory data analysis; questionnaire survey		This study investigated the required duties of pharmacists in a kaifukuki rehabilitation ward from the viewpoint of the ward physicians and nurses. A questionnaire survey was distributed to 27 facilities with kaifukuki rehabilitation wards. The questionnaire examined which duties the physicians and nurses expected from pharmacists while on the ward (4 areas, 10 items), as well as the time required for pharmacists to carry out those duties. Multivariate analysis was used to investigate which types of work took the most time for pharmacists on kaifukuki rehabilitation wards. Responses were received from 43 physicians and 184 nurses who worked on the kaifukuki rehabilitation wards of 19 facilities. The results revealed that the essential duties performed by pharmacists were the management of medical supplies, instruction on the use of self-medicating drugs at the time of introduction, and monitoring drug side effects. Furthermore, some duties, such as the distribution of medicines and changing or suggesting new drugs, required pharmacists to spend extended time on the ward. The responses indicated that physicians and nurses recognized the necessity for pharmacists to perform ward duties along with their routine work. This study shows that physicians and nurses working in kaifukuki rehabilitation wards demand proactive participation from pharmacists in appropriate medical therapy, such as instruction in the administration of medications and assessment at the time of prescription changes.	[Fujihara, Hisato] Showa Univ, Fujigaoka Rehabil Hosp, Dept Pharm, Aoba Ku, Yokohama, Kanagawa 2278518, Japan; [Fujihara, Hisato; Murayama, Jun-ichiro] Showa Univ, Sch Pharm, Dept Hosp Pharmaceut, Shinagawa Ku, Tokyo 1428555, Japan; [Fujihara, Hisato; Koinuma, Masayoshi; Yumoto, Tetsuro; Maeda, Takuya; Kamite, Mariko; Kawahara, Eiko; Soeda, Shinji; Takimoto, Atsushi; Tamura, Kazuyoshi; Nakamura, Masatoshi; Kaneta, Mitsumasa; Takao, Yoshihiro; Saito, Masahisa; Kagaya, Hajime] Kanagawa Soc Hosp Pharmacists, Isoko Ku, Yokohama, Kanagawa 2350007, Japan; [Koinuma, Masayoshi] Teikyo Heisei Univ, Sch Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Yumoto, Tetsuro] Hoshi Univ, Div Pharm Profess Dev & Res, Shinagawa Ku, Tokyo 1420063, Japan; [Maeda, Takuya] Yokohama Asahi Chuo Gen Hosp, Dept Pharm, Asahi Ku, Yokohama, Kanagawa 2410801, Japan; [Kamite, Mariko] Yokohama City Univ, Med Hosp, Dept Pharm, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Kawahara, Eiko] Yokosuka Kyosai Hosp, Dept Pharm, Yokosuka, Kanagawa 2388558, Japan; [Soeda, Shinji] Tokai Univ, Dept Pharm, Hachioji Hosp, Hachioji, Tokyo 1920032, Japan; [Takimoto, Atsushi] Saiseikai Yokohamashi Tobu Hosp, Dept Pharm, Tsurumi Ku, Yokohama, Kanagawa 2308765, Japan; [Tamura, Kazuyoshi] Kitasato Univ Hosp, Dept Pharm, Minami Ku, Sagamihara, Kanagawa 2320375, Japan; [Nakamura, Masatoshi] Shonan Atsugi Hosp, Dept Pharm, Atsugi, Kanagawa 2438551, Japan; [Kaneta, Mitsumasa] Seirei Yokohama Hosp, Dept Pharm, Hodogaya Ku, Yokohama, Kanagawa 2408521, Japan; [Takao, Yoshihiro] Yokohama Municipal Citizens Hosp, Dept Pharm, Hodogaya Ku, Yokohama, Kanagawa 2400062, Japan; [Saito, Masahisa] Odawara Municipal Hosp, Dept Pharm, Odawara, Kanagawa 2500055, Japan; [Kagaya, Hajime] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Tokyo 2040004, Japan	Fujihara, H (reprint author), Showa Univ, Fujigaoka Rehabil Hosp, Dept Pharm, Aoba Ku, 2-1-1 Fujigaoka, Yokohama, Kanagawa 2278518, Japan.	h-fujihara@cmed.showa-u.ac.jp					Akuzawa M., 2011, JMC, V19, P87; [Anonymous], 2012, IGAKUTSUSHINSYA, P865; Fujihara H., 2013, J JPN SOC HOSP PHARM, V49, P975; Ishikawa Makoto, 2006, Nihon Rinsho, V64 Suppl 7, P774; Ochiai K., 2004, ACTA SCI VALETTVDINI, V9, P21	5	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					969	975				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500008		
J	Sugino, M; Mikami, M; Ishihara, T; Hosoya, O; Juni, K				Sugino, Masahiro; Mikami, Mitsuhiro; Ishihara, Tomoki; Hosoya, Osamu; Juni, Kazuhiko			Effect of Adhesives on the Properties of Adhesion, Drug Release and Skin Permeation of Lidocaine Tapes	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						adhesive property; releasing profile; skin permeation; generic drug; lidocaine tape	FORMULATIONS; PENETRATION; VEHICLES; INFUSION	A generic drug is defined as a drug product that is comparable to a brand name drug in terms of dosage, form, strength, route of administration, quality, performance characteristics, and indicated use. Generic drugs for topical use, in the case of sheet-like products, are required to be the same as the original drug in terms of application area and dosage form. The composition of such generic drug formulations may differ from that of the original product. The adhesive of any pharmaceutically-active tape that directly contacts the skin plays a role in delivering the active ingredient into the skin, and affects the sensation and ease of handling. Therefore, adhesives are an important ingredient in these products. Thus, the aim of this study was to characterize original and generic lidocaine tape products, and to evaluate the adhesive properties of each. The tack force, peel strength and shear adhesion were measured as adhesive properties. In addition, in vitro drug releasing profiles and skin permeation profiles of the products were evaluated. In vivo transdermal absorption was also evaluated to predict the possibility of adverse effects. Adhesive properties differed among the three analyzed products. These differences may have been caused by differences in the adhesives. Drug-releasing profiles and skin permeation profiles also differed among the three products, even though the pharmacokinetics were not significantly different. By obtaining an adequate understanding of the characteristics of original and generic products, we will be able to provide better tailor-made medications for drug therapies for patients.	[Sugino, Masahiro; Mikami, Mitsuhiro; Ishihara, Tomoki; Hosoya, Osamu; Juni, Kazuhiko] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Sugino, M (reprint author), Josai Univ, Fac Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	msugino@josai.ac.jp					[Anonymous], 2011, COMMUNICATION; [Anonymous], 2013, COMMUNICATION; Ghafourian T, 2010, EUR J PHARM SCI, V41, P612, DOI 10.1016/j.ejps.2010.08.014; [Anonymous], 2011, PACK INS YOUP TAP 18; BASSAN MM, 1974, AM HEART J, V87, P302, DOI 10.1016/0002-8703(74)90069-6; CHENG YH, 1994, BIOL PHARM BULL, V17, P1640; Ford (web catalogue) Autographed Letter Signed (Alexr Peddie MD. F. RCP.), 2015, COMMUNICATION; GROSSMAN JI, 1969, AM J CARDIOL, V24, P191, DOI 10.1016/0002-9149(69)90403-2; HO HO, 1994, J PHARM PHARMACOL, V46, P636; Inoue Y, 2012, INT J PHARMACEUT, V436, P265, DOI 10.1016/j.ijpharm.2012.06.023; Karadzovska D, 2013, ADV DRUG DELIVER REV, V65, P265, DOI 10.1016/j.addr.2012.01.019; Matsui R, 2005, DRUG DEV IND PHARM, V31, P729, DOI 10.1080/03639040500216147; Ministry of Health Labour and Welfare, 2006, GUID BIOEQ STUD DIFF; Ministry of Health Labour and Welfare, 2010, GUID BIOEQ STUD FORM; Ministry of Health Labour and Welfare, 2006, GUID BIOEQ STUD GEN; OCHS HR, 1983, J CLIN PHARMACOL, V23, P186; Oshima S., 2012, JPN J PHARM PALLIAT, V5, P7; Samaras EG, 2012, INT J PHARMACEUT, V434, P280, DOI 10.1016/j.ijpharm.2012.05.012; Sasagawa I., 2012, JJSPC, V19, P544; Sugibayashi K., 1987, XENOBIO METABOL DISP, V2, P71; VIEGAS O, 1975, ANESTHESIOLOGY, V43, P491, DOI 10.1097/00000542-197510000-00019; Wang CX, 2012, AAPS PHARMSCITECH, V13, P1179, DOI 10.1208/s12249-012-9849-5; Wang CX, 2012, AAPS PHARMSCITECH, V13, P556, DOI 10.1208/s12249-012-9778-3	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					977	985				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500009		
J	Haruki, Y; Hagiya, H; Sakuma, A; Haruki, M; Oka, Y; Sugiyama, T; Kawakami, Y; Kondo, S				Haruki, Yuto; Hagiya, Hideharu; Sakuma, Akiko; Haruki, Mai; Oka, Yasue; Sugiyama, Tetsuhiro; Kawakami, Yasuhiro; Kondo, Sachiyo			Investigation of Intravenous Azithromycin Treatment Safety When Reducing Solvent for Intensive Care Unit Patients	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						azithromycin; intensive care unit; peripheral phlebitis; safety; volume of solvent	DISEASES	Intravenous azithromycin (AZM) was approved for use in December 2011 in Japan. In general, intravenous AZM injections are diluted to 1 mg/mL, with a total infusion volume of 500 mL to avoid phlebitis. Patients in intensive care units (ICUs) require small infusion volumes. We retrospectively evaluated the total AZM infusion volume in 65 ICU patients receiving AZM treatment from December 2011 to August 2014. Thirteen patients (20.0%) received a reduced volume [100 mL (5 mg/mL) or 250 mL (2 mg/mL)] using an infusion pump over 2 h. No peripheral phlebitis was observed in any patient. Based on this result, it is assumed that AZM can be safely administered to ICU patients even though the volume of solvent is reduced. AZM is widely recommended for the treatment of community-acquired respiratory infections and is used in patients with severe infections. Further investigation is required in additional patients to understand the effects of AZM volume reduction in greater detail.	[Haruki, Yuto; Sakuma, Akiko; Haruki, Mai; Oka, Yasue; Sugiyama, Tetsuhiro; Kondo, Sachiyo] Tsuyama Chuo Hosp, Dept Pharm, Okayama 7080841, Japan; [Hagiya, Hideharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008558, Japan; [Kawakami, Yasuhiro] Okayama Saiseikai Gen Hosp, Dept Pharm, Kita Ku, Okayama 7000013, Japan	Haruki, Y (reprint author), Tsuyama Chuo Hosp, Dept Pharm, Kawasaki 1756, Okayama 7080841, Japan.	staygold0320@gmail.com					Friedlander AL, 2010, CHEST, V138, P1202, DOI 10.1378/chest.10-0196; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; committee for the JRS guidelines in management of respiratory infections, 2007, JRS GUID MAN COMM AC; Dychter Samuel S, 2012, J Infus Nurs, V35, P84, DOI 10.1097/NAN.0b013e31824237ce; Fukuda Y, 2006, EUR RESPIR J, V27, P1020, DOI 10.1183/09031936.06.00116805; Luke DR, 1997, ANN PHARMACOTHER, V31, P965; Roca GM, 2012, MED CLIN-BARCELONA, V139, P185, DOI 10.1016/j.medcli.2011.12.021; Thorsteinsson S B, 1989, Scand J Infect Dis Suppl, V60, P116; UCHIDA H, 2014, JPN J CHEMOTHER, V62, P382; Vorbach H, 2002, J ANTIMICROB CHEMOTH, V49, P407, DOI 10.1093/jac/49.2.407	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					987	990				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500010		
J	Umetsu, R; Abe, J; Ueda, N; Kato, Y; Nakayama, Y; Kinosada, Y; Nakamura, M				Umetsu, Ryogo; Abe, Junko; Ueda, Natsumi; Kato, Yamato; Nakayama, Yoko; Kinosada, Yasutomi; Nakamura, Mitsuhiro			Adverse Event Trends Associated with Over-the-counter Drugs: Data Mining of the Japanese Adverse Drug Event Report Database	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						over-the-counter drug; Japanese Adverse Drug Event Report database; clustering	TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; PHARMACISTS; MEDICATIONS; SYSTEM	Over-the-counter (OTC) drugs play an important role in self-medication. To ensure patient safety, pharmacists should ask patients to pay attention to possible adverse events (AE) associated with OTC drugs and educate patients about the symptoms related to those AEs. The aims of the present study were as follows: (1) to assess the tendency of AEs to occur with OTC drug use in Japan; (2) to detect a safety signal for OTC drugs using the reporting odds ratio (ROR); and (3) to evaluate clustery features, which include suspected drugs and therapeutic classifications, and safety signal indices (number of reports and the ROR), using cluster analysis. The number of reports of AEs following use of combination cold remedy, antipyretic and analgesic remedy, and herbal medicine was 1007, 566, and 221, respectively. We set the cluster number at five; clustery features obtained were as follows: (1) high reporting rate for skin and subcutaneous tissue disorder AEs was the largest group related to combination cold remedy; (2) high reporting rate for nervous system disorder AEs including dizziness was the second largest group. The same medicinal ingredient may demonstrate similar tendencies of the occurrence of AEs and similar clustery features in the Japanese Adverse Drug Event Report database. Our analysis of AEs associated with OTC drugs may be useful for pharmacists and patients alike. Further studies are required to draw better-informed conclusions.	[Umetsu, Ryogo; Abe, Junko; Ueda, Natsumi; Kato, Yamato; Nakayama, Yoko; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu 5011196, Japan; [Abe, Junko] Med Database Co LTD, Shibuya Ku, Tokyo 1500011, Japan; [Kinosada, Yasutomi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011194, Japan	Nakamura, M (reprint author), Gifu Pharmaceut Univ, Lab Drug Informat, 1-25-4 Daigakunishi, Gifu 5011196, Japan.	mnakamura@gifu-pu.ac.jp					Levi N, 2009, PEDIATRICS, V123, pE297, DOI 10.1542/peds.2008-1923; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Barvaliya M, 2011, J POSTGRAD MED, V57, P115, DOI 10.4103/0022-3859.81865; Everitt BS, 2011, CLUSTER ANAL; Fujita T., 2009, JPN J PHARMACOEPIDEM, V14, P27; Gregoire F., 2010, BR J CLIN PHARM, V69, P67; Hoffman KB, 2014, DRUG SAFETY, V37, P283, DOI 10.1007/s40264-014-0150-2; Horiuchi T, 2010, YAKUGAKU ZASSHI, V130, P1623, DOI 10.1248/yakushi.130.1623; Ito Y., 2006, NIPPON YAKURIGAKU ZA, V127, P425; Ministry of Health Labour and Welfare, 2012, PROBL EXTR UZ CESK R, V293, P3; Ministry of Health Labour and Welfare, IPP IYAK SEIH GUN TO; Nakamura Takeshi, 2007, Yakuzaigaku, V67, P80; Narui K., 2013, JPN J PHARM HLTH CAR, V39, P726; Takahashi Y., 2014, JPN J PHARMACOEPIDEM, V19, P14; Umetsu R, 2014, YAKUGAKU ZASSHI, V134, P299; van Puijenbroek EP, 1999, BRIT J CLIN PHARMACO, V47, P689, DOI 10.1046/j.1365-2125.1999.00957.x; Yahune A., 1996, JPN J CLIN PHARM THE, V27, P635	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	AUG	2015	135	8					991	1000				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DO	WOS:000358820500011		
J	Mashitani, T; Hayashino, Y; Okamura, S; Kitatani, M; Furuya, M; Iburi, T; Kuwata, H; Tsujii, S; Ishii, H				Mashitani, Tsuyoshi; Hayashino, Yasuaki; Okamura, Shintaro; Kitatani, Masako; Furuya, Miyuki; Iburi, Tadao; Kuwata, Hirohito; Tsujii, Satoru; Ishii, Hitoshi			Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8)	ACTA DIABETOLOGICA			English	Article						Insulin; Self-care activities; Omission; Quality of life	GLYCEMIC CONTROL; TREATMENT SATISFACTION; TREATMENT PREFERENCES; QUESTIONNAIRE; THERAPY; VALIDATION; ADHERENCE; MELLITUS; IMPACT; ADULTS	We investigated the association between diabetes treatment-related quality of life (QOL) and levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes. Data from 1394 patients with type 2 diabetes on insulin therapy were obtained from a diabetes registry in Japan. We used the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire and relative risk regression analysis to assess the independent association of high levels of self-care activities in insulin injection and DTR-QOL scores while adjusting for possible confounders. The mean age, BMI and HbA1c level were 65.8 years, 24.8 kg/m(2) and 62 mmol/mol (7.8 %), respectively. The frequency of insulin injection omission was associated with DTR-QOL scores. In the multivariable-adjusted model, the relative risks for high levels of self-care activities in insulin injection was 1.15 (95 % confidence interval, 1.05-1.26) in the highest quintile compared with those in the lowest quintile of DTR-QOL scores. Subgroup analysis confirmed this association in patients < 65 years. DTR-QOL was associated with self-reported levels of self-care activities in insulin injection, particularly among Japanese patients < 65 years with type 2 diabetes. DTR-QOL might be a useful tool to identify patients who consequently omit insulin. For patients with low DTR-QOL score, healthcare providers should discuss their treatment-related problems to prevent insulin injection omission.	[Mashitani, Tsuyoshi; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 6348552, Japan; [Hayashino, Yasuaki; Okamura, Shintaro; Kitatani, Masako; Furuya, Miyuki; Iburi, Tadao; Kuwata, Hirohito; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, Tenri, Nara 6328552, Japan	Mashitani, T (reprint author), Nara Med Univ, Dept Diabetol, 840 Shijo Cho, Kashihara, Nara 6348552, Japan.	mashiyan@gmail.com		Hayashino, Yasuaki/0000-0002-2932-8478	Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]	This study was partially supported by the Manpei Suzuki Diabetes Foundation and JSPS KAKENHI (Grant Number 25460641); however, they played no role in the study design or conduct, data collection, analysis or interpretation, and the preparation, review or approval of the manuscript. We would like to especially thank Yukari Moritsuji, Yuki Fujita, Noriko Nakamura and Yoko Sakamoto (Department of Endocrinology, Tenri Hospital) for their clerical support. The authors would like to thank Enago (www.enago.jp) for the English language review.	American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Kobayashi M, 2006, DIABETES RES CLIN PR, V73, P198, DOI 10.1016/j.diabres.2006.01.013; Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348; Peyrot M, 2005, DIABETES CARE, V28, P53, DOI 10.2337/diacare.28.1.53; Davies MJ, 2013, DIABETIC MED, V30, P512, DOI 10.1111/dme.12128; Trento M, 2014, ACTA DIABETOL, V51, P509, DOI 10.1007/s00592-013-0530-6; Hommel E, 2014, ACTA DIABETOL, V51, P845, DOI 10.1007/s00592-014-0598-7; Anderson RT, 2004, CLIN THER, V26, P565, DOI 10.1016/S0149-2918(04)90059-8; Chung JO, 2014, ACTA DIABETOL, V51, P1065, DOI 10.1007/s00592-014-0677-9; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x; Uchmanowicz I, 2013, ACTA DIABETOL, V50, P217, DOI 10.1007/s00592-011-0280-2; Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Mollema ED, 2000, DIABETES CARE, V23, P765, DOI 10.2337/diacare.23.6.765; Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562; Cherubini V, 2014, ACTA DIABETOL, V51, P43, DOI 10.1007/s00592-013-0466-x; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002; Chung JO, 2013, INTERNAL MED, V52, P179, DOI 10.2169/internalmedicine.52.7513; Cramer JA, 2005, DIABETES CARE, V28, P78, DOI 10.2337/diacare.28.1.78; Dhatt GS, 2005, CLIN CHIM ACTA, V358, P81, DOI 10.1016/j.cccn.2005.02.009; EuroQol Group, 1990, Health Policy, V16, P199; Garg SK, 2015, ENDOCR PRACT, V21, P143, DOI 10.4158/EP14079.OR; TURNER RC, 1995, DIABETES, V44, P1249; Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424; Ishii H, 2008, DIABETES RES CLIN PR, V81, P169, DOI 10.1016/j.diabres.2008.03.020; Ishii Hitoshi, 2012, J Med Econ, V15, P556, DOI 10.3111/13696998.2012.665111; LEWIS KS, 1988, DIABETIC MED, V5, P235; Martinez L, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-53; Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006; Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X; NICE, 2008, TYP 2 DIAB NAT CLIN; NICE, 2004, TYP 1 DIAB DIAGN MAN; Sato F, 2013, DIABETOL INT, V5, P21, DOI 10.1007/s13340-013-0125-z; Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69; DCCT Res Grp, 1988, DIABETES CARE, V11, P725	40	1	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0940-5429	1432-5233		ACTA DIABETOL	Acta Diabetol.	AUG	2015	52	4					639	647		10.1007/s00592-015-0725-0		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CN0EE	WOS:000358085800002		
J	Cantat, S; Oguiso, K				Cantat, Serge; Oguiso, Keiji			BIRATIONAL AUTOMORPHISM GROUPS AND THE MOVABLE CONE THEOREM FOR CALABI-YAU MANIFOLDS OF WEHLER TYPE VIA UNIVERSAL COXETER GROUPS	AMERICAN JOURNAL OF MATHEMATICS			English	Article							K3 SURFACES; ENRIQUES SURFACES; REFLECTION GROUPS; MINIMAL MODELS; DYNAMICS; VARIETIES; CONJECTURE; DIMENSION; SPACES	Thanks to the theory of Coxeter groups, we produce the first family of Calabi-Yau manifolds X of arbitrary dimension n, for which Bir(X) is infinite and the Kawamata-Morrison movable cone conjecture is satisfied. For this family, the movable cone is explicitly described; it's fractal nature is related to limit sets of Kleinian groups and to the Apollonian Gasket. Then, we produce explicit examples of (biregular) automorphisms with positive entropy on some Calabi-Yau varieties.	[Cantat, Serge] CNRS, DMA, ENS ULM, UMR 8553, F-75230 Paris 05, France; [Oguiso, Keiji] Osaka Univ, Dept Math, Toyonaka, Osaka 5600043, Japan; [Oguiso, Keiji] Korea Inst Adv Study, Seoul 130722, South Korea	Cantat, S (reprint author), Univ Rennes 1, CNRS, IRMAR, UMR 6625, Bat 22-23 Campus Beaulieu, F-35042 Rennes, France.	serge.cantat@univ-rennes1.fr; oguiso@math.sci.osaka-u.ac.jp			JSPS Program [22340009]; KIAS Scholar Program	Research supported by JSPS Program 22340009 and by the KIAS Scholar Program.	Oguiso K, 2003, J ALGEBRAIC GEOM, V12, P405; Totaro B, 2010, DUKE MATH J, V154, P241, DOI 10.1215/00127094-2010-039; Cantat S, 2012, J AM MATH SOC, V25, P863; Birkar C, 2010, J AM MATH SOC, V23, P405; McMullen CT, 2002, J REINE ANGEW MATH, V545, P201; Oguiso K, 2011, J REINE ANGEW MATH, V661, P215, DOI 10.1515/CRELLE.2011.077; MORRISON DR, 1993, ASTERISQUE, P243; Kawamata Y, 2008, PUBL RES I MATH SCI, V44, P419, DOI 10.2977/prims/1210167332; Markman E, 2011, SPRINGER PROC MATH, V8, P257, DOI 10.1007/978-3-642-20300-8_15; Baragar A, 2011, CAN J MATH, V63, P481, DOI 10.4153/CJM-2011-006-7; Barth W., 2004, COMPACT COMPLEX SURF, V4; BARTH W, 1983, INVENT MATH, V73, P383, DOI 10.1007/BF01388435; Beardon A. F., 1995, GRAD TEXTS MATH, V91; Benoist Y, 2000, INVENT MATH, V141, P149, DOI 10.1007/PL00005789; BORCEA C, 1991, P S PURE MATH, V52, P83; BORCHERDS RE, 1998, INT MATH RES NOTICES, V19, P1011; Cantat S, 2001, ACTA MATH-DJURSHOLM, V187, P1, DOI 10.1007/BF02392831; Cossec F. R., 1989, ENRIQUES SURFACES 1, VI; Dinh TC, 2010, J ALGEBRAIC GEOM, V19, P473; Dolgachev IV, 2008, B AM MATH SOC, V45, P1; Fryers M. J., PREPRINT; GRASSI A, 1993, DUKE MATH J, V71, P831, DOI 10.1215/S0012-7094-93-07130-X; Gromov M., 2003, ENSEIGN MATH, V49, P217; Humphreys J., 1990, CAMBRIDGE STUD ADV M, V29; Kawaguchi S, 2008, AM J MATH, V130, P159, DOI 10.1353/ajm.2008.0008; Kawamata Y, 1997, INT J MATH, V8, P665, DOI 10.1142/S0129167X97000354; KAWAMATA Y, 1988, ANN MATH, V127, P93, DOI 10.2307/1971417; Kondo S., 1986, JAPAN J MATH, V12, P191; LAZARSFELD R., 2004, ERGEB MATH GRENZGEB, V48; Lee NH, 2009, COMMUN ANAL GEOM, V17, P283; Magnus W., 1974, PURE APPL MATH, V61; McMullen CT, 1998, AM J MATH, V120, P691, DOI 10.1353/ajm.1998.0031; Mcmullen CT, 2007, PUBL MATH-PARIS, V105, P49, DOI 10.1007/s10240-007-0004-x; MUKAI S, 1984, INVENT MATH, V77, P383, DOI 10.1007/BF01388829; Nikulin V., 1987, P INT C MATH BERK, V1, P654; Prendergast-Smith A, 2012, J MATH SCI-U TOKYO, V19, P243; Ratcliffe J.G., 2006, GRAD TEXTS MATH, V149; SILVERMAN JH, 1991, INVENT MATH, V105, P347, DOI 10.1007/BF01232270; VINBERG EB, 1985, RUSS MATH SURV+, V40, P31, DOI 10.1070/RM1985v040n01ABEH003527; Voisin C., 2003, CAMBRIDGE STUD ADV M, VII; WEHLER J, 1988, ARCH MATH, V50, P73, DOI 10.1007/BF01313498; WILSON PMH, 1997, AMS IP STUD ADV MATH, V1, P381; Zhang De-Qi, 2009, J DIFFER GEOM, V82, P691	43	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	0002-9327	1080-6377		AM J MATH	Am. J. Math.	AUG	2015	137	4					1013	1044		10.1353/ajm.2015.0023		32	Mathematics	Mathematics	CN2CL	WOS:000358227900004		
J	Oshima, Y				Oshima, Yoshiki			ON THE RESTRICTION OF ZUCKERMAN'S DERIVED FUNCTOR MODULES A(q)(lambda) TO REDUCTIVE SUBGROUPS	AMERICAN JOURNAL OF MATHEMATICS			English	Article							DISCRETE DECOMPOSABILITY; STANDARD MODULES; BRANCHING LAWS; RESPECT; REPRESENTATIONS; LOCALIZATION; COHOMOLOGY; VARIETIES	In this article, we study the restriction of Zuckerman's derived functor (g, K)-modules A(q)(lambda) to g' for symmetric pairs of reductive Lie algebras (g, g'). When the restriction decomposes into irreducible (g', K')-modules, we give an upper bound for the branching law. In particular, we prove that each (g', K')-module occurring in the restriction is isomorphic to a submodule of A(q')(lambda') for a parabolic subalgebra q' of g', and determine their associated varieties. For the proof, we realize A(q)(lambda) on complex partial flag varieties by using D-modules.	Univ Tokyo, Kavli IPMU WPI, Chiba 2778583, Japan	Oshima, Y (reprint author), Univ Tokyo, Kavli IPMU WPI, 5-1-5 Kashiwanoha Kashiwa, Chiba 2778583, Japan.	yoshiki.oshima@ipmu.jp			Japan Society for the Promotion of Science for Young Scientists	Research supported by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists.	KOBAYASHI T, 1993, P JPN ACAD A-MATH, V69, P262; HECHT H, 1987, INVENT MATH, V90, P297, DOI 10.1007/BF01388707; KOBAYASHI T, 1994, INVENT MATH, V117, P181, DOI 10.1007/BF01232239; Bien F. V., 1990, MATH NOTES, V39; Borel A., 1991, GRADUATE TEXTS MATH, V126; Duflo M, 2010, P JPN ACAD A-MATH, V86, P49, DOI 10.3792/pjaa.86.49; Gross B., 2000, P S PURE MATH, V68, P255; Hochschild G. P., 1981, GRAD TEXTS MATH, V75; Kitchen SN, 2012, REPRESENT THEOR, V16, P317; Knapp A. W., 1995, PRINCETON MATH SERIE, V45; Kobayashi T, 1998, INVENT MATH, V131, P229, DOI 10.1007/s002220050203; Kobayashi T, 2012, ADV MATH, V231, P2013, DOI 10.1016/j.aim.2012.07.006; Kobayashi T, 1998, ANN MATH, V147, P709; Kobayashi T, 2011, CONTEMP MATH, V557, P23; Kobayashi T, 2003, ADV MATH, V180, P513, DOI 10.1016/S0001-8708(03)00013-6; Loke HY, 2000, J FUNCT ANAL, V172, P377, DOI 10.1006/jfan.1999.3450; Milicic D., 1998, PROGR MATH, V158, P209; Orsted B., 2008, SYMMETRY INTEGR GEOM, V4, P19; Oshima Y, 2013, PUBL RES I MATH SCI, V49, P361, DOI 10.4171/PRIMS/108; Sekiguchi H, 2011, P JPN ACAD A-MATH, V87, P31, DOI 10.3792/pjaa.87.31; Vogan D. A., 1991, PROGR MATH, V101, P315	21	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	0002-9327	1080-6377		AM J MATH	Am. J. Math.	AUG	2015	137	4					1099	1138		10.1353/ajm.2015.0026		40	Mathematics	Mathematics	CN2CL	WOS:000358227900007		
J	Okazaki, T; Yamauchi, T				Okazaki, Takeo; Yamauchi, Takuya			ENDOSCOPIC LIFTS TO THE SIEGEL MODULAR THREEFOLD RELATED TO KLEIN'S CUBIC THREEFOLD (vol 135, pg 183, 2013)	AMERICAN JOURNAL OF MATHEMATICS			English	Correction									[Okazaki, Takeo] Nara Woman Univ, Fac Sci, Dept Math, Nara 6308506, Japan; [Yamauchi, Takuya] Kagoshima Univ, Fac Educ, Dept Math, Kagoshima 8900065, Japan	Okazaki, T (reprint author), Nara Woman Univ, Fac Sci, Dept Math, Nara 6308506, Japan.	okazaki@cc.nara-wu.ac.jp; yamauchi@edu.kagoshima-u.ac.jp					Okazaki T, 2013, AM J MATH, V135, P183	1	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	0002-9327	1080-6377		AM J MATH	Am. J. Math.	AUG	2015	137	4					1147	1147		10.1353/ajm.2015.0030		1	Mathematics	Mathematics	CN2CL	WOS:000358227900009		
J	Kawakami, R; Ohmori, T; Sakuraba, H; Ohshima, T				Kawakami, Ryushi; Ohmori, Taketo; Sakuraba, Haruhiko; Ohshima, Toshihisa			Identification of a novel amino acid racemase from a hyperthermophilic archaeon Pyrococcus horikoshii OT-3 induced by D-amino acids	AMINO ACIDS			English	Article						Hyperthermophilic archaea; Pyrococcus horikoshii; Amino acid requirement; D-Amino acid utilization; Amino acid racemase	PERFORMANCE LIQUID-CHROMATOGRAPHY; ASPARTATE RACEMASE; PYROBACULUM-ISLANDICUM; O-PHTHALDIALDEHYDE; CRYSTAL-STRUCTURE; MECHANISM; REQUIREMENTS; DERIVATIZATION; BIOSYNTHESIS; PURIFICATION	To date, there have been few reports analyzing the amino acid requirement for growth of hyperthermophilic archaea. We here found that the hyperthermophilic archaeon Pyrococcus horikoshii OT-3 requires Thr, Leu, Val, Phe, Tyr, Trp, His and Arg in the medium for growth, and shows slow growth in medium lacking Met or Ile. This largely corresponds to the presence, or absence, of genes related to amino acid biosynthesis in its genome, though there are exceptions. The amino acid requirements were dramatically lost by addition of d-isomers of Met, Leu, Val, allo-Ile, Phe, Tyr, Trp and Arg. Tracer analysis using C-14-labeled d-Trp showed that d-Trp in the medium was used as a protein component in the cells, suggesting the presence of d-amino acid metabolic enzymes. Pyridoxal 5'-phosphate (PLP)-dependent racemase activity toward Met, Leu and Phe was detected in crude extract of P. horikoshii and was enhanced in cells grown in the medium supplemented with d-amino acids, especially d-allo-Ile. The gene encoding the racemase was narrowed down to one open reading frame on the basis of enzyme purification from P. horikoshii cells, and the recombinant enzyme exhibited PLP-dependent racemase activity toward several amino acids, including Met, Leu and Phe, but not Pro, Asp or Glu. This is the first report showing the presence in a hyperthermophilic archaeon of a PLP-dependent amino acid racemase with broad substrate specificity that is likely responsible for utilization of d-amino acids for growth.	[Kawakami, Ryushi] Univ Tokushima, Div Environm Symbiosis Studies, Grad Sch Integrated Arts & Sci, Tokushima, Tokushima 7708502, Japan; [Ohmori, Taketo; Ohshima, Toshihisa] Osaka Inst Technol, Fac Engn, Dept Biomed Engn, Asahi Ku, Osaka 5358585, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Kawakami, R (reprint author), Univ Tokushima, Div Environm Symbiosis Studies, Grad Sch Integrated Arts & Sci, 1-1 Minamijosanjima Cho, Tokushima, Tokushima 7708502, Japan.	kawakami@tokushima-u.ac.jp					WATRIN L, 1995, APPL ENVIRON MICROB, V61, P1138; HOAKI T, 1994, APPL ENVIRON MICROB, V60, P2898; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sakuraba H, 2002, EXTREMOPHILES, V6, P275, DOI 10.1007/s00792-001-0254-3; Ohtaki A, 2008, PROTEINS, V70, P1167, DOI 10.1002/prot.21528; HOAKI T, 1993, APPL ENVIRON MICROB, V59, P610; Knaggs AR, 2003, NAT PROD REP, V20, P119, DOI 10.1039/b100399m; Mutaguchi Y, 2013, J BACTERIOL, V195, P5207, DOI 10.1128/JB.00709-13; Tishkov VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P40, DOI 10.1007/s10541-005-0050-2; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; Long ZQ, 2001, BIOCHEM BIOPH RES CO, V281, P317, DOI 10.1006/bbrc.2001.4353; Liu LJ, 2002, J MOL BIOL, V319, P479, DOI 10.1016/S0022-2836(02)00296-6; ASWAD DW, 1984, ANAL BIOCHEM, V137, P405, DOI 10.1016/0003-2697(84)90106-4; Gonzalez JM, 1998, EXTREMOPHILES, V2, P123, DOI 10.1007/s007920050051; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291; Kawakami R, 2005, FEBS J, V272, P4044, DOI 10.1111/j.1742-4658.2005.04810.x; Kawakami R, 2004, J BIOCHEM, V136, P541, DOI 10.1093/jb/mvh157; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kita A, 2009, PROTEINS, V74, P240, DOI 10.1002/prot.22244; Matsumoto M, 1999, J BACTERIOL, V181, P6560; Nagata Y, 1999, BBA-PROTEIN STRUCT M, V1435, P160, DOI 10.1016/S0167-4838(99)00208-3; Ohnishi M, 2008, J BACTERIOL, V190, P1359, DOI 10.1128/JB.01184-07; Robb Frank T., 1995, P167; Yoshida T, 2006, PROTEINS, V64, P502, DOI 10.1002/prot.21010	27	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1579	1587		10.1007/s00726-015-2001-6		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100009		
J	Kawamura, S; Ishihara, K; Masuoka, N				Kawamura, Shougo; Ishihara, Kohji; Masuoka, Noriyoshi			Property of angiotensin-I converting enzyme inhibitor in Japanese burdock root	AMINO ACIDS			English	Meeting Abstract									[Kawamura, Shougo; Ishihara, Kohji; Masuoka, Noriyoshi] Okayama Univ Sci, Dept Life Sci, Okayama, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1609	1610				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100018		
J	Masuoka, N; Zukeran, A; Kubo, I				Masuoka, Noriyoshi; Zukeran, Ayumi; Kubo, Isao			Inhibition of xanthine oxidase by alkyl phenol compounds	AMINO ACIDS			English	Meeting Abstract									[Masuoka, Noriyoshi; Zukeran, Ayumi; Kubo, Isao] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1609	1609				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100017		
J	Oda, M; Watanabe, S; Hirata, K; Shigesue, N; Suzumoto, K; Tanigawa, M; Tamegai, H; Kato, C; Nishimura, K				Oda, Mayumi; Watanabe, Shota; Hirata, Kohki; Shigesue, Natsue; Suzumoto, Koichiro; Tanigawa, Minoru; Tamegai, Hideyuki; Kato, Chiaki; Nishimura, Katsushi			Characterization of D-amino acid dehydrogenase in a deep-sea piezophilic bacterium, Shewanella violacea DSS12	AMINO ACIDS			English	Meeting Abstract									[Oda, Mayumi; Watanabe, Shota; Hirata, Kohki; Shigesue, Natsue; Suzumoto, Koichiro; Tanigawa, Minoru; Nishimura, Katsushi] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Tokyo 101, Japan; [Tamegai, Hideyuki] Nihon Univ, Coll Humanities & Sci, Dept Chem, Tokyo, Japan; [Kato, Chiaki] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1610	1610				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100019		
J	Bianchi, MG; Cavaliere, F; Almau, CM; Allegri, M; Chiu, M; Amor, S; van der Valk, P; Kagechika, H; Bussolati, O				Bianchi, Massimiliano G.; Cavaliere, Fabio; Matute Almau, Carlos; Allegri, Manfredi; Chiu, Martina; Amor, Sandra; van der Valk, Paul; Kagechika, Hiroyuki; Bussolati, Ovidio			Induction of the glutamate transporter EAAT3/EAAC1 in oligodendroglial cells: possible implications for cytoprotection in demyelinating conditions	AMINO ACIDS			English	Meeting Abstract									[Bianchi, Massimiliano G.; Allegri, Manfredi; Chiu, Martina; Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci SBiBiT, I-43100 Parma, Italy; [Cavaliere, Fabio; Matute Almau, Carlos] Univ Pais Vasco UPV EHU, Dept Neurociencias, Leioa, Spain; [Cavaliere, Fabio; Matute Almau, Carlos] Achucarro Basque Ctr Neurosci UPV EHU, Zamudio, Spain; [Cavaliere, Fabio; Matute Almau, Carlos] Inst Salud Carlos III, CIBERNED, Leioa, Spain; [Amor, Sandra; van der Valk, Paul] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan			Bussolati, Ovidio/B-7589-2013	Bussolati, Ovidio/0000-0002-4301-2939				0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1620	1620				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100035		
J	Yokoyama, Y; Kita, K; Hatano, S; Yokokawa, A				Yokoyama, Yukio; Kita, Kenta; Hatano, Sayumi; Yokokawa, Ayaka			Fast organo-cation chromatography of amino acids, nucleobases and nucleosides, and oligopeptides using a novel polyfunctional low-capacity cation-exchange column	AMINO ACIDS			English	Meeting Abstract									[Yokoyama, Yukio; Kita, Kenta; Hatano, Sayumi; Yokokawa, Ayaka] Yokohama Natl Univ, Yokohama, Kanagawa 240, Japan		yokyuk@ynu.ac.jp						0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1627	1628				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100058		
J	Tamura, R				Tamura, Rui			Highly efficient chiral resolution of DL-arginine and DL-phenylalanine by cocrystal formation followed by recrystallization under preferential enrichment conditions	AMINO ACIDS			English	Meeting Abstract									[Tamura, Rui] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1628	1629				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100061		
J	Tujioka, K; Yamada, T; Yokogoshi, H; Akiduki, S; Hishida, Y; Hayase, K				Tujioka, K.; Yamada, T.; Yokogoshi, H.; Akiduki, S.; Hishida, Y.; Hayase, K.			Role of thyroid hormone on the brain protein synthesis in rats fed the ornithine	AMINO ACIDS			English	Meeting Abstract									[Tujioka, K.] Ohkagakuen Univ, Fac Early Childhood Care & Educ, Toyoake, Aichi, Japan; [Yamada, T.; Yokogoshi, H.] Chubu Univ, Dept Food & Nutr Sci, Kasugai, Aichi 487, Japan; [Akiduki, S.; Hishida, Y.] KYOWA HAKKO BIO CO LTD, Healthcare Prod Dev Ctr, Tsukuba, Ibaraki, Japan; [Hayase, K.] Aichi Univ Educ, Dept Home Econ, Kariya, Aichi 448, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1637	1638				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100088		
J	Tojo, Y; Okamura, C; Takase, K; Mita, M; Hamase, K				Tojo, Yosuke; Okamura, Chieko; Takase, Kayo; Mita, Masashi; Hamase, Kenji			Free D-amino acids as physiologically active molecules in skin	AMINO ACIDS			English	Meeting Abstract									[Tojo, Yosuke; Okamura, Chieko; Takase, Kayo; Mita, Masashi] Shiseido Res Ctr, Yokohama, Kanagawa, Japan; [Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan							Tojo Y, 2008, J CHROMATOGR B, V875, P174, DOI 10.1016/j.jchromb.2008.06.025	1	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1652	1652				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100128		
J	Murakami, S; Fujita, M; Nakamura, M; Sakono, M; Nishizono, S; Sato, M; Imaizumi, K; Fukuda, N				Murakami, Shigeru; Fujita, Michiko; Nakamura, Masakazu; Sakono, Masanobu; Nishizono, Shoko; Sato, Masao; Imaizumi, Katsumi; Fukuda, Nobuhiro			Mechanism of the cholesterol-lowering effect of taurine	AMINO ACIDS			English	Meeting Abstract									[Murakami, Shigeru] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Fujita, Michiko; Nakamura, Masakazu; Sakono, Masanobu] Miyazaki Univ, Dept Biochem & Appl Biosci, Miyazaki, Japan; [Nishizono, Shoko] Sojo Univ, Fac Biotechnol & Life Sci, Kumamoto, Japan; [Sato, Masao; Imaizumi, Katsumi] Kyushu Univ, Fac Agr, Kyushu, Japan; [Fukuda, Nobuhiro] Miyazaki Int Coll, Sch Educ, Miyazaki, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1653	1654				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100132		
J	Vu, PL; Takatori, R; Iwamoto, T; Akagi, Y; Satsu, H; Totsuka, M; Chida, K; Sato, K; Shimizu, M				Phuong Le Vu; Takatori, Ryo; Iwamoto, Taku; Akagi, Yutaka; Satsu, Hideo; Totsuka, Mamoru; Chida, Kazuhiro; Sato, Kenji; Shimizu, Makoto			Prolyl-hydroxyproline, a collagen dipeptide, alters gene expression in a co-culture of mouse skin cells	AMINO ACIDS			English	Meeting Abstract									[Phuong Le Vu; Takatori, Ryo; Iwamoto, Taku; Akagi, Yutaka; Satsu, Hideo; Totsuka, Mamoru; Shimizu, Makoto] Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Satsu, Hideo] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gumma 3710816, Japan; [Chida, Kazuhiro] Univ Tokyo, Dept Anim Resource Sci, Tokyo 1138657, Japan; [Sato, Kenji] Kyoto Prefectural Univ, Div Appl Life Sci, Kyoto 6068522, Japan; [Shimizu, Makoto] Tokyo Univ Agr, Dept Nutr Sci, Tokyo 1568502, Japan		ms205346@nodai.ac.jp						0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1655	1656				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100138		
J	Yamashita, Y; Ohashi, Y; Takamatsu, S; Onoue, N; Morimoto, K; Tajima, Y; Aono, S; Onouchi, H; Naito, S				Yamashita, Yui; Ohashi, Yubun; Takamatsu, Seidai; Onoue, Noriyuki; Morimoto, Kyoko; Tajima, Yoko; Aono, Shiro; Onouchi, Hitoshi; Naito, Satoshi			Feedback regulation of methionine biosynthesis mediated by ribosome stalling in Arabidopsis	AMINO ACIDS			English	Meeting Abstract									[Yamashita, Yui; Ohashi, Yubun; Takamatsu, Seidai; Onoue, Noriyuki; Morimoto, Kyoko; Tajima, Yoko; Aono, Shiro; Onouchi, Hitoshi; Naito, Satoshi] Hokkaido Univ, Grad Sch Life Sci, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1657	1657				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100143		
J	Soda, K				Soda, Kuniyasu			Biological background of polyamine-induced lifespan extension	AMINO ACIDS			English	Meeting Abstract									[Soda, Kuniyasu] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1665	1665				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100167		
J	Kikuta, K; Kubota, D; Morioka, H; Nakamura, M; Matsumoto, M; Yoshida, A; Chuman, H; Kawai, A; Kondo, T				Kikuta, Kazutaka; Kubota, Daisuke; Morioka, Hideo; Nakamura, Masaya; Matsumoto, Morio; Yoshida, Akihiko; Chuman, Hirokazu; Kawai, Akira; Kondo, Tadashi			Proteomic study to develop biomarkers related to MRI findings of myxofibrosarcoma	AMINO ACIDS			English	Meeting Abstract									[Kikuta, Kazutaka; Kubota, Daisuke; Kondo, Tadashi] Natl Canc Ctr, Res Inst, Div Rare Canc Res, Tokyo 104, Japan; [Kikuta, Kazutaka; Morioka, Hideo; Nakamura, Masaya; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Yoshida, Akihiko] Natl Canc Ctr, Div Diag Pathol, Tokyo, Japan; [Kikuta, Kazutaka; Chuman, Hirokazu; Kawai, Akira] Natl Canc Ctr, Div Orthoped Surg, Tokyo, Japan		kkikuta922@gmail.com						0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1672	1672				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100189		
J	Miyazaki, T; Ishikura, K; Honda, A; Ra, SG; Ohmori, H; Matsuzaki, Y				Miyazaki, Teruo; Ishikura, Keisuke; Honda, Akira; Ra, Song-Gyu; Ohmori, Hajime; Matsuzaki, Yasushi			Serum concentrations of 3-hydroxyisobutyrate and 3-hydroxy-3-methylbutyrate as BCAA metabolites in endurance exercise	AMINO ACIDS			English	Meeting Abstract									[Miyazaki, Teruo; Honda, Akira; Matsuzaki, Yasushi] Tokyo Med Univ, Ibaraki Med Ctr, Ami, Ibaraki, Japan; [Ishikura, Keisuke; Ra, Song-Gyu; Ohmori, Hajime] Univ Tsukuba, Tsukuba, Ibaraki, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1675	1676				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100201		
J	Nagahara, N; Nagano, M; Ito, T; Suzuki, H				Nagahara, Noriyuki; Nagano, Masatoshi; Ito, Takaaki; Suzuki, Hidenori			14th International Congress on Amino Acids, Peptides and Proteins Redox regulation of a multifunctional enzyme, 3-mercaptopyruvate sulfurtransferase	AMINO ACIDS			English	Meeting Abstract									[Nagahara, Noriyuki] Nippon Med Sch, Isotope Res Ctr, Tokyo 113, Japan; [Nagano, Masatoshi; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol Experi Med, Kumamoto, Japan		noriyuki@nms.ac.jp						0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1685	1685				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100227		
J	Sakai, R; Toue, S; Chin, K; Kodama, R; Amao, M; Kawamata, Y; Watanabe, A; Miwa, T; Smriga, M; Kimura, T				Sakai, Ryosei; Toue, Sakino; Chin, Keigi; Kodama, Riho; Amao, Michiko; Kawamata, Yasuko; Watanabe, Akiko; Miwa, Tadashi; Smriga, Miro; Kimura, Takeshi			Plasma methionine and S-adenosylmethionine are potential biomarkers to determine tolerable upper intake level of methionine	AMINO ACIDS			English	Meeting Abstract									[Sakai, Ryosei; Toue, Sakino; Chin, Keigi; Kodama, Riho; Amao, Michiko; Kawamata, Yasuko; Watanabe, Akiko; Miwa, Tadashi; Smriga, Miro; Kimura, Takeshi] Ajinomoto Co Inc, Tokyo 148315, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1686	1686				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100230		
J	Oikawa, M; Chiba, M; Fujimoto, C; Ishikawa, Y				Oikawa, Masato; Chiba, Manami; Fujimoto, Chikako; Ishikawa, Yuichi			Biology-oriented diverted synthesis of glutamate analogs	AMINO ACIDS			English	Meeting Abstract									[Oikawa, Masato; Chiba, Manami; Fujimoto, Chikako; Ishikawa, Yuichi] Yokohama City Univ, Kanazawa Ku, Yokohama, Kanagawa 232, Japan		moikawa@yokohama-cu.ac.jp						0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1690	1690				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100241		
J	Hirato, Y; Tanigawa, M; Oda, M; Nishimura, K				Hirato, Yuki; Tanigawa, Minoru; Oda, Mayumi; Nishimura, Katsushi			Expression and Characterization of Alanine Racemase from the Green Alga Chlamydomonas reinhardtii	AMINO ACIDS			English	Meeting Abstract									[Hirato, Yuki; Tanigawa, Minoru; Oda, Mayumi; Nishimura, Katsushi] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Tokyo 102, Japan; [Nishimura, Katsushi] Nihon Univ, Dept Biotechnol & Mat Chem, Jr Coll, Tokyo 102, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1694	1694				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100254		
J	Miyatake, T; Yoshizawa, S; Arakawa, T; Shiraki, K				Miyatake, Takumi; Yoshizawa, Shunsuke; Arakawa, Tsutomu; Shiraki, Kentaro			The effect of charge state of arginine on heat-induced protein aggregation	AMINO ACIDS			English	Meeting Abstract									[Miyatake, Takumi; Yoshizawa, Shunsuke; Shiraki, Kentaro] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Arakawa, Tsutomu] Alliance Prot Labs, San Diego, CA 92121 USA								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1694	1694				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100256		
J	Fukada, Y				Fukada, Yoshitaka			Post-translational modifications of clock proteins bolster circadian rhythms	AMINO ACIDS			English	Meeting Abstract									[Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Tokyo 1138654, Japan								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	AUG	2015	47	8					1695	1695				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JH	WOS:000358175100258		
J	Grzeskowiak, L; Endo, A; Beasley, S; Salminen, S				Grzeskowiak, Lukasz; Endo, Akihito; Beasley, Shea; Salminen, Seppo			Microbiota and probiotics in canine and feline welfare	ANAEROBE			English	Article						Dog; Cat; Gut microbiota; Probiotic; Prebiotic; Veterinary care; Health	INFLAMMATORY-BOWEL-DISEASE; LACTIC-ACID BACTERIA; ENTEROCOCCUS-FAECIUM SF68; LACTOBACILLUS-ACIDOPHILUS STRAIN; IN-SITU HYBRIDIZATION; HEALTHY ADULT DOGS; RNA GENE ANALYSIS; INTESTINAL MICROBIOTA; ANTIMICROBIAL RESISTANCE; FECAL MICROBIOTA	Dogs and cats have been cohabiting with us for thousands of years. They are the major human companions. Today, dogs and cats live in urban areas. Cats and most dogs are on high carbohydrate diets and face similar life-style challenges as the human beings. The health and well-being of companion animals, just as their owners, depends on the gut microbes. Providing a proper care and nutritionally balanced diet to companion animals is recognised as a part of our responsibility to maintain the health and well being of our pet. However, as microbiota differences may facilitate exposure to pathogens and harmful environmental influences, it is prudent to search for novel tools to protect dogs and cats and at the same time the human owners from pathogens. Specific probiotic strains and/or their defined combinations may be useful in the canine and feline nutrition, therapy, and care. Probiotic supplementations have been successful in the prevention and treatment of acute gastroenteritis, treatment of IBD, and prevention of allergy in companion animals. New challenges for probiotic applications include maintenance of obesity and overweight, urogenital tract infections, Helicobacter gastritis and parasitic infections. The probiotics of human origin appear to be among the new promising tools for the maintenance of pets' health. However, the host-derived microorganisms might be the most appropriate probiotic source. Therefore, more controlled trials are needed to characterise new and safe probiotic preparations with an impact on general health and well being as well as health maintenance in dogs and cats. (C) 2015 Elsevier Ltd. All rights reserved.	[Grzeskowiak, Lukasz; Salminen, Seppo] Univ Turku, Funct Foods Forum, Turku 20014, Finland; [Endo, Akihito] Tokyo Univ Agr, Fac Bioind, Dept Food & Cosmet Sci, Sapporo, Hokkaido, Japan; [Beasley, Shea] Vetcare Ltd, Mantsala, Finland	Grzeskowiak, L (reprint author), Univ Turku, Funct Foods Forum, Itainen Pitkakatu 4 A, Turku 20014, Finland.	lukgrz@me.com					Simpson KW, 2009, J VET INTERN MED, V23, P476, DOI 10.1111/j.1939-1676.2009.0283.x; Araujo IC, 2010, J FELINE MED SURG, V12, P509, DOI 10.1016/j.jfms.2010.01.008; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Herstad HK, 2010, J SMALL ANIM PRACT, V51, P34, DOI 10.1111/j.1748-5827.2009.00853.x; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Lamendella R, 2008, APPL ENVIRON MICROB, V74, P575, DOI 10.1128/AEM.01221-07; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Silva BC, 2013, BENEF MICROBES, V4, P267, DOI 10.3920/BM2012.0048; McGreevy PD, 2005, VET REC, V156, P695; Damborg P, 2008, VET MICROBIOL, V132, P190, DOI 10.1016/j.vetmic.2008.04.026; vandenBogaard AE, 1997, NEW ENGL J MED, V337, P1558, DOI 10.1056/NEJM199711203372117; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Sykora J, 2005, J CLIN GASTROENTEROL, V39, P692; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Gisbert JP, 2014, DIGEST DIS SCI, V59, P383, DOI 10.1007/s10620-013-2900-x; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Marshall-Jones ZV, 2006, AM J VET RES, V67, P1005, DOI 10.2460/ajvr.67.6.1005; Suchodolski JS, 2011, VET CLIN N AM-SMALL, V41, P261, DOI 10.1016/j.cvsm.2010.12.006; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Mikkola R, 2000, EUR J BIOCHEM, V267, P4068, DOI 10.1046/j.1432-1033.2000.01467.x; Summa M, 2012, J CLIN VIROL, V53, P244, DOI 10.1016/j.jcv.2011.12.014; Sauter SN, 2006, J ANIM PHYSIOL AN N, V90, P269, DOI 10.1111/j.1439-0396.2005.00595.x; Handl S, 2013, FEMS MICROBIOL ECOL, V84, P332, DOI 10.1111/1574-6941.12067; Hagman R, 2014, THERIOGENOLOGY, V82, P114, DOI 10.1016/j.theriogenology.2014.03.007; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Kim SY, 2007, MICROBIOL IMMUNOL, V51, P919; Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464; Jia J, 2010, FEMS MICROBIOL ECOL, V71, P304, DOI 10.1111/j.1574-6941.2009.00812.x; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Harmoinen J, 2004, ANTIMICROB AGENTS CH, V48, P75, DOI 10.1128/AAC.48.1.75-79.2004; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Malewska K, 2011, POL J VET SCI, V14, P165, DOI 10.2478/v10181-011-0026-7; Grzeskowiak L, 2014, J APPL MICROBIOL, V116, P1308, DOI 10.1111/jam.12477; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Barry KA, 2011, J ANIM SCI, V89, P3163, DOI 10.2527/jas.2010-3445; Cohen SP, 2002, WESTERN J NURS RES, V24, P621, DOI 10.1177/019394502236636; Christensen HR, 2002, J IMMUNOL, V168, P171; Hang I, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-201; Hutchins RG, 2013, J VET INTERN MED, V27, P1368, DOI 10.1111/jvim.12174; Mercenier A, 2003, CURR PHARM DESIGN, V9, P175, DOI 10.2174/1381612033392224; Baillon MLA, 2004, AM J VET RES, V65, P338, DOI 10.2460/ajvr.2004.65.338; Zentek J, 2003, J ANIM PHYSIOL AN N, V87, P397, DOI 10.1046/j.0931-2439.2003.00451.x; Marcinakova M, 2006, FOLIA MICROBIOL, V51, P239, DOI 10.1007/BF02932129; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; Pascher M, 2008, ARCH ANIM NUTR, V62, P107, DOI 10.1080/17450390801892583; Biagi G, 2007, VET MICROBIOL, V124, P160, DOI 10.1016/j.vetmic.2007.03.013; Bunesova V, 2012, VET MICROBIOL, V160, P501, DOI 10.1016/j.vetmic.2012.06.005; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stoeker LL, 2013, VET IMMUNOL IMMUNOP, V153, P146, DOI 10.1016/j.vetimm.2013.01.017; Manninen TJK, 2006, APPL ENVIRON MICROB, V72, P6539, DOI 10.1128/AEM.02977-05; Delucchi L, 2008, CAN VET J, V49, P991; Luoto R, 2014, J ALLERGY CLIN IMMUN, V133, P405, DOI 10.1016/j.jaci.2013.08.020; Joffe D, 2011, CAN VET J, V52, P1323; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Roddie G, 2008, VET PARASITOL, V152, P85, DOI 10.1016/j.vetpar.2007.12.008; MACDONALD ML, 1984, ANNU REV NUTR, V4, P521; Clauss M, 2010, ZOO BIOL, V29, P687, DOI 10.1002/zoo.20302; Strompfova V, 2006, ANAEROBE, V12, P75, DOI 10.1016/j.anaerobe.2005.12.001; Walker WA, 2008, CLIN INFECT DIS, V46, pS87, DOI 10.1086/523335; Hammerum AM, 2012, CLIN MICROBIOL INFEC, V18, P619, DOI 10.1111/j.1469-0691.2012.03829.x; Bybee SN, 2011, J VET INTERN MED, V25, P856, DOI 10.1111/j.1939-1676.2011.0738.x; Weese JS, 2002, CAN VET J, V43, P771; Tang YR, 2012, APPL ENVIRON MICROB, V78, P7156, DOI 10.1128/AEM.01975-12; Kanasugi H, 1997, INT J IMMUNOPHARMACO, V19, P655; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Cerquetella M, 2012, REV ESP ENFERM DIG, V104, P65, DOI 10.4321/s1130-01082012000200004; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Sarowska J, 2013, ADV CLIN EXP MED, V22, P759; Benyacoub J, 2003, J NUTR, V133, P1158; Arfaee F., 2014, COMP CLIN PATHOL, V23, P135, DOI [http://dx.doi.org/10.1007/s00580-012-1584-5, DOI 10.1007/s00580-012-1584-5]; Beasley SS, 2006, J APPL MICROBIOL, V101, P131, DOI 10.1111/j.1365-2006.02884.x; Beloshapka AN, 2013, FEMS MICROBIOL ECOL, V84, P532, DOI 10.1111/1574-6941.12081; BENNO Y, 1992, J VET MED SCI, V54, P703; Colliard L., 2006, J NUTR, V136, P1951; DEBOER AS, 1991, APPL MICROBIOL BIOT, V36, P1; de Regt MJA, 2008, J ANTIMICROB CHEMOTH, V62, P1401, DOI 10.1093/jac/dkn390; FAO/WHO, 2002, GEN AN HLTH SPLOTL, P2002; Fieni F, 2014, REPROD DOMEST ANIM, V49, P28, DOI 10.1111/rda.12302; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Grzeskowiak L, 2013, J APPL MICROBIOL, V115, P539, DOI 10.1111/jam.12235; Hand D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053115; Harmoinen J., 2005, APPL ENVIRON MICROB, DOI [http://dx.doi.org/10.1128/AEM.71.8A169, DOI 10.1128/AEM.71.8A169]; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Holmes K.L., 2005, VET REC, V91, P695; Jergens AE, 2009, J VET INTERN MED, V23, P16, DOI 10.1111/j.1939-1676.2008.0211.x; Jergens Albert E, 2012, Front Biosci (Elite Ed), V4, P1404; Johnston K.L, 2001, COMP BACTERIAL FLORA, V218; Kelley R L, 2009, Vet Ther, V10, P121; Mahony D.O., 2009, PORTRAIT CANINE PROB, V139, P106, DOI [http://dx.doi.org/10.1016/j.vetmic.2009.05.002, DOI 10.1016/J.VETMIC.2009.05.002]; Marsella F., 2009, AM J VET RES, V70, P735, DOI [http://dx.doi.org/10.2460/ajvr.70.6.735, DOI 10.2460/AJVR.70.6.735]; Marsella F., 2012, VET IMMUNOL IMMUNOP, V146, P185, DOI [http://dx.doi.org/10.1016/j.vetimm.2012.02.013, DOI 10.1016/J.VETIMM.2012.02.013]; Mccoy S, 2007, J FOOD SCI, V72, pM94, DOI 10.1111/j.1750-3841.2007.00310.x; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Moyaert H, 2006, RES VET SCI, V81, P1, DOI 10.1016/j.rvsc.2005.10.004; Nermes M, 2013, ISRN ALLERGY, V2013, DOI [DOI 10.1155/2013/827934, http://dx.doi.org/10.1155/2013/827934]; Rodrigues H., 2013, PLOS ONE, V9, DOI [http://dx.doi.org/10.1371/journal.pone.003197, DOI 10.1371/J0URNAL.P0NE.003197]; Rossi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094699; Sarchahi A., 2013, VET MED PRAHA, P582; Tabrizi AS, 2010, VET MICROBIOL, V140, P142, DOI 10.1016/j.vetmic.2009.07.019; Strompfova V, 2014, ANAEROBE, V28, P37, DOI 10.1016/j.anaerobe.2014.05.001; Sturgeon A., 2014, VET J, DOI [http://dx.doi.org/10.1016/j.tvj1.2014.01.024, DOI 10.1016/J.TVJ1.2014.01.024]; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	112	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1075-9964	1095-8274		ANAEROBE	Anaerobe	AUG	2015	34						14	23		10.1016/j.anaerobe.2015.04.002		10	Microbiology	Microbiology	CN0IZ	WOS:000358098600003		
J	Li, ZP; Summanen, PH; Komoriya, T; Henning, SM; Lee, RP; Carlson, E; Heber, D; Finegold, SM				Li, Zhaoping; Summanen, Paula H.; Komoriya, Tomoe; Henning, Susanne M.; Lee, Ru-Po; Carlson, Eliisa; Heber, David; Finegold, Sydney M.			Pomegranate ellagitannins stimulate growth of gut bacteria in vitro: Implications for prebiotic and metabolic effects	ANAEROBE			English	Article						Pomegranate; Pomegranate extract; Pomegranate juice; Bifidobacteria; Lactobacilli; Intestinal bacteria; Prebiotic	MICROBIOTA; EXTRACT; ANTIOXIDANT; ANTIBACTERIAL; INFLAMMATION; OVERWEIGHT; BIFIDOBACTERIUM; JUICE	The present study investigated the effect of pomegranate extract (POMx) and pomegranate juice (POM juice) on the growth of major groups of intestinal bacteria: Enterobacteriaceae, Bacteroides fragilis group, clostridia, bifidobacteria, and lactobacilli, and the utilization of pomegranate polyphenols by Bifidobacterium and Lactobacillus. The total phenolic content of the pomegranate extract and juice was determined using the Folin-Ciocalteau colorimetric method and reported as gallic acid equivalent (GAE). The polyphenol composition was determined by HPLC. Stool specimens were incubated with 400, 100, and 25 mu g/ml GAE POMx and POM juice and subjected to selective culture. Bifidobacterium and Lactobacillus strains were incubated with 400 mu g/ml GAE POMx and POM juice and metabolites were analyzed. POMx and POM juice increased the mean counts of Bifidobacterium and Lactobacillus and significantly inhibited the growth of B. fragilis group, clostridia, and Enterobacteriaceae in a dose response manner. Bifidobacterium and Lactobacillus utilized ellagic acid and glycosyl ellagic acid but little or no punicalin was utilized. Neither POMx nor POM juice was converted to urolithins by the test bacteria or the in vitro stool cultures. The effect of pomegranate on the gut bacteria considered to be beneficial (Bifidobacterium and Lactobacillus) suggests that pomegranate may potentially work as a prebiotic. The concept that polyphenols such as those in pomegranate impact gut microbiota populations may establish a new role for polyphenols in human health. Published by Elsevier Ltd.	[Li, Zhaoping; Finegold, Sydney M.] VA Med Ctr West Los Angeles, Dept Med, Los Angeles, CA 90073 USA; [Li, Zhaoping; Summanen, Paula H.; Komoriya, Tomoe; Finegold, Sydney M.] VA Med Ctr West Los Angeles, Dept Res Serv, Los Angeles, CA 90073 USA; [Finegold, Sydney M.] Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Li, Zhaoping; Finegold, Sydney M.] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Li, Zhaoping; Henning, Susanne M.; Lee, Ru-Po; Carlson, Eliisa; Heber, David] Univ Calif Los Angeles, Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA; [Komoriya, Tomoe] Nihon Univ, Coll Ind Technol, Dept Sustainable Engn, Tokyo 102, Japan	Li, ZP (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Warren Hall,900 Weyburn Pl,Suite 14-171, Los Angeles, CA 90095 USA.	ZLi@mednet.ucla.edu			Department of Medicine, David Geffen School of Medicine at UCLA	This study is funded by Department of Medicine, David Geffen School of Medicine at UCLA. We thank Jeff Gornbein, Ph.D., UCLA, for statistical analysis.	Collado MC, 2008, AM J CLIN NUTR, V88, P894; ROGOSA M, 1951, J BACTERIOL, V62, P132; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Gomez-Caravaca AM, 2013, J AGR FOOD CHEM, V61, P5328, DOI 10.1021/jf400684n; Shema-Didi L, 2012, FREE RADICAL BIO MED, V53, P297, DOI 10.1016/j.freeradbiomed.2012.05.013; Mertens-Talcott SU, 2006, J AGR FOOD CHEM, V54, P8956, DOI 10.1021/jf061674h; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Kondo S, 2010, BIOSCI BIOTECH BIOCH, V74, P1656, DOI 10.1271/bbb.100267; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Neyrinck AM, 2013, BRIT J NUTR, V109, P802, DOI 10.1017/S0007114512002206; Shukla M, 2008, NUTRITION, V24, P733, DOI 10.1016/j.nut.2008.03.013; Bialonska D, 2010, INT J FOOD MICROBIOL, V140, P175, DOI 10.1016/j.ijfoodmicro.2010.03.038; Bialonska D, 2009, J AGR FOOD CHEM, V57, P8344, DOI 10.1021/jf901931b; Reddy MK, 2007, PLANTA MED, V73, P461, DOI 10.1055/s-2007-967167; Seeram NP, 2008, J MED FOOD, V11, P390, DOI 10.1089/jmf.2007.650; BEERENS H, 1990, LETT APPL MICROBIOL, V11, P155, DOI 10.1111/j.1472-765X.1990.tb00148.x; Cani Patrice D, 2012, Gut Microbes, V3, P279, DOI 10.4161/gmic.19625; Fawole OA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-200; Finegold S. M., 2014, NUTRITION, V10, P1210; Heber D, 2007, J AGR FOOD CHEM, V55, P10050, DOI 10.1021/jf071689v; Jousimies-Somer H. R., 2002, WADSORTH KTL ANAEROB, Vsixth; Panichayupakaranant P, 2010, FOOD CHEM, V123, P400, DOI 10.1016/j.foodchem.2010.04.054; Seeram MP, 2006, J NUTT, V136, P2481; Singleton V L, 1969, Adv Food Res Suppl, V1, P1; Spilmont M, 2014, EUR J NUTR, V53, P1155, DOI 10.1007/s00394-013-0615-6; Su XW, 2012, FOODBORNE PATHOG DIS, V9, P573, DOI 10.1089/fpd.2011.1046	27	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1075-9964	1095-8274		ANAEROBE	Anaerobe	AUG	2015	34						164	168		10.1016/j.anaerobe.2015.05.012		5	Microbiology	Microbiology	CN0IZ	WOS:000358098600026		
J	Katayama, S; Tagomori, M; Morita, N; Yamasaki, T; Nariya, H; Okada, M; Watanabe, M; Hitsumoto, Y				Katayama, Seiichi; Tagomori, Mika; Morita, Naomi; Yamasaki, Tsutomu; Nariya, Hirofumi; Okada, Mariko; Watanabe, Mariko; Hitsumoto, Yasuo			Determination of the Clostridium perfringens-binding site on fibronectin	ANAEROBE			English	Article						Clostridium perfringens; Fibronectin; Binding site	PROTEINS; ADHESIN	The extracellular matrix protein fibronectin (Fn) is known to bind to the surface of Clostridium perfringens cells. Fn is a disulfide-linked homodimer protein, with each Fn polypeptide consisting of three types of repeating modules: 12 type I, 2 type II, and 15-17 type III modules. To determine the epitope on Fn recognized by C. perfringens cells, anti-Fn monoclonal antibodies (mAbs) and various Fn fragments (III2-10, rIII(2-4), rIII(5-7), rIII(8), rIII(9), rIII(10)) were employed. Although two C perfringens-derived Fn-binding proteins, FbpA and FbpB, have been reported, they appear not to be the bacterium's surface Fn receptor. Moreover, both FbpA and FbpB were found to bind to C perfringens cells. To avoid confusion, a mutant C perfringens lacking both the fbpA and fbpB genes (MW5) was prepared using an in-frame deletion system. MW5 cells bound Fn on their surface, suggesting the presence of a putative Fn receptor(s) on C perfringens cells. Of several anti-Fn mAbs, both HB39 and MO inhibited the binding of Fn to MW5 cells. HB39 reacted strongly with III2-10 and rIII(9), and weakly with rIII(2-4), rIII(10) and rIII(5-7) in Western blotting analysis. Binding of HB39 to Fn was inhibited in the presence of either rIII(9) or rIII(10), but not in the presence of rIII(2-4), rIII(5-7), or rIII(8). Binding of Fn to MW5 cells was strongly inhibited by both III2-10 and rills, marginally inhibited by rIII(2-4), but not affected by rIII(5-7), rIII(8), or rIII(10). Significant binding of MW5 cells to immobilized rIII(9) and rIII(10) as well as immobilized III2-10 was observed. The region of Fn recognized by C perfringens was thus mapped to the region encompassed by III9 and (C) 2014 Elsevier Ltd. All rights reserved.	[Katayama, Seiichi; Tagomori, Mika; Morita, Naomi; Yamasaki, Tsutomu; Watanabe, Mariko; Hitsumoto, Yasuo] Okayama Univ Sci, Dept Life Sci, Fac Sci, Kita Ku, Okayama, Okayama 7000005, Japan; [Nariya, Hirofumi] Kagawa Univ, Dept Microbiol, Fac Med, Miki, Kagawa 7610793, Japan; [Okada, Mariko] Ehime Prefectural Univ Hlth Sci, Dept Med Technol, Tobe, Ehime 7912101, Japan	Hitsumoto, Y (reprint author), Okayama Univ Sci, Dept Life Sci, Fac Sci, Kita Ku, 1-1 Ridai Cho, Okayama, Okayama 7000005, Japan.	hitsumot@dls.ous.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of japan [23590524]	This work was supported by a Grant-in-aid For Scientific Research (No. 23590524) from the Ministry of Education, Culture, Sports, Science, and Technology of japan.	[Anonymous], 2012, J BIOL CHEM; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micnif.2006.03.011; Hitsumoto Y, 2014, ANAEROBE, V25, P67, DOI 10.1016/j.anaerobe.2013.11.002; Felek S, 2009, INFECT IMMUN, V77, P825, DOI 10.1128/IAI.00913-08; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; BORSI L, 1986, ANAL BIOCHEM, V155, P335, DOI 10.1016/0003-2697(86)90443-4; Okada M, 2006, HYBRIDOMA, V25, P202, DOI 10.1089/hyb.2006.25.202; Katayama S, 2006, ACTA MED OKAYAMA, V60, P351; Katayama S, 2009, ANAEROBE, V15, P155, DOI 10.1016/j.anaerobe.2009.03.001; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; MATSUSHITA C, 1994, PLASMID, V31, P317, DOI 10.1006/plas.1994.1035; Mosher OF, 1984, ANNU REV MED, V35, P561; Mullen LM, 2008, INFECT IMMUN, V76, P1093, DOI 10.1128/IAI.01349-07; Nariya H, 2011, APPL ENVIRON MICROB, V77, P1375, DOI 10.1128/AEM.01572-10; Prabhakaran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005412; Sambrook J., 1989, MOL CLONING LAB MANU; Yamasaki T, 2010, MICROBIOL IMMUNOL, V54, P221, DOI 10.1111/j.1348-0421.2010.00201.x; Yamasaki T, 2010, J ANAL BIOSCI, V33, P173	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1075-9964	1095-8274		ANAEROBE	Anaerobe	AUG	2015	34						174	181		10.1016/j.anaerobe.2014.11.007		8	Microbiology	Microbiology	CN0IZ	WOS:000358098600028		
J	Yamamoto, S; Tamata, Y; Sejima, K; Kinoshita, M; Suzuki, S				Yamamoto, Sachio; Tamata, Yoko; Sejima, Kaori; Kinoshita, Mitsuhiro; Suzuki, Shigeo			Chiral separation of D/L-aldoses by micellar electrokinetic chromatography using a chiral derivatization reagent and a phenylboronic acid complex	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Chiral separation; D/L-Aldose separation; Micellar electrokinetic chromatography; Phenylboronic acid complex; (S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole	CAPILLARY ELECTROMIGRATION TECHNIQUES; D-TAGATOSE; L-GLUCOSE; L-FRUCTOSE; ELECTROPHORESIS; ENANTIOMERS; BORATE; CE; MONOSACCHARIDES; RESOLUTION	A novel method was developed for d/l-isomeric separation of aldopentoses and aldohexoses as their (S)-(+)-4-(N,N-dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole derivatives using phenylboronate buffer containing sodium dodecyl sulfate as a background electrolyte. The combination of derivatization with a chiral labeling reagent and micellar electrokinetic chromatography with phenylboronate made possible the efficient separation of d/l isomers as well as epimeric isomers of aldopentoses and aldohexoses. Laser-induced fluorescence detection permitted the micromolar-level determination of monosaccharide derivatives. The limit of detection was 105 amol (300 nM), and the repeatabilities of the migration times and peak area responses were 0.8 % and 7.9 % (relative standard deviation; n = 6), respectively. The method was applied to the determination of d/l- galactose in red seaweed.	[Yamamoto, Sachio; Tamata, Yoko; Sejima, Kaori; Kinoshita, Mitsuhiro; Suzuki, Shigeo] Kinki Univ, Fac Pharmaceut Sci, Higashi, Osaka 5778502, Japan	Yamamoto, S (reprint author), Kinki Univ, Fac Pharmaceut Sci, 3-4-1 Kowakae, Higashi, Osaka 5778502, Japan.	yamamoto@phar.kindai.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by the "Antiaging Center Project" for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, 2013-2014.	Amin NC, 2012, J CHROMATOGR A, V1264, P1, DOI 10.1016/j.chroma.2012.09.057; Jac P, 2013, J SEP SCI, V36, P52, DOI 10.1002/jssc.201200836; Itoh H, 1996, J FERMENT BIOENG, V81, P351, DOI 10.1016/0922-338X(96)80590-3; Sanchez-Hernandez L, 2014, ELECTROPHORESIS, V35, P12, DOI 10.1002/elps.201300355; CHEETHAM PSJ, 1993, ENZYME MICROB TECH, V15, P105, DOI 10.1016/0141-0229(93)90032-W; Schwaninger AE, 2012, J CHROMATOGR A, V1269, P122, DOI 10.1016/j.chroma.2012.07.045; Castro-Puyana M, 2012, ELECTROPHORESIS, V33, P147, DOI 10.1002/elps.201100385; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Yanagisawa M, 2011, PROCESS BIOCHEM, V46, P2111, DOI 10.1016/j.procbio.2011.08.001; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77; Giuffrida A, 2014, J CHROMATOGR A, V1363, P41, DOI 10.1016/j.chroma.2014.08.041; Kuhn R, 1999, ELECTROPHORESIS, V20, P2605, DOI 10.1002/(SICI)1522-2683(19990901)20:13<2605::AID-ELPS2605>3.3.CO;2-D; Goncalves AG, 2002, CARBOHYD RES, V337, P2443, DOI 10.1016/S0008-6215(02)00318-X; Lopes JF, 2008, J CHROMATOGR A, V1188, P34, DOI 10.1016/j.chroma.2007.12.016; STEFANSSON M, 1993, J AM CHEM SOC, V115, P11573, DOI 10.1021/ja00077a064; Marinho-Soriano E, 2003, BIORESOURCE TECHNOL, V90, P329, DOI 10.1016/S0960-8524(03)00112-3; Livesey G, 1996, J NUTR, V126, P1601; Fanali S, 2009, ELECTROPHORESIS, V30, pS203, DOI 10.1002/elps.200900056; Aturki Z, 2011, ELECTROPHORESIS, V32, P2602, DOI 10.1002/elps.201100153; Bautista DA, 2000, J FOOD PROTECT, V63, P71; Chankvetadze B, 2009, ELECTROPHORESIS, V30, pS211, DOI 10.1002/elps.200900102; Errea MI, 2003, CARBOHYD RES, V338, P943, DOI 10.1016/S0008-6215(03)00037-5; Grassmann E, 1985, SCIENCE, V230, P813; Hasehira K, 2011, CARBOHYD RES, V346, P2693, DOI 10.1016/j.carres.2011.09.021; HOFFSTETTERKUHN S, 1991, ANAL CHEM, V63, P1541, DOI 10.1021/ac00015a009; HONDA S, 1981, J CHROMATOGR, V226, P341, DOI 10.1016/S0378-4347(00)86068-5; Kodama S, 2007, ELECTROPHORESIS, V28, P3930, DOI 10.1002/elps.200700306; Kuo CY, 2011, MOLECULES, V16, P1682, DOI 10.3390/molecules16021682; Lawson CJ, 2002, NEUROBIOL LEARN MEM, V77, P17, DOI 10.1006/nlme.2000.4001; Leang K, 2003, J BIOSCI BIOENG, V95, P310, DOI 10.1016/S1389-1723(03)80036-1; Ma RJ, 2014, POLYM CHEM-UK, V5, P1503, DOI 10.1039/c3py01202f; Plotka JM, 2012, TRAC-TREND ANAL CHEM, V31, P23, DOI 10.1016/j.trac.2011.06.021; Sui L, 2005, INT J ONCOL, V27, P907; TOYOOKA T, 1992, ANALYST, V117, P727, DOI 10.1039/an9921700727; Zhang HZ, 2012, J SEP SCI, V35, P1236, DOI 10.1002/jssc.201200067	36	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	AUG	2015	407	20					6201	6206		10.1007/s00216-015-8802-3		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CN4AS	WOS:000358371200032		
J	Kikuchi, Y; Kuraoka, A				Kikuchi, Y.; Kuraoka, A.			Sexual Dimorphism of Endocranial, Facial and Limb Measurements in the Yellow Baboon (Papio cynocephalus)	ANATOMIA HISTOLOGIA EMBRYOLOGIA			English	Article							MANDRILLS MANDRILLUS-SPHINX; VIRUNGA MOUNTAIN GORILLAS; OLD-WORLD MONKEYS; HAMADRYAS BABOONS; NASALIS-LARVATUS; NATIONAL-PARK; ANTHROPOID PRIMATES; MULTILEVEL SOCIETY; CANINE DIMORPHISM; SOCIAL-STRUCTURE	The present study focused on the sexual dimorphism of yellow baboon (Papio cynocephalus) to clarify its relationship with social behaviour. The degree of sexual dimorphism in the endocranial volume is the lowest among the investigated measurements. Among the facial measurements, the degree value of sexual dimorphism was the maximum (38.4%) for palate length and the minimum for palate breadth at the upper second molar (M2) (16.8%). Reduced major axis (RMA) regression analysis indicated that most positive allometry in relation to body mass was barely shown in the endocranial volume, palate length, palate breadth at M2 and mandibular ramal width. On the other hand, most negative allometry in relation to body mass was barely indicated in the bizygomatic breadth, skull length, humeral length and femoral length. The plate breadth at M2 in males was smaller than that in females in equivalent to body mass. The results of the present study suggest that more males have longer pointed muzzles than females, which is considered to create an impressive view of large canine teeth. This contributes to display among males and agonistic encounters rather than to necessity of increased facial size due to larger body size or dietary influences.	[Kikuchi, Y.; Kuraoka, A.] Saga Univ, Div Human Anat & Biol Anthropol, Dept Anat & Physiol, Fac Med, Saga 8498501, Japan	Kikuchi, Y (reprint author), Saga Univ, Div Human Anat & Biol Anthropol, Dept Anat & Physiol, Fac Med, Saga 8498501, Japan.	kikuchiy@cc.saga-u.ac.jp			JSPS Nairobi research station	We extend our gratitude to the Office of the President of the Republic of Kenya, the directors, especially Idle Farah and Emma Mbua, and the staff of the National Museums of Kenya for permission to carry out research in Kenya. The JSPS Nairobi research station provided us supports to conduct research in Kenya.	ALTMANN SA, 1974, AM ZOOL, V14, P221; Jolly CJ, 2011, AM J PRIMATOL, V73, P291, DOI 10.1002/ajp.20896; Abernethy KA, 2002, J ZOOL, V258, P131, DOI 10.1017/S0952836902001267; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; YAMAGIWA J, 1987, PRIMATES, V28, P1, DOI 10.1007/BF02382180; Matsuda I, 2010, AM J PHYS ANTHROPOL, V142, P235, DOI 10.1002/ajpa.21218; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; PLAVCAN JM, 1992, AM J PHYS ANTHROPOL, V87, P461, DOI 10.1002/ajpa.1330870407; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Frost SR, 2003, ANAT REC PART A, V275A, P1048, DOI 10.1002/ar.a.10112; Yamagiwa J, 2009, PRIMATES, V50, P293, DOI 10.1007/s10329-009-0163-0; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Barton RA, 1996, BEHAV ECOL SOCIOBIOL, V38, P321, DOI 10.1007/s002650050248; HARCOURT AH, 1979, ANIM BEHAV, V27, P325, DOI 10.1016/0003-3472(79)90166-0; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Schreier AL, 2009, AM J PRIMATOL, V71, P948, DOI 10.1002/ajp.20736; Gilbert CC, 2009, J HUM EVOL, V57, P298, DOI 10.1016/j.jhevol.2009.05.013; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; YAMAGIWA J, 1993, BIOL CONSERV, V64, P83, DOI 10.1016/0006-3207(93)90386-F; KUMMER H, 1984, ANIM BEHAV, V32, P965, DOI 10.1016/S0003-3472(84)80208-0; Henzi P, 2003, EVOL ANTHROPOL, V12, P217, DOI 10.1002/evan.10121; Rogers ME, 1996, AM J PRIMATOL, V40, P297, DOI 10.1002/(SICI)1098-2345(1996)40:4<297::AID-AJP1>3.0.CO;2-T; Boonratana R, 2000, INT J PRIMATOL, V21, P497, DOI 10.1023/A:1005496004129; Caldecott J.O., 1981, Malaysian Applied Biology, V10, P213; Cheney D.L., 1987, P227; Cochard L. R., 1985, SIZE SCALING PRIMATE, P231; Colmenares F, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P242; Colmenares F, 2006, AM J PRIMATOL, V68, P21, DOI 10.1002/ajp.20204; Dunn J, 2013, J ANAT, V223, P337, DOI 10.1111/joa.12085; Fooden J, 2000, FIELDIANA ZOOLOGY, V96, P1; Fukase H, 2011, AM J PHYS ANTHROPOL, V144, P607, DOI 10.1002/ajpa.21449; Groves C., 2001, PRIMATE TAXONOMY; HARVEY PH, 1978, J ZOOL, V186, P475; HOSHINO J, 1984, Primates, V25, P295, DOI 10.1007/BF02382268; Imbrie J., 1956, B AM MUS NAT HIST, V108, P215; Jolly C., 2007, PRIMATES PERSPECTIVE, P240; Jolly Clifford J., 1993, P67; Kamilar J. M., 2006, PRIMATE BIOGEOGRAPHY, P168; KELLEY J, 1995, AM J PHYS ANTHROPOL, V96, P365, DOI 10.1002/ajpa.1330960405; Kingdon J., 1997, KINGDON FIELD GUIDE; Koppe T, 2004, ANN ANAT, V186, P367, DOI 10.1016/S0940-9602(04)80065-7; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Kummer H., 1971, PRIMATE SOC; Leigh SR, 2006, AM J PHYS ANTHROPOL, V130, P71, DOI 10.1002/ajpa.20319; Leigh SR, 2005, AM J PHYS ANTHROPOL, V127, P296, DOI 10.1002/ajpa.20096; Leigh SR, 2008, J HUM EVOL, V55, P75, DOI 10.1016/j.jhevol.2008.01.001; LEIGH SR, 1991, AM J PHYS ANTHROPOL, V84, P193; LEUTENEGGER W, 1985, FOLIA PRIMATOL, V44, P82, DOI 10.1159/000156199; Leutenegger W., 1982, International Journal of Primatology, V3, P387, DOI 10.1007/BF02693740; Van Schaik Carel P., 1996, P3, DOI 10.1017/CBO9780511752414.003; McNeilage A, 2001, ORYX, V35, P39, DOI 10.1046/j.1365-3008.2001.00154.x; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Nystrom P, 2004, AM J PHYS ANTHROPOL, V125, P279, DOI 10.1002/ajpa.10274; Organ JM, 2006, J HUM EVOL, V51, P113, DOI 10.1016/j.jhevol.2006.01.007; Phillips-Conroy JE, 2009, AM J PHYS ANTHROPOL, P211; Pickford M., 1986, P77; PLOTNICK RE, 1989, SYST ZOOL, V38, P144, DOI 10.2307/2992383; RAVOSA MJ, 1991, INT J PRIMATOL, V12, P403, DOI 10.1007/BF02547620; Shea B., 1988, HETEROCHRONY EVOLUTI, P237; Shea B.T., 1985, P175; Shea B. T., 1986, HUM EVOL, V1, P97, DOI 10.1007/BF02437489; STEUDEL K, 1982, AM J PHYS ANTHROPOL, V59, P419, DOI 10.1002/ajpa.1330590412; Willmore KE, 2009, EVOLUTION, V63, P799, DOI 10.1111/j.1558-5646.2008.00593.x; Wood C. D., 1982, ATLAS PRIMATE GROSS; YEAGER CP, 1990, AM J PRIMATOL, V20, P95, DOI 10.1002/ajp.1350200204; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	68	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0340-2096	1439-0264		ANAT HISTOL EMBRYOL	Anat. Histol. Embryol.	AUG	2015	44	4					275	282		10.1111/ahe.12136		8	Anatomy & Morphology; Veterinary Sciences	Anatomy & Morphology; Veterinary Sciences	CN1JV	WOS:000358176700006		
J	Yabuki, A; Sawa, M; Chang, HS; Yamato, O				Yabuki, A.; Sawa, M.; Chang, H. -S.; Yamato, O.			A Practical Technique for Electron Microscopy of Buffy Coats in Dogs and Cats	ANATOMIA HISTOLOGIA EMBRYOLOGIA			English	Article							CELLS	Plastic hematocrit tubes (PHTs) are convenient tools for electron microscopy (EM) of peripheral blood buffy coats, and the PHT-EM technique is expected to be a practical method for veterinary clinical medicine. In this study, fixatives composed of various concentrations of sucrose, glutaraldehyde, and phosphate buffer (PB) were tested for preparing canine and feline buffy coats. The highest quality images were obtained using a fixative consisting of 2.5% glutaraldehyde in 0.1m PB, and it was concluded that this method allows clinicians who are inexperienced in histological techniques can conveniently transport buffy coat samples to diagnostic laboratories for analysis by EM.	[Yabuki, A.; Sawa, M.; Chang, H. -S.; Yamato, O.] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Clin Pathol, Kagoshima 890, Japan	Yabuki, A (reprint author), Kagoshima Univ, Joint Fac Vet Med, Lab Vet Clin Pathol, Kagoshima 890, Japan.	yabu@vet.kagoshima-u.ac.jp					Anderson GW, 2006, ULTRASTRUCT PATHOL, V30, P373, DOI 10.1080/01913120500406566; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; BONE Q, 1971, J CELL BIOL, V49, P571, DOI 10.1083/jcb.49.3.571; BUORO IBJ, 1989, VET REC, V125, P434; Dvorak A M, 1981, Pathol Annu, V16 Pt 1, P101; Dykstra M. J., 1993, MANUAL APPL TECHNIQU, P64; GRINDEM CB, 1985, VET PATHOL, V22, P456; HATTORI A, 1970, Archivum Histologicum Japonicum, V32, P307; IWADARE T, 1990, STAIN TECHNOL, V65, P205; MILLS AE, 1990, ULTRASTRUCT PATHOL, V14, P173	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0340-2096	1439-0264		ANAT HISTOL EMBRYOL	Anat. Histol. Embryol.	AUG	2015	44	4					317	320		10.1111/ahe.12143		4	Anatomy & Morphology; Veterinary Sciences	Anatomy & Morphology; Veterinary Sciences	CN1JV	WOS:000358176700011		
J	Ino, H; Masamune, T; Sato, H; Okuyama, K; Wada, K; Iwashita, H; Ishiyama, T; Oguchi, T; Sessler, DI; Matsukawa, T				Ino, Hirofumi; Masamune, Taishi; Sato, Hiroaki; Okuyama, Katsumi; Wada, Keiichi; Iwashita, Hironobu; Ishiyama, Tadahiko; Oguchi, Takeshi; Sessler, Daniel I.; Matsukawa, Takashi			The Effects of Blood Glucose Concentration on the Shivering Threshold in Rabbits	ANESTHESIA AND ANALGESIA			English	Article							BROWN ADIPOSE-TISSUE; COLD-EXPOSURE; MUSCLE GLYCOGEN; NONSHIVERING THERMOGENESIS; VASOCONSTRICTION THRESHOLD; NONLINEAR DECREASES; CORE-TEMPERATURE; PLASMA-GLUCOSE; HUMANS; HYPOGLYCEMIA	BACKGROUND: Hyperglycemia is common in critically ill and surgical patients, as are core temperature disturbances. The effect of hyperglycemia on thermoregulatory defenses remains unknown. We determined the effect of blood glucose concentration on the shivering threshold in rabbits. METHODS: Twenty-seven rabbits lightly anesthetized with isoflurane were randomly assigned to infusions of (1) saline, (2) insulin titrated to produce blood glucose concentrations 60 to 100 mg/dL, or (3) 50% dextrose titrated to produce blood glucose concentrations 200 to 300 mg/dL. Core temperature was reduced at a rate of 2 to 3 degrees C/h by perfusing water at 10 degrees C through a plastic tube positioned in the colon. Cooling continued until shivering was observed by an investigator blinded to treatment or until esophageal (core) temperature reached 34 degrees C. Core temperatures at the onset of shivering defined the threshold. All analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC). RESULTS: Rabbits given saline shivered at 37.2 0.5 degrees C (mean +/- SD). Rabbits given insulin shivered at 36.3 +/- 1.1 degrees C. Rabbits given dextrose shivered at 38.0 +/- 0.6 degrees C. The shivering threshold increased as a function of blood glucose concentration: shivering threshold (degrees C) = 0.009 [blood glucose concentration (mg/dL)] + 35.6, r(2) = 0.53. The shivering threshold thus increased approximately 1 degrees C for each 100 mg/dL increase in blood glucose concentration. CONCLUSIONS: Hyperglycemia increases the threshold for shivering, whereas hypoglycemia lowers the threshold on rabbits.	[Ino, Hirofumi; Masamune, Taishi; Sato, Hiroaki; Iwashita, Hironobu; Ishiyama, Tadahiko; Oguchi, Takeshi; Matsukawa, Takashi] Univ Yamanashi, Dept Anesthesiol, Tokyo, Japan; [Okuyama, Katsumi] Shizuoka Childrens Hosp, Dept Anesthesiol, Tokyo, Japan; [Wada, Keiichi] Fujiyoshida Municipal Hosp, Dept Anesthesiol, Tokyo, Japan; [Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA	Ino, H (reprint author), Univ Yamanashi, Dept Anesthesiol, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	hino@yamanashi.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [B-23791692]	This work was supported by Grants-in-Aid for Scientific Research Number B-23791692 from the Japan Society for the Promotion of Science, Tokyo, Japan. None of the authors has a personal financial interest in this work.	Alfonsi P, 1998, ANESTHESIOLOGY, V89, P43, DOI 10.1097/00000542-199807000-00009; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Shibuya K, 2009, J NEUROSURG ANESTH, V21, P40, DOI 10.1097/ANA.0b013e31818b22d5; GALE EAM, 1983, CLIN SCI, V65, P263; Xiong JY, 1996, ANESTHESIOLOGY, V85, P240, DOI 10.1097/00000542-199608000-00003; LESLIE K, 1994, ANESTHESIOLOGY, V81, P353, DOI 10.1097/00000542-199408000-00013; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; KURZ A, 1995, ANESTHESIOLOGY, V83, P491, DOI 10.1097/00000542-199509000-00007; GALE EAM, 1981, CLIN SCI, V61, P463; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; KLUGER MJ, 1991, PHYSIOL REV, V71, P93; Abdelmalak BB, 2013, BRIT J ANAESTH, V111, P209, DOI 10.1093/bja/aet050; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; ANNADATA R, 1995, ANESTHESIOLOGY, V83, P1205, DOI 10.1097/00000542-199512000-00011; KURZ A, 1995, ANESTHESIOLOGY, V82, P870, DOI 10.1097/00000542-199504000-00008; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; Kurz A, 1997, ANESTHESIOLOGY, V86, P1046, DOI 10.1097/00000542-199705000-00007; LOPEZ M, 1994, ANESTHESIOLOGY, V80, P780, DOI 10.1097/00000542-199404000-00009; Haman F, 2004, J APPL PHYSIOL, V96, P32, DOI 10.1152/japplphysiol.00427.2003; Haman F, 2002, J APPL PHYSIOL, V93, P77, DOI 10.1152/japplphysiol.00773.2001; Haman F, 2005, J PHYSIOL-LONDON, V566, P247, DOI 10.1113/jphysiol.2005.086272; Blondin DP, 2010, EUR J APPL PHYSIOL, V108, P289, DOI 10.1007/s00421-009-1210-7; Blondin DP, 2012, MED SCI SPORT EXER, V44, P1706, DOI 10.1249/MSS.0b013e318254e952; Hales J.R.S., 1985, CARDIOVASCULAR SHUNT, P433; Hori T, 1997, JAPANESE J ACUTE MED, V21, P1009; Ikeda T, 1998, ANESTHESIOLOGY, V88, P858, DOI 10.1097/00000542-199804000-00003; Imai Y, 2008, EUR J ANAESTH, V25, P450, DOI 10.1017/S026502150800392X; JORIS J, 1994, ANESTHESIOLOGY, V80, P268, DOI 10.1097/00000542-199402000-00006; MAGGS DG, 1994, AM J PHYSIOL-REG I, V267, pR1266; Masamune T, 2009, ANESTH ANALG, V109, P96, DOI 10.1213/ane.0b013e3181a1a5ed; Mizobe T, 2006, ANESTHESIOLOGY, V104, P1124, DOI 10.1097/00000542-200606000-00005; Oka T, 1994, AM J PHYSIOL, V267, pR289; Ota K, 1997, AM J PHYSIOL-REG I, V272, pR532; Plattner O, 1997, ANESTHESIOLOGY, V86, P772, DOI 10.1097/00000542-199704000-00006; SILVA NL, 1984, AM J PHYSIOL, V247, pR335; STRAUCH BS, 1969, J AMER MED ASSOC, V210, P345; Young AJ, 2007, APPL PHYSIOL NUTR ME, V32, P793, DOI 10.1139/H07-041	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	AUG	2015	121	2					525	531		10.1213/ANE.0000000000000844		7	Anesthesiology	Anesthesiology	CN4FU	WOS:000358386800008		
J	Okada, K; Archer, CR; Katsuki, M; Suzaki, Y; Sharma, MD; House, CM; Hosken, DJ				Okada, Kensuke; Archer, C. Ruth; Katsuki, Masako; Suzaki, Yu; Sharma, Manmohan D.; House, Clarissa M.; Hosken, David J.			Polyandry and fitness in female horned flour beetles, Gnatocerus cornutus	ANIMAL BEHAVIOUR			English	Article						Coleoptera; female choice; Fisherian process; good genes; Insecta; monandry; polyandry; sexual selection	GENETIC BENEFITS; OFFSPRING VIABILITY; POPULATION BIOLOGY; SPERM COMPETITION; SEXUAL CONFLICT; LIFE-HISTORY; COSTS; EVOLUTION; ATTRACTIVENESS; INSECTS	Although polyandry is common, it is often unclear why females mate with multiple males, because although polyandry may provide females with direct or indirect fitness benefits, it can also be costly. Our understanding of polyandry is also restricted by the relative paucity of studies that disentangle the fitness effects of mating more than once with a single male and mating with multiple males. Here we investigated potential benefits and costs of polyandry in the horned beetle, Gnatocerus cornutus, while controlling for the number of matings. We found that female life span was independent of mating frequency, indicating that mating itself is not very costly. However, females that mated more than once laid more eggs and had greater lifetime reproductive success than singly mated females. Because the magnitude of these effects was similar in monandrous and polyandrous females, this improved fertility was due to multiple mating itself, rather than mating with multiple males. However, although polyandrous females produced more attractive sons, these males tended to have smaller mandibles and so may fare less well in male-male competition. These results indicate that polyandry is relatively cost free, at least in the laboratory, and has direct and indirect benefits to female fitness. However, because the attractive sons produced by polyandrous females may fight less well, the indirect benefits of polyandry will depend on the intensity of male-male competition and how free females are to exert mate choice. Where competition between males is intense, polyandry benefits via son attractiveness may be reduced and perhaps even carry costs to female fitness. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Okada, Kensuke; Suzaki, Yu] Okayama Univ, Grad Sch Environm & Life Sci, Lab Evolutionary Ecol, Okayama, Japan; [Archer, C. Ruth] Max Planck Inst Demog Res, Max Planck Res Grp, Modelling Evolut Aging, Rostock, Germany; [Archer, C. Ruth] Max Planck Inst Demog Res, MaxNetAging Sch, Rostock, Germany; [Katsuki, Masako] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sharma, Manmohan D.; House, Clarissa M.; Hosken, David J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	Hosken, DJ (reprint author), Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Tremough Penryn TR10 9FE, Cornwall, England.	D.J.Hosken@exeter.ac.uk			Japanese Ministry of Education, Science, Sports and Culture [KAKENHI 25840157]	This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI 25840157) from Japanese Ministry of Education, Science, Sports and Culture. We thank the Editor and referees for helpful comments which greatly improved the manuscript.	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Bleu J, 2012, ANIM BEHAV, V83, P131, DOI 10.1016/j.anbehav.2011.10.017; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Queller DC, 1997, P ROY SOC B-BIOL SCI, V264, P1555, DOI 10.1098/rspb.1997.0216; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; BURPEE DM, 1993, EVOL ECOL, V7, P240, DOI 10.1007/BF01237742; Okada K, 2009, ANIM BEHAV, V77, P1057, DOI 10.1016/j.anbehav.2009.01.008; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Okada K, 2010, BEHAV ECOL SOCIOBIOL, V64, P361, DOI 10.1007/s00265-009-0852-0; Okada K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0281; Taylor ML, 2014, TRENDS ECOL EVOL, V29, P376, DOI 10.1016/j.tree.2014.04.005; Harano T, 2010, CURR BIOL, V20, P2036, DOI 10.1016/j.cub.2010.10.023; Kokko H, 2013, ENTOMOL EXP APPL, V146, P26, DOI 10.1111/j.1570-7458.2012.01296.x; Arnqvist G, 2005, BEHAV ECOL, V16, P123, DOI 10.1093/beheco/arh119; Hosken DJ, 2003, EVOL BIOL, V33, P173; TSUDA Y, 1984, APPL ENTOMOL ZOOL, V19, P129; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705; Katsuki M, 2012, ECOL LETT, V15, P193, DOI 10.1111/j.1461-0248.2011.01725.x; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Katsuki M, 2012, ECOL ENTOMOL, V37, P463, DOI 10.1111/j.1365-2311.2012.01390.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Huchard E, 2012, P ROY SOC B-BIOL SCI, V279, P1371, DOI 10.1098/rspb.2011.1326; Okada K, 2011, J EVOLUTION BIOL, V24, P363, DOI 10.1111/j.1420-9101.2010.02170.x; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; Demuth JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028690; Harano T, 2015, J EVOLUTION BIOL, V28, P320, DOI 10.1111/jeb.12563; Holloway GJ, 1987, FUNCT ECOL, V1, P229, DOI 10.2307/2389425; Holman L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0053; Hosken DJ, 1999, BEHAV ECOL, V10, P462, DOI 10.1093/beheco/10.4.462; Jayas D. S., 1994, STORED GRAIN ECOSYST; Kemp D. J., 2011, BEHAV ECOLOGY, V23, P191; Okada K., 2010, BIOL LETT; Pai AT, 2002, P ROY SOC B-BIOL SCI, V269, P361, DOI 10.1098/rspb.2001.1893; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Pizzari T., 2013, SCIENCES, V368; Poiani A, 2000, AUK, V117, P1061, DOI 10.1642/0004-8038(2000)117[1061:STDAPC]2.0.CO;2; Reding L., 2014, EVOLUTION, V69, P264; Rivera A. C., 2002, J INSECT SCI, P2; Simmons LW, 2011, BIOL LETTERS, V7, P419, DOI 10.1098/rsbl.2010.0976; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Thornhill R, 1983, EVOLUTION INSECT MAT; TSUDA Y, 1985, RES POPUL ECOL, V27, P77, DOI 10.1007/BF02515481; Yamane T., 2010, P ROYAL SOC B	56	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	AUG	2015	106						11	16		10.1016/j.anbehav.2015.05.008		6	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CN3HG	WOS:000358315700004		
J	Carle, T; Yamashita, T; Yamawaki, Y				Carle, Thomas; Yamashita, Takashi; Yamawaki, Yoshifumi			Aversion for bitter taste reveals sexual differences in alimentation strategies in a praying mantis	ANIMAL BEHAVIOUR			English	Article						aversive behaviour; feeding strategy; praying mantis; sexual dimorphism; bitter taste	GRASSHOPPER SCHISTOCERCA-AMERICANA; DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; SINENSIS SAUSSURE; FOOD LIMITATION; APIS-MELLIFERA; EGG-PRODUCTION; BODY-SIZE; DIMORPHISM; BEHAVIOR	Insects, as well as vertebrates, possess morphological, physiological and behavioural sexual dimorphisms. Because they are commonly bigger and produce eggs, female insects usually require more and specific energy intake. In addition to quantitative and qualitative requirements in food for reproduction, animals also have to avoid eating lethal toxins. The praying mantis Tenodera aridifolia is a good model to investigate sexual differences in feeding behaviour because its sexual dimorphism is marked in terms of morphology and behaviour. Here, we observed that females ate approximately four times as much prey as males. We then investigated the attacking and feeding behaviours of praying mantises by presenting mealworms injected with bitter solutions (quinine hydrochloride dihydrate or denatonium benzoate at 50 or 500 mM) as prey. We observed that males had a low level of acceptance for bitter prey: unlike females, they reduced consumption of mealworms injected with 50 mM of these bitter solutions. However, they showed higher motivation (unlike females, their rate of attack on prey increased when they reduced their consumption of mealworms). This difference in ingestion between the sexes did not seem to be due to different sensitivities for these bitter solutions (there was no detectable difference between the sexes in time taken to drink drops of these bitter solutions). Instead, this seems related to males and females having different feeding strategies based on different nutritive requirements. The possible effects of nutritional composition of prey on avoidance behaviours in predatory insects are discussed. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Carle, Thomas; Yamashita, Takashi; Yamawaki, Yoshifumi] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Carle, T (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	th.carle@gmail.com			Fyssen Foundation; Japan Society for the Promotion of Science [PE12038]; Mishima Kaiun Memorial Foundation	This work was supported by a postdoctoral fellowship from the Fyssen Foundation and the Japan Society for the Promotion of Science (PE12038) to T.C., as well as a grant from the Mishima Kaiun Memorial Foundation.	Amrein H., 2005, CURR BIOL, V15, P673; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Wilder SM, 2008, ANIM BEHAV, V76, P439, DOI 10.1016/j.anbehav.2008.01.023; ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.1111/j.1467-8624.1988.tb03683.x; LEE JC, 1990, ANIM BEHAV, V39, P163, DOI 10.1016/S0003-3472(05)80736-5; SHINE R, 1988, AM NAT, V131, P124, DOI 10.1086/284778; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Parker LA, 2003, LEARN BEHAV, V31, P165; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; GIVENS RP, 1978, ECOLOGY, V59, P309, DOI 10.2307/1936376; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; ROSPARS JP, 1988, INT J INSECT MORPHOL, V17, P243, DOI 10.1016/0020-7322(88)90041-4; McPherson FJ, 2012, ANIM REPROD SCI, V131, P109, DOI 10.1016/j.anireprosci.2012.02.007; Ling F, 2014, J NEUROSCI, V34, P7148, DOI 10.1523/JNEUROSCI.0649-14.2014; Halpin CG, 2013, ANIM BEHAV, V85, P1315, DOI 10.1016/j.anbehav.2013.03.021; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Skelhorn J, 2008, ANIM BEHAV, V75, P827, DOI 10.1016/j.anbehav.2007.07.003; Sanchez MGD, 2011, CHEM SENSES, V36, P675, DOI 10.1093/chemse/bjr040; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; Mitchell BK, 1999, MICROSC RES TECHNIQ, V47, P401, DOI 10.1002/(SICI)1097-0029(19991215)47:6<401::AID-JEMT4>3.0.CO;2-7; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Weiland R, 2010, CHEM SENSES, V35, P841, DOI 10.1093/chemse/bjq092; Maxwell MR, 2010, ECOL ENTOMOL, V35, P775, DOI 10.1111/j.1365-2311.2010.01239.x; LEATHER SR, 1988, OIKOS, V51, P386, DOI 10.2307/3565323; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Barry KL, 2010, ANIM BEHAV, V80, P405, DOI 10.1016/j.anbehav.2010.05.024; VOLLRATH F, 1992, NATURE, V360, P156, DOI 10.1038/360156a0; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; BIRKHEAD TR, 1988, BEHAVIOUR, V106, P112, DOI 10.1163/156853988X00115; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Barry KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078164; Barry KL, 2013, OIKOS, V122, P1058, DOI 10.1111/j.1600-0706.2012.00164.x; BERENBAUM MR, 1984, AM MIDL NAT, V111, P64, DOI 10.2307/2425543; BERNAYS EA, 1988, PHYSIOL ENTOMOL, V13, P131, DOI 10.1111/j.1365-3032.1988.tb00916.x; Bernays EA, 1994, HOST PLANT SELECTION; Brown V.K., 1975, International J Insect Morph Embryol, V4, P49, DOI 10.1016/0020-7322(75)90005-7; Carle T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098324; Darwin C., 1871, DESCENT MAN SELECTIO; Davis C. J., 1986, NAUSEA VOMITING MECH, P65; Dusse K, 1997, P ENTOMOL SOC WASH, V99, P490; EISENBERG RM, 1981, AM MIDL NAT, V106, P209, DOI 10.2307/2425157; GORDON HT, 1968, AM ZOOL, V8, P131; Halpin C. G., 2014, P ROYAL SOC B, V281; HEPPNER CC, 1986, PHARMACOL BIOCHEM BE, V24, P1555, DOI 10.1016/0091-3057(86)90484-3; Hurst V, 2014, J COMP PHYSIOL A, V200, P881, DOI 10.1007/s00359-014-0932-0; LEIMAR O, 1994, P ROY SOC B-BIOL SCI, V258, P121, DOI 10.1098/rspb.1994.0151; Liske E, 1999, PRAYING MANTIDS, P224; MATSURA T, 1975, Researches on Population Ecology (Tokyo), V17, P64, DOI 10.1007/BF02510878; Matsura T, 1999, PRAYING MANTIDS, P61; MATSURA T, 1983, OECOLOGIA, V56, P306, DOI 10.1007/BF00379704; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; POSTLETHWAIT JH, 1980, DEV BIOL, V79, P379, DOI 10.1016/0012-1606(80)90123-2; Prete F. R., 1999, THE PRAYING MANTIDS; Rogers SM, 2003, ADV INSECT PHYSIOL, V31, P141, DOI 10.1016/S0065-2806(03)31003-3; ROSS MARY H., 1960, ANN ENT SOC AMER, V53, P550; Sato K, 2014, J NEUROPHYSIOL, V112, P671, DOI 10.1152/jn.00049.2014; Skelhorn J, 2011, ANIM BEHAV, V81, P825, DOI 10.1016/j.anbehav.2011.01.017; Skelhorn J, 2006, ANIM BEHAV, V72, P827, DOI 10.1016/j.anbehav.2005.12.010; Spector AC, 2002, J NEUROSCI, V22, P1937; Terashima J, 2005, CELL DEATH DIFFER, V12, P429, DOI 10.1038/sj.cdd.4401587; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936; Tuffnell J., 2011, 21 C 2011 EUR CHEM R; Walker SE, 2002, CAN J ZOOL, V80, P679, DOI 10.1139/Z02-037; Wallace AR, 1879, SCIENCE, V2, P128; WICKMAN PO, 1989, OIKOS, V56, P209, DOI 10.2307/3565338; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	73	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	AUG	2015	106						79	87		10.1016/j.anbehav.2015.05.010		9	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CN3HG	WOS:000358315700012		
J	Chijiiwa, H; Kuroshima, H; Hori, Y; Anderson, JR; Fujita, K				Chijiiwa, Hitomi; Kuroshima, Hika; Hori, Yusuke; Anderson, James R.; Fujita, Kazuo			Dogs avoid people who behave negatively to their owner: third-party affective evaluation	ANIMAL BEHAVIOUR			English	Article						cooperation; dogs; helping; image scoring; moral judgement; negativity bias; social eavesdropping; social evaluation; social preference; third-party evaluation	SOCIAL EVALUATION; COOPERATION; RECIPROCITY; MONKEYS; INFANTS	Social eavesdropping, or social evaluation of third-party interactions, is a first step to image scoring, which is a key feature of humans' large-scale cooperative society. Here we asked whether domestic dogs evaluate humans interacting with one another over neutral objects. In two experimental conditions, the dog's owner tried to open a container to get a junk object that was inside, then requested help from an actor sitting next to her/him, while the dog watched the interaction. In the Helper condition, the actor held the container stable to help the owner to open it. In the Nonhelper condition, the actor turned away and refused to help. In the Control condition, the actor simply turned away in the absence of any request for help. A neutral person sat at the other side of the owner throughout these interactions. After the interaction the actor and the neutral person each offered a piece of food to the dog. Dogs chose food randomly in the Helper and the Control conditions, but were biased against the actor in the Nonhelper condition. The dogs' avoidance of someone who behaved negatively to the owner suggests that social eavesdropping may be shared with a nonprimate species. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Chijiiwa, Hitomi; Kuroshima, Hika; Hori, Yusuke; Anderson, James R.; Fujita, Kazuo] Kyoto Univ, Grad Sch Letters, Kyoto 6068501, Japan; [Hori, Yusuke] Japan Soc Promot Sci, Tokyo, Japan	Fujita, K (reprint author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan.	kfujita@bun.kyoto-u.ac.jp			JSPS [25240020, 25118002]	This study was financially supported by the JSPS Grant-in-Aide for Scientific Research (A) No. 25240020 to K.F. and that for Priority Areas No. 25118002. We thank Aya Norikiyo and Saki Saito for their assistance in conducting experiments and Eriko Ogura for her help in recruiting participants. We also thank all dogs and dog owners for their cooperation. We declare that we have no conflicts of interest with respect to the authorship or the publication of this article.	Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Kawai N, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0058; Anderson JR, 2013, COGNITION, V127, P140, DOI 10.1016/j.cognition.2012.12.007; Anderson JR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2495; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Kundey SMA, 2011, ANIM COGN, V14, P291, DOI 10.1007/s10071-010-0362-5; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Marshall-Pescini S, 2011, ANIM BEHAV, V81, P1177, DOI 10.1016/j.anbehav.2011.02.029; Nitzschner M, 2014, ANIM BEHAV, V90, P263, DOI 10.1016/j.anbehav.2014.01.035; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Vaish A, 2010, CHILD DEV, V81, P1661, DOI 10.1111/j.1467-8624.2010.01500.x; Freidin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079198; Miklösi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Nitzschner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046880; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Engelmann JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048433	20	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	AUG	2015	106						123	127		10.1016/j.anbehav.2015.05.018		5	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CN3HG	WOS:000358315700017		
J	Hayakawa, K; Sakamoto, T; Ishii, A; Yamaji, K; Uemoto, Y; Sasago, N; Kobayashi, E; Kobayashi, N; Matsuhashi, T; Maruyama, S; Matsumoto, H; Oyama, K; Mannen, H; Sasazaki, S				Hayakawa, Kiri; Sakamoto, Takayuki; Ishii, Atsushi; Yamaji, Keita; Uemoto, Yoshinobu; Sasago, Nanae; Kobayashi, Eiji; Kobayashi, Naohiko; Matsuhashi, Tamako; Maruyama, Shin; Matsumoto, Hirokazu; Oyama, Kenji; Mannen, Hideyuki; Sasazaki, Shinji			The g.841G > C SNP of FASN gene is associated with fatty acid composition in beef cattle	ANIMAL SCIENCE JOURNAL			English	Article						FASN; fatty acid composition; GWAS; Holstein; Japanese Black cattle	JAPANESE BLACK CATTLE; ELEMENT-BINDING PROTEIN-1; WHOLE-GENOME ASSOCIATION; SATURATED FAT; POLYMORPHISMS; SYNTHASE; DESATURASE; GENOTYPE	The objective of the current study is to evaluate the association between fatty acid composition and fatty acid synthase gene polymorphisms as responsible mutations. For this purpose, we selected seven previously reported single nucleotide polymorphisms (SNPs) in FASN gene, including one within promoter region (g.841G>C) and six non-synonymous SNPs (g.8805C>T, g.13126C>T, g.15532A>C, g.16024A>G, g.16039C>T, g.17924A>G), and genotyped them in Japanese Black cattle. Genotyping results revealed that g.8805 C>T and g.17924 A>G were monomorphic loci. Genome-wide association analysis including the other five SNPs revealed that only g.841G>C showed significant associations with the percentages of C14:0, C14:1, C16:1 and C18:1 at 5% genome-wide significance level. In order to further evaluate the effect, we genotyped g.841G>C using additional three populations, including two Japanese Black populations and a Holstein cattle population. g.16024A>G was also genotyped and included in the analysis because it has been reported to be associated with fatty acid composition in Japanese Black cattle. In the result of analysis of variance, g.841G>C showed stronger effects on fatty acid percentage than those of g.16024A>G in all populations. These results suggested that g.841G>C would be a responsible mutation for fatty acid composition and contribute to production of high-grade beef as a selection marker in beef cattle.	[Hayakawa, Kiri; Sakamoto, Takayuki; Ishii, Atsushi; Yamaji, Keita; Matsumoto, Hirokazu; Mannen, Hideyuki; Sasazaki, Shinji] Kobe Univ, Grad Sch Agr Sci, Lab Anim Breeding & Genet, Nada Ku, Kobe, Hyogo 6578501, Japan; [Uemoto, Yoshinobu; Sasago, Nanae] Natl Livestock Breeding Ctr, Fukushima, Japan; [Kobayashi, Eiji] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Kobayashi, Naohiko; Matsuhashi, Tamako; Maruyama, Shin] Gifu Prefectural Livestock Res Inst, Takayama, Gifu, Japan; [Oyama, Kenji] Kobe Univ, Food Resources Educ & Res Ctr, Kasai, Hyogo, Japan	Sasazaki, S (reprint author), Kobe Univ, Grad Sch Agr Sci, Lab Anim Breeding & Genet, Nada Ku, Kobe, Hyogo 6578501, Japan.	sasazaki@kobe-u.ac.jp					Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Zhang S, 2008, ANIM GENET, V39, P62, DOI 10.1111/j.1365-2052.2007.01681.x; RUDEL LL, 1995, ARTERIOSCL THROM VAS, V15, P2101; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; MELTON SL, 1982, J FOOD SCI, V47, P699, DOI 10.1111/j.1365-2621.1982.tb12694.x; Hoashi S, 2007, MAMM GENOME, V18, P880, DOI 10.1007/s00335-007-9072-y; DRYDEN FD, 1970, J ANIM SCI, V31, P36; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Matsuhashi T, 2011, J ANIM SCI, V89, P12, DOI 10.2527/jas.2010-3121; WESTERLING DB, 1979, J ANIM SCI, V48, P1343; Ordovas L, 2008, PHYSIOL GENOMICS, V34, P144, DOI 10.1152/physiolgenomics.00043.2008; Taniguchi M, 2004, MAMM GENOME, V15, P142, DOI 10.1007/s00335-003-2286-8; Roy R, 2006, ANIM GENET, V37, P215, DOI 10.1111/j.1365-2052.2006.01434.x; Abe T, 2009, BIOCHEM GENET, V47, P397, DOI 10.1007/s10528-009-9235-5; Oh D, 2012, MOL BIOL REP, V39, P4083, DOI 10.1007/s11033-011-1190-7; Uemoto Y, 2011, ANIM GENET, V42, P141, DOI 10.1111/j.1365-2052.2010.02088.x; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Folch J, 1957, J BIOL CHEM, V226, P487; Gilmour AR, 2006, ASREML USER GUIDE RE; Ishii A, 2012, ANIMAL SCI J, V84, P675; KEYS A, 1974, AM J CLIN NUTR, V27, P188; Leah GG, 2011, LIPIDS, V46, P209; Li C., 2011, ANIMAL GENETICS, V43, P93; WOOLLETT LA, 1992, J LIPID RES, V33, P77; Yeon SH, 2013, MEAT SCI, V94, P133, DOI 10.1016/j.meatsci.2013.01.002	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	AUG	2015	86	8					737	746		10.1111/asj.12357		10	Agriculture, Dairy & Animal Science	Agriculture	CN1KZ	WOS:000358180200001		
J	Yayou, K; Ito, S; Yamamoto, N				Yayou, Ken-ichi; Ito, Shuichi; Yamamoto, Naoyuki			Relationships between postnatal plasma oxytocin concentrations and social behaviors in cattle	ANIMAL SCIENCE JOURNAL			English	Article						Holstein heifer calf; individual variation in social behavior; organizational effect; postnatal oxytocin	CEREBROSPINAL-FLUID; CALVES; PREFERENCES; VASOPRESSIN; PENETRATION; EXPOSURE; RECEPTOR; ANXIETY; MICE	We examined the associations between natural individual variations in basal oxytocin (OXT) in postnatal cattle and social behavioral traits. At 1, 2 and 6 weeks of age, the basal OXT exhibited individual variability in 20 Holstein heifer calves. Cluster analysis of mean OXT for these time periods obtained two subgroups: high OXT (HOXT; n=9) and low OXT (LOXT; n=11). Social behaviors were observed for 2 days at week 6 after introduction into a four-peer group, and at 10-14 months of age (10 months) immediately and 1 week, 1 month and 5 months after introduction into 11-15 heifers. At week 6, the main effect of the OXT groups was not significant for all social behaviors. At 10 months, there tended to be interactions between the OXT groups and time periods with respect to the frequency of escape behaviors. LOXT heifers exhibited more escape behaviors than HOXT heifers on the first day of the second sociality tests. At 10 months, HOXT heifers exhibited both attacking and affiliative behavior for peers more than LOXT heifers during 5 months after the second social introduction. This suggests that postnatal OXT concentrations may have long-lasting effects on individual differences among social behavioral traits in cattle.	[Yayou, Ken-ichi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Ito, Shuichi] Tokai Univ, Kumamoto, Japan; [Yamamoto, Naoyuki] Natl Agr Res Ctr Western Reg, Ooda, Japan	Yayou, K (reprint author), Natl Inst Agrobiol Sci, Neurobiol Lab, 2 Ikenodai, Tsukuba, Ibaraki 3058602, Japan.	ken318@affrc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20380151, 23580382]	The authors thank the members of the Livestock Research Support Center of the National Institute of Livestock and Grassland Science for their support in these studies, and with the feeding and management of experimental animals. We also thank Dr Onaka for his kind advice concerning the oxytocin assay and Dr Fukasawa for his support with the statistical analysis. This work was partially supported by a Grants-in-Aid for Scientific Research (B) (No. 20380151) and (C) (No. 23580382) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; De Dreu CKW, 2012, HORM BEHAV, V61, P419, DOI 10.1016/j.yhbeh.2011.12.009; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Neumann ID, 2012, TRENDS NEUROSCI, V35, P649, DOI 10.1016/j.tins.2012.08.004; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Yamamura K, 1999, RES POPUL ECOL, V41, P229; Yayou K, 2010, PHYSIOL BEHAV, V99, P362, DOI 10.1016/j.physbeh.2009.11.016; Kagerbauer SM, 2013, J NEUROENDOCRINOL, V25, P668, DOI 10.1111/jne.12038; TENNESSEN T, 1985, APPL ANIM BEHAV SCI, V14, P37, DOI 10.1016/0168-1591(85)90036-X; Higashida H, 2010, J NEUROENDOCRINOL, V22, P373, DOI 10.1111/j.1365-2826.2010.01976.x; Andari E, 2014, CEREB CORTEX, V24, P479, DOI 10.1093/cercor/bhs328; Faerevik G, 2006, APPL ANIM BEHAV SCI, V99, P205, DOI 10.1016/j.applanim.2005.01.012; Phillips CJC, 2001, J DAIRY SCI, V84, P2424; Cushing BS, 2005, NEUROSCI BIOBEHAV R, V29, P1089, DOI 10.1016/j.neubiorev.2005.04.001; Bales KL, 2003, BEHAV NEUROSCI, V117, P854, DOI 10.1037/0735-7044.117.4.854; Bowen MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027237; Chevaleyre V, 2000, J NEUROSCI, V20, P5813; Clark CL, 2013, PSYCHONEUROENDOCRINO, V38, P1208, DOI 10.1016/j.psyneuen.2012.10.017; Duve LR, 2012, J DAIRY SCI, V95, P5936, DOI 10.3168/jds.2012-5428; Eaton JL, 2011, DEV PSYCHOBIOL, V54, P92; Hattori T, 2014, NEUROSCI RES, DOI [10.1016/j.neures.2014.05.003, DOI 10.1016/J.NEURES.2014.05.003]; Kemp Andrew H, 2010, Biol Psychiatry, V67, pe33, DOI 10.1016/j.biopsych.2009.11.019; KONDO S, 1984, APPL ANIM ETHOL, V11, P217, DOI 10.1016/0304-3762(84)90028-2; Mogi K, 2014, PHYSIOL BEHAV, V133, P68, DOI 10.1016/j.physbeh.2014.05.010; SHOAF SE, 1989, AM J VET RES, V50, P396; Suraev AS, 2014, HORM BEHAV, V65, P488, DOI 10.1016/j.yhbeh.2014.03.002; Tohmi M, 2007, NEUROSCIENCE, V150, P234, DOI 10.1016/j.neuroscience.2007.08.034; Tops Mattie, 2013, Front Psychol, V4, P761, DOI 10.3389/fpsyg.2013.00761; Yamamoto Y, 2004, NEUROSCIENCE, V125, P947, DOI 10.1016/j.neuroscience.2004.02.028; Yayou K, 2014, ANIM SCI J, V85, P481, DOI 10.1111/asj.12151; Young LJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2151, DOI 10.1038/npp.2011.124	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	AUG	2015	86	8					806	813		10.1111/asj.12363		8	Agriculture, Dairy & Animal Science	Agriculture	CN1KZ	WOS:000358180200009		
J	Nagaya, Y; Okumura, K; Mori, T				Nagaya, Yasunobu; Okumura, Keisuke; Mori, Takamasa			Recent developments of JAEA's Monte Carlo code MVP for reactor physics applications	ANNALS OF NUCLEAR ENERGY			English	Article						Monte carlo; MVP; Neutron/photon transport; Reactor physics; Reactor design; Criticality safety	EIGENVALUE CALCULATIONS; SCATTERING; JENDL-4.0; IMPACT; MODEL	This paper describes the recent development status of a Monte Carlo code MVP developed at Japan Atomic Energy Agency. The basic features and capabilities of MVP are overviewed. In addition, new capabilities useful for reactor analysis are also described. (C) 2014 Elsevier Ltd. All rights reserved.	[Nagaya, Yasunobu; Okumura, Keisuke; Mori, Takamasa] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan	Nagaya, Y (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan.	nagaya.yasunobu@jaea.go.jp					Okumura K, 2000, J NUCL SCI TECHNOL, V37, P128; Meulekamp RK, 2006, NUCL SCI ENG, V152, P142; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Becker B, 2009, ANN NUCL ENERGY, V36, P470, DOI 10.1016/j.anucene.2008.12.001; Chiba G, 2011, J NUCL SCI TECHNOL, V48, P172, DOI 10.3327/jnst.48.172; Dagan R., 2006, PHYSOR 2006 ANS TOP; Dagan R., 2011, PROG NUCL SCI TECHNO, V2, P782; Feghhi SAH, 2008, ANN NUCL ENERGY, V35, P1397, DOI 10.1016/j.anucene.2008.01.018; Kiedrowski BC, 2011, NUCL SCI ENG, V168, P226; Lee D, 2009, ANN NUCL ENERGY, V36, P274, DOI 10.1016/j.anucene.2008.11.026; MORI T, 1992, J NUCL SCI TECHNOL, V29, P325; Mori T., 2004, PRODUCTION MVP NEUTR; Mori T, 2009, J NUCL SCI TECHNOL, V46, P793, DOI 10.3327/jnst.46.793; Mori T., 1994, MVP GMVP GEN PURPOSE; Mori T., 1999, INT C MATH COMP REAC, P987; Mori T., 2001, T AM NUCL SOC, V84, P45; Mosteller R.D., 2006, 062968 LAUR LOS AL N; Murata I, 1996, NUCL SCI ENG, V123, P96; Murata I., 1996, PACKING SIMULATION C; Nagaya Y, 2011, ANN NUCL ENERGY, V38, P254, DOI 10.1016/j.anucene.2010.10.020; Nagaya Y, 2005, J NUCL SCI TECHNOL, V42, P428, DOI 10.3327/jnst.42.428; Nagaya Y., 2011, PROG NUCL SCI TECHNO, V2, P842; Nagaya Y., 2013, JOINT INT C SUP NUCL; Nagaya Y, 2005, 1348 JAERI; Nagaya Y., 2004, PHYSOR 2004 PHYS FUE; Nauchi Y, 2010, J NUCL SCI TECHNOL, V47, P977, DOI 10.3327/jnst.47.977; OECD/NEA Nuclear Science Committee, 2008, INT HDB EV CRIT SAF; OECD/NEA Nuclear Science Committee, 2012, INT HDB EV REACT PHY; Okumura K., 2011, PRODUCTION NEUTRON C; Okumura K., 2007, SRAC2006 COMPREHENSI; OUISLOUMEN M, 1991, NUCL SCI ENG, V107, P189; Saito S., 1994, 1332 JAERI; TERRELL J, 1957, PHYS REV, V108, P783, DOI 10.1103/PhysRev.108.783; Tsuruta H., 1978, 1254 JAERI; Ueki T, 1997, NUCL SCI ENG, V125, P1; Werner CJ, 2002, PROG NUCL ENERG, V41, P385, DOI 10.1016/S0149-1970(02)00019-7	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	AUG	2015	82				SI		85	89		10.1016/j.anucene.2014.09.037		5	Nuclear Science & Technology	Nuclear Science & Technology	CN0IJ	WOS:000358097000011		
J	Sato, T; Niita, K; Matsuda, N; Hashimoto, S; Iwamoto, Y; Furuta, T; Noda, S; Ogawa, T; Iwase, H; Nakashima, H; Fukahori, T; Okumura, K; Kai, T; Chiba, S; Sihver, L				Sato, Tatsuhiko; Niita, Koji; Matsuda, Norihiro; Hashimoto, Shintaro; Iwamoto, Yosuke; Furuta, Takuya; Noda, Shusaku; Ogawa, Tatsuhiko; Iwase, Hiroshi; Nakashima, Hiroshi; Fukahori, Tokio; Okumura, Keisuke; Kai, Tetsuya; Chiba, Satoshi; Sihver, Lembit			Overview of particle and heavy ion transport code system PHITS	ANNALS OF NUCLEAR ENERGY			English	Article						PHITS; Particle transport code; Monte Carlo; Nuclear reaction model; Nuclear data library	MONTE-CARLO-SIMULATION; REFERENCE COMPUTATIONAL PHANTOMS; MICRODOSIMETRIC KINETIC-MODEL; DOSE CONVERSION COEFFICIENTS; IMPROVEMENT; NEUTRONS; ENERGIES; THERAPY; SPECTRA; PROTONS	A general purpose Monte Carlo Particle and Heavy Ion Transport code System, PHITS, is being developed through the collaboration of several institutes in Japan and Europe. The Japan Atomic Energy Agency is responsible for managing the entire project. PHITS can deal with the transport of nearly all particles, including neutrons, protons, heavy ions, photons, and electrons, over wide energy ranges using various nuclear reaction models and data libraries. It is written in Fortran language and can be executed on almost all computers. All components of PHITS such as its source, executable and data-library files are assembled in one package and then distributed to many countries via the Research Organization for Information Science and Technology, the Data Bank of the Organization for Economic Co-operation and Development's Nuclear Energy Agency, and the Radiation Safety Information Computational Center. More than 1500 researchers have been registered as PHITS users, and they apply the code to various research and development fields such as nuclear technology, accelerator design, medical physics, and cosmic-ray research. This paper briefly summarizes the physics models implemented in PHITS, and introduces some important functions useful for specific applications, such as an event generator mode and beam transport functions. (C) 2014 Elsevier Ltd. All rights reserved.	[Sato, Tatsuhiko; Matsuda, Norihiro; Hashimoto, Shintaro; Iwamoto, Yosuke; Furuta, Takuya; Noda, Shusaku; Ogawa, Tatsuhiko; Nakashima, Hiroshi; Fukahori, Tokio; Okumura, Keisuke; Kai, Tetsuya] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Niita, Koji] Res Org Informat Sci & Technol, Tokai, Ibaraki 3191106, Japan; [Iwase, Hiroshi] High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; [Chiba, Satoshi] Tokyo Inst Technol, Tokyo 1528550, Japan; [Sihver, Lembit] Chalmers, SE-41296 Gothenburg, Sweden	Sato, T (reprint author), Japan Atom Energy Agcy, Shirakata Shirane 2-4, Tokai, Ibaraki 3191195, Japan.	sato.tatsuhiko@jaea.go.jp		Iwamoto, Yosuke/0000-0003-4688-6508	Center for Computational Science & e-Systems of JAEA	The development and distribution of PHITS have been greatly supported by the Center for Computational Science & e-Systems of JAEA. We thank our colleagues at Kyushu University, RIKEN, CEA/Saclay, and JAXA for their supports in improving PHITS under the collaboration contracts between JAEA and each institute.	Niita K, 2006, RADIAT MEAS, V41, P1080, DOI 10.1016/j.radmeas.2006.07.013; Broeders CHM, 2004, J NUCL MATER, V328, P197, DOI 10.1016/j.jnucmat.2004.05.002; Sato T, 2012, RADIAT RES, V178, P341, DOI 10.1667/RR2842.1; Boudard A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014606; MOLIERE G, 1948, Z NATURFORSCH A, V3, P78; Abe S, 2012, IEEE T NUCL SCI, V59, P965, DOI 10.1109/TNS.2012.2187215; Sato T, 2010, PHYS MED BIOL, V55, P2235, DOI 10.1088/0031-9155/55/8/008; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Iwase H, 2002, J NUCL SCI TECHNOL, V39, P1142, DOI 10.3327/jnst.39.1142; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Hashimoto S, 2014, NUCL INSTRUM METH B, V333, P27, DOI 10.1016/j.nimb.2014.04.007; BONDORF JP, 1995, PHYS REP, V257, P133, DOI 10.1016/0370-1573(94)00097-M; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; BETHE HA, 1953, PHYS REV, V89, P1256, DOI 10.1103/PhysRev.89.1256; NIITA K, 1995, PHYS REV C, V52, P2620, DOI 10.1103/PhysRevC.52.2620; Sato T, 2009, PHYS MED BIOL, V54, P1997, DOI 10.1088/0031-9155/54/7/009; Armstrong T.W., 1973, ORNL4869; Cullen D.E., 1997, UCRL50400, V6, P1997; Ebisawa T, 2009, NUCL INSTRUM METH A, V600, P126, DOI 10.1016/j.nima.2008.11.090; Endo A, 2013, RADIAT PROT DOSIM, V154, P142, DOI 10.1093/rpd/ncs199; Furihata S, 2000, NUCL INSTRUM METH B, V171, P251, DOI 10.1016/S0168-583X(00)00332-3; Furusaka M, 2004, NUCL INSTRUM METH A, V529, P223, DOI 10.1016/j.nima.2004.04.211; Furuta T., 2012, IFMBE P, P2099; Geissel H., 2014, ATIMA GSI; Greene G.A., 2003, P 6 INT M NUCL APPL, P881; Halbleib J. A., 1992, SAND911634 SAND NAT; Harada M, 2005, J NUCL MATER, V343, P197, DOI 10.1016/j.jnucmat.2005.01.023; Hirayama H., 2005, SLACR730 NAT ACC LAB; ICRP I, 1991, ICRP PUBL, V60; ICRU, 1983, 36 ICRU; ICRU, 1986, 40 ICRU; Itoh S, 2012, NUCL INSTRUM METH A, V661, P86, DOI 10.1016/j.nima.2011.09.037; Iwamoto Y, 2012, NUCL INSTRUM METH B, V274, P57, DOI 10.1016/j.nimb.2011.11.038; Iwase H, 2001, NUCL INSTRUM METH B, V183, P374, DOI 10.1016/S0168-583X(01)00706-6; JUNG P, 1983, J NUCL MATER, V117, P70, DOI 10.1016/0022-3115(83)90011-9; Kai T., 2001, DCHAIN SP 2001 HIGH; Kobayashi H, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P206, DOI 10.1109/IRPS.2009.5173252; Mishima K, 2009, NUCL INSTRUM METH A, V600, P342, DOI 10.1016/j.nima.2008.11.087; Nara Y, 2000, PHYS REV C, V61; Niita K, 2011, J KOREAN PHYS SOC, V59, P827, DOI 10.3938/jkps.59.827; Niita K., 2010, PHITS PARTICLE HEAVY; Niita K, 2001, NUCL INSTRUM METH B, V184, P406, DOI 10.1016/S0168-583X(01)00784-4; Nose H, 2005, J NUCL SCI TECHNOL, V42, P250, DOI 10.3327/jnst.42.250; Ogawa T, 2013, NUCL INSTRUM METH A, V723, P36, DOI 10.1016/j.nima.2013.04.078; Perkins S.T., 1991, UCRL50400 LAWR LIV N; Sakaki H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.126401; Sato T, 2011, RADIAT PROT DOSIM, V143, P491, DOI 10.1093/rpd/ncq484; Sato T, 2006, RADIAT PROT DOSIM, V122, P41, DOI 10.1093/rpd/ncl407; Sihver L, 2010, ADV SPACE RES, V45, P892, DOI 10.1016/j.asr.2010.01.002; Theis C, 2006, NUCL INSTRUM METH A, V562, P827, DOI 10.1016/j.nima.2006.02.125; Tsuda S, 2010, PHYS MED BIOL, V55, P5089, DOI 10.1088/0031-9155/55/17/013; VAVILOV PV, 1957, SOV PHYS JETP-USSR, V5, P749; X-5 Monte Carlo Team, 2003, LAUR031987 LOW AL NA; Yonai S, 2012, MED PHYS, V39, P5028, DOI 10.1118/1.4736823	54	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	AUG	2015	82				SI		110	115		10.1016/j.anucene.2014.08.023		6	Nuclear Science & Technology	Nuclear Science & Technology	CN0IJ	WOS:000358097000014		
J	Nagaya, Y				Nagaya, Yasunobu			Calculation of reactor kinetics parameters with Monte Carlo differential operator sampling	ANNALS OF NUCLEAR ENERGY			English	Article						Reactor kinetics parameters; Effective delayed neutron fraction; Neutron generation time; Monte Carlo; Differential operator sampling	DELAYED NEUTRON FRACTION; NUCLEAR-SCIENCE; GENERATION TIME; BENCHMARKING; ENDF/B-VII.0; TECHNOLOGY; JENDL-4.0; LIBRARY	The methods to calculate the reactor kinetics parameters of beta(eff) and Lambda with the differential operator sampling have been reviewed. The comparison of the results obtained with the differential operator sampling and iterated fission probability approaches has been performed. It is shown that the differential operator sampling approach gives the same results as the iterated fission probability approach within the statistical uncertainty. In addition, the prediction accuracy of the evaluated nuclear data library JENDL-4.0 for the measured beta(eff)/Lambda and beta(eff) values is also examined. It is shown that JENDL-4.0 gives a good prediction except for the uranium-233 systems. The present results imply the need for revisiting the uranium-233 nuclear data evaluation and performing the detailed sensitivity analysis. (C) 2014 Elsevier Ltd. All rights reserved.	Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan	Nagaya, Y (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan.	nagaya.yasunobu@jaea.go.jp					Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; Meulekamp RK, 2006, NUCL SCI ENG, V152, P142; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Chadwick MB, 2006, NUCL DATA SHEETS, V107, P2931, DOI 10.1016/j.nds.2006.11.001; Chiba G, 2011, J NUCL SCI TECHNOL, V48, P1471, DOI 10.3327/jnst.48.1471; Feghhi SAH, 2008, ANN NUCL ENERGY, V35, P1397, DOI 10.1016/j.anucene.2008.01.018; Hurwitz Jr H., 1964, NAVAL REACTOR PHYS H, VI, P864; Kahler AC, 2011, NUCL DATA SHEETS, V112, P2997, DOI 10.1016/j.nds.2011.11.003; Kiedrowski BC, 2011, NUCL SCI ENG, V168, P226; Nagaya Y, 2011, ANN NUCL ENERGY, V38, P254, DOI 10.1016/j.anucene.2010.10.020; Nagaya Y, 2005, J NUCL SCI TECHNOL, V42, P428, DOI 10.3327/jnst.42.428; Nagaya Y, 2010, ANN NUCL ENERGY, V37, P1308, DOI 10.1016/j.anucene.2010.05.017; Nagaya Y, 2005, 1348 JAERI; Nauchi Y., 2005, J NUCL SCI TECHNOL; Nauchi Y, 2010, J NUCL SCI TECHNOL, V47, P977, DOI 10.3327/jnst.47.977; NEA Nuclear Science Committee, 2008, NEANSCDOC9508 OECD; OECD Nuclear Energy Agency, 2012, NEANSCDOC20061 OECD; van der Marck SC, 2006, NUCL DATA SHEETS, V107, P3061, DOI 10.1016/j.nds.2006.11.002; Verboomen B, 2006, ANN NUCL ENERGY, V33, P911, DOI 10.1016/j.anucene.2006.05.001	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	AUG	2015	82				SI		226	229		10.1016/j.anucene.2014.08.064		4	Nuclear Science & Technology	Nuclear Science & Technology	CN0IJ	WOS:000358097000027		
J	Imaizumi, A; Liem, AA; Yang, CF; Chen, W; Chen, SH; Chen, HC				Imaizumi, Atsushi; Liem, Anita A.; Yang, Chun-Fan; Chen, Wency; Chen, Shih-heng; Chen, Hung-Chi			Long-Term Outcomes of Simultaneous Skin and Bowel Flaps for Esophageal Reconstruction	ANNALS OF PLASTIC SURGERY			English	Article							SQUAMOUS-CELL CARCINOMA; RADIAL FOREARM FLAP; COLON INTERPOSITION; ORAL-CAVITY; FOLLOW-UP; PHARYNGOESOPHAGEAL RECONSTRUCTION; HISTOLOGICAL-CHANGES; CORROSIVE INJURY; REPLACEMENT; CHILDREN	Esophageal reconstruction can be performed with skin or bowel flaps. The choice of flap remains controversial, as the long-term outcomes of skin flaps cannot always be assessed in patients with limited life expectancies due to advanced malignancy, unlike the pediatric and benign cases which have had esophageal reconstruction using bowel flaps. We report the long-term clinical and histopathological outcomes in a series of 45 cases repaired with combined skin and bowel flaps. Four patients developed symptomatic strictures after corrosive esophageal injuries were repaired with a combination of a tubed free radial forearm fasciocutaneous flap and a pedicled bowel flap. On average, 24 years had passed since uneventful initial esophageal reconstructions. Barium esophagograms were obtained in all cases and pathological examination was performed upon all surgical specimens. The cutaneous portions of the reconstructed esophagus exhibited a variety of findings on barium examination. Each of the 4 cases developed an esophagocutaneous fistula after revision; an average of 4 surgeries was required to close these fistulae. The inner surfaces of the portion of esophagus repaired with skin flaps showed extensive ulceration, polypoid lesions, and fibrosis. Pathology specimens from skin flaps showed extensive acute and chronic inflammation, microabscesses, fibrosis, and acanthosis, with depletion and degeneration of the pilosebaceous units. By contrast, adjacent parts of the esophagus repaired with bowel were widely patent with normal appearing mucosa. Our findings indicate that a bowel flap is durable with good tolerance to gastrointestinal content over long periods, whereas skin flaps often developed morphological changes and could not maintain long-term esophageal function without eventual stricture and dysphagia. We therefore recommend use of bowel flaps for esophageal reconstruction in patients with long life expectancy.	[Imaizumi, Atsushi] Prefectural Okinawa Chubu Hosp, Dept Plast Surg, Okinawa, Japan; [Imaizumi, Atsushi; Liem, Anita A.; Chen, Shih-heng; Chen, Hung-Chi] China Med Univ Hosp, Dept Plast & Reconstruct Surg, Taichung 40447, Taiwan; [Yang, Chun-Fan] China Med Univ Hosp, Dept Pathol, Taichung 40447, Taiwan; [Chen, Wency] I Shou Univ, Dept Gastroenterol, E Da Hosp, Kaohsiung, Taiwan	Chen, HC (reprint author), China Med Univ Hosp, Dept Plast & Reconstruct Surg, 2 Yuh Der Rd, Taichung 40447, Taiwan.	D19722@mail.cmuh.org.tw					Yu PR, 2006, PLAST RECONSTR SURG, V117, P968, DOI 10.1097/01.prs.0000200622.13312.d3; Chan YW, 2011, J PLAST RECONSTR AES, V64, P1022, DOI 10.1016/j.bjps.2011.03.021; Agarwal S, 2010, DERMATITIS, V21, P138, DOI 10.2310/6620.2010.09103; Yu PR, 2010, CANCER-AM CANCER SOC, V116, P1718, DOI 10.1002/cncr.24947; Badran D, 1998, CLIN ANAT, V11, P379, DOI 10.1002/(SICI)1098-2353(1998)11:6<379::AID-CA3>3.0.CO;2-H; Beahm EK, 1997, AM J SURG, V174, P492; BROMBERG BE, 1968, ANN SURG, V168, P269, DOI 10.1097/00000658-196808000-00013; CHEN H, 1989, PLAST RECONSTR SURG, V84, P980, DOI 10.1097/00006534-198912000-00020; CHEN HC, 1988, ANN THORAC SURG, V45, P39; Copcu E, 2009, PLAST RECONSTR SURG, V124, p156E, DOI 10.1097/PRS.0b013e3181a8082e; Eroschenko VP, 2000, FIORES ATLAS HISTOLO, V9th, P9; Ho ACW, 2011, EUR ARCH OTO-RHINO-L, V268, P147, DOI 10.1007/s00405-010-1410-0; Horvath OP, 2000, DIS ESOPHAGUS, V13, P251, DOI 10.1046/j.1442-2050.2000.00122.x; Iseli TA, 2002, HEAD NECK-J SCI SPEC, V24, P87, DOI 10.1002/hed.1154; ISOLAURI J, 1991, AM J GASTROENTEROL, V86, P277; ISOLAURI J, 1988, AM J SURG, V155, P498, DOI 10.1016/S0002-9610(88)80122-3; LAQUAGLIA MP, 1987, J PEDIATR SURG, V22, P44, DOI 10.1016/S0022-3468(87)80013-1; MITCHELL IM, 1989, BRIT J SURG, V76, P681, DOI 10.1002/bjs.1800760710; Monnier Y, 2008, EUR ARCH OTO-RHINO-L, V265, P831, DOI 10.1007/s00405-007-0526-3; RING WS, 1982, J THORAC CARDIOV SUR, V83, P918; Rubino C, 2002, ANN PLAS SURG, V49, P362, DOI 10.1097/01.SAP.0000017980.64753.15; Shibahara T, 2000, J ORAL MAXIL SURG, V58, P495, DOI 10.1016/S0278-2391(00)90009-0; Shibahara T, 2006, J ORAL MAXIL SURG, V64, P1255, DOI 10.1016/j.joms.2006.04.022; Sinclair A, 2004, CLIN ANAT, V17, P227, DOI 10.1002/ca.10180; Stadelmann WK, 1998, AM J SURG, V176, p39S; Stadelmann WK, 1998, AM J SURG, V176, P26, DOI DOI 10.1016/J.CLINDERMATOL.2009.05.012; Woolgar JA, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-2; Yamataka A, 2000, J PEDIATR SURG, V35, P1623, DOI 10.1053/jpsu.2000.18333	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	AUG	2015	75	2					180	185		10.1097/SAP.0000000000000067		6	Surgery	Surgery	CN4RC	WOS:000358416900012		
J	Takata, A; Takiguchi, S; Miyazaki, Y; Miyata, H; Takahashi, T; Kurokawa, Y; Yamasaki, M; Nakajima, K; Mori, M; Kangawa, K; Doki, Y				Takata, Akihiro; Takiguchi, Shuji; Miyazaki, Yasuhiro; Miyata, Hiroshi; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Mori, Masaki; Kangawa, Kenji; Doki, Yuichiro			Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy	ANNALS OF SURGERY			English	Article						esophagectomy; ghrelin; systemic inflammatory response syndrome (SIRS)	NEUTROPHIL ELASTASE INHIBITOR; LYMPH-NODE DISSECTION; ACUTE LUNG INJURY; CANCER-PATIENTS; DOUBLE-BLIND; NEOADJUVANT CHEMOTHERAPY; AMERICAN-COLLEGE; SURGICAL STRESS; STEROID-THERAPY; SEVERE SEPSIS	Objective: A prospective randomized phase II trial was conducted to evaluate the efficacy of ghrelin administration in reducing systemic inflammatory response syndrome (SIRS) duration after esophagectomy. Background: Esophagectomy for esophageal cancer is highly invasive and leads to prolonged SIRS duration and postoperative complications. Ghrelin has multiple effects, including anti-inflammatory effects. Methods: Forty patients undergoing esophagectomy were randomly assigned to either the ghrelin group (n = 20), which received continuous infusion of ghrelin (0.5 g/kg/h) for 5 days, or the placebo group (n = 20), which received pure saline for 5 days. The primary endpoint was SIRS duration. The secondary endpoints were the incidence of postoperative complications, time of a negative nitrogen balance, changes in body weight and composition, and levels of inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6). Results: The ghrelin group had a shorter SIRS duration and lower CRP and IL-6 levels than did the placebo group. The incidence of pulmonary complications was lower in the ghrelin group than in the placebo group, whereas other complications did not differ between the groups. Although time of the negative nitrogen balance was shorter in the ghrelin group than in the placebo group, changes in total body weight and lean body weight did not differ significantly. Conclusions: Postoperative ghrelin administration was effective for inhibiting inflammatory mediators and improving the postoperative clinical course of patients with esophageal cancer.	[Takata, Akihiro; Takiguchi, Shuji; Miyazaki, Yasuhiro; Miyata, Hiroshi; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Kangawa, Kenji] Natl Cardiovasc Ctr, Res Ctr, Dept Biochem, Osaka, Japan	Takiguchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2,E-2 Yamadaoka, Suita, Osaka 5650871, Japan.	stakiguchi@gesurg.med.osaka-u.ac.jp			Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science, and Technology [23591929]	This work was supported in part by a grant from the Ministry of Health, Labour and Welfare and by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (No. 23591929). Shuji Takiguchi is currently receiving a grant from the Ministry of Education, Culture, Sports, Science and Technology (No. 23591929), and Yuichiro Doki is currently receiving a grant from the Ministry of Health, Labour and Welfare. However, the authors declare no conflicts of interest.	Akamoto S, 2007, SURG TODAY, V37, P359, DOI 10.1007/s00595-006-3409-0; Vila G, 2007, J CLIN ENDOCR METAB, V92, P3930, DOI 10.1210/jc.2007-1194; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; SAKAMOTO K, 1994, CYTOKINE, V6, P181, DOI 10.1016/1043-4666(94)90040-X; Strasser F, 2008, BRIT J CANCER, V98, P300, DOI 10.1038/sj.bjc.6604148; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Masuda Y, 2000, BIOCHEM BIOPH RES CO, V276, P905, DOI 10.1006/bbrc.2000.3568; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Yamamoto K, 2013, SURG TODAY, V43, P48, DOI 10.1007/s00595-012-0342-2; Ryugo M, 2006, SURG TODAY, V36, P321, DOI 10.1007/s00595-005-3160-y; [Anonymous], 2009, J PHYSIOL PHARMACOL; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106; Yamamoto K, 2010, SURGERY, V148, P31, DOI 10.1016/j.surg.2009.11.026; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Xu XB, 2008, ENDOCRINOLOGY, V149, P4183, DOI 10.1210/en.2008-0255; Akamizu T, 2005, J CLIN ENDOCR METAB, V90, P6, DOI 10.1210/jc.2004-1640; Doki Y, 2006, SURGERY, V139, P797, DOI 10.1016/j.surg.2005.11.015; Tomimaru Y, 2006, J SURG ONCOL, V93, P422, DOI 10.1002/jso.20475; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-5110C; Adachi S, 2010, GASTROENTEROLOGY, V138, P1312, DOI 10.1053/j.gastro.2009.12.058; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Muckart DJJ, 1997, CRIT CARE MED, V25, P1789, DOI 10.1097/00003246-199711000-00014; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; Li Y, 2013, ENDOCRINE, V43, P376, DOI 10.1007/s12020-012-9761-5; Hirai T, 1998, SURG TODAY, V28, P576; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Hiura Y, 2012, CANCER-AM CANCER SOC, V118, P4785, DOI 10.1002/cncr.27430; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; Daly JM, 2000, J AM COLL SURGEONS, V190, P572; Kawahara Y, 2010, DIS ESOPHAGUS, V23, P329, DOI 10.1111/j.1442-2050.2009.01010.x; Koch A, 2010, CRIT CARE, V14, DOI 10.1186/cc9029; Kodama T, 2008, PULM PHARMACOL THER, V21, P774, DOI 10.1016/j.pupt.2008.05.001; Liu XY, 2013, INFLAMMATION, V36, P1286, DOI 10.1007/s10753-013-9667-2; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Morita M, 2008, DIS ESOPHAGUS, V21, P30, DOI 10.1111/j.1442-2050.2007.00725.x; Ono S, 1999, AM J SURG, V177, P78, DOI 10.1016/S0002-9610(98)00300-6; Osugi H, 2002, SURG ENDOSC, V16, P1588, DOI 10.1007/s00464-002-9019-z; Sato A, 2005, DIS ESOPHAGUS, V18, P151, DOI 10.1111/j.1442-2050.2005.00485.x; Sato N, 2001, EUR SURG RES, V33, P279, DOI 10.1159/000049718; Sato N, 2002, ANN SURG, V236, P184, DOI 10.1097/01.SLA.0000022025.67985.53; Shimada H, 2000, SURGERY, V128, P791, DOI 10.1067/msy.2000.108614; Shimakawa T, 2008, ANTICANCER RES, V28, P2321; Sobin LH, 2009, TNM CLASSIFICATION M; Tsukada K, 2006, DIGEST LIVER DIS, V38, P240, DOI 10.1016/j.dld.2005.12.012; Viklund P, 2006, ANN SURG, V243, P204, DOI 10.1097/01.sla.0000197698.17794.eb; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011; Yamasaki M, 2011, J SURG ONCOL, V104, P623, DOI 10.1002/jso.21991	54	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					230	236		10.1097/SLA.0000000000000986		7	Surgery	Surgery	CM8KG	WOS:000357948600007		
J	Miyata, H; Yamasaki, M; Miyazaki, Y; Takahashi, T; Kurokawa, Y; Nakajima, K; Takiguchi, S; Mori, M; Doki, Y				Miyata, Hiroshi; Yamasaki, Makoto; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro			Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma	ANNALS OF SURGERY			English	Article						esophageal cancer; lymph node metastasis; neoadjuvant chemotherapy; neoadjuvnat therapy; supraclavicular	POSITRON-EMISSION-TOMOGRAPHY; CANCER STAGING SYSTEM; PREOPERATIVE CHEMOTHERAPY; PATHOLOGICAL RESPONSE; JUNCTIONAL CANCER; THERAPY; TRIAL; DISSECTION; SURGERY; NUMBER	Objective: To examine the clinical implications of supraclavicular (SC) lymph node (LN) metastasis in patients with esophageal squamous cell carcinoma (ESCC) who receive neoadjuvant chemotherapy, followed by surgery. Background: Indications for surgery for esophageal cancer often do not include cases with SCLN metastasis because the latter is considered distant metastasis. However, neaodjuvant therapy may change the clinical importance of SCLN metastasis. Methods: In 323 patients with ESCC who underwent neoadjuvant chemotherapy, the correlations between SCLN metastasis and clinicopathological factors including survival were examined. Results: The incidence of SCLN metastasis was 17.6% before therapy and 14.6% after therapy. In patients with SCLN metastasis at baseline, the incidence of posttherapy SCLN metastasis was significantly lower in major responders to chemotherapy than in minor responders. The total number of metastatic LNs was significantly higher in patients with posttherapy SCLN metastasis than in patients with metastatic LN but no SCLN (10.9 vs 3.9; P 0.001). Survival was shorter in patients with SCLN metastasis than in those with metastatic LN without SCLN (3-year overall survival rate; 20.1% vs 45.7%; P = 0.003). However, there was no significant difference in survival between patients with SCLN metastasis before but not after therapy and patients without SCLN metastasis before and after chemotherapy (3-year overall survival rate; 64.9% vs 58.2%; P = 0.2071). Conclusions: This study showed that SCLN metastasis in ESCC reflects the number of metastatic LNs. SCLN metastasis should not be considered as contraindication to curative surgery in multimodal treatment of ESCC because preoperative treatment can change SC nodal status.	[Miyata, Hiroshi; Yamasaki, Makoto; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, Suita, Osaka 5650871, Japan	Miyata, H (reprint author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiyata@gesurg.med.osaka-u.ac.jp					Ajani Jaffer A, 2008, J Natl Compr Canc Netw, V6, P818; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; Miyata H, 2006, J SURG ONCOL, V93, P477, DOI 10.1002/jso.20453; VANOVERHAGEN H, 1992, GASTROINTEST RADIOL, V17, P305; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Miyata H, 2011, ANN SURG, V253, P279, DOI 10.1097/SLA.0b013e318206824f; van Westreenen HL, 2004, J CLIN ONCOL, V22, P3805, DOI 10.1200/JCO.2004.01.083; Peyre CG, 2008, ANN SURG, V248, P979, DOI 10.1097/SLA.0b013e3181904f3c; Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Taniyama Y, 2013, ANN THORAC SURG, V95, P1930, DOI 10.1016/j.athoracsur.2013.03.069; Swisher SG, 2005, ANN SURG, V241, P810, DOI 10.1097/01.sla.0000161983.82345.85; Schneider PM, 2005, ANN SURG, V242, P684, DOI 10.1097/01.sla.0000186170.38348.7b; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Li HC, 2012, J SURG ONCOL, V105, P548, DOI 10.1002/jso.22148; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Donohoe CL, 2013, ANN SURG, V258, P784, DOI 10.1097/SLA.0b013e3182a66588; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Bancewicz J, 2002, LANCET, V359, P1727; Japanese Society for Esophageal Diseases, 2007, GUID CLIN PATH STUD; Law S, 1997, J THORAC CARDIOV SUR, V114, P210, DOI 10.1016/S0022-5223(97)70147-8; Mariette C, 2008, ANN SURG, V247, P365, DOI 10.1097/SLA.0b013e31815aaadf; Miyata H, 2013, BRIT J SURG, V100, P1490, DOI 10.1002/bjs.9253; Rizk N, 2006, J THORAC CARDIOV SUR, V132, P1374, DOI 10.1016/j.jtcvs.2006.07.039; Shimada H, 2006, AM J SURG, V191, P250, DOI 10.1016/j.amjsurg.2005.07.035; Sobin LH, 2009, TNM CLASSIFICATION M; Tabira Y, 2000, J AM COLL SURGEONS, V191, P232, DOI 10.1016/S1072-7515(00)00348-3; Tachimori Y, 2011, DIS ESOPHAGUS, V24, P33, DOI 10.1111/j.1442-2050.2010.01086.x; Udagawa H, 2012, J SURG ONCOL, V106, P742, DOI 10.1002/jso.23122; Van Vliet EPM, 2007, J SURG ONCOL, V96, P200, DOI 10.1002/jso.20819; von Rahden BHA, 2004, CURR OPIN GASTROEN, V20, P391, DOI 10.1097/00001574-200407000-00016	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					280	285		10.1097/SLA.0000000000000933		6	Surgery	Surgery	CM8KG	WOS:000357948600015		
J	Low, DE; Alderson, D; Cecconello, I; Chang, AC; Darling, GE; D'Journo, XB; Griffin, SM; Holscher, AH; Hofstetter, WL; Jobe, BA; Kitagawa, Y; Kucharczuk, JC; Law, SYK; Lerut, TE; Maynard, N; Pera, M; Peters, JH; Pramesh, CS; Reynolds, JV; Smithers, BM; van Lanschot, JJB				Low, Donald E.; Alderson, Derek; Cecconello, Ivan; Chang, Andrew C.; Darling, Gail E.; D'Journo, Xavier Benoit; Griffin, S. Michael; Hoelscher, Arnulf H.; Hofstetter, Wayne L.; Jobe, Blair A.; Kitagawa, Yuko; Kucharczuk, John C.; Law, Simon Ying Kit; Lerut, Toni E.; Maynard, Nick; Pera, Manuel; Peters, Jeffrey H.; Pramesh, C. S.; Reynolds, John V.; Smithers, B. Mark; van Lanschot, J. Jan B.			International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy Esophagectomy Complications Consensus Group (ECCG)	ANNALS OF SURGERY			English	Article						complications; esophageal cancer; esophagectomy; quality measures	SEVERITY GRADING SYSTEM; QUALITY-OF-LIFE; LONG-TERM SURVIVAL; POSTOPERATIVE COMPLICATIONS; SURGICAL COMPLICATIONS; TRANSTHORACIC ESOPHAGECTOMY; GASTROESOPHAGEAL JUNCTION; IMPROVEMENT PROGRAM; AMERICAN-COLLEGE; POTENTIAL IMPACT	Introduction: Perioperative complications influence long- and short-term outcomes after esophagectomy. The absence of a standardized system for defining and recording complications and quality measures after esophageal resection has meant that there is wide variation in evaluating their impact on these outcomes. Methods: The Esophageal Complications Consensus Group comprised 21 high-volume esophageal surgeons from 14 countries, supported by all the major thoracic and upper gastrointestinal professional societies. Delphi surveys and group meetings were used to achieve a consensus on standardized methods for defining complications and quality measures that could be collected in institutional databases and national audits. Results: A standardized list of complications was created to provide a template for recording individual complications associated with esophagectomy. Where possible, these were linked to preexisting international definitions. A Delphi survey facilitated production of specific definitions for anastomotic leak, conduit necrosis, chyle leak, and recurrent nerve palsy. An additional Delphi survey documented consensus regarding critical quality parameters recommended for routine inclusion in databases. These quality parameters were documentation on mortality, comorbidities, completeness of data collection, blood transfusion, grading of complication severity, changes in level of care, discharge location, and readmission rates. Conclusions: The proposed system for defining and recording perioperative complications associated with esophagectomy provides an infrastructure to standardize international data collection and facilitate future comparative studies and quality improvement projects.	[Low, Donald E.] Virginia Mason Med Ctr, Seattle, WA 98111 USA; [Alderson, Derek] Univ Birmingham, Birmingham, W Midlands, England; [Cecconello, Ivan] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Chang, Andrew C.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Darling, Gail E.] Toronto Gen Hosp, Toronto, ON, Canada; [D'Journo, Xavier Benoit] St Marguerite Hosp, Marseille, France; [Griffin, S. Michael] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hoelscher, Arnulf H.] Univ Cologne, D-50931 Cologne, Germany; [Hofstetter, Wayne L.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Jobe, Blair A.] Allegheny Hlth Networks Esophageal & Thorac Inst, Pittsburgh, PA USA; [Kitagawa, Yuko] Keio Univ, Tokyo, Japan; [Kucharczuk, John C.] Univ Penn, Philadelphia, PA 19104 USA; [Law, Simon Ying Kit] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lerut, Toni E.] Katholieke Univ Leuven, Leuven, Belgium; [Maynard, Nick] Oxford Radcliffe Hosp, Oxford, England; [Pera, Manuel] Hosp Univ Mar, Barcelona, Spain; [Peters, Jeffrey H.] Univ Rochester Surg, Rochester, NY USA; [Pramesh, C. S.] Tata Hosp, Bombay, Maharashtra, India; [Reynolds, John V.] Trinity Coll Dublin, Dublin, Ireland; [Smithers, B. Mark] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia; [van Lanschot, J. Jan B.] Erasmus MC, Rotterdam, Netherlands	Low, DE (reprint author), Virginia Mason Med Ctr, Sect Gen Thorac Surg, 1100 Ninth Ave,C6-SUR, Seattle, WA 98111 USA.	donald.low@virginiamason.org			Hayward Family Foundation	Hayward Family Foundation for supporting the project; Sheraz Markar, MD, Henner Schmidt, MD, and Bonnie Marston for assistance with data collection and manuscript preparation, and Madhan Kuppusamy, MD, for development of the ECCG Web site; study consultants, Baj Wijnhoven, MD, and Ulysses Ribeiro, MD; and Birmingham Clinical Trials United for statistical assistance.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Koch CG, 2012, J AM COLL SURGEONS, V214, P798, DOI 10.1016/j.jamcollsurg.2011.12.037; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; Wright CD, 2009, J THORAC CARDIOV SUR, V137, P587, DOI 10.1016/j.jtcvs.2008.11.042; Walters DM, 2014, ANN THORAC SURG, V98, P506, DOI 10.1016/j.athoracsur.2014.03.041; Velanovich V, 2013, J SURG RES, V183, P104, DOI 10.1016/j.jss.2013.01.021; Carrott PW, 2012, J AM COLL SURGEONS, V215, P331, DOI 10.1016/j.jamcollsurg.2012.04.030; Merkow RP, 2012, ARCH SURG-CHICAGO, V147, P1009, DOI 10.1001/2013.jamasurg.96; Munitiz V, 2010, BRIT J SURG, V97, P714, DOI 10.1002/bjs.6942; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Scarpa M, 2013, J GASTROINTEST SURG, V17, P421, DOI 10.1007/s11605-012-2069-1; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Page RD, 2013, ANN THORAC SURG, V95, P292, DOI 10.1016/j.athoracsur.2012.09.048; Markar SR, 2012, J GASTROINTEST SURG, V16, P1055, DOI 10.1007/s11605-011-1731-3; Blencowe NS, 2012, ANN SURG, V255, P658, DOI 10.1097/SLA.0b013e3182480a6a; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Lagarde SM, 2008, ANN SURG, V247, P71, DOI 10.1097/SLA.0b013e31815b695e; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.245561c; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Low DE, 2007, J GASTROINTEST SURG, V11, P1395, DOI 10.1007/s11605-007-0265-1; Strasberg SM, 2009, ANN SURG, V250, P177, DOI 10.1097/SLA.0b013e3181afde41; Bruce J, 2001, Health Technol Assess, V5, P1; Centers for Medicare and Medicaid Services, READM RED PROGR; Cerfolio RJ, 2004, CHEST, V126, P1187, DOI 10.1378/chest.126.4.1187; Courrech SE, 2010, BRIT J SURG, V97, P1482; Staal EFWC, 2010, EJSO-EUR J SURG ONC, V36, P1035, DOI 10.1016/j.ejso.2010.08.131; Cuhls K., DELPHI METHOD; Cunha AB, NOSOCOMIAL HEALTHCAR; Dresner SM, 2000, EUR J SURG ONCOL, V26, P492, DOI 10.1053/ejso.1999.0929; Dunst CM, 2010, J GASTROINTEST SURG, V14, P108, DOI 10.1007/s11605-009-1029-x; Hall MJ, 2011, NCHS DATA BRIEF, V62, P1; Hall WH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-94; Hanna George B, 2012, Semin Thorac Cardiovasc Surg, V24, P176, DOI 10.1053/j.semtcvs.2012.10.004; Hii MW, 2013, BRIT J SURG, V100, P95, DOI 10.1002/bjs.8973; Kelly KN, 2014, J GASTROINTEST SURG, V18, P35, DOI 10.1007/s11605-013-2354-7; Low DE, 2010, J GASTROINTEST SURG, V14, P1646, DOI 10.1007/s11605-010-1325-5; Morris M, 2012, J AM COLL SURGEONS, V215, pS97; Porembka MR, 2010, J AM COLL SURGEONS, V210, P286, DOI 10.1016/j.jamcollsurg.2009.12.004; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; van der Sluis PC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-230; Veen EJ, 2005, ARCH SURG-CHICAGO, V140, P1078, DOI 10.1001/archsurg.140.11.1078; Viklund P, 2005, WORLD J SURG, V29, P841, DOI 10.1007/s00268-005-7887-9; Visser A, 2014, WORLD J SURG, V38, P1019, DOI 10.1007/s00268-013-2376-z; Walters DM, 2014, ANN THORAC SURG, V98, P511; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991	52	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					286	294		10.1097/SLA.0000000000001098		9	Surgery	Surgery	CM8KG	WOS:000357948600016		
J	Kurita, N; Miyata, H; Gotoh, M; Shimada, M; Imura, S; Kimura, W; Tomita, N; Baba, H; Kitagawa, Y; Sugihara, K; Mori, M				Kurita, Nobuhiro; Miyata, Hiroaki; Gotoh, Mitsukazu; Shimada, Mitsuo; Imura, Satoru; Kimura, Wataru; Tomita, Naohiro; Baba, Hideo; Kitagawa, Yukou; Sugihara, Kenichi; Mori, Masaki			Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System	ANNALS OF SURGERY			English	Article						distal gastrectomy; gastric cancer; National Clinical Database; risk model of mortality; surgical outcome	RANDOMIZED CLINICAL-TRIAL; UNIVERSAL HEALTH-CARE; POSTOPERATIVE MORBIDITY; D2 GASTRECTOMY; SURGICAL TRIAL; MORTALITY; SURGERY; D1; ADENOCARCINOMA; PREDICTORS	Objective: To establish a risk model for distal gastrectomy in Japanese patients with gastric cancer. Background: Risk stratification for distal gastrectomy in Japanese patients with gastric cancer improves surgical outcomes. Methods: The National Clinical Database was constructed for risk determination in gastric cancer-related gastrectomy among Japanese individuals. Data from 33,917 gastric cancer cases (1737 hospitals) were used. The primary outcomes were 30-day and operative mortalities. Data were randomly assigned to risk model development (27,220 cases) and test validation (6697 cases) subsets. Stepwise selection was used for constructing 30-day and operative mortality logistic models. Results: The 30-day, in-hospital, and operative mortality rates were 0.52%, 1.16%, and 1.2%, respectively. The morbidity was 18.3%. The 30-day and operative mortality models included 17 and 21 risk factors, respectively. Thirteen variables overlapped: age, need for total assistance in activities of daily living preoperatively or within 30 days after surgery, cerebrovascular disease history, more than 10% weight loss, uncontrolled ascites, American Society of Anesthesiologists score ( class 3), white blood cell count more than 12,000/L or 11,000/L, anemia (hemoglobin: males, <13.5 g/dL; females, <12.5 g/dL; or hematocrit: males, <37%; females <32%), serum albumin less than 3.5 or 3.8 g/dL, alkaline phosphatase more than 340 IU/L, serum creatinine more than 1.2 mg/dL, serum Na less than 135 mEq/L, and prothrombin time-international normalized ratio more than 1.25 or 1.1. The C-indices for the 30-day and operative mortalities were 0.785 (95% confidence interval, 0.705-0.865; P < 0.001) and 0.798 (95% confidence interval, 0.746-0.851; P < 0.001), respectively. Conclusions: The risk model developed using nationwide Japanese data on distal gastrectomy in gastric cancer can predict surgical outcomes.	[Kurita, Nobuhiro; Sugihara, Kenichi; Mori, Masaki] Japanese Soc Gastroenterol Surg, Tokyo, Japan; [Miyata, Hiroaki; Gotoh, Mitsukazu; Shimada, Mitsuo; Kimura, Wataru; Tomita, Naohiro; Baba, Hideo; Kitagawa, Yukou] Japanese Soc Gastroenterol Surg, Database Comm, Tokyo, Japan; [Miyata, Hiroaki; Gotoh, Mitsukazu] Natl Clin Database, Tokyo, Japan; [Imura, Satoru] Japanese Soc Gastroenterol Surg, Working Grp Database Comm, Tokyo, Japan	Kurita, N (reprint author), Japanese Soc Gastroenterol Surg, 104-0041 Chuouku Sintomi,1-14-1 Cent East Bldg 5F, Tokyo, Japan.	gogokuri@qc4.so-net.ne.jp					Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Degiuli M, 2010, BRIT J SURG, V97, P643, DOI 10.1002/bjs.6936; Smith JK, 2007, ARCH SURG-CHICAGO, V142, P387, DOI 10.1001/archsurg.142.4.387; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Miyata H, 2014, SURG TODAY, V44, P1991, DOI 10.1007/s00595-013-0802-3; Mahar AL, 2012, GASTRIC CANCER, V15, pS125, DOI 10.1007/s10120-011-0088-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Park DJ, 2005, BRIT J SURG, V92, P1099, DOI 10.1002/bjs.4952; Watanabe M, 2014, ANN SURG, V260, P1034, DOI 10.1097/SLA.0000000000000781; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Wu CW, 2004, BRIT J SURG, V91, P283, DOI 10.1002/bjs.4433; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Degiuli M, 2004, EJSO, V30, P303, DOI 10.1016/j.ejso.2003.11.020; Grossmann EM, 2002, SURGERY, V131, P484, DOI 10.1067/msy.2002.123806; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Degiuli M, 2014, BRIT J SURG, V101, P23, DOI 10.1002/bjs.9345; Cuschieri A, 1996, LANCET, V347, P995, DOI 10.1016/S0140-6736(96)90144-0; Haga Y, 2004, SURGERY, V135, P586, DOI 10.1016/j.surg.2003.11.012; Kimura W, 2014, ANN SURG, V259, P773, DOI 10.1097/SLA.0000000000000263; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Borja-Cacho D, 2010, ANN SURG ONCOL, V17, P2274, DOI 10.1245/s10434-010-1176-z; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327; Dhir M, 2012, J GASTROINTEST SURG, V16, P2026, DOI 10.1007/s11605-012-2010-7; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Kenjo A, 2014, J AM COLL SURGEONS, V218, P412, DOI 10.1016/j.jamcollsurg.2013.11.007; Konno H, 2013, JPN J GASTROENTEROL, V46, P952; Mahar AL, 2012, J AM COLL SURGEONS, V214, P860, DOI 10.1016/j.jamcollsurg.2011.12.050; Onate-Ocana LF, 2000, ANN SURG ONCOL, V7, P281, DOI 10.1007/s10434-000-0281-9; Sasako M, 1997, BRIT J SURG, V84, P1567, DOI 10.1111/j.1365-2168.1997.02842.x; Soreide JA, 1996, ARCH SURG-CHICAGO, V131, P481; Suzuki H, 2011, CANCER SCI, V102, P226, DOI 10.1111/j.1349-7006.2010.01749.x; Wang HL, 2013, AM J SURG, V205, P466, DOI 10.1016/j.amjsurg.2012.06.011	36	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					295	303		10.1097/SLA.0000000000001127		9	Surgery	Surgery	CM8KG	WOS:000357948600017		
J	Mise, Y; Hasegawa, K; Shindoh, J; Ishizawa, T; Aoki, T; Sakamoto, Y; Sugawara, Y; Makuuchi, M; Kokudo, N				Mise, Yoshihiro; Hasegawa, Kiyoshi; Shindoh, Junichi; Ishizawa, Takeaki; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Makuuchi, Masatoshi; Kokudo, Norihiro			The Feasibility of Third or More Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma	ANNALS OF SURGERY			English	Article						hepatectomy; hepatocellular carcinoma; parenchymal-sparing hepatectomy; recurrence; repeat resection	2ND HEPATIC RESECTION; LIVER RESECTION; RISK-FACTORS; INTRAHEPATIC RECURRENCE; BILE LEAKAGE; PROGNOSTIC-FACTORS; MULTIVARIATE-ANALYSIS; TERM OUTCOMES; TRANSPLANTATION; EXPERIENCE	Objectives: To investigate the feasibility and prognostic benefits of third or more hepatectomy (third or more Hx) for recurrent hepatocellular carcinoma. Background: Second hepatectomy (second Hx) has been accepted as an effective treatment of recurrent hepatocellular carcinoma after first hepatectomy (first Hx). However, the feasibility and efficacy of third or more Hx have not been adequately assessed. Methods: Data were reviewed from 1340 patients with hepatocellular carcinoma who underwent curative hepatectomy. Among them, 941, 289, and 110 underwent first Hx, second Hx, and third or more Hx, respectively. Surgical outcomes and long-term survival were compared among the groups. Results: Surgical duration was significantly longer in third or more Hx (median, 6.4 hours) than in second Hx (median, 5.9 hours). Postoperative bile leakage and wound infection were more frequently observed in third or more Hx versus second Hx (12.5% vs 6.2%, [P = 0.04] and 2.9% vs 0.4% [P = 0.03], respectively). Three and 5-year disease-free survival rates were 36.8% and 27.1% in first Hx, 24.4% and 17.9 % in second Hx, and 26.1% and 12.8% in third or more Hx, respectively (P < 0.01 [first Hx vs third Hx], P = 0.95 [second Hx vs third or more Hx]). The 5-year overall survival rates from each resection were similar among the groups (65.3%, 60.5%, 68.2%, respectively). The 5- and 10-year overall survival rates from initial hepatectomy in patients who received third or more Hx were 91.4% and 75.5%, respectively. Conclusions: Third or more Hx is technically demanding in terms of surgical duration and morbidity compared with second Hx. However, aggressive repeat resection offers a survival similar to second Hx, leading to cumulative long-term survival from initial resection.	[Mise, Yoshihiro; Hasegawa, Kiyoshi; Shindoh, Junichi; Ishizawa, Takeaki; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo 1138655, Japan; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Adler M, 2008, LIVER TRANSPLANT, V14, P526, DOI 10.1002/lt.21399; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Wu CC, 2009, BRIT J SURG, V96, P1049, DOI 10.1002/bjs.6690; Chen MF, 2003, WORLD J SURG, V27, P443, DOI 10.1007/s00268-002-6708-7; Freeman RB, 2006, AM J TRANSPLANT, V6, P1416, DOI 10.1111/j.1600-6143.2006.01321.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Kubota K, 1997, HEPATOLOGY, V26, P1176; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Shindoh J, 2013, HPB, V15, P31, DOI 10.1111/j.1477-2574.2012.00552.x; Fan ST, 2012, NAT REV GASTRO HEPAT, V9, P732, DOI 10.1038/nrgastro.2012.158; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Yamashita Y, 2001, ANN SURG, V233, P45, DOI 10.1097/00000658-200101000-00008; Nagano Y, 2003, WORLD J SURG, V27, P695, DOI 10.1007/s00268-003-6907-x; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Yeh CN, 2002, J SURG ONCOL, V81, P195, DOI 10.1002/jso.10178; Adam R, 2012, ANN SURG, V256, P883, DOI 10.1097/SLA.0b013e318273bad0; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Capussotti L, 2006, ARCH SURG-CHICAGO, V141, P690, DOI 10.1001/archsurg.141.7.690; Nathan H, 2009, ANN SURG, V249, P799, DOI 10.1097/SLA.0b013e3181a38eb5; Sadamori H, 2013, BRIT J SURG, V100, P122, DOI 10.1002/bjs.8957; Sadamori H, 2012, DIGEST SURG, V29, P149, DOI 10.1159/000337313; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Grazi GL, 2001, ANN SURG, V234, P71, DOI 10.1097/00000658-200107000-00011; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Huang ZY, 2012, ANN SURG ONCOL, V19, P2515, DOI 10.1245/s10434-012-2269-7; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; MAKUUCHI M, 1990, SURGERY, V107, P521; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O; Arii S, 1998, J Hepatobiliary Pancreat Surg, V5, P86, DOI 10.1007/PL00009956; Belghiti J, 2012, Liver Cancer, V1, P71, DOI 10.1159/000342403; Chan DL, 2013, SURG ONCOL, V22, pE23, DOI 10.1016/j.suronc.2013.02.009; Earl TM, 2013, SEMIN LIVER DIS, V33, P282, DOI 10.1055/s-0033-1351783; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Imamurai H, 1999, BRIT J SURG, V86, P1032, DOI 10.1046/j.1365-2168.1999.01185.x; Itamoto T, 2007, SURGERY, V141, P589, DOI 10.1016/j.surg.2006.12.014; Kobayashi A, 2006, HEPATO-GASTROENTEROL, V53, P736; Kubo S, 2008, WORLD J SURG, V32, P632, DOI 10.1007/s00268-007-9365-z; Morimura R, 2012, HEPATO-GASTROENTEROL, V59, P809, DOI 10.5754/hge09655; Nakajima Y, 2001, J AM COLL SURGEONS, V192, P339, DOI 10.1016/S1072-7515(00)00789-4; Poon RTP, 2001, J CLIN ONCOL, V19, P3037; Roayaie S, 2011, J HEPATOL, V55, P346, DOI 10.1016/j.jhep.2010.11.026; SUENAGA M, 1994, SURGERY, V115, P452; TAKAYAMA T, 1991, SURGERY, V109, P226; Wong RJ, 2014, DIGEST DIS SCI, V59, P183, DOI 10.1007/s10620-013-2947-8; Yamashita Y, 2013, SURGERY, V154, P1038, DOI 10.1016/j.surg.2013.04.046; Zheng Z, 2014, TRANSPLANTATION, V97, P227, DOI 10.1097/TP.0b013e3182a89383; Zhou YM, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-55	50	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					347	357		10.1097/SLA.0000000000000882		11	Surgery	Surgery	CM8KG	WOS:000357948600023		
J	Ogiso, S; Conrad, C; Araki, K; Nomi, T; Anil, Z; Gayet, B				Ogiso, Satoshi; Conrad, Claudius; Araki, Kenichiro; Nomi, Takeo; Anil, Zeynal; Gayet, Brice			Laparoscopic Transabdominal With Transdiaphragmatic Access Improves Resection of Difficult Posterosuperior Liver Lesions	ANNALS OF SURGERY			English	Article						colorectal metastasis; laparoscopic liver resection; posterosuperior segment; transdiaphragmatic; transthoracic	OPEN HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; REPEAT HEPATECTOMY; 2-STAGE HEPATECTOMY; METASTASES; SURGERY; TUMORS; SEGMENTS; FEASIBILITY; EXPERIENCE	Objective: We describe the technical details and evaluate the safety, feasibility, and usefulness of a combined lateral and abdominal (CLA) approach for laparoscopic resection of liver segments 7 and 8. Background: Laparoscopic resection of lesions in the posterosuperior area of segments 7 and 8 is technically challenging, and currently there is no standardized laparoscopic approach. Methods: Through review of a prospectively maintained database, we identified 44 patients who underwent laparoscopic resection of lesions in segment 7 or 8. Twenty-five patients required the CLA approach because their lesions were more posterosuperior and intraparenchymal; 19 patients underwent resection with a regular abdominal-only approach of more accessible anteroinferior lesions. We reviewed operative details and video footage of these operations and compared the outcomes of the 2 groups. Results: In the group treated with the CLA approach, deep location was more frequent (88% vs 42%; P = 0.035), median tumor diameter was larger (24.5 mm vs 15 mm; P = 0.114), and the median weight of the excised parenchyma was greater (56.5 g vs 23 g; P = 0.093). Median operative time was longer in the CLA approach group (217.5 minutes vs 165 minutes; P = 0.046), but blood loss, rate of conversion to open surgery, surgical margin status, morbidity, and mortality were similar between the 2 groups. Conclusions: The CLA approach permits safe laparoscopic resection of lesions in the posterosuperior area of segments 7 and 8, allowing surgeons to overcome the difficulties of limited visualization and access to the target lesions.	[Ogiso, Satoshi; Conrad, Claudius; Araki, Kenichiro; Nomi, Takeo; Anil, Zeynal; Gayet, Brice] Paris Descartes Univ, Inst Mutualiste Montsouris, Dept Digest Pathol, Paris, France; [Ogiso, Satoshi] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatopancreatobiliary & Transplant Surg, Kyoto, Japan; [Conrad, Claudius] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	Conrad, C (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Div Surg, Hepatopancreatobiliary Surg, 1400 Pressler,Unit 1484, Houston, TX 77030 USA.	cconrad1@mdanderson.org					Adam R, 1997, ANN SURG, V225, P60; Edwin B, 2011, SCAND J SURG, V100, P54; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Cho JY, 2008, SURG ENDOSC, V22, P2344, DOI 10.1007/s00464-008-9966-0; Gayet B, 2007, AM J SURG, V194, P685, DOI 10.1016/j.amjsurg.2006.11.044; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; Kazaryan AM, 2011, SURG ENDOSC, V25, P3881, DOI 10.1007/s00464-011-1815-x; Topal B, 2008, SURG ENDOSC, V22, P2208, DOI 10.1007/s00464-008-0023-9; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Shafaee Z, 2011, J AM COLL SURGEONS, V212, P171, DOI 10.1016/j.jamcollsurg.2010.10.012; Croome KP, 2010, ARCH SURG-CHICAGO, V145, P1109, DOI 10.1001/archsurg.2010.227; Ishizawa T, 2012, ANN SURG, V256, P959, DOI 10.1097/SLA.0b013e31825ffed3; Dagher I, 2009, ANN SURG, V250, P856, DOI 10.1097/SLA.0b013e3181bcaf46; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Adam R, 1997, ANN SURG, V225, P51, DOI 10.1097/00000658-199701000-00006; Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89; Dagher I, 2010, J AM COLL SURGEONS, V211, P16, DOI 10.1016/j.jamcollsurg.2010.03.012; Cho JY, 2008, SURGERY, V144, P32, DOI 10.1016/j.surg.2008.03.020; Laurent A, 2003, ARCH SURG-CHICAGO, V138, P763, DOI 10.1001/archsurg.138.7.763; Suzuki S, 2001, SURGERY, V129, P421, DOI 10.1067/msy.2001.112486; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Kaneko H, 1996, SURGERY, V120, P468, DOI 10.1016/S0039-6060(96)80065-1; Gold JS, 2008, ANN SURG, V247, P109, DOI 10.1097/SLA.0b013e3181557e47; Bryant R, 2009, ANN SURG, V250, P103, DOI 10.1097/SLA.0b013e3181ad6660; van Det MJ, 2009, SURG ENDOSC, V23, P1279, DOI 10.1007/s00464-008-0148-x; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/01.SLA.0000018658.57709.09; Vibert E, 2006, BRIT J SURG, V93, P67, DOI 10.1002/bjs.5150; Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Belli GL, 2009, SURG ENDOSC, V23, P1807, DOI 10.1007/s00464-009-0344-3; Chen HY, 2008, ANN SURG ONCOL, V15, P800, DOI 10.1245/s10434-007-9749-1; Dokmak S, 2012, WORLD J SURG, V36, P2692, DOI 10.1007/s00268-012-1725-7; Gagner M, 2004, SURG CLIN N AM, V84, P451, DOI 10.1016/j.suc.2003.11.002; Gumbs AA, 2008, J GASTROINTEST SURG, V12, P1154, DOI 10.1007/s11605-007-0455-x; Hu JX, 2009, SURGERY, V146, P854, DOI 10.1016/j.surg.2009.06.008; Ikeda T, 2013, J HEPATO-BIL-PAN SCI, V20, P145, DOI 10.1007/s00534-012-0558-y; Jaeck D, 2004, ANN SURG, V240, P1049; Kazaryan AM, 2010, ARCH SURG-CHICAGO, V145, P34, DOI 10.1001/archsurg.2009.229; Kishi Y, 2012, BRIT J SURG, V99, P1105, DOI 10.1002/bjs.8790; Koffron AJ, 2007, ANN SURG, V246, P392; Koffron AJ, 2007, ANN SURG, V246, P385, DOI 10.1097/SLA.0b013e318146996c; Lin NC, 2012, ANN SURG, V257, P205; Mazziotti A, 2000, ARCH SURG-CHICAGO, V135, P1224, DOI 10.1001/archsurg.135.10.1224; Nakajima Y, 2001, J AM COLL SURGEONS, V192, P339, DOI 10.1016/S1072-7515(00)00789-4; Torzilli G, 2012, ANN SURG, V255, P270, DOI 10.1097/SLA.0b013e318232b375; Welsh FKS, 2010, HPB, V12, P188, DOI 10.1111/j.1477-2574.2009.00143.x	46	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					358	365		10.1097/SLA.0000000000001015		8	Surgery	Surgery	CM8KG	WOS:000357948600024		
J	Honda, M; Kuriyama, A; Noma, H; Nunobe, S; Furukawa, TA				Honda, Michitaka; Kuriyama, Akira; Noma, Hisashi; Nunobe, Souya; Furukawa, Toshi A.			Is There No Significant Difference in the Incidence of Anastomotic Leakage Between the Hand-sewn and Mechanical Esophagogastric Anastomosis? Reply	ANNALS OF SURGERY			English	Letter							STAPLED INTRATHOROCIC ANASTOMOSIS; GASTRIC TUBE RECONSTRUCTION; SUTURED NECK ANASTOMOSIS; THORACIC ANASTOMOSIS; ESOPHAGEAL RESECTION; CANCER		[Honda, Michitaka; Nunobe, Souya] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Okayama, Japan; [Noma, Hisashi] Inst Stat Math, Dept Data Sci, Tokyo, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol, Kyoto, Japan	Honda, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan.	michitaka.honda@jfcr.or.jp					Walther B, 2003, ANN SURG, V238, P803, DOI 10.1097/01.sla.0000098624.04100.b1; Dai JG, 2011, SURGERY, V149, P404, DOI 10.1016/j.surg.2010.08.005; Honda M, 2013, ANN SURG, V257, P238, DOI 10.1097/SLA.0b013e31826d4723; Okuyama M, 2007, SURG TODAY, V37, P947, DOI 10.1007/s00595-007-3541-5; Peracchia A, 2003, ANN SURG, V238, P812	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					e81	U19		10.1097/SLA.0000000000000592		4	Surgery	Surgery	CM8KM	WOS:000357949400018		
J	Tanaka, K; Endo, I				Tanaka, Kuniya; Endo, Itaru			ALPPS: Short-term Outcome and Functional Changes in the Future Liver Remnant	ANNALS OF SURGERY			English	Letter							PORTAL-VEIN LIGATION		[Tanaka, Kuniya] Teikyo Univ, Chiba Med Ctr, Dept Surg, Chiba, Japan; [Endo, Itaru] Yokohama City Univ, Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan	Tanaka, K (reprint author), Teikyo Univ, Chiba Med Ctr, Dept Surg, Chiba, Japan.	U17-92TS@med.teikyo-u.ac.jp					Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; de Santibanes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d; Andriani OC, 2012, ANN SURG, V256, pE5, DOI 10.1097/SLA.0b013e318265fbbe	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					e88	e89		10.1097/SLA.0000000000000665		2	Surgery	Surgery	CM8KM	WOS:000357949400025		
J	Techaruvichit, P; Takahashi, H; Vesaratchavest, M; Keeratipibul, S; Kuda, T; Kimura, B				Techaruvichit, Punnida; Takahashi, Hajime; Vesaratchavest, Mongkol; Keeratipibul, Suwimon; Kuda, Takashi; Kimura, Bon			Development of Multiple-Locus Variable-Number Tandem-Repeat Analysis for Molecular Subtyping of Campylobacter jejuni by Using Capillary Electrophoresis	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							FIELD GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; TYPING SYSTEM; CONTAMINATION; IDENTIFICATION; COUNTRIES; PRODUCTS; STRAINS; GENOME	Campylobacter jejuni is a common cause of the frequently reported food-borne diseases in developed and developing nations. This study describes the development of multiple-locus variable-number tandem-repeat (VNTR) analysis (MLVA) using capillary electrophoresis as a novel typing method for microbial source tracking and epidemiological investigation of C. jejuni. Among 36 tandem repeat loci detected by the Tandem Repeat Finder program, 7 VNTR loci were selected and used for characterizing 60 isolates recovered from chicken meat samples from retail shops, samples from chicken meat processing factory, and stool samples. The discrimination ability of MLVA was compared with that of multilocus sequence typing (MLST). MLVA (diversity index of 0.97 with 31 MLVA types) provided slightly higher discrimination than MLST (diversity index of 0.95 with 25 MLST types). The overall concordance between MLVA and MLST was estimated at 63% by adjusted Rand coefficient. MLVA predicted MLST type better than MLST predicted MLVA type, as reflected by Wallace coefficient (Wallace coefficient for MLVA to MLST versus MLST to MLVA, 86% versus 51%). MLVA is a useful tool and can be used for effective monitoring of C. jejuni and investigation of epidemics caused by C. jejuni.	[Techaruvichit, Punnida; Takahashi, Hajime; Kuda, Takashi; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan; [Vesaratchavest, Mongkol] BETAGRO Grp, Ctr Res & Dev, Klongluang, Pathumthani, Thailand; [Keeratipibul, Suwimon] Chulalongkorn Univ, Dept Food Technol, Bangkok, Thailand	Takahashi, H (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan.	hajime@kaiyodai.ac.jp	Kimura, Bon/O-1879-2014	Kimura, Bon/0000-0002-3071-1343			Acik MN, 2006, J MED MICROBIOL, V55, P331, DOI 10.1099/jmm.0.46373-0; Hanninen ML, 2001, APPL ENVIRON MICROB, V67, P1581, DOI 10.1128/AEM.67.4.1581-1586.2001; Pasqualotto AC, 2007, J CLIN MICROBIOL, V45, P522, DOI 10.1128/JCM.02136-06; Miya S, 2008, INT J FOOD MICROBIOL, V124, P239, DOI [10.1016/j.ijfoodmicro.2008.03.023, 10.1016/ijfoodmicro.2008.03.023]; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Liu YC, 2003, J CLIN MICROBIOL, V41, P4388, DOI 10.1128/JCM.41.9.4388-4394.2003; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Suzuki H, 2009, J VET MED SCI, V71, P255, DOI 10.1292/jvms.71.255; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Haguenoer E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-171; Lindstedt BA, 2004, J MICROBIOL METH, V58, P213, DOI 10.1016/j.mimet.2004.03.016; Pendleton S, 2013, POULTRY SCI, V92, P573, DOI 10.3382/ps.2012-02695; Coker AO, 2002, EMERG INFECT DIS, V8, P237; Batz MB, 2012, J FOOD PROTECT, V75, P1278, DOI 10.4315/0362-028X.JFP-11-418; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Corcoran D, 2006, LETT APPL MICROBIOL, V43, P560, DOI 10.1111/j.1472-765X.2006.01987.x; Harth-Chu E, 2009, APPL ENVIRON MICROB, V75, P4079, DOI 10.1128/AEM.02729-08; Infectious Disease Surveillance Center, 2010, CAMP ENT JAP 2006 20, V31; Ivanova K, 2010, EUROSURVEILLANCE, V15, P8; Keeratipibul S, 2012, FOOD CONTROL, V27, P64, DOI 10.1016/j.foodcont.2012.02.026; Keeratipibul S, 2009, J FOOD PROTECT, V72, P1821; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Mullane NR, 2008, APPL ENVIRON MICROB, V74, P1223, DOI 10.1128/AEM.01726-07; Patchanee P, 2012, J MICROBIOL BIOTECHN, V22, P1467, DOI 10.4014/jmb.1112.12049; Pinto FR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-44; Sobral D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033967; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118	31	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	AUG	2015	81	16					5318	5325		10.1128/AEM.01151-15		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CN2UX	WOS:000358278600005		
J	Koja, N; Young, JC; Suzuki, T				Koja, Nozomu; Young, John C.; Suzuki, Takehito			Quasi-three-dimensional post-array for propagation and focusing of a terahertz spoof surface plasmon polariton	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							PHOTOCONDUCTIVE ANTENNAS; MAGNETOINDUCTIVE WAVES; FREQUENCIES	This paper presents a quasi-three-dimensional post-array designed to propagate a terahertz spoof surface plasmon polariton (terahertz spoof SPP) with confinement. A transmission line making use of a terahertz spoof SPP is a promising device in the terahertz wave band, and there are many previous reports of two-dimensional structures. Three-dimensional structures provide sophisticated designs for transmission lines propagating a terahertz spoof SPP. Eigenmode analysis is used to derive a dispersion diagram for one post with boundary conditions extracted from the full model. The propagation frequency of the terahertz spoof SPP increases with lower heights or smaller diameters, and that remains virtually unchanged for post-spacing and thickness of a substrate. The analysis of the full model confirms the confinement of a terahertz spoof SPP vertically on the post-array. The magnitude of the electric field is strong around the top and bottom and weak at approximately one-third height. The terahertz spoof SPP is confined in the space around the post-array as well as a substrate, while it is confined only on substrates in conventional two-dimensional structures. The designed post-array can control the three-dimensional focusing of a terahertz spoof SPP in an arbitrary volume of space.	[Koja, Nozomu; Suzuki, Takehito] Ibaraki Univ, Dept Elect & Elect Engn, Hitachi, Ibaraki 3168511, Japan; [Young, John C.] Univ Kentucky, Elect & Comp Engn, Lexington, KY 40506 USA	Suzuki, T (reprint author), Ibaraki Univ, Dept Elect & Elect Engn, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan.	takehito@mx.ibaraki.ac.jp			Japan Society for the Promotion of Science (JSPS) [26706017, 26600108]	The authors wish to thank Mr. Yudai Kishi and Mr. Takahisa Togashi for their kind support to complete this paper. The authors also wish to thank Dr. Keisuke Takano and Prof. Masanori Hangyo for valuable comments during the execution of this study. This research has been supported by a Grant-in-Aid for Young Scientists (A) (No. 26706017) from Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Challenging Exploratory Research (No. 26600108) from the Japan Society for the Promotion of Science (JSPS), and commissioned by the Strategic Information and Communications R&D Promotion Programme (SCOPE) (No. 122103011) from the Ministry of Internal Affairs and Communications.	Hughes S, 2003, J APPL PHYS, V93, P4880, DOI 10.1063/1.1560877; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shadrivov IV, 2007, PHYSICA B, V394, P180, DOI 10.1016/j.physb.2006.12.038; Tao H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.147401; Takano K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3654156; Song K, 2009, IEEE T ELECTRON DEV, V56, P2792, DOI 10.1109/TED.2009.2030838; Wiltshire MCK, 2003, ELECTRON LETT, V39, P215, DOI 10.1049/el:20030138; Maier SA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176805; Kan T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4809533; Fan KB, 2011, OPT EXPRESS, V19, P12619, DOI 10.1364/OE.19.012619; Shamonina E, 2002, J APPL PHYS, V92, P6252, DOI 10.1063/1.1510945; Piao ZS, 2000, JPN J APPL PHYS 1, V39, P96, DOI 10.1143/JJAP.39.96; Hibbins AP, 2005, SCIENCE, V308, P670, DOI 10.1126/science.1109043; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; Koja N., 2013, 74 AUT M 2009 JAP SO, V18, pA14; Kumada N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2353; Laurette S, 2012, IEEE T THZ SCI TECHN, V2, P340, DOI 10.1109/TTHZ.2012.2189207; Monnai Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4759042; Reinhard B, 2010, OPT LETT, V35, P1320, DOI 10.1364/OL.35.001320; Withayachumnankul W., 2012, TERAHERTZ MAGNETIC P; Yashiro M., 2013, ANAL DESIGN PLANAR D	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	AUG	2015	120	2					479	485		10.1007/s00339-015-9259-0		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CN2FM	WOS:000358236200011		
J	Miyamoto, W; Takao, M; Innami, K; Miki, S; Matsushita, T				Miyamoto, Wataru; Takao, Masato; Innami, Ken; Miki, Shinya; Matsushita, Takashi			Ligament reconstruction with single bone tunnel technique for chronic symptomatic subtle injury of the Lisfranc joint in athletes	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Lisfranc joint; Lisfranc ligament; Ligament reconstruction; Subtle injury	TARSOMETATARSAL JOINT; SCREW FIXATION; MANAGEMENT; MIDFOOT	Only few procedures for Lisfranc ligaments reconstruction to treat subtle injury of the Lisfranc joint have been reported. We have developed a novel technique for Lisfranc ligaments reconstruction, which was applied to treat chronic symptomatic subtle injuries that had failed to respond to initial treatment or were misdiagnosed. This article describes the technique and its operative outcome in a small case series. Between April 2011 and October 2013, 5 (4 male and 1 female) athletes with a mean age of 19.4 (range 17-21) years were diagnosed with chronic subtle injury of the Lisfranc joint and underwent our novel reconstructive operation. In this technique, only a bone tunnel between the medial cuneiform and the second metatarsal bone is needed for near-anatomical reconstruction of the dorsal and interosseous ligaments. All patients were evaluated before and at 1 year after surgery using the American Orthopaedic Foot and Ankle Society (AOFAS) scale for the ankle-midfoot. In addition, the interval between surgery and return to athletic activity, defined as return to near pre-injury performance level, was investigated. Mean duration of postoperative follow-up was 18.8 (range 12-26) months. Mean AOFAS score improved significantly from 74.6 +/- A 2.5 (range 71-77) preoperatively to 96.0 +/- A 5.5 (range 90-100) at 1 year after the operation (p < 0.01). All patients were able to return to their previous athletic activities and the interval between surgery and return to athletic activity was 16.8 +/- A 1.1 (range 15-18) weeks. There was no complication related to the operation. The results of this study suggest that our technique of Lisfranc ligaments reconstruction using autologous graft is effective for athletes with chronic subtle injury. Level IV, retrospective case series.	[Miyamoto, Wataru; Takao, Masato; Innami, Ken; Miki, Shinya; Matsushita, Takashi] Teikyo Univ, Sch Med, Dept Orthopaed Surg, Itabashi Ku, Tokyo 1738605, Japan	Miyamoto, W (reprint author), Teikyo Univ, Sch Med, Dept Orthopaed Surg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	miyamoto@med.teikyo-u.ac.jp					Coss HS, 1998, FOOT ANKLE INT, V19, P537; Brin YS, 2010, FOOT ANKLE INT, V31, P624, DOI 10.3113/FAI.2010.0624; Thordarson DB, 2002, FOOT ANKLE INT, V23, P1003; CURTIS MJ, 1993, AM J SPORT MED, V21, P497, DOI 10.1177/036354659302100403; Nunley JA, 2002, AM J SPORT MED, V30, P871; FACISZEWSKI T, 1990, J BONE JOINT SURG AM, V72A, P1519; Alberta FG, 2005, FOOT ANKLE INT, V26, P462; Lee CA, 2004, FOOT ANKLE INT, V25, P365; Myerson MS, 2008, J BONE JOINT SURG AM, V90A, P2522; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349; dePalma L, 1997, FOOT ANKLE INT, V18, P356; Hirano T, 2014, FOOT ANKLE SURG, V20, P221, DOI 10.1016/j.fas.2014.04.005; Lundeen G, 2009, FOOT ANKLE INT, V30, P713, DOI 10.3113/FAI.2009.0713; Nery C, 2012, FOOT ANKLE CLIN, V17, P407, DOI 10.1016/j.fcl.2012.06.003; Watson TS, 2010, J AM ACAD ORTHOP SUR, V18, P718	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	AUG	2015	135	8					1063	1070		10.1007/s00402-015-2250-6		8	Orthopedics; Surgery	Orthopedics; Surgery	CN4DS	WOS:000358380700004		
J	Suda, K; Mitsudomi, T				Suda, Kenichi; Mitsudomi, Tetsuya			Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity	ARCHIVES OF TOXICOLOGY			English	Review						Molecular biomarkers; Cytotoxic chemotherapy; Personalized therapy; Acquired resistance; EGFR tyrosine kinase inhibitor	GROWTH-FACTOR-RECEPTOR; CISPLATIN PLUS GEMCITABINE; RANDOMIZED PHASE-III; PREDOMINANT HISTOLOGIC SUBTYPE; KRAS GENE-MUTATIONS; ACQUIRED-RESISTANCE; OPEN-LABEL; ADENOCARCINOMA CLASSIFICATION; MET AMPLIFICATION; DNA-REPAIR	Lung cancers with an epidermal growth factor receptor (EGFR) gene mutation account for similar to 40 % of adenocarcinomas in East Asians and similar to 15 % of those in Caucasians and African Americans, which makes them one of the most common molecularly defined lung cancer subsets. The discriminative clinical and pathological features of lung cancers with EGFR mutations have been intensively studied, and the predictive role of an EGFR mutation for treatment with EGFR tyrosine kinase inhibitors (EGFR-TKIs) is well established. However, controversial issues remain regarding the clinical and therapeutic implications of EGFR mutations in lung cancers. These include the prognostic impact of the EGFR mutation, its predictive implication for successful treatment with anticancer agents other than EGFR-TKIs, appropriate cytotoxic agents for lung cancers with this mutation, and the chemosensitivity of EGFR-mutation-positive lung cancers after acquisition of resistance to EGFR-TKIs. In this review, we discuss these unanswered but important questions, referring to in vitro studies, basic research, retrospective analyses, and the results of phase III clinical trials.	[Suda, Kenichi; Mitsudomi, Tetsuya] Kinki Univ, Dept Surg, Div Thorac Surg, Fac Med, Osaka 5898511, Japan	Suda, K (reprint author), Kinki Univ, Dept Surg, Div Thorac Surg, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	ascaris@surg2.med.kyushu-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [15K18450]; Japan Surgical Society (JSS); Kaibara Morikazu Medical Science Promotion Foundation; Uehara Memorial Foundation; Takeda Science Foundation	Current research in my laboratory is supported by Grants-in-Aid of Cancer Research from the Ministry of Education, Science, Sports, and Culture of Japan (K. Suda, 15K18450), grants from the Japan Surgical Society (JSS) Young Researcher Award 2014 (K. Suda), the Kaibara Morikazu Medical Science Promotion Foundation (K. Suda), the Uehara Memorial Foundation (T. Mitsudomi), and the Takeda Science Foundation (T. Mitsudomi).	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Christoph DC, 2013, J THORAC ONCOL, V8, P19, DOI 10.1097/JTO.0b013e31827628ff; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Takano T, 2008, J CLIN ONCOL, V26, P5589, DOI 10.1200/JCO.2008.16.7254; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI [10.1056/NEJMoa1214271, 10.1056/oa1214271]; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Fang S, 2014, ONCOTARGETS THER, V7, P1185, DOI 10.2147/OTT.S63665; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Postel-Vinay S, 2012, NAT REV CLIN ONCOL, V9, P144, DOI 10.1038/nrclinonc.2012.3; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Kim YT, 2013, J THORAC ONCOL, V8, P171, DOI 10.1097/JTO.0b013e318277a3bb; Kalikaki A, 2010, LUNG CANCER, V69, P110, DOI 10.1016/j.lungcan.2009.09.010; Kelly K, 2001, J CLIN ONCOL, V19, P3210; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sonobe M, 2007, J SURG ONCOL, V95, P63, DOI 10.1002/jso.20547; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Gandara DR, 2010, J THORAC ONCOL, V5, P1933, DOI 10.1097/JTO.0b013e3181fd418d; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; [Anonymous], 2014, CANC MANAG RES; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Mochinaga K, 2014, CLIN LUNG CANCER, V15, P136, DOI 10.1016/j.cllc.2013.09.002; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Giovannetti E, 2005, MOL PHARMACOL, V68, P110, DOI 10.1124/mol.104.009373; Janjigian YY, 2011, J THORAC ONCOL, V6, P569, DOI 10.1097/JTO.0b013e318202bffe; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Shim HS, 2011, ARCH PATHOL LAB MED, V135, P1329, DOI 10.5858/arpa.2010-0493-OA; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Liu HP, 2010, J THORAC ONCOL, V5, P1175, DOI 10.1097/JTO.0b013e3181e2f4d6; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ceppi P, 2006, CANCER, V107, P1589, DOI 10.1002/cncr.22208; Okuda K, 2008, LUNG CANCER, V62, P105, DOI 10.1016/j.lungcan.2008.02.021; Ren SX, 2012, CANCER-AM CANCER SOC, V118, P5588, DOI 10.1002/cncr.27603; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Mariano C, 2014, LUNG CANCER, V83, P73, DOI 10.1016/j.lungcan.2013.10.007; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Yanagawa N, 2014, ANN THORAC SURG, V98, P453, DOI 10.1016/j.athoracsur.2014.04.108; [Anonymous], 2012, J CLIN ONCOL S; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Suda K, 2009, J THORAC ONCOL, V4, P1, DOI 10.1097/JTO.0b013e3181913c9f; Izar B, 2013, ANN THORAC SURG, V96, P962, DOI 10.1016/j.athoracsur.2013.05.091; D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Wu YL, 2013, J THORAC ONCOL, V8, pS603; [Anonymous], 2013, MOL CLIN ONCOL; Suehisa H, 2007, J CLIN ONCOL, V25, P3952, DOI 10.1200/JCO.2007.11.8646; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Kobayashi N, 2008, J THORAC ONCOL, V3, P704, DOI 10.1097/JTO.0b013e31817c6080; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Chen Z, 2014, INT J CLIN EXP PATHO, V7, P8039; Dong XP, 2013, CLIN LUNG CANCER, V14, P680, DOI [10.1016/j.cllc.2013.05.004, 10.1016/j.dlc.2013.05.004]; Filipits M, 2011, LUNG CANCER, V74, P355, DOI 10.1016/j.lungcan.2011.06.005; Hotta K, 2007, J THORAC ONCOL, V2, P632, DOI 10.1097/JTO.0b013e318074bc0d; Hu HC, 2014, ONCOTARGETS THER, V7, P1423, DOI 10.2147/OTT.S58900; Jie L, 2014, PATHOL RES PRACT, V210, P176; Kim YH, 2012, CANCER CHEMOTH PHARM, V70, P271, DOI 10.1007/s00280-012-1910-2; Lim KH, 2007, MED ONCOL, V24, P388, DOI 10.1007/s12032-007-0018-8; Lin MW, 2014, J SURG ONCOL, V110, P99, DOI 10.1002/jso.23628; Liu WS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0771-9; Mizuuchi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123901; Nakamura H, 2014, CLIN LUNG CANCER, V16, P209; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Schmid-Bindert G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077948; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Song ZB, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0645-1; Suda K, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/645681, DOI 10.1155/2014/645681]; Suda K, 2012, AGING DIS, V3, P438; Suda K, 2014, PROG TUMOR RES, V41, P62, DOI 10.1159/000355902; Suda K, 2013, PTEN STRUCTURE MECH, V1st, P17; Suda K, 2015, J THORAC ONCOL, V10, P230, DOI 10.1097/JTO.0000000000000439; Sun Y, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-148; Tabara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041017; Tseng JS, 2014, ONCOTARGETS THER, V7, P799, DOI 10.2147/OTT.S62639; Vilmar A C, 2011, Eur Respir Rev, V20, P45, DOI 10.1183/09059180.00007310; Wu SG, 2011, LUNG CANCER, V72, P333, DOI 10.1016/j.lungcan.2010.10.012; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Xu CW, 2015, EXP THER MED, V9, P880, DOI 10.3892/etm.2015.2196; Yamashita F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071356	102	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	AUG	2015	89	8					1227	1240		10.1007/s00204-015-1524-7		14	Toxicology	Toxicology	CN2GF	WOS:000358238100005		
J	Shimokawa, H; Satoh, K				Shimokawa, Hiroaki; Satoh, Kimio			2015 ATVB Plenary Lecture Translational Research on Rho-Kinase in Cardiovascular Medicine	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Review						cardiovascular disease; heart failure; hypertension; inflammation; rho-associated kinases	VASCULAR SMOOTH-MUSCLE; CORONARY-ARTERY SPASM; LONG-TERM INHIBITION; PIGS IN-VIVO; INDUCED PULMONARY-HYPERTENSION; ABDOMINAL-AORTIC-ANEURYSM; NITRIC-OXIDE SYNTHASE; E-DEFICIENT MICE; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION; SUPPRESSES NEOINTIMAL FORMATION	Rho-kinase (ROCKs) is an important downstream effector of the small GTP-binding protein Ras homolog gene family member A. There are 2 isoforms of ROCK, ROCK1 and ROCK2, and they have different functions in several vascular components. The Ras homolog gene family member A/ROCK pathway plays an important role in various fundamental cellular functions, including contraction, motility, proliferation, and apoptosis, whereas its excessive activity is involved in the pathogenesis of cardiovascular diseases. For the past 20 years, a series of translational research studies have demonstrated the important roles of ROCK in the pathogenesis of cardiovascular diseases. At the molecular and cellular levels, ROCK upregulates several molecules related to inflammation, thrombosis, and fibrosis. In animal experiments, ROCK plays an important role in the pathogenesis of vasospasm, arteriosclerosis, hypertension, pulmonary hypertension, and heart failure. Finally, at the human level, ROCK is substantially involved in the pathogenesis of coronary vasospasm, angina pectoris, hypertension, pulmonary hypertension, and heart failure. Furthermore, ROCK activity in circulating leukocytes is a useful biomarker for the assessment of disease severity and therapeutic responses in vasospastic angina, heart failure, and pulmonary hypertension. In addition to fasudil, many other ROCK inhibitors are currently under development for various indications. Thus, the ROCK pathway is an important novel therapeutic target in cardiovascular medicine.	[Shimokawa, Hiroaki; Satoh, Kimio] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp			Network Medicine from Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan [21790698, 23659408, 24390193, 15H02535, 15H04816, 15K15046]; Ministry of Health, Labor, and Welfare, Tokyo, Japan [10102895, 15545346]	This work was supported, in part, by the grant-in-aid for Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine and the grants-in-aid for Scientific Research (21790698, 23659408, 24390193, 15H02535, 15H04816, and 15K15046), all of which are from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan, and the grants-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare, Tokyo, Japan (10102895, 15545346).	Abe K, 2006, J CARDIOVASC PHARM, V48, P280, DOI 10.1097/01.fjc.0000248244.64430.4a; Aizawa K, 2012, CIRC J, V76, P2552, DOI 10.1253/circj.CJ-12-0662; Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; ASANO T, 1987, J PHARMACOL EXP THER, V241, P1033; Kandabashi T, 2002, ARTERIOSCL THROM VAS, V22, P243, DOI 10.1161/hq0202.104274; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278; Miyata K, 2000, ARTERIOSCL THROM VAS, V20, P2351; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Shimokawa H, 1999, J MOL CELL CARDIOL, V31, P23, DOI 10.1006/jmcc.1998.0841; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1591, DOI 10.1161/ATVBAHA.112.300922; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Radeff JM, 2004, J BONE MINER RES, V19, P1882, DOI 10.1359/JBMR.040806; Katsumata N, 1997, CIRCULATION, V96, P4357; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Do E Z, 2009, CIRC J, V73, P1731; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Hiroki J, 2004, J MOL CELL CARDIOL, V37, P537, DOI 10.1016/j.yjmcc.2004.05.008; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Shibata R, 2009, CIRC J, V73, P608; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Akama T, 2013, BIOORG MED CHEM LETT, V23, P5870, DOI 10.1016/j.bmcl.2013.08.096; Jin ZG, 2000, CIRC RES, V87, P789; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Kim H, 2005, CLIN IMMUNOL, V116, P217, DOI 10.1016/j.clim.2005.05.004; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; ALEXANDER RW, 1995, HYPERTENSION, V25, P155; Gavazzi G, 2007, HYPERTENSION, V50, P189, DOI 10.1161/HYPERTENSIONAHA.107.089706; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Shiroto T, 2009, J AM COLL CARDIOL, V54, P2321, DOI 10.1016/j.jacc.2009.07.045; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Shibata R, 2001, CIRCULATION, V103, P284; Haack KKV, 2013, HYPERTENSION, V61, P723, DOI 10.1161/HYPERTENSIONAHA.111.00396; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Matsui T, 1996, EMBO J, V15, P2208; BAAS AS, 1995, CIRC RES, V77, P29; Satoh K, 2014, J MOL CELL CARDIOL, V73, P50, DOI 10.1016/j.yjmcc.2013.12.022; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Elvers M, 2012, BLOOD, V120, P1317, DOI 10.1182/blood-2011-12-398438; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Takai Y, 2001, PHYSIOL REV, V81, P153; Shimizu T, 2013, ARTERIOSCL THROM VAS, V33, P2780, DOI 10.1161/ATVBAHA.113.301357; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Sawada N, 2000, CIRCULATION, V101, P2030; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Amano M, 1996, J BIOL CHEM, V271, P20246; Satoh K, 2010, CIRC J, V74, P2249, DOI 10.1253/circj.CJ-10-0904; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Nakamura K, 1998, CIRCULATION, V98, P794; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Vanhoutte PM, 2001, J CLIN INVEST, V107, P23, DOI 10.1172/JCI11832; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Morikawa K, 2003, J CLIN INVEST, V112, P1871, DOI 10.1172/JCI200319351; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Xie ZW, 2015, J CLIN INVEST, V125, P324, DOI 10.1172/JCI76881; Soga J, 2011, ARTERIOSCL THROM VAS, V31, P2353, DOI 10.1161/ATVBAHA.111.227892; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JC131311; Badejo AM, 2008, AM J PHYSIOL-LUNG C, V295, pL828, DOI 10.1152/ajplung.00042.2008; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1302.105938; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Akama T, 2013, J PHARMACOL EXP THER, V347, P615, DOI 10.1124/jpet.113.207662; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Kandabashi T, 2000, CIRCULATION, V101, P1319; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Yamakawa T, 2000, HYPERTENSION, V35, P313; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108; Weintraub NL, 2009, NEW ENGL J MED, V361, P1114, DOI 10.1056/NEJMcibr0905244; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Yao L, 2013, CARDIOVASC RES, V97, P509, DOI 10.1093/cvr/cvs371; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Satoh K, 2011, ARTERIOSCL THROM VAS, V31, P1116, DOI 10.1161/ATVBAHA.110.214601; GRIENDLING KK, 1994, CIRC RES, V74, P1141; Matsumoto Y, 2004, ARTERIOSCL THROM VAS, V24, P181, DOI 10.1161/01.ATV.0000105053.46994.5B; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; Fukumoto Y, 2013, CIRC J, V77, P2619, DOI 10.1253/circj.CJ-13-0443; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Funakoshi Y, 2001, HYPERTENSION, V38, P100; Berk BC, 2001, PHYSIOL REV, V81, P999; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BERK BC, 1986, SCIENCE, V232, P87, DOI 10.1126/science.3485309; Cai YJ, 2015, CIRC RES, V116, P1120, DOI 10.1161/CIRCRESAHA.116.304408; Casey DB, 2010, AM J PHYSIOL-HEART C, V299, pH184, DOI 10.1152/ajpheart.00181.2009; Chapados R, 2006, CIRC RES, V99, P837, DOI 10.1161/01.RES.0000246172.77441.f1; Chihara K, 1997, J BIOL CHEM, V272, P25121, DOI 10.1074/jbc.272.40.25121; Dhaliwal JS, 2009, J PHARMACOL EXP THER, V330, P334, DOI 10.1124/jpet.109.151449; Dhaliwal JS, 2007, AM J PHYSIOL-LUNG C, V293, pL1306, DOI 10.1152/ajplung.00189.2007; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto M, 2001, CIRC RES, V89, P583, DOI 10.1161/hh1901.097084; Eto Y, 2000, AM J PHYSIOL-HEART C, V278, pH1744; Fukui S, 2008, J CARDIOVASC PHARM, V51, P317, DOI 10.1097/FJC.0b013e31816533b7; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; GRIENDLING KK, 1987, HYPERTENSION, V9, P181; Hattori T, 2004, CIRC RES, V94, P46, DOI 10.1161/01.RES.0000107196.21335.2B; Hizume T, 2006, CIRC RES, V99, P767, DOI 10.1161/01.RES.0000244093.69985.2f; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; IKEBE M, 1985, J BIOL CHEM, V260, P27; ITO A, 1995, J CLIN INVEST, V96, P1288, DOI 10.1172/JCI118163; Ito K, 2005, CLIN EXP HYPERTENS, V27, P269, DOI 10.1081/CEH-200048876; Ito K, 2004, HYPERTENSION, V43, P156, DOI 10.1161/01.HYP.0000114602.82140.a4; Ito K, 2003, CIRC RES, V92, P1337, DOI 10.1161/01.RES.0000079941.59846.D4; Itoh T, 2004, AM J RESP CRIT CARE, V170, P1204, DOI 10.1164/rccm.200404-455OC; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; Khromykh LM, 2007, CELL IMMUNOL, V249, P46, DOI 10.1016/j.cellimm.2007.11.002; Kishi H, 2000, J BIOCHEM-TOKYO, V128, P719; Mohri M, 2003, J AM COLL CARDIOL, V41, P15, DOI 10.1016/S0735-1097(02)02632-3; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Nihei T, 2014, CIRC J, V78, P1183, DOI 10.1253/circj.CJ-13-1458; Nishioka T, 2015, BIOCH BIOPH IN PRESS, DOI [10.1016/j.bbapap.2015.03.001, DOI 10.1016/J.BBAPAP.2015.03.001]; Noda K, 2015, TOHOKU J EXP MED, V235, P171, DOI 10.1620/tjem.235.171; Oi K, 2004, ARTERIOSCL THROM VAS, V24, P918, DOI 10.1161/01.ATV.0000126678.93747.80; OMAR HA, 1991, CIRC RES, V69, P601; Rikitake Yoshiyuki, 2005, Expert Rev Cardiovasc Ther, V3, P441, DOI 10.1586/14779072.3.3.441; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Saito T, 2013, CIRCULATION, V127, P104, DOI 10.1161/CIRCULATIONAHA.112.135608; Satoh S, 2001, JPN J PHARMACOL, V87, P34, DOI 10.1254/jjp.87.34; Satoh K, 2013, CIRC J, V77, P447, DOI 10.1253/circj.CJ-12-0805; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Satoh K, 2006, CIRCULATION, V113, P1442, DOI 10.1161/CIRCULATIONAHA.105.583732; Satoh K, 2009, CARDIOVASC RES, V81, P226, DOI 10.1093/cvr/cvn244; Satoh K, 2015, CIRC RES, V116, P1098, DOI 10.1161/CIRCRESAHA.115.306139; Satoh K, 2014, CIRC RES, V115, P738, DOI 10.1161/CIRCRESAHA.115.304563; Satoh S, 2002, LIFE SCI, V72, P103, DOI 10.1016/S0024-3205(02)02178-1; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751; Seasholtz TM, 1999, CIRC RES, V84, P1186; Seizer P, 2015, ARTERIOSCL THROM VAS, V35, P655, DOI 10.1161/ATVBAHA.114.305112; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; SETO M, 1993, EXP MOL PATHOL, V58, P1, DOI 10.1006/exmp.1993.1001; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; Shimokawa Hiroaki, 2002, Journal of Cardiovascular Pharmacology, V40, P751, DOI 10.1097/00005344-200211000-00013; SHIMOKAWA H, 1983, SCIENCE, V221, P560, DOI 10.1126/science.6408736; Shimokawa H, 2002, J CARDIOVASC PHARM, V39, P319, DOI 10.1097/00005344-200203000-00001; Shimokawa H, 2014, EUR HEART J, V35, P3180, DOI 10.1093/eurheartj/ehu427; Shimokawa H, 2000, JPN CIRC J, V64, P1, DOI 10.1253/jcj.64.1; Shimokawa H, 2001, CARDIOVASC RES, V51, P169, DOI 10.1016/S0008-6363(01)00291-7; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Takagi Y, 2009, CIRC J, V73, P767; Takeda K, 2001, ARTERIOSCL THROM VAS, V21, P868; Takefuji M, 2013, J EXP MED, V210, P665, DOI 10.1084/jem.20122126; Tsuburaya R, 2012, EUR HEART J, V33, P791, DOI 10.1093/eurheartj/ehr145; Utsunomiya T, 2001, BRIT J PHARMACOL, V134, P1724, DOI 10.1038/sj.bjp.0704410; Vahebi S, 2005, CIRC RES, V96, P740, DOI 10.1161/01.RES.0000162457.56568.7d; Amerongen GPV, 2000, CIRC RES, V87, P335; Wang L, 2010, J CLIN IMMUNOL, V30, P24, DOI 10.1007/s10875-009-9329-1; Yada T, 2005, J AM COLL CARDIOL, V45, P599, DOI 10.1016/j.jacc.2004.10.053	180	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	AUG	2015	35	8					1756	1769		10.1161/ATVBAHA.115.305353		14	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CN2ZC	WOS:000358291100004		
J	van Lessen, M; Nakayama, M; Kato, K; Kim, JM; Kaibuchi, K; Adams, RH				van Lessen, Max; Nakayama, Masanori; Kato, Katsuhiro; Kim, Jung Mo; Kaibuchi, Kozo; Adams, Ralf H.			Regulation of Vascular Endothelial Growth Factor Receptor Function in Angiogenesis by Numb and Numb-Like	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						angiogenesis; endocytosis; endothelial cell; endothelial cell sprouting and proliferation; VEGF signaling; VEGFR2	INTEGRIN ENDOCYTOSIS; SPATIAL REGULATION; EPSIN DEFICIENCY; CELL-MIGRATION; UP-REGULATION; TUMOR-GROWTH; MICE; TRAFFICKING; NOTCH; LYMPHANGIOGENESIS	Objective Vascular endothelial growth factor (VEGF) signaling is a major regulator of physiological and pathological angiogenesis. VEGF receptor activity is strongly controlled by endocytosis, which can terminate or enhance signal transduction in the angiogenic endothelium, but the exact molecular regulation of these processes remains incompletely understood. We have therefore examined the function of Numb family clathrin-associated sorting proteins in angiogenesis. Approach and Results We show that Numb proteins are expressed by endothelial cells during retinal angiogenesis in mice. Inducible inactivation of the Numb/Numbl genes in the postnatal endothelium led to impaired vessel growth, reduced endothelial proliferation and sprouting, and decreased VEGF receptor activation. Biochemistry and cell biology experiments established that Numb can interact with VEGFR2 and VEGFR3 and controls VEGF receptor activation in response to ligand stimulation. Experiments in cultured endothelial cells showed that Numb proteins counteract VEGF receptor degradation and promote VEGFR2 recycling back to the plasma membrane. Conclusions Numb proteins control VEGF receptor endocytosis, signaling, and recycling in endothelial cells, which promotes the angiogenic growth of blood vessels.	[van Lessen, Max; Nakayama, Masanori; Kato, Katsuhiro; Kim, Jung Mo; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [van Lessen, Max; Nakayama, Masanori; Kato, Katsuhiro; Kim, Jung Mo; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Kato, Katsuhiro; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan	Adams, RH (reprint author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	ralf.adams@mpi-muenster.mpg.de			Max Planck Society; University of Munster; EMBO LTF program; Deutsche Forschungsgemeinschaft [SFB 629]; Deutsche Forschungsgemeinschaft (Cells-in-Motion Cluster of Excellence; EXC-CiM)	Funding was provided by the Max Planck Society, the University of Munster, the EMBO LTF program, and the Deutsche Forschungsgemeinschaft (SFB 629 and Cells-in-Motion Cluster of Excellence; EXC-CiM).	Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Bogdanovic O, 2012, DEV CELL, V23, P782, DOI 10.1016/j.devcel.2012.09.004; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Lanahan AA, 2010, DEV CELL, V18, P713, DOI [10.1016/j.devcel.2010.02.016, 10.1016/j.devce1.2010.02.016]; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Zhou PC, 2011, DEV CELL, V20, P610, DOI 10.1016/j.devcel.2011.04.006; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Tessneer KL, 2014, ARTERIOSCL THROM VAS, V34, P331, DOI 10.1161/ATVBAHA.113.302586; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Wilson A, 2007, J IMMUNOL, V178, P6746; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Pasula S, 2012, J CLIN INVEST, V122, P4424, DOI 10.1172/JCI64537; Nakayama M, 2008, DEV CELL, V14, P205, DOI [10.1016/j.devcel.2007.11.021, 10.1016/j.devce1.2007.11.021]; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; El-Hashash AHK, 2012, J HISTOCHEM CYTOCHEM, V60, P675, DOI 10.1369/0022155412451582; Izumi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041116; Liu XL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005413; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Nakayama M, 2013, EXP CELL RES, V319, P1340, DOI 10.1016/j.yexcr.2013.03.008; Smith MJ, 2007, MOL CELL BIOL, V27, P4601, DOI 10.1128/MCB.00782-07; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160	53	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	AUG	2015	35	8					1815	1825		10.1161/ATVBAHA.115.305473		11	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CN2ZC	WOS:000358291100011		
J	Tanaka, F; Tanaka, F; Tanaka, A; Uchino, T				Tanaka, Fumina; Tanaka, Fumihiko; Tanaka, Ai; Uchino, Toshitaka			Mathematical modelling of thin-layer drying according to particle size distribution in crushed feed rice	BIOSYSTEMS ENGINEERING			English	Article						Crushed feed rice; Drying; Particle size distribution; Monte Carlo method; Page model	ROUGH RICE; SIMULATION	A thin-layer drying model taking into account the particle size distribution of crushed feed rice was developed to simulate moisture content during high-temperature drying. The model was based on the Page equation, which was regarded as a suitable empirical equation to describe the thin-layer drying of rice. The proposed model, with an assumed a Rosin Rammler distribution, successfully predicted the mean moisture content of rice during drying experiments with a mean error of 0.5% dry basis at 60, 70, and 80 degrees C. In order to investigate the effect of particle size distribution of rice on the drying process, a stochastic model based on Monte Carlo simulations was developed. The model developed here could provide useful information on the drying behaviour of rice particles, individually and collectively, in a thin layer bed. It was clear that uniform drying could be achieved by increasing the drying temperature. (C) 2015 IAgrE. Published by Elsevier Ltd. All rights reserved.	[Tanaka, Fumina] JA ZENNOH FUKUREN, Chuo Ku, Fukuoka 8100001, Japan; [Tanaka, Fumihiko; Uchino, Toshitaka] Kyushu Univ, Fac Agr, Dept Bioprod Environm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Tanaka, Ai] Kyushu Univ, Grad Sch Bioresource & Bioenvirom Sci, Higashi Ku, Fukuoka 8128581, Japan	Tanaka, F (reprint author), Kyushu Univ, Fac Agr, Dept Bioprod Environm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	fumit@bpes.kyushu-u.ac.jp					Hacihafizoglu O, 2008, FOOD BIOPROD PROCESS, V86, P268, DOI 10.1016/j.fbp.2008.01.002; Basunia MA, 2001, J FOOD ENG, V47, P295, DOI 10.1016/S0260-8774(00)00133-3; BakkerArkema FW, 1997, J AGR ENG RES, V66, P281, DOI 10.1006/jaer.1996.0144; Cihan A, 2007, J FOOD ENG, V79, P293, DOI 10.1016/j.jfoodeng.2006.01.057; Cronin K, 1998, J FOOD ENG, V35, P233, DOI 10.1016/S0260-8774(98)00011-9; Liu Q., 1997, J AGR ENG RES, V66, P274; Liu QA, 1997, J AGR ENG RES, V66, P267, DOI 10.1006/jaer.1996.0146; Seto J., 1960, CHEM ANALIST, V9, P939; Tanaka F, 2008, LWT-FOOD SCI TECHNOL, V41, P1567, DOI 10.1016/j.lwt.2007.10.020; Tanaka F., 2014, ENV FOOD, V7, P133; Tanaka F, 2008, BIOSYST ENG, V100, P53, DOI 10.1016/j.biosystemseng.2008.01.009; Tanaka S. I., 2000, Journal of the Japanese Society of Agricultural Machinery, V62, P104	12	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1537-5110	1537-5129		BIOSYST ENG	Biosyst. Eng.	AUG	2015	136						87	91		10.1016/j.biosystemseng.2015.05.007		5	Agricultural Engineering; Agriculture, Multidisciplinary	Agriculture	CN4GT	WOS:000358389300009		
J	Ochi, T				Ochi, Toshio			Apocalyptic Memories and Subjective Movements: Differentiation by Political Power in Postwar Japan	BOUNDARY 2-AN INTERNATIONAL JOURNAL OF LITERATURE AND CULTURE			English	Article									[Ochi, Toshio] Niigata Univ Int & Informat Studies Japan, Dept Informat Culture, Niigata, Japan; [Ochi, Toshio] NYU, Int Ctr Adv Studies, Project Cold War Global Conflict, New York, NY 10003 USA	Ochi, T (reprint author), Univ Chicago, Chicago, IL 60637 USA.						[Anonymous], 1996, REPORT COUNCIL PUBLI	1	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	0190-3659	1527-2141		BOUNDARY TWO	Boundary 2-Int. J. Lit. Cult.	AUG	2015	42	3					55	61		10.1215/01903659-2919495		7	Cultural Studies; Literature	Cultural Studies; Literature	CN1NL	WOS:000358186600005		
J	Ohno, N; Murai, H; Suzuki, Y; Kiyosawa, M; Tokumaru, AM; Ishii, K; Ohno-Matsui, K				Ohno, Naonori; Murai, Hideki; Suzuki, Yukihisa; Kiyosawa, Motohiro; Tokumaru, Aya M.; Ishii, Kenji; Ohno-Matsui, Kyoko			Alteration of the optic radiations using diffusion-tensor MRI in patients with retinitis pigmentosa	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							LATERAL GENICULATE-NUCLEUS; VISUAL-CORTEX; MORPHOMETRIC-ANALYSIS; HUMAN GLAUCOMA; PATHWAY; NERVE; DEGENERATION; RETINAS; ATROPHY	Purpose To evaluate alteration of the optic radiation (OR) in patients with retinitis pigmentosa (RP) using fractional anisotropy (FA) measured by diffusion tensor MRI. Methods We performed MRI and evaluated alteration of the ORs in 17 patients with RP and 27 healthy controls. Regions of interest were placed over the bilateral anterior and posterior areas of the ORs, and we measured the FA value of each region. Visual field (VF) tests were examined in all subjects, and we corrected the residual VF area according to the projection area to the striate cortex. Differences between the FA values of patients and healthy controls were tested. We performed regression analyses between the sum of the corrected VF areas and FA values in the anterior or posterior contralateral ORs in patients with RP. Moreover, we performed regression analyses between the average of FA values of ORs and the average of both eyes of visual acuity in patients with RP. Results FA values of the bilateral anterior and posterior ORs were lower in patients with RP (anterior right, p=0.012; posterior right, p=0.0004; anterior left, p=0.0008; and posterior left, p=0.0004) compared with those of healthy controls. In patients with RP, significant correlations were observed between average FA values of anterior ORs and average visual acuity (correlation coefficient (r)=-0.54; p= 0.025). Conclusions In patients with RP, alterations may occur not only in the retina but also in the brain.	[Ohno, Naonori; Murai, Hideki; Suzuki, Yukihisa; Kiyosawa, Motohiro; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Ohno, Naonori; Murai, Hideki; Suzuki, Yukihisa; Ishii, Kenji] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo 1730015, Japan; [Kiyosawa, Motohiro] Kiyosawa Eye Clin, Tokyo, Japan; [Tokumaru, Aya M.] Tokyo Metropolitan Geriatr Hosp, Dept Diagnost Radiol, Tokyo 173, Japan; [Tokumaru, Aya M.] Inst Gerontol, Tokyo, Japan	Ishii, K (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Sakae Cho 35-2, Tokyo 1730015, Japan.	ishii@pet.tmig.or.jp					Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Walia S, 2007, INVEST OPHTH VIS SCI, V48, P4748, DOI 10.1167/iovs.07-0404; John SK, 2000, MOL VIS, V6, P204; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Michelson G, 2013, GRAEF ARCH CLIN EXP, V251, P243, DOI 10.1007/s00417-011-1887-2; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Grover S, 1998, OPHTHALMOLOGY, V105, P1069, DOI 10.1016/S0161-6420(98)96009-2; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Horton JC, 2006, CAN J OPHTHALMOL, V41, P584; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Eng JG, 2011, INVEST OPHTH VIS SCI, V52, P4610, DOI 10.1167/iovs.09-4936; Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013; Oishi A, 2009, EYE, V23, P561, DOI 10.1038/eye.2008.63; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Murai H, 2013, JPN J OPHTHALMOL, V57, P257, DOI 10.1007/s10384-013-0233-0; Falsini B, 2012, INVEST OPHTH VIS SCI, V53, P7701, DOI 10.1167/iovs.12-11017; Holladay JT, 1997, J REFRACT SURG, V13, P388; Iarossi G, 2003, INVEST OPHTH VIS SCI, V44, P866, DOI 10.1167/iovs.01-1256; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Liang ZJ, 2008, CEREBROVASC DIS, V25, P209, DOI 10.1159/000113858; Lin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068084; Sandberg MA, 2005, AM J OPHTHALMOL, V140, P100, DOI 10.1016/j.ajo.2005.02.038; STONE JL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1634	26	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	AUG	2015	99	8					1051	1054		10.1136/bjophthalmol-2014-305809		4	Ophthalmology	Ophthalmology	CN3BC	WOS:000358297200008		
J	Nishi, T; Ueda, T; Hasegawa, T; Miyata, K; Ogata, N				Nishi, Tomo; Ueda, Tetsuo; Hasegawa, Taiji; Miyata, Kimie; Ogata, Nahoko			Retinal thickness in children with anisohypermetropic amblyopia	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LATERAL GENICULATE-NUCLEUS; UNILATERAL AMBLYOPIA; ANISOMETROPIC AMBLYOPIA; CHOROIDAL THICKNESS; LAYER THICKNESS; HUMAN FOVEA	Purpose To determine the thickness of the fovea in eyes of children with anisohypermetropic amblyopia, their fellow eyes and eyes of age-matched controls. Additionally, to assess the effects of optical treatment on the foveal thickness in eyes with anisohypermetropic amblyopia. Materials and methods Twenty-one patients (6.0 +/- 2.3 years, mean +/- SD) with anisohypermetropic amblyopia and 25 age-matched controls (5.6 +/- 1.9 years) were studied. Spectral-domain optical coherence tomography (SD-OCT) was used to obtain OCT images. The foveal thickness and the thickness of the outer nuclear layer (ONL), photoreceptor inner segment (IS) layer and outer segment (OS) layer were measured by the embedded OCT software. Results The length of the OS was significantly greater in the fellow eyes (48.0 +/- 6.6 mu m) than in the amblyopic eyes (42.4 +/- 4.6 mu m, p = 0.03). One year after the optical treatment of the anisohypermetropia, the best-corrected visual acuity (BCVA) improved and the length of the OS was significantly increased (p = 0.0001). After optical treatment, there was no more significant difference in the OS length between the amblyopic eyes and the fellow eyes (p = 0.95). The change of BCVA was significantly correlated with the change of the length of the OS 1 year after the treatment (r = 0.52; p = 0.0004). Conclusions Anisohypermetropic amblyopic eyes have qualitative and quantitative differences in the retinal microstructures of the fovea from normal eyes. An increase in the OS length was detected in the amblyopic eyes after the optical treatment. A significant correlation was found between the increased OS length and better BCVA.	[Nishi, Tomo; Ueda, Tetsuo; Hasegawa, Taiji; Miyata, Kimie; Ogata, Nahoko] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara 6348522, Japan	Nishi, T (reprint author), Nara Med Univ, Dept Ophthalmol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	tomon@naramed-u.ac.jp					Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; Nishi T, 2014, BRIT J OPHTHALMOL, V98, P228, DOI 10.1136/bjophthalmol-2013-303938; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Park KA, 2012, INVEST OPHTH VIS SCI, V53, P7201, DOI 10.1167/iovs.12-10599; Stewart CE, 2005, INVEST OPHTH VIS SCI, V46, P3152, DOI 10.1167/iovs.05-0357; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Yen MY, 2004, INVEST OPHTH VIS SCI, V45, P2224, DOI 10.1167/iovs.03-0297; VONNOORDEN GK, 1983, INVEST OPHTH VIS SCI, V24, P788; El-Dairi MA, 2009, ARCH OPHTHALMOL-CHIC, V127, P50, DOI 10.1001/archophthalmol.2008.553; Pineles SL, 2009, AM J OPHTHALMOL, V148, P551, DOI 10.1016/j.ajo.2009.05.007; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4; Al-Haddad CE, 2013, BRIT J OPHTHALMOL, V97, P318, DOI 10.1136/bjophthalmol-2012-302434; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Haeri M, 2013, BIOPHYS J, V104, P300, DOI 10.1016/j.bpj.2012.11.3835; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; Huynh SC, 2009, JAAPOS, V13, P148; Ohlsson J., 2004, STRABISMUS, V13, P15, DOI 10.1080/09273970590890949; Ooto S, 2010, GRAEF ARCH CLIN EXP, V248, P1077, DOI 10.1007/s00417-010-1338-5; Patel PJ, 2009, INVEST OPHTH VIS SCI, V50, P399, DOI 10.1167/iovs.08-1697; Szigeti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088363	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	AUG	2015	99	8					1060	1064		10.1136/bjophthalmol-2014-305685		5	Ophthalmology	Ophthalmology	CN3BC	WOS:000358297200010		
J	Takahashi, H; Nomura, Y; Tan, X; Fujino, Y; Kawashima, H; Yanagi, Y				Takahashi, Hidenori; Nomura, Yoko; Tan, Xue; Fujino, Yujiro; Kawashima, Hidetoshi; Yanagi, Yasuo			Effects of posterior vitreous detachment on aqueous humour levels of VEGF and inflammatory cytokines	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							RETINAL VEIN OCCLUSION; MACULAR DEGENERATION; VITREOMACULAR ADHESION; CHOROIDAL NEOVASCULARIZATION; THERAPY; EDEMA	Purpose To investigate the association of posterior vitreous detachment (PVD) with aqueous levels of vascular endothelial growth factor (VEGF) and other inflammatory cytokines. Methods These are prospective comparative studies. Subjects comprised 98 eyes for VEGF concentration and 80 eyes for other cytokines, which are normal except for cataract. PVD was examined by B-mode ultrasonography, and the subjects were divided into complete PVD group (PVD group) or the other group (without PVD group). At the beginning of cataract surgery, aqueous humour was collected and the concentrations of VEGF and other inflammatory cytokines were determined using ELISA and a multiplex cytokine assay, respectively. The concentrations of these cytokines were compared between the two groups. Results Complete PVD was observed in 56 (57%) eyes for VEGF concentration analysis, and 51 (64%) eyes for the other cytokines analysis. The concentrations of VEGF, adjusted for the average age, axial length and gender distribution, was 47 pg/ mL in the PVD group and 72 pg/mL in the without PVD group. The concentrations of IP10, MCP-1, CXCL13 and CCL11 were 53, 450, 3.8 and 6.0 pg/ mL in the PVD group, and 100, 560, 7.0 and 8.4 pg/ mL in the without PVD group, respectively. Multiple regression analysis revealed that the logarithmic concentration of VEGF, IP-10, MCP-1, CXCL13 and CCL11 were significantly lower in the eyes with PVD than in those without PVD independently of age, sex and axial length (p = 0.01, p = 0.002, p = 0.009, 0.006 and 0.03, respectively). Conclusions PVD is related to the change in the multiple intraocular inflammatory cytokines.	[Takahashi, Hidenori; Nomura, Yoko; Tan, Xue; Yanagi, Yasuo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; [Takahashi, Hidenori; Nomura, Yoko; Tan, Xue; Yanagi, Yasuo] Univ Tokyo, Fac Med, Tokyo 1138655, Japan; [Takahashi, Hidenori; Kawashima, Hidetoshi] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Takahashi, Hidenori; Fujino, Yujiro] Japan Community Hlth Care Org, Tokyo Shinjuku Med Ctr, Dept Ophthalmol, Tokyo, Japan	Yanagi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yanagi-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The study was supported in part by grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This paper is derived from details presented at the Annual Meeting of the Macula Society, 2012.	Agawa T, 2014, RETINA-J RET VIT DIS, V34, P1811, DOI 10.1097/IAE.0000000000000157; Noma H, 2010, EUR J OPHTHALMOL, V20, P402; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sebag J, 2007, GRAEF ARCH CLIN EXP, V245, P576, DOI 10.1007/s00417-006-0394-3; Robison CD, 2009, AM J OPHTHALMOL, V148, P79, DOI 10.1016/j.ajo.2009.01.014; Uney GO, 2014, RETINA-J RET VIT DIS, V34, P32, DOI 10.1097/IAE.0b013e318295f72e; Silveira AC, 2010, VISION RES, V50, P698, DOI 10.1016/j.visres.2009.09.016; Mojana F, 2008, AM J OPHTHALMOL, V146, P218, DOI 10.1016/j.ajo.2008.04.027; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Nomura Y, 2011, OPHTHALMOLOGY, V118, P853, DOI 10.1016/j.ophtha.2010.09.001; Terao R, 2014, JPN J OPHTHALMOL, V58, P139, DOI 10.1007/s10384-013-0302-4; Mayr-Sponer U, 2013, OPHTHALMOLOGY, V120, P2620, DOI 10.1016/j.ophtha.2013.05.032; Simpson ARH, 2012, SURV OPHTHALMOL, V57, P498, DOI 10.1016/j.survophthal.2012.01.011; Lee SJ, 2011, OPHTHALMOLOGY, V118, P101, DOI 10.1016/j.ophtha.2010.04.015; Ondes F, 2000, JPN J OPHTHALMOL, V44, P91, DOI 10.1016/S0021-5155(99)00174-4; Quiram PA, 2007, RETINA-J RET VIT DIS, V27, P1090; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Nomura Y, 2014, JPN J OPHTHALMOL, V58, P443, DOI 10.1007/s10384-014-0333-5; Quaranta-El Maftouhi M, 2006, EUR J OPHTHALMOL, V16, P134; Spinetti G, 2001, BIOCHEM BIOPH RES CO, V289, P19, DOI 10.1006/bbrc.2001.5924; Stefansson E, 2006, ACTA OPHTHALMOL SCAN, V84, P718, DOI 10.1111/j.1600-0420.2006.00778.x; Weber-Krause Brigitte, 1996, Ophthalmologe, V93, P660, DOI 10.1007/s003470050054; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085	24	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	AUG	2015	99	8					1065	1069		10.1136/bjophthalmol-2014-306051		5	Ophthalmology	Ophthalmology	CN3BC	WOS:000358297200011		
J	Hosokawa, M; Shiraga, F; Yamashita, A; Shiragami, C; Ono, A; Shirakata, Y; Kimura, S; Shiode, Y; Kawata, T; Hosogi, M; Fujiwara, A; Morizane, Y				Hosokawa, Mio; Shiraga, Fumio; Yamashita, Ayana; Shiragami, Chieko; Ono, Aoi; Shirakata, Yukari; Kimura, Shuhei; Shiode, Yusuke; Kawata, Tetsuhiro; Hosogi, Mika; Fujiwara, Atsushi; Morizane, Yuki			Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							PHOTODYNAMIC THERAPY; VEGF-TRAP; BEVACIZUMAB AVASTIN; GROWTH-FACTOR; RANIBIZUMAB; EFFICACY; VERTEPORFIN; PERICYTES; SAFETY	Background This study aims to evaluate the therapeutic effect of intravitreal aflibercept injection for polypoidal choroidal vasculopathy (PCV). Methods Eighteen eyes of 17 consecutive patients with PCV received three consecutive monthly intravitreal injections of aflibercept and one additional injection 2 months later (four injections totally). All patients underwent eye examinations, which included bestcorrected visual acuity (BCVA), fluorescein angiography, indocyanine green angiography, and optical coherence tomography. The primary endpoint of the study was the regression of polypoidal lesions. The secondary endpoints were BCVA, central retinal thickness (CRT) and changes in retinal exudation. Results Six months after the first aflibercept injection, the polypoidal lesions were completely resolved in 14 eyes (77.7%) and partially resolved in 4 eyes (22.2%). Although branching choroidal vascular networks were still present in all eyes, retinal exudative changes had completely resolved in 17 eyes (94.4%), and the mean CRT decreased significantly from 407.2 +/- 100.1 mu m to 229.1 +/- 57.2 mu m (p < 0.0001). BCVA (logarithm of the minimal angle of resolution, logMAR) improved significantly from 0.414 +/- 0.384 at baseline to 0.297 +/- 0.334 after 6 months (p = 0.016). Conclusions At 6 months, aflibercept monotherapy effectively reduced polyps, retinal exudation and CRT in patients with PCV.	[Hosokawa, Mio; Shiraga, Fumio; Kimura, Shuhei; Shiode, Yusuke; Kawata, Tetsuhiro; Hosogi, Mika; Fujiwara, Atsushi; Morizane, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Okayama 7008558, Japan; [Yamashita, Ayana; Shiragami, Chieko; Ono, Aoi; Shirakata, Yukari] Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa 760, Japan	Hosokawa, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	hmo529@okayama-u.ac.jp					Hirami Y, 2007, RETINA-J RET VIT DIS, V27, P335, DOI 10.1097/01.iae.0000233647.78726.46; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Mordenti J, 1999, TOXICOL PATHOL, V27, P536, DOI 10.1177/019262339902700507; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Kokame GT, 2010, BRIT J OPHTHALMOL, V94, P297, DOI 10.1136/bjo.2008.150029; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Uyama M, 1999, ARCH OPHTHALMOL-CHIC, V117, P1035; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Cho HJ, 2011, EYE, V26, P426; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Hikichi T, 2010, AM J OPHTHALMOL, V150, P674, DOI 10.1016/j.ajo.2010.05.026; Ohr Matthew, 2012, Ther Adv Chronic Dis, V3, P153, DOI 10.1177/2040622312446007; Shahar J, 2006, RETINA-J RET VIT DIS, V26, P262, DOI 10.1097/00006982-200603000-00002; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	AUG	2015	99	8					1087	1091		10.1136/bjophthalmol-2014-305275		5	Ophthalmology	Ophthalmology	CN3BC	WOS:000358297200015		
J	Uchida, A; Inoue, M; Bissen-Miyajima, H; Hirakata, A				Uchida, Atsuro; Inoue, Makoto; Bissen-Miyajima, Hiroko; Hirakata, Akito			Dynamic changes of optical aberrations during restoration of optical properties of hydrophobic acrylic intraocular lens ejected through cartridge	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							ASSISTED CATARACT-SURGERY; TRANSCONJUNCTIVAL VITRECTOMY; VITREORETINAL DISEASES; GLISTENING FORMATION; COMBINED 23-GAUGE; MACULAR HOLES; PHACOEMULSIFICATION; TEMPERATURE; PHACOVITRECTOMY; IMPLANTATION	Aim To evaluate the effect of temperature on the restoration of the optical properties of hydrophobic acrylic intraocular lenses (IOLs) after ejection through a cartridge into a temperature-controlled water chamber. Methods Acrylic IOLs (SA60AT; iSert 251; W-60; X-70; and VA-70AD) were loaded into a cartridge with viscoelastic material and ejected into a water chamber at 24 degrees C or 34 degrees C. A wavefront analyser was used to measure the spherical and cylindrical powers, and the higher-order aberrations of the optics of the IOLs. The time to restore the cylindrical power to within 0.1 dioptres of the baseline power was determined. Results Surface irregularities of the IOLs after ejection were detected in the dioptric power maps but not in the higher-order aberration maps. The cylindrical power and the astigmatic and coma aberrations recovered immediately at 34 degrees C but were delayed at 24 degrees C. The restoration time of all IOLs at 24 degrees C was significantly longer than that at 34 degrees C (p < 0.05). Conclusions The dioptric power maps determined by the wavefront analyser can detect and follow the restoration of the optical properties of hydrophobic acrylic IOLs immediately after ejection. The restoration time was dependent on the temperature of the water chamber.	[Uchida, Atsuro] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Inoue, Makoto; Hirakata, Akito] Kyorin Univ, Sch Med, Kyorin Eye Ctr, Tokyo 1818611, Japan; [Inoue, Makoto; Bissen-Miyajima, Hiroko] Suidobashi Hosp, Tokyo Dent Coll, Dept Ophthalmol, Tokyo, Japan	Inoue, M (reprint author), Kyorin Univ, Sch Med, Kyorin Eye Ctr, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	inoue@eye-center.org		Uchida, Atsuro/0000-0002-1378-7151			Sun H, 2011, J CATARACT REFR SURG, V37, P386, DOI 10.1016/j.jcrs.2010.09.018; Muselier A, 2010, AM J OPHTHALMOL, V150, P387, DOI 10.1016/j.ajo.2010.04.008; Dugas B, 2010, AM J OPHTHALMOL, V149, P302, DOI 10.1016/j.ajo.2009.09.011; Packer M, 2010, J CATARACT REFR SURG, V36, P747, DOI 10.1016/j.jcrs.2009.11.029; Kato K, 2001, J CATARACT REFR SURG, V27, P1493, DOI 10.1016/S0886-3350(01)00895-1; Heath G, 2010, EYE, V24, P214, DOI [10.1038/eye.2009.292-cme, 10.1038/eye.2009.292]; Oshika T, 2007, BRIT J OPHTHALMOL, V91, P185, DOI 10.1136/bjo.2006.099945; Rubenstein JB, 2013, CURR OPIN OPHTHALMOL, V24, P30, DOI 10.1097/ICU.0b013e32835ac853; Fujishima H, 1996, BRIT J OPHTHALMOL, V80, P29, DOI 10.1136/bjo.80.1.29; Oshima Y, 2006, ANN ACAD MED SINGAP, V35, P175; Sisk RA, 2010, BRIT J OPHTHALMOL, V94, P1028, DOI 10.1136/bjo.2009.175984; Bali SJ, 2012, GRAEF ARCH CLIN EXP, V250, P1549, DOI 10.1007/s00417-012-2080-y; Crnej A, 2014, ACTA OPHTHALMOL, V92, P353; Erie JC, 2010, J CATARACT REFR SURG, V36, P483, DOI 10.1016/j.jcrs.2009.09.037; Gomez-Resa M, 2014, OPHTHALMIC RES, V52, P141, DOI 10.1159/000367716; Gregori NZ, 2002, J CATARACT REFR SURG, V28, P1262, DOI 10.1016/S0886-3350(02)01224-5; Li WS, 2009, ACTA OPHTHALMOL, V87, P896, DOI 10.1111/j.1755-3768.2008.01383.x; Liu J, 2013, PLOS ONE, V8, P77860; Lyle WA, 1996, J CATARACT REFR SURG, V22, P1456; OGURA Y, 1991, AM J OPHTHALMOL, V111, P179; Sugar A, 2001, J CATARACT REFR SURG, V27, P1741, DOI 10.1016/S0886-3350(01)00894-X; Thompson JT, 2004, AM J OPHTHALMOL, V137, P250, DOI 10.1016/j.ajo.2003.09.020; Tranos PG, 2007, EYE, V21, P802, DOI 10.1038/sj.eye.6702339	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	AUG	2015	99	8					1143	1148		10.1136/bjophthalmol-2014-306592		6	Ophthalmology	Ophthalmology	CN3BC	WOS:000358297200026		
J	Matsumoto, T; Goulopoulou, S; Taguchi, K; Tostes, RC; Kobayashi, T				Matsumoto, Takayuki; Goulopoulou, Styliani; Taguchi, Kumiko; Tostes, Rita C.; Kobayashi, Tsuneo			Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes	BRITISH JOURNAL OF PHARMACOLOGY			English	Review							ENDOTHELIUM-DEPENDENT CONTRACTIONS; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; TREATMENT-INDUCED IMPROVEMENT; ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM STRESS; NONMUSCLE MYOSIN-II; FLUID SHEAR-STRESS; WISTAR-KYOTO RATS; NF-KAPPA-B	Vascular dysfunction plays a pivotal role in the development of systemic complications associated with arterial hypertension and diabetes. The endothelium, or more specifically, various factors derived from endothelial cells tightly regulate vascular function, including vascular tone. In physiological conditions, there is a balance between endothelium-derived factors, that is, relaxing factors (endothelium-derived relaxing factors; EDRFs) and contracting factors (endothelium-derived contracting factors; EDCFs), which mediate vascular homeostasis. However, in disease states, such as diabetes and arterial hypertension, there is an imbalance between EDRF and EDCF, with a reduction of EDRF signalling and an increase of EDCF signalling. Among EDCFs, COX-derived vasoconstrictor prostanoids play an important role in the development of vascular dysfunction associated with hypertension and diabetes. Moreover, uridine adenosine tetraphosphate (Up(4)A), identified as an EDCF in 2005, also modulates vascular function. However, the role of Up(4)A in hypertension- and diabetes-associated vascular dysfunction is unclear. In the present review, we focused on experimental and clinical evidence that implicate these two EDCFs (vasoconstrictor prostanoids and Up(4)A) in vascular dysfunction associated with hypertension and diabetes.	[Matsumoto, Takayuki; Taguchi, Kumiko; Kobayashi, Tsuneo] Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 1428501, Japan; [Goulopoulou, Styliani] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol & Anat Obstet & Gynecol, Ft Worth, TX USA; [Tostes, Rita C.] Univ Sao Paulo, Dept Pharmacol, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil	Matsumoto, T (reprint author), Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 1428501, Japan.	t-matsu@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; JSPS KAKENHI [26460107]; American Heart Association [13SDG17050056]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology, Japan, by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan, and by JSPS KAKENHI Grant Number 26460107 and by the American Heart Association (13SDG17050056, S. G.) and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	Akamine EH, 2006, J VASC RES, V43, P401, DOI 10.1159/000094790; Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Almabrouk TAM, 2014, BRIT J PHARMACOL, V171, P595, DOI 10.1111/bph.12479; Aloysius UI, 2012, VASC PHARMACOL, V57, P81, DOI 10.1016/j.vph.2011.11.009; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Burnstock G, 2014, PHARMACOL REV, V66, P102, DOI 10.1124/pr.113.008029; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Matsumoto T, 2009, J PHARMACOL EXP THER, V329, P324, DOI 10.1124/jpet.108.148718; Song DZ, 2004, HYPERTENSION, V43, P667, DOI 10.1161/01.HYP.0000118018.77344.4e; Matsumoto T, 2008, AM J PHYSIOL-HEART C, V295, pH1165, DOI 10.1152/ajpheart.00486.2008; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Vanhoutte PM, 2009, CLIN PHARMACOL THER, V86, P212, DOI 10.1038/clpt.2009.108; Triggle CR, 2005, CAN J PHYSIOL PHARM, V83, P681, DOI 10.1139/Y05-069; Griffith TM, 2004, BRIT J PHARMACOL, V141, P881, DOI 10.1038/sj.bjp.0705698; Matsumoto T, 2007, AM J PHYSIOL-HEART C, V293, pH1480, DOI 10.1152/ajpheart.00229.2007; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Zou MH, 2002, DIABETES, V51, P198; Wong MSK, 2010, ACTA PHARMACOL SIN, V31, P1095, DOI 10.1038/aps.2010.127; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Forstermann U, 2011, BRIT J PHARMACOL, V164, P213, DOI 10.1111/j.1476-5381.2010.01196.x; Bolego C, 2006, BIOCHEM BIOPH RES CO, V339, P188, DOI 10.1016/j.bbrc.2005.11.017; Ferreira NS, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00034; Toth P, 2011, J CEREBR BLOOD F MET, V31, P2096, DOI 10.1038/jcbfm.2011.74; Tang EHC, 2009, PHARMACOL THERAPEUT, V122, P140, DOI 10.1016/j.pharmthera.2009.02.006; Huxley VH, 2010, CARDIOVASC RES, V87, P230, DOI 10.1093/cvr/cvq142; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; GE T, 1995, CIRC RES, V76, P1003; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Nacci C, 2009, ENDOCRINOLOGY, V150, P849, DOI 10.1210/en.2008-1069; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P1776, DOI 10.1161/ATVBAHA.107.143958; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Li M, 2008, AM J PHYSIOL-HEART C, V294, pH2444, DOI 10.1152/ajpheart.01121.2007; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Jankowski V, 2005, NAT MED, V11, P223, DOI 10.1038/nm1188; Wong MSK, 2010, AM J PHYSIOL-HEART C, V298, pH1260, DOI 10.1152/ajpheart.01068.2009; Matsumoto T, 2007, FREE RADICAL BIO MED, V42, P993, DOI 10.1016/j.freeradbiomed.2006.12.028; Barton M, 2012, BRIT J PHARMACOL, V165, P591, DOI 10.1111/j.1476-5381.2011.01472.x; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Rovati GE, 2010, TRENDS PHARMACOL SCI, V31, P102, DOI 10.1016/j.tips.2009.11.007; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; Dantas APV, 1999, HYPERTENSION, V34, P914; Tostes RC, 2008, CLIN SCI, V114, P85, DOI 10.1042/CS20070169; Vanhoutte PM, 2008, J PHYSIOL-LONDON, V586, P5295, DOI 10.1113/jphysiol.2008.161430; Spitler KM, 2013, AM J PHYSIOL-HEART C, V305, pH344, DOI 10.1152/ajpheart.00952.2012; Davidge ST, 1998, CIRC RES, V83, P388; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Sparks MA, 2013, HYPERTENSION, V61, P166, DOI 10.1161/HYPERTENSIONAHA.112.193250; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Bunimov Natalia, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P268, DOI 10.2174/187152908786786250; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1676, DOI 10.1111/bph.12449; Hart EC, 2011, ACTA PHYSIOL, V203, P155, DOI 10.1111/j.1748-1716.2010.02192.x; Li ZM, 2011, HYPERTENSION, V58, P926, DOI 10.1161/HYPERTENSIONAHA.111.173807; Khalil RA, 2005, HYPERTENSION, V46, P249, DOI 10.1161/01.HYP.0000172945.06681.a4; Ndisang JF, 2001, BRIT J PHARMACOL, V134, P1689, DOI 10.1038/sj.bjp.0704427; Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004; Kassan M, 2013, DIABETES, V62, P2078, DOI 10.2337/db12-1374; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; KATUSIC ZS, 1989, AM J PHYSIOL, V257, pH33; Kittikulsuth W, 2013, BRIT J PHARMACOL, V168, P318, DOI 10.1111/j.1476-5381.2012.01922.x; Takada Y, 1997, BIOCHEM BIOPH RES CO, V240, P737, DOI 10.1006/bbrc.1997.7734; Tang EHC, 2007, BRIT J PHARMACOL, V151, P15, DOI 10.1038/sj.bjp.0707190; Roman RJ, 2002, PHYSIOL REV, V82, P131; Taguchi K, 2014, BIOL PHARM BULL, V37, P1056, DOI 10.1248/bpb.b14-00157; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; Matsumoto T, 2014, PFLUG ARCH EUR J PHY, V466, P331, DOI 10.1007/s00424-013-1330-0; Matsumoto T, 2012, PHARMACOL RES, V65, P81, DOI 10.1016/j.phrs.2011.09.005; Amer M, 2010, CARDIOL REV, V18, P204, DOI 10.1097/CRD.0b013e3181ce1521; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Toda N, 2010, PHARMACOL THERAPEUT, V127, P189, DOI 10.1016/j.pharmthera.2010.04.009; Grgic I, 2009, BRIT J PHARMACOL, V157, P509, DOI 10.1111/j.1476-5381.2009.00132.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; Tang EHC, 2005, AM J PHYSIOL-HEART C, V289, pH2434, DOI 10.1152/ajpheart.00568.2005; Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Taddei S, 1998, CIRCULATION, V97, P2222; Belhassen L, 2003, J AM COLL CARDIOL, V41, P1198, DOI 10.1016/S0735-1097(03)00048-2; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Ellinsworth DC, 2014, CARDIOVASC RES, V102, P9, DOI 10.1093/cvr/cvu015; Siller-Matula JM, 2010, BRIT J PHARMACOL, V159, P502, DOI 10.1111/j.1476-5381.2009.00555.x; Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Zhang L, 2002, J HYPERTENS, V20, P237, DOI 10.1097/00004872-200202000-00013; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Linder AE, 2008, VASC PHARMACOL, V48, P202, DOI 10.1016/j.vph.2008.03.003; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Barton M, 2010, PFLUG ARCH EUR J PHY, V460, P825, DOI 10.1007/s00424-010-0860-y; Rapoport RM, 1996, HYPERTENSION, V28, P64; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Del Turco S, 2014, VASC PHARMACOL, V62, P49, DOI 10.1016/j.vph.2014.03.007; Traupe T, 2002, J HYPERTENS, V20, P2239, DOI 10.1097/00004872-200211000-00024; Kraskiewicz H, 2012, TRENDS PHARMACOL SCI, V33, P53, DOI 10.1016/j.tips.2011.10.002; Balakumar P, 2012, FREE RADICAL BIO MED, V53, P271, DOI 10.1016/j.freeradbiomed.2012.05.005; Tang EHC, 2010, PFLUG ARCH EUR J PHY, V459, P995, DOI 10.1007/s00424-010-0786-4; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Favero G, 2014, BIOMED RES INT, DOI 10.1155/2014/801896; Jerez S, 2008, EUR J PHARMACOL, V580, P182, DOI 10.1016/j.ejphar.2007.10.037; Matsumoto T, 2011, AM J PHYSIOL-HEART C, V301, pH409, DOI 10.1152/ajpheart.00084.2011; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4; Gluais P, 2007, EUR J PHARMACOL, V556, P107, DOI 10.1016/j.ejphar.2006.10.050; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; KAUSER K, 1995, HYPERTENSION, V25, P517; TADDEI S, 1993, HYPERTENSION, V21, P929; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Dong Li-Hua, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P119; Sobrino A, 2010, J MOL ENDOCRINOL, V44, P237, DOI 10.1677/JME-09-0112; Hansen PB, 2010, ACTA PHYSIOL, V200, P171, DOI 10.1111/j.1748-1716.2010.02135.x; Yang XQ, 2008, CLIN EXP PHARMACOL P, V35, P1097, DOI 10.1111/j.1440-1681.2007.04756.x; Duckles SP, 2010, PFLUG ARCH EUR J PHY, V459, P841, DOI 10.1007/s00424-010-0797-1; Bruder-Nascimento T, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-90; Versari D, 2009, BRIT J PHARMACOL, V157, P527, DOI 10.1111/j.1476-5381.2009.00240.x; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Miao CY, 2012, BRIT J PHARMACOL, V165, P643, DOI 10.1111/j.1476-5381.2011.01404.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1652, DOI 10.1111/bph.12448; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Campia U, 2012, BRIT J PHARMACOL, V165, P561, DOI 10.1111/j.1476-5381.2011.01661.x; HAYASHI T, 1995, BIOCHEM BIOPH RES CO, V214, P847, DOI 10.1006/bbrc.1995.2364; Goulopoulou S, 2015, TRENDS MOL MED, V21, P88, DOI 10.1016/j.molmed.2014.11.009; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Meyer MR, 2012, HYPERTENSION, V59, P507, DOI 10.1161/HYPERTENSIONAHA.111.184606; Virdis A, 2010, PFLUG ARCH EUR J PHY, V459, P1015, DOI 10.1007/s00424-009-0783-7; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Zhou MS, 2001, J HYPERTENS, V19, P421, DOI 10.1097/00004872-200103000-00010; Zhou ZC, 2013, PHARMACOL RES, V67, P10, DOI 10.1016/j.phrs.2012.09.011; Taba Y, 2000, CIRC RES, V86, P967; Korbecki J, 2013, J PHYSIOL PHARMACOL, V64, P409; Kamata K, 1996, BRIT J PHARMACOL, V119, P583; Kobayashi T, 2008, BRIT J PHARMACOL, V155, P974, DOI 10.1038/bjp.2008.327; Mukohda M, 2012, J PHARMACOL SCI, V120, P26, DOI 10.1254/jphs.12088FP; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Szabo C, 2009, BRIT J PHARMACOL, V156, P713, DOI 10.1111/j.1476-5381.2008.00086.x; Nakano T, 2015, ANAT SCI INT, V90, P22, DOI 10.1007/s12565-014-0265-7; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Francois H, 2004, HYPERTENSION, V43, P364, DOI 10.1161/01.HYP.0000112225.27560.24; Matsumoto T, 2009, J PHARMACOL SCI, V110, P326, DOI 10.1254/jphs.09116FP; Ishida K, 2012, ACTA PHYSIOL, V205, P255, DOI 10.1111/j.1748-1716.2011.02403.x; ASANO H, 1994, J HYPERTENS, V12, P383; AUCHSCHWELK W, 1990, HYPERTENSION, V15, P699; Bagi Zsolt, 2006, Pharmacol Rep, V58 Suppl, P52; Baretella O, 2014, LIFE SCI, V118, P206, DOI 10.1016/j.lfs.2013.12.214; Bazi Z, 2012, BRIT J PHARMACOL, V165, P544; Bolla M, 2002, J VASC RES, V39, P353, DOI 10.1159/000065547; Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x; Burger NZ, 2009, AM J PHYSIOL-ENDOC M, V296, pE503, DOI 10.1152/ajpendo.90517.2008; Calder P. C., 2012, J NUTR, V142, P592, DOI DOI 10.3945/JN.111.155259; Cau SBA, 2011, BRIT J PHARMACOL, V164, P372, DOI 10.1111/j.1476-5381.2011.01360.x; Chamorro Angel, 2009, Cerebrovasc Dis, V27 Suppl 3, P20, DOI 10.1159/000209262; Chan CKY, 2009, J PHARMACOL EXP THER, V329, P820, DOI 10.1124/jpet.108.148247; Chan YC, 2007, J CARDIOVASC PHARM, V49, P355, DOI 10.1097/FJC.0b013e318046f329; Cheuk BLY, 2000, BIOL REPROD, V63, P775; Chignalia AZ, 2015, CLIN SCI, V129, P39, DOI 10.1042/CS20140548; Costa SQ, 1998, J HYPERTENS, V16, pS80; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Davi G., 2012, HDB EXP PHARM, V210, P261, DOI DOI 10.1007/978-3-642-29423-5_; Denniss SG, 2010, AM J PHYSIOL-HEART C, V298, pH1391, DOI 10.1152/ajpheart.01233.2009; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; DOHI Y, 1990, HYPERTENSION, V16, P170; ESCALANTE B, 1989, J PHARMACOL EXP THER, V248, P229; FARHAT MY, 1995, J CARDIOVASC PHARM, V25, P495, DOI 10.1097/00005344-199503000-00023; Feletou M, 2004, PHARMACOL RES, V49, P565, DOI 10.1016/j.phrs.2003.10.017; Feletou M, 2008, FRONT BIOSCI, V13, P4198, DOI 10.2741/3000; Flammer A. J., 2010, SWISS MED WEEKLY, V140, DOI DOI 10.4414/SMW.2010.13122; Ford RJ, 2011, AM J PHYSIOL-HEART C, V300, pH64, DOI 10.1152/ajpheart.00597.2010; Francois H, 2008, AM J PHYSIOL-RENAL, V295, pF1096, DOI 10.1152/ajprenal.00369.2007; Garcia-Redondo AB, 2015, J HYPERTENS, V33, P77, DOI 10.1097/HJH.0000000000000383; Gelosa P, 2010, J PHARMACOL EXP THER, V334, P199, DOI 10.1124/jpet.110.165787; Giannarelli C, 2010, THROMB HAEMOSTASIS, V104, P949, DOI [10.1160/TH10-03-0195, 10.1160/TH10.03.0195]; Gluais P, 2006, AM J PHYSIOL-HEART C, V291, pH2255, DOI 10.1152/ajpheart.01115.2005; Gomez E, 2008, AM J PHYSIOL-HEART C, V295, pH2198, DOI 10.1152/ajpheart.00507.2008; Sandoval YHG, 2014, CURR VASC PHARMACOL, V12, P202; Gonzales RJ, 2009, J CEREBR BLOOD F MET, V29, P244, DOI 10.1038/jcbfm.2008.115; Goulopoulou S, 2012, AM J PHYSIOL-HEART C, V302, pH2477, DOI 10.1152/ajpheart.00900.2011; Gui Y, 2011, J CARDIOVASC PHARM, V58, P654, DOI 10.1097/FJC.0b013e318231e929; Gui Y, 2008, AM J PHYSIOL-LUNG C, V294, pL733, DOI 10.1152/ajplung.00403.2007; HATTORI Y, 1991, AM J PHYSIOL, V261, pH1086; Hermenegildo C, 2006, CURR PHARM DESIGN, V12, P205, DOI 10.2174/138161206775193136; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; HISHIKAWA K, 1995, FEBS LETT, V360, P291, DOI 10.1016/0014-5793(95)00124-R; HOLLENBERG SM, 1994, AM J PHYSIOL-HEART C, V267, pH2290; Huang A, 1997, HYPERTENSION, V29, P1351; Hutchison SJ, 1997, J AM COLL CARDIOL, V29, P800; Ishida K, 2011, AM J PHYSIOL-HEART C, V301, pH1850, DOI 10.1152/ajpheart.00502.2011; Jankowski V, 2013, J MOL MED, V91, P1095, DOI 10.1007/s00109-013-1036-y; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Kahonen M, 1998, AM J PHYSIOL-HEART C, V275, pH15; KAMATA K, 1989, BRIT J PHARMACOL, V97, P614; KATUSIC ZS, 1988, STROKE, V19, P476; Kawka DW, 2007, BBA-MOL CELL BIOL L, V1771, P45, DOI 10.1016/j.bbalip.2006.09.015; Keen HL, 1997, HYPERTENSION, V29, P310; Kobayashi T, 2000, BRIT J PHARMACOL, V131, P231, DOI 10.1038/sj.bjp.0703572; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Li M, 2005, AM J PHYSIOL-HEART C, V289, pH1542, DOI 10.1152/ajpheart.01024.2004; Liu CQ, 2009, BIOCHEM PHARMACOL, V78, P374, DOI 10.1016/j.bcp.2009.04.022; Lopez-Lopez JG, 2011, J PHARMACOL EXP THER, V338, P400, DOI 10.1124/jpet.111.179515; Maguire JJ, 2014, BRIT J PHARMACOL, V171, P5555, DOI 10.1111/bph.12874; Manrique C, 2014, ANN NY ACAD SCI, V1311, P135; Marrachelli VG, 2010, PHARMACOL RES, V61, P62, DOI 10.1016/j.phrs.2009.06.008; Martinez AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106372; MASUDA A, 1991, CIRC RES, V69, P638; Matsumoto T, 2011, ADV PHARM SCI, V2011; Matsumoto T, 2009, ATHEROSCLEROSIS, V205, P87, DOI 10.1016/j.atherosclerosis.2008.11.015; Matsumoto Takayuki, 2008, Journal of Smooth Muscle Research, V44, P41, DOI 10.1540/jsmr.44.41; Matsumoto T, 2014, LIFE SCI, V118, P129, DOI 10.1016/j.lfs.2013.12.216; Matsumoto T, 2010, PHARMACOL RES, V62, P271, DOI 10.1016/j.phrs.2010.03.003; MEAGHER EA, 1993, CIRCULATION, V88, P1324; Meyer MC, 1997, AM J PHYSIOL-HEART C, V272, pH2264; Michel F, 2008, AM J PHYSIOL-RENAL, V294, pF120, DOI 10.1152/ajprenal.00111.2007; Michel FS, 2008, BRIT J PHARMACOL, V155, P217, DOI 10.1038/bjp.2008.256; MIKKOLA T, 1995, J CLIN ENDOCR METAB, V80, P1832, DOI 10.1210/jc.80.6.1832; MILLER VM, 1990, AM J PHYSIOL, V258, pR1502; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Naik V, 2012, CARDIOVASC RES, V94, P545, DOI 10.1093/cvr/cvs126; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Nobe K, 2008, BRIT J PHARMACOL, V155, P1204, DOI 10.1038/bjp.2008.365; Numaguchi Y, 1999, CARDIOVASC RES, V41, P682, DOI 10.1016/S0008-6363(98)00239-9; Okon EB, 2002, BRIT J PHARMACOL, V137, P545, DOI 10.1038/sj.bjp.0704884; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Pries A. R., 2006, V176, P1; Qu C, 2010, J PHARMACOL EXP THER, V334, P373, DOI 10.1124/jpet.110.167098; Quilley J, 2003, HYPERTENSION, V42, P837, DOI 10.1161/01.HYP.0000085650.29823.F2; Ramos-Alves FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050593; Ramos-Alves FE, 2012, BRIT J PHARMACOL, V166, P2198, DOI 10.1111/j.1476-5381.2012.01945.x; Randriamboavonjy V, 2003, HYPERTENSION, V41, P801, DOI 10.1161/01.HYP.0000047240.33861.6B; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Salvemini D, 2013, AM J PHYSIOL-REG I, V304, pR473, DOI 10.1152/ajpregu.00355.2012; Sanchez A, 2010, BRIT J PHARMACOL, V159, P604, DOI 10.1111/j.1476-5381.2009.00553.x; SCHROR K, 1994, EUR J CLIN INVEST, V24, P50; Schuchardt M, 2012, KIDNEY INT, V81, P256, DOI 10.1038/ki.2011.326; Schuchardt M, 2011, J MOL MED, V89, P799, DOI 10.1007/s00109-011-0750-6; SCHWARTZMAN ML, 1989, J BIOL CHEM, V264, P11658; Sherman TS, 2002, AM J RESP CELL MOL, V26, P610; Shi Y, 2008, ACTA PHARMACOL SIN, V29, P185, DOI 10.1111/j.1745-7254.2008.00749.x; Shi Y, 2007, BRIT J PHARMACOL, V150, P624, DOI 10.1038/sj.bjp.0706999; Sullivan JC, 2005, HYPERTENSION, V45, P406, DOI 10.1161/01.hyp.0000156879.83448.93; Taddei S, 2000, J CARDIOVASC PHARM, V35, pS37, DOI 10.1097/00005344-200000002-00009; TADDEI S, 1993, HYPERTENSION, V21, P9; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Tejera N, 1999, CLIN SCI, V97, P19, DOI 10.1042/CS19980392; Toda N, 2013, BRIT J PHARMACOL, V168, P519, DOI 10.1111/j.1476-5381.2012.02194.x; Tolle M, 2010, BRIT J PHARMACOL, V161, P530, DOI 10.1111/j.1476-5381.2010.00914.x; Tostes RC, 2003, BRAZ J MED BIOL RES, V36, P1143, DOI 10.1590/S0100-879X2003000900002; Valentin FO, 2004, J BIOL CHEM, V279, P8316, DOI 10.1074/jbc.M306761200; Vapaatalo H, 2001, Med Sci Monit, V7, P1075; Vessieres E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068217; Villalba N, 2011, AM J PHYSIOL-HEART C, V300, pH2044, DOI 10.1152/ajpheart.01204.2010; Wang Y, 2014, VASC PHARMACOL, V61, P16, DOI 10.1016/j.vph.2014.02.001; Wiedon A, 2012, BIOCHEM BIOPH RES CO, V417, P1035, DOI 10.1016/j.bbrc.2011.12.088; WILLIAMS SP, 1988, EUR J PHARMACOL, V145, P205, DOI 10.1016/0014-2999(88)90231-2; Wilson SJ, 2009, J LIPID RES, V50, P1047, DOI 10.1194/jlr.M800447-JLR200; Wong SL, 2010, ADV PHARMACOL, V60, P61, DOI [10.1016/B978-0-12-385061-4.00003-9, 10.1016/S1054-3589(10)60007-5]; Yang D, 2003, HYPERTENSION, V41, P136, DOI 10.1161/01.HYP.0000047669.93078.A7; Yang D, 2004, J CARDIOVASC PHARM, V43, P815, DOI 10.1097/00005344-200406000-00011; Yang D, 2004, FUND CLIN PHARMACOL, V18, P321, DOI 10.1111/j.1472-8206.2004.00247.x; Yang D, 2003, HYPERTENSION, V41, P143, DOI 10.1161/01.HYP.0000047651.45322.16; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005; Zuccollo A, 2005, CIRCULATION, V112, P3001, DOI 10.1161/CIRCULATIONHA.105.581892	287	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	AUG	2015	172	16					3980	4001		10.1111/bph.13205		22	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CN5FB	WOS:000358454100004		
J	Iguchi, T; Hiraki, T; Gobara, H; Fujiwara, H; Matsui, Y; Sugimoto, S; Toyooka, S; Oto, T; Miyoshi, S; Kanazawa, S				Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Sugimoto, Seiichiro; Toyooka, Shinichi; Oto, Takahiro; Miyoshi, Shinichiro; Kanazawa, Susumu			Simultaneous Multiple Preoperative Localizations of Small Pulmonary Lesions Using a Short Hook Wire and Suture System	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Non-vascular interventions; Lung/pulmonary; Cancer	ASSISTED THORACOSCOPIC SURGERY; TOMOGRAPHY-GUIDED LOCALIZATION; NODULES; RESECTION; MARKING; EXPERIENCE; LUNG	The aim of the study was to retrospectively evaluate simultaneous multiple hook wire placement outcomes before video-assisted thoracoscopic surgery (VATS). Thirty-eight procedures were performed on 35 patients (13 men and 22 women; mean age, 59.9 years) with 80 lung lesions (mean diameter 7.9 mm) who underwent simultaneous multiple hook wire placements for preoperative localizations. The primary endpoints were technical success, complications, procedure duration, and VATS outcome; secondary endpoints included comparisons between technical success rates, complication rates, and procedure durations of the 238 single-placement procedures performed. Complications were also evaluated. In 35 procedures including 74 lesions, multiple hook wire placements were technically successful; in the remaining three procedures, the second target placement was aborted because of massive pneumothorax after the first placement. Although complications occurred in 34 procedures, no grade 3 or above adverse event was observed. The mean procedure duration was 36.4 +/- A 11.8 min. Three hook wires dislodged during patient transport to the surgical suite. Seventy-four successfully marked lesions were resected. Six lesions without hook wires were successfully resected after detection by palpation with an additional mini-thoracotomy or using subtle pleural changes as a guide. The complication rates and procedure durations of multiple-placement procedures were significantly higher (P = 0.04) and longer (P < 0.001) than those in the single-placement group, respectively, while the technical success rate was not significantly different (P = 0.051). Simultaneous multiple hook wire placements before VATS were clinically feasible, but increased the complication rate and lengthened the procedure time.	[Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu] Okayama Univ, Dept Radiol, Sch Med, Kita Ku, Okayama 7008558, Japan; [Sugimoto, Seiichiro; Toyooka, Shinichi; Oto, Takahiro; Miyoshi, Shinichiro] Okayama Univ, Dept Gen Thorac Surg, Sch Med, Kita Ku, Okayama 7008558, Japan; [Toyooka, Shinichi] Okayama Univ, Dept Clin Genom Med, Sch Med, Kita Ku, Okayama 7008558, Japan	Iguchi, T (reprint author), Okayama Univ, Dept Radiol, Sch Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	iguchi@ba2.so-net.ne.jp; takaoh@tc4.so-net.ne.jp; gobara@cc.okayama-u.ac.jp; hirofujiwar@gmail.com; wckyh140@yahoo.co.jp; sei1675sugi@yahoo.co.jp; shintoyooka@gmail.com; yellowpeachoto@hotmail.com; smiyoshi@md.okayama-u.ac.jp; susumu@cc.okayama-u.ac.jp					Suzuki K, 1999, CHEST, V115, P563, DOI 10.1378/chest.115.2.563; Saito H, 2002, J THORAC CARDIOV SUR, V124, P1198, DOI 10.1067/mtc.2002.127331; Ciriaco P, 2004, EUR J CARDIO-THORAC, V25, P429, DOI 10.1016/j.ejcts.2003.11.036; Ichinose J, 2013, ANN THORAC SURG, V96, P1203, DOI 10.1016/j.athoracsur.2013.05.026; Miyoshi K, 2009, EUR J CARDIO-THORAC, V36, P378, DOI 10.1016/j.ejcts.2009.03.039; Dendo S, 2002, RADIOLOGY, V225, P511, DOI 10.1148/radiol.2252011025; KANAZAWA S, 1995, CARDIOVASC INTER RAD, V18, P122, DOI 10.1007/BF02807237; Seo JM, 2012, J THORAC CARDIOV SUR, V143, P809, DOI 10.1016/j.jtcvs.2011.10.038; Chen SF, 2011, SURG ENDOSC, V25, P1723, DOI 10.1007/s00464-010-1502-3; Gonflotti A, 2007, EUR J CARDIO-THORAC, V32, P843, DOI 10.1016/j.ejcts.2007.09.002; Iguchi T, 2014, CARDIOVASC INTERVENT; Kanazawa S, 1998, AM J ROENTGENOL, V170, P332; Matsumoto S, 2004, EUR J CARDIO-THORAC, V26, P469, DOI 10.1016/j.ejcts.2004.05.013; Nakashima S, 2010, ANN THORAC SURG, V89, P212, DOI 10.1016/j.athoracsur.2009.09.075; Santambrogio R, 1999, ANN THORAC SURG, V68, P218, DOI 10.1016/S0003-4975(99)00459-2; Yoshida Y, 2011, INTERACT CARDIOV TH, V13, P25, DOI 10.1510/icvts.2011.266932	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	AUG	2015	38	4					971	976		10.1007/s00270-014-1028-5		6	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CN1KE	WOS:000358177900023		
J	Katsumori, T; Miura, H; Suzuki, G; Nishimura, T				Katsumori, Tetsuya; Miura, Hiroshi; Suzuki, Gen; Nishimura, Takeshi			Angiographic Endpoint Using "Artificial Flow" on Uterine Artery Embolization for Leiomyomas in the Circumstance with no Free Flow in Uterine Artery	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							ACRYL GELATIN MICROSPHERES; FIBROIDS		[Katsumori, Tetsuya; Miura, Hiroshi; Suzuki, Gen; Nishimura, Takeshi] Saiseikai Shiga Hosp, Dept Radiol, Ritto, Shiga 5203046, Japan	Katsumori, T (reprint author), Saiseikai Shiga Hosp, Dept Radiol, Ohashi 2-4-1, Ritto, Shiga 5203046, Japan.	katsumo@eurus.dti.ne.jp; miurak@koto.kpu-m.ac.jp; gensuzu@nike.eonet.ne.jp; taknishi0131@gmail.com					Stokes LS, 2010, J VASC INTERV RADIOL, V21, P1153, DOI 10.1016/j.jvir.2010.03.015; Pelage JP, 2003, J VASC INTERV RADIOL, V14, P15, DOI 10.1097/01.RVI.0000052287.26939.b0; Pelage JP, 2005, RADIOGRAPHICS, V25, pS99, DOI 10.1148/rg.25si055510; Spies JB, 2003, J VASC INTERV RADIOL, V14, P11, DOI 10.1097/01.RVI.0000052286.26939.f9; Spies JB, 2001, J VASC INTERV RADIOL, V12, P1059, DOI 10.1016/S1051-0443(07)61591-7	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	AUG	2015	38	4					1047	1049		10.1007/s00270-015-1103-6		3	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CN1KE	WOS:000358177900036		
J	Noda, NN; Fujioka, Y				Noda, Nobuo N.; Fujioka, Yuko			Atg1 family kinases in autophagy initiation	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Atg1 complex; ULK1 complex; Atg13; Atg17; FIP200; Kinase domain; MIT domain	DEPENDENT PROTEIN-KINASE; CELLULAR SELF-DIGESTION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; DIRECT PHOSPHORYLATION; INDEPENDENTLY TARGET; REGULATES AUTOPHAGY; MAMMALIAN AUTOPHAGY; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE	Autophagosome formation, a landmark event in autophagy, is accomplished by the concerted actions of Atg proteins. Among all Atg proteins, Atg1 kinase in yeast and its counterpart in higher eukaryotes, ULK1 kinase, function as the most upstream factor in this process and mediate autophagy initiation. In this review, we summarize current knowledge of the structure, molecular function, and regulation of Atg1 family kinases in the initiation of autophagy.	[Noda, Nobuo N.; Fujioka, Yuko] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 1410021, Japan; [Noda, Nobuo N.] JST, CREST, Tokyo, Japan	Noda, NN (reprint author), Inst Microbial Chem BIKAKEN, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	nn@bikaken.or.jp	Noda, Nobuo/P-1397-2015	Noda, Nobuo/0000-0002-6940-8069			Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; Papinski D, 2014, MOL CELL, V53, P471, DOI 10.1016/j.molcel.2013.12.011; Ichimura Y, 2000, NATURE, V408, P488; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Lazarus MB, 2015, ACS CHEM BIOL, V10, P257, DOI 10.1021/cb500835z; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Jao CC, 2013, P NATL ACAD SCI USA, V110, P5486, DOI 10.1073/pnas.1220306110; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2010, AUTOPHAGY, V6, P764; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Alers S, 2014, AUTOPHAGY, V10, P944, DOI 10.4161/auto.28987; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbre.2007.02.150; Stjepanovic G, 2014, P NATL ACAD SCI USA, V111, P12793, DOI 10.1073/pnas.1407214111; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Mercer CA, 2009, AUTOPHAGY, V5, P649; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Suzuki SW, 2015, P NATL ACAD SCI USA, V112, P3350, DOI 10.1073/pnas.1421092112; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Li FQ, 2014, PLANT CELL, V26, P788, DOI 10.1105/tpc.113.120014; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Kijanska M, 2010, AUTOPHAGY, V6, P1168, DOI 10.4161/auto.6.8.13849; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Hosokawa N, 2009, AUTOPHAGY, V5, P973; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Yeh YY, 2011, J BIOL CHEM, V286, P28931, DOI 10.1074/jbc.M111.250324; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Yeh YY, 2011, AUTOPHAGY, V7, P716, DOI 10.4161/auto.7.7.15155; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Chew LH, 2013, AUTOPHAGY, V9, P1467, DOI 10.4161/auto.25687; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Hegedus K., 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Iwaya N, 2013, J BIOCHEM, V153, P473, DOI 10.1093/jb/mvt012; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Mao K, 2013, P NATL ACAD SCI USA, V110, pE2875, DOI 10.1073/pnas.1300064110; Noda NN, ANN REV BIO IN PRESS; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013	102	2	2	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	AUG	2015	72	16					3083	3096		10.1007/s00018-015-1917-z		14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CN0EX	WOS:000358088000006		
J	Li, YQ; Li, P; Liang, HM; Zhao, ZQ; Hashimoto, M; Wei, JS				Li, Yaqiong; Li, Ping; Liang, Huimin; Zhao, Zhiquan; Hashimoto, Makoto; Wei, Jianshe			Gaucher-Associated Parkinsonism	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Review						Gaucher disease; Parkinsonism; Glucocerebrosidase; Synuclein; Lysosome	ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE MUTATIONS; LEWY BODIES; MOUSE MODEL; DISEASE PATIENTS; GENE; GBA; CARRIERS; SUSCEPTIBILITY; AGGREGATION	Gaucher disease is associated with Parkinson's disease (PD) by mutations in glucocerebrosidase (GCase). The gene encoding GCase, glucosidase beta acid (GBA), is an important risk factor for PD. Findings from large studies have shown that patients with PD have an increased frequency of mutations in GBA and that GBA mutation carriers exhibit diverse parkinsonian phenotypes and Lewy body pathology. Although the mechanism for this association remains elusive, some hypotheses have been proposed to explain it, including gain of function caused by GBA mutations, which increases alpha-synuclein (alpha-syn) aggregation, loss of function due to lysosomal enzyme deficiency, which affects alpha-syn clearance, and even a bidirectional feedback loop, but each of these hypotheses has its limitations. It is also worth noting that many findings have implicated the interaction between alpha-syn and GCase, indicating the essential role of the interaction in the pathogenesis of GBA-associated parkinsonism. Therefore, the current review focuses on alpha-syn and GCase, and it provides some new thoughts that may be helpful for understanding the alpha-syn-GCase interaction and unraveling the exact mechanism underlying GBA-associated parkinsonism.	[Li, Yaqiong; Li, Ping; Liang, Huimin; Zhao, Zhiquan; Wei, Jianshe] Henan Univ, Inst Brain Sci Res, Sch Life Sci, Lab Brain Funct & Dis, Kaifeng 475004, Peoples R China; [Hashimoto, Makoto] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1560057, Japan	Wei, JS (reprint author), Henan Univ, Inst Brain Sci Res, Sch Life Sci, Lab Brain Funct & Dis, Kaifeng 475004, Peoples R China.	jswei@henu.edu.cn			National Natural Science Foundation of China [81271410]	This work is supported by the National Natural Science Foundation of China, grant 81271410 (JW).	Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Rosenbloom B, 2011, BLOOD CELL MOL DIS, V46, P95, DOI 10.1016/j.bcmd.2010.10.006; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Schapira AHV, 2013, P NATL ACAD SCI USA, V110, P3214, DOI 10.1073/pnas.1300822110; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Nishioka K, 2011, PARKINSONISM RELAT D, V17, P55, DOI 10.1016/j.parkreldis.2010.09.009; Bembi B, 2003, NEUROLOGY, V61, P99; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Williams SS, 2009, J NEUROL NEUROSUR PS, V80, P667, DOI 10.1136/jnnp.2008.155895; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Rothaug M, 2014, P NATL ACAD SCI USA, V111, P15573, DOI 10.1073/pnas.1405700111; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; Mata IF, 2008, ARCH NEUROL-CHICAGO, V65, P379, DOI 10.1001/archneurol.2007.68; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Ross GW, 2006, MOVEMENT DISORD, V21, P2062, DOI 10.1002/mds.21076; Wei JS, 2009, AM J PATHOL, V174, P1891, DOI 10.2353/ajpath.2009.080680; Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x; Halperin A, 2006, BLOOD CELL MOL DIS, V36, P426, DOI 10.1016/j.bcmd.2006.02.004; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Brockmann K, 2011, NEUROLOGY, V77, P276, DOI 10.1212/WNL.0b013e318225ab77; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Choy FYM, 2007, BLOOD CELL MOL DIS, V38, P287, DOI 10.1016/j.bcmd.2006.11.003; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Farfel-Becker T, 2014, HUM MOL GENET, V23, P843, DOI 10.1093/hmg/ddt468; Campbell TN, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-12; Choy FY, 2011, INT J CELL BIOL, V2011; Clark LN, 2005, MOVEMENT DISORD, V20, P100, DOI 10.1002/mds.20320; DePaolo J, 2009, MOVEMENT DISORD, V24, P1571, DOI 10.1002/mds.22538; do Rosario Almeida M, 2012, FRONT NEUROL, V3, P65; Hruska KS, 2006, J BIOMED BIOTECHNOL, V2006, P78549; Kalinderi K, 2009, NEUROSCI LETT, V452, P87, DOI 10.1016/j.neulet.2009.01.029; Lesage S, 2010, HUM MOL GENET, V20, P202; Mao XY, 2010, NEUROSCI LETT, V469, P256, DOI 10.1016/j.neulet.2009.12.007; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; McNeill A, 2012, MOVEMENT DISORD, V27, P526, DOI 10.1002/mds.24945; McNeill A, 2012, J NEUROL NEUROSUR PS, V83, P853, DOI 10.1136/jnnp-2012-302402; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sybertz E, 2014, J LIPID RES, V55, P1996, DOI 10.1194/jlr.R047381; Ziegler SG, 2007, MOL GENET METAB, V91, P195, DOI 10.1016/j.ymgme.2007.03.004; Zokaei N, 2014, BRAIN, V137, P2303, DOI 10.1093/brain/awu143	70	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2015	35	6					755	761		10.1007/s10571-015-0176-8		7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CN2YC	WOS:000358288100001		
J	Hashikawa, N; Ogawa, T; Sakamoto, Y; Ogawa, M; Matsuo, Y; Zamami, Y; Hashikawa-Hobara, N				Hashikawa, Naoya; Ogawa, Takumi; Sakamoto, Yusuke; Ogawa, Mami; Matsuo, Yumi; Zamami, Yoshito; Hashikawa-Hobara, Narumi			Time Course of Behavioral Alteration and mRNA Levels of Neurotrophic Factor Following Stress Exposure in Mouse	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Depression; BDNF; NGF; mRNA; Mouse	MAJOR DEPRESSIVE DISORDER; ANIMAL-MODEL; EARLY IMPROVEMENT; MOOD DISORDERS; RAT-BRAIN; EXPRESSION; MICE; NEUROGENESIS; HIPPOCAMPUS; ANXIETY	Stress is known to affect neurotrophic factor expression, which induces depression-like behavior. However, whether there are time-dependent changes in neurotrophic factor mRNA expression following stress remains unclear. In the present study, we tested whether chronic stress exposure induces long-term changes in depression-related behavior, serum corticosterone, and hippocampal proliferation as well as neurotrophic factor family mRNA levels, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3), and ciliary neurotrophic factor (CNTF), in the mouse hippocampus. The mRNA level of neurotrophic factors (BDNF, NGF, NT-3, and CNTF) was measured using the real-time PCR. The serum corticosterone level was evaluated by enzyme-linked immunosorbent assay, and, for each subject, the hippocampal proliferation was examined by 5-bromo-2-deoxyuridine immunostaining. Mice exhibited depression-like behavior in the forced-swim test (FST) and decreased BDNF mRNA and hippocampal proliferation in the middle of the stress exposure. After 15 days of stress exposure, we observed increased immobility in the FST, serum corticosterone levels, and BDNF mRNA levels and degenerated hippocampal proliferation, maintained for at least 2 weeks. Anhedonia-like behavior in the sucrose preference test and NGF mRNA levels were decreased following 15 days of stress. NGF mRNA levels were significantly higher 1 week after stress exposure. The current data demonstrate that chronic stress exposure induces prolonged BDNF and NGF mRNA changes and increases corticosterone levels and depression-like behavior in the FST, but does not alter other neurotrophic factors or performance in the sucrose preference test.	[Hashikawa, Naoya; Ogawa, Takumi; Sakamoto, Yusuke; Ogawa, Mami; Matsuo, Yumi; Hashikawa-Hobara, Narumi] Okayama Univ Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan; [Zamami, Yoshito] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Med Drug Design, Kita Ku, Okayama, Japan	Hashikawa-Hobara, N (reprint author), Okayama Univ Sci, Dept Life Sci, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.	hobara@dls.ous.ac.jp					Russo-Neustadt A, 2001, BEHAV BRAIN RES, V120, P87, DOI 10.1016/S0166-4328(00)00364-8; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; SMITH MA, 1995, J NEUROSCI, V15, P1768; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Shirayama Y, 2002, J NEUROSCI, V22, P3251; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Chourbaji S, 2004, MOL BRAIN RES, V121, P28, DOI 10.1016/j.molbrainres.2003.11.002; Uchida S, 2011, P NATL ACAD SCI USA, V108, P1681, DOI 10.1073/pnas.1016424108; Jiao J, 2013, MOL PSYCHIATR, V18, P1273, DOI 10.1038/mp.2012.136; Kessler RC, 2008, PSYCHOL MED, V38, P365, DOI 10.1017/S0033291707002012; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; Yasui-Furukori N, 2013, PSYCHIAT RES, V210, P220, DOI 10.1016/j.psychres.2013.05.015; Reus GZ, 2011, NEUROCHEM RES, V36, P460, DOI 10.1007/s11064-010-0364-3; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Szegedi A, 2009, J CLIN PSYCHIAT, V70, P344; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; MacMaster FP, 2008, BIOL PSYCHIAT, V63, P385, DOI 10.1016/j.biopsych.2007.05.005; Angelucci F, 2004, PROG BRAIN RES, V146, P151, DOI 10.1016/S0079-6123(03)46011-1; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; D'Sa C, 2002, BIPOLAR DISORD, V4, P183, DOI 10.1034/j.1399-5618.2002.01203.x; Jacobsen JPR, 2006, BRAIN RES, V1110, P221, DOI 10.1016/j.brainres.2006.06.077; Lucca G, 2008, CURR NEUROVASC RES, V5, P207, DOI 10.2174/156720208786413406; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Nikulina EM, 2008, EUR J NEUROSCI, V27, P2272, DOI 10.1111/j.1460-9568.2008.06176.x; van Calker D, 2009, J AFFECT DISORDERS, V114, P243, DOI 10.1016/j.jad.2008.07.023; Benelli A, 1999, BRIT J PHARMACOL, V127, P645, DOI 10.1038/sj.bjp.0702589; Ihne JL, 2012, NEUROPHARMACOLOGY, V62, P464, DOI 10.1016/j.neuropharm.2011.08.045; Kordower JH, 1999, EXP NEUROL, V159, P4, DOI 10.1006/exnr.1999.7156; McGeary JE, 2011, NEUROPEPTIDES, V45, P317, DOI 10.1016/j.npep.2011.06.002; Peruga I, 2012, BEHAV BRAIN RES, V229, P325, DOI 10.1016/j.bbr.2012.01.020; Sakamoto Y, 2015, YAKUGAKU ZASSHI, V135, P151, DOI 10.1248/yakushi.14-00180; Schaaf M J, 2000, Stress, V3, P201, DOI 10.3109/10253890009001124; Shi CG, 2010, NEUROCHEM RES, V35, P1302, DOI 10.1007/s11064-010-0183-6	40	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2015	35	6					807	817		10.1007/s10571-015-0174-x		11	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CN2YC	WOS:000358288100006		
J	Zhang, L; Rothfels, CJ; Ebihara, A; Schuettpelz, E; Le Pechon, T; Kamau, P; He, H; Zhou, XM; Prado, J; Field, A; Yatskievych, G; Gao, XF; Zhang, LB				Zhang, Liang; Rothfels, Carl J.; Ebihara, Atsushi; Schuettpelz, Eric; Le Pechon, Timothee; Kamau, Peris; He, Hai; Zhou, Xin-Mao; Prado, Jefferson; Field, Ashley; Yatskievych, George; Gao, Xin-Fen; Zhang, Li-Bing			A global plastid phylogeny of the brake fern genus Pteris (Pteridaceae) and related genera in the Pteridoideae	CLADISTICS			English	Review							MAXIMUM-LIKELIHOOD; CHLOROPLAST DNA; DRYOPTERIS DRYOPTERIDACEAE; ERIOSORUS PTERIDACEAE; EVOLUTIONARY LINEAGES; MODEL SELECTION; SEQUENCES; PARSIMONY; TAENITIDOIDEAE; MONILOPHYTES	The brake fern genus Pteris belongs to the Pteridaceae subfamily Pteridoideae. It contains 200-250 species distributed on all continents except Antarctica, with its highest species diversity in tropical and subtropical regions. The monophyly of Pteris has long been in question because of its great morphological diversity and because of the controversial relationships of the Australian endemic monospecific genus Platyzoma. The circumscription of the Pteridoideae has likewise been uncertain. Previous studies typically had sparse sampling of Pteris species and related genera and used limited DNA sequence data. In the present study, DNA sequences of six plastid loci of 146 accessions representing 119 species of Pteris (including the type of the genus) and 18 related genera were used to infer a phylogeny using maximum-likelihood, Bayesian-inference and maximum-parsimony methods. Our major results include: (i) the previous uncertain relationships of Platyzoma were due to long-branch attraction; (ii) Afropteris, Neurocallis, Ochropteris and Platyzoma are all embedded within a well-supported Pteris sensu lato; (iii) the traditionally circumscribed Jamesonia is paraphyletic in relation to a monophyletic Eriosorus; (iv) Pteridoideae contains 15 genera: Actiniopteris, Anogramma, Austrogramme, Cerosora, Cosentinia, Eriosorus, Jamesonia, Nephopteris (no molecular data), Onychium, Pityrogramma, Pteris, Pterozonium, Syngramma, Taenitis and Tryonia; and (v) 15 well-supported clades within Pteris are identified, which differ from one another on molecular, morphological and geographical grounds, and represent 15 major evolutionary lineages. (C) The Willi Hennig Society 2014.	[Zhang, Liang; Le Pechon, Timothee; Zhou, Xin-Mao; Gao, Xin-Fen] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China; [Rothfels, Carl J.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; [Schuettpelz, Eric] Smithsonian Inst, Dept Bot MRC 166, Natl Museum Nat Hist, Washington, DC 20013 USA; [Kamau, Peris] Natl Museums Kenya, Dept Bot, Nairobi, Kenya; [He, Hai] Chongqing Normal Univ, Dept Biol, Chongqing 400047, Peoples R China; [Prado, Jefferson] Inst Bot Herbario SP, BR-04301012 Sao Paulo, Brazil; [Field, Ashley] James Cook Univ, Australian Trop Herbarium, Smithfield, Qld 4878, Australia; [Field, Ashley] Queensland Herbarium, Dept Sci Informat Technol Innovat & Arts, Toowong, Qld 4066, Australia; [Yatskievych, George; Zhang, Li-Bing] Missouri Bot Garden, St Louis, MO 63166 USA	Gao, XF (reprint author), Chinese Acad Sci, Chengdu Inst Biol, POB 416, Chengdu 610041, Sichuan, Peoples R China.	xfgao@cib.ac.cn; Libing.Zhang@mobot.org	Prado, Jefferson/C-4766-2012	Prado, Jefferson/0000-0003-4783-3125			AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALSTON A. H. G., 1956, BOL SOC BROTERIANA, V30, P5; SHIEH WC, 1966, BOT MAG TOKYO, V79, P283; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Zhang LB, 2001, AM J BOT, V88, P2331, DOI 10.2307/3558393; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Li CX, 2006, J PLANT RES, V119, P589, DOI 10.1007/s10265-006-0003-x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Nixon KC, 1996, CLADISTICS, V12, P221, DOI 10.1111/j.1096-0031.1996.tb00010.x; Kao Tzu-Tong, 2008, Taiwania, V53, P394; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Siddall ME, 1999, CLADISTICS, V15, P9, DOI 10.1006/clad.1998.0079; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Rai HS, 2010, AM J BOT, V97, P1444, DOI 10.3732/ajb.0900305; Prado J, 2007, TAXON, V56, P355; Schuettpelz E, 2006, TAXON, V55, P897; Bouma WLM, 2010, AUST SYST BOT, V23, P143, DOI 10.1071/SB09047; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.2307/2413529; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; ZURAWSKI G, 1984, GENETICS, V106, P735; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Chao YS, 2012, INT J MOL SCI, V13, P4523, DOI 10.3390/ijms13044523; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; WAGNER FS, 1980, AM J BOT, V67, P733, DOI 10.2307/2442666; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; Smith AR, 2006, TAXON, V55, P705; Autrey J. C., 2008, FLORE MASCAREIGNES R, P110; Baker J. G., 1868, SYNOPSIS FILICUM, P153; Baker J. G., 1874, SYNOPSIS FILICUM, P127; GASTONY G J, 1975, American Fern Journal, V65, P71, DOI 10.2307/1546741; Bostock P. D., 1998, FLORA AUSTR, V48, P248; Brown R., 1810, PRODROMUS FLORAE NOV, P160; Chao Y-S, 2012, J BOT, V2012, P1; Christ H., 1897, FARNKRAUTER ERDE, P339; Christensen C., 1906, INDEX FILICUM SIVE E; Christensen C., 1934, INDEX FILICUM SUPPLE, P131; Cochran AT, 2014, PHYTOKEYS, V35, P23, DOI 10.3897/phytokeys.35.6886; Copeland E. B, 1947, GENERA FILICUM; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Fee A. L. A., 1852, MEM FAM FOUG, V5, P60; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENST.J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hieronymus G., 1914, HEDWIGIA, V54, P283; Holmgren P.K., 1998, INDEX HERBARIORUM GL; Hooker W. J., 1858, SPECIES FILICUM, V2, P154; Jaruwattanaphan T, 2013, SYST BOT, V38, P15, DOI 10.1600/036364413X661980; KATO M, 1992, BOT MAG TOKYO, V105, P105, DOI 10.1007/BF02489407; Li C-X, 2004, J GENETICS MOL BIOL, V15, P58; Liao W.-B., 2013, FLORA CHINA, V2-3, P181; Lin Su-Juan, 1996, Journal of Japanese Botany, V71, P214; Linnaeus C., 1753, SPECIES PLANTARUM, P1073; Mickel J.T., 2004, MEMOIRS NEW YORK BOT, V88, P1; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Moore T., 1857, INDEX FILICUM SYNOPS; Nakai T., 1950, B NATL MUSEUM, V31, P1; Nakazato T, 2003, SYST BOT, V28, P490; Pol D, 2004, SYST BIOL, V53, P949, DOI 10.1080/10635150490888868; Prado J, 2000, B I BOT, V13, P103; Presl C.B., 1836, TENTAMEN PTERIDOGRAP; PUNETHA N, 1989, P INDIAN AS-PLANT SC, V99, P131; Rambaut A, 2007, TRACER 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothfels C., 2008, BRAKE FERNS MAIDENHA; Rothfels CJ, 2008, TAXON, V57, P712; Sanchez-Baracaldo P, 2004, AM J BOT, V91, P274, DOI 10.3732/ajb.91.2.274; Sanchez-Baracaldo P, 2004, AM FERN J, V94, P126, DOI 10.1640/0002-8444(2004)094[0126:PROTST]2.0.CO;2; Schneider H, 2013, PHYTOTAXA, V77, P49, DOI 10.11646/phytotaxa.77.4.1; Sigel EM, 2011, SYST BOT, V36, P554, DOI 10.1600/036364411X583547; Smith A.R., 1981, FLORA OF CHIAPAS 2; Smith J., 1875, HIST FILICUM, P295; Smith J., 1841, HOOKERS J BOT, V4, P147; Sundue M, 2009, BOT J LINN SOC, V161, P422, DOI 10.1111/j.1095-8339.2009.01012.x; Swofford D, 2002, PAUP 4 0 B10 PHYLOGE; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tardieu-Blot M. L., 1958, FL MADAGASC, V5, P65; Tavare S., 1986, LECTURES MATH LIFE S, V17, P57; Thompson J. M., 1917, R BR T R SOC EDINB E, V51, P631; Tryon A. F., 1982, FERNS ALLIED PLANTS, P332; TRYON ALICE F., 1961, RHODORA, V63, P91; TRYON AF, 1967, SCIENCE, V156, P1109, DOI 10.1126/science.156.3778.1109; TRYON AF, 1964, AM J BOT, V51, P939, DOI 10.2307/2440244; Tryon R. M., 1989, FIELDIANA BOT, V22, P78; Tryon R. M., 1962, CONTRIB GRAY HERB, V189, P52; Tryon R. M., 1990, FAMILIES GENERA VASC, P230; Wagner Jr. W. H., 1978, ACTA PHYTOTAX GEOBOT, V3, P3; Walker T. G., 1960, KEW B, V14, P321, DOI 10.2307/4114745; WALKER TG, 1962, EVOLUTION, V16, P27, DOI 10.2307/2406264; Wang Z. R., 1989, Acta Phytotaxonomica Sinica, V27, P421; Wolf PG, 1999, PLANT SYST EVOL, V219, P263, DOI 10.1007/BF00985583; Wu S. - W., 1990, FLORA REPUBL POP SIN, P15; WuS-H Ching R-C, 1983, ACTA BOT AUSTROSINIC, V1, P1; Yang D. M., 2011, SYSMATIC STUDIES PTE; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang L, 2014, PHYTOTAXA, V174, P116; Zhang L. B., 2010, SYST BOT, V35, P1; Zhang LB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-180; ZHANG LB, 2006, SYST BOT, V31, P107	105	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-3007	1096-0031		CLADISTICS	Cladistics	AUG	2015	31	4					406	423		10.1111/cla.12094		18	Evolutionary Biology	Evolutionary Biology	CN1KS	WOS:000358179500002		
J	Clouse, RM; Janda, M; Blanchard, B; Sharma, P; Hoffmann, BD; Andersen, AN; Czekanski-Moir, JE; Krushelnycky, P; Rabeling, C; Wilson, EO; Economo, EP; Sarnat, EM; General, DM; Alpert, GD; Wheeler, WC				Clouse, Ronald M.; Janda, Milan; Blanchard, Benjamin; Sharma, Prashant; Hoffmann, Benjamin D.; Andersen, Alan N.; Czekanski-Moir, Jesse E.; Krushelnycky, Paul; Rabeling, Christian; Wilson, Edward O.; Economo, Evan P.; Sarnat, Eli M.; General, David M.; Alpert, Gary D.; Wheeler, Ward C.			Molecular phylogeny of Indo-Pacific carpenter ants (Hymenoptera: Formicidae, Camponotus) reveals waves of dispersal and colonization from diverse source areas	CLADISTICS			English	Article							MITOCHONDRIAL-DNA; VICARIANCE ANALYSIS; SEQUENCE ALIGNMENT; BIOGEOGRAPHY; EVOLUTIONARY; ORIGIN; PHYLOGEOGRAPHY; ARCHIPELAGO; INFERENCE; ISLANDS	Ants that resemble Camponotus maculatus (Fabricius, 1782) present an opportunity to test the hypothesis that the origin of the Pacific island fauna was primarily New Guinea, the Philippines, and the Indo-Malay archipelago (collectively known as Malesia). We sequenced two mitochondrial and four nuclear markers from 146 specimens from Pacific islands, Australia, and Malesia. We also added 211 specimens representing a larger worldwide sample and performed a series of phylogenetic analyses and ancestral area reconstructions. Results indicate that the Pacific members of this group comprise several robust clades that have distinctly different biogeographical histories, and they suggest an important role for Australia as a source of Pacific colonizations. Malesian areas were recovered mostly in derived positions, and one lineage appears to be Neotropical. Phylogenetic hypotheses indicate that the orange, pan-Pacific form commonly identified as C.chloroticus Emery 1897 actually consists of two distantly related lineages. Also, the lineage on Hawai?i, which has been called C.variegatus (Smith, 1858), appears to be closely related to C.tortuganus Emery, 1895 in Florida and other lineages in the New World. In Micronesia and Polynesia the C.chloroticus-like species support predictions of the taxon-cycle hypothesis and could be candidates for human-mediated dispersal. (C) The Willi Hennig Society 2014.	[Clouse, Ronald M.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Clouse, Ronald M.; Sharma, Prashant; Wheeler, Ward C.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Janda, Milan] Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice 37005, Czech Republic; [Janda, Milan; Rabeling, Christian; Wilson, Edward O.; Alpert, Gary D.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Blanchard, Benjamin] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Hoffmann, Benjamin D.; Andersen, Alan N.] CSIRO Land & Water Flagship, Darwin, NT 0822, Australia; [Czekanski-Moir, Jesse E.] Univ Oklahoma, Dept Biol, Program Ecol & Evolutionary Biol, Norman, OK 73019 USA; [Krushelnycky, Paul] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Economo, Evan P.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Sarnat, Eli M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [General, David M.] Univ Philippines Los Banos, Los Banos 4031, Laguna, Philippines	Clouse, RM (reprint author), Univ N Carolina, Dept Bioinformat & Genom, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	ronaldmclouse@gmail.com	Hoffmann, Ben/A-2746-2011; Andersen, Alan/F-8763-2010	Hoffmann, Ben/0000-0002-4010-4723; 	DARPA [W911NF-05-1-0271]; Marie Curie Fellowship [PIOFGA2009-25448]; Czech Science Foundation [P505/12/2467]; Czech Ministry of Education Grant [6007665801]; US National Science Foundation [DEB 0515678]; Putnam Expedition Grants (Museum of Comparative Zoology); Harvard Society of Fellows; Australian Studies Committee of Harvard; American Museum of Natural History's Research Experience for Undergraduates program (NSF)	We thank the following funders for supporting this work: DARPA (W911NF-05-1-0271), Marie Curie Fellowship (PIOFGA2009-25448), Czech Science Foundation (P505/12/2467), Czech Ministry of Education Grant (6007665801), US National Science Foundation (DEB 0515678), Putnam Expedition Grants (Museum of Comparative Zoology), the Harvard Society of Fellows, the Australian Studies Committee of Harvard, and the American Museum of Natural History's Research Experience for Undergraduates program (NSF). We are grateful to Stefan Cover at the Museum of Comparative Zoology for assistance with sampling mounted specimens. Simon Robson at James Cook University generously made available specimens from the late Ross H. Crozier's collection, the localities for which were determined with the assistance of Ellen Schluens and Corrie Moreau. We are grateful to P. Riha for the graphic design of maps, to M. Borovanska and E. Youngerman for specimens and data management, to the staff of the New Guinea Binatang Research Center for field assistance, to V. Novotny, S. E. Miller and N. Pierce for assistance with Papua New Guinea (PNG) projects, to the PNG Department of Environment and Conservation for assistance with research permits, to the Department of Environmental Protection and Conservation of the Republic of Vanuatu for assistance with research permits, and to Miss Donna Kalfatak and the citizens of Penaoru village for assistance with field work. Research in Micronesia was made possible through the generous assistance of the Chuuk Visitor's Bureau, the College of Micronesia, The Conservation Society of Pohnpei, Yap State Department of Resources and Development, the Belau National Museum, and the University of Guam. Special field assistance on the island of Tol (in Chuuk) was kindly provided by the Techuo family, and on Pohnpei Island by Amos Eperiam and Nixon Daniel. Specimen loans from Palau were arranged by Alan Olsen. Daniel Janies and the Department of Bioinformatics and Genomics at UNC Charlotte provided important computing and imaging support. Brian Fisher helped us locate sequences of important Malagasy and African specimens. Anupam Kumar and Sameer Siddiqi investigated hybridization and prepared data for network analysis. We thank the three anonymous reviewers for their helpful suggestions on earlier versions of this manuscript.	MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1554/03-361; Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SIMPSON GG, 1977, P AM PHILOS SOC, V121, P107; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Baldwin BG, 2010, ANN BOT-LONDON, V105, P849, DOI 10.1093/aob/mcq052; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Pennings PS, 2011, J EVOLUTION BIOL, V24, P871, DOI 10.1111/j.1420-9101.2010.02223.x; [Anonymous], 2012, ANTS FIJI; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x; JERMIIN LS, 1994, J MOL EVOL, V38, P282; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Rabeling C, 2013, ANNU REV ENTOMOL, V58, P273, DOI 10.1146/annurev-ento-120811-153710; Economo EP, 2012, AM NAT, V180, pE1, DOI 10.1086/665996; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; CERDA X, 2011, BIOL INVASIONS, V14, P323; Chenuil A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-276; Clouse Ronald M., 2007, Micronesica, V39, P171; Clouse RM, 2007, ZOOTAXA, P1; Donisthorpe H., 1915, ENTOMOL REC J VAR, V27, P221; Foucaud J, 2010, EVOL APPL, V3, P363, DOI 10.1111/j.1752-4571.2010.00119.x; Garb JE, 2006, J BIOGEOGR, V33, P201, DOI 10.1111/j.1365-2699.2005.01398.x; Goropashnaya AV, 2007, ANN ZOOL FENN, V44, P462; GRESSITT JL, 1982, ENTOMOL GEN, V8, P1; GRESSITT JL, 1974, ANNU REV ENTOMOL, V19, P293, DOI 10.1146/annurev.en.19.010174.001453; Hafiz Ur R., 2013, S PACIFIC STUD, V33, P101; Hall T., 2007, BIOEDIT; Harbaugh DT, 2009, J BIOGEOGR, V36, P230, DOI 10.1111/j.1365-2699.2008.02008.x; Holloway J. D., 1998, GEOLOGICAL SIGNAL DI, P291; Huxley T. H., 1868, J ZOOL, V1868, P294; Irestedt M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0309; Kannan L, 2014, J COMPUT BIOL, V21, P303, DOI 10.1089/cmb.2013.0134; Keppel G, 2009, J BIOGEOGR, V36, P1035, DOI 10.1111/j.1365-2699.2009.02095.x; Leppanen J, 2011, ECOL EVOL, V1, P46, DOI 10.1002/ece3.6; McArthur Archie J., 2006, Myrmecologische Nachrichten, V8, P99; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Pang G.-F., 2009, J GUANGXI NORMAL U, V27, P62; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sharma PP, 2011, INVERTEBR SYST, V25, P106, DOI 10.1071/IS11002; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; Steiner FM, 2006, EUR J ENTOMOL, V103, P619; Sy Vinh L, 2009, CLADISTICS, V26, P72, DOI [10.1111/j.1096-0031.2009.00282.x, DOI 10.1111/J.1096-0031.2009.00282.X]; Wallace A. R., 1859, IBIS, V1, P449; Wills BD, 2014, BIOL J LINN SOC, V113, P423, DOI 10.1111/bij.12386; Wilson E. O., 1996, BISHOP MUS OCCAS PAP, V45, P3; WILSON EDWARD O., 1967, PAC INSECTS MONOGR, V14, P1; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.2307/2405948; Yu Y, 2011, RASP RECONSTRUCT ANC; Zimmerman E. C., 1948, INSECTS OF HAWAII, V1	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-3007	1096-0031		CLADISTICS	Cladistics	AUG	2015	31	4					424	437		10.1111/cla.12099		14	Evolutionary Biology	Evolutionary Biology	CN1KS	WOS:000358179500003		
J	Shi, F; Ge, QS; Yang, B; Li, JP; Yang, FM; Ljungqvist, FC; Solomina, O; Nakatsuka, T; Wang, NL; Zhao, S; Xu, CX; Fang, KY; Sano, M; Chu, GQ; Fan, ZX; Gaire, NP; Zafar, MU				Shi, Feng; Ge, Quansheng; Yang, Bao; Li, Jianping; Yang, Fengmei; Ljungqvist, Fredrik Charpentier; Solomina, Olga; Nakatsuka, Takeshi; Wang, Ninglian; Zhao, Sen; Xu, Chenxi; Fang, Keyan; Sano, Masaki; Chu, Guoqiang; Fan, Zexin; Gaire, Narayan P.; Zafar, Muhammad Usama			A multi-proxy reconstruction of spatial and temporal variations in Asian summer temperatures over the last millennium	CLIMATIC CHANGE			English	Article							SURFACE AIR-TEMPERATURE; SYSTEM MODEL; CLIMATE; VARIABILITY; RESOLUTION; MONSOON; CHINA; CMIP5	To investigate climate variability in Asia during the last millennium, the spatial and temporal evolution of summer (June-July-August; JJA) temperature in eastern and south-central Asia is reconstructed using multi-proxy records and the regularized expectation maximization (RegEM) algorithm with truncated total least squares (TTLS), under a point-by-point regression (PPR) framework. The temperature index reconstructions show that the late 20th century was the warmest period in Asia over the past millennium. The temperature field reconstructions illustrate that temperatures in central, eastern, and southern China during the 11th and 13th centuries, and in western Asia during the 12th century, were significantly higher than those in other regions, and comparable to levels in the 20th century. Except for the most recent warming, all identified warm events showed distinct regional expressions and none were uniform over the entire reconstruction area. The main finding of the study is that spatial temperature patterns have, on centennial time-scales, varied greatly over the last millennium. Moreover, seven climate model simulations, from the Coupled Model Intercomparison Project Phase 5 (CMIP5), over the same region of Asia, are all consistent with the temperature index reconstruction at the 99 % confidence level. Only spatial temperature patterns extracted as the first empirical orthogonal function (EOF) from the GISS-E2-R and MPI-ESM-P model simulations are significant and consistent with the temperature field reconstruction over the past millennium in Asia at the 90 % confidence level. This indicates that both the reconstruction and the simulations depict the temporal climate variability well over the past millennium. However, the spatial simulation or reconstruction capability of climate variability over the past millennium could be still limited. For reconstruction, some grid points do not pass validation tests and reveal the need for more proxies with high temporal resolution, accurate dating, and sensitive temperature signals, especially in central Asia and before AD 1400.	[Shi, Feng; Chu, Guoqiang] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Ge, Quansheng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Yang, Bao; Wang, Ninglian] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Li, Jianping] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Li, Jianping] Joint Ctr Global Change Studies, Beijing, Peoples R China; [Yang, Fengmei] China Meteorol Adm Training Ctr, Beijing, Peoples R China; [Ljungqvist, Fredrik Charpentier] Stockholm Univ, Dept Hist, S-10691 Stockholm, Sweden; [Ljungqvist, Fredrik Charpentier] Stockholm Univ, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Solomina, Olga] Russian Acad Sci, Inst Geog, Moscow V71, Russia; [Solomina, Olga] Tomsk State Univ, Tomsk 634050, Russia; [Nakatsuka, Takeshi; Xu, Chenxi; Sano, Masaki] Res Inst Humanity & Nat, Kyoto, Japan; [Zhao, Sen] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China; [Fang, Keyan] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China; [Fan, Zexin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Kunming, Yunnan, Peoples R China; [Gaire, Narayan P.] Nepal Acad Sci & Technol, Fac Sci, Khumaltar, Lalitpur, Nepal; [Gaire, Narayan P.] Tribhuvan Univ, Cent Dept Environm Sci, Kathmandu, Nepal; [Zafar, Muhammad Usama] Fed Urdu Univ, Lab Dendrochronol & Plant Ecol, Karachi, Pakistan	Ge, QS (reprint author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	geqs@igsnrr.ac.cn	Ljungqvist, Fredrik/I-5770-2012	Ljungqvist, Fredrik/0000-0003-0220-3947	CAS Strategic Priority Research Program Grant [XDA05080800, XDB03020500]; National Natural Science Foundation of China [41301220]; China Meteorological Administration Drought Research [IAM201213]; West Light Program for Talent Cultivation of Chinese Academy of Sciences	Version B of the reconstruction is a contribution to the PAGES Asia2k working group. We are indebted to Lucien von Gunten for helpful comments and assistance, and thank Edward R. Cook, Brendan Buckley, Kevin Anchukaitis, Paul J. Krusic, Chun Qin, Xuemei Shao, Jingyun Zheng, Hemant Borgaonkar, Katsuhiko Kimura, Masumi Zaiki, Koh Yasue, Achim Brauning, Jiangfeng Li, Yujiang Yuan, Hongbing Liu, Yu Liu, Qibing Zhang, Jinbao Li, Jianfeng Peng, Xiaohua Gou, Haifeng Zhu, Shaowu Wang, Deer Zhang, Jonathan Palmer, Paul Sheppard, Margit Schwikowski, Tatyana Papina and other scientists who have contributed their proxy data for the study region to the publicly available database. The study was jointly funded by the CAS Strategic Priority Research Program Grant (XDA05080800; XDB03020500), and the National Natural Science Foundation of China (41301220). Feng Shi was supported by China Meteorological Administration Drought Research (IAM201213) and West Light Program for Talent Cultivation of Chinese Academy of Sciences.	Schurer AP, 2013, J CLIMATE, V26, P6954, DOI 10.1175/JCLI-D-12-00826.1; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Wu TW, 2010, CLIM DYNAM, V34, P123, DOI 10.1007/s00382-008-0487-2; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Wang J, 2014, CLIM PAST, V10, P1, DOI 10.5194/cp-10-1-2014; Schmidt GA, 2012, GEOSCI MODEL DEV, V5, P185, DOI 10.5194/gmd-5-185-2012; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Anchukaitis KJ, 2012, NAT GEOSCI, V5, P836, DOI 10.1038/ngeo1645; Ljungqvist FC, 2012, CLIM PAST, V8, P227, DOI 10.5194/cp-8-227-2012; Cook ER, 2013, CLIM DYNAM, V41, P2957, DOI 10.1007/s00382-012-1611-x; Schmidt GA, 2014, J ADV MODEL EARTH SY, V6, P141, DOI 10.1002/2013MS000265; Wang SW, 2007, CHINESE SCI BULL, V52, P3272, DOI 10.1007/s11434-007-0425-4; Landrum L, 2013, J CLIMATE, V26, P1085, DOI 10.1175/JCLI-D-11-00326.1; Ge QS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041281; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Shi F, 2012, SCI CHINA EARTH SCI, V55, P2058, DOI 10.1007/s11430-012-4374-7; Mann ME, 2012, NAT GEOSCI, V5, P202, DOI [10.1038/ngeo1394, 10.1038/NGEO1394]; Li JP, 2013, GEOPHYS RES LETT, V40, P5497, DOI 10.1002/2013GL057877; Jungclaus JH, 2010, CLIM PAST, V6, P723, DOI 10.5194/cp-6-723-2010; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Wu GX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00404; Esper J, 2013, B VOLCANOL, V75, P1; Ge QS, 2013, SCI CHINA EARTH SCI, V56, P321, DOI 10.1007/s11430-012-4370-y; Guiot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009972; Man WM, 2014, ADV ATMOS SCI, V31, P765, DOI 10.1007/s00376-013-3123-y; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Masson-Delmotte V., 2013, CLIMATE CHANGE 2013; Neukom R, 2011, CLIM DYNAM, V37, P35, DOI 10.1007/s00382-010-0793-3; Newman L, 2009, PAGES NEWS, V17, P130; Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/ngeo1797, 10.1038/NGEO1797]; Timmreck C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040083; Wang S, 1990, ACTA METEOROLOGICA S, V4, P428; Yang FM, 2013, THEOR APPL CLIMATOL, V114, P553, DOI 10.1007/s00704-013-0858-4; Zhang D, 1980, CHINESE SCI BULL, V25, P497	38	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-0009	1573-1480		CLIMATIC CHANGE	Clim. Change	AUG	2015	131	4					663	676		10.1007/s10584-015-1413-3		14	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CN1KR	WOS:000358179400015		
J	Hibino, K; Takayabu, I; Nakaegawa, T				Hibino, Kenshi; Takayabu, Izuru; Nakaegawa, Tosiyuki			Objective estimate of future climate analogues projected by an ensemble AGCM experiment under the SRES A1B scenario	CLIMATIC CHANGE			English	Article							DISTRIBUTIONS	Climate analogues (CAs), regions whose present climates are similar to the future climate of a target place, are identified to assess the effects of climate change towards the end of the 21st century. The location of CAs and their present climates yield information that may be used to mitigate the harmful impacts of climate change. Present (1979-2003) and future (2075-2099) climates are projected in an ensemble experiment using the atmospheric general circulation model of the Meteorological Research Institute in Japan. The ensemble members consist of combinations of four distributions of sea surface temperature, three convection schemes, and two initial conditions. The emission scenario for greenhouse gases is A1B of the Special Report on Emissions Scenarios. A new method to identify the location of CAs is introduced, in which the uncertainty in the climate projection is taken into account. CAs for all land regions of the world are presented and those of four capital cities are analyzed in detail. The CAs are generally distributed equator-ward from the target places, consistent with the global warming. It is also found that ensemble experiments that encompass the uncertainty of climate projections can yield robust results for the CA and lead to reliable assessments of climate change.	[Hibino, Kenshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Takayabu, Izuru; Nakaegawa, Tosiyuki] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan	Hibino, K (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	hibino.kenshi.gn@u.tsukuba.ac.jp; takayabu@mri-jma.go.jp; tnakaega@mri-jma.go.jp			SOUSEI program of MEXT, Japan	We are thankful to Drs Mizuta and Yoshida of the Meteorological Research Institute for providing the results of the AGCMs analyzed in this paper. This research is supported by the SOUSEI program of MEXT, Japan.	Koven CD, 2013, NAT GEOSCI, V6, P452, DOI [10.1038/ngeo1801, 10.1038/NGEO1801]; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Boberg F, 2012, NAT CLIM CHANGE, V2, P433, DOI 10.1038/NCLIMATE1454; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Deser Clara, 2012, Climate Dynamics, V38, DOI 10.1007/s00382-010-0977-x; Buser CM, 2009, CLIM DYNAM, V33, P849, DOI 10.1007/s00382-009-0588-6; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Ordonez A, 2013, ECOL LETT, V16, P773, DOI 10.1111/ele.12110; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Hallegatte S, 2007, CLIMATIC CHANGE, V82, P47, DOI 10.1007/s10584-006-9161-z; Endo H, 2012, J GEOPHYS RES ATMOS, V117; Ishizaki NN, 2012, J METEOROL SOC JPN, V90B, P65, DOI 10.2151/jmsj.2012-B05; Kain JS, 1993, METEOROL MONOGR, V46, P165; Kopf S, 2008, NAT HAZARD EARTH SYS, V8, P905; Nakaegawa T, 2013, HYDROL PROCESS, V27, P3301, DOI 10.1002/hyp.9831; Nakicenovic N, 2000, SPECIAL REPORT EMISS; PARRY ML, 1989, CLIMATIC CHANGE, V15, P95, DOI 10.1007/BF00138848; Ramirez-Villegas J, 2011, CLIMATE ANALOGUES FI; RANDALL DA, 1993, METEOR MON, V24, P137; Rayner N. A., 2003, J GEOPHYS RES, V108, P1984, DOI DOI 10.1029/2002JD002670; Wilby R. L., 2004, GUIDELINES USE CLIMA; Yukimoto S, 2011, METEOROLOGICAL RES I	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-0009	1573-1480		CLIMATIC CHANGE	Clim. Change	AUG	2015	131	4					677	689		10.1007/s10584-015-1396-0		13	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CN1KR	WOS:000358179400016		
J	Toyonaga, E; Hata, H; Shimizu, H				Toyonaga, E.; Hata, H.; Shimizu, H.			Nipple-like tumour of the shoulder in a male patient	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Editorial Material							GLOMUS TUMOR; TENDON		[Toyonaga, E.; Hata, H.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Hata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	hata07jp@yahoo.co.jp					Akgun RC, 2010, ACTA ORTHOP TRAUMATO, V44, P250, DOI 10.3944/AOTT.2010.2174; Lee DW, 2011, J EUR ACAD DERMATOL, V25, P1392, DOI 10.1111/j.1468-3083.2011.03979.x; Schiefer TK, 2006, MAYO CLIN PROC, V81, P1337; MATLOUB HS, 1992, J HAND SURG-AM, V17A, P472, DOI 10.1016/0363-5023(92)90353-Q; Leger Marie, 2010, Dermatol Online J, V16, P11; Tomak Y, 2003, J SHOULDER ELB SURG, V12, P401, DOI 10.1016/S1058-2746(02)00029-0	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	AUG	2015	40	6					700	702		10.1111/ced.12609		3	Dermatology	Dermatology	CN1RP	WOS:000358198100025		
J	Korekawa, A; Nakano, H; Aizu, T; Kitamura, H; Harada, K; Sawamura, D				Korekawa, A.; Nakano, H.; Aizu, T.; Kitamura, H.; Harada, K.; Sawamura, D.			A reddish, pedunculated, granulomatous nodule on the nasal dorsum	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Editorial Material							APOCRINE HIDROCYSTOMA; CYSTADENOMA		[Korekawa, A.; Nakano, H.; Aizu, T.; Sawamura, D.] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori 0368562, Japan; [Kitamura, H.; Harada, K.] Aomori Prefectural Cent Hosp, Dept Dermatol, Aomori, Japan	Sawamura, D (reprint author), Hirosaki Univ, Grad Sch Med, Dept Dermatol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	m981027@cc.hirosaki-u.ac.jp					Lopez V, 2013, INT J DERMATOL, V52, P502, DOI 10.1111/j.1365-4632.2011.04893.x; MEHREGAN AH, 1964, ARCH DERMATOL, V90, P274; Robinson AR, 1893, J CUTAN GENITO UR DI, V11, P293; Sugiyama A, 2007, J CUTAN PATHOL, V34, P912, DOI 10.1111/j.1600-0560.2007.00757.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	AUG	2015	40	6					703	705		10.1111/ced.12613		3	Dermatology	Dermatology	CN1RP	WOS:000358198100026		
J	Hatano, M; Matsumoto, Y; Fukushi, J; Matsunobu, T; Endo, M; Okada, S; Iura, K; Kamura, S; Fujiwara, T; Iida, K; Fujiwara, Y; Nabeshima, A; Yokoyama, N; Fukushima, S; Oda, Y; Iwamoto, Y				Hatano, Mihoko; Matsumoto, Yoshihiro; Fukushi, Jun-ichi; Matsunobu, Tomoya; Endo, Makoto; Okada, Seiji; Iura, Kunio; Kamura, Satoshi; Fujiwara, Toshifumi; Iida, Keiichiro; Fujiwara, Yuko; Nabeshima, Akira; Yokoyama, Nobuhiko; Fukushima, Suguru; Oda, Yoshinao; Iwamoto, Yukihide			Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						Ewing sarcoma; Cadherin-11; Bone metastasis; Osteoblasts; Adhesion molecule; Chemokinesis	SARCOMA/PRIMITIVE NEUROECTODERMAL TUMOR; PROSTATE-CANCER METASTASIS; CHILDRENS-ONCOLOGY-GROUP; THERAPEUTIC IMPLICATIONS; GROWTH-FACTOR; MICROENVIRONMENT; EXPRESSION; OSTEOBLASTS; ADHESION; INVASION	Ewing sarcoma (ES) is a small round-cell tumor of the bones and soft tissues. ES frequently causes distant metastases, particularly in the lung and bone, which worsens patient prognosis. Cadherin-11 (Cad-11) is an adhesion molecule that is highly expressed in osteoblasts. Its expression is associated with bone metastases in prostate and breast cancer patients, and is known to occur in ES. Here we investigated the effects of Cad-11 on bone metastases of ES. Human ES cell lines RD-ES, SK-ES-1, SK-N-MC, and TC-71 cells were transduced with lentivirus containing Cad-11 shRNA or control shRNA (ES/Cad-11 and ES/Ctr). RD-ES and TC-71 were infected with a lentivirus luciferase vector. Adhesion assays were performed using these cells and recombinant Cad-11-Fc chimera or mouse osteoblast cell line MC3T3-E1. Cell motility was investigated via wound-healing assay. Intracardiac injection of RD-ES/Cad-11 and RD-ES/Ctr was used to create a mouse model of experimental bone metastasis. The association between Cad-11 expression and bone metastases and clinical prognosis in ES patients was analyzed by immunohistochemistry. We found knockdown of Cad-11 in ES cells resulted in reduced attachment ability and cell motility. In a mouse model of metastasis, RD-ES/Cad-11 cells caused fewer metastases than RD-ES/Ctr cells. The expression of Cad-11 in ES patients was significantly related to bone metastases (P < 0.05, logistic regression) and poorer overall survival (P < 0.05, log-rank test). These findings may explain that Cad-11 in ES cells may be essential for cell adhesion and motility, and is a promising molecular target for patients with ES.	[Hatano, Mihoko; Matsumoto, Yoshihiro; Fukushi, Jun-ichi; Matsunobu, Tomoya; Endo, Makoto; Okada, Seiji; Kamura, Satoshi; Fujiwara, Toshifumi; Iida, Keiichiro; Fujiwara, Yuko; Nabeshima, Akira; Yokoyama, Nobuhiko; Fukushima, Suguru; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Higashi Ku, Fukuoka 8128582, Japan; [Iura, Kunio; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan	Matsumoto, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ymatsu@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [25293325]; Ministry of Health, Labor and Welfare of Japan	We thank Dr. Junji Kishimoto for the helpful suggestions on statistics. This work was supported by a Grant-in-Aid for Scientific Research (25293325) from the Japan Society for the Promotion of Science (Y. Iwamoto), and a Grant-in-Aid for Clinical Research Evidence-Based Medicine and Cancer Research from the Ministry of Health, Labor and Welfare of Japan (Y. Iwamoto).	Burchill SA, 2003, J CLIN PATHOL, V56, P96, DOI 10.1136/jcp.56.2.96; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Zhang YF, 2010, CANCER LETT, V292, P1, DOI 10.1016/j.canlet.2009.11.003; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Iwamoto Y, 2007, JPN J CLIN ONCOL, V37, P79, DOI 10.1093/jjco/hyl142; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Tomita K, 2000, CANCER RES, V60, P3650; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Fujiwara-Okada Y, 2013, BRIT J CANCER, V108, P836, DOI 10.1038/bjc.2012.579; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Tamura D, 2008, INT J ONCOL, V33, P17; Mbalaviele G, 2006, J BONE MINER RES, V21, P1821, DOI 10.1359/JBMR.060811; Adamowicz M, 2006, GENE CHROMOSOME CANC, V45, P829, DOI 10.1002/gcc.20343; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Yoneda T, 2005, BIOCHEM BIOPH RES CO, V328, P679, DOI 10.1016/j.bbrc.2004.11.070; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Angst BD, 2001, J CELL SCI, V114, P629; Guan H, 2008, MOL CANCER THER, V7, P1807, DOI 10.1158/1535-7163.MCT-08-0058; Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633; Yagi T, 2000, GENE DEV, V14, P1169; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Bernstein ML, 2006, J CLIN ONCOL, V24, P152, DOI 10.1200/JCO.2005.02.1717; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Chung LWK, 2003, CANCER, V97, P772, DOI 10.1002/cncr.11140; Deng Z, 2013, BIOMED RES INT, V2013; Feltes CM, 2002, CANCER RES, V62, P6688; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Franzius C, 2006, EUR J NUCL MED MOL I, V33, P1432, DOI 10.1007/s00259-006-0106-6; Iida K, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-21; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260; Lee YC, 2013, MOL CANCER RES, V11, P1401, DOI 10.1158/1541-7786.MCR-13-0108; Lee YC, 2010, J PATHOL, V221, P68, DOI 10.1002/path.2687; Li Yong, 2011, Genes Cancer, V2, P880, DOI 10.1177/1947601911433129; Miser JS, 2007, PEDIATR BLOOD CANCER, V49, P894, DOI 10.1002/pbc.21233; Ohali A, 2004, ONCOGENE, V23, P8997, DOI 10.1038/sj.onc.1208060; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; Pinkerton CR, 2001, EUR J CANCER, V37, P1338, DOI 10.1016/S0959-8049(01)00131-9; Pishvaian MJ, 1999, CANCER RES, V59, P947; Satcher RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089880; Schulte JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070962; TAKEICHI M, 1987, SEIKAGAKU, V59, P1; Tantivejkul K, 2004, J CELL BIOCHEM, V91, P706, DOI 10.1002/jcb.10664; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Warde Nick, 2011, Nat Rev Rheumatol, V7, P374, DOI 10.1038/nrrheum.2011.85	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	AUG	2015	32	6					579	591		10.1007/s10585-015-9729-y		13	Oncology	Oncology	CN2KL	WOS:000358249700006		
J	Nakagawa, H; Kusuyama, T; Ogawa, K				Nakagawa, H.; Kusuyama, T.; Ogawa, K.			Primary oropharyngeal herpes simplex virus infection in adults: a profile of thirty-two immunoserologically confirmed cases	CLINICAL OTOLARYNGOLOGY			English	Letter									[Nakagawa, H.] Seibo Int Catholic Hosp, Dept Otolaryngol, Tokyo 1618521, Japan; [Kusuyama, T.] Tokyo Voice Clin, Tokyo, Japan; [Ogawa, K.] Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan	Nakagawa, H (reprint author), Seibo Int Catholic Hosp, Dept Otolaryngol, Shinjuku Ku, 2-5-1 Nakaochiai, Tokyo 1618521, Japan.	hnakagawa@seibokai.or.jp					COREY L, 1986, NEW ENGL J MED, V314, P749, DOI 10.1056/NEJM198603203141205; Friedman HM, 2006, J CLIN VIROL, V35, P103, DOI 10.1016/j.jcv.2005.03.008; Greenberg M. S, 2003, BURKETS ORAL MED DIA, V10th, P50; Hwang Y. S., 1999, HERPES, V6, P16; Klapper P. E., 2004, PRINCIPLES PRACTICE, P27, DOI 10.1002/0470020970.ch2A; KLOTZ DA, 1974, GASTROINTEST ENDOSC, V20, P71; Marcon Mario J., 1997, Clinical Microbiology Newsletter, V19, P9, DOI 10.1016/S0196-4399(97)84243-2; POU A, 1995, AM J OTOLARYNG, V16, P216, DOI 10.1016/0196-0709(95)90108-6; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; Stoopler Eric T, 2003, Dent Clin North Am, V47, P517, DOI 10.1016/S0011-8532(03)00018-1	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1749-4478	1749-4486		CLIN OTOLARYNGOL	Clin. Otolaryngol.	AUG	2015	40	4					393	396		10.1111/coa.12394		4	Otorhinolaryngology	Otorhinolaryngology	CN0DU	WOS:000358084400016		
J	Mookiah, MRK; Acharya, UR; Fujita, H; Koh, JEW; Tan, JH; Noronha, K; Bhandary, SV; Chua, CK; Lim, CM; Laude, A; Tong, L				Mookiah, Muthu Rama Krishnan; Acharya, U. Rajendra; Fujita, Hamido; Koh, Joel E. W.; Tan, Jen Hong; Noronha, Kevin; Bhandary, Sulatha V.; Chua, Chua Kuang; Lim, Choo Min; Laude, Augustinus; Tong, Louis			Local configuration pattern features for age-related macular degeneration characterization and classification	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Retina; Age-related macular degeneration; Fundus imaging; Local configuration pattern; Support vector machine	RETINAL FUNDUS IMAGES; ADAPTIVE HISTOGRAM EQUALIZATION; DIABETIC-RETINOPATHY; AUTOMATIC DETECTION; DRUSEN DETECTION; SEGMENTATION; DIAGNOSIS; EXTRACTION; DISEASE; RECOGNITION	Age-related Macular Degeneration (AMD) is an irreversible and chronic medical condition characterized by drusen, Choroidal Neovascularization (CNV) and Geographic Atrophy (GA). AMD is one of the major causes of visual loss among elderly people. It is caused by the degeneration of cells in the macula which is responsible for central vision. AMD can be dry or wet type, however dry AMD is most common. It is classified into early, intermediate and late AMD. The early detection and treatment may help one to stop the progression of the disease. Automated AMD diagnosis may reduce the screening time of the clinicians. In this work, we have introduced LCP to characterize normal and AMD classes using fundus images. Linear Configuration Coefficients (CC) and Pattern Occurrence (PO) features are extracted from fundus images. These extracted features are ranked using p-value of the t-test and fed to various supervised classifiers viz. Decision Tree (DT), Nearest Neighbour (k-NN), Naive Bayes (NB), Probabilistic Neural Network (PNN) and Support Vector Machine (SVM) to classify normal and AMD classes. The performance of the system is evaluated using both private (Kasturba Medical Hospital, Manipal, India) and public domain datasets viz. Automated Retinal Image Analysis (ARIA) and STructured Analysis of the Retina (STARE) using ten-fold cross validation. The proposed approach yielded best performance with a highest average accuracy of 97.78%, sensitivity of 98.00% and specificity of 97.50% for STARE dataset using 22 significant features. Hence, this system can be used as an aiding tool to the clinicians during mass eye screening programs to diagnose AMD. (C) 2015 Elsevier Ltd. All rights reserved.	[Mookiah, Muthu Rama Krishnan; Acharya, U. Rajendra; Koh, Joel E. W.; Tan, Jen Hong; Chua, Chua Kuang] Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore; [Acharya, U. Rajendra] SIM Univ, Sch Sci & Technol, Dept Biomed Engn, Singapore 599491, Singapore; [Acharya, U. Rajendra] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Fujita, Hamido] Iwate Prefectural Univ, Fac Software & Informat Sci, Takizawa, Iwate 0200693, Japan; [Noronha, Kevin] St Francis Inst Technol, Dept Elect & Telecommun, Bombay 400103, Maharashtra, India; [Bhandary, Sulatha V.] Kasturba Med Coll & Hosp, Dept Ophthalmol, Manipal 576104, Karnataka, India; [Lim, Choo Min] Ngee Ann Polytech, Sch Engn, Singapore 599489, Singapore; [Laude, Augustinus] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Tong, Louis] Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore 168751, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Tong, Louis] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Mookiah, MRK (reprint author), Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore.	mkm2@np.edu.sg	Engineering, Faculty /I-7935-2015	Engineering, Faculty /0000-0002-4848-7052	Social Innovation Research Fund (SIRF) [T1202]	Authors thank Social Innovation Research Fund (SIRF/Project Code: T1202), Singapore for providing grant for this research. Also authors would like to acknowledge Head of Department and all staff members of Department of Ophthalmology, Kasturba Medical College, Manipal, India for sharing the images for this study.	Age Related Eye Disease Study Group, 2001, AM J OPHTHALMOL, V132, P668; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Burlina P, 2011, IEEE ENG MED BIO, P3962, DOI 10.1109/IEMBS.2011.6090984; Haleem MS, 2013, COMPUT MED IMAG GRAP, V37, P581, DOI 10.1016/j.compmedimag.2013.09.005; Zheng YL, 2012, INVEST OPHTH VIS SCI, V53, P8310, DOI 10.1167/iovs.12-9576; Cheng J, 2012, IEEE IMAGE PROC, P2805; Mookiah MRK, 2014, MED BIOL ENG COMPUT, V52, P781, DOI 10.1007/s11517-014-1180-8; Tomar D, 2015, KNOWL-BASED SYST, V81, P131, DOI 10.1016/j.knosys.2015.02.009; Chowriappa P, 2013, COMPUT BIOL MED, V43, P2156, DOI 10.1016/j.compbiomed.2013.10.003; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Brandon L, 2003, LECT NOTES COMPUT SC, V2878, P618; Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485; Niemeijer M, 2007, INVEST OPHTH VIS SCI, V48, P2260, DOI 10.1167/iovs.06-0996; Kose C, 2010, J MED SYST, V34, P1, DOI 10.1007/s10916-008-9210-4; Ramlugun GS, 2012, EXPERT SYST APPL, V39, P1141, DOI 10.1016/j.eswa.2011.07.115; Agurto C, 2011, INVEST OPHTH VIS SCI, V52, P5862, DOI 10.1167/iovs.10-7075; Soliz P, 2008, 2008 IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS & INTERPRETATION, P65, DOI 10.1109/SSIAI.2008.4512286; Raffei AFM, 2015, KNOWL-BASED SYST, V74, P40, DOI 10.1016/j.knosys.2014.11.002; Bartlett H, 2007, SURV OPHTHALMOL, V52, P655, DOI 10.1016/.j.survophthal.2007.08.022; Lam L, 1997, IEEE T SYST MAN CY A, V27, P553, DOI 10.1109/3468.618255; Mookiah MRK, 2013, KNOWL-BASED SYST, V39, P9, DOI 10.1016/j.knosys.2012.09.008; Antal B, 2012, IEEE T BIO-MED ENG, V59, P1720, DOI 10.1109/TBME.2012.2193126; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Kose C, 2008, COMPUT BIOL MED, V38, P611, DOI 10.1016/j.compbiomed.2008.02.008; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Liang ZY, 2010, IEEE ENG MED BIO, P4100; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Hijazi MHA, 2012, KNOWL-BASED SYST, V29, P83, DOI 10.1016/j.knosys.2011.07.002; Ben Sbeh Z, 2001, IEEE T MED IMAGING, V20, P1321, DOI 10.1109/42.974927; Freund DE, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P61, DOI 10.1109/ISBI.2009.5192983; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Bock R, 2010, MED IMAGE ANAL, V14, P471, DOI 10.1016/j.media.2009.12.006; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Barriga E.S., 2009, 22 IEEE INT S COMP B, P1; Bhuiyan A., 2014, J COMPUT SCI SYST BI, V7; Cunningham P., 2007, MULTIPLE CLASSIFIER, P1; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Duda R. O., 2012, PATTERN CLASSIFICATI; Galar M, 2015, KNOWL-BASED SYST, V81, P76, DOI 10.1016/j.knosys.2015.02.008; Gun AM, 2008, FUNDAMENTALS STAT, VI; Guo Y., 2011, BMVC CIT, P1; Gutierrez-Rodriguez AE, 2015, KNOWL-BASED SYST, V82, P70, DOI 10.1016/j.knosys.2015.02.019; Hijazi M.H.A., 2015, INT J SIMUL SYST SCI, P57; Hijazi M.H.A., 2010, IEEE INT JOINT C NEU, P3501; Kohavi R, 1995, INT JOINT CONF ARTIF, V14, P1137, DOI DOI 10.1067/M0D.2000.109031; Kwak JT, 2015, EXPERT SYST APPL, V42, P4529, DOI 10.1016/j.eswa.2015.01.055; Mookiah MRK, 2014, COMPUT BIOL MED, V53, P55, DOI 10.1016/j.compbiomed.2014.07.015; Mookiah MRK, 2013, J MECH MED BIOL, V13; Mora AD, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-59; Normando E.M., 2013, DRUG DISCOV TODAY TH, V10, pe35; Rapantzikos K., 2003, MED IMAGE ANAL, V7, P95; Santos-Villalobos H, 2011, IEEE ENG MED BIO, P6236, DOI 10.1109/IEMBS.2011.6091540; Singh Kesar, BOOTSTRAP STAT UNPUB; Vapnik V.N., 1998, STAT LEARNING THEORY, V1; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; You WJ, 2014, KNOWL-BASED SYST, V55, P15, DOI 10.1016/j.knosys.2013.10.004; Zarbin M., 2008, SURV OPHTHALMOL, V53; Zhao MB, 2015, KNOWL-BASED SYST, V76, P148, DOI 10.1016/j.knosys.2014.12.014; Zuiderveld K., 1994, GRAPHICS GEMS, P474	61	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	AUG 1	2015	63						208	218		10.1016/j.compbiomed.2015.05.019		11	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CN2RJ	WOS:000358269300023		
J	Pham, TD				Pham, Tuan D.			'Current Informatics and Technology in Biology and Medicine'	COMPUTERS IN BIOLOGY AND MEDICINE			English	Editorial Material									Univ Aizu, Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima 9658580, Japan	Pham, TD (reprint author), Univ Aizu, Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima 9658580, Japan.	tdpham@u-aizu.ac.jp						0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	AUG 1	2015	63						228	228		10.1016/j.compbiomed.2015.06.010		1	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CN2RJ	WOS:000358269300025		
J	Zheng, Y; Wei, DM; Zhu, X; Chen, WX; Fukuda, K; Shimokawa, H				Zheng, Yi; Wei, Daming; Zhu, Xin; Chen, Wenxi; Fukuda, Koji; Shimokawa, Hiroaki			Ventricular fibrillation mechanisms and cardiac restitutions: An investigation by simulation study on whole-heart model	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Ventricular fibrillation; Action potential duration restitution; Conduction velocity restitution; Computer simulation; Whole-heart model	ACTION-POTENTIAL DURATION; PROBABILISTIC CELLULAR-AUTOMATA; SPATIAL DYNAMICS SIMULATION; MYOPATHIC HUMAN HEARTS; COMPUTER-SIMULATION; BRUGADA SYNDROME; GLOBAL-ISCHEMIA; MOTHER ROTORS; STIMULATION; REPERFUSION	Background: The action potential duration (APD) and the conduction velocity (CV) restitution have been reported to be important in the maintenance and conversion of ventricular fibrillation (VF), whose mechanisms remain poorly understood. Multiple-wavelet and/or mother-rotor have been regarded as the main VF mechanisms, and APD restitution (APDR) and CV restitution (CVR) properties are involved in the mutual conversion or transition between VF and ventricular tachycardia (VT). Methods and results: The effects of APDR (both its slope and heterogeneity) and CVR on VF organization and conversion were examined using a "rule-based" whole-heart model. The results showed that different organizations of simulated VF were manifestations of different restitution configurations. Multiple-wavelet and mother-rotor VF mechanisms could recur in models with steep and heterogeneous APDR, respectively. Suppressing the excitability either decreased or increased the VF complexity under the steep or shallow APDR, respectively. The multiple-wavelet VF changed into a VT in response to a flattening of the APDR, and the VT degenerated into a mother-rotor VF due to the APDR heterogeneity. Conclusions: Our results suggest that the mechanisms of VF are tightly related to cardiac restitution properties. From a viewpoint of the "rule-based" whole-heart model, our work supports the hypothesis that the synergy between APDR and CVR contributes to transitions between multiple-wavelet and mother-rotor mechanisms in the VF. (C) 2014 Elsevier Ltd. All rights reserved.	[Zheng, Yi; Zhu, Xin; Chen, Wenxi] Univ Aizu, Biomed Informat Technol Lab, Aizu Wakamatsu, Fukushima 9658580, Japan; [Wei, Daming; Fukuda, Koji; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan	Wei, DM (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Seiryo Machi 1-1, Sendai, Miyagi 9808574, Japan.	daming.wei@ekgtechnol.com			Japan Society for the Promotion of Science (JSPS) [24500369]	We would like to thank Dr. Osamu Okazaki from the National Center for Global Health and Medicine (Japan) for his precious advice. We also thank Dr. Xiaomei Wu, Dr. Cuiwei Yang, and Dr. Weijia Lu for their valuable assistances to the simulation study. This work is supported in part by the Grant-in-aid for Scientific Research, No. 24500369 Japan Society for the Promotion of Science (JSPS).	Atienza FA, 2005, REV ESP CARDIOL, V58, P41; Kasanuki H, 1997, CIRCULATION, V95, P2277; KOLLER BS, 1995, CIRCULATION, V91, P2378; Ten Tusscher KHWJ, 2007, CIRC RES, V100, pE87, DOI 10.1161/CIRCRESAHA.107.150730; Koller ML, 2005, CIRCULATION, V112, P1542, DOI 10.1161/CIRCULATIONAHA.104.502831; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Masse S, 2009, AM J PHYSIOL-HEART C, V297, pH1984, DOI 10.1152/ajpheart.00101.2009; Tabereaux PB, 2009, HEART RHYTHM, V6, P405, DOI 10.1016/j.hrthm.2008.11.005; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Nash MP, 2006, CIRCULATION, V114, P536, DOI 10.1161/CIRCULATIONAHA.105.602870; Lever NA, 2007, EUROPACE, V9, P1054, DOI 10.1093/europace/eum194; Bandman O, 2002, LECT NOTES COMPUT SC, V2493, P10; Xie FG, 2004, J CLIN INVEST, V113, P686, DOI 10.1172/JCI200417341; Wu TJ, 2004, CIRCULATION, V110, P2110, DOI 10.1161/01.CIR.0000143834.51102.91; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Bradley CP, 2011, CIRC-ARRHYTHMIA ELEC, V4, P684, DOI 10.1161/CIRCEP.110.961284; Ashino S, 2011, CIRC J, V75, P2080, DOI 10.1253/circj.CJ-11-0227; Bandman O, 2003, LECT NOTES COMPUT SC, V2763, P20; Bandman OL, 2005, FUTURE GENER COMP SY, V21, P633, DOI 10.1016/j.future.2004.05.003; Bingen BO, 2013, CARDIOVASC RES, V97, P161, DOI 10.1093/cvr/cvs288; Bueno-Orovio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052234; Cherry E.M., 2011, NONLINEAR DYNAM, V66, P1; Choi BR, 2001, CIRC RES, V89, pE30; Engelstein ED, 1998, HEART ARTERIES VEINS; Huizar J.F., 2007, AM J PHYSIOL-HEART C, V293; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Latcu GD, 2011, J INTERV CARD ELECTR, V30, P199, DOI 10.1007/s10840-010-9541-1; Li L, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1192, DOI 10.1161/CIRCEP.113.000459; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Nishiyama A, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.054003; Ryzhii E, 2009, J ELECTROCARDIOL, V42, P319, DOI [10.1016/j.jelectrocard.2008.12.015, 10.1016/j.jelcctrocard.2008.12.015]; Salama G, 2007, J ELECTROCARDIOL, V40, pS56, DOI 10.1016/j.jelectrocard.2007.06.021; Samie FH, 2001, CARDIOVASC RES, V50, P242, DOI 10.1016/S0008-6363(00)00289-3; Selvaraj R.J., 2007, AM J PHYSIOL-HEART C, V292, pH1262; Spector PS, 2012, EUROPACE, V14, pV106, DOI 10.1093/europace/eus278; Viskin S., 2008, ELECT DIS HEART GENE, P588, DOI 10.1007/978-1-84628-854-8_41; WEI DM, 1995, IEEE T BIO-MED ENG, V42, P343; Wei DM, 1997, PROG BIOPHYS MOL BIO, V67, P17, DOI 10.1016/S0079-6107(97)00012-6; Weiss JN, 1999, CIRCULATION, V99, P2819; Wu TJ, 2002, CIRCULATION, V106, P1859, DOI 10.1161/01.CIR.0000031334.49170.FB; Zemlin CW, 2001, PHYS REV E, V63; Zhu X, 2012, PACE, V35, P718, DOI 10.1111/j.1540-8159.2012.03379.x	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	AUG 1	2015	63						261	268		10.1016/j.compbiomed.2014.06.014		8	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CN2RJ	WOS:000358269300029		
J	Igarashi, A; Kamiya, K; Kobashi, H; Shimizu, K				Igarashi, Akihito; Kamiya, Kazutaka; Kobashi, Hidenaga; Shimizu, Kimiya			Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery	CORNEA			English	Article						tear film; optical quality; objective scattering index; rebamipide	IN-SITU KERATOMILEUSIS; NEUROTROPHIC EPITHELIOPATHY; SODIUM HYALURONATE; TEAR-FILM; OCULAR SURFACE; MYOPIC LASIK; RISK-FACTORS; MULTICENTER; INCREASES; DENSITY	Purpose:To assess the changes in intraocular scattering before and after instillation of rebamipide ophthalmic suspension in patients with dry eye after corneal refractive surgery.Methods:This study enrolled 60 eyes of 30 dry eye patients undergoing corneal refractive surgery. Patients were randomly assigned to start topical administration of rebamipide ophthalmic suspension (rebamipide group) or artificial tears (control group) 4 times daily for 4 weeks. Tear secretion, tear break-up time (TBUT), and the fluorescein score were measured before and after treatment. Intraocular light scattering was also measured as the objective scattering index (OSI) at 0.5-second intervals over 10 seconds.Results:In the rebamipide group, the Schirmer I test, TBUT, and fluorescein score improved significantly, from 11.4 9.0 mm, 2.2 +/- 0.7 seconds, and 4.3 +/- 1.3 to 14.9 +/- 7.4 mm, 4.5 +/- 1.7 seconds, and 1.9 +/- 1.0, respectively (P = 0.006, P < 0.001, P < 0.001, Wilcoxon signed rank test). We found significant improvements in OSI at 5.0 to 10.0 seconds after blinking (5-8 seconds, P = 0.01; 9 seconds, P = 0.02; 10 seconds, P < 0.001). The mean OSI, the OSI change rate, and the OSI slope of the linear regression line improved significantly, from 2.73 +/- 1.52, 74.7 +/- 69.5%, and 0.10 +/- 0.12 to 2.19 +/- 1.19, 28.6 +/- 48.7%, and 0.04 +/- 0.08, respectively (P = 0.02, 0.003, and 0.03).Conclusions:Rebamipide ophthalmic suspension was effective for improving both ocular surface parameters and optical quality in patients with dry eye undergoing corneal refractive surgery, suggesting that it may hold promise for the treatment of such patients.	[Igarashi, Akihito; Kamiya, Kazutaka; Kobashi, Hidenaga; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 2520374, Japan	Igarashi, A (reprint author), Kitasato Univ, Sch Med, Dept Ophthalmol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	iki0478@yahool.co.jp					Lee SJ, 2006, AM J OPHTHALMOL, V141, P1009, DOI 10.1016/j.ajo.2006.01.048; De Paiva CS, 2004, AM J OPHTHALMOL, V137, P109, DOI 10.1016/S0002-9394(03)00897-3; De Paiva CS, 2006, AM J OPHTHALMOL, V141, P438, DOI 10.1016/j.ajo.2005.10.006; Lee JB, 2000, J CATARACT REFR SURG, V26, P1326, DOI 10.1016/S0886-3350(00)00566-6; Benito A, 2011, J CATARACT REFR SURG, V37, P1481, DOI 10.1016/j.jcrs.2011.03.036; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; Stachs O, 2010, J REFRACT SURG, V26, P159, DOI 10.3928/1081597X-20100224-01; Ambrosio R, 2008, J REFRACT SURG, V24, P396; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Urashima H, 2004, CORNEA, V23, P613, DOI 10.1097/01.ico.0000126436.25751.fb; Kamiya K, 2012, EYE, V26, P1363, DOI 10.1038/eye.2012.166; Kinoshita S, 2013, OPHTHALMOLOGY, V120, P1158, DOI 10.1016/j.ophtha.2012.12.022; Urashima H, 2012, J OCUL PHARMACOL TH, V28, P264, DOI 10.1089/jop.2011.0147; Savini G, 2004, J REFRACT SURG, V20, P803; Albietz JM, 2002, J REFRACT SURG, V18, P113; Takeji Y, 2012, J OCUL PHARMACOL TH, V28, P259, DOI 10.1089/jop.2011.0142; Kinoshita S, 2014, AM J OPHTHALMOL, V157, P576, DOI 10.1016/j.ajo.2013.11.010; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; Linna TU, 2000, INVEST OPHTH VIS SCI, V41, P393; Llovet F, 2010, OPHTHALMOLOGY, V117, P232, DOI 10.1016/j.ophtha.2009.07.011; Wilson SE, 2001, OPHTHALMOLOGY, V108, P1082, DOI 10.1016/S0161-6420(01)00587-5; Bigham M, 2005, J CATARACT REFR SURG, V31, P2340, DOI 10.1016/j.jcrs.2005.05.033; Bissada NK, 1976, PROSPECTIVE STUDY UR, V7, P70; Davies JB, 2008, OPHTHAL SURG LAS IM, V39, P221; Diaz-Valle D, 2012, J CATARACT REFR SURG, V38, P1192, DOI 10.1016/j.jcrs.2012.02.040; Kobashi H, 2014, J CATARACT REFR SURG, V40, P2019, DOI 10.1016/j.jcrs.2014.03.028; Kobashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082427; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Rodriguez-Prats JL, 2007, J REFRACT SURG, V23, P559; Sambursky R, 2011, CURR OPIN OPHTHALMOL, V22, P294, DOI 10.1097/ICU.0b013e32834787bb; Shimazaki J., 2007, J EYE, V24, P181; SHIMMURA S, 1995, BRIT J OPHTHALMOL, V79, P1007, DOI 10.1136/bjo.79.11.1007; Shoja MR, 2007, EUR J OPHTHALMOL, V17, P1; Tanaka M, 2004, J CATARACT REFR SURG, V30, P2311, DOI 10.1016/j.jcrs.2004.02.086	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	AUG	2015	34	8					895	900		10.1097/ICO.0000000000000456		6	Ophthalmology	Ophthalmology	CN1XO	WOS:000358214300009		
J	Shiohara, T; Mizukawa, Y; Aoyama, Y				Shiohara, Tetsuo; Mizukawa, Yoshiko; Aoyama, Yumi			Monitoring the acute response in severe hypersensitivity reactions to drugs	CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY			English	Review							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; SOLUBLE FAS LIGAND; T-CELLS; ERUPTIONS; INTERLEUKIN-10; SKIN; PATHOGENESIS; GRANULYSIN; INFECTION	Purpose of review Severe adverse drug reactions (ADRs) including Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) are acute life-threatening conditions. There is the urgent need for reliable, noninvasive and standardized laboratory tests for identifying patients at higher risk of developing severe ADRs. Recent findings Although previous studies demonstrated the pathogenic role of TNF-alpha, IFN-gamma, IL-10, perforin/granzyme B, Fas L and granulysin in the development of severe ADRs, there have been no biomarkers predicting progression to severe ADRs. We, therefore, measured serum levels of cytokines/chemokines as well as other biological markers in patients who presented with clinical symptoms suggestive of ADRs at their initial presentation. The results show that sFas L represents a useful early biomarker that can predict the subsequent progression to TEN, but not SJS, particularly when combined with the increase in IL-6 and IP-10. The increased levels of IL-6 and IP-10 are reliable biomarkers predictive of the progression to severe ADRs, such as SJS/TEN and DiHS/DRESS. The use of a combination of several early biomarkers, although not sufficiently sensitive or specific on its own when used alone, could increase the diagnostic and prognostic utility for the prediction of severe ADRs.	[Shiohara, Tetsuo; Mizukawa, Yoshiko] Kyorin Univ, Sch Med, Dept Dermatol, Mitaka, Tokyo 1818611, Japan; [Shiohara, Tetsuo] Kyorin Univ, Sch Med, Div Flow Cytometry, Mitaka, Tokyo 1818611, Japan; [Aoyama, Yumi] Kawasaki Med Univ, Kawasaki Hosp, Dept Dermatol, Okayama, Japan	Shiohara, T (reprint author), Kyorin Univ, Sch Med, Dept Dermatol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	tpshio@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (to T.S.) and the Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan (to T.S.).	Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Yang C, 2014, J AM ACAD DERMATOL, V70, P1096, DOI 10.1016/j.jaad.2013.12.025; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Murata J, 2008, J ALLERGY CLIN IMMUN, V122, P992, DOI 10.1016/j.jaci.2008.06.013; Castrejon JL, 2010, J ALLERGY CLIN IMMUN, V125, P411, DOI 10.1016/j.jaci.2009.10.031; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Correia O, 2002, J AM ACAD DERMATOL, V47, P58, DOI 10.1067/mjd.2002.120473; Wolkenstein P, 1998, LANCET, V352, P1586, DOI 10.1016/S0140-6736(98)02197-7; Abe R, 2003, AM J PATHOL, V162, P1515, DOI 10.1016/S0002-9440(10)64284-8; Depta JPH, 2004, J ALLERGY CLIN IMMUN, V113, P519, DOI 10.1016/j.jaci.2003.11.030; Caproni M, 2006, BRIT J DERMATOL, V154, P1006, DOI 10.1111/j.1365-2133.2006.07211.x; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Polak ME, 2013, BRIT J DERMATOL, V168, P539, DOI 10.1111/bjd.12109; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Shiohara T, 2009, CURR OPIN ALLERGY CL, V9, P316, DOI 10.1097/ACI.0b013e32832cda4c; Posadas SJ, 2002, J ALLERGY CLIN IMMUN, V109, P155, DOI 10.1067/mai.2002.120563; Shiohara T, 2012, CHEM IMMUNOL ALLERGY, V97, P106, DOI 10.1159/000335623; Brahimi N, 2010, EUR J DERMATOL, V20, P461, DOI 10.1684/ejd.2010.0980; Breathnach S M, 1995, Australas J Dermatol, V36, P187, DOI 10.1111/j.1440-0960.1995.tb00970.x; KAUPPINEN K, 1991, CLEV CLIN J MED, V58, P64; Lipowicz S, 2013, BRIT J DERMATOL, V168, P726, DOI 10.1111/bjd.12133; Mizukawa Y, 2010, CLIN EXP DERMATOL, V35, P493, DOI 10.1111/j.1365-2230.2009.03622.x; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Saito N, 2012, BRIT J DERMATOL, V167, P452, DOI 10.1111/j.1365-2133.2012.10921.x; Shiohara Tetsuo, 2014, Current Immunology Reviews, V10, P41, DOI 10.2174/1573395510666140616234723; Stur K, 2007, J INVEST DERMATOL, V127, P802, DOI 10.1038/sj.jid.5700648; Teraki Y, 2013, J ALLERGY CLIN IMMUN, V131, P907, DOI 10.1016/j.jaci.2012.08.042; Yoon SY, 2013, J ALLERGY CLIN IMMUN, V132, P981, DOI 10.1016/j.jaci.2013.04.038	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1528-4050	1473-6322		CURR OPIN ALLERGY CL	Curr. Opin. Allergy Clin. Immunol.	AUG	2015	15	4					294	299		10.1097/ACI.0000000000000180		6	Allergy; Immunology	Allergy; Immunology	CN1GJ	WOS:000358166200004		
J	Itoh, M; Pickart, RS; Kikuchi, T; Fukamachi, Y; Ohshima, KI; Simizu, D; Arrigo, KR; Vagle, S; He, JF; Ashjian, C; Mathis, JT; Nishino, S; Nobre, C				Itoh, Motoyo; Pickart, Robert S.; Kikuchi, Takashi; Fukamachi, Yasushi; Ohshima, Kay I.; Simizu, Daisuke; Arrigo, Kevin R.; Vagle, Svein; He, Jianfeng; Ashjian, Carin; Mathis, Jeremy T.; Nishino, Shigeto; Nobre, Carolina			Water properties, heat and volume fluxes of Pacific water in Barrow Canyon during summer 2010	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						Polar oceanography; Arctic Ocean; Chukchi Sea; Heat fluxes; Volume transports; Water properties	CHUKCHI SEA SHELF; ARCTIC-OCEAN; FLOW; TRANSPORT; DYNAMICS; BASIN; ICE; TEMPERATURE; VARIABILITY; CIRCULATION	Over the past few decades, sea ice retreat during summer has been enhanced in the Pacific sector of the Arctic basin, likely due in part to increasing summertime heat flux of Pacific-origin water from the Bering Strait. Barrow Canyon, in the northeast Chukchi Sea, is a major conduit through which the Pacific-origin water enters the Arctic basin. This paper presents results from 6 repeat high-resolution shipboard hydrographic/velocity sections occupied across Barrow Canyon in summer 2010. The different Pacific water masses feeding the canyon - Alaskan coastal water (ACW), summer Bering Sea water (BSW), and Pacific winter water (PWW) - all displayed significant intra-seasonal variability. Net volume transports through the canyon were between 0.96 and 1.70 Sv poleward, consisting of 0.41-0.98 Sv of warm Pacific water (ACW and BSW) and 0.28-0.65 Sv of PWW. The poleward heat flux also varied strongly, ranging from 8.56 TW to 24.56 TW, mainly due to the change in temperature of the warm Pacific water. Using supplemental mooring data from the core of the warm water, along with wind data from the Pt. Barrow weather station, we derive and assess a proxy for estimating heat flux in the canyon for the summer time period, which is when most of the heat passes northward towards the basin. The average heat flux for 2010 was estimated to be 3.34 TW, which is as large as the previous record maximum in 2007. This amount of heat could melt 315,000 km(2) of 1-meter thick ice, which likely contributed to significant summer sea ice retreat in the Pacific sector of the Arctic Ocean. (C) 2015 The Authors. Published by Elsevier Ltd.	[Itoh, Motoyo; Kikuchi, Takashi; Nishino, Shigeto] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Pickart, Robert S.; Ashjian, Carin; Nobre, Carolina] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Fukamachi, Yasushi; Ohshima, Kay I.; Simizu, Daisuke] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Simizu, Daisuke] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Arrigo, Kevin R.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Vagle, Svein] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada; [He, Jianfeng] Polar Res Inst China, Shanghai, Peoples R China; [Mathis, Jeremy T.] NOAA Pacific Marine Lab, Seattle, WA 98115 USA	Itoh, M (reprint author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	motoyo@jamstec.go.jp			Green Network of Excellence Program (GRENE Program); US National Science Foundation [ARC-1203906, ARC-1023331, PLR-1041102]; Department of Fisheries and Oceans Canada; Japan Agency for Marine-Earth Science and Technology; Joint Research Program of the Institute of Low Temperature Science, Hokkaido University [2014-23]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20221001]; Cooperative Institute for the North Atlantic Region (NOAA) [NA09OAR4320129]; US National Oceanographic and Atmospheric Administration; Arctic Climate Change Research Project 'Rapid Change of the Arctic Climate System and its Global Influences' by Ministry of Education, Culture, Sports, Science and Technology Japan	We are greatly indebted to the officers and crew of the USCGC Healy, CCGS Sir Wilfrid Laurier, R/V Xue Long, R/V Annika Marie and R/V Mimi, and the scientists and technicians who collected the data. We sincerely thank Jackie Grebmeier, the lead investigator of the DBO program. Thanks are extended to Hajo Eicken, Andy Mahoney, the Barrow Arctic Consortium, UMIAQ and the North Slope Borough Department of Wildlife Management for the mooring observations. Comments by Stephen Oldconen and two anonymous reviewers were very helpful for improving the manuscript. MI and TK thank William J. Williams and Andrey Proshutinsky who were the lead investigators of the CCGS Louis S St-Laurent cruise. CA thanks Robert G. Campbell and Stephen Oldconen, co-principal investigators of the project associated with the R/V Annika Marie cruise. MI acknowledges Amane Fujiwara for the MODIS SST processing. MI, RP, and CA are indebted to Frank Bahr for processing the shipboard ADCP data. MI and SN acknowledge Michio Aoyama for processing the nutrient data associated with the R/V Mimi cruise. MI, TIC, YE KO and DS were supported by Green Network of Excellence Program (GRENE Program), Arctic Climate Change Research Project 'Rapid Change of the Arctic Climate System and its Global Influences' by Ministry of Education, Culture, Sports, Science and Technology Japan. RP was supported by grant ARC-1203906 from the US National Science Foundation. CA was supported by grant ARC-1023331 from the US National Science Foundation and by the Cooperative Institute for the North Atlantic Region (NOAA Cooperative Agreement NA09OAR4320129) with funds provided by the US National Oceanographic and Atmospheric Administration through an Interagency Agreement between the US Bureau of Ocean and Energy Management and the National Marine Mammal Laboratory. SV was supported by the Department of Fisheries and Oceans Canada. MI and TIC were supported by the Japan Agency for Marine-Earth Science and Technology. MI, TM, YF and KO were supported by Grant no. 2014-23 from Joint Research Program of the Institute of Low Temperature Science, Hokkaido University. YF and KO were supported by grants-in-aid 20221001 for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. JTM was supported by grant PLR-1041102 from the US National Science Foundation.	AAGAARD K, 1990, J GEOPHYS RES-OCEANS, V95, P18163, DOI 10.1029/JC095iC10p18163; Aagaard K., 1989, J GEOPHYS RES, V94, P485, DOI DOI 10.1029/JC094IC10P14485; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Kawaguchi Y, 2012, DEEP-SEA RES PT I, V66, P90, DOI 10.1016/j.dsr.2012.04.006; Pickart RS, 2013, DEEP-SEA RES PT I, V76, P35, DOI 10.1016/j.dsr.2013.01.007; Watanabe E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006259; Codispoti LA, 2005, DEEP-SEA RES PT II, V52, P3199, DOI 10.1016/j.dsr2.2005.10.007; DAVIS RE, 1976, J PHYS OCEANOGR, V6, P249, DOI 10.1175/1520-0485(1976)006<0249:POSSTA>2.0.CO;2; Yamamoto-Kawai M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003858; Pickart RS, 2010, DEEP-SEA RES PT II, V57, P5, DOI 10.1016/j.dsr2.2009.08.002; Mordy CW, 2010, MAR CHEM, V121, P157, DOI 10.1016/j.marchem.2010.04.004; Pickart RS, 2005, DEEP-SEA RES PT II, V52, P3175, DOI 10.1016/j.dsr2.2005.10.009; Shroyer EL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007650; Weingartner T, 2013, CONT SHELF RES, V67, P5, DOI 10.1016/j.csr.2013.03.012; Pickart RS, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001912; Watanabe E, 2009, J PHYS OCEANOGR, V39, P2194, DOI 10.1175/2009JPO4010.1; Nikolopoulos A, 2009, DEEP-SEA RES PT II, V56, P1164, DOI 10.1016/j.dsr2.2008.10.014; Munchow A, 1997, J PHYS OCEANOGR, V27, P1402, DOI 10.1175/1520-0485(1997)027<1402:SFADON>2.0.CO;2; Iwamoto K, 2014, J GEOPHYS RES-OCEANS, V119, P3574, DOI 10.1002/2013JC009749; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; von Appen WJ, 2012, J PHYS OCEANOGR, V42, P329, DOI 10.1175/JPO-D-11-026.1; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; Weingartner TJ, 1998, J GEOPHYS RES-OCEANS, V103, P7647, DOI 10.1029/98JC00374; Woodgate RA, 2005, DEEP-SEA RES PT II, V52, P3116, DOI 10.1016/j.dsr2.2005.10.016; PAQUETTE RG, 1974, J MAR RES, V32, P195; Spall MA, 2008, J PHYS OCEANOGR, V38, P1644, DOI 10.1175/2007JPO3829.1; Weingartner T, 2005, DEEP-SEA RES PT II, V52, P3150, DOI 10.1016/j.dsr2.2005.10.015; Aoyama M., 2010, COMP NUTR WORLDS OCE, P1; ARMSTRON.FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; Barwell-Clarke J., 1996, CAN TECH REP HYDROGR, V182, P43; Brugler E., 2014, PROG OCEANOGR; CAVALIERI DJ, 1994, J GEOPHYS RES-OCEANS, V99, P18343, DOI 10.1029/94JC01169; Coachman L.K., 1975, BERING STRAIT REGION, P172; Emery W., 1997, DATA ANAL METHODS PH, P638; Gong D., 2015, DEEP SEA 2 IN PRESS; Gordon LI., 1995, WOCE HYDROGRAPHIC PR; Hydes D. M., 2010, ICPO PUBLICATION SER, V134; Itoh M., 2010, MR1005 JAMSTECH; Itoh M, 2013, J GEOPHYS RES-OCEANS, V118, P4363, DOI 10.1002/jgrc.20290; Itoh M., 2012, J OCEANOGR; Mills MM, 2015, DEEP-SEA RES PT II, V118, P105, DOI 10.1016/j.dsr2.2015.02.007; Nakayama Y, 2012, J PHYS OCEANOGR, V42, P179, DOI 10.1175/JPO-D-11-018.1; Nishino S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047885; Nishino S, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2003JC002118; Okkonen S.R., 2009, J GEOPHYS RES OCEANS, V114; Perovich D., 2007, GEOPHYS RES LETT, V34; Perovich D., 2008, GEOPHYS RES LETT, V35; Roach A., 1996, J GEOPHYS RES, V100, pC9; Sato K., 2010, COMP NUTR WORLDS OCE, P43; Shimada K, 2001, GEOPHYS RES LETT, V28, P3441, DOI 10.1029/2001GL013168; Signorini SR, 1997, J GEOPHYS RES-OCEANS, V102, P18661, DOI 10.1029/97JC00739; Steele M., 2004, J GEOPHYS RES, V109; Von Storch H, 1999, STAT ANAL CLIMATE RE, P484; Wang J., 2009, J GEOPHYS RES, V114; Williams J.W., 2010, JOINT OCEAN ICE STUD; Woodgate RA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054092; Woodgate RA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026931	57	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	AUG	2015	102						43	54		10.1016/j.dsr.2015.04.004		12	Oceanography	Oceanography	CN1MP	WOS:000358184400004		
J	Satoh, A; Mitogawa, K; Makanae, A				Satoh, Akira; Mitogawa, Kazumasa; Makanae, Aki			Regeneration inducers in limb regeneration	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						accessory limb model; axolotl; blastema; limb regeneration; Xenopus	FIBROBLAST GROWTH-FACTOR; XENOPUS-LAEVIS; AMBYSTOMA-MEXICANUM; PLANARIAN REGENERATION; URODELE AMPHIBIANS; DIGIT REGENERATION; NERVE DEPENDENCE; AXOLOTL; INDUCTION; BLASTEMA	Limb regeneration ability, which can be observed in amphibians, has been investigated as a representative phenomenon of organ regeneration. Recently, an alternative experimental system called the accessory limb model was developed to investigate early regulation of amphibian limb regeneration. The accessory limb model contributed to identification of limb regeneration inducers in urodele amphibians. Furthermore, the accessory limb model may be applied to other species to explore universality of regeneration mechanisms. This review aims to connect the insights recently gained to emboss universality of regeneration mechanisms among species. The defined molecules (BMP7 (or2)+FGF2+FGF8) can transform skin wound healing to organ (limb) regeneration responses. The same molecules can initiate regeneration responses in some species.	[Satoh, Akira; Mitogawa, Kazumasa; Makanae, Aki] Okayama Univ, RCIS, Kita Ku, Okayama 7008530, Japan	Satoh, A (reprint author), Okayama Univ, RCIS, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	satoha@cc.okayama-u.ac.jp	SATOH, Akira/B-2420-2011		 [26711015]	We thank Ms. T. Satoh for much support. This work was supported by Grant-in-Aid for Young Scientists (A) (#26711015 to A.S.).	Abe M, 2012, EUR J DERMATOL, V22, P46, DOI 10.1684/ejd.2011.1582; ALBERT P, 1987, CELL DIFFER DEV, V21, P63, DOI 10.1016/0045-6039(87)90449-0; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Agata K, 2003, DEV DYNAM, V226, P308, DOI 10.1002/dvdy.10249; Ide H, 2012, DEV DYNAM, V241, P435, DOI 10.1002/dvdy.23728; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Satoh A, 2008, DEV GROWTH DIFFER, V50, P743, DOI 10.1111/j.1440-169X.2008.01072.x; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Endo T, 2000, DEV BIOL, V220, P296, DOI 10.1006/dbio.2000.9641; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Endo T, 1997, DEV DYNAM, V209, P227, DOI 10.1002/(SICI)1097-0177(199706)209:2<227::AID-AJA8>3.0.CO;2-K; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Cannata SM, 2001, DEV BIOL, V231, P436, DOI 10.1006/dbio.2001.0161; Yoshino J, 2004, DEV GROWTH DIFFER, V46, P523; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Endo T, 2007, DEV GROWTH DIFFER, V49, P121, DOI 10.1111/j.1440-169x.2007.00914.x; ATHIPPOZHY A, 2014, REGENERATION, V1, P1, DOI DOI 10.1002/REG2.14; BROCKES JP, 1984, SCIENCE, V225, P1280, DOI 10.1126/science.6474177; BROCKES JP, 1986, CELL, V45, P301, DOI 10.1016/0092-8674(86)90394-6; Denis J.F., 2013, ADV WOUND CARE NEW R, V2, P250; Dungan KM, 2002, J EXP ZOOL, V292, P540, DOI 10.1002/jez.10104; Endo T., 2015, SALAMANDERS REGENERA, V1290, P101; Globus M, 1988, NEUROMITOGENIC ROLE, P675; Gospodarowicz D, 1980, Ann N Y Acad Sci, V339, P151, DOI 10.1111/j.1749-6632.1980.tb15976.x; Goss R.J., 1969, PRINCIPLES REGENERAT; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Hirata A, 2010, DEV GROWTH DIFFER, V52, P343, DOI 10.1111/j.1440-169X.2009.01165.x; Kostakopoulou K, 1997, INT J DEV BIOL, V41, P747; Makanae A, 2012, ANAT REC, V295, P1566, DOI 10.1002/ar.22529; Makanae A, 2014, DEV BIOL, V396, P57, DOI 10.1016/j.ydbio.2014.09.021; Makanae A, 2013, DEV BIOL, V381, P213, DOI 10.1016/j.ydbio.2013.05.010; Makanae A., 2014, REGENERATION, V1, P1, DOI [10.1002/reg2.16, DOI 10.1002/REG2.16]; Mccusker C., 2015, REGENERATION, V2, P54; Mitogawa K., 2014, REGENERATION, V1, P26, DOI [10.1002/reg2.11, DOI 10.1002/REG2.11]; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Satoh A, 2012, ZOOL SCI, V29, P191, DOI 10.2108/zsj.29.191; Satoh A, 2006, DEV DYNAM, V235, P1065, DOI 10.1002/dvdy.20701; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; TAYLOR GP, 1994, DEV BIOL, V163, P282, DOI 10.1006/dbio.1994.1144; Tonge DA, 2000, NEUROSCIENCE, V100, P201, DOI 10.1016/S0306-4522(00)00255-4; Yokoyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021721; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Zenjari C, 1997, DEV GROWTH DIFFER, V39, P15	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	AUG	2015	57	6					421	429		10.1111/dgd.12230		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CN2GW	WOS:000358239900001		
J	Taniura, H; Tanabe, N; Bando, Y; Arai, N				Taniura, Hideo; Tanabe, Naoya; Bando, Yumi; Arai, Natsumi			Nse1 and Nse4, subunits of the Smc5-Smc6 complex, are involved in Dictyostelium development upon starvation	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						Nse1; Nse3; Nse4; Smc5-Smc6 complex; pdsA; cellular development; Dictyostelium discoideum	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; DNA-REPAIR COMPLEX; DISCOIDEUM; GENE; CELL; MORPHOGENESIS; AGGREGATION; PROMOTERS; PROTEINS; GROWTH	The Smc5-Smc6 complex contains a heterodimeric core of two SMC proteins and non-Smc elements (Nse1-6), and plays an important role in DNA repair. We investigated the functional roles of Nse4 and Nse1 in Dictyostelium discoideum. Nse4 and Nse3 expressed as Flag-tagged fusion proteins were highly enriched in nuclei, while Nse1 was localized in whole cells. Using yeast two-hybrid assays, only the interaction between Nse3 and Nse1 was detected among the combinations. However, all of the interactions among these three proteins were recognized by co-immunoprecipitation assay using cell lysates prepared from the cells expressing green fluorescent protein (GFP)- or Flag-tagged fusion proteins. GFP-tagged Nse1, which localized in whole cells, was translocated to nuclei when co-expressed with Flag-tagged Nse3 or Nse4. RNAi-mediated Nse1 and Nse4 knockdown cells (Nse1 KD and Nse4 KD cells) were generated and found to be more sensitive to UV-induced cell death than control cells. Upon starvation, Nse1 and Nse4 KD cells had increases in the number of smaller fruiting bodies that formed on non-nutrient agar plates or aggregates that formed under submerged culture. We found a reduction in the mRNA level of pdsA, in vegetative and 8h-starved Nse4 KD cells, and pdsA knockdown cells displayed effects similar to Nse4 KD cells. Our results suggest that Nse4 and Nse1 are involved in not only the cellular DNA damage response but also cellular development in D. discoideum.	[Taniura, Hideo; Tanabe, Naoya; Bando, Yumi; Arai, Natsumi] Ritsumeikan Univ, Coll Pharmaceut Sci, Neurochem Lab, Kusatsu, Shiga 5258577, Japan	Taniura, H (reprint author), Ritsumeikan Univ, Coll Pharmaceut Sci, Neurochem Lab, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	hideo@fc.ritsumei.ac.jp					Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; MacLellan WR, 2000, MOL CELL BIOL, V20, P8903, DOI 10.1128/MCB.20.23.8903-8915.2000; FAURE M, 1990, MOL CELL BIOL, V10, P1921; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; DesPiccoli G., 2009, CHROMOSOME RES, V17, P251; FAURE M, 1988, P NATL ACAD SCI USA, V85, P8076, DOI 10.1073/pnas.85.21.8076; Garcia GL, 2009, MOL BIOL CELL, V20, P3295, DOI 10.1091/mbc.E09-03-0223; HALL AL, 1993, DEV BIOL, V157, P73, DOI 10.1006/dbio.1993.1113; Harvey SH, 2004, MOL CELL BIOL, V24, P662, DOI 10.1128/MCB.24.2.662-674.2004; Hudson JJR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017270; Jang W, 2008, J R SOC INTERFACE, V5, pS49, DOI 10.1098/rsif.2008.0067.focus; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; McDonald WH, 2003, J BIOL CHEM, V278, P45460, DOI 10.1074/jbc.M308828200; Sucgang R, 1997, DEV BIOL, V192, P181, DOI 10.1006/dbio.1997.8720; Taniura H, 2006, J BIOL CHEM, V281, P12336, DOI 10.1074/jbc.M512723200; Veltman DM, 2008, J CELL SCI, V121, P120, DOI 10.1242/jcs.015602	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	AUG	2015	57	6					430	443		10.1111/dgd.12223		14	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CN2GW	WOS:000358239900002		
J	Mogi, M; Uji, S; Yokoi, H; Suzuki, T				Mogi, Makoto; Uji, Susumu; Yokoi, Hayato; Suzuki, Tohru			Early development of circadian rhythmicity in the suprachiamatic nuclei and pineal gland of teleost, flounder (Paralichthys olivaeus), embryos	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						circadian rhythm; early development; flounder; pineal gland; suprachiasmatic nucleus	SOLEA-SENEGALENSIS; CLOCK; EXPRESSION; LIGHT; MELATONIN; FISH; PERIOD2; OSCILLATORS; DOPAMINE; TARGETS	Circadian rhythms enable organisms to coordinate multiple physiological processes and behaviors with the earth's rotation. In mammals, the suprachiasmatic nuclei (SCN), the sole master circadian pacemaker, has entrainment mechanisms that set the circadian rhythm to a 24-h cycle with photic signals from retina. In contrast, the zebrafish SCN is not a circadian pacemaker, instead the pineal gland (PG) houses the major circadian oscillator. The SCN of flounder larvae, unlike that of zebrafish, however, expresses per2 with a rhythmicity of daytime/ON and nighttime/OFF. Here, we examined whether the rhythm of per2 expression in the flounder SCN represents the molecular clock. We also examined early development of the circadian rhythmicity in the SCN and PG. Our three major findings were as follows. First, rhythmic per2 expression in the SCN was maintained under 24h dark (DD) conditions, indicating that a molecular clock exists in the flounder SCN. Second, onset of circadian rhythmicity in the SCN preceded that in the PG. Third, both 24h light (LL) and DD conditions deeply affected the development of circadian rhythmicity in the SCN and PG. This is the first report dealing with the early development of circadian rhythmicity in the SCN in fish.	[Mogi, Makoto; Yokoi, Hayato; Suzuki, Tohru] Tohoku Univ, Grad Sch Agr Sci, Lab Marine Life Sci & Genet, Sendai, Miyagi 9818555, Japan; [Uji, Susumu] Fisheries Res Agcy, Natl Res Inst Aquaculture, Farming Biol Div, Watarai, Mie 5160193, Japan	Suzuki, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Marine Life Sci & Genet, Sendai, Miyagi 9818555, Japan.	suzukitr@bios.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22380104, 22780170]	Grant sponsor: Ministry of Education, Culture, Sports, Science and Technology of Japan, grant numbers 22380104 and 22780170.	Martin-Robles AJ, 2012, CHRONOBIOL INT, V29, P1195, DOI 10.3109/07420528.2012.719963; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Noche RR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-7; Mendoza J, 2014, NEUROSCIENCE, V282, P230, DOI 10.1016/j.neuroscience.2014.07.081; Tamai TK, 2005, BIOCHEM SOC T, V33, P962; Martin-Robles AJ, 2012, J COMP PHYSIOL B, V182, P673, DOI 10.1007/s00360-012-0653-z; Boeuf G, 1999, AQUACULTURE, V177, P129, DOI 10.1016/S0044-8486(99)00074-5; Abraham U, 2003, CHRONOBIOL INT, V20, P657, DOI 10.1081/CBI-120022414; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Kurokawa T, 2002, GEN COMP ENDOCR, V126, P30, DOI 10.1006/gcen.2001.7774; Whitmore D, 1998, NAT NEUROSCI, V1, P701; Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Zheng BH, 1999, NATURE, V400, P169; Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Vigh B, 2002, HISTOL HISTOPATHOL, V17, P555; Seron-Ferre M, 2012, MOL CELL ENDOCRINOL, V349, P68, DOI 10.1016/j.mce.2011.07.039; Watanabe N, 2012, GEN COMP ENDOCR, V178, P400, DOI 10.1016/j.ygcen.2012.06.012; Iigo M, 2007, GEN COMP ENDOCR, V154, P91, DOI 10.1016/j.ygcen.2007.06.013; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; NOWAK JZ, 1989, NEUROCHEM INT, V14, P397, DOI 10.1016/0197-0186(89)90027-2; Ben-Moshe Z, 2014, BIOMED RES INT, DOI 10.1155/2014/235781; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; EBIHARA S, 1992, J COMP PHYSIOL A, V171, P63; Frenette E, 2012, VITAM HORM, V89, P1, DOI 10.1016/B978-0-12-394623-2.00001-9; Houdek P, 2015, DEV NEUROBIOL, V75, P131, DOI 10.1002/dneu.22213; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; MINAMI T, 1982, Nippon Suisan Gakkaishi, V48, P1581; Moore HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086176; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pna5.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	AUG	2015	57	6					444	452		10.1111/dgd.12222		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CN2GW	WOS:000358239900003		
J	Matsunaga, E; Nambu, S; Oka, M; Iriki, A				Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Iriki, Atsushi			Complex and dynamic expression of cadherins in the embryonic marmoset cerebral cortex	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						cadherin; embryo; gene expression; marmoset; neocortex	II CLASSIC CADHERINS; DIFFERENTIAL EXPRESSION; COMMON MARMOSET; HUMAN NEOCORTEX; VOCAL SYSTEM; BRAIN; MOUSE; EVOLUTION; PRIMATE; MORPHOGENESIS	Cadherin is a cell adhesion molecule widely expressed in the nervous system. Previously, we analyzed the expression of nine classic cadherins (Cdh4, Cdh6, Cdh7, Cdh8, Cdh9, Cdh10, Cdh11, Cdh12, and Cdh20) and T-cadherin (Cdh13) in the developing postnatal common marmoset (Callithrix jacchus) brain, and found differential expressions between mice and marmosets. In this study, to explore primate-specific cadherin expression at the embryonic stage, we extensively analyzed the expression of these cadherins in the developing embryonic marmoset brain. Each cadherin showed differential spatial and temporal expression and exhibited temporally complicated expression. Furthermore, the expression of some cadherins differed from that in rodent brains, even at the embryonic stage. These results suggest the possibility that the differential expressions of diverse cadherins are involved in primate specific cortical development, from the prenatal to postnatal period.	[Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama 3510198, Japan	Matsunaga, E (reprint author), AbbVie GK, Med, Minato Ku, 3-5-27 Mita, Tokyo 1086302, Japan.	eijimatsunaga@gmail.com			RIKEN; JSPS KAKENHI [25750403]; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Dr Kimie Niimi (RIKEN BSI RRC) for marmoset cesarean section. This research was supported by RIKEN Incentive Research Projects, JSPS KAKENHI Grant number 25750403 (E.M.), and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (to A.I.).	Alfano C, 2013, DEV NEUROBIOL, V73, P411, DOI 10.1002/dneu.22067; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Yamazaki Y, 2011, EXP BRAIN RES, V213, P63, DOI 10.1007/s00221-011-2778-9; Pistorio AL, 2006, J ACOUST SOC AM, V120, P1655, DOI 10.1121/1.2225899; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Hikishima K, 2013, NEUROSCIENCE, V230, P102, DOI 10.1016/j.neuroscience.2012.09.053; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Lefkovics K, 2012, J COMP NEUROL, V520, P1387, DOI 10.1002/cne.22801; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.0.CO;2-I; Kessaris N, 2014, CURR OPIN NEUROBIOL, V26, P79, DOI 10.1016/j.conb.2013.12.012; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457; Etzrodt J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-153; Hoerder-Suabedissen A, 2013, CEREB CORTEX, V23, P1473, DOI 10.1093/cercor/bhs137; Inoue T, 2001, DEVELOPMENT, V128, P561; Ju MJ, 2004, NEUROSCIENCE, V128, P785, DOI 10.1016/j.neuroscience.2004.06.063; Krishna K., 2009, CEREB CORTEX, V19, P388, DOI 10.1093/cercor/bhn090; Krubitzer LA, 2012, P NATL ACAD SCI USA, V109, P10647, DOI 10.1073/pnas.1201891109; Kuwako K, 2014, CELL REP, V9, P311, DOI 10.1016/j.celrep.2014.08.063; LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Matsunaga E, 2013, J COMP NEUROL, V521, P4027, DOI 10.1002/cne.23389; Matsunaga E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025272; Matsunaga E, 2011, NEUROREPORT, V22, P629, DOI 10.1097/WNR.0b013e3283491665; Matsunaga E, 2014, CURR OPIN NEUROBIOL, V28, P28, DOI 10.1016/j.conb.2014.06.001; Matsunaga E, 2014, DEV GROWTH DIFFER, V56, P535, DOI 10.1111/dgd.12154; Matsunaga E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00028; Matsunaga E, 2008, J COMP NEUROL, V508, P329, DOI 10.1002/cne.21676; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Neudert F, 2008, J COMP NEUROL, V511, P736, DOI 10.1002/cne.21865; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Takahashi M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-87; Treubert-Zimmermann U, 2002, J NEUROSCI, V22, P7617	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	AUG	2015	57	6					474	483		10.1111/dgd.12228		10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CN2GW	WOS:000358239900006		
J	Matsunaga, E; Nambu, S; Oka, M; Tanaka, M; Taoka, M; Iriki, A				Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Tanaka, Michio; Taoka, Miki; Iriki, Atsushi			Identification of tool use acquisition-associated genes in the primate neocortex	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						gene expression; macaque; microarray; parietal cortex; tool use	F-SPONDIN; CORTICAL CONNECTIONS; OBJECT MANIPULATION; PARIETAL CORTEX; CEREBRAL-CORTEX; NEURAL CREST; BODY SCHEMA; MONKEYS; EXPRESSION; GRAY	Japanese macaques are able to learn how to use rakes to take food after only a few weeks of training. Since tool-use training induced rapid morphological changes in some restricted brain areas, this system will be a good model for studying the neural basis of plasticity in human brains. To examine the mechanisms of tool-use associated brain expansion on the molecular and cellular level, here, we performed comprehensive analysis of gene expressions with microarray. We identified various transcripts showing differential expression between trained and untrained monkeys in the region around the lateral and intraparietal sulci. Among candidates, we focused on genes related to synapse formation and function. Using quantitative reverse transcription-polymerase chain reaction and histochemical analysis, we confirmed at least three genes (ADAM19, SPON2, and WIF1) with statistically different expression levels in neurons and glial cells. Comparative analysis revealed that tool use-associated genes were more obviously expressed in macaque monkeys than marmosets or mice. Thus, our findings suggest that cognitive tasks induce structural changes in the neocortex via gene expression, and that learning-associated genes innately differ with relation to learning ability.	[Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Tanaka, Michio; Taoka, Miki; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama 3510198, Japan	Matsunaga, E (reprint author), AbbVie GK, Med, Minato Ku, 3-5-27 Mita, Tokyo 1086302, Japan.	eijimatsunaga@gmail.com; iriki@brain.riken.jp			JSPS KAKENHI [25750403]; RIKEN; JSPS through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by MEXT of Japan	We thank Mr Keisuke Fukumoto (RIKEN BSI Research Resources Center: RRC) for technical assistance with microarray experiment, RIKEN RRC for DNA sequence analysis and the FANTOM Consortium Core Group for mouse cDNA clone, Drs Akihiro Kawasaki, Chihiro Yokoyama (RIKEN Center for Life Science Technologies) and Dr. Kimie Niimi (RIKEN RRC) for marmoset caesarian section, and Dr. Shigeyoshi Itohara for lab facility. The monkeys used in this study were provided by the National BioResource Project 'Japanese Monkeys' of the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was supported by JSPS KAKENHI Grant number 25750403, and RIKEN Incentive Research Projects (to E.M.), the JSPS through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP) and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the MEXT of Japan (to A.I.). The authors declare no competing financial interests.	Alfandari D, 2009, SEMIN CELL DEV BIOL, V20, P153, DOI 10.1016/j.semcdb.2008.09.006; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; MURRAY EA, 1984, BEHAV BRAIN RES, V11, P67, DOI 10.1016/0166-4328(84)90009-3; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Cipolloni PB, 1999, J COMP NEUROL, V403, P431; Yamazaki Y, 2011, EXP BRAIN RES, V213, P63, DOI 10.1007/s00221-011-2778-9; Hiester BG, 2013, MOL CELL NEUROSCI, V56, P115, DOI 10.1016/j.mcn.2013.04.006; Iriki A, 2012, PHILOS T R SOC B, V367, P10, DOI 10.1098/rstb.2011.0190; Taoka M, 2013, SOMATOSENS MOT RES, V30, P140, DOI 10.3109/08990220.2013.779246; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Li YL, 2009, EMBO J, V28, P286, DOI 10.1038/emboj.2008.288; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; RIDLEY RM, 1976, BRAIN RES, V109, P656, DOI 10.1016/0006-8993(76)90048-2; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Iriki A, 1996, NEUROREPORT, V7, P2325; Hsieh JC, 1999, NATURE, V398, P431; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; CASELLI RJ, 1993, NEUROLOGY, V43, P762; Driemeyer J, 2008, PLOS ONE, V3, P1; Fukazawa T, 2013, NEUROSCI LETT, V545, P29, DOI 10.1016/j.neulet.2013.04.006; Hihara S, 2006, NEUROPSYCHOLOGIA, V44, P2636, DOI 10.1016/j.neuropsychologia.2005.11.020; Iriki A., 2014, SOC NEUR ABST, V93; Ishibashi H, 2002, COGNITIVE BRAIN RES, V14, P3, DOI 10.1016/S0926-6410(02)00056-3; Ishibashi H, 2002, MOL BRAIN RES, V102, P110, DOI 10.1016/S0169-328X(02)00201-2; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kuhn S, 2014, MOL PSYCHIATR, V19, P265, DOI 10.1038/mp.2013.120; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Matsunaga E, 2015, NEUROSCIENCE, V284, P566, DOI 10.1016/j.neuroscience.2014.10.032; Matsunaga E, 2014, DEV GROWTH DIFFER, V56, P535, DOI 10.1111/dgd.12154; Matsunaga E, 2015, DEV GROWTH DIFFER, V57, P200, DOI 10.1111/dgd.12194; Neuner R., 2008, MECH DEVELOP, V126, P240; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Schiffmacher AT, 2014, MOL BIOL CELL, V25, P41, DOI 10.1091/mbc.E13-08-0459; Umemiya T, 1997, DEV BIOL, V186, P165, DOI 10.1006/dbio.1997.8591	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	AUG	2015	57	6					484	495		10.1111/dgd.12227		12	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CN2GW	WOS:000358239900007		
J	Hattori, Y; Hattori, K; Suzuki, T				Hattori, Yuichi; Hattori, Kohshi; Suzuki, Tokiko			Differential Modulation of Cardiac Sympathetic Neural Control and beta-Adrenoceptor-G Protein Signaling Cascade in Rats With Type 1 and Type 2 Diabetes	DIABETES			English	Editorial Material							AUTONOMIC NEUROPATHY; NERVOUS-SYSTEM; EXPRESSION; CARDIOMYOPATHY; MELLITUS; HEARTS		[Hattori, Yuichi; Suzuki, Tokiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 930, Japan; [Hattori, Kohshi] Tokyo Univ Hosp, Anesthesiol & Pain Relief Ctr, Tokyo 113, Japan	Hattori, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 930, Japan.	yhattori@med.u-toyama.ac.jp					AKIYAMA N, 1989, DIABETES, V38, P231, DOI 10.2337/diabetes.38.2.231; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; TOMLINSON KC, 1992, PHARMACOL REV, V44, P103; Thackeray JT, 2011, NUCL MED BIOL, V38, P1059, DOI 10.1016/j.nucmedbio.2011.04.002; Zhu WZ, 2005, CIRC RES, V97, P507, DOI 10.1061/01.RES.0000184615.56822.bd; Daniels A, 2010, ACTA PHYSIOL, V200, P11, DOI 10.1111/j.1748-1716.2010.02102.x; FELDMAN AM, 1993, CIRCULATION, V87, P27; GANDO S, 1993, BRIT J PHARMACOL, V109, P1276; Gando S, 1997, J PHARMACOL EXP THER, V282, P475; GANGULY PK, 1986, CIRC RES, V59, P684; Gerritsen J, 2000, DIABETOLOGIA, V43, P561, DOI 10.1007/s001250051344; Kaul CL, 1999, CLIN EXP HYPERTENS, V21, P95, DOI 10.3109/10641969909068653; Lahaye SL, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-72; Matsuda N, 2000, N-S ARCH PHARMACOL, V361, P53, DOI 10.1007/s002109900169; Matsuda N, 1999, BIOCHEM PHARMACOL, V58, P881, DOI 10.1016/S0006-2952(99)00164-1; Pencic-Popovic B, 2014, VOJNOSANIT PREGL, V71, P1109, DOI 10.2298/VSP1412109P; Schmidt RE, 2003, AM J PATHOL, V163, P21, DOI 10.1016/S0002-9440(10)63626-7; Thaung HPA, 2015, DIABETES, V64, P2944, DOI 10.2337/db14-0955; WICHELHAUS A, 1994, AM J PHYSIOL, V267, pH548	20	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	AUG	2015	64	8					2708	2710		10.2337/db15-0503		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CN8EL	WOS:000358671300007		
J	Kato, Y; Iwata, T; Morikawa, S; Yamato, M; Okano, T; Uchigata, Y				Kato, Yuka; Iwata, Takanori; Morikawa, Shunichi; Yamato, Masayuki; Okano, Teruo; Uchigata, Yasuko			Allogeneic Transplantation of an Adipose-Derived Stem Cell Sheet Combined With Artificial Skin Accelerates Wound Healing in a Rat Wound Model of Type 2 Diabetes and Obesity	DIABETES			English	Article							FIBROBLAST-GROWTH-FACTOR; STROMAL CELLS; BONE-MARROW; IN-VIVO; POSTNATAL NEOVASCULARIZATION; STEM/STROMAL CELLS; ENDOTHELIAL-CELLS; BLOOD-VESSELS; FOOT ULCERS; TISSUE	One of the most common complications of diabetes is diabetic foot ulcer. Diabetic ulcers do not heal easily due to diabetic neuropathy and reduced blood flow, and nonhealing ulcers may progress to gangrene, which necessitates amputation of the patient's foot. This study attempted to develop a new cell-based therapy for nonhealing diabetic ulcers using a full-thickness skin defect in a rat model of type 2 diabetes and obesity. Allogeneic adipose-derived stem cells (ASCs) were harvested from the inguinal fat of normal rats, and ASC sheets were created using cell sheet technology and transplanted into full-thickness skin defects in Zucker diabetic fatty rats. The results indicate that the transplantation of ASC sheets combined with artificial skin accelerated wound healing and vascularization, with significant differences observed 2 weeks after treatment. The ASC sheets secreted large amounts of several angiogenic growth factors in vitro, and transplanted ASCs were observed in perivascular regions and incorporated into the newly constructed vessel structures in vivo. These results suggest that ASC sheets accelerate wound healing both directly and indirectly in this diabetic wound-healing model. In conclusion, allogeneic ASC sheets exhibit potential as a new therapeutic strategy for the treatment of diabetic ulcers.	[Kato, Yuka; Uchigata, Yasuko] Tokyo Womens Med Univ, Sch Med, Diabet Ctr, Tokyo, Japan; [Kato, Yuka; Iwata, Takanori; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Morikawa, Shunichi] Tokyo Womens Med Univ, Sch Med, Dept Anat & Dev Biol, Tokyo, Japan	Okano, T (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan.	iwata.takanori@twmu.ac.jp; tokano@twmu.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems CSTEC from the MEXT, Japan	This study was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems "Cell Sheet Tissue Engineering Center (CSTEC)" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Aguiree F., 2013, IDF DIABETES ATLAS; Lin YC, 2013, ACTA BIOMATER, V9, P5243, DOI 10.1016/j.actbio.2012.09.028; Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x; Ali MM, 2014, CHEM SOC REV, V43, P3324, DOI 10.1039/c3cs60439j; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; Szoke K, 2012, STEM CELL TRANSL MED, V1, P658, DOI 10.5966/sctm.2012-0069; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Felder JM, 2012, PLAST RECONSTR SURG, V130, P145, DOI 10.1097/PRS.0b013e318254b1ea; Greenhalgh DG, 2003, CLIN PLAST SURG, V30, P37, DOI 10.1016/S0094-1298(02)00066-4; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; O'Loughlin A, 2013, DIABETES, V62, P2588, DOI 10.2337/db12-1822; RICHARD JL, 1995, DIABETES CARE, V18, P64, DOI 10.2337/diacare.18.1.64; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Trottier V, 2008, STEM CELLS, V26, P2713, DOI 10.1634/stemcells.2008-0031; MATSUDA K, 1993, BIOMATERIALS, V14, P1030, DOI 10.1016/0142-9612(93)90197-A; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cerqueira MT, 2013, BIOMACROMOLECULES, V14, P3997, DOI 10.1021/bm4011062; Briscoe DM, 1999, TRANSPLANTATION, V67, P1590, DOI 10.1097/00007890-199906270-00014; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Priya SG, 2008, TISSUE ENG PT B-REV, V14, P105, DOI 10.1089/teb.2007.0318; Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x; Kuhlmann J, 2003, DIABETES, V52, P138, DOI 10.2337/diabetes.52.1.138; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Oltman CL, 2005, AM J PHYSIOL-ENDOC M, V289, pE113, DOI 10.1152/ajpendo.00594.2004; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Morikawa S, 2011, HISTOL HISTOPATHOL, V26, P979; Greaves NS, 2013, WOUND REPAIR REGEN, V21, P194, DOI 10.1111/wrr.12029; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; SUZUKI S, 1990, BRIT J PLAST SURG, V43, P47, DOI 10.1016/0007-1226(90)90044-Z; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Blumberg SN, 2012, DIABETES RES CLIN PR, V96, P1, DOI 10.1016/j.diabres.2011.10.032; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Cianfarani F, 2013, WOUND REPAIR REGEN, V21, P545, DOI 10.1111/wrr.12051; Coppey LJ, 2002, DIABETES METAB RES, V18, P49, DOI 10.1002/dmrr.257; Da Silva ML, 2008, STEM CELLS, V26, P2287, DOI DOI 10.1634/STEMCELLS.2007-1122; Frykberg Robert G, 2006, J Foot Ankle Surg, V45, pS1, DOI 10.1016/S1067-2516(07)60001-5; Iwata T, 2015, J TISSUE ENG REGEN M, V9, P343, DOI 10.1002/term.1785; Kim BM, 1999, BRIT J PLAST SURG, V52, P573, DOI 10.1054/bjps.1999.3162; Koga Y, 2007, J SURG RES, V137, P30, DOI 10.1016/j.jss.2006.05.041; McLaughlin MM, 2013, ORGANOGENESIS, V9, P79, DOI 10.4161/org.24946; MORSE A, 1945, J DENT RES, V24, P143, DOI 10.1177/00220345450240030501; Slavkovsky R, 2011, WOUND REPAIR REGEN, V19, P515, DOI 10.1111/j.1524-475X.2011.00703.x; Watanabe N, 2013, HUM GENE THER, V24, P283, DOI 10.1089/hum.2012.162; Xing LY, 2011, OBES SURG, V21, P1937, DOI 10.1007/s11695-011-0377-2; Zuk P., 2013, REGENERATIVE MED TIS	60	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	AUG	2015	64	8					2723	2734		10.2337/db14-1133		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CN8EL	WOS:000358671300012		
J	Sato, S; Saisho, Y; Inaishi, J; Kou, KS; Murakami, R; Yamada, T; Itoh, H				Sato, Seiji; Saisho, Yoshifumi; Inaishi, Jun; Kou, Kinsei; Murakami, Rie; Yamada, Taketo; Itoh, Hiroshi			Effects of Glucocorticoid Treatment on beta- and alpha-Cell Mass in Japanese Adults With and Without Diabetes	DIABETES			English	Article							INSULIN SENSITIVITY; HEALTHY HUMANS; DNA-DAMAGE; ISLET; PREDNISOLONE; MECHANISM; EXPANSION; PROLIFERATION; CARBOHYDRATE; REGENERATION	The aim of this study was 1) to clarify beta-cell regenerative capacity in the face of glucocorticoid (GC)-induced insulin resistance and 2) to clarify the change in beta- and alpha-cell mass in GC-induced diabetes in humans. We obtained the pancreases from 100 Japanese autopsy case subjects. The case subjects were classified according to whether or not they had received GC therapy before death and the presence or absence of diabetes. Fractional beta-cell area (%BCA) and alpha-cell area (%ACA) were quantified, and the relationship with GC therapy was evaluated. As a result, in case subjects without diabetes, there was no significant difference in %BCA between case subjects with and without GC therapy (1.66 +/- 1.05% vs. 1.21 +/- 0.59%, P = 0.13). %ACA was also not significantly different between the two groups. In case subjects with type 2 diabetes, %BCA and %ACA were both significantly reduced compared with control subjects without diabetes; however, neither %BCA nor %ACA was significantly decreased in case subjects with GC-induced diabetes. There was a significant negative correlation between %BCA and HbA(1c) measured before death; however, this relationship was attenuated in case subjects with GC therapy. In conclusion, the current study suggests that beta- and alpha-cell mass remain largely unchanged in the face of GC-induced insulin resistance in Japanese individuals, implying limited capacity of beta-cell regeneration in adult humans. The absence of apparent beta-cell deficit in case subjects with GC-induced diabetes suggests that GC-induced diabetes is mainly caused by insulin resistance and/or beta-cell dysfunction, but not necessarily a deficit of beta-cell mass.	[Sato, Seiji; Saisho, Yoshifumi; Inaishi, Jun; Kou, Kinsei; Murakami, Rie; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan	Saisho, Y (reprint author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	ysaisho@keio.jp			Nateglinide Memorial Toyoshima Research and Education Fund; Daiwa Securities Health Foundation; Japan Diabetes Foundation; Keio Gijuku Academic Development Funds	This study was supported by funding from the Nateglinide Memorial Toyoshima Research and Education Fund, the Daiwa Securities Health Foundation, the Japan Diabetes Foundation, and Keio Gijuku Academic Development Funds (Y.S.).	Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Wolffenbuttel BHR, 2013, DIABETES CARE, V36, P2931, DOI 10.2337/dc12-2711; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; MULLER WA, 1970, NEW ENGL J MED, V283, P109, DOI 10.1056/NEJM197007162830301; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; GURWITZ JH, 1994, ARCH INTERN MED, V154, P97, DOI 10.1001/archinte.154.1.97; Mizukami H, 2014, DIABETES CARE, V37, P1966, DOI 10.2337/dc13-2018; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034; van Raalte DH, 2011, DIABETOLOGIA, V54, P2103, DOI 10.1007/s00125-011-2174-9; Rafacho A, 2011, HORM METAB RES, V43, P275, DOI 10.1055/s-0030-1269896; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Gregg BE, 2012, J CLIN ENDOCR METAB, V97, P3197, DOI 10.1210/jc.2012-1206; MCMAHON M, 1988, DIABETES METAB REV, V4, P17; TAPPY L, 1994, J CLIN ENDOCR METAB, V79, P1063, DOI 10.1210/jc.79.4.1063; Petersons CJ, 2013, DIABETES CARE, V36, P2822, DOI 10.2337/dc12-2617; Sacks DB, 2013, DIABETES, V62, P41, DOI 10.2337/db12-1485; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Fardet L, 2011, RHEUMATOLOGY, V50, P1982, DOI 10.1093/rheumatology/ker017; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Saisho Y, 2015, WORLD J DIABETES, V6, P109, DOI 10.4239/wjd.v6.i1.109; Caballero F, 2014, CELL TRANSPLANT, V23, P139, DOI 10.3727/096368912X659916; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; Giles JT, 2015, ARTHRITIS RHEUMATOL, V67, P626, DOI 10.1002/art.38986; Hansen KB, 2012, J CLIN ENDOCR METAB, V97, P1363, DOI 10.1210/jc.2011-2594; Henriksen JE, 1997, DIABETOLOGIA, V40, P1439; Hsu WC, 2012, DIABETES CARE, V35, P1189, DOI 10.2337/dc12-0212; Jörns Anne, 2010, Pancreas, V39, P1167, DOI 10.1097/MPA.0b013e3181dfce4f; Kilimnik G, 2011, PLOS ONE, V6; Kou K, 2014, J CLIN ENDOCR METAB, V99, P1733, DOI 10.1210/jc.2013-3731; Kou K, 2013, J CLIN ENDOCR METAB, V98, P3724, DOI 10.1210/jc.2013-1373; Larsson H, 1999, DIABETOLOGIA, V42, P936, DOI 10.1007/s001250051251; Linssen MML, 2011, CELL SIGNAL, V23, P1708, DOI 10.1016/j.cellsig.2011.06.002; Rafacho A, 2009, AM J PHYSIOL-ENDOC M, V296, pE681, DOI 10.1152/ajpendo.90931.2008; Sullivan BA, 2015, DIABETES, V64, P1698; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Yoneda S, 2013, J Clin Endocrinol Metab, V98, P2053, DOI 10.1210/jc.2012-3832	46	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	AUG	2015	64	8					2915	2927		10.2337/db15-0151		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CN8EL	WOS:000358671300029		
J	Matsubara, T; Araki, M; Abe, H; Ueda, O; Jishage, K; Mima, A; Goto, C; Tominaga, T; Kinosaki, M; Kishi, S; Nagai, K; Iehara, N; Fukushima, N; Kita, T; Arai, H; Doi, T				Matsubara, Takeshi; Araki, Makoto; Abe, Hideharu; Ueda, Otoya; Jishage, Kou-ichi; Mima, Akira; Goto, Chisato; Tominaga, Tatsuya; Kinosaki, Masahiko; Kishi, Seiji; Nagai, Kojiro; Iehara, Noriyuki; Fukushima, Naoshi; Kita, Toru; Arai, Hidenori; Doi, Toshio			Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy	DIABETES			English	Article							GROWTH-FACTOR-BETA; MESANGIAL CELLS; TGF-BETA; MOUSE; GENE; ACTIVATION; EXPRESSION; RECEPTOR; MICE; EXPANSION	Diabetic nephropathy is the leading cause of end-stage renal disease. It is pathologically characterized by the accumulation of extracellular matrix in the mesangium, of which the main component is alpha 1/alpha 2 type IV collagen (Col4a1/a2). Recently, we identified Smad1 as a direct regulator of Col4a1/a2 under diabetic conditions in vitro. Here, we demonstrate that Smad1 plays a key role in diabetic nephropathy through bone morphogenetic protein 4 (BMP4) in vivo. Smad1-overexpressing mice (Smad1-Tg) were established, and diabetes was induced by streptozotocin. Nondiabetic Smad1-Tg did not exhibit histological changes in the kidney; however, the induction of diabetes resulted in an similar to 1.5-fold greater mesangial expansion, consistent with an increase in glomerular phosphorylated Smad1. To address regulatory factors of Smad1, we determined that BMP4 and its receptor are increased in diabetic glomeruli and that diabetic Smad1-Tg and wild-type mice treated with a BMP4-neutralizing antibody exhibit decreased Smad1 phosphorylation and similar to 40% less mesangial expansion than those treated with control IgG. Furthermore, heterozygous Smad1 knockout mice exhibit attenuated mesangial expansion in the diabetic condition. The data indicate that BMP4/Smad1 signaling is a critical cascade for the progression of mesangial expansion and that blocking this signal could be a novel therapeutic strategy for diabetic nephropathy.	[Matsubara, Takeshi; Araki, Makoto; Iehara, Noriyuki] Kyoto Univ, Dept Nephrol, Kyoto, Japan; [Abe, Hideharu; Mima, Akira; Tominaga, Tatsuya; Kishi, Seiji; Nagai, Kojiro; Doi, Toshio] Univ Tokushima, Dept Nephrol, Tokushima 770, Japan; [Ueda, Otoya; Jishage, Kou-ichi; Kinosaki, Masahiko; Fukushima, Naoshi] Chugai Pharmaceut Co Ltd, Shizuoka, Japan; [Goto, Chisato] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [Kita, Toru] Kobe City Med Ctr Gen Hosp, Kyoto, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Aichi, Japan	Matsubara, T (reprint author), Kyoto Univ, Dept Nephrol, Kyoto, Japan.	mtake@kuhp.kyoto-u.ac.jp; abeabe@clin.med.tokushima-u.ac.jp			Kidney Foundation of Japan [JKFB09-41]; Takeda Science Foundation;  [21790808];  [21591033];  [25461221]	This study was supported by Grants-in-Aid for Young Scientists (B) (21790808), Grants-in-Aid for Scientific Research (21591033), Grants-in-Aid for Scientific Research (C) (25461221), the Kidney Foundation of Japan (JKFB09-41), and Takeda Science Foundation.	Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; Anderson GJ, 2008, NAT CHEM BIOL, V4, P15, DOI 10.1038/nchembio0108-15; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Tanaka M, 2010, J CLIN INVEST, V120, P768, DOI 10.1172/JCI39569; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; CHAVERS BM, 1989, NEW ENGL J MED, V320, P966, DOI 10.1056/NEJM198904133201503; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Dudley AT, 1997, DEV DYNAM, V208, P349; LIU F, 1995, MOL CELL BIOL, V15, P3479; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Wang SN, 2004, J BIOL CHEM, V279, P23200, DOI 10.1074/jbc.M311998200; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Fogo AB, 1999, EXP NEPHROL, V7, P147; Huang SX, 2000, GENE, V258, P43, DOI 10.1016/S0378-1119(00)00396-6; Huang SX, 2002, GENESIS, V32, P76, DOI 10.1002/gene.10059; Kishi S, 2011, J BIOL CHEM, V286, P32162, DOI 10.1074/jbc.M111.244541; Mima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017929; Miyata T, 2002, J CLIN INVEST, V109, P585, DOI 10.1172/JCI200214336; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Ohashi S, 2004, J BIOL CHEM, V279, P19816, DOI 10.1074/jbc.M310428200; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Striker G E, 1970, Hum Pathol, V1, P615, DOI 10.1016/S0046-8177(70)80060-0; STRIKER LJ, 1991, LAB INVEST, V64, P446; Suganami Takayoshi, 2005, FASEB J, V19, P127; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	42	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	AUG	2015	64	8					2978	2990		10.2337/db14-0893		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CN8EL	WOS:000358671300035		
J	Nishimura, R; Osonoi, T; Kanada, S; Jinnouchi, H; Sugio, K; Omiya, H; Ubukata, M; Sakai, S; Samukawa, Y				Nishimura, R.; Osonoi, T.; Kanada, S.; Jinnouchi, H.; Sugio, K.; Omiya, H.; Ubukata, M.; Sakai, S.; Samukawa, Y.			Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study	DIABETES OBESITY & METABOLISM			English	Article						24-h glucose variability; continuous glucose monitoring; luseogliflozin; SGLT2 inhibitor; type 2 diabetes	SGLT2 INHIBITOR; PHASE-II; MONOTHERAPY; EFFICACY; 12-WEEK; SAFETY; TS-071; POTENT	The aim of the present study was to determine the effects of luseogliflozin on 24-h glucose levels, assessed by continuous glucose monitoring, and on pharmacodynamic variables measured throughout the day. In this double-blind, placebo-controlled, crossover study, 37 patients with type 2 diabetes mellitus inadequately controlled with diet and exercise were randomized into two groups. Patients in each group first received luseogliflozin then placebo for 7 days each, or vice versa. After 7 days of treatment, the mean 24-h glucose level was significantly lower with luseogliflozin than with placebo [mean (95% confidence interval) 145.9 (134.4-157.5) mg/dl vs 168.5 (156.9-180.0) mg/dl; p < 0.001]. The proportion of time spent with glucose levels >= 70 to <= 180 mg/dl was significantly greater with luseogliflozin than with placebo [median (interquartile range) 83.2 (67.7-96.5)% vs 71.9 (46.9-83.3)%; p < 0.001] without inducing hypoglycaemia. The decrease in glucose levels was accompanied by reductions in serum insulin levels throughout the day.	[Nishimura, R.] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Osonoi, T.] Naka Kinen Clin, Ibaraki, Japan; [Kanada, S.] OCROM Clin, Osaka, Japan; [Jinnouchi, H.] Jinnouchi Hosp, Kumamoto, Japan; [Sugio, K.; Omiya, H.; Ubukata, M.; Sakai, S.; Samukawa, Y.] Taisho Pharmaceut Co Ltd, Tokyo 1708633, Japan	Sakai, S (reprint author), Taisho Pharmaceut Co Ltd, Toshima Ku, 3-24-1 Takada, Tokyo 1708633, Japan.	so-sakai@so.taisho.co.jp			Taisho Pharmaceutical Co., Ltd, Tokyo, Japan; Taisho Pharmaceutical Co., Ltd.	This study was supported by Taisho Pharmaceutical Co., Ltd, Tokyo, Japan. The authors wish to thank Nicholas D. Smith, PhD, of Edanz Group Ltd., for providing editorial support, which was funded by Taisho Pharmaceutical Co., Ltd.	Seino Y, 2014, CURR MED RES OPIN, V30, P1245, DOI 10.1185/03007995.2014.912983; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; Yamamoto K, 2011, BRIT J PHARMACOL, V164, P181, DOI 10.1111/j.1476-5381.2011.01340.x; Seino Y, 2014, CURR MED RES OPIN, V30, P1219, DOI 10.1185/03007995.2014.901943; Markham A, 2014, DRUGS, V74, P945, DOI 10.1007/s40265-014-0230-8; Nishimura R, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0169-9; Sasaki T, 2011, DIABETOLOGIA, V54, pS345; Seino Y, 2014, CURR MED RES OPIN, V30, P1231, DOI 10.1185/03007995.2014.909390	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	AUG	2015	17	8					800	804		10.1111/dom.12481		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CN6IL	WOS:000358538200011		
J	Fukasawa, M; Suzuki, Y; Nakajima, S; Asano, K; Narisawa, T; Kim, Y				Fukasawa, Maiko; Suzuki, Yuriko; Nakajima, Satomi; Asano, Keiko; Narisawa, Tomomi; Kim, Yoshiharu			Systematic Consensus Building on Disaster Mental Health Services After the Great East Japan Earthquake by Phase	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						disaster; mental health services; acute period	RANDOMIZED CONTROLLED-TRIAL; SELF-HELP INFORMATION; TRAUMATIC INJURY; STRESS-DISORDER; GUIDELINES; DELPHI	Objective: We intended to build consensus on appropriate disaster mental health services among professionals working in the area affected by the Great East Japan Earthquake. Methods: We focused on the first 3 months after the disaster, divided into 3 phases: immediate aftermath, acute phase, and midphase. We adopted the Delphi process and asked our survey participants (n = 115) to rate the appropriateness of specific mental health services in each phase and comment on them. We repeated this process 3 times, giving participants feedback on the results of the previous round. Through this process, we determined the criterion for positive consensus for each item as having the agreement of more than 80% of the participants. Results: We found that the importance of acute psychiatric care and prescribing regular medication for psychiatric patients gained positive consensus in the immediate aftermath and acute phase. Counseling and psychoeducation after traumatic events or provision of information gained consensus in the acute phase and midphase, and screening of mental distress gained consensus in the midphase. Conclusions: Higher priority was given to continuous psychiatric services in the immediate aftermath and mental health activities in later phases.	[Fukasawa, Maiko; Suzuki, Yuriko; Nakajima, Satomi; Asano, Keiko; Kim, Yoshiharu] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Asano, Keiko] Musashino Univ, Grad Sch, Tokyo, Japan; [Narisawa, Tomomi] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Kodaira, Tokyo 1878553, Japan	Fukasawa, M (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan.	s05fukasawa@ncnp.go.jp			Health and Labour Science Research Grants for Research on Health Security Control and Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare, Japan	This study was funded by Health and Labour Science Research Grants for Research on Health Security Control and Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare, Japan.	Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158; Turpin G, 2005, BRIT J PSYCHIAT, V187, P76, DOI 10.1192/bjp.187.1.76; Bisson JI, 2010, BRIT J PSYCHIAT, V196, P69, DOI 10.1192/bjp.bp.109.066266; Brewin CR, 2010, PSYCHOL MED, V40, P2049, DOI 10.1017/S0033291710000206; Suzuki Y, 2012, EPIDEMIOL PSYCH SCI, V21, P7, DOI 10.1017/S2045796011000795; Fukasawa M, 2013, J TRAUMA STRESS, V26, P201, DOI 10.1002/jts.21787; Kim Y, 2011, PSYCHIAT CLIN NEUROS, V65, P539, DOI 10.1111/j.1440-1819.2011.02270.x; Kim Y, 2003, GUIDELINES LOCAL MEN; Kelly CM, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-49; Linstone H.A., 1975, DELPHI METHOD TECHNI; National Child Traumatic Stress Network and National Center for PTSD, 2006, PSYCHOL 1 FIELD OPER, V2nd; National Information Center of Disaster Mental Health, 2012, REPORT SURVEY KOKORO; Roberts NP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007944.pub2; Scholes C, 2007, BEHAV RES THER, V45, P2527, DOI 10.1016/j.brat.2007.06.009; Suzuki Y, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-7; Te Brake Hans, 2009, Nurs Health Sci, V11, P336, DOI 10.1111/j.1442-2018.2009.00491.x; The European Network for Traumatic Stress (TENTS), 2008, TENTS GUIDELINES PSY; World Health Organization War Trauma Foundation World Vision International, 2011, PSYCHOL 1 AID GUIDE	18	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	AUG	2015	9	4					359	366		10.1017/dmp.2015.13		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN2YY	WOS:000358290600006		
J	Nakaya, N; Nakamura, T; Tsuchiya, N; Tsuji, I; Hozawa, A; Tomita, H				Nakaya, Naoki; Nakamura, Tomohiro; Tsuchiya, Naho; Tsuji, Ichiro; Hozawa, Atsushi; Tomita, Hiroaki			The Association Between Medical Treatment of Physical Diseases and Psychological Distress After the Great East Japan Earthquake: The Shichigahama Health Promotion Project	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						psychological warfare; preventive health services; mental disorders; public health; earthquakes	OHSAKI COHORT 2006; SCREENING SCALES; MENTAL-HEALTH; POPULATION; DEPRESSION; METAANALYSIS; ADULTS; RISK; DISABILITY; DISASTER	Objective: Physical disease patients are known to experience high levels of psychological distress. This study examined the association between the medical treatment of physical diseases and psychological distress in the coastal area affected by the Great East Japan Earthquake. Methods: Using cross-sectional data, we studied 3032 individuals aged >= 40 years who lived in Shichigahama, Miyagi, Japan. We examined the associations between 8 medical treatments for physical diseases and psychological distress, defined as Kessler Psychological Distress scale score >= 13 of 24 points. To investigate the associations, we performed multiple logistic regression analyses. Results: There were statistically significant associations between psychological distress and medical treatments for myocardial infarction/angina pectoris (odds ratio [OR] = 1.8, 95% confidence interval [CI] = 1.0-3.0) and liver disease (OR = 3.1, 95% CI = 1.0-7.7). The other 4 medical treatments for physical diseases had ORs of 1.3 or higher and were positively associated with psychological distress: cancer, hyperlipidemia, kidney disease, and diabetes mellitus. The degree of damage to homes did not affect the association between most of the medical treatments for physical diseases and psychological distress. Conclusions: In the disaster area, most of the medical treatments for physical diseases had positive associations with psychological distress, irrespective of the degree of damage to homes.	[Nakaya, Naoki; Nakamura, Tomohiro; Tsuchiya, Naho; Tsuji, Ichiro; Hozawa, Atsushi; Tomita, Hiroaki] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808573, Japan; [Tomita, Hiroaki] Tohoku Univ, Dept Disaster Psychiat, Int Res Inst Disaster Sci, Sendai, Miyagi 9808573, Japan; [Tsuji, Ichiro] Tohoku Univ Grad Sch Med, Div Epidemiol, Dept Publ Hlth & Forens Med, Sendai, Miyagi, Japan	Nakaya, N (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, 2-1 Seiryo, Sendai, Miyagi 9808573, Japan.	nakaya-thk@umin.ac.jp			Japanese Society for the Promotion of Science (JSPS) [26350863]; Kurokawa Cancer Research Foundation; MEXT Tohoku Medical Megabank Project	This study was supported by grants from the Japanese Society for the Promotion of Science (JSPS) for the Grant-in-Aid for Scientific Research (C) (No. 26350863) and the Grant-in-Aid from the Kurokawa Cancer Research Foundation. This work was supported by the MEXT Tohoku Medical Megabank Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDA RF, 1992, ARCH INTERN MED, V152, P829, DOI 10.1001/archinte.152.4.829; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Oldehinkel Albertine J, 2011, Neurosci Biobehav Rev, V35, P1757, DOI 10.1016/j.neubiorev.2010.10.013; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Jordan HT, 2011, PREV MED, V53, P370, DOI 10.1016/j.ypmed.2011.10.014; Lenze EJ, 2001, AM J GERIAT PSYCHIAT, V9, P113, DOI 10.1176/appi.ajgp.9.2.113; Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873; Hjollund NH, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-12; Dickens C, 2002, PSYCHOSOM MED, V64, P52; Dalton SO, 2009, J CLIN ONCOL, V27, P1440, DOI 10.1200/JCO.2008.20.5526; Aromaa A, 1994, Acta Psychiatr Scand Suppl, V377, P77; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY; Hozawa A, 2009, AM J CLIN NUTR, V90, P1390, DOI 10.3945/ajcn.2009.28214; Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076; Ministry of Health Labour and Welfare, 2007, PATIENTS SURVEY 2005; Ministry of Health Labour and Welfare, 2010, PATIENTS SURVEY 2005; Ministry of Health Labour and Welfare, 2013, PATIENTS SURVEY 2005; Nakaya N, 2014, EUR J PUBLIC HEALTH, V24, P45, DOI 10.1093/eurpub/ckt017; Picavet HSJ, 1997, AM J PUBLIC HEALTH, V87, P1680, DOI 10.2105/AJPH.87.10.1680; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Tayama J, 2012, PSYCHOSOMATICS, V53, P196, DOI 10.1016/j.psym.2011.11.005; WHO, 2004, GLOB BURD DIS 2004 U; Yamanaka K, 2013, WORLD J GASTROENTERO, V19, P7426, DOI 10.3748/wjg.v19.i42.7426	27	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	AUG	2015	9	4					374	381		10.1017/dmp.2015.52		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN2YY	WOS:000358290600008		
J	Shigemura, J; Harada, N; Tanichi, M; Nagamine, M; Shimizu, K; Katsuda, Y; Tokuno, S; Tsumatori, G; Yoshino, A				Shigemura, Jun; Harada, Nahoko; Tanichi, Masaaki; Nagamine, Masanori; Shimizu, Kunio; Katsuda, Yoshiaki; Tokuno, Shinichi; Tsumatori, Gentaro; Yoshino, Aihide			Rumor-Related and Exclusive Behavior Coverage in Internet News Reports Following the 2009 H1N1 Influenza Outbreak in Japan	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						pandemic; risk communication; public behavior; rumor; stigmatization	PUBLIC PERCEPTIONS; EMERGENCIES; RESPONSES; DISASTER; STIGMA	Objective: We sought to elucidate news article reporting of adverse public psychosocial behaviors, in particular, rumor-related coverage (eg, panic, demagoguery) and exclusive behavior coverage (negative behaviors, eg, discrimination, bullying) during the 2009 influenza A (H1N1) influenza pandemic in Japan. Methods: We examined 154 Internet news-site articles reporting adverse public psychosocial responses in the first 60 days of the outbreak. Rumor-related coverage and exclusive behavior coverage were dichotomously coded as included or not. Moreover, we assessed whether or not health information (eg, coping methods, virus toxicity information) or emphasis on information quality (eg, importance of information, cautions about overreactions) were simultaneously reported. Results: Rumor-related coverage (n = 120, 77.9%) was less likely to simultaneously report public health information (eg, toxicity information, health support information, and cautions about overreactions; P < .05). Conversely, exclusive behavior coverage (n = 41, 26.6%) was more likely to report public health information (P < .05). Conclusions: Rumor-related coverage was less likely to have accompanying public health information, whereas exclusive behavior coverage was more likely to include it. During public health crises, it is essential to understand that rumors and exclusive behaviors have adverse effects on the public and that accompanying public health information may help people take proactive coping actions.	[Shigemura, Jun; Tanichi, Masaaki; Yoshino, Aihide] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 3598513, Japan; [Harada, Nahoko] Natl Def Med Coll, Div Nursing, Sch Med, Tokorozawa, Saitama 3598513, Japan; [Harada, Nahoko] Boston Coll, William F Connell Sch Nursing, Chestnut Hill, MA 02167 USA; [Tanichi, Masaaki] Self Def Forces Cent Hosp, Dept Psychiat, Tokyo, Japan; [Nagamine, Masanori; Shimizu, Kunio] Natl Def Med Coll Res Inst, Div Behav Sci, Tokorozawa, Saitama, Japan; [Katsuda, Yoshiaki] Kansai Univ Social Welf, Dept Social Welf, Ako, Japan; [Tokuno, Shinichi; Tsumatori, Gentaro] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama 3598513, Japan	Shigemura, J (reprint author), Natl Def Med Coll, Dept Psychiat, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	shige@ndmc.ac.jp					[Anonymous], 2013 NATL MEDIA CONT; Bromet EJ, 2007, HEALTH PHYS, V93, P516; Harada Nahoko, 2013, Western Pac Surveill Response J, V4, P44, DOI 10.5365/WPSAR.2013.4.2.010; Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123; Mawson AR, 2005, PSYCHIATRY, V68, P95, DOI 10.1521/psyc.2005.68.2.95; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; [Anonymous], 2009, EC IMPACT NOVEL INFL; Barrett R, 2008, J INFECT DIS, V197, pS34, DOI 10.1086/524986; Chan M., 2009, WORLD NOW START 2009; Goodwin R, 2013, J INFECTION, V67, P458, DOI 10.1016/j.jinf.2013.06.014; Kamigaki T, 2009, PLOS CURRENTS, V1; Person B, 2004, EMERG INFECT DIS, V10, P358; Potential damage to the travel industry, 2009, YOMIURI SHIMBUN, P11; Reynolds Barbara, 2008, Health Promot Pract, V9, p13S, DOI 10.1177/1524839908325267; Rubin GJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2651; Shigemura Jun, 2009, Am J Disaster Med, V4, P133; Wada K., 2010, Open Public Health Journal, V3, P13	17	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	AUG	2015	9	4					459	463		10.1017/dmp.2015.57		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN2YY	WOS:000358290600020		
J	Kuniyoshi, K; Sakuramoto, H; Yoshitake, K; Ikeo, K; Furuno, M; Tsunoda, K; Kusaka, S; Shimomura, Y; Iwata, T				Kuniyoshi, Kazuki; Sakuramoto, Hiroyuki; Yoshitake, Kazutoshi; Ikeo, Kazuho; Furuno, Masaaki; Tsunoda, Kazushige; Kusaka, Shunji; Shimomura, Yoshikazu; Iwata, Takeshi			Reduced rod electroretinograms in carrier parents of two Japanese siblings with autosomal recessive retinitis pigmentosa associated with PDE6B gene mutations	DOCUMENTA OPHTHALMOLOGICA			English	Article						PDE6B; Retinitis pigmentosa; Congenital stationary night blindness; Electroretinograms; Carrier; Autosomal recessive; Japanese	STATIONARY NIGHT BLINDNESS; BETA-SUBUNIT GENE; CGMP-PHOSPHODIESTERASE; RETINAL DEGENERATION; FAMILY; MOUSE; PHOTORECEPTORS; IDENTIFICATION; RESCUE	Purpose To present the clinical and genetic findings in two siblings with autosomal recessive retinitis pigmentosa (RP) and their non-symptomatic parents. Methods We studied two siblings, a 48-year-old woman and her 44-year-old brother, and their parents. They had general ophthalmic examinations including ophthalmoscopy, perimetry, and electroretinography (ERG). Their whole exomes were analyzed by the next-generation sequence technique. Results The two siblings had night blindness for a long time, and clinical examinations revealed diffuse retinal degeneration with bone spicule pigmentation, constriction of the visual field, and non-recordable ERGs. Their parents were non-symptomatic and had normal fundi; however, their rod ERGs were reduced. Genetic examination revealed compound heterozygous mutations of I535N and H557Y in the PDE6B gene in the siblings, and the parents were heterozygous carriers of the mutations. Conclusions Heterozygous mutation in the PDE6B gene can cause a reduction in the rod function to different degrees.The retinal function of non-symptomatic carriers of autosomal recessive RP should be evaluated with care.	[Kuniyoshi, Kazuki; Sakuramoto, Hiroyuki; Shimomura, Yoshikazu] Kinki Univ, Fac Med, Dept Ophthalmol, Osaka Sayama City, Osaka 5898511, Japan; [Yoshitake, Kazutoshi; Ikeo, Kazuho] Natl Inst Genet, Lab DNA Data Anal, Shizuoka, Japan; [Furuno, Masaaki] RIKEN Ctr Life Sci Technol, Div Genom Technol, Life Sci Accelerator Technol Grp, Transcriptome Technol Team, Yokohama, Kanagawa, Japan; [Tsunoda, Kazushige] Natl Hosp Org Tokyo, Med Ctr, Lab Visual Physiol, Natl Inst Sensory Organs, Tokyo, Japan; [Kusaka, Shunji] Kinki Univ, Fac Med, Sakai Hosp, Dept Ophthalmol, Osaka, Japan; [Iwata, Takeshi] Natl Hosp Org, Tokyo Med Ctr, Div Mol & Cellular Biol, Natl Inst Sensory Organs, Tokyo, Japan	Kuniyoshi, K (reprint author), Kinki Univ, Fac Med, Dept Ophthalmol, 377-2 Ohno Higashi, Osaka Sayama City, Osaka 5898511, Japan.	kuniyoshi-kazuki@umin.net			Ministry of Health, Labour and Welfare, Japan [13803661, 23164001, 82259921]; Japan Society for the Promotion of Science, Japan [23592597]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors thank Professor Duco Hamasaki of the Bascom Palmer Eye Institute of the University of Miami for critical discussion and final manuscript revisions; Miss Seiko Kawamura, CO, of the Seichokai Fuchu Hospital (Osaka, Japan); and Mr. Tomoaki Nishio of TOMEY Corporation (Nagoya, Japan) for their assistance for ERG examinations. The authors wish to acknowledge RIKEN GeNAS for the sequencing of the exome-enriched libraries. This research was supported by the research grants to T.I., K.T., and K.K. from the Ministry of Health, Labour and Welfare, Japan (13803661), to K.T. and K.K. from the Ministry of Health, Labour and Welfare, Japan (23164001), Y.S from the Ministry of Health, Labour and Welfare, Japan (82259921), S.K. and K.K. from Japan Society for the Promotion of Science, Japan (23592597), and to M.F. from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) for RIKEN Omics Science Center.	Adzhubei I, 2013, CURR PROTOC HUM GENE, V7, P20, DOI DOI 10.1002/0471142905.HG0720S76; Allocca M, 2011, INVEST OPHTH VIS SCI, V52, P5713, DOI 10.1167/iovs.10-6269; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Ali S, 2011, MOL VIS, V17, P1373; Kuniyoshi K, 2014, DOC OPHTHALMOL, V128, P219, DOI 10.1007/s10633-014-9436-z; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Kim C, 2012, MOL VIS, V18, P2398; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; BAYES M, 1995, HUM MUTAT, V5, P228, DOI 10.1002/humu.1380050307; Shen S, 2014, OPHTHALMIC GENET, V35, P142, DOI 10.3109/13816810.2014.915328; Barabas P, 2010, ADV EXP MED BIOL, V664, P491, DOI 10.1007/978-1-4419-1399-9_56; Bocquet B, 2013, MOL VIS, V19, P2487; Daiger SP, 2015, RETNET; DANCIGER M, 1995, GENOMICS, V30, P1; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Gross AK, 2011, ADLERS PHYSL EYE, V11th, P394; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P1; Hmani-Aifa M, 2009, EUR J HUM GENET, V17, P474, DOI 10.1038/ejhg.2008.167; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Kyoto University, 2014, HUM GEN VAR BROWS; Manes G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095768; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; National Institute of Genetics (NIG), 2014, CELL INN PROGR; Rambusch SHA, 1909, OVERSIGT KGL DANSKE, V3, P337; Saga M, 1998, CURR EYE RES, V17, P332, DOI 10.1076/ceyr.17.3.332.5214; Tsang SH, 2007, HUM MUTAT, V28, P243, DOI 10.1002/humu.20425; Valverde D, 1996, HUM MUTAT, V8, P393, DOI 10.1002/humu.1380080403; Valverde D, 1996, HUM GENET, V97, P35; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; Weleber RG, 2006, RETINA, V1, P395	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	AUG	2015	131	1					71	79		10.1007/s10633-015-9497-7		9	Ophthalmology	Ophthalmology	CN1OY	WOS:000358190700008		
J	Hirano, M; Isono, C; Sakamoto, H; Ueno, S; Kusunoki, S; Nakamura, Y				Hirano, Makito; Isono, Chiharu; Sakamoto, Hikaru; Ueno, Shuichi; Kusunoki, Susumu; Nakamura, Yusaku			Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson's Disease	DYSPHAGIA			English	Article						Dysphagia; Parkinson's disease; Rotigotine; DOSS; Deglutition	DOPAMINERGIC STIMULATION; CONTROLLED-TRIAL; DOUBLE-BLIND; DISORDERS; RESPONSES; PLACEBO; NERVES; SYSTEM	Abnormal swallowing, dysphagia, is a potentially fatal symptom in Parkinson's disease (PD) and is characterized by frequent silent aspiration, an unrecognized risk of suffocation and aspiration pneumonia. Several studies have reported that the injection of apomorphine, a dopamine agonist, alleviated dysphagia in some patients with PD. The effects of other antiparkinson medications against dysphagia remain controversial. Rotigotine is another dopamine agonist with non-oral administration, i.e., a transdermal patch. Its noninvasiveness seems to render this medicine even more suitable than apomorphine for dysphasic patients. However, no direct evidence has been reported. In the present retrospective open-label study, we for the first time objectively showed that rotigotine improved swallowing on videofluoroscopic examination in dysphagic patients with PD.	[Hirano, Makito; Isono, Chiharu; Sakamoto, Hikaru; Ueno, Shuichi; Nakamura, Yusaku] Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol,Minami Ku, Sakai, Osaka 5900132, Japan; [Hirano, Makito; Ueno, Shuichi; Kusunoki, Susumu] Kinki Univ, Dept Neurol, Fac Med, Osakasayama, Japan	Hirano, M (reprint author), Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol,Minami Ku, 2-7-1 Harayamadai, Sakai, Osaka 5900132, Japan.	hirano_makito@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461297]; University Research Grant from Kinki University [KD03]	Makito Hirano received travel expenses and honoraria for lectures from Ono, Otsuka, and Takeda Pharmaceuticals. This study was partly supported by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461297 to MH) and by a University Research Grant from Kinki University (KD03 to MH). Chiharu Isono, Shuichi Ueno, Hikaru Sakamoto, Susumu Kusunoki, and Yusaku Nakamura report no conflict of interest (COI), as confirmed by the institutional COI committee.	Tison F, 1996, MOVEMENT DISORD, V11, P729, DOI 10.1002/mds.870110622; Giladi N, 2007, MOVEMENT DISORD, V22, P2398, DOI 10.1002/mds.21741; Watts RL, 2007, NEUROLOGY, V68, P272, DOI 10.1212/01.wnl.0000252355.79284.22; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P119, DOI 10.1097/NEN.0b013e3182801cde; Jankovic J, 2007, ARCH NEUROL-CHICAGO, V64, P676, DOI 10.1001/archneur.64.5.676; Isono C, 2013, DYSPHAGIA, V28, P413, DOI 10.1007/s00455-013-9450-4; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; LeWitt PA, 2007, NEUROLOGY, V68, P1262, DOI 10.1212/01.wnl.0000259516.61938.bb; Hunter PC, 1997, J NEUROL NEUROSUR PS, V63, P579, DOI 10.1136/jnnp.63.5.579; GEAN CJ, 1989, ARCH DERMATOL RES, V281, P95, DOI 10.1007/BF00426585; Higo R, 2005, EUR ARCH OTO-RHINO-L, V262, P646, DOI 10.1007/s00405-004-0883-0; Jia YX, 1998, AM J PHYSIOL-REG I, V274, pR76; Longemann JA, 1983, EVALUATION TREATMENT; Melo A, 2013, PARKINSONISM RELAT D, V19, P279, DOI 10.1016/j.parkreldis.2012.11.017; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P614, DOI 10.1097/NEN.0b013e3182965886; O'Neil KH, 1999, DYSPHAGIA, V14, P139, DOI 10.1007/PL00009595; Poewe W, 2005, NEUROLOGY, V65, pS11; Troche MS, 2014, CHEST, V146, P1294, DOI 10.1378/chest.14-0066; Warnecke T, 2014, PARKINSONISM RELAT D, V20, P1033, DOI 10.1016/j.parkreldis.2014.06.016; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	AUG	2015	30	4					452	456		10.1007/s00455-015-9622-5		5	Otorhinolaryngology	Otorhinolaryngology	CN1OZ	WOS:000358190800009		
J	Hayashi, S; Yamada, H; Bando, M; Saijo, Y; Nishio, S; Hirata, Y; Klein, AL; Sata, M				Hayashi, Shuji; Yamada, Hirotsugu; Bando, Mika; Saijo, Yoshihito; Nishio, Susumu; Hirata, Yukina; Klein, Allan L.; Sata, Masataka			Optimal Analysis of Left Atrial Strain by Speckle Tracking Echocardiography: P-wave versus R-wave Trigger	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						left atrium; strain; two-dimensional speckle tracking echocardiography; three-dimensional echocardiography	TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; CLINICAL-IMPLICATIONS; COMPUTED-TOMOGRAPHY; VOLUME; MECHANICS; VALIDATION; SIZE; RECOMMENDATIONS; QUANTIFICATION; FIBRILLATION	BackgroundLeft atrial (LA) strain analysis using speckle tracking echocardiography is useful for assessing LA function. However, there is no established procedure for this method. Most investigators have determined the electrocardiographic R-wave peak as the starting point for LA strain analysis. To test our hypothesis that P-wave onset should be used as the starting point, we measured LA strain using 2 different starting points and compared the strain values with the corresponding LA volume indices obtained by three-dimensional (3D) echocardiography. MethodsWe enrolled 78 subjects (6117years, 25 males) with and without various cardiac diseases in this study and assessed global longitudinal LA strain by two-dimensional speckle tracking strain echocardiography using EchoPac software. We used either R-wave peak or P-wave onset as the starting point for determining LA strains during the reservoir (Rres, Pres), conduit (Rcon, Pcon), and booster pump (Rpump, Ppump) phases. We determined the maximum, minimum, and preatrial contraction LA volumes, and calculated the LA total, passive, and active emptying fractions using 3D echocardiography. ResultsThe correlation between Pres and LA total emptying fraction was better than the correlation between Rres and LA total emptying fraction (r=0.458 vs. 0.308, P=0.026). Pcon and Ppump exhibited better correlation with the corresponding 3D echocardiographic parameters than Rcon (r=0.560 vs. 0.479, P=0.133) and Rpump (r=0.577 vs. 0.345, P=0.003), respectively. ConclusionsLA strain in any phase should be analyzed using P-wave onset as the starting point rather than R-wave peak.	[Hayashi, Shuji; Nishio, Susumu; Hirata, Yukina] Tokushima Univ Hosp, Ultrasound Examinat Ctr, Tokushima 7708504, Japan; [Yamada, Hirotsugu; Bando, Mika; Saijo, Yoshihito; Sata, Masataka] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima 7708504, Japan; [Klein, Allan L.] Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, Cleveland, OH 44106 USA	Yamada, H (reprint author), Tokushima Univ Hosp, Dept Cardiovasc Med, 2-50-1 Kuramoto, Tokushima 7708504, Japan.	yamadah@tokushima-u.ac.jp			JSPS KAKENHI [22500437]	This research was partially supported by JSPS KAKENHI through a Gant-in-Aid for Scientific Research (C) (grant number 22500437).	Buechel RR, 2013, INT J CARDIOVAS IMAG, V29, P601, DOI 10.1007/s10554-012-0127-0; Miyasaka Y, 2011, J AM SOC ECHOCARDIOG, V24, P680, DOI 10.1016/j.echo.2011.03.009; Bang CN, 2013, INT J CARDIOL, V168, P2322, DOI 10.1016/j.ijcard.2013.01.060; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Mor-Avi V, 2012, JACC-CARDIOVASC IMAG, V5, P769, DOI 10.1016/j.jcmg.2012.05.011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Blume GG, 2011, EUR J ECHOCARDIOGR, V12, P421, DOI 10.1093/ejechocard/jeq175; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Rohner A, 2011, EUR J ECHOCARDIOGR, V12, P497, DOI 10.1093/ejechocard/jer066; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; To ACY, 2011, JACC-CARDIOVASC IMAG, V4, P788, DOI 10.1016/j.jcmg.2011.02.018; Tops LF, 2010, EUR HEART J, V31, P542, DOI 10.1093/eurheartj/ehq005; Delgado V, 2008, AM J CARDIOL, V101, P1285, DOI 10.1016/j.amjcard.2007.12.028; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Wakami K, 2009, J AM SOC ECHOCARDIOG, V22, P847, DOI 10.1016/j.echo.2009.04.026; Saraiva RM, 2010, J AM SOC ECHOCARDIOG, V23, P172, DOI 10.1016/j.echo.2009.11.003; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Takemoto Y, 2005, AM J CARDIOL, V96, P832, DOI 10.1016/j.amjcard.2005.05.031; Todaro MC, 2012, EUR HEART J-CARD IMG, V13, P973, DOI 10.1093/ehjci/jes174; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Motoki H, 2013, J AM SOC ECHOCARDIOG, V26, P640, DOI 10.1016/j.echo.2013.02.014; Vieira MJ, 2014, J AM SOC ECHOCARDIOG, V27, P463, DOI 10.1016/j.echo.2014.01.021; Kim DG, 2009, ECHOCARDIOGR-J CARD, V26, P1179, DOI 10.1111/j.1540-8175.2009.00955.x; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Matsumoto K, 2014, J AM SOC ECHOCARDIOG, V27, P430, DOI 10.1016/j.echo.2013.12.016; Vieira NG, 2014, ECHOCARDIOGR-J CARD, V31, P265, DOI 10.1111/echo.12366	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	AUG	2015	32	8					1241	1249		10.1111/echo.12834		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN3IZ	WOS:000358320500006		
J	Kinoshita, R				Kinoshita, Ryo			Asset allocation under higher moments with the GARCH filter	EMPIRICAL ECONOMICS			English	Article						Portfolio allocation; GARCH model; Non-normality	PORTFOLIO SELECTION; T-DISTRIBUTION; MODELS; SKEWNESS; DISTRIBUTIONS; VOLATILITY	Except for several pairs of utility functions and distribution functions, expected utility maximization problems do not have closed-form solutions so that these problems often require complex numerical optimizations. The paper proposes an approximated solution to this problem using higher moments of returns. Utility functions are approximated by polynomials by the Taylor expansion, and thus, expected utility functions are approximated by linear combinations of moments. With the GARCH effects, a simple approach to estimate conditional higher moments is given. In an empirical study, the strategy is compared to alternative strategies such as mean variance optimization and static optimization.	Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 560, Japan	Kinoshita, R (reprint author), Osaka Univ, Grad Sch Econ, 1-7 Machikaneyama, Toyonaka, Osaka 560, Japan.	r-kinoshita@econ.osaka-u.ac.jp					Adcock CJ, 2010, ANN OPER RES, V176, P221, DOI 10.1007/s10479-009-0586-4; Ang A, 2002, REV FINANC STUD, V15, P1137, DOI 10.1093/rfs/15.4.1137; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; TAUCHEN G, 1991, ECONOMETRICA, V59, P371, DOI 10.2307/2938261; Bauwens L, 2005, J BUS ECON STAT, V23, P346, DOI 10.1198/073500104000000523; Sahu SK, 2003, CAN J STAT, V31, P129, DOI 10.2307/3316064; Harvey CR, 1999, J FINANC QUANT ANAL, V34, P465, DOI 10.2307/2676230; HANSEN BE, 1994, INT ECON REV, V35, P705, DOI 10.2307/2527081; Longin F, 2001, J FINANC, V56, P649, DOI 10.1111/0022-1082.00340; Fleming J, 2001, J FINANC, V56, P329, DOI 10.1111/0022-1082.00327; de Athayde GM, 2004, J ECON DYN CONTROL, V28, P1335, DOI 10.1016/S0165-1889(02)00084-2; Jondeau E, 2006, EUR FINANC MANAG, V12, P29, DOI 10.1111/j.1354-7798.2006.00309.x; Jondeau E, 2003, J ECON DYN CONTROL, V27, P1699, DOI 10.1016/S0165-1889(02)00079-9; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.2307/2975974; Azzalini A, 2003, J ROY STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391; Barone-Adesi G., 2002, EUROPEAN FINANCIAL M, V8, P31, DOI 10.1111/1468-036X.00175; Garlappi L, 2011, MATH FINANCIAL EC, V5, P121; Glosten L., 1992, J FINANC, V46, P1779; Guidolin Massimo, 2008, REV FINANC STUD, V21, P889; Harvey CR, 2010, QUANT FINANC, V10, P469, DOI 10.1080/14697681003756877; Jondeau E, 2012, J FINANC ECONOMET, V10, P84, DOI 10.1093/jjfinec/nbr006; Konno H., 1993, Annals of Operations Research, V45, DOI 10.1007/BF02282050; Lhabitant FS, 1998, USE TAYLOR SERIES AP; Mencia J, 2009, J ECONOMETRICS, V153, P105, DOI 10.1016/j.jeconom.2009.05.001; Patton A. J., 2004, J FINANCIAL ECONOMET, V2, P130, DOI 10.1093/jjfinec/nbh006	25	0	0	PHYSICA-VERLAG GMBH & CO	HEIDELBERG	PO BOX 10 52 80, 69042 HEIDELBERG, GERMANY	0377-7332	1435-8921		EMPIR ECON	Empir. Econ.	AUG	2015	49	1					235	254		10.1007/s00181-014-0871-1		20	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CN0YH	WOS:000358140800010		
J	Ishii, H; Petrenko, AB; Tobita, T; Furutani, K; Baba, H				Ishii, Hideaki; Petrenko, Andrey B.; Tobita, Toshiyuki; Furutani, Kenta; Baba, Hiroshi			Anaesthesia and orphan disease: marked attenuation of motor evoked potentials by high-dose dexmedetomidine in a child with Angelman syndrome undergoing scoliosis surgery A case report with pharmacokinetic analysis	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Letter									[Ishii, Hideaki; Petrenko, Andrey B.; Tobita, Toshiyuki; Furutani, Kenta; Baba, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Div Anaesthesiol, Niigata 9518510, Japan	Ishii, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Anaesthesiol, Chuo Ku, 1-757 Asahi Machi, Niigata 9518510, Japan.	hishii@med.niigata-u.ac.jp					Mahmoud M, 2010, ANESTHESIOLOGY, V112, P1364, DOI 10.1097/ALN.0b013e3181d74f55; Petroz GC, 2006, ANESTHESIOLOGY, V105, P1098, DOI 10.1097/00000542-200612000-00009; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Diaz SM, 2007, PEDIATR CRIT CARE ME, V8, P419; Anschel DJ, 2008, J CLIN NEUROPHYSIOL, V25, P56, DOI 10.1097/WNP.0b013e318163cca6; Tobias JD, 2008, PEDIATR ANESTH, V18, P1082, DOI 10.1111/j.1460-9592.2008.02733.x; DYCK JB, 1993, ANESTHESIOLOGY, V78, P821, DOI 10.1097/00000542-199305000-00003; Bevinetto CM, 2014, J CLIN ANESTH, V26, P75, DOI 10.1016/j.jclinane.2013.07.015; Kunisawa T, 2012, J ANESTH, V26, P254, DOI 10.1007/s00540-011-1312-3; Landsman IS, 2012, PEDIATR ANESTH, V22, P263, DOI 10.1111/j.1460-9592.2011.03661.x; Potts AL, 2008, PEDIATR ANESTH, V18, P722, DOI 10.1111/j.1460-9592.2008.02653.x; Ramanathan KR, 2008, ANAESTHESIA, V63, P659, DOI 10.1111/j.1365-2044.2008.05439.x	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	AUG	2015	32	8					587	589		10.1097/EJA.0000000000000258		3	Anesthesiology	Anesthesiology	CN2YE	WOS:000358288400013		
J	Kagami, M; Mizuno, S; Matsubara, K; Nakabayashi, K; Sano, S; Fuke, T; Fukami, M; Ogata, T				Kagami, Masayo; Mizuno, Seiji; Matsubara, Keiko; Nakabayashi, Kazuhiko; Sano, Shinichiro; Fuke, Tomoko; Fukami, Maki; Ogata, Tsutomu			Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; CHROMOSOME 14Q32.2; GENETIC ETIOLOGY; METHYLATION; HYPOMETHYLATION; DISORDERS; DISEASE; 11P15	Maternal uniparental disomy 14 (UPD(14)mat) and related (epi)genetic aberrations affecting the 14q32.2 imprinted region result in a clinically recognizable condition which is recently referred to as Temple Syndrome (TS). Phenotypic features in TS include pre- and post-natal growth failure, prominent forehead, and feeding difficulties that are also found in Silver-Russell Syndrome (SRS). Thus, we examined the relevance of UPD(14)mat and related (epi) genetic aberrations to the development of SRS in 85 Japanese patients who satisfied the SRS diagnostic criteria proposed by Netchine et al and had neither epimutation of the H19-DMR nor maternal uniparental disomy 7. Pyrosequencing identified hypomethylation of the DLK1-MEG3 intergenic differentially methylated region (IG-DMR) and the MEG3-DMR in two cases. In both cases, microsatellite analysis showed biparental transmission of the homologs of chromosome 14, with no evidence for somatic mosaicism with full or segmental maternal isodisomy involving the imprinted region. FISH and array comparative genomic hybridization revealed neither deletion of the two DMRs nor discernible copy number alteration in the 14q32.2 imprinted region. Methylation patterns were apparently normal in other six disease-associated DMRs. In addition, a thorough literature review revealed a considerable degree of phenotypic overlap between SRS and TS, although body asymmetry was apparently characteristic of SRS. The results indicate the occurrence of epimutation affecting the IG-DMR and the MEG3-DMR in the two cases, and imply that UPD(14)mat and related (epi)genetic aberrations constitute a rare but important underlying factor for SRS.	[Kagami, Masayo; Matsubara, Keiko; Sano, Shinichiro; Fuke, Tomoko; Fukami, Maki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo 1578535, Japan; [Mizuno, Seiji] Cent Hosp, Aichi Human Serv Ctr, Dept Pediat, Aichi, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo 1578535, Japan; [Ogata, Tsutomu] Hamamatsu Univ, Sch Med, Dept Pediat, Hamamatsu, Shizuoka, Japan	Kagami, M (reprint author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo 1578535, Japan.	kagami-ms@ncchd.go.jp; tomogata@hama-med.ac.jp			Japan Society for the Promotion of Science [25253023, 23390083]; Ministry of Health, Labor, and Welfare [H22-161]; Grants for National Center for Child Health and Development [23A-1, 25-10]; Takeda Science Foundation; Japan Foundation for Pediatric Research	This work was supported by the Grants-in-Aid for Scientific Research (A) (25253023) and Research (B) (23390083) from the Japan Society for the Promotion of Science; by the Grant-in-Aid for Research on Intractable Diseases (H22-161) from the Ministry of Health, Labor, and Welfare; by the Grants for National Center for Child Health and Development (23A-1, 25-10); and by the Grants from Takeda Science Foundation and from the Japan Foundation for Pediatric Research.	Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Ioannides Y, 2014, J MED GENET, V51, P495, DOI 10.1136/jmedgenet-2014-102396; Inokuchi M, 2007, ACTA PAEDIATR, V96, P1674, DOI 10.1111/j.1651-2227.2007.00490.x; Eggermann T, 2010, AM J MED GENET C, V154C, P355, DOI 10.1002/ajmg.c.30274; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Hosoki K, 2008, EUR J HUM GENET, V16, P1019, DOI 10.1038/ejhg.2008.90; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Hoffmann K, 2011, BEST PRACT RES CL EN, V25, P77, DOI 10.1016/j.beem.2010.09.004; Poole RL, 2013, AM J MED GENET A, V161, P2174, DOI 10.1002/ajmg.a.36049; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Court F, 2013, HUM MUTAT, V34, P595, DOI 10.1002/humu.22276; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Temple IK, 2007, J MED GENET, V44, P637, DOI 10.1136/jmg.2007.050807; Buiting K, 2008, HUM MUTAT, V29, P1141, DOI 10.1002/humu.20771; Bruce S, 2010, J MED GENET, V47, P816, DOI 10.1136/jmg.2009.069427; Kagami M, 2012, EUR J HUM GENET, V20, P928, DOI 10.1038/ejhg.2012.26; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Mitter D, 2006, AM J MED GENET A, V140A, P2039, DOI 10.1002/ajmg.a.31414; Berends MJW, 1999, AM J MED GENET, V84, P76, DOI 10.1002/(SICI)1096-8628(19990507)84:1<76::AID-AJMG16>3.0.CO;2-F; Binder G, 2011, BEST PRACT RES CL EN, V25, P153, DOI 10.1016/j.beem.2010.06.005; Fuke T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060105; Hitchins MP, 2001, J MED GENET, V38, P810, DOI 10.1136/jmg.38.12.810; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Spengler S, 2010, J MED GENET, V47, P356, DOI 10.1136/jmg.2009.070052; Zechner U, 2009, CLIN GENET, V75, P251, DOI 10.1111/j.1399-0004.2008.01116.x	29	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	AUG	2015	23	8					1062	1067		10.1038/ejhg.2014.234		6	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CM9DH	WOS:000358006100013		
J	Tajima, S; Ikeda, Y; Enomoto, H; Imao, M; Horinouchi, Y; Izawa-Ishizawa, Y; Kihira, Y; Miyamoto, L; Ishizawa, K; Tsuchiya, K; Tamaki, T				Tajima, Soichiro; Ikeda, Yasumasa; Enomoto, Hideaki; Imao, Mizuki; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Miyamoto, Licht; Ishizawa, Keisuke; Tsuchiya, Koichiro; Tamaki, Toshiaki			Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice	EUROPEAN JOURNAL OF NUTRITION			English	Article						Iron metabolism; Angiotensin II; Hepcidin; Ferritin	ANTIMICROBIAL PEPTIDE; INSULIN-RESISTANCE; OXIDATIVE STRESS; SERUM FERRITIN; MACROPHAGE POLARIZATION; REGULATORY PROTEINS; ENDOTHELIAL-CELLS; UP-REGULATION; RENAL INJURY; METABOLISM	Purpose Angiotensin II (ANG II) has been shown to affect iron metabolism through alteration of iron transporters, leading to increased cellular and tissue iron contents. Serum ferritin, a marker of body iron storage, is elevated in various cardiovascular diseases, including hypertension. However, the associated changes in iron absorption and the mechanism underlying increased iron content in a hypertensive state remain unclear. Methods The C57BL6/J mice were treated with ANG II to generate a model of hypertension. Mice were divided into three groups: (1) control, (2) ANG II-treated, and (3) ANG II-treated and ANG II receptor blocker (ARB)-administered (ANG II-ARB) groups. Results Mice treated with ANG II showed increased serum ferritin levels compared to vehicle-treated control mice. In ANG II-treated mice, duodenal divalent metal transporter-1 and ferroportin (FPN) expression levels were increased and hepatic hepcidin mRNA expression and serum hepcidin concentration were reduced. The mRNA expression of bone morphogenetic protein 6 and CCAAT/enhancer-binding protein alpha, which are regulators of hepcidin, was also down-regulated in the livers of ANG II-treated mice. In terms of tissue iron content, macrophage iron content and renal iron content were increased by ANG II treatment, and these increases were associated with reduced expression of transferrin receptor 1 and FPN and increased expression of ferritin. These changes induced by ANG II treatment were ameliorated by the administration of an ARB. Conclusions Angiotensin II (ANG II) altered the expression of duodenal iron transporters and reduced hepcidin levels, contributing to the alteration of body iron distribution.	[Tajima, Soichiro; Ikeda, Yasumasa; Enomoto, Hideaki; Imao, Mizuki; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Miyamoto, Licht; Ishizawa, Keisuke; Tsuchiya, Koichiro; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 7708503, Japan; [Tajima, Soichiro] Kyushu Univ Hosp, Dept Pharm, Fukuoka 812, Japan; [Enomoto, Hideaki] Univ Tokushima, Fac Med, Student Lab, Tokushima 7708503, Japan	Ikeda, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yasuike@tokushima-u.ac.jp			JSPS KAKENHI [25750044, 24591203]; Regional Innovation Cluster Program; Setsuro Fujii Memorial Osaka Foundation for Promotion of Fundamental Medical Research	This work was supported by a JSPS KAKENHI Grant (No. 25750044 to S.T.) and in part by the Regional Innovation Cluster Program and the Setsuro Fujii Memorial Osaka Foundation for Promotion of Fundamental Medical Research (to T.T.), and by a JSPS KAKENHI Grant (No. 24591203 to Y.I.).	Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; JACOBS A, 1975, NEW ENGL J MED, V292, P951, DOI 10.1056/NEJM197505012921805; Vanoaica L, 2010, CELL METAB, V12, P273, DOI 10.1016/j.cmet.2010.08.003; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Ogihara T, 2002, HYPERTENSION, V40, P872, DOI 10.1161/01.HYP.0000040262.48405.A8; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Yeh KY, 2000, AM J PHYSIOL-GASTR L, V279, pG1070; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Wrede CE, 2006, EUR J ENDOCRINOL, V154, P333, DOI 10.1530/eje.1.02083; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Atlas Steven A, 2007, J Manag Care Pharm, V13, P9; CATT KJ, 1969, BRIT MED J, V1, P819; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P2282, DOI 10.1161/01.ATV.0000181763.57495.2b; Ishizaka N, 2005, AM J PHYSIOL-REG I, V288, pR1063, DOI 10.1152/ajpregu.00281.2004; Ishizaka N, 2007, HYPERTENS RES, V30, P195, DOI 10.1291/hypres.30.195; Ishizaka N, 2002, LAB INVEST, V82, P87; Ishizaka N, 2002, CIRCULATION, V106, P1840, DOI 10.1161/01.CIR.0000031161.77536.02; Khan ZA, 2005, FREE RADICAL RES, V39, P1203, DOI 10.1080/10715760500143254; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Ma LJ, 2011, AM J PHYSIOL-RENAL, V300, pF1203, DOI 10.1152/ajprenal.00468.2010; Nanami M, 2005, ARTERIOSCL THROM VAS, V25, P2495, DOI 10.1161/01.ATV.0000190610.63878.20; Tajima S, 2010, HYPERTENS RES, V33, P713, DOI 10.1038/hr.2010.63; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488	44	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	AUG	2015	54	5					709	719		10.1007/s00394-014-0749-1		11	Nutrition & Dietetics	Nutrition & Dietetics	CN1PG	WOS:000358191500004		
J	Vuts, J; Francke, W; Mori, K; Zarbin, PHG; Hooper, AM; Millar, JG; Pickett, JA; Toth, M; Chamberlain, K; Caulfield, JC; Woodcock, CM; Troger, AG; Csonka, EB; Birkett, MA				Vuts, Jozsef; Francke, Wittko; Mori, Kenji; Zarbin, Paulo H. G.; Hooper, Antony M.; Millar, Jocelyn G.; Pickett, John A.; Toth, Miklos; Chamberlain, Keith; Caulfield, John C.; Woodcock, Christine M.; Troeger, Armin G.; Csonka, Eva Balintne; Birkett, Michael A.			Pheromone Bouquet of the Dried Bean Beetle, Acanthoscelides obtectus (Col.: Chrysomelidae), Now Complete	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Pheromones; Bioassay; Coleoptera; Acanthoscelides; Bruchinae	SAY COLEOPTERA; BRUCHIDAE; IDENTIFICATION; COMPONENTS; ALCOHOLS; ECOLOGY; BONDS	Male-specific volatile components, released by the dried bean beetle, Acanthoscelides obtectus, were identified as methyl (E,R)-2,4,5-tetradecatrienoate, methyl (2E,4Z,7Z)-2,4,7-decatrienoate, methyl (2E,4Z)-2,4-decadienoate, octadecanal and the sesquiterpenes (3Z,6E)- and (3E,6E)-alpha-farnesene. In olfactometer bioassays, pure methyl (E, R)-2,4,5-tetradecatrienoate was only weakly attractive to unmated females. However, a blend of the six identified compounds released in physiologically relevant ratios and doses proved to be as active as headspace odours collected from live males.	[Vuts, Jozsef; Hooper, Antony M.; Pickett, John A.; Chamberlain, Keith; Caulfield, John C.; Woodcock, Christine M.; Birkett, Michael A.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England; [Francke, Wittko; Troeger, Armin G.] Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany; [Mori, Kenji] Toyo Gosei Co Ltd, Photosensit Mat Res Ctr, Inzai City, Chiba 2701609, Japan; [Zarbin, Paulo H. G.] Univ Fed Parana, Dept Chem, BR-81531990 Curitiba, Parana, Brazil; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Toth, Miklos; Csonka, Eva Balintne] Plant Protect Inst HAS, Agr Res Ctr, H-1022 Budapest, Hungary	Birkett, MA (reprint author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England.	mike.birkett@rothamsted.ac.uk			Hungarian Scientific Research Fund (OTKA) [K81494]; Hungarian Research and Technology Innovation Fund [OMFB-00609/2010]; Royal Society, United Kingdom [IE111142]; Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom	This work was in part supported by the Hungarian Scientific Research Fund (OTKA) (grant number K81494), by the Hungarian Research and Technology Innovation Fund (grant number OMFB-00609/2010) and by the Royal Society, United Kingdom (grant IE111142 to J. V.). Rothamsted receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom.	AERSSENS MHPJ, 1990, SYNTHETIC COMMUN, V20, P3421, DOI 10.1080/00397919008051583; Agelopoulos NG, 1998, J CHEM ECOL, V24, P1161, DOI 10.1023/A:1022442818196; Annoscia D., 2010, INT SOC CHEM EC 26 A, p[P029, 212]; Svatos A, 1997, ANAL CHEM, V69, P1827, DOI 10.1021/ac960890u; ATTYGALLE AB, 1993, P NATL ACAD SCI USA, V90, P5204, DOI 10.1073/pnas.90.11.5204; SOUTHGATE BJ, 1979, ANNU REV ENTOMOL, V24, P449, DOI 10.1146/annurev.en.24.010179.002313; Kaiser R, 2000, CHIMIA, V54, P346; ALDRICH JR, 1991, ENVIRON ENTOMOL, V20, P477; Abate T, 1996, ANNU REV ENTOMOL, V41, P45; Barrett AGM, 1997, J ORG CHEM, V62, P9376, DOI 10.1021/jo971569u; BYERS JA, 1988, NATURWISSENSCHAFTEN, V75, P153, DOI 10.1007/BF00405312; Dewhirst SY, 2008, J CHEM ECOL, V34, P1575, DOI 10.1007/s10886-008-9561-9; GERWICK WH, 1993, HYDROBIOLOGIA, V261, P653; Golebiowski M, 2008, J STORED PROD RES, V44, P386, DOI 10.1016/j.jspr.2008.02.010; GRIFFITH WP, 1987, J CHEM SOC CHEM COMM, P1625, DOI 10.1039/c39870001625; HALSTEAD DG, 1973, J STORED PROD RES, V9, P109, DOI 10.1016/0022-474X(73)90018-0; Hope J. A., 1967, Journal of Stored Products Research, V3, P387, DOI 10.1016/0022-474X(67)90042-2; HORLER DF, 1970, J CHEM SOC C, P859, DOI 10.1039/j39700000859; IMURA O, 1990, SERIES ENTOM, V46, P257; KOBAYASHI A, 1989, J AGR FOOD CHEM, V37, P151, DOI 10.1021/jf00085a035; Mori K., TETRAHEDRON IN PRESS; Mori K, 2012, TETRAHEDRON, V68, P1936, DOI 10.1016/j.tet.2011.12.064; Pettersson J, 1970, INSECT SYST EVOL, V1, P63; PIRKLE WH, 1978, J ORG CHEM, V43, P2091, DOI 10.1021/jo00405a001; RAMAIAH P, 1995, J ORG CHEM, V60, P6211, DOI 10.1021/jo00124a046; The National Institute of Standards and Technology, 2008, NIST EPA NIH MASS SP	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	AUG	2015		22					4843	4846		10.1002/ejoc.201500196		4	Chemistry, Organic	Chemistry	CN4AO	WOS:000358370700005		
J	Meneghetti, F; Villa, S; Masciocchi, D; Barlocco, D; Toma, L; Han, DC; Kwon, BM; Ogo, N; Asai, A; Legnani, L; Gelain, A				Meneghetti, Fiorella; Villa, Stefania; Masciocchi, Daniela; Barlocco, Daniela; Toma, Lucio; Han, Dong-Cho; Kwon, Byoung-Mog; Ogo, Naohisa; Asai, Akira; Legnani, Laura; Gelain, Arianna			Ureido-Pyridazinone Derivatives: Insights into the Structural and Conformational Properties for STAT3 Inhibition	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Medicinal chemistry; Cancer; Inhibitors; Signal transduction; Conformation analysis; Proteins	POLARIZABLE CONTINUUM MODEL; MOLECULAR TARGETS; GENE-REGULATION; CANCER; TRANSFORMATION; DENSITY; SYSTEM	Three new ureido-pyridazinone derivatives, which are structurally related to the known STAT3 inhibitor AVS-0288, were designed by taking into account the structure-activity relationships determined for several ureido-oxadiazole derivatives previously studied by our group. Their synthesis was first attempted through suitable 5-aminopyridazinone intermediates (6a and 6b), which molecular structures were confirmed by means of X-ray diffraction data on 6a. Amine functionalization was unsuccessful, therefore, an alternative method was devised. Dual-luciferase and AlphaScreen-based assays were used to test their activity. The obtained data were rationalized on the basis of a modeling study, which focused our attention on the geometrical preferences of the ureido moiety. Computational results seem to indicate that both the 1,2,5-oxadiazole ring and the extended ZZ arrangement are essential and probably act in a synergistic way to confer significant activity against STAT3.	[Meneghetti, Fiorella; Villa, Stefania; Masciocchi, Daniela; Barlocco, Daniela; Gelain, Arianna] Univ Milan, Dipartimento Sci Farmaceut, I-20133 Milan, Italy; [Toma, Lucio; Legnani, Laura] Univ Pavia, Dipartimento Chim, I-27100 Pavia, Italy; [Han, Dong-Cho; Kwon, Byoung-Mog] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Lab Chem Biol & Genom, Taejon 305333, South Korea; [Han, Dong-Cho; Kwon, Byoung-Mog] Univ Sci & Technol, Dept Biomol Sci, Taejon 305333, South Korea; [Ogo, Naohisa; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Suruga Ku, Shizuoka 4228526, Japan	Villa, S (reprint author), Univ Milan, Dipartimento Sci Farmaceut, Via L Mangiagalli 25, I-20133 Milan, Italy.	stefania.villa@unimi.it		Toma, Lucio/0000-0001-8916-7445	University of Milan; University of Pavia; Italian Ministero dell' Universita e della Ricerca (MIUR); KRIBB Research Initiative Program; Bio-Synergy Research Project [2012M3A9C404877]	The authors acknowledge the financial support of the Universities of Milan and Pavia and the Italian Ministero dell' Universita e della Ricerca (MIUR) (funds PRIN 2010-11). B. M. K. was supported by the KRIBB Research Initiative Program and the Bio-Synergy Research Project (2012M3A9C404877).	Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Buettner R, 2002, CLIN CANCER RES, V8, P945; Barone V, 1998, J COMPUT CHEM, V19, P404, DOI 10.1002/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Cossi M, 1996, CHEM PHYS LETT, V255, P327, DOI 10.1016/0009-2614(96)00349-1; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; CIGNARELLA G, 1980, SYNTHESIS-STUTTGART, P825; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Kwon B.-M., [No title captured], Patent No. [US 20080051442, 20080051442]; Laguna R, 1997, CHEM PHARM BULL, V45, P1151; Masciocchi D, 2012, MEDCHEMCOMM, V3, P592, DOI 10.1039/c2md20018j; Masciocchi D., 2011, FUTURE MED CHEM, V3, P367; Masciocchi D, 2013, MEDCHEMCOMM, V4, P1181, DOI 10.1039/c3md00095h; Sherf BA, 1996, PROMEGA NOTES, V57, P2; Shin DS, 2010, MEDCHEMCOMM, V1, P156, DOI 10.1039/c0md00057d; Sotelo E, 1999, J HETEROCYCLIC CHEM, V36, P985; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Villa S, 2012, CHEM BIODIVERS, V9, P1240, DOI 10.1002/cbdv.201100339	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	AUG	2015		22					4907	4912		10.1002/ejoc.201500599		6	Chemistry, Organic	Chemistry	CN4AO	WOS:000358370700013		
J	Yamaguchi, S; Tanaka, H; Takahashi, T				Yamaguchi, Sho; Tanaka, Hiroshi; Takahashi, Takashi			Reagent Control of a Birch Reduction for the Synthesis of a 2-Deoxyoligosaccharide Possessing a 1,4-Dialkylhydroquinone	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Reduction; Oligosaccharides; Quinones; Deoxysugars; Synthetic methods	LANDOMYCIN-A; STEREOSELECTIVE-SYNTHESIS; SULFATED OLIGOSACCHARIDE; HEXASACCHARIDE FRAGMENT; NATURAL-PRODUCTS; CHEMISTRY; SUGARS; ACID	We have developed a versatile deprotection method for the synthesis of 2-deoxyoligosaccharides containing a 1,4-dialkylhydroquinone moiety at the anomeric position. The Birch reduction of a 2,6-dideoxy monosaccharide with potassium and 1,3-pentadiene gave the deprotected product without any undesired reduction. The utility of this method was then demonstrated in the Birch reduction of a landomycin E deoxytrisaccharide. Pd-catalysed hydrogenation led to the ano-merization, or cleavage, of the glycosidic linkages. In contrast, Birch reduction based on the optimized conditions followed by treatment with mCPBA (m-chloroperoxybenzoic acid) provided the fully deprotected deoxytrisaccharide in 65% overall yield. These results show that the Birch reduction is a powerful deprotection method for the synthesis of complex natural glycosides, including 2-deoxyoligosaccharides.	[Yamaguchi, Sho; Tanaka, Hiroshi; Takahashi, Takashi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Meguro Ku, Tokyo 1528552, Japan; [Takahashi, Takashi] Yokohama Coll Pharm 601, Fac Pharmaceut Sci, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Tanaka, H (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Meguro Ku, 2-12-1-H-101 Ookayama, Tokyo 1528552, Japan.	thiroshi@apc.titech.ac.jp; ttak@hamayaku.ac.jp	Tanaka, Hiroshi/I-2402-2012		Japan Society for the Promotion of Science (JSPS) [DC2]	This work was financially supported by the Japan Society for the Promotion of Science (JSPS) through a Research Fellowship for Young Scientists (DC2).	WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Yang XY, 2011, J AM CHEM SOC, V133, P12433, DOI 10.1021/ja205339p; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; Zhou MQ, 2008, ORG LETT, V10, P2283, DOI 10.1021/ol800697k; Tanaka H, 2010, CHEM-ASIAN J, V5, P1407, DOI 10.1002/asia.200900640; HOOK JM, 1986, NAT PROD REP, V3, P35, DOI 10.1039/np9860300035; Guo Y, 1998, J AM CHEM SOC, V120, P1392, DOI 10.1021/ja973348b; Roush WR, 2000, J AM CHEM SOC, V122, P6124, DOI 10.1021/ja000743k; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Kirschning A, 1997, TOP CURR CHEM, V188, P1; Yu B, 2002, ORG LETT, V4, P1919, DOI 10.1021/ol0259286; FUKASE K, 1993, TETRAHEDRON LETT, V34, P2187; Fuwa H, 2004, TETRAHEDRON LETT, V45, P4795, DOI 10.1016/j.tetlet.2004.04.083; Kirschning A, 1998, EUR J ORG CHEM, P2267; MCCLOSKEY CM, 1957, ADV CARBOHYD CHEM, V12, P137; PHILIPS KD, 1973, CARBOHYD RES, V30, P281, DOI 10.1016/S0008-6215(00)81814-5; Roush WR, 2001, J ORG CHEM, V66, P6389, DOI 10.1021/jo015756a; SCHON I, 1984, CHEM REV, V84, P287, DOI 10.1021/cr00061a004; Tanaka H, 2007, ANGEW CHEM INT EDIT, V46, P2505, DOI 10.1002/anie.200604031; Tanaka H., 2007, ANGEW CHEM, V119, P2557, DOI 10.1002/ange.200604031; Tanaka H, 2009, CHEM-ASIAN J, V4, P1114, DOI 10.1002/asia.200800448; Xia J, 2000, CHEM-EUR J, V6, P3442, DOI 10.1002/1521-3765(20000915)6:18<3442::AID-CHEM3442>3.0.CO;2-V; Xia J, 2000, TETRAHEDRON LETT, V41, P2773, DOI 10.1016/S0040-4039(00)00261-6	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	AUG	2015		22					4939	4943		10.1002/ejoc.201500515		5	Chemistry, Organic	Chemistry	CN4AO	WOS:000358370700017		
J	Okugawa, N; Moriyama, K; Togo, H				Okugawa, Naoki; Moriyama, Katsuhiko; Togo, Hideo			Introduction of Ether Groups onto Electron-Deficient Nitrogen-Containing Heteroaromatics Using Radical Chemistry under Transition-Metal-Free Conditions	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Crown ethers; Nitrogen heterocycles; Radical reactions; Alkylation; Photolysis	SELECTIVE HOMOLYTIC ALKYLATION; NUCLEOPHILIC CHARACTER; GENERAL-METHOD; BASES; QUINOLINE; FUNCTIONALIZATION; ARYLATION; ACYLATION; PYRIDINE; REAGENT	Electron-deficient nitrogen-containing heteroaromatics, such as quinoline, isoquinoline, and pyridine, were treated with benzoyl peroxide in dioxane, tetrahydropyran, tetrahydrofuran, diethyl ether, and dipropyl ether at 80 degrees C to form alkylated nitrogen-containing heteroaromatics in good yields under transition-metal-free conditions. This method was successfully applied to the preparation of lariat aza-crown ethers using 18-crown-6 or 15-crown-5 with quinoline and isoquinoline in the presence of benzoyl peroxide in good yields under irradiation conditions with a Hg lamp.	[Okugawa, Naoki; Moriyama, Katsuhiko; Togo, Hideo] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Togo, H (reprint author), Chiba Univ, Grad Sch Sci, Inage Ku, Yayoi Cho 1-33, Chiba 2638522, Japan.	togo@faculty.chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [25105710]; Chiba University (Iodine Research Project)	Financial support from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in the form of a Grant-in-Aid for Scientific Research (grant number 25105710) and Chiba University (Iodine Research Project) is gratefully acknowledged.	Bentley KW, 2006, NAT PROD REP, V23, P444, DOI 10.1039/b509523a; Kan J, 2015, ANGEW CHEM INT EDIT, V54, P2199, DOI 10.1002/anie.201408630; FONTANA F, 1991, J ORG CHEM, V56, P2866, DOI 10.1021/jo00008a050; Jin J, 2015, ANGEW CHEM INT EDIT, V54, P1565, DOI 10.1002/anie.201410432; Mai WP, 2015, ORG BIOMOL CHEM, V13, P2750, DOI 10.1039/c4ob02524e; Fournet A, 2003, BIOORG MED CHEM LETT, V13, P891, DOI 10.1016/S0960-894X(02)01085-5; Basa PN, 2012, J ORG CHEM, V77, P8428, DOI 10.1021/jo301193n; BURATTI W, 1971, TETRAHEDRON, V27, P3655, DOI 10.1016/S0040-4020(01)97776-2; BARTON DHR, 1986, TETRAHEDRON LETT, V27, P1327, DOI 10.1016/S0040-4039(00)84250-1; CARONNA T, 1976, TETRAHEDRON LETT, P1731; CARONNA T, 1977, J CHEM SOC PERK T 1, P865, DOI 10.1039/p19770000865; CASTAGNINO E, 1986, TETRAHEDRON LETT, V27, P6337, DOI 10.1016/S0040-4039(00)87802-8; CASTALDI G, 1984, TETRAHEDRON LETT, V25, P3897, DOI 10.1016/S0040-4039(01)91198-0; COPPA F, 1992, TETRAHEDRON LETT, V33, P3057, DOI 10.1016/S0040-4039(00)79599-2; Cragg P. J., 2012, SUPRAMOLECULAR CHEM; Giese B., 1986, RADICALS ORGANIC SYN, P210; Keri RS, 2014, BIOMED PHARMACOTHER, V68, P1161, DOI 10.1016/j.biopha.2014.10.007; Mancini I, 2004, ORG BIOMOL CHEM, V2, P1368, DOI 10.1039/b400782d; MINISCI F, 1985, TETRAHEDRON, V41, P4157, DOI 10.1016/S0040-4020(01)97191-1; MINISCI F, 1970, TETRAHEDRON, V26, P4083, DOI 10.1016/S0040-4020(01)93049-2; MINISCI F, 1968, TETRAHEDRON LETT, P5609; MINISCI F, 1973, SYNTHESIS-STUTTGART, P1; Pan C., 2015, CHEM COMMUN, V51, P5786; Rao J. J., 1992, TETRAHEDRON LETT, V33, P4133; Su N, 1999, J ORG CHEM, V64, P8855, DOI 10.1021/jo991081o; Sun W, 2015, ORG BIOMOL CHEM, V13, P4596, DOI 10.1039/c5ob00237k; Togo H., 1994, B CHEM SOC JPN, V67, P2552; TOGO H, 1993, CHEM LETT, P641, DOI 10.1246/cl.1993.641; Togo H., 2004, ADV FREE RADICAL REA, P157, DOI 10.1016/B978-008044374-4/50006-2; TOGO H, 1991, CHEM LETT, P2063, DOI 10.1246/cl.1991.2063; TOGO H, 1991, TETRAHEDRON LETT, V32, P3377, DOI 10.1016/S0040-4039(00)92711-4; Xue GP, 2002, TETRAHEDRON, V58, P4809, DOI 10.1016/S0040-4020(02)00451-9; Yamazaki O, 1999, TETRAHEDRON, V55, P3735, DOI 10.1016/S0040-4020(98)01180-6; Yamazaki O, 1998, TETRAHEDRON LETT, V39, P1921, DOI 10.1016/S0040-4039(98)00048-3; ZELETCHONOK YB, 1988, TETRAHEDRON LETT, V29, P5037, DOI 10.1016/S0040-4039(00)80673-5	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	AUG	2015		22					4973	4981		10.1002/ejoc.201500584		9	Chemistry, Organic	Chemistry	CN4AO	WOS:000358370700022		
J	Yamaguchi, K; Noda, T; Tomizawa, T; Kanai, E; Hioki, H				Yamaguchi, Kota; Noda, Takeshi; Tomizawa, Toshiki; Kanai, Eriko; Hioki, Hideaki			Solid-Phase Friedlander Synthesis Using an Alkoxyamine Linker	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Combinatorial chemistry; Synthetic methods; Solid-phase synthesis; Nitrogen heterocycles	MICROWAVE-ASSISTED SYNTHESIS; QUINOLINE DERIVATIVES; IONIC LIQUID; DESIGN	A quinoline library was prepared by combinatorial synthesis using an alkoxyamine linker. Substrates were loaded onto a solid support containing an oxime linkage. After selected reactions on the solid support, the products were cleaved by a Friedlander-type reaction with ketones under acidic conditions to afford the corresponding quinolines. The recyclability of the solid support was also investigated.	[Yamaguchi, Kota; Tomizawa, Toshiki; Kanai, Eriko; Hioki, Hideaki] Gunma Univ, Fac Educ, Maebashi, Gumma 3718510, Japan; [Noda, Takeshi] Kanagawa Inst Technol, Dept Appl Biosci, Atsugi, Kanagawa 2430292, Japan	Hioki, H (reprint author), Gunma Univ, Fac Educ, Maebashi, Gumma 3718510, Japan.	hioki@gunma-u.ac.jp					Puri SC, 2005, J NAT PROD, V68, P1717, DOI 10.1021/np0502802; Akbari J, 2010, J COMB CHEM, V12, P137, DOI 10.1021/cc9001313; Tabassum S, 2014, J MOL STRUCT, V1070, P10, DOI 10.1016/j.molstruc.2014.04.009; Tukulula M, 2012, EUR J MED CHEM, V57, P259, DOI 10.1016/j.ejmech.2012.08.047; Subiros-Funosas R, 2009, CHEM-EUR J, V15, P9394, DOI 10.1002/chem.200900614; El-Feky SA, 2014, J FLUORINE CHEM, V161, P87, DOI 10.1016/j.jfluchem.2014.02.012; Tu SJ, 2009, J COMB CHEM, V11, P239, DOI 10.1021/cc800094m; Kumar S, 2012, CHEM BIOL DRUG DES, V79, P104, DOI 10.1111/j.1747-0285.2011.01255.x; Xia LK, 2014, ACS COMB SCI, V16, P333, DOI 10.1021/co500002s; Bharate JB, 2014, ACS COMB SCI, V16, P624, DOI 10.1021/co500047w; Bojinov VB, 2003, ORG LETT, V5, P2185, DOI 10.1021/ol034687e; Hioki H, 2012, TETRAHEDRON LETT, V53, P4337, DOI 10.1016/j.tetlet.2012.06.008; Lee SH, 1998, TETRAHEDRON LETT, V39, P9469, DOI 10.1016/S0040-4039(98)02147-9; Matsushita K, 2010, J COMB CHEM, V12, P311, DOI 10.1021/cc9001795; Nedeltchev AK, 2011, J POLYM SCI POL CHEM, V49, P1907, DOI 10.1002/pola.24619; Patteux C, 2003, ORG LETT, V5, P3061, DOI 10.1021/ol035049z; Scott DA, 2013, BIOORG MED CHEM LETT, V23, P4591, DOI 10.1016/j.bmcl.2013.06.031; Yamaguchi K, 2014, TETRAHEDRON LETT, V55, P5793, DOI 10.1016/j.tetlet.2014.08.095	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	AUG	2015		22					4990	4995		10.1002/ejoc.201500426		6	Chemistry, Organic	Chemistry	CN4AO	WOS:000358370700024		
J	van Doormaal, N; Ohashi, H; Koike, S; Kaji, K				van Doormaal, Nick; Ohashi, Haruka; Koike, Shinsuke; Kaji, Koichi			Influence of human activities on the activity patterns of Japanese sika deer (Cervus nippon) and wild boar (Sus scrofa) in Central Japan	EUROPEAN JOURNAL OF WILDLIFE RESEARCH			English	Article						Cervus nippon; Sus scrofa; Hunting; Camera traps; Activity pattern; Human activity	AGRICULTURAL LANDSCAPES; HABITAT SELECTION; HUMAN DISTURBANCE; ROE DEER; LAND-USE; FOREST; PREFECTURE; BEHAVIOR; DENSITY; DAMAGE	Human ageing and population decline in Japan are causing agricultural field abandonment and providing new habitats for Japanese sika deer and wild boar. These species have expanded their distribution and increased in abundance across Japan and are causing increased agricultural damage. Effective countermeasures must factor in the behavioural flexibility of sika deer and wild boar. The aim of this study was to examine the effects of hunting and indirect human activities on the activity patterns of sika deer in central Japan and compare these with previous findings on wild boar. Camera traps were used to observe activity patterns of both species and that of humans. Sika deer and wild boar were most active at night during the non-hunting season. Hunting activities significantly reduced sika deer and wild boar activity patterns. In the non-hunting season, nocturnal activity of sika deer increased with decreasing distance to settlement. A similar, but weak response was also observed for wild boar. This study suggests that sika deer and wild boar avoid humans and human-dominated areas by being nocturnal. The recent introduction of night hunting might help to control wildlife populations, but monitoring will be necessary to confirm this expectation.	[van Doormaal, Nick] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Ohashi, Haruka] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Koike, Shinsuke; Kaji, Koichi] Univ Agr & Technol, Inst Agr, Grad Sch Tokyo, Fuchu, Tokyo 1838509, Japan	Kaji, K (reprint author), Univ Agr & Technol, Inst Agr, Grad Sch Tokyo, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	kkaji@cc.tuat.ac.jp	Koike, Shinsuke/C-4619-2013; Kaji, Koichi/C-8355-2013	Kaji, Koichi/0000-0001-6578-9995	Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo University of Agriculture and Technology	This study was supported by the "Development of wildlife management system with DPSIR scheme" project, from special budgets for research and education in fiscal year 2010-2011 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank to the prefectural office of Tochigi and the city offices of Sano and Ashikaga for facilitating our survey. We also thank the local residents in Sano and Ashikaga for allowing us to establish camera trap stations around the settlements. Tokyo University of Agriculture and Technology supported N. van Doormaal as an academic intern. Thanks to Ludek Bartos and an anonymous referee for commenting on the submitted manuscript.	Adams C.E., 2006, URBAN WILDLIFE MANAG; Agetsuma N, 2014, MAMM BIOL, V79, P44, DOI 10.1016/j.mambio.2013.05.002; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943002003172; BALMFORD A, 1993, J ZOOL, V231, P652; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Putman RJ, 1998, MAMMAL REV, V28, P141, DOI 10.1046/j.1365-2907.1998.00031.x; Ohashi H, 2013, EUR J WILDLIFE RES, V59, P167, DOI 10.1007/s10344-012-0661-z; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037//0033-2909.118.3.392; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Kaji K, 2010, POPUL ECOL, V52, P373, DOI 10.1007/s10144-010-0219-4; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; Gortazar C, 2000, MAMMALIA, V64, P411, DOI 10.1515/mamm.2000.64.4.411; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Swann DE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P27, DOI 10.1007/978-4-431-99495-4_3; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Keuling O, 2009, MAMM BIOL, V74, P145, DOI 10.1016/j.mambio.2008.05.007; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; Cahill S, 2003, WILDLIFE BIOL, V9, P3; Saito M, 2012, INT J PEST MANAGE, V58, P65, DOI 10.1080/09670874.2011.648230; Schley L, 2008, EUR J WILDLIFE RES, V54, P589, DOI 10.1007/s10344-008-0183-x; Young J, 2005, BIODIVERS CONSERV, V14, P1641, DOI 10.1007/s10531-004-0536-z; Kitchen AM, 2000, CAN J ZOOL, V78, P853, DOI 10.1139/cjz-78-5-853; Hewison AJM, 2001, CAN J ZOOL, V79, P679, DOI 10.1139/cjz-79-4-679; Agetsuma N, 2007, ECOL RES, V22, P390, DOI 10.1007/s11284-007-0358-z; McLoughlin PD, 2011, BASIC APPL ECOL, V12, P654, DOI 10.1016/j.baae.2011.09.001; Barton K, 2013, PACKAGE MUMIN MODEL; Bartos L, 2003, FOLIA ZOOL, V52, P1; Bartos L, 1991, WILDLIFE CONSERVATIO, P205; Borkowski J, 2001, ACTA THERIOL, V46, P195, DOI 10.1007/BF03192428; Borkowski J, 1998, ANN ZOOL FENN, V35, P181; Burnham K. P., 2002, MODEL SELECTION MULT; Conover M. R., 2001, RESOLVING HUMAN WILD; Conover MR, 2001, WILDLIFE SOC B, V29, P521; Decker D.J., 1996, HUM DIMENSIONS WILDL, V1, P70; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Fournier D.A., 2011, OPTIM METHOD SOFTW, V27, P233, DOI DOI 10.1080/10556788.2011.597854; Fukamachi K, 2001, LANDSCAPE ECOL, V16, P703, DOI 10.1023/A:1014464909698; Ikeda K, 2001, J FOR RES, V54, P121; Inoue Y, 1976, ANN REP NARA DEER RE, V2, P31; Kamei T, 2010, MAMM STUDY, V35, P235, DOI 10.3106/041.035.0403; Kamler JF, 2007, J MAMMAL, V88, P508, DOI 10.1644/06-MAMM-A-169R.1; Kuwabara T, 2010, J RURAL EC, V2010, P305; McCullough DR, 2008, SIKA DEER BIOL MANAG; Ministry of Agriculture Forestry and Fisheries, 2012, REP RES PHYS 2010 WO; Ministry of Internal Affairs and Communications of Japan Statistics Bureau, 2010, POP CENS JAP 2010; Ministry of the Environment, 2011, CHAPT 2 HLTH INT HUM; Miura Shingo, 2009, P453, DOI 10.1007/978-4-431-09429-6_32; Ohtsuka-Ito E, 1998, WILDL CONSERV JPN, V3, P95; Oliver W, 2008, IUCN 2014 IUCN RED L; Pienkowski MW, 1998, J APPL ECOL, V35, P596; R Core Team, 2014, R LANG ENV STAT COMP; Russo D, 2007, EFFECTS LAND ABANDON, P53; Spitz F., 1986, Pig News and Information, V7, P171; Swanson Graeme M., 2009, P595, DOI 10.1007/978-4-431-09429-6_40; Takatsuki Seiki, 2007, Mammal Study, V32, P115, DOI 10.3106/1348-6160(2007)32[115:MVIWFC]2.0.CO;2; Takatsuki S, 1980, VEGETATION NARA PARK, P113; Torii Harumi, 2009, P347, DOI 10.1007/978-4-431-09429-6_25; United Nations Population Division, 2001, REPL MIGR IS SOL DEC; Uno H, 2006, JPN ECOL RES, V21, P215; Uzal A, 2013, EUR J WILDLIFE RES, V59, P563, DOI 10.1007/s10344-013-0705-z; VOGEL WO, 1989, WILDLIFE SOC B, V17, P406; Woodroffe R, 2005, CONSERVATION BIOL; Yamada S, 2007, AGR ECOSYST ENVIRON, V119, P88, DOI 10.1016/j.agee.2006.06.011; Yokoyama M, 2000, ECOL RES, V15, P345, DOI 10.1046/j.1440-1703.2000.00355.x	73	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1612-4642	1439-0574		EUR J WILDLIFE RES	Eur. J. Wildl. Res.	AUG	2015	61	4					517	527		10.1007/s10344-015-0922-8		11	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	CN2OS	WOS:000358262200003		
J	Fukui, T; Inui, T				Fukui, Takao; Inui, Toshio			Use of early phase online vision for grip configuration is modulated according to movement duration in prehension	EXPERIMENTAL BRAIN RESEARCH			English	Article						Reach-to-grasp movements; Movement duration; Online vision; Grip aperture	TO-GRASP MOVEMENTS; CHANGING OBJECT SIZE; VISUAL FEEDBACK; REACHING MOVEMENTS; HAND POSITION; NATURAL PREHENSION; KINEMATIC ANALYSIS; MANUAL PREHENSION; OBSTACLE POSITION; APERTURE CLOSURE	Our previous study (Hum Mov Sci 25:349-371, 2006) investigated whether and how online vision in the early phase of movement influences the control of reach-to-grasp movements (movement duration: approximately 1000 ms). We used liquid-crystal shutter goggles to manipulate the duration of available online vision during the movement and specified that online vision during the early phase influences grasping movements. The current study examined the effect of online early phase vision on the grip configuration according to the movement duration and compared it between two different movement durations (approximately 500 and 1000 ms). We found that non-availability of early phase online vision affected the grip configuration (i.e., inducing a larger peak grip aperture) even in the shorter movement duration. The influential period for online vision for grasping control shifts to an earlier time when movement time is shorter (i.e., from approximately 214 to 106 ms after movement onset), indicating a flexible mechanism for grip configuration according to the movement duration and the available online vision.	[Fukui, Takao; Inui, Toshio] Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan	Fukui, T (reprint author), Res Inst Natl Rehabil, Ctr Persons Disabil, Dept Rehabil Brain Funct, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	fukui-takao@rehab.go.jp			MEXT, Japan [25119503]	The authors wish to thank Dr. Makoto Wada for a discussion of the data analysis. We also thank Dr. Claude Prablanc and anonymous reviewers for their constructive comments on the manuscript. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Constructive Developmental Science" (25119503) from MEXT, Japan.	Alberts JL, 2002, EXP BRAIN RES, V143, P417, DOI 10.1007/s00221-002-1005-0; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; Whitwell RL, 2008, EXP BRAIN RES, V188, P603, DOI 10.1007/s00221-008-1395-8; SOECHTING JF, 1983, J NEUROPHYSIOL, V49, P548; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Gaveau V, 2014, NEUROPSYCHOLOGIA, V55, P25, DOI 10.1016/j.neuropsychologia.2013.12.005; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Hesse C, 2009, J MOTOR BEHAV, V41, P253, DOI 10.3200/JMBR.41.3.253-273; Connolly JD, 1999, EXP BRAIN RES, V125, P281, DOI 10.1007/s002210050684; Chapman CS, 2008, EXP BRAIN RES, V191, P83, DOI 10.1007/s00221-008-1499-1; Bradshaw MF, 2003, SPATIAL VISION, V16, P295, DOI 10.1163/156856803322467545; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297; Brockmole JR, 2013, CURR DIR PSYCHOL SCI, V22, P38, DOI 10.1177/0963721412465065; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Sarlegna FR, 2015, VISION RES, V110, P144, DOI 10.1016/j.visres.2014.07.001; Chapman CS, 2011, NEUROPSYCHOLOGIA, V49, P1703, DOI 10.1016/j.neuropsychologia.2011.02.048; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Sedda A, 2011, EXP BRAIN RES, V209, P365, DOI 10.1007/s00221-011-2559-5; Berthier NE, 1996, J MOTOR BEHAV, V28, P187; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Fukui T, 2006, HUM MOVEMENT SCI, V25, P349, DOI 10.1016/j.humov.2006.02.002; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; Rand MK, 2007, EXP BRAIN RES, V181, P447, DOI 10.1007/s00221-007-0945-9; Churchill A, 2000, EXP BRAIN RES, V134, P81, DOI 10.1007/s002210000444; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Chapman CS, 2010, EXP BRAIN RES, V202, P363, DOI 10.1007/s00221-009-2140-7; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262; Fukui T, 2013, HUM MOVEMENT SCI, V32, P580, DOI 10.1016/j.humov.2013.03.004; GEORGOPOULOS AP, 1981, J NEUROPHYSIOL, V46, P725; Heath M, 2004, EXP BRAIN RES, V158, P378, DOI 10.1007/s00221-004-1988-9; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jeannerod M, 1992, VISION MOTOR CONTROL, P197; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299; Kudoh N, 1997, EXP BRAIN RES, V117, P457, DOI 10.1007/s002210050241; Prablanc C, 2003, PROG BRAIN RES, V142, P155; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; Rand MK, 2006, EXP BRAIN RES, V174, P74, DOI 10.1007/s00221-006-0423-9; ROSSETTI Y, 1994, EXP BRAIN RES, V101, P323; Tubaldi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001795; Turella Luca, 2014, Front Hum Neurosci, V8, P686, DOI 10.3389/fnhum.2014.00686; van de Kamp C, 2009, J MOTOR BEHAV, V41, P427, DOI 10.3200/35-08-033; WALLACE SA, 1988, J MOTOR BEHAV, V20, P81; Whitwell RL, 2009, EXP BRAIN RES, V194, P619, DOI 10.1007/s00221-009-1737-1; WING AM, 1986, J MOTOR BEHAV, V18, P245; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; ZAAL FTJM, 1993, HUM MOVEMENT SCI, V12, P339, DOI 10.1016/0167-9457(93)90023-I	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	AUG	2015	233	8					2257	2268		10.1007/s00221-015-4295-8		12	Neurosciences	Neurosciences & Neurology	CN3JR	WOS:000358322500002		
J	Miyazaki, J; Yamamoto, H; Ichimura, Y; Yamashiro, H; Murase, T; Yamamoto, T; Umeda, M; Higuchi, T				Miyazaki, Jungo; Yamamoto, Hiroki; Ichimura, Yoshikatsu; Yamashiro, Hiroyuki; Murase, Tomokazu; Yamamoto, Tetsuya; Umeda, Masahiro; Higuchi, Toshihiro			Inter-hemispheric desynchronization of the human MT plus during visually induced motion sickness	EXPERIMENTAL BRAIN RESEARCH			English	Article						Human visual cortex; Optokinetic nystagmus (OKN); Vection; Functional magnetic resonance imaging (fMRI); Visual motion	OPTOKINETIC STIMULATION; VESTIBULAR CORTEX; EYE-MOVEMENTS; SELF-MOTION; AREAS; FMRI; SUSCEPTIBILITY; NYSTAGMUS; BRAIN	Visually induced motion sickness (VIMS) is triggered in susceptible individuals by stationary viewing of moving visual scenes. VIMS is often preceded by an illusion of self-motion (vection) and/or by inappropriate optokinetic nystagmus (OKN) responses associated with increased activity in the human motion-sensitive middle temporal area (MT+). Neuroimaging studies have reported predominant right hemispheric activation in MT+ during both vection and OKN, suggesting that VIMS may result from desynchronization of activity between left and right MT+ cortices. However, this possibility has not been directly tested. To this end, we presented VIMS-free and VIMS-inducing movies in that order while measuring the temporal correlations between corresponding left and right visual cortices (including MT+) using functional magnetic resonance imaging. The inter-hemispheric correlation was reduced significantly during the viewing of the VIMS-inducing movie compared to the control VIMS-free movie in the MT+ of subjects reporting VIMS, but not in insusceptible subjects. In contrast, there were no significant inter-hemispheric differences within VIMS-free or VIMS-inducing movie exposure for visual area V1, V2, V3, V3A or V7. Our findings provide the first evidence for an association between asynchronous bilateral MT+ activation and VIMS. Desynchronization of left and right MT+ regions may reflect hemispheric asymmetry in the activities of functional networks involved in eye movement control, vection perception and/or postural control.	[Miyazaki, Jungo; Ichimura, Yoshikatsu] Canon Inc, Corp R&D, Tokyo, Japan; [Yamamoto, Hiroki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Yamashiro, Hiroyuki] Aino Univ, Dept Med Engn, Osaka, Japan; [Murase, Tomokazu; Umeda, Masahiro] Meiji Univ Integrat Med, Dept Med Informat, Kyoto, Japan; [Yamamoto, Tetsuya] Kyoto Univ, Grad Sch Engn, Kyoto 6068501, Japan; [Higuchi, Toshihiro] Meiji Univ Integrat Med, Dept Neurosurg, Kyoto, Japan	Yamamoto, H (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, YoshidaNihonmatsu Cho, Kyoto 6068501, Japan.	yamamoto@cv.jinkan.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23135517, 25135720]; Japan Society for the Promotion of Science (JSPS) [22530793]	We thank Yoshimichi Ejima and Shigeko Takahashi for their helpful comments. We also thank anonymous reviewers for their constructive comments and suggestions. This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan" (23135517, 25135720) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grants-in-Aid for Scientific Research (22530793) from the Japan Society for the Promotion of Science (JSPS) to H. Yamamoto.	Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Smith AT, 2012, CEREB CORTEX, V22, P1068, DOI 10.1093/cercor/bhr179; Huk AC, 2002, J NEUROSCI, V22, P7195; Bos JE, 1998, BRAIN RES BULL, V47, P537, DOI 10.1016/S0361-9230(98)00088-4; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Dieterich M, 2003, EXP BRAIN RES, V148, P117, DOI 10.1007/s00221-002-1267-6; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Dieterich M, 1998, BRAIN, V121, P1479, DOI 10.1093/brain/121.8.1479; REASON JT, 1978, J ROY SOC MED, V71, P819; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Konen CS, 2005, EXP BRAIN RES, V165, P203, DOI 10.1007/s00221-005-2289-7; EBENHOLTZ SM, 1994, AVIAT SPACE ENVIR MD, V65, P1032; Ellis S. R., 1991, Computing Systems in Engineering, V2, DOI 10.1016/0956-0521(91)90001-L; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Bates D, 2014, J STAT SOFTW UNPUB; CHEUNG BSK, 1991, AVIAT SPACE ENVIR MD, V62, P527; De Rosario-Martinez H., 2013, PHIA POSTHOC INTERAC; Ebenholtz SM, 1992, PRESENCE, V1, P302; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; Griffin M. J., 1990, HDB HUMAN VIBRATION; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Kennedy R S, 1968, Acta Otolaryngol, V66, P533, DOI 10.3109/00016486809126317; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI DOI 10.1207/S15327108IJAP0303_; Napadow V, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12084; Napadow V, 2012, CEREB CORTEX, V23, P806, DOI [10.1093/cercor/bhs073, DOI 10.1093/CERCOR/BHS073]; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294; R Development Core Team, 2013, R LANG ENV STAT COMP; Reason JT, 1975, MOTION SICKNESS; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Shupak A, 2006, AVIAT SPACE ENVIR MD, V77, P1213; Yamamoto H, 2008, VISUAL CORTEX NEW RE, P195; Yamamoto H, 2012, HUM BRAIN MAPP, V33, P121, DOI 10.1002/hbm.21200; Yamamoto T, 2009, NEUROSCI RES, V65, pS173, DOI 10.1016/j.neures.2009.09.910; ZAR J.H., 2009, BIOSTATISTICAL ANAL	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	AUG	2015	233	8					2421	2431		10.1007/s00221-015-4312-y		11	Neurosciences	Neurosciences & Neurology	CN3JR	WOS:000358322500018		
J	Matsumura, A; Emoto, MC; Suzuki, S; Iwahara, N; Hisahara, S; Kawamata, J; Suzuki, H; Yamauchi, A; Sato-Akaba, H; Fujii, HG; Shimohama, S				Matsumura, Akihiro; Emoto, Miho C.; Suzuki, Syuuichirou; Iwahara, Naotoshi; Hisahara, Shin; Kawamata, Jun; Suzuki, Hiromi; Yamauchi, Ayano; Sato-Akaba, Hideo; Fujii, Hirotada G.; Shimohama, Shun			Evaluation of oxidative stress in the brain of a transgenic mouse model of Alzheimer disease by in vivo electron paramagnetic resonance imaging	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Alzheimer disease; Hippocampus; EPR; Imaging; ROS; Redox status; Oxidative stress; Microglia; Astrocytes; Amy loid-beta; Free radicals	AMYLOID BETA-PROTEIN; MILD COGNITIVE IMPAIRMENT; REDOX STATUS; A-BETA; NADPH OXIDASE; INFLAMMATORY RESPONSE; APPSWE/PS1DE9 MICE; ESR SPECTROSCOPY; REDUCING ABILITY; MICROGLIAL CELLS	Alzheimer disease (AD) is a neurodegenerative disease clinically characterized by progressive cognitive dysfunction. Deposition of amyloid-beta (A beta) peptides is the most important pathophysiological hallmark of AD. Oxidative stress induced by reactive oxygen species is prominent in AD, and several reports suggest the relationship between a change in redox status and AD pathology containing progressive A beta deposition, the activation of glial cells, and mitochondrial dysfunction. Therefore, we performed immunohistochemical analysis using a transgenic mouse model of AD (APdE9) and evaluated the activity of superoxide dismutase in brain tissue homogenates of ArdE9 mice in vitro. Together with those analyses, in vivo changes in redox status with age in both wild-type (WT) and APdE9 mouse brains were measured noninvasively by three-dimensional electron paramagnetic resonance (EPR) imaging using nitroxide (3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine-1-yloxy) as a redox-sensitive probe. Both methods found similar changes in redox status with age, and in particular a significant change in redox status in the hippocampus was observed noninvasively by EPR imaging between ArdE9 mice and age-matched WT mice from 9 to 18 months of age. EPR imaging clearly visualized the accelerated change in redox status of APdE9 mouse brain compared with WT. The evaluation of the redox status in the brain of AD model rodents by EPR imaging should be useful for diagnostic study of AD. (C) 2015 Elsevier Inc. All rights reserved.	[Matsumura, Akihiro; Suzuki, Syuuichirou; Iwahara, Naotoshi; Hisahara, Shin; Kawamata, Jun; Suzuki, Hiromi; Yamauchi, Ayano; Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido 0608543, Japan; [Emoto, Miho C.; Fujii, Hirotada G.] Sapporo Med Univ, Ctr Med Educ, Sapporo, Hokkaido 0608543, Japan; [Sato-Akaba, Hideo] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Osaka 5608531, Japan	Shimohama, S (reprint author), Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido 0608543, Japan.	shimoha@sapmed.ac.jp			Japan Society for the Promotion of Science (JSPS) [23659460, 24659352]; JSPS [22390180, 26293280, 24791318]; Smoking Research Foundation	We are especially grateful to Dr. Kazuyuki Takata, Dr. Yoshihisa Kitamura, Dr. Masanori Sasaki, Dr. Osamu Honmou, and Dr. Nobuhiro Mikuni for their assistance throughout this study. We thank Mr. Nobuyuki Fukuoka for preparing the manuscript. This study was supported in part by Grant-in-Aid for Challenging Exploratory Research No. 23659460 (S.S.) and 24659352 (AM.) from the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (B) Nos. 22390180 (S.S.) and 26293280 (H.G.F.) from the JSPS, Grant-in-Aid for Young Scientists (B) No, 24791318 (M.C.E,) from the JSPS, and grants from the Smoking Research Foundation (S.S.)	Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kuppusamy P, 2002, CANCER RES, V62, P307; Utsumi H, 2006, J PHARMACOL EXP THER, V317, P228, DOI 10.1124/jpet.105.095166; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Pratico D, 2001, J NEUROSCI, V21, P4183; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Emoto MC, 2014, FREE RADICAL BIO MED, V74, P222, DOI 10.1016/j.freeradbiomed.2014.06.026; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Combs CK, 2001, J NEUROSCI, V21, P1179; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Samuni A, 2002, J AM CHEM SOC, V124, P8719, DOI 10.1021/ja017587h; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Yu LJ, 2015, LIFE SCI, V121, P104, DOI 10.1016/j.lfs.2014.11.021; Zhang C, 2012, J ALZHEIMERS DIS, V28, P655, DOI 10.3233/JAD-2011-111244; Takata K, 2007, FEBS LETT, V581, P475, DOI 10.1016/j.febslet.2007.01.009; Krishna MC, 1996, J BIOL CHEM, V271, P26026; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Zhang W, 2012, NEUROBIOL AGING, V33, P2661, DOI 10.1016/j.neurobiolaging.2011.12.023; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Zhang W, 2012, FREE RADICAL BIO MED, V52, P1443, DOI 10.1016/j.freeradbiomed.2012.01.023; Keller JN, 2005, NEUROLOGY, V64, P1152; Fujii H, 2011, MAGN RESON MED, V65, P295, DOI 10.1002/mrm.22598; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Takata K, 2004, J NEUROSCI RES, V78, P880, DOI 10.1002/jnr.20340; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Caia GL, 2012, J MAGN RESON, V216, P21, DOI 10.1016/j.jmr.2011.10.017; Fujii HG, 2013, MAGN RESON IMAGING, V31, P130, DOI 10.1016/j.mri.2012.06.021; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; Hyun DH, 2010, EXP NEUROL, V225, P423, DOI 10.1016/j.expneurol.2010.07.020; Lee MCI, 2013, J CLIN BIOCHEM NUTR, V52, P1, DOI 10.3164/jcbn.12-58; Lee MC, 2004, HYPERTENS RES, V27, P485, DOI 10.1291/hypres.27.485; Luccarini I, 2012, NEUROSCI LETT, V506, P94, DOI 10.1016/j.neulet.2011.10.056; Matsumura A, 2015, J ALZHEIMERS DIS, V44, P409, DOI 10.3233/JAD-141572; Moreira PI, 2005, J NEURAL TRANSM, V112, P921, DOI 10.1007/s00702-004-0242-8; Nunomura A, 2004, NEUROBIOL DIS, V17, P108, DOI 10.1016/j.nbd.2004.06.003; Prince M, 2014, WORLD ALZHEIMER REPO; Sato-Akaba H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3033161; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Takeshita K, 2002, BBA-GEN SUBJECTS, V1573, P156, DOI 10.1016/S0304-4165(02)00420-8; Utsumi H, 2003, ARCH BIOCHEM BIOPHYS, V416, P1, DOI 10.1016/S0003-9861(03)00285-6; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Yamato M, 2010, FREE RADICAL RES, V44, P249, DOI 10.3109/10715760903456084; Yokoyama H, 2002, NEUROCHEM RES, V27, P243, DOI 10.1023/A:1014840722626; Yokoyama H, 2004, MAGN RESON IMAGING, V22, P1305, DOI 10.1016/j.jmri.2004.09.003	66	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	AUG	2015	85						165	173		10.1016/j.freeradbiomed.2015.04.013		9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CN1RO	WOS:000358198000016		
J	Matsui, H; Takahashi, T; Overby, A; Murayama, SY; Yoshida, H; Yamamoto, Y; Nishiyama, K; Seto, Y; Takahashi, T; Mukai, T; Nakamura, M				Matsui, Hidenori; Takahashi, Tetsufumi; Overby, Anders; Murayama, Somay Yamagata; Yoshida, Haruno; Yamamoto, Yuji; Nishiyama, Keita; Seto, Yasuyuki; Takahashi, Takashi; Mukai, Takao; Nakamura, Masahiko			Mouse Models for Assessing the Protective Efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis Infection Associated with the Development of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	HELICOBACTER			English	Article						Helicobacter suis; Lactobacillus gasseri; MALT lymphoma; C57BL; 6 mouse; quantitative PCR	HEILMANNII-LIKE ORGANISMS; GNOTOBIOTIC MURINE MODEL; PYLORI INFECTION; MALT LYMPHOMA; MICE; INHIBITION; ANIMALS; ANGIOGENESIS; SUPPRESSION; EXPRESSION	BackgroundHelicobacter suis strain TKY infection has been strongly associated with the development of gastric mucosa-associated lymphoid tissue (MALT) lymphoma in a C57BL/6J mouse model. Materials and Methods1. C57BL/6J mice were intragastrically administered Lactobacillus strains once daily with 10(8)-10(9) colony-forming units (CFU), starting 2days before intragastric infection with H.suis TKY (approximately 1x10(4) copies of 16S rRNA genes) or H.pylori Sydney strain 1 (SS1; 3x10(8) CFU) and continuing for 14days after infection. 2. C57BL/6J mice were given powdered feed mixed with lyophilized L.gasseri SBT2055 (LG2055) cells (5x10(8) CFU/g), starting 2weeks before intragastric infection with H.suis TKY and continuing 12months after infection. Results1. Among the 5 Lactobacillus strains that we examined, only LG2055 exhibited significantly preventive efficacy against both H.suis TKY and H.pylori SS1 at day 15 after infection. 2. Dietary supplementation with LG2055 protected mice from the formation of round protrusive lesions in the gastric fundus 12months after infection with H.suis TKY, whereas such lesions had developed in the gastric fundus of nonsupplemented mice 12months after infection. In addition, the formation of lymphoid follicles in gastric mucus layers was suppressed by dietary LG2055 at 3months after infection. ConclusionsLG2055 administration is effective for suppressing the progression of gastric MALT lymphoma by reducing H.suis colonization.	[Matsui, Hidenori; Yoshida, Haruno; Takahashi, Takashi] Kitasato Univ, Kitasato Inst Life, Sci & Grad Sch Infect Control Sci, Dept Infect Control & Immunol,Minato Ku, Tokyo 1088641, Japan; [Takahashi, Tetsufumi; Overby, Anders; Nakamura, Masahiko] Kitasato Univ, Ctr Clin Pharm & Clin Sci, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Murayama, Somay Yamagata] Nihon Univ, Mol Cell Biol Lab, Sch Pharm, Funabashi, Chiba, Japan; [Yamamoto, Yuji; Nishiyama, Keita; Mukai, Takao] Kitasato Univ, Sch Vet Med & Anim Sci, Dept Anim Sci, Towada, Aomori 034, Japan; [Seto, Yasuyuki] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Kawagoe, Saitama, Japan	Matsui, H (reprint author), Kitasato Univ, Kitasato Inst Life, Sci & Grad Sch Infect Control Sci, Dept Infect Control & Immunol,Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	hmatsui@lisci.kitasato-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [21590491, 21580334, 22590690, 25460935, 23790155, 25860099]; Kitasato University	This study was financially supported by grants-in-aid for Scientific Research (C) (nos. 21590491, 21580334, 22590690, and 25460935) and for Young Scientists (B) (nos. 23790155 and 25860099) from the Japan Society for the Promotion of Science (JSPS). Financial support was also provided in the form of a President's Research Fellowship from Kitasato University.	Fujiwara S, 2001, J APPL MICROBIOL, V90, P343, DOI 10.1046/j.1365-2672.2001.01251.x; Yamamoto K, 2014, MUCOSAL IMMUNOL, V7, P1244, DOI 10.1038/mi.2014.14; Mukai T, 2002, FEMS IMMUNOL MED MIC, V32, P105, DOI 10.1016/S0928-8244(01)00284-X; Kabir AMA, 1997, GUT, V41, P49; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Baele M, 2008, INT J SYST EVOL MICR, V58, P1350, DOI 10.1099/ijs.0.65133-0; Matsui H, 2014, HELICOBACTER, V19, P260, DOI 10.1111/hel.12127; Wang KY, 2004, AM J CLIN NUTR, V80, P737; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Baele M, 2009, FEMS IMMUNOL MED MIC, V55, P306, DOI 10.1111/j.1574-695X.2009.00535.x; Aiba Y, 1998, AM J GASTROENTEROL, V93, P2097; Chisholm SA, 2003, DIAGN MICR INFEC DIS, V46, P1, DOI 10.1016/S0732-893(02)00547-3; Connolly E., 2004, NUTRAFOODS, V3, P37; DesBruyne E, 2012, VET MICROBIOL, V160, P449; Dhanani AS, 2013, J APPL MICROBIOL, V115, P546, DOI 10.1111/jam.12249; Foss DL, 2013, J SWINE HEALTH PROD, V21, P242; Fujimura S, 2012, J CLIN MICROBIOL, V50, P1134, DOI 10.1128/JCM.06262-11; Haesebrouck F, 2011, HELICOBACTER, V16, P339, DOI 10.1111/j.1523-5378.2011.00849.x; Kadooka Y, 2012, J PEDIATR GASTR NUTR, V55, P66, DOI 10.1097/MPG.0b013e3182533a2b; Lesbros-Pantoflickova D, 2007, J NUTR, V137, p812S; Lopez-Brea M, 2008, J ANTIMICROB CHEMOTH, V61, P139, DOI 10.1093/jac/dkm404; Matsui H, 2008, ANTIMICROB AGENTS CH, V52, P2988, DOI 10.1128/AAC.01662-07; Matsui H, 2010, CURR TRENDS MICROBIO, V6, P27; Mladenova-Hristova I., 2013, Trakia Journal of Sciences, V11, P299; Nakamura M, 2010, J GASTROEN HEPATOL, V25, pS1, DOI 10.1111/j.1440-1746.2010.06230.x; Nakamura M, 2007, INFECT IMMUN, V75, P1214, DOI 10.1128/IAI.01459-06; Nakamura M., 2007, Inflammopharmacology, V15, P115, DOI 10.1007/s10787-006-1549-x; Nakamura M, 2008, J GASTROEN HEPATOL, V23, pS157, DOI 10.1111/j.1440-1746.2008.05554.x; Nakamura M, 2014, CURR PHARM DESIGN, V20, P1097; Nishikawa K, 2007, FEMS IMMUNOL MED MIC, V50, P268, DOI 10.1111/j.1574-695X.2007.00252.x; Nishiyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108827; Nishiyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083703; Pena JA, 2004, APPL ENVIRON MICROB, V70, P558, DOI 10.1128/AEM.70.1.558-568.2004; Priestnall SL, 2004, J CLIN MICROBIOL, V42, P2144, DOI 10.1128/JCM.42.5.2144-2151.2004; Sakai F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105370; STOLTE M, 1994, SCAND J GASTROENTERO, V29, P1061, DOI 10.3109/00365529409094888; Takahashi T, 2007, HELICOBACTER, V12, P532, DOI 10.1111/j.1523-5378.2007.00524.x; Trebesius K, 2001, J CLIN MICROBIOL, V39, P1510, DOI 10.1128/JCM.39.4.1510-1516.2001	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	AUG	2015	20	4					291	298		10.1111/hel.12203		8	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CN1FT	WOS:000358164300006		
J	Kaneda, H; Furuya, T; Sugito, K; Goto, S; Kawashima, H; Inoue, M; Hosoda, T; Masuko, T; Ohashi, K; Ikeda, T; Koshinaga, T; Hoshino, M; Goto, H				Kaneda, H.; Furuya, T.; Sugito, K.; Goto, S.; Kawashima, H.; Inoue, M.; Hosoda, T.; Masuko, T.; Ohashi, K.; Ikeda, T.; Koshinaga, T.; Hoshino, M.; Goto, H.			Preoperative ultrasonographic evaluation of the contralateral patent processus vaginalis at the level of the internal inguinal ring is useful for predicting contralateral inguinal hernias in children: a prospective analysis	HERNIA			English	Article						Inguinal hernia; Contralateral occurrence; Ultrasonography; Children; Prospective study	DIAGNOSTIC PNEUMOPERITONEUM; LAPAROSCOPIC EVALUATION; PEDIATRIC-PATIENTS; METAANALYSIS; HERNIOGRAPHY; ULTRASOUND	The current study aimed to verify the usefulness of preoperative ultrasonographic evaluation of contralateral patent processus vaginalis (PPV) at the level of the internal inguinal ring. This was a prospective study of patients undergoing unilateral inguinal hernia repair at two institutions during 2010-2011. The sex, age at initial operation, birth weight, initial operation side, and the preoperative diameter of the contralateral PPV as determined using ultrasonography (US) were recorded. We analyzed the incidence of contralateral inguinal hernia, risk factors, and the usefulness of the preoperative major diameter of the contralateral PPV. The follow-up period was 36 months. All 105 patients who underwent unilateral hernia repair completed 36 months of follow-up, during which 11 patients (10.5 %) developed a contralateral hernia. The following covariates were not associated with contralateral hernia development: sex (p = 0.350), age (p = 0.185), birth weight (p = 0.939), and initial operation side (p = 0.350). The preoperative major diameter of the contralateral PPV determined using US was significantly wider among patients with a contralateral hernia than those without a contralateral hernia (p = 0.001). When the 105 patients were divided into two groups according to cut-off values of the preoperative major diameter of the contralateral PPV (wide group, > 2.0 mm; narrow group, a parts per thousand currency sign2.0 mm), a significant association was observed between the preoperative major diameter of the contralateral PPV and patient outcomes (p = 0.001). We used US and confirmed the usefulness of a preoperative evaluation of the major diameter of the contralateral PPV at the level of the internal inguinal ring in pediatric patients with unilateral inguinal hernias.	[Kaneda, H.; Furuya, T.; Sugito, K.; Goto, S.; Kawashima, H.; Inoue, M.; Hosoda, T.; Masuko, T.; Ohashi, K.; Ikeda, T.; Koshinaga, T.] Nihon Univ, Sch Med, Dept Pediat Surg, Itabashi Ku, Tokyo 1738610, Japan; [Hoshino, M.; Goto, H.] Tokyo Metropolitan Otsuka Hosp, Dept Pediat Surg, Toshima Ku, Tokyo, Japan	Sugito, K (reprint author), Nihon Univ, Sch Med, Dept Pediat Surg, Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan.	sugitou.kiminobu@nihon-u.ac.jp; koshinaga.tsugumichi@nihon-u.ac.jp					Chen KC, 1998, J PEDIATR SURG, V33, P1784, DOI 10.1016/S0022-3468(98)90284-6; SPARKMAN RS, 1962, SURGERY, V51, P393; Erez I, 2002, J PEDIATR SURG, V37, P865, DOI 10.1053/jpsu.2002.32889; Chou TY, 1996, RADIOLOGY, V201, P385; DOWNEY EC, 1995, J PEDIATR SURG, V30, P1271, DOI 10.1016/0022-3468(95)90483-2; Hata S, 2004, J PEDIATR SURG, V39, P1396, DOI 10.1016/j.jpedsurg.2004.05.006; Hoshino M, 2014, HERNIA, V18, P333, DOI 10.1007/s10029-013-1099-2; Ikeda H, 2000, J PEDIATR SURG, V35, P1746, DOI 10.1053/jpsu.2000.19239; Juda ZJ, 1996, J PEDIATR SURG, V31, P656; Kervancioglu R, 2000, ACTA RADIOL, V41, P653, DOI 10.1080/028418500127346081; Kokorowski PJ, 2014, HERNIA, V18, P311, DOI 10.1007/s10029-013-1146-z; LAWRENZ K, 1994, CLIN RADIOL, V49, P546, DOI 10.1016/S0009-9260(05)82934-4; Miltenburg DW, 1998, J PEDIATR SURG, V33, P874, DOI 10.1016/S0022-3468(98)90664-9; POWELL RW, 1985, J PEDIATR SURG, V20, P418, DOI 10.1016/S0022-3468(85)80232-3; Stanley TL, 2007, SEMINARS PEDIAT SURG, V16, P50; Sutcliffe JR, 1999, CLIN RADIOL, V54, P468, DOI 10.1016/S0009-9260(99)90835-8; Tackett LD, 1999, J PEDIATR SURG, V34, P684, DOI 10.1016/S0022-3468(99)90356-1; Toki A, 2003, J PEDIATR SURG, V38, P224, DOI 10.1053/jpsu.2003.50048; Van Glabeke E, 1999, J PEDIATR SURG, V34, P1213, DOI 10.1016/S0022-3468(99)90154-9; Watanabe T, 2008, J PEDIATR SURG, V43, P1543, DOI 10.1016/j.jpedsurg.2007.11.010; Wulkan ML, 1996, J PEDIATR SURG, V31, P1174, DOI 10.1016/S0022-3468(96)90112-8	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	AUG	2015	19	4					595	598		10.1007/s10029-014-1317-6		4	Surgery	Surgery	CN3KP	WOS:000358325400008		
J	Tamano, H; Minamino, T; Fujii, H; Takada, S; Nakamura, M; Ando, M; Takeda, A				Tamano, Haruna; Minamino, Tatsuya; Fujii, Hiroaki; Takada, Shunsuke; Nakamura, Masatoshi; Ando, Masaki; Takeda, Atsushi			Blockade of intracellular Zn2+ signaling in the dentate gyrus erases recognition memory via impairment of maintained LTP	HIPPOCAMPUS			English	Article						memory retention; dentate gyrus; Zn2+ signaling; LTP maintenance; F-actin	LONG-TERM POTENTIATION; DENDRITIC SPINES; ACTIN POLYMERIZATION; PKM-ZETA; IN-VIVO; F-ACTIN; ZINC; CAMKII; MAINTENANCE; PLASTICITY	There is no evidence on the precise role of synaptic Zn2+ signaling on the retention and recall of recognition memory. On the basis of the findings that intracellular Zn2+ signaling in the dentate gyrus is required for object recognition, short-term memory, the present study deals with the effect of spatiotemporally blocking Zn2+ signaling in the dentate gyrus after LTP induction and learning. Three-day-maintained LTP was impaired 1 day after injection of clioquinol into the dentate gyrus, which transiently reduced intracellular Zn2+ signaling in the dentate gyrus. The irreversible impairment was rescued not only by co-injection of ZnCl2, which ameliorated the loss of Zn2+ signaling, but also by pre-injection of Jasplakinolide, a stabilizer of F-actin, prior to clioquinol injection. Simultaneously, 3-day-old space recognition memory was impaired 1 day after injection of clioquinol into the dentate gyrus, but not by pre-injection of Jasplakinolide. Jasplakinolide also rescued both impairments of 3-day-maintained LTP and 3-day-old memory after injection of ZnAF-2DA into the dentate gyrus, which blocked intracellular Zn2+ signaling in the dentate gyrus. The present paper indicates that the blockade and/or loss of intracellular Zn2+ signaling in the dentate gyrus coincidently impair maintained LTP and recognition memory. The mechanism maintaining LTP via intracellular Zn2+ signaling in dentate granule cells, which may be involved in the formation of F-actin, may retain space recognition memory. (c) 2015 Wiley Periodicals, Inc.	[Tamano, Haruna; Minamino, Tatsuya; Ando, Masaki; Takeda, Atsushi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, Shizuoka 4228526, Japan; [Fujii, Hiroaki; Takada, Shunsuke; Nakamura, Masatoshi; Takeda, Atsushi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Shizuoka 4228526, Japan	Takeda, A (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp					Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145, DOI 10.1016/S0074-7742(08)60279-2; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Takeda A, 2010, NEUROSCIENCE, V171, P443, DOI 10.1016/j.neuroscience.2010.09.017; Lee SJ, 2011, J BIOL CHEM, V286, P40847, DOI 10.1074/jbc.M111.245993; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Ding JD, 2013, J COMP NEUROL, V521, P3570, DOI 10.1002/cne.23372; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; VALLEE BL, 1993, PHYSIOL REV, V73, P79; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; ElsGhazi I, 2006, EXP BIOL MED, V231, P1500; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Ismail T, 2008, NEUROSCIENCE, V157, P697, DOI 10.1016/j.neuroscience.2008.09.011; Kerkhoff E, 2011, EUR J CELL BIOL, V90, P922, DOI 10.1016/j.ejcb.2010.10.011; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Martel G, 2011, BEHAV BRAIN RES, V223, P233, DOI 10.1016/j.bbr.2011.04.020; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; Takeda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028615; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Yang XW, 2013, BBA-GEN SUBJECTS, V1830, P4179, DOI 10.1016/j.bbagen.2013.04.030	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	AUG	2015	25	8					952	962		10.1002/hipo.22418		11	Neurosciences	Neurosciences & Neurology	CN1JS	WOS:000358176400008		
J	Weber, SM; Ribero, D; O'Reilly, EM; Kokudo, N; Miyazaki, M; Pawlik, TM				Weber, Sharon M.; Ribero, Dario; O'Reilly, Eileen M.; Kokudo, Norihiro; Miyazaki, Masaru; Pawlik, Timothy M.			Intrahepatic Cholangiocarcinoma: expert consensus statement	HPB			English	Article							COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA; BILIARY-TRACT CANCERS; HILAR CHOLANGIOCARCINOMA; GALLBLADDER CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; PERIPHERAL CHOLANGIOCARCINOMA; PERIHILAR CHOLANGIOCARCINOMA; ADJUVANT CHEMOTHERAPY; STAGING LAPAROSCOPY; PROGNOSTIC-FACTORS	An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists met on 15 January 2014 to review current evidence on the management of intrahepatic cholangiocarcinoma (ICC) in order to establish practice guidelines and to agree on consensus statements. The treatment of ICC requires a coordinated, multidisciplinary approach to optimize survival. Biopsy is not necessary if the surgeon suspects ICC and is planning curative resection, although biopsy should be obtained before systemic or locoregional therapies are initiated. Assessment of resectability is best accomplished using cross-sectional imaging [computed tomography (CT) or magnetic resonance imaging (MRI)], but the role of positron emission tomography (PET) is unclear. Resectability in ICC is defined by the ability to completely remove the disease while leaving an adequate liver remnant. Extrahepatic disease, multiple bilobar or multicentric tumours, and lymph node metastases beyond the primary echelon are contraindications to resection. Regional lymphadenectomy should be considered a standard part of surgical therapy. In patients with high-risk features, the routine use of diagnostic laparoscopy is recommended. The preoperative diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) by imaging studies is extremely difficult. Surgical resection remains the mainstay of treatment, but survival is worse than in HCC alone. There are no adequately powered, randomized Phase III trials that can provide definitive recommendations for adjuvant therapy for ICC. Patients with high-risk features (lymphovascular invasion, multicentricity or satellitosis, large tumours) should be encouraged to enrol in clinical trials and to consider adjuvant therapy. Cisplatin plus gemcitabine represents the standard-of-care, front-line systemic therapy for metastatic ICC. Genomic analyses of biliary cancers support the development of targeted therapeutic interventions.	[Weber, Sharon M.] Univ Wisconsin, Dept Surg, Madison, WI 53792 USA; [Ribero, Dario] Mauriziano Umberto I Hosp, Dept Gen Surg & Surg Oncol, Turin, Italy; [O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA; [Kokudo, Norihiro] Univ Tokyo, Artificial Organ & Liver Transplantat Div, Hepatobiliary Pancreat Surg Div, Dept Surg,Grad Sch Med, Tokyo, Japan; [Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Surg, Chiba, Japan; [Pawlik, Timothy M.] Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA	Weber, SM (reprint author), Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Clin Sci Ctr 7375, H4-730,600 Highland Ave, Madison, WI 53792 USA.	webers@surgery.wisc.edu					Ali SM, 2013, ANN SURG ONCOL, V20, P2023, DOI 10.1245/s10434-012-2808-2; Sulpice L, 2012, BRIT J SURG, V99, P1711, DOI 10.1002/bjs.8953; Chong YS, 2012, CLIN RADIOL, V67, P766, DOI 10.1016/j.crad.2012.01.004; Lee J, 2012, LANCET ONCOL, V13, P181, DOI 10.1016/S1470-2045(11)70301-1; Tamandl D, 2008, ANN SURG ONCOL, V15, P2787, DOI 10.1245/s10434-008-0081-1; Takada T, 2002, CANCER, V95, P1685, DOI 10.1002/cncr.10831; Portolani N, 2008, ANN SURG ONCOL, V15, P1880, DOI 10.1245/s10434-008-9933-y; Nakagawa T, 2005, WORLD J SURG, V29, P728, DOI 10.1007/s00268-005-7761-9; Lang H, 2009, J AM COLL SURGEONS, V208, P218, DOI 10.1016/j.jamcollsurg.2008.10.017; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Jarnagin WR, 2002, CANCER, V94, P2040, DOI 10.1002/cncr.10392; Hoffmann RT, 2012, CARDIOVASC INTER RAD, V35, P105, DOI 10.1007/s00270-011-0142-x; Park SY, 2011, CLIN RADIOL, V66, P322, DOI 10.1016/j.crad.2010.11.002; HAMRICKTURNER J, 1992, AM J ROENTGENOL, V158, P77; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Goere D, 2006, SURG ENDOSC, V20, P721, DOI 10.1007/s00464-005-0583-x; El-Serag HB, 2009, HEPATOLOGY, V49, P116, DOI 10.1002/hep.22606; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Corvera CU, 2008, J AM COLL SURGEONS, V206, P57, DOI 10.1016/j.jamcollsurg.2007.07.002; Fowler KJ, 2013, AM J ROENTGENOL, V201, P332, DOI 10.2214/AJR.12.9488; Thomas MB, 2007, CRIT REV ONCOL HEMAT, V61, P44, DOI 10.1016/j.critrevonc.2006.07.006; Valls C, 2000, ABDOM IMAGING, V25, P490, DOI 10.1007/s002610000079; Ibrahim SM, 2008, CANCER, V113, P2119, DOI 10.1002/cncr.23818; Shimada K, 2009, SURGERY, V145, P411, DOI 10.1016/j.surg.2008.11.010; GOODMAN ZD, 1985, CANCER, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z; Ribero D, 2012, ARCH SURG-CHICAGO, V147, P1107, DOI 10.1001/archsurg.2012.1962; ALLEN RA, 1949, AM J PATHOL, V25, P647; Koh KC, 2005, AM J SURG, V189, P120, DOI 10.1016/j.amjsurg.2004.03.018; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Jarnagin WR, 2009, ANN ONCOL, V20, P1589, DOI 10.1093/annonc/mdp029; Dodson RM, 2013, J AM COLL SURGEONS, V217, P736, DOI 10.1016/j.jamcollsurg.2013.05.021; Weber SM, 2001, J AM COLL SURGEONS, V193, P384, DOI 10.1016/S1072-7515(01)01016-X; Farges O, 2011, ANN SURG, V254, P824, DOI 10.1097/SLA.0b013e318236c21d; Yin X, 2012, ANN SURG ONCOL, V19, P2869, DOI 10.1245/s10434-012-2328-0; PITT HA, 1995, ANN SURG, V221, P788, DOI 10.1097/00000658-199506000-00017; Kuhlmann JB, 2012, EUR J GASTROEN HEPAT, V24, P437, DOI 10.1097/MEG.0b013e3283502241; Nathan H, 2009, ANN SURG ONCOL, V16, P14, DOI 10.1245/s10434-008-0180-z; Ercolani G, 2010, ANN SURG, V252, P107, DOI 10.1097/SLA.0b013e3181e462e6; Hasegawa S, 2007, WORLD J SURG, V31, P1256, DOI 10.1007/s00268-007-9001-y; Aoba T, 2013, ANN SURG, V257, P718, DOI 10.1097/SLA.0b013e3182822277; Kim YJ, 2003, EUR J NUCL MED MOL I, V30, P1467, DOI 10.1007/s00259-003-1297-8; D'Angelica M, 2003, ANN SURG ONCOL, V10, P183, DOI 10.1245/ASO.2003.03.091; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Farges O, 2011, CANCER-AM CANCER SOC, V117, P2170, DOI 10.1002/cncr.25712; Hezel AF, 2008, ONCOLOGIST, V13, P415, DOI 10.1634/theoncologist.2007-0252; Saxena A, 2010, ANN SURG ONCOL, V17, P484, DOI 10.1245/s10434-009-0777-x; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Lee JH, 2011, J CLIN GASTROENTEROL, V45, P69, DOI 10.1097/MCG.0b013e3181ce5dfa; Neoptolemos JP, 2012, JAMA-J AM MED ASSOC, V308, P147, DOI 10.1001/jama.2012.7352; El Rassi Z, 1999, EUR J SURG ONCOL, V25, P375; Groeschl RT, 2013, J SURG ONCOL, V107, P608, DOI 10.1002/jso.23289; Kiefer MV, 2011, CANCER-AM CANCER SOC, V117, P1498, DOI 10.1002/cncr.25625; Yano Y, 2003, JPN J CLIN ONCOL, V33, P283, DOI 10.1093/jjco/hyg056; Jarnagin WR, 2003, CANCER, V98, P1689, DOI 10.1002/cncr.11699; Vogl TJ, 2012, INT J CANCER, V131, P733, DOI 10.1002/ijc.26407; Todoroki T, 2000, INT J RADIAT ONCOL, V46, P581, DOI 10.1016/S0360-3016(99)00472-1; Gleeson FC, 2008, GASTROINTEST ENDOSC, V67, P438, DOI 10.1016/j.gie.2007.07.018; Maithel SK, 2013, CANCER-AM CANCER SOC, V119, P3929, DOI 10.1002/cncr.28312; desJong MC, 2011, J CLIN ONCOL, V29, P3140; Eckel F, 2007, EXPERT OPIN EMERG DR, V12, P571, DOI 10.1517/14728214.12.4.571; Edge S, 2009, AJCC CANC STAGING MA; Hammill CW, 2008, J AM COLL SURGEONS, V207, P594, DOI 10.1016/j.jamcollsurg.2008.04.031; Hyder H, 2014, JAMA SURG, V149, P432; Jarnagin WR, 2006, J CLIN ONCOL, V24, P1152, DOI 10.1200/JCO.2005.04.6631; Jonas S, 2009, ANN SURG, V249, P303, DOI 10.1097/SLA.0b013e318195e164; Kim KH, 2009, ANN SURG ONCOL, V16, P623, DOI 10.1245/s10434-008-0278-3; Levy MJ, 2012, CURR OPIN GASTROEN, V28, P244, DOI 10.1097/MOG.0b013e32835005bc; Liver Cancer Study Group of Japan, 1989, JPN J SURG, V19, P98; Luo XW, 2014, J GASTROINTEST SURG, V18, P562, DOI 10.1007/s11605-013-2447-3; Macdonald O Kenneth, 2002, Surg Oncol Clin N Am, V11, P941, DOI 10.1016/S1055-3207(02)00038-8; MURAKAMI T, 1995, JMRI-J MAGN RESON IM, V5, P165, DOI 10.1002/jmri.1880050210; Nathan H, 2007, J GASTROINTEST SURG, V11, P1488, DOI 10.1007/s11605-007-0282-0; Ohtsuka M, 2009, HEPATO-GASTROENTEROL, V56, P1; Okami J, 2003, J GASTROINTEST SURG, V7, P850, DOI 10.1016/S1091-255X(03)00140-9; Shen WF, 2011, WORLD J SURG, V35, P2083, DOI 10.1007/s00268-011-1171-y; Subbiah Ishwaria M, 2013, Oncotarget, V4, P153; Theise ND, 2010, WHO CLASSIFICATION T, P225; Wang J, 2010, J ONCOL, V2010; Xu HX, 2012, BRIT J RADIOL, V1016, P1029; Yamamoto M, 2001, J Hepatobiliary Pancreat Surg, V8, P154, DOI 10.1007/s005340170039	80	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1365-182X	1477-2574		HPB	HPB	AUG	2015	17	8					669	680		10.1111/hpb.12441		12	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN0ZL	WOS:000358144500004		
J	Mansour, JC; Aloia, TA; Crane, CH; Heimbach, JK; Nagino, M; Vauthey, JN				Mansour, John C.; Aloia, Thomas A.; Crane, Christopher H.; Heimbach, Julie K.; Nagino, Masato; Vauthey, Jean-Nicolas			Hilar Cholangiocarcinoma: expert consensus statement	HPB			English	Article							PREOPERATIVE BILIARY DRAINAGE; ENDOSCOPIC NASOBILIARY DRAINAGE; PRIMARY SCLEROSING CHOLANGITIS; PORTAL-VEIN EMBOLIZATION; IN-SITU HYBRIDIZATION; RANDOMIZED PHASE-II; PERIHILAR CHOLANGIOCARCINOMA; LIVER-TRANSPLANTATION; TRACT CANCER; SURGICAL-TREATMENT	An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists met on 15 January 2014 to review current evidence on the management of hilar cholangiocarcinoma in order to establish practice guidelines and to agree consensus statements. It was established that the treatment of patients with hilar cholangiocarcinoma requires a coordinated, multidisciplinary approach to optimize the chances for both durable survival and effective palliation. An adequate diagnostic and staging work-up includes high-quality cross-sectional imaging; however, pathologic confirmation is not required prior to resection or initiation of a liver transplant trimodal treatment protocol. The ideal treatment for suitable patients with resectable hilar malignancy is resection of the intra- and extrahepatic bile ducts, as well as resection of the involved ipsilateral liver. Preoperative biliary drainage is best achieved with percutaneous transhepatic approaches and may be indicated for patients with cholangitis, malnutrition or hepatic insufficiency. Portal vein embolization is a safe and effective strategy for increasing the future liver remnant (FLR) and is particularly useful for patients with an FLR of <30%. Selected patients with unresectable hilar cholangiocarcinoma should be evaluated for a standard trimodal protocol incorporating external beam and endoluminal radiation therapy, systemic chemotherapy and liver transplantation. Post-resection chemoradiation should be offered to patients who show high-risk features on surgical pathology. Chemoradiation is also recommended for patients with locally advanced, unresectable hilar cancers. For patients with locally recurrent or metastatic hilar cholangiocarcinoma, first-line chemotherapy with gemcitabine and cisplatin is recommended based on multiple Phase II trials and a large randomized controlled trial including a heterogeneous population of patients with biliary cancers.	[Mansour, John C.] Univ Texas Southwestern, Div Surg Oncol, Dallas, TX USA; [Aloia, Thomas A.; Vauthey, Jean-Nicolas] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Crane, Christopher H.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Heimbach, Julie K.] Mayo Clin, Dept Surg, Rochester, MN USA; [Nagino, Masato] Nagoya Univ, Dept Surg, Nagoya, Aichi 4648601, Japan	Mansour, JC (reprint author), UT Southwestern Med Ctr, Div Surg Oncol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	john.mansour@utsouthwestern.edu					Malka D, 2014, LANCET ONCOL, V15, P819, DOI 10.1016/S1470-2045(14)70212-8; Hong JC, 2011, ARCH SURG-CHICAGO, V146, P683, DOI 10.1001/archsurg.2011.116; Iacono C, 2013, ANN SURG, V257, P191, DOI 10.1097/SLA.0b013e31826f4b0e; VAUTHEY JN, 1994, SEMIN LIVER DIS, V14, P109, DOI 10.1055/s-2007-1007302; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Walter T, 2013, J VASC INTERV RADIOL, V24, P113, DOI 10.1016/j.jvir.2012.09.019; Bangarulingam SY, 2010, HEPATOLOGY, V51, P174, DOI 10.1002/hep.23277; Song SC, 2013, ANZ J SURG, V83, P268, DOI 10.1111/j.1445-2197.2012.06195.x; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Aloia TA, 2007, AM J SURG, V193, P702, DOI 10.1016/j.amjsurg.2006.10.024; Alberts SR, 2005, CANCER, V103, P111, DOI 10.1002/cncr.20753; Kobayashi A, 2010, BRIT J SURG, V97, P56, DOI 10.1002/bjs.6788; Tsavaris N, 2004, INVEST NEW DRUG, V22, P193, DOI 10.1023/B:DRUG.0000011797.09549.53; Valek V, 2007, EUR J RADIOL, V62, P175, DOI 10.1016/j.ejrad.2007.01.037; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Ghafoori AP, 2011, INT J RADIAT ONCOL, V81, P654, DOI 10.1016/j.ijrobp.2010.06.018; Kubicka S, 2001, HEPATO-GASTROENTEROL, V48, P783; Cheng QB, 2012, EJSO-EUR J SURG ONC, V38, P1197, DOI 10.1016/j.ejso.2012.08.009; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Kim TH, 2011, INT J RADIAT ONCOL, V81, pE853, DOI 10.1016/j.ijrobp.2010.12.019; Laurent A, 2008, HPB, V10, P126, DOI 10.1080/13651820802007472; Cheng Q, 2007, EJSO-EUR J SURG ONC, V33, P202, DOI 10.1016/j.ejso.2006.09.033; PITT HA, 1995, ANN SURG, V221, P788, DOI 10.1097/00000658-199506000-00017; Juntermanns B, 2013, ANN SURG ONCOL, V20, P277, DOI 10.1245/s10434-012-2486-0; Kow AWC, 2012, WORLD J SURG, V36, P1112, DOI 10.1007/s00268-012-1497-0; Abulkhir A, 2008, ANN SURG, V247, P49, DOI 10.1097/SLA.0b013e31815f6e5b; Hasegawa S, 2007, WORLD J SURG, V31, P1256, DOI 10.1007/s00268-007-9001-y; Andre T, 2004, ANN ONCOL, V15, P1339, DOI 10.1093/annonc/mdh351; Lee SG, 2010, J HEPATO-BIL-PAN SCI, V17, P476, DOI 10.1007/s00534-009-0204-5; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Nuzzo G, 2012, ARCH SURG-CHICAGO, V147, P26, DOI 10.1001/archsurg.2011.771; Valle JW, 2009, BRIT J CANCER, V101, P621, DOI 10.1038/sj.bjc.6605211; [Anonymous], 1999, NEW ENGL J MED; Rea DJ, 2004, ARCH SURG-CHICAGO, V139, P514, DOI 10.1001/archsurg.139.5.514; WETTER LA, 1991, AM J SURG, V161, P57, DOI 10.1016/0002-9610(91)90361-G; Patel AH, 2000, AM J GASTROENTEROL, V95, P204; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Paik WH, 2009, GASTROINTEST ENDOSC, V69, P55, DOI 10.1016/j.gie.2008.04.005; Halling KC, 2007, HUM PATHOL, V38, P1137, DOI 10.1016/j.humpath.2007.04.015; Heimbach JK, 2011, HPB, V13, P356, DOI 10.1111/j.1477-2574.2011.00298.x; Kipp BR, 2004, AM J GASTROENTEROL, V99, P1675, DOI 10.1111/j.1572-0241.2004.30281.x; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Kim S, 2002, INT J RADIAT ONCOL, V54, P414, DOI 10.1016/S0360-3016(02)02952-8; Jarnagin WR, 2003, CANCER, V98, P1689, DOI 10.1002/cncr.11699; Borghero Y, 2008, ANN SURG ONCOL, V15, P3147, DOI 10.1245/s10434-008-9998-7; Todoroki T, 2000, INT J RADIAT ONCOL, V46, P581, DOI 10.1016/S0360-3016(99)00472-1; Nimura Y, 2008, HPB, V10, P130, DOI 10.1080/13651820801992666; BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170; Rocha FG, 2010, J HEPATO-BIL-PAN SCI, V17, P490, DOI 10.1007/s00534-009-0205-4; Blechacz BRA, 2009, CURR OPIN GASTROEN, V25, P238, DOI 10.1097/MOG.0b013e3283292383; Breitenstein S, 2008, HPB, V10, P120, DOI 10.1080/13651820801992583; Darwish Murad S, 2012, GASTROENTEROLOGY, V143, P88, DOI DOI 10.1053/J.GASTR0.2012.04.008; DesBellis M, 2002, GASTROINTEST ENDOSC, V56, P552; Edge SB, 2010, AJCC CANC STAGING MA; George Cherian, 2010, World J Gastrointest Oncol, V2, P146, DOI 10.4251/wjgo.v2.i3.146; Heimbach JK, 2004, LIVER TRANSPL S2, V10, P65; Hsu C, 2004, BRIT J CANCER, V90, P1715, DOI 10.1038/sj.bjc.6601796; Jarnagin William, 2005, HPB (Oxford), V7, P244, DOI 10.1080/13651820500372533; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Juntermanns B, 2011, HEPATO-GASTROENTEROL, V58, P265; Knox JJ, 2004, ANN ONCOL, V15, P770, DOI 10.1093/annonc/mdh172; Kornek GV, 2004, ANN ONCOL, V15, P478, DOI 10.1093/annonc/mdh096; Kuhn R, 2002, INVEST NEW DRUG, V20, P351, DOI 10.1023/A:1016209901417; McCormack L, 2006, AM J TRANSPLANT, V6, P1731, DOI 10.1111/j.1600-6143.2006.01358.x; Merion RM, 2004, LIVER TRANSPLANT, V10, P69; Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; Nakeeb A, 2002, SURGERY, V132, P555, DOI 10.1067/msy.2002.127555; Nishio Hideki, 2005, HPB (Oxford), V7, P259, DOI 10.1080/13651820500373010; Palavecino M, 2009, SURG ONCOL CLIN N AM, V18, P257, DOI 10.1016/j.soc.2008.12.007; Rea DJ, 2005, ANN SURG, V242, P451, DOI 10.1097/01.sla.0000179678.13285.fa; Rea DJ, 2004, ARCH SURG-CHICAGO, V139, P523; vansDelden OM, 2008, EUR RADIOL, V18, P448; Vauthey Jean-Nicolas, 2003, Radiology, V227, P107, DOI 10.1148/radiol.2271010938; Wahab Mohamed Abdel, 2012, Hepatogastroenterology, V59, P321, DOI 10.5754/hge11999	75	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1365-182X	1477-2574		HPB	HPB	AUG	2015	17	8					691	699		10.1111/hpb.12450		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN0ZL	WOS:000358144500006		
J	Ito, A; Abe, N; Kawachi, Y; Kawasaki, I; Ueno, A; Yoshida, K; Sakai, S; Matsue, Y; Fujii, T				Ito, Ayahito; Abe, Nobuhito; Kawachi, Yousuke; Kawasaki, Iori; Ueno, Aya; Yoshida, Kazuki; Sakai, Shinya; Matsue, Yoshihiko; Fujii, Toshikatsu			Distinct neural correlates of the preference-related valuation of supraliminally and subliminally presented faces	HUMAN BRAIN MAPPING			English	Article						preference; value; subliminal; ventral striatum; ventromedial prefrontal cortex; dorsomedial prefrontal cortex	VENTROMEDIAL PREFRONTAL CORTEX; MEDIAL ORBITOFRONTAL CORTEX; HUMAN BRAIN; FACIAL ATTRACTIVENESS; REWARD VALUE; MERE EXPOSURE; GOAL VALUES; FMRI; CHOICE; SYSTEM	Recent neuroimaging studies have investigated the neural substrates involved in the valuation of supraliminally presented targets and the subsequent preference decisions. However, the neural mechanisms of the valuation of subliminally presented targets, which can guide subsequent preference decisions, remain to be explored. In the present study, we determined whether the neural systems associated with the valuation of supraliminally presented faces are involved in the valuation of subliminally presented faces. The subjects were supraliminally and subliminally presented with faces during functional magnetic resonance imaging (fMRI). Following fMRI, the subjects were presented with pairs of faces and were asked to choose which face they preferred. We analyzed brain activation by back-sorting the fMRI data according to the subjects' choices. The present study yielded two main findings. First, the ventral striatum and the ventromedial prefrontal cortex predict preferences only for supraliminally presented faces. Second, the dorsomedial prefrontal cortex may predict preferences for subliminally presented faces. These findings indicate that neural correlates of the preference-related valuation of faces are dissociable, contingent upon whether the subjects consciously perceive the faces. Hum Brain Mapp 36:2865-2877, 2015. (c) 2015 Wiley Periodicals, Inc.	[Ito, Ayahito; Abe, Nobuhito] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan; [Ito, Ayahito; Ueno, Aya] Japan Soc Promot Sci, Tokyo, Japan; [Kawachi, Yousuke; Matsue, Yoshihiko; Fujii, Toshikatsu] Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi 9893201, Japan; [Kawasaki, Iori] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Ueno, Aya] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan; [Yoshida, Kazuki] Hokkaido Univ, Div Hlth Sci, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Sakai, Shinya] Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Sapporo, Hokkaido, Japan	Ito, A (reprint author), Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Aoba Ku, 6-149-1 Kunimigaoka, Sendai, Miyagi 9893201, Japan.	ayahito.ito@gmail.com			Japan Society for the Promotion of Science (JSPS) [13J03819, 24300102]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21120007]; Uehiro Foundation on Ethics and Education	Contract grant sponsor: Japan Society for the Promotion of Science (JSPS); Contract grant numbers: 13J03819 (to A.I.) and 24300102 (to T.F.); Contract grant sponsor: The Ministry of Education, Culture, Sports, Science and Technology (MEXT); Contract grant numbers: 21120007 (to T.F.); Contract grant sponsor: The Uehiro Foundation on Ethics and Education (to N.A.)	Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Izuma K, 2013, NEURON, V78, P563, DOI 10.1016/j.neuron.2013.03.023; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Salimpoor VN, 2013, SCIENCE, V340, P216, DOI 10.1126/science.1231059; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; McNamee D, 2013, NAT NEUROSCI, V16, P479, DOI 10.1038/nn.3337; MURPHY ST, 1995, J PERS SOC PSYCHOL, V69, P589, DOI 10.1037/0022-3514.69.4.589; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Karremans JC, 2006, J EXP SOC PSYCHOL, V42, P792, DOI 10.1016/j.jesp.2005.12.002; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Oei NYL, 2012, NEUROPSYCHOPHARMACOL, V37, P1729, DOI 10.1038/npp.2012.19; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; Scheele D, 2013, P NATL ACAD SCI USA, V110, P20308, DOI 10.1073/pnas.1314190110; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Tsukiura T, 2011, SOC COGN AFFECT NEUR, V6, P138, DOI 10.1093/scan/nsq025; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Monahan JL, 2000, PSYCHOL SCI, V11, P462, DOI 10.1111/1467-9280.00289; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; HABER SN, 1995, J NEUROSCI, V15, P4851; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Brett M., 2002, NEUROIMAGE, V16, P2; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Falk Emily B, 2014, J Adolesc Health, V54, pS22, DOI 10.1016/j.jadohealth.2013.12.035; Gillath O, 2012, SOC COGN AFFECT NEUR, V7, P924, DOI 10.1093/scan/nsr065; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P503, DOI 10.1016/B978-0-12-374176-9.00032-4; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Lebreton M, 2012, J NEUROSCI, V32, P7146, DOI 10.1523/JNEUROSCI.4821-11.2012; Park J, 2010, P NATL ACAD SCI USA, V107, P14552, DOI 10.1073/pnas.1004374107; Rigoard P, 2011, NEUROSURGERY, V68, P1102, DOI 10.1227/NEU.0b013e3182098e48; Ueno A, 2014, NEUROSCI LETT, V566, P142, DOI 10.1016/j.neulet.2014.02.047; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	AUG	2015	36	8					2865	2877		10.1002/hbm.22813		13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CM8KP	WOS:000357949900002		
J	Aoyagi, K; Rossignol, E; Hamdan, FF; Mulcahy, B; Xie, L; Nagamatsu, S; Rouleau, GA; Zhen, M; Michaud, JL				Aoyagi, Kyota; Rossignol, Elsa; Hamdan, Fadi F.; Mulcahy, Ben; Xie, Lin; Nagamatsu, Shinya; Rouleau, Guy A.; Zhen, Mei; Michaud, Jacques L.			A Gain-of-Function Mutation in NALCN in a Child with Intellectual Disability, Ataxia, and Arthrogryposis	HUMAN MUTATION			English	Article						NALCN; de novo; gain-of-function; C; elegans; Na+-leak	SODIUM LEAK CHANNEL; NEURONAL EXCITABILITY; CATION CHANNEL; LOCOMOTION; HYPOTONIA; DELAY	NALCN and its homologues code for the ion channel responsible for half of background Na+-leak conductance in vertebrate and invertebrate neurons. Recessive mutations in human NALCN cause intellectual disability (ID) with hypotonia. Here, we report a de novo heterozygous mutation in NALCN affecting a conserved residue (p.R1181Q) in a girl with ID, episodic and persistent ataxia, and arthrogryposis. Interestingly, her episodes of ataxia were abolished by the administration of acetazolamide, similar to the response observed in episodic ataxia associated with other ion channels. Introducing the analogous mutation in the Caenorhabditis elegans homologue nca-1 induced a coiling locomotion phenotype, identical to that obtained with previously characterized C. elegans gain-of-function nca alleles, suggesting that p.R1181Q confers the same property to NALCN. This observation thus suggests that dominant mutations in NALCN can cause a neurodevelopmental phenotype that overlaps with, while being mostly distinct from that associated with recessive mutations in the same gene.	[Aoyagi, Kyota; Nagamatsu, Shinya] Kyorin Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Rossignol, Elsa; Hamdan, Fadi F.; Michaud, Jacques L.] CHU St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Rossignol, Elsa; Michaud, Jacques L.] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Rossignol, Elsa; Michaud, Jacques L.] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Mulcahy, Ben; Xie, Lin; Zhen, Mei] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5S 1A8, Canada; [Mulcahy, Ben; Xie, Lin; Zhen, Mei] Univ Toronto, Inst Med Sci, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Michaud, JL (reprint author), CHU St Justine Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	zhen@lunenfeld.ca; jacques.michaud@recherche-ste-justine.qc.ca			Canadian Institutes of Health Research [FRN 119440, MOP 209314]	Contract grant sponsor: Canadian Institutes of Health Research (FRN 119440, MOP 209314).	Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Spacey SD, 2004, ANN NEUROL, V56, P213, DOI 10.1002/ana.20169; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Xie L, 2013, NEURON, V77, P1069, DOI 10.1016/j.neuron.2013.01.018; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Al-Sayed MD, 2013, AM J HUM GENET, V93, P721, DOI 10.1016/j.ajhg.2013.08.001; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Gao SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7323; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Koroglu C, 2013, J MED GENET, V50, P515, DOI 10.1136/jmedgenet-2013-101634; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; vansden Bogaard R, 2000, EUR J HUM GENET, V8, P513; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	AUG	2015	36	8					753	757		10.1002/humu.22797		5	Genetics & Heredity	Genetics & Heredity	CN4CM	WOS:000358376600004		
J	Mitsuyama, S; Ohtsubo, M; Minoshima, S; Shimizu, N				Mitsuyama, Susumu; Ohtsubo, Masafumi; Minoshima, Shinsei; Shimizu, Nobuyoshi			The KM-parkin-DB: A Sub-set MutationView Database Specialized for PARK2 (PARKIN) Variants	HUMAN MUTATION			English	Article						Parkinson disease; PARKIN; PARK2; Database	UBIQUITIN-PROTEIN LIGASE; DISEASE; GENE; LOCUS	We previously isolated PARKIN (PARK2) as a gene responsible for a unique sort of Parkinson disease, namely Autosomal Recessive Juvenile Parkinsonism (ARJP). In this study, we surveyed all the available literature describing PARK2 gene/Parkin protein mutations found in Parkinson disease patients. Only carefully evaluated data were deposited in the graphical database MutationView () to construct KM-parkin-DB, an independent sub-set database. Forty-four articles were selected for data curation regarding clinical information such as ethnic origins, manifested symptoms, onset age, and hereditary patterns as well as mutation details including base changes and zygosity. A total of 366 cases were collected from 39 ethnic origins and 96 pathogenic mutations were found. PARK2 gene mutations were found also in some general Parkinson disease patients. The majority (63%) of mutations in PARK2 were restricted to two particular domains (UBL and RING1) of the Parkin protein. In these domains, two major mutations, a large deletion (DelEx3) and a point mutation (p.Arg275Trp), were located.	[Mitsuyama, Susumu] Keio Univ, Sch Med, Lab Gene Med, Tsukuba, Ibaraki 3002611, Japan; [Ohtsubo, Masafumi; Minoshima, Shinsei] Hamamatsu Univ Sch Med, Dept Photomed Genom, Med Photon Res Ctr, Basic Med Photon Lab, Hamamatsu, Shizuoka, Japan; [Shimizu, Nobuyoshi] Keio Univ, Adv Res Ctr Genome Super Power, Tsukuba, Ibaraki 3002611, Japan	Shimizu, N (reprint author), Keio Univ, Adv Res Ctr Genome Super Power, 2 Okubo, Tsukuba, Ibaraki 3002611, Japan.	smzgsp@dmb.med.keio.ac.jp			Japan Society for the Promotion of Sciences (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Contract grant sponsor: a Grant-in-Aid for Publication of Scientific Research Results from the Japan Society for the Promotion of Sciences (JSPS) and a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Kitada T, 1998, NATURE, V392, P605; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Shimura H, 2000, NAT GENET, V25, P302; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Minoshima S, 2001, NUCLEIC ACIDS RES, V29, P327, DOI 10.1093/nar/29.1.327; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sato S, 2011, PARKINSONS DIS, V2011	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	AUG	2015	36	8					E2430	E2440		10.1002/humu.22803		11	Genetics & Heredity	Genetics & Heredity	CN4CM	WOS:000358376600001		
J	Kokubo, Y; Iwashima, Y				Kokubo, Yoshihiro; Iwashima, Yoshio			Higher Blood Pressure as a Risk Factor for Diseases Other Than Stroke and Ischemic Heart Disease	HYPERTENSION			English	Review							CHRONIC KIDNEY-DISEASE; INCIDENT ATRIAL-FIBRILLATION; CONVERTING ENZYME-INHIBITORS; VITAMIN-D STATUS; PERIODONTAL-DISEASE; COGNITIVE DECLINE; DOUBLE-BLIND; FOLLOW-UP; CARDIOVASCULAR-DISEASES; CEREBROVASCULAR-DISEASE		[Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Iwashima, Yoshio] Natl Cerebral & Cardiovasc Ctr, Dept Med, Div Nephrol & Hypertens, Suita, Osaka 5658565, Japan	Kokubo, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	ykokubo@hsp.ncvc.go.jp			National Cerebral and Cardiovascular Center [22-4-5];  [25253048];  [25293147];  [26670320]	This work was supported by the Intramural Research Fund of the National Cerebral and Cardiovascular Center (22-4-5), and by Grant-in-Aid for Scientific Research (A, No. 25253048; B, No. 25293147) and Challenging Exploratory Research (No. 26670320) in Japan.	Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Tsuruya K, 2015, CURR OPIN NEPHROL HY, V24, P154, DOI 10.1097/MNH.0000000000000099; Taguchi A, 2004, HYPERTENSION, V43, P1297, DOI 10.1161/01.HYP.0000128335.45571.ce; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Kilander L, 1998, HYPERTENSION, V31, P780; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Aronow WS, 2011, CIRCULATION, V123, P2434, DOI 10.1161/CIR.0b013e31821daaf6; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Lewington S, 2002, LANCET, V360, P1903; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Grundvold I, 2012, HYPERTENSION, V59, P198, DOI 10.1161/HYPERTENSIONAHA.111.179713; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; Wuhl E, 2009, NEW ENGL J MED, V361, P1639; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Holmlund A, 2006, J PERIODONTOL, V77, P1173, DOI 10.1902/jop.2006.050233; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/01.hjh.0000059028.82022.89; Desvarieux M, 2010, J HYPERTENS, V28, P1413, DOI 10.1097/HJH.0b013e328338cd36; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; LINDEMAN RD, 1984, KIDNEY INT, V26, P861, DOI 10.1038/ki.1984.229; Iwashima Y, 2014, AM J HYPERTENS, V27, P710, DOI 10.1093/ajh/hpt227; Sharp SI, 2011, INT J GERIATR PSYCH, V26, P661, DOI 10.1002/gps.2572; Ruitenberg A, 2001, DEMENT GERIATR COGN, V12, P33, DOI 10.1159/000051233; Nesse W, 2010, J PERIODONTOL, V81, P1622, DOI 10.1902/jop.2010.100058; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; Rivas-Tumanyan S, 2012, AM J HYPERTENS, V25, P770, DOI 10.1038/ajh.2012.32; Forman JP, 2010, HYPERTENSION, V55, P1283, DOI 10.1161/HYPERTENSIONAHA.109.148619; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Godin O, 2011, CIRCULATION, V123, P266, DOI 10.1161/CIRCULATIONAHA.110.961052; Ohrui T, 2004, J AM GERIATR SOC, V52, P649, DOI 10.1111/j.1532-5415.2004.52178_7.x; Glynn RJ, 1999, JAMA-J AM MED ASSOC, V281, P438, DOI 10.1001/jama.281.5.438; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Kokubo Y, 2009, STROKE, V40, P2674, DOI 10.1161/STROKEAHA.109.550707; Stocks T, 2012, HYPERTENSION, V59, P802, DOI 10.1161/HYPERTENSIONAHA.111.189258; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Jorde R, 2005, J HYPERTENS, V23, P1639, DOI 10.1097/01.hjh.0000179764.40701.36; Matsubayashi K, 1997, STROKE, V28, P2169; Tsakos G, 2010, J HYPERTENS, V28, P2386, DOI 10.1097/HJH.0b013e32833e0fe1; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Tsioufis C, 2011, ATHEROSCLEROSIS, V219, P1, DOI 10.1016/j.atherosclerosis.2011.04.030; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Ninomiya T, 2008, CIRCULATION, V118, P2694, DOI 10.1161/CIRCULATIONAHA.108.792903; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123; Batty G David, 2014, J Negat Results Biomed, V13, P8, DOI 10.1186/1477-5751-13-8; Batty GD, 2003, BRIT J CANCER, V89, P1243, DOI 10.1038/sj.bjc.6601255; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; BRAZY PC, 1989, KIDNEY INT, V35, P670, DOI 10.1038/ki.1989.37; Dementia Collaborative Research Centres Australia, 2010, DEM RISK RED PRACT G; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Geleijnse JM, 2011, AM J HYPERTENS, V24, P253, DOI 10.1038/ajh.2010.199; HACHINSK.VC, 1974, LANCET, V2, P207; Huang YL, 2014, AM J KIDNEY DIS, V63, P76, DOI 10.1053/j.ajkd.2013.07.024; Imig JD, 2015, HYPERTENSION, V65, P476, DOI 10.1161/HYPERTENSIONAHA.114.03585; JOHANSSON I, 1994, COMMUNITY DENT ORAL, V22, P431, DOI 10.1111/j.1600-0528.1994.tb00792.x; Kokubo Y, 2015, AM J HYPERTENS, DOI [10.1093/ajh/hpv038, DOI 10.1093/AJH/HPV038]; Lee M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4249; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Mancia G, 2013, J HYPERTENS, V131, P1281, DOI DOI 10.1097/01.HJH.0000431740.32696.CC; MCCARRON DA, 1980, HYPERTENSION, V2, P162; Moretti Rita, 2008, Vasc Health Risk Manag, V4, P395; Odili AN, 2010, J HYPERTENS, V28, P2382, DOI 10.1097/HJH.0b013e328341bb1c; Ohya Y, 2001, HYPERTENS RES, V24, P655, DOI 10.1291/hypres.24.655; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Posner HB, 2002, NEUROLOGY, V58, P1175; Ronco C, 2010, CONTRIB NEPHROL, V165, P54, DOI 10.1159/000313745; Rouch L, 2015, CNS DRUGS, V29, P113, DOI 10.1007/s40263-015-0230-6; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Volzke H, 2006, J HYPERTENS, V24, P1257, DOI [10.1097/01.hjh.0000234104.15992.df, DOI 10.1097/01.HJH.0000234104.15992.DF.]; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606	85	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	AUG	2015	66	2					254	259		10.1161/HYPERTENSIONAHA.115.03480		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM3PN	WOS:000357595100003		
J	Hueber, G; Tsutsumi, J; Seth, M; Morris, AS; Staszewski, RB				Hueber, Gernot; Tsutsumi, Jun; Seth, Marten; Morris, Arthur S., III; Staszewski, R. Bogdan			Cost-Efficient, High-Volume Transmission	IEEE MICROWAVE MAGAZINE			English	Article							WIRELESS TRANSCEIVERS; COUPLING FACTOR; SAW SUBSTRATE; RECEIVER; CMOS; BAND; PCS; ARCHITECTURES; DUPLEXER; US		[Hueber, Gernot] NXP Semicond, Graz, Austria; [Tsutsumi, Jun] Taiyo Yuden, Sakai, Osaka, Japan; [Seth, Marten; Morris, Arthur S., III] WiSpry, Irvine, CA USA; [Staszewski, R. Bogdan] Univ Coll Dublin, Dublin, Ireland	Hueber, G (reprint author), NXP Semicond, Graz, Austria.	ghue@xmt.at; tsutsumi-jun@jty.yuden.co.jp; marten.seth@wispry.com; art.morris@wispry.com; robert.staszewski@ucd.ie					3GPP, 2015, 25101 3GPP TS; 3GPP, 2012, 25101 3GPP TS; 3GPP, 2015, 36101 3GPP TS; 3rd Generation Partnership Project, 2013, 25101 3GPP TS; Aigner R, 2003, IEEE MTT-S, P2001, DOI 10.1109/MWSYM.2003.1210552; Staszewski RB, 2005, IEEE J SOLID-ST CIRC, V40, P2469, DOI 10.1109/JSSC.2005.857417; [Anonymous], 2012, W CDMA; Brandolini M, 2005, IEEE T MICROW THEORY, V53, P1026, DOI 10.1109/TMTT.2005.843505; Fabiano I, 2013, IEEE J SOLID-ST CIRC, V48, P3067, DOI 10.1109/JSSC.2013.2271859; Murphy D, 2012, IEEE J SOLID-ST CIRC, V47, P2943, DOI 10.1109/JSSC.2012.2217832; Staszewski RB, 2004, IEEE J SOLID-ST CIRC, V39, P2278, DOI 10.1109/JSSC.2004.836345; Mirabbasi S, 2000, IEEE COMMUN MAG, V38, P132, DOI 10.1109/35.883502; Miura M, 2004, ULTRASON, P1322; Staszewski RB, 2011, IEEE J SOLID-ST CIRC, V46, P2904, DOI 10.1109/JSSC.2011.2162769; Abidi AA, 2004, IEEE J SOLID-ST CIRC, V39, P549, DOI 10.1109/JSSC.2004.825247; Muhammad K, 2006, IEEE J SOLID-ST CIRC, V41, P1772, DOI 10.1109/JSSC.2006.877271; [Anonymous], 2013, ACMD 6102; Crols J., 1997, CMOS WIRELESS TRANSC; Darabi H., 2008, P IEEE SOL STAT CIRC, P206; De Luis JR, 2010, IEEE MTT S INT MICR, P1146, DOI 10.1109/MWSYM.2010.5515957; De Luis JR, 2012, IEEE T ANTENN PROPAG, V60, P5484, DOI 10.1109/TAP.2012.2207869; Iwaki M., 2011, P 41 EUR MICR C, P751; Kadota M, 2004, ULTRASON, P1970; Kadota M, 2014, 2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), P2031, DOI 10.1109/ULTSYM.2014.0506; Kadota M., 2012, P IEEE INT FREQ CONT, P1; Kimura T, 2014, 2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), P795, DOI 10.1109/ULTSYM.2014.0195; Kimura T., 2003, P IEEE MTT S INT MIC, P861; Komatsu T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HD24; Krenik W., 2006, P 2006 IEEE AS PAC M, P1795; Lee TH, 1999, IEEE RAD FREQ INTEGR, P3, DOI 10.1109/RFIC.1999.805227; Madadi I., P IEEE S VLSI CIRC, P1; Matsuda S., 2010, P IEEE ULTRASON S, P633; Mikhemar M., 2009, P SOL STAT CIRC C FE, P386; Morris A., 2014, P IEEE MTT S INT MIC, P1; Morris A. S., 2013, P IEEE MTT S INT MIC, P1; Morrison AP, 2012, PSYCHOL MED, V42, P1049, DOI 10.1017/S0033291711001899; Nakamura H, 2012, IEEE INT ULTRA SYM, P1248, DOI 10.1109/ULTSYM.2012.0311; Nakamura H, 2008, ULTRASON, P594, DOI 10.1109/ULTSYM.2008.0142; Nishihara T., 2008, P IEEE INT ULTR S, P831; Razavi B., 1998, RF MICROELECTRONICS; Staszewski R. B., 2008, P IEEE SOL STAT CIRC, P208; Staszewski R. B., 2006, ALL DIGITAL FREQUENC; Staszewski RB, 2012, IEEE DES TEST COMPUT, V29, P7, DOI 10.1109/MDT.2012.2209392; Staszewski R. B., 2002, THESIS U TEXAS DALLA; Tafazolli R., 2004, TECHNOLOGIES WIRELES; Tohidian M, 2014, ISSCC DIG TECH PAP I, V57, P72, DOI 10.1109/ISSCC.2014.6757343; Tsutsumi J, 2003, P IEEE INT FREQ CONT, P861; Tsutsumi J, 2009, 2009 EUROPEAN MICROWAVE CONFERENCE, VOLS 1-3, P322, DOI 10.1109/EUMC.2009.5295960; Yamanouchi K, 2001, ULTRASON, P189, DOI 10.1109/ULTSYM.2001.991606	49	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1527-3342	1557-9581		IEEE MICROW MAG	IEEE Microw. Mag.	AUG	2015	16	7					26	45		10.1109/MMM.2015.2431235		20	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CM7TS	WOS:000357900000005		
J	Hashimoto, KY; Kimura, T; Matsumura, T; Hirano, H; Kadota, M; Esashi, M; Tanaka, S				Hashimoto, Ken-ya; Kimura, Tetsuya; Matsumura, Takeshi; Hirano, Hideki; Kadota, Michio; Esashi, Masayoshi; Tanaka, Shuji			Moving Tunable Filters Forward	IEEE MICROWAVE MAGAZINE			English	Article							LITHIUM-NIOBATE; RECEIVER; DEVICES; CMOS; RESONATORS; RADIO; FILMS		[Hashimoto, Ken-ya] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Kimura, Tetsuya] Murata Mfg Corp Ltd, Kyoto, Japan; [Matsumura, Takeshi] Natl Inst Informat & Commun Technol, Yokosuka, Kanagawa, Japan; [Hirano, Hideki; Kadota, Michio; Tanaka, Shuji] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Esashi, Masayoshi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 980, Japan	Hashimoto, KY (reprint author), Chiba Univ, Grad Sch Engn, Chiba, Japan.	k.hashimoto@faculty.chiba-u.jp; t_kimura@murata.co.jp; matsumura@nict.go.jp; hirano@mems.mech.tohoku.ac.jp; mkadota@mems.mech.tohoku.ac.jp; esashi@mems.mech.tohoku.ac.jp; tanaka@mems.mech.tohoku.ac.jp			Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Strategic Information and Communications R&D Promotion Program (SCOPE)	We would like to thank the members of the project, the anonymous students at Chiba University and Tohoku University, and the Murata Manufacturing Corporation Ltd. for their support and discussions. This research was supported by the Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and the Strategic Information and Communications R&D Promotion Program (SCOPE).	Andersson S, 2005, ANALOG INTEGR CIRC S, V44, P213, DOI 10.1007/s10470-005-3002-2; [Anonymous], 2008, IEEE J SOLID-ST CIRC; Berge J, 2007, IEEE MICROW WIREL CO, V17, P655, DOI 10.1109/LMWC.2007.903445; Staszewski RB, 2004, IEEE J SOLID-ST CIRC, V39, P2278, DOI 10.1109/JSSC.2004.836345; Tanaka S, 2012, IEEE T ULTRASON FERR, V59, P1800, DOI 10.1109/TUFFC.2012.2384; Abidi AA, 2007, IEEE J SOLID-ST CIRC, V42, P954, DOI 10.1109/JSSC.2007.894307; Kadota M, 2013, IEEE T ULTRASON FERR, V60, P2129, DOI 10.1109/TUFFC.2013.2803; Hirano H, 2014, 2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), P803, DOI 10.1109/ULTSYM.2014.0197; Adam JD, 2002, IEEE T MICROW THEORY, V50, P721, DOI 10.1109/22.989957; Yasue T, 2012, SENSOR ACTUAT A-PHYS, V188, P456, DOI 10.1016/j.sna.2012.01.017; Bagheri R., 2006, IEEE INT SOL STAT CI, P1932, DOI DOI 10.1109/ISSCC.2006.1696251; Chamseddine A., 2006, EURASIP J WIREL COMM, P1; Choi K., 2009, P ISDRS, P1, DOI 10.1109/ICUT.2009.5405699; Darfeuille S., 2005, P GERM MICR C, P102; Dubois MA, 2006, IEEE J SOLID-ST CIRC, V41, P7, DOI 10.1109/JSSC.2005.858627; Elbrecht L., 2004, IEEE MICR S, V2, P927; Estes J. C., 2008, INT MICR S, P1035; Ezell E., 1993, P IEEE ULTR S, P2009; Fenzi N. O., 2010, P IEEE ULTR S, P864; Govergian S., 2012, IEEE MICR S, P1; Harada H., 2008, P 3 IEEE INT S NEW F, P1; Harada H., 2005, P 1 IEEE INT S NEW F, P539; Hashimoto K, 2005, P EUR MICR ASS, V1, P38; Hassan M., 2005, Proceedings. DCC 2006. Data Compression Conference; Hikichi K., 2014, P IEEE FREQ CONTR S, P246; Hirano H., 2013, J MICROMECH MICROENG, V23; Inaba M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HD05; Isobe A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HD09; Kadota M, 2007, JPN J APPL PHYS 1, V46, P4714, DOI 10.1143/JJAP.46.4714; Kadota M., 2014, P IEEE ULTR S, P2013; Kadota M., 2013, P IEEE ULTRASON S, P1668; Kadota M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HD11; Kester W., 2008, APERTURE TIME APERTU; Kimura T, 2014, 2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), P795, DOI 10.1109/ULTSYM.2014.0195; Koli K, 2010, IEEE J SOLID-ST CIRC, V45, P2807, DOI 10.1109/JSSC.2010.2075270; Komatsu T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HD24; Konno A., 2013, JPN J APPL PHYS, V52; Kraus G. M., 2004, IEEE MTT S INT MICR, V2, P429; Kuypers JH, 2007, ULTRASON, P1233, DOI 10.1109/ULTSYM.2007.310; Lu F., 2004, IEEE MICROW MAG, V4, P75; Lu XM, 2013, IEEE TOP CONF POWER, P82; Matsumura T., 2010, P IEEE ULTRASON S, P979; Maurer L., 2005, IST MOB WIR SUMM FRE; Maurer L, 2008, IEEE MICROW MAG, V9, P83, DOI 10.1109/MMM.2008.915364; Mitola III J., 1992, P NAT TEL C 1992 NTC; Muhammad K., 2004, P 2004 INT S CIRC SY, VI, P577; Nguyen C. T. Y., 2006, P IEEE ULTR S, P953; Nishihara T., 2008, IEEE MICR S, P831; Omori T, 2013, 2013 8TH EUROPEAN MICROWAVE INTEGRATED CIRCUITS CONFERENCE (EUMIC), P548; Omori T., 2014, P AS PAC MICR C, P1309; Osugi Y., 2007, P IEEE MTT S, P873; Ruby R. C., 2001, P IEEE ULTR S, P813; Samoto T, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/3/035015; Santos H. J. de L., 2006, IEEE MICROW MAG, V7, P50; Smole P, 2003, P IEEE INT FREQ CONT, P903; Tilmans H. A. C., 2003, J MICROMECH MICROENG, V13, P139; Uher J., 2002, IEEE T MICROW THEORY, V50, P721; Weigel R, 2002, IEEE T MICROW THEORY, V50, P738, DOI 10.1109/22.989958; Xaio H., 2004, P IEEE S CIRC SYST, P197; Yuan J., 2000, P 2 INT C MICR MILL, P315; Zhang G., 2014, P EUR MICR INT CIRC, P253; Zhu XH, 2003, J ELECTRON MATER, V32, P1125, DOI 10.1007/s11664-003-0098-y	62	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1527-3342	1557-9581		IEEE MICROW MAG	IEEE Microw. Mag.	AUG	2015	16	7					89	97		10.1109/MMM.2015.2431237		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CM7TS	WOS:000357900000010		
J	Qin, XM; Shen, JB; Mao, XY; Li, XL; Jia, YD				Qin, Xiameng; Shen, Jianbing; Mao, Xiaoyang; Li, Xuelong; Jia, Yunde			Robust Match Fusion Using Optimization	IEEE TRANSACTIONS ON CYBERNETICS			English	Article						Exposure fusion; moving scenes; optimization; patch-based match; random walker	EXPOSURE FUSION; TONE REPRODUCTION; IMAGE FUSION; VISIBILITY; STEREO; SCENES	In this paper, we present a novel patch-based match and fusion algorithm by taking account of moving scene in a multiple exposure image sequence using optimization. A uniform iterative approach is developed to match and find the corresponding patches in different exposure images, which are then fused in each iteration. Our approach does not need to align the input multiple exposure images before the fusion process. Considering that the pixel values are affected by various exposure time, we design a new patch-based energy function that will be optimized to improve the matching accuracy. An efficient patch-based exposure fusion approach using the random walker algorithm is developed to preserve the moving objects from the input multiple exposure images. To the best of our knowledge, our algorithm is the first patch-based exposure fusion work to preserve the moving objects of dynamic scenes that does not need the registration process of different exposure images. Experimental results of moving scenes demonstrate that our algorithm achieves visually pleasing fusion results without ghosting artifacts, while the results produced by the state-of-the-art exposure fusion and tone mapping algorithms exhibit different levels of ghosting artifacts.	[Qin, Xiameng; Shen, Jianbing; Jia, Yunde] Beijing Inst Technol, Sch Comp Sci, Beijing Lab Intelligent Informat Technol, Beijing 100081, Peoples R China; [Mao, Xiaoyang] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4000016, Japan; [Li, Xuelong] Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Ctr Opt Imagery Anal & Learning, Xian 710119, Peoples R China	Shen, JB (reprint author), Beijing Inst Technol, Sch Comp Sci, Beijing Lab Intelligent Informat Technol, Beijing 100081, Peoples R China.	qxm0405@bit.edu.cn; shenjianbing@bit.edu.cn; mao@yamanashi.ac.jp; xuelong_li@opt.ac.cn; jiayunde@bit.edu.cn			National Basic Research Program of China (973 Program) [2013CB328805]; NSFC-Guangdong Union Foundation [U1035004]; National Natural Science Foundation of China [61272359, 61125106]; Program for New Century Excellent Talents in University [NCET-11-0789]; JSPS KAKENHI [26240015, 26560006]; Chinese Academy of Sciences [KGZD-EW-T03]; Beijing Higher Education Young Elite Teacher Project; Beijing Municipal Education Commission	Manuscript received March 1, 2014; revised June 11, 2014 and August 1, 2014; accepted August 30, 2014. Date of publication September 16, 2014; date of current version July 15, 2015. This work was supported in part by the National Basic Research Program of China (973 Program) under Grant 2013CB328805, in part by the Key Program of NSFC-Guangdong Union Foundation under Grant U1035004, in part by the National Natural Science Foundation of China under Grant 61272359 and Grant 61125106, in part by the Program for New Century Excellent Talents in University under Grant NCET-11-0789, in part by JSPS KAKENHI under Grant 26240015 and Grant 26560006, in part by the Key Research Program of the Chinese Academy of Sciences under Grant KGZD-EW-T03, in part by the Beijing Higher Education Young Elite Teacher Project, and in part by the Joint Building Program of Beijing Municipal Education Commission. This paper was recommended by Associate Editor J. Wang. (Corresponding author: J. Shen.)	Jinno T, 2012, IEEE T IMAGE PROCESS, V21, P358, DOI 10.1109/TIP.2011.2160953; Heo YS, 2011, IEEE T PATTERN ANAL, V33, P807, DOI 10.1109/TPAMI.2010.136; Reinhard E, 2002, ACM T GRAPHIC, V21, P267; Song ML, 2010, IEEE T PATTERN ANAL, V32, P1537, DOI 10.1109/TPAMI.2009.74; Reinhard E, 2005, IEEE T VIS COMPUT GR, V11, P13, DOI 10.1109/TVCG.2005.9; Tumblin J, 2005, PROC CVPR IEEE, P103; Zhang YM, 2010, IEEE T SYST MAN CY B, V40, P719, DOI 10.1109/TSMCB.2009.2021272; Zhang W, 2010, PROC CVPR IEEE, P530, DOI 10.1109/CVPR.2010.5540168; Seetzen H, 2004, ACM T GRAPHIC, V23, P760, DOI 10.1145/1015706.1015797; Li YZ, 2005, ACM T GRAPHIC, V24, P836, DOI 10.1145/1073204.1073271; Granados M, 2010, PROC CVPR IEEE, P215, DOI 10.1109/CVPR.2010.5540208; Fusiello A, 1997, PROC CVPR IEEE, P858, DOI 10.1109/CVPR.1997.609428; Yang QX, 2012, PROC CVPR IEEE, P1402; Song ML, 2012, IEEE T IMAGE PROCESS, V21, P341, DOI 10.1109/TIP.2011.2157514; Han JG, 2013, NEUROCOMPUTING, V111, P70, DOI 10.1016/j.neucom.2012.12.015; Liu Z, 2012, IEEE T PATTERN ANAL, V34, P94, DOI 10.1109/TPAMI.2011.109; Shen R, 2011, IEEE T IMAGE PROCESS, V20, P3634, DOI 10.1109/TIP.2011.2150235; Jacobs K, 2008, IEEE COMPUT GRAPH, V28, P84, DOI 10.1109/MCG.2008.23; Snidaro L, 2007, IEEE T SYST MAN CY B, V37, P1044, DOI 10.1109/TSMCB.2007.895331; Aydin TO, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360668; Chung F. R., 1997, SPECTRAL GRAPH THEOR; Debevec P.E., 1997, P ACM SIGGRAPH 97, P369; Gallo O., 2009, P IEEE INT C COMP PH, P1; HaCohen Y, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964965; Larson GW, 1997, IEEE T VIS COMPUT GR, V3, P291, DOI 10.1109/2945.646233; Li ZG, 2012, IEEE T IMAGE PROCESS, V21, P4672, DOI 10.1109/TIP.2012.2207396; Mantiuk R, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964935; Mertens T., 2008, COMPUT GRAPH FORUM, V28, P161; Mitsunaga T, 1999, 1999 IEEE COMP SOC C, V1, P374; Pece F, 2010, Proceedings 2010 Conference on Visual Media Production (CVMP 2010). 7th European Conference on Visual Media Production, DOI 10.1109/CVMP.2010.8; Photometric, 2012, COMM AV HDR PROC SOF; Reinhard E., 2005, HIGH DYNAMIC RANGE I; Sen P, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2366145.2366222; Shen JB, 2014, IEEE T CYBERNETICS, V44, P1579, DOI 10.1109/TCYB.2013.2290435; Shen JB, 2012, VISUAL COMPUT, V28, P463, DOI 10.1007/s00371-011-0642-3; Singh H., 2014, SCI WORLD J, V2014; Smith MI, 2005, P SOC PHOTO-OPT INS, V5782, P29, DOI 10.1117/12.597618; Tocci MD, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964936; Ward G., 2003, Journal of Graphics Tools, V8; Zaveri T., 2011, J PATTERN RECOGNIT R, V6, P140	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2267	2168-2275		IEEE T CYBERNETICS	IEEE T. Cybern.	AUG	2015	45	8					1549	1560		10.1109/TCYB.2014.2355140		12	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CN1XD	WOS:000358213100014		
J	Yamamoto, H; Ueda, M				Yamamoto, Hirosuke; Ueda, Masashi			Multiple Object Identification Coding	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Identification coding; channel coding; multiple objects; passive feedback; common randomness	INFORMATION-TRANSFER; GENERAL-THEORY; CHANNELS; CODES	In the case of ordinary identification coding, a code is devised to identify a single object among N objects. But, in this paper, we consider a coding problem to identify K objects at once among N objects in the both cases that K objects are ranked or not ranked. By combining Moulin-Koetter scheme with the epsilon-almost strongly universal class of hash functions used in Kurosawa-Yoshida scheme, an efficient and explicit coding scheme is proposed for K-multiple-object identification (K-MOID) coding. Furthermore, it is shown that the K-MOID capacity C-K-MOID, which is the maximum achievable coding rate in the K-MOID coding, is equal to the ordinary channel capacity, and the proposed scheme can attain C-K-MOID.	[Yamamoto, Hirosuke] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Ueda, Masashi] Univ Tokyo, Dept Math Informat, Bunkyo 1138656, Japan	Yamamoto, H (reprint author), Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan.	hirosuke@ieee.org; ueda.masashi.fx6@jp.nssol.nssmc.com			Japan Society for the Promotion of Science through KAKENHI [25289111, 26630169]	Manuscript received September 1, 2014; revised March 31, 2015; accepted May 17, 2015. Date of publication June 4, 2015; date of current version July 10, 2015. This work was supported by the Japan Society for the Promotion of Science through KAKENHI under Grant 25289111 and Grant 26630169. This paper was presented at the 2014 IEEE International Symposium on Information Theory.	AHLSWEDE R, 1989, IEEE T INFORM THEORY, V35, P15, DOI 10.1109/18.42172; Ahlswede R, 2008, DISCRETE APPL MATH, V156, P1348, DOI 10.1016/j.dam.2007.07.007; AHLSWEDE R, 1989, IEEE T INFORM THEORY, V35, P30, DOI 10.1109/18.42173; Ahlswede R, 2006, LECT NOTES COMPUT SC, V4123, P1; Ahlswede R, 2006, LECT NOTES COMPUT SC, V4123, P51; Han TS, 1997, IEEE T INFORM THEORY, V43, P599; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; Koetter R., 2006, P SPIE SECUR STEGANO, V6072; Kurosawa K, 1999, IEEE T INFORM THEORY, V45, P2091, DOI 10.1109/18.782144; Steinberg Y, 2001, IEEE T INFORM THEORY, V47, P1410, DOI 10.1109/18.923724; HAN TS, 1992, IEEE T INFORM THEORY, V38, P14, DOI 10.1109/18.108245; VERDU S, 1993, IEEE T INFORM THEORY, V39, P30, DOI 10.1109/18.179339; Yamamoto H, 2014, IEEE INT SYMP INFO, P1241, DOI 10.1109/ISIT.2014.6875031	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	AUG	2015	61	8					4269	4276		10.1109/TIT.2015.2441058		8	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CM8HI	WOS:000357939400011		
J	Wei, KM; Dong, MX; Ota, K; Xu, K				Wei, Kaimin; Dong, Mianxiong; Ota, Kaoru; Xu, Ke			CAMF: Context-Aware Message Forwarding in Mobile Social Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Mobile social networks; forwarding/receiving capability; knapsack problem; forwarding profit maximization	DELAY TOLERANT NETWORKS; DISSEMINATION; DRIVEN	In mobile social networks (MSN), with the aim of conserving limited resources, egotistic nodes might refuse to forward messages for other nodes. Different from previous work which mainly focuses on promoting cooperation between selfish nodes, we consider it from a more pragmatic perspective in this paper. Be specific, we regard selfishness as a native attribute of a system and allow nodes to exhibit selfish behavior in the process of message forwarding. Apparently, selfishness has a profound influence on routing efficiency, and thus novel mechanisms are necessary to improve routing performance when self-centered nodes are considered. We first put forward a stateless approach to measure encounter opportunities between nodes, and represent forwarding capabilities of nodes by combining the acquired encounter opportunities with node selfishness. We then quantify receiving capabilities of nodes based on their available buffer size and energy. Taking both forwarding and receiving capabilities into account, we finally present a forwarding set mechanism, which could be deduced to a multiple knapsack problem to maximize the forwarding profit. Consequently, we take all the above studies into the design of a context-aware message forwarding algorithm (CAMF). Extensive trace-driven simulations show that CAMF outperforms other existing algorithms greatly. In fact, it achieves a surprisingly high routing performance while consumes low transmission cost and resource in MSN.	[Wei, Kaimin; Xu, Ke] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Dong, Mianxiong] Natl Inst Informat & Commun Technol, Informat Serv Platform Lab, Kyoto, Japan; [Ota, Kaoru] Muroran Inst Technol, Dept Informat & Elect Engn, Sapporo, Hokkaido, Japan	Wei, KM (reprint author), Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China.	weikaimin@nlsde.buaa.edu.cn; mx.dong@nict.go.jp; ota@csse.muroran-it.ac.jp; kexu@nlsde.buaa.edu.cn		Ota, Kaoru/0000-0002-3382-1652	National 863 Program of China [2012AA011005]; State Key Lab of Software Development Environment [SKLSDE-2013ZX-06]; NSFC [61450110085]; State Key Laboratory of Industrial Control Technology [ICT1407]; JSPS KAKENHI [25880002, 26730056]; JSPS A3 Foresight Program	The authors thank the anonymous reviewers for their patient review and valuable comments which significantly improve the quality of this paper. This research was supported by National 863 Program of China (Grant No. 2012AA011005), the fund of the State Key Lab of Software Development Environment (Grant No. SKLSDE-2013ZX-06), NSFC Grant No. 61450110085, the fund of the State Key Laboratory of Industrial Control Technology (Grant No. ICT1407), JSPS KAKENHI (Grant No. 25880002, 26730056) and JSPS A3 Foresight Program. K. Ota is the corresponding author of this paper.	Liang XH, 2012, IEEE T VEH TECHNOL, V61, P3209, DOI 10.1109/TVT.2012.2202932; Wei KM, 2014, IEEE COMMUN SURV TUT, V16, P556, DOI 10.1109/SURV.2013.042313.00103; Zhu HJ, 2009, IEEE T VEH TECHNOL, V58, P4628, DOI 10.1109/TVT.2009.2020105; Zhou H, 2013, IEEE INT CONF MOB, P333, DOI 10.1109/MASS.2013.54; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Wei KM, 2013, J COMMUN NETW-S KOR, V15, P504, DOI 10.1109/JCN.2013.000090; Hui P, 2008, MOBIHOC'08: PROCEEDINGS OF THE NINTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P241, DOI 10.1145/1374618.1374652; Fan JL, 2013, IEEE T PARALL DISTR, V24, P734, DOI 10.1109/TPDS.2012.171; Mei A, 2009, IEEE INFOCOM SER, P2106, DOI 10.1109/INFCOM.2009.5062134; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; Li Z, 2012, IEEE T MOBILE COMPUT, V11, P1287, DOI 10.1109/TMC.2011.151; Li QH, 2012, AD HOC NETW, V10, P1619, DOI 10.1016/j.adhoc.2011.07.007; Mei A, 2011, IEEE INFOCOM SER, P251, DOI 10.1109/INFCOM.2011.5935076; Cao Y, 2013, IEEE T VEH TECHNOL, V62, P2339, DOI 10.1109/TVT.2013.2238958; Chen B. B., 2010, P IEEE C COMP COMM, P875; Dong M, 2014, J SUPERCOMPUT, P1, DOI 10.1007/s11227-014-1161-6; Frakes W. B., 1992, INFORM RETRIEVAL DAT; Hui P., 2009, P IEEE INFOCOM WORKS, P1, DOI DOI 10.1145/1514411.1514417; Keranen A., 2009, P 2 INT C SIM TOOLS, P55; Li Y, 2010, IEEE COMMUN LETT, V14, P1026, DOI 10.1109/LCOMM.2010.093010.100492; Scott J., 2006, CRAWDAD TRACE CAMBRI; Vahdat A., 2002, CS200006 DUK U; Wei L., 2011, P IEEE ICC, P1; Zhang L., 1986, J COMPUT SCI TECHNOL, V1, P46, DOI 10.1007/BF02943300; Zhou J, 2012, GLOB TELECOMM CONF, P985	25	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	AUG	2015	26	8					2178	2187		10.1109/TPDS.2014.2346212		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CN2BW	WOS:000358226400009		
J	Fujii, T; Sato, T; Takeda, K; Hasebe, K; Kakitsuka, T; Matsuo, S				Fujii, Takuro; Sato, Tomonari; Takeda, Koji; Hasebe, Koichi; Kakitsuka, Takaaki; Matsuo, Shinji			Epitaxial growth of InP to bury directly bonded thin active layer on SiO2/Si substrate for fabricating distributed feedback lasers on silicon	IET OPTOELECTRONICS			English	Article						indium compounds; III-V semiconductors; silicon compounds; silicon; elemental semiconductors; semiconductor lasers; distributed feedback lasers; optical fabrication; epitaxial growth; optical modulation; photoluminescence; epitaxial growth; directly bonded thin active layer; distributed feedback laser fabrication; silicon; heterogeneous integration method; modulation efficiency; thermal oxidation; thermal strain; growth temperature; photoluminescence; laser thickness; critical thickness; distributed feedback laser; continuous-wave operation; nonreturn-to-zero signal; bit rate 40 Gbit; s; current 15 mA; InP-SiO2-Si	PHOTONIC-CRYSTAL LASER; ROOM-TEMPERATURE; DFB LASER; OPERATION; REGROWTH	The authors have developed a new heterogeneous-integration method for fabricating semiconductor lasers with high modulation efficiency on Si substrates. The method employs the direct bonding of an InP-based active layer to the SiO2 layer of a thermally oxidised Si substrate (SiO2/Si substrate), followed by the epitaxial growth of InP to form a buried heterostructure (BH). By using the InP membrane, the authors realise epitaxial growth of an InP on the InP membrane directly bonded to Si without crystal quality degradation. Both a theoretical estimation and photoluminescence measurements revealed that the total laser thickness must be less than the critical thickness determined by the applied thermal strain. The authors confirmed that the crystal quality of the BH is comparable to that fabricated on an InP substrate when using a 250-nm-thick InP-based membrane. A distributed feedback laser fabricated on a SiO2/Si substrate exhibited continuous-wave operation up to 100 degrees C and was directly modulated by a 40 Gbit/s non-return-to-zero signal with a bias current of 15 mA. These results indicate that epitaxial growth using a directly bonded InP-based active layer on a SiO2/Si substrate allows us to achieve lasers with high modulation efficiency and to use a large-scale Si wafer as a fabrication platform, resulting in low-cost fabrication.	[Fujii, Takuro; Sato, Tomonari; Takeda, Koji; Hasebe, Koichi; Kakitsuka, Takaaki; Matsuo, Shinji] NTT Corp, Nanophoton Ctr, Atsugi, Kanagawa 2430198, Japan; [Fujii, Takuro; Takeda, Koji; Hasebe, Koichi; Kakitsuka, Takaaki; Matsuo, Shinji] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Fujii, T (reprint author), NTT Corp, Nanophoton Ctr, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	fujii.takuro@lab.ntt.co.jp	Matsuo, Shinji/H-4093-2011		New Energy and Industrial Technology Development Organization (NEDO)	The authors thank T. Yamamoto for fruitful discussions. They also thank K. Ishibashi, Y. Shouji and Y. Yokoyama for fabricating the device. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO).	Matsuo S, 2014, OPT EXPRESS, V22, P12139, DOI 10.1364/OE.22.012139; Stankovic S, 2012, IEEE PHOTONIC TECH L, V24, P2155, DOI 10.1109/LPT.2012.2223666; Fang AW, 2006, OPT EXPRESS, V14, P9203, DOI 10.1364/OE.14.009203; Matsuo S, 2010, NAT PHOTONICS, V4, P648, DOI [10.1038/nphoton.2010.177, 10.1038/NPHOTON.2010.177]; Liu JF, 2010, OPT LETT, V35, P679, DOI 10.1364/OL.35.000679; MATTHEWS JW, 1974, J CRYST GROWTH, V27, P118, DOI 10.1016/S0022-0248(74)80055-2; Okamoto T, 2003, IEEE J SEL TOP QUANT, V9, P1361, DOI 10.1109/JSTQE.2003.819495; Matsuo S, 2012, OPT EXPRESS, V20, P3773, DOI 10.1364/OE.20.003773; Ben Bakir B, 2011, OPT EXPRESS, V19, P10317, DOI 10.1364/OE.19.010317; Jain SR, 2011, OPT EXPRESS, V19, P13692, DOI 10.1364/OE.19.013692; Lee AD, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2247979; Liu AY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863223; Matsumoto K, 2013, J CRYST GROWTH, V370, P133, DOI 10.1016/j.jcrysgro.2012.09.063; Matsuo S, 1997, ELECTRON LETT, V33, P1148, DOI 10.1049/el:19970752; Morral AFI, 2003, APPL PHYS LETT, V83, P5413, DOI 10.1063/1.1637429; Sato T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.111202; SUGO M, 1990, APPL PHYS LETT, V57, P593, DOI 10.1063/1.103608; VANDELEUR RHM, 1988, J APPL PHYS, V64, P3043, DOI 10.1063/1.341568; Wada H, 1996, IEEE PHOTONIC TECH L, V8, P1426, DOI 10.1109/68.541538; Zhang C, 2013, ECS SOLID STATE LETT, V2, pQ82, DOI 10.1149/2.008311ssl	20	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8768	1751-8776		IET OPTOELECTRON	IET Optoelectron.	AUG	2015	9	4			SI		151	157		10.1049/iet-opt.2014.0138		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CN0SF	WOS:000358123000003		
J	Watanabe, T; Kokubun, Y				Watanabe, Tatsuhiko; Kokubun, Yasuo			Stacked polymer waveguide type fan-in/fan-out device for dense multi-core fibre	IET OPTOELECTRONICS			English	Article						optical polymers; optical waveguides; optical fibre communication; laminates; resins; optical fibre losses; stacked polymer waveguide type fan-in; fan-out device; dense multicore fibre; 19-core uncoupled multi-core fibre; laminated polymer waveguide; poly-methyl-methacrylate; ultra-violet cured epoxy resin; solvent-free oligomer; UV-curing; core alignment; spin-coat condition; insertion loss; cross-talk; coupling loss; index contrast; absorption loss	TEMPERATURE	A compact fan-in/fan-out waveguide device for 19-core uncoupled multi-core fibre (MCF) was demonstrated using laminated polymer waveguide. The core was made of poly-methyl-methacrylate and the cladding was made of ultra-violet (UV) cured epoxy resin which is solvent-free oligomer. Since the oligomer does not shrink after UV-curing, the surface of the cladding over the core ridge was flattened and the multiple layers can be laminated. The accurate core alignment in the vertical direction was realised by controlling the spin-coat condition of cladding material precisely. The insertion loss from a 19-core fibre to 19 single-core fibres was measured to be <20 dB and the sum of the cross-talk from all neighbouring cores was lower than -40 dB. The coupling loss which is caused by the offset of the core position and the spot size mismatch at the facet between the MCF core and the waveguide was <1.8 dB. It was shown that the coupling loss and the insertion loss can be improved by adopting a properly selected pair of polymer materials with appropriate value of index contrast and low absorption loss.	[Watanabe, Tatsuhiko; Kokubun, Yasuo] Yokohama Natl Univ, Grad Sch Engn, Yokohama, Kanagawa 240, Japan	Watanabe, T (reprint author), Yokohama Natl Univ, Grad Sch Engn, Yokohama, Kanagawa 240, Japan.	watanabe-tatsuhiko-hz@ynu.jp			National Institute of Information and Communications Technology (NICT), Japan	The authors express their sincere thanks to Furukawa Electric Co. Ltd., for supplying the 19-core MCF. They also thank Mr. Y. Hatakeyama of NTT Advanced Technologies Corp. for fruitful discussion. This research was supported in part by the National Institute of Information and Communications Technology (NICT), Japan.	Akiyama T, 2001, IEEE T MICROW THEORY, V49, P2055, DOI 10.1109/22.954830; Watanabe T, 2012, OPT EXPRESS, V20, P26317, DOI 10.1364/OE.20.026317; Richardson DJ, 2013, NAT PHOTONICS, V7, P354, DOI [10.1038/nphoton.2013.94, 10.1038/NPHOTON.2013.94]; Watanabe T, 1998, APPL PHYS LETT, V72, P1533, DOI 10.1063/1.120574; Doerr CR, 2011, IEEE PHOTONIC TECH L, V23, P597, DOI 10.1109/LPT.2011.2118748; Kang ES, 2002, APPL PHYS LETT, V81, P1438, DOI 10.1063/1.1501448; Thomson RR, 2007, OPT EXPRESS, V15, P11691, DOI 10.1364/OE.15.011691; Klaus W, 2012, IEEE PHOTONIC TECH L, V24, P1902, DOI 10.1109/LPT.2012.2217490; Kokubun Y., 2013, LIGHTWAVE ENG; KOKUBUN Y, 1995, APPL OPTICS, V34, P6862, DOI 10.1364/AO.34.006862; Sano A, 2013, OPT EXPRESS, V21, P16777, DOI 10.1364/OE.21.016777; Shafiee H, 2011, POLYM J, V43, P306, DOI 10.1038/pj.2010.136; Wiesmann R, 1996, ELECTRON LETT, V32, P2329, DOI 10.1049/el:19961533	13	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8768	1751-8776		IET OPTOELECTRON	IET Optoelectron.	AUG	2015	9	4			SI		158	162		10.1049/iet-opt.2014.0137		5	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CN0SF	WOS:000358123000004		
J	Zelaya, H; Tada, A; Vizoso-Pinto, MG; Salva, S; Kanmani, P; Aguero, G; Alvarez, S; Kitazawa, H; Villena, J				Zelaya, Hortensia; Tada, Asuka; Guadalupe Vizoso-Pinto, Maria; Salva, Susana; Kanmani, Paulraj; Agueero, Graciela; Alvarez, Susana; Kitazawa, Haruki; Villena, Julio			Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage	INFLAMMATION RESEARCH			English	Article						Influenza virus; Lactobacillus rhamnosus CRL1505; Inflammation; Coagulation; TLR3; Poly(I:C)	RESPIRATORY SYNCYTIAL VIRUS; ACUTE CORONARY SYNDROMES; TOLL-LIKE RECEPTOR-3; MALNOURISHED MICE; IMMUNOMODULATORY ACTIVITY; IMPROVES RESISTANCE; ENDOTHELIAL-CELLS; FLU VACCINATION; ACUTE INFECTION; FOLLOW-UP	To evaluate the effect of the nasal administration of live and heat-killed Lactobacillus rhamnosus CRL1505 (Lr1505) on immune-coagulative response during influenza virus (IFV) infection to improve survival and reduce lung injury. Six-week-old BALB/c mice were treated with live or heat-killed Lr1505 by the nasal route during two consecutive days. Treated and untreated control mice were then nasally challenged with IFV. Both viable and non-viable Lr1505 protected infected mice by reducing pulmonary injury and lung viral loads trough several mechanisms: (a) Inflammatory cytokines were efficiently regulated allowing higher clearance of virus and reduction of inflammatory lung tissue damage, associated to higher levels of the regulatory cytokine IL-10. (b) The antiviral immune response was enhanced with improved levels of type I interferons, CD4(+)IFN-gamma(+) lymphocytes, and lung CD11c(+)CD11b(low)CD103(+) and CD11c(+)CD11b(high)CD103(-) dendritic cells. (c) The procoagulant state was reversed mainly by down-regulating tissue factor expression and restoring thrombomodulin levels in lung. The capacity of Lr1505 to improve the outcome of IFV infection would be related to its ability to beneficially modulate lung TLR3-triggered immune response. Our work is the first to demonstrate the ability of an immunobiotic strain to beneficially modulate inflammation-coagulation interactions during IFV infection. Interestingly, non-viable L. rhamnosus CRL1505 was as effective as the viable strain to beneficially modulate respiratory antiviral immune response.	[Zelaya, Hortensia; Guadalupe Vizoso-Pinto, Maria; Salva, Susana; Agueero, Graciela; Alvarez, Susana; Villena, Julio] Immunobiot Res Grp, San Miguel De Tucuman, Argentina; [Zelaya, Hortensia; Salva, Susana; Alvarez, Susana; Villena, Julio] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina; [Zelaya, Hortensia; Agueero, Graciela; Alvarez, Susana] Tucuman Univ, Inst Appl Biochem, Fac Biochem Chem & Pharm, San Miguel De Tucuman, Argentina; [Tada, Asuka; Kanmani, Paulraj; Kitazawa, Haruki] Tohoku Univ, Food & Feed Immunol Grp, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Tada, Asuka; Kanmani, Paulraj; Kitazawa, Haruki; Villena, Julio] Tohoku Univ, Livestock Immunol Unit, Int Educ & Res Ctr Food & Agr Immunol CFAI, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Guadalupe Vizoso-Pinto, Maria] Lab Infect Biol INSIBIO CONICET UNT, San Miguel De Tucuman, Argentina	Kitazawa, H (reprint author), Tohoku Univ, Food & Feed Immunol Grp, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	haruki@bios.tohoku.ac.jp; jcvillena@cerela.org.ar			Japan Society for the Promotion of Science (JSPS) [PICT-2010-1381, 24380146, 26660216]	This work was supported by a grant PICT-2010-1381 to Dr. S. Alvarez and, by a Grant-in-Aid for Scientific Research (B)(2) (No. 24380146) and Challenging Exploratory Research (No. 26660216) from the Japan Society for the Promotion of Science (JSPS) to Dr. H. Kitazawa.	Aguero G, 2006, NUTRITION, V22, P810, DOI 10.1016/j.nut.2006.03.013; Herold S, 2006, J IMMUNOL, V177, P1817; Villena J, 2009, MICROBIOL IMMUNOL, V53, P636, DOI 10.1111/j.1348-0421.2009.00171.x; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Richert LE, 2014, EUR J IMMUNOL, V44, P397, DOI 10.1002/eji.201343587; Arimori Y, 2013, ANTIVIR RES, V99, P230, DOI [10.1016/j.antiviral.2013.05.007, 10.1016/j.antivira1.2013.05.007]; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Ciszewski A, 2008, EUR HEART J, V29, P1350, DOI 10.1093/eurheartj/ehm581; Visseren FLJ, 2000, THROMB HAEMOSTASIS, V84, P319; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Aeffner F, 2011, AM J PHYSIOL-LUNG C, V301, pL99, DOI 10.1152/ajplung.00398.2010; Villena J, 2005, J NUTR, V135, P1462; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Chiba E, 2013, INT IMMUNOPHARMACOL, V17, P373, DOI 10.1016/j.intimp.2013.06.024; Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323; Armstrong SM, 2013, ANTIVIR RES, V99, P113, DOI 10.1016/j.antiviral.2013.05.003; Ciszewski A, 2008, VACCINE, V26, P4411, DOI 10.1016/j.vaccine.2008.06.078; Corre B, 2013, EUR J IMMUNOL, V43, P2730, DOI 10.1002/eji.201242977; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Goeijenbier M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-134; Gurfinkel EP, 2004, TEX HEART I J, V31, P28; Gurfinkel EP, 2004, EUR HEART J, V25, P25, DOI 10.1016/j.ehj.2003.10.018; Haro C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-28; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; Keller TT, 2006, CIRC RES, V99, P1261, DOI 10.1161/01.RES.0000250834.29108.1a; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Loomba RS, 2012, J CARDIOVASC PHARM T, V17, P277, DOI 10.1177/1074248411429965; Sawai R, 2008, J ETHNOPHARMACOL, V118, P108, DOI 10.1016/j.jep.2008.03.013; Schutten Martin, 2013, MLO Med Lab Obs, V45, P38; Shibamiya A, 2009, BLOOD, V113, P714, DOI 10.1182/blood-2008-02-137901; Takeda S, 2011, INT IMMUNOPHARMACOL, V11, P1976, DOI 10.1016/j.intimp.2011.08.007; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Villena J, 2013, PROBIOTICS IMMUNOBIO, P128; Zelaya H, 2011, CAN J PHYSIOL PHARM, V89, P41, DOI 10.1139/y10-102; Zelaya H, 2014, INT IMMUNOPHARMACOL, V19, P161, DOI 10.1016/j.intimp.2013.12.020	45	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	AUG	2015	64	8					589	602		10.1007/s00011-015-0837-6		14	Cell Biology; Immunology	Cell Biology; Immunology	CN0ZN	WOS:000358144700004		
J	Eguchi, H; Shimazu, A; Kawakami, N; Inoue, A; Nakata, A; Tsutsumi, A				Eguchi, Hisashi; Shimazu, Akihito; Kawakami, Norito; Inoue, Akiomi; Nakata, Akinori; Tsutsumi, Akizumi			Work engagement and high-sensitivity C-reactive protein levels among Japanese workers: a 1-year prospective cohort study	INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH			English	Review						Cardiovascular disease; C-reactive protein; Inflammation; Prospective studies; Work engagement	CORONARY-HEART-DISEASE; MIDDLE-AGED ADULTS; CARDIOVASCULAR-DISEASE; JOB-SATISFACTION; RISK; ASSOCIATION; STRESS; HEALTH; WELL; MEN	Evidence on the association between psychological well-being and high-sensitivity C-reactive protein (hs-CRP) levels is limited. We carried out a prospective study to investigate the association between work engagement and hs-CRP levels in a group of Japanese workers. Our cohort included 1,857 men and 657 women aged 65 and under, and free from major illness, working at two manufacturing worksites in Japan. Baseline examinations were conducted from April to June 2011 to determine the demographic and lifestyle characteristics and levels of work engagement. Blood samples were obtained from participants at baseline and after 1 year. Participants were classified into tertiles of low, moderate, and high work engagement at baseline. Hs-CRP levels were split into low (a parts per thousand currency sign3.0 mg/L) and high (> 3.0 mg/L). We used multiple logistic regression analyses to evaluate the association between work engagement at baseline and hs-CRP levels at follow-up, adjusting for hs-CRP at baseline and potential confounding factors. Participants reporting moderate and high levels of work engagement at baseline had significantly lower odds ratios (ORs) of having high hs-CRP levels at follow-up than those with low levels of work engagement at baseline [OR of moderate level 0.44, 95 % confidence interval (CI) 0.24-0.81; OR of high level 0.57, 95 % CI 0.33-0.99; p for trend < 0.05]. Findings suggest that work engagement has beneficial effects on workers' cardiovascular health.	[Eguchi, Hisashi; Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Shimazu, Akihito; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Dept Mental Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Nakata, Akinori] Univ Occupat & Environm Hlth, Dept Occupat & Community Hlth Nursing, Sch Hlth Sci, Kitakyushu, Fukuoka 807, Japan	Eguchi, H (reprint author), Kitasato Univ, Sch Med, Dept Publ Hlth, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	eguchi-sgy@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan: "Elucidation of social stratification mechanisms and control over health inequalities in contemporary Japan: New interdisciplinary areas of social and health sciences" (The Project "Social Stratification and Health"). This study was conducted as part of the Japanese Study of Health, Occupation and Psychosocial Factors related to Equity (J-HOPE). The funding organizations had no role in the conception and design of the study, the collection and analysis of data, interpretation of the findings, or writing the manuscript.	Ahmadi-Abhari S, 2013, EUR J CLIN INVEST, V43, P899, DOI 10.1111/eci.12116; Amati M, 2010, J OCCUP HEALTH, V52, P31; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Wilson PWF, 1998, CIRCULATION, V97, P1837; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Sonnentag S, 2011, EUR J WORK ORGAN PSY, V20, P29, DOI 10.1080/1359432X.2010.510639; Steptoe A, 2001, CLIN SCI, V101, P185, DOI 10.1042/CS20010038; Erbel R, 2012, EUR HEART J, V33, P1201, DOI 10.1093/eurheartj/ehs076; Gimeno D, 2008, PSYCHONEUROENDOCRINO, V33, P1322, DOI 10.1016/j.psyneuen.2008.07.006; Bunderson JS, 2009, ADMIN SCI QUART, V54, P32, DOI 10.2189/asqu.2009.54.1.32; Heath NM, 2013, CYTOKINE, V63, P172, DOI 10.1016/j.cyto.2013.04.030; Robles TF, 2005, CURR DIR PSYCHOL SCI, V14, P111, DOI 10.1111/j.0963-7214.2005.00345.x; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Bakker AB, 2008, WORK STRESS, V22, P187, DOI 10.1080/02678370802393649; Shimazu A, 2009, IND HEALTH, V47, P495; Halbesleben JRB, 2009, J APPL PSYCHOL, V94, P1452, DOI 10.1037/a0017595; Langelaan S, 2006, SCAND J WORK ENV HEA, V32, P339; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279; Molloy GJ, 2009, SOC SCI MED, V69, P223, DOI 10.1016/j.socscimed.2009.05.010; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Shimazu A, 2012, IND HEALTH, V50, P316, DOI 10.2486/indhealth.MS1355; Berry JD, 2007, AM HEART J, V154, P80, DOI 10.1016/j.ahj.2007.03.042; Brummett BH, 2013, PSYCHOSOM MED, V75, P882, DOI 10.1097/PSY.0000000000000005; Cheng YW, 2014, INT J CARDIOL, V171, P419, DOI 10.1016/j.ijcard.2013.12.035; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; Joseph NT, 2014, PSYCHOSOM MED, V76, P347, DOI 10.1097/PSY.0000000000000071; Nakata A, 2010, BRAIN BEHAV IMMUN, V24, P1268, DOI 10.1016/j.bbi.2010.05.004; Nakata Akinori, 2012, Methods Mol Biol, V934, P39, DOI 10.1007/978-1-62703-071-7_3; Schaufeli WB, 2002, J HAPPINESS STUD, V3, P71, DOI DOI 10.1023/A:1015630930326; Seppala P, 2011, J POSIT PSYCHOL, V7, P95; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Shishehbor MH, 2002, AM J MED, V113, P643, DOI 10.1016/S0002-9343(02)01324-4; Steptoe A, 2003, PSYCHOSOM MED, V65, P461, DOI 10.1097/01.PSY.0000035717.78650.A1; Suarez EC, 2013, BRAIN BEHAV IMMUN, V32, P144, DOI 10.1016/j.bbi.2013.03.009; TyHallberg UE, 2007, SCAND J PSYCHOL, V48, P135	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-0131	1432-1246		INT ARCH OCC ENV HEA	Int. Arch. Occup. Environ. Health	AUG	2015	88	6					651	658		10.1007/s00420-014-0995-9		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN2IX	WOS:000358245400001		
J	Doki, S; Sasahara, S; Matsuzaki, I				Doki, Shotaro; Sasahara, Shinichiro; Matsuzaki, Ichiyo			Psychological approach of occupational health service to sick leave due to mental problems: a systematic review and meta-analysis	INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH			English	Review						Mental illness; Meta-analysis; Occupational health services; Return to work; Sick leave	RANDOMIZED CONTROLLED-TRIAL; PSYCHOSOCIAL WORK-ENVIRONMENT; MAJOR DEPRESSIVE DISORDER; WORKPLACE INTERVENTION; RETURN; EMPLOYEES; ABSENCE; STRESS; CARE; CONSULTATION	The effects of interventions by occupational health services on sick leave prompted by psychiatric disorders were examined with respect to intervention method and the number of sick leave days. The intervention methods used by occupational health services were systematically reviewed by searching three databases and manual searching. A meta-analysis of the number of sick leave days comparing the intervention group [intervention + care as usual (CAU)] and control group (CAU alone) was performed. In addition, subanalyses were conducted for the duration until sick-listed workers' return to work after sick leave (Subgroup 1) and the number of non-sick-listed workers' total sick leave days (Subgroup 2). Ten studies were extracted and integrated, and the subjects were subsequently sorted into the intervention group (n = 434, 322, and 756 in subgroup 1, subgroup 2, and total, respectively) and control group (n = 413, 385, and 798 in subgroup 1, subgroup 2, and total, respectively). All studies employed an intervention method of problem-solving treatment or cognitive behavioral therapy (CBT). There were no significant differences between the intervention and control groups in subgroup 1 or 2. However, the combined intervention group had significantly fewer total sick leave days than the combined control group (mean difference -6.64 days, 95 % CI -12.68 to -0.59, I (2) = 0 %). The combined study of sick-listed and non-sick-listed workers indicates occupational health services implement problem-solving treatment or CBT interventions, which can shorten total sick leave duration.	[Doki, Shotaro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Sasahara, Shinichiro; Matsuzaki, Ichiyo] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Matsuzaki, Ichiyo] Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan	Sasahara, S (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	s-sshara@md.tsukuba.ac.jp					Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465; Lagerveld SE, 2012, J OCCUP HEALTH PSYCH, V17, P220, DOI 10.1037/a0027049; Haland AT, 2010, BEHAV RES THER, V48, P547, DOI 10.1016/j.brat.2010.03.005; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Stansfeld SA, 2011, OCCUP ENVIRON MED, V68, P408, DOI 10.1136/oem.2010.056994; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Berking M, 2013, PSYCHOTHER PSYCHOSOM, V82, P234, DOI 10.1159/000348448; Arnetz BB, 2003, J OCCUP ENVIRON MED, V45, P499, DOI 10.1097/01.jom.0000063628.37065.45; Vlasveld MC, 2013, OCCUP ENVIRON MED, V70, P223, DOI 10.1136/oemed-2012-100793; van der Klink JJL, 2001, AM J PUBLIC HEALTH, V91, P270, DOI 10.2105/AJPH.91.2.270; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443; van Oostrom SH, 2010, OCCUP ENVIRON MED, V67, P603, DOI 10.1136/oem.2009.051979; Rebergen DS, 2009, J OCCUP ENVIRON MED, V51, P305, DOI 10.1097/JOM.0b013e3181990d32; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Wang JL, 2010, CAN J PSYCHIAT, V55, P598; Brouwers EPM, 2007, EUR J PUBLIC HEALTH, V17, P214, DOI 10.1093/eurpub/ckl099; Kant I, 2008, J OCCUP REHABIL, V18, P79, DOI 10.1007/s10926-007-9114-z; Kivisto S, 2008, OCCUP MED-OXFORD, V58, P88, DOI 10.1093/occmed/kqm138; Sanati KA, 2011, J OCCUP REHABIL, V21, P474, DOI 10.1007/s10926-011-9310-8; Anema JR, 2006, J OCCUP REHABIL, V16, P41, DOI 10.1007/s10926-005-9001-4; Arends I, 2014, SOC SCI MED, V100, P123, DOI 10.1016/j.socscimed.2013.10.041; Brouwer S, 2011, OCCUP ENV MED S1, V68, pA29; Grade Working Group, 2004, BMJ-BRIT MED J, V328, P1490, DOI [10.1136/bmj.328.7454.1490, DOI 10.1136/BMJ.328.7454.1490]; Guyatt GH, 2008, BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Muto T, 1999, IND HEALTH, V37, P243, DOI 10.2486/indhealth.37.243; Mynors-Wallis L., 2005, PROBLEM SOLVING TREA; Namba Katsuyuki, 2012, Sangyo Eiseigaku Zasshi, V54, P276; Proper KI, 2004, OCCUP ENVIRON MED, V61, P275, DOI 10.1136/oem.2002.005769; Stefan SG, 2012, COGNITIVE THER RES, V36, P427; THASE ME, 1995, CNS DRUGS, V4, P261, DOI 10.2165/00023210-199504040-00004; van der Feltz-Cornelis CM, 2010, NEUROPSYCH DIS TREAT, V6, P375; WHO, 2008, GLOB BURD DIS 2004 U; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581; Willert MV, 2011, SCAND J WORK ENV HEA, V37, P186, DOI 10.5271/sjweh.3130; World Health Organization, 2003, INV MENT HLTH	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-0131	1432-1246		INT ARCH OCC ENV HEA	Int. Arch. Occup. Environ. Health	AUG	2015	88	6					659	667		10.1007/s00420-014-0996-8		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN2IX	WOS:000358245400002		
J	Khalid, N; Kobayashi, I; Wang, Z; Neves, MA; Uemura, K; Nakajima, M; Nabetani, H				Khalid, Nauman; Kobayashi, Isao; Wang, Zheng; Neves, Marcos A.; Uemura, Kunihiko; Nakajima, Mitsutoshi; Nabetani, Hiroshi			Formulation of monodisperse oil-in-water emulsions loaded with ergocalciferol and cholecalciferol by microchannel emulsification: insights of production characteristics and stability	INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY			English	Article						Cholecalciferol; ergocalciferol; microchannel emulsification; monodispersity; oil-in-water emulsion; stability	DELIVERY-SYSTEMS; DROPLETS; MICELLES; COHORT; SIZE	Nutritional deficiencies of ergocalciferol (VD2) and cholecalciferol (VD3) cause skeletal deformations. The primary aim of this study was to encapsulate VD2 and VD3 in food-grade oil-in-water (O/W) emulsions by using microchannel emulsification (MCE). Silicon asymmetric straight-through microchannel (MC) array consisting of 10313 channels, each having an 11x104m microslot connected to a 10m circular microholes. 1% (w/w) sodium cholate or Tween 20 in water was used as the continuous phase, while 0.5% (w/w) of each VD2 and VD3 in different oils served as the dispersed phase. Monodisperse O/W emulsions with Sauter mean diameters of 28 to 32m and relative span factor widths below 0.3 were formulated via an asymmetric straight-through MC array under appropriate operating conditions. The monodisperse O/W emulsions stabilised with Tween 20 remained stable for >30days with encapsulation efficiencies (EEs) of VD2 and VD3 of above 70% at 4 and 25 degrees C. In contrast, those stabilised with sodium cholate had stability of >30days with their EEs of over 70% only at 25 degrees C.	[Khalid, Nauman; Kobayashi, Isao; Wang, Zheng; Neves, Marcos A.; Uemura, Kunihiko; Nakajima, Mitsutoshi; Nabetani, Hiroshi] NARO, Food Engn Div, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Khalid, Nauman; Nabetani, Hiroshi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Wang, Zheng; Neves, Marcos A.; Nakajima, Mitsutoshi] Univ Tsukuba, Alliance Res North Afr, Tsukuba, Ibaraki 3058572, Japan; [Neves, Marcos A.; Nakajima, Mitsutoshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Kobayashi, I (reprint author), NARO, Food Engn Div, Natl Food Res Inst, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	isaok@affrc.go.jp					Tippetts M, 2012, J DAIRY SCI, V95, P4768, DOI 10.3168/jds.2011-5134; Neves MA, 2008, IND ENG CHEM RES, V47, P6405, DOI 10.1021/ie071552u; Khalid N, 2014, COLLOID SURFACE A, V458, P69, DOI 10.1016/j.colsurfa.2014.04.019; Loftsson T, 2006, AAPS PHARMSCITECH, V7; Khalid N, 2014, COLLOID SURFACE A, V459, P247, DOI 10.1016/j.colsurfa.2014.07.014; Haham M, 2012, FOOD FUNCT, V3, P737, DOI 10.1039/c2fo10249h; Vladisavljevic GT, 2012, MICROFLUID NANOFLUID, V13, P151, DOI 10.1007/s10404-012-0948-0; Wagner CL, 2006, BREASTFEED MED, V1, P59, DOI 10.1089/bfm.2006.1.59; Guttoff M, 2015, FOOD CHEM, V171, P117, DOI 10.1016/j.foodchem.2014.08.087; Vladisavljevic GT, 2011, MICROFLUID NANOFLUID, V10, P1199, DOI 10.1007/s10404-010-0750-9; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Gonnet M, 2010, J CONTROL RELEASE, V146, P276, DOI 10.1016/j.jconrel.2010.01.037; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Neves MA, 2008, FOOD BIOPHYS, V3, P126, DOI 10.1007/s11483-008-9056-9; Christakos S, 2010, ENDOCRIN METAB CLIN, V39, P243, DOI 10.1016/j.ecl.2010.02.002; Kawakatsu T, 1997, J AM OIL CHEM SOC, V74, P317, DOI 10.1007/s11746-997-0143-8; Souilem S, 2014, FOOD BIOPROCESS TECH, V7, P2014, DOI 10.1007/s11947-013-1182-9; Sugiura S, 2002, J PHYS CHEM B, V106, P9405, DOI 10.1021/jp0259871; Nakamura K, 2000, AM J CLIN NUTR, V71, P1161; GRADY LT, 1980, J PHARM SCI, V69, P1099, DOI 10.1002/jps.2600690932; Halder E, 2006, INDIAN J CHEM A, V45, P2591; Hamada Y, 2002, CRYST GROWTH DES, V2, P579, DOI 10.1021/cg025540h; Jojart B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102114; Purwanti N, 2015, COLLOID SURFACE A, V466, P66, DOI 10.1016/j.colsurfa.2014.10.058; Ruiz CC, 2003, COLLOID POLYM SCI, V281, P531, DOI 10.1007/s00396-002-0801-1; Stio M, 2002, IUBMB LIFE, V53, P175, DOI 10.1080/15216540290098837; Varade D, 2004, INDIAN J BIOCHEM BIO, V41, P107	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-5423	1365-2621		INT J FOOD SCI TECH	Int. J. Food Sci. Technol.	AUG	2015	50	8					1807	1814		10.1111/ijfs.12832		8	Food Science & Technology	Food Science & Technology	CN2MR	WOS:000358256100015		
J	Ikeda, R; Tateda, M; Okoshi, A; Morita, S; Hashimoto, S				Ikeda, Ryoukichi; Tateda, Masaru; Okoshi, Akira; Morita, Shinkichi; Hashimoto, Sho			Extraosseous chondroma of anterior neck in pediatric patient	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Extraosseous chondroma; Anterior neck mass; Thyroid cartilage	TISSUE; HEAD	Extraosseous chondroma (EC) is uncommon soft tissue tumor composed of hyaline cartilage without connection to bone or periosteum. The frequent sites of EC are the hands and feet and rarely reported in the pediatric population and anterior neck lesion. We present an extremely rare case of anterior neck mass in a 5-year-old male who underwent total resection, with the final diagnosis of EC. The review of the literature showed that all cases of EC in anterior neck lesion have been found in young age and preoperative diagnosis was difficult. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ikeda, Ryoukichi; Tateda, Masaru; Okoshi, Akira; Morita, Shinkichi; Hashimoto, Sho] Natl Sendai Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Miyagino Ku, Sendai, Miyagi 9838520, Japan	Ikeda, R (reprint author), Natl Sendai Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Miyagino Ku, 2-8-8 Miyagino, Sendai, Miyagi 9838520, Japan.	ryoukich@hotmail.com					Adaletli I., 2011, CASE REP ORTHOP, V2011; Adelchi Croce, 2014, BMC Res Notes, V7, P790, DOI 10.1186/1756-0500-7-790; Baatenburg de Jong Robert J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P98, DOI 10.1097/00020840-200404000-00008; Divino CM, 1996, PEDIATR SURG INT, V11, P54, DOI 10.1007/BF00174588; Kamysz JW, 1996, PEDIATR RADIOL, V26, P145, DOI 10.1007/BF01372095; Karaman Emin, 2012, Ear Nose Throat J, V91, pE1; Kudawara I, 2001, CLIN RADIOL, V56, P779, DOI 10.1053/crad.2000.0783; O'Callaghan J, 2008, OTOLARYNG HEAD NECK, V139, P594, DOI 10.1016/j.otohns.2008.06.020; Razek AA, 2011, RADIOGRAPHICS, V31, P1923, DOI 10.1148/rg.317115095; Singh R, 2006, J Orthop Surg (Hong Kong), V14, P192; Watanabe F., 2012, CASE REP MED, V2012	11	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	AUG	2015	79	8					1374	1376		10.1016/j.ijporl.2015.06.011		3	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	CN4HX	WOS:000358392300039		
J	Yan, F; Iliyasu, AM; Venegas-Andraca, SE; Yang, HM				Yan, Fei; Iliyasu, Abdullah M.; Venegas-Andraca, Salvador E.; Yang, Huamin			Video Encryption and Decryption on Quantum Computers	INTERNATIONAL JOURNAL OF THEORETICAL PHYSICS			English	Article						Quantum video; Video encryption; Video decryption; Quantum measurement; Color transformation; Quantum communication	FLEXIBLE REPRESENTATION; PROCESSING APPLICATIONS; EFFICIENT IMAGE; TRANSFORMATIONS; ALGORITHMS; OPERATIONS	A method for video encryption and decryption on quantum computers is proposed based on color information transformations on each frame encoding the content of the encoding the content of the video. The proposed method provides a flexible operation to encrypt quantum video by means of the quantum measurement in order to enhance the security of the video. To validate the proposed approach, a tetris tile-matching puzzle game video is utilized in the experimental simulations. The results obtained suggest that the proposed method enhances the security and speed of quantum video encryption and decryption, both properties required for secure transmission and sharing of video content in quantum communication.	[Yan, Fei; Yang, Huamin] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun 130022, Peoples R China; [Yan, Fei; Iliyasu, Abdullah M.] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan; [Iliyasu, Abdullah M.] Salman Bin Abdulaziz Univ, Coll Engn, Al Kharj 11942, Saudi Arabia; [Venegas-Andraca, Salvador E.] Tecnol Monterrey Escuela Ciencias & Ingn, Atizapan De Zaragoza 52926, Estado De Mexic, Mexico	Yang, HM (reprint author), Changchun Univ Sci & Technol, Sch Comp Sci & Technol, 7089 Weixing Rd, Changchun 130022, Peoples R China.	yanfei@cust.edu.cn; yan@hrt.dis.titech.ac.jp			Salman Bin Abdulaziz University Saudi Arabia via the Deanship for Scientific Research [2014/01/2079]; Tecnologico deMonterrey-Escuela de Ciencias e Ingenieria and CONACyT [41594]	The study is sponsored in full by the Salman Bin Abdulaziz University Saudi Arabia via the Deanship for Scientific Research Project Number 2014/01/2079. Additionally, SEVA gratefully acknowledges the financial support of Tecnologico deMonterrey-Escuela de Ciencias e Ingenieria and CONACyT (SNI member number 41594).	Yang YG, 2013, QUANTUM INF PROCESS, V12, P3477, DOI 10.1007/s11128-013-0612-y; Iliyasu AM, 2011, INT J QUANTUM INF, V9, P1459, DOI 10.1142/S0219749911008015; Bhargava B, 2004, MULTIMED TOOLS APPL, V24, P57, DOI 10.1023/B:MTAP.0000033983.62130.00; Liu FW, 2010, COMPUT SECUR, V29, P3, DOI 10.1016/j.cose.2009.06.004; Maniccam SS, 2004, PATTERN RECOGN, V37, P725, DOI 10.1016/j.patcog.2003.08.011; Hua TX, 2015, INT J THEOR PHYS, V54, P526, DOI 10.1007/s10773-014-2245-z; Zhou RG, 2013, INT J THEOR PHYS, V52, P1802, DOI 10.1007/s10773-012-1274-8; Le PQ, 2011, QUANTUM INF PROCESS, V10, P63, DOI 10.1007/s11128-010-0177-y; Iliyasu AM, 2013, ENTROPY-SWITZ, V15, P2874, DOI 10.3390/e15082874; Iliyasu AM, 2013, INT J UNCONV COMPUT, V9, P125; Le PQ, 2011, STUD COMPUT INTELL, V372, P179; Le PQ, 2011, THEOR COMPUT SCI, V412, P1406, DOI 10.1016/j.tcs.2010.11.029; Le Phuc Q, 2010, IAENG International Journal of Applied Mathematics, V40; Mink A., 2006, P SPIE QUANTUM INFOR, V6244; Nielsen M, 2000, QUANTUM COMPUTATION; Shi C., 1999, P INT C PAR DISTR PR; Song XH, 2014, QUANTUM INF PROCESS, V13, P1765, DOI 10.1007/s11128-014-0768-0; Sun B., 2014, J ADV COMPUT INTELL, V18; Sun B., 2013, J ADV COMPUT INTELL, V17, P404; Sun B., 2011, IEEE 7 INT S INT SIG, P1; Tosun A.S., 2000, IEEE INT C MULT EXP, V1, P119; Yan F, 2014, ENTROPY-SWITZ, V16, P5290, DOI 10.3390/e16105290; Yan F., 2012, IEEE WORLD C COMP IN, P1; Yan F., 2013, INT J INNOV COMPUT A, V5, P199; Yan F, 2015, QUANTUM INF PROCESS, V14, P1675, DOI 10.1007/s11128-014-0912-x	25	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7748	1572-9575		INT J THEOR PHYS	Int. J. Theor. Phys.	AUG	2015	54	8					2893	2904		10.1007/s10773-015-2524-3		12	Physics, Multidisciplinary	Physics	CN1QC	WOS:000358193800040		
J	Sugitani, K; Arai, Y; Takamiya, H; Terauchi, R; Nakagawa, S; Ueshima, K; Kubo, T				Sugitani, Kazuya; Arai, Yuji; Takamiya, Hisatake; Terauchi, Ryu; Nakagawa, Shuji; Ueshima, Keiichiro; Kubo, Toshikazu			Factors affecting range of motion after total knee arthroplasty in patients with more than 120 degrees of preoperative flexion angle	INTERNATIONAL ORTHOPAEDICS			English	Article						Range of motion; Total knee arthroplasty; Posterior tibial slope; Varus deformity; Posterior condylar offset	INFLUENCE POSTOPERATIVE FLEXION; POSTERIOR TIBIAL SLOPE; SATISFACTION; IMPINGEMENT; REPLACEMENT; THICKNESS; SYSTEM; POST	Purpose The postoperative flexion angle reportedly shows a positive correlation with the preoperative flexion angle, but in some cases, the postoperative flexion angle decreases in patients with a large preoperative flexion angle. The purpose of this study was to investigate factors affecting the range of motion after total knee arthroplasty (TKA) in patients with a large preoperative flexion angle. Methods The study evaluated 120 knees with more than 120 degrees of preoperative flexion angle that underwent NexGen LPS-Flex mobile bearing. The groups with and without a reduction in the postoperative flexion angle were compared. Also, a logistic regression analysis was performed, where the presence or absence of a reduction in the postoperative flexion angle was the dependent variable and age, sex, body mass index (BMI), preoperative femorotibial angle (FTA), gamma angle, delta angle, pre/postoperative change amount in posterior condylar offset (PCO), pre/postoperative change amount in joint line, and pre/postoperative change amount in patellar thickness were independent variables. Results Those with preoperative FTA of 186 degrees or larger did not have a reduction in the postoperative flexion angle, compared with the angle of 185 degrees or smaller. Those with delta angle of 83 degrees or smaller also did not have a reduction in the postoperative flexion angle, compared with the angle of 84 degrees or larger. Conclusions Our results showed that preoperative FTA and delta angle had an impact on a reduction in the postoperative flexion angle. The installation angle of the tibial component in the sagittal plane is important.	[Sugitani, Kazuya; Arai, Yuji; Takamiya, Hisatake; Terauchi, Ryu; Nakagawa, Shuji; Ueshima, Keiichiro; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan	Arai, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.	sugikazuyasugi@yahoo.co.jp; yarai89046@nike.eonet.ne.jp					FIGGIE HE, 1986, J BONE JOINT SURG AM, V68A, P1035; Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; EWALD FC, 1989, CLIN ORTHOP RELAT R, P9; Shi XJ, 2013, KNEE SURG SPORT TR A, V21, P2696, DOI 10.1007/s00167-012-2058-7; Callaghan JJ, 2002, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000036530.46246.5e; Sekiya H, 2009, CLIN ORTHOP RELAT R, V467, P1582, DOI 10.1007/s11999-008-0588-6; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P127, DOI 10.1007/s11999-012-2533-y; Bellemans J, 2010, KNEE SURG SPORT TR A, V18, P152, DOI 10.1007/s00167-009-0903-0; Bellemans J, 2005, KNEE SURG SPORT TR A, V13, P193, DOI 10.1007/s00167-004-0557-x; Winemaker M, 2012, J ARTHROPLASTY, V27, P1437, DOI 10.1016/j.arth.2011.12.015; Ritter MA, 2003, J BONE JOINT SURG AM, V85A, P1278; Noble PC, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/011.blo.0000238825.63648.1e; Banks SA, 2002, J BONE JOINT SURG AM, V84A, P37; Bengs BC, 2006, J ARTHROPLASTY, V21, P650, DOI 10.1016/j.arth.2005.07.020; Choi HR, 2014, INT ORTHOP, V38, P1641, DOI 10.1007/s00264-014-2421-z; Dhollander AAM, 2013, KNEE SURG SPORT TR A, V21, P2817, DOI 10.1007/s00167-012-2245-6; Gatha Nehal M, 2004, J Knee Surg, V17, P196; Hamai S, 2008, J BONE JOINT SURG BR, V90B, P1180, DOI 10.1302/0301-620X.90B9.20298; Kansara D, 2006, J ARTHROPLASTY, V21, P809, DOI 10.1016/j.arth.2005.08.023; Kawamura H, 2001, J Orthop Sci, V6, P248, DOI 10.1007/s007760100043; Kuster MS, 2004, ARCH ORTHOP TRAUM SU, V124, P415, DOI 10.1007/s00402-004-0700-7; Menciere ML, 2014, INT ORTHOP, V38, P2079, DOI 10.1007/s00264-014-2372-4; Mihalko W, 2006, CLIN ORTHOP RELAT R, P283, DOI 10.1097/01.blo.0000218756.89439.06; Russell RD, 2014, KNEE SURG SPORT TR A, V22, P1644, DOI 10.1007/s00167-013-2378-2; Whiteside LA, 1988, J ARTHROPLASTY, V3, P51; Yagishita K, 2001, Bull Hosp Jt Dis, V60, P23	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	AUG	2015	39	8					1535	1540		10.1007/s00264-015-2710-1		6	Orthopedics	Orthopedics	CN4FE	WOS:000358385000012		
J	Hernigou, P; Guissou, I; Homma, Y; Poignard, A; Chevallier, N; Rouard, H; Lachaniette, CHF				Hernigou, Philippe; Guissou, Isaac; Homma, Yasuhiro; Poignard, Alexandre; Chevallier, Nathalie; Rouard, Helene; Lachaniette, Charles Henri Flouzat			Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes	INTERNATIONAL ORTHOPAEDICS			English	Article						Ankle fracture; Non-union; Diabetes; Mesenchymal stem cells; Bone graft; Bone marrow aspiration in diabetic patients	PERIPHERAL ARTERIAL-DISEASE; OPERATIVE TREATMENT; MONONUCLEAR-CELLS; METABOLIC STATE; FRACTURES; MELLITUS; FOOT; TRANSPLANTATION; MANAGEMENT; NEUROARTHROPATHY	Purpose Clinical studies in diabetic patients have demonstrated that there is a high incidence of complications in distal tibia and ankle fracture treatments. One strategy to mitigate issues with wound healing and infection in diabetic patients is to use a percutaneous technique in which autologous, bone marrow-derived, concentrated cells are injected at the site of non-unions. Methods Eighty-six ankle non-union in diabetic patients were treated with bone marrow mesenchymal stem cells (BM-MSCs) delivered in an autologous bone marrow concentrate (BMC). Clinical outcomes of the 86 diabetic non-union patients treated with BMC were compared with 86 diabetic matched non-unions treated with a standard bone iliac crest autograft. Results Treatment with BMC promoted non-union healing in 70 among 86 diabetic patients (82.1 %) with a low number of complications. Of the 86 diabetic patients treated with iliac bone graft, 53 (62.3 %) had healing; major complications were observed: 5 amputations, 11 osteonecroses of the fracture wound edge and 17 infections. Conclusions In diabetic patients with ankle non-unions, treatment with BM-MSCs from bone marrow concentrate may be preferable in view of the high risks of major complications after open surgery and iliac bone grafting, and improved healing rates compared with standard iliac bone autograft treatment.	[Hernigou, Philippe; Guissou, Isaac; Poignard, Alexandre; Chevallier, Nathalie; Rouard, Helene; Lachaniette, Charles Henri Flouzat] Univ Paris, Hop Henri Mondor, Dept Orthopaed Surg, Creteil, France; [Homma, Yasuhiro] Juntendo Univ, Dept Orthopaed, Tokyo, Japan	Hernigou, P (reprint author), Univ Paris, Hop Henri Mondor, Dept Orthopaed Surg, Creteil, France.	philippe.hernigou@wanadoo.fr					Clark N, 2003, DIABETES CARE, V26, P3333; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Johnson JE, 1998, J BONE JOINT SURG AM, V80A, P1700; Liu M, 2008, J CELL MOL MED, V12, P1155, DOI 10.1111/j.1582-4934.2008.00288.x; Pinzur MS, 2005, FOOT ANKLE INT, V26, P545; Costigan W, 2007, FOOT ANKLE INT, V28, P32, DOI 10.3113/FAI.2007.0006; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; HOLMES GB, 1994, FOOT ANKLE INT, V15, P182; Blotter RH, 1999, FOOT ANKLE INT, V20, P687; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Fabrin J, 2000, DIABETES CARE, V23, P796, DOI 10.2337/diacare.23.6.796; Jani MM, 2003, FOOT ANKLE INT, V24, P838; Ganesh SP, 2005, J BONE JOINT SURG AM, V87A, P1712, DOI 10.2106/JBJS.D.02625; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Jones KB, 2005, J BONE JOINT SURG BR, V87B, P489, DOI 10.1302/0301-620X.87B4; Flynn JM, 2000, FOOT ANKLE INT, V21, P311; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Smieja M, 1999, J GEN INTERN MED, V14, P418, DOI 10.1046/j.1525-1497.1999.05208.x; McCormack RG, 1998, J BONE JOINT SURG BR, V80B, P689, DOI 10.1302/0301-620X.80B4.8648; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Gomez-Barrena E, 2014, INT ORTHOP, V38, P1803, DOI 10.1007/s00264-014-2332-z; Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115; Bartsch T, 2007, CLIN RES CARDIOL, V96, P891, DOI 10.1007/s00392-007-0569-x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Follak N, 2005, DIABETES-METAB RES, V21, P288, DOI 10.1002/dmrr.537; Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; COFIELD RH, 1983, FOOT ANKLE, V4, P15; Boddenberg U, 2004, ZBL CHIR, V129, P453, DOI 10.1055/s-2004-832398; Chochola M, 2008, INT ANGIOL, V27, P281; De Vriese AS, 2008, J INTERN MED, V263, P395, DOI 10.1111/j.1365-2796.2007.01899.x; Ebihara Y, 2014, BRIT J HAEMATOL, V164, P459, DOI 10.1111/bjh.12638; Follak N, 2004, HISTOL HISTOPATHOL, V19, P473; Gandhi Ankur, 2006, Foot Ankle Clin, V11, P805, DOI 10.1016/j.fcl.2006.06.009; Hinsenkamp M, 2015, INT ORTHOP, V39, P137, DOI 10.1007/s00264-014-2562-0; Le Nail LR, 2014, INT ORTHOP, DOI [10.1007/s00264-014-2342-x(9):1845-1853, DOI 10.1007/S00264-014-2342-X(9):1845-1853]; Lechner A, 2003, AM J PHYSIOL-ENDOC M, V284, pE259, DOI 10.1152/ajpendo.00393.2002; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Perry Mark D, 2005, J Surg Orthop Adv, V14, P85; Schepers T, 2013, INT ORTHOP, V37, P489, DOI 10.1007/s00264-012-1753-9; SCHON LC, 1995, ORTHOP CLIN N AM, V26, P375; Schon LC, 1998, CLIN ORTHOP RELAT R, P116	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	AUG	2015	39	8					1639	1643		10.1007/s00264-015-2738-2		5	Orthopedics	Orthopedics	CN4FE	WOS:000358385000026		
J	Uchiyama, T; Okamoto, H; Ogata, A; Tajima, Y; Takase, Y; Suzuyama, K				Uchiyama, Taku; Okamoto, Hiroaki; Ogata, Atsushi; Tajima, Yutaka; Takase, Yukinori; Suzuyama, Kenji			Treatment of a ruptured aneurysm involved in a double origin of the posterior inferior cerebellar artery	INTERVENTIONAL NEURORADIOLOGY			English	Article						Double origin; posterior inferior cerebellar artery; endovascular treatment; aneurysm	ENDOVASCULAR TREATMENT; COILING	Double origin of the posterior inferior cerebellar artery (DOPICA) is a rare anatomical variation, and can be associated with intracranial aneurysm formation. We describe a 66-year-old woman case of a ruptured aneurysm involved in a DOPICA. We performed aneurysmal coil embolization for the ruptured aneurysm involved in the cranial channel of DOPICA, but the aneurysm relapsed two months later. We subsequently performed internal trapping of the cranial channel because of well visualization of the distal flow by the balloon occlusion test. Endovascular trapping of a channel is one of the effective treatments of an aneurysm involved in DOPICA.	[Uchiyama, Taku; Okamoto, Hiroaki; Tajima, Yutaka; Suzuyama, Kenji] Karatsu Red Cross Hosp, Dept Neurosurg, Saga, Japan; [Ogata, Atsushi; Takase, Yukinori] Saga Univ, Fac Med, Dept Neurosurg, Saga, Japan	Uchiyama, T (reprint author), Imari Arita Kyoritsu Hosp, Dept Neurosurg, 860 Kou, Arita Cho, Saga, Japan.	m01010tu@jichi.ac.jp					Mercier P, 2008, INTERV NEURORADIOL, V14, P49; Pasco A, 2002, J NEUROSURG, V96, P127, DOI 10.3171/jns.2002.96.1.0127; Fan F, 2011, CATHETER CARDIO INTE, V77, P150, DOI 10.1002/ccd.22685; Koh JS, 2012, J KOREAN NEUROSURG S, V51, P40, DOI 10.3340/jkns.2012.51.1.40; Kwon BJ, 2007, NEUROSURGERY, V61, P242, DOI [10.1227/01.neu.0000303976.22054.9d, 10.1227/01.NEU.0000280120.36270.37]; Lee SH, 2011, INTERV NEURORADIOL, V17, P183; Lesley WS, 2007, AM J ROENTGENOL, V189, P893, DOI 10.2214/AJR.07.2453; Trivelato FP, 2011, INTERV NEURORADIOL, V17, P351; Vora N, 2009, J NEUROIMAGING, V19, P65, DOI 10.1111/j.1552-6569.2008.00243.x	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	AUG	2015	21	4					451	455		10.1177/1591019915590363		5	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CN3LR	WOS:000358328400004		
J	Nobu, MK; Narihiro, T; Rinke, C; Kamagata, Y; Tringe, SG; Woyke, T; Liu, WT				Nobu, Masaru K.; Narihiro, Takashi; Rinke, Christian; Kamagata, Yoichi; Tringe, Susannah G.; Woyke, Tanja; Liu, Wen-Tso			Microbial dark matter ecogenomics reveals complex synergistic networks in a methanogenic bioreactor	ISME JOURNAL			English	Article							SP-NOV.; DEGRADING TEREPHTHALATE; PELOBACTER-CARBINOLICUS; SYNTROPHIC ASSOCIATION; PHYLOGENETIC DIVERSITY; ACETOBACTERIUM-WOODII; ELECTRON BIFURCATION; ENERGY-CONSERVATION; COMMUNITY STRUCTURE; CANDIDATE DIVISION	Ecogenomic investigation of a methanogenic bioreactor degrading terephthalate (TA) allowed elucidation of complex synergistic networks of uncultivated microorganisms, including those from candidate phyla with no cultivated representatives. Our previous metagenomic investigation proposed that Pelotomaculum and methanogens may interact with uncultivated organisms to degrade TA; however, many members of the community remained unaddressed because of past technological limitations. In further pursuit, this study employed state-of-the-art omics tools to generate draft genomes and transcriptomes for uncultivated organisms spanning 15 phyla and reports the first genomic insight into candidate phyla Atribacteria, Hydrogenedentes and Marinimicrobia in methanogenic environments. Metabolic reconstruction revealed that these organisms perform fermentative, syntrophic and acetogenic catabolism facilitated by energy conservation revolving around H-2 metabolism. Several of these organisms could degrade TA catabolism by-products (acetate, butyrate and H-2) and syntrophically support Pelotomaculum. Other taxa could scavenge anabolic products (protein and lipids) presumably derived from detrital biomass produced by the TA-degrading community. The protein scavengers expressed complementary metabolic pathways indicating syntrophic and fermentative step-wise protein degradation through amino acids, branched-chain fatty acids and propionate. Thus, the uncultivated organisms may interact to form an intricate syntrophy-supported food web with Pelotomaculum and methanogens to metabolize catabolic by-products and detritus, whereby facilitating holistic TA mineralization to CO2 and CH4.	[Nobu, Masaru K.; Narihiro, Takashi; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Narihiro, Takashi; Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Rinke, Christian; Tringe, Susannah G.; Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA USA; [Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan	Liu, WT (reprint author), Univ Illinois, Dept Civil & Environm Engn, 205 North Mathews Ave, Urbana, IL 61801 USA.	wtliu@illinois.edu	Liu, Wen-Tso/C-8788-2011; 	Liu, Wen-Tso/0000-0002-8700-9803; Rinke, Christian/0000-0003-4632-1187; Tringe, Susannah/0000-0001-6479-8427	US Department of Energy Office of Science [DE-AC02-05CH11231]; US Department of Energy [DE-SC0006771]; Energy Biosciences Institute (EBI) at the University of Illinois Urbana-Champaign (UIUC)	We acknowledge Peiying Hong, Xianzheng Li and Hideyuki Tamaki for sample preparation. We thank Bernhard Schink for etymological advice on Prokaryote Candidatus nomenclature. We also thank reviewers for invaluable input. The work conducted by the US Department of Energy Joint Genome Institute is supported by the US Department of Energy Office of Science under Contract No. DE-AC02-05CH11231. This work is also supported by the US Department of Energy under Award DE-SC0006771 to the University of Illinois, Urbana-Champaign, and a grant from the Energy Biosciences Institute (EBI) at the University of Illinois Urbana-Champaign (UIUC) to WTL.	Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; THAUER RK, 1977, BACTERIOL REV, V41, P100; Qiu YL, 2004, APPL ENVIRON MICROB, V70, P1617, DOI 10.1128/AEM.70.32.1617-1626.2004; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; HUGENHOLTZ J, 1989, J BACTERIOL, V171, P2873; MOUNTFORT DO, 1984, INT J SYST BACTERIOL, V34, P216; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Qiu YL, 2006, ARCH MICROBIOL, V185, P172, DOI 10.1007/s00203-005-0081-5; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Sieber JR, 2010, ENVIRON MICROBIOL, V12, P2289, DOI 10.1111/j.1462-2920.2010.02237.x; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Qiu YL, 2008, APPL ENVIRON MICROB, V74, P2051, DOI 10.1128/AEM.02378-07; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI 10.1099/ijs.0.02165-0; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Baena S, 1998, ANAEROBE, V4, P241, DOI 10.1006/anae.1998.0170; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Wu JH, 2001, MICROBIOL-UK, V147, P373; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; Chen CL, 2004, MICROBIOL-SGM, V150, P3429, DOI 10.1099/mic.0.27193-0; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Harmsen HJM, 1998, INT J SYST BACTERIOL, V48, P1383; Glockner J, 2010, ENVIRON MICROBIOL, V12, P1218, DOI 10.1111/j.1462-2920.2010.02164.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Juottonen H, 2005, ENVIRON MICROBIOL, V7, P1547, DOI 10.1111/j.1462-2920.2005.00838.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CONRAD RS, 1974, J BACTERIOL, V118, P103; DUBOURGUIER HC, 1986, ARCH MICROBIOL, V145, P248, DOI 10.1007/BF00443653; Fardeau ML, 1997, ANAEROBE, V3, P405, DOI 10.1006/anae.1997.0126; Kosaka T, 2008, GENOME RES, V18, P442, DOI [10.1101/gr.7136508, 10.1107/gr.7136508]; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; MATTHIES C, 1992, APPL ENVIRON MICROB, V58, P1435; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Muller B, 2013, MICROBIOLOGYOPEN, V2, P35, DOI 10.1002/mbo3.50; Nobu MK, 2014, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.12444, DOI 10.1111/1462-2920.12444]; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Plugge CM, 2002, INT J SYST EVOL MICR, V52, P401, DOI 10.1099/ijs.0.01949-0; QATIBI AI, 1991, FEMS MICROBIOL ECOL, V85, P233, DOI 10.1111/j.1574-6968.1991.tb04729.x; Qiu YL, 2003, ARCH MICROBIOL, V179, P457, DOI 10.1007/s00203-003-0557-0; Rotaru AE, 2012, APPL ENVIRON MICROB, V78, P7645, DOI 10.1128/AEM.01946-12; Schink B, 2013, PROKARYOTES, P471, DOI DOI 10.1007/978-3-642-30123-0_59; Schink B., 2006, SYNTROPHISM PROKARYO; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Sieber JR, 2014, ENVIRON MICROBIOL, V16, P177, DOI 10.1111/1462-2920.12269; Speece R. E., 1996, ANAEROBIC BIOTECHNOL; STIEB M, 1986, ARCH MICROBIOL, V144, P291, DOI 10.1007/BF00410965; Taylor MB, 2005, ASTR SOC P, V347, P29; Tremblay PL, 2013, MBIO, V4, DOI 10.1128/mBio.00406-12; WILDENAUER FX, 1986, FEMS MICROBIOL ECOL, V38, P373; Wu JH, 2013, APPL ENVIRON MICROB, V79, P105, DOI 10.1128/AEM.02327-12	65	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	AUG	2015	9	8					1710	1722		10.1038/ismej.2014.256		13	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	CN2OA	WOS:000358260100003		
J	Miyamoto, Y; Sakai, A; Hattori, M; Nara, K				Miyamoto, Yumiko; Sakai, Atsushi; Hattori, Masahira; Nara, Kazuhide			Strong effect of climate on ectomycorrhizal fungal composition: evidence from range overlap between two mountains	ISME JOURNAL			English	Article							COMMUNITY STRUCTURE; COMPREHENSIVE FRAMEWORK; LACCARIA-AMETHYSTINA; SPATIAL STRUCTURE; PLANT DIVERSITY; REGIONAL-SCALE; FORESTS; HOST; ECOSYSTEMS; GRADIENT	Separating the effects of environmental factors and spatial distance on microbial composition is difficult when these factors covary. We examined the composition of ectomycorrhizal (EM) fungi along elevation gradients on geographically distant mountains to clarify the effect of climate at the regional scale. Soil cores were collected from various forest types along an elevation gradient in southwestern Japan. Fungal species were identified by the internal transcribed spacer regions of the rDNA using direct sequencing. The occurrence of fungal species in this study was compared with a previous study conducted on a mountain separated by similar to 550 km. In total, we recorded 454 EM fungi from 330 of 350 soil cores. Forty-seven fungal species (similar to 20% of the total excluding singletons) were shared between two mountains, mostly between similar forest types on both mountains. Variation partitioning in redundancy analysis revealed that climate explained the largest variance in EM fungal composition. The similarity of forest tree composition, which is usually determined by climatic conditions, was positively correlated with the similarity of the EM fungal composition. However, the lack of large host effects implied that communities of forest trees and EM fungi may be determined independently by climate. Our data provide important insights that host plants and mutualistic fungi may respond to climate change idiosyncratically, potentially altering carbon and nutrient cycles in relation to the plant-fungus associations.	[Miyamoto, Yumiko; Nara, Kazuhide] Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba 2778563, Japan; [Sakai, Atsushi] Forestry & Forest Prod Res Inst, Kochi, Japan; [Hattori, Masahira] Univ Tokyo, Ctr Om & Bioinformat, Tokyo, Japan	Miyamoto, Y (reprint author), Univ Tokyo, Dept Nat Environm Studies, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	miyamoto_y@nenv.k.u-tokyo.ac.jp; nara@k.u-tokyo.ac.jp					KIRA T, 1991, ECOL RES, V6, P185, DOI 10.1007/BF02347161; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Lilleskov EA, 2007, NEW PHYTOL, V174, P250, DOI 10.1111/j.1469-8137.2007.02023.x; Queloz V, 2011, GLOBAL ECOL BIOGEOGR, V20, P160, DOI 10.1111/j.1466-8238.2010.00589.x; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Peay KG, 2013, ISME J, V7, P1852, DOI 10.1038/ismej.2013.66; Thebault E, 2013, J BIOGEOGR, V40, P759, DOI 10.1111/jbi.12015; Tedersoo L, 2014, MOL ECOL, V23, P992, DOI 10.1111/mec.12660; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Bahram M, 2013, J ECOL, V101, P1335, DOI 10.1111/1365-2745.12120; Roy M, 2008, MOL ECOL, V17, P2825, DOI 10.1111/j.1365-294X.2008.03790.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Johnson NC, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12085; Koide RT, 2014, NEW PHYTOL, V201, P433, DOI 10.1111/nph.12538; Roy M, 2013, NEW PHYTOL, V198, P1228, DOI 10.1111/nph.12212; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Trocha LK, 2012, MYCORRHIZA, V22, P121, DOI 10.1007/s00572-011-0387-x; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Colwell RK, 2012, J PLANT ECOL-UK, V5, P3, DOI 10.1093/jpe/rtr044; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Tedersoo L, 2013, NEW PHYTOL, V199, P822, DOI 10.1111/nph.12328; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Jarvis S, 2013, GLOBAL CHANGE BIOL, V19, P1688, DOI 10.1111/gcb.12178; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Lilleskov EA, 2004, FEMS MICROBIOL ECOL, V49, P319, DOI 10.1016/j.femsec.2004.04.004; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Murata M, 2013, MYCORRHIZA, V23, P641, DOI 10.1007/s00572-013-0504-0; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Dickie IA, 2014, BOTANY, V92, P149, DOI 10.1139/cjb-2013-0091; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Richard F, 2005, NEW PHYTOL, V166, P1011, DOI 10.1111/j.1469-8137.2005.01382.x; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; Edwards IP, 2010, MOL ECOL, V19, P1469, DOI 10.1111/j.1365-294X.2010.04566.x; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; Toljander JF, 2006, NEW PHYTOL, V170, P873, DOI 10.1111/j.1469-8137.2006.01718.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Bruns TD, 2002, INTEGR COMP BIOL, V42, P352, DOI 10.1093/icb/42.2.352; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Bahram M, 2013, MYCORRHIZA, V23, P11, DOI 10.1007/s00572-012-0445-z; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Kennedy PG, 2003, J ECOL, V91, P1071, DOI 10.1046/j.1365-2745.2003.00829.x; Kennedy PG, 2010, FUNGAL ECOL, V3, P195, DOI 10.1016/j.funeco.2009.08.005; Lindquist EJ, 2012, 169 FAO UN EUR COMM; Miyamoto Y, 2014, ISME J, V8, P1739, DOI 10.1038/ismej.2014.34; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Parrent JL, 2006, ECOLOGY, V87, P2278, DOI 10.1890/0012-9658(2006)87[2278:CANAAE]2.0.CO;2; Pickles BJ, 2012, MOL ECOL, V21, P5110, DOI 10.1111/j.1365-294X.2012.05739.x; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; R Development Core Team, 2013, R LANG ENV STAT COMP; Smith ME, 2009, NEW PHYTOL, V182, P295, DOI 10.1111/j.1469-8137.2009.02801.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taylor Andy F. S., 2005, Mycologist, V19, P102, DOI 10.1017/S0269915X05003034; The Japan Meteorological Agency, 2014, MESH AV 2010; Wadud MA, 2014, MYCORRHIZA, V24, P551, DOI 10.1007/s00572-014-0571-x	67	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	AUG	2015	9	8					1870	1879		10.1038/ismej.2015.8		10	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	CN2OA	WOS:000358260100016		
J	Shibuta, Y; Ohno, M; Takaki, T				Shibuta, Yasushi; Ohno, Munekazu; Takaki, Tomohiro			Solidification in a Supercomputer: From Crystal Nuclei to Dendrite Assemblages	JOM			English	Article							PHASE-FIELD SIMULATION; COMPETITIVE GRAIN-GROWTH; MOLECULAR-DYNAMICS SIMULATIONS; CELLULAR-AUTOMATON MODEL; ADAPTIVE MESH REFINEMENT; SOLID-LIQUID INTERFACE; NICKEL-BASE SUPERALLOY; DIRECTIONAL SOLIDIFICATION; BINARY ALLOY; LATTICE BOLTZMANN	Thanks to the recent progress in high-performance computational environments, the range of applications of computational metallurgy is expanding rapidly. In this paper, cutting-edge simulations of solidification from atomic to microstructural levels performed on a graphics processing unit (GPU) architecture are introduced with a brief introduction to advances in computational studies on solidification. In particular, million-atom molecular dynamics simulations captured the spontaneous evolution of anisotropy in a solid nucleus in an undercooled melt and homogeneous nucleation without any inducing factor, which is followed by grain growth. At the microstructural level, the quantitative phase-field model has been gaining importance as a powerful tool for predicting solidification microstructures. In this paper, the convergence behavior of simulation results obtained with this model is discussed, in detail. Such convergence ensures the reliability of results of phase-field simulations. Using the quantitative phase-field model, the competitive growth of dendrite assemblages during the directional solidification of a binary alloy bicrystal at the millimeter scale is examined by performing two-and three-dimensional large-scale simulations by multi-GPU computation on the supercomputer, TSUBAME2.5. This cutting-edge approach using a GPU supercomputer is opening a new phase in computational metallurgy.	[Shibuta, Yasushi] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Ohno, Munekazu] Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Takaki, Tomohiro] Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan	Shibuta, Y (reprint author), Univ Tokyo, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	shibuta@material.t.u-tokyo.ac.jp	Shibuta, Yasushi/A-6301-2010; Ohno, Munekazu/A-5222-2012	Ohno, Munekazu/0000-0001-5383-412X	Japan Society for the Promotion of Science (JSPS), Japan [25289266, 25289006]; Iron and Steel Institute of Japan (ISIJ); Strategic Programs for Innovative Research (SPIRE), MEXT; Computational Materials Science Initiative (CMSI), Japan	This work was supported by Grant-in-Aid for Scientific Research (B) (Nos. 25289266 and 25289006) from Japan Society for the Promotion of Science (JSPS), Japan; 22th (T.T and M.O) and 23th (Y.S) ISIJ Research Promotion Grants from the Iron and Steel Institute of Japan (ISIJ), the Strategic Programs for Innovative Research (SPIRE), MEXT; and the Computational Materials Science Initiative (CMSI), Japan. Part of this work was supported by the Joint Usage/Research Center for Interdisciplinary Large-scale Information Infrastructures (JHPCN) and the High Performance Computing Infrastructure (HPCI) in Japan for the computational environment. Y.S. would like to thank Ms. Kanae Oguchi for support in the development of the source code for the GPU environment for the molecular dynamics simulations. T.T. also thanks Mr. Shinji Sakane, Prof. Takashi Shimokawabe, and Prof. Takayuki Aoki for the support in the large-scale simulations using the TSUBAME2.5 supercomputer.	Shibuta Y, 2011, CHEM PHYS LETT, V502, P82, DOI 10.1016/j.cplett.2010.12.020; WALTON D, 1959, T AM I MIN MET ENG, V215, P447; Hoyt JJ, 1999, ACTA MATER, V47, P3181, DOI 10.1016/S1359-6454(99)00189-5; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Streitz FH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.225701; Tourret D, 2015, ACTA MATER, V82, P64, DOI 10.1016/j.actamat.2014.08.049; Mathiesen RH, 1999, PHYS REV LETT, V83, P5062, DOI 10.1103/PhysRevLett.83.5062; Shibuta Y, 2008, ISIJ INT, V48, P1582, DOI 10.2355/isijinternational.48.1582; Takaki T, 2014, ACTA MATER, V81, P272, DOI 10.1016/j.actamat.2014.08.035; RAPPAZ M, 1993, ACTA METALL MATER, V41, P345, DOI 10.1016/0956-7151(93)90065-Z; Gurevich S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011603; Ohno M, 2010, ISIJ INT, V50, P1879, DOI 10.2355/isijinternational.50.1879; Folch R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011602; Ohno M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051603; Hashimoto R, 2011, ISIJ INT, V51, P1664, DOI 10.2355/isijinternational.51.1664; Provatas N, 1998, PHYS REV LETT, V80, P3308, DOI 10.1103/PhysRevLett.80.3308; GANDIN CA, 1994, ACTA METALL MATER, V42, P2233, DOI 10.1016/0956-7151(94)90302-6; Shibuta Y, 2012, ISIJ INT, V52, P2205, DOI 10.2355/isijinternational.52.2205; Kim SG, 1999, PHYS REV E, V60, P7186, DOI 10.1103/PhysRevE.60.7186; Provatas N, 1999, J COMPUT PHYS, V148, P265, DOI 10.1006/jcph.1998.6122; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Granasy L, 2004, J PHYS-CONDENS MAT, V16, pR1205, DOI 10.1088/0953-8984/16/41/R01; SHAN XW, 1993, PHYS REV E, V47, P1815, DOI 10.1103/PhysRevE.47.1815; Gandin CA, 2013, JOM-US, V65, P1122, DOI 10.1007/s11837-013-0679-z; Steinbach I, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/7/073001; Karma A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.115701; Bogno A, 2011, ACTA MATER, V59, P4356, DOI 10.1016/j.actamat.2011.03.059; Li JJ, 2012, ACTA MATER, V60, P1478, DOI 10.1016/j.actamat.2011.11.037; Zhou YZ, 2008, ACTA MATER, V56, P2631, DOI 10.1016/j.actamat.2008.02.022; Hoyt JJ, 2003, MAT SCI ENG R, V41, P121, DOI 10.1016/S0927-796X(03)00036-6; Yang CB, 2013, J ALLOY COMPD, V578, P577, DOI 10.1016/j.jallcom.2013.07.006; Pocheau A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051608; Karma A, 1998, PHYS REV E, V57, P4323, DOI 10.1103/PhysRevE.57.4323; Ohno M, 2010, ACTA MATER, V58, P6134, DOI 10.1016/j.actamat.2010.07.031; Ohno M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031603; Esaka H, 2003, MATER TRANS, V44, P829, DOI 10.2320/matertrans.44.829; Shibuta Y, 2009, CHEM PHYS LETT, V475, P264, DOI 10.1016/j.cplett.2009.05.051; Greenwood M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.246101; Ohno M, 2010, ACTA MATER, V58, P5749, DOI 10.1016/j.actamat.2010.06.050; Yasuda H, 2012, IOP CONF SER-MAT SCI, V33, DOI 10.1088/1757-899X/33/1/012036; Takaki T, 2014, ISIJ INT, V54, P437, DOI 10.2355/isijinternational.54.437; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Echebarria B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061604; Takaki T, 2013, J CRYST GROWTH, V382, P21, DOI 10.1016/j.jcrysgro.2013.07.028; Watanabe Y, 2010, ISIJ INT, V50, P1158, DOI 10.2355/isijinternational.50.1158; Qi Y, 2001, J CHEM PHYS, V115, P385, DOI 10.1063/1.1373664; Eshraghi M, 2012, J CRYST GROWTH, V354, P129, DOI 10.1016/j.jcrysgro.2012.06.002; ANDERSON MP, 1984, ACTA METALL MATER, V32, P783, DOI 10.1016/0001-6160(84)90151-2; Karma A, 1996, PHYS REV E, V53, pR3017, DOI 10.1103/PhysRevE.53.R3017; Morris JR, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144104; Emmerich H, 2008, ADV PHYS, V57, P1, DOI 10.1080/00018730701822522; Sun DY, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.174103; Boettinger WJ, 2002, ANNU REV MATER RES, V32, P163, DOI 10.1146/annurev.matsci.32.101901.155803; FINNIS MW, 1984, PHILOS MAG A, V50, P45; Asta M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.100101; Li TS, 2009, NAT MATER, V8, P726, DOI [10.1038/nmat2508, 10.1038/NMAT2508]; Akamatsu S, 1997, PHYS REV E, V56, P4479, DOI 10.1103/PhysRevE.56.4479; Parisi A, 2008, ACTA MATER, V56, P1348, DOI 10.1016/j.actamat.2007.11.037; Wang ZJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041604; Asadi E, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.024105; Asadi E, 2015, ACTA MATER, V86, P169, DOI 10.1016/j.actamat.2014.12.010; Berghoff M., 2013, SCI WORLD J, V2013; Boussinot G, 2010, ACTA MATER, V58, P1750, DOI 10.1016/j.actamat.2009.11.017; Dantzig J.A., 2009, SOLIDIFICATION, P1; Deschamps J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011605; Ding F, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187950; D'Souza N, 2002, J MATER SCI, V37, P481, DOI 10.1023/A:1013753120867; Echebarria B, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021608; Emmerich H, 2006, J PHYS-CONDENS MAT, V18, P11121, DOI 10.1088/0953-8984/18/49/006; ESAKA H, 1985, J CRYST GROWTH, V72, P578, DOI 10.1016/0022-0248(85)90208-8; GODFREY AW, 1995, PHILOS MAG A, V72, P737; Guo Z, 2015, COMPUT PHYS COMMUN, V190, P89, DOI 10.1016/j.cpc.2015.01.016; Jackson K.A., 1965, Acta Metallurgica, V13, DOI 10.1016/0001-6160(65)90061-1; Jacot A, 2002, ACTA MATER, V50, P1909, DOI 10.1016/S1359-6454(01)00442-6; Jelinek B, 2014, COMPUT PHYS COMMUN, V185, P939, DOI 10.1016/j.cpc.2013.09.013; Juric D, 1996, J COMPUT PHYS, V123, P127, DOI 10.1006/jcph.1996.0011; Kim SG, 2007, ACTA MATER, V55, P4391, DOI 10.1016/j.actamat.2007.04.004; KOBAYASHI R, 1993, PHYSICA D, V63, P410, DOI 10.1016/0167-2789(93)90120-P; Koseki T., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/S1468-6996(03)00026-3; Kurz W., 1998, FUNDAMENTALS SOLIDIF, P1; Lan CW, 2003, ACTA MATER, V51, P1857, DOI 10.1016/S1359-6454(02)00582-7; Lan CW, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031601; Liu ZY, 2013, METALL MATER TRANS A, V44A, P5113, DOI 10.1007/s11661-013-1840-6; Oguchi K, 2009, ISIJ INT, V49, P1536; Oguchi K, 2012, J JPN I MET, V76, P462, DOI 10.2320/jinstmet.76.462; Potts R. B., 1952, MATH P CAMBRIDGE PHI, V48, P106, DOI DOI 10.1017/S0305004100027419; Ramirez JC, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051607; Ramirez JC, 2005, ACTA MATER, V53, P1721, DOI 10.1016/j.actamat.2004.12.021; Rosam J, 2008, ACTA MATER, V56, P4559, DOI 10.1016/j.actamat.2008.05.029; Rosam J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.030601; Shibuta Y., 2015, UNPUB; Shibuta Y, 2007, CHEM PHYS LETT, V445, P265, DOI 10.1016/j.cplett.2007.07.098; Shibuta Y., 2008, J CHEM PHYS, V129; Shibuta Y, 2014, SCRIPTA MATER, V86, P20, DOI 10.1016/j.scriptamat.2014.04.021; Shibuta Y, 2010, PHYS CHEM CHEM PHYS, V12, P731, DOI 10.1039/b919869e; Shimokawabe T., 2011, P 2011 SC INT C HIGH, V1; SROLOVITZ DJ, 1983, SCRIPTA METALL MATER, V17, P241, DOI 10.1016/0036-9748(83)90106-0; Takaki T., IOP C SER M IN PRESS; Takaki T, 2005, J CRYST GROWTH, V283, P263, DOI 10.1016/j.jcrysgro.2005.05.064; Tonhardt R., 2013, J CRYST GROWTH, V213, P161; Yamanaka A, 2011, J CRYST GROWTH, V318, P40, DOI 10.1016/j.jcrysgro.2010.10.096	101	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	AUG	2015	67	8					1793	1804		10.1007/s11837-015-1452-2		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CN3LW	WOS:000358329000016		
J	Nakamura, N; Ogi, H; Hirao, M				Nakamura, N.; Ogi, H.; Hirao, M.			Review on Acoustic Transducers for Resonant Ultrasound Spectroscopy	JOM			English	Article							TEMPERATURE ELASTIC-CONSTANTS; LASER-DOPPLER INTERFEROMETRY; QUARTZ-CRYSTAL-MICROBALANCE; ATOMIC-FORCE MICROSCOPE; INTERNAL-FRICTION; OSCILLATOR; SOLIDS; WAVES; FILM; COEFFICIENTS	Determination of elastic constants using resonant ultrasound spectroscopy requires transducers that can measure resonance frequencies accurately and identify the vibrational mode of each resonance frequency. We developed three transducers, namely an electromagnetic acoustic transducer, a tripod piezoelectric transducer coupled with a laser Doppler interferometer, and an antenna transmission transducer, for use with various materials and in different measurement circumstances. Their capability in resonant ultrasound spectroscopy and their applications are described.	[Nakamura, N.; Ogi, H.; Hirao, M.] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Nakamura, N (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	nobutomo@me.es.osaka-u.ac.jp					Alers G. A., 1982, REV PROGR QNDE A, V2A, P271; THOMPSON RB, 1978, IEEE T SON ULTRASON, V25, P7; Nakamura N, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819974; Nakamura N, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731657; Ogi H, 1999, J ACOUST SOC AM, V106, P660, DOI 10.1121/1.427607; MIGLIORI A, 1993, PHYSICA B, V183, P1, DOI 10.1016/0921-4526(93)90048-B; MAYNARD JD, 1992, J ACOUST SOC AM, V91, P1754, DOI 10.1121/1.402455; MOCHIZUKI E, 1987, J PHYS EARTH, V35, P159; Suzuki Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064105; Maynard J, 1996, PHYS TODAY, V49, P26, DOI 10.1063/1.881483; DEMAREST HH, 1971, J ACOUST SOC AM, V49, P768, DOI 10.1121/1.1912415; Heyliger P, 2000, J ACOUST SOC AM, V107, P1235, DOI 10.1121/1.428413; Hirao M., 2003, EMATS SCI IND; Hurley DH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3327428; KAWASHIMA K, 1985, IEEE T SON ULTRASON, V32, P514; KUOKKALA VT, 1992, REV SCI INSTRUM, V63, P3136, DOI 10.1063/1.1142566; LEDBETTER H, 1995, J APPL PHYS, V78, P1542, DOI 10.1063/1.360247; LEDBETTER H, 1995, J MATER RES, V10, P1352, DOI 10.1557/JMR.1995.1352; Maxfield W. B., 1983, MATER EVAL, V41, P1399; Nakamura N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908039; Nakamura N, 2012, J APPL PHYS, V111, DOI 10.1063/1.3674271; Nakamura N, 2004, ACTA MATER, V52, P765, DOI 10.1016/j.actamat.2003.10.1012; Nurmalia N., 2013, JPN J APPL PHYS, V52; Ogi H, 2014, ULTRASONICS, V54, P1963, DOI 10.1016/j.ultras.2014.05.002; Ogi H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2908437; Ogi H, 2006, J APPL PHYS, V100, DOI 10.1063/1.2335684; Ogi H, 2002, J ACOUST SOC AM, V112, P2553, DOI 10.1121/1.1512700; Ogi H, 2006, ANAL CHEM, V78, P6903, DOI 10.1021/ac061004a; Ogi H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174107; Ogi H., 2002, PHILOS MAG A, V83, P503; Ogi H, 2003, IEEE T ULTRASON FERR, V50, P553, DOI 10.1109/TUFFC.2003.1201468; Ogi H, 2002, J APPL PHYS, V91, P4857, DOI 10.1063/1.1457542; Ogi H, 2013, P JPN ACAD B-PHYS, V89, P401, DOI 10.2183/pjab.89.401; Ogi H, 1999, ACTA MATER, V47, P2787, DOI 10.1016/S1359-6454(99)00124-X; Ogi H, 2004, ACTA MATER, V52, P2075, DOI 10.1016/j.actamat.2004.01.002; Ogi H, 2003, APPL PHYS LETT, V83, P464, DOI 10.1063/1.1593819; OHNO I, 1990, PHYS CHEM MINER, V17, P371; Ohno I., 1976, Journal of Physics of the Earth, V24; Rabe U, 1998, APPL PHYS A-MATER, V66, pS277, DOI 10.1007/s003390051145; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Sedlak P., 2008, P 1 INT S LAS ULTR S; So JH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.036103; Tarumi R, 2009, ISIJ INT, V49, P1432; Tarumi R, 2013, PHILOS MAG, V93, P4532, DOI 10.1080/14786435.2013.837225; Thompson R.B., 1990, PHYS ACOUSTICS, VXIX, P157; Tian J, 2008, IEEE T ULTRASON FERR, V55, P499, DOI 10.1109/TUFFC.2008.668; VASILE CF, 1979, J APPL PHYS, V50, P2583, DOI 10.1063/1.326265; Yamanaka K, 1998, APPL PHYS A-MATER, V66, pS313, DOI 10.1007/s003390051153	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	AUG	2015	67	8					1849	1855		10.1007/s11837-015-1457-x		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CN3LW	WOS:000358329000023		
J	Oka, S; Miyamoto, K				Oka, S.; Miyamoto, K.			Reproductive biology and growth of bluestripe herring Herklotsichthys quadrimaculatus (Ruppell, 1837) in the northernmost waters	JOURNAL OF APPLIED ICHTHYOLOGY			English	Article							CLUPEIDAE; KIRIBATI; PACIFIC	In order to examine the reproductive biology and growth of Herklotsichthys quadrimaculatus in the northernmost part of its reproductive range, the size frequency, gonadal development, and otolith daily increments of this species were collected from the coastal waters of Okinawa Island, southern Japan. Juveniles (<25mm standard length, SL) were found from April to August. Their size increased to ca. 100mm SL in November and subsequently remained unchanged. The gonadosomatic index of females was higher (>3.0) between March and August, which was the estimated spawning period. The modal hatching period back-calculated from otolith daily increments was from April to May, which would be the peak of spawning. Because mature and spent ovaries also contained mature and immature oocytes, it was concluded that females spawn several times during the spawning season. Age determination from otolith increments showed logistic growth up to 97mm (ca. 180days post-hatch), after which growth was almost stagnant. Maximum size and age were 121.6mm SL and 384days, respectively. The adult size decreased between August and September, indicating a change in the age cohort. Thus, the fish reached the end of their lifespans after spawning. Some of these ecological features were different from those of a previous study performed in southern areas; these differences suggest a flexible life history that could change to adapt to the surrounding environment.	[Oka, S.; Miyamoto, K.] Okinawa Churashima Fdn, Motobu, Okinawa 9050206, Japan	Oka, S (reprint author), Okinawa Churashima Fdn, 888 Ishikawa, Motobu, Okinawa 9050206, Japan.	sh-oka@okichura.jp					Akamine Tatsuro, 1995, Bulletin of the National Research Institute of Fisheries Science, V7, P189; MILTON DA, 1993, J FISH BIOL, V43, P89, DOI 10.1006/jfbi.1993.1112; FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F; Aonuma Y., 2002, FISHES JAPAN PICTORI, p[243, 1463]; Bapary MA, 2010, FISHERIES SCI, V76, P769, DOI 10.1007/s12562-010-0272-0; Conand F, 1984, RESOURCES APPAT VIVA; Dalzell P., 1987, TUNA BILLFISH ASSESS, V20, P1; Hallier J. P, 1990, ACIAR P, V30, P60; Hata H., 2011, NAT KAGOSHIMA, V37, P49; HIDA T S, 1977, NOAA (National Oceanic and Atmospheric Administration) Technical Report NMFS (National Marine Fisheries Service) Circular, V408, P63; Marichamy R., 1971, Indian Journal of Fisheries, V18, P148; Milton D. A., 1993, TUNA BAITFISH FUJI S, V52, P79; MILTON DA, 1994, FISH B-NOAA, V92, P102; Moussac G., 1986, CYBIUM, V10, P31; Whitehead P. J. P., 1985, FAO FISH SYNOP, V7, P1; WILLIAMS VR, 1983, FISH B-NOAA, V81, P587	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0175-8659	1439-0426		J APPL ICHTHYOL	J. Appl. Ichthyol.	AUG	2015	31	4					709	713		10.1111/jai.12811		5	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CN0DO	WOS:000358083600018		
J	Sawayama, E; Takagi, M				Sawayama, E.; Takagi, M.			Isolation and characterization of tandem repeat sequences in the growth hormone gene of the red seabream, Pagrus major (Temminck & Schlegel, 1843)	JOURNAL OF APPLIED ICHTHYOLOGY			English	Article							FLOUNDER PARALICHTHYS-OLIVACEUS; ENCODING GENE; GENOMIC STRUCTURE; SPARUS-AURATA; SEA BREAM; GH GENE; NUCLEOTIDE-SEQUENCE; RAINBOW-TROUT; POLYMORPHISM; DNA		[Sawayama, E.] Marua Suisan Co Ltd, R&D Div, Sukagawa, Ehime, Japan; [Takagi, M.] Ehime Univ, Tarumi Branch, South Ehime Fisheries Res Ctr, Matsuyama, Ehime 7908566, Japan	Takagi, M (reprint author), Ehime Univ, Tarumi Branch, South Ehime Fisheries Res Ctr, 3-5-7 Tarumi, Matsuyama, Ehime 7908566, Japan.	takagi@agr.ehime-u.ac.jp			Ehime Industrial Promotion Foundation; Ehime University	This work was partly supported by grants from the Ehime Industrial Promotion Foundation and Ehime University.	AGELLON LB, 1988, P NATL ACAD SCI USA, V85, P5136, DOI 10.1073/pnas.85.14.5136; Almuly R, 2008, COMP BIOCHEM PHYS D, V3, P43, DOI 10.1016/j.cbd.2006.12.006; Almuly R, 2000, GENOME, V43, P836, DOI 10.1139/gen-43-5-836; Almuly R, 2005, FISHERIES SCI, V71, P479, DOI 10.1111/j.1444-2906.2005.00991.x; Ma Q, 2012, GENE, V493, P92, DOI 10.1016/j.gene.2011.11.015; Kang JH, 2002, FISHERIES SCI, V68, P494, DOI 10.1046/j.1444-2906.2002.00453.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; MALE R, 1992, BIOCHIM BIOPHYS ACTA, V1130, P345, DOI 10.1016/0167-4781(92)90452-6; Venkatesh B, 1997, GENE, V187, P211, DOI 10.1016/S0378-1119(96)00750-0; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; DEVLIN RH, 1993, CAN J FISH AQUAT SCI, V50, P1738, DOI 10.1139/f93-195; Dybus A, 2002, ARCH TIERZUCHT, V45, P421; TANAKA M, 1995, GENE, V165, P321, DOI 10.1016/0378-1119(95)00532-B; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; BER R, 1993, GENE, V125, P143, DOI 10.1016/0378-1119(93)90321-S; Gross R, 1999, AQUACULTURE, V173, P73, DOI 10.1016/S0044-8486(98)00470-0; Murata O, 1996, FISHERIES SCI, V62, P845; Goodman H. M, 1993, ENDOCRINOLOGY GROWTH, P93; HARRIS AS, 1991, AQUACULTURE, V92, P157, DOI 10.1016/0044-8486(91)90017-2; HOJ S, 1993, ANIM GENET, V24, P91; Knorr C, 1997, ANIM GENET, V28, P124, DOI 10.1111/j.1365-2052.1997.00093.x; Kocour M, 2011, AQUACULTURE, V310, P298, DOI 10.1016/j.aquaculture.2010.10.006; Kuhnlein U, 1997, ANIM GENET, V28, P116, DOI 10.1111/j.1365-2052.1997.00076.x; MOMOTA H, 1988, NUCLEIC ACIDS RES, V16, P3107, DOI 10.1093/nar/16.7.3107; Murata O., 2005, AQUACULTURE SYSTEM, V1, P83; Ohkubo T, 1996, J MOL ENDOCRINOL, V16, P63; Quere N, 2010, AQUAT LIVING RESOUR, V23, P285, DOI 10.1051/alr/2010021; Sawayama E., 2014, AQUAC RES IN PRESS, DOI [10.1111/are.12498, DOI 10.1111/ARE.12498]; Tambasco DD, 2003, J ANIM BREED GENET, V120, P51, DOI 10.1046/j.1439-0388.2003.00371.x; Taniguchi N., 2011, J ANIMAL GENET, V39, P16; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0175-8659	1439-0426		J APPL ICHTHYOL	J. Appl. Ichthyol.	AUG	2015	31	4					762	766		10.1111/jai.12800		5	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CN0DO	WOS:000358083600032		
J	Tsukeoka, T; Tsuneizumi, Y; Lee, TH				Tsukeoka, Tadashi; Tsuneizumi, Yoshikazu; Lee, Tae Hyun			A Useful Anatomical Reference Guide for Stem Anteversion during Total Hip Arthroplasty in the Dysplastic Hip	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; stem anteversion; landmark; developmental dysplasia of the hip; computer simulation	FEMORAL ANTEVERSION; CALCAR-FEMORALE; REPLACEMENT; ACCURACY; MOTION; RANGE; FEMUR; NECK	Computed tomography scans of 50 dysplastic hips were obtained and reconstructed using preoperative planning software for total hip arthroplasty. The anteversion of the stem implanted parallel to the line connecting the trochanteric fossa and the middle of the medial cortex of the femoral neck (T line) was measured. The cutting heights of 5 mm and 10 mm above the lesser trochanter were simulated. The mean difference of the anteversion of the stem using the T line and the native femoral anteversion was 2.7 degrees (95% CI: 1.0 degrees-4.5 degrees) and 3.5 degrees (95% CI: 1.5 degrees-5.5 degrees) at cutting heights of 5 mm and 10 mm respectively. An anteversion using a T line is compatible with native femoral anteversion even in developmental dysplasia of the hip. (C) 2015 Elsevier Inc. All rights reserved.	[Tsukeoka, Tadashi; Tsuneizumi, Yoshikazu; Lee, Tae Hyun] Chiba Rehabil Ctr, Dept Orthopaed Surg, Chiba, Japan	Tsukeoka, T (reprint author), Chiba Rehabil Ctr, Dept Orthopaed Surg, Midori Ku, 1-45-2 Hondacho, Chiba, Japan.						Dorr LD, 2009, J BONE JOINT SURG AM, V91A, P2598, DOI 10.2106/JBJS.H.01225; Heller MO, 2001, CLIN BIOMECH, V16, P644, DOI 10.1016/S0268-0033(01)00053-5; Suh KT, 2006, J ARTHROPLASTY, V21, P599, DOI 10.1016/j.arth.2005.04.042; Sugano N, 1998, J COMPUT ASSIST TOMO, V22, P610, DOI 10.1097/00004728-199807000-00019; Widmer KH, 2004, J ORTHOPAED RES, V22, P815, DOI 10.1016/j.orthres.2003.11.001; Sariali E, 2009, J BONE JOINT SURG BR, V91B, P333, DOI 10.1302/0301-620X.91B3.21390; Malik A, 2007, J BONE JOINT SURG AM, V89A, P1832, DOI 10.2106/JBJS.F.01313; Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319; Kitada M, 2011, J ARTHROPLASTY, V26, P674, DOI 10.1016/j.arth.2010.08.001; KINGSLEY PC, 1948, J BONE JOINT SURG AM, V30-A, P745; Yoshimine F, 2006, J BIOMECH, V39, P1315, DOI 10.1016/j.jbiomech.2005.03.008; Muller M, 2011, INT ORTHOP, V35, P981, DOI 10.1007/s00264-010-1047-z; Eckrich S G, 1994, J Arthroplasty, V9, P419, DOI 10.1016/0883-5403(94)90053-1; Kleemann RU, 2003, J ORTHOPAED RES, V21, P767, DOI 10.1016/S0736-0266(03)00040-8; CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15; BERGMANN G, 1995, J BIOMECH, V28, P535, DOI 10.1016/0021-9290(94)00105-D; GRIFFIN JB, 1982, CLIN ORTHOP RELAT R, P211; Karnezis IA, 2001, ARCH ORTHOP TRAUM SU, V121, P343, DOI 10.1007/s004020000237; Newell RLM, 1997, CLIN ANAT, V10, P27, DOI 10.1002/(SICI)1098-2353(1997)10:1<27::AID-CA5>3.0.CO;2-Q; Noble PC, 2003, CLIN ORTHOP RELAT R, P27, DOI 10.3097/01.blo.0000096819.67494.32; STILES RG, 1990, INVEST RADIOL, V25, P1311, DOI 10.1097/00004424-199012000-00007; Tsukeoka T, 2014, ARCH ORTHOP TRAUM SU, V134, P873, DOI 10.1007/s00402-014-1978-8; Unlu MC, 2011, ARCH ORTHOP TRAUM SU, V131, P1317, DOI 10.1007/s00402-011-1282-9	23	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	AUG	2015	30	8					1393	1396		10.1016/j.arth.2015.03.030		4	Orthopedics	Orthopedics	CN0DN	WOS:000358083400019		
J	Takada, R; Jinno, T; Koga, D; Hirao, M; Muneta, T; Okawa, A				Takada, Ryohei; Jinno, Tetsuya; Koga, Daisuke; Hirao, Masanobu; Muneta, Takeshi; Okawa, Atsushi			Is Drain Tip Culture Prognostic of Surgical Site Infection? Results of 1380 Drain Tip Cultures in Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; surgical site infection; drain tip culture; prognostic value; timing of drain removal	JOINT ARTHROPLASTY; SUCTION DRAINAGE; REPLACEMENT; OPERATIONS	The purpose of this study was to evaluate a prognostic value of drain tip culture for surgical site infection (SSI) after total hip arthroplasty. A total of 1380 closed suction drain tips cultured after removal in primary total hip arthroplasty were included in this study. Drains were removed in 12-72 hours after surgery. Drain tip cultures were positive in 11 cases (0.8%). SSI was found in 4 cases (0.3%), where the drain tip cultures were all negative. The sensitivity of drain tip culture for infection after surgery was 0%, and the specificity was 99.7%. We concluded that, drain tip culture cannot be prognostic for SSI after total hip arthroplasty. Routine use of drain tip culture is not supported. (C) 2015 Elsevier Inc. All rights reserved.	[Takada, Ryohei; Jinno, Tetsuya; Koga, Daisuke; Hirao, Masanobu; Muneta, Takeshi; Okawa, Atsushi] Tokyo Med & Dent Univ, Med Hosp, Dept Orthopaed Surg, Tokyo 1138519, Japan	Jinno, T (reprint author), Tokyo Med & Dent Univ, Med Hosp, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						WILLETT KM, 1988, J BONE JOINT SURG BR, V70, P607; WAUGH TR, 1961, J BONE JOINT SURG AM, V43, P939; Weinrauch P, 2005, ANZ J SURG, V75, P887, DOI 10.1111/j.1445-2197.2005.03546.x; DRINKWATER CJ, 1995, J ARTHROPLASTY, V10, P185, DOI 10.1016/S0883-5403(05)80125-1; Saleh K, 2002, J ORTHOPAED RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Sankar B, 2004, INT ORTHOP, V28, P311, DOI 10.1007/s00264-004-0561-2; Girvent R, 1994, Acta Orthop Belg, V60, P290; OVERGAARD S, 1993, ACTA ORTHOP SCAND, V64, P417; Petsatodis G, 2009, ARCH ORTHOP TRAUM SU, V129, P1645, DOI 10.1007/s00402-009-0844-6; SORENSEN AI, 1991, ACTA ORTHOP SCAND, V62, P451, DOI 10.3109/17453679108996642	10	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	AUG	2015	30	8					1407	1409		10.1016/j.arth.2015.02.038		3	Orthopedics	Orthopedics	CN0DN	WOS:000358083400022		
J	Okamoto, S; Mizu-uchi, H; Okazaki, K; Hamai, S; Nakahara, H; Iwamoto, Y				Okamoto, Shigetoshi; Mizu-uchi, Hideki; Okazaki, Ken; Hamai, Satoshi; Nakahara, Hiroyuki; Iwamoto, Yukihide			Effect of Tibial Posterior Slope on Knee Kinematics, Quadriceps Force, and Patellofemoral Contact Force After Posterior-Stabilized Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; tibial posterior slope; computer simulation; knee instability; patellofemoral contact force; quadriceps force	MOMENT ARM; IMPINGEMENT; REPLACEMENT; ALIGNMENT; IMPLANT; FLEXION; MODEL; POST; BIOMECHANICS; MALALIGNMENT	We used a musculoskeletal model validated with in vivo data to evaluate the effect of tibial posterior slope on knee kinematics, quadriceps force, and patellofemoral contact force after posterior-stabilized total knee arthroplasty. The maximum quadriceps force and patellofemoral contact force decreased with increasing posterior slope. Anterior sliding of the tibial component and anterior impingement of the anterior aspect of the tibial post were observed with tibial posterior slopes of at least 5 degrees and 10 degrees, respectively. Increased tibial posterior slope contributes to improved exercise efficiency during knee extension, however excessive tibial posterior slope should be avoided to prevent knee instability. Based on our computer simulation we recommend tibial posterior slopes of less than 5 degrees in posterior-stabilized total knee arthroplasty. (C) 2015 Elsevier Inc. All rights reserved.	[Okamoto, Shigetoshi; Mizu-uchi, Hideki; Okazaki, Ken; Hamai, Satoshi; Nakahara, Hiroyuki; Iwamoto, Yukihide] Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Fukuoka 8128582, Japan	Mizu-uchi, H (reprint author), Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.						Barrack RL, 2001, CLIN ORTHOP RELAT R, P46; Wong J, 2011, J ORTHOP RES, V29, P347, DOI 10.1002/jor.21221; Shi XJ, 2013, KNEE SURG SPORT TR A, V21, P2696, DOI 10.1007/s00167-012-2058-7; Shimizu N, 2013, J ARTHROPLASTY, V28, P1707, DOI 10.1016/j.arth.2013.03.026; Hamai S, 2008, J ORTHOP RES, V26, P435, DOI 10.1002/jor.20512; D'Lima DD, 2001, CLIN ORTHOP RELAT R, P213; Ostermeier S, 2006, KNEE SURG SPORT TR A, V14, P934, DOI 10.1007/s00167-006-0078-x; Colwell CW, 2011, CLIN BIOMECH, V26, P52, DOI 10.1016/j.clinbiomech.2010.08.009; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P127, DOI 10.1007/s11999-012-2533-y; Rodricks DJ, 2007, J BONE JOINT SURG AM, V89A, P89, DOI 10.2106/JBJS.E.00492; Bellemans J, 2005, KNEE SURG SPORT TR A, V13, P193, DOI 10.1007/s00167-004-0557-x; Vessely MB, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000229356.81749.11; Browne C, 2005, KNEE, V12, P81, DOI 10.1016/j.knee.2004.05.006; Bai B, 2000, J ARTHROPLASTY, V15, P916, DOI 10.1054/arth.2000.9058; Fitzpatrick CK, 2012, J BIOMECH, V45, P2092, DOI 10.1016/j.jbiomech.2012.05.035; Mihalko WM, 2012, CLIN ORTHOP RELAT R, V470, P186, DOI 10.1007/s11999-011-2145-y; BLANKEVOORT L, 1991, J BIOMECH, V24, P1019, DOI 10.1016/0021-9290(91)90019-J; Giffin JR, 2004, AM J SPORT MED, V32, P376, DOI 10.1177/0363546503258880; Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32; Banks SA, 2002, J BONE JOINT SURG AM, V84A, P37; Barrett WP, 2011, J ARTHROPLASTY, V26, P1273, DOI 10.1016/j.arth.2011.04.037; Chiu YS, 2004, J ARTHROPLASTY, V19, P1045, DOI 10.1016/j.arth.2004.04.013; Hamai S, 2008, J BONE JOINT SURG BR, V90B, P1180, DOI 10.1302/0301-620X.90B9.20298; Heegaard JH, 2001, CLIN BIOMECH, V16, P415, DOI 10.1016/S0268-0033(01)00020-1; Li GA, 2005, J ORTHOP RES, V23, P536, DOI 10.1016/j.orhtres.2004.09.005; Li LM, 2011, J BIOMECH, V44, P1507, DOI 10.1016/j.jbiomech.2011.03.012; Mizu-uchi H, 2011, J ARTHROPLASTY, V26, P721, DOI 10.1016/j.arth.2010.08.002; Mizu-uchi H, 2012, J ARTHROPLASTY, V27, P1710, DOI 10.1016/j.arth.2012.03.041; Morra EA, 2012, J BONE JOINT SURG AM, V94, P1; Wachowski MM, 2012, ANN ANAT, V194, P195, DOI 10.1016/j.aanat.2011.01.013; WASIELEWSKI RC, 1994, CLIN ORTHOP RELAT R, P31	31	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	AUG	2015	30	8					1439	1443		10.1016/j.arth.2015.02.042		5	Orthopedics	Orthopedics	CN0DN	WOS:000358083400029		
J	Joensen, KG; Tetzschner, AMM; Iguchi, A; Aarestrup, FM; Scheutz, F				Joensen, Katrine G.; Tetzschner, Anna M. M.; Iguchi, Atsushi; Aarestrup, Frank M.; Scheutz, Flemming			Rapid and Easy In Silico Serotyping of Escherichia coli Isolates by Use of Whole-Genome Sequencing Data	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							H-ANTIGEN; GENE-CLUSTER; O-ANTIGENS; STRAINS; IDENTIFICATION; RESTRICTION; BACTERIA	Accurate and rapid typing of pathogens is essential for effective surveillance and outbreak detection. Conventional serotyping of Escherichia coli is a delicate, laborious, time-consuming, and expensive procedure. With whole-genome sequencing (WGS) becoming cheaper, it has vast potential in routine typing and surveillance. The aim of this study was to establish a valid and publicly available tool for WGS-based in silico serotyping of E. coli applicable for routine typing and surveillance. A FASTA database of specific O-antigen processing system genes for O typing and flagellin genes for H typing was created as a component of the publicly available Web tools hosted by the Center for Genomic Epidemiology (CGE) (www.genomicepidemiology.org). All E. coli isolates available with WGS data and conventional serotype information were subjected to WGS-based serotyping employing this specific SerotypeFinder CGE tool. SerotypeFinder was evaluated on 682 E. coli genomes, 108 of which were sequenced for this study, where both the whole genome and the serotype were available. In total, 601 and 509 isolates were included for O and H typing, respectively. The O-antigen genes wzx, wzy, wzm, and wzt and the flagellin genes fliC, flkA, fllA, flmA, and flnA were detected in 569 and 508 genome sequences, respectively. SerotypeFinder for WGS-based O and H typing predicted 560 of 569 O types and 504 of 508 H types, consistent with conventional serotyping. In combination with other available WGS typing tools, E. coli serotyping can be performed solely from WGS data, providing faster and cheaper typing than current routine procedures and making WGS typing a superior alternative to conventional typing strategies.	[Joensen, Katrine G.; Aarestrup, Frank M.] Tech Univ Denmark, Div Epidemiol & Microbial Genom, Natl Food Inst, DK-2800 Lyngby, Denmark; [Joensen, Katrine G.; Tetzschner, Anna M. M.; Scheutz, Flemming] Statens Serum Inst, Dept Microbiol & Infect Control, WHO Collaborating Ctr Reference & Res Escherichia, DK-2300 Copenhagen, Denmark; [Iguchi, Atsushi] Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 88921, Japan	Scheutz, F (reprint author), Statens Serum Inst, Dept Microbiol & Infect Control, WHO Collaborating Ctr Reference & Res Escherichia, DK-2300 Copenhagen, Denmark.	FSC@ssi.dk		Joensen, Katrine/0000-0002-0350-105X			RATINER YA, 1983, FEMS MICROBIOL LETT, V19, P37; Ratiner YA, 1998, J BACTERIOL, V180, P979; Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Ratiner YA, 2010, ARCH MICROBIOL, V192, P267, DOI 10.1007/s00203-010-0556-x; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ORSKOV I, 1977, BACTERIOL REV, V41, P667; Feng L, 2008, J BACTERIOL, V190, P4470, DOI 10.1128/JB.01937-07; Wang L, 2010, SUBCELL BIOCHEM, V53, P123, DOI 10.1007/978-90-481-9078-2_6; Beutin Lothar, 2005, BMC Microbiol, V5, P4, DOI 10.1186/1471-2180-5-4; Blank TE, 2003, EMERG INFECT DIS, V9, P113; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; KAUFFMANN F, 1947, J IMMUNOL, V57, P71; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Macnab RM, 1987, ESCHERICHIA COLI SAL, V1, P70; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; ORSKOV I, 1975, ACTA PATH MICRO IM B, V83, P121; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tominaga A, 2004, GENES GENET SYST, V79, P1, DOI 10.1266/ggs.79.1; Tozzoli R, 2014, PATHOGENIC ESCHERICH, P1; Trees E, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00718-14, 10.1128/genomeA.00718-14]; Whitfield C., 1994, P437; Wyres Kelly L, 2014, Pathogens, V3, P437, DOI 10.3390/pathogens3020437	35	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	AUG	2015	53	8					2410	2426		10.1128/JCM.00008-15		17	Microbiology	Microbiology	CN2YV	WOS:000358290200006		
J	Iguchi, A; Iyoda, S; Seto, K; Morita-Ishihara, T; Scheutz, F; Ohnishi, M				Iguchi, Atsushi; Iyoda, Sunao; Seto, Kazuko; Morita-Ishihara, Tomoko; Scheutz, Flemming; Ohnishi, Makoto		Pathogenic E Coli Working Grp Japa	Escherichia coli O-Genotyping PCR: a Comprehensive and Practical Platform for Molecular O Serogrouping	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							ANTIGEN GENE-CLUSTER; SHIGA-TOXIN; DIVERSITY; LIPOPOLYSACCHARIDE; VIRULENCE; O157; O111	The O serogrouping of pathogenic Escherichia coli is a standard method for subtyping strains for epidemiological studies and enhancing phylogenetic studies. In particular, the identification of strains of the same O serogroup is essential in outbreak investigations and surveillance. In a previous study, we analyzed the O-antigen biosynthesis gene cluster in all known E. coli O serogroups (A. Iguchi et al., DNA Res, 22: 101-107, 2015, http://dx.doi.org/10.1093/dnares/dsu043). Based on those results, we have arranged 162 PCR primer pairs for the identification or classification of O serogroups. Of these, 147 pairs were used to identify 147 individual O serogroups with unique O-antigen biosynthesis genes, and the other 15 pairs were used to identify 15 groups of strains (Gp1 to Gp15). Each of these groups consisted of strains with identical or very similar O-antigen biosynthesis genes, and the groups represented a total of 35 individual O serogroups. We then used the 162 primer pairs to create 20 multiplex PCR sets. Each set contained six to nine primer pairs that amplify products of markedly different sizes. This genetic methodology (E. coli O-genotyping PCR) allowed for comprehensive, rapid, and low-cost typing. Validation of the PCR system using O-serogroup references and wild strains showed that the correct O serogroups were specifically and accurately identified for 100% (182/182) and 90.8% (522/575) of references and wild strains, respectively. The PCR-based system reported here might be a promising tool for the subtyping of E. coli strains for epidemiological studies as well as for the surveillance of pathogenic E. coli during outbreaks.	[Iguchi, Atsushi] Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 88921, Japan; [Iyoda, Sunao; Morita-Ishihara, Tomoko; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Seto, Kazuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 537, Japan; [Scheutz, Flemming] Statens Serum Inst, Dept Microbiol Infect Control, DK-2300 Copenhagen, Denmark; [Scheutz, Flemming] Statens Serum Inst, WHO Collaborating Ctr Reference & Res Escherichia, DK-2300 Copenhagen, Denmark	Iguchi, A (reprint author), Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 88921, Japan.	iguchi@med.miyazaki-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan [H25-Syokuhin-Wakate-018, H24-Shinkou-Ippan-012]; Japan Science and Technology Agency [AS242Z00217P]; University of Miyazaki; Japanese Ministry of Education, Culture, Sports, Science, and Technology	This work was supported by Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan to A.I. (H25-Syokuhin-Wakate-018) and M.O. (H24-Shinkou-Ippan-012), the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (AS242Z00217P) from Japan Science and Technology Agency to A.I., and a Scientific Research Grant on Priority Areas from the University of Miyazaki and the Program to Disseminate Tenure Tracking System from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to A.I.	Armstrong GL, 1996, EPIDEMIOL REV, V18, P29; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Beutin L, 2009, J APPL MICROBIOL, V106, P1122, DOI 10.1111/j.1365-2672.2008.04076.x; Coimbra RS, 2000, RES MICROBIOL, V151, P639, DOI 10.1016/S0923-2508(00)00134-0; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; ORSKOV I, 1977, BACTERIOL REV, V41, P667; Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118; Corbett D, 2008, ADV APPL MICROBIOL, V65, P1, DOI 10.1016/S0065-2164(08)00601-1; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; Geue L, 2014, MICROBIOL IMMUNOL, V58, P77, DOI 10.1111/1348-0421.12120; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Penner JL, 1997, J INFECT DIS, V176, pS135, DOI 10.1086/513778; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096904	21	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	AUG	2015	53	8					2427	2432		10.1128/JCM.00321-15		6	Microbiology	Microbiology	CN2YV	WOS:000358290200007		
J	Ikuta, K; Ogawa, H; Hashimoto, H; Okano, W; Tani, A; Sato, E; Kosugi, I; Kobayashi, T; Omori, K; Suzutani, T				Ikuta, Kazufumi; Ogawa, Hiroshi; Hashimoto, Hiromi; Okano, Wataru; Tani, Akiko; Sato, Etsuko; Kosugi, Isao; Kobayashi, Takahiro; Omori, Koichi; Suzutani, Tatsuo			Restricted infection of murine cytomegalovirus (MCMV) in neonatal mice with MCMV-induced sensorineural hearing loss	JOURNAL OF CLINICAL VIROLOGY			English	Article						Cytomegalovirus; Hearing loss; Animal model	CMV INFECTION; INNER-EAR; DISEASE; EPIDEMIOLOGY; MECHANISMS; DEAFNESS; INVITRO	Background: Congenital infection with human Cytomegalovirus (HCMV) is known to be a causative agent of sensorineural hearing loss (SNHL). Objectives: To clarify the nongenetic etiology of SNHL by identifying the Cytomegalovirus (CMV)-infected region in the cochleae. Study design: We established an animal model of SNHL by injecting neonatal Balb/c mice with intracerebral murine Cytomegalovirus (MCMV) within 24 h after delivery. Results: At 3 weeks of age, unilateral and bilateral SNHL were observed in 24% (5/21) and 29% (6/21) of the mice, respectively. SNHL thereafter progressed, with 79% of mice developing bilateral SNHL by 6 weeks of age. MCMV antigens and DNA were detected in the spiral ganglion, and cells surrounding the meninges and scala tympani at 1 week of age. However, both MCMV antigens and DNA had completely disappeared by 2 weeks of age. It is possible that the MCMV reached the spiral ganglion via cerebrospinal fluid as the result of meningitis, as the stria vascularis was found to be MCMV antigen negative. Myosin VI expression in the outer hair cells was lost at 3 weeks of age. MCMV and myosin VI expression disappeared before and during SNHL progression, respectively. Conclusions: There was a definite lag time between the period in which MCMV antigens/DNA-positive cells were observed and that in which SNHL developed and myosin VI-negative hair cells were observed. Further study is needed to explore the role of MCMV in the loss of myosin VI expression in the outer hair cells. (C) 2015 Elsevier B.V. All rights reserved.	[Ikuta, Kazufumi; Hashimoto, Hiromi; Kobayashi, Takahiro; Suzutani, Tatsuo] Fukushima Med Univ, Sch Med, Dept Microbiol, Fukushima 9601295, Japan; [Ogawa, Hiroshi; Okano, Wataru; Tani, Akiko; Sato, Etsuko; Omori, Koichi] Fukushima Med Univ, Sch Med, Dept Otolaryngol, Fukushima 9601295, Japan; [Ogawa, Hiroshi] Fukushima Med Univ, Sch Med, Aizu Med Ctr, Dept Otolaryngol, Fukushima 9601295, Japan; [Kosugi, Isao] Hamamatsu Univ Sch Med, Dept Pathol 2, Hamamatsu, Shizuoka 4313192, Japan	Suzutani, T (reprint author), Fukushima Med Univ, Sch Med, Dept Microbiol, 1 Hikarigaoka, Fukushima 9601295, Japan.				Ministry of Education, Culture, Sports, Science and Technology, Japan [22791034, 25870580, 21592162]; Health and Labour Sciences Research Grants for Child Health and Development from the Ministry of Health, Labour and Welfare, Japan [H20-kodomo-007]; Kurozumi Medical Foundation; Takeda Science Foundation; Intelligent Cosmos Academic Foundation; Health Research on Children, Youth and Families from the Ministry of Health, Labour and Welfare, Japan [H25-jisedai-003]	This work was partly supported by Grant-in-Aids for Young Scientists (B) (Ikuta, KAKENHI 22791034 and 25870580) and for Scientific Research (C) (Ogawa, KAKENHI 21592162) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health and Labour Sciences Research Grants for Child Health and Development (Suzutani, H20-kodomo-007) and Health Research on Children, Youth and Families (Suzutani, H25-jisedai-003), from the Ministry of Health, Labour and Welfare, Japan; and grants from the Kurozumi Medical Foundation (Ikuta), the Takeda Science Foundation (Ikuta), and the Intelligent Cosmos Academic Foundation (Ikuta).	Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Teissier N, 2011, ACTA NEUROPATHOL, V122, P763, DOI 10.1007/s00401-011-0895-y; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Ishiwata M, 2006, ARCH VIROL, V151, P2181, DOI 10.1007/s00705-006-0793-0; MYERS EN, 1968, LARYNGOSCOPE, V78, P1904, DOI 10.1288/00005537-196811000-00005; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; DAHLE AJ, 1974, J SPEECH HEAR DISORD, V39, P320; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Dahle A J, 2000, J Am Acad Audiol, V11, P283; DAVIS GL, 1981, AM J OTOL, V3, P156; DAVIS GL, 1977, LAB INVEST, V37, P20; Friedman T. B., 1999, AM J MED GENET, V89; Katano H, 2007, MICROBES INFECT, V9, P183, DOI 10.1016/j.micinf.2006.11.004; Kawasaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017492; Korver AMH, 2009, J CLIN VIROL, V46, pS27, DOI 10.1016/j.jcv.2009.09.007; Koyano S, 2011, BMJ OPEN IN PRESS; MEDEARIS DN, 1964, B JOHNS HOPKINS HOSP, V114, P181; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Mutnal MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033143; Ogawa H., 2007, J INFECT DIS, V195, P7; REYNOLDS DW, 1974, NEW ENGL J MED, V290, P291, DOI 10.1056/NEJM197402072900601; Sakao-Suzuki Makiko, 2014, Ann Clin Transl Neurol, V1, P570, DOI 10.1002/acn3.88; Schachtele SJ, 2011, J NEUROVIROL, V17, P201, DOI 10.1007/s13365-011-0024-7; STAGNO S, 1985, NEW ENGL J MED, V313, P1270, DOI 10.1056/NEJM198511143132006; STAGNO S, 1977, PEDIATRICS, V59, P669; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	AUG	2015	69						138	145		10.1016/j.jcv.2015.06.083		8	Virology	Virology	CN3IH	WOS:000358318400030		
J	Imataki, O; Uemura, M				Imataki, Osamu; Uemura, Makiko			Ganciclovir-resistant HHV-6 encephalitis that progressed rapidly after bone marrow transplantation	JOURNAL OF CLINICAL VIROLOGY			English	Article						Adult T-cell leukemia/lymphoma (ATLL); Human herpesvirus-6 (HHV-6); Ganciclovir (GCV); Foscarnet; Stem cell transplantation (SCT)	STEM-CELL TRANSPLANTATION; HUMAN HERPESVIRUS-6; HUMAN-HERPESVIRUS-6 INFECTION; CYTOMEGALOVIRUS DISEASE; DOSE GANCICLOVIR; REACTIVATION; ANTIVIRALS; RECIPIENTS; FOSCARNET; THERAPY		[Imataki, Osamu; Uemura, Makiko] Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol & Stem Cell Transplantat, Miki, Kagawa 7610793, Japan	Imataki, O (reprint author), Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.						Erice A, 1999, CLIN MICROBIOL REV, V12, P286; Singh N, 1996, ANN INTERN MED, V124, P1065; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Hentrich M, 2005, BRIT J HAEMATOL, V128, P66, DOI 10.1111/j.1365-2141.2004.05254.x; Piret J, 2014, REV MED VIROL, V24, P186, DOI 10.1002/rmv.1787; Yoshikawa T, 2004, BRIT J HAEMATOL, V124, P421, DOI 10.1046/j.1365-2141.2003.04788.x; Dulery R, 2012, BIOL BLOOD MARROW TR, V18, P1080, DOI 10.1016/j.bbmt.2011.12.579; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.200.00307; Kato K, 2013, INT J HEMATOL, V97, P430, DOI 10.1007/s12185-013-1278-z; BURNS WH, 1990, J INFECT DIS, V162, P634; Agut H, 2011, J CLIN VIROL, V52, P164, DOI 10.1016/j.jcv.2011.06.008; Scheurer ME, 2013, BONE MARROW TRANSPL, V48, P574, DOI 10.1038/bmt.2012.180; Bhanushali MJ, 2013, NEUROLOGY, V80, P1494, DOI 10.1212/WNL.0b013e31828cf8a2; Zerr DM, 2002, CLIN INFECT DIS, V34, P309, DOI 10.1086/338044; Baldwin K, 2011, J NEUROVIROL, V17, P193, DOI 10.1007/s13365-011-0019-4; Bounaadja L, 2013, J CLIN VIROL, V58, P279, DOI 10.1016/j.jcv.2013.06.024; Isaacson E, 2005, CLIN INFECT DIS, V40, P890, DOI 10.1086/427944; Ishiyama K, 2012, TRANSPL INFECT DIS, V14, P33, DOI 10.1111/j.1399-3062.2011.00662.x; Kanda Y, 2002, TRANSPLANTATION, V73, P568, DOI 10.1097/00007890-200202270-00015; Ogata M, 2013, BONE MARROW TRANSPL, V48, P257, DOI 10.1038/bmt.2012.121; Olli-Lahdesmaki T, 2010, PEDIATR NEUROL, V43, P53, DOI 10.1016/j.pediatrneurol.2010.02.003; Zerr DM, 2006, J CLIN VIROL, V37, pS52, DOI 10.1016/S1386-6532(06)70012-9	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	AUG	2015	69						176	178		10.1016/j.jcv.2015.06.097		3	Virology	Virology	CN3IH	WOS:000358318400036		
J	Namba, H; Nagayama, T				Namba, Hisaaki; Nagayama, Toshiki			Excitatory connections of nonspiking interneurones in the terminal abdominal ganglion of the crayfish	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Article						Electrical coupling; Chemical synapse; Local circuit	LOCAL INTERNEURONS; NEURONS; MOTONEURONS; AFFERENTS; ENHANCEMENT; SYNAPSES; CIRCUITS; MUSCLE; LOCUST	The output effects of the nonspiking interneurones in the crayfish terminal abdominal ganglion upon the uropod motor neurones were characterized using simultaneous intracellular recordings. Inhibitory interactions from nonspiking interneurones to the uropod motor neurones were one-way and chemically mediated. The depolarization of the motor neurones with current injection increased the amplitude of the nonspiking interneurone-mediated hyperpolarization, while hyperpolarization of the motor neurone decreased it. By contrast, excitatory interactions from the nonspiking interneurones to the motor neurones were not mediated via chemical synaptic transmissions. These excitatory connections with the slow motor neurones were one-way while connections with fast motor neurones were bidirectional. Nonspiking interneurone-mediated membrane depolarization of the motor neurones was not affected by the passage of hyperpolarizing current. Each motor neurone spike elicited a time-locked EPSP in the nonspiking interneurones with very short delay (0.2 ms) that suggested electrical coupling between nonspiking interneurones and motor neurones. Nonspiking interneurones directly control the organization of slow motor neurone activity, while they appear to regulate the background activity of the fast motor neurones. A single nonspiking interneurone is possible to inhibit some inter and/or motor neurones via direct chemical synapses and simultaneously excite other neurones via electrical synapses.	[Namba, Hisaaki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata 951, Japan; [Nagayama, Toshiki] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan	Nagayama, T (reprint author), Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan.	nagayama@sci.kj.yamagata-u.ac.jp			Ministry of Education, Science, Sport, and Culture [25440165]	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sport, and Culture to TN (25440165). All experiments were carried out in accordance with the Guide for the care and use of Laboratory animals of Yamagata University (Japan).	Namba H, 2004, J COMP PHYSIOL A, V190, P615, DOI 10.1007/s00359-004-0516-5; Wildman M, 2002, J EXP BIOL, V205, P3651; Antonsen BL, 2003, J COMP NEUROL, V466, P1, DOI 10.1002/cne.10802; NAGAYAMA T, 1986, EXP BIOL, V46, P75; NAGAYAMA T, 1994, HISTOL HISTOPATHOL, V9, P791; NAGAYAMA T, 1987, J COMP NEUROL, V257, P347, DOI 10.1002/cne.902570304; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Fan RJ, 2005, J COMP PHYSIOL A, V191, P1157, DOI 10.1007/s00359-005-0047-8; NAGAYAMA T, 1984, J COMP PHYSIOL, V154, P499, DOI 10.1007/BF00610164; NAMBA H, 1994, J NEUROPHYSIOL, V72, P235; PAUL DH, 1985, J NEUROPHYSIOL, V54, P28; Rodriguez MJ, 2012, J NEUROPHYSIOL, V107, P1917, DOI 10.1152/jn.01070.2011; BURROWS M, 1992, TRENDS NEUROSCI, V15, P226, DOI 10.1016/0166-2236(92)90040-F; BURROWS M, 1980, J PHYSIOL-LONDON, V298, P213; Bush BMH, 1981, NEURONES IMPULSES, P147; Curti S, 2004, J NEUROSCI, V24, P3999, DOI 10.1523/JNEUROSCI.0077-04.2004; ELMANIRA A, 1993, J NEUROPHYSIOL, V69, P2248; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P326; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; HEITLER WJ, 1991, J COMP PHYSIOL A, V169, P707; Marder E., 1987, P263; Nagayama T, 2002, J COMP PHYSIOL A, V188, P621, DOI 10.1007/s00359-002-0337-3; Nagayama T, 2005, J EXP ZOOL PART A, V303A, P66, DOI 10.1002/jez.a.135; Nagayama T, 1997, J COMP NEUROL, V389, P138; Nagayama T, 2004, J COMP NEUROL, V474, P123, DOI 10.1002/cne.20124; Newland PL, 1997, J COMP PHYSIOL A, V181, P103, DOI 10.1007/s003590050097; PEREDA AE, 1995, J NEUROSCI, V15, P5943; Rela L, 2003, J NEUROSCI, V23, P682; Rodriguez MJ, 2009, J COMP PHYSIOL A, V195, P491, DOI 10.1007/s00359-009-0426-7; Shepherd GM, 1981, NEURONES IMPULSES, P255; Smarandache-Wellmann C, 2014, J NEUROSCI, V34, P793, DOI 10.1523/JNEUROSCI.2642-13.2014; TAKEUCHI A, 1965, J PHYSIOL-LONDON, V177, P225; Werblin FS, 1979, NEUROSCIENCES 4TH ST, V8th, P193	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	AUG	2015	201	8					773	781		10.1007/s00359-015-1017-4		9	Behavioral Sciences; Neurosciences; Physiology; Zoology	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	CN3KX	WOS:000358326200004		
J	Zhang, DW; Shen, SJ; Zhao, YX; Jin, WL; Ueda, T				Zhang, Dawei; Shen, Shijun; Zhao, Yuxi; Jin, Weiliang; Ueda, Tamon			Cracking Behavior of CFRP Laminate-Strengthened RC Beams with Premechanical and Postmechanical Environmental Damage	JOURNAL OF COMPOSITES FOR CONSTRUCTION			English	Article						Crack spacing; Carbon fiber-reinforced polymer (CFRP); Strengthening; Interface; Bond; Corrosion	FIBER-REINFORCED POLYMER; CONCRETE BEAMS; STEEL REINFORCEMENT; CORROSION; REHABILITATION; BOND; FRP; REPAIR; PLATES	The main objectives of this study are to investigate the effects of three types of predamage and postdamage on the cracking behaviors of carbon fiber-reinforced polymer (CFRP)-strengthened reinforced concrete RC beams and to develop a rational methodology for predicting the average stabilized crack spacing. The predamage is induced by either sustained loading only or by the combination of sustained loading and corrosion. The predamage involved a sustained loading with an anchor tightening system, an electrochemical process to accelerate the migration of chlorides from an external electrolyte into the tested beams, and a wetting-drying cycle process with a controlled current to accelerate the corrosion of the reinforcing steel bars in the tested beams. The postdamage was induced by wetting-drying cycles. A loading test was conducted to determine the cracking behaviors of stabilized flexural cracks in the CFRP-strengthened beams with or without damage. The crack patterns, crack spacings, and test beam widths were recorded and compared, and the related mechanism was discussed. It was found that after CFRP strengthening, the effect of predamage or postdamage on the crack spacing and width is not as distinct as in the unstrengthened cases. The sustained loading predamaged beam showed insignificant differences in crack spacing and width compared to beams without predamage. Subsequently, a model capable of evaluating the crack behaviors of CFRP-strengthened beams with or without damage was developed. The analytical approach is based on equilibrium and compatibility equations to elucidate the average stresses of concrete and the CFRP laminate of a CFRP-strengthened beam element. (C) 2014 American Society of Civil Engineers.	[Zhang, Dawei; Shen, Shijun; Zhao, Yuxi; Jin, Weiliang] Zhejiang Univ, Inst Struct Engn, Hangzhou 310058, Zhejiang, Peoples R China; [Ueda, Tamon] Hokkaido Univ, Lab Engn Maintenance Syst, Sapporo, Hokkaido 0608628, Japan	Zhao, YX (reprint author), Zhejiang Univ, Inst Struct Engn, Hangzhou 310058, Zhejiang, Peoples R China.	yxzhao@zju.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LR12E08001]; Natural Science Foundation of China [81308494]	The financial support from the Zhejiang Provincial Natural Science Foundation of China (Grant No. LR12E08001) and the Natural Science Foundation of China (Grant No. 81308494) is greatly appreciated.	Oehlers DJ, 2001, COMPOS PART A-APPL S, V32, P1345, DOI 10.1016/S1359-835X(01)00089-6; Badawi M, 2010, J COMPOS CONSTR, V14, P323, DOI 10.1061/(ASCE)CC.1943-5614.0000065; Bonacci JF, 2000, ACI STRUCT J, V97, P703; Masoud S, 2001, J COMPOS CONSTR, V5, P228, DOI 10.1061/(ASCE)1090-0268(2001)5:4(228); Ceroni F, 2009, COMPOS PART B-ENG, V40, P17, DOI 10.1016/j.compositesb.2008.07.004; Zhao YX, 2013, CONSTR BUILD MATER, V48, P348, DOI 10.1016/j.conbuildmat.2013.06.091; Sciolti MS, 2010, J COMPOS CONSTR, V14, P823, DOI 10.1061/(ASCE)CC.1943-5614.0000132; Tuakta C, 2011, COMPOS PART B-ENG, V42, P145, DOI 10.1016/j.compositesb.2010.11.002; [Anonymous], 2013, INT FED STRUCT CONCR; Lau D, 2010, MECH MATER, V42, P1031, DOI 10.1016/j.mechmat.2010.09.001; ASTM, 2002, G190 ASTM; Canadian Standard Associations (CSA), 2004, S474 CSA; Debaiky AS, 2002, ACI MATER J, V99, P129; El Maaddawy TA, 2003, J MATER CIVIL ENG, V15, P41, DOI 10.1061/(ASCE)0899-1561(2003)15:(41); El Maaddawy T, 2005, J COMPOS CONSTR, V9, P187, DOI 10.1061/(ASCE)1090-0268(2005)9:2(187); Holloway L. C., 1999, STRENGTHENING REINFO; JIANG DH, 1984, J AM CONCRETE I, V81, P251; Kankam CK, 1997, J STRUCT ENG-ASCE, V123, P79, DOI 10.1061/(ASCE)0733-9445(1997)123:1(79); LUPING T, 1993, ACI MATER J, V89, P49; Masoud S, 2006, CEMENT CONCRETE COMP, V28, P969, DOI 10.1016/j.cemconcomp.2006.07.013; Nossoni G, 2010, J MATER CIVIL ENG, V22, P314, DOI 10.1061/(ASCE)MT.1943-5533.0000020; Raoof M, 2000, P I CIVIL ENG-STR B, V140, P291; Saadatmanesh H, 2010, ACI MATER J, V107, P267; Wang C. Y., 1998, P 2 INT C COMP INFR, P548; Wang CY, 2004, J COMPOS CONSTR, V8, P219, DOI 10.1061/(ASCE)1090-0268(2004)8:3(219); Wootton IA, 2003, J COMPOS CONSTR, V7, P339, DOI 10.1061/(ASCE)1090-0268(2003)7:4(339); Zhang DW, 2012, J ADV CONCR TECHNOL, V10, P285, DOI 10.3151/jact.10.285; Zhang DW, 2011, J MATER CIVIL ENG, V23, P1460, DOI 10.1061/(ASCE)MT.1943-5533.0000316	28	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0268	1943-5614		J COMPOS CONSTR	J. Compos. Constr.	AUG	2015	19	4							04014066	10.1061/(ASCE)CC.1943-5614.0000522		10	Engineering, Civil; Mechanics; Materials Science, Composites	Engineering; Mechanics; Materials Science	CN1KH	WOS:000358178200003		
J	Turkistani, A; Nakashima, S; Shimada, Y; Tagami, J; Sadr, A				Turkistani, A.; Nakashima, S.; Shimada, Y.; Tagami, J.; Sadr, A.			Microgaps and Demineralization Progress around Composite Restorations	JOURNAL OF DENTAL RESEARCH			English	Article						composite resins; adhesives; microleakage; demineralization; fluoride(s); imaging	OPTICAL COHERENCE TOMOGRAPHY; SECONDARY CARIES DEVELOPMENT; WALL LESION DEVELOPMENT; IN-VITRO; GAP SIZE; ADHESIVE PERFORMANCE; FUNCTIONAL MONOMERS; DENTIN; DIAGNOSIS; SITU	This study investigated the influence of adhesives and marginal sealing on demineralization progress using optical coherence tomography (OCT). Cavities (4 x 2 mm) were prepared in bovine incisors and restored using Clearfil SE Protect (SP), Bond Force (BF), Scotchbond Universal (SB), or G-Bond Plus (GB), followed by Estelite Flow Quick flowable composite. The control group received no adhesive (n = 10). After 3-d incubation in artificial saliva and 10,000 thermal cycles, gaps at enamel and dentin margins were measured at 8 locations on cross-sectional images obtained from each restoration using swept-source OCT at 1310-nm wavelength. Specimens were demineralized using acidified gel (pH = 4.5) for 5 wk and scanned every week to monitor the lesion progress at the same marginal locations. Repeated-measures analysis of variance showed that demineralization period and adhesive type and their interaction had a significant effect on the lesion size in both substrates (P < 0.001). SP, BF, and SB had significantly lower enamel and dentin initial gaps than the control and GB (P < 0.05). Enamel lesion progress was slower in the fluoride-releasing adhesives SP and BF and significantly different from SB, GB, and the control (P < 0.001). SP and BF dentin lesions were significantly different from GB and the control (P < 0.001), but not from SB (P > 0.05). A significant positive correlation (P < 0.05) was found between initial gap length and formed lesion size in both substrates, which was stronger in enamel (r = 0.63) than dentin (r = 0.35). Microgaps forming at the margins of restorations depend on adhesives and significantly contribute to the progress of demineralization around the margins, while fluoride release may decrease the rate of progression.	[Turkistani, A.] King Abdulaziz Univ, Conservat Dent Sci, Operat Dent Div, Jeddah 21413, Saudi Arabia; [Turkistani, A.; Nakashima, S.; Shimada, Y.; Tagami, J.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Cariol & Operat Dent Dept, Tokyo, Japan; [Sadr, A.] Univ Washington, Sch Dent, Dept Restorat Dent, Seattle, WA 98195 USA	Sadr, A (reprint author), Univ Washington, Sch Dent, Biomimet Biomat Biophoton & Technol Lab, Dept Restorat Dent, 1959 Northeast Pacific St,Box 357456, Seattle, WA 98195 USA.	arsadr@uw.edu			Japan Society for the Promotion of Science [24792019]; King Abdulaziz University	The authors are thankful to Dr. Yasunori Sumi of the National Center for Geriatrics and Gerontology, Japan, for his support in designing this study. This research was supported in part by grants-in-aid for scientific research no. 24792019 from the Japan Society for the Promotion of Science and partly by King Abdulaziz University. The funders had no role in study conception or design, data acquisition and analysis, decision to publish, or preparation of the article. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Cenci MS, 2009, CARIES RES, V43, P97, DOI 10.1159/000209341; Nakagawa H, 2013, J DENT, V41, P80, DOI 10.1016/j.jdent.2012.10.007; Turkistani A, 2014, DENT MATER, V30, P993, DOI 10.1016/j.dental.2014.05.010; van de Sande FH, 2014, J DENT, V42, P1171, DOI 10.1016/j.jdent.2014.07.003; Hariri I, 2013, CARIES RES, V47, P18, DOI 10.1159/000342416; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; SANO H, 1995, OPER DENT, V20, P18; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022; Yoshida Y, 2004, J DENT RES, V83, P454; Kuper NK, 2014, J DENT RES, V93, P108, DOI 10.1177/0022034514534262; Totiam P, 2007, CARIES RES, V41, P467, DOI 10.1159/000107934; Mjor IA, 2005, J AM DENT ASSOC, V136, P1426; Pretty IA, 2006, J DENT, V34, P727, DOI 10.1016/j.jdent.2006.06.001; Kuper NK, 2013, J DENT RES, V92, P383, DOI 10.1177/0022034513481040; Cenci MS, 2008, CARIES RES, V42, P369, DOI 10.1159/000151663; Van Landuyt KL, 2008, DENT MATER, V24, P1412, DOI 10.1016/j.dental.2008.02.018; Jones RS, 2006, CARIES RES, V40, P81, DOI 10.1159/000091052; Fried D, 2002, J BIOMED OPT, V7, P618, DOI 10.1117/1.1509752; Nassar HM, 2011, CARIES RES, V45, P346, DOI 10.1159/000329384; Heintze SD, 2010, DENT MATER, V26, P993, DOI 10.1016/j.dental.2010.06.003; Natsume Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600448; Opdam NJM, 2007, DENT MATER, V23, P2, DOI 10.1016/j.dental.2005.11.036; Barata JS, 2012, AM J DENT, V25, P244; Thomas RZ, 2007, CARIES RES, V41, P399, DOI 10.1159/000104799; Van Landuyt KL, 2008, J DENT RES, V87, P757; Diercke K, 2009, CLIN ORAL INVEST, V13, P439, DOI 10.1007/s00784-009-0250-z; Bista B, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076020; Gernhardt CR, 2004, OPER DENT, V29, P454; Hosoya Y, 2010, J DENT, V38, P214, DOI 10.1016/j.jdent.2009.10.006; Kidd E.A., 2004, J DENT RES, V83, P35; Kuper NK, 2014, J DENT RES, V94, P62; Mandurah MM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046006; Nikaido T., 2011, JPN DENT SCI REV, V47, P31, DOI 10.1016/j.jdsr.2010.04.002; Sadr A, 2011, PROC SPIE, V7884, DOI 10.1117/12.877351	34	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	AUG	2015	94	8					1070	1077		10.1177/0022034515589713		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN1LR	WOS:000358182000008		
J	Hashimoto, M; Sasaki, JI; Yamaguchi, S; Kawai, K; Kawakami, H; Iwasaki, Y; Imazato, S				Hashimoto, M.; Sasaki, J. I.; Yamaguchi, S.; Kawai, K.; Kawakami, H.; Iwasaki, Y.; Imazato, S.			Gold Nanoparticles Inhibit Matrix Metalloproteases without Cytotoxicity	JOURNAL OF DENTAL RESEARCH			English	Article						adhesives; biocompatibility; restorative dentistry; nanotechnology; dental; electron microscopy	PLATINUM NANOPARTICLES; COLLAGEN DEGRADATION; CELLULAR UPTAKE; IN-VITRO; TOXICITY; CELLS; SILVER; CARIES; RAMAN; MMPS	Nanoparticles (NPs) are currently the focus of considerable attention for dental applications; however, their biological effects have not been fully elucidated. The long-term, slow release of matrix metalloproteases (MMPs) digests collagen fibrils within resin-dentin bonds. Therefore, MMP inhibitors can prolong the durability of resin-dentin bonds. However, there have been few reports evaluating the combined effect of MMP inhibition and the cytotoxic effects of NPs for dentin bonding. The aim of this study was to evaluate MMP inhibition and cytotoxic responses to gold (AuNPs) and platinum nanoparticles (PtNPs) stabilized by polyvinylpyrrolidone (PVP) in cultured murine macrophages (RAW264) by using MMP inhibition assays, measuring cell viability and inflammatory responses (quantitative reverse transcription polymerase chain reaction [RT-qPCR]), and conducting a micromorphological analysis by fluorescence and transmission electron microscopy. Cultured RAW264 cells were exposed to metal NPs at various concentrations (1, 10, 100, and 400 mu g/mL). AuNPs and PtNPs markedly inhibited MMP-8 and MMP-9 activity. Although PtNPs were cytotoxic at high concentrations (100 and 400 mu g/mL), no cytotoxic effects were observed for AuNPs at any concentration. Transmission electron microscopy images showed a significant nonrandom intercellular distribution for AuNPs and PtNPs, which were mostly observed to be localized in lysosomes but not in the nucleus. RT-qPCR analysis demonstrated inflammatory responses were not induced in RAW264 cells by AuNPs or PtNPs. The cytotoxicity of nanoparticles might depend on the core metal composition and arise from a "Trojan horse" effect; thus, MMP inhibition could be attributed to the surface charge of PVP, which forms the outer coating of NPs. The negative charge of the surface coating of PVP binds to Zn2+ from the active center of MMPs by chelate binding and results in MMP inhibition. In summary, AuNPs are attractive NPs that effectively inhibit MMP activity without cytotoxicity or inflammatory responses.	[Hashimoto, M.; Sasaki, J. I.; Yamaguchi, S.; Imazato, S.] Osaka Univ, Dept Biomat Sci, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kawai, K.; Kawakami, H.] Miyoshi Oil & Fat Co Ltd, Tokyo, Japan; [Iwasaki, Y.] Kansai Univ, Div Chem & Mat Engn, Fac Chem Mat & Bioengn, Osaka, Japan	Hashimoto, M (reprint author), Osaka Univ, Dept Biomat Sci, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	masanori-h@mue.biglobe.ne.jp	Iwasaki, Yasuhiko/D-6870-2011		Japan Society for the Promotion of Science (JSPS) [26462953, 26293409]	This work was supported in part by Grants-in-Aid for Scientific Research (Nos. 26462953 and 26293409) from the Japan Society for the Promotion of Science (JSPS). A part of the present experiment, TEM was carried out at the Research Center for Ultra-high Voltage Electron Microscopy, Osaka University. The authors are grateful to Dr. Ryusuke Kuwahara and Prof. Shogo Muranaka for their technical support. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Zhang K, 2013, J BIOMED MATER RES B, V101B, P929, DOI 10.1002/jbm.b.32898; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Oliveira-Ogliari A, 2015, DENT MATER, V31, P68, DOI 10.1016/j.dental.2014.11.011; Borodko Y, 2006, J PHYS CHEM B, V110, P23052, DOI 10.1021/jp063338+; Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87; Mironava T, 2013, TOXICOL IN VITRO, V27, P882, DOI 10.1016/j.tiv.2013.01.005; Osorio R, 2011, EUR J ORAL SCI, V119, P79, DOI 10.1111/j.1600-0722.2010.00789.x; Mazzoni A, 2015, J DENT RES, V94, P241, DOI 10.1177/0022034514562833; Huhn D, 2013, ACS NANO, V7, P3253, DOI 10.1021/nn3059295; Sokolowski J, 2014, ACTA BIOENG BIOMECH, V16, P51, DOI 10.5277/abb140107; Pinkhasova P, 2012, LANGMUIR, V28, P2529, DOI 10.1021/la2047992; Tjaderhane L, 2013, DENT MATER, V29, P116, DOI 10.1016/j.dental.2012.08.004; Liu G, 2010, METHODS MOL BIOL, V610, P123, DOI 10.1007/978-1-60327-029-8_8; Fraga S, 2013, J APPL TOXICOL, V33, P1111, DOI 10.1002/jat.2865; Sabella S, 2014, NANOSCALE, V6, P7052, DOI 10.1039/c4nr01234h; Asharani PV, 2010, NANOMEDICINE-UK, V5, P51, DOI [10.2217/nnm.09.85, 10.2217/NNM.09.85]; Gearheart LA, 2001, J PHYS CHEM B, V105, P12609, DOI 10.1021/jp0106606; Tsoli M, 2005, SMALL, V1, P841, DOI 10.1002/smll.200500104; Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207; Selvakannan P, 2004, J COLLOID INTERF SCI, V269, P97, DOI 10.1016/S0021-9797(03)00616-7; Yoshihisa Y, 2011, FREE RADICAL RES, V45, P326, DOI 10.3109/10715762.2010.532494; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Tanakit A, 2012, DALTON T, V41, P6507, DOI 10.1039/c2dt12373h; Liu Y, 2011, J DENT RES, V90, P953, DOI 10.1177/0022034510391799; Tezvergil-Mutluay A, 2011, J DENT RES, V90, P535, DOI 10.1177/0022034510389472; Garner SJ, 2015, J DENT, V43, P362, DOI 10.1016/j.jdent.2014.12.005; Hashimoto M, 2014, J BIOMATER TISS ENG, V4, P51, DOI 10.1166/jbt.2014.1141; Imazato S, 2014, DENT MATER, V30, P97, DOI 10.1016/j.dental.2013.06.003; Osorio R, 2014, J DENT RES, V93, P1258, DOI 10.1177/0022034514551608; Scheffel DLS, 2014, DENT MATER, V30, P227, DOI 10.1016/j.dental.2013.11.007; Tezvergil-Mutluay A, 2012, J DENT RES, V91, P192, DOI 10.1177/0022034511427705; Yamada M, 2014, WILEY INTERDISCIP RE, V7, P428	36	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	AUG	2015	94	8					1085	1091		10.1177/0022034515589282		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN1LR	WOS:000358182000010		
J	Yamamoto, R; Oida, S; Yamakoshi, Y				Yamamoto, R.; Oida, S.; Yamakoshi, Y.			Dentin Sialophosphoprotein-derived Proteins in the Dental Pulp	JOURNAL OF DENTAL RESEARCH			English	Article						tooth; polyadenylation; odontoblast; extracellular matrix; HPLC; real-time polymerase chain reaction	ODONTOBLAST DIFFERENTIATION; TISSUE EXPRESSION; GENOMIC STRUCTURE; IN-VITRO; DSPP; SIALOPROTEIN; GENE; CLEAVAGE; CELLS; PHOSPHOPROTEIN	Porcine dentin sialophosphoprotein (DSPP), the most abundant noncollagenous protein in dentin, is critical for proper mineralization of tooth dentin. DSPP is processed by proteases into 3 major domains: dentin sialoprotein (DSP), dentin glycoprotein (DGP), and dentin phosphoprotein (DPP). There are at least 2 mRNA variants expressed from the Dspp gene: one encodes the full-length DSPP protein (DSP+DGP+DPP); the other encodes only DSP. The shorter transcript is generated through the use of a polyadenylation signal within intron 4, immediately following the DSP coding region (DGP and DPP are encoded by exon 5). We fractionated DSPP-derived proteins from the dental pulp of developing porcine incisors using heparin chromatography. DSP was identified, but little DPP could be detected in any fractions. BMP-1 digestion of DSPP-derived proteins extracted from dental pulp did not generate new DPP bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (indicating an absence of intact DSPP), although the results suggested another BMP-1 cleavage site within DSP. We further purified DSPP-derived protein by reversed-phase high-performance liquid chromatography. Its amino acid composition was similar to DSP. Expression of the full-length Dspp mRNA by quantitative real-time polymerase chain reaction analysis was significantly higher in odontoblasts than in pulp, while expression of the DSP-only mRNA was almost equal in odontoblasts and in the body of the pulp. Expression of the full-length Dspp mRNA was also significantly higher than the expression of DSP-only mRNA in odontoblasts. Both the full-length and the DSP-only Dspp mRNA showed only trace expression in the pulp tip. We conclude that use of the 3' polyadenylation signal in exon 5 predominates in fully differentiated odontoblasts, while both polyadenylation signals are used throughout odontoblast differentiation.	[Yamamoto, R.; Oida, S.; Yamakoshi, Y.] Tsurumi Univ, Dept Biochem & Mol Biol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan	Yamakoshi, Y (reprint author), Tsurumi Univ, Dept Biochem & Mol Biol, Sch Dent Med, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	yamakoshi-y@tsurumi-u.ac.jp			JSPS KAKENHI [26462982, 25861901]	We thank Drs. James P. Simmer, School of Dentistry, University of Michigan, and Hayato Ohshima, Niigata University Graduate School of Medical and Dental Sciences, for their helpful advice. This study was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (C; 26462982) and Grant-in-Aid for Young Scientists (B; 25861901). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Tziafas D, 2010, J ENDODONT, V36, P781, DOI 10.1016/j.joen.2010.02.006; Lu H, 2007, BIOCHEM BIOPH RES CO, V352, P630, DOI 10.1016/j.bbrc.2006.11.066; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Liu MY, 2012, MOLECULES, V17, P1219, DOI 10.3390/molecules17021219; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Guo SL, 2014, STEM CELLS DEV, V23, P2883, DOI 10.1089/scd.2014.0066; Bakopoulou A, 2011, ARCH ORAL BIOL, V56, P709, DOI 10.1016/j.archoralbio.2010.12.008; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014; Oida S, 2002, J DENT RES, V81, P103; BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; Butler W T, 1992, Oper Dent, VSuppl 5, P18; Chang SR, 1996, CALCIFIED TISSUE INT, V59, P149, DOI 10.1007/s002239900101; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Jonsson M, 1978, J CHROMATOGR, V21, P234; Lin H, 2011, J ENDODONT, V37, P948, DOI 10.1016/j.joen.2011.03.030; LINDE A, 1980, J BIOL CHEM, V255, P5931; Liu H, 2002, NUCLEIC ACIDS RES, V30, P2417, DOI 10.1093/nar/30.11.2417; MacDougall M, 1997, CYTOGENET CELL GENET, V79, P121, DOI 10.1159/000134697; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Nakatomi M, 2013, J ENDODONT, V39, P612, DOI 10.1016/j.joen.2012.12.016; Ozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081655; Quispe-Salcedo A, 2012, BIOMED RES-TOKYO, V33, P119; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Yam JWP, 2005, GENE, V357, P55, DOI 10.1016/j.gene.2005.05.025; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-6; Yamakoshi Y, 2003, EUR J ORAL SCI, V111, P60, DOI 10.1034/j.1600-0722.2003.00009.x; Yamakoshi Y, 2013, ARCH ORAL BIOL, V58, P1569, DOI 10.1016/j.archoralbio.2013.08.005; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Yang RT, 2014, CONNECT TISSUE RES, V55, P142, DOI 10.3109/03008207.2014.923863; Yuan GH, 2010, DENT HYPOTHESES, V1, P69, DOI 10.5436/j.dehy.2010.1.00012; Zhang Y, 2014, J DENT RES, V93, P155, DOI 10.1177/0022034513516631; Zhu QL, 2012, CONNECT TISSUE RES, V53, P307, DOI 10.3109/03008207.2011.650301	40	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	AUG	2015	94	8					1120	1127		10.1177/0022034515585715		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN1LR	WOS:000358182000015		
J	Nagano, K; Hasegawa, Y; Yoshida, Y; Yoshimura, F				Nagano, K.; Hasegawa, Y.; Yoshida, Y.; Yoshimura, F.			A Major Fimbrilin Variant of Mfa1 Fimbriae in Porphyromonas gingivalis	JOURNAL OF DENTAL RESEARCH			English	Article						bacteria; bacterial virulence; genetics; adhesives; biofilm(s); periodontal disease(s)/periodontitis	COMPLETE GENOME SEQUENCE; STREPTOCOCCUS-GORDONII; MINOR FIMBRIAE; STRAIN W83; PROTEIN; PURIFICATION; COMPONENTS; BIOFILMS; ROLES	The periodontal pathogen Porphyromonas gingivalis is known to express 2 distinct types of fimbriae: FimA and Mfa1 fimbriae. However, we previously reported that fimbria-like structures were found in a P. gingivalis strain in which neither FimA nor Mfa1 fimbriae were detected. In this study, we identified a major protein in the bacterial lysates of the strain, which has been reported as the 53-kDa major outer membrane protein of P. gingivalis (53K protein) and subsequently reported as a major fimbrilin of a novel-type fimbria. Sequencing of the chromosomal DNA of the strain showed that the 53k gene (encoding the 53K protein) was located at a locus corresponding to the mfa1 gene (encoding the Mfa1 protein, which is a major fimbrilin of Mfa1 fimbriae) of the ATCC 33277 type strain. However, the 53K and Mfa1 proteins showed a low amino acid sequence homology and different antigenicity. The 53K protein was detected in 34 of 84 (41%) P. gingivalis strains, while the Mfa1 protein was detected in 44% of the strains. No strain expressed both 53K and Mfa1 proteins. Additionally, fimbriae were normally expressed in mutants in which the 53k and mfa1 genes were interchanged. These results indicate that the 53K protein is another major fimbrilin of Mfa1 fimbriae in P. gingivalis.	[Nagano, K.; Hasegawa, Y.; Yoshida, Y.; Yoshimura, F.] Aichi Gakuin Univ, Dept Microbiol, Sch Dent, Nagoya, Aichi 4648650, Japan	Nagano, K (reprint author), Aichi Gakuin Univ, Dept Microbiol, Sch Dent, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	nagano@dpc.agu.ac.jp			JSPS [25462880]	We thank Mikie Sato and Yuki Abiko for their contribution to MS and RT-PCR analyses. This work was supported by JSPS KAKENHI Grant Number 25462880 (K.N.). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Abiko Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089051; Abiko Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113565; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Takahashi Y, 2006, CELL MICROBIOL, V8, P738, DOI 10.1111/j.1462-5822.2005.00661.x; Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; Hasegawa Y, 2009, MICROBIOL-SGM, V155, P3333, DOI 10.1099/mic.0.028928-0; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Umemoto T, 2003, J PERIODONTOL, V74, P119, DOI 10.1902/jop.2003.74.1.119; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Hiramine H, 2003, FEMS MICROBIOL LETT, V229, P49, DOI 10.1016/S0378-1097(03)00788-2; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627; Hasegawa Y, 2013, MOL ORAL MICROBIOL, V28, P467, DOI 10.1111/omi.12040; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Lin XH, 2006, INFECT IMMUN, V74, P6011, DOI 10.1128/IAI.00797-06; YOSHIMURA F, 1984, J BACTERIOL, V160, P949; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Zeituni AE, 2009, J IMMUNOL, V183, P5694, DOI 10.4049/jimmunol.0901030; Hamada N, 1996, INFECT IMMUN, V64, P4788; Arai M, 2000, FEMS MICROBIOL LETT, V193, P75, DOI 10.1111/j.1574-6968.2000.tb09405.x; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hongyo H, 1997, MICROBIOS, V92, P47; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Kokeguchi S, 1990, Dent Jpn (Tokyo), V27, P29; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	AUG	2015	94	8					1143	1148		10.1177/0022034515588275		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN1LR	WOS:000358182000018		
J	Mori, K; Yanagita, M; Hasegawa, S; Kubota, M; Yamashita, M; Yamada, S; Kitamura, M; Murakami, S				Mori, K.; Yanagita, M.; Hasegawa, S.; Kubota, M.; Yamashita, M.; Yamada, S.; Kitamura, M.; Murakami, S.			Necrosis-induced TLR3 Activation Promotes TLR2 Expression in Gingival Cells	JOURNAL OF DENTAL RESEARCH			English	Article						immunity; inflammation; Toll-like receptors (TLRs); periodontal tissues/periodontium; epithelial cells; fibroblasts	TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; MESSENGER-RNA; SYNOVIAL FIBROBLASTS; MOUSE MACROPHAGES; GENE-EXPRESSION; DENDRITIC CELLS; MICRORNAS	Damage-associated molecular patterns (DAMPs), endogenous molecules released from injured or dying cells, evoke sterile inflammation that is not induced by microbial pathogens. Periodontal diseases are infectious diseases caused by oral microorganisms; however, in some circumstances, DAMPs might initiate inflammatory responses before host cells recognize pathogen-associated molecular patterns. Here, we showed that the necrotic cell supernatant (NCS) functioned as an endogenous danger signal when released from necrotic epithelial cells exposed to repeat freeze thawing. The NCS contained RNA and stimulated the production of inflammatory cytokines interleukin 6 (IL-6) and IL-8 from gingival epithelial cells and gingival fibroblasts. Targeted knockdown of Toll-like receptor 3 (TLR3) in these cells significantly suppressed the ability of the NCS to induce IL-6 and IL-8 production. Epithelial cells and fibroblasts recognized the NCS from heterologous cells. Interestingly, the activation of TLR3, rather than other TLRs, induced TLR2 mRNA expression and proteins in gingival epithelial cells, and pretreatment with the NCS or polyinosinic: polycytidylic acid (Poly(I:C)), a strong TLR3 activator, enhanced inflammatory cytokine production induced by subsequent stimulation with Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide, a TLR2 agonist. Moreover, the NCS reduced the expression of epithelial tight junction molecules zona occludens 1 and occludin and increased the permeability of epithelial tight junctions. These findings suggest that endogenous danger signal molecules such as self-RNA released from necrotic cells are recognized by TLR3 and that a subsequent increase of TLR2 expression in periodontal compartments such as gingival epithelial cells and gingival fibroblasts may enhance the inflammatory response to periodontopathic microbes recognized by TLR2 such as P. gingivalis, which also disrupts epithelial barrier functions. Thus, DAMPs may be involved in the development and prolongation of periodontal disease.	[Mori, K.; Yanagita, M.; Hasegawa, S.; Kubota, M.; Yamashita, M.; Yamada, S.; Kitamura, M.; Murakami, S.] Osaka Univ, Dept Periodontol, Div Oral Biol & Dis Control, Suita, Osaka 5650871, Japan	Yanagita, M (reprint author), Osaka Univ, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	yanagita@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [23249086, 23593057, 26463133, 26893145]	This study was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 23249086, 23593057, 26463133, and 26893145). The authors are grateful to Dr. Tsuyoshi Fujita (Hiroshima University) for help with the cell permeability experiment. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	An HZ, 2002, IMMUNOL LETT, V81, P165, DOI 10.1016/S0165-2478(02)00010-X; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Ohkuni T, 2011, TOXICOL APPL PHARM, V250, P29, DOI 10.1016/j.taap.2010.09.023; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Zihni C, 2014, J CELL SCI, V127, P3401, DOI 10.1242/jcs.145029; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Matsuguchi T, 2000, J IMMUNOL, V165, P5767; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Yanagita M, 2008, J ENDODONT, V34, P1061, DOI 10.1016/j.joen.2008.06.005; JOHNSON DA, 1976, J PERIODONTAL RES, V11, P349, DOI 10.1111/j.1600-0765.1976.tb00089.x; KUMADA H, 1995, J BACTERIOL, V177, P2098; Robbins GR, 2014, MOL CELL, V54, P297, DOI 10.1016/j.molcel.2014.03.029; Mahanonda R, 2007, J IMMUNOL, V178, P1151; Brentano F, 2005, ARTHRITIS RHEUM, V52, P2656, DOI 10.1002/art.21273; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Lim DM, 2011, AM J PHYSIOL-GASTR L, V301, pG91, DOI 10.1152/ajpgi.00471.2010; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Tatematsu M, 2014, BIOCHEM J, V458, P195, DOI 10.1042/BJ20131492; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Stoecklin-Wasmer C, 2012, J DENT RES, V91, P934, DOI 10.1177/0022034512456551; OGAWA T, 1993, FEBS LETT, V332, P197, DOI 10.1016/0014-5793(93)80512-S; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Melkamu T, 2013, J CELL COMMUN SIGNAL, V7, P109, DOI 10.1007/s12079-012-0185-z; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Ebe N, 2011, J DENT RES, V90, P235, DOI 10.1177/0022034510385688; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; Mariotti A, 1999, Ann Periodontol, V4, P7, DOI 10.1902/annals.1999.4.1.7; Murakami S, 2002, J DENT RES, V81, P236; Murakami S, 2001, INT IMMUNOL, V13, P1533, DOI 10.1093/intimm/13.12.1533; SAUK JJ, 1988, J ORAL PATHOL MED, V17, P496, DOI 10.1111/j.1600-0714.1988.tb01323.x; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002	39	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	AUG	2015	94	8					1149	1157		10.1177/0022034515589289		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN1LR	WOS:000358182000019		
J	Horinuki, E; Shinoda, M; Shimizu, N; Koshikawa, N; Kobayashi, M				Horinuki, E.; Shinoda, M.; Shimizu, N.; Koshikawa, N.; Kobayashi, M.			Orthodontic Force Facilitates Cortical Responses to Periodontal Stimulation	JOURNAL OF DENTAL RESEARCH			English	Article						somatosensory cortex; insular cortex; pain; periodontal ligament; experimental tooth movement; optical imaging	EXPERIMENTAL TOOTH MOVEMENT; C-FOS EXPRESSION; SPATIOTEMPORAL PROFILES; RAT; NEURONS; NUCLEUS; AREAS; PAIN; CORTEX; NERVE	Somatosensory information derived from the periodontal ligaments plays a critical role in identifying the strength and direction of occlusal force. The orthodontic force needed to move a tooth often causes uncomfortable sensations, including nociception around the tooth, and disturbs somatosensory information processing. However, it has mostly remained unknown whether orthodontic treatment modulates higher brain functions, especially cerebrocortical activity. To address this issue, we first elucidated the cortical region involved in sensory processing from the periodontal ligaments and then examined how experimental tooth movement (ETM) changes neural activity in these cortical regions. We performed in vivo optical imaging to identify the cortical responses evoked by electrical stimulation of the maxillary and mandibular incisor and the first molar periodontal ligaments in the rat. In naive rats, electrical stimulation of the mandibular periodontal ligaments initially evoked neural excitation in the rostroventral part of the primary somatosensory cortex (S1), the ventrocaudal part of the secondary somatosensory cortex (S2), and the insular oral region (IOR), whereas maxillary periodontal ligaments elicited excitation only in S2/IOR rostrodorsally adjacent to the mandibular periodontal ligament-responding region. In contrast, maximum responses to mandibular and maxillary periodontal stimulation were observed in S1 and S2/IOR, and the 2 responses nearly overlapped. One day after ETM (maxillary molar movement by Waldo's method), the maximum response to stimulation of the maxillary molar periodontal ligament induced larger and broader excitation in S2/IOR, although the initial responses were not affected. Taken together with the histologic findings of IL-1 beta expression and macrophage infiltration in the periodontal ligament of the ETM models, inflammation induced by ETM may play a role in the facilitation of S2/IOR activity. From the clinical viewpoints, the larger amplitude of cortical excitation may induce higher sensitivity to pain responding to nonnoxious stimuli, and enlargement of the responding area may reflect radiating pain.	[Horinuki, E.; Koshikawa, N.; Kobayashi, M.] Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 1018310, Japan; [Horinuki, E.; Shimizu, N.] Nihon Univ, Sch Dent, Dept Orthodont, Chiyoda Ku, Tokyo 1018310, Japan; [Shinoda, M.] Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 1018310, Japan; [Shinoda, M.; Shimizu, N.; Koshikawa, N.; Kobayashi, M.] Nihon Univ, Sch Dent, Div Oral & Craniomaxillofacial Res, Dent Res Ctr,Chiyoda Ku, Tokyo 1018310, Japan; [Kobayashi, M.] RIKEN, Mol Imaging Res Ctr, Chuo Ku, Kobe, Hyogo, Japan	Kobayashi, M (reprint author), Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, 8-13 Kanda Surugadai, Tokyo 1018310, Japan.	kobayashi.masayuki@nihon-u.ac.jp			JSPS KAKENHI from MEXT [25293379]; MEXT; Dental Research Centre, Nihon University School of Dentistry; Promotion and Mutual Aid Corporation for Private Schools of Japan	We thank Prof. K. Iwata for his critical comments on the manuscript and Drs. Satoshi Fujita, Naoko Mizoguchi, and Hiroko Nakamura for their technical advice and assistance. This work was supported by JSPS KAKENHI 25293379 from MEXT to M.K.; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, to M.K.; a research grant from the Dental Research Centre, Nihon University School of Dentistry, to M.K.; and the Promotion and Mutual Aid Corporation for Private Schools of Japan to N.K. and M.K. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	ZHANG GX, 1990, BRAIN RES BULL, V24, P221, DOI 10.1016/0361-9230(90)90209-I; Iida C, 2010, NEUROSCIENCE, V169, P1739, DOI 10.1016/j.neuroscience.2010.06.031; YAMAMOTO T, 1984, J NEUROPHYSIOL, V51, P616; Takemura M, 2000, EXP BRAIN RES, V130, P113, DOI 10.1007/s002210050013; SAITO M, 1991, AM J ORTHOD DENTOFAC, V99, P226, DOI 10.1016/0889-5406(91)70005-H; Lund JP, 2006, DYSPHAGIA, V21, P167, DOI 10.1007/s00455-006-9027-6; Magdalena CM, 2004, J DENT RES, V83, P50; Sugimoto T, 1997, J COMP NEUROL, V378, P425, DOI 10.1002/(SICI)1096-9861(19970217)378:3<425::AID-CNE9>3.0.CO;2-5; Fujita S, 2012, NEUROSCIENCE, V206, P201, DOI 10.1016/j.neuroscience.2012.01.014; Meikle MC, 2006, EUR J ORTHODONT, V28, P221, DOI 10.1093/ejo/cj1001; Fujita S, 2010, NEUROSCIENCE, V165, P278, DOI 10.1016/j.neuroscience.2009.09.073; Krishnan V, 2007, EUR J ORTHODONT, V29, P170, DOI 10.1093/ejo/cjl081; Luppanapornlarp S, 2010, EUR J ORTHODONT, V32, P596, DOI 10.1093/ejo/cjp158; JONES M, 1992, AM J ORTHOD DENTOFAC, V102, P373, DOI 10.1016/0889-5406(92)70054-E; Joviliano P, 2008, BRAIN RES BULL, V76, P396, DOI 10.1016/j.brainresbull.2008.03.010; BYERS MR, 1985, J COMP NEUROL, V231, P500, DOI 10.1002/cne.902310408; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660; Deguchi T, 2006, J DENT RES, V85, P658; Fujisawa N, 2012, EXP BRAIN RES, V219, P191, DOI 10.1007/s00221-012-3078-8; Fukui T, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-18; Hasegawa M, 2012, J DENT RES, V91, P1141, DOI 10.1177/0022034512462397; Hiroshima K, 2001, BRAIN RES, V908, P161, DOI 10.1016/S0006-8993(01)02639-7; Jones M L, 1992, J Clin Orthod, V26, P311; KATO J, 1994, ARCH ORAL BIOL, V39, P723, DOI 10.1016/0003-9969(94)90100-7; KVINNSLAND I, 1990, EUR J ORTHODONT, V12, P320; Lumb BM, 2002, EXP PHYSIOL, V87, P281, DOI 10.1113/eph8702356; Maeda N, 2014, BRAIN RES, V1543, P200, DOI 10.1016/j.brainres.2013.11.024; Nakamura H, 2015, J COMP NEUROL, V523, P1162, DOI 10.1002/cne.23692; Proffit WR, 2013, CONT ORTHODONTICS; Remple MS, 2003, J COMP NEUROL, V467, P105, DOI 10.1002/cne.10909; Tadokoro O, 2002, J PERIODONTAL RES, V37, P456, DOI 10.1034/j.1600-0765.2002.01374.x; TOREBJORK HE, 1990, EXP BRAIN RES, V81, P509, DOI 10.1007/BF02423499; WALDO CM, 1954, J DENT RES, V33, P481, DOI 10.1177/00220345540330040701; Watanabe M, 2002, NEUROSCI LETT, V335, P99, DOI 10.1016/S0304-3940(02)01163-1; Yamashiro T, 1998, J DENT RES, V77, P1920; Yamashiro T, 2001, J DENT RES, V80, P1854; Yamashiro T, 1997, NEUROREPORT, V8, P2351, DOI 10.1097/00001756-199707070-00049; Zhang W, 2003, J DENT RES, V82, P565	38	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	AUG	2015	94	8					1158	1166		10.1177/0022034515586543		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN1LR	WOS:000358182000020		
J	Schimmel, M; Christou, P; Miyazaki, H; Halazonetis, D; Herrmann, FR; Muller, F				Schimmel, Martin; Christou, Panagiotis; Miyazaki, Hideo; Halazonetis, Demetrios; Herrmann, Francois R.; Mueller, Frauke			A novel colourimetric technique to assess chewing function using two-coloured specimens: Validation and application	JOURNAL OF DENTISTRY			English	Article						Mastication; Edentulous mouth; Symptom assessment; Chewing gum	MASTICATORY PERFORMANCE; MIXING ABILITY; QUANTITATIVE-EVALUATION; ORAL-HEALTH; GUM TEST; EFFICIENCY; OVERDENTURES; INDIVIDUALS; ADULTS; FORCE	Objectives: Chewing efficiency may be evaluated using cohesive specimen, especially in elderly or dysphagic patients. The aim of this study was to evaluate three two-coloured chewing gums for a colour-mixing ability test and to validate a new purpose built software (ViewGum(C)). Methods: Dentate participants (dentate-group) and edentulous patients with mandibular two-implant overdentures (IOD-group) were recruited. First, the dentate-group chewed three different types of two-coloured gum (gum1-gum3) for 5, 10, 20, 30 and 50 chewing cycles. Subsequently the number of chewing cycles with the highest intra-and inter-rater agreement was determined visually by applying a scale (SA) and opto-electronically (ViewGum(C), Bland-Altman analysis). The ViewGum(C) software determines semi-automatically the variance of hue (VOH); inadequate mixing presents with larger VOH than complete mixing. Secondly, the dentate-group and the IOD-group were compared. Results: The dentate-group comprised 20 participants (10 female, 30.3 +/- 6.7 years); the IOD-group 15 participants (10 female, 74.6 +/- 8.3 years). Intra-rater and inter-rater agreement (SA) was very high at 20 chewing cycles (95.00-98.75%). Gums 1-3 showed different colour-mixing characteristics as a function of chewing cycles, gum1 showed a logarithmic association; gum2 and gum3 demonstrated more linear behaviours. However, the number of chewing cycles could be predicted in all specimens from VOH (all p < 0.0001, mixed linear regression models). Both analyses proved discriminative to the dental state. Conclusion: ViewGum(C) proved to be a reliable and discriminative tool to opto-electronically assess chewing efficiency, given an elastic specimen is chewed for 20 cycles and could be recommended for the evaluation of chewing efficiency in a clinical and research setting. Clinical Significance: Chewing is a complex function of the oro-facial structures and the central nervous system. The application of the proposed assessments of the chewing function in geriatrics or special care dentistry could help visualising oro-functional or dental comorbidities in dysphagic patients or those suffering from protein-energy malnutrition. (C) 2015 The Authors. Published by Elsevier Ltd.	[Schimmel, Martin] Univ Bern, Div Gerodontol, Sch Dent Med, CH-3010 Bern, Switzerland; [Schimmel, Martin; Mueller, Frauke] Univ Geneva, Div Gerodontol & Removable Prosthodont, Dent Univ Clin, CH-1205 Geneva, Switzerland; [Miyazaki, Hideo] Niigata Univ, Div Prevent Dent, Dept Oral Hlth Sci, Grad Sch Med & Dent Sci,Chuo Ku, Niigata 9518514, Japan; [Halazonetis, Demetrios] Univ Athens, Dept Orthodont, Sch Dent, Athens 11527, Greece; [Herrmann, Francois R.; Mueller, Frauke] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Thonex, Switzerland	Schimmel, M (reprint author), Univ Bern, Div Gerodontol, Sch Dent Med, Freiburgstr 7, CH-3010 Bern, Switzerland.	martin.schimmel@zmk.unibe.ch; slowdent@yahoo.com; hideomiy@dent.niigata-u.ac.jp; dhal@dhal.com; francois.herrmann@hcuge.ch; frauke.mueller@unige.ch	Muller, Frauke/C-3835-2014	Muller, Frauke/0000-0003-3981-0134	8020 Promotion Foundation (Japan); Division of Gerodontology and Removable Prosthodontics, University of Geneva (Switzerland)	We would like to express our gratitude to the volunteers who participated in these experiments. We would like to thank the 8020 Promotion Foundation (Japan) for providing the samples of gum2 and for their generous support. We would like to express our gratitude to Mr. A. Burki and Prof. Ph. Zysset, Institute for Surgical Technology and Biomechanics, University of Bern for selflessly evaluating the hardness of the gums and to Prof. T. Nef, Gerontechnology and Rehabilitation Centre, University of Bern for his altruistic support. Funding by private research funds of the Division of Gerodontology and Removable Prosthodontics, University of Geneva (Switzerland).	Allison PJ, 2000, COMMUNITY DENT HLTH, V17, P172; Anastassiadou V, 2001, Gerodontology, V18, P79, DOI 10.1111/j.1741-2358.2001.00079.x; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Schimmel M, 2011, J DENT RES, V90, P230, DOI 10.1177/0022034510383860; Stenman U, 2012, GERODONTOLOGY, V29, pE440, DOI 10.1111/j.1741-2358.2011.00495.x; MANLY RS, 1950, J DENT RES, V29, P448, DOI 10.1177/00220345500290040701; Schimmel M, 2013, CLIN ORAL INVEST, V17, P867, DOI 10.1007/s00784-012-0769-2; KAYSER AF, 1981, J ORAL REHABIL, V8, P457, DOI 10.1111/j.1365-2842.1981.tb00519.x; Muller F, 2012, CLIN ORAL IMPLAN RES, V23, P144, DOI 10.1111/j.1600-0501.2011.02213.x; Hasegawa Y, 2007, J DENT RES, V86, P64; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; van Kampen FMC, 2004, J DENT RES, V83, P708; Fontijn-Tekamp FA, 2000, J DENT RES, V79, P1519; Woda A, 2010, J BIOMECH, V43, P1667, DOI 10.1016/j.jbiomech.2010.03.002; Remond D, 2007, AM J CLIN NUTR, V85, P1286; van der Bilt A, 2010, J ORAL REHABIL, V37, P79, DOI 10.1111/j.1365-2842.2009.02040.x; LIEDBERG B, 1991, Dysphagia, V6, P211, DOI 10.1007/BF02493529; van der Bilt A, 2011, J ORAL REHABIL, V38, P754, DOI 10.1111/j.1365-2842.2010.02197.x; Elsig F, 2015, GERODONTOLOGY, V32, P149, DOI 10.1111/ger.12079; Speksnijder CM, 2009, EUR J ORAL SCI, V117, P580, DOI 10.1111/j.1600-0722.2009.00675.x; [Anonymous], 2006, NIHON KYOSEI SHIKA G; Hirano K, 2004, J ORAL REHABIL, V31, P199, DOI 10.1111/j.1365-2842.2004.01175.x; Sheiham A, 2001, J DENT RES, V80, P408; Eberhard L, 2012, J ORAL REHABIL, V39, P338, DOI 10.1111/j.1365-2842.2011.02275.x; Endo T, 2014, ODONTOLOGY, V102, P68, DOI 10.1007/s10266-012-0089-7; Gaudenz J, 1902, ARCH HYG, V39, P230; Halazonetis DJ, 2013, J ORAL REHABIL, V40, P329, DOI 10.1111/joor.12043; Hamdan NM, 2013, J DENT RES, V92, p146S, DOI 10.1177/0022034513504948; Hayakawa I, 1998, INT J PROSTHODONT, V11, P173; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Muller F, 2013, J DENT RES, V92, p154S, DOI 10.1177/0022034513509630; Prinz JF, 1999, J ORAL REHABIL, V26, P243, DOI 10.1046/j.1365-2842.1999.00362.x; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; The Academy of Prosthodontics, 2005, J PROSTHET DENT, V94, P10; Van der Bilt A, 2012, J ORAL REHABIL, V39, P11, DOI 10.1111/j.1365-2842.2011.02229.x; Woda A, 2011, J ORAL REHABIL, V38, P781, DOI 10.1111/j.1365-2842.2011.02235.x; Woda A, 2010, J DENT RES, V89, P281, DOI 10.1177/0022034509357022	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	AUG	2015	43	8					955	964		10.1016/j.jdent.2015.06.003		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN0DW	WOS:000358084800008		
J	Jo, A; Kanazawa, M; Sato, Y; Iwaki, M; Akiba, N; Minakuchi, S				Jo, Ayami; Kanazawa, Manabu; Sato, Yusuke; Iwaki, Maiko; Akiba, Norihisa; Minakuchi, Shunsuke			A randomized controlled trial of the different impression methods for the complete denture fabrication: Patient reported outcomes	JOURNAL OF DENTISTRY			English	Article						Complete denture; Impression technique; Patient satisfaction; Patient reported outcomes; Oral health-related quality of life; Edentulous patients	QUALITY-OF-LIFE; HEALTH IMPACT PROFILE; TRADITIONAL TECHNIQUES; JAPANESE VERSION; SATISFACTION; QUESTIONNAIRE; RELIABILITY; VALIDITY; ABILITY; WEARERS	Objectives: To compare the effect of conventional complete dentures (CD) fabricated using two different impression methods on patient-reported outcomes in a randomized controlled trial (RCT). Methods: A cross-over RCT was performed with edentulous patients, required maxillomandibular CDs. Mandibular CDs were fabricated using two different methods. The conventional method used a custom tray border moulded with impression compound and a silicone. The simplified used a stock tray and an alginate. Participants were randomly divided into two groups. The C-S group had the conventional method used first, followed by the simplified. The S-C group was in the reverse order. Adjustment was performed four times. A wash out period was set for 1 month. The primary outcome was general patient satisfaction, measured using visual analogue scales, and the secondary outcome was oral health-related quality of life, measured using the Japanese version of the Oral Health Impact Profile for edentulous (OHIP-EDENT-J) questionnaire scores. Results: Twenty-four participants completed the trial. With regard to general patient satisfaction, the conventional method was significantly more acceptable than the simplified. No significant differences were observed between the two methods in the OHIP-EDENT-J scores. Conclusions: This study showed CDs fabricated with a conventional method were significantly more highly rated for general patient satisfaction than a simplified. Clinical significance: CDs, fabricated with the conventional method that included a preliminary impression made using alginate in a stock tray and subsequently a final impression made using silicone in a border moulded custom tray resulted in higher general patient satisfaction. (C) 2015 Elsevier Ltd. All rights reserved.	[Jo, Ayami; Kanazawa, Manabu; Sato, Yusuke; Iwaki, Maiko; Akiba, Norihisa; Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Gerodontol & Oral Rehabil, Bunkyo Ku, Tokyo 1138549, Japan	Kanazawa, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Gerodontol & Oral Rehabil, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	m.kanazawa.gerd@tmd.ac.jp			JSPS KAKENHI [23792208]	This work was supported by JSPS KAKENHI grant number 23792208.	Yamazaki M, 2007, J ORAL REHABIL, V34, P159, DOI 10.1111/j.1365-2842.2006.01693.x; Stober T, 2012, CLIN ORAL INVEST, V16, P313, DOI 10.1007/s00784-010-0483-x; Montero J, 2011, COMMUNITY DENT ORAL, V39, P515, DOI 10.1111/j.1600-0528.2011.00620.x; Ellis JS, 2011, GERODONTOLOGY, V28, P62, DOI 10.1111/j.1741-2358.2009.00348.x; Komagamine Y, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-45; Regis RR, 2013, J ORAL REHABIL, V40, P535, DOI 10.1111/joor.12063; Allen F, 2002, INT J PROSTHODONT, V15, P446; Hyde TP, 2014, J DENT, V42, P895, DOI 10.1016/j.jdent.2014.02.005; Awad MA, 1998, COMMUNITY DENT ORAL, V26, P400, DOI 10.1111/j.1600-0528.1998.tb01978.x; John MT, 2004, INT J PROSTHODONT, V17, P503; Montero J, 2013, J DENT, V41, P493, DOI 10.1016/j.jdent.2013.01.006; BROOKS RG, 1991, HEALTH POLICY, V18, P37, DOI 10.1016/0168-8510(91)90142-K; BERG E, 1984, ACTA ODONTOL SCAND, V42, P119, DOI 10.3109/00016358409035249; Carlsson Gunnar E, 2009, J Prosthodont Res, V53, P3, DOI 10.1016/j.jpor.2008.08.003; Cooper LF, 2009, J PROSTHODONT, V18, P116, DOI 10.1111/j.1532-849X.2009.00441.x; Cunha TR, 2013, J DENT, V41, P133, DOI 10.1016/j.jdent.2012.09.008; Hanji Y, 2006, J JAPAN PROSTHODONTI, V50, P54; Hyde TP, 1999, J PROSTHET DENT, V81, P295, DOI 10.1016/S0022-3913(99)70272-6; Kawai Y, 2005, J DENT, V33, P659, DOI 10.1016/j.jdent.2005.01.005; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; Omar R, 2013, J DENT, V41, P852, DOI 10.1016/j.jdent.2013.07.013; Owen PC, 2004, INT J PROSTHODONT, V17, P261; Paulino MR, 2015, J PROSTHET DENT, V113, P12, DOI 10.1016/j.prosdent.2014.08.004; Sato Y, 2012, GERODONTOLOGY, V29, pE1033, DOI 10.1111/j.1741-2358.2011.00606.x; Suzuki K, 2001, J JAPAN PROSTHODONTI, V45, P106; Yamaga E, 2013, J DENT, V41, P710, DOI 10.1016/j.jdent.2013.05.015	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	AUG	2015	43	8					989	996		10.1016/j.jdent.2015.05.007		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN0DW	WOS:000358084800012		
J	Wataya-Kaneda, M				Wataya-Kaneda, Mari			Mammalian target of rapamycin and tuberous sclerosis complex	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Mammalian target of rapamycin (mTOR); Tuberous sclerosis complex (TSC); Rapamycin; Autophagy; Energy metabolism; PI3K-Akt-mTOR pathway	CELL-GROWTH; AMINO-ACIDS; RAPTOR PHOSPHORYLATION; RAG GTPASES; MTOR; AUTOPHAGY; AKT; METABOLISM; TSC2; ACTIVATION	Mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase that is a member of the phosphoinositide 3-kinase (PI3K)-related kinase (PIKK) family. mTOR forms two distinct complexes, mTORC1 and mTORC2. mTORC1 has emerged as a central regulator of cellular metabolism, cell proliferation, cellular differentiation, autophagy and immune response regulation. In contrast to mTORC1, mTORC2, which is not well understood, participates in cell survival and the regulation of actin and cytokeratin organization. In addition, mTORC1 has been implicated in many diseases, including cancer, metabolic diseases, neurological disease, genetic diseases and longevity/aging. One of the diseases resulting from dysfunction of mTORC1 is tuberous sclerosis complex (TSC), which reflects all the symptoms that arise in response to mTORC1 dysfunction. TSC is a multiple hamartomas syndrome with epilepsy, autism, mental retardation and hypopigmented macules that are caused by the constitutive activation of mTORC1 resulting from genetic mutation of TSC1 or TSC2. Inhibitors of mTORC1, such as rapamycin, effectively suppress the symptoms of TSC. This article summarizes the current knowledge on mTOR and the efficacy of mTORC1 inhibitors in the treatment of TSC. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Wataya-Kaneda, Mari] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Osaka, Japan	Wataya-Kaneda, M (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mkaneda@derma.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461690]; Ministry of Health, Labor and Welfare of Japan [H24-Nanchi-ippan-008]	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in Aid for Scientific Research No. 25461690), and by a grant from the Ministry of Health, Labor and Welfare of Japan (No. H24-Nanchi-ippan-008).	Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Wataya-Kaneda M, 2012, ARCH DERMATOL, V148, P138, DOI 10.1001/archderm.148.1.138; Jung CH, 2011, AUTOPHAGY, V7, P1212, DOI 10.4161/auto.7.10.16660; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Dunlop EA, 2011, AUTOPHAGY, V7, P737, DOI 10.4161/auto.7.7.15491; Muncy J, 2009, J CHILD NEUROL, V24, P477, DOI 10.1177/0883073808324535; Rosborough BR, 2013, BLOOD, V121, P3619, DOI 10.1182/blood-2012-08-448290; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; vanSlegtenhorst M, 1997, SCIENCE, V277, P805; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Peter C, 2010, CURR OPIN IMMUNOL, V22, P655, DOI 10.1016/j.coi.2010.08.010; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406; Curatolo P, 2015, PEDIATR NEUROL, V52, P281, DOI 10.1016/j.pediatrneurol.2014.10.028; NELLIST M, 1993, CELL, V75, P1305; Salminen A, 2012, INT J CELL BIOL, V2012; Sato A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2295; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757	50	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	AUG	2015	79	2					93	100		10.1016/j.jdermsci.2015.04.005		8	Dermatology	Dermatology	CN2SU	WOS:000358273000001		
J	Kiso, M; Hamazaki, TS; Itoh, M; Kikuchi, S; Nakagawa, H; Okochi, H				Kiso, Masahiro; Hamazaki, Tatsuo S.; Itoh, Munenari; Kikuchi, Sota; Nakagawa, Hidemi; Okochi, Hitoshi			Synergistic effect of PDGF and FGF2 for cell proliferation and hair inductive activity in murine vibrissal dermal papilla in vitro	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Dermal papilla; FGF2; PDGF-AA; PDGFR; Hair inductive activity	GROWTH-FACTOR PDGF; FOLLICLE DEVELOPMENT; RECEPTOR; MORPHOGENESIS; ACTIVATION; MOUSE; BETA; REGENERATION; CONTRIBUTE; VERSICAN	Background: The dermal papilla is composed of a small clump of mesenchymal cells, called dermal papilla cells (DPCs). DPCs closely interact with epidermal cells to give rise to hair follicles and shafts during hair follicle development and the hair cycle. DPCs are promising cell sources for hair regeneration therapy for alopecia patients. However, once DPCs are put into conventional two-dimensional culture conditions, they quickly lose their capability to produce hair follicles. Objective: We aimed to expand a sufficiently large population of DPCs that retain their hair inductive activity. Methods: Murine DPCs were cultured in the presence of platelet-derived growth factor-AA (PDGF-AA) and fibroblast growth factor 2 (FGF2). Expressions of follicular-related genes were analyzed by real time PCR and hair inductive activity was determined by patch assay and chamber assay in vivo. Results: FGF2 significantly increased the expression of platelet-derived growth factor receptor alpha (PDGFR alpha) in cultured vibrissal DPCs. PDGF-AA, a ligand of PDGFRa, promoted proliferation of DPCs synergistically when utilized with FGF2 and enhanced the expression of several follicular-related genes in DPCs. Hair reconstitution assays revealed that DPCs treated with both PDGF-AA and FGF-2 were able to maintain their hair inductive activity better than those treated with FGF2 alone. Conclusion: Both cell proliferation and hair inductive activity in murine DPCs are maintained by the synergistic effect of FGF2 and PDGF-AA. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Hamazaki, Tatsuo S.; Okochi, Hitoshi] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo 1628655, Japan; [Kiso, Masahiro; Itoh, Munenari; Kikuchi, Sota; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Okochi, H (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	hokochi@ri.ncgm.go.jp			JSPS KAKENHI Grant [25670756]	We thank S. Yabe for helpful discussion, and we also thank S. Fukuda, F. Takeda and K. Nashiro for valuable technical assistance. We are grateful to Dr. Barbara Lee Smith Pierce (University of Maryland University College) for editorial work in the preparation of this manuscript. This work was supported by JSPS KAKENHI Grant Number 25670756 to H.O.	Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F; HELDIN CH, 1992, EMBO J, V11, P4251; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kamp H, 2003, EXP DERMATOL, V12, P662, DOI 10.1034/j.1600-0625.2003.00089.x; Osada A, 2007, TISSUE ENG, V13, P975, DOI 10.1089/ten.2006.0304; Higgins CA, 2013, P NATL ACAD SCI USA, V110, P19679, DOI 10.1073/pnas.1309970110; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158; JAHODA CAB, 1993, J INVEST DERMATOL, V101, P584, DOI 10.1111/1523-1747.ep12366039; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; REYNOLDS AJ, 1992, DEVELOPMENT, V115, P587; Tobin DJ, 2003, J INVEST DERMATOL, V120, P895, DOI 10.1046/j.1523-1747.2003.12237.x; DUCROS DL, 1995, J INVEST DERMATOL, V105, P426, DOI 10.1111/1523-1747.ep12321131; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; HEIDARAN MA, 1991, J BIOL CHEM, V266, P20232; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; Liang Y, 2011, EXP DERMATOL, V20, P1011, DOI 10.1111/j.1600-0625.2011.01366.x; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331	31	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	AUG	2015	79	2					110	118		10.1016/j.jdermsci.2015.04.007		9	Dermatology	Dermatology	CN2SU	WOS:000358273000003		
J	Nodake, Y; Matsumoto, S; Miura, R; Honda, H; Ishibashi, G; Matsumoto, S; Dekio, I; Sakakibara, R				Nodake, Yuichi; Matsumoto, Said; Miura, Ryoko; Honda, Hidetoshi; Ishibashi, Genji; Matsumoto, Shuzo; Dekio, Itaru; Sakakibara, Ryuzo			Pilot study on novel skin care method by augmentation with Staphylococcus epidermidis, an autologous skin microbe - A blinded randomized clinical trial	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Staphylococcus epidermidis; Skin microbiota; Augmentation with S. epidermidis; Skin care; Skin moisture retention; Basic cosmetics	BACTERIA DETECTION APPARATUS; HUMAN MELANOCYTES; ULTRAVIOLET-B; INFECTIONS; EXPRESSION; PEPTIDES; IMMUNITY; DEFENSE	Background and objective: Staphylococcus epidermidis is an autologous bacterium that is beneficial to skin health. Our goal was to develop a novel, personalized basic cosmetic that exploits this characteristic. Methods: We conducted a double-blinded, randomized clinical trial on augmentation with S. epidermidis as a pilot study, in which S. epidermidis was collected from the subject, cultured for proliferation, and then continuously applied to the subject's own face before sleep twice per week for four weeks in order to increase colonization levels. Results: The results showed that this treatment increased the lipid content of the skin and suppressed water evaporation, thereby markedly improving skin moisture retention. Moreover, augmentation with S. epidermidis maintained a low acidic condition on the skin surface. The low risk of undesirable effects induced by augmentation with S. epidermidis was also confirmed by measuring erythema and melanin levels. Conclusions: These results may serve as a driving force to accelerate the development of novel, personalized basic cosmetics. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Nodake, Yuichi; Matsumoto, Said; Miura, Ryoko; Sakakibara, Ryuzo] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Biochem, Nagasaki 8593298, Japan; [Matsumoto, Said; Miura, Ryoko; Honda, Hidetoshi] BIOGENOMICS Co Ltd, Dept Res & Dev, Nagasaki 8560022, Japan; [Ishibashi, Genji] Kyushu Womens Univ, Dept Nutr, Yahatanishi Ku, Kitakyushu, Fukuoka 8078586, Japan; [Matsumoto, Shuzo] Ind Technol Ctr Nagasaki, Appl Technol Div, Nagasaki 8560026, Japan; [Dekio, Itaru] Tokyo Womens Med Univ, Med Ctr East, Dept Dermatol, Tokyo 1168567, Japan	Nodake, Y (reprint author), Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Biochem, 2825-7 Huis Ten Bosch, Nagasaki 8593298, Japan.	nodake@niu.ac.jp			National Natural Science Foundation of China [81273320, 81271750, 81300928, 81371734, 81472885]	We thank Professors Boquan Jin and Kun Yang for their valuable advice and suggestions. This research was funded by the National Natural Science Foundation of China (81273320, 81271750, 81300928, 81371734 and 81472885).	Al-Mahrous M, 2010, PEPTIDES, V31, P1661, DOI 10.1016/j.peptides.2010.06.006; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Otto M, 2004, FRONT BIOSCI, V9, P841, DOI 10.2741/1295; FARRELL AM, 1993, J GEN MICROBIOL, V139, P267; Hamada R, 2011, IET NANOBIOTECHNOL, V5, P25, DOI 10.1049/iet-nbt.2010.0011; EVANS CA, 1950, J INVEST DERMATOL, V15, P305, DOI 10.1038/jid.1950.105; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Spellberg B, 2000, LIFE SCI, V67, P477, DOI 10.1016/S0024-3205(00)00653-6; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Martineau F, 2000, J ANTIMICROB CHEMOTH, V46, P527, DOI 10.1093/jac/46.4.527; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Blau K, 1979, 1993 HDB DERIVATIVES, V2nd; Dobrev H, 2005, SKIN RES TECHNOL, V11, P120, DOI 10.1111/j.1600-0846.2005.00090.x; Enomoto DNH, 1996, J AM ACAD DERMATOL, V35, P381, DOI 10.1016/S0190-9622(96)90601-5; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Hedin G, 1993, Scand J Infect Dis Suppl, V90, P1; Hunt KM, 2012, APPL ENVIRON MICROB, V78, P4763, DOI 10.1128/AEM.00477-12; IMAI K, 1985, J BIOCHEM-TOKYO, V98, P1405; Kaneko A, 1997, DRUG DELIV SYST, V12, P339; Kikuchi H, 2004, MED CONSULT NEW REM, V41, P893; Kikutani T, 2012, GERODONTOLOGY, V29, pE560, DOI 10.1111/j.1741-2358.2011.00517.x; Knapp DR, 1979, HDB ANAL DERIVATIZAT; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MARPLES MJ, 1969, BRIT J DERMATOL, VS 81, P2, DOI 10.1111/j.1365-2133.1969.tb12827.x; Noble W C, 1968, Br J Dermatol, V80, P279, DOI 10.1111/j.1365-2133.1968.tb12299.x; Nodake Y, 2013, J COSMET DERMATOL SC, V3, P172; Rennekampff H O, 2002, Kongressbd Dtsch Ges Chir Kongr, V119, P749; SCHEIMANN LG, 1960, J INVEST DERMATOL, V34, P171; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; TAKAHASHI M, 1984, J SOC COSMET CHEM, V35, P171; TOMITA Y, 1987, J INVEST DERMATOL, V89, P299, DOI 10.1111/1523-1747.ep12471536	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	AUG	2015	79	2					119	126		10.1016/j.jdermsci.2015.05.001		8	Dermatology	Dermatology	CN2SU	WOS:000358273000004		
J	Numata, S; Teye, K; Krol, RP; Karashima, T; Fukuda, S; Matsuda, M; Ishii, N; Furumura, M; Ohata, C; Saminathan, SD; Ariffin, R; Pramono, ZAD; Leong, KF; Hamada, T; Hashimoto, T				Numata, Sanae; Teye, Kwesi; Krol, Rafal P.; Karashima, Tadashi; Fukuda, Shunpei; Matsuda, Mitsuhiro; Ishii, Norito; Furumura, Minao; Ohata, Chika; Saminathan, Sasi D.; Ariffin, Roziana; Pramono, Zacharias A. D.; Leong, Kin Fon; Hamada, Takahiro; Hashimoto, Takashi			Mutation study for 9 genes in 23 unrelated patients with autosomal recessive congenital ichthyosis in Japan and Malaysia (vol 78, pg 82, 2015)	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Correction									[Numata, Sanae; Teye, Kwesi; Krol, Rafal P.; Karashima, Tadashi; Fukuda, Shunpei; Matsuda, Mitsuhiro; Ishii, Norito; Furumura, Minao; Ohata, Chika; Hamada, Takahiro; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Numata, Sanae; Teye, Kwesi; Krol, Rafal P.; Karashima, Tadashi; Fukuda, Shunpei; Matsuda, Mitsuhiro; Ishii, Norito; Furumura, Minao; Ohata, Chika; Hamada, Takahiro; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan; [Saminathan, Sasi D.; Ariffin, Roziana] Kuala Lumpur Hosp, Dept Med Genet, Kuala Lumpur, Malaysia; [Pramono, Zacharias A. D.] Natl Skin Ctr, Dept Res, Singapore, Singapore; [Leong, Kin Fon] Gen Hosp, Dept Dermatol, Kuala Lumpur, Malaysia	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan.	hashimot@med.kurume-u.ac.jp					Numata S, 2015, J DERMATOL SCI, V78, P82, DOI 10.1016/j.jdermsci.2015.02.006	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	AUG	2015	79	2					179	180		10.1016/j.jdermsci.2015.05.009		2	Dermatology	Dermatology	CN2SU	WOS:000358273000013		
J	Shimada, Y				Shimada, Yoshihisa			Novel Crossing Devices vs the Skill of Artisans: Is It a Tie Thus Far?	JOURNAL OF ENDOVASCULAR THERAPY			English	Editorial Material						peripheral artery disease; endovascular procedures; stenosis; occlusion; superficial femoral artery; popliteal artery; anterior tibial artery; posterior tibial artery; peroneal artery; chronic total occlusion; crossing device; guidewire; microcatheter	CHRONIC TOTAL OCCLUSIONS; SUPERFICIAL FEMORAL-ARTERY; SUBINTIMAL ANGIOPLASTY; INTRALUMINAL RECANALIZATION; RETROGRADE APPROACH; REVASCULARIZATION; MANAGEMENT; POPLITEAL		Shiroyama Hosp, Cardiovasc Ctr, Habikino, Osaka 5830872, Japan	Shimada, Y (reprint author), Shiroyama Hosp, Cardiovasc Ctr, 2-8-1 Habikino, Habikino, Osaka 5830872, Japan.	shimada@shiroyama-hsp.or.jp					Montero-Baker M, 2008, J ENDOVASC THER, V15, P594, DOI 10.1583/08-2440.1; Bown MJ, 2009, EUR J VASC ENDOVASC, V38, P323, DOI 10.1016/j.ejvs.2009.05.014; Gallagher KA, 2011, J ENDOVASC THER, V18, P624, DOI 10.1583/11-3539.1; Kawarada O, 2010, J ENDOVASC THER, V17, P255, DOI 10.1583/09-2966.1; Banerjee S, 2014, J ENDOVASC THER, V21, P71, DOI 10.1583/12-4009MR.1; Banerjee S, 2015, J ENDOVASC THER, V22, P525, DOI 10.1177/1526602815587707; Bosiers M, 2014, J ENDOVASC THER, V21, P61, DOI 10.1583/12-4083R.1; Charalambous N, 2010, CARDIOVASC INTER RAD, V33, P25, DOI 10.1007/s00270-009-9700-x; Chun JY, 2010, J CARDIOVASC SURG, V51, P213; Gandini R, 2009, J ENDOVASC THER, V16, P23, DOI 10.1583/08-2520.1; Hong SJ, 2013, J ENDOVASC THER, V20, P782, DOI 10.1583/13-4398MR.1; Kawarada O, 2014, J ENDOVASC THER, V21, P266, DOI 10.1583/13-4460MR.1; Noory E, 2009, J ENDOVASC THER, V16, P619, DOI 10.1583/09-2784.1; Shimada Y, 2014, J ENDOVASC THER, V21, P779, DOI 10.1583/14-4801C.1; Shimada Y, 2012, J ENDOVASC THER, V19, P620, DOI 10.1583/JEVT-12-3927.1; Sultan S, 2014, J CARDIOVASC SURG, V55, P813; Wiesinger B, 2009, J ENDOVASC THER, V16, P213, DOI 10.1583/08-2496C.1	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	AUG	2015	22	4					535	537		10.1177/1526602815590971		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CN0QU	WOS:000358119200010		
J	Soga, Y; Tomoi, Y; Fujihara, M; Okazaki, S; Yamauchi, Y; Shintani, Y; Suzuki, K				Soga, Yoshimitsu; Tomoi, Yusuke; Fujihara, Masahiko; Okazaki, Shinya; Yamauchi, Yasutaka; Shintani, Yoshiaki; Suzuki, Kenji		SCALLOP Investigators	Perioperative and Long-term Outcomes of Endovascular Treatment for Subclavian Artery Disease From a Large Multicenter Registry	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						subclavian artery disease; endovascular therapy; stenosis; occlusion; balloon angioplasty; stent; patency	PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SIROLIMUS-ELUTING STENT; OCCLUSIVE DISEASE; FOLLOW-UP; INNOMINATE; REVASCULARIZATION; IMPLANTATION; STENOSIS; BYPASS	Purpose: To investigate the perioperative and long-term outcomes of endovascular therapy (EVT) for subclavian artery disease in a large-scale multicenter study. Methods: The study analyzed the outcomes from a multicenter retrospective registry (SubClavian Artery disease treated with endovascuLar therapy; muLticenter retrOsPective registry: SCALLOP) of 718 consecutive patients with upper extremity artery disease who underwent EVT between January 2003 and December 2012 at 37 Japanese cardiovascular centers. Of the 718 patients enrolled in the registry, 162 patients were excluded, leaving 553 patients (mean 70 +/- 7 years, range 41-91; 405 men) who underwent primary EVT for de novo subclavian artery disease (560 arms). Results: Procedure success was achieved in 96.8% (100% for stenoses, 91% for total occlusions). The perioperative complication rate was 9.2%. Stroke was found in 1.8%, with ipsilateral posterior infarction accounting for 0.9%. The 30-day mortality was 0.7%. The mean follow-up was 39 +/- 24 months. Primary patency estimates were 90.6%+/- 1.3%, 83.4%+/- 1.8%, and 80.5%+/- 2.2% at 1, 3, and 5 years, respectively. There was no significant difference in primary patency between stenotic and occlusive lesions. Secondary patency estimates were 99.2%+/- 0.4%, 98.2%+/- 0.6%, and 97.7%+/- 0.8% at 1, 3, and 5 years, respectively. The respective overall survival rates were 94.6%+/- 1.0%, 86.8%+/- 1.7%, and 79.0%+/- 2.4%. There were 86 deaths during follow-up, of which half were due to cardiovascular causes. On multivariate analysis, critical hand ischemia (hazard ratio [HR] 4.6, 95% CI 2.06 to 10.2, p<0.001), cerebrovascular disease (HR 1.9, 95% CI 1.14 to 3.06, p=0.01), current smoking (HR 1.8, 95% 1.14 to 2.79, p=0.01), and lesion length (in 1-cm increments; HR 1.02, 95% CI 1.00 to 1.04, p=0.03) were negative independent predictors of primary patency, while IVUS use (HR 0.6, 95% CI 0.30 to 0.96, p=0.04) was a positive predictor of primary patency. Conclusion: Primary angioplasty/stenting for subclavian artery disease afforded acceptable outcomes in terms of perioperative complications and long-term patency.	[Soga, Yoshimitsu; Tomoi, Yusuke] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka 8020001, Japan; [Fujihara, Masahiko] Kishiwada Tokushukai Hosp, Dept Cardiol, Kishiwada, Japan; [Okazaki, Shinya] Juntendo Univ Hosp, Dept Cardiol, Tokyo, Japan; [Yamauchi, Yasutaka] Kikuna Mem Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Shintani, Yoshiaki] Shin Koga Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Suzuki, Kenji] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan	Soga, Y (reprint author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 1-2-3 Asano, Kitakyushu, Fukuoka 8020001, Japan.	sogacchy@yahoo.co.jp					ACKERMANN H, 1988, STROKE, V19, P431; Angle J Fritz, 2003, Vasc Endovascular Surg, V37, P89, DOI 10.1177/153857440303700202; Brountzos EN, 2004, CARDIOVASC INTER RAD, V27, P616, DOI 10.1007/s00270-004-0218-y; Korner M, 1999, VASA-J VASCULAR DIS, V28, P117, DOI 10.1024/0301-1526.28.2.117; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Schillinger M, 2002, J ENDOVASC THER, V9, P139, DOI 10.1583/1545-1550(2002)009<0139:OOCVIT>2.0.CO;2; Przewlocki T, 2006, CATHETER CARDIO INTE, V67, P519, DOI 10.1002/ccd.20695; Soga Y, 2012, CIRC J, V76, P2697, DOI 10.1253/circj.CJ-12-0492; Rodriguez-Lopez JA, 1999, ANN VASC SURG, V13, P254, DOI 10.1007/s100169900254; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; AbuRahma AF, 2007, J ENDOVASC THER, V14, P698, DOI 10.1583/1545-1550(2007)14[698:AASVCB]2.0.CO;2; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; de Vries JPPM, 2005, J VASC SURG, V41, P19, DOI 10.1016/j.jvs.2004.09.030; Henry M, 1999, J ENDOVASC SURG, V6, P33, DOI 10.1583/1074-6218(1999)006<0033:PTAOTS>2.0.CO;2; Mathias K, 1980, Rofo, V132, P346, DOI 10.1055/s-2008-1056576; Sakai C, 2007, Interv Neuroradiol, V13 Suppl 1, P135; Song LP, 2012, J ENDOVASC THER, V19, P44, DOI 10.1583/11-3692.1; Sullivan TM, 1998, J VASC SURG, V28, P1059, DOI 10.1016/S0741-5214(98)70032-1; Wada Takeshi, 2014, Neuroradiol J, V27, P213, DOI 10.15274/NRJ-2014-10023	20	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	AUG	2015	22	4					626	633		10.1177/1526602815590579		8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CN0QU	WOS:000358119200025		
J	Maeda, K; Kanaoka, Y; Ohki, T; Sumi, M; Toya, N; Fujita, T				Maeda, Koji; Kanaoka, Yuji; Ohki, Takao; Sumi, Makoto; Toya, Naoki; Fujita, Tetsuji			Better Clinical Practice Could Overcome Patient-Related Risk Factors of Vascular Surgical Site Infections	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						abdominal aortic aneurysm; thoracic aortic aneurysm; endovascular aneurysm repair; thoracic endovascular aortic repair; endograft; infection; stent-graft	ANEURYSM REPAIR; POVIDONE-IODINE; ENDOGRAFT INFECTION; GRAFT INFECTION; AORTIC-ANEURYSM; SURGERY; COMPLICATIONS; CHLORHEXIDINE; EPIDEMIOLOGY; ANTISEPSIS	Purpose: To clarify the current status of surgical site infection (SSI) during endovascular aortic repair and to define risk factors for SSI among the patients who underwent thoracic or abdominal stent-graft repair through a groin incision. Methods: Between 2006 and 2013, data were collected from 1604 patients (mean age 75.2 +/- 9.5 years; 1282 men) with 2799 groin incisions for transfemoral access during aortic stent-graft procedures. SSIs were classified as superficial or deep (both occurring within 30 days) or organ/space infections (occurring within 1 year after surgery) according to the Centers for Disease Control and Prevention guidelines. Strategies in place for minimizing SSIs were (1) employing oblique groin incisions, (2) covering the incision with saline-soaked gauze, (3) irrigating the incision thoroughly with saline per layer, and (4) using absorbable sutures. Results: Overall incidence of SSI was 0.4% (6 patients). The majority of SSIs were late-onset prosthetic graft infections (5, 0.3%). Five of the 6 were successfully treated with conservative therapy; one patient died of sepsis. Univariate analysis showed additional therapy (eg, coil embolization) with a stent-graft procedure was a risk factor for SSI. Conclusion: Appropriate antibiotic administration, oblique groin incision, meticulous operative technique, protection against airborne infection during the operation, and closed dressings may avert vascular wound SSIs.	[Maeda, Koji; Kanaoka, Yuji; Ohki, Takao; Sumi, Makoto; Toya, Naoki; Fujita, Tetsuji] Jikei Univ, Sch Med, Dept Surg, Div Vasc Surg, Tokyo 1058461, Japan	Maeda, K (reprint author), Jikei Univ, Sch Med, Dept Surg, Div Vasc Surg,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	koji-m@jikei.ac.jp					Anderson DJ, 2008, INFECT CONT HOSP EP, V29, pS51, DOI 10.1086/591064; Neumayer L, 2007, J AM COLL SURGEONS, V204, P1178, DOI 10.1016/j.jamcollsurg.2007.03.022; Lawrence PF, 2011, SEMIN VASC SURG, V24, P199, DOI 10.1053/j.semvascsurg.2011.10.014; Murphy EH, 2013, J VASC SURG, V58, P1179, DOI 10.1016/j.jvs.2013.04.040; Fiorani P, 2003, J ENDOVASC THER, V10, P919, DOI 10.1583/1545-1550(2003)010<0919:EGIPRO>2.0.CO;2; Setacci C, 2010, J CARDIOVASC SURG, V51, P33; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Vogel TR, 2010, J VASC SURG, V51, P122, DOI 10.1016/j.jvs.2009.08.006; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Edmiston CE, 2005, SURGERY, V138, P573, DOI 10.1016/j.surg.2005.06.045; Harbarth S, 2000, CIRCULATION, V101, P2916; Bandyk DF, 2008, SEMIN VASC SURG, V21, P119, DOI 10.1053/j.semvascsurg.2008.05.008; REIFSNYDER T, 1992, J VASC SURG, V15, P843; Nienaber CA, 2013, CIRC-CARDIOVASC INTE, V6, P407, DOI 10.1161/CIRCINTERVENTIONS.113.000463; Boltz MM, 2011, SURGERY, V150, P934, DOI 10.1016/j.surg.2011.04.006; Noorani A, 2010, BRIT J SURG, V97, P1614, DOI 10.1002/bjs.7214; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Balin AK, 2002, DERMATOL SURG, V28, P210, DOI 10.1046/j.1524-4725.2002.01161.x; Nelson PR, 2014, J VASC SURG, V59, P1181, DOI 10.1016/j.jvs.2013.10.101; Caiati JM, 2000, ANN VASC SURG, V14, P248, DOI 10.1007/s100169910042; Centers for Disease Control and Prevention, 2015, SURG SIT INF SSI EV; Chuter TAM, 1998, J ENDOVASC SURG, V5, P259, DOI 10.1583/1074-6218(1998)005<0259:FAEFEA>2.0.CO;2; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; Faraday N, 2012, ANN SURG, V24, P1; Fatima J, 2013, J VASC SURG, V58, P171; Hobbs SD, 2010, J CARDIOVASC SURG, V51, P5; Jackson A, 2014, COCHRANE DB SYST REV, V27; Laser A, 2010, J VASC SURG, V54, P58; Lawrence J C, 1997, J Wound Care, V6, P23; Ohki T, 2001, ANN SURG, V234, P323, DOI 10.1097/00000658-200109000-00006; Perl TM, 1998, ANN PHARMACOTHER, V32, pS7; Slappy A L Jackson, 2003, Vasc Endovascular Surg, V37, P105; Wenzel RP, 1995, J HOSP INFECT, V30, P1	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	AUG	2015	22	4					640	646		10.1177/1526602815591553		7	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CN0QU	WOS:000358119200027		
J	Senphan, T; Benjakul, S; Kishimura, H				Senphan, Theeraphol; Benjakul, Soottawat; Kishimura, Hideki			Purification and Characterization of Trypsin from Hepatopancreas of Pacific White Shrimp	JOURNAL OF FOOD BIOCHEMISTRY			English	Article							PYLORIC CECA; PROCAMBARUS-CLARKII; ENZYMATIC-PROPERTIES; ANIONIC TRYPSINS; PROTEASE; VISCERA; EFFICIENCY; DIGESTION; CRAYFISH; ENZYMES	Trypsin from hepatopancreas of Pacific white shrimp (Litopenaeus vannamei) was purified to homogeneity using ammonium sulfate precipitation and a series of chromatographies including diethylaminoethyl sepharose and soybean trypsin inhibitor sepharose 4B columns. Trypsin was purified to 50.4-fold with a yield of 13.7%. Based on native-polyacrylamide gel electrophoresis (PAGE), the purified trypsin showed a single band. Trypsin had a molecular weight of 24kDa as estimated by sodium dodecyl sulphate-PAGE. The optimal pH and temperature for -N-benzoyl-dl-arginine-p-nitroanilide (BAPNA) hydrolysis were 8.0 and 60C, respectively. Trypsin was stable to heat treatment up to 60C and over a pH range of 7.0-11.0. The activity was strongly inhibited by soybean N--tosyl-L-lysine chloromethyl ketone. Purified trypsin had Michaelis-Menten constant (K-m) and catalytic constant (k(cat)) of 1.60mM and 3.33s(-1), respectively, when BAPNA was used as the substrate. Trypsin with high k(cat) indicated its high capacity of hydrolysis and it could serve as a promising protease. Practical ApplicationsPacific white shrimp hepatopancreas generally serves as a major source of proteases, especially trypsin and chymotrypsin, which can be used as an alternative food processing aid. Proteases in the hepatopancreas can be recovered and further used, in which the cost of commercially available proteases can be reduced. Furthermore, the by-product can be better exploited and the extracted proteases can increase the revenues for the shrimp processor.	[Senphan, Theeraphol; Benjakul, Soottawat] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand; [Kishimura, Hideki] Hokkaido Univ, Res Fac Fisheries Sci, Lab Marine Prod & Food Sci, Hakodate, Hokkaido, Japan	Benjakul, S (reprint author), Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand.	soottawat.b@psu.ac.th			Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission	This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission. The TRF Distinguished Research Professor Grant was also acknowledged.	LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; VEGAVILLASANTE F, 1995, COMP BIOCHEM PHYS B, V112, P123, DOI 10.1016/0305-0491(95)00039-B; Barkia A, 2010, FISH PHYSIOL BIOCHEM, V36, P893, DOI 10.1007/s10695-009-9365-z; Castillo-Yanez FJ, 2005, COMP BIOCHEM PHYS B, V140, P91, DOI 10.1016/j.cbpc.2004.09.031; Kishimura H, 2008, FOOD CHEM, V106, P194, DOI 10.1016/j.foodchem.2007.05.056; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Balti R, 2009, FOOD CHEM, V113, P146, DOI 10.1016/j.foodchem.2008.07.059; Oh ES, 2000, J FOOD BIOCHEM, V24, P251, DOI 10.1111/j.1745-4514.2000.tb00699.x; Khantaphant S, 2010, FOOD CHEM, V120, P658, DOI 10.1016/j.foodchem.2009.09.098; Senphan T, 2014, J FUNCT FOODS, V6, P147, DOI 10.1016/j.jff.2013.10.001; Kishimura H, 2002, COMP BIOCHEM PHYS B, V132, P485, DOI 10.1016/S1096-4959(02)00062-3; Klomklao S, 2006, J AGR FOOD CHEM, V54, P5617, DOI 10.1021/jf060699d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Aoki H, 2003, J AGR FOOD CHEM, V51, P777, DOI 10.1021/jf020673w; Ben Khaled H, 2008, J SCI FOOD AGR, V88, P2654, DOI 10.1002/jsfa.3386; Bustos RO, 1999, PROCESS BIOCHEM, V35, P327, DOI 10.1016/S0032-9592(99)00075-8; Fernandez GAV, 2001, COMP BIOCH PHYSL B, V130, P331; GALGANI FG, 1985, COMP BIOCHEM PHYS B, V81, P447, DOI 10.1016/0305-0491(85)90340-2; GATES BJ, 1969, BIOCHEMISTRY-US, V8, P4483, DOI 10.1021/bi00839a039; Hau PV, 2006, J FOOD BIOCHEM, V30, P478; HONJO I, 1990, NIPPON SUISAN GAKK, V56, P1627; Jeong YW, 2000, J FOOD BIOCHEM, V24, P311, DOI 10.1111/j.1745-4514.2000.tb00703.x; KIM HR, 1994, COMP BIOCHEM PHYS B, V107, P197, DOI 10.1016/0305-0491(94)90040-X; KIM HR, 1992, COMP BIOCHEM PHYS B, V103, P391, DOI 10.1016/0305-0491(92)90310-N; Kim M, 2013, J FOOD BIOCHEM, V37, P732, DOI 10.1111/j.1745-4514.2012.00672.x; Perera E, 2012, BIOL BULL-US, V222, P158; Perera E., 2014, J COMP PHYSIOL B, V1, P1; Senphan T, 2015, FOOD CHEM, V166, P498, DOI 10.1016/j.foodchem.2014.06.054; Senphan T, 2014, SEP PURIF TECHNOL, V129, P57, DOI 10.1016/j.seppur.2014.03.025; Sriket C, 2012, FOOD CHEM, V134, P351, DOI 10.1016/j.foodchem.2012.02.173; Steel R.G., 1980, PRINCIPLES PROCEDURE; Torrissen KR, 2000, FOOD SCI, V97, P215; Valdez-Melchor RG, 2013, J FOOD BIOCHEM, V37, P694, DOI 10.1111/j.1745-4514.2012.00667.x; Villalba-Villalba AG, 2013, FOOD CHEM, V141, P940, DOI 10.1016/j.foodchem.2013.03.078; WHITAKER JR, 1965, J AM CHEM SOC, V87, P2728, DOI 10.1021/ja01090a034; Wu ZQ, 2014, INT J PEPT RES THER, V20, P531, DOI 10.1007/s10989-014-9415-y; Wu ZQ, 2008, INT J PEPT RES THER, V14, P113, DOI 10.1007/s10989-007-9119-7	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8884	1745-4514		J FOOD BIOCHEM	J. Food Biochem.	AUG	2015	39	4					388	397		10.1111/jfbc.12147		10	Biochemistry & Molecular Biology; Food Science & Technology	Biochemistry & Molecular Biology; Food Science & Technology	CN3NN	WOS:000358333700005		
J	Sai-Ut, S; Benjakul, S; Sumpavapol, P; Kishimura, H				Sai-Ut, Samart; Benjakul, Soottawat; Sumpavapol, Punnanee; Kishimura, Hideki			Antioxidant Activity of Gelatin Hydrolysate Produced from Fish Skin Gelatin Using Extracellular Protease from Bacillus amyloliquefaciensH11	JOURNAL OF FOOD PROCESSING AND PRESERVATION			English	Article							SIMULATED GASTROINTESTINAL DIGESTION; ENZYME-INHIBITORY PEPTIDES; FUNCTIONAL-PROPERTIES; COLLAGEN; FLAVOURZYME; ALCALASE; SYSTEMS; MUSCLE	Antioxidant activities of gelatin hydrolysates (GHs) from unicorn leatherjacket skin prepared using extracellular protease from Bacillus amyloliquefaciensH11 (GH-H11) with different degrees of hydrolysis (DHs) were comparatively studied with those of hydrolysate produced using Alcalase (GH-Al). Antioxidative activities of hydrolysates produced by both proteases increased with increasing DH (P<0.05). With DHs of 20-40%, GH-H11 showed higher 2,2-azinobis(3-ethylbenzothiazoline-6-sulphonic acid) radical-scavenging activity and ferric-reducing antioxidant power than GH-Al (P<0.05), but no differences in chelating activity were found (P>0.05). Both hydrolysates (100 and 1,000ppm) could inhibit lipid peroxidation in lecithin liposome system in a dose-dependent manner. In vitro simulated gastrointestinal digestion study indicated that the antioxidative activity of GH was not affected by pepsin, while further hydrolysis by pancreatin enhanced the antioxidative activity. The dominant antioxidative peptides in GH-H11 and GH-Al had molecular weights of approximately 750 and 3,600Da, respectively. Practical ApplicationsBacillus amyloliquefaciensH11 protease could hydrolyze gelatin more effectively than Alcalase. Gelatin hydrolysate using B.amyloliquefaciensH11 protease had high antioxidant activity than that prepared by Alcalase. Antioxidative peptide could be useful for the food industry owing to process specificity and the economic value of producing bioactive peptide for commercial use.	[Sai-Ut, Samart; Benjakul, Soottawat; Sumpavapol, Punnanee] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand; [Kishimura, Hideki] Hokkaido Univ, Grad Sch Fisheries Sci, Dept Marine Bioresources Chem, Hakodate, Hokkaido, Japan	Benjakul, S (reprint author), Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand.	soottawat.b@psu.ac.th			National Research University Project of Thailand's Office of the Higher Education Commission; TRF Senior Research Scholar Program; Graduate School, Prince of Songkla University	The authors wish to thank National Research University Project of Thailand's Office of the Higher Education Commission, the TRF Senior Research Scholar Program and Graduate School, Prince of Songkla University for funding this project.	Aleman A, 2011, LWT-FOOD SCI TECHNOL, V44, P407, DOI 10.1016/j.lwt.2010.09.003; Wu HC, 2003, FOOD RES INT, V36, P949, DOI 10.1016/S0963-9969(03)00104-2; Gimenez B, 2009, FOOD HYDROCOLLOID, V23, P1322, DOI 10.1016/j.foodhyd.2008.09.010; You LJ, 2010, FOOD CHEM, V120, P810, DOI 10.1016/j.foodchem.2009.11.018; Liu Q, 2010, FOOD CHEM, V118, P403, DOI 10.1016/j.foodchem.2009.05.013; Thiansilakul Y, 2007, J FOOD BIOCHEM, V31, P266, DOI 10.1111/j.1745-4514.2007.00111.x; Chen M, 2012, INNOV FOOD SCI EMERG, V16, P341, DOI 10.1016/j.ifset.2012.07.009; Klompong V, 2008, INT J FOOD SCI TECH, V43, P1019, DOI 10.1111/j.1365-2621.2007.01555.x; Phanturat P, 2010, LWT-FOOD SCI TECHNOL, V43, P86, DOI 10.1016/j.lwt.2009.06.010; Megias C, 2009, LWT-FOOD SCI TECHNOL, V42, P1496, DOI 10.1016/j.lwt.2009.04.008; Pena-Ramos EA, 2002, J FOOD SCI, V67, P2952, DOI 10.1111/j.1365-2621.2002.tb08844.x; Bayram T, 2008, TALANTA, V75, P705, DOI 10.1016/j.talanta.2007.12.007; Klompong V, 2007, FOOD CHEM, V102, P1317, DOI 10.1016/j.foodchem.2006.07.016; Mendis E, 2005, J AGR FOOD CHEM, V53, P581, DOI 10.1021/jf048877v; Lin L, 2006, J SCI FOOD AGR, V86, P2290, DOI 10.1002/jsfa.2600; Davalos A, 2004, J FOOD PROTECT, V67, P1939; Gimenez B, 2009, FOOD CHEM, V114, P976, DOI 10.1016/j.foodchem.2008.10.050; Zhang YF, 2012, PEPTIDES, V38, P13, DOI 10.1016/j.peptides.2012.08.014; Yang JL, 2008, FOOD CHEM, V110, P128, DOI 10.1016/j.foodchem.2008.01.072; Kim SK, 2001, J AGR FOOD CHEM, V49, P2992, DOI 10.1021/jf001119u; Benjakul S, 1997, J AGR FOOD CHEM, V45, P3423, DOI 10.1021/jf970294g; LASKIN DL, 1986, J LEUKOCYTE BIOL, V39, P255; Binsan W, 2008, FOOD CHEM, V106, P185, DOI 10.1016/j.foodchem.2007.05.065; Jia JP, 2010, J SCI FOOD AGR, V90, P635, DOI 10.1002/jsfa.3861; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Khantaphant S, 2011, LWT-FOOD SCI TECHNOL, V44, P1139, DOI 10.1016/j.lwt.2010.10.009; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P1690, DOI 10.1016/j.biortech.2007.04.005; Khantaphant S, 2008, COMP BIOCHEM PHYS B, V151, P410, DOI 10.1016/j.cbpb.2008.08.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Kim SK, 2001, J AGR FOOD CHEM, V49, P1984, DOI 10.1021/jf000494j; Thiansilakul Y, 2007, FOOD CHEM, V103, P1385, DOI 10.1016/j.foodchem.2006.10.055; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Nalinanon S, 2011, FOOD CHEM, V124, P1354, DOI 10.1016/j.foodchem.2010.07.089; Benzie I. F. F., 1996, ANAL BIOCHEM, V239, P170; Cinq-Mars CD, 2008, J AGR FOOD CHEM, V56, P410, DOI 10.1021/jf072277p; Frankel EN, 1997, J AM OIL CHEM SOC, V74, P1309, DOI 10.1007/s11746-997-0062-8; Kaewruang P., 2013, FOOD BIOSCIENCE, V2, P1; Kato S, 2011, J FUNCT FOODS, V3, P50, DOI 10.1016/j.jff.2010.11.005; Kittiphattanabawon P, 2012, FOOD CHEM, V135, P1118, DOI 10.1016/j.foodchem.2012.05.080; Lee BJ, 1997, J FOOD SCI, V62, P931, DOI 10.1111/j.1365-2621.1997.tb15009.x; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133; Sai-Ut S, 2013, FOOD SCI BIOTECHNOL, V22, P1015, DOI 10.1007/s10068-013-0178-6; Sliyt R., 2009, PROCESS BIOCHEM, V44, P668; Steel R.G., 1980, PRINCIPLES PROCEDURE; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8892	1745-4549		J FOOD PROCESS PRES	J. Food Process Preserv.	AUG	2015	39	4					394	403		10.1111/jfpp.12244		10	Food Science & Technology	Food Science & Technology	CN4ZR	WOS:000358439600008		
J	Masaka, K; Torita, H; Kon, H; Fukuchi, M				Masaka, Kazuhiko; Torita, Hiroyuki; Kon, Hirokazu; Fukuchi, Minoru			Seasonality of sprouting in the exotic tree Robinia pseudoacacia L. in Hokkaido, northern Japan	JOURNAL OF FOREST RESEARCH			English	Article						Clipping; Robinia pseudoacacia; Seasonality; Sprouting; Vegetation cover	BLACK-LOCUST; POPULUS-TREMULOIDES; BIOMASS PRODUCTION; TIME; REGENERATION; LITTER	Robinia pseudoacacia L., one of the major invasive tree species in Japan, has been used for coppice wood production worldwide. However, we have little knowledge of the species' sprouting characteristics. Here, we tested seasonality in R. pseudoacacia sprout development. We removed aboveground parts of R. pseudoacacia at different times throughout the year (spring, summer, autumn, and winter) and censused sprout demographics for three consecutive growing seasons thereafter. The most vigorous sprouting was observed among trees cut in winter, while sprouting was lowest among those cut in summer. Sprout abundance in the spring- and autumn-cut treatments was intermediate between that of winter- and summer-cut treatments. Both trunk diameter and season affected stump sprout biomass after three growing seasons, following the same seasonal pattern as above. We found a negative relationship between the herbaceous vegetation cover height and the biomass of root suckers. Both trunk removal in summer and consecutive sprout-clipping treatments contributed to the decline of living stumps. Our results show that R. pseudoacacia trees should be cut during the dormant season to facilitate coppicing and in the summer to facilitate control or removal. Conservation of herbaceous vegetation cover, together with consecutive sprout clipping, will aid the complete removal of this species.	[Masaka, Kazuhiko; Torita, Hiroyuki; Kon, Hirokazu; Fukuchi, Minoru] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan	Masaka, K (reprint author), Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan.	masaka-kazuhiko@hro.or.jp					Anderson D, 2001, B ECOL SOC AM, V82, P160; Landhausser SM, 2007, FORESTRY, V80, P481, DOI 10.1093/forestry/cpm035; Stenvall N, 2009, CAN J FOREST RES, V39, P1531, DOI 10.1139/X09-066; Von Holle B, 2006, BIODIVERS CONSERV, V15, P2197, DOI 10.1007/s10531-004-6906-8; Jung SC, 2009, J FOREST RES-JPN, V14, P101, DOI 10.1007/s10310-008-0109-1; BONGARTEN BC, 1992, FOREST ECOL MANAG, V55, P315, DOI 10.1016/0378-1127(92)90108-L; Benesperi R, 2012, BIODIVERS CONSERV, V21, P3555, DOI 10.1007/s10531-012-0380-5; JONES RH, 1986, AM J BOT, V73, P1723, DOI 10.2307/2444238; Beck DE, 1974, SE201 USDA FOR SERV, P1; Bohm C, 2011, ANN FOR RES, V54, P215; BORING LR, 1984, J ECOL, V72, P749, DOI 10.2307/2259529; Crawley MJ., 2005, STAT INTRO USING R; DeGomez T, 2001, HORTTECHNOLOGY, V11, P279; Gonzalez-Munoz N, 2014, BIOL INVASIONS, V16, P269, DOI 10.1007/s10530-013-0516-x; Groninger JW, 2006, NORTH J APPL FOR, V23, P94; HARRINGTON CA, 1984, CAN J FOREST RES, V14, P357; Huntley J. C., 1990, SILVICS N AM, P755; Iliev N, 2005, J KOREAN FOR SCI, V94, P21; Janzen D. H., 2000, Biodiversity, V1, P7; JOHANSSON T, 1992, FOREST ECOL MANAG, V53, P263, DOI 10.1016/0378-1127(92)90046-C; KAYS JS, 1991, FOREST SCI, V37, P524; Keresztesi B., 1980, Unasylva, V32, P23; Kramer P.J., 1979, PHYSL WOODY PLANTS; Kurokochi H, 2010, PLANT ECOL, V210, P31, DOI 10.1007/s11258-010-9735-8; Kurokochi H, 2012, JPN J FOREST ENV, V54, P101; Landhausser SM, 2006, SCAND J FOREST RES, V21, P299, DOI 10.1080/02827580600813313; Larcher W, 1994, OKOPHYSIOLOGIE PFLAN; Larsen JA, 1935, J-FOR, V33, P616; LAVERTU D, 1994, J VEG SCI, V5, P561, DOI 10.2307/3235983; Lee CS, 2004, FOREST ECOL MANAG, V189, P281, DOI 10.1016/j.foreco.2003.08.012; Maekawa M, 1997, LANDSCAPE URBAN PLAN, V37, P37, DOI 10.1016/S0169-2046(96)00368-4; Masaka K, 2013, FOR SCI, P59; Masaka K., 2013, Journal of the Japanese Forest Society, V95, P15, DOI 10.4005/jjfs.95.15; Matsui Z, 1951, REPORT SAPPORO BRANC, V69, P132; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Motta R, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009012; Ogawa M., 1996, Journal of the Japanese Forestry Society, V78, P195; R Development Core Team, 2013, R LANG ENV STAT COMP; Rédei K., 2011, Acta Silvatica & Lignaria Hungarica, V7, P125; Rédei K., 2011, SEEFOR, V2, P101; Sakio H., 2003, Journal of the Japanese Forestry Society, V85, P355; Shimizu H, 2014, MULTILEVEL MODELINGS; Tamura H, 2007, J JPN SOC REVEGET TE, V32, P432; Yamada K., 2007, Japanese Journal of Conservation Ecology, V12, P94; Yamada K., 2009, Journal of the Japanese Forest Society, V91, P42, DOI 10.4005/jjfs.91.42; Zuur A., 2009, MIXED EFFECTS MODELS	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	AUG	2015	20	4					386	395		10.1007/s10310-015-0488-z		10	Forestry	Forestry	CN1BB	WOS:000358149100003		
J	Akashi, N; Unno, A; Terazawa, K				Akashi, Nobuhiro; Unno, Akira; Terazawa, Kazuhiko			Significance of woody browse preferences in evaluating the impact of sika deer browsing on tree seedlings	JOURNAL OF FOREST RESEARCH			English	Article						Browse preference; Cervus nippon; Generalized linear model; Hokkaido	EASTERN HOKKAIDO; NORTHERN JAPAN; FORESTS; OVERABUNDANCE; POPULATION; DYNAMICS; DENSITY; INDEX	The growing populations of sika deer (Cervus nippon yesoensis) in Hokkaido, Japan, are having increasingly negative impacts on forests. Although the percentage or frequency of browsed twigs and seedlings is a useful index of the impact of deer on forests, differences in the browse preferences of deer among tree species should also be considered. We evaluated the woody browse preferences of sika deer and examined a method for evaluating deer impacts based on the occurrence of browsing scars on seedlings, together with browse preferences. We also validated the percentages of browsed seedlings irrespective of browse preferences as an index of deer impact. We measured the heights of seedlings 30-200 cm tall in five 5 x 20 m plots located in Abies sachalinensis plantations in each of seven tracts and recorded browsing damage that occurred on leader shoots of seedlings. Browse species preference was evaluated using a generalized linear model (GLM) that included the seven tracts, species, and seedling height as explanatory variables. The results of the GLM suggest that differences in browse preferences among species are continuous and cannot be categorized discretely. The tract coefficients are considered to be an index of deer impact levels and can be estimated from the percentage of browsed seedlings for a species if the species coefficient is given. Simple percentages of browsed seedlings can also be used as an index of impact level, regardless of browse preferences, though these may be inaccurate, especially when the site is dominated by significantly preferred or avoided species.	[Akashi, Nobuhiro; Unno, Akira; Terazawa, Kazuhiko] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan	Akashi, N (reprint author), Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan.	akashi-nobuhiro@hro.or.jp			JSPS KAKENHI [25450222]; Mitsui Co., Ltd.	This work was supported by JSPS KAKENHI Grant Number 25450222 and the Mitsui & Co., Ltd. Environment Fund for the project "Development of assessment method on impacts by sika deer to natural vegetation for ecosystem management".	Akashi N., 2013, Journal of the Japanese Forest Society, V95, P259; Akashi N., 2009, Journal of the Japanese Forest Society, V91, P178, DOI 10.4005/jjfs.91.178; Akashi N, 2011, J FOREST RES-JPN, V16, P500, DOI 10.1007/s10310-010-0245-2; Akashi N, 2009, ECOL RES, V24, P247, DOI 10.1007/s11284-008-0504-2; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; ANDERSON RC, 1994, ECOL APPL, V4, P104, DOI 10.2307/1942119; Forsyth DM, 2002, NEW ZEAL J ZOOL, V29, P323; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Boulanger V, 2009, FOREST ECOL MANAG, V258, P1397, DOI 10.1016/j.foreco.2009.06.055; Noguchi M, 2004, FOREST ECOL MANAG, V190, P335, DOI 10.1016/j.foreco.2003.10.024; Augustine DJ, 2003, ECOSCIENCE, V10, P472; Castleberry Steven B., 1999, Southern Journal of Applied Forestry, V23, P78; FRELICH LE, 1985, BIOL CONSERV, V34, P99, DOI 10.1016/0006-3207(85)90103-X; Fujiki D, 2010, J FOREST RES-JPN, V15, P140, DOI 10.1007/s10310-009-0172-2; Hothorn Torsten, 2013, MULTCOMP SIMULTANEOU; Igota H, 2004, ECOL RES, V19, P169, DOI 10.1111/j.1440-1703.2003.00621.x; Koda R, 2011, FOREST ECOL MANAG, V262, P432, DOI 10.1016/j.foreco.2011.04.009; Koh S, 2010, FOREST ECOL MANAG, V259, P1472, DOI 10.1016/j.foreco.2010.01.021; Kojima Y., 2006, Journal of the Japanese Forest Society, V88, P337, DOI 10.4005/jjfs.88.337; Morellet N, 2001, WILDLIFE SOC B, V29, P1243; Mosbacher E.V., 2009, Wildlife Biology in Practice, V5, P11; R Core Team, 2014, R LANG ENV STAT COMP; Reimoser Friedrich, 2011, P144; Sakabe Tomoko, 1998, Research Bulletin of the Hokkaido University Forests, V55, P113; Sakuragi M, 2003, WILDLIFE BIOL, V9, P141; Suzuki M., 2011, Journal of the Japanese Forest Society, V93, P213, DOI 10.4005/jjfs.93.213; Sweetapple PJ, 2004, WILDLIFE SOC B, V32, P137, DOI 10.2193/0091-7648(2004)32[137:SRASMF]2.0.CO;2; Takahashi Y, 1997, T MTG HOKKAIDO BR JA, V45, P84; Takayanagi A, 1991, REP KYOTO U FOR, V22, P13; Toyooka K, 1983, DISTRIBUTION MAP SAS; Umeki K, 1999, J VEG SCI, V10, P815, DOI 10.2307/3237306; Uno H, 2000, MAMM STUDY, V25, P45; Uno H, 2006, ECOL RES, V21, P624, DOI 10.1007/s11284-006-0158-x; Yamamura H, 2008, POPUL ECOL, V50, P131	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	AUG	2015	20	4					396	402		10.1007/s10310-015-0492-3		7	Forestry	Forestry	CN1BB	WOS:000358149100004		
J	Tahara, K; Kojima, K; Shinohara, K				Tahara, Ko; Kojima, Katsumi; Shinohara, Kenji			Gel-filtration analysis to detect Al-binding ligands in Eucalyptus camaldulensis	JOURNAL OF FOREST RESEARCH			English	Article						Aluminum resistance; Citrate; Eucalyptus camaldulensis; Gel-filtration chromatography	ALUMINUM-RESISTANCE; ACID SOILS; AQUEOUS-SOLUTION; ROOT-TIPS; TOLERANCE; PLANTS; MECHANISMS; TOXICITY; IDENTIFICATION; EQUILIBRIUM	Aluminum (Al) toxicity is a major factor limiting plant growth on acid soils; inhibited root elongation is a characteristic symptom. To elucidate mechanisms of Al resistance in plants, we developed a simple method to separate Al-binding ligands from plant roots by gel-filtration chromatography. In this method, an eluent consisting of Homopipes buffer flows through a Sephadex G-25 column. Free Al ions do not pass through the column, but Al-ligand complexes can be fractionated according to differences in their molecular sizes. We applied the method to Eucalyptus camaldulensis (Myrtaceae) and successfully separated Al-binding ligands from roots. One peak of Al-ligand complex increased with Al treatment of seedlings, which can be explained by Al-induced accumulation of citrate in roots.	[Tahara, Ko; Shinohara, Kenji] Forestry & Forest Prod Res Inst, Dept Mol & Cell Biol, Tsukuba, Ibaraki 3058687, Japan; [Kojima, Katsumi] Univ Tokyo, Asian Nat Environm Sci Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Shinohara, Kenji] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Tahara, K (reprint author), Forestry & Forest Prod Res Inst, Dept Mol & Cell Biol, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	taharako@affrc.go.jp	Tahara, Ko/B-4761-2008	Tahara, Ko/0000-0002-9219-7191	Japan Society for the Promotion of Science [19880034]; Gender Equality Office of the Forestry and Forest Products Research Institute	We thank Dr. Hiroki Osawa of The University of Tokyo, Japan, for providing the high-performance liquid chromatography facilities, and Drs. Shuichiro Yoshinaga and Yuko Ito of the Forestry and Forest Products Research Institute, Japan, for providing the inductively coupled plasma-optical emission spectrometer facilities. This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant no. 19880034), and by the Research Support Program of the Gender Equality Office of the Forestry and Forest Products Research Institute.	Tahara K, 2005, J FOR RES-JPN, V10, P325, DOI 10.1007/s10310-005-0153-z; Delhaize E, 2012, TRENDS PLANT SCI, V17, P341, DOI 10.1016/j.tplants.2012.02.008; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Wenzl P, 2001, PLANT PHYSIOL, V125, P1473, DOI 10.1104/pp.125.3.1473; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.arplant.46.1.237; Tahara K, 2008, PLANT SOIL, V302, P175, DOI 10.1007/s11104-007-9464-5; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1; Brunner I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00172; Ikka T, 2013, PHYTOCHEMISTRY, V94, P142, DOI 10.1016/j.phytochem.2013.06.016; Kinraide TB, 2001, PLANT SOIL, V235, P75, DOI 10.1023/A:1011941729727; OHMAN LO, 1988, INORG CHEM, V27, P2565; Osawa H, 2011, PLANT PHYSIOL, V155, P433, DOI 10.1104/pp.110.166967; SJOBERG S, 1985, J CHEM SOC DALTON, P2665, DOI 10.1039/dt9850002665; Tahara K, 2005, SOIL SCI PLANT NUTR, V51, P397, DOI 10.1111/j.1747-0765.2005.tb00045.x; Tahara K, 2014, PLANT PHYSIOL, V164, P683, DOI 10.1104/pp.113.222885	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	AUG	2015	20	4					411	414		10.1007/s10310-015-0487-0		4	Forestry	Forestry	CN1BB	WOS:000358149100006		
J	Tamaki, I; Nomura, K; Nomura, R; Tate, C; Ogiso, M; Miyakami, Y; Yabe, Y				Tamaki, Ichiro; Nomura, Katsushige; Nomura, Reiko; Tate, Chieko; Ogiso, Mika; Miyakami, Yoshihiro; Yabe, Yumiko			Seedling survival and growth during the 2 years following seed germination of Magnolia stellata, a threatened subcanopy tree, after clearcutting	JOURNAL OF FOREST RESEARCH			English	Article						Frost heave; Magnoliaceae; Satoyama; Soil moisture	EMERGENCE	The two-year survival and growth of seedlings of Magnolia stellata were monitored at a site following clearcutting. The mortality rate during the growing season of the first year was 3.4 %, much lower than reported in previous studies, possibly because of the high light levels due to clearcutting. In contrast, the mortality rate during the winter season of the first year was 7.7 %, and 10 of 13 individuals were killed by uprooting due to frost heave in wet locations. Individuals that grew in wet sites and germinated early exhibited good height growth in the first year. However, in the second year, no effects of the moisture conditions or germination timing on the relative growth rate were detected, although there was a correlation between initial height and height growth. This result suggests that the soil moisture conditions and the length of the growing period have strong effects during the early period of life but gradually reduce in influence as the plants grow. We found that soil moisture conditions had positive and negative effects on seedling growth and survival in the growing and winter seasons, respectively, of the first year, but not in the second year. This suggests that effects of the particular environment can vary greatly depending on life stage.	[Tamaki, Ichiro] Gifu Acad Forest Sci & Culture, Gifu 5013714, Japan; [Nomura, Katsushige; Nomura, Reiko] Assoc Green Nat, Tajimi, Gifu 5070072, Japan; [Tate, Chieko] Assoc Conservat Shidekobushi & Nat, Gifu 5095122, Japan; [Ogiso, Mika] Tajimi City Govt, Forestry & Pk Sect, Tajimi, Gifu 5078703, Japan; [Miyakami, Yoshihiro] Tajimi City Govt, Environm Sect, Tajimi, Gifu 5078703, Japan; [Yabe, Yumiko] Tajimi City Cultural Properties Preservat Ctr, Tajimi, Gifu 5070071, Japan	Tamaki, I (reprint author), Gifu Acad Forest Sci & Culture, 88 Sodai, Gifu 5013714, Japan.	garageit@gmail.com					Seiwa K, 2000, OECOLOGIA, V123, P208, DOI 10.1007/s004420051007; Asai N, 1997, STUD INFORM SCI, V5, P101; Goulet France, 1995, New Forests, V9, P67, DOI 10.1007/BF00028927; Hiroki S, 1995, STUD INFOR SCI, V1, P1; Japan Association for Shidekobushi Conservation, 1996, WILD STAND SHID STAR; Kisanuki H, 2008, J FOREST RES-JPN, V13, P143, DOI 10.1007/s10310-008-0066-8; R Core Team, 2014, R LANG ENV STAT COMP; Setsuko S, 2008, CHUBU FOR RES, V56, P5; Tabata H, 2001, FOREST CIVILISATIONS, P155; Tamaki I., 2014, Journal of the Japanese Forest Society, V96, P193, DOI 10.4005/jjfs.96.193	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	AUG	2015	20	4					415	419		10.1007/s10310-015-0490-5		5	Forestry	Forestry	CN1BB	WOS:000358149100007		
J	Suzuki, S; Uehara, T; Ohira, Y; Ikusaka, M				Suzuki, Shingo; Uehara, Takanori; Ohira, Yoshiyuki; Ikusaka, Masatomi			Narcolepsy with Cataplexy in an Elderly Woman	JOURNAL OF GENERAL INTERNAL MEDICINE			English	Article						cataplexy; narcolepsy; orexin/hypocretin; video; elderly		A 72-year-old woman was referred for a 15-year history of brief attacks of generalized weakness that occurred when she was tense or startled. During these episodes, she squatted, closed her eyes, and had difficulty speaking, but there was no disturbance of consciousness. The cerebrospinal fluid level of orexin/hypocretin was low (92 ng/L), leading to a diagnosis of narcolepsy with cataplexy according to the International Classification of Sleep Disorders (ICSD)-2 criteria. Cataplexy should be considered for sudden attacks of weakness lasting less than 2 minutes and with no alteration of consciousness. Measurement of cerebrospinal fluid levels of orexin/hypocretin is recommended when the diagnosis is uncertain.	[Suzuki, Shingo; Uehara, Takanori; Ohira, Yoshiyuki; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba, Chiba 2608677, Japan	Suzuki, S (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	shngszkthk@yahoo.co.jp					Akintomide GS, 2011, NEUROPSYCH DIS TREAT, V7, P507, DOI 10.2147/NDT.S23624; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Overeem S, 2011, SLEEP MED, V12, P12, DOI 10.1016/j.sleep.2010.05.010; Nevsimalova S, 2013, J NEUROL, V260, P767, DOI 10.1007/s00415-012-6702-4; Mignot E, 2006, BRAIN, V129, P1609, DOI 10.1093/brain/wal079; Nishino S, 2010, ACTA PHYSIOL, V198, P209, DOI 10.1111/j.1748-1716.2009.02012.x; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Dauvilliers Y, 2004, NEUROLOGY, V62, P46; Kumar Swarup, 2014, J Clin Diagn Res, V8, P190, DOI 10.7860/JCDR/2014/7295.4057; Pandi-Perumal Seithikurippu R, 2013, Front Neurol, V4, P152, DOI 10.3389/fneur.2013.00152; Strambi LF, 2013, LANCET NEUROL, V12, P1039, DOI [10.1016/S1474-4422(13)70178-9, 10.1016/S1474-4422(13)70178-3]	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0884-8734	1525-1497		J GEN INTERN MED	J. Gen. Intern. Med.	AUG	2015	30	8					1222	1224		10.1007/s11606-015-3277-7		3	Health Care Sciences & Services; Medicine, General & Internal	Health Care Sciences & Services; General & Internal Medicine	CN3WR	WOS:000358359400039		
J	Huang, Y; Cheng, HL; Osada, T; Hosoya, A; Zhang, F				Huang, Y.; Cheng, H. L.; Osada, T.; Hosoya, A.; Zhang, F.			Mechanical Behavior of Clean Sand at Low Confining Pressure: Verification with Element and Model Tests	JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING			English	Article						Clean sand; Low confining pressure; Microgravity; Cyclic loading tests; Monotonic loading tests; Model tests	SHEAR-STRENGTH; ENVIRONMENT; DILATANCY; SOILS	Confining pressure significantly influences the mechanical behavior of soil. Understanding geotechnical problems related to low confining pressures requires precise modeling of soil behavior at low confining stress. Yet laboratory tests, including element tests under low confining pressure, are so far quite limited. In this note, a series of element tests under low confining pressure (5-20 kPa) were carried out to investigate the effect of low confining pressure on the mechanical behavior of loose and medium dense Toyoura sand. Element tests include undrained cyclic loading tests, as well as drained and undrained strain-controlled monotonic loading tests. The results show that loose sand under low confining pressure behaves much like dense sand under higher pressure. Model tests of slope failure flow under microgravity, carried out to supplement the element test results, also confirmed the previously mentioned mechanical behavior. The results obtained in this paper provide a more fundamental understanding of geotechnical problems related to low confining stress. (C) 2015 American Society of Civil Engineers.	[Huang, Y.; Cheng, H. L.] Tongji Univ, Coll Civil Engn, Dept Geotech Engn, Shanghai 200092, Peoples R China; [Osada, T.; Hosoya, A.; Zhang, F.] Nagoya Inst Technol, Dept Civil Engn, Nagoya, Aichi 4668555, Japan	Huang, Y (reprint author), Tongji Univ, Coll Civil Engn, Dept Geotech Engn, Shanghai 200092, Peoples R China.	yhuang@tongji.edu.cn; 89hualin@tongji.edu.cn; 24418512@stn.nitech.ac.jp; 22117055@stn.nitech.ac.jp; cho.ho@nitech.ac.jp	Huang, Yu/K-8849-2012	Huang, Yu/0000-0002-9935-7717	National Natural Science Foundation of China [41372355, 41072202]; Program for New Century Excellent Talents in University [NCET-11-0382]	The research reported in this paper was supported by the National Natural Science Foundation of China (Grant Nos. 41372355 and 41072202) and the Program for New Century Excellent Talents in University (Grant No. NCET-11-0382).	Alshibli KA, 2003, J GEOTECH GEOENVIRON, V129, P483, DOI 10.1061/(ASCE)1090-0241(2003)129:6(483); Fannin RJ, 2005, GEOTECHNIQUE, V55, P467, DOI 10.1680/geot.2005.55.6.467; BALDI G, 1984, J GEOTECH ENG-ASCE, V110, P403; Chakraborty T, 2010, J GEOTECH GEOENVIRON, V136, P527, DOI 10.1061/(ASCE)GT.1943-5606.0000237; Fukushima S., 1984, SOILS FOUND, V24, P30, DOI DOI 10.3208/SANDF1972.24.4_; Ghazavi M., 2008, P 12 INT C INT ASS C, P1272; HARDIN BO, 1989, J GEOTECH ENG-ASCE, V115, P769; Huang Y, 2013, LANDSLIDES, V10, P493, DOI 10.1007/s10346-013-0403-7; Jin YJ, 2010, SOILS FOUND, V50, P177, DOI 10.3208/sandf.50.177; Kobayashi T, 2009, SOILS FOUND, V49, P115, DOI 10.3208/sandf.49.115; KOLYMBAS D, 1990, POWDER TECHNOL, V60, P99, DOI 10.1016/0032-5910(90)80136-M; Lancelot L, 2006, J ENG MECH-ASCE, V132, P1396, DOI 10.1061/(ASCE)0733-9399(2006)132:12(1396); Ponce V.M., 1971, J SOIL MECH FDN DIV, V8, P625; Sture S., 2005, P GEOM TEST MOD SIM, P187; Sture S., 2004, P 9 BIENN C ENG CONS, P78; Tatsuoka F., 1986, SOILS FOUND, V26, P65; Verdugo R, 1996, SOILS FOUND, V36, P81, DOI DOI 10.3208/SANDF.36.2_81; Vrettos C, 2012, J GEOTECH GEOENVIRON, V138, P508, DOI 10.1061/(ASCE)GT.1943-5606.0000619; Yang S., 2003, J OCEAN U QINGDAO, V2, P207	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0241	1943-5606		J GEOTECH GEOENVIRON	J. Geotech. Geoenviron. Eng.	AUG	2015	141	8							06015005	10.1061/(ASCE)GT.1943-5606.0001330		6	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CN1JF	WOS:000358174800009		
J	Ke, L; Takahashi, A				Ke, Lin; Takahashi, Akihiro			Drained Monotonic Responses of Suffusional Cohesionless Soils	JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING			English	Article							INTERNAL EROSION; BEHAVIOR; MINIMUM; MAXIMUM; SANDS; STATE	Mechanical consequences of suffusion on the noncohesive soils with various initial fine contents under different initial effective confining pressures are presented in this paper. By using the modified triaxial permeameter, seepage tests and successive drained monotonic compression tests are performed. It is found that soil-drained strength decreases after suffusion and a temporary drop in stiffness at the initial stage of shearing with respect to the axial strain ranging from 0 to 1% is observed. The tests suggest that suffusion might create a distinct packing of soil grains, which might result from possible accumulation of fine grains at the spots where the constriction size-representing the size of pore channels in a soil-is smaller than that of fines. Those surviving fines after suffusion may function as reinforcement or jamming at the subsequent compression, resulting in a larger initial stiffness of the suffusional soils. (C) 2015 American Society of Civil Engineers.	[Ke, Lin; Takahashi, Akihiro] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan	Takahashi, A (reprint author), Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	tsingtaolin@gmail.com; takihiro@cv.titech.ac.jp	Takahashi, Akihiro/B-9306-2015	Takahashi, Akihiro/0000-0003-1206-5066	Japanese Government (Monbukagakusho: MEXT); JSPS KAKENHI [25420498]	The first author acknowledges the scholarship support of the Japanese Government (Monbukagakusho: MEXT) for performing this research. This work was supported by JSPS KAKENHI Grant No. 25420498.	Hicher PY, 2013, GEOTECHNIQUE, V63, P118, DOI 10.1680/geot.11.P.020; Wood DM, 2010, GEOTECHNIQUE, V60, P447, DOI 10.1680/geot.2010.60.6.447; Lade PV, 1998, GEOTECH TEST J, V21, P336; Ke L, 2012, SOILS FOUND, V52, P698, DOI 10.1016/j/sandf.2012.07.010; Jiang MJ, 2003, COMPUT GEOTECH, V30, P579, DOI [10.1016/S0266-352X(03)00064-8, 10.1016/S0266-325X(03)00064-8]; Thevanayagam S, 2000, GEOTECHNIQUE, V50, P1; Chang DS, 2011, GEOTECH TEST J, V34, P579; SKEMPTON AW, 1994, GEOTECHNIQUE, V44, P449; ASTM, 2012, D476711 ASTM; ASTM, 2012, D718111 ASTM; ASTM, 2012, D248711 ASTM; Chang C. S., 2012, NSF CMMI ENG RES INN; Cubrinovski M, 2002, SOILS FOUND, V42, P65; Ferreira PMV, 2006, GEOTECHNIQUE, V56, P445, DOI 10.1680/geot.56.7.445; Ke L, 2014, GEOTECH TEST J, V37, DOI 10.1520/GTJ20130049; Kezdi A., 1979, SOIL PHYS SELECTED T; Sugita H., 2008, DAMAGE INVESTIGATION; Thevanayagam S, 2007, EARTHQ ENG ENG VIB, V6, P123, DOI 10.1007/s11803-007-0705-7; Xiao M., 2012, GEOTECH TEST J, V35, P1	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0241	1943-5606		J GEOTECH GEOENVIRON	J. Geotech. Geoenviron. Eng.	AUG	2015	141	8							04015033	10.1061/(ASCE)GT.1943-5606.0001327		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CN1JF	WOS:000358174800006		
J	Wang, YJ; Shi, RZ; Shi, JM				Wang, Yanjun; Shi, Ruizhi; Shi, Jianming			Duality and robust duality for special nonconvex homogeneous quadratic programming under certainty and uncertainty environment	JOURNAL OF GLOBAL OPTIMIZATION			English	Article						Duality and robust duality; Uncertain environment; Homogenous quadratic programming; Semidefinite programming	OPTIMIZATION; RELAXATION; RANK	In this paper, we discuss a kind of special nonconvex homogenous quadratic programming (HQP) and the methods to solve the HQP in an environment with certainty or uncertainty. In an environment with certainty, we first establish a strong duality between the HQP and its Lagrange dual problem, with the help of the fact that the Lagrange dual problem is equivalent to a convex semidefinite programming (SDP). Then we obtain a global solution to the HQP by solving the convex SDP. Furthermore, in an environment with uncertainty, we formulate the robust counterpart of the HQP to cope with uncertainty. We also establish the robust strong duality between the robust counterpart and its optimistic counterpart under a mild assumption. Since the counterpart is equivalent to a convex SDP under the same assumption, we can obtain a global solution to the robust counterpart by solving the convex SDP under the same assumption.	[Wang, Yanjun] Shanghai Univ Finance & Econ, Sch Math, Shanghai 200433, Peoples R China; [Shi, Ruizhi] Univ Minnesota, Dept Ind & Syst Engn, Minneapolis, MN USA; [Shi, Jianming] Tokyo Univ Sci, Sch Management, Tokyo 162, Japan	Wang, YJ (reprint author), Shanghai Univ Finance & Econ, Sch Math, Shanghai 200433, Peoples R China.	wangyj@mail.shufe.edu.cn			NSFC [11271243]; Innovation Program of Shanghai Municipal Education Commission [12ZZ071]; Shanghai Pujiang Program [11PJC059]; Muroran Institute of Technology (MuIT), Japan	This research was partially supported by NSFC 11271243, Innovation Program of Shanghai Municipal Education Commission (12ZZ071), Shanghai Pujiang Program (11PJC059) and Muroran Institute of Technology (MuIT), Japan.	Luo ZQ, 2010, IEEE SIGNAL PROC MAG, V27, P20, DOI 10.1109/MSP.2010.936019; Jeyakumar V, 2012, NONLINEAR ANAL-THEOR, V75, P1362, DOI 10.1016/j.na.2011.04.006; BARVINOK AI, 1995, DISCRETE COMPUT GEOM, V13, P189, DOI 10.1007/BF02574037; Pataki G, 1998, MATH OPER RES, V23, P339, DOI 10.1287/moor.23.2.339; SHAPIRO A, 1982, PSYCHOMETRIKA, V47, P187, DOI 10.1007/BF02296274; Beck A, 2009, OPER RES LETT, V37, P1, DOI 10.1016/j.orl.2008.09.010; Mutapcic A, 2007, CONFERENCE RECORD OF THE FORTY-FIRST ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS & COMPUTERS, VOLS 1-5, P1224; Song EB, 2011, INT CONF ACOUST SPEE, P3096; Jeyakumar V, 2010, SIAM J OPTIMIZ, V20, P3384, DOI 10.1137/100791841; Wiesel A, 2006, IEEE T SIGNAL PROCES, V54, P161, DOI 10.1109/TSP.2005.861073; Bengtsson M., 2001, HDB ANTENNAS WIRELES; Birge JR, 2011, SPRINGER SER OPER RE, P3, DOI 10.1007/978-1-4614-0237-4; Boyd S, 2004, CONVEX OPTIMIZATION; Boyd S.P., 1994, LINEAR MATRIX INEQUA; Goldsmith A., 2003, IEEE J SEL AREA COMM, V21, P1437; Huang Y., 2009, IEEE T SIGNAL PROCES, V58, P664; Jeyakumar V, 2011, J OPTIMIZ THEORY APP, V151, P292, DOI 10.1007/s10957-011-9896-1; Luo Z.Q., 2010, CONVEX OPTIMIZATION; Meyer C. D., 2001, MATRIX ANAL APPL LIN	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-5001	1573-2916		J GLOBAL OPTIM	J. Glob. Optim.	AUG	2015	62	4			SI		643	659		10.1007/s10898-015-0281-8		17	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	CN0VD	WOS:000358131100003		
J	Ikeda, T; Atobe, T; Fujimoto, D; Inasawa, A; Asai, M				Ikeda, Tomoaki; Atobe, Takashi; Fujimoto, Daisuke; Inasawa, Ayumu; Asai, Masahito			Self-Noise Effects on Aerodynamics of Cambered Airfoils at Low Reynolds Number	JOURNAL OF GUIDANCE CONTROL AND DYNAMICS			English	Article							TRAILING-EDGE NOISE; FREQUENCY SELECTION; FLOW; INSTABILITY; WAKE; GENERATION; SIMULATION; AEROFOIL; BODY	Aerodynamics of cambered airfoils are investigated numerically, using aNACA four-digit series of 6% thickness at low Reynolds number Re = 10; 000 and moderate Mach number M = 0.2, by focusing on the relation of aeroacoustic effects and hydrodynamic flow unsteadiness. Two-dimensional numerical simulations show that the onset of an acoustic feedback loop leads to an abrupt increase in lift force. Associated with the feedback process, the evolution of two-dimensional vortices in the suction-side boundary layer shifts a separation bubble toward the leading edge, which causes a relatively steep pressure recovery near the trailing edge. Through a parametric study on airfoil shape, the aerodynamically favorable feature of aft camber is further enhanced with the presence of an acoustic feedback loop. In addition, the aft camber airfoil successfully forms a laminar separation bubble in three-dimensional calculations at the present Reynolds number, developing transitional behavior on the suction side, supposedly prompted by the airfoil tones. Although the boundary layer shows three-dimensional complexity, still the formation of an acoustic feedback loop is strongly suggested, via the comparison of spanwise correlations.	[Ikeda, Tomoaki; Atobe, Takashi] Japan Aerosp Explorat Agcy, Aerodynam Res Group, Tokyo 1828522, Japan; [Fujimoto, Daisuke; Inasawa, Ayumu; Asai, Masahito] Tokyo Metropolitan Univ, Dept Aerosp Engn, Tokyo 1910065, Japan	Ikeda, T (reprint author), Japan Aerosp Explorat Agcy, Aerodynam Res Group, Tokyo 1828522, Japan.				Japan Society for the Promotion of Science [5420139]	This work was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant 5420139). Computational resources were provided by the Japan Aerospace Exploration Agency Supercomputer System.	Adams NA, 1998, THEOR COMP FLUID DYN, V12, P109, DOI 10.1007/s001620050102; Nash EC, 1999, J FLUID MECH, V382, P27, DOI 10.1017/S002211209800367X; Jones LE, 2010, J FLUID MECH, V648, P257, DOI 10.1017/S0022112009993089; LISSAMAN PBS, 1983, ANNU REV FLUID MECH, V15, P223, DOI 10.1146/annurev.fl.15.010183.001255; Pier B, 1998, PHYS FLUIDS, V10, P2433, DOI 10.1063/1.869784; Inasawa A, 2013, AIAA J, V51, P1695, DOI 10.2514/1.J052203; Ikeda T, 2009, AIAA J, V47, P2658, DOI 10.2514/1.42110; Sunada S, 2002, J AIRCRAFT, V39, P331, DOI 10.2514/2.2931; McAlpine A, 1999, J SOUND VIB, V222, P753, DOI 10.1006/jsvi.1998.2085; Chomaz JM, 2005, ANNU REV FLUID MECH, V37, P357, DOI 10.1146/annurev.fluid.37.061903.175810; Desquesnes G, 2007, J FLUID MECH, V591, P155, DOI 10.1017/S0022112007007896; Pier B, 2002, J FLUID MECH, V458, P407, DOI 10.1017/S0022112002008054; Pier B, 2001, J FLUID MECH, V435, P145; ROBERTS WB, 1980, AIAA J, V18, P25, DOI 10.2514/3.50726; Okamoto M, 1996, J EXP BIOL, V199, P281; Lian YS, 2007, AIAA J, V45, P1501, DOI 10.2514/1.25812; MONKEWITZ PA, 1988, PHYS FLUIDS, V31, P999, DOI 10.1063/1.866720; ARBEY H, 1983, J FLUID MECH, V134, P33, DOI 10.1017/S0022112083003201; Anyoji M., 2011, 20110852 AIAA; Asai M, 2011, J FLUID MECH, V675, P574, DOI 10.1017/jfm.2011.37; Atobe T., 2012, 20120700 AIAA; Ikeda T, 2012, J SOUND VIB, V331, P556, DOI 10.1016/j.jsv.2011.09.019; Itoh N, 2012, T JPN SOC AERONAUT S, V55, P356; Jones LE, 2011, J SOUND VIB, V330, P6137, DOI 10.1016/j.jsv.2011.07.009; Kojima R, 2013, J AIRCRAFT, V50, P187, DOI 10.2514/1.C031849; Kunz P. J, 2003, THESIS STANFORD U ST; Liebeck R. H, 1992, 19922735 AIAA; LONGHOUSE RE, 1977, J SOUND VIB, V53, P25, DOI 10.1016/0022-460X(77)90092-X; MAUGHMER MD, 1989, J AIRCRAFT, V26, P148, DOI 10.2514/3.45736; Paterson R. W., 1973, J AIRCRAFT, V10, P296, DOI DOI 10.2514/3.60229; Shyy W., 2008, AERODYNAMICS LOW REY, p[29, 45, 144]	31	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0731-5090	1533-3884		J GUID CONTROL DYNAM	J. Guid. Control Dyn.	AUG	2015	53	8					2256	2269		10.2514/1.J053664		14	Engineering, Aerospace; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CN1DT	WOS:000358157900015		
J	Chen, FS; Yamada, T; Sato, M; Aoyama, A; Takahagi, A; Menju, T; Sato, T; Sonobe, M; Omasa, M; Date, H				Chen, Fengshi; Yamada, Tetsu; Sato, Masaaki; Aoyama, Akihiro; Takahagi, Akihiro; Menju, Toshi; Sato, Toshihiko; Sonobe, Makoto; Omasa, Mitsugu; Date, Hiroshi			Postoperative pulmonary function and complications in living-donor lobectomy	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article						computed tomography; donor; living-donor lobar lung transplantation; lobectomy; preoperative evaluation	LOBAR-LUNG TRANSPLANTATION; PERIOPERATIVE COMPLICATIONS; OUTCOMES	BACKGROUND: Successful living-donor lobar lung transplantation largely depends on the donor's outcome. Because surgical skills and pen-operative management have evolved over time, this study evaluated the recent outcomes of donor lobectomies. METHODS: Between 2008 and 2014, 48 consecutive living-donor lobar lung transplantations with 85 donor lobectomies were performed at Kyoto University. All donors were prospectively followed up regularly until 1 year after surgery. RESULTS: Right and left lower lobectomies were performed in 49 and 36 donors, respectively. Pulmonary arterial branches were sacrificed at equal frequency in both lobectomies, whereas pulmonary arterioplasty was only performed in left lower lobectomy (n = 9). All donors were discharged after the lobectomies, and none died during follow-up. Post-operative complications occurred in 24 donors (28%) overall, without a significant difference between donor sides. Intraoperative complications were found in 2 donors. Early and late post-operative complications were noted in 17 and 6 donors, respectively. Pneumothorax, pleuritis, and pleural effusion were the most frequent. Post-operative pulmonary function sequentially recovered more than expected and was not significantly affected by the sacrifice of pulmonary arterial branches during lobectomy. By contrast, pulmonary function at 1 year after donor lobectomy in the donors who had pen-operative complications was significantly lower than that in the donors who did not, although even postoperative pulmonary function in the donors with pen-operative complications still recovered more than expected. CONCLUSIONS: Living-donor lobectomies have been safely performed in recent decades with low morbidities and without mortality. (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.	[Chen, Fengshi; Yamada, Tetsu; Sato, Masaaki; Aoyama, Akihiro; Takahagi, Akihiro; Menju, Toshi; Sato, Toshihiko; Sonobe, Makoto; Omasa, Mitsugu; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Kyoto 6068507, Japan	Date, H (reprint author), Kyoto Univ, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp					Date H, 2003, J THORAC CARDIOV SUR, V126, P476, DOI 10.1016/S0022-5223(03)00235-6; Bowdish ME, 2004, AM J TRANSPLANT, V4, P1283, DOI 10.1111/j.1600-6143.2004.00514.x; Chen FS, 2012, TRANSPL INT, V25, P732, DOI 10.1111/j.1432-2277.2012.01444.x; Barr ML, 2006, TRANSPLANTATION, V81, P1373, DOI 10.1097/01.tp.0000216825.56841.cd; Battafarano RJ, 2000, J THORAC CARDIOV SUR, V120, P909, DOI 10.1067/mtc.2000.110685; Camargo Spencer Marcantônio, 2008, J Bras Pneumol, V34, P256, DOI 10.1590/S1806-37132008000500003; Chen F, 2013, AM J TRANSPLANT, V13, P3003, DOI 10.1111/ajt.12476; Chen FS, 2012, EUR J CARDIO-THORAC, V42, pE138, DOI 10.1093/ejcts/ezs460; Chen FS, 2011, J HEART LUNG TRANSPL, V30, P572, DOI 10.1016/j.healun.2010.11.019; Chen FS, 2012, TRANSPL INT, V25, P153, DOI 10.1111/j.1432-2277.2011.01401.x; Date H, 2011, CURR OPIN ORGAN TRAN, V16, P453, DOI 10.1097/MOT.0b013e32834a9997; Date H, 2004, J HEART LUNG TRANSPL, V23, P547, DOI 10.1016/j.healun.2003.07.005; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Kubo Hiroshi, 2011, Gen Thorac Cardiovasc Surg, V59, P231, DOI 10.1007/s11748-010-0757-x; Mizobuchi T, 2013, J THORAC CARDIOV SUR, V146, P1253, DOI 10.1016/j.jtcvs.2013.05.038; Prager LM, 2006, J HEART LUNG TRANSPL, V25, P1206, DOI 10.1016/j.healun.2006.06.014; Starnes VA, 1996, J THORAC CARDIOV SUR, V112, P1284, DOI 10.1016/S0022-5223(96)70142-3; Toyazaki Toshiya, 2011, Gen Thorac Cardiovasc Surg, V59, P440, DOI 10.1007/s11748-010-0683-y; Yusen RD, 2014, AM J TRANSPLANT, V14, P1846, DOI 10.1111/ajt.12771	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	AUG	2015	34	8					1089	1094		10.1016/j.healun.2015.03.016		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CN1MH	WOS:000358183600012		
J	Ito, T				Ito, Tetsuhide			Highlights of topic "Pancreatic neuroendocrine tumors update"	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Editorial Material									Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan	Ito, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	itopapa@intmed3.med.kyushu-u.ac.jp					Dois R., 2015, J HEPATOBILIARY PANC, V22, P610; Imamura M, 2015, J HEPATO-BIL-PAN SCI, V22, P602, DOI 10.1002/jhbp.209; Kasajima A, 2015, J HEPATO-BIL-PAN SCI, V22, P586, DOI 10.1002/jhbp.208	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					573	573		10.1002/jhbp.237		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600003		
J	Ito, T; Lee, L; Hijioka, M; Kawabe, K; Kato, M; Nakamura, K; Ueda, K; Ohtsuka, T; Igarashi, H				Ito, Tetsuhide; Lee, Lingaku; Hijioka, Masayuki; Kawabe, Ken; Kato, Masaki; Nakamura, Kazuhiko; Ueda, Keijiro; Ohtsuka, Takao; Igarashi, Hisato			The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Epidemiology; Nationwide survey; Pancreatic neuroendocrine tumors	STRATEGY	Pancreatic neuroendocrine tumors (PNETs) were considered an extremely rare disease. However, in recent years, the number of patients with PNET has increased rapidly. According to an epidemiological survey conducted in Japan, the number of treated patients with PNETs in 2010 was approximately 1.2-times that in 2005, and the number of new incidences of non-functional PNETs in 2010 was approximately 1.7-times that in 2005. Among functional PNETs, insulinoma was most prevalent, followed by gastrinoma. To diagnose PNETs, correct histological diagnosis is most important. According to the World Health Organization 2010 classification criteria, neuroendocrine tumors (NETs) are categorized into well-differentiated NETs and poorly differentiated neuroendocrine carcinomas (NECs). NECs accounted for 7.6% of all NETs, and functional and non-functional PNETs accounted for 2.1% and 10.1%, respectively. Patients with distant metastasis accounted for 19.9%, and those with multiple endocrine neoplasia type 1 accounted for 4.3%. When treating PNETs, it is necessary to correctly evaluate the functionality and progression of tumors, the presence or absence of metastasis, and the degrees of differentiation and malignant potential of tumors. A new registration system from the Japan Neuroendocrine Tumor Society will start to be used in 2015, which will help further dissemination of Japanese epidemiological information to the world.	[Ito, Tetsuhide; Lee, Lingaku; Hijioka, Masayuki; Kawabe, Ken; Kato, Masaki; Nakamura, Kazuhiko; Ueda, Keijiro; Igarashi, Hisato] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ohtsuka, Takao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan	Ito, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	itopapa@intmed3.med.kyushu-u.ac.jp					Niina Y, 2012, GUT LIVER, V6, P287, DOI 10.5009/gnl.2012.6.3.287; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Bosmans FT, 2010, WHO WHO CLASSIFICATI; Igarashi H, 2014, J GASTROENTEROL, V49, P511, DOI 10.1007/s00535-013-0794-1; Imamura M, 2010, WORLD J GASTROENTERO, V16, P4519, DOI 10.3748/wjg.v16.i36.4519; Itos T, 2010, J GASTROENTEROL, V45, P234; Itos T, 2007, J GASTROENTEROL, V42, P497; Itos T., 2012, BEST PRACT RES CLIN, V26, P737; Itos T, 2015, J GASTROENTEROL, V50, P58; Itos T, 2012, JPN J CLIN ONCOL, V42, P903; Itos T, 2012, J GASTROENTEROL, V47, P941; Itos T, 2013, MEDICINE, V92, P135; Itos T, 2013, INVEST NEW DRUGS, V31, P1265; Raymond E, 2011, NEW ENGL J MED, V364, P1082; Tsutsumi K, 2012, J GASTROENTEROL, V47, P678, DOI 10.1007/s00535-012-0540-0; Yaos JC, 2011, NEW ENGL J MED, V364, P514	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					574	577		10.1002/jhbp.225		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600004		
J	Kasajima, A; Yazdani, S; Sasano, H				Kasajima, Atsuko; Yazdani, Samaneh; Sasano, Hironobu			Pathology diagnosis of pancreatic neuroendocrine tumors	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Histopathology; Immunohistochemistry; Pancreatic neuroendocrine tumor	HIPPEL-LINDAU-DISEASE; KI67 PROLIFERATIVE INDEX; TRANSCRIPTION FACTOR-I; ACINAR-CELL CARCINOMA; ENDOCRINE NEOPLASMS; CHROMOGRANIN-A; SYSTEM; MICROADENOMATOSIS; INCLUSIONS; EXPRESSION	Histopathology of pancreatic neuroendocrine tumors (PNETs) typically displays characteristic features. However, pathologists may encounter histological variants that may resemble other pancreatic tumors. Immunohistochemistry is a powerful tool in confirming neuroendocrine differentiation and differentiating PNETs with other pancreatic neoplasms. Histopathological features could be associated with inherited syndromes. Once the pathology diagnosis of neuroendocrine tumor was made, an accurate grading based on World Health Organization (WHO) classification is required. This review will focus on histology variants, immunohistochemistry and WHO classification of PNET.	[Kasajima, Atsuko; Sasano, Hironobu] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Yazdani, Samaneh; Sasano, Hironobu] Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan	Kasajima, A (reprint author), Tohoku Univ Hosp, Dept Pathol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kasajima@patholo2.med.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Mitsui Life Social Welfare Foundation	This work is partly supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology and Mitsui Life Social Welfare Foundation.	Perren A, 2006, AM J SURG PATHOL, V30, P1047, DOI 10.1097/00000478-200608000-00018; Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Jann H, 2011, CANCER-AM CANCER SOC, V117, P3332, DOI 10.1002/cncr.25855; Chan ES, 2012, AM J SURG PATHOL, V36, P737, DOI 10.1097/PAS.0b013e31824aba59; Volante M, 2007, MODERN PATHOL, V20, P1172, DOI 10.1038/modpathol.3800954; Anlauf M, 2006, AM J SURG PATHOL, V30, P560, DOI 10.1097/01.pas.0000194044.01104.25; Shia J, 2004, AM J SURG PATHOL, V28, P271, DOI 10.1097/00000478-200402000-00018; Rindi G, 2012, J NATL CANCER I, V104, P764, DOI 10.1093/jnci/djs208; Ohike N, 2004, VIRCHOWS ARCH, V445, P231, DOI 10.1007/s00428-004-1037-x; Hammel PR, 2000, GASTROENTEROLOGY, V119, P1087, DOI 10.1053/gast.2000.18143; Singh R, 2006, AM J SURG PATHOL, V30, P194, DOI 10.1097/01.pas.0000184819.71752.ad; Yang ZH, 2011, AM J SURG PATHOL, V35, P853, DOI 10.1097/PAS.0b013e31821a0696; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Fujiyoshi Y, 2008, HISTOPATHOLOGY, V52, P305, DOI 10.1111/j.1365-2559.2007.02950.x; Dhall D, 2012, HUM PATHOL, V43, P489, DOI 10.1016/j.humpath.2011.06.011; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Hoang MP, 2001, AM J SURG PATHOL, V25, P602, DOI 10.1097/00000478-200105000-00006; Lubensky IA, 1998, AM J PATHOL, V153, P223, DOI 10.1016/S0002-9440(10)65563-0; Kloppel G, 2010, VIRCHOWS ARCH, V456, P595, DOI 10.1007/s00428-010-0924-6; Kaufmann O, 2000, HISTOPATHOLOGY, V36, P415; Bordelanou L, 2008, J AM COLL SURGEONS, V206, P1154, DOI 10.1016/j.jamcollsurg.2007.12.040; Bosmans FT, 2010, WHO CLASSIFICATION T, V4th; Chetty R, 2004, ENDOCR PATHOL, V15, P141, DOI 10.1385/EP:15:2:141; Chetty R, 2006, AM J SURG PATHOL, V30, P1630, DOI 10.1097/01.pas.0000213380.32666.99; Farrells JM, 2014, CANCER CYTOPATHOL, V112, P770; Hasegawa T, 2014, ENDOSCOPY, V46, P32, DOI 10.1055/s-0033-1344958; Hosoda W, 2013, PATHOL INT, V63, P176, DOI 10.1111/pin.12045; Kims MJ, 2008, HUM PATHOL, V39, P251; Kims SA, 2014, HUM PATHOL, V45, P166; Koos J, 2012, MODERN PATHOL, V25, P893; Koos J, 2013, ENDOCR PATHOL, V24, P184; Larson AM, 2012, CLIN GENET, V82, P558, DOI 10.1111/j.1399-0004.2011.01805.x; McCall CM, 2013, AM J SURG PATHOL, V37, P1671, DOI 10.1097/PAS.0000000000000089; Ordonez NG, 2000, AM J SURG PATHOL, V24, P1217; Serra S, 2006, ENDOCR PATHOL, V17, P75, DOI 10.1385/EP:17:1:75; Singhi AD, 2014, MODERN PATHOL, V27, P1355, DOI 10.1038/modpathol.2014.40; TOTSCH M, 1992, HUM PATHOL, V23, P312, DOI 10.1016/0046-8177(92)90113-H; Velayoudom-Cephise FL, 2013, ENDOCR-RELAT CANCER, V20, P649, DOI 10.1530/ERC-13-0027; Verset Laurine, 2011, World J Gastrointest Oncol, V3, P144, DOI 10.4251/wjgo.v3.i10.144; Volante M, 2006, VIRCHOWS ARCH, V448, P545, DOI 10.1007/s00428-006-0154-0	40	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					586	593		10.1002/jhbp.208		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600006		
J	Imamura, M; Nakamoto, Y; Uose, S; Komoto, I; Awane, M; Taki, Y				Imamura, Masayuki; Nakamoto, Yuji; Uose, Suguru; Komoto, Izumi; Awane, Masaaki; Taki, Yoshiro			Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Functioning duodenal neuroendocrine tumor; Functioning pancreaticoduodenal neuroendocrine tumor; Gastrinoma; Insulinoma	ENDOCRINE NEOPLASIA TYPE-1; ZOLLINGER-ELLISON-SYNDROME; CALCIUM-SENSING RECEPTOR; HYPERINSULINEMIC HYPOGLYCEMIA; INJECTION TEST; SURGICAL-MANAGEMENT; EUS-FNA; GASTRINOMA; PANCREAS; CELLS	Functioning pancreaticoduodenal neuroendocrine tumors (PD-NETs) are popular in a textbook, but they are still unfamiliar to a general clinician, and delay of diagnosis or misdiagnosis has been reported even today. It is a consensus that sporadic functioning PD-NET is cured only by surgical resection. So, early detection and early resection is the gold standard for the treatment of functioning PD-NET. Functioning PD-NETs in patients with multiple endocrine neoplasia type 1 (MEN 1) are often multiple. You should check about MEN 1 whenever you encountered multiple PD-NET. They are diagnosed in younger age than sporadic cases. In most cases they are accompanied with numerous microscopic or macroscopic nonfunctioning P-NETs, which are potentially metastatic and the most common cause of death in MEN 1 patients. (c) Japanese Society of Hepato-Biliary-Pancreatic Surgery	[Imamura, Masayuki; Komoto, Izumi] Kansai Elect Power Hosp, Neuroendocrine Tumor Ctr, Fukushima Ku, Osaka 5530003, Japan; [Nakamoto, Yuji] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Uose, Suguru] Kansai Elect Power Hosp, Dept Gastroenterol, Fukushima Ku, Osaka 5530003, Japan; [Komoto, Izumi; Awane, Masaaki; Taki, Yoshiro] Kansai Elect Power Hosp, Dept Surg, Fukushima Ku, Osaka 5530003, Japan	Imamura, M (reprint author), Kansai Elect Power Hosp, Neuroendocrine Tumor Ctr, Fukushima Ku, 2-1-7 Fukushima, Osaka 5530003, Japan.	qqpn9bmd@water.ocn.ne.jp					Abernethy LJ, 1998, ARCH DIS CHILD, V78, P359; Abou-Saif A, 2001, GASTROENTEROLOGY, V120, P1271, DOI 10.1053/gast.2001.23242; Anlauf M, 2005, AM J SURG PATHOL, V29, P524, DOI 10.1097/01.pas.0000151617.14598.ae; Kwekkeboom DJ, 2010, ENDOCR-RELAT CANCER, V17, pR53, DOI 10.1677/ERC-09-0078; GANDA OP, 1977, NEW ENGL J MED, V296, P963, DOI 10.1056/NEJM197704282961703; Imamura M, 2011, WORLD J GASTROENTERO, V17, P1343, DOI 10.3748/wjg.v17.i10.1343; Yamazaki M, 2012, ENDOCR J, V59, P797; DOPPMAN JL, 1995, ANN INTERN MED, V123, P269; Tanaka S, 2000, PATHOL INT, V50, P146, DOI 10.1046/j.1440-1827.2000.01016.x; Wilder RM, 1927, J AMER MED ASSOC, V89, P348; YALOW RS, 1959, NATURE, V184, P1648, DOI 10.1038/1841648b0; [Anonymous], 2000, AM J GASTROENTERIL, V23, P70; Kloppel G, 2007, ENDOCR PATHOL, V18, P150, DOI 10.1007/s12022-007-0025-5; Modlin IM, 2008, J NATL CANCER I, V100, P1282, DOI 10.1093/jnci/djn275; Sakurai A, 2012, ENDOCR J, V59, P859; Norton JA, 2004, ANN SURG, V240, P757, DOI 10.1097/01.sla.0000143252.02142.3e; Tonelli F, 2005, J INTERN MED, V257, P38, DOI 10.1111/j.1365-2796.2004.01424.x; Azemoto N, 2012, CLIN RES HEPATOL GAS, V36, pE43, DOI 10.1016/j.clinre.2011.12.003; BALLS KF, 1959, J CLIN ENDOCR METAB, V19, P1134; Bartsch DK, 2005, ANN SURG, V242, P757, DOI 10.1097/01.sla.0000189549.51913.d8; BLOOM SR, 1973, LANCET, V2, P14; Bosman FT, 2010, WHO CLASSIFICATION T; Diaz R, 2003, DIGEST DIS SCI, V48, P1665, DOI 10.1023/A:1024700831418; Doherty GM, 2009, SPRINGER SPEC SURG S, P523, DOI 10.1007/978-1-84628-881-4_39; Gimm O, 2009, SPRINGER SPEC SURG S, P567, DOI 10.1007/978-1-84628-881-4_43; Gines A, 2002, GASTROINTEST ENDOSC, V56, P291, DOI 10.1067/mge.2002.125823; GREGORY RA, 1960, LANCET, V1, P1045; Hasegawa T, 2014, ENDOSCOPY, V46, P32, DOI 10.1055/s-0033-1344958; Ichimura Tatsunosuke, 2003, Int J Gastrointest Cancer, V33, P99, DOI 10.1385/IJGC:33:2-3:99; Imamura M, 2009, WORLD J SURG S1, V33, pS67; IMAMURA M, 1989, ANN SURG, V210, P710, DOI 10.1097/00000658-198912000-00004; Imamura M, 1994, J HEP BIL PANCR SURG, V1, P530, DOI 10.1007/BF01211915; Imamura M, 2009, SPRINGER SPEC SURG S, P507, DOI 10.1007/978-1-84628-881-4_38; IMAMURA M, 1987, ANN SURG, V205, P230, DOI 10.1097/00000658-198703000-00003; Imamura M, 2005, WORLD J SURG, V29, P203, DOI 10.1007/s00268-004-7585-z; Itami A, 2001, LIFE SCI, V70, P119, DOI 10.1016/S0024-3205(01)01380-7; Jensen RT, 2001, SURG ENDOCRINOLOGY, P292; Kato M, 1997, SURGERY, V122, P1203, DOI 10.1016/S0039-6060(97)90228-2; Gupta S. K., 2012, International Journal of Endocrinology and Metabolism, V10, P629; Maheshwari Rushikesh Raviraj, 2013, Indian J Endocrinol Metab, V17, pS215, DOI 10.4103/2230-8210.119576; Mori Yasuhisa, 2014, JOP, V15, P66, DOI 10.6092/1590-8577/1884; Nakayama S, 2009, ENDOCRINE, V35, P143, DOI 10.1007/s12020-009-9146-6; Niederle B, 2009, SPRINGER SPEC SURG S, P471, DOI 10.1007/978-1-84628-881-4_36; Noda S, 1999, ANN THORAC SURG, V67, P532, DOI 10.1016/S0003-4975(98)01205-3; Norton Jeffrey A, 2006, J Natl Compr Canc Netw, V4, P148; OBERHELMAN H, 1961, ANN SURG, V153, P214, DOI 10.1097/00000658-196115320-00008; PEARSE AGE, 1974, CLIN GASTROENTEROL, V3, P491; SANO T, 1988, ENDOCR REV, V9, P357; SERVICE FJ, 1991, MAYO CLIN PROC, V66, P711; Thompson NW, 1998, J INTERN MED, V243, P495; UNGER ROGER H., 1963, JOUR CLIN INVEST, V42, P987; VAIR DB, 1987, CAN J SURG, V30, P108; Vella A, 2009, SPRINGER SPEC SURG S, P493, DOI 10.1007/978-1-84628-881-4_37; Wada M, 2002, WORLD J SURG, V26, P1291, DOI 10.1007/s00268-002-6528-9; Watt David Graham, 2013, JOP, V14, P510, DOI 10.6092/1590-8577/1622; Wellbourn RB, 1978, APUDOMA PANCREAS, P561; WILKINSO.DS, 1971, P ROY SOC MED, V64, P1197; Yabe D, 2013, DIABETES RES CLIN PR, V102, pE1, DOI 10.1016/j.diabres.2013.08.005; Yamashita Suguru, 2013, World J Gastrointest Surg, V5, P68, DOI 10.4240/wjgs.v5.i3.68	59	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					602	609		10.1002/jhbp.209		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600008		
J	Doi, R				Doi, Ryuichiro			Determinants of surgical resection for pancreatic neuroendocrine tumors	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Distal pancreatectomy; Gastrinoma; Insulinoma; Non-functioning tumor; Pancreaticoduodenectomy	ZOLLINGER-ELLISON-SYNDROME; ENDOCRINE NEOPLASIA TYPE-1; HEPATIC-METASTASES; LIVER METASTASES; DUODENAL GASTRINOMAS; NATURAL-HISTORY; MANAGEMENT; SURVIVAL; SURGERY; INSULINOMAS	Pancreatic neuroendocrine tumors (pNETs) include functioning and non-functional tumors. Functioning tumors consist of tumors that produce a variety of hormones and their clinical effects. Therefore, determinants of resection of pNETs should be discussed for each group of tumors. Less than 10% of insulinomas are malignant, therefore more than 90% of the cases can be cured by surgical resection. Lymphadenectomy is generally not necessary in insulinoma operation. If preoperative localization of the insulinoma is completed, enucleation from the pancreatic body or tail, and distal pancreatectomy can be performed safely by laparoscopy. When preoperative localization of a sporadic insulinoma is not confirmed, surgical exploration is needed. Intraoperative localization of a tumor, intraoperative insulin sampling and frozen section are required. The crucial purpose of surgical resection is to control inappropriate insulin secretion by removing all insulinomas. Gastrinomas are usually located in the duodenum or pancreas, which secrete gastrin and cause Zollinger-Ellison syndrome (ZES). Duodenal gastrinomas are usually small, therefore they are not seen on preoperative imaging studies or endoscopic ultrasound, and can be found only at surgery if a duodenotomy is performed. In addition, lymph node metastasis is found in 40-60% of cases. Therefore, the experienced surgeons should direct operation for gastrinomas. Surgical exploration with duodenotomy should be performed at a laparotomy. Other functioning pNETs can occur in the pancreas or in other locations. Curative resection is always recommended whenever possible after optimal symptomatic control of the clinical syndrome by medical treatment. Indications for surgery depend on clinical symptom control, tumor size, location, extent, malignancy and presence of metastasis. A lot of non-functioning pNETs are found incidentally according to the quality improvement of imaging techniques. Localized, small, malignant non-functioning pNETs should be operated on aggressively, while in possibly benign tumors smaller than 2 cm the surgical risk-benefit ratio should be carefully weighted. Surgical liver resection is generally proposed in curative intent to all patients with operable metastases from G1 or G2 pNET. The benefits of surgical resection of liver metastases have been demonstrated in terms of overall survival and quality of life. Complete resection is associated with better long-term survival.	Otsu Red Cross Hosp, Dept Surg, Otsu, Shiga 5208511, Japan	Doi, R (reprint author), Otsu Red Cross Hosp, Dept Surg, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan.	doir@kuhp.kyoto-u.ac.jp					Mathur A, 2009, SURG CLIN N AM, V89, P1105, DOI 10.1016/j.suc.2009.06.009; Yigitler C, 2003, LIVER TRANSPLANT, V9, pS18, DOI 10.1053/jlts.2003.50194; Fendrich V, 2009, NAT REV CLIN ONCOL, V6, P419, DOI 10.1038/nrclinonc.2009.82; Anlauf M, 2006, AM J SURG PATHOL, V30, P560, DOI 10.1097/01.pas.0000194044.01104.25; Sarmiento JM, 2003, J AM COLL SURGEONS, V197, P29, DOI 10.1016/S1072-7515(03)00230-8; O'Toole D, 2006, NEUROENDOCRINOLOGY, V84, P189, DOI 10.1159/000098011; Zhao YP, 2011, J SURG ONCOL, V103, P169, DOI 10.1002/jso.21773; Tonelli F, 2006, ANN SURG, V244, P61, DOI 10.1097/01.sla.0000218073.77254.62; Fischer L, 2008, BRIT J SURG, V95, P627, DOI 10.1002/bjs.6051; Elias D, 2009, EJSO-EUR J SURG ONC, V35, P1092, DOI 10.1016/j.ejso.2009.02.017; Norton JA, 2001, ANN SURG, V234, P495, DOI 10.1097/00000658-200110000-00009; Triponez F, 2006, ANN SURG, V243, P265, DOI 10.1097/01.sla.000197715.96762.68; Akerstrom G, 2007, BEST PRACT RES CL EN, V21, P87, DOI 10.1016/j.beem.2006.12.004; Kulke MH, 2010, PANCREAS, V39, P735, DOI 10.1097/MPA.0b013e3181ebb168; Oberg K, 2010, SEMIN ONCOL, V37, P594, DOI 10.1053/j.seminoncol.2010.10.014; Jensen RT, 2006, NEUROENDOCRINOLOGY, V84, P173, DOI 10.1159/000098009; Elias D, 2003, SURGERY, V133, P375, DOI 10.1067/msy.2003.114; Gimm O, 2007, LANGENBECK ARCH SURG, V392, P679, DOI 10.1007/s00423-006-0144-3; Steinmuller T, 2008, NEUROENDOCRINOLOGY, V87, P47, DOI 10.1159/000111037; Norton JA, 1999, NEW ENGL J MED, V341, P635, DOI 10.1056/NEJM199908263410902; Kianmanesh R, 2008, ANN SURG, V247, P659, DOI 10.1097/SLA.0b013e31816a7061; Smith JK, 2010, J SURG RES, V163, P63, DOI 10.1016/j.jss.2010.04.017; Ahlman H, 2000, DIGESTION, V62, P59, DOI 10.1159/000051857; Norton JA, 2006, ANN SURG, V244, P410, DOI 10.1097/01.sla.0000234802.44320.a5; Ellison EC, 2009, CURR PROB SURG, V46, P13, DOI 10.1067/j.cpsurg.2008.09.001; Metz DC, 2008, GASTROENTEROLOGY, V135, P1469, DOI 10.1053/j.gastro.2008.05.047; Bettini R, 2011, SURGERY, V150, P75, DOI 10.1016/j.surg.2011.02.022; THOM AK, 1991, SURGERY, V110, P1086; Chamberlain RS, 2000, J AM COLL SURGEONS, V190, P432, DOI 10.1016/S1072-7515(00)00222-2; Richards ML, 2011, WORLD J SURG, V35, P785, DOI 10.1007/s00268-011-0970-5; Falconi M, 2006, NEUROENDOCRINOLOGY, V84, P196, DOI 10.1159/000098012; Kondo S, 2003, LANGENBECK ARCH SURG, V388, P101, DOI 10.1007/s00423-003-0375-5; Falconi M, 2008, BRIT J SURG, V95, P85, DOI 10.1002/bjs.5652; Guettier JM, 2009, J CLIN ENDOCR METAB, V94, P1074, DOI 10.1210/jc.2008-1986; Falconi M, 2010, ANN SURG ONCOL, V17, P1621, DOI 10.1245/s10434-010-0949-8; Chen H, 1998, J AM COLL SURGEONS, V187, P88, DOI 10.1016/S1072-7515(98)00099-4; Jensen RI, 2008, CANCER-AM CANCER SOC, V113, P1807, DOI 10.1002/cncr.23648; Fernandez-Cruz L, 2008, WORLD J SURG, V32, P904, DOI 10.1007/s00268-008-9467-2; Alexander HR, 1998, ANN SURG, V228, P228, DOI 10.1097/00000658-199808000-00013; Touzios JG, 2005, ANN SURG, V241, P776, DOI 10.1097/01.sla.0000161981.58631.ab; Hemming AW, 2003, ANN SURG, V237, P686, DOI 10.1097/00000658-200305000-00011; Norton JA, 2004, ANN SURG, V240, P757, DOI 10.1097/01.sla.0000143252.02142.3e; Kouvaraki MA, 2006, WORLD J SURG, V30, P643, DOI 10.1007/s00268-006-0360-y; Gibril F, 2004, MEDICINE, V83, P43, DOI 10.1097/01.md.0000112297.72510.32; Kaltsas G, 2010, ENDOCR-RELAT CANCER, V17, pR173, DOI 10.1677/ERC-10-0024; Morrow EH, 2009, SURG CLIN N AM, V89, P1091, DOI 10.1016/j.suc.2009.06.018; Akyildiz HY, 2010, SURGERY, V148, P1288, DOI 10.1016/j.surg.2010.09.014; Bartsch DK, 2007, WIEN KLIN WOCHENSCHR, V119, P602, DOI 10.1007/s00508-007-0883-3; Aranha GV, 2005, AM J SURG, V189, P223, DOI 10.1016/j.amsurg.2004.11.005; des Herders WW, 2006, NEUROENDOCRINOLOGY, V84, P183; Desai K K, 2009, Minerva Gastroenterol Dietol, V55, P425; Dois R, 2004, PANCREAS, V28, P247; Ekeblads S., 2007, ADV EXP MED BIOL, V654, P771; Espana-Gomez MN, 2009, WORLD J SURG, V33, P1966, DOI 10.1007/s00268-009-0145-9; Fendrich Volker, 2010, World J Hepatol, V2, P367, DOI 10.4254/wjh.v2.i10.367; Fendrich V, 2007, BRIT J SURG, V94, P1331, DOI 10.1002/bjs.5987; FRAKER DL, 1994, ANN SURG, V220, P320, DOI 10.1097/00000658-199409000-00008; Franz RC, 2007, S AFR J SURG, V45, P58; Garbrechts N, 2008, ENDOCR RELAT CANC, V15, P229; Gibril Fathia, 2005, Curr Gastroenterol Rep, V7, P114, DOI 10.1007/s11894-005-0049-2; Guettier JM, 2010, EXPERT REV ENDOCRINO, V5, P217, DOI DOI 10.1586/EEM.09.83; Hodul Pamela, 2006, Cancer Control, V13, P61; Arbuckle JD, 2009, BRIT J SURG, V96, P185, DOI 10.1002/bjs.6465; Itos T, 2010, J GASTROENTEROL, V45, P234; Jonkers YMH, 2007, ENDOCR-RELAT CANCER, V14, P769, DOI 10.1677/ERC-07-0111; Kato M, 1997, SURGERY, V122, P1203, DOI 10.1016/S0039-6060(97)90228-2; Kianmanesh R, 2005, J CHIR-PARIS, V142, P208, DOI 10.1016/S0021-7697(05)80906-8; KRUDY AG, 1984, AM J ROENTGENOL, V143, P585; LONDON JF, 1991, RADIOLOGY, V178, P763; Lorenz K, 2007, WIEN KLIN WOCHENSCHR, V119, P597, DOI 10.1007/s00508-007-0882-4; MACFARLANE MP, 1995, SURGERY, V118, P973, DOI 10.1016/S0039-6060(05)80102-3; Norton JA, 2007, J AM COLL SURGEONS, V205, pS34, DOI 10.1016/j.jamcollsurg.2007.06.320; Norton Jeffrey A, 2006, J Natl Compr Canc Netw, V4, P148; Norton JA, 2003, ANN SURG, V237, P650, DOI 10.1097/00000658-200305000-00007; Ques FG, 1995, AM J SURG, V169, P36; Reddy SK, 2010, SURG CLIN N AM, V90, P853, DOI 10.1016/j.suc.2010.04.016; Roys PK, 2000, MEDICINE, V79, P379; Sarmiento Juan M, 2003, Surg Oncol Clin N Am, V12, P231, DOI 10.1016/S1055-3207(02)00076-5; SUGG SL, 1993, ANN SURG, V218, P138, DOI 10.1097/00000658-199308000-00004; The Guidelines Committee of the Japan Neuroendocrine Tumor Society, 2015, CLIN GUID GASTR NEUR; Vanderveen K, 2010, CANCER TREAT RES, V153, P235, DOI 10.1007/978-1-4419-0857-5_13	81	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					610	617		10.1002/jhbp.224		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600009		
J	Igarashi, H; Hijioka, M; Lee, L; Ito, T				Igarashi, Hisato; Hijioka, Masayuki; Lee, Lingaku; Ito, Tetsuhide			Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Lanreotide; Octreotide; Pancreatic neuroendocrine tumors; Somatostatin analog	INSULINOMA PATIENTS; OCTREOTIDE; THERAPY; HYPOGLYCEMIA; RECEPTORS; EFFICACY	Basically, pancreatic neuroendocrine tumor (PNET) should be treated surgically; however, in unresectable cases, a treatment that aims to improve the prognosis by inhibiting the growth of the tumor and control the clinical symptoms becomes necessary. In the case of functional tumors, the quality of life of patients is decreased by not only the symptoms with tumor invasion and/or metastasis but also by the symptoms of hormone excess. The efficacy of somatostatin analogs against the latter has been previously reported, and their sustained release formulations have been developed. Somatostatin analogs are recommended to treat the endocrine symptoms of functional PNET; however, in case they can cause hypoglycemia in patients with insulinoma. On the other hand, results from the PROMID study demonstrated a tumor-stabilizing effect when octreotide LAR (long acting repeatable) was used to treat patients with advanced midgut NET; however, there has been no consensus regarding its antitumor effect for PNET. Additionally, a recent result from the CLARINET study suggests that lanreotide autogel has an antitumor effect against nonfunctional NET including PNET. Further clinical study results are awaited.	[Igarashi, Hisato] Kyushu Univ Hosp, Clin Educ Ctr, Fukuoka 812, Japan; [Igarashi, Hisato; Hijioka, Masayuki; Lee, Lingaku; Ito, Tetsuhide] Kyushu Univ, Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan	Igarashi, H (reprint author), Kyushu Univ, Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	igaras@med.kyushu-u.ac.jp					Alexander EK, 2002, CLIN ENDOCRINOL, V57, P827, DOI 10.1046/j.1365-2265.2002.01660.x; Angeletti S, 1998, GUT, V42, P792; Strosberg J, 2010, WORLD J GASTROENTERO, V16, P2963, DOI 10.3748/wjg.v16.i24.2963; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Oberg K, 2004, ANN ONCOL, V15, P966, DOI 10.1093/annonc/mdh216; MATON PN, 1989, GASTROENTEROLOGY, V97, P827; Panzuto F, 2006, ANN ONCOL, V17, P461, DOI 10.1093/annonc/mdj113; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Ito T, 2012, J GASTROENTEROL, V47, P941, DOI 10.1007/s00535-012-0642-8; Oberg KE, 2010, ANN ONCOL, V21, P72, DOI 10.1093/annonc/mdq290; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; REUBI JC, 1990, CANCER RES, V50, P5969; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Moller LN, 2003, BBA-BIOMEMBRANES, V1616, P1, DOI 10.1016/S0005-2736(03)00235-9; Appetecchia M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-19; Igarashi H, 2013, PANCREATIC TUMORS, P154; Janson Eva Tiensuu, 2006, Pituitary, V9, P249, DOI 10.1007/s11102-006-0271-4; Japan Neuroendocrine Tumor Society (JNETS), CLIN GUID GASTR NEUR; ODORISIO TM, 1989, ENDOCRIN METAB CLIN, V18, P545; Schmid Herbert A, 2004, Neuroendocrinology, V80 Suppl 1, P47, DOI 10.1159/000080741; STEHOUWER CDA, 1989, ACTA ENDOCRINOL-COP, V121, P34; Vezzosi D, 2005, EUR J ENDOCRINOL, V152, P757, DOI 10.1530/eje.1.01901	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					618	622		10.1002/jhbp.227		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600010		
J	Ikeda, M; Okuyama, H; Takahashi, H; Ohno, I; Shimizu, S; Mitsunaga, S; Kondo, S; Morizane, C; Ueno, H; Okusaka, T				Ikeda, Masafumi; Okuyama, Hiroyuki; Takahashi, Hideaki; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Kondo, Shunsuke; Morizane, Chigusa; Ueno, Hideki; Okusaka, Takuji			Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Chemotherapy; Cisplatin; Everolimus; Ki-67; Neuroendocrine carcinoma	SMALL-CELL; CISPLATIN; TUMORS; ETOPOSIDE; FOREGUT; GUIDELINES; IRINOTECAN; NEOPLASMS; HINDGUT; MIDGUT	Pancreatic neuroendocrine carcinoma (P-NEC) resembles small cell lung carcinoma in its biologic and clinical features, such as rapid growth and relatively high sensitivity to platinum-based chemotherapy. And, etoposide plus cisplatin (EP) or irinotecan plus cisplatin (IP), recommended by guidelines for the treatment of small cell lung carcinoma, has also been widely used for the treatment of unresectable NEC. Both regimens have been demonstrated to show favorable efficacy and have been acknowledged as de facto standard regimens for unresectable NEC, although it remains unclear which of the two regimens might yield more favorable outcomes. Therefore, a phase III trial of EP vs. IP has been planned for unresectable gastrointestinal, hepatobiliary or pancreatic NEC by the Japan Clinical Oncology Group. For patients with unresectable NEC who are refractory or intolerant to these regimens, no standard regimens have been established. Everolimus, an mTOR inhibitor, is likely to be effective in such patients, as there have been sporadic reports of the usefulness of everolimus in the treatment of P-NEC. A multicenter phase II trial is underway to elucidate the efficacy and safety of everolimus in patients with P-NEC who are refractory or intolerant to EP or IP.	[Ikeda, Masafumi; Okuyama, Hiroyuki; Takahashi, Hideaki; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba 2778577, Japan; [Kondo, Shunsuke; Morizane, Chigusa; Ueno, Hideki; Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan	Ikeda, M (reprint author), Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	masikeda@east.ncc.go.jp					Chin K, 2008, JPN J CLIN ONCOL, V38, P426, DOI 10.1093/jjco/hyn041; Iwasa S, 2010, JPN J CLIN ONCOL, V40, P313, DOI 10.1093/jjco/hyp173; Mitry E, 1999, BRIT J CANCER, V81, P1351, DOI 10.1038/sj.bjc.6690325; Fjallskog MLH, 2001, CANCER, V92, P1101, DOI 10.1002/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V; Bollard J, 2013, NEUROENDOCRINOLOGY, V97, P331, DOI 10.1159/000347063; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; Plockinger U, 2004, NEUROENDOCRINOLOGY, V80, P394, DOI 10.1159/000085237; Hijioka S, 2015, J GASTROENTEROL, V50, P564, DOI 10.1007/s00535-014-0987-2; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Nilsson O, 2006, NEUROENDOCRINOLOGY, V84, P212, DOI 10.1159/000098013; Ahlman H, 2008, NEUROENDOCRINOLOGY, V87, P40, DOI 10.1159/000109976; Yachida S, 2012, AM J SURG PATHOL, V36, P173, DOI 10.1097/PAS.0b013e3182417d36; Bosmans FT, 2010, WHO CLASSIFICATION T, V4th; Catena L, 2011, TARGET ONCOL, V6, P65, DOI 10.1007/s11523-011-0171-z; Fonseca Paula J, 2013, Case Rep Oncol, V6, P441, DOI 10.1159/000354754; Itos T, 2015, J GASTROENTEROL, V50, P58; Jins S, 2011, ONKOLOGIE, V34, P378; Klimstras D., 2013 ASCO ANN M EV P; Kulke MH, 2006, DIGEST DIS SCI, V51, P1033, DOI 10.1007/s10620-006-8001-3; Mani MA, 2008, J CLIN ONCOL, V26; NCCN. org, 2014, SMALL CELL LUNG CANC; NCCN. org, 2014, NEUR TUM NCCN CLIN P; Okita NT, 2011, GASTRIC CANCER, V14, P161, DOI 10.1007/s10120-011-0025-5; Scoazecs JY, 2012, J CLIN ONCOL S, V30; Shida T, 2010, CANCER CHEMOTH PHARM, V65, P889, DOI 10.1007/s00280-009-1094-6; Sorbye H, 2012, ANN ONCOL, V24, P152; Yamaguchis T, 2012, J CLIN ONCOL S4, V30; Yaos JC, 2011, NEW ENGL J MED, V364, P514; Yaos JC, 2008, J CLIN ONCOL, V26, P3063	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					623	627		10.1002/jhbp.228		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600011		
J	Okusaka, T; Ueno, H; Morizane, C; Kondo, S; Sakamoto, Y; Takahashi, H; Ohno, I; Shimizu, S; Mitsunaga, S; Ikeda, M				Okusaka, Takuji; Ueno, Hideki; Morizane, Chigusa; Kondo, Shunsuke; Sakamoto, Yasunari; Takahashi, Hideaki; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Ikeda, Masafumi			Cytotoxic chemotherapy for pancreatic neuroendocrine tumors	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Chemotherapy; Fluoropyrimidine; Neuroendocrine tumor; Streptozocin; Temozolomide	ISLET-CELL-CARCINOMA; PHASE-II TRIAL; ENDOCRINE CARCINOMAS; STREPTOZOCIN; DOXORUBICIN; FLUOROURACIL; TEMOZOLOMIDE; DACARBAZINE; 5-FLUOROURACIL; CAPECITABINE	Advanced neuroendocrine tumors are incurable, and most patients will succumb to the disease. Chemotherapies with cytotoxic agents such as streptozocin, 5-fluorouracil, or temozolomide have been frequently used as drug therapies for neuroendocrine tumors. Streptozocin, which is the only approved cytotoxic agent available for the treatment of this disease in many countries, has been considered a key agent for the treatment of advanced neuroendocrine tumors based on the results of phase III studies. However, the widespread acceptance of streptozocin-based chemotherapy for this indication has been limited by concerns regarding toxicity. Recent prospective and retrospective studies showed the promising activity of a temozolomide-based regimen, although an adequate prospective controlled study defining the role of temozolomide in the treatment of neuroendocrine tumors is lacking. The promising activity of cytotoxic agents awaits confirmation; solid evidence-based recommendations and treatment decisions are needed for the optimal use of chemotherapy against this disease.	[Okusaka, Takuji; Ueno, Hideki; Morizane, Chigusa; Kondo, Shunsuke; Sakamoto, Yasunari] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Chuo Ku, Tokyo 1040045, Japan; [Takahashi, Hideaki; Ohno, Izumi; Shimizu, Satoshi; Mitsunaga, Shuichi; Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan	Okusaka, T (reprint author), Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tokusaka@ncc.go.jp			Chugai Pharmaceutical Co., Ltd.; Taiho Pharmaceutical Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.	Research funding: Takuji Okusaka, Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd.	Abbasi S, 2014, PANCREAS, V43, P1303, DOI 10.1097/MPA.0000000000000174; MOERTEL CG, 1980, NEW ENGL J MED, V303, P1189, DOI 10.1056/NEJM198011203032101; Turner NC, 2010, BRIT J CANCER, V102, P1106, DOI 10.1038/sj.bjc.6605618; Delaunoit T, 2004, EUR J CANCER, V40, P515, DOI 10.1016/j.ejca.2003.09.035; Fjallskog MLH, 2008, NEUROENDOCRINOLOGY, V88, P53, DOI 10.1159/000117575; Bajetta E, 2007, CANCER CHEMOTH PHARM, V59, P637, DOI 10.1007/s00280-006-0306-6; Cheng PNM, 1999, CANCER, V86, P944, DOI 10.1002/(SICI)1097-0142(19990915)86:6<944::AID-CNCR8>3.0.CO;2-P; McCollum AD, 2004, AM J CLIN ONCOL-CANC, V27, P485, DOI 10.1097/01.coc.0000135343.06038.eb; Fine RL, 2013, CANCER CHEMOTH PHARM, V71, P663, DOI 10.1007/s00280-012-2055-z; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Ansell SM, 2001, CANCER, V91, P1543, DOI 10.1002/1097-0142(20010415)91:8<1543::AID-CNCR1163>3.0.CO;2-N; Ekeblad S, 2007, CLIN CANCER RES, V13, P2986, DOI 10.1158/1078-0432.CCR-06-2053; Meyer T, 2014, EUR J CANCER, V50, P902, DOI 10.1016/j.ejca.2013.12.011; Kulke MH, 2009, CLIN CANCER RES, V15, P338, DOI 10.1158/1078-0432.CCR-08-1476; BRODER LE, 1973, ANN INTERN MED, V79, P108; Kouvaraki MA, 2004, J CLIN ONCOL, V22, P4762, DOI 10.1200/JCO.2004.04.024; Bajetta E, 1998, CANCER, V83, P372, DOI 10.1002/(SICI)1097-0142(19980715)83:2<372::AID-CNCR23>3.0.CO;2-P; Weatherstone K, 2012, TARGET ONCOL, V7, P161, DOI 10.1007/s11523-012-0224-y; Kulke MH, 2004, CANCER, V101, P934, DOI 10.1002/cncr.20466; Kulke MH, 2006, J CLIN ONCOL, V24, P401, DOI 10.1200/JJCO.2005.03.6046; Strosberg JR, 2011, CANCER-AM CANCER SOC, V117, P268, DOI 10.1002/cncr.25425; Walter T, 2010, CLIN COLORECTAL CANC, V9, P248, DOI 10.3816/CCC.2010.n.037; Ramanathan RK, 2001, ANN ONCOL, V12, P1139, DOI 10.1023/A:1011632713360; Bajetta E, 2001, TUMORI, V87, P219; Brixi-Benmansour H, 2011, DIGEST LIVER DIS, V43, P912, DOI 10.1016/j.dld.2011.07.001; BUKOWSKI RM, 1992, J CLIN ONCOL, V10, P1914; DIBARTOLOMEO M, 1995, ANN ONCOL, V6, P77; ERIKSSON B, 1990, CANCER, V65, P1883, DOI 10.1002/1097-0142(19900501)65:9<1883::AID-CNCR2820650902>3.0.CO;2-3; Ferrarotto Renata, 2013, Rare Tumors, V5, pe35, DOI 10.4081/rt.2013.e35; Fine RL, 2014, J CLIN ONCOL, V32; FRAME J, 1988, AM J CLIN ONCOL-CANC, V11, P490, DOI 10.1097/00000421-198808000-00015; Hammel P, 2012, TARGET ONCOL, V7, P169, DOI 10.1007/s11523-012-0228-7; Lius L, 2006, CLIN CANCER RES, V12, P328; MOERTEL CG, 1992, NEW ENGL J MED, V326, P519, DOI 10.1056/NEJM199202203260804; Ollivier S, 1998, AM J CLIN ONCOL-CANC, V21, P237, DOI 10.1097/00000421-199806000-00005; Pavel Marianne E, 2005, Int J Gastrointest Cancer, V35, P179, DOI 10.1385/IJGC:35:3:179; Peixoto Renata D'Alpino, 2014, J Gastrointest Oncol, V5, P247, DOI 10.3978/j.issn.2078-6891.2014.019; Rivera E, 1998, AM J CLIN ONCOL-CANC, V21, P36, DOI 10.1097/00000421-199802000-00008; Saif Muhammad Wasif, 2013, JOP, V14, P498, DOI 10.6092/1590-8577/1589; Suns W, 2005, J CLIN ONCOL, V23, P4897; Yaos JC, 2011, NEW ENGL J MED, V364, P514; Yaos JC, 2012, EUR ONCOL HAEMATOL, V8, P217	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					628	633		10.1002/jhbp.257		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600012		
J	Hatano, E; Okuno, M; Nakamura, K; Ishii, T; Seo, S; Taura, K; Yasuchika, K; Yazawa, T; Zaima, M; Kanazawa, A; Terajima, H; Kaihara, S; Adachi, Y; Inoue, N; Furumoto, K; Manaka, D; Tokka, A; Furuyama, H; Doi, K; Hirose, T; Horimatsu, T; Hasegawa, S; Matsumoto, S; Sakai, Y; Uemoto, S				Hatano, Etsuro; Okuno, Masayuki; Nakamura, Kojiro; Ishii, Takamichi; Seo, Satoru; Taura, Kojiro; Yasuchika, Kentaro; Yazawa, Takefumi; Zaima, Masazumi; Kanazawa, Akiyoshi; Terajima, Hiroaki; Kaihara, Satoshi; Adachi, Yukihito; Inoue, Naoya; Furumoto, Katsuyoshi; Manaka, Dai; Tokka, Atsuo; Furuyama, Hiroaki; Doi, Koji; Hirose, Tetsuro; Horimatsu, Takahiro; Hasegawa, Suguru; Matsumoto, Shigemi; Sakai, Yoshiharu; Uemoto, Shinji			Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Colorectal liver metastasis; Conversion; Hepatic resection; Resectability	LONG-TERM SURVIVAL; MULTICENTER PHASE-II; ONLY METASTASES; HEPATIC METASTASES; 1ST-LINE TREATMENT; PLUS BEVACIZUMAB; NEOADJUVANT CHEMOTHERAPY; SURGICAL RESECTION; UPFRONT RESECTION; RESCUE SURGERY	BackgroundPatients with colorectal liver metastasis (CRLM) might be down-staged by chemotherapy from an initially unresectable stage to a resectable stage. Because the tumor response to preoperative chemotherapy has been correlated with resection rate, the improved efficacy from the concept that only the patients without K-ras mutations receive an anti-EGFR antibody might be expected to increase the conversion rate. The purpose of this study is to evaluate the conversion rate from unresectable CRLM to complete resection. MethodsWe conducted a multi-institutional phase II trial for unresectable CRLM. Patients received mFOLFOX6 with either bevacizumab (bev) or cetuximab (cet) based on K-ras status (UMIN000004310). Planned treatment was for six cycles during which tumors were assessed for resectability every three cycles. Patients whose disease was unresectable after six cycles switched their chemotherapy regimen from mFOLFOX6 to FOLFIRI. The primary endpoint was R0 resection rate. ResultsThirty-five patients with unresectable CRLM were enrolled. A total of 22/12 patients with K-ras wild-type/mutant (wt/mt) were treated with mFOLFOX6 plus cet/bev, respectively. The overall response rate was 64.7% (wt/mt; 77.3%/41.7%, P=0.04). In 20 patients (58.8%), hepatectomy was performed according to protocol treatment, and the conversion rate was 72.7%/33.3% in wt/mt patients, respectively (P=0.03). Finally, 23 patients (67.6%) underwent hepatectomy, and the conversion rate was 77.2%/50.0% in wt/mt patients (P=0.09). The overall R0 resection rate was 47.1% (wt/mt; 50.0%/41.7%, P=0.36). ConclusionsThis prospective study showed that combined chemotherapy based on K-ras status can facilitate conversion to resection in patients with unresectable CRLM.	[Hatano, Etsuro; Okuno, Masayuki; Nakamura, Kojiro; Ishii, Takamichi; Seo, Satoru; Taura, Kojiro; Yasuchika, Kentaro; Hasegawa, Suguru; Sakai, Yoshiharu; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068507, Japan; [Yazawa, Takefumi; Zaima, Masazumi] Shiga Med Ctr Adults, Dept Surg, Moriyama, Shiga, Japan; [Kanazawa, Akiyoshi] Osaka Red Cross Hosp, Dept Surg, Osaka, Japan; [Terajima, Hiroaki] Kitano Hosp, Dept Gastroenterol Surg & Oncol, Osaka, Japan; [Kaihara, Satoshi] Kobe City Med Ctr Gen Hosp, Dept Surg, Kobe, Hyogo, Japan; [Adachi, Yukihito] Saiseikai Noe Hosp, Dept Surg, Osaka, Japan; [Inoue, Naoya] Kansai Elect Power Hosp, Dept Surg, Osaka, Japan; [Furumoto, Katsuyoshi] Kishiwada City Hosp, Dept Surg, Osaka, Japan; [Manaka, Dai] Kyoto Katsura Hosp, Dept Surg, Kyoto, Japan; [Tokka, Atsuo] Shimane Prefectural Cent Hosp, Dept Surg, Izumo, Shimane, Japan; [Furuyama, Hiroaki] Tenri Yorozu Hosp, Dept Surg, Tenri, Nara, Japan; [Doi, Koji] Fukui Red Cross Hosp, Dept Surg, Fukui, Japan; [Hirose, Tetsuro] Takamatsu Red Cross Hosp, Dept Surg, Takamatsu, Kagawa, Japan; [Horimatsu, Takahiro; Matsumoto, Shigemi] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto 606, Japan	Hatano, E (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	etsu@kuhp.kyoto-u.ac.jp					Wanebo HJ, 2004, ANN SURG, V240, P657; Giacchetti S, 1999, ANN ONCOL, V10, P663, DOI 10.1023/A:1008347829017; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yamaguchi T, 2008, HEPATO-GASTROENTEROL, V55, P173; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Cummings LC, 2007, CANCER, V109, P718, DOI 10.1002/cncr.22448; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Masi G, 2009, ANN SURG, V249, P420, DOI 10.1097/SLA.0b013e31819a0486; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Bismuth H, 1996, ANN SURG, V224, P509, DOI 10.1097/00000658-199610000-00009; Wong R, 2011, ANN ONCOL, V22, P2042, DOI 10.1093/annonc/mdq714; Okines A, 2009, BRIT J CANCER, V101, P1033, DOI 10.1038/sj.bjc.6605259; Gruenberger T, 2015, ANN ONCOL, V26, P702, DOI 10.1093/annonc/mdu580; Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278; Folprecht G, 2014, ANN ONCOL, V25, P1018, DOI 10.1093/annonc/mdu088; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Folprecht G, 2005, ANN ONCOL, V16, P1311, DOI 10.1093/annonc/mdi246; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Alberts SR, 2005, J CLIN ONCOL, V23, P9243, DOI 10.1200/JCO.2005.07.740; Morris EJA, 2010, BRIT J SURG, V97, P1110, DOI 10.1002/bjs.7032; Kornprat P, 2007, ANN SURG ONCOL, V14, P1151, DOI 10.1245/s10434-006-9068-y; Beppu T, 2014, ANTICANCER RES, V34, P6655; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; Bismuth H., 1996, ANN SURG, V224, P520; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Jaeck D, 1997, BRIT J SURG, V84, P977, DOI 10.1002/bjs.1800840719; Jis JH, 2013, CANCER CHEMOTH PHARM, V72, P223; Kato T, 2003, DIS COLON RECTUM, V46, pS22, DOI 10.1097/01.DCR.0000089106.71914.00; Nathan H, 2010, J AM COLL SURGEONS, V210, P755, DOI 10.1016/j.jamcollsurg.2009.12.041; Pearsons RK., 2010, YB GASTROENTEROL, V2010, P91; Power DG, 2011, CRIT REV ONCOL HEMAT, V79, P251, DOI 10.1016/j.critrevonc.2010.08.001; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; Takahashi T, 2013, INT J CLIN ONCOL, V18, P335, DOI 10.1007/s10147-012-0382-z; Uetake H, 2015, ANN SURG ONCOL, V22, P908, DOI 10.1245/s10434-014-4094-7; Yes LC, 2013, J CLIN ONCOL, V31, P1931	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	AUG	2015	22	8					634	645		10.1002/jhbp.254		12	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CN3MT	WOS:000358331600013		
J	Tateoka, Y				Tateoka, Yumiko			Bisphenol A Concentration in Breast Milk following Consumption of a Canned Coffee Drink	JOURNAL OF HUMAN LACTATION			English	Article						Bisphenol A; breastfeeding	METABOLISM; URINE; SERUM; RAT	Background: Bisphenol A (BPA) is generally considered to be an endocrine disruptor. Previous reports indicate that the BPA content in breast milk is higher than that in serum; however, BPA is considered to be excreted in the urine and not to accumulate in the body. Objective: The current study aimed at evaluating the migration of BPA from a commercially available canned coffee drink in a container that was coated with vinyl chloride resin into breast milk. Methods: Ten women who had breastfed for 12 months, were ready to cease breastfeeding, and drank commercially available canned coffee drinks daily were approached to participate. A canned coffee drink in which the can contained vinyl chloride resin was chosen. Samples (5 mL each) of urine and breast milk were collected prior to and after ingestion (1 h, 2 h, 4 h, and 6 h) of a 190-mL canned coffee drink. BPA measurements were conducted using an ELISA kit. Results: Each 190-mL can of coffee contained 196.9 ng/mL BPA, resulting in 37.4 g that was consumed in each drink. In breast milk, peak BPA excretion occurred at 1 hour; in urine, excretion occurred rapidly during the first hour, remaining relatively unchanged at 2 hours. Conclusion: The present results indicate that BPA is excreted into the breast milk in addition to the urine and feces. Therefore, it is important to reduce both direct and indirect dietary BPA intake.	[Tateoka, Yumiko] Shiga Univ Med Sci, Dept Clin Nursing, Otsu, Shiga 5202192, Japan	Tateoka, Y (reprint author), Shiga Univ Med Sci, Fac Nursing, Dept Clin Nursing, Seta Tsukinowacho, Otsu, Shiga 5202192, Japan.	ytateoka@belle.shiga-med.ac.jp			Showa Shell Environment Research grant	The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by a Showa Shell Environment Research grant.	Yokota H, 1999, BIOCHEM J, V340, P405, DOI 10.1042/0264-6021:3400405; Kawamura Y, 1999, J FOOD HYG SOC JPN, V40, P158; Kuroda N, 2003, J PHARMACEUT BIOMED, V30, P1743, DOI 10.1016/S0731-7085(02)00516-2; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Cagen SZ, 1999, TOXICOL SCI, V50, P36, DOI 10.1093/toxsci/50.1.36; CLIMIE IJG, 1981, XENOBIOTICA, V11, P401; Hirahara F, 2002, INT S 5 END DISR RES; KNAAK JB, 1966, TOXICOL APPL PHARM, V8, P175, DOI 10.1016/S0041-008X(66)80001-7; Kodaira T, 2000, GASTROINTESTINAL HOR, P74; Kuruto R, 2003, P 6 ANN M JAP SOC EN; Lawrence RA, 1983, PHYSL LACTATION PROD, P38; Tateoka Y, 2004, J JPN ACAD MID, V18, P63; Usuki Y, 2000, BIO CLIN, V15, P145; Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239	15	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0890-3344	1552-5732		J HUM LACT	J. Hum. Lact.	AUG	2015	31	3					474	478		10.1177/0890334414563732		5	Nursing; Obstetrics & Gynecology; Pediatrics	Nursing; Obstetrics & Gynecology; Pediatrics	CM9ZN	WOS:000358070300023		
J	Mishra, BK; Herath, S				Mishra, Binaya Kumar; Herath, Srikantha			Assessment of Future Floods in the Bagmati River Basin of Nepal Using Bias-Corrected Daily GCM Precipitation Data	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Bias correction; Climate change; Global climate model (GCM); Homogeneous precipitation region; Rainfall-runoff model; Flood frequency	20-KM MESH AGCM; CLIMATE-CHANGE; WATER-RESOURCES; FREQUENCY-ANALYSIS; RAINFALL; SIMULATION; MODEL; VARIABILITY; REGIONALIZATION; PROJECTIONS	In this paper, climate change impact on flood frequency has been investigated in Bagmati River Basin of Nepal using bias-corrected global climate model (GCM) precipitation output. The research reported in this paper employed a high-resolution (approximately 20-km) daily GCM precipitation and temperature output of Meteorological Research Institute (MRI), Japan. Comparison of observation and GCM data pointed out that the MRI-GCM precipitation consists of significant biases in frequency and intensity values. Quantile-quantile mapping method of GCM bias correction was applied for minimizing the biases in precipitation frequencies and intensities. Concept of homogeneous precipitation regions was introduced to link the uneven observation data stations and GCM grid cells. Analyses of return period curves, shape, and scale factors at different observation stations enabled delineation of three homogeneous precipitation regions. Accordingly, regional quantile-quantile bias-correction technique was developed for minimizing biases in MRI-GCM precipitation output. A distributed rainfall-runoff model enabled generation of streamflow series using bias-corrected GCM output for 1979-2003 and 2075-2099 periods, as current and future scenarios, respectively. Finally, comparative flood frequency analyses were carried out for the simulated annual daily maximum streamflow series of current and future climates. The analyses revealed that the climate change will result more extreme precipitation events in monsoon months and less precipitation in other months. The analyses also revealed that flood events will be significantly increased in future. The range of change in 2-100 year return period floods was from 24-40%. (C) 2014 American Society of Civil Engineers.	[Mishra, Binaya Kumar] Univ Tokyo, Integrated Res Syst Sustainabil Sci, Bunkyo Ku, Tokyo 1138654, Japan; [Herath, Srikantha] United Nations Univ, Tokyo 1508925, Japan	Mishra, BK (reprint author), Univ Tokyo, Integrated Res Syst Sustainabil Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	mishra@ir3s.u-tokyo.ac.jp					Abbs D., 2007, IMPACT CLIMATE CHANG; Agrawala S., 2003, DEV CLIMATE CHANGE N; Andreassian V., 2006, IAHS PUBLICATION; Githui F, 2009, INT J CLIMATOL, V29, P1823, DOI 10.1002/joc.1828; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; Comrie AC, 1998, CLIMATE RES, V10, P201, DOI 10.3354/cr010201; Acharya N, 2013, METEOROL APPL, V20, P349, DOI 10.1002/met.1294; Ines AVM, 2006, AGR FOREST METEOROL, V138, P44, DOI 10.1016/j.agrformet.2006.03.009; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Leander R, 2007, J HYDROL, V332, P487, DOI 10.1016/j.jhydrol.2006.08.006; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Dankers R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009719; Wang GQ, 2012, HYDROL EARTH SYST SC, V16, P231, DOI 10.5194/hess-16-231-2012; Sharma D, 2007, HYDROL EARTH SYST SC, V11, P1373; Elshamy ME, 2009, HYDROL EARTH SYST SC, V13, P551; Hansen JW, 2006, CLIM RES, V33, P27, DOI 10.3354/cr033027; Mpelasoka FS, 2009, J HYDROMETEOROL, V10, P1168, DOI 10.1175/2009JHM1045.1; Raziei T, 2008, HYDROL EARTH SYST SC, V12, P1309; HOSKING JRM, 1993, WATER RESOUR RES, V29, P271, DOI 10.1029/92WR01980; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Babel MS, 2014, THEOR APPL CLIMATOL, V115, P639, DOI 10.1007/s00704-013-0910-4; Brath A., 2004, J HYDROL, V291, P272; Chaudhary P., 2009, Journal of Forest and Livelihood, V8, P4; Chaulagain N. P., 2006, THESIS U FLENSBURG G; Chiew F. H. S., 2008, CLIMATE DATA HYDROLO; Coulibaly P., 2004, S021501 MCMASTER U D; Dhital YP, 2013, J GEOGR SCI, V23, P612, DOI 10.1007/s11442-013-1032-8; FAO, 2003, FAO LAND WAT DIG MED, V1; Gautam D. K., 2004, P INT C HYDR, P1; Gray W., 2005, CHC2005060 NIWA; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Hosking J. R. M., 2005, LMOMENTS FORTRAN ROU; Hosking JRM, 1997, REGIONAL FREQUENCY A; IPCC, 2000, SPEC REP EM SCEN; Jarvis A., 2008, HOLE FILLED SRTM GLO; Kachroo RK, 2000, HYDROLOG SCI J, V45, P437, DOI 10.1080/02626660009492340; Kirono D. G. C., 2011, 034 CAWCR; Kitoh A, 2008, CLIM DYNAM, V31, P389, DOI 10.1007/s00382-007-0285-2; Kleinn J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005143; Kusunoki S., 2008, J DISASTER RES, V3, P4; Lawrence D., 2011, 5 NWRED; Mishra B. K., 2011, P INT C ADDR CLIM CH, P275; Mishra B. K., 2008, ANN J HYDRAUL ENG, V52, P91; Mizuta R, 2006, J METEOROL SOC JPN, V84, P165, DOI 10.2151/jmsj.84.165; Mohammadnejad R., 2010, CLIMATE CHANGE IMPAC; Montanari A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011412; Moors EJ, 2011, ENVIRON SCI POLICY, V14, P758, DOI 10.1016/j.envsci.2011.03.005; Moretti G, 2007, ENVIRON MODELL SOFTW, V22, P823, DOI 10.1016/j.envsoft.2006.02.012; MOSLEY MP, 1981, J HYDROL, V49, P173, DOI 10.1016/0022-1694(81)90211-0; Nakayama Keisuke, 2011, Hydrological Research Letters, V5, DOI 10.3178/HRL.5.47; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NCVST, 2009, VULN EYES VULN CLIM; Portoghese I, 2011, NAT HAZARD EARTH SYS, V11, P2497, DOI 10.5194/nhess-11-2497-2011; Rajendran K, 2008, J CLIMATE, V21, P3722, DOI 10.1175/2008JCLI1950.1; Rao AR, 2000, FLOOD FREQUENCY ANAL; Ritzema H. P., 1994, DRAINAGE PRINCIPLES; Roy L, 2001, HYDROL PROCESS, V15, P3167, DOI 10.1002/hyp.323; SCS, 1972, SCS NAT ENG HDB; Sharma B. P., 2005, GATEWAY LAND WATER I; Shavalova M. V., 2003, CLIM RES, V23, P233; Shrestha MS, 2008, J FLOOD RISK MANAG, V1, P89, DOI 10.1111/j.1753-318X.2008.00011.x; Solomon S., 2007, SUMMARY POLICYMAKERS; Sperna Weiland F. C., 2010, HYDROL EARTH SYST SC, V7, P687; Strahler AN, 1964, HDB APPL HYDROLOGY; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Trenberth K. E., 2008, ENCY HYDROLOGICAL SC; Zhu T., 2010, CLIMATE CHANGE IMPLI	67	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	AUG	2015	20	8							05014027	10.1061/(ASCE)HE.1943-5584.0001090		11	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CN1KB	WOS:000358177500003		
J	Ayano, M; Tsukamoto, H; Kohno, K; Ueda, N; Tanaka, A; Mitoma, H; Akahoshi, M; Arinobu, Y; Niiro, H; Horiuchi, T; Akashi, K				Ayano, Masahiro; Tsukamoto, Hiroshi; Kohno, Kentaro; Ueda, Naoyasu; Tanaka, Atsushi; Mitoma, Hiroki; Akahoshi, Mitsuteru; Arinobu, Yojiro; Niiro, Hiroaki; Horiuchi, Takahiko; Akashi, Koichi			Increased CD226 Expression on CD8(+) T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis	JOURNAL OF IMMUNOLOGY			English	Article							EFFECTOR FUNCTIONS; MEDIATED CYTOTOXICITY; MOLECULAR-MECHANISMS; MICROARRAY ANALYSIS; DERMAL FIBROSIS; CD8+T CELLS; PVR CD155; SCLERODERMA; DISEASE; DNAM-1	Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular damage and fibrosis of the skin and internal organs. Because activated and oligoclonally expanded CD8(+) T cells can be detected in peripheral blood and lungs of SSc patients, effector memory CD8(+) T cells may play a critical role for organ involvement in SSc; however, the pathogenic functions of effector memory CD8(+) T cells remain incompletely understood. In this study, we performed DNA microarray analysis of the sort-purified effector memory CD8(+) T cells from SSc patients and healthy controls, and showed that the expression of genes related to immune response and cell adhesion, including CD226 (also known as DNAX accessory molecule-1 [DNAM-1]), was significantly altered. Moreover, detailed analysis of CD226 revealed that CD226 high CD8(+) T cells were increased in SSc patients (mean, 50.7%) compared with healthy controls (32.9%) and were appreciably associated with the severity of skin sclerosis and interstitial lung disease. Furthermore, CD226(+)CD8(+) T cells produced higher amount of various cytokines than CD226 2 ones, and CD226 high CD8(+) T cells from SSc patients showed upregulated IL-13 production and positive correlation with the cytotoxic capacity of CD8(+) T cells against HUVECs. Finally, the neutralization of CD226 in CD8(+) T cells impaired costimulation, cytokine productions, and cytolysis against HUVECs. These findings indicate that upregulated CD226 expression on CD8(+) T cells reflects disease severity and is involved in SSc pathogenesis via the production of various cytokines, including profibrotic IL-13 and endothelial cell injury, and that CD226 may be a useful target in the treatment of SSc.	[Ayano, Masahiro; Tsukamoto, Hiroshi; Tanaka, Atsushi; Mitoma, Hiroki; Akahoshi, Mitsuteru; Arinobu, Yojiro; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Kohno, Kentaro] Natl Kyushu Med Ctr, Dept Hematol, Fukuoka 8108563, Japan; [Ueda, Naoyasu] Miyazaki Prefectural Miyazaki Hosp, Dept Internal Med, Miyazaki 8808510, Japan; [Niiro, Hiroaki] Kyushu Univ Hosp, Clin Educ Ctr, Fukuoka 8128582, Japan; [Horiuchi, Takahiko] Kyushu Univ, Beppu Hosp, Dept Internal Med, Beppu, Oita 8740836, Japan	Tsukamoto, H (reprint author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsukamot@intmed1.med.kyushu-u.ac.jp			Ministry of Health, Labour, and Welfare [H24-Jitsuyoka-Kokusai-004]; Ministry of Education, Culture, Sports, Science and Technology of Japan (Japan Society for the Promotion of Science, KAKENHI Grants) [24591465, 15K09527]	This work was supported by grants from the Ministry of Health, Labour, and Welfare (H24-Jitsuyoka-Kokusai-004) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (Japan Society for the Promotion of Science, KAKENHI Grants 24591465 and 15K09527).	Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Lozano E, 2013, J IMMUNOL, V191, P3673, DOI 10.4049/jimmunol.1300945; LEROY EC, 1988, J RHEUMATOL, V15, P202; Smyth GK, 2005, STAT BIOL HEALTH, P397; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Sgonc R, 2000, ARTHRITIS RHEUM-US, V43, P2550, DOI 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Kahaleh MB, 1999, CLIN IMMUNOL, V91, P188, DOI 10.1006/clim.1999.4694; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Baraut J, 2010, AUTOIMMUN REV, V10, P65, DOI 10.1016/j.autrev.2010.08.003; Fuschiotti P, 2009, ARTHRITIS RHEUM, V60, P1119, DOI 10.1002/art.24432; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Dardalhon V, 2005, J IMMUNOL, V175, P1558; Avouac J, 2013, ANN RHEUM DIS, V72, P1089, DOI 10.1136/annrheumdis-2012-201759; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Gu YS, 2008, SEMIN ARTHRITIS RHEU, V38, P132, DOI 10.1016/j.semarthrit.2007.10.010; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sakkas LI, 2004, ARTHRITIS RHEUM, V50, P1721, DOI 10.1002/art.20315; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Fuschiotti P, 2013, ARTHRITIS RHEUM-US, V65, P236, DOI 10.1002/art.37706; Fuschiotti P, 2011, CYTOKINE, V56, P544, DOI 10.1016/j.cyto.2011.08.030; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Luzina IG, 2003, ARTHRITIS RHEUM, V48, P2262, DOI 10.1002/art.11080; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Sgonc R, 1996, J CLIN INVEST, V98, P785, DOI 10.1172/JCI118851; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; Bossini-Castillo L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3809; Dieude P, 2011, ARTHRITIS RHEUM-US, V63, P1097, DOI 10.1002/art.30204; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenblatt MB, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0297-8; GUSTAFSSON R, 1990, ANN RHEUM DIS, V49, P40, DOI 10.1136/ard.49.1.40; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Lympany PA, 1999, EUR J CLIN INVEST, V29, P173, DOI 10.1046/j.1365-2362.1999.00434.x; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Maier LM, 2009, IMMUNOL REV, V229, P322, DOI 10.1111/j.1600-065X.2009.00777.x; MASI A T, 1980, Arthritis and Rheumatism, V23, P581, DOI 10.1002/art.1780230510; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Oertelt S, 2005, AUTOIMMUN REV, V4, P414, DOI 10.1016/j.autrev.2005.05.004; SASAKI E, 2001, J JPN RESP SOC, V39, P383; Shibuya Akira, 2005, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V4, P53, DOI 10.2174/1568014053005390; Tiev KP, 2005, CLIN EXP IMMUNOL, V139, P348, DOI 10.1111/j.1365-2249.2004.02647.x	50	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	AUG 1	2015	195	3					892	900		10.4049/jimmunol.1403046		9	Immunology	Immunology	CM9ZO	WOS:000358070400019		
J	Ito, D; Nojima, S; Nishide, M; Okuno, T; Takamatsu, H; Kang, SJ; Kimura, T; Yoshida, Y; Morimoto, K; Maeda, Y; Hosokawa, T; Toyofuku, T; Ohshima, J; Kamimura, D; Yamamoto, M; Murakami, M; Morii, E; Rakugi, H; Isaka, Y; Kumanogoh, A				Ito, Daisuke; Nojima, Satoshi; Nishide, Masayuki; Okuno, Tatsusada; Takamatsu, Hyota; Kang, Sujin; Kimura, Tetsuya; Yoshida, Yuji; Morimoto, Keiko; Maeda, Yohei; Hosokawa, Takashi; Toyofuku, Toshihiko; Ohshima, Jun; Kamimura, Daisuke; Yamamoto, Masahiro; Murakami, Masaaki; Morii, Eiichi; Rakugi, Hiromi; Isaka, Yoshitaka; Kumanogoh, Atsushi			mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8(+) T Cells	JOURNAL OF IMMUNOLOGY			English	Article							MAMMALIAN PROTEIN; SEMAPHORIN; RECEPTORS; EFFECTOR; SEMA4A; GROWTH; GUIDANCE; PATHWAY; TRANSMEMBRANE; INFECTION	Mammalian target of rapamycin (mTOR) plays crucial roles in activation and differentiation of diverse types of immune cells. Although several lines of evidence have demonstrated the importance of mTOR-mediated signals in CD4(+) T cell responses, the involvement of mTOR in CD8(+) T cell responses is not fully understood. In this study, we show that a class IV semaphorin, SEMA4A, regulates CD8(+) T cell activation and differentiation through activation of mTOR complex (mTORC) 1. SEMA4A(-/-) CD8(+) T cells exhibited impairments in production of IFN-gamma and TNF-alpha and induction of the effector molecules granzyme B, perforin, and FAS-L. Upon infection with OVA-expressing Listeria monocytogenes, pathogen-specific effector CD8(+) T cell responses were significantly impaired in SEMA4A(-/-) mice. Furthermore, SEMA4A(-/-) CD8(+) T cells exhibited reduced mTORC1 activity and elevated mTORC2 activity, suggesting that SEMA4A is required for optimal activation of mTORC1 in CD8(+) T cells. IFN-g production and mTORC1 activity in SEMA4A(-/-) CD8(+) T cells were restored by administration of recombinant Sema4A protein. In addition, we show that plexin B2 is a functional receptor of SEMA4A in CD8(+) T cells. Collectively, these results not only demonstrate the role of SEMA4A in CD8(+) T cells, but also reveal a novel link between a semaphorin and mTOR signaling.	[Ito, Daisuke; Nojima, Satoshi; Nishide, Masayuki; Okuno, Tatsusada; Takamatsu, Hyota; Kang, Sujin; Kimura, Tetsuya; Yoshida, Yuji; Morimoto, Keiko; Maeda, Yohei; Hosokawa, Takashi; Toyofuku, Toshihiko; Kumanogoh, Atsushi] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr, Dept Immunopathol, Suita, Osaka 5650871, Japan; [Ito, Daisuke; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Ito, Daisuke; Nishide, Masayuki; Takamatsu, Hyota; Kang, Sujin; Kimura, Tetsuya; Yoshida, Yuji; Morimoto, Keiko; Hosokawa, Takashi; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Ito, Daisuke; Nojima, Satoshi; Nishide, Masayuki; Takamatsu, Hyota; Kang, Sujin; Kimura, Tetsuya; Yoshida, Yuji; Morimoto, Keiko; Hosokawa, Takashi; Toyofuku, Toshihiko; Kumanogoh, Atsushi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; [Nojima, Satoshi; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Okuno, Tatsusada] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; [Kang, Sujin] Osaka Univ, Grad Sch Med, Dept Clin Applicat Biol, Suita, Osaka 5650871, Japan; [Maeda, Yohei] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650871, Japan; [Toyofuku, Toshihiko] Osaka Univ, Grad Sch Med, Dept Immunol & Regenerat Med, Suita, Osaka 5650871, Japan; [Ohshima, Jun; Yamamoto, Masahiro] Osaka Univ, Microbial Dis Res Inst, Dept Immunoparasitol, Suita, Osaka 5650871, Japan; [Ohshima, Jun; Yamamoto, Masahiro] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr, Lab Immunoparasitol, Suita, Osaka 5650871, Japan; [Kamimura, Daisuke; Murakami, Masaaki] Hokkaido Univ, Grad Sch Med, Inst Med Genet, Dept Mol Neuroimmunol, Sapporo, Hokkaido 0600815, Japan	Nojima, S (reprint author), Osaka Univ, Grad Sch Med, Dept Pathol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	s_nojima@molpath.med.osaka-u.ac.jp; kumanogo@imed3.med.osaka-u.ac.jp			Core Research for Evolutional Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation	This work was supported by research grants from Core Research for Evolutional Science and Technology; the Ministry of Education, Culture, Sports, Science and Technology of Japan (to A.K.); the Ministry of Health, Labour, and Welfare of Japan (to A.K.); and the Takeda Science Foundation (to S.N.).	Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; SABERS CJ, 1995, J BIOL CHEM, V270, P815; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Luchino J, 2013, CANCER CELL, V24, P673, DOI 10.1016/j.ccr.2013.09.010; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Chen JL, 2014, INT J DEV NEUROSCI, V35, P35, DOI 10.1016/j.ijdevneu.2014.03.006; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Nakatsuji Y, 2012, J IMMUNOL, V188, P4858, DOI 10.4049/jimmunol.1102023; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Goldberg EL, 2014, J IMMUNOL, V193, P757, DOI 10.4049/jimmunol.1400188; Holl EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043333; Kamimura D, 2007, J EXP MED, V204, P1803, DOI 10.1084/jem.20070543; Nukazuka A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1495; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Toyofaku T, 2007, ADV EXP MED BIOL, V600, P109; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Yukawa K, 2010, INT J MOL MED, V25, P225, DOI 10.3892/ijmm_00000334; Yukawa K, 2005, INT J MOL MED, V16, P115	54	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	AUG 1	2015	195	3					934	943		10.4049/jimmunol.1403038		10	Immunology	Immunology	CM9ZO	WOS:000358070400022		
J	Torres-Bacete, J; Delgado-Martin, C; Gomez-Moreira, C; Simizu, S; Rodriguez-Fernandez, JL				Torres-Bacete, Jesus; Delgado-Martin, Cristina; Gomez-Moreira, Carolina; Simizu, Siro; Luis Rodriguez-Fernandez, Jose			The Mammalian Sterile 20-like 1 Kinase Controls Selective CCR7-Dependent Functions in Human Dendritic Cells	JOURNAL OF IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CCR7; NF-KAPPA-B; PROTEIN-KINASE; LYMPH-NODES; RHO-KINASE; T-CELLS; MST1; ACTIVATION; APOPTOSIS; PHOSPHORYLATION	The chemokine receptor CCR7 directs mature dendritic cells (mDCs) to the lymph nodes where these cells control the initiation of the immune response. CCR7 regulates chemotaxis, endocytosis, survival, migratory speed, and cytoarchitecture in mDCs. The molecular mechanisms used by CCR7 to regulate these functions in mDCs are not completely understood. The mammalian sterile 20-like 1 kinase (Mst1) plays a proapoptotic role under stress conditions; however, recently, it has been shown that Mst1 can also control homeostatic cell functions under normal conditions. In this study, we show that stimulation of CCR7 in mDCs induces Gai-dependent activation of Mst1, suggesting the involvement of this kinase in the control of CCR7-dependent functions. Analysis of the mDCs in which Mst1 expression levels were reduced with small interfering RNA shows that this kinase mediates CCR7-dependent effects on cytoarchitecture, endocytosis and migratory speed but not on chemotaxis or survival. In line with these results, biochemical analysis indicates that Mst1 does not control key signaling regulators of CCR7-dependent chemotaxis or survival. In contrast, Mst1 regulates downstream of CCR7 and, of note, independently of G(alpha 13), the RhoA pathway. Reduction of Mst1 inhibits CCR7-dependent phosphorylation of downstream targets of RhoA, including cofilin, myosin L chain, and myosin L chain phosphatase. Consistent with the role of the latter molecules as modulators of the actin cytoskeleton, mDCs with reduced Mst1 also displayed a dramatic reduction in actin barbed-end formation that could not be recovered by stimulating CCR7. The results indicate that the kinase Mst1 controls selective CCR7-dependent functions in human mDCs.	[Torres-Bacete, Jesus; Delgado-Martin, Cristina; Gomez-Moreira, Carolina; Luis Rodriguez-Fernandez, Jose] CSIC, Ctr Invest Biol, Dept Microbiol Mol & Biol Infecc, E-28040 Madrid, Spain; [Simizu, Siro] RIKEN Adv Sci Inst, Dept Biol Chem, Yokohama, Kanagawa 2300045, Japan	Rodriguez-Fernandez, JL (reprint author), CSIC, Ctr Invest Biol, Calle Ramiro Maeztu 9, E-28040 Madrid, Spain.	rodrifer@cib.csic.es	Partearroyo, CIB-Biblioteca/L-3262-2014	Partearroyo, CIB-Biblioteca/0000-0002-1692-4481	Ministerio de Ciencia e Innovacion Grant [SAF2008-01468]; Ministerio de Economia y Competitividad Grants [SAF2011-023890, SAF2014-53151-R]; "Redes Tematicas de Investigacion Cooperativa en Salud" Program/Instituto de Salud Carlos III (Red de Inflamacion y Enfermedades Reumaticas [RIER]) Grant [RD08/0075]; Consejeria de Educacion y Empleo from Comunidad de Madrid Grant [(Raphyme) S2010/BMD-2350]; Junta de Ampliacion de Estudios Doctores contract; European Social Fund; Formacion de Personal Investigador Fellowship; RIER [RD08/0075]; Consejeria de Educacion y Empleo, Comunidad de Madrid [Raphyme S2010/BMD-2350]	This work was partially supported by Ministerio de Ciencia e Innovacion Grant SAF2008-01468, Ministerio de Economia y Competitividad Grants SAF2011-023890 and SAF2014-53151-R, "Redes Tematicas de Investigacion Cooperativa en Salud" Program/Instituto de Salud Carlos III (Red de Inflamacion y Enfermedades Reumaticas [RIER]) Grant RD08/0075, and Consejeria de Educacion y Empleo from Comunidad de Madrid Grant (Raphyme) S2010/BMD-2350. J.T.-B. was supported by a Junta de Ampliacion de Estudios Doctores contract conferred by the Consejo Superior de Investigaciones Cientificas, which is cofinanced by the European Social Fund. C.D.-M. was partially supported by a Formacion de Personal Investigador Fellowship, conferred by the Ministerio de Educacion y Ciencia (Spain) and by a contract associated with Grant RD08/0075 (RIER). C.G.-M. was supported by a contract associated with Grant Raphyme S2010/BMD-2350 (Consejeria de Educacion y Empleo, Comunidad de Madrid).	Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; CREASY CL, 1995, J BIOL CHEM, V270, P21695; Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Liu F, 2001, AM J RESP CELL MOL, V24, P711; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Huang S, 2001, J BIOL CHEM, V276, P40977, DOI 10.1074/jbc.M105242200; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Amano M, 1996, J BIOL CHEM, V271, P20246; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Gomez-Cabanas L, 2014, NAT PROTOC, V9, P1102, DOI 10.1038/nprot.2014.078; Qin FN, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-31; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Rodriguez-Fernandez JL, 2001, J BIOL CHEM, V276, P40518, DOI 10.1074/jbc.M102896200; Ueda Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2105; Vichalkovski A, 2005, CELL SIGNAL, V17, P447, DOI 10.1016/j.cellsig.2004.09.010; Watabe M, 1999, ONCOGENE, V18, P5211, DOI 10.1038/sj.onc.1202901; Yin HL, 2012, CELL MOL IMMUNOL, V9, P439, DOI 10.1038/cmi.2012.30	50	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	AUG 1	2015	195	3					973	981		10.4049/jimmunol.1401966		9	Immunology	Immunology	CM9ZO	WOS:000358070400026		
J	Iguchi, T; Aoki, K; Ikawa, T; Taoka, M; Taya, C; Yoshitani, H; Toma-Hirano, M; Koiwai, O; Isobe, T; Kawamoto, H; Masai, H; Miyatake, S				Iguchi, Tomohiro; Aoki, Kazuhisa; Ikawa, Tomokatsu; Taoka, Masato; Taya, Choji; Yoshitani, Hiroshi; Toma-Hirano, Makiko; Koiwai, Osamu; Isobe, Toshiaki; Kawamoto, Hiroshi; Masai, Hisao; Miyatake, Shoichiro			BTB-ZF Protein Znf131 Regulates Cell Growth of Developing and Mature T Cells	JOURNAL OF IMMUNOLOGY			English	Article							BETA-SELECTION CHECKPOINT; PRE-TCR; INTERLEUKIN-7 RECEPTOR; INDUCED PROLIFERATION; LYMPHOCYTE EGRESS; INHIBITOR P21; LINEAGE FATE; C-MYC; TRANSCRIPTION; SURVIVAL	Many members of the BTB-ZF family have been shown to play important roles in lymphocyte development and function. The role of zinc finger Znf131 (also known as Zbtb35) in T cell lineage was elucidated through the production of mice with floxed allele to disrupt at different stages of development. In this article, we present that Znf131 is critical for T cell development during double-negative to double-positive stage, with which significant cell expansion triggered by the pre-TCR signal is coupled. In mature T cells, Znf131 is required for the activation of effector genes, as well as robust proliferation induced upon TCR signal. One of the cyclin-dependent kinase inhibitors, p21(Cip1) encoded by cdkn1a gene, is one of the targets of Znf131. The regulation of T cell proliferation by Znf131 is in part attributed to its suppression on the expression of p21(Cip1).	[Iguchi, Tomohiro; Aoki, Kazuhisa; Yoshitani, Hiroshi; Miyatake, Shoichiro] Tokyo Metropolitan Inst Med Sci, Lab Self Def Gene Regulat, Setagaya Ku, Tokyo 1568506, Japan; [Iguchi, Tomohiro; Koiwai, Osamu] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Ikawa, Tomokatsu] RIKEN, Young Chief Investigators Lab Immune Regenerat, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Biochem Lab, Hachioji, Tokyo 1920397, Japan; [Taya, Choji] Tokyo Metropolitan Inst Med Sci, Anim Res Div, Tokyo 1568506, Japan; [Toma-Hirano, Makiko] Univ Tokyo, Grad Sch Med, Dept Otolaryngol, Tokyo 1138655, Japan; [Kawamoto, Hiroshi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunol, Field Regenerat Control, Kyoto 6068507, Japan; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Tokyo 1568506, Japan	Miyatake, S (reprint author), Tokyo Metropolitan Inst Med Sci, Lab Self Def Gene Regulat, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	miyatake-si@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society of the Promotion of Science [26460585]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society of the Promotion of Science (Grant 26460585).	ANDERSON SJ, 1992, EMBO J, V11, P4877; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Arias CF, 2007, J IMMUNOL, V178, P2296; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Huang F, 2006, IMMUNITY, V25, P571, DOI 10.1016/j.immuni.2006.08.021; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Oh Y, 2012, J BIOL CHEM, V287, P17517, DOI 10.1074/jbc.M111.336354; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Ciofani M, 2004, J IMMUNOL, V172, P5230; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; Goulvestre C, 2005, J IMMUNOL, V175, P6959; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Kappes DJ, 2010, IMMUNOL REV, V238, P182, DOI 10.1111/j.1600-065X.2010.00958.x; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Oh Y, 2013, J BIOL CHEM, V288, P9102, DOI 10.1074/jbc.M112.438234; Oh Y, 2013, BIOCHEM BIOPH RES CO, V430, P400, DOI 10.1016/j.bbrc.2012.11.031; Pajerowski AG, 2010, BLOOD, V116, P2684, DOI 10.1182/blood-2010-02-268391; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Saba I, 2011, J IMMUNOL, V187, P2982, DOI 10.4049/jimmunol.1101451; Saba I, 2011, BLOOD, V117, P3370, DOI 10.1182/blood-2010-09-310680; Santiago-Raber ML, 2001, J IMMUNOL, V167, P4067; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; VERNACHIO J, 1989, J IMMUNOL, V142, P48	60	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	AUG 1	2015	195	3					982	993		10.4049/jimmunol.1500602		12	Immunology	Immunology	CM9ZO	WOS:000358070400027		
J	Suzuki, M; Morita, R; Hirata, Y; Shichita, T; Yoshimura, A				Suzuki, Mayu; Morita, Rimpei; Hirata, Yasuko; Shichita, Takashi; Yoshimura, Akihiko			Spred1, a Suppressor of the Ras-ERK Pathway, Negatively Regulates Expansion and Function of Group 2 Innate Lymphoid Cells	JOURNAL OF IMMUNOLOGY			English	Article							NATURAL HELPER-CELLS; ALLERGIC LUNG INFLAMMATION; AIRWAY INFLAMMATION; LEGIUS SYNDROME; IL-33; CYTOKINES; IMMUNITY; ASTHMA; GATA3; PROLIFERATION	Cytokines from group 2 innate lymphoid cells (ILC2s) have been implicated in acute allergic responses, such as papain-induced lung inflammation. However, the means of homeostatic regulation of ILC2s have not been established. In this study, we demonstrated that Spred1, a negative regulator of the Ras-ERK pathway, plays an important role in the proliferation and apoptosis of ILC2s and in cytokine secretion from ILC2s. Intranasal administration of papain stimulated IL-5 and IL-13 production in the lung, which was enhanced when Spred1 was deleted. In vitro, Spred1(-/-) ILC2s proliferated faster than wild type ILC2s did and produced higher levels of cytokines in response to IL-33. On the contrary, a MEK inhibitor suppressed ILC2 proliferation and cytokine production. Spred1 deficiency resulted in stabilization of GATA3, which has been shown to play essential roles in the maintenance and cytokine production of ILC2. These data suggest that Spred1 negatively regulates ILC2 development and functions through the suppression of the Ras-ERK pathway.	[Suzuki, Mayu; Morita, Rimpei; Hirata, Yasuko; Shichita, Takashi; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Suzuki, Mayu; Morita, Rimpei; Hirata, Yasuko; Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Shichita, Takashi] Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Yoshimura, A (reprint author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp			Japan Society for the Promotion of Science [2522105]; Precursory Research for Embryonic Science and Technology; SENSHIN Research Foundation; Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center Hospital of Neurology and Psychiatry from the Uehara Memorial Foundation [22-4]	This work was supported by a Grant-in-Aid for Scientific Research (S) (2522105) from Japan Society for the Promotion of Science and an Intramural Research Grant (22-4) for Neurological and Psychiatric Disorders of National Center Hospital of Neurology and Psychiatry from the Uehara Memorial Foundation (to A.Y.), and by Precursory Research for Embryonic Science and Technology, the SENSHIN Research Foundation, the Kanae Foundation for the Promotion of Medical Science, and the Takeda Science Foundation (to T.S.).	Chan H, 1999, MOL CELL BIOL, V19, P2098; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Ishizaki T, 2011, GENES CELLS, V16, P803, DOI 10.1111/j.1365-2443.2011.01529.x; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Tamiya T, 2013, J IMMUNOL, V191, P2360, DOI 10.4049/jimmunol.1301276; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Yu HS, 2010, J KOREAN MED SCI, V25, P829, DOI 10.3346/jkms.2010.25.6.829; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Funakoshi-Tago M, 2011, CELL SIGNAL, V23, P363, DOI 10.1016/j.cellsig.2010.10.006; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Brems Hilde, 2013, Keio Journal of Medicine, V62, P107, DOI 10.2302/kjm.2013-0002-RE; Brestoff J. R., NATURE, V519, P242; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Mjosberg J, 2012, EUR J IMMUNOL, V42, P1093, DOI 10.1002/eji.201242549; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Veinotte LL, 2008, BLOOD, V111, P4201, DOI 10.1182/blood-2007-04-087577	38	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	AUG 1	2015	195	3					1273	1281		10.4049/jimmunol.1500531		9	Immunology	Immunology	CM9ZO	WOS:000358070400055		
J	Kajita, A; Morizane, S; Takiguchi, T; Yamamoto, T; Yamada, M; Iwatsuki, K				Kajita, Ai; Morizane, Shin; Takiguchi, Tetsuya; Yamamoto, Takenobu; Yamada, Masao; Iwatsuki, Keiji			Interferon-Gamma Enhances TLR3 Expression and Anti-Viral Activity in Keratinocytes	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; NF-KAPPA-B; CELLULAR-RESPONSES; T-LYMPHOCYTES; INFECTION; BETA; CELLS; ENCEPHALITIS	Toll-like receptors (TLRs) recognize specific microbial products in the innate immune response. TLR3, a double-stranded RNA sensor, is thought to have an important role in viral infections, but the regulation of TLR3 expression and its function in keratinocytes are not fully understood. Here we show the Th1 cytokine IFN-gamma increased the TLR3 expression via STAT1 in cultured normal human epidermal keratinocytes (NHEKs). Co-stimulation with IFN-gamma and the TLR3 ligand poly (I:C) synergistically increased the expression of IFN-beta, IL-6, IL-8, and human beta-defensin-2 in NHEKs compared with poly (I:C) or IFN-gamma alone. These synergistic inductions were significantly inhibited by an endosomal acidification inhibitor, chloroquine, and by TLR3 siRNA. Co-stimulation with IFN-gamma and poly (I:C) also significantly enhanced the anti-viral activity against herpes simplex virus type-1 in NHEKs compared with poly (I:C) or IFN-gamma alone. In addition to the in vitro findings, an immunohistochemical analysis revealed IFN-gamma positive cells surrounding herpetic vesicles. These findings indicate that IFN-gamma might contribute to the innate immune response to cutaneous viral infections by enhancing TLR3 expression and function in keratinocytes.	[Kajita, Ai; Morizane, Shin; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan; [Takiguchi, Tetsuya] Hamamatsu Univ Sch Med, Dept Plast Surg, Hamamatsu, Shizuoka 4313192, Japan; [Yamamoto, Takenobu] Kawasaki Med Univ, Dept Dermatol, Kurashiki, Okayama, Japan; [Yamada, Masao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Virol, Okayama 7008558, Japan	Morizane, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	zanemori@cc.okayama-u.ac.jp			Lydia O'Leary Memorial Foundation	We thank Dr Kenshi Yamasaki, Department of Dermatology, Tohoku University Graduate School of Medicine, for advice in this project. This work was supported by Lydia O'Leary Memorial Foundation.	Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Pollard KM, 2013, DISCOV MED, V87, P123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Takiguchi T, 2014, BRIT J DERMATOL, V171, P492, DOI 10.1111/bjd.12942; Morizane S, 2012, J INVEST DERMATOL, V132, P135, DOI 10.1038/jid.2011.259; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Zhang SQ, 2011, INFLAMM RES, V60, P1031, DOI 10.1007/s00011-011-0364-z; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Hazrati E, 2006, J IMMUNOL, V177, P8658; Veiga-Parga T, 2012, J IMMUNOL, V189, P5924, DOI 10.4049/jimmunol.1202322; Ermertcan AT, 2011, J EUR ACAD DERMATOL, V25, P997, DOI 10.1111/j.1468-3083.2011.04049.x; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Miettinen M, 2001, GENES IMMUN, V2, P349, DOI 10.1038/sj.gene.6363791; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Crack LR, 2012, CLIN EXP DERMATOL, V37, P534, DOI 10.1111/j.1365-2230.2012.04305.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; CUNNINGHAM AL, 1984, J IMMUNOL, V132, P197; CUNNINGHAM AL, 1983, J IMMUNOL, V130, P2397; Fujisawa H, 1997, J INTERF CYTOK RES, V17, P721, DOI 10.1089/jir.1997.17.721; Kalali BN, 2008, J IMMUNOL, V181, P2694; Kimura K, 2012, J DERMATOL SCI, V66, P64, DOI 10.1016/j.jdermsci.2012.02.006; Lembo David, 2006, FASEB J, V20, P148; Morizane S, 2005, BRIT J DERMATOL, V153, P981, DOI 10.1111/j.1365-2133.2005.06849.x; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; TEBAS P, 1995, ANTIMICROB AGENTS CH, V39, P1287; TORSETH JW, 1987, J INFECT DIS, V155, P641	45	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	AUG	2015	135	8					2005	2011		10.1038/jid.2015.125		7	Dermatology	Dermatology	CN2SL	WOS:000358272100011		
J	Herro, R; Antunes, RD; Aguilera, AR; Tamada, K; Croft, M				Herro, Rana; Antunes, Ricardo Da S.; Aguilera, Amelia R.; Tamada, Koji; Croft, Michael			The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; HERPESVIRUS ENTRY MEDIATOR; ALLERGIC AIRWAY INFLAMMATION; LYMPHOTOXIN BETA-RECEPTOR; ATOPIC-DERMATITIS; RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; SYSTEMIC-SCLEROSIS; TNF SUPERFAMILY; SEVERE ASTHMA	Several inflammatory diseases including scleroderma and atopic dermatitis display dermal thickening, epidermal hypertrophy, or excessive accumulation of collagen. Factors that might promote these features are of interest for clinical therapy. We previously reported that LIGHT, a TNF superfamily molecule, mediated collagen deposition in the lungs in response to allergen. We therefore tested whether LIGHT might similarly promote collagen accumulation and features of skin fibrosis. Strikingly, injection of recombinant soluble LIGHT into naive mice, either subcutaneously or systemically, promoted collagen deposition in the skin and dermal and epidermal thickening. This replicated the activity of bleomycin, an antibiotic that has been previously used in models of scleroderma in mice. Moreover skin fibrosis induced by bleomycin was dependent on endogenous LIGHT activity. The action of LIGHT in vivo was mediated via both of its receptors, HVEM and LT beta R, and was dependent on the innate cytokine TSLP and TGF-beta. Furthermore, we found that HVEM and LT beta R were expressed on human epidermal keratinocytes and that LIGHT could directly promote TSLP expression in these cells. We reveal an unappreciated activity of LIGHT on keratinocytes and suggest that LIGHT may be an important mediator of skin inflammation and fibrosis in diseases such as scleroderma or atopic dermatitis.	[Herro, Rana; Antunes, Ricardo Da S.; Aguilera, Amelia R.; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Tamada, Koji] Yamaguchi Univ, Sch Med, Dept Immunol, Yamaguchi, Japan	Croft, M (reprint author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 9420 Athena Circle, La Jolla, CA 92037 USA.	mick@liai.org			NIH [AI070535, AI100905]	We thank Klaus Pfeffer and Steve Ziegler for providing mice deficient in LIGHT, HVEM, and TSLPR. This work was supported by NIH grants AI070535 and AI100905 to MC	Usategui A, 2013, ANN RHEUM DIS, V72, P2018, DOI 10.1136/annrheumdis-2012-202279; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Kotani H, 2012, CLIN EXP IMMUNOL, V168, P318, DOI 10.1111/j.1365-2249.2012.04576.x; Lee EB, 2010, PEDIAT ALLERG IMM-UK, V21, pE457, DOI 10.1111/j.1399-3038.2009.00919.x; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Li MR, 2014, SCI CHINA LIFE SCI, V57, P209, DOI 10.1007/s11427-014-4613-6; Ying S, 2008, J IMMUNOL, V181, P2790; Alysandratos KD, 2010, ANN ALLERG ASTHMA IM, V105, P403, DOI 10.1016/j.anai.2010.09.017; Gao PS, 2010, J ALLERGY CLIN IMMUN, V125, P1403, DOI 10.1016/j.jaci.2010.03.016; Yamamoto T, 2005, EXP DERMATOL, V14, P81, DOI 10.1111/j.0906-6705.2005.00280.x; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; JAHODA CAB, 1991, J CELL SCI, V99, P627; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Miyagaki T, 2012, J INVEST DERMATOL, V132, P1280, DOI 10.1038/jid.2011.470; Sano Y, 2013, CLIN EXP IMMUNOL, V171, P330, DOI 10.1111/cei.12021; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Latorre V, 2013, J INVEST DERMATOL, V133, P2771, DOI 10.1038/jid.2013.255; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Coda AB, 2011, GENOMICS, V98, P431, DOI 10.1016/j.ygeno.2011.08.009; Mackay F, 1996, J BIOL CHEM, V271, P24934; Yamamoto T, 2006, ARCH DERMATOL RES, V297, P333, DOI 10.1007/s00403-005-0635-z; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Yoshizaki A, 2010, ARTHRITIS RHEUM-US, V62, P2476, DOI 10.1002/art.27498; Boin F, 2009, NAT REV RHEUMATOL, V5, P357, DOI 10.1038/nrrheum.2009.108; Ishida S, 2008, J RHEUMATOL, V35, P960; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Pierer M, 2007, RHEUMATOLOGY, V46, P1063, DOI 10.1093/rheumatology/kem063; Ware CF, 2009, ADV EXP MED BIOL, V647, P146, DOI 10.1007/978-0-387-89520-8_10; Yamamoto T, 2009, EUR J DERMATOL, V19, P14, DOI 10.1684/ejd.2008.0570; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Zhu Z, 2011, SCI REP-UK, V1, DOI 10.1038/srep00023	41	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	AUG	2015	135	8					2109	2118		10.1038/jid.2015.110		10	Dermatology	Dermatology	CN2SL	WOS:000358272100023		
J	Dhas, MK; Utsumi, H; Jawahar, A; Benial, AMF				Dhas, M. Kumara; Utsumi, Hideo; Jawahar, A.; Benial, A. Milton Franklin			Dynamic nuclear polarization properties of nitroxyl radical in high viscous liquid using Overhauser-enhanced Magnetic Resonance Imaging (OMRI)	JOURNAL OF MAGNETIC RESONANCE			English	Article						Overhauser enhancement; ESR; Nitroxyl radical; Carbamoyl-PROXYL; Dynamic nuclear polarization; Overhauser-enhanced magnetic resonance imaging	AQUEOUS SAMPLES; MRI; SPECTROSCOPY; OXYGEN; EPR; MOBILITY; BLOOD; FIELD; MICE	The dynamic nuclear polarization (DNP) studies were carried out for N-15 labeled carbamoyl-PROXYL in pure water and pure water/glycerol mixtures of different viscosities (1.8 cP, 7 cP and 14 cP). The dependence of DNP parameters was demonstrated over a range of agent concentration, viscosities, RE power levels and ESR irradiation time. DNP spectra were also recorded for 2 mM concentration of N-15 labeled carbamoyl-PROXYL in pure water and pure water/glycerol mixtures of different viscosities. The DNP factors were measured as a function of ESR irradiation time, which increases linearly up to 2 mM agent concentration in pure water and pure water/glycerol mixtures of different viscosities. The DNP factor started declining in the higher concentration region (similar to 3 mM), which is due to the ESR line width broadening. The water proton spin-lattice relaxation time was measured at very low Zeeman field (14.529 mT). The increased DNP factor (35%) was observed for solvent 2 (eta = 1.8 cP) compared with solvent 1 (eta = 1 cP). The increase in the DNP factor was brought about by the shortening of water proton spin-lattice relaxation time of solvent 2. The decreased DNP factors (30% and 53%) were observed for solvent 3 (eta = 7 cP) and solvent 4 (eta = 14 cP) compared with solvent 2, which is mainly due to the low value of coupling parameter in high viscous liquid samples. The longitudinal relaxivity, leakage factor and coupling parameter were estimated. The coupling parameter values reveal that the dipolar interaction as the major mechanism. The longitudinal relaxivity increases with the increasing viscosity of pure water/glycerol mixtures. The leakage factor showed an asymptotic increase with the increasing agent concentration. It is envisaged that the results reported here may provide guidelines for the design of new viscosity prone nitroxyl radicals, suited to the biological applications of DNP. (C) 2015 Elsevier Inc. All rights reserved.	[Dhas, M. Kumara; Benial, A. Milton Franklin] NMSSVN Coll, Dept Phys, Madurai 625019, Tamil Nadu, India; [Utsumi, Hideo] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 8128582, Japan; [Jawahar, A.] NMSSVN Coll, Dept Chem, Madurai 625019, Tamil Nadu, India	Benial, AMF (reprint author), NMSSVN Coll, Dept Phys, Madurai 625019, Tamil Nadu, India.	miltonfranklin@yahoo.com			UGC Research Award scheme, New Delhi [30-35/2011(SA-II)];  [P 04489]	The authors A. Milton Franklin Benial, A. Jawahar and M. Kumara Dhas thank the college management for encouragement and permission to carry out this work. This work was supported by the Grant-in-Aid for JSPS Postdoctoral Fellowship for Foreign Researchers (ID No. P 04489). This work was also supported by the UGC Research Award scheme, New Delhi (F.No. 30-35/2011(SA-II)).	Benial AMF, 2011, APPL MAGN RESON, V40, P311, DOI 10.1007/s00723-011-0220-x; Guiberteau T, 1996, J MAGN RESON SER B, V110, P47, DOI 10.1006/jmrb.1996.0006; Lingwood MD, 2010, J MAGN RESON, V205, P247, DOI 10.1016/j.jmr.2010.05.008; Efimova OV, 2011, J MAGN RESON, V209, P227, DOI 10.1016/j.jmr.2011.01.011; Krishna MC, 2002, P NATL ACAD SCI USA, V99, P2216, DOI 10.1073/pnas.042671399; Yamato M, 2011, NEUROCHEM INT, V59, P804, DOI 10.1016/j.neuint.2011.08.010; Yamato M, 2003, FREE RADICAL BIO MED, V35, P1619, DOI 10.1016/j.freeradbiomed.2003.09.013; Lingwood MD, 2009, J MAGN RESON, V201, P137, DOI 10.1016/j.jmr.2009.09.002; SOSNOVSKY G, 1995, J ORG CHEM, V60, P3414, DOI 10.1021/jo00116a029; Lingwood MD, 2012, J MAGN RESON, V216, P94, DOI 10.1016/j.jmr.2012.01.007; Davis RM, 2011, FREE RADICAL BIO MED, V50, P459, DOI 10.1016/j.freeradbiomed.2010.11.028; Utsumi H, 2006, P NATL ACAD SCI USA, V103, P1463, DOI 10.1073/pnas.0510670103; Ardenkjaer-Larsen JH, 1998, J MAGN RESON, V133, P1, DOI 10.1006/jmre.1998.1438; Benial AMF, 2006, J MAGN RESON, V182, P273, DOI 10.1016/j.jmr.2006.06.025; de Sousa PL, 1998, J MAGN RESON, V135, P118, DOI 10.1006/jmre.1998.1559; Efimova OV, 2011, J MAGN RESON, V212, P197, DOI 10.1016/j.jmr.2011.06.030; Elas M, 2003, MAGNET RESON MED, V49, P682, DOI 10.1002/mrm.10408; Garcia S, 2010, J MAGN RESON, V203, P138, DOI 10.1016/j.jmr.2009.12.012; Gonzalez PM, 2013, COMP BIOCHEM PHYS A, V165, P439, DOI 10.1016/j.cbpa.2013.02.021; GRUCKER D, 1995, J MAGN RESON SER B, V106, P101, DOI 10.1006/jmrb.1995.1019; Hawkins C.L., 1840, BIOCHIM BIOPHYS ACTA, V2014, P708; Khramtsov VV, 2010, J MAGN RESON, V202, P267, DOI 10.1016/j.jmr.2009.11.017; Kosem N, 2012, FREE RADICAL BIO MED, V53, P328, DOI 10.1016/j.freeradbiomed.2012.04.026; Li HH, 2002, MAGNET RESON MED, V48, P530, DOI 10.1002/mrm.10222; LURIE DJ, 1989, J MAGN RESON, V84, P431, DOI 10.1016/0022-2364(89)90392-2; Matsumoto K, 2004, J PHARMACOL EXP THER, V310, P1076, DOI 10.1124/jpet.104.066647; Matsumoto S, 2005, MAGNET RESON MED, V54, P213, DOI 10.1002/mrm.20564; Murugesan R, 2002, MAGNET RESON MED, V48, P523, DOI 10.1002/mrm.10221; Nestle N, 2005, MAGN RESON IMAGING, V23, P183, DOI 10.1016/j.mri.2004.11.027; NICHOLSON I, 1994, J MAGN RESON SER B, V104, P250, DOI 10.1006/jmrb.1994.1082; Tomizawa A, 2011, BBA-GEN SUBJECTS, V1810, P1309, DOI 10.1016/j.bbagen.2011.06.011	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	AUG	2015	257						32	38		10.1016/j.jmr.2015.05.009		7	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CN3PV	WOS:000358339700005		
J	Kim, HS; Lee, KS; Ohno, Y; van Beek, EJR; Biederer, J				Kim, Hyun Su; Lee, Kyung Soo; Ohno, Yoshiharu; van Beek, Edwin J. R.; Biederer, Juergen		2013 Int Workshop Pulm Functional	PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Review						cancer imaging; lung cancer; PET; CT; MRI; PET; MRI	POSITRON-EMISSION-TOMOGRAPHY; SOLITARY PULMONARY NODULES; TURBO SPIN-ECHO; CONTRAST-ENHANCED MRI; DRY PLEURAL DISSEMINATION; MEDIASTINAL LYMPH-NODES; METABOLIC TUMOR VOLUME; GROUND-GLASS OPACITY; DUAL-MODALITY PET/CT; COMPUTED-TOMOGRAPHY	Positron emission tomography / computed tomography (PET/CT), with its metabolic data of F-18-fluorodeoxyglucose (FDG) cellular uptake in addition to morphologic CT data, is an established technique for staging of lung cancer and has higher sensitivity and accuracy for lung nodule characterization than conventional approaches. Its strength extends outside the chest, with unknown metastases detected or suspected metastases excluded in a significant number of patients. Lastly, PET/CT is used in the assessment of therapy response. Magnetic resonance imaging (MRI) in the chest has been difficult to establish, but with the advent of new sequences is starting to become an increasingly useful alternative to conventional approaches. Diffusion-weighted MRI (DWI) is useful for distinguishing benign and malignant pulmonary nodules, has high sensitivity and specificity for nodal staging, and is helpful for evaluating an early response to systemic chemotherapy. Whole-body MRI/PET promises to contribute additional information with its higher soft-tissue contrast and much less radiation exposure than PET/CT and has become feasible for fast imaging and can be used for cancer staging in patients with a malignant condition. J. Magn. Reson. Imaging 2015;42:247-260.	[Kim, Hyun Su; Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul 135710, South Korea; [Kim, Hyun Su; Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Samsung Med Ctr, Seoul 135710, South Korea; [Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Div Funct & Diagnost Imaging Res, Dept Radiol, Kobe, Hyogo 657, Japan; [Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Kobe, Hyogo 657, Japan; [van Beek, Edwin J. R.] Univ Edinburgh, Clin Res Imaging Ctr, Edinburgh EH8 9YL, Midlothian, Scotland; [Biederer, Juergen] Gross Gerau Cty Hosp, Radiol Darmstadt, Gross Gerau, Germany	Lee, KS (reprint author), Sungkyunkwan Univ, Sch Med, Dept Radiol, Samsung Med Ctr, 50 Ilwon Dong, Seoul 135710, South Korea.	kyungs.lee@samsung.com					Ackman JB, 2014, J THORAC IMAG, V29, P252, DOI 10.1097/RTI.0000000000000072; Ohno Y, 2008, J MAGN RESON IMAGING, V27, P1284, DOI 10.1002/jmri.21348; Wu LM, 2012, J SURG RES, V178, P304, DOI 10.1016/j.jss.2012.03.074; Hyun SH, 2014, EUR J NUCL MED MOL I, V41, P50, DOI 10.1007/s00259-013-2530-8; Becker N, 2012, J CANCER RES CLIN, V138, P1475, DOI 10.1007/s00432-012-1228-9; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Shim SS, 2005, RADIOLOGY, V236, P1011, DOI 10.1148/radiol.2363041310; Puderbach M, 2007, EUR J RADIOL, V64, P345, DOI 10.1016/j.ejrad.2007.08.009; Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128; Ohno Y, 2004, RADIOLOGY, V231, P872, DOI 10.1148/radiol.2313030103; Lauenstein TC, 2004, RADIOLOGY, V233, P139, DOI 10.1148/radiol.2331030777; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Ohno Y, 2011, RADIOLOGY, V261, P605, DOI 10.1148/radiol.11110281; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; Song MK, 2012, CANCER SCI, V103, P477, DOI 10.1111/j.1349-7006.2011.02164.x; Henzler T, 2012, ROFO-FORTSCHR RONTG, V184, P340, DOI 10.1055/s-0031-1299277; Chandarana H, 2013, RADIOLOGY, V268, P874, DOI 10.1148/radiol.13130620; Erasmus JJ, 1998, AM J ROENTGENOL, V170, P1369; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Park GC, 2013, ANN ONCOL, V24, P208, DOI 10.1093/annonc/mds247; Takenaka D, 2002, EUR J RADIOL, V44, P216, DOI 10.1016/S0720-048X(02)00271-1; Stolzmann P, 2013, INVEST RADIOL, V48, P241, DOI 10.1097/RLI.0b013e31826f2de9; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Yi CA, 2013, CANCER-AM CANCER SOC, V119, P1784, DOI 10.1002/cncr.28000; Usuda K, 2011, ANN THORAC SURG, V91, P1689, DOI 10.1016/j.athoracsur.2011.02.037; Wurslin C, 2013, J NUCL MED, V54, P464, DOI 10.2967/jnumed.112.105296; GREEN S, 1992, INVEST NEW DRUG, V10, P239, DOI 10.1007/BF00944177; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Tsuchida T, 2013, J MAGN RESON IMAGING, V38, P80, DOI 10.1002/jmri.23959; Brix G, 2005, J NUCL MED, V46, P608; Higashi K, 1998, J NUCL MED, V39, P1016; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P43; Chang YC, 2012, J MAGN RESON IMAGING, V36, P387, DOI 10.1002/jmri.23660; Vesselle H, 2008, J THORAC ONCOL, V3, P971, DOI 10.1097/JTO.0b013e31818307a7; Hyun SH, 2013, ANN SURG, V257, P364, DOI 10.1097/SLA.0b013e318262a6ec; Koyama H, 2010, EUR RADIOL, V20, P790, DOI 10.1007/s00330-009-1615-z; Lee HY, 2012, RADIOLOGY, V264, P884, DOI 10.1148/radiol.12111793; Dinkel J, 2013, LUNG CANCER, V82, P76, DOI 10.1016/j.lungcan.2013.07.006; Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P59; Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199; Nomori H, 2008, J THORAC CARDIOV SUR, V135, P816, DOI 10.1016/j.jtcvs.2007.10.035; Yi CA, 2008, RADIOLOGY, V248, P632, DOI 10.1148/radiol.2482071822; Fink C, 2007, INVEST RADIOL, V42, P377, DOI 10.1097/01.rli.0000261926.86278.96; Kim HY, 2007, RADIOLOGY, V245, P267, DOI 10.1148/radiol.2451061682; Stroobants S, 2003, EUR J RADIOL, V45, P49, DOI 10.1016/S0720-048X(02)00282-6; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628; Regier M, 2011, J MED IMAG RADIAT ON, V55, P266, DOI 10.1111/j.1754-9485.2011.02263.x; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853; Kono R, 2007, AM J ROENTGENOL, V188, P26, DOI 10.2214/AJR.05.1446; Lee HY, 2009, LUNG CANCER, V65, P170, DOI 10.1016/j.lungcan.2008.11.009; Foroulis CN, 2013, J THORAC DIS, V5, pS342, DOI 10.3978/j.issn.2072-1439.2013.04.08; Yi CA, 2006, J NUCL MED, V47, P443; Jeong YJ, 2007, AM J ROENTGENOL, V188, P57, DOI 10.2214/AJR.05.2131; Schrevens L, 2004, ONCOLOGIST, V9, P633, DOI 10.1634/theoncologist.9-6-633; Lowe VJ, 1998, J CLIN ONCOL, V16, P1075; Beyer T, 2000, J NUCL MED, V41, P1369; Werner-Wasik M, 2001, INT J RADIAT ONCOL, V51, P56, DOI 10.1016/S0360-3016(01)01615-7; Goo JM, 2000, RADIOLOGY, V216, P117; Mac Manus MP, 2003, J CLIN ONCOL, V21, P1285, DOI 10.1200/JCO.2003.07.054; Chang Q, 2012, CLIN IMAG, V36, P98, DOI 10.1016/j.clinimag.2011.07.002; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Biederer J, 2003, RADIOLOGY, V227, P475, DOI 10.1148/radiol.2272020635; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Attenberger UI, 2009, INVEST RADIOL, V44, P525, DOI 10.1097/RLI.0b013e3181b4c252; Barkhausen J, 2001, RADIOLOGY, V220, P252; Biederer J, 2010, J MAGN RESON IMAGING, V32, P1388, DOI 10.1002/jmri.22386; Biederer Jürgen, 2012, Insights Imaging, V3, P373, DOI 10.1007/s13244-011-0142-z; Biederer J, 2012, Insights Imaging, V3, P355, DOI 10.1007/s13244-011-0146-8; Boiselle PM, 2013, J THORAC IMAG, V28, P137, DOI 10.1097/RTI.0b013e31828cafe7; Both M, 2005, EUR J RADIOL, V53, P478, DOI 10.1016/j.ejrad.2004.05.007; Bruegel M, 2007, J MAGN RESON IMAGING, V25, P73, DOI 10.1002/jmri.20824; Chen YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052213; Deslauriers J, 2000, CHEST, V117, p96S, DOI 10.1378/chest.117.4_suppl_1.96S; Devaraj A, 2007, CLIN RADIOL, V62, P97, DOI 10.1016/j.crad.2006.09.015; Fabel M, 2009, EUR RADIOL, V19, P391, DOI 10.1007/s00330-008-1148-x; Gaeta M, 2012, EUR J RADIOL, V81, P3587, DOI 10.1016/j.ejrad.2011.12.022; GAMSU G, 1987, INVEST RADIOL, V22, P853, DOI 10.1097/00004424-198711000-00001; Halpern BS, 2005, CHEST, V128, P2289, DOI 10.1378/chest.128.4.2289; Hasegawa I, 2008, J THORAC IMAG, V23, P157, DOI 10.1097/RTI.0b013e318166d2f5; Heye T, 2012, ACTA RADIOL, V53, P153, DOI 10.1258/ar.2011.110445; Hintze C, 2006, RADIOLOGE, V46, P256; Hintze C, 2006, RADIOLOGE, V46, P251, DOI 10.1007/s00117-005-1334-7; Jeong SY, 2008, LUNG CANCER, V61, P186, DOI 10.1016/j.lungcan.2007.12.021; Kim YK, 2011, RADIOLOGY, V260, P568, DOI 10.1148/radiol.11110053; Koyama H, 2008, EUR RADIOL, V18, P2120, DOI 10.1007/s00330-008-1001-2; Lee KS, 2007, CHEST, V131, P1516, DOI 10.1378/chest.06-2526; Magnani P, 1999, J CARDIOVASC SURG, V40, P741; Morikawa M, 2009, J NUCL MED, V50, P81, DOI 10.2967/jnumed.108.056408; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ohba Yasuomi, 2011, Asian Cardiovasc Thorac Ann, V19, P108, DOI 10.1177/0218492310385152; Pauls S, 2011, CLIN IMAG, V35, P259, DOI 10.1016/j.clinimag.2010.07.002; Pauls S, 2012, EUR J RADIOL, V81, P178, DOI 10.1016/j.ejrad.2010.09.001; Pisters KMW, 2005, NEW ENGL J MED, V352, P2640, DOI 10.1056/NEJMe058110; Puderbach M, 2008, EUR RADIOL, V18, P2102, DOI 10.1007/s00330-008-0974-1; Razek AAKA, 2011, J COMPUT ASSIST TOMO, V35, P248, DOI 10.1097/RCT.0b013e31820ccf73; Regier M, 2007, EUR RADIOL, V17, P1341, DOI 10.1007/s00330-006-0422-z; Robinson LA, 2007, CHEST, V132, p243S, DOI 10.1378/chest.07-1379; Sakai F, 1994, J Thorac Imaging, V9, P51, DOI 10.1097/00005382-199424000-00009; Satoh S, 2013, MAGN RESON MED SCI, V12, P31, DOI 10.2463/mrms.2012-0020; Saunders CAB, 1999, ANN THORAC SURG, V67, P790, DOI 10.1016/S0003-4975(98)01257-0; Schaefer JF, 2006, LUNG CANCER-J IASLC, V53, P39, DOI 10.1016/j.lungcan.2006.03.010; Schlemmer HP, 2005, INVEST RADIOL, V40, P64, DOI 10.1097/01.rli.0000149250.37033.7c; Shim SS, 2006, J COMPUT ASSIST TOMO, V30, P70, DOI 10.1097/01.rct.0000185383.50636.d1; SHIOYA S, 1988, RADIOLOGY, V167, P105; Stroobants Sigrid G, 2003, Clin Lung Cancer, V4, P242, DOI 10.3816/CLC.2003.n.005; Sung YM, 2008, AM J ROENTGENOL, V190, P246, DOI 10.2214/AJR.07.2508; Toloza EM., 2003, CHEST, V123, p137S; Vansteenkiste JF, 1998, EUR J NUCL MED, V25, P1495, DOI 10.1007/s002590050327; VANSTINTEREN H, 2002, LANCET, V359, P1388; WAHL RL, 1994, RADIOLOGY, V191, P371; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Weder W, 1998, ANN THORAC SURG, V66, P886, DOI 10.1016/S0003-4975(98)00675-4; Sundaresan SR, 1998, ANN THORAC SURG, V66, P892; Wild J M, 2012, Insights Imaging, V3, P345, DOI 10.1007/s13244-012-0176-x; Wu LM, 2013, MAGN RESON IMAGING, V31, P235, DOI 10.1016/j.mri.2012.07.009; Wu NY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-242	120	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	AUG	2015	42	2					247	260		10.1002/jmri.24776		14	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CN2NM	WOS:000358258600003		
J	Ohno, Y; Seki, S; Koyama, H; Yoshikawa, T; Matsumoto, S; Takenaka, D; Kassai, Y; Yui, M; Sugimura, K				Ohno, Yoshiharu; Seki, Shinichiro; Koyama, Hisanobu; Yoshikawa, Takeshi; Matsumoto, Sumiaki; Takenaka, Daisuke; Kassai, Yoshimori; Yui, Masao; Sugimura, Kazuro			3D ECG- and respiratory-gated non-contrast-enhanced (CE) perfusion MRI for postoperative lung function prediction in non-small-cell lung cancer patients: A comparison with thin-section quantitative computed tomography, dynamic CE-perfusion MRI, and perfusion scan	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						lung; magnetic resonance (MR); lung cancer; perfusion; lung function	CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; REGIONAL PULMONARY PERFUSION; RESECTION CANDIDATES; VENTILATORY FUNCTION; MANAGEMENT; DIAGNOSIS; SCINTIGRAPHY; SPECT; FLOW	PurposeTo compare predictive capabilities of non-contrast-enhanced (CE)- and dynamic CE-perfusion MRIs, thin-section multidetector computed tomography (CT) (MDCT), and perfusion scan for postoperative lung function in non-small cell lung cancer (NSCLC) patients. Materials and MethodsSixty consecutive pathologically diagnosed NSCLC patients were included and prospectively underwent thin-section MDCT, non-CE-, and dynamic CE-perfusion MRIs and perfusion scan, and had their pre- and postoperative forced expiratory volume in one second (FEV1) measured. Postoperative percent FEV1 (po%FEV1) was then predicted from the fractional lung volume determined on semiquantitatively assessed non-CE- and dynamic CE-perfusion MRIs, from the functional lung volumes determined on quantitative CT, from the number of segments observed on qualitative CT, and from uptakes detected on perfusion scans within total and resected lungs. Predicted po%FEV(1)s were then correlated with actual po%FEV(1)s, which were %FEV(1)s measured postoperatively. The limits of agreement were also determined. ResultsAll predicted po%FEV(1)s showed significant correlation (0.73r0.93, P<0.0001) and limits of agreement with actual po%FEV1 (non-CE-perfusion MRI: 0.310.0%, dynamic CE-perfusion MRI: 1.0 +/- 10.8%, perfusion scan: 2.2 +/- 14.1%, quantitative CT: 1.2 +/- 9.0%, qualitative CT: 1.5 +/- 10.2%). ConclusionNon-CE-perfusion MRI may be able to predict postoperative lung function more accurately than qualitatively assessed MDCT and perfusion scan. J. Magn. Reson. Imaging 2015;42:340-353.	[Ohno, Yoshiharu; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Kobe, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res, Kobe, Hyogo 6500017, Japan; [Seki, Shinichiro; Koyama, Hisanobu; Takenaka, Daisuke; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Div Radiol, Kobe, Hyogo 6500017, Japan; [Takenaka, Daisuke] Hyogo Canc Ctr, Dept Radiol, Akashi, Hyogo, Japan; [Kassai, Yoshimori; Yui, Masao] Toshiba Med Syst Corp, Otawara, Japan	Ohno, Y (reprint author), Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yosirad@kobe-u.ac.jp			Toshiba Medical Systems Corporation; Eizai Co., Ltd.	Contract grant sponsor: Toshiba Medical Systems Corporation; Contract grant sponsor: Eizai Co., Ltd.	American Thoracic Society, 1987, AM REV RESPIR DIS, V136, P1285; American Thoracic Society, 1991, AM REV RESPIR DIS, V144, P1202; Socinski MA, 2013, CHEST, V143, pE341, DOI 10.1378/chest.12-2361; Ohno Y, 2004, J MAGN RESON IMAGING, V20, P353, DOI 10.1002/jmrt.20137; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Ohno Y, 2011, EUR J RADIOL, V77, P97, DOI 10.1016/j.ejrad.2009.07.024; Raviv S, 2011, AM J RESP CRIT CARE, V183, P1138, DOI 10.1164/rccm.201008-1274CI; Korst RJ, 1998, ANN THORAC SURG, V66, P898, DOI 10.1016/S0003-4975(98)00697-3; Ohno Y, 2007, ACAD RADIOL, V14, P830, DOI 10.1016/j.acra.2007.03.013; Lipson DA, 2002, MAGNET RESON MED, V47, P1073, DOI 10.1002/mrm.10172; Beckles MA, 2003, CHEST, V123, P105; BLAND JM, 1986, LANCET, V1, P307; Bolliger CT, 2002, RESPIRATION, V69, P482, DOI 10.1159/000066474; BOLLIGER CT, 1995, AM J RESP CRIT CARE, V151, P1472; BRUNELLI A, 2013, CHEST S, V143, pSE166; Colice GL, 2007, CHEST, V132, p161S; Giordano A, 1997, CHEST, V111, P1542, DOI 10.1378/chest.111.6.1542; Hatabu H, 1999, MAGNET RESON MED, V42, P1033, DOI 10.1002/(SICI)1522-2594(199912)42:6<1033::AID-MRM7>3.0.CO;2-7; Iwasawa T, 2002, J MAGN RESON IMAGING, V15, P685, DOI 10.1002/jmri.10121; Levin DL, 2001, MAGNET RESON MED, V46, P166, DOI 10.1002/mrm.1172; Mai VM, 1999, MAGN RESON IMAGING, V17, P355, DOI 10.1016/S0730-725X(98)00190-8; Mazzone PJ, 2005, AM J MED, V118, P578, DOI 10.1016/j.amjmed.2004.12.024; Nikolaou K, 2004, INVEST RADIOL, V39, P537, DOI 10.1097/01.rli.0000133813.22873.47; Ogasawara N, 2004, J MAGN RESON IMAGING, V20, P601, DOI 10.1002/jmri.20150; Ohno Y, 2005, RADIOLOGY, V236, P704, DOI 10.1148/radiol.2361040005; Ohno Y, 2007, AM J ROENTGENOL, V189, P400, DOI 10.2214/AJR.07.2084; Ohno Y, 2014, AM J ROENTGENOL, V202, P493, DOI 10.2214/AJR.13.10833; PIERCE RJ, 1994, AM J RESP CRIT CARE, V150, P947; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Risse F, 2006, J MAGN RESON IMAGING, V24, P1284, DOI 10.1002/jmri.20747; Sinjan EA, 1999, INT SURG, V84, P185; Sommer G, 2013, EUR J RADIOL, V82, pE879, DOI 10.1016/j.ejrad.2013.06.030; Suga K, 2004, EUR J NUCL MED MOL I, V31, P280; Takahashi M, 2003, EUR J RADIOL, V46, P45, DOI 10.1016/S0720-048X(02)00331-5; Wyser C, 1999, AM J RESP CRIT CARE, V159, P1450	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	AUG	2015	42	2					340	353		10.1002/jmri.24800		14	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CN2NM	WOS:000358258600012		
J	Fujii, S; Nougaret, S; Escal, L; Azria, D; Assenat, E; Rouanet, P; Reinhold, C; Guiu, B				Fujii, Shinya; Nougaret, Stephanie; Escal, Laure; Azria, David; Assenat, Eric; Rouanet, Philippe; Reinhold, Caroline; Guiu, Boris			MR imaging of locally advanced low rectal cancer: Relationships between imaging findings and the pathological tumor regression grade	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MRI; rectal cancer; chemoradiation therapy; tumor regression grade	MESORECTAL FASCIA INVASION; RADIATION-THERAPY; COMPLETE RESPONSE; NEOADJUVANT CHEMORADIOTHERAPY; RESECTION MARGIN; ACELLULAR MUCIN; CHEMOTHERAPY; CARCINOMA; ACCURACY; OUTCOMES	BackgroundTo evaluate the relationship between MR measurements and the pathological tumor regression grade (pTRG). MethodsTwo radiologists independently reviewed the pre- and postchemoradiation therapy (CRT) rectal MR images of 73 consecutive patients with locally advanced low rectal cancer who underwent neoadjuvant CRT and subsequent surgery and measured tumor diameter, area, signal intensity (SI). The percentage reduction rate for each parameter was calculated. The absolute SI ratio reduction rate was defined as the absolute value of the SI ratio reduction rate. The Kruskal-Wallis test and multivariate analysis were performed to assess the correlation between each parameter and the pTRG. Receiver operating characteristic (ROC) curves were plotted for predicting favorable regression outcomes (pTRG 3-4). ResultsIn multivariate analysis, the absolute SI ratio reduction rate was a significant predictor of pTRG for both radiologists. Area under the ROC curve (Az) values were 0.77-0.709 for diameter reduction rate, 0.757-0.694 for area, 0.652-0.648 for the SI ratio, 0.736-0.837 for the absolute SI ratio. ConclusionThe absolute SI ratio reduction rate was significantly associated with pTRG and predicted favorable responses to CRT. Measurement of the diameter reduction rate is convenient and reliable in predicting favorable responses. J. Magn. Reson. Imaging 2015;42:421-426.	[Fujii, Shinya] Tottori Univ, Fac Med, Div Radiol, Dept Pathophysiol & Therapeut Sci, Yonago, Tottori 6838504, Japan; [Nougaret, Stephanie; Reinhold, Caroline] McGill Univ, MUHC, Dept Abdominal Imaging, Montreal, PQ, Canada; [Escal, Laure; Guiu, Boris] CHU Montpellier, Dept Imaging, St Eloi Hosp, Montpellier, France; [Azria, David] ICM, Dept Radiotherapy, Montpellier, France; [Assenat, Eric] CHU Montpellier, Dept Oncol, Montpellier, France; [Rouanet, Philippe] ICM, Dept Surg, Montpellier, France	Fujii, S (reprint author), Tottori Univ, Fac Med, Div Radiol, Dept Pathophysiol & Therapeut Sci, 36-1,Nishi Cho, Yonago, Tottori 6838504, Japan.	sfujii@grape.med.tottori-u.ac.jp					Smith NJ, 2008, AM J ROENTGENOL, V191, P1517, DOI 10.2214/AJR.08.1298; Kim DJ, 2010, RADIOGRAPHICS, V30, P503, DOI 10.1148/rg.302095046; Patel UB, 2011, J CLIN ONCOL, V29, P3753, DOI 10.1200/JCO.2011.34.9068; Kluza E, 2013, EUR RADIOL, V23, P253, DOI 10.1007/s00330-012-2578-z; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Nougaret S, 2012, RADIOLOGY, V263, P409, DOI 10.1148/radiol.12111263; Kim MJ, 2003, J COMPUT ASSIST TOMO, V27, P48, DOI 10.1097/00004728-200301000-00010; Vecchio FM, 2005, INT J RADIAT ONCOL, V62, P752, DOI 10.1016/j.ijrobp.2004.11.017; Brown G, 1999, RADIOLOGY, V211, P215; Kim YH, 2005, INT J RADIAT ONCOL, V62, P761, DOI 10.1016/j.ijrobp.2004.11.005; Yeo SG, 2010, INT J RADIAT ONCOL, V78, P164, DOI 10.1016/j.ijrobp.2009.07.1682; Patel UB, 2012, ANN SURG ONCOL, V19, P2842, DOI 10.1245/s10434-012-2309-3; Vliegen RFA, 2008, RADIOLOGY, V246, P454, DOI [10.1148/radiol.2462070042, 10.1148/radio1.2462070042]; Curvo-Semedo L, 2011, RADIOLOGY, V260, P734, DOI 10.1148/radiol.11102467; Salerno GV, 2009, DIS COLON RECTUM, V52, P632, DOI 10.1007/DCR.0b013e3181a0a37e; Smith KD, 2010, ANN SURG, V251, P261, DOI 10.1097/SLA.0b013e3181bdfc27; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Ha HI, 2013, EUR RADIOL, V23, P3345; Haider MA, 2007, RADIOLOGY, V244, P196, DOI 10.1148/radiol.2441060398; Kim SH, 2009, J MAGN RESON IMAGING, V29, P1093, DOI 10.1002/jmri.21742; Shia J, 2011, AM J SURG PATHOL, V35, P127, DOI 10.1097/PAS.0b013e318200cf78; Shihab OC, 2011, ANN SURG ONCOL, V18, P3278, DOI 10.1245/s10434-011-1776-2; Taylor FGM, 2008, AM J ROENTGENOL, V191, P1827, DOI 10.2214/AJR.08.1004; Torkzad MR, 2007, EUR RADIOL, V17, P1566, DOI 10.1007/s00330-006-0518-5	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	AUG	2015	42	2					421	426		10.1002/jmri.24783		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CN2NM	WOS:000358258600020		
J	Ye, FX; Xu, YH; Hojamberdiev, M; Lai, YJ; Wang, C; Wang, X				Ye, Fangxia; Xu, Yunhua; Hojamberdiev, Mirabbos; Lai, Yujun; Wang, Chong; Wang, Xin			Effect of Carbide Ceramic Zone on Wear Resistance of the (Fe,Cr)(7)C-3/Fe Surface Gradient Composite	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						ceramic zone; (Fe,Cr)(7)C-3; mechanical properties; microstructure; surface gradient composite	IRON MATRIX COMPOSITES; IN-SITU FABRICATION; MECHANICAL-PROPERTIES; FRACTURE-TOUGHNESS; ABRASIVE WEAR; WHITE IRON; MICROSTRUCTURE; CR; ALLOYS; (CR,FE)(23)C-6	In this work, we report on the influence of microstructure and mechanical properties of the (Fe,Cr)(7)C-3 ceramic zone on wear resistance of the (Fe,Cr)(7)C-3/Fe surface gradient composite fabricated by in situ synthesis method followed by a post-heat treatment at 1100 A degrees C for 20 h in argon atmosphere. The phase composition, microstructure, nanoindentation hardness, elastic modulus, fracture toughness, and relative wear resistance of the (Fe,Cr)(7)C-3/Fe surface gradient composite were investigated by means of x-ray diffraction, scanning electron microscopy, nanoindentation tester, and wear resistance testing instrument, respectively. The XRD results showed that (Fe,Cr)(7)C-3 is the predominant crystalline phases in the fabricated composite. The volume fraction of the (Fe,Cr)(7)C-3 particulates formed has a gradient distribution from the surface to the iron matrix, and the microstructure also changes significantly. The (Fe,Cr)(7)C-3 bulk ceramic zone with the volume fraction of about 100% and the (Fe,Cr)(7)C-3 dense ceramic zone with the volume fraction of about 90% were synthesized on the upper surface of the (Fe,Cr)(7)C-3/Fe surface gradient composite, respectively. The average nanoindentation hardness and elastic modulus of the (Fe,Cr)(7)C-3 bulk ceramic zone of the composite were determined to be 12.711 and 256.054 GPa, respectively. The fracture toughness of the (Fe,Cr)(7)C-3 bulk ceramic zone is in the range of 2.06-4.19 MPa m(1/2), and its relative wear resistance is about 56 times higher than that of the iron matrix. The (Fe,Cr)(7)C-3 dense ceramic zone with rod-like, secondary (Fe,Cr)(7)C-3 particulates was formed at the bottom of the (Fe,Cr)(7)C-3 bulk ceramic zone. Rod-like, secondary (Fe,Cr)(7)C-3 particulates are dense and grew in the direction of the iron substrate, providing higher wear resistance to the composite. The wear mechanisms of the (Fe,Cr)(7)C-3 bulk and dense ceramic zones are considered to be microcutting, microcracking, and spalling pit.	[Ye, Fangxia; Xu, Yunhua; Wang, Chong; Wang, Xin] Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China; [Hojamberdiev, Mirabbos] Shinshu Univ, Dept Environm Sci & Technol, Fac Engn, Nagano 3808553, Japan; [Xu, Yunhua; Lai, Yujun] Xian Univ Architecture & Technol, Inst Wear Resistant Mat, Xian 710055, Peoples R China	Xu, YH (reprint author), Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China.	yunhuaxu_xauat@yahoo.com; hmirabbos@gmail.com			National High Technology Research and Development Program of China (863 Program) [2013AA031803]; National Natural Science Foundation of China [51374169]	The present work was financially supported by the National High Technology Research and Development Program of China (863 Program, No. 2013AA031803). The authors also acknowledge the financial support from the National Natural Science Foundation of China (No. 51374169).	Ye FX, 2014, MATER CHEM PHYS, V147, P823, DOI 10.1016/j.matchemphys.2014.06.026; Zhong LS, 2013, CERAM INT, V39, P731, DOI 10.1016/j.ceramint.2012.06.085; DELANNAY F, 1987, J MATER SCI, V22, P1, DOI 10.1007/BF01160545; Zhong LS, 2011, MATER DESIGN, V32, P3790, DOI 10.1016/j.matdes.2011.03.031; Chang CM, 2010, TRIBOL INT, V43, P929, DOI 10.1016/j.triboint.2009.12.045; Casellas D, 2007, ACTA MATER, V55, P4277, DOI 10.1016/j.actamat.2007.03.028; Wiengmoon A, 2011, MATER CHEM PHYS, V125, P739, DOI 10.1016/j.matchemphys.2010.09.064; BERNS H, 1995, WEAR, V181, P271, DOI 10.1016/0043-1648(95)90034-9; Coronado JJ, 2011, WEAR, V270, P287, DOI 10.1016/j.wear.2010.10.070; Fan C, 2006, SURF COAT TECH, V201, P908, DOI 10.1016/j.surfcoat.2006.01.010; [Anonymous], E38411E1 ASTM; Zhang QM, 2003, SURF COAT TECH, V162, P140, DOI 10.1016/S0257-8972(02)00697-7; Niu LB, 2010, J MATER PROCESS TECH, V210, P1986, DOI 10.1016/j.jmatprotec.2010.07.013; Colaco R, 2003, WEAR, V254, P625, DOI 10.1016/S0043-1648(03)00185-6; Coronado JJ, 2011, WEAR, V270, P823, DOI 10.1016/j.wear.2011.02.009; Hao S., 1992, HIGH CHROMIUM WEAR R; Hill H, 2011, WEAR, V271, P1895, DOI 10.1016/j.wear.2010.11.031; Junyl S., 1987, P INT C WEAR MATERIA, P661; Kootsookos A, 2008, MAT SCI ENG A-STRUCT, V490, P313, DOI 10.1016/j.msea.2008.01.036; Lin CM, 2010, MAT SCI ENG A-STRUCT, V527, P5038, DOI 10.1016/j.msea.2010.04.073; Liu HH, 2008, MAT SCI ENG A-STRUCT, V478, P324, DOI 10.1016/j.msea.2007.06.012; Liu YF, 2006, SURF COAT TECH, V201, P863, DOI 10.1016/j.surfcoat.2005.12.048; Lu LM, 2003, MAT SCI ENG A-STRUCT, V347, P214, DOI 10.1016/S0921-5093(02)00588-9; Mechanical Industry Standard of China, JBT75061994; Niu LB, 2010, J MATER SCI, V45, P4532, DOI 10.1007/s10853-010-4549-6; Niu LB, 2011, ADV MATER RES-SWITZ, V189-193, P1176, DOI 10.4028/www.scientific.net/AMR.189-193.1176; TSYPIN II, 1991, MET SCI HEAT TREAT+, V33, P759, DOI 10.1007/BF00800696; Wang YP, 2011, WEAR, V271, P1623, DOI 10.1016/j.wear.2010.12.029; Ye FX, 2013, APPL SURF SCI, V280, P297, DOI 10.1016/j.apsusc.2013.04.152; Zhong LS, 2012, J COMPOS MATER, V46, P895, DOI 10.1177/0021998311412832; Zum K.H., 1980, Z METALLKD, V71, P103	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	AUG	2015	24	8					2898	2907		10.1007/s11665-015-1582-2		10	Materials Science, Multidisciplinary	Materials Science	CN3OG	WOS:000358335600007		
J	Shaikh, FUA; Mihashi, H; Kobayakawa, A				Shaikh, Faiz Uddin Ahmed; Mihashi, Hirozo; Kobayakawa, A.			Corrosion Durability of Reinforcing Steel in Cracked High-Performance Fiber-Reinforced Cementitious Composite Beams	JOURNAL OF MATERIALS IN CIVIL ENGINEERING			English	Article						Crack width; Crack resistance; High-performance fiber-reinforced cementitious composite (HPFRCC); Fiber; Steel reinforcement corrosion	CHLORIDE-INDUCED CORROSION; CONCRETE; WIDTH	This paper reports test results on the corrosion durability of reinforcing steel in three series of precracked beams of ordinary mortar; a high-performance fiber-reinforced cementitious composite (HPFRCC) containing polyethylene (PE) fibers, referred as mono HPFRCC; and hybrid combinations of steel cord (SC) and PE fibers, referred as hybrid HPFRCC. In each series three precracked beams with a maximum crack width of 0.1-0.5 mm were tested. All beams were subjected to an accelerated corrosion regime consisting of applying constant 3-V DC potential across rebar (anode) and cathode and cyclic wetting and drying cycles. The durability performance of the specimens was examined through regular monitoring of corrosion current-hence, the calculated steel loss, the corrosion-induced damage measured by the longitudinal crack width and through visual inspection. At the end of the corrosion tests, the reinforcing bars in all specimens were exposed to observe the corrosion depth, corroded area, actual amount of steel loss, and residual tensile strength. Results showed that the hybrid HPFRCC specimens exhibited better performance than did the mortar and mono HPFRCC specimens. Relationships of maximum crack width with actual steel loss, maximum corrosion depth, and residual tensile strength were observed in mono and hybrid HPFRCC beams. However, no correlation between maximum crack width and corroded area was observed in all series. The relationship of maximum corrosion depth and actual amount of corrosion in the hybrid and mono HPFRCC series was also observed in this study. (C) 2014 American Society of Civil Engineers.	[Shaikh, Faiz Uddin Ahmed] Curtin Univ, Dept Civil Engn, Perth, WA 6155, Australia; [Mihashi, Hirozo; Kobayakawa, A.] Tohoku Univ, Dept Architecture & Bldg Sci, Sendai, Miyagi 9808579, Japan	Shaikh, FUA (reprint author), Curtin Univ, Dept Civil Engn, Perth, WA 6155, Australia.	s.ahmed@curtin.edu.au		Shaikh, Faiz/0000-0002-5234-0619			Ahmed S. F. U., 2010, AUST J CIV ENG, V8, P27; Auyeung Y, 2000, ACI MATER J, V97, P214; [Anonymous], 1991, DARMSTADT CONCRETE; Vidal T, 2004, CEMENT CONCRETE RES, V34, P165, DOI 10.1016/S0008-8846(03)00246-1; Schiessl P, 1997, ACI MATER J, V94, P56; Mihashi H, 2011, J ADV CONCR TECHNOL, V9, P159, DOI 10.3151/jact.9.159; Homma D, 2009, J ADV CONCR TECHNOL, V7, P217; Granju JL, 2005, CEMENT CONCRETE RES, V35, P572, DOI 10.1016/j.cemconres.2004.06.032; Arya C, 1996, CEMENT CONCRETE RES, V26, P345, DOI 10.1016/S0008-8846(96)85022-8; Bentur A., 1997, STEEL CORROSION CONC, P41; Japan Concrete Institute (JCI), 2004, STAND COLL JCI, P91; Karasawa T., 2004, P JAPAN CONCRETE I, V26, P873; Li VC, 2003, J ADV CONCR TECHNOL, V1, P215, DOI DOI 10.3151/JACT.1.215; Maaddawy T. A. E., 2003, J MATER CIVIL ENG, V15, P41; Maalej M., 2003, J ADV CONCR TECHNOL, V1, P307, DOI 10.3151/jact.1.307; Miyazato S., 2005, P ICF; Mohammed TU, 2001, J MATER CIVIL ENG, V13, P194, DOI 10.1061/(ASCE)0899-1561(2001)13:3(194); Okada K., 1980, ACI SP, V65, P237; Otieno M. B., 2009, P CONCRETE REPAIR RE; Reinhardt H. W., 1992, HIGH PERFORMANCE FIB, P565; Rossi P., 2000, P 5 INT RILEM S BEF, P87; Sahamaran M., 2008, ACI MATER J, V105, P243; Sahmaran M, 2008, CAN J CIVIL ENG, V35, P236, DOI 10.1139/L07-117; Sangoju B, 2011, J MATER CIVIL ENG, V23, P1057, DOI 10.1061/(ASCE)MT.1943-5533.0000260	24	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0899-1561	1943-5533		J MATER CIVIL ENG	J. Mater. Civ. Eng.	AUG	2015	27	8							04014228	10.1061/(ASCE)MT.1943-5533.0001191		10	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CN1KQ	WOS:000358179300020		
J	Sugano, K; Nakata, A; Tsuchiya, T; Tabata, O				Sugano, K.; Nakata, A.; Tsuchiya, T.; Tabata, O.			High-speed pulsed mixing in a short distance with high-frequency switching of pumping from three inlets	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						micromixing; pulsed mixing; micropump	GOLD NANOPARTICLES; SEQUENTIAL SEGMENTATION; CHIP TECHNOLOGIES; MICROMIXER; MICROCHANNELS; FLOW	In this study, we propose a mixing method using alternate pulsed flows from three inlets with flow direction control. In conventional pulsed mixing, a residual flow near the sidewalls inhibits the rapid mixing of two solutions at high switching frequency. In this study, we addressed this issue in order to perform rapid mixing in a short distance with a low Reynolds number. We fabricated a microfluidic mixing device consisting of a cross-shaped mixing channel with three inlet microchannels and three valveless micropumps. In conventional T-shaped or Y-shaped mixing channels, a residual flow is observed because of the incomplete switching of solutions. The three inlet configuration enabled us to split the residual flow at a switching frequency of pumping of up to 200 Hz, thus resulting in rapid mixing. Furthermore, by controlling the flow direction at the confluent area using the reverse flow of the micropump, the mixing speed was dramatically increased because of the complete switching of the two solutions. As a result, we achieved the mixing time of 3.6 ms and the mixing length of 20.7 mu m, which were necessary to achieve a 90% mixing ratio at a high micropump switching frequency of 400 Hz and reverse flow ratio of 1/4.	[Sugano, K.] Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Nakata, A.; Tsuchiya, T.; Tabata, O.] Kyoto Univ, Grad Sch Engn, Dept Micro Engn, Nishikyo Ku, Kyoto 6158540, Japan	Sugano, K (reprint author), Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	sugano@mech.kobe-u.ac	Sugano, Koji/A-1766-2013		Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports and Culture (MEXT); 'Nanotechnology Network' of MEXT, Japan	This research was partially supported by Grant-in-Aid, KAKENHI, Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Science, Sports and Culture (MEXT). A part of this work was conducted in Kyoto-Advanced Nanotechnology Network, supported by 'Nanotechnology Network' of MEXT, Japan. This work was also supported in part by the Core-to-Core Program promoted by Japan Society for the Promotion of Science (JSPS).	Wagner J, 2005, NANO LETT, V5, P685, DOI 10.1021/nl050097t; Jana NR, 2001, ADV MATER, V13, P1389, DOI 10.1002/1521-4095(200109)13:18<1389::AID-ADMA1389>3.0.CO;2-F; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Sugano K, 2010, MICROFLUID NANOFLUID, V9, P1165, DOI 10.1007/s10404-010-0637-9; Bally F, 2011, CHEM ENG SCI, V66, P1449, DOI 10.1016/j.ces.2010.07.026; Lee SW, 2006, J MICROMECH MICROENG, V16, P1067, DOI 10.1088/0960-1317/16/5/027; Luty-Blocho M, 2011, CHEM ENG J, V171, P279, DOI 10.1016/j.cej.2011.03.104; Tabeling P, 2004, PHILOS T ROY SOC A, V362, P987, DOI 10.1098/rsta.2003.1358; Nguyen NT, 2005, LAB CHIP, V5, P1320, DOI 10.1039/b507548c; Johnson TJ, 2002, ANAL CHEM, V74, P45, DOI 10.1021/ac010895d; Bu MQ, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/7/074002; Abgrall P, 2007, J MICROMECH MICROENG, V17, pR15, DOI 10.1088/0960-1317/17/5/R01; Dykman L, 2012, CHEM SOC REV, V41, P2256, DOI 10.1039/c1cs15166e; Zhao CX, 2011, CHEM ENG SCI, V66, P1463, DOI 10.1016/j.ces.2010.08.039; Hessel V, 2005, CHEM ENG SCI, V60, P2479, DOI 10.1016/j.ces.2004.11.033; Bessoth FG, 1999, ANAL COMMUN, V36, P213, DOI 10.1039/a902237f; Knauer A, 2011, CHEM ENG J, V166, P1164, DOI 10.1016/j.cej.2010.12.028; Kumar V, 2011, CHEM ENG SCI, V66, P1329, DOI 10.1016/j.ces.2010.08.016; Bouquey M, 2008, CHEM ENG J, V135, pS93, DOI 10.1016/j.cej.2007.07.043; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; Ansari MA, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/5/055007; Phillips TW, 2014, LAB CHIP, V14, P3172, DOI 10.1039/c4lc00429a; Ahmed-Omer B, 2007, ORG BIOMOL CHEM, V5, P733, DOI 10.1039/b615072a; Fujii T, 2003, LAB CHIP, V3, P193, DOI 10.1039/b301410j; Lim TW, 2011, LAB CHIP, V11, P100, DOI 10.1039/c005325m; Trietsch SJ, 2011, CHEMOMETR INTELL LAB, V108, P64, DOI 10.1016/j.chemolab.2011.03.005; Yamamoto D, 2013, CHEM ENG J, V227, P145, DOI 10.1016/j.cej.2012.08.065; Tofteberg T, 2010, MICROFLUID NANOFLUID, V8, P209, DOI 10.1007/s10404-009-0456-z; Dodge A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056312; Murakami Y, 2014, SENSOR ACTUAT B-CHEM, V194, P528, DOI 10.1016/j.snb.2013.12.100; Nguyen NT, 2006, BIOMED MICRODEVICES, V8, P133, DOI 10.1007/s10544-006-7708-4; Nguyen NT, 2005, MICROFLUID NANOFLUID, V1, P373, DOI 10.1007/s10404-005-0039-6; Sugano K, 2010, IEE J T SENSORS MICR, V130-E, P292; Wagner J, 2005, CHEM ENG J, V135, pS104; Yoshida Jun-ichi, 2013, Drug Discov Today Technol, V10, pe53, DOI 10.1016/j.ddtec.2012.10.013	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	AUG	2015	25	8							084003	10.1088/0960-1317/25/8/084003		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CN3XE	WOS:000358360700004		
J	Wang, M; Tsukamoto, T; Tanaka, S				Wang, Min; Tsukamoto, Takashiro; Tanaka, Shuji			Uncooled infrared thermal imaging sensor using vacuum-evaporated europium phosphor	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						infrared thermal imaging sensor; Eu(TTA)(3); IR-to-visible conversion	MICROBOLOMETER IRFPA; DETECTOR; RESOLUTION; ARRAY	This paper reports an uncooled infrared (IR) thermal imaging sensor using europium phosphor, Eu(TTA)(3), as a temperature-sensitive medium. An Eu(TTA)(3) thin film was evaporated and deposited on a thermally isolated microstructure made of SU-8. The temperature dependency of luminescence from Eu(TTA)(3) was used to convert the IR radiation power into visible-light intensity, which can be captured and digitized by a charge-coupled device (CCD) camera. The temperature coefficient of luminescence from the evaporated Eu(TTA)(3) was -2.1 +/- 0.4% K-1. Thermal images of a heater at 75-370 degrees C were acquired via a Ge lens. The minimum detectable temperature, noise-equivalent temperature difference (NETD), and thermal response time were measured as 75 degrees C, 2.66 K at 370 degrees C, and 0.2 s, respectively.	[Wang, Min; Tsukamoto, Takashiro; Tanaka, Shuji] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan	Wang, M (reprint author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan.	wangmin@mems.mech.tohoku.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program	This research was partly supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program.	Alfaro M, 2007, P SOC PHOTO-OPT INS, V6678, pJ6781, DOI 10.1117/12.732198; Nguyen NT, 2004, J MICROMECH MICROENG, V14, P969, DOI 10.1088/0960-1317/14/7/018; Rogalski A, 2003, PROG QUANT ELECTRON, V27, P59, DOI 10.1016/S0079-6727(02)00024-1; Hunter SR, 2007, P SOC PHOTO-OPT INS, V6542, pF5421, DOI 10.1117/12.726316; Zhao Y, 2002, J MICROELECTROMECH S, V11, P136; Schaferling M, 2012, ANGEW CHEM INT EDIT, V51, P3532, DOI 10.1002/anie.201105459; Eminoglu S, 2008, J MICROELECTROMECH S, V17, P20, DOI 10.1109/JMEMS.2007.910235; Alfaro M, 2010, APPL OPTICS, V49, P5444, DOI 10.1364/AO.49.005444; Tsukamoto T, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/11/114015; Basu BBJ, 2008, J LUMIN, V128, P1701, DOI 10.1016/j.jlumin.2008.03.024; KOLODNER P, 1982, APPL PHYS LETT, V40, P782, DOI 10.1063/1.93258; Barton DL, 1996, MICROELECTRON ENG, V31, P271, DOI 10.1016/0167-9317(95)00349-5; Dong FL, 2007, SENSOR ACTUAT A-PHYS, V133, P236, DOI 10.1016/j.sna.2006.04.031; Hirota M, 2007, SENSOR ACTUAT A-PHYS, V135, P146, DOI 10.1016/j.sna.2006.06.058; Ishizuya T, 2002, PROC IEEE MICR ELECT, P578; Jerominek H, 1996, P SOC PHOTO-OPT INS, V2882, P111, DOI 10.1117/12.250694; Kruse P W, 2002, UNCOOLED THERMAL IMA, P49; Kruse P W, 1997, SEMICONDUCT SEMIMET, V47, P17; Ma W, 2014, 2014 IEEE 27TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), P1225; Potkay J A, 2006, P SOL STAT SENS ACT, P144; Sedky S, 1999, IEEE T ELECTRON DEV, V46, P675, DOI 10.1109/16.753700; Steffanson M, 2014, OPTO-ELECTRON REV, V22, P1, DOI 10.2478/s11772-014-0176-0; Teranishi N, 1997, SEMICONDUCT SEMIMET, V47, P203; Vedel C, 1999, P SOC PHOTO-OPT INS, V3698, P276, DOI 10.1117/12.354529; Wada H, 2000, SENSOR MATER, V12, P315; Wang M, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/3/035012; WOOD RA, 1993, P SOC PHOTO-OPT INS, V2020, P322; Wood R. A., 1997, SEMICONDUCT SEMIMET, V47, P43; Yu XM, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/057001	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	AUG	2015	25	8							085001	10.1088/0960-1317/25/8/085001		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CN3XE	WOS:000358360700016		
J	Nakano, S; Ishii, I; Shinmura, K; Tamaki, K; Hishiki, T; Akahoshi, N; Ida, T; Nakanishi, T; Kamata, S; Kumagai, Y; Akaike, T; Fukuda, K; Sano, M; Suematsu, M				Nakano, Shintaro; Ishii, Isao; Shinmura, Ken; Tamaki, Kayoko; Hishiki, Takako; Akahoshi, Noriyuki; Ida, Tomoaki; Nakanishi, Tsuyoshi; Kamata, Shotaro; Kumagai, Yoshito; Akaike, Takaaki; Fukuda, Keiichi; Sano, Motoaki; Suematsu, Makoto			Hyperhomocysteinemia abrogates fasting-induced cardioprotection against ischemia/reperfusion by limiting bioavailability of hydrogen sulfide anions	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Fasting; Homocysteine persulfide; Hydrogen sulfide anion (HS-); Ischemia/reperfusion injury; Transsulfuration; Preconditioning	CYSTATHIONINE BETA-SYNTHASE; ISCHEMIA-REPERFUSION INJURY; TERM CALORIC RESTRICTION; NITRIC-OXIDE SYNTHASE; DEFICIENT MICE; ANIMAL-MODEL; GAMMA-LYASE; SIGNALING MOLECULE; OXIDATIVE STRESS; HOMOCYSTEINE	Elevated plasma homocysteine levels are considered an independent risk factor for cardiovascular diseases. Experimental evidence has shown that hydrogen sulfide anion (HS-) protects the myocardium from ischemia/reperfusion (IR) injury. Both homocysteine levels and endogenous HS- production are mainly regulated by two transsulfuration enzymes, cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CTH). We hypothesized that the transsulfuration pathway plays essential roles in the development of cardiac adaptive responses against ischemia, and investigated the roles of homocysteine, HS-, and transsulfuration enzymes in fasting-induced cardioprotection against IR injury utilizing hyperhomocysteinemic Cbs (-/-) and Cth (-/-) mice. Langendorff -perfused hearts were subjected to 25-min global ischemia, followed by 60-min reperfusion. Two-day fasting ameliorated left ventricular dysfunction after reperfusion via propargylglycine- and glibenclamide-sensitive pathways in wild-type mice but not in Cbs (-/-) or Cth (-/-) mice, although fasting induced cardiac expression of several Nrf2 target antioxidant genes in both wild-type and Cth (-/-) mice. Intraperitoneal administration of sodium hydrosulfide (a HS- donor) at 24 h prior to IR improved myocardial recovery in wild-type mice but not in Cth (-/-) or high-methionine-diet-fed (thus intermediately hyperhomocysteinemic) wild-type mice. Quantitative analysis of reactive sulfur species using monobromobimane derivatization methods revealed that homocysteine efficiently captures HS- to form homocysteine persulfide in the hearts as well as in the in vitro reactions. Here we propose a novel molecular and pathophysiological basis for hyperhomocysteinemia; excessive circulatory homocysteine interferes with HS--related cardioprotection against IR injury by capturing endogenous HS- to form homocysteine persulfide. Two-day fasting of mice ameliorates ischemia/reperfusion injury in Langendorff hearts. H2S-producing enzymes, CBS and CTH, are essential in fasting-induced cardioprotection. Administration of a H2S donor (NaHS) confers cardioprotection against IR injury. NaHS effects are absent in Cth (-/-), Cbs (-/-), and dietary hyperhomocysteinemic mice. Homocysteine captures cardioprotective HS- to form homocysteine persulfide.	[Nakano, Shintaro; Hishiki, Takako; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo 1058512, Japan; [Ishii, Isao; Kamata, Shotaro] Keio Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1058512, Japan; [Shinmura, Ken; Tamaki, Kayoko] Keio Univ, Sch Med, Dept Geriatr Med, Tokyo 1058512, Japan; [Tamaki, Kayoko; Hishiki, Takako; Akahoshi, Noriyuki; Suematsu, Makoto] JST, Suematsu Gas Biol Project, ERATO, Tokyo, Japan; [Ida, Tomoaki; Akaike, Takaaki] Tohoku Univ, Dept Environm Hlth Sci & Mol Toxicol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Nakanishi, Tsuyoshi] Shimadzu Co Ltd, MS Business Unit, Kyoto, Japan; [Kumagai, Yoshito] Univ Tsukuba, Environm Biol Lab, Sch Med, Ibaraki, Japan; [Fukuda, Keiichi; Sano, Motoaki] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1058512, Japan	Ishii, I (reprint author), Keio Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Shibakoen 1-5-30, Tokyo 1058512, Japan.	isao-ishii@umin.ac.jp	Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336	Program for Strategic Research Foundation at Private Universities from the MEXT of Japan; Keio Univ.; ERATO Suematsu Gas Biology Project from JST;  [25460072];  [25220103];  [25461116];  [24651265]	This study was supported by Grants-in-Aid for Scientific Research [25460072 and 25220103 to I. I., 25461116 to K.S., 24651265 to T.H.] and the Program for Strategic Research Foundation at Private Universities (2011-2015) to I. I. from the MEXT of Japan; Keio Univ. Special Grant-in-Aid for Innovative Collaborative Research Project to I. I.; and ERATO Suematsu Gas Biology Project to M.Su. from JST. M. Su. was the leader of CREST, JST for FY2014.	Ahmet, 2005, CIRCULATION, V112, P3115; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Choumenkovitch SF, 2002, J NUTR, V132, P2157; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Jakubowski H, 2007, CLIN CHEM LAB MED, V45, P1704, DOI 10.1515/CCLM.2007.338; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Hagiya YF, 2015, TOXICOL APPL PHARM, V282, P195, DOI 10.1016/j.taap.2014.11.015; Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Chang L, 2008, AMINO ACIDS, V34, P573, DOI 10.1007/s00726-007-0011-8; Akahoshi N, 2014, AM J PHYSIOL-RENAL, V306, pF1462, DOI 10.1152/ajprenal.00623.2013; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/nchembio.1018, 10.1038/NCHEMBIO.1018]; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Shinmura K, 2005, J MOL CELL CARDIOL, V39, P285, DOI 10.1016/j.yjmcc.2005.03.010; Ono K, 2014, FREE RADICAL BIO MED, V77, P82, DOI 10.1016/j.freeradbiomed.2014.09.007; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Fujii K, 2005, ANTIOXID REDOX SIGN, V7, P788, DOI 10.1089/ars.2005.7.788; Shinmura K, 2015, AM J PHYSIOL-HEART C, V308, pH894, DOI 10.1152/ajpheart.00333.2014; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kamata S, 2014, MOL NUTR FOOD RES, V58, P1309, DOI 10.1002/mnfr.201300758; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Hogg N, 1999, FREE RADICAL BIO MED, V27, P28, DOI 10.1016/S0891-5849(99)00029-5; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mudd S.H., 2001, METABOLIC MOL BASES, P2007; Ohmura M, 2015, NITRIC OXIDE-BIOL CH, V46, P102, DOI 10.1016/j.niox.2014.11.005; Ramasamy R, 2001, BASIC RES CARDIOL, V96, P463, DOI 10.1007/s003950170028; Ranucci M, 2009, EUR HEART J, V30, P995, DOI 10.1093/eurheartj/ehp015; SCHNEIDER CA, 1991, CIRC RES, V68, P1045; Toyoda Y, 2000, AM J PHYSIOL-HEART C, V279, pH2694; Yamamoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4480	48	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	AUG	2015	93	8					879	889		10.1007/s00109-015-1271-5		11	Genetics & Heredity; Medicine, Research & Experimental	Genetics & Heredity; Research & Experimental Medicine	CN3LA	WOS:000358326500007		
J	Takami, H; Fukushima, S; Fukuoka, K; Suzuki, T; Yanagisawa, T; Matsushita, Y; Nakamura, T; Arita, H; Mukasa, A; Saito, N; Kanamori, M; Kumabe, T; Tominaga, T; Kobayashi, K; Nagane, M; Iuchi, T; Tamura, K; Maehara, T; Sugiyama, K; Nakada, M; Kanemura, Y; Nonaka, M; Yokogami, K; Takeshima, H; Narita, Y; Shibui, S; Nakazato, Y; Nishikawa, R; Ichimura, K; Matsutani, M				Takami, Hirokazu; Fukushima, Shintaro; Fukuoka, Kohei; Suzuki, Tomonari; Yanagisawa, Takaaki; Matsushita, Yuko; Nakamura, Taishi; Arita, Hideyuki; Mukasa, Akitake; Saito, Nobuhito; Kanamori, Masayuki; Kumabe, Toshihiro; Tominaga, Teiji; Kobayashi, Keiichi; Nagane, Motoo; Iuchi, Toshihiko; Tamura, Kaoru; Maehara, Taketoshi; Sugiyama, Kazuhiko; Nakada, Mitsutoshi; Kanemura, Yonehiro; Nonaka, Masahiro; Yokogami, Kiyotaka; Takeshima, Hideo; Narita, Yoshitaka; Shibui, Soichiro; Nakazato, Yoichi; Nishikawa, Ryo; Ichimura, Koichi; Matsutani, Masao			Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors	JOURNAL OF NEURO-ONCOLOGY			English	Article						Expression; Germ cell tumor; Germinoma; Human chorionic gonadotropin; Real-time polymerase chain reaction	SYNCYTIOTROPHOBLASTIC GIANT-CELLS; CENTRAL-NERVOUS-SYSTEM; SERUM HCG-BETA; BREAST-CANCER; GERMINOMA; CLASSIFICATION; PATHOGENESIS; PROGNOSIS; CARCINOMA; TISSUE	Human chorionic gonadotropin (hCG) production has been utilized as a diagnostic marker for germinoma with syncytiotrophoblastic giant cells (STGC) and choriocarcinoma. Elevated hCG in germinoma is considered to predict less favorable prognosis, and an intensive treatment strategy may accordingly be applied. However, there is some evidence that any germinoma may produce hCG to varying extent. We investigated mRNA expression of the hCG beta subunit (hCG beta) using real time quantitative polymerase chain reaction in 94 germ cell tumors (GCTs). Most (93.3 %) GCTs showed higher expression levels compared with that of normal brain tissue (1.09 x 10(0)-1.40 x 10(5) fold). The expression was the highest in GCTs which harbor choriocarcinoma or STGC components. The expression level of hCG beta in germinoma was highly variable (1.09 x 10(0)-5.88 x 10(4) fold) in linear but not bimodal distribution. hCG concentrations in serum and CSF correlated with gene expression, especially when GCTs with single histological component were analyzed separately. The expression was not significantly associated with recurrence in pure germinoma. These results suggest that the serum/CSF hCG levels may need to be interpreted with caution as most GCTs appear to have the capacity of producing hCG irrespective of their histology. The clinical significance of ubiquitous hCG expression in GCTs needs further investigation.	[Takami, Hirokazu; Fukushima, Shintaro; Fukuoka, Kohei; Matsushita, Yuko; Nakamura, Taishi; Arita, Hideyuki; Ichimura, Koichi] Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, Tokyo 1040045, Japan; [Takami, Hirokazu; Mukasa, Akitake; Saito, Nobuhito] Univ Tokyo, Fac Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; [Fukuoka, Kohei; Yanagisawa, Takaaki] Saitama Med Univ, Int Med Ctr, Div Pediat Neurooncol, Hidaka, Saitama 3501298, Japan; [Suzuki, Tomonari; Nishikawa, Ryo; Matsutani, Masao] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Hidaka, Saitama 3501298, Japan; [Matsushita, Yuko; Narita, Yoshitaka; Shibui, Soichiro] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo 1040045, Japan; [Nakamura, Taishi] Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa 2360004, Japan; [Arita, Hideyuki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Kanamori, Masayuki; Kumabe, Toshihiro; Tominaga, Teiji] Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kumabe, Toshihiro] Kitasato Univ, Dept Neurosurg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Kobayashi, Keiichi; Nagane, Motoo] Kyorin Univ, Fac Med, Dept Neurosurg, Mitaka, Tokyo 1818611, Japan; [Iuchi, Toshihiko] Chiba Canc Ctr, Dept Neurosurg, Chuo Ku, Chiba 2600801, Japan; [Tamura, Kaoru; Maehara, Taketoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, Bunkyo Ku, Tokyo 1130034, Japan; [Sugiyama, Kazuhiko] Hiroshima Univ, Dept Neurosurg, Fac Med, Hiroshima 7348551, Japan; [Nakada, Mitsutoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa 9208641, Japan; [Kanemura, Yonehiro; Nonaka, Masahiro] Osaka Natl Hosp, Natl Hosp Org, Dept Neurosurg, Osaka 5400006, Japan; [Kanemura, Yonehiro] Osaka Natl Hosp, Natl Hosp Org, Inst Clin Res, Div Regenerat Med,Chuo Ku, Osaka 5400006, Japan; [Yokogami, Kiyotaka; Takeshima, Hideo] Miyazaki Univ, Dept Neurosurg, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Nakazato, Yoichi] Hidaka Hosp, Dept Pathol, Takasaki, Gunma 3700001, Japan	Ichimura, K (reprint author), Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kichimur@ncc.go.jp			research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This study was supported by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We thank Dr Hideki Katakami for sharing valuable data and inspiring the project, and Dr Sylvia Kocialkowski for critical reading of the manuscript.	Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Oosterhuis JW, 2007, INT J ANDROL, V30, P256, DOI 10.1111/j.1365-2605.2007.00793.x; Sano K, 1999, J NEUROSURG, V90, P258, DOI 10.3171/jns.1999.90.2.0258; Tan C, 2013, J PATHOL, V229, P4, DOI 10.1002/path.4098; Allred DC, 1998, MODERN PATHOL, V11, P155; Gobel U, 2000, ANN ONCOL, V11, P263, DOI 10.1023/A:1008360523160; Cole LA, 2012, MOL CELL ENDOCRINOL, V349, P232, DOI 10.1016/j.mce.2011.10.029; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Fukushima S, 2014, ACTA NEUROPATHOL, V127, P911, DOI 10.1007/s00401-014-1247-5; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; Sawamura Y, 1998, EUR J CANCER, V34, P104, DOI 10.1016/S0959-8049(97)10045-4; Louhimo J, 2002, INT J CANCER, V101, P545, DOI 10.1002/ijc.90009; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; BJORNSSON J, 1985, J NEUROPATH EXP NEUR, V44, P32, DOI 10.1097/00005072-198501000-00003; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; Fujimaki T, 2011, NEURO-ONCOLOGY, V13, pI13; Ikura Y, 1996, PATHOL RES PRACT, V192, P595; Inamura T, 1999, J NEUROL NEUROSUR PS, V66, P654, DOI 10.1136/jnnp.66.5.654; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Katakami H, 2003, HORM CLIN, V51, P196; Lempiainen A, 2014, UROL ONCOL-SEMIN ORI, V32, P727, DOI 10.1016/j.urolonc.2013.11.007; MADERSBACHER S, 1994, CANCER RES, V54, P5096; Mostofi FK, 1973, TUMORS MALE GENITAL; Ogino H, 2005, INT J RADIAT ONCOL, V62, P803, DOI 10.1016/j.ijrpbp.2004.10.026; Shibamoto Y, 1997, INT J RADIAT ONCOL, V37, P505, DOI 10.1016/S0360-3016(96)00611-6; Shibui S, 2014, REPORT BRAIN TUMOR R; TAMAKI N, 1990, CHILD NERV SYST, V6, P3, DOI 10.1007/BF00262257; TEILUM G, 1965, ACTA PATHOL MIC SC, V64, P407; Utsuki Satoshi, 2005, Brain Tumor Pathol, V22, P9, DOI 10.1007/s10014-004-0171-0; Utsuki S, 1999, ACTA NEUROCHIR, V141, P975, DOI 10.1007/s007010050404; Vartiainen J, 2008, INT J CANCER, V122, P2125, DOI 10.1002/ijc.23322; Wong JM, 2010, J NEUROSURG-PEDIATR, V6, P295, DOI 10.3171/2010.6.PEDS09541; YAMAGAMI T, 1987, ACTA NEUROCHIR, V86, P33, DOI 10.1007/BF01419502; Zeng N, 2009, NEUROPATH APPL NEURO, V35, P353, DOI 10.1111/j.1365-2990.2008.01001.x	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	AUG	2015	124	1					23	32		10.1007/s11060-015-1809-y		10	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CN1EO	WOS:000358160300004		
J	Sasaki, H; Hirose, Y; Yazaki, T; Kitamura, Y; Katayama, M; Kimura, T; Fujiwara, H; Toda, M; Ohira, T; Yoshida, K				Sasaki, Hikaru; Hirose, Yuichi; Yazaki, Takahito; Kitamura, Yohei; Katayama, Makoto; Kimura, Tokuhiro; Fujiwara, Hirokazu; Toda, Masahiro; Ohira, Takayuki; Yoshida, Kazunari			Upfront chemotherapy and subsequent resection for molecularly defined gliomas	JOURNAL OF NEURO-ONCOLOGY			English	Article						Neoadjuvant; Upfront chemotherapy; Glioma; 1p19q; Second-look resection	LOW-GRADE GLIOMAS; NEOADJUVANT TEMOZOLOMIDE; OLIGODENDROGLIAL TUMORS; GENETIC ABERRATIONS; IDH2 MUTATIONS; II GLIOMAS; PHASE-II; ADULTS; SURVIVAL; MARKER	Functional preservation is critical in glioma surgery, and the extent of resection influences survival outcome. Neoadjuvant chemotherapy is a promising option because of its potential to facilitate tumor shrinkage and maximum tumor resection. The object of this study was to assess the utility of the neoadjuvant strategy in a prospective series of gliomas with favorable molecular status. Twenty-six consecutive cases of diffuse gliomas of WHO grade II or III with either 1p19q codeletion or MGMT methylation were treated with upfront chemotherapy following maximal safe removal. In cases of incomplete initial surgery, second-look resection was intended after tumor volume decrease by chemotherapy. Among 22 evaluable cases, chemotherapy led to a median change in the sum of the product of perpendicular diameters of -35 %, and 14 out of the 22 cases (64 %) showed objective response. Second-look resection after tumor volume decrease was performed in 12 out of 19 cases of incomplete initial surgery (GTR/STR 9, removal of residual methionine PET uptake 3). The median progression-free survival among the 22 patients with grade II tumors was 57 months, with some cases showing durable progression-free survival after second-look resection. MIB-1 indices of the second-look resected tumors were lower than those of the initial tumors, and the methylation status of the MGMT gene was unchanged. Neoadjuvant chemotherapy based on molecular guidance often produces significant volume decrease of incompletely resected gliomas. Radical second-look resection is an optional advantage of upfront chemotherapy for chemosensitive gliomas compared with initial radiotherapy.	[Sasaki, Hikaru; Yazaki, Takahito; Kitamura, Yohei; Toda, Masahiro; Ohira, Takayuki; Yoshida, Kazunari] Keio Univ, Dept Neurosurg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Hirose, Yuichi] Fujita Hlth Univ Sch Med, Dept Neurosurg, Toyoake, Aichi 4701192, Japan; [Katayama, Makoto] Kawasaki Municipal Hosp, Dept Neurosurg, Kawasaki Ku, Kawasaki, Kanagawa 2100013, Japan; [Kimura, Tokuhiro] Keio Univ, Dept Pathol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Fujiwara, Hirokazu] Keio Univ, Dept Diagnost Radiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Sasaki, H (reprint author), Keio Univ, Dept Neurosurg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsasaki@keio.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science [20591721, 23592141, 25462278]	The present study was supported by Grant-in-Aid for Scientific Research (KAKENHI) by The Ministry of Education, Culture, Sports, Science and Technology and The Japan Society for the Promotion of Science (Grant Number 20591721, 23592141, 25462278). We greatly thank Ms. Yuko Aikawa, Ms. Naoko Tsuzaki, and Ms. Kiyomi Koide from the Department of Neurosurgery at Keio University School of Medicine for their technical assistance. We thank Dr. Yoshio Uchino from the Department of Neurosurgery at Chiba Ryogo Center for performing the <SUP>11</SUP>C-methionine PET analyses. We also thank Dr. Akira Miyajima from the Department of Urology and Dr. Yoshiyuki Ishii and Dr. Maiko Takahashi from the Department of Surgery at Keio University School of Medicine for instructions in updated treatments of their specialty areas.	Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Viaccoz A, 2012, CURR OPIN ONCOL, V24, P694, DOI 10.1097/CCO.0b013e328357f503; Levin N, 2006, CANCER, V106, P1759, DOI 10.1002/cncr.21809; Pirotte BJM, 2009, NEUROSURGERY, V64, P471, DOI 10.1227/01.NEU.0000338949.94496.85; Hirose Y, 2001, J MOL DIAGN, V3, P62, DOI 10.1016/S1525-1578(10)60653-8; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Blonski M, 2012, J NEURO-ONCOL, V106, P353, DOI 10.1007/s11060-011-0670-x; Kesari S, 2009, CLIN CANCER RES, V15, P330, DOI 10.1158/1078-0432.CCR-08-0888; Peyre M, 2010, NEURO-ONCOLOGY, V12, P1078, DOI 10.1093/neuonc/noq055; Brada M, 2003, ANN ONCOL, V14, P1715, DOI 10.1093/annonc/mdg371; Kaloshi G, 2007, NEUROLOGY, V68, P1831, DOI 10.1212/01.wnl.0000262034.26310.a2; Hoang-Xuan K, 2004, J CLIN ONCOL, V22, P3133, DOI 10.1200/JCO.2004.10.169; Tanaka Y, 2009, J NEUROSURG, V110, P163, DOI 10.3171/2008.4.17569; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Everhard S, 2006, ANN NEUROL, V60, P740, DOI 10.1002/ana.21044; Lassman AB, 2011, NEURO-ONCOLOGY, V13, P649, DOI 10.1093/neuonc/nor040; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Meeks JJ, 2012, EUR UROL, V62, P523, DOI 10.1016/j.eururo.2012.05.048; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; Blonski M, 2013, J NEURO-ONCOL, V113, P267, DOI 10.1007/s11060-013-1106-6; Ezaki T, 2011, MOL MED REP, V4, P1101, DOI 10.3892/mmr.2011.573; Jo J, 2014, J NEURO-ONCOL, V120, P155, DOI 10.1007/s11060-014-1538-7; Louis DN, 2007, WHO CLASSIFICATION T; Miwa T, 2011, NEUROSURGERY, V68, P206, DOI 10.1227/NEU.0b013e3181fd2c2e; Nishiyama Y, 2014, NEUROSURG REV, V37, P291, DOI 10.1007/s10143-013-0515-5; Lee IH, 2009, INT J RADIAT ONCOL, V73, P479, DOI 10.1016/j.ijrobp.2008.04.050; van den Bent MJ, 2013, J CLIN ONCOL, V31, P653, DOI 10.1200/JCO.2012.46.6896; Voloschin AD, 2005, NEURO-ONCOLOGY, V7, P97, DOI 10.1215/S1152851704000560; Wen PY, 2007, NEUROLOGY, V68, P1762, DOI 10.1212/01.wnl.0000266866.13748.a9	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	AUG	2015	124	1					127	135		10.1007/s11060-015-1817-y		9	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CN1EO	WOS:000358160300016		
J	Yuki, I; Spitzer, D; Guglielmi, G; Duckwiler, G; Fujimoto, M; Takao, H; Jahan, R; Tateshima, S; Murayama, Y; Vinuela, F				Yuki, Ichiro; Spitzer, Daniel; Guglielmi, Guido; Duckwiler, Gary; Fujimoto, Motoaki; Takao, Hiroyuki; Jahan, Reza; Tateshima, Satoshi; Murayama, Yuichi; Vinuela, Fernando			Immunohistochemical analysis of a ruptured basilar top aneurysm autopsied 22 years after embolization with Guglielmi detachable coils	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article							THROMBUS ORGANIZATION	The authors report on the histologic and immunohistochemical analyses of a cerebral aneurysm embolized with platinum coils and with the longest observation period. A 58-year-old woman presenting with subarachnoid hemorrhage due to ruptured basilar top aneurysm was treated with Guglielmi detachable coils (GDC) 22 years ago. She was the 15th case since the GDC was introduced. After she died of unrelated causes, an autopsy and thorough histologic examination were performed. Gross examination revealed no adhesion between the aneurysm wall and the surrounding brain tissue. Histologic and immunohistochemical analyses demonstrated that the cavity of the aneurysm was filled with homogeneous collagenous fibrous tissue, while the neck was completely covered by a dense collagenous neointima and a smooth muscle cell layer. The unique histologic results of this case may contribute to a better understanding of the long-term evolution of the healing process in intracranial aneurysms successfully treated with the GDC.	[Yuki, Ichiro] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo 1058471, Japan; [Yuki, Ichiro] Univ Calif Los Angeles, Med Ctr, Dept Radiol, Los Angeles, CA USA; [Spitzer, Daniel] Hudson Valley Neurosurg, Dept Neurosurg, Los Angeles, CA USA; [Guglielmi, Guido; Duckwiler, Gary; Fujimoto, Motoaki; Takao, Hiroyuki; Jahan, Reza; Tateshima, Satoshi; Vinuela, Fernando] Univ Calif Los Angeles, Med Ctr, Dept Radiol Sci, Los Angeles, CA USA; [Murayama, Yuichi] Jikei Univ Hosp, Dept Neurosurg, Tokyo, Japan	Yuki, I (reprint author), Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Nishishinbashi 3-19-18, Tokyo 1058471, Japan.	ichiroyuki@gmail.com					Dai DY, 2005, AM J NEURORADIOL, V26, P2560; Bavinzski G, 1999, J NEUROSURG, V91, P284, DOI 10.3171/jns.1999.91.2.0284; Dai D, 2005, AM J NEURORADIOL, V26, P1932; Groden C, 2003, AM J NEURORADIOL, V24, P579; Killer M, 2010, J BIOMED MATER RES B, V94B, P486, DOI 10.1002/jbm.b.31660; Killer-Oberpfalzer M, 2012, CARDIOVASC PATHOL, V21, P299, DOI 10.1016/j.carpath.2011.09.010; Szikora I, 2006, AM J NEURORADIOL, V27, P283; Yuki I, 2007, J NEUROSURG, V107, P109, DOI 10.3171/JNS-07/07/0109	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478	1759-8486		J NEUROINTERV SURG	J. NeuroInterventional Surg.	AUG	2015	7	8					E29	U15		10.1136/neurintsurg-2014-011260.rep		4	Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	CN2OI	WOS:000358261100003		
J	Nagao, J; Miyashita, M; Nakagawa, Y; Miyagawa, H				Nagao, Junya; Miyashita, Masahiro; Nakagawa, Yoshiaki; Miyagawa, Hisashi			Chemical synthesis of La1 isolated from the venom of the scorpion Liocheles australasiae and determination of its disulfide bonding pattern	JOURNAL OF PEPTIDE SCIENCE			English	Article						scorpion venom; peptide synthesis; native chemical ligation; disulfide bond; MS/MS	TRANSCRIPTOMIC ANALYSIS; AUSTRALIAN SCORPION; PEPTIDES; PROTEINS; COMPONENTS; DIVERSITY; EVOLUTION; LIGATION; PROTEOME; CHANNELS	La1 is a 73-residue cysteine-rich peptide isolated from the scorpion Liocheles australasiae venom. Although La1 is the most abundant peptide in the venom, its biological function remains unknown. Here, we describe a method for efficient chemical synthesis of La1 using the native chemical ligation (NCL) strategy, in which three peptide components of less than 40 residues were sequentially ligated. The peptide thioester necessary for NCL was synthesized using an aromatic N-acylurea approach with Fmoc-SPPS. After completion of sequential NCL, disulfide bond formation was carried out using a dialysis method, in which the linear peptide dissolved in an acidic solution was dialyzed against a slightly alkaline buffer to obtain correctly folded La1. Next, we determined the disulfide bonding pattern of La1. Enzymatic and chemical digests of La1 without reduction of disulfide bonds were analyzed by liquid chromatography/mass spectrometry (LC/MS), which revealed two of four disulfide bond linkages. The remaining two linkages were assigned based on MS/MS analysis of a peptide fragment containing two disulfide bonds. Consequently, the disulfide bonding pattern of La1 was found to be similar to that of a von Willebrand factor type C (VWC) domain. To our knowledge, this is the first report of the experimental determination of the disulfide bonding pattern of peptides having a single VWC domain as well as their chemical synthesis. La1 synthesized in this study will be useful for investigation of its biological role in the venom. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.	[Nagao, Junya; Miyashita, Masahiro; Nakagawa, Yoshiaki; Miyagawa, Hisashi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan	Miyashita, M (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan.	miyamasa@kais.kyoto-u.ac.jp			MEXT KAKENHI, Japan [25513001]	We are grateful to Professor Fumihiko Sato (Kyoto University) for MALDI-TOF MS analysis. This study was partly supported by MEXT KAKENHI (grant no. 25513001), Japan.	O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Bergeron ZL, 2012, TOXINS, V4, P1082, DOI 10.3390/toxins4111082; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Chen YH, 2011, DEV COMP IMMUNOL, V35, P661, DOI 10.1016/j.dci.2011.01.010; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; Holbourn KP, 2009, J CELL COMMUN SIGNAL, V3, P25, DOI 10.1007/s12079-009-0048-4; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; He YW, 2013, J PROTEOMICS, V89, P1, DOI 10.1016/j.jprot.2013.06.007; Harrison PL, 2014, TOXICON, V88, P115, DOI 10.1016/j.toxicon.2014.06.006; Miyashita M, 2007, TOXICON, V50, P428, DOI 10.1016/j.toxicon.2007.04.012; Hojo H, 2014, CURR OPIN STRUC BIOL, V26, P16, DOI 10.1016/j.sbi.2014.03.002; Kamachi S, 2014, ACTA CRYSTALLOGR F, V70, P915, DOI 10.1107/S2053230X14010589; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; Ramirez KL, 2012, TOXICON, V60, P184, DOI 10.1016/j.toxicon.2012.04.174; Rodriguez de la Vega R.C., 2013, HDB BIOL ACTIVE PEPT, P423; SABATIER JM, 1987, INT J PEPT PROT RES, V30, P125; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	AUG	2015	21	8					636	643		10.1002/psc.2778		8	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CN4AD	WOS:000358369300003		
J	Chen, YL; Shimada, H; Sasaoka, T; Matsui, K; Araki, K; Watanabe, D				Chen, Yanlong; Shimada, Hideki; Sasaoka, Takashi; Matsui, Kikuo; Araki, Koichi; Watanabe, Dai			Application and Pipeline Vertical Displacement Analysis of Chemical Grouting for Pipeline Position Restoration Method	JOURNAL OF PIPELINE SYSTEMS ENGINEERING AND PRACTICE			English	Article						Vertical displacement; Pipeline position; Restoration; Numerical analysis		The chemical grouting method presented in this paper can restore the position of a pipeline by precisely and rapidly reinforcing the failed pipeline foundation. The method can also improve the meandering and sagging conditions of a pipeline. A case study found that the method is an effective, rapid, and precise trenchless restoration technology for pipeline position restoration. Moreover, discussion results are presented of some patterns of injection tests that were conducted in the laboratory to determine the relationship between the types of grout material and the soil permeability. According to the experimental results, the grout is injected into the lower permeable soil primarily by fracture grouting. Additionally, numerical analysis was conducted by using finite-element analysis software, and the outcome showed that this numerical analysis can be used as an assessment method for predicting the vertical displacement of a pipeline after applying the chemical grouting pipeline position restoration method. (C) 2013 American Society of Civil Engineers.	[Chen, Yanlong] China Univ Min & Technol, State Key Lab Geomech & Deep Underground Engn, Xuzhou 221008, Peoples R China; [Shimada, Hideki; Sasaoka, Takashi; Matsui, Kikuo] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Nishi Ku, Fukuoka 8190395, Japan; [Araki, Koichi; Watanabe, Dai] Fuso Technol Co Ltd, Sumida Ku, Tokyo 1310033, Japan	Chen, YL (reprint author), China Univ Min & Technol, State Key Lab Geomech & Deep Underground Engn, Univ Rd, Xuzhou 221008, Peoples R China.	chenyanlongcumt@gmail.com			Global-Centre of Excellence (GCOE) in Novel Carbon Resource Science, Kyushu University	The authors are grateful for financial assistance provided by the Global-Centre of Excellence (GCOE) in Novel Carbon Resource Science, Kyushu University.	Zhou WX, 2011, J INFRASTRUCT SYST, V17, P216, DOI 10.1061/(ASCE)IS.1943-555X.0000063; [Anonymous], PHASE2 7 0 COMP SOFT; Vipulanandan C, 2009, J GEOTECH GEOENVIRON, V135, P1190, DOI 10.1061/(ASCE)GT.1943-5606.0000064; Hossam A. K., 2010, INT J PRESSURE VESSE, V87, P373; Ihle CF, 2012, MINER ENG, V32, P54, DOI 10.1016/j.mineng.2012.03.002; Nel DT, 2011, J S AFR INST CIV ENG, V53, P9; Ozgurel H. G., 2005, P PIP DIV SPEC C ASC, P631; Shimada Hideki, 2012, Geotechnical and Geological Engineering, V30, DOI 10.1007/s10706-011-9467-0	8	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1949-1190	1949-1204		J PIPELINE SYST ENG	J. Pipel. Syst. Eng. Pract.	AUG	2015	6	3			SI				A4013002	10.1061/(ASCE)PS.1949-1204.0000110		7	Engineering, Civil; Water Resources	Engineering; Water Resources	CN1LB	WOS:000358180400001		
J	Ito, T; Nagaishi, R; Kimura, T; Kim, SY				Ito, Tatsuya; Nagaishi, Ryuji; Kimura, Takaumi; Kim, Seong-Yun			Study on radiation effects on (MOTDGA-TOA)/SiO2-P adsorbent for separation of platinum group metals from high-level radioactive waste	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Macroporous silica-based adsorbent; Platinum group metals (PGMs); High level liquid waste (HLLW); Gamma-ray irradiation	ION-EXCHANGE CHARACTERISTICS; LIQUID WASTE; NITRIC-ACID; THIODIGLYCOLAMIDE T(2EH)TDGA; PARTITIONING PROCESS; PALLADIUM; EXTRACTION; ACTINIDES; RECOVERY; BEHAVIOR	To discuss the applicability of a novel macroporous silica-based (MOTDGA-TOA)/SiO2-P adsorbent which was developed to separate platinum group metals (PGMs) from high level liquid waste by extraction chromatography to radiation field, batch adsorption behavior, stability of the adsorbent and retention capability of PGMs under irradiation were investigated by using gamma-ray emitted from Co-60. Difference of adsorption behaviors of Ru(III), Rh(III) and Pd(II) were not observed with or without the irradiation up to 100 kGy of absorbed dose at least. The retention ratio of Pd(II) showed very gradual decrease, and was over 99 % at absorbed dose of about 800 kGy.	[Ito, Tatsuya; Kim, Seong-Yun] Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Nagaishi, Ryuji; Kimura, Takaumi] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Kim, SY (reprint author), Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, 6-6-01-2 Aza Aoba Aramaki, Sendai, Miyagi 9808579, Japan.	kim@qse.tohoku.ac.jp					Ando Y, 1999, 99004 JAERI; YAMAGISHI I, 1993, J NUCL SCI TECHNOL, V30, P717, DOI 10.3327/jnst.30.717; Wei Y, 2000, NUCL TECHNOL, V132, P413; Ruhela R, 2012, RADIOCHIM ACTA, V100, P37, DOI [10.1524/ract.2012.1892, 10.1524/ract.2011.1892]; Narita H, 2008, MINER ENG, V21, P483, DOI 10.1016/j.mineng.2008.01.011; Magill J, 2003, NUCL ENERG-J BR NUCL, V42, P263, DOI 10.1680/nuen.42.5.263.37622; Bush RP, 1991, PLATIN MET REV, V35, P202; Daskshinamoorthy A, 2008, DESALINATION, V232, P26; HUBBELL J. H., 1995, NISTIR; Ito T, 2013, SEP SCI TECHNOL, V48, P2616, DOI 10.1080/01496395.2013.807290; Kim SY, 2013, J RADIOANAL NUCL CH, V295, P1043, DOI 10.1007/s10967-012-1878-8; KONDO Y, 1992, J NUCL SCI TECHNOL, V29, P140; Kondo Y, 1991, JAERIM91147; Kononova ON, 2008, J POROUS MAT, V15, P61, DOI 10.1007/s10934-006-9052-8; KRAUSE C, 1991, J MATER RES, V6, P2535, DOI 10.1557/JMR.1991.2535; Lee SH, 1999, KOREAN J CHEM ENG, V16, P571, DOI 10.1007/BF02708133; Lee SH, 2004, KOREAN J CHEM ENG, V21, P1038, DOI 10.1007/BF02705590; Nagaishi R, 2001, RADIAT PHYS CHEM, V60, P369, DOI 10.1016/S0969-806X(00)00410-2; Nagaishi R., 2014, Japan Patent, Patent No. [5424297 B2, 5424297]; Nash KL, 2011, WOODHEAD PUBL SER EN, P1, DOI 10.1533/9780857092274; Ruhela R, 2011, SEP SCI TECHNOL, V46, P965, DOI 10.1080/01496395.2010.539191	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	AUG	2015	305	2					419	427		10.1007/s10967-015-4014-8		9	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CN2LQ	WOS:000358253100010		
J	Kritsananuwat, R; Arae, H; Fukushi, M; Sahoo, SK; Chanyotha, S				Kritsananuwat, Rawiwan; Arae, Hideki; Fukushi, Masahiro; Sahoo, Sarata Kumar; Chanyotha, Supitcha			Natural radioactivity survey on soils originated from southern part of Thailand as potential sites for nuclear power plants from radiological viewpoint and risk assessment	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Natural radionuclides; Soil; gamma-Spectroscopy; ICP-MS; Radiological risk	GAMMA DOSE-RATE; MASS-SPECTROMETRY; SAMPLES; RADIONUCLIDES; TH-232; K-40; RA-226; AREAS; SPECTROSCOPY; SEDIMENTS	Natural radioactivity in surface soil samples collected at potential sites from southern part of Thailand to set up nuclear power plants has been investigated. U-238 and Th-232 were determined by inductively coupled plasma mass spectrometry whereas gamma-ray spectroscopy was used for K-40 determination. The activity concentrations for U-238, Th-232 and K-40 varied in range from 4 to 122, 6 to 170 and 5 to 1,422 Bq kg(-1), respectively. The large variation of radionuclide concentrations showed heterogeneous distribution that could be attributed to geological origin. The radiation hazard parameters were estimated from activity concentration of U-238, Th-232 and K-40 in accordance with the UNSCEAR 2000. Data obtained indicated that soils in the study areas did not pose any significant radiological health hazard to the local population.	[Kritsananuwat, Rawiwan; Arae, Hideki; Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 260, Japan; [Kritsananuwat, Rawiwan; Fukushi, Masahiro] Tokyo Metropolitan Univ, Dept Radiol Sci, Tokyo 158, Japan; [Kritsananuwat, Rawiwan; Chanyotha, Supitcha] Chulalongkorn Univ, Dept Nucl Engn, Bangkok, Thailand	Sahoo, SK (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, 4-9-1 Anagawa, Chiba 260, Japan.	sahoo@nirs.go.jp			Tokyo Metropolitan Government, Tokyo, Japan; National Institute of Radiological Sciences (NIRS), Chiba, Japan	The author (RK) is very much thankful to Tokyo Metropolitan Government, Tokyo, Japan for the award of doctoral fellowship "Asian Human Resources Fund" at Tokyo Metropolitan University and National Institute of Radiological Sciences (NIRS), Chiba, Japan for all experimental studies. RK would like to thank specially Chulalongkorn University team members for their kind support during field study.	Akozcan S, 2013, ENVIRON EARTH SCI, V71, P4611; Alatise OO, 2008, J ENVIRON RADIOACTIV, V99, P1746, DOI 10.1016/j.jenvrad.2008.06.014; Charro E, 2013, J ENVIRON RADIOACTIV, V124, P84, DOI 10.1016/j.jenvrad.2013.04.011; Dragovic S, 2006, J ENVIRON RADIOACTIV, V89, P150, DOI 10.1016/j.jenvrad.2006.05.002; Agbalagba EO, 2012, J ENVIRON RADIOACTIV, V109, P64, DOI 10.1016/j.jenvrad.2011.10.012; Santawamaitre T, 2011, NUCL INSTRUM METH A, V652, P920, DOI 10.1016/j.nima.2010.10.057; Hilal MA, 2014, J ENVIRON RADIOACTIV, V136, P121, DOI 10.1016/j.jenvrad.2014.05.016; Pongsoi P, 2013, RENEW SUST ENERG REV, V24, P586, DOI 10.1016/j.rser.2013.03.038; Montes ML, 2012, J ENVIRON RADIOACTIV, V105, P30, DOI 10.1016/j.jenvrad.2011.09.014; Nath BN, 1997, GEOCHIM COSMOCHIM AC, V61, P2375; Jankovic M, 2008, RADIAT MEAS, V43, P1448, DOI 10.1016/j.radmeas.2008.03.004; Hannan MA, 2013, J RADIOANAL NUCL CH, V295, P729, DOI 10.1007/s10967-012-1840-9; Al-Hamarneh IF, 2009, RADIAT MEAS, V44, P102, DOI 10.1016/j.radmeas.2008.11.005; Nisi S, 2009, APPL RADIAT ISOTOPES, V67, P828, DOI 10.1016/j.apradiso.2009.01.021; Lariviere D, 2006, SPECTROCHIM ACTA B, V61, P877, DOI 10.1016/j.sab.2006.07.004; Orgun Y, 2007, APPL RADIAT ISOTOPES, V65, P739, DOI 10.1016/j.apradiso.2006.06.011; Al-Kharouf SJ, 2008, J ENVIRON RADIOACTIV, V99, P1192, DOI 10.1016/j.jenvrad.2008.02.001; Tufail M, 2013, J RADIOANAL NUCL CH, V298, P1085, DOI 10.1007/s10967-013-2619-3; El Samad O, 2013, J ENVIRON RADIOACTIV, V125, P36, DOI 10.1016/j.jenvrad.2013.02.010; EPA, 1992, GUID DAAT US RISK B; Gaso MI, 2013, J RADIOANAL NUCL CH, V296, P1213, DOI 10.1007/s10967-012-2386-6; Guagliardi I., 2013, INT J ENVIRON RES, V7, P645; Hussain RO, 2011, APPL PHYS SCI, P3; ICRP, 1991, ANN ICRP, V21; Kessaratikoon P., 2008, KMITL SCI J A, V8, P52; Kovacs T, 2013, J ENVIRON RADIOACTIV, V122, P70, DOI 10.1016/j.jenvrad.2013.02.007; Kritsananuwat R, 2015, J RADIOANAL NUCL CH, V303, P325, DOI 10.1007/s10967-014-3376-7; Krmar M, 2013, J ENVIRON RADIOACTIV, V117, P31, DOI 10.1016/j.jenvrad.2011.12.023; Akozcan S, 2014, J RADIOANAL NUCL CH, V299, P95, DOI 10.1007/s10967-013-2730-5; Lee SK, 2009, J ENVIRON RADIOACTIV, V100, P368, DOI 10.1016/j.jenvrad.2009.01.001; Lu XW, 2013, J RADIOANAL NUCL CH, V295, P1845, DOI 10.1007/s10967-012-2241-9; Nenadovic S, 2012, SCI TOTAL ENVIRON, V429, P309, DOI 10.1016/j.scitotenv.2012.04.054; Ojovan MI, 2005, INTRO NUCL WASTE IMM, P43, DOI 10.1016/B978-008044462-8/50007-7; Peterson J., 2007, RADIOLOGICAL CHEM FA; Rahman SU, 2009, J RADIOL PROT, V29, P499, DOI 10.1088/0952-4746/29/4/004; Ramola RC, 2008, J RADIOL PROT, V28, P379, DOI 10.1088/0952-4746/28/3/008; Sahoo SK, 2013, ACTA GEOPHYS, V61, P876, DOI 10.2478/s11600-013-0131-3; Saidou Bochud FO, 2011, RADIAT MEAS, V46, P254; Saleh MA, 2013, J ENVIRON RADIOACTIV, V124, P130, DOI [10.1016/j.jenvrad.2013.04.013, 10.1016/j.jenvrad2013.04.013]; Tsai TL, 2008, J RADIOL PROT, V28, P347, DOI 10.1088/0952-4746/28/3/005; UNSCEAR, 2008, SOURC EFF ION RAD UN; UNSCEAR, 2000, SOURC EFF ION RAD	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	AUG	2015	305	2					487	499		10.1007/s10967-015-3994-8		13	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CN2LQ	WOS:000358253100018		
J	Yamashita, Y; Yanase, N; Nagano, T; Mitamura, H; Naganawa, H				Yamashita, Yuji; Yanase, Nobuyuki; Nagano, Tetsushi; Mitamura, Hisayoshi; Naganawa, Hirochika			Decontamination and volume reduction of cesium-contaminated soil by combining soil solidification with interpolyelectrolyte complex and wet classification	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Soil decontamination; Cesium; Interpolyelectrolyte complex; Solidification; Wet classification; Volume reduction	NUCLEAR-POWER-PLANT; FUKUSHIMA; ACCIDENT; RADIONUCLIDES; CS-137; I-131	We propose a method for the decontamination and waste volume reduction of cesium-contaminated soil. The soils were solidified with an interpolyelectrolyte complex solution and classified into several size fractions by wet sieving. Gamma-ray spectrometry of these fractions showed that the distribution ratio of the activity concentration of coarse soil particles decreased, whereas that of soil particles under 0.075 mm increased relative to reference samples. Results showed that the fine soil particles, on which radioactive cesium accumulates, were removed from the surface of the coarse soil particles during sieving and washing, and remained in the washing water.	[Yamashita, Yuji] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yanase, Nobuyuki; Nagano, Tetsushi; Mitamura, Hisayoshi; Naganawa, Hirochika] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan	Yamashita, Y (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.	yamashita.yuji.gm@u.tsukuba.ac.jp			Strategic Funds for the Promotion of Science and Technology, Japan	The authors thank Professor Kenichi Ito (Univ. of Miyazaki, Japan) and Dr. Hirohisa Yamada (National Institute for Materials Science, Japan) for the support of wet classification, and Dr. Mitsuru Yamamura and Mr. Toru Ujiie (Japan Conservation Engineers & Co., LTD.) for the support of radioactivity measurement. This research was supported by the Strategic Funds for the Promotion of Science and Technology, Japan.	Tsuiki M, 2012, GRASSL SCI, V58, P227, DOI 10.1111/grs.12005; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Chen QY, 2009, WASTE MANAGE, V29, P390, DOI 10.1016/j.wasman.2008.01.019; Fujiwara T, 2012, J ENVIRON RADIOACTIV, V113, P37, DOI 10.1016/j.jenvrad.2012.04.007; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; BAKEEV KN, 1992, MACROMOLECULES, V25, P4249, DOI 10.1021/ma00043a003; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; International Atomic Energy Agency, 1989, IAEA TECHN REP SER, V300; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Naganawa Hirochika, 2011, Transactions of the Atomic Energy Society of Japan, V10, DOI 10.3327/taesj.J11.017; Olin-Estes TJ, 2001, J HAZARD MATER, V85, P39, DOI 10.1016/S0304-3894(01)00220-5; Sakai M, 2014, ENVIRON POLLUT, V187, P112, DOI 10.1016/j.envpol.2014.01.002	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	AUG	2015	305	2					583	587		10.1007/s10967-015-4016-6		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CN2LQ	WOS:000358253100029		
J	Okanishi, H; Shibuya, H; Miyasaka, T; Asano, K; Sato, T; Watari, T				Okanishi, H.; Shibuya, H.; Miyasaka, T.; Asano, K.; Sato, T.; Watari, T.			Adenosquamous carcinoma of the oesophagus in a dog	JOURNAL OF SMALL ANIMAL PRACTICE			English	Article							BARRETTS-ESOPHAGUS; ADENOCARCINOMA; SARCOMAS; SPIROCERCOSIS	A six-year-old mixed-breed male dog weighing 7.0kg was presented with chronic vomiting and regurgitation. Endoscopic examination revealed prominent oesophageal dilation in the thoracic region, multiple small greyish-white nodules over the oesophageal lumen and cauliflower-like masses in the caudal oesophagus. Histopathological studies revealed a characteristic pattern of coexisting elements of infiltrating adenocarcinoma and squamous cell carcinoma. Immunohistochemical staining with anti-cytokeratin AE1+AE3 was positive in both types of neoplastic cells. Neoplastic glandular cells stained positively for cytokeratin 8 while neoplastic squamous cells stained positively for cytokeratin 5/6. On the basis of these findings, the dog was diagnosed with oesophageal adenosquamous carcinoma. The case history and findings suggest that the malignancy might have developed from Barrett's oesophagus following irritation of the oesophageal mucosa due to chronic vomiting and regurgitation.	[Okanishi, H.; Watari, T.] Nihon Univ, Fac Bioresource Sci, Dept Vet Med, Lab Vet Internal Med, Fujisawa, Kanagawa 2520880, Japan; [Shibuya, H.; Miyasaka, T.; Sato, T.] Nihon Univ, Fac Bioresource Sci, Dept Vet Med, Lab Vet Pathol, Fujisawa, Kanagawa 2520880, Japan; [Asano, K.] Nihon Univ, Fac Bioresource Sci, Dept Vet Med, Lab Vet Surg, Fujisawa, Kanagawa 2520880, Japan	Okanishi, H (reprint author), Nihon Univ, Fac Bioresource Sci, Dept Vet Med, Lab Vet Internal Med, Fujisawa, Kanagawa 2520880, Japan.						RIDGWAY RL, 1979, J AM VET MED ASSOC, V174, P700; Ranen E, 2004, VET PARASITOL, V119, P209, DOI 10.1016/j.vetpar.2003.10.023; RANDOLPH JF, 1984, J AM VET MED ASSOC, V184, P98; Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; BARRETT NR, 1950, BRIT J SURG, V38, P175, DOI 10.1002/bjs.18003815005; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; COTCHIN E., 1966, ANN ROYAL COLL SURG ENGL, V38, P92; Gibson CJ, 2010, VET PATHOL, V47, P116, DOI 10.1177/0300985809352973; Head K. W., 2002, Tumors in domestic animals, P401, DOI 10.1002/9780470376928.ch8; IVOGHLI B, 1978, VET MED SM ANIM CLIN, V73, P47; MCCAW D, 1980, J AM ANIM HOSP ASSOC, V16, P561; Noguchi Tsuyoshi, 2002, Jpn J Thorac Cardiovasc Surg, V50, P537; Ranen E, 2004, VET SURG, V33, P428, DOI 10.1111/j.1532-950X.2004.04062.x; Shinozuka J, 2001, J VET MED SCI, V63, P91, DOI 10.1292/jvms.63.91; Sugihara T., 1988, JAPANESE J GASTROENT, V21, P2695; Takiguchi M, 1997, J AM ANIM HOSP ASSOC, V33, P42; Yachida S, 2004, ONCOLOGY-BASEL, V66, P218, DOI 10.1159/000077998	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4510	1748-5827		J SMALL ANIM PRACT	J. Small Anim. Pract.	AUG	2015	56	8					521	523		10.1111/jsap.12333		3	Veterinary Sciences	Veterinary Sciences	CN5CD	WOS:000358446300008		
J	Halpin-Healy, T; Takeuchi, KA				Halpin-Healy, Timothy; Takeuchi, Kazumasa A.			A KPZ Cocktail-Shaken, not Stirred...	JOURNAL OF STATISTICAL PHYSICS			English	Article						Nonequilibrium growth; Extremal paths; Universal limit distributions	PARISI-ZHANG EQUATION; UPPER CRITICAL DIMENSION; DISORDERED HIERARCHICAL LATTICES; RENORMALIZATION-GROUP ANALYSIS; QUENCHED RANDOM IMPURITIES; NOISY BURGERS-EQUATION; ON-SOLID MODEL; DIRECTED POLYMERS; INTERFACE GROWTH; UNIVERSAL FLUCTUATIONS	The stochastic partial differential equation proposed nearly three decades ago by Kardar, Parisi and Zhang (KPZ) continues to inspire, intrigue and confound its many admirers. Here, we (i) pay debts to heroic predecessors, (ii) highlight additional, experimentally relevant aspects of the recently solved 1+1 KPZ problem, (iii) use an expanding substrates formalism to gain access to the 3d radial KPZ equation and, lastly, (iv) examining extremal paths on disordered hierarchical lattices, set our gaze upon the fate of d = infinity KPZ. Clearly, there remains ample unexplored territory within the realm of KPZ and, for the hearty, much work to be done, especially in higher dimensions, where numerical and renormalization group methods are providing a deeper understanding of this iconic equation.	[Halpin-Healy, Timothy] Columbia Univ, Barnard Coll, Dept Phys, New York, NY 10027 USA; [Takeuchi, Kazumasa A.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Halpin-Healy, T (reprint author), Columbia Univ, Barnard Coll, Dept Phys, 3009 Broadway, New York, NY 10027 USA.	healy@phys.columbia.edu	Takeuchi, Kazumasa/E-8052-2011	Takeuchi, Kazumasa/0000-0002-7217-6860	KAKENHI from JSPS [25707033]; KAKENHI from MEXT in Japan [25103004]	The authors would like to express their gratitude to Herbert Spohn for his many years of inspired work, wisdom, and stamina on behalf of the KPZ cause. Thanks, too, to Joel Lebowitz for keeping the statistical mechanical fire well-lit through the generations. This work is supported in part by KAKENHI ( No. 25707033 from JSPS and No. 25103004 "Fluctuation & Structure" from MEXT in Japan).	Almeida RAL, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045309; Alves SG, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/05/P05007; Alves SG, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.020103; EDWARDS SF, 1982, P ROY SOC LOND A MAT, V381, P17, DOI 10.1098/rspa.1982.0056; Krug J, 1997, ADV PHYS, V46, P139, DOI 10.1080/00018739700101498; TANG LH, 1992, PHYS REV A, V45, P7162, DOI 10.1103/PhysRevA.45.7162; Ferrari PL, 2011, J STAT PHYS, V144, P1123, DOI 10.1007/s10955-011-0318-4; Lassig M, 1997, PHYS REV LETT, V78, P903, DOI 10.1103/PhysRevLett.78.903; KARDAR M, 1986, PHYS REV LETT, V56, P889, DOI 10.1103/PhysRevLett.56.889; Batchelor MT, 1998, PHYSICA A, V260, P11, DOI 10.1016/S0378-4371(98)00326-4; RACZ Z, 1994, PHYS REV E, V50, P3530, DOI 10.1103/PhysRevE.50.3530; Tracy CA, 2009, COMMUN MATH PHYS, V290, P129, DOI 10.1007/s00220-009-0761-0; Monthus C, 2006, EUR PHYS J B, V53, P39, DOI 10.1140/epjb/e2006-00341-4; Amir G, 2011, COMMUN PUR APPL MATH, V64, P466, DOI 10.1002/cpa.20347; Majumdar SN, 2005, J STAT PHYS, V119, P777, DOI 10.1007/s10955-005-3022-4; FOLTIN G, 1994, PHYS REV E, V50, pR639, DOI 10.1103/PhysRevE.50.R639; Halpin-Healy T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.010103; IMBRIE JZ, 1988, J STAT PHYS, V52, P609, DOI 10.1007/BF01019720; Kelling J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061150; Dean DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046121; MOORE MA, 1995, PHYS REV LETT, V74, P4257, DOI 10.1103/PhysRevLett.74.4257; Calabrese P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.250603; Kim JM, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.034102; Tracy CA, 1996, COMMUN MATH PHYS, V177, P727, DOI 10.1007/BF02099545; Colaiori F, 2001, PHYS REV LETT, V86, P3946, DOI 10.1103/PhysRevLett.86.3946; Castellano C, 1998, PHYS REV LETT, V80, P3527, DOI 10.1103/PhysRevLett.80.3527; Takeuchi KA, 2012, J STAT PHYS, V147, P853, DOI 10.1007/s10955-012-0503-0; AMAR JG, 1990, PHYS REV A, V41, P3399, DOI 10.1103/PhysRevA.41.3399; DERRIDA B, 1989, EUROPHYS LETT, V8, P111, DOI 10.1209/0295-5075/8/2/001; MOSER K, 1994, J PHYS A-MATH GEN, V27, P4049, DOI 10.1088/0305-4470/27/12/013; Takeuchi KA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.230601; FORREST BM, 1990, PHYS REV LETT, V64, P1405, DOI 10.1103/PhysRevLett.64.1405; Hairer M, 2013, ANN MATH, V178, P559, DOI 10.4007/annals.2013.178.2.4; O'Connell N, 2012, ANN PROBAB, V40, P437, DOI 10.1214/10-AOP632; Johansson K, 2000, COMMUN MATH PHYS, V209, P437, DOI 10.1007/s002200050027; HUSE DA, 1985, PHYS REV LETT, V54, P2708, DOI 10.1103/PhysRevLett.54.2708; Halpin-Healy T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.069903; Frey E, 1999, EUROPHYS LETT, V47, P14, DOI 10.1209/epl/i1999-00343-4; TANG LH, 1992, J STAT PHYS, V67, P819, DOI 10.1007/BF01049729; Alves SG, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48003; HWA T, 1991, PHYS REV A, V44, pR7873; HALPINHEALY T, 1995, PHYS REP, V254, P215, DOI 10.1016/0370-1573(94)00087-J; MEAKIN P, 1993, PHYS REP, V235, P189, DOI 10.1016/0370-1573(93)90047-H; COOK J, 1989, J STAT PHYS, V57, P89, DOI 10.1007/BF01023636; KARDAR M, 1985, PHYS REV LETT, V55, P1157, DOI 10.1103/PhysRevLett.55.1157; Prahofer M, 2002, J STAT PHYS, V108, P1071, DOI 10.1023/A:1019791415147; KIM JM, 1989, PHYS REV LETT, V62, P2289, DOI 10.1103/PhysRevLett.62.2289; BAER RM, 1968, MATH COMPUT, V22, P385, DOI 10.2307/2004668; ROUX S, 1991, J STAT PHYS, V65, P183, DOI 10.1007/BF01329855; MARITAN A, 1992, PHYS REV LETT, V69, P3193, DOI 10.1103/PhysRevLett.69.3193; Antal T, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046140; Seppalainen T, 2012, ANN PROBAB, V40, P19, DOI 10.1214/10-AOP617; Majumdar SN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.225501; KRUG J, 1990, J PHYS A-MATH GEN, V23, pL987, DOI 10.1088/0305-4470/23/18/009; Raychaudhuri S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.136101; Imamura T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190603; Maunuksela J, 1997, PHYS REV LETT, V79, P1515, DOI 10.1103/PhysRevLett.79.1515; Palasantzas G, 2002, SURF SCI, V507, P357, DOI 10.1016/S0039-6028(02)01271-2; Okounkov A, 2000, INT MATH RES NOTICES, P1043; Sasamoto T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.230602; Baik J, 2000, J STAT PHYS, V100, P523, DOI 10.1023/A:1018615306992; KARDAR M, 1987, NUCL PHYS B, V290, P582, DOI 10.1016/0550-3213(87)90203-3; GWA LH, 1992, PHYS REV A, V46, P844, DOI 10.1103/PhysRevA.46.844; Kriecherbauer T, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/40/403001; HALPINHEALY T, 1991, PHYS REV A, V44, pR3415; KARDAR M, 1985, PHYS REV LETT, V55, P2923, DOI 10.1103/PhysRevLett.55.2923; Ala-Nissila T, 1998, PHYS REV LETT, V80, P887, DOI 10.1103/PhysRevLett.80.887; KIM JM, 1991, PHYS REV A, V44, P2345, DOI 10.1103/PhysRevA.44.2345; Aldous D, 1999, B AM MATH SOC, V36, P413, DOI 10.1090/S0273-0979-99-00796-X; Derrida B, 1999, J STAT PHYS, V94, P1, DOI 10.1023/A:1004519626804; DERRIDA B, 1990, PHYS REV A, V41, P4160, DOI 10.1103/PhysRevA.41.4160; Bertini L, 1997, COMMUN MATH PHYS, V183, P571, DOI 10.1007/s002200050044; MEDINA E, 1989, PHYS REV A, V39, P3053, DOI 10.1103/PhysRevA.39.3053; Marinari E, 2000, J PHYS A-MATH GEN, V33, P8181, DOI 10.1088/0305-4470/33/46/303; Halpin-Healy T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.170602; Miettinen L, 2005, EUR PHYS J B, V46, P55, DOI 10.1140/epjb/e2005-00235-y; GWA LH, 1992, PHYS REV LETT, V68, P725, DOI 10.1103/PhysRevLett.68.725; Baik J, 1999, J AM MATH SOC, V12, P1119, DOI 10.1090/S0894-0347-99-00307-0; DERRIDA B, 1990, PHYSICA A, V163, P71, DOI 10.1016/0378-4371(90)90316-K; Prahofer M, 2000, PHYS REV LETT, V84, P4882, DOI 10.1103/PhysRevLett.84.4882; Canet L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.150601; HUSE DA, 1985, PHYS REV LETT, V55, P2924, DOI 10.1103/PhysRevLett.55.2924; DERRIDA B, 1988, J STAT PHYS, V51, P817, DOI 10.1007/BF01014886; Schutz GM, 1997, J STAT PHYS, V86, P1265, DOI 10.1007/BF02183623; Barkema GT, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042116; Barraquand G., ARXIV150103445; Bornemann F., 2010, MATH COMPUT, V79; Borodin A, 2014, ANN PROBAB, V42, P2314, DOI 10.1214/13-AOP868; Borodin A., ARXIV14076977; Borodin A, 2014, PROBAB THEORY REL, V158, P225, DOI 10.1007/s00440-013-0482-3; Calabrese P, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/10011; Calabrese P, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20002; Carrasco ISS, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/123057; Corwin I., ARXIV150207374; Corwin I., 2012, RANDOM MATRICES THEO, V1, P1; Dean DS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.110402; DHAR D, 1987, PHASE TRANSIT, V9, P51; Dotsenko V, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20003; DOTY CA, 1992, PHYS REV LETT, V69, P1979, DOI 10.1103/PhysRevLett.69.1979; Fogedby HC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031104; Fogedby HC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.195702; FREY E, 1994, PHYS REV E, V50, P1024, DOI 10.1103/PhysRevE.50.1024; Frey E, 1996, PHYS REV E, V53, P4424, DOI 10.1103/PhysRevE.53.4424; Gueudre T, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/26006; Gumbel E. J, 1958, STAT EXTREMES; Gyorgyi G, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021123; Halpin-Healy T, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/50001; HALPINHEALY T, 1989, PHYS REV LETT, V63, P917, DOI 10.1103/PhysRevLett.63.917; Halpin-Healy T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042118; HALPINHEALY T, 1990, PHYS REV A, V42, P711, DOI 10.1103/PhysRevA.42.711; Johansson K., ARXIV150200941; Kim JM, 1998, PHYS REV LETT, V80, P888, DOI 10.1103/PhysRevLett.80.888; Kloss T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051124; KRUG J, 1992, PHYS REV A, V45, P638, DOI 10.1103/PhysRevA.45.638; Lassig M, 1998, PHYS REV LETT, V80, P2366, DOI 10.1103/PhysRevLett.80.2366; Le Doussal P, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/06/P06001; Lee DS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150601; Majumdar SN, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011103; Masoudi AA, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/L02001; Monthus C, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/01/P01008; Monthus C, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051109; Myllys M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051103; Myllys M, 2001, Phys Rev E Stat Nonlin Soft Matter Phys, V64, P036101, DOI 10.1103/PhysRevE.64.036101; Odylyzko A. M., 1999, ATT BELL LABS TECHNI; Oliveira TJ, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.040102; Oliveira TJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.010601; Pagnani A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.010102; Perlsman E., 2012, PHYS REV E, V85; Prahofer M., 2003, STOCHASTIC SURFACE G; Rambeau J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041131; Rodriguez-Laguna J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/05/P05032; Santachiara R, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/02/P02009; Santalla SN, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/033018; Santalla SN, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.010401; Schehr G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056103; Singha SB, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08006; Spohn H., ARXIV12010645; Takeuchi KA, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/05/P05007; Takeuchi KA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00034; Takeuchi KA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.210604; TRACY CA, 1994, COMMUN MATH PHYS, V159, P151, DOI 10.1007/BF02100489; VANBEIJEREN H, 1985, PHYS REV LETT, V54, P2026, DOI 10.1103/PhysRevLett.54.2026	142	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	AUG	2015	160	4			SI		794	814		10.1007/s10955-015-1282-1		21	Physics, Mathematical	Physics	CN8BB	WOS:000358660400002		
J	Hong, JK; Uang, CM; Okazaki, T; Engelhardt, MD				Hong, Jong-Kook; Uang, Chia-Ming; Okazaki, Taichiro; Engelhardt, Michael D.			Link-to-Column Connection with Supplemental Web Doublers in Eccentrically Braced Frames	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Eccentrically braced frame (EBF); Link-to-column connection; Seismic design; Finite-element analysis; Metal and composite structures		When an eccentrically braced frame configuration requires that the links be connected to the columns, standard seismic guidelines offer little guidance on the link-to-column connection design. Recent testing showed that several welded moment connection details that have been developed after the 1994 Northridge earthquake for special moment frames still cannot prevent brittle fracture in the link flange groove welds. In support of an experimental study on the development of reliable link-to-column connection details, the supplemental web doubler connection is proposed. The connection uses a pair of partial-height doubler plates that are parallel to and offset from the web in the link panel next to the column. Finite-element analyses were conducted to guide the development of design requirements, including the minimum reinforced length, minimum supplemental doubler thickness, and weld design requirement. A closed-form solution, with some minor adjustment based on the finite-element analysis results, for the calculation of the required shear force in the supplemental doublers is also proposed. A step-by-step design procedure is presented. (C) 2014 American Society of Civil Engineers.	[Hong, Jong-Kook] Samsung C&T Corp, Seoul 137956, South Korea; [Uang, Chia-Ming] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Okazaki, Taichiro] Hokkaido Univ, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Engelhardt, Michael D.] Univ Texas Austin, Dept Civil Architectural & Environm Engn, Austin, TX 78712 USA	Okazaki, T (reprint author), Hokkaido Univ, Grad Sch Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	tokazaki@eng.hokudai.ac.jp			American Institute of Steel Construction	The American Institute of Steel Construction sponsored the research reported in this paper. The advice and support provided by Mr. Tom Schlafly (AISC Director of Research), Dr. Tom Sabol, and Dr. Subhash Goel throughout the research reported in this paper are greatly appreciated. The opinions expressed in this paper are those of the writers and do not necessarily reflect the views of the sponsor or the individuals noted in this paper.	AISC, 2010, 34110 AISC ANSIAISC; American Welding Society (AWS), 2009, D18 AWS; ENGELHARDT MD, 1992, J STRUCT ENG-ASCE, V118, P3067, DOI 10.1061/(ASCE)0733-9445(1992)118:11(3067); [Anonymous], ABAQUS 6 5 COMP SOFT; Civjan SA, 2001, J STRUCT ENG-ASCE, V127, P230, DOI 10.1061/(ASCE)0733-9445(2001)127:3(230); Horne M. R., 1971, PLASTIC THEORY STRUC; Kaufmann E., 2001, 0113 ATLSS LEH U; MALLEY JO, 1984, J STRUCT ENG-ASCE, V110, P2275; Okazaki T., 2014, J STRUCT ENG, DOI [10.1061/(ASCE) ST.1943-541X .0001041, DOI 10.1061/(ASCE)ST.1943-541X]; Okazaki T, 2006, J STRUCT ENG-ASCE, V132, P1334, DOI 10.1061/(ASCE)0733-9445(2006)132:9(1334); Tsai K. C., 2000, P 1 INT C STRUCT STA; Yu QS, 2000, J STRUCT ENG-ASCE, V126, P69, DOI 10.1061/(ASCE)0733-9445(2000)126:1(69)	12	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	AUG	2015	141	8							04014200	10.1061/(ASCE)ST.1943-541X.0001170		8	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CN1RX	WOS:000358198900016		
J	Okazaki, T; Engelhardt, MD; Hong, JK; Uang, CM; Drolias, A				Okazaki, Taichiro; Engelhardt, Michael D.; Hong, Jong-Kook; Uang, Chia-Ming; Drolias, Apostolos			Improved Link-to-Column Connections for Steel Eccentrically Braced Frames	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Seismic design; Cyclic tests; Connections; Welded; Eccentrically braced frame; Metal and composite structure		Link-to-column connections in steel eccentrically braced frames must be capable of sustaining large cyclic forces and inelastic rotations. United States code provisions require that satisfactory performance of link-to-column connections be verified by testing under a prescribed loading protocol. However, there are few link-to-column connection details that have satisfied these testing criteria. This paper describes a pilot investigation of two promising link-to-column connection details, as follows: (1) the fillet welded connection, which uses fillet welds or a combination of fillet and groove welds between the link and the column flange; and (2) the supplemental web doubler connection, which reinforces the connection region using a pair of doubler plates in the first link web panel next to the column, parallel to but offset from the link web. These two details showed excellent performance in a series of eight tests. This paper describes these link-to-column connection details, summarizes the results of cyclic loading tests, and discusses design issues and approaches for these connections. (C) 2014 American Society of Civil Engineers.	[Okazaki, Taichiro] Hokkaido Univ, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Engelhardt, Michael D.] Univ Texas Austin, Dept Civil Architectural & Environm Engn, Austin, TX 78712 USA; [Hong, Jong-Kook] Samsung C&T Corp, Seoul 137956, South Korea; [Uang, Chia-Ming] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Drolias, Apostolos] Pagonis Chroneas Kinatos & Associates, Athens 11524, Greece	Okazaki, T (reprint author), Hokkaido Univ, Grad Sch Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	tokazaki@eng.hokudai.ac.jp			AISC	The writers gratefully acknowledge the funding provided for this project by the AISC (Director of Research Tom Schlafly). Dr. Subash Goel, Dr. Tom Sabol, and Mr. Tom Schlafly provided valuable guidance throughout the course of the research reported in this paper. Special thanks are extended to the staff at the Phil M. Ferguson Structural Engineering Laboratory at the University of Texas at Austin for their assistance. The opinions expressed in this paper are those of the writers and do not necessarily reflect the views of the sponsors or the individuals noted in this paper.	AISC, 2010, 35810 AISC ANSIAISC; AISC, 2010, 34110 AISC ANSIAISC; Okazaki T, 2005, J STRUCT ENG-ASCE, V131, P1526, DOI 10.1061/(ASCE)0733-9445(2005)131:10(1526); Okazaki T, 2007, J CONSTR STEEL RES, V63, P751, DOI 10.1016/j.jcsr.2006.08.004; Richards PW, 2006, J STRUCT ENG-ASCE, V132, P1183, DOI 10.1061/(ASCE)0733-9445(2006)132:8(1183); POPOV EP, 1988, J CONSTR STEEL RES, V10, P321, DOI 10.1016/0143-974X(88)90034-X; Astaneh-Asl A., 1997, STEEL TIPS; ASTM, 2006, A992 ASTM; Civjan SA, 2001, J STRUCT ENG-ASCE, V127, P230, DOI 10.1061/(ASCE)0733-9445(2001)127:3(230); Drolias A., 2007, THESIS U TEXAS AUSTI; FEMA, 1995, FEMA267; FEMA (Federal Emergency Management Agency), 2000, FEMA350; Hong J.-K., 2014, J STRUCT ENG, DOI [10.1061/(ASCE)ST.1943-541X.0001170, DOI 10.1061/(ASCE)ST.1943-541X.0001170,04014200]; Okazaki T., 2004, THESIS U TEXAS AUSTI; Okazaki T., 2006, P 8 US NAT C EARTH E; Okazaki T, 2006, J STRUCT ENG-ASCE, V132, P1334, DOI 10.1061/(ASCE)0733-9445(2006)132:9(1334); Yu QS, 2000, J STRUCT ENG-ASCE, V126, P69, DOI 10.1061/(ASCE)0733-9445(2000)126:1(69)	17	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	AUG	2015	141	8							04014201	10.1061/(ASCE)ST.1943-541X.0001041		8	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CN1RX	WOS:000358198900001		
J	Chaiklangmuang, S; Kurosawa, K; Li, LY; Morishita, K; Takarada, T				Chaiklangmuang, Suparin; Kurosawa, Keisuke; Li, Liuyun; Morishita, Kayoko; Takarada, Takayuki			Thermal degradation behavior of coffee residue in comparison with biomasses and its product yields from gasification	JOURNAL OF THE ENERGY INSTITUTE			English	Article						Devolatilization; Coffee residue; Thermogravimetry; Biomass; Gasification	BROWN-COAL CHAR; BY-PRODUCTS; SUPERCRITICAL WATER; NITROGEN-COMPOUNDS; ACTIVATED CARBONS; GAS-PRODUCTION; NI CATALYSTS; PYROLYSIS; KINETICS; WASTES	The thermal degradation behavior of coffee residue in comparison with that of several biomass samples and coffee residue steam catalytic gasification were investigated. Devolatilization was carried out using the thermogravimetric method, at temperatures ranging from 30 degrees C to 1000 degrees C. By and large, coffee residue decomposition was easier than that of other biomasses, but it was less than that of chicken feces; also, the devolatilization behaviors of the biomasses depended predominantly on the type of biomass. Steam catalytic gasification was carried out in the two-stage quartz-fixed bed that used Ni-loaded brown coal catalyst to produce fuel gases at low reaction temperatures, ranging from 500 degrees C to 650 degrees C, and at a steam pressure of 30 kPa. Particularly noteworthy was the fact that the total gas yield increased significantly with increase in temperature. According to Total Organic Carbon results, at temperatures above 550 degrees C, the light tar materials were almost constant. As evident from the results of the LY-Ni coal pyrolysis, at a catalytic bed temperature of 600 degrees C, there is a slight interfere of the LY-Ni catalyst in the biomass gasification yield, and it would be possible to take the advantage of brown coal to produce the gas products, H-2, CO, CO2 and CH4, from the coffee residue steam catalytic gasification. (C) 2014 Energy Institute. Published by Elsevier Ltd. All rights reserved.	[Chaiklangmuang, Suparin] Chiang Mai Univ, Dept Ind Chem, Fac Sci, Chiang Mai 50200, Thailand; [Kurosawa, Keisuke; Li, Liuyun; Morishita, Kayoko; Takarada, Takayuki] Gunma Univ, Fac Engn, Dept Chem & Biol Engn, Kiryu, Gumma 3768515, Japan	Chaiklangmuang, S (reprint author), Chiang Mai Univ, Dept Ind Chem, Fac Sci, Chiang Mai 50200, Thailand.	suparin.c@cmu.ac.th			Commission on Higher Education, Thailand	The authors wish to acknowledge the financial support of the Commission on Higher Education, Thailand. The authors are also grateful to the Division of Environmental Engineering Science, Faculty of Science & Technology, Gunma University and the Faculty of Science, Chiang Mai University.	Adegoroye A, 2004, FUEL, V83, P1949, DOI 10.1016/j.fuel.2004.04.006; Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028; Wang Y, 2007, FUEL PROCESS TECHNOL, V88, P243, DOI 10.1016/j.fuproc.2006.10.002; Tsai WT, 2012, J ANAL APPL PYROL, V93, P63, DOI 10.1016/j.jaap.2011.09.010; Yoshida T, 2004, BIOMASS BIOENERG, V26, P71, DOI 10.1016/S0961-9534(03)00063-1; Pompeo F, 2005, INT J HYDROGEN ENERG, V30, P1399, DOI 10.1016/j.ijhydene.2004.10.004; Lua AC, 2004, J ANAL APPL PYROL, V72, P279, DOI 10.1016/j.jaap.2004.08.001; Ponte S, 2002, WORLD DEV, V30, P1099, DOI 10.1016/S0305-750X(02)00032-3; Meesuk S, 2012, J ANAL APPL PYROL, V94, P238, DOI 10.1016/j.jaap.2011.12.011; Murakami T, 2007, FUEL, V86, P244, DOI 10.1016/j.fuel.2006.05.025; Lapuerta M, 2004, BIOMASS BIOENERG, V27, P385, DOI 10.1016/j.biombioe.2003.11.010; Sutton D, 2001, BIORESOURCE TECHNOL, V80, P111, DOI 10.1016/S0960-8524(01)00086-4; Brand D, 2000, ENZYME MICROB TECH, V27, P127, DOI 10.1016/S0141-0229(00)00186-1; Xiao XB, 2013, FUEL, V103, P135, DOI 10.1016/j.fuel.2011.06.077; Karayildirim T, 2006, FUEL, V85, P1498, DOI 10.1016/j.fuel.2005.12.002; Pandey A, 2000, BIOCHEM ENG J, V6, P153, DOI 10.1016/S1369-703X(00)00084-X; Nakagawa H, 2004, FUEL, V83, P719, DOI 10.1016/j.fuel.2003.09.020; Senneca O, 2007, FUEL PROCESS TECHNOL, V88, P87, DOI 10.1016/j.fuproc.2006.09.002; Silva MA, 1998, BIOMASS BIOENERG, V14, P457, DOI 10.1016/S0961-9534(97)10034-4; Yang XQ, 2010, CATAL COMMUN, V11, P383, DOI 10.1016/j.catcom.2009.11.006; Gonzalez JF, 2006, FUEL PROCESS TECHNOL, V87, P149, DOI 10.1016/j.fuproc.2005.08.010; Garcia L, 2001, FUEL PROCESS TECHNOL, V69, P157, DOI 10.1016/S0378-3820(00)00138-7; Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005; Yanik J, 2007, FUEL, V86, P2410, DOI 10.1016/j.fuel.2007.01.025; Pinto F, 2007, FUEL, V86, P2052, DOI 10.1016/j.fuel.2007.01.019; Li LY, 2010, FUEL PROCESS TECHNOL, V91, P889, DOI 10.1016/j.fuproc.2009.08.003; Minowa T, 1998, CATAL TODAY, V45, P411, DOI 10.1016/S0920-5861(98)00277-6; Basu P., 2006, COMBUSTION GASIFICAT; Boonamnuayvitaya V, 2005, SEP PURIF TECHNOL, V42, P159, DOI 10.1016/j.seppur.2004.07.007; Cheewasu P., 2014, INT J HYDROGEN ENERG, V39, P3649; Furosawa T., 2007, INT J HYDROGEN ENERG, V32, P699; Haykiri-Acma H, 2007, FUEL PROCESS TECHNOL, V88, P417, DOI 10.1016/j.fuproc.2006.11.002; Kimura T, 2006, APPL CATAL B-ENVIRON, V68, P160, DOI 10.1016/j.apcatb.2006.08.007; Kurosawa K., 2006, 1 BIOM C 17 18 JAN, P114; Lapuerta M, 2007, BIOMASS BIOENERG, V31, P13, DOI 10.1016/j.biombioe.2006.05.003; Li LY, 2013, BIOMASS BIOENERG, V56, P456, DOI 10.1016/j.biombioe.2013.05.028; Mogi H., 2006, 1 BIOM C JAP I EN 17, P116; Swierczynski D, 2008, CHEM ENG PROCESS, V47, P508, DOI 10.1016/j.cep.2007.01.012; Wang TJ, 2006, FUEL PROCESS TECHNOL, V87, P421, DOI 10.1016/j.fuproc.2005.10.006; Yamasaki K., 2005, LOW TEMPERATURE GASI	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1743-9671	1746-0220		J ENERGY INST	J. Energy Inst.	AUG	2015	88	3					323	331		10.1016/j.joei.2014.08.001		9	Energy & Fuels	Energy & Fuels	CN0IH	WOS:000358096800014		
J	Demircan, O; Ashibe, S; Kosui, T; Nakai, A				Demircan, Ozgur; Ashibe, Shinsuke; Kosui, Tatsuya; Nakai, Asami			Tensile and bending properties of biaxial weft-knitted and cross-ply thermoplastic composites	JOURNAL OF THERMOPLASTIC COMPOSITE MATERIALS			English	Article						Biaxial weft-knitted thermoplastic composites; twisting; unidirectional composites; tensile; bending and impact properties; scanning electron microscopy	REINFORCED POLYPROPYLENE COMPOSITES; MECHANICAL-PROPERTIES; YARN; DEFORMATION; BEHAVIOR; STITCH	In this study, within the scope of experiments, two kinds of biaxial weft-knitted (BWK) fabrics with aramid (AR) and polyamide 66 (PA66) stitch fibers were used as reinforcement systems to fabricate thermoplastic composites with PA66 resin yarn. Then final composite became BWK with AR stitch yarn and cross-ply. The mechanical properties of composites were investigated by conducting tensile and three-point bending tests on specimens. In all specimens, PA66 was commingled with AR yarn. AR was used as reinforcement. In preliminary studies, AR unidirectional composites with AR/PA66 commingled fibers and with various twisting angles were produced and appropriate twisting angle was found by conducting tensile and three-point bending impact tests on specimens. Because of the higher volume fraction of the cross-ply composites, tensile and three-point bending properties of the cross-ply composite structures had higher than the BWK composites with the AR stitch yarn.	[Demircan, Ozgur] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Adv Fibrosci, Kyoto 606, Japan; [Demircan, Ozgur] Sabanci Univ, Mat Sci & Engn Program, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey; [Demircan, Ozgur] Ondokuz Mayis Univ, Fac Engn, Mat Sci & Engn Dept, Samsun, Turkey; [Ashibe, Shinsuke; Kosui, Tatsuya] Shima Seiki Mfg Ltd, R&D New Technol Applicat, Wakayama, Japan; [Nakai, Asami] Gifu Univ, Fac Engn, Dept Mech Engn, Gifu 50111, Japan	Demircan, O (reprint author), Sabanci Univ, Mat Sci & Engn Program, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.	ozgurd@sabanciuniv.edu					Abounaim M, 2011, COMPOS SCI TECHNOL, V71, P511, DOI 10.1016/j.compscitech.2010.12.029; Abounaim M, 2010, COMPOS SCI TECHNOL, V70, P363, DOI 10.1016/j.compscitech.2009.11.008; Khondker OA, 2006, COMPOS PART A-APPL S, V37, P2285, DOI 10.1016/j.compositesa.2005.12.032; Haller P, 2006, COMPOS PART B-ENG, V37, P278, DOI 10.1016/j.compositesb.2006.01.003; Hufenbach W, 2009, COMPOS SCI TECHNOL, V69, P1422, DOI 10.1016/j.compscitech.2008.09.033; Anwar KO, 1997, 11 C COMP MAT ICCM 1, P388; Bernhardsson J, 2000, J THERMOPLAST COMPOS, V13, P292, DOI 10.1106/X5VY-2TF0-Y3UA-D5DQ; Cheng KB, 2000, J THERMOPLAST COMPOS, V13, P378, DOI 10.1106/MHKX-74A6-PKEM-J7PL; Demircan O, 2011, P ASME 2011 INT MECH, P223; Demircan O, 2014, ADV COMPOS MATER, V23, P239, DOI 10.1080/09243046.2013.851062; Demircan O, 2012, 8 AS AUSTR ASS COMP; Hou M, 1997, COMPOS PART A-APPL S, V28, P695, DOI 10.1016/S1359-835X(97)00013-4; Hufenbach W, 2006, MECH COMPOS MATER, V42, P151, DOI 10.1007/s11029-006-0026-3; Karger-Kocsis J, 1998, COMPOS PART A-APPL S, V29, P1319, DOI 10.1016/S1359-835X(98)00042-6; KargerKocsis J, 1997, APPL COMPOS MATER, V4, P209, DOI 10.1007/BF02481390; Khondker OA, 2001, COMPOS PART A-APPL S, V32, P1513, DOI 10.1016/S1359-835X(01)00051-3; Li HX, 2010, J REINF PLAST COMP, V29, P1820, DOI 10.1177/0731684409335402; LI JJ, 2010, J TEXT I, V101, P33; Rajwin AJ, 2011, INDIAN J FIBRE TEXT, V37, P343; Takano N, 2004, COMPOS SCI TECHNOL, V64, P2153, DOI 10.1016/j.compscitech.2004.03.016; Torun AR, 2011, J APPL POLYM SCI, V123, P246; Xue P, 2002, COMPOS PART A-APPL S, V33, P113, DOI 10.1016/S1359-835X(01)00067-7; Ye L, 1995, APPL COMPOSITE MAT, V1, P415, DOI DOI 10.1007/BF00706502; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P473, DOI 10.1177/0892705707082326; Zaixia F, 2006, J THERMOPLAST COMPOS, V19, P113, DOI 10.1177/0892705706055446; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P487, DOI 10.1177/0892705707082327	26	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0892-7057	1530-7980		J THERMOPLAST COMPOS	J. Thermoplast. Compos. Mater.	AUG	2015	28	8					1233	1249		10.1177/0892705714530751		17	Materials Science, Composites	Materials Science	CN5ES	WOS:000358453200010		
J	Kinoshita, T; Asai, T; Suzuki, T				Kinoshita, Takeshi; Asai, Tohru; Suzuki, Tomoaki			Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						arterial graft; coronary artery bypass graft; chronic kidney disease; off-pump surgery; propensity score	STERNAL WOUND-INFECTION; CORONARY-ARTERY; DIABETIC-PATIENTS; BYPASS SURGERY; SAPHENOUS-VEIN; RADIAL ARTERY; FOLLOW-UP; ON-PUMP; SURVIVAL; OUTCOMES	Background: We compared the outcomes in propensity score-matched patients who had chronic kidney disease (CKD) undergoing off-pump coronary bypass grafting, with either a bilateral or single skeletonized internal thoracic artery (ITA). Methods: Of 1254 consecutive patients undergoing isolated coronary bypass surgery (1248 by the off-pump technique without emergent conversion to cardiopulmonary bypass), the 1203 who received a skeletonized, single (n = 453) or bilateral (n = 750), ITA graft were enrolled, after excluding the 6 patients who received preoperative percutaneous cardiopulmonary support and the 75 who had only 1 target vessel in the left coronary area. A total of 412 pairs were matched using propensity scores. Kaplan-Meier analyses were used to assess all-cause and cardiac-related mortality, by CKD stage (assessed by glomerular filtration rate [GFR]: <30; 30-60; >60 mL/minute/1.73 m(2)). Multivariate Cox proportional hazard models were used to assess for association of bilateral grafting with mortality. A test for interaction of bilateral ITA grafting and estimated GFR was conducted. Results: No significant difference was found in the incidence of 30-day mortality, stroke, or deep sternal infection between the 2 groups. Although an advanced stage of CKD decreased overall survival, a benefit of bilateral ITA grafting for all-cause and cardiac-related mortality occurred relatively early in the followup period and was not influenced by CKD stage. Bilateral ITA grafting was independently associated with a lower risk of both all-cause and cardiac-related mortality in patients with an estimated GFR of <60. No interaction was found between bilateral ITA grafting and estimated GFR in either model. Conclusions: In patients who have CKD, off-pump, skeletonized, left-side bilateral ITA grafting is associated with lower risk of all-cause and cardiac-related mortality, and does not increase operative risk.	[Kinoshita, Takeshi; Asai, Tohru; Suzuki, Tomoaki] Shiga Univ Med Sci, Div Cardiovasc Surg, Otsu, Shiga 5202192, Japan	Kinoshita, T (reprint author), Shiga Univ Med Sci, Otsu, Shiga 5202192, Japan.	kinotakekinotake@yahoo.co.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070; Saso S, 2010, ANN THORAC SURG, V89, P661, DOI 10.1016/j.athoracsur.2009.08.018; Tranbaugh RF, 2014, J THORAC CARDIOV SUR, V147, P133, DOI 10.1016/j.jtcvs.2013.08.040; Pevni D, 2007, J THORAC CARDIOV SUR, V133, P1220, DOI 10.1016/j.jtcvs.2006.07.060; Suzuki T, 2013, ANN THORAC SURG, V96, P90, DOI 10.1016/j.athoracsur.2013.04.018; Kinoshita T, 2011, CIRCULATION, V124, pS130, DOI 10.1161/CIRCULATIONAHA.110.010892; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Kapetanakis EI, 2004, ANN THORAC SURG, V78, P1564, DOI 10.1016/j.athoracsur.2004.05.019; Moss E, 2015, J THORAC CARDIOV SUR, V149, P175, DOI 10.1016/j.jtcvs.2014.09.011; Kinoshita T, 2012, ANN THORAC SURG, V93, P531, DOI 10.1016/j.athoracsur.2011.09.077; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Hemo E, 2013, J THORAC CARDIOV SUR, V146, P586, DOI 10.1016/j.jtcvs.2012.04.024; Kim KB, 2014, J THORAC CARDIOV SUR, V148, P901, DOI 10.1016/j.jtcvs.2014.03.057; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Puskas JD, 2012, ANN THORAC SURG, V94, P710, DOI 10.1016/j.athoracsur.2012.03.082; Manabe S, 2010, ANN THORAC SURG, V89, P683, DOI 10.1016/j.athoracsur.2009.11.053; Dorman MJ, 2012, CIRCULATION, V126, P2935, DOI 10.1161/CIRCULATIONAHA.112.117606; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Takagi H, 2014, J THORAC CARDIOV SUR, V148, P1282, DOI 10.1016/j.jtcvs.2014.01.010; Raja SG, 2014, J THORAC CARDIOV SUR, V148, P1275, DOI 10.1016/j.jtcvs.2013.11.045; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Asai Tohru, 2013, Ann Cardiothorac Surg, V2, P552, DOI 10.3978/j.issn.2225-319X.2013.07.08; Benedetto U, 2014, J THORAC CARDIOV SUR, V148, P2706, DOI 10.1016/j.jtcvs.2014.07.088; Benedetto U, 2014, J THORAC CARDIOVASC, V149, P841; Buxton BF, 2014, J THORAC CARDIOV SUR, V148, P1238, DOI 10.1016/j.jtcvs.2014.06.056; Hillis GS, 2006, CIRCULATION, V113, P1056, DOI 10.1161/CIRCULATIONAHA.105.591990; Kieser TM, 2014, J THORAC CARDIOV SUR, V148, P1887, DOI 10.1016/j.jtcvs.2014.02.022; Lev-Ran O, 2005, J THORAC CARDIOV SUR, V129, P307, DOI 10.1016/j.jtcvs.2004.06.013; Magee MJ, 2008, ANN THORAC SURG, V85, P494, DOI 10.1016/j.athoracsur.2007.10.008; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	31	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	AUG	2015	150	2					315	321		10.1016/j.jtcvs.2015.04.058		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CN3CJ	WOS:000358301100021		
J	Hasegawa, T; Oshima, Y; Maruo, A; Matsuhisa, H; Tanaka, A; Noda, R; Matsushima, S				Hasegawa, Tomomi; Oshima, Yoshihiro; Maruo, Ayako; Matsuhisa, Hironori; Tanaka, Akiko; Noda, Rei; Matsushima, Shunsuke			Aortic arch geometry after the Norwood procedure: The value of arch angle augmentation	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						aortic arch geometry; Norwood procedure; aortopulmonary space; arch angle augmentation	LEFT-HEART SYNDROME; LEFT-VENTRICULAR MASS; RISK-FACTORS; RECONSTRUCTION; EXPERIENCE; REPAIR; COMPRESSION; COARCTATION; OPERATION; RECOARCTATION	Objective: Aortic arch reconstruction in the Norwood procedure is occasionally associated with postoperative airway and branch pulmonary artery stenosis, as well as recoarctation. This study investigated geometric changes in the aortic arch after the Norwood procedure and evaluated the efficacy of arch angle augmentation with glutaraldehyde-treated autologous pericardium in aortic arch reconstruction. Methods: Of 52 consecutive patients who underwent the Norwood procedure between 1998 and 2013, a total of 36 patients who underwent postoperative multidetector-row computed tomographic angiography were reviewed retrospectively, and divided into 2 groups according to whether arch angle augmentation with glutaraldehyde-treated autologous pericardium was performed (AAA group, 26 patients) or not (NA group, 10 patients). Results: The neoaortic arch in the Norwood procedure was characterized by having a significantly smaller angle, being lower in height, and being narrower than that in age-matched control patients with a normal aortic arch. Moreover, all of these arch geometric measurements were significantly larger in the AAA group than in the NA group. Freedom from reintervention and reoperation for broncho-malacia or branch pulmonary artery stenosis, caused by extrinsic compression of the neoaorta, was significantly better at 1 year in the AAA group than in the NA group. Recoarctation of the neoaorta was documented in only 1 (3.8%) patient in the AAA group versus 3 patients (30%) in the NA group. Conclusions: Arch angle augmentation with glutaraldehyde-treated autologous pericardium in the Norwood procedure creates more aortopulmonary space with a smoother arch angle and diminished incidence of postoperative recoarctation, bronchial compression, or branch pulmonary artery compression.	[Hasegawa, Tomomi; Oshima, Yoshihiro; Maruo, Ayako; Matsuhisa, Hironori; Tanaka, Akiko; Noda, Rei; Matsushima, Shunsuke] Kobe Childrens Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6540081, Japan	Hasegawa, T (reprint author), Kobe Childrens Hosp, Dept Cardiovasc Surg, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	tohasegawa_kch@hp.pref.hyogo.jp					Agnoletti G, 2008, J THORAC CARDIOV SUR, V135, P568, DOI 10.1016/j.jtcvs.2007.10.020; Itatani K, 2012, J THORAC CARDIOV SUR, V144, P130, DOI 10.1016/j.jtcvs.2011.08.013; Ohye RG, 2010, NEW ENGL J MED, V362, P1980, DOI 10.1056/NEJMoa0912461; An HS, 2013, ANN THORAC SURG, V96, P2192, DOI 10.1016/j.athoracsur.2013.07.016; Ou P, 2008, J THORAC CARDIOV SUR, V135, P62, DOI 10.1016/j.jtcvs.2007.03.059; Fraser CD, 1995, ANN THORAC SURG, V60, pS546, DOI 10.1016/0003-4975(95)00848-9; Ou P, 2007, J AM COLL CARDIOL, V49, P883, DOI 10.1016/j.jacc.2006.10.057; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Cleuziou J, 2013, ANN THORAC SURG, V95, P935, DOI 10.1016/j.athoracsur.2012.11.015; NORWOOD WI, 1983, NEW ENGL J MED, V308, P23, DOI 10.1056/NEJM198301063080106; Ashcraft TM, 2008, ANN THORAC SURG, V85, P1397, DOI 10.1016/j.athoracsur.2007.11.054; Baker CJ, 2005, ANN THORAC SURG, V80, P1647, DOI 10.1016/j.athotacsur.2005.04.064; Barron DJ, 2009, J THORAC CARDIOV SUR, V138, P528, DOI 10.1016/j.jtcvs.2009.05.004; Bernabei M, 2013, INTERACT CARDIOV TH, V16, P282, DOI 10.1093/icvts/ivs510; Burkhart HM, 2005, J THORAC CARDIOV SUR, V130, P61, DOI 10.1016/j.jtcvs.2005.02.060; Chiu Peixuan, 2013, Asian Cardiovasc Thorac Ann, V21, P151, DOI 10.1177/0218492312449637; Davies RR, 2014, J THORAC CARDIOV SUR, V147, P706, DOI 10.1016/j.jtcvs.2013.10.038; De CE, 2007, AM J CARDIOL, V99, P1284; DURAN CMG, 1995, ANN THORAC SURG, V60, pS428, DOI 10.1016/0003-4975(95)00200-5; Garcia-Hernandez JA, 2007, REV ESP CARDIOL, V60, P732, DOI 10.1016/S1885-5857(08)60009-2; Griselli M, 2006, J THORAC CARDIOV SUR, V131, P418, DOI 10.1016/j.jtcvs.2005.08.066; Hasegawa T, 2014, CARDIOL YOUNG, V24, P559, DOI 10.1017/S1047951113000899; Ishino K, 1999, J THORAC CARDIOV SUR, V117, P920, DOI 10.1016/S0022-5223(99)70373-9; Khaghani A, 1997, EUR J CARDIO-THORAC, V11, P604, DOI 10.1016/S1010-7940(96)01144-X; Kim YM, 2002, ANN THORAC SURG, V73, P881, DOI 10.1016/S0003-4975(01)03405-1; Lamers LJ, 2012, J THORAC CARDIOV SUR, V143, P1098, DOI 10.1016/j.jtcvs.2011.09.037; Lashley Daniel, 2007, Congenit Heart Dis, V2, P410, DOI 10.1111/j.1747-0803.2007.00133.x; McCrindle BW, 2005, J THORAC CARDIOV SUR, V129, P343, DOI 10.1016/j.jtcvs.2004.10.004; Menon A, 2011, ANN THORAC SURG, V91, P1300, DOI 10.1016/j.athoracsur.2010.10.016; Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026; NORWOOD WI, 1980, AM J CARDIOL, V45, P87, DOI 10.1016/0002-9149(80)90224-6; Ntsinjana HN, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-101; Poirier NC, 2000, J THORAC CARDIOV SUR, V120, P875, DOI 10.1067/mtc.2000.109540; Sakurai T, 2012, ANN THORAC SURG, V94, P1534, DOI 10.1016/j.athoracsur.2012.05.097	34	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	AUG	2015	150	2					358	366		10.1016/j.jtcvs.2015.05.012		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CN3CJ	WOS:000358301100030		
J	Tanaka, Y; Miyamoto, T; Minami, K; Miyaji, K				Tanaka, Yuki; Miyamoto, Takashi; Minami, Kazutomo; Miyaji, Kagami			Useful surgical instruments for the resection of subaortic stenosis	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material									[Tanaka, Yuki; Miyamoto, Takashi] Gunma Childrens Med Ctr, Dept Cardiovasc Surg, Shibukawa, Japan; [Minami, Kazutomo] Kitakanto Cardiovasc Hosp, Dept Cardiovasc Surg, Shibukawa, Japan; [Miyaji, Kagami] Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Sagamihara, Kanagawa 228, Japan	Tanaka, Y (reprint author), Gunma Childrens Med Ctr, Dept Pediat Cardiac Surg, 779 Shimohakoda, Shibukawa, Gunma 3778577, Japan.	tfjgp484@yahoo.co.jp					MORROW AG, 1961, ANN SURG, V154, P181, DOI 10.1097/00000658-196108000-00003; ASHRAF H, 1985, J THORAC CARDIOV SUR, V90, P864; DOUVILLE EC, 1990, ANN THORAC SURG, V50, P33; DOUVILLE EC, 1990, ANN THORAC SURG, V50, P29; Hirata Y, 2009, J THORAC CARDIOV SUR, V137, P1168, DOI 10.1016/j.jtcvs.2008.11.039	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	AUG	2015	150	2					421	422		10.1016/j.jtcvs.2015.03.062		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CN3CJ	WOS:000358301100045		
J	Sano, N; Satow, T; Maruyama, D; Kataoka, H; Morita, K; Ishibashi-Ueda, H; Iihara, K				Sano, Noritaka; Satow, Tetsu; Maruyama, Daisuke; Kataoka, Hiroharu; Morita, Ken-ichi; Ishibashi-Ueda, Hatsue; Iihara, Koji			Relationship between histologic features and outcomes of carotid revascularization for radiation-induced stenosis	JOURNAL OF VASCULAR SURGERY			English	Article							ARTERY STENOSIS; NECK IRRADIATION; RESTENOSIS; RISK; ENDARTERECTOMY; ANGIOPLASTY; DISEASE; MANAGEMENT; SURGERY; THERAPY	Objective: This study aimed to elucidate the relationships between preoperative carotid imaging results, histologic characteristics, and surgical treatment outcomes of radiation-induced carotid stenosis (RICS), using control subjects without RICS for comparison. Methods: We retrospectively reviewed records of 17 patients who underwent carotid revascularization for 22 instances of RICS, including 10 cases of carotid artery stenting (CAS), 11 cases of carotid endarterectomy (CEA), and 1 case of CEA with retrograde CAS, between July 2004 and April 2013. The controls were 475 patients with no history of radiation therapy who underwent carotid revascularization in a similar period. Preoperative magnetic resonance imaging (MRI), ultrasonography (US), and computed tomography angiography results were correlated with outcomes of histologic analysis of CEA specimens. End points included ipsilateral and contralateral stroke, myocardial infarction, restenosis, instent thrombosis, and target lesion revascularization. Results: Vulnerable plaques on carotid MRI (86% vs 64.2%; P = .010) and mobile (27% vs 8.0%; P = .008) and ulcerative (50% vs 15.8%; P < .001) plaques on US were more frequent in the RICS group. All revascularization procedures were successful, and no occlusion occurred. Adverse events in the CAS group, including one minor stroke and one transient ischemic attack within 30 days as well as five ipsilateral neurologic events after 30 days, including three minor strokes and two transient ischemic attacks, were significantly more frequent than in the CEA group. All three cases of late ipsilateral stroke displayed vulnerable plaque on preoperative MRI and late in-stent thrombosis or restenosis on US. Conclusions: Our radiologic and histologic analyses revealed that advanced RICS is often accompanied by formation of vulnerable plaque. CEA can prevent undesirable late outcomes in such cases.	[Sano, Noritaka; Satow, Tetsu; Maruyama, Daisuke; Kataoka, Hiroharu; Morita, Ken-ichi; Iihara, Koji] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan; [Sano, Noritaka] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Morita, Ken-ichi] Niigata Univ, Brain Res Inst, Dept Neurosurg, Niigata 95021, Japan; [Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan	Iihara, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kiihara@ns.med.kyushu-u.ac.jp					Al-Mubarak N, 2000, J ENDOVASC THER, V7, P36, DOI 10.1583/1545-1550(2000)007<0036:CSFSRI>2.3.CO;2; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-00007; Dorresteijn LDA, 2002, J CLIN ONCOL, V20, P282, DOI 10.1200/JCO.20.1.282; Fokkema M, 2012, STROKE, V43, P793, DOI 10.1161/STROKEAHA.111.633743; Akutsu N, 2012, AM J NEURORADIOL, V33, P1557, DOI 10.3174/ajnr.A3002; Rajagopal V, 2003, AM J MED, V115, P547, DOI 10.1016/S0002-9343(03)00477-7; Gujral DM, 2014, RADIOTHER ONCOL, V110, P31, DOI 10.1016/j.radonc.2013.08.009; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; ATKINSON JLD, 1989, NEUROSURGERY, V24, P171; Cheng SWK, 2004, J VASC SURG, V39, P409, DOI 10.1016/j.jvs.2003.08.031; Cheng SWK, 1999, AM J SURG, V178, P323, DOI 10.1016/S0002-9610(99)00184-1; Egashira Yusuke, 2010, No Shinkei Geka, V38, P913; Favre JP, 2008, J VASC SURG, V48, P852, DOI 10.1016/j.jvs.2008.05.069; Fokkema M, 2012, EUR J VASC ENDOVASC, V43, P643, DOI 10.1016/j.ejvs.2012.02.023; Funaki T, 2011, J VASC SURG, V53, P977, DOI 10.1016/j.jvs.2010.10.105; Harrod-Kim P, 2005, AM J NEURORADIOL, V26, P1781; Hassen-Khodja R, 2000, ANN VASC SURG, V14, P608, DOI 10.1007/s100169910110; Hishikawa T, 2010, J NEUROSURG, V113, P890, DOI 10.3171/2010.3.JNS091057; Lam WWM, 2002, CEREBROVASC DIS, V13, P168, DOI 10.1159/000047771; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Protack CD, 2007, J VASC SURG, V45, P110, DOI 10.1016/j.jvs.2006.08.083; Shankar JJS, 2012, NEURORADIOLOGY, V54, P1347, DOI 10.1007/s00234-012-1031-y; Skelly CL, 2006, J VASC SURG, V44, P1010, DOI 10.1016/j.jvs.2006.06.039; Taguchi Y, 2011, JPN J STROKE, V33, P67; Tallarita T, 2011, J VASC SURG, V53, pe1; Tallarita T, 2011, J VASC SURG, V53, P629, DOI 10.1016/j.jvs.2010.09.056; Timaran CH, 2011, J VASC SURG, V53, P1679, DOI 10.1016/j.jvs.2010.11.122; Yamada K, 2010, ATHEROSCLEROSIS, V208, P161, DOI 10.1016/j.atherosclerosis.2009.06.024; Younis GA, 2007, CATHETER CARDIO INTE, V69, P673, DOI 10.1002/ccd.20809; Yu SCH, 2014, STROKE, V45, P1402, DOI 10.1161/STROKEAHA.113.003995	30	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	AUG	2015	62	2					370	+		10.1016/j.jvs.2015.03.021		9	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CN4WT	WOS:000358431900018		
J	Maeda, S; Nakamura, T				Maeda, Shusaku; Nakamura, Takashi			Decalcification of Heavily Calcified Common Femoral Artery Utilizing Cavitron Ultrasonic Surgical Aspirator	JOURNAL OF VASCULAR SURGERY			English	Meeting Abstract	30th Annual Meeting of the Western-Vascular-Society and Australia-and-New-Zealand-Society-for-Vascular-Surgery	SEP 19-22, 2015	Wailea, HI	Western Vasc Soc, Australia & New Zealand Soc Vasc Surg					[Maeda, Shusaku; Nakamura, Takashi] Osaka Rosai Hosp, Sakai, Osaka, Japan								0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	AUG	2015	62	2					525	526				4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CN4WT	WOS:000358431900049		
J	Obara, H; Sekimoto, Y; Matsubara, K; Fujimura, N; Kitagawa, Y				Obara, Hideaki; Sekimoto, Yasuhito; Matsubara, Kentaro; Fujimura, Naoki; Kitagawa, Yuko			Comparison of Vascular Remodeling And Integration Between the Bioresorbable Poly-L-Lactic Acid Scaffold Stent and the Metallic Stent in Porcine Iliac Artery	JOURNAL OF VASCULAR SURGERY			English	Meeting Abstract	30th Annual Meeting of the Western-Vascular-Society and Australia-and-New-Zealand-Society-for-Vascular-Surgery	SEP 19-22, 2015	Wailea, HI	Western Vasc Soc, Australia & New Zealand Soc Vasc Surg					[Obara, Hideaki; Sekimoto, Yasuhito; Matsubara, Kentaro; Fujimura, Naoki; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan								0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	AUG	2015	62	2					531	531				1	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CN4WT	WOS:000358431900061		
J	Hirohata, Y; Arii, J; Liu, ZM; Shindo, K; Oyama, M; Kozuka-Hata, H; Sagara, H; Kato, A; Kawaguchi, Y				Hirohata, Yoshitaka; Arii, Jun; Liu, Zhuoming; Shindo, Keiko; Oyama, Masaaki; Kozuka-Hata, Hiroko; Sagara, Hiroshi; Kato, Akihisa; Kawaguchi, Yasushi			Herpes Simplex Virus 1 Recruits CD98 Heavy Chain and beta 1 Integrin to the Nuclear Membrane for Viral De-Envelopment	JOURNAL OF VIROLOGY			English	Article							AMINO-ACID TRANSPORTERS; PROTEIN-KINASE US3; CELL-FUSION; MONOCLONAL-ANTIBODIES; GLYCOPROTEINS GB; VIRION ENVELOPE; EGRESS COMPLEX; INFECTED-CELLS; LAMIN A/C; RECEPTOR	Herpesviruses have evolved a unique mechanism for nucleocytoplasmic transport of nascent nucleocapsids: the nucleocapsids bud through the inner nuclear membrane (INM; primary envelopment), and the enveloped nucleocapsids then fuse with the outer nuclear membrane (de-envelopment). Little is known about the molecular mechanism of herpesviral de-envelopment. We show here that the knockdown of both CD98 heavy chain (CD98hc) and its binding partner beta 1 integrin induced membranous structures containing enveloped herpes simplex virus 1 (HSV-1) virions that are invaginations of the INM into the nucleoplasm and induced aberrant accumulation of enveloped virions in the perinuclear space and in the invagination structures. These effects were similar to those of the previously reported mutation(s) in HSV-1 proteins gB, gH, UL31, and/or Us3, which were shown here to form a complex(es) with CD98hc in HSV-1-infected cells. These results suggested that cellular proteins CD98hc and beta 1 integrin synergistically or independently regulated HSV-1 de-envelopment, probably by interacting directly and/or indirectly with these HSV-1 proteins. IMPORTANCE Certain cellular and viral macromolecular complexes, such as Drosophila large ribonucleoprotein complexes and herpesvirus nucleocapsids, utilize a unique vesicle-mediated nucleocytoplasmic transport: the complexes acquire primary envelopes by budding through the inner nuclear membrane into the space between the inner and outer nuclear membranes (primary envelopment), and the enveloped complexes then fuse with the outer nuclear membrane to release de-enveloped complexes into the cytoplasm (de-envelopment). However, there is a lack of information on the molecular mechanism of de-envelopment fusion. We report here that HSV-1 recruited cellular fusion regulatory proteins CD98hc and beta 1 integrin to the nuclear membrane for viral de-envelopment fusion. This is the first report of cellular proteins required for efficient de-envelopment of macromolecular complexes during their nuclear egress.	[Hirohata, Yoshitaka; Arii, Jun; Liu, Zhuoming; Shindo, Keiko; Kato, Akihisa; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol,Minato Ku, Tokyo, Japan; [Hirohata, Yoshitaka; Arii, Jun; Liu, Zhuoming; Shindo, Keiko; Kato, Akihisa; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control,Minato Ku, Tokyo, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko; Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan	Kawaguchi, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol,Minato Ku, Tokyo, Japan.	ykawagu@ims.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers; Japan Society for the Promotion of Science; Program of Japan Initiative for Global Research Network on Infectious Diseases; Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; Takeda Science Foundation; Tokyo Biochemical Research Foundation; Asahi Glass Foundation	This study was supported by the Funding Program for Next Generation World-Leading Researchers and Grants for Scientific Research from the Japan Society for the Promotion of Science, a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases, and a grant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan, as well as grants from the Takeda Science Foundation, the Tokyo Biochemical Research Foundation, and the Asahi Glass Foundation.	Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; OHTA H, 1994, EMBO J, V13, P2044; Prager GW, 2007, J BIOL CHEM, V282, P24477, DOI 10.1074/jbc.M702877200; Wisner TW, 2009, J VIROL, V83, P3115, DOI 10.1128/JVI.01462-08; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; ITO Y, 1992, J VIROL, V66, P5999; Okamoto K, 1997, J GEN VIROL, V78, P83; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Desai PJ, 2012, J VIROL, V86, P594, DOI 10.1128/JVI.05988-11; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Kudo Y, 2004, FEBS LETT, V577, P473, DOI 10.1016/j.febslet.2004.10.047; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Liu ZM, 2014, J VIROL, V88, P4657, DOI 10.1128/JVI.00137-14; Tanaka Y, 2006, ONCOGENE, V25, P633; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Kawaguchi Y, 1997, J VIROL, V71, P7328; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Wang RN, 2005, DIABETES, V54, P2080, DOI 10.2337/diabetes.54.7.2080; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; Kato A, 2009, J VIROL, V83, P250, DOI 10.1128/JVI.01451-08; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Higuchi S, 1998, J BONE MINER RES, V13, P44, DOI 10.1359/jbmr.1998.13.1.44; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Yang K, 2011, P NATL ACAD SCI USA, V108, P14276, DOI 10.1073/pnas.1108564108; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Mou F, 2008, J VIROL, V82, P8094, DOI 10.1128/JVI.00874-08; Toropova K, 2011, J VIROL, V85, P7513, DOI 10.1128/JVI.00837-11; Morimoto T, 2009, J VIROL, V83, P11624, DOI 10.1128/JVI.00993-09; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; OHGIMOTO S, 1995, J IMMUNOL, V155, P3585; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995; Fenczik CA, 1997, NATURE, V390, P81; Gianni T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003806; Kato A, 2014, J VIROL, V88, P7776, DOI 10.1128/JVI.00603-14; Maruzuru Y, 2013, J VIROL, V87, P9323, DOI 10.1128/JVI.01581-13; Roizman B, 2013, FIELDS VIROLOGY, V2, P1823; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059	54	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	AUG	2015	89	15					7799	7812		10.1128/JVI.00741-15		14	Virology	Virology	CN2UP	WOS:000358277800029		
J	Tang, HMV; Gao, WW; Chan, CP; Cheng, Y; Deng, JJ; Yuen, KS; Iha, H; Jin, DY				Tang, Hei-Man Vincent; Gao, Wei-Wei; Chan, Chi-Ping; Cheng, Yun; Deng, Jian-Jun; Yuen, Kit-San; Iha, Hidekatsu; Jin, Dong-Yan			SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription	JOURNAL OF VIROLOGY			English	Article							INNATE ANTIVIRAL RESPONSE; LONG TERMINAL REPEATS; EPSTEIN-BARR-VIRUS; NF-KAPPA-B; HTLV-1 TAX; DEPENDENT TRANSCRIPTION; BINDING PROTEIN; FACTOR CREB; ACTIVATION; SIRTUINS	Human T-cell leukemia virus type 1 (HTLV-1)-associated diseases are poorly treatable, and HTLV-1 vaccines are not available. High proviral load is one major risk factor for disease development. HTLV-1 encodes Tax oncoprotein, which activates transcription from viral long terminal repeats (LTR) and various types of cellular promoters. Counteracting Tax function might have prophylactic and therapeutic benefits. In this work, we report on the suppression of Tax activation of HTLV-1 LTR by SIRT1 deacetylase. The transcriptional activity of Tax on the LTR was largely ablated when SIRT1 was overexpressed, but Tax activation of NF-kappa B was unaffected. On the contrary, the activation of the LTR by Tax was boosted when SIRT1 was depleted. Treatment of cells with resveratrol shunted Tax activity in a SIRT1-dependent manner. The activation of SIRT1 in HTLV-1-transformed T cells by resveratrol potently inhibited HTLV-1 proviral transcription and Tax expression, whereas compromising SIRT1 by specific inhibitors augmented HTLV-1 mRNA expression. The administration of resveratrol also decreased the production of cell-free HTLV-1 virions from MT2 cells and the transmission of HTLV-1 from MT2 cells to uninfected Jurkat cells in coculture. SIRT1 associated with Tax in HTLV-1-transformed T cells. Treatment with resveratrol prevented the interaction of Tax with CREB and the recruitment of CREB, CRTC1, and p300 to Tax-responsive elements in the LTR. Our work demonstrates the negative regulatory function of SIRT1 in Tax activation of HTLV-1 transcription. Small-molecule activators of SIRT1 such as resveratrol might be considered new prophylactic and therapeutic agents in HTLV-1-associated diseases. IMPORTANCE Human T-cell leukemia virus type 1 (HTLV-1) causes a highly lethal blood cancer or a chronic debilitating disease of the spinal cord. Treatments are unsatisfactory, and vaccines are not available. Disease progression is associated with robust expression of HTLV-1 genes. Suppressing HTLV-1 gene expression might have preventive and therapeutic benefits. It is therefore critical that host factors controlling HTLV-1 gene expression be identified and characterized. This work reveals a new host factor that suppresses HTLV-1 gene expression and a natural compound that activates this suppression. Our findings not only provide new knowledge of the host control of HTLV-1 gene expression but also suggest a new strategy of using natural compounds for prevention and treatment of HTLV-1-associated diseases.	[Tang, Hei-Man Vincent; Gao, Wei-Wei; Chan, Chi-Ping; Cheng, Yun; Deng, Jian-Jun; Yuen, Kit-San; Jin, Dong-Yan] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Iha, Hidekatsu] Oita Univ, Dept Infect Dis, Yufu, Japan	Jin, DY (reprint author), Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China.	dyjin@hku.hk			Hong Kong Research Grants Council [HKU7674/12M, HKU7686/13M, HKU1/CRF/11G]; Hong Kong Health and Medical Research Fund [13121052]; S. K. Yee Medical Research Fund	This work was supported by the S. K. Yee Medical Research Fund (2011), Hong Kong Research Grants Council (grants HKU7674/12M, HKU7686/13M, and HKU1/CRF/11G), and Hong Kong Health and Medical Research Fund (grant 13121052).	Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Banerjee P, 2010, BLOOD, V115, P2640, DOI 10.1182/blood-2009-10-246959; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Tang HMV, 2014, NUCLEIC ACIDS RES, V42, P12455, DOI 10.1093/nar/gku925; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Lawson M, 2010, BBA-GENE REGUL MECH, V1799, P726, DOI 10.1016/j.bbagrm.2010.06.003; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Ma GY, 2015, P NATL ACAD SCI USA, V112, P2216, DOI 10.1073/pnas.1419198112; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Watanabe T, 1997, INT J HEMATOL, V66, P257; Siu KL, 2014, J VIROL, V88, P4866, DOI 10.1128/JVI.03649-13; Kim BK, 2008, HEPATOLOGY, V48, P361, DOI 10.1002/hep.22359; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Ching Yick-Pang, 2004, Retrovirology, V1, P18, DOI 10.1186/1742-4690-1-18; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; Fields P, 2012, CURR HEMATOL MALIG R, V7, P267, DOI 10.1007/s11899-012-0139-9; Jiang S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-73; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043; Lodewick J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-75; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Monteserin-Garcia J, 2013, FASEB J, V27, P1561, DOI 10.1096/fj.12-220129; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; SEMMES OJ, 1995, J VIROL, V69, P1827; Simonis N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-26; Siu KL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-3; Siu KL, 2014, CELL MOL IMMUNOL, V11, P141, DOI 10.1038/cmi.2013.61; Chan CP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-47; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Tang HMV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-40; Tang HMV, 2015, SCI REP-UK, V5, DOI 10.1038/srep07897; Wu HL, 2012, CELL MICROBIOL, V14, P546, DOI 10.1111/j.1462-5822.2011.01740.x; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070	50	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	AUG	2015	89	16					8623	8631		10.1128/JVI.01229-15		9	Virology	Virology	CN2UT	WOS:000358278200044		
J	Oishi, K; Yamayoshi, S; Kawaoka, Y				Oishi, Kohei; Yamayoshi, Seiya; Kawaoka, Yoshihiro			Mapping of a Region of the PA-X Protein of Influenza A Virus That Is Important for Its Shutoff Activity	JOURNAL OF VIROLOGY			English	Article							HOST RESPONSE; SEGMENT 3; ENDONUCLEASE; SUPPRESSION	Influenza A virus PA-X comprises an N-terminal PA endonuclease domain and a C-terminal PA-X-specific domain. PA-X reduces host and viral mRNA accumulation via its endonuclease function. Here, we found that the N-terminal 15 amino acids, particularly six basic amino acids, in the C-terminal PA-X-specific region are important for PA-X shutoff activity. These six basic amino acids enabled a PA deletion mutant to suppress protein expression at a level comparable to that of wild-type PA-X.	[Oishi, Kohei; Yamayoshi, Seiya; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo, Japan	Kawaoka, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan.	yamayo@ims.u-tokyo.ac.jp; kawaokay@svm.vetmed.wisc.edu			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; ERATO (Japan Science and Technology Agency); Strategic Basic Research Programs of the Japan Science and Technology Agency; NIH Functional Genomics award (Characterization of Novel Genes Encoded by RNA and DNA Viruses) [U19 AI 107810]	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by grants-in-aid from the Ministry of Health, Labor, and Welfare, Japan; by ERATO (Japan Science and Technology Agency); by Strategic Basic Research Programs of the Japan Science and Technology Agency; and by an NIH Functional Genomics award (Characterization of Novel Genes Encoded by RNA and DNA Viruses; U19 AI 107810).	Shi M, 2012, J VIROL, V86, P12411, DOI 10.1128/JVI.01677-12; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Hayashi T, 2015, J VIROL, V89, P6442, DOI 10.1128/JVI.00319-15; Gao HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08262; Desmet EA, 2013, J VIROL, V87, P3108, DOI 10.1128/JVI.02826-12; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Hu J, 2015, J VIROL, V89, P4126, DOI 10.1128/JVI.02132-14; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Gao H, 2015, J GEN VIROL; Hatta M, 2000, ARCH VIROL, V145, P895, DOI 10.1007/s007050050682; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; SanzEzquerro JJ, 1996, J VIROL, V70, P1905	14	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	AUG	2015	89	16					8661	8665		10.1128/JVI.01132-15		5	Virology	Virology	CN2UT	WOS:000358278200049		
J	Okamoto, K; Sakakibara, J				Okamoto, Koji; Sakakibara, Jun			The 16th international symposium on flow visualization, ISFV16	JOURNAL OF VISUALIZATION			English	Editorial Material									[Okamoto, Koji] Univ Tokyo, Tokyo, Japan; [Sakakibara, Jun] Meiji Univ, Tokyo 101, Japan	Okamoto, K (reprint author), Univ Tokyo, Tokyo, Japan.	okamoto@n.t.u-tokyo.ac.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		407	407		10.1007/s12650-015-0304-z		1	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200001		
J	Ninomiya, N; Kubo, Y; Barada, D; Kiire, T				Ninomiya, Nao; Kubo, Yamato; Barada, Daisuke; Kiire, Tomohiro			Direct measurement of longitudinal velocity by Doppler phase-shifting holography	JOURNAL OF VISUALIZATION			English	Article									[Ninomiya, Nao; Kubo, Yamato; Barada, Daisuke; Kiire, Tomohiro] Utsunomiya Univ, Grad Sch Adv Interdisciplinary Sci, Utsunomiya, Tochigi 3218585, Japan	Ninomiya, N (reprint author), Utsunomiya Univ, Grad Sch Adv Interdisciplinary Sci, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	nino@utmu.jp			Center for Optical Research and Education (CORE) at Utsunomiya University; Project for Bio-imaging and Sensing at Utsunomiya University; JSPS KAKENHI [25420147]	A part of this work has been supported by the Center for Optical Research and Education (CORE) at Utsunomiya University, the Project for Bio-imaging and Sensing at Utsunomiya University and the JSPS KAKENHI Grant Number 25420147. All supports are greatly acknowledged.	Kikuchi Y, 2010, OPT LETT, V35; Schnars U., 2005, DIGITAL HOLOGRAPHY D	2	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		409	412		10.1007/s12650-014-0249-7		4	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200002		
J	Abe, A; Wang, J; Shioda, M; Maeno, S				Abe, A.; Wang, J.; Shioda, M.; Maeno, S.			Observation and analysis of interactive phenomena between microbubbles and underwater shock wave	JOURNAL OF VISUALIZATION			English	Article						Microbubble; Shock wave interaction; Rebound shock wave; Microjet; Enlarged observation; Microscopic observation; Numerical analysis		This paper reports the observation and analysis of the microbubble motion induced by an underwater shock wave. In the analysis, Herring's bubble motion equation was numerically solved using an experimental shock wave pressure profile. The pressure attenuation of the rebound shock wave of a microbubble was also estimated by numerical simulation. The motion behaviors of the microbubbles during their interaction with an electric discharge shock wave, such as their rebound, shock wave generation, and microjet formation, were observed by magnified visualization. To improve the observation accuracy, spatial positioning control of the microbubbles was employed. The experimentally determined time variation of the diameter of the microbubbles when they collapsed spherically was in agreement with the results of the numerical analyses, and the latter also revealed a very high pressure of the rebound shock wave. There were, however, discrepancies between the experimental and analytical results for non-spherical collapse. It is thought that spherical collapse produces stronger rebound shock waves and that the probability of such collapse increases with decreasing diameter of the bubble. In addition, it was demonstrated that single and multiple microbubbles moved vigorously after interaction with a shock wave and the latter coalesced into a single bubble within several hundred microseconds.	[Abe, A.; Wang, J.; Shioda, M.; Maeno, S.] Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 6580022, Japan	Abe, A (reprint author), Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 6580022, Japan.	a-abe@maritime.kobe-u.ac.jp			JSPS KAKENHI [22360367, 25630405]	This study was supported by JSPS KAKENHI (Grant Numbers 22360367 and 25630405). The authors would like to express their gratitude to Messrs. Satoshi Matsumura and Akira Hirami of Nac Inc., Messrs. Takaaki Mizushima and Hiroyuki Usui of Nobby Tech. Ltd., and Mr. Katsuhiro Takayama of Photoron Co. for their technical assistance in the visualization processes of the study.	Abe A, 2007, P 26 INT S SHOCK WAV, P869; Abe A, 2013, SHOCK WAVE SCI TECHN, V8, P339; Ding Z, 1996, J FLUID MECH, V309, P183, DOI 10.1017/S0022112096001607; Wolfrum B, 2003, PHYS FLUIDS, V15, P2916, DOI 10.1063/1.1608938; Class NK, 2014, LATEST INFORM APPROV; Fukuda S, 2012, P 28 INT S SHOCK 12, P909; Herring C, 1941, 236 OSRD; International Maritime Organization, 2004, INT CONV CONTR MAN S; Maeno S, 2013, 29 INT S SHOCK WAV; YEE HC, 1985, J COMPUT PHYS, V57, P327, DOI 10.1016/0021-9991(85)90183-4	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		437	447		10.1007/s12650-014-0257-7		11	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200005		
J	Shibata, S; Nishio, S; Sou, A; Akayama, D; Mashida, M				Shibata, Shora; Nishio, Shigeru; Sou, Akira; Akayama, Daisuke; Mashida, Makoto			Evaluation of cavitation in injector nozzle and correlation with liquid atomization	JOURNAL OF VISUALIZATION			English	Article						Fuel injection; Cavitation; Atomization; Liquid jet flow; Image processing	FLOW; JET	Present paper describes the correlation between occurrence of cavitation inside injector nozzle and progress of atomization in discharged liquid jet flow. A transparent two-dimensional shape nozzle was designed and it was used for flow visualization. The visualized images both of cavitation and atomization were obtained simultaneously. The cavitation was evaluated by applying image analysis. The quantitative analysis on length, thickness and their fluctuations of cavitation was made, and the correlation with atomization was examined. The authors proposed an evaluation method of atomization in the previous study, and it was combined with evaluation method of cavitation developed in this study. It is found that the change of cavitation and progress of atomization are synchronized, and that a strong correlation between them exists. The best performance of atomization may be obtained by controlling the cavitation inside nozzle, and obtained aspects with this study will be utilized for the design of fuel injection nozzle of internal combustion engines.	[Shibata, Shora; Nishio, Shigeru; Sou, Akira; Akayama, Daisuke] Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan; [Mashida, Makoto] DENSO Corp, Kariya, Aichi, Japan	Nishio, S (reprint author), Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan.	nishio@maritime.kobe-u.ac.jp			Graduate school students of Kobe University	The authors show their gratitude to Mr. Kibayashi and Ms. Nishimura, Graduate school students of Kobe University, for their great support on experiments. The authors show their appreciation to Photron Ltd for their support on introducing high-speed camera system to this project.	Akayama Daisuke, 2013, Journal of Flow Visualization and Image Processing, V20; [Anonymous], 2008, J FLUID SCI TECHNOL, DOI 10.1299/jfst.3.622; REITZ RD, 1982, PHYS FLUIDS, V25, P1730, DOI 10.1063/1.863650; Sou A, 2007, INT J HEAT MASS TRAN, V50, P3575, DOI 10.1016/j.ijheatmasstransfer.2006.12.033; Henry ME, 2000, ATOMIZATION SPRAY, V10, P545; Andriotis A, 2008, J FLUID MECH, V610, P195, DOI 10.1017/S0022112008002668; Bergwerk W., 1959, Proceedings of the Institution of Mechanical Engineers, V173; Chaves H., 1995, 950290 SOC AUT ENG, V104, P645; Hayashi T., 2012, 12 TRIENN INT C LIQ; Hiroyasu H, 1991, P ICLASS 91, P275; Miranda R, 2003, P INT C LIQ AT SPRAY; Soteriou C, 1995, 950080 SOC AUT ENG	12	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		481	492		10.1007/s12650-015-0282-1		12	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200009		
J	Hara, S; Watanabe, T; Furukawa, H; Endo, S				Hara, S.; Watanabe, T.; Furukawa, H.; Endo, S.			Effects of a radial gap on vortical flow structures around a rotating disk in a cylindrical casing	JOURNAL OF VISUALIZATION			English	Article						Rotating flow; Rotating disk; Rotor-stator cavity; Taylor vortex; Radial gap	TAYLOR VORTEX FLOW; SMALL ASPECT RATIO; STATIONARY DISK; COUETTE-FLOW; TRANSITION; TURBULENCE	The flow generated by the rotation of the disk in a stationary cylindrical casing is investigated by the numerical and experimental approaches. When the rotating disk has finite radius and thickness, there exists the axial gap between the disk surface and the end wall of the casing and the radial gap between the disk tip and the side wall of the casing. The flows in these gaps show complex flow structures depending on the geometric and kinetic parameters. In this study, five disks with different radii are introduced and the effects of the radial gap width and the Reynolds number on the flow structures are investigated. The flow with steady Taylor vortices emerges in the radial gap at relatively low Reynolds numbers. When the Reynolds number is moderate, Taylor vortices in the radial gap have the wavy structures in the azimuthal direction. The flow with the wavy structure is classified into two types: one is the normal mode and the other is the anomalous mode. The latter type has the extra vortices at the corner of the casing. At the higher Reynolds numbers, the turbulent Taylor vortices appear in the radial gap. In this case, the disturbances in the radial gap propagate inward along the end walls of the casing and the spiral vortices occur near the disk tip in the upper and lower axial gaps. The dependency of the flow structure on the radial gap width is clarified.	[Hara, S.; Watanabe, T.; Endo, S.] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Furukawa, H.] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan	Hara, S (reprint author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	info@vi.cs.is.nagoya-u.ac.jp					JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Schouveiler L, 1998, PHYS FLUIDS, V10, P2695, DOI 10.1063/1.869793; Schouveiler L, 2001, J FLUID MECH, V443, P329; Dong S, 2007, J FLUID MECH, V587, P373, DOI 10.1017/S0022112007007367; Launder B, 2010, ANNU REV FLUID MECH, V42, P229, DOI 10.1146/annurev-fluid-121108-145514; Cros A, 2002, PHYS FLUIDS, V14, P3755, DOI 10.1063/1.1508796; Meeuwse M, 2012, AICHE J, V58, P247, DOI 10.1002/aic.12586; AUBRY N, 1994, PHYS FLUIDS, V6, P2800, DOI 10.1063/1.868168; BENJAMIN TB, 1981, P ROY SOC LOND A MAT, V377, P221, DOI 10.1098/rspa.1981.0122; Cros A, 2005, EUR J MECH B-FLUID, V24, P409, DOI 10.1016/j.euromechflu.2004.11.002; Guermond JL, 2002, J FLUID MECH, V450, P169, DOI 10.1017/S0022112001006383; Hendriks F, 2010, MICROSYST TECHNOL, V16, P93, DOI 10.1007/s00542-008-0765-2; Nakamura I, 1996, ACTA MECH, V117, P33, DOI 10.1007/BF01181035; NAKAMURA I, 1989, JSME INT J II-FLUID, V32, P388; Washizu T, 2013, FLOW TURBUL COMBUST, V91, P607, DOI 10.1007/s10494-013-9494-4; Watanabe T, 2010, EXP FLUIDS, V48, P631, DOI 10.1007/s00348-009-0785-4; Watanabe T, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3493640; Wu SC, 2009, EXP THERM FLUID SCI, V33, P875, DOI 10.1016/j.expthermflusci.2009.03.008	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		501	510		10.1007/s12650-015-0292-z		10	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200011		
J	Sakurai, T; Handa, T; Koike, S; Mii, K; Nakano, A				Sakurai, Takayuki; Handa, Taro; Koike, Shunsuke; Mii, Katsuhito; Nakano, Aoi			Study on the particle traceability in transonic and supersonic flows using molecular tagging velocimetry	JOURNAL OF VISUALIZATION			English	Article						Particle image velocimetry; Molecular tagging velocimetry; Particle traceability; Supersonic flow; Drag coefficient	MICROJETS; DRAG	Particle image velocimetry (PIV) has become a powerful tool for flow velocity measurements in wind tunnel testing. However, it is generally difficult to apply the PIV technique to supersonic flows because of unreliable particle traceability. In the present study, the PIV and MTV (molecular tagging velocimetry) techniques are applied to transonic and supersonic flows, in which a normal shock wave appears, to evaluate particle traceability. Based on this work, it is found that the PIV data largely deviate from the MTV data behind a normal shock wave for both flows. The drag coefficient is also estimated for a particle from the velocity data measured by the two techniques. Its value is then compared to the drag coefficient value calculated from an empirical formula for particle Mach numbers ranging between 0.1 and 0.9. Based on the results, it is found that the experimental data can be reproduced reasonably well by the formula for particle Reynolds numbers higher than similar to 1. However, the data associated with particle Reynolds numbers lower than similar to 1 deviate largely from the formula.	[Sakurai, Takayuki; Handa, Taro; Mii, Katsuhito] Kyushu Univ, Dept Energy & Environm Engn, Kasuga, Fukuoka 8168580, Japan; [Koike, Shunsuke] Japan Aerosp Explorat Agcy, Inst Aeronaut Technol, Chofu, Tokyo 1828522, Japan; [Nakano, Aoi] Kawasaki Heavy Ind Co Ltd, Chem Plant Dept, Chuo Ku, Kobe, Hyogo 6508670, Japan	Handa, T (reprint author), Kyushu Univ, Dept Energy & Environm Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	t.handa@kyudai.jp					Loth E, 2008, AIAA J, V46, P2219, DOI 10.2514/1.28943; Lempert WR, 2003, EXP FLUIDS, V34, P403, DOI 10.1007/s00348-002-0576-7; Koike S, 2007, AIAA J, V45, P2770, DOI [10.2514/1.30962, 10.2514/1-30962]; Elliott G. S., 2009, 20091265 AIAA; Handa T, 2012, J VIS SOC JPN, V32-125, P26; Handa T, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1725-5; Handa T, 2011, EXP FLUIDS, V50, P1685, DOI 10.1007/s00348-010-1029-3; Kahler CJ, 2002, EXP FLUIDS, V33, P736, DOI [10.1007/s00348-002-0492-X, 10.1007/s00348-002-0492-x]; Kobayashi T, 2002, HDB PARTICLE IMAGE V, P137; Lempert WR, 2002, AIAA J, V40, P1065, DOI 10.2514/2.1789; Soo SL, 1967, FLUID DYNAMICS MULTI, P31; Stadler JR, 1951, 2423140 NACA TN, P1; Westerweel J., 2011, PARTICLE IMAGE VELOC	13	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		511	520		10.1007/s12650-015-0286-x		10	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200012		
J	Ota, M; Kurihara, K; Aki, K; Miwa, Y; Inage, T; Maeno, K				Ota, M.; Kurihara, K.; Aki, K.; Miwa, Y.; Inage, T.; Maeno, K.			Quantitative density measurement of the lateral jet/cross-flow interaction field by colored-grid background oriented schlieren (CGBOS) technique	JOURNAL OF VISUALIZATION			English	Article						Supersonic flow; Flow visualization; Background oriented schlieren; Computed tomography		The colored-grid background oriented schlieren (CGBOS) technique is applied to the measurement of the interaction field of lateral jet and cross-flow. The test model is designed based on DLR's generic model. Experiments were carried out in supersonic blow-down wind tunnel of JAXA/ISAS with 0.6 m x 0.6 m test section. Free-stream Mach number is set to 2.0. The quantitative experimental data obtained by CGBOS technique and the reconstruction results of the density for the interaction field between cross-flow and lateral jet are described. Unsteady phenomena in the lateral jet/cross-flow interaction field are also measured using color high-speed camera. The growth of the interaction field is reconstructed and visualized three dimensionally.	[Ota, M.; Kurihara, K.; Aki, K.; Miwa, Y.] Chiba Univ, Grad Sch Engn, Dept Mech Engn, Chiba 2638522, Japan; [Inage, T.] Salesian Polytech, Dept Mech & Elect Engn, Tokyo 1940215, Japan; [Maeno, K.] Kisarazu Natl Coll Technol, Chiba 2920041, Japan	Ota, M (reprint author), Chiba Univ, Grad Sch Engn, Dept Mech Engn, Chiba 2638522, Japan.	ota@faculty.chiba-u.jp			JSPS KAKENHI [25420848]	This work was supported by JSPS KAKENHI Grant Number 25420848. The authors thank Prof. T. Abe and the technical staff at JAXA/ISAS for their support in the experiments.	Adeli R, 2012, P 15 INT S FLOW VIS; Venkatakrishnan L, 2004, EXP FLUIDS, V37, P237, DOI 10.1007/s00348-004-0807-1; Meier GEA, 2002, EXP FLUIDS, V33, P181, DOI 10.1007/s00348-002-0450-7; Kak AC, 1988, PRINCIPLE COMPUTERIZ; Leopold F, 2013, J FLOW CONTROL MEASU, V1, P69; Leopold F, 2006, P 12 INT S FLOW VIS; Leopold F, 2012, P 15 INT S FLOW VIS; Ota M, 2015, EXP FLUIDS, V56, P1; Ota M, 2007, FLOW MEAS INSTRUM, V18, P295, DOI 10.1016/j.flowmeasinst.2007.09.001; Ota M, 2012, P 15 INT S FLOW VIS	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		543	552		10.1007/s12650-015-0297-7		10	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200015		
J	Haniu, T; Hasegawa, H				Haniu, T.; Hasegawa, H.			Three-dimensional vortex structure using phase-averaged stereoscopic PIV for an oscillating airfoil	JOURNAL OF VISUALIZATION			English	Article						Unsteady flow; Vortex; Wake; Unsteady fluid force; Pitching oscillation; Discoid airfoil		A quasi-steady-state approach to the prediction of fluid forces acting on an insect wing leads to errors that suggest that flight is impossible. However, because biological flight does occur, the effect of unsteady fluid forces must be important to flight. The propulsive forces of these animals are related to unsteady fluid forces accompanied with the movement of vortices. Therefore, unsteady fluid forces must also be considered when estimating the propulsive force of swimming the front crawl and the flat scull technique in synchronized swimming. The purpose of this study was to investigate the effect of a three-dimensional airfoil shape on three-dimensional vortex structure for a high reduced frequency. The vortex structure and its behavior for a discoid airfoil were investigated. Furthermore, the vortex structure of the discoid airfoil was compared with that of a rectangular. The vortical flow fields were measured in the wake of the discoid airfoil using a stereoscopic particle images velocimetry technique. The three-dimensional vortex structure was depicted by plotting iso-vorticity surface calculated from the reconstructed velocity data. Compared with the rectangular airfoil, a strong vortex exists over a prolonged period of time in the wake of the discoid airfoil.	[Haniu, T.; Hasegawa, H.] Akita Univ, Grad Sch Engn & Resource Sci, Akita 0108502, Japan	Haniu, T (reprint author), Akita Univ, Grad Sch Engn & Resource Sci, Akita 0108502, Japan.	t-haniu@mech.akita-u.ac.jp					BERGER MAM, 1995, J BIOMECH, V28, P125, DOI 10.1016/0021-9290(94)00053-7; Wang ZJ, 2000, J FLUID MECH, V410, P323, DOI 10.1017/S0022112099008071; Azuma A, 1993, FLUID DYNAM, P20; Hasegawa Hiroaki, 2010, Journal of Fluid Science and Technology, V5, DOI 10.1299/jfst.5.270; Matsuuchi K, 2008, J BIOMECH, V42, P42; Sana SP, 2003, J EXP BIOL, V206, P4191; Schleihauf R, 1983, 3 DIMENSIONAL ANAL H, P173	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	AUG	2015	18	3			SI		553	561		10.1007/s12650-015-0301-2		9	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CN2VU	WOS:000358281200016		
J	Middleton, KK; Muller, B; Araujo, PH; Fujimaki, Y; Rabuck, SJ; Irrgang, JJ; Tashman, S; Fu, FH				Middleton, K. K.; Muller, B.; Araujo, P. H.; Fujimaki, Y.; Rabuck, S. J.; Irrgang, J. J.; Tashman, S.; Fu, F. H.			Is the native ACL insertion site "completely restored" using an individualized approach to single-bundle ACL-R?	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Percentage of reconstructed area; Anatomic; ACL reconstruction	ANTERIOR CRUCIATE LIGAMENT; POSTEROLATERAL FIBER-BUNDLES; HAMSTRING AUTOGRAFT; TUNNEL APERTURE; GRAFT SIZE; PART 2; RECONSTRUCTION; ATTACHMENTS; REPLACEMENT; PREDICTORS	The goal of individualized anatomic anterior cruciate ligament reconstruction (ACL-R) is to reproduce each patient's native insertion site as closely as possible. The amount of the native insertion site that is recreated by the tunnel aperture area is currently unknown, as are the implications of the degree of coverage. As such, the goals of this study are to determine whether individualized anatomic ACL-R techniques can maximally fill the native insertion site and to attempt to establish a crude measure to evaluate the percentage of reconstructed area as a first step towards elucidating the implications of complete footprint restoration. This is a prospective pilot study of 45 patients who underwent primary single-bundle anatomic ACL-R from May 2011 to April 2012. Length and width of the native insertion site were measured intraoperatively. Using published guidelines, reconstruction technique and graft choice were determined to maximize the percentage of reconstructed area. Native femoral and tibial insertion site area and femoral tunnel aperture area were calculated using the formula for area of an ellipse. On the tibial side, tunnel aperture area was calculated with respect to drill diameter and drill guide angle. Percentage of reconstructed area was calculated by dividing total tunnel aperture area by the native insertion site area. The mean areas for the native femoral and tibial insertion sites were 83 +/- A 20 and 125 +/- A 20 mm(2), respectively. The mean tunnel aperture area for the femoral side was 65 +/- A 17, and 86 +/- A 17 mm(2) for the tibial tunnel aperture area. On average, percentage of reconstructed area was 79 +/- A 13 % for the femoral side, and 70 +/- A 12 % for the tibial side. Anatomic ACL-R does not restore the native insertion site in its entirety. Percentage of reconstructed area serves as a rudimentary tool for evaluating the degree of native insertion site coverage using current individualized anatomic techniques and provides a starting point from which to evaluate the clinical significance of complete footprint restoration. IV.	[Middleton, K. K.; Muller, B.; Araujo, P. H.; Fujimaki, Y.; Rabuck, S. J.; Irrgang, J. J.; Tashman, S.; Fu, F. H.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Muller, B.] Univ Amsterdam, Acad Med Ctr, Orthopaed Res Ctr Amsterdam, Dept Orthopaed Surg, NL-1105 AZ Amsterdam, Netherlands; [Araujo, P. H.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biomech Med & Rehabil Locomotor Syst, BR-14049900 Ribeirao Preto, SP, Brazil; [Fujimaki, Y.] Showa Univ, Sch Med, Dept Orthopaed Surg, Shinagawa Ku, Shinagawa, Tokyo 1428666, Japan	Fu, FH (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Kaufman Med Bldg,Suite 1011,3941 Fifth Ave, Pittsburgh, PA 15203 USA.	ffu@upmc.edu					Harner CD, 1999, ARTHROSCOPY, V15, P741, DOI 10.1016/S0749-8063(99)70006-X; Edwards A, 2007, KNEE SURG SPORT TR A, V15, P1414, DOI 10.1007/s00167-007-0417-6; Tashman S, 2008, OPER TECHN SPORT MED, V16, P116, DOI 10.1053/j.otsm.2008.10.005; van Eck CF, 2010, ARTHROSCOPY, V26, P258, DOI 10.1016/j.arthro.2009.07.027; CLANCY WG, 1981, J BONE JOINT SURG AM, V63, P1270; Kamien PM, 2013, AM J SPORT MED, V41, P1808, DOI 10.1177/0363546513493896; Edwards A, 2008, KNEE SURG SPORT TR A, V16, P29, DOI 10.1007/s00167-007-0410-0; Kopf S, 2011, AM J SPORT MED, V39, P108, DOI 10.1177/0363546510377399; Magnussen RA, 2012, ARTHROSCOPY, V28, P526, DOI 10.1016/j.arthro.2011.11.024; Hofbauer M, 2014, KNEE SURG SPORT TR A, V22, P979, DOI 10.1007/s00167-013-2562-4; GROOD ES, 1992, J ORTHOPAED RES, V10, P878, DOI 10.1002/jor.1100100617; Siebold R, 2011, KNEE SURG SPORT TR A, V19, P699, DOI 10.1007/s00167-010-1376-x; Hussein M, 2012, AM J SPORT MED, V40, P1781, DOI 10.1177/0363546512446928; SHINO K, 1984, J BONE JOINT SURG BR, V66, P672; Voos JE, 2010, KNEE SURG SPORT TR A, V18, P1282, DOI [10.1007/s00167-010-1162-9, 10.1007/s00167-010-1129-x]; Karlsson J, 2011, AM J SPORT MED, V39, P2016, DOI 10.1177/0363546511402660; Auge WK, 1999, ARTHROSCOPY, V15, P877, DOI 10.1053/ar.1999.v15.0150871; Bedi A, 2011, AM J SPORT MED, V39, P366, DOI 10.1177/0363546510388157; Debandi A, 2012, KNEE SURG SPORT TR A, V21, P589; Hensler D, 2011, J BONE JOINT SURG AM, V93A, P2063, DOI 10.2106/JBJS.J.01705; Iriuchishima T, 2012, KNEE SURG SPORT TR A, V22, P207; Kopf S, 2010, J BONE JOINT SURG AM, V92A, P871, DOI 10.2106/JBJS.H.01680; NOYES FR, 1983, CLIN ORTHOP RELAT R, P71; Park SY, 2012, KNEE SURG SPORT TR A, V21, P1111; Rabuck Stephen J, 2012, Arthrosc Tech, V1, pe23, DOI 10.1016/j.eats.2011.12.004; Van der Bracht H, 2013, KNEE SURG SPORT TR A, V22, P291; Zantop T, 2008, AM J SPORT MED, V36, P678, DOI 10.1177/0363546508314414	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	AUG	2015	23	8					2145	2150		10.1007/s00167-014-3043-0		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CN4BZ	WOS:000358375200002		
J	Suzuki, S; Yasunaga, H; Matsui, H; Fushimi, K; Kondo, K; Yamasoba, T				Suzuki, Sayaka; Yasunaga, Hideo; Matsui, Hiroki; Fushimi, Kiyohide; Kondo, Kenji; Yamasoba, Tatsuya			Complication rates after functional endoscopic sinus surgery: Analysis of 50,734 Japanese patients	LARYNGOSCOPE			English	Article						Chronic rhinosinusitis; functional endoscopic sinus surgery; intraoperative complication; postoperative complication; nationwide study; types of surgery	TOXIC-SHOCK-SYNDROME; CHRONIC RHINOSINUSITIS; MAJOR COMPLICATIONS; CONSENT	ObjectiveThe complication rates associated with different types of functional endoscopic sinus surgery (FESS) remain to be fully examined. Study DesignRetrospective cohort study. MethodsWe extracted data from the Japanese Diagnosis Procedure Combination database on 50,734 patients (aged16 years) who underwent FESS for chronic rhinosinusitis between 2007 and 2013. We focused on specific types of surgery and stratified the patients into three groups: group 1 (single sinus surgery), group 2 (multiple sinus surgery), and group 3 (whole sinus surgery). Patient characteristics and early postoperative complications including cerebrospinal fluid (CSF) leakage, orbital injury, severe hemorrhage, and toxic shock syndrome (TSS) that occurred during 1 to 2 weeks of each hospitalization were compared. Multivariable logistic regression analysis was performed to assess the association between overall complication rate and background characteristics, with adjustment for within-hospital clustering. ResultsThe overall complication rate was 0.50%; the rates of CSF leakage, orbital injury, hemorrhage requiring surgery, blood transfusion, and TSS were 0.09%, 0.09%, 0.10%, 0.18%, and 0.02%, respectively. Ethmoidectomy combined with sphenoidotomy was associated with higher overall complication rates (1.40%). The rate of orbital injury was highest in group 2, whereas that of other complications did not differ significantly among the groups. Extent of FESS showed no significant association with overall complication rate. ConclusionMore extensive FESS was not associated with increased rates of postoperative CSF leakage, hemorrhage, or TSS. Multiple sinus surgery was associated with a higher rate of orbital injury. The extent of surgery did not significantly affect the overall complication rate. Level of Evidence2b. Laryngoscope, 125:1785-1791, 2015	[Suzuki, Sayaka; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Suzuki, Sayaka; Kondo, Kenji; Yamasoba, Tatsuya] Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 113, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Suzuki, S (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sayasuzuki-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare of Japan [H26-Policy-011]	This study was funded by the Ministry of Health, Labour and Welfare of Japan (grant: Research on Policy Planning and Evaluation; grant number: H26-Policy-011). The authors have no other funding, financial relationships, or conflicts of interest to disclose.	ABRAM AC, 1994, LARYNGOSCOPE, V104, P927; Park IH, 2010, INT J PEDIATR OTORHI, V74, P1347, DOI 10.1016/j.ijporl.2010.08.018; Sharp HR, 2001, CLIN OTOLARYNGOL, V26, P33, DOI 10.1046/j.1365-2273.2001.00394.x; Dalziel K, 2006, AM J RHINOL, V20, P506, DOI 10.2500/ajr.2006.20.2923; Stankiewicz JA, 2011, LARYNGOSCOPE, V121, P2684, DOI 10.1002/lary.21446; Tschopp KP, 2008, RHINOLOGY, V46, P116; Vashishta R, 2013, INT FORUM ALLERGY RH, V3, P788, DOI 10.1002/alr.21182; CUMBERWORTH VL, 1994, CLIN OTOLARYNGOL, V19, P248, DOI 10.1111/j.1365-2273.1994.tb01225.x; MAY M, 1994, LARYNGOSCOPE, V104, P1080; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Patel AM, 2010, OTOLARYNG CLIN N AM, V43, P905, DOI 10.1016/j.otc.2010.04.014; Smith TL, 2007, AM J RHINOL, V21, P80, DOI 10.2500/ajr.2007.21.2962; Wolf JS, 2002, LARYNGOSCOPE, V112, P774, DOI 10.1097/00005537-200205000-00002; Hopkins C, 2006, LARYNGOSCOPE, V116, P1494, DOI 10.1097/01.mlg.0000230399.24306.50; Spaeth J, 1997, INT J PEDIATR OTORHI, V39, P25, DOI 10.1016/S0165-5876(96)01458-9; Younis RT, 1996, ARCH OTOLARYNGOL, V122, P83; [Anonymous], 2011, ASIAN PAC J DIS MANA; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Siedek V, 2013, EUR ARCH OTO-RHINO-L, V270, P141, DOI 10.1007/s00405-012-1973-z; Mueller SA, 2010, J LARYNGOL OTOL, V124, P500, DOI 10.1017/S0022215109992325; Ramakrishnan VR, 2012, INT FORUM ALLERGY RH, V2, P34, DOI 10.1002/alr.20101; Ramakrishnan VR, 2013, INT FORUM ALLERGY RH, V3, P236, DOI 10.1002/alr.21094; VLEMING M, 1992, ARCH OTOLARYNGOL, V118, P617; KENNEDY DW, 1985, ARCH OTOLARYNGOL, V111, P576; Asaka D, 2012, AM J RHINOL ALLERGY, V26, P61, DOI 10.2500/ajra.2012.26.3711; Castillo Laurent, 1996, Rhinology (Utrecht), V34, P215; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dursun E, 1998, EUR ARCH OTO-RHINO-L, V255, P504, DOI 10.1007/s004050050108; GALLO UE, 1990, ANN EMERG MED, V19, P1332, DOI 10.1016/S0196-0644(05)82299-1; JACOBSON JA, 1986, ARCH OTOLARYNGOL, V112, P329; Nakamura M, 2013, EAT WEIGHT DISORD-ST, V18, P437, DOI 10.1007/s40519-013-0051-x; Stammberger H, 1985, Ann Otol Rhinol Laryngol Suppl, V119, P1; Weber R, 2000, RHINOLOGY, V38, P49; Wolf JS, 2005, LARYNGOSCOPE, V115, P4992	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	AUG	2015	125	8					1785	1791		10.1002/lary.25334		7	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CN4DJ	WOS:000358379700015		
J	Fotios, S; Atli, D; Cheal, C; Hara, N				Fotios, S.; Atli, D.; Cheal, C.; Hara, N.			Lamp spectrum and spatial brightness at photopic levels: Investigating prediction using S/P ratio and gamut area	LIGHTING RESEARCH & TECHNOLOGY			English	Article							SCENE BRIGHTNESS; PERCEPTION; JUDGMENTS; LUMINANCE; LIGHT	An experiment was carried out to investigate spatial brightness at photopic levels under lighting of different spectral power distributions. One aim was to replicate the experiment reported in 1990 by Berman etal. demonstrating that light with a higher scotopic / photopic (S/P) ratio would be perceived as brighter. In addition, a third SPD was included to investigate gamut area and two additional procedures were employed to provide concurrent validity of the findings. It was concluded that while lighting of higher S/P ratio was brighter, the S/P ratio alone was insufficient to predict spatial brightness. A metric for the chromatic contribution is also needed, this being provided by gamut area in the current work.	[Fotios, S.; Atli, D.; Cheal, C.] Univ Sheffield, Sch Architecture, Sheffield S10 2TN, S Yorkshire, England; [Hara, N.] Kansai Univ, Dept Architecture, Suita, Osaka, Japan	Fotios, S (reprint author), Univ Sheffield, Sch Architecture, Arts Tower,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	steve.fotios@sheffield.ac.uk			Kansai University's Overseas Research Program	Naoya Hara's contribution to this work was funded by the Kansai University's Overseas Research Program for the year of 2012.	Fotios SA, 2011, LIGHTING RES TECHNOL, V43, P143, DOI 10.1177/1477153510393932; WAGNER G, 1972, J OPT SOC AM, V62, P1508, DOI 10.1364/JOSA.62.001508; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; Akashi Y, 2006, ENERG BUILDINGS, V38, P588, DOI 10.1016/j.enbuild.2005.09.005; Fotios SA, 2010, LIGHTING RES TECHNOL, V42, P183, DOI 10.1177/1477153509355506; Bullough JD, 2014, LEUKOS, V10, P3, DOI 10.1080/15502724.2013.827516; Rea MS, 2008, COLOR RES APPL, V33, P192, DOI 10.1002/col.20399; Royer MP, 2012, LEUKOS, V9, P89, DOI 10.1582/LEUKOS.2012.09.02.002; Rea MS, 2011, LIGHTING RES TECHNOL, V43, P7, DOI 10.1177/1477153510370821; Houser KW, 2009, LEUKOS, V6, P119, DOI 10.1582/LEUKOS.2009.06.02003; Fotios SA, 2007, LIGHTING RES TECHNOL, V39, P233, DOI 10.1177/1477153507080805; Berman S. M., 1990, Lighting Research and Technology, V22; Berman S., CIE PUBLICATION, Vx009-1995, P171; Berman SM, 2008, LIGHTING RES TECHNOL, V40, P373, DOI 10.1177/1477153508097975; Boyce P, 2013, LIGHTING RES TECHNOL, V45, P519, DOI 10.1177/1477153513504072; Boyce P, 2010, LIGHTING RES TECHNOL, V42, P5, DOI 10.1177/1477153510362949; Boyce P. R., 1990, Lighting Research and Technology, V22; Boyce PR, 2003, HUMAN FACTORS LIGHTI; Boyce P. R., 1977, Lighting Research and Technology, V9; Cohen J., 1992, CURRENT DIRECTIONS P, V1, P98, DOI [10.1111/1467-8721.ep10768783, DOI 10.1111/1467-8721.EP10768783]; Commission Internationale de l'E ' clairage, 2014, 2062014 CIE; Dunn-Rankin P., 2004, SCALING METHODS; Field A, 2005, DISCOVERING STAT USI; Fotios S, 2012, LEUKOS, V8, P261, DOI 10.1582/LEUKOS.2012.08.04.002; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P80, DOI 10.1177/1477153513503170; Fotios S., 2005, Lighting Research & Technology, V37, DOI 10.1191/1365782805li133oa; Fotios S, 2013, COMP METRICS RELATIV, P209; Fotios S., 1997, Lighting Research and Technology, V29; Fotios SA, 2011, LIGHTING RES TECHNOL, V43, P73, DOI 10.1177/1477153510369478; Fotios SA, 2013, LEUKOS, V9, P245, DOI 10.1582/LEUKOS.2013.09.04.002; Fotios S. A., 2001, Lighting Research & Technology, V33, DOI 10.1177/136578280103300306; Guo X., 2004, Lighting Research & Technology, V36, DOI 10.1191/1365782804li112oa; Han S, 2003, ILLUMINANCE CCT DECO, pD3 282; Han S., 2002, THESIS RENSSELAER PO; Houser KW, 2003, FINAL REPORT CALIFOR; Hu X, 2006, LEUKOS, V3, P69, DOI 10.1582/LEUKOS.2006.03.01.004; Hunt R. W. G., 1995, MEASURING COLOUR; Ikegami R, 2012, CURR BIOL, V22, P1, DOI 10.1016/j.cub.2011.12.009; Illuminating Engineering Society of North America, 2013, IESTM2413; LABOEUF RA, 2006, J BEHAV DECIS MAKING, V19, P393; Ramasoot T, 2012, LIGHTING RES TECHNOL, V44, P197, DOI 10.1177/1477153511413354; Rea M. S., 1986, Lighting Research and Technology, V18; Society for Light and Lighting, 2002, COD FOR LIGHT; Tregenza P, 1998, DESIGN LIGHTING; UCHIKAWA K, 1986, J OPT SOC AM A, V3, P34, DOI 10.1364/JOSAA.3.000034; Ware C, 1983, NRC PUBLICATION, V26055; Yaguchi H, 1983, COLOUR VISION PHYSL	48	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1477-1535	1477-0938		LIGHTING RES TECHNOL	Lighting Res. Technol.	AUG	2015	47	5					595	612		10.1177/1477153514542295		18	Construction & Building Technology; Optics	Construction & Building Technology; Optics	CN4EL	WOS:000358382900009		
J	Nakajima, T; Geddie, W; Anayama, T; Ko, HM; Santos, GD; Boerner, S; Wang, T; Wang, YH; Li, M; Pham, NA; Tsao, MS; Yasufuku, K				Nakajima, Takahiro; Geddie, William; Anayama, Takashi; Ko, Hyang Mi; Santos, Gilda da Cunha; Boerner, Scott; Wang, Tao; Wang, Yu-hui; Li, Ming; Nhu-An Pham; Tsao, Ming Sound; Yasufuku, Kazuhiro			Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration	LUNG CANCER			English	Article						Patient-derived tumor xenograft; Preclinical model; Non-small cell lung cancer; Transbronchial needle aspiration; Translational research; Endobronchial ultrasound	CELL LUNG-CANCER; FEATURES; LESSONS	Objectives: There has been limited utility for laboratory tumor models to predict clinical performance of cancer drugs. Clinical drug trials usually recruit patients that have advanced disease, therefore preclinical tumor models that closely reflect this characteristic will be more reliable to test candidate drugs. We evaluated the use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to sample metastatic lymph nodes in patients to establish patient-derived tumorxenograft (PDX) models of advanced lung cancer. Materials and methods: Cell suspensions from TBNA aspirates were implanted into the subcutaneous tissue of NSG (NOD scid) gamma) mice. The success rate of PDX establishment was associated with tumor histopathology and the cellularity and cytopathological diagnosis of the primary EBUS-TBNA samples. Results: From December 2011 to June 2012, 19 patients were enrolled in this study. Successful engraftment was achieved in 8/19 cases (42.1%). The duration between inoculation and tumor formation averaged 62.4 days (13-144 days). The engrafted tumors included 3 adenocarcinomas (3/12: 25%), 2 squamous cell carcinomas (2/3: 67%), 1 large cell carcinoma (1/1:100%), and 2 small cell carcinomas (2/3: 67%). Conclusion: EBUS-TBNA samples can be used for establishment of tumor xenograft model in immunodeflcient mice. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nakajima, Takahiro; Anayama, Takashi; Yasufuku, Kazuhiro] Univ Toronto, Div Thorac Surg, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Nakajima, Takahiro] Chiba Univ, Dept Gen Thorac Surg, Grad Sch Med, Chiba, Japan; [Geddie, William; Ko, Hyang Mi; Santos, Gilda da Cunha; Boerner, Scott; Wang, Tao; Tsao, Ming Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2C4, Canada; [Wang, Tao; Wang, Yu-hui; Li, Ming; Nhu-An Pham; Tsao, Ming Sound] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON, Canada	Yasufuku, K (reprint author), Univ Toronto, Intervent Thorac Surg Program, Div Thorac Surg, Toronto Gen Hosp,Univ Hlth Network, 200 Elizabeth St,9N-957, Toronto, ON M5G 2C4, Canada.	kazuhiro.yasufuku@uhn.ca			Ontario Research Fund Research Excellence Award [RE-03-020]; Princess Margaret Cancer Foundation; Ontario Ministry of Health and Long Term Care	Sources of support: This work was partially supported by Ontario Research Fund Research Excellence RE-03-020 Award, Princess Margaret Cancer Foundation, and Ontario Ministry of Health and Long Term Care.	Merk J, 2011, EUR J CARDIO-THORAC, V40, pE29, DOI 10.1016/j.ejcts.2011.02.010; Nakajima T, 2011, J THORAC ONCOL, V6, P203, DOI 10.1097/JTO.0b013e318200f496; Walrath JC, 2010, ADV CANCER RES, V106, P113, DOI 10.1016/S0065-230X(10)06004-5; Choi SYC, 2014, ADV DRUG DELIVER REV, V79-80, P222, DOI 10.1016/j.addr.2014.09.009; Silvestri GA, 2013, CHEST, V143, pE211, DOI 10.1378/chest.12-2355; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Park B, 2013, CANCER SCI, V104, P631, DOI 10.1111/cas.12123; Dimou Anastasios, 2014, J Pers Med, V4, P386, DOI 10.3390/jpm4030386; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Wada H, 2010, ANN THORAC SURG, V90, P229, DOI 10.1016/j.athoracsur.2010.03.106; Cho YB, 2014, J SURG RES, V187, P502, DOI 10.1016/j.jss.2013.11.010; Christensen CL, 2009, EXPERT REV ANTICANC, V9, P437, DOI [10.1586/era.09.10, 10.1586/ERA.09.10]; Santos GD, 2011, CANCER CYTOPATHOL, V119, P361, DOI 10.1002/cncy.20166; Dodbiba L, 2013, LAB INVEST, V93, P397, DOI 10.1038/labinvest.2013.8; Leong TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106862; Lodhia KA, 2015, BBA-REV CANCER, V1855, P223, DOI 10.1016/j.bbcan.2015.03.002; Nakajima Takahiro, 2013, Gen Thorac Cardiovasc Surg, V61, P390, DOI 10.1007/s11748-013-0224-6; Stewart EL, 2015, J CLIN ONCO IN PRESS; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227	20	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	AUG	2015	89	2					110	114		10.1016/j.lungcan.2015.05.018		5	Oncology; Respiratory System	Oncology; Respiratory System	CN4HA	WOS:000358390000005		
J	Nishino, K; Imamura, F; Kumagai, T; Katakami, N; Hata, A; Okuda, C; Urata, Y; Hattori, Y; Tachihara, M; Yokota, S; Nishimura, T; Kaneda, T; Satouchi, M; Morita, S; Negoro, S				Nishino, Kazumi; Imamura, Fumio; Kumagai, Toru; Katakami, Nobuyuki; Hata, Akito; Okuda, Chiyuki; Urata, Yoshiko; Hattori, Yosihihiro; Tachihara, Motoko; Yokota, Souichirou; Nishimura, Takashi; Kaneda, Toshihiko; Satouchi, Miyako; Morita, Satoshi; Negoro, Shunichi			A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)	LUNG CANCER			English	Article						Non-squamous non-small-cell lung cancer; Bevacizumab; Docetaxel; S-1; Second-line; Phase II	METASTATIC COLORECTAL-CANCER; PLUS-BEVACIZUMAB; DOUBLE-BLIND; TRIAL; FLUOROURACIL; LEUCOVORIN; AFLIBERCEPT; OXALIPLATIN; PLACEBO; CARBOPLATIN	Objectives: This randomized phase II trial investigated the efficacy and safety of docetaxel plus bevacizumab and S-1 plus bevacizumab in the second-line treatment of non-squamous (non-Sq) non-small-cell lung cancer (NSCLC). Materials and methods: Patients with non-Sq NSCLC who experienced disease progression after prior platinum-based chemotherapy with or without bevacizumab were randomly assigned to receive docetaxel plus bevacizumab (DB) once every 3 weeks or S-1 orally twice daily on days 1-14 plus bevacizumab (SB) on day 1 every 3 weeks until disease progression. Results: Ninety patients were randomized. The median progression-free survival (PFS) was 3.9 months (95% confidence interval [CI] = 3.0-6.5) in DB and 3.5 months (95% CI = 2.9-5.9) in SB. The objective response rate was significantly higher in DB than in SB (22.2% vs. 2.2%; P = 0.004), whereas the disease control rates of the arms were identical (62.2% vs. 62.2%; P = 1.00). Patients receiving DB were more likely to have >= grade 3 neutropenia (93.4% vs. 4.4%) and febrile neutropenia (33.3% vs. 0%) than SB. In DB, PFS and overall survival (OS) were significantly longer among bevacizumab-neve patients than among bevacizumab-experienced patients (median PFS: 7.2 vs. 2.9 months; P = 0.004; and median OS: 21.3 vs. 14.1 months; P = 0.012). Conclusion: DB and SB produced modest PFS benefits in the second-line treatment of patients with advanced non-Sq NSCLC. Because of the toxicity of DB and the low response rate of SB, neither regimen warrants further investigation, excluding DB in bevacizumab-naive patients with advanced non-Sq NSCLC. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nishino, Kazumi; Imamura, Fumio; Kumagai, Toru] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Higashinari Ku, Osaka 5378511, Japan; [Katakami, Nobuyuki; Hata, Akito; Okuda, Chiyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Urata, Yoshiko; Hattori, Yosihihiro; Satouchi, Miyako] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan; [Tachihara, Motoko] Kobe Univ, Grad Sch Med, Dept Resp Med, Kobe, Hyogo 657, Japan; [Yokota, Souichirou] Toneyama Natl Hosp, Natl Hosp Org, Dept Thorac Oncol, Toyonaka, Osaka, Japan; [Nishimura, Takashi] Kyoto Katsura Hosp, Dept Resp Med, Kyoto, Japan; [Kaneda, Toshihiko] West Hosp, Kobe City Med Ctr, Dept Resp Med, Kobe, Hyogo, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Negoro, Shunichi] Hyogo Canc Ctr, Dept Med Oncol, Akashi, Hyogo, Japan	Nishino, K (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	nishinishipptruth@yahoo.co.jp			Chugai Pharmaceutical	Dr. Nishino, Dr. Katakami, Dr. Hattori, Dr. Urata, Dr. Tachihara, and Dr. Negoro have received honoraria from Chugai Pharmaceutical. Dr. Imamura, Dr. Satouchi, and Prof. Morita have received honoraria from Chugai Pharmaceutical and TAIHO Pharmaceutical. Prof. Morita has received research funding from Chugai Pharmaceutical. All other authors made no disclosure.	de Boer RH, 2011, J CLIN ONCOL, V29, P1067, DOI 10.1200/JCO.2010.29.5717; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Ramlau R, 2012, J CLIN ONCOL, V30, P3640, DOI 10.1200/JCO.2012.42.6932; Yamada Y, 2013, LANCET ONCOL, V14, P1278, DOI 10.1016/S1470-2045(13)70490-X; Tabernero J, 2014, EUR J CANCER, V50, P320, DOI 10.1016/j.ejca.2013.09.013; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bartolotti M, 2014, FUTURE ONCOL, V10, P1417, DOI [10.2217/fon.14.57, 10.2217/FON.14.57]; Ferlay J., 2012, INT J CANCER, V136, pE359, DOI DOI 10.1002/IJC.29210; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Nukatsuka M, 2012, EXP THER MED, V3, P755, DOI 10.3892/etm.2012.484; Ohyanagi F, 2014, ANTICANCER RES, V34, P5153; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Shiroyama T, 2011, LUNG CANCER, V74, P85, DOI 10.1016/j.lungcan.2011.01.017; Totani Y, 2009, CANCER CHEMOTH PHARM, V64, P1181, DOI 10.1007/s00280-009-0981-1; Urata Y, 2013, CANCER-AM CANCER SOC, V119, P2275, DOI 10.1002/cncr.28048	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	AUG	2015	89	2					146	153		10.1016/j.lungcan.2015.05.022		8	Oncology; Respiratory System	Oncology; Respiratory System	CN4HA	WOS:000358390000010		
J	Hirachi, T; Ishii, H; Tada, Y; Noguchi, T; Haraguchi, Y; Tateishi, H; Mizoguchi, Y; Kato, TA; Kawashima, T; Monji, A				Hirachi, T.; Ishii, H.; Tada, Y.; Noguchi, T.; Haraguchi, Y.; Tateishi, H.; Mizoguchi, Y.; Kato, T. A.; Kawashima, T.; Monji, A.			Mania occurring during systemic lupus erythematosus relapse and its amelioration on clinical and neuroimaging follow-up	LUPUS			English	Article						Systemic lupus erythematosus (SLE); relapse; mania; single-photon emission computed tomography (SPECT); magnetic resonance imaging (MRI)	CENTRAL-NERVOUS-SYSTEM; EMISSION COMPUTED-TOMOGRAPHY; INVOLVEMENT; DISORDERS; MOOD; SLE	Psychiatric manifestations of systemic lupus erythematosus (SLE) that are commonly preceded by organic syndromes include confusional states, anxiety disorder, cognitive dysfunction, mood disorder and psychosis. A 35-year-old woman was admitted to hospital with a relapse of SLE. Laboratory data were exacerbated, with some physical symptoms, and her primary psychiatric symptom was mania. The symptoms were reduced by treatment with prednisolone, methylprednisolone and aripiprazole. Magnetic resonance imaging and single-photon emission computed tomography (SPECT) using I-123-IMP was then performed and analyzed with three-dimensional stereotactic surface projection. This case emphasizes that SLE can commence with organic syndromes and relapse with predominantly psychiatric symptoms, and that the treatment efficacy may be confirmed using a follow-up of SPECT.	[Hirachi, T.; Ishii, H.; Haraguchi, Y.; Tateishi, H.; Mizoguchi, Y.; Kawashima, T.; Monji, A.] Saga Univ, Dept Psychiat, Saga 8498501, Japan; [Tada, Y.] Saga Univ, Dept Rheumatol, Saga 8498501, Japan; [Noguchi, T.] Saga Univ, Dept Radiol, Saga 8498501, Japan; [Kato, T. A.] Kyushu Univ, Dept Neuropsychiat, Grad Sch Med Sci, Fukuoka 812, Japan	Hirachi, T (reprint author), Saga Univ, Dept Psychiat, Fac Med, Nabeshima 5-1-1, Saga 8498501, Japan.	si5059@cc.saga-u.ac.jp					Alao AO, 2009, PSYCHOSOMATICS, V50, P543, DOI 10.1176/appi.psy.50.5.543; [Anonymous], 1999, ARTHRITIS RHEUM, V42, P599; Benabarre A, 2005, AUST NZ J PSYCHIAT, V39, P227, DOI 10.1080/j.1440-1614.2004.01558.x; Meszaros ZS, 2012, J CLIN PSYCHIAT, V73, P993, DOI [10.4088/JCP.11m07043, 10.4088/JCP.11r07425]; Bhangle SD, 2013, RHEUMATOL INT, V33, P1923, DOI 10.1007/s00296-013-2750-z; Bachen EA, 2009, ARTHRIT RHEUM-ARTHR, V61, P822, DOI 10.1002/art.24519; Castellino G, 2008, AUTOIMMUN REV, V7, P297, DOI 10.1016/j.autrev.2007.11.022; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Bogaczewicz J, 2014, LUPUS, V23, P193; Castellino G, 2008, RHEUMATOLOGY, V47, P319, DOI [10.1093/rheumatology/kem354, 10.1093/rheumatology/em354]; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P605, DOI 10.1093/rheumatology/41.6.605; Khan S, 2000, ACTA PSYCHIAT SCAND, V101, P406, DOI 10.1034/j.1600-0447.2000.101005406.x; Nishimura K, 2012, PSYCHOSOMATICS, V53, P289, DOI 10.1016/j.psym.2011.08.010; Zhang X, 2005, ARTHRIT RHEUM-ARTHR, V53, P845, DOI 10.1002/art.21591	14	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	AUG	2015	24	9					990	993		10.1177/0961203315570161		4	Rheumatology	Rheumatology	CN2OW	WOS:000358262600014		
J	Maehara, T; Murota, K				Maehara, Takanori; Murota, Kazuo			A framework of discrete DC programming by discrete convex analysis	MATHEMATICAL PROGRAMMING			English	Article							VALUATED MATROID INTERSECTION; SUBMODULAR FUNCTION; OPTIMIZATION; DUALITY	A theoretical framework of difference of discrete convex functions (discrete DC functions) and optimization problems for discrete DC functions is established. Standard results in continuous DC theory are exported to the discrete DC theory with the use of discrete convex analysis. A discrete DC algorithm, which is a discrete analogue of the continuous DC algorithm (Concave-Convex procedure in machine learning) is proposed. The algorithm contains the submodular-supermodular procedure as a special case. Exploiting the polyhedral structure of discrete convex functions, the algorithms tailored to specific types of discrete DC functions are proposed.	[Maehara, Takanori] Natl Inst Informat, Kawarabayashi Project, ERATO, JST, Tokyo 1018430, Japan; [Murota, Kazuo] Univ Tokyo, Dept Math Informat, Tokyo 1138656, Japan	Maehara, T (reprint author), Natl Inst Informat, Kawarabayashi Project, ERATO, JST, Tokyo 1018430, Japan.	maehara@nii.ac.jp; murota@mist.i.u-tokyo.ac.jp			KAKENHI [21360045, 26280004]; Aihara Project, the FIRST program from JSPS	The authors thank Satoru Iwata and Akiyoshi Shioura for helpful discussions, Tom McCormick and Maurice Queyranne for communicating references [43]. This work is supported by KAKENHI (21360045, 26280004) and the Aihara Project, the FIRST program from JSPS.	Murota K, 1999, MATH OPER RES, V24, P95, DOI 10.1287/moor.24.1.95; Vondrak J, 2008, ACM S THEORY COMPUT, P67; Horst R, 1999, J OPTIMIZ THEORY APP, V103, P1, DOI 10.1023/A:1021765131316; Yuille AL, 2003, NEURAL COMPUT, V15, P915, DOI 10.1162/08997660360581958; [Anonymous], 1959, PAC J MATH, V9, P707; TOPKIS DM, 1978, OPER RES, V26, P305, DOI 10.1287/opre.26.2.305; TOLAND JF, 1979, ARCH RATION MECH AN, V71, P41, DOI 10.1007/BF00250669; Iwata S, 2009, PROCEEDINGS OF THE TWENTIETH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1230; Lee J, 2009, ACM S THEORY COMPUT, P323; DRESS AWM, 1992, ADV MATH, V93, P214, DOI 10.1016/0001-8708(92)90028-J; Kolmogorov V, 2009, DISCRETE OPTIM, V6, P378, DOI 10.1016/j.disopt.2009.04.006; Bacak M, 2011, OPTIMIZATION, V60, P961, DOI 10.1080/02331931003770411; Birkhoff G., 1937, DUKE MATH J, V3, P443, DOI 10.1215/S0012-7094-37-00334-X; Calinescu G, 2011, SIAM J COMPUT, V40, P1740, DOI 10.1137/080733991; Edmonds J., 1970, COMBINATORIAL STRUCT, P69; Favati P., 1990, RICERCA OPERATIVA, V53, P3; Feige U, 2011, SIAM J COMPUT, V40, P1133, DOI 10.1137/090779346; Frank A., 2011, OXFORD LECT SERIES M, V38; FRANK A, 1988, MATH PROGRAM, V42, P489, DOI 10.1007/BF01589418; Frank A., 1984, C MATH SOC J BOLYAI, V37, P285; Fujishige S, 2000, MATH PROGRAM, V88, P129, DOI 10.1007/PL00011371; Fujishige S, 2005, ANN DISCR MATH, V58, P1; Hirai H, 2004, JPN J IND APPL MATH, V21, P391; Hiriart-Urruty J.B., 1989, E MAJ INT S, V43, P219; HIRIARTURRUTY JB, 1985, LECT NOTES ECON MATH, V256, P37; Hiriart-Urruty JB, 1993, CONVEX ANAL MINIMIZA; Iyer R., 2012, P 28 C UNC ART INT, P407; Iyer R., 2013, P 30 INT C MACH LEAR, P855; Kawahara Y., 2011, P 25 ANN C NEUR INF, P2106; Kawahara Y, 2011, PATTERN RECOGN LETT, V32, P235, DOI 10.1016/j.patrec.2010.08.008; McCormick ST, 1996, OPER RES LETT, V19, P95, DOI 10.1016/0167-6377(96)00016-8; McCormick S.T., 2006, HDB OPERATIONS RES M, V12, P321; MILLER BL, 1971, SIAM J APPL MATH, V21, P166, DOI 10.1137/0121018; Moriguclii Satoko, 2012, Journal of the Operations Research Society of Japan, V55; Moriguchi S, 2005, IEICE T FUND ELECTR, VE88A, P1104, DOI 10.1093/ietfec/e88-a.5.1104; Murota K., 2000, MATRICES MATROIDS SY; Murota K., 2014, OPER RES LE IN PRESS; Murota K, 1996, SIAM J DISCRETE MATH, V9, P562, DOI 10.1137/S0895480195280009; Murota K, 1997, J COMB THEORY B, V69, P59, DOI 10.1006/jctb.1996.1723; Murota K, 1996, SIAM J DISCRETE MATH, V9, P545, DOI 10.1137/S0895480195279994; Murota K, 1998, MATH PROGRAM, V83, P313, DOI 10.1007/BF02680565; Murota K., 2003, DISCRETE CONVEX ANAL; Murota K, 2009, RESEARCH TRENDS IN COMBINATORIAL OPTIMIZATION, P219, DOI 10.1007/978-3-540-76796-1_11; Narasimhan M., 2005, P 21 ANN C UNC ART I, P404; Onn S, 2010, ZUR LECT ADV MATH, P1, DOI 10.4171/093; Orlin JB, 2009, MATH PROGRAM, V118, P237, DOI 10.1007/s10107-007-0189-2; Queyranne M., 2004, ELECT NOTES DISCRETE, V17, P5, DOI 10.1016/j.endm.2004.03.003; Schrijver A., 2003, COMBINATORIAL OPTIMI; Singer I., 1979, Bulletin of the Australian Mathematical Society, V20; Tao P.D., 1997, ACTA MATH VIETNAMICA, V22, P289; Tao P.D., 1987, INT SERIES NUMER MAT, V84, P277; Tuy H., 1995, HDB GLOBAL OPTIMIZAT, P149; TUY H, 1987, MATH PROGRAM STUD, V30, P150	53	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5610	1436-4646		MATH PROGRAM	Math. Program.	AUG	2015	152	1-2					435	466		10.1007/s10107-014-0792-y		32	Computer Science, Software Engineering; Operations Research & Management Science; Mathematics, Applied	Computer Science; Operations Research & Management Science; Mathematics	CN2ZO	WOS:000358292600014		
J	Karzhemanov, I				Karzhemanov, Ilya			Fano threefolds with canonical Gorenstein singularities and big degree	MATHEMATISCHE ANNALEN			English	Article							3-FOLDS	We provide a complete classification of Fano threefolds having canonical Gorenstein singularities and anticanonical degree (-K-X)(3) = 64.	Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Karzhemanov, I (reprint author), Univ Tokyo, Kavli IPMU WPI, 5-2-3 Kashiwanoha, Kashiwa, Chiba 2778583, Japan.	ilya.karzhemanov@ipmu.jp			RFFI [08-01-00395-a]; World Premier International Research Initiative (WPI), MEXT, Japan; Japan Mathematical Society (Kakenhi) [26887009];  [N.Sh.-1987.2008.1]	The work was partially supported by RFFI Grant No. 08-01-00395-a, Grant N.Sh.-1987.2008.1, World Premier International Research Initiative (WPI), MEXT, Japan, and Grant-in-Aid for Scientific Research (26887009) from Japan Mathematical Society (Kakenhi).	Prokhorov YG, 2009, J ALGEBRAIC GEOM, V18, P151; MORI S, 1981, MANUSCRIPTA MATH, V36, P147, DOI 10.1007/BF01170131; Kreuzer M, 2004, COMPUT PHYS COMMUN, V157, P87, DOI 10.1016/S0010-4655(03)00491-0; CUTKOSKY S, 1988, MATH ANN, V280, P521, DOI 10.1007/BF01456342; Dolgachev IV, 2012, CLASSICAL ALGEBRAIC GEOMETRY: A MODERN VIEW, P1, DOI 10.1017/CBO9781139084437; DOLGACHEV I, 1982, LECT NOTES MATH, V956, P34; Fulton W., 1993, INTRO TORIC VARIETIE; Griffiths P., 1978, PRINCIPLES ALGEBRAIC; Grothendieck Alexander, 1958, B SOC MATH FRANCE, V86, P137; Hartshorne R., 1977, ALGEBRAIC GEOMETRY; Hirzebruch F., 1966, TOPOLOGICAL METHODS; Iano-Fletcher AR, 2000, LOND MATH S, V281, P101; ISKOVSKIH VA, 1978, MATH USSR IZV+, V12, P469, DOI 10.1070/IM1978v012n03ABEH001994; Iskovskikh V.A., 1980, ENGL T J SOVIET MATH, V13, P745; ISKOVSKIH VA, 1977, MATH USSR IZV+, V11, P485, DOI 10.1070/IM1977v011n03ABEH001733; Iskovskikh V.A., 1999, ALGEBRAIC GEOMETRY, V47; Jahnke P, 2011, CENT EUR J MATH, V9, P449, DOI 10.2478/s11533-011-0023-1; Jahnke P, 2005, MATH ANN, V333, P569, DOI 10.1007/s00208-005-0682-y; Jahnke P., 2010, MATH ZEIT, V269, P1129; Jahnke P, 2008, ADV GEOM, V8, P387, DOI 10.1515/ADVGEOM.2008.026; Jahnke P, 2006, COMPOS MATH, V142, P422, DOI 10.1112/S0010437X05001673; Karzhemanov I.V, 2009, RUSS AC SC SB MATH+, V200, P111; KAWAMATA Y, 1988, ANN MATH, V127, P93, DOI 10.2307/1971417; Kawamata Yujiro, 1987, ADV STUDIES PURE MAT, V10, P283; Kollar J., 1998, BIRATIONAL GEOMETRY; KOLLAR J, 1989, NAGOYA MATH J, V113, P15; Kollar J., 1997, P S PURE MATH, V62, P221; Mori S., 1988, J AM MATH SOC, V1, P117, DOI 10.2307/1990969; Mukai S., 1995, SUGAKU, V47, P125; Namikawa Y, 1997, J ALGEBRAIC GEOM, V6, P307; Prokhorov YuG, 2005, RUSSIAN ACAD SCI SB, V196, P81; Przyjalkowsky V.V., 2005, RUSS AC SC IZV MATH+, V69, P145; Reid M., 1983, PROJECTIVE MORPHISMS; Reid M., 1979, CANONICAL 3 FOLDS AL, P273; Shin K.-H., 1989, TOKYO J MATH, V12, P375	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	AUG	2015	362	3-4					1107	1142		10.1007/s00208-014-1149-9		36	Mathematics	Mathematics	CN1FH	WOS:000358162800016		
J	Okuyama, Y				Okuyama, Yusuke			Quantitative approximations of the Lyapunov exponent of a rational function over valued fields	MATHEMATISCHE ZEITSCHRIFT			English	Article						Periodic point; Lyapunov exponent; Quantitative approximation; Non-archimedean dynamics; Complex dynamics	NON-ARCHIMEDEAN DYNAMICS; EQUIDISTRIBUTION; MAPS; THEOREM; POINTS	We establish a quantitative approximation formula of the Lyapunov exponent of a rational function of degree more than one over an algebraically closed field of characteristic that is complete with respect to a non-trivial and possibly non-archimedean absolute value, in terms of the multipliers of periodic points of the rational function. This quantifies both our former convergence result over general fields and the one-dimensional version of Berteloot-Dupont-Molino's one over archimedean fields.	Kyoto Inst Technol, Div Math, Sakyo Ku, Kyoto 6068585, Japan	Okuyama, Y (reprint author), Kyoto Inst Technol, Div Math, Sakyo Ku, Kyoto 6068585, Japan.	okuyama@kit.ac.jp			JSPS [24740087]	The author thanks the referee for a very careful scrutiny and invaluable comments. This research was partially supported by JSPS Grant-in-Aid for Young Scientists (B), 24740087.	APOSTOL T. M., 1976, INTRO ANAL NUMBER TH; Baker M, 2009, J REINE ANGEW MATH, V626, P205, DOI 10.1515/CRELLE.2009.008; BAKER M., 2010, MATH SURVEYS MONOGRA, V159; Baker MH, 2006, ANN I FOURIER, V56, P625; Benedetto R., 2010, NONARCHIMEDEAN DYNAM; Berteloot F., 2010, RIV MATH U PARMA, V1, P263; Berteloot F., 2001, COURS SPECIALISES, V7; Berteloot F, 2008, ANN I FOURIER, V58, P2137; Chambert-Loir A, 2006, J REINE ANGEW MATH, V595, P215, DOI 10.1515/CRELLE.2006.049; DeMarco L, 2003, MATH ANN, V326, P43, DOI 10.1007/s00208-002-0404-7; Favre C, 2010, P LOND MATH SOC, V100, P116, DOI 10.1112/plms/pdp022; Jonsson M, 1998, ERGOD THEOR DYN SYST, V18, P613, DOI 10.1017/S0143385798108209; Jonsson M., 2004, LECT NOTES MATH, V1853; Jonsson M., 2012, ARXIV E PRINTS; Ljubich M.Ju., 1983, ERGOD THEOR DYN SYST, V3, P351, DOI DOI 10.1017/S0143385700002030; Milnor J., 2006, ANN MATH STUDIES, V160; Okuyama Y, 2013, MATH Z, V273, P811, DOI 10.1007/s00209-012-1032-x; Okuyama Y., 2011, CONFORM GEOM DYN, V15, P152; Okuyama Y, 2012, ACTA ARITH, V152, P267, DOI 10.4064/aa152-3-3; Okuyama Y, 2013, ACTA ARITH, V161, P101, DOI 10.4064/aa161-2-1; PRZYTYCKI F, 1993, P AM MATH SOC, V119, P309, DOI 10.2307/2159858; Rivera-Letelier J, 2003, ASTERISQUE, P147; Silverman J. H., 2007, GRADUATE TEXTS MATH, V241; Sodin M., 1992, ADV SOVIET MATH, V11, P7; Szpiro L., 2012, MEMORY OF SERGE LANG, P609; Thuillier A., 2005, THESIS U RENNES, V1; Tsuji M., 1959, POTENTIAL THEORY MOD	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	AUG	2015	280	3-4					691	706		10.1007/s00209-015-1443-6		16	Mathematics	Mathematics	CN1VL	WOS:000358208300005		
J	Ozawa, R; Shioya, T				Ozawa, Ryunosuke; Shioya, Takashi			Limit formulas for metric measure invariants and phase transition property	MATHEMATISCHE ZEITSCHRIFT			English	Article						Metric measure space; Concentration of measure; Observable diameter; Separation distance; Pyramid; Dissipation		We generalize the observable diameter and the separation distance for metric measure spaces to those for pyramids, and prove some limit formulas for these invariants for a convergent sequence of pyramids. We obtain various applications of our limit formulas as follows. We have a criterion of the phase transition property for a sequence of metric measure spaces or pyramids, and find some examples of symmetric spaces of noncompact type with the phase transition property. We also give a simple proof of a theorem in Funano and Shioya (Geom Funct Anal 23(3):888-936, 2013) on the limit of an N-Levy family.	[Ozawa, Ryunosuke; Shioya, Takashi] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan	Shioya, T (reprint author), Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan.	takashioya@m.tohoku.ac.jp					MILMAN VD, 1988, ASTERISQUE, P273; Funano K, 2013, GEOM FUNCT ANAL, V23, P888, DOI 10.1007/s00039-013-0215-x; GROMOV M, 1983, AM J MATH, V105, P843, DOI 10.2307/2374298; Billingsley P, 1999, WILEY SERIES PROBABI; Bogachev V. I., 2007, MEASURE THEORY, VI; Bogachev VI, 2007, MEASURE THEORY, VII; Burago D., 2001, GRADUATE STUDIES MAT, V33; Elek G., PREPRINT; Gromov M., 2007, METRIC STRUCTURES RI; Kechris A. S., 1995, GRADUATE TEXTS MATH, V156; Ledoux M., 2001, MATH SURVEYS MONOGRA, V89; Levy P., 1951, PROBLEMES CONCRETS A; Ozawa R, 2015, MANUSCRIPTA MATH, V147, P501, DOI 10.1007/s00229-015-0730-1; Shioya T., IRMA SER EU IN PRESS; Shioya T., PREPRINT	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	AUG	2015	280	3-4					759	782		10.1007/s00209-015-1447-2		24	Mathematics	Mathematics	CN1VL	WOS:000358208300009		
J	Kase, R				Kase, Ryoichi			Taking tilting modules from the poset of support tilting modules	MATHEMATISCHE ZEITSCHRIFT			English	Article						Tilting modules; Tilting mutations; Representations of quivers		C. Ingalls and H. Thomas defined support tilting modules for path algebras. From tau-tilting theory introduced by T. Adachi, O. Iyama and I. Reiten, a partial order on the set of basic tilting modules defined by D. Happel and L. Unger is extended as a partial order on the set of support tilting modules. In this paper, we study a combinatorial relationship between the poset of basic tilting modules and basic support tilting modules. We will show that the subposet of tilting modules is uniquely determined by the poset structure of the set of support tilting modules.	Nara Womens Univ, Dept Math, Nara, Nara 6308506, Japan	Kase, R (reprint author), Nara Womens Univ, Dept Math, Kitauoya Nishimachi, Nara, Nara 6308506, Japan.	r-kase@cc.nara-wu.ac.jp					Ingalls C, 2009, COMPOS MATH, V145, P1533, DOI 10.1112/S0010437X09004023; Adachi T, 2014, COMPOS MATH, V150, P415, DOI 10.1112/S0010437X13007422; Happel D, 2005, ALGEBR REPRESENT TH, V8, P147, DOI 10.1007/s10468-005-3595-2; Assem I., 2006, LONDON MATH SOC STUD, V1; AUSLANDER M., 1995, CAMBRIDGE STUDIES AD, V36; Brenner S., 1979, LECT NOTES MATH, V832, P103; Happel D., 1988, LONDON MATH SOC LECT, V119; Happel D, 2005, J ALGEBRA, V284, P857, DOI 10.1016/j.jalgebra.2004.11.007; Jasso G., ARXIV13022709; Riedtmann C, 1991, MATH HELV, V66, P70	10	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	AUG	2015	280	3-4					893	904		10.1007/s00209-015-1454-3		12	Mathematics	Mathematics	CN1VL	WOS:000358208300016		
J	Hirose, M; Sato, N				Hirose, Minoru; Sato, Nobuo			On the functional equation of the normalized Shintani L-function of several variables	MATHEMATISCHE ZEITSCHRIFT			English	Article						Functional equation; Shintani L-function; Hurwitz-Lerch zeta function; L-function	ZETA-FUNCTIONS	In this paper, we introduce the normalized Shintani L-function of several variables by an integral representation and prove its functional equation. The Shintani L-function is a generalization to several variables of the Hurwitz-Lerch zeta function and the functional equation given in this paper is a generalization of the functional equation of Hurwitz-Lerch zeta function. In addition to the functional equation, we give special values of the normalized Shintani L-function at non-positive integers and some positive integers.	[Hirose, Minoru; Sato, Nobuo] Kyoto Univ, Dept Math, Sakyo Ku, Kyoto 6068502, Japan	Hirose, M (reprint author), Kyoto Univ, Dept Math, Sakyo Ku, Kitashirakawaoiwake Cho, Kyoto 6068502, Japan.	hirose@math.kyoto-u.ac.jp			JSPS [231733, 257323]	This work was supported by JSPS Grant-in-Aid for Scientific Research Numbers 231733, 257323.	Hecke E, 1920, MATH Z, V6, P11, DOI 10.1007/BF01202991; Matsumoto K, 2004, MATH PROC CAMBRIDGE, V136, P1, DOI 10.1017/S0305004103007035; Hida H., 1993, ELEMENTARY THEORY L; Hirose M., 2013, ARXIV13126218V1MATHN; Lerch M., 1887, ACTA MATH, V11, P19, DOI DOI 10.1007/BF02612318; SATO F, 1982, TOHOKU MATH J, V34, P437, DOI 10.2748/tmj/1178229205; Shintani T., 1976, J FAC SCI U TOKY IAM, V23, P393; Tate J., 1979, P S PURE MATH 2, V33, P3	8	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	AUG	2015	280	3-4					1085	1092		10.1007/s00209-015-1467-y		8	Mathematics	Mathematics	CN1VL	WOS:000358208300027		
J	Goda, K; Hatta-Ohashi, Y; Akiyoshi, R; Sugiyama, T; Sakai, I; Takahashi, T; Suzuki, H				Goda, Kazuhito; Hatta-Ohashi, Yoko; Akiyoshi, Ryutaro; Sugiyama, Takashi; Sakai, Ikuko; Takahashi, Takeo; Suzuki, Hirobumi			Combining fluorescence and bioluminescence microscopy	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						luciferin; PKC; NF-B; single-cell analysis	PROMOTER ACTIVITY; GENE-EXPRESSION; LIVING CELLS; PROTEIN-KINASE; STEM-CELLS; SINGLE; REPORTER; CLOCK; QUANTIFICATION; SYSTEM	Bioluminescence microscopy has revealed that gene expression in individual cells can respond differently to the same stimulus. To understand this phenomenon, it is important to sequentially observe the series of events from cellular signal transduction to gene expression regulated by specific transcription factors derived from signaling cascades in individual cells. However, these processes have been separately analyzed with fluorescence and bioluminescence microscopy. Furthermore, in culture medium, the background fluorescence of luciferina substrate of luciferase in promoter assays of gene expression in cultured cellsconfounds the simultaneous observation of fluorescence and bioluminescence. Therefore, we optimized conditions for optical filter sets based on spectral properties and the luciferin concentration based on cell permeability for fluorescence observation combined with bioluminescence microscopy. An excitation and emission filter set (492-506 nm and 524-578 nm) was suitable for green fluorescent protein and yellow fluorescent protein imaging of cells, and >100 M luciferin was acceptable in culture medium based on kinetic constants and the estimated intracellular concentration. Using these parameters, we present an example of sequential fluorescence and bioluminescence microscopic observation of signal transduction (translocation of protein kinase C alpha from the cytoplasm to the plasma membrane) coupled with activation of gene expression by nuclear factor of kappa light polypeptide B in individual cells and show that the gene expression response is not completely concordant with upstream signaling following stimulation with phorbol-12-myristate-13-acetate. Our technique is a powerful imaging tool for analysis of heterogeneous gene expression together with upstream signaling in live single cells. Microsc. Res. Tech. 78:715-722, 2015. (c) 2015 Wiley Periodicals, Inc.	[Goda, Kazuhito; Hatta-Ohashi, Yoko; Akiyoshi, Ryutaro; Sugiyama, Takashi; Sakai, Ikuko; Takahashi, Takeo; Suzuki, Hirobumi] Olympus Corp, Corp Res & Dev Ctr, Hachioji, Tokyo 1928512, Japan	Suzuki, H (reprint author), Olympus Corp, Corp Res & Dev Ctr, Adv Anal Technol Dept, Kuboyama 2-3, Hachioji, Tokyo 1928512, Japan.	hirobumi2_suzuki@ot.olympus.co.jp					Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; Shin Y, 2007, EXP MOL MED, V39, P97; Pratx G, 2013, J NUCL MED, V54, P1841, DOI 10.2967/jnumed.112.113365; Ogoh K, 2014, J MICROSC-OXFORD, V253, P191, DOI 10.1111/jmi.12109; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/nmeth.1557, 10.1038/NMETH.1557]; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Sugiyama T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05352; Sramek C, 2011, INVEST OPHTH VIS SCI, V52, P1780, DOI 10.1167/iovs.10-5917; Akiyoshi R, 2014, ANAL BIOANAL CHEM, V406, P5703, DOI 10.1007/s00216-014-8000-8; Kwon H, 2010, BIOTECHNIQUES, V48, P460, DOI 10.2144/000113419; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/nmeth.1573, 10.1038/NMETH.1573]; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/nmeth.1577, 10.1038/NMETH.1577]; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Huang RM, 2011, MOL IMAGING, V10, P215, DOI 10.2310/7290.2010.00045; Asai S, 2008, NEUROSCI LETT, V434, P289, DOI 10.1016/j.neulet.2008.01.075; Aschrafi A, 2003, BBA-MOL CELL BIOL L, V1634, P30, DOI 10.1016/j.bbalip.2003.08.004; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Castano JP, 1996, MOL ENDOCRINOL, V10, P599, DOI 10.1210/me.10.5.599; Cosby N., 2009, SCREENING, V4, P28; desWet JR, 1987, MOL CELL BIOL, V7, P725; DIBNER C, 2008, EMBO J, V28, P123; Fukuda H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023568; Hatta-Ohashi Y, 2009, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P355, DOI 10.1142/9789812839589_0081; Horibe T, 2014, LUMINESCENCE, V29, P96, DOI 10.1002/bio.2508; Kennedy HJ, 1997, J BIOL CHEM, V272, P20636, DOI 10.1074/jbc.272.33.20636; Maire E, 2000, ANAL BIOCHEM, V280, P118, DOI 10.1006/abio.2000.4503; Patrick PS, 2014, MOL IMAGING BIOL, V16, P626, DOI 10.1007/s11307-014-0741-4; Pratx G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046285; Rogers KL, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937236; SELIGER HH, 1961, P NATL ACAD SCI USA, V47, P1129, DOI 10.1073/pnas.47.8.1129; Suzuki H, 2007, BIOLUMINESCENCE AND CHEMILUMINESCENCE: CHEMISTRY, BIOLOGY AND APPLICATIONS, P53, DOI 10.1142/9789812770196_0013; Suzuki T, 2011, ANAL BIOCHEM, V415, P182, DOI 10.1016/j.ab.2011.03.039; Takasuka N, 1998, ENDOCRINOLOGY, V139, P1361, DOI 10.1210/en.139.3.1361; WHITE MRH, 1995, J CELL SCI, V108, P441	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	AUG	2015	78	8					715	722		10.1002/jemt.22529		8	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	CN3MZ	WOS:000358332300010		
J	Aoyama, M; Saka, M				Aoyama, M.; Saka, M.			Evaluation of electromigration resistance of lead-free solders using unpassivated stripe-shaped samples	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							DIFFUSION; TIN	To improve the reliability of electronic devices, electromigration (EM) in lead-free solders is actively being studied. In particular, EM testing methods that use 1-D stripe samples have significant merit. However, some aspects of the reasonability of the EM resistance evaluation remain to be discussed. In this study, the validity of the evaluation method utilising stripe-shaped samples without passivation was verified. Sn-3.0Ag-0.5Cu (SAC) and Sn-3.5Ag-0.5Cu-0.07Ni-0.01Ge (SACNG) solders (in wt.%) with a reference of four nine Sn were used as testing materials for the verification. EM resistance was evaluated by measuring the total volume of hillocks observed in the designated region per unit time of current supply. First, the effect of sample length on EM was confirmed by observing the hillock volume, which increased based on the sample length. In addition, EM resistance was ranked Sn < SAC < SACNG under a combination of experimental conditions as well as under another combination of the conditions. Therefore, the consistency of the EM resistance ranking regardless of the experimental conditions was shown through the experiment. Furthermore, an evaluation formula including the effects of sample length on the EM was derived. Finally, it was theoretically shown that the present method of EM resistance evaluation was consistent regardless of the experimental conditions. These experimental results and theoretical discussion demonstrated the validity of the presented evaluation method.	[Aoyama, M.; Saka, M.] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan	Saka, M (reprint author), Tohoku Univ, Dept Nanomech, Aoba Ku, Aoba 6-6-01, Sendai, Miyagi 9808579, Japan.	saka@ism.mech.tohoku.ac.jp			JKA through its promotion funds from AUTORACE; JSPS [23360050]	This study was subsidised by JKA through its promotion funds from AUTORACE and supported by JSPS Grant-in-Aid for Scientific Research (B) 23360050. The authors would like to acknowledge Associate Prof. Tohmyoh, H. and Assistant Prof. Li, Y. at Tohoku University for their valuable discussion throughout this work.	Abe H, 2006, INT J FRACTURE, V138, P219, DOI 10.1007/s10704-006-0059-6; Lin CF, 2012, METALL MATER TRANS A, V43A, P2571, DOI 10.1007/s11661-012-1276-4; BLECH IA, 1976, J APPL PHYS, V47, P1203, DOI 10.1063/1.322842; HO PS, 1989, REP PROG PHYS, V52, P301, DOI 10.1088/0034-4885/52/3/002; Zhao X, 2012, MICROSYST TECHNOL, V18, P2077, DOI 10.1007/s00542-012-1577-y; HUNTINGTON HB, 1961, J PHYS CHEM SOLIDS, V20, P76, DOI 10.1016/0022-3697(61)90138-X; MEAKIN JD, 1960, T AM I MIN MET ENG, V218, P463; HUANG FH, 1974, PHYS REV B, V9, P1479, DOI 10.1103/PhysRevB.9.1479; Wang PC, 2001, APPL PHYS LETT, V78, P3598, DOI 10.1063/1.1371251; Lu MH, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P149, DOI 10.1109/IRPS.2009.5173241; Carslaw HS, 1959, CONDUCTION HEAT SOLI, P133; Chen CM, 2008, J ALLOY COMPD, V461, P235, DOI 10.1016/j.jallcom.2007.07.059; Hasegawa M, 2005, P 11 INT C FRACT; National Astronomical Observatory of Japan, 2012, CHRON SCI TABL 2013; Saka M, 2009, MICROSYST TECHNOL, V15, P17, DOI 10.1007/s00542-008-0642-z; Sasagawa K, 2011, ENG MATER, P15, DOI 10.1007/978-3-642-15411-9_2; Watanabe H, 2006, P MS T, V2006, P135; Wei CC, 2005, J MATER RES, V20, P2072, DOI 10.1557/JMR.2005.0257	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	AUG	2015	21	8					1777	1785		10.1007/s00542-014-2284-7		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CN1WN	WOS:000358211400022		
J	Nakai, N; Kawano, F; Nakata, K				Nakai, Naoya; Kawano, Fuminori; Nakata, Ken			Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Mechanical stimulus; Mammalian target of rapamycin; AMP-activated protein kinase; Protein synthesis	MTOR SIGNALING PATHWAYS; ACETYL-COA CARBOXYLASE; AMINO-ACIDS; S6 KINASE; RAT-LIVER; INSULIN; LEUCINE; PHOSPHORYLATION; TRANSLATION; INHIBITION	Cellular protein synthesis is believed to be antagonistically regulated by mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) signaling pathways. In the present study, we examined the relationship between mTOR/p70 S6 kinase (p70S6K) and AMPK in response to mechanical stretch. C2C12 myoblasts were grown on a silicone elastomer chamber to confluence and further cultured in differentiation medium for 4 days to form multinucleated myotubes. Cells were subjected to 15 % cyclic uniaxial stretch for 4 h at a frequency of 1 Hz. Phosphorylation of p70S6K at threonine 389 and AMPK at threonine 172 of the catalytic alpha subunit were concomitantly increased by mechanical stretch. Stimulation of the mTOR pathway by adding leucine and insulin increased the phosphorylation of p70S6K without inactivation of AMPK. In contrast, addition of compound C, a pharmacological inhibitor of AMPK, increased the phosphorylation of p70S6K in stretched cells. Activation of AMPK by the addition of 5-amino-4-imidazolecarboxamide ribonucleoside reduced the phosphorylation of p70S6K in response to mechanical stretch. In conclusion, crosstalk between mTOR and AMPK signaling was not tightly regulated in response to physiological stimuli, such as mechanical stress and/or nutrients. However, pharmacological modulation of AMPK influenced the mTOR/p70S6K signaling pathway.	[Nakai, Naoya; Kawano, Fuminori; Nakata, Ken] Osaka Univ, Dept Hlth & Sports Sci, Grad Sch Med, Toyonaka, Osaka 5600043, Japan	Nakai, N (reprint author), Univ Shiga Prefecture, Dept Nutr, Sch Human Cultures, 2500 Hassaka Cho, Hikone, Shiga 5228533, Japan.	nakai@hss.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [25350813]	This work was supported by a Grant-in-Aid for Scientific Research C (25350813 to N.N.) from the Japan Society for the Promotion of Science (JSPS), Japan.	Hawley SA, 1996, J BIOL CHEM, V271, P27879; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1301/nr.2007.mar.122-129; Hornberger TA, 2006, J CELL BIOCHEM, V97, P1207, DOI 10.1002/jcb.20671; Walker DK, 2011, MED SCI SPORT EXER, V43, P2249, DOI 10.1249/MSS.0b013e318223b037; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Kimball SR, 2006, MED SCI SPORT EXER, V38, P1958, DOI 10.1249/01.mss.0000233796.16411.13; Sasai N, 2010, MUSCLE NERVE, V41, P100, DOI 10.1002/mus.21473; Du M, 2007, J ANIM SCI, V85, P919, DOI 10.2527/jas.2006-342; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Drummond MJ, 2008, CURR OPIN CLIN NUTR, V11, P222, DOI 10.1097/MCO.0b013e3282fa17fb; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Reiter AK, 2005, AM J PHYSIOL-ENDOC M, V288, pE980, DOI 10.1152/ajpendo.00333.2004; Barazzoni R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1117, DOI 10.1152/ajpendo.00067.2012; Mounier R, 2011, CELL CYCLE, V10, P2640, DOI 10.4161/cc.10.16.17102; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299; Thomson DM, 2008, J APPL PHYSIOL, V104, P625, DOI 10.1152/japplphysiol.00915.2007; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; Gamble J, 1997, METABOLISM, V46, P1270, DOI 10.1016/S0026-0495(97)90229-8; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Beauloye C, 2001, FEBS LETT, V505, P348, DOI 10.1016/S0014-5793(01)02788-0; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Gautsch TA, 1998, AM J PHYSIOL-CELL PH, V274, pC406; Goodman Craig A, 2014, Rev Physiol Biochem Pharmacol, V166, P43, DOI 10.1007/112_2013_17; Jensen Thomas E, 2014, Mol Metab, V3, P742, DOI 10.1016/j.molmet.2014.07.005; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Kudchodkar SB, 2007, J VIROL, V81, P3649, DOI 10.1128/JVI.02079-06; Lawrence JC, 2001, INT J SPORT NUTR EXE, V11, pS177; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Miyamoto L, 2013, AM J PHYSIOL-CELL PH, V305, pC1214, DOI 10.1152/ajpcell.00162.2013; Nakai N, 2010, MOL CELLS, V30, P513, DOI 10.1007/s10059-010-0147-3; Nakai N, 2006, BIOCHEM BIOPH RES CO, V343, P1244, DOI 10.1016/j.bbrc.2006.03.074; Padmasekar M, 2011, STEM CELLS DEV, V20, P2163, DOI 10.1089/scd.2010.0581; Rennie MJ, 2006, J NUTR, V136, p264S; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	AUG	2015	406	1-2					285	292		10.1007/s11010-015-2446-7		8	Cell Biology	Cell Biology	CN1WR	WOS:000358211800029		
J	Himi, E; Taketa, S				Himi, Eiko; Taketa, Shin			Isolation of candidate genes for the barley Ant1 and wheat Rc genes controlling anthocyanin pigmentation in different vegetative tissues	MOLECULAR GENETICS AND GENOMICS			English	Article						Anthocyanin biosynthesis; Barley; R2R3 MYB; Wheat	MICROSATELLITE CONSENSUS MAP; TRITICUM-AESTIVUM L.; HORDEUM-VULGARE; BREAD WHEAT; GENOME; RICE; MAIZE	MYB transcription factors exist in a large copy number and control various plant phenotypes. We cloned R2R3 MYB-type transcription factors that determine the coloration of basal sheaths in barley and wheat coleoptiles. These genes are highly homologous to maize C1 and rice OsC1, regulators for anthocyanin biosynthesis, but they control seed pigmentation in maize and rice. On the basis of high homology, barley and wheat counterparts are designated HvC1 and TaC1, respectively. HvC1 gene is located on the short arm of chromosome 7H, and TaC1 genes are located on the short arms of chromosomes 7A, 7B, and 7D (TaC1-A1, B1, and D1, respectively). HvC1 is a strong candidate for Ant1 because of (1) complete co-segregation of anthocyanin pigmentation phenotype of the basal sheath with the HvC1 genotype in genetic mapping, and (2) complete deletion of the HvCl gene in two anthocyanin-decreased allelic mutants (ant1.1 and ant1.2) that were induced by irradiation. In contrast, colorless coleoptile wheat lines had lesions in all three genomes consisting of a single-nucleotide substitution or a 1-bp deletion of TaC1-A1, a 1.7-kb insertion of TaC1-B1, and a 2.0-kb insertion of TaC1-D1. At least one normal TaC1 gene appears to be sufficient to produce anthocyanin pigments in wheat coleoptiles. Previous crossing experiments localized Rc (red coleoptile) genes to homoeologous group 7 chromosomes and deduced Rc genotypes of several wheat lines. Their TaC1 gene sequence variation coincided with deduced Rc genotypes; therefore, the present molecular genetic study demonstrates that TaC1 is a strong candidate for Rc in wheat.	[Himi, Eiko; Taketa, Shin] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Himi, E (reprint author), Natl Agr & Food Res Org NARO, Tohoku Agr Res Ctr, 4 Akahira, Morioka, Iwate 0200198, Japan.	eikohimi@affrc.go.jp			Wesco Scientific Promotion Foundation; Sapporo Bioscience Foundation	This work was supported by the Wesco Scientific Promotion Foundation and the Sapporo Bioscience Foundation. The authors thank Ms. Fumiko Katayama, Mr. Yuichi Kikuchi, and Ms. Noriko Hirose for their technical assistance and Dr. M. Roder (IPK) for barley SSR primer information. CS deletion lines for the short arms of 7A, 7B, and 7D were provided by the National BioResource Project.	Druka A, 2003, GENE, V302, P171, DOI 10.1016/S0378-1119(02)01105-8; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Endo TR, 1996, J HERED, V87, P295; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Khlestkina EK, 2010, MOL BREEDING, V25, P125, DOI 10.1007/s11032-009-9312-9; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Himi E, 2011, THEOR APPL GENET, V122, P1561, DOI 10.1007/s00122-011-1555-2; Himi E, 2005, EUPHYTICA, V143, P239, DOI 10.1007/s10681-005-7854-4; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; DEVOS KM, 1995, THEOR APPL GENET, V91, P282, DOI 10.1007/BF00220890; Hu JP, 1996, GENETICS, V142, P1021; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; CONE KC, 1993, PLANT CELL, V5, P1795; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Franckowiak J. D., 2012, Barley Genetics Newsletter, V42, P36; Himi E, 2012, EUPHYTICA, V188, P141, DOI 10.1007/s10681-011-0552-5; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; Jende-Strid B., 1978, Barley Genetics Newsletter, V8, P57; Jende-Strid B., 1984, Barley Genetics Newsletter, V14, P76; Khlestkina EK, 2002, THEOR APPL GENET, V104, P632, DOI 10.1007/s00122-001-0788-x; Khlestkina EK, 2011, CEREAL RES COMMUN, V39, P465, DOI 10.1556/CRC.39.2011.4.1; Khlestkina EK, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-88; KRISTIANSEN KN, 1991, MOL GEN GENET, V230, P49; Li JZ, 2003, THEOR APPL GENET, V107, P1021, DOI 10.1007/s00122-003-1345-6; Li S., 2014, PLANT SIGNAL BEHAV, V9, DOI DOI 10.4161/PSB.27522; Li WL, 1999, THEOR APPL GENET, V98, P226, DOI 10.1007/s001220051062; McIntosh RA, 2010, CATALOGUE GENE SYMBO; Taketa S, 2011, BREEDING SCI, V61, P80, DOI 10.1270/jsbbs.61.80	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	AUG	2015	290	4					1287	1298		10.1007/s00438-015-0991-0		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CN2JD	WOS:000358246000007		
J	Matsuno, K; Fujimura, T				Matsuno, Koya; Fujimura, Tatsuhito			Do rice suspension-cultured cells treated with abscisic acid mimic developing seeds?	MOLECULAR GENETICS AND GENOMICS			English	Article						ABA; Oil bodies; OsVP1; Phytic acid; Seed storage proteins; Starch	ADP-GLUCOSE PYROPHOSPHORYLASE; STORAGE PROTEIN GENES; ORYZA-SATIVA L.; TRANSCRIPTION FACTOR; STARCH SYNTHESIS; OIL BODIES; SUPERIOR SPIKELETS; OLEOSIN ISOFORMS; TRANSGENIC RICE; ALEURONE LAYER	Starch synthesis is activated in the endosperm during seed development and also in rice suspension cells cultured with abscisic acid. In the anticipation that the mechanisms of starch synthesis are similar between the endosperm and the suspension cells cultured with abscisic acid, expression of genes involved in starch synthesis was evaluated in the suspension cells after abscisic acid treatment. However, it was found that the regulatory mechanism of starch synthesis in the suspension cells cultured with abscisic acid was different from that in developing seeds. Expression analyses of genes involved in oil bodies, which accumulate in the embryo and aleurone layer, and seed storage proteins, which accumulate mainly in the endosperm, showed that the former were activated in the suspension cells cultured with abscisic acid, but the latter were not. Master regulators for embryogenesis, OsVP1 (homologue of AtABI3) and OsLFL1 (homologue of AtFUS3 or AtLFL2), were expressed in the suspension cells at levels comparable to those in the embryo. From these results, it is suggested that interactions between regulators and abscisic acid control the synthesis of phytic acid and oil bodies in the cultured cells and embryo. We suggest that the system of suspension cells cultured with abscisic acid helps to reveal the mechanisms of phytic acid and oil body synthesis in embryo.	[Matsuno, Koya; Fujimura, Tatsuhito] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan	Matsuno, K (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	s0921207@gmail.com; fujimura.tatsuhit.gw@u.tsukuba.ac.jp					Akihiro T, 2006, FEBS LETT, V580, P5947, DOI 10.1016/j.febslet.2006.09.065; Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Agboola S, 2005, J CEREAL SCI, V41, P283, DOI 10.1016/j.jcs.2004.10.007; Kawakatsu T, 2009, PLANT J, V59, P908, DOI 10.1111/j.1365-313X.2009.03925.x; Wang FF, 2013, PLANT PHYSIOL, V161, P1251, DOI 10.1104/pp.112.212282; Wu CY, 1998, PLANT CELL PHYSIOL, V39, P885; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; ODELL BL, 1972, J AGR FOOD CHEM, V20, P718, DOI 10.1021/jf60181a021; Lee SK, 2007, PLANT MOL BIOL, V65, P531, DOI 10.1007/s11103-007-9153-z; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI 10.1104/pp.127.2.459; Iwai T, 2012, PLANT PHYSIOL, V160, P2007, DOI 10.1104/pp.112.206573; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P300, DOI 10.1093/pcp/pci031; Xie ZY, 2008, MOL BIOL EVOL, V25, P1581, DOI 10.1093/molbev/msn105; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; YAMAGATA H, 1982, PLANT PHYSIOL, V70, P1094, DOI 10.1104/pp.70.4.1094; Nakase M, 1996, GENE, V170, P223, DOI 10.1016/0378-1119(95)00887-X; Satoh H, 2003, PLANT PHYSIOL, V133, P1111, DOI 10.1104/pp.103.021527; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1049/j.1467-7653.2003.00055.x; Ichihara K, 2003, LIPIDS, V38, P881, DOI 10.1007/s11745-003-1139-0; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Yamamoto MP, 2006, PLANT PHYSIOL, V141, P1694, DOI 10.1104/pp.106.082826; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Wang JC, 2013, J EXP BOT, V64, P3453, DOI 10.1093/jxb/ert187; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; To A, 2012, PLANT CELL, V24, P5007, DOI 10.1105/tpc.112.106120; Kawakatsu T, 2008, J EXP BOT, V59, P4233, DOI 10.1093/jxb/ern265; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Pouvreau B, 2011, PLANT PHYSIOL, V156, P674, DOI 10.1104/pp.111.173641; CHU CC, 1975, SCI SINICA, V18, P659; CAGAMPAN.GB, 1966, CEREAL CHEM, V43, P145; Chen DH, 2012, PLANT PHYSIOL BIOCH, V60, P18, DOI 10.1016/j.plaphy.2012.07.022; CHOUDHURY NH, 1980, PHYTOCHEMISTRY, V19, P1063, DOI 10.1016/0031-9422(80)83057-3; Chuang RLC, 1996, J BIOCHEM-TOKYO, V120, P74; Crowe AJ, 2000, PLANT SCI, V151, P171, DOI 10.1016/S0168-9452(99)00214-9; LUTHE DS, 1983, PLANT SCI LETT, V32, P147, DOI 10.1016/0304-4211(83)90110-4; Matsuno K, 2014, PLANT SCI, V217, P152, DOI 10.1016/j.plantsci.2013.12.015; Nakagawa H, 1996, PLANT CELL PHYSIOL, V37, P355; OGAWA M, 1979, PLANT CELL PHYSIOL, V20, P19; Peng LT, 2007, BIOCHEM BIOPH RES CO, V360, P251, DOI 10.1016/j.bbrc.2007.06.041; Phillips J, 1997, EMBO J, V16, P4489, DOI 10.1093/emboj/16.15.4489; SANO Y, 1986, EUPHYTICA, V35, P1, DOI 10.1007/BF00028534; Suzuki M, 2003, PLANT PHYSIOL, V132, P1664, DOI 10.1104/pp.103.022475; VILLAREAL RM, 1978, PHYTOCHEMISTRY, V17, P177, DOI 10.1016/S0031-9422(00)94141-4; Yamamoto A, 2010, PLANT CELL PHYSIOL, V51, P2031, DOI 10.1093/pcp/pcq162; Yoshida S, 1976, ROUTINE PROCEDURE GR, V3rd, P61	62	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	AUG	2015	290	4					1551	1562		10.1007/s00438-015-1018-6		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CN2JD	WOS:000358246000029		
J	Inoue, T; Yuo, T; Ohta, T; Hitomi, E; Ichitani, K; Kawase, M; Taketa, S; Fukunaga, K				Inoue, Takahiko; Yuo, Takahisa; Ohta, Takeshi; Hitomi, Eriko; Ichitani, Katsuyuki; Kawase, Makoto; Taketa, Shin; Fukunaga, Kenji			Multiple origins of the phenol reaction negative phenotype in foxtail millet, Setaria italica (L.) P. Beauv., were caused by independent loss-of-function mutations of the polyphenol oxidase (Si7PPO) gene during domestication	MOLECULAR GENETICS AND GENOMICS			English	Article						Crop evolution; Domestication; Foxtail millet; Phenol color reaction (Phr); Polyphenol oxidase (PPO); Setaria italica	GEOGRAPHICAL-DISTRIBUTION; GENOME SEQUENCE; COLOR-REACTION; ORYZA-SATIVA; RICE; DIFFERENTIATION; TOMATO; INHERITANCE; LANDRACES; EVOLUTION	Foxtail millet shows variation in positive phenol color reaction (Phr) and negative Phr in grains, but predominant accessions of this crop are negative reaction type, and the molecular genetic basis of the Phr reaction remains unresolved. In this article, we isolated polyphenol oxidase (PPO) gene responsible for Phr using genome sequence information and investigated molecular genetic basis of negative Phr and crop evolution of foxtail millet. First of all, we searched for PPO gene homologs in a foxtail millet genome database using a rice PPO gene as a query and successfully found three copies of the PPO gene. One of the PPO gene homologs on chromosome 7 showed the highest similarity with PPO genes expressed in hulls (grains) of other cereal species including rice, wheat, and barley and was designated as Si7PPO. Phr phenotypes and Si7PPO genotypes completely co-segregated in a segregating population. We also analyzed the genetic variation conferring negative Phr reaction. Of 480 accessions of the landraces investigated, 87 (18.1 %) showed positive Phr and 393 (81.9 %) showed negative Phr. In the 393 Phr negative accessions, three types of loss-of-function Si7PPO gene were predominant and independently found in various locations. One of them has an SNP in exon 1 resulting in a premature stop codon and was designated as stop codon type, another has an insertion of a transposon (Si7PPO-TE1) in intron 2 and was designated as TE1-insertion type, and the other has a 6-bp duplication in exon 3 resulting in the duplication of 2 amino acids and was designated as 6-bp duplication type. As a rare variant of the stop codon type, one accession additionally has an insertion of a transposon, Si7PPO-TE2, in intron 2 and was designated as "stop codon +TE2 insertion type". The geographical distribution of accessions with positive Phr and those with three major types of negative Phr was also investigated. Accessions with positive Phr were found in subtropical and tropical regions at frequencies of ca. 25-67 % and those with negative Phr were broadly found in Europe and Asia. The stop codon type was found in 285 accessions and was broadly distributed in Europe and Asia, whereas the TE-1 insertion type was found in 99 accessions from Europe and Asia but was not found in India. The 6-bp duplication type was found in only 8 accessions from Nansei Islands (Okinawa Prefecture) of Japan. We also analyzed Phr in the wild ancestor and concluded that the negative Phr type was likely to have originated after domestication of foxtail millet. It was also implied that negative Phr of foxtail millet arose by multiple independent loss of function of PPO gene through dispersal because of some advantages under some environmental conditions and human selection as in rice and barley.	[Inoue, Takahiko; Ohta, Takeshi; Hitomi, Eriko; Fukunaga, Kenji] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara 7270023, Japan; [Yuo, Takahisa; Taketa, Shin] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Ichitani, Katsuyuki] Kagoshima Univ, Fac Agr, Kagoshima 8908580, Japan; [Kawase, Makoto] NIAS, Genebank, Tsukuba, Ibaraki 3058602, Japan	Fukunaga, K (reprint author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara 7270023, Japan.	fukunaga@pu-hiroshima.ac.jp			NIAS Genebank Project, NIAS, Japan; Visiting Researcher's Program of the Institute of Plant Science and Resources, Okayama University	This work was partially supported by NIAS Genebank Project, NIAS, Japan and by the Visiting Researcher's Program of the Institute of Plant Science and Resources, Okayama University.	MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; KAWASE M, 1987, JPN J BREED, V37, P1; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Eda M, 2013, GENET RESOUR CROP EV, V60, P265, DOI 10.1007/s10722-012-9832-8; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Kim JY, 2001, PLANT SCI, V161, P1145, DOI 10.1016/S0168-9452(01)00522-2; Gu XY, 2004, GENETICS, V166, P1503, DOI 10.1534/genetics.166.3.1503; Kawase M, 2005, MOL GENET GENOMICS, V274, P131, DOI 10.1007/s00438-005-0013-8; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Hirano R, 2011, GENOME, V54, P498, DOI [10.1139/g11-015, 10.1139/G11-015]; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Thipyapong P, 2004, PLANT SCI, V167, P693, DOI 10.1016/j.plantsci.2004.04.008; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; He XY, 2007, THEOR APPL GENET, V115, P47, DOI 10.1007/s00122-007-0539-8; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061; BOSS PK, 1995, PLANT MOL BIOL, V27, P429, DOI 10.1007/BF00020197; DARMENCY H, 1987, PLANT BREEDING, V99, P30, DOI 10.1111/j.1439-0523.1987.tb01146.x; Fukunaga K, 2002, MOL GENET GENOMICS, V268, P214, DOI 10.1007/s00438-002-0728-8; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Gu XY, 2005, GENETICS, V171, P695, DOI 10.1534/genetics.105.043612; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; KAWASE M, 1984, THEOR APPL GENET, V67, P529, DOI 10.1007/BF00264899; KAWASE M, 1982, THEOR APPL GENET, V63, P117, DOI 10.1007/BF00303690; Kihara H, 1942, BOT MAG, V20, P63; LI HW, 1945, J AM SOC AGRON, V37, P32; Nakayama H, 1999, GENES GENET SYST, V74, P293, DOI 10.1266/ggs.74.293; Oka HI, 1953, JPN J BREED, V3, P33; TAKAHASHI N, 1983, JPN J BREED, V33, P243; Takeda K, 1996, EUPHYTICA, V90, P217, DOI 10.1007/BF00023861; Taketa S, 2010, J PSYCHIATR RES, P1; THIPYAPONG P, 1995, PHYTOCHEMISTRY, V40, P673, DOI 10.1016/0031-9422(95)00359-F	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	AUG	2015	290	4					1563	1574		10.1007/s00438-015-1022-x		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CN2JD	WOS:000358246000030		
J	Sato, H; Kato, T; Arawaka, S				Sato, Hiroyasu; Kato, Takeo; Arawaka, Shigeki			Potential of Cellular and Animal Models Based on a Prion-Like Propagation of alpha-Synuclein for Assessing Antiparkinson Agents	MOLECULAR NEUROBIOLOGY			English	Article						Aggregation; alpha-Synuclein; Fibril; Parkinson's disease; Prion; Propagation	MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; LEWY BODY; NONMOTOR SYMPTOMS; CEREBROSPINAL-FLUID; BRAIN PATHOLOGY; TRANSMISSION; MUTATION; MICE; INCLUSIONS	The pathological hallmark of Parkinson's disease (PD) is the loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies (LBs). LBs are intracellular inclusions typically found in these neurons and in noradrenergic neurons of the locus coeruleus in patients with PD. However, LBs can be found more widely in neurons of the olfactory bulb, cerebral cortex, and spinal cord. Additionally, LBs appear in neurons of the cardiac, cutaneous, and intestinal autonomic nervous systems. LBs are composed of fibrillar aggregates of alpha-synuclein (alpha-syn). The widespread distribution of LBs indicates that alpha-syn aggregation occurs in neurons in various areas, supporting the concept that PD is not only a simple movement disorder but also a complex one with nonmotor impairments. However, it is unclear how alpha-syn pathology spreads in the nervous system. Postmortem analyses of patients with PD who received transplants of fetal mesencephalic dopaminergic neurons revealed LB formation in surviving grafts, providing a crucial clue regarding the host-to-graft disease propagation. Recent experiments demonstrated that fibrillar alpha-syn is transferred from neurons to neurons in cellular and animal models, suggesting that fibrillar alpha-syn is repeatedly generated in cells by triggering the continuous conversion of normal soluble species into fibrillar ones. These findings suggest a "prion-like" mechanism for alpha-syn propagation in the pathogenesis of PD. This review summarizes the experimental findings on the prion-like propagation of alpha-syn and discusses the potential of cellular and animal models for testing the protective effects of chemical agents against neurodegeneration in PD.	[Sato, Hiroyasu; Kato, Takeo; Arawaka, Shigeki] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata 9909585, Japan	Arawaka, S (reprint author), Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	arawaka@med.id.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23591230, 26870068]	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 23591230) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.A.) and a Grant-in-Aid for Young Scientists (B) (No. 26870068) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H.S.).	Angot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039465; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Jellinger KA, 2011, J NEUROL SCI, V310, P107, DOI 10.1016/j.jns.2011.04.012; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Hansen C, 2012, TRENDS MOL MED, V18, P248, DOI 10.1016/j.molmed.2012.03.002; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Rey NL, 2013, ACTA NEUROPATHOL, V126, P555, DOI 10.1007/s00401-013-1160-3; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dunning CJR, 2012, PROG NEUROBIOL, V97, P205, DOI 10.1016/j.pneurobio.2011.11.003; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Foulds PG, 2012, NEUROBIOL DIS, V45, P188, DOI 10.1016/j.nbd.2011.08.003; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; Lee Y., 2012, COLD SPRING HARB PER, V2; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; LENNOX G, 1989, J NEUROL NEUROSUR PS, V52, P67, DOI 10.1136/jnnp.52.1.67; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reyes JF, 2013, GLIA, V62, P387; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Russo Isabella, 2012, Am J Neurodegener Dis, V1, P217; Sacino Amanda N, 2013, Acta Neuropathol Commun, V1, P38, DOI 10.1186/2051-5960-1-38; Wang Y., 2012, SCI TRANSL MED, V4	68	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2015	52	1					226	235		10.1007/s12035-014-8858-7		10	Neurosciences	Neurosciences & Neurology	CN3QO	WOS:000358341600021		
J	Maeta, S; Nakauchi, N; Urakawa, H				Maeta, Shun; Nakauchi, Nobumitsu; Urakawa, Hajime			Triharmonic isometric immersions into a manifold of non-positively constant curvature	MONATSHEFTE FUR MATHEMATIK			English	Article						Harmonic map; Triharmonic map; Chen's conjecture; Generalized Chen's conjecture	BIHARMONIC MAPS; HARMONIC MAPS; RIEMANNIAN-MANIFOLDS; MAPPINGS	A triharmonic map is a critical point of the 3-energy in the space of smooth maps between two Riemannian manifolds. We study the generalized Chen's conjecture for a triharmonic isometric immersion into a space form of non-positive constant curvature. We show that if the domain is complete and both the 4-energy of , and the -norm of the tension field , are finite, then such an immersion is minimal.	[Maeta, Shun] Shimane Univ, Div Math, Matsue, Shimane 6908504, Japan; [Nakauchi, Nobumitsu] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan; [Urakawa, Hajime] Tohoku Univ, Inst Int Educ, Sendai, Miyagi 9808576, Japan	Maeta, S (reprint author), Shimane Univ, Div Math, Nishikawatsu 1060, Matsue, Shimane 6908504, Japan.	shun.maeta@gmail.com; nakauchi@yamaguchi-u.ac.jp; urakawa@math.is.tohoku.ac.jp			Japan Society for the Promotion of Science [25887044, 24540213, 25400154]	S. Maeta supported by the Grant-in-Aid for Research Activity Start-up, Japan Society for the Promotion of Science, No. 25887044.; N. Nakauchi supported by the Grant-in-Aid for the Scientific Research (C), Japan Society for the Promotion of Science, No 24540213.; H. Urakawa supported by the Grant-in-Aid for the Scientific Research (C), Japan Society for the Promotion of Science, No 25400154.	YAU ST, 1976, INDIANA U MATH J, V25, P659, DOI 10.1512/iumj.1976.25.25051; Loubeau E, 2007, T AM MATH SOC, V359, P5239, DOI 10.1090/S0002-9947-07-03934-7; Lamm T, 2005, CALC VAR PARTIAL DIF, V22, P421, DOI 10.1007/s00526-004-0283-8; GAFFNEY MP, 1954, ANN MATH, V60, P140, DOI 10.2307/1969703; Baird P, 2010, ADV CALC VAR, V3, P49, DOI 10.1515/ACV.2010.003; Nakauchi N, 2013, RESULTS MATH, V63, P467, DOI 10.1007/s00025-011-0209-7; EELLS J, 1964, AM J MATH, V86, P109, DOI 10.2307/2373037; Ou YL, 2012, MICH MATH J, V61, P531; SCHOEN R, 1976, COMMENT MATH HELV, V51, P333; Loubeau E, 2005, COMPOS MATH, V141, P729, DOI 10.1112/S0010437X04001204; EELLS J, 1988, B LOND MATH SOC, V20, P385, DOI 10.1112/blms/20.5.385; Nakauchi N, 2011, ANN GLOB ANAL GEOM, V40, P125, DOI 10.1007/s10455-011-9249-1; Sasahara T, 2005, PUBL MATH-DEBRECEN, V67, P285; Nakauchi N, 2014, GEOMETRIAE DEDICATA, V169, P263, DOI 10.1007/s10711-013-9854-1; Baird P., 1981, LECT NOTES MATH, V894, P1; Caddeo R., 2001, CONT MATH, V288, P286; Chen B.Y., 1991, SOOCHOW J MATH, V17, P169; Eells J., 1978, B LOND MATH SOC, V10, P1, DOI 10.1112/blms/10.1.1; Eells J., 1983, CBMS AM MATH SOC, V50; Gudmundsson S., BIBLIO HARMONIC MORP; GUOYING JIANG, 2009, NOTE MAT, V28, P209; Ichiyama T., 2009, NOTE MATEMATICA, V28, P233; ICHIYAMA T., 2010, NOTE MAT, V30, P15; Ishihara S., 1975, HOKKAIDO MATH J, V4, P234; Kasue A., 2001, RIEMANNIAN GEOMETRY; Loubeau E, 2010, TOHOKU MATH J, V62, P55; Maeta S., P AM MATH S IN PRESS; Maeta S, 2012, P AM MATH SOC, V140, P1835; MONTALDO S., 2006, REV UNION MAT ARGENT, V47, P1; Nakauchi N., ARXIV13075089V2; Oniciuc C., 2005, PUBL MATH-DEBRECEN, V67, P285; Wang S.B., 1989, J NANCHANG U, V13, P24; Wang ZP, 2011, MATH Z, V269, P917, DOI 10.1007/s00209-010-0766-6; Wood J. C., 2003, HARMONIC MORPHISMS R	34	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-9255	1436-5081		MONATSH MATH	Mon.heft. Math.	AUG	2015	177	4					551	567		10.1007/s00605-014-0713-4		17	Mathematics	Mathematics	CN2QE	WOS:000358266000004		
J	Hirai, Y; Asahata, S; Ainoda, Y; Fujita, T; Miura, H; Hizuka, N; Kikuchi, K				Hirai, Yuji; Asahata, Sayaka; Ainoda, Yusuke; Fujita, Takahiro; Miura, Hitomi; Hizuka, Naomi; Kikuchi, Ken			Candidemia Diagnosed from Peripheral Blood Smear: Case Report and Review of Literature 1954-2013	MYCOPATHOLOGIA			English	Article						Candida parapsilosis; Candidaemia; Peripheral blood smear	BONE-MARROW-TRANSPLANTATION; CANDIDIASIS; FUNGEMIA; PATIENT; PSEUDOHYPHAE; PARAPSILOSIS; TROPICALIS; ALBICANS; YEAST	Yeast with pseudohyphae or those that have been phagocytized by white blood cells are coincidentally found in peripheral blood smears. The clinical diagnostic value and outcome of candidaemia diagnosed from peripheral blood smears (CPBSs) are unclear. A 45-year-old man with diabetes and panhypopituitarism for 20 years received 10 mg of hydrocortisone and 100 mu g of levothyroxine sodium hydrate daily. He has been admitted seven times because of adrenal failure triggered by infections and was admitted for pneumonia. On day 56, some budding yeast was found microscopically in a peripheral blood smear with May-Giemsa staining. Some of them were phagocytized by white blood cells. The two blood cultures yielded Candida parapsilosis. Despite antifungal treatment and removal of an intravenous catheter, on day 98 (42 days after the candidaemia diagnosis), the patient died. We analysed 36 cases including the present case. Almost all CPBS patients (96.5 %, n = 29) were using an intravenous catheter. The most frequently isolated species was C. parapsilosis (35.1 %), followed by C. albicans (29.7 %). The overall mortality rate was 53.6 % (n = 28). The time from the discovery of yeast-like pathogens using peripheral blood smears to death ranged from a few hours to 93 days (median 19 days). The present results suggest that intravenous catheter use and the underlying conditions of patients are responsible for CPBSs. The detection of yeast in peripheral blood smears suggests advanced infections with uncontrollable complications, which means a poor prognosis. Rapid detection methods besides blood culture are needed.	[Hirai, Yuji; Asahata, Sayaka; Ainoda, Yusuke; Fujita, Takahiro; Kikuchi, Ken] Tokyo Womens Med Univ, Dept Infect Dis, Shinjuku Ku, Tokyo 1628666, Japan; [Hirai, Yuji] Tokyo Womens Med Univ, Dept Hematol, Tokyo 1628666, Japan; [Miura, Hitomi] Tokyo Womens Med Univ, Dept Clin Lab, Tokyo 1628666, Japan; [Hizuka, Naomi] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo 1628666, Japan	Hirai, Y (reprint author), Tokyo Womens Med Univ, Dept Infect Dis, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	hirai.yuji@twmu.ac.jp					MONIHAN JM, 1986, ARCH PATHOL LAB MED, V110, P1180; Anaissie EJ, 1998, AM J MED, V104, P238, DOI 10.1016/S0002-9343(98)00030-8; Westblade LF, 2012, BLOOD, V119, P1105, DOI 10.1182/blood-2011-03-343616; Laffler TG, 2013, J CLIN MICROBIOL, V51, P3535, DOI 10.1128/JCM.00876-13; Kim HR, 2008, ANN HEMATOL, V87, P557, DOI 10.1007/s00277-008-0464-1; Wisplinghoff H, 2014, INT J ANTIMICROB AG, V43, P78, DOI 10.1016/j.ijantimicag.2013.09.005; Yera H, 2004, J CLIN PATHOL, V57, P196, DOI 10.1136/jcp.2003.9340; Clancy CJ, 2013, CLIN INFECT DIS, V56, P1284, DOI 10.1093/cid/cit006; GIRMENIA C, 1994, EUR J HAEMATOL, V52, P124; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Berrouane Y, 1998, J CLIN PATHOL, V51, P537; Lesesve JF, 2009, INT J LAB HEMATOL, V31, P572, DOI 10.1111/j.1751-553X.2008.01069.x; Bakshi Sameer, 2003, Indian Pediatr, V40, P903; Branda JA, 2007, ARCH PATHOL LAB MED, V131, P97; BUCHMAN AL, 1988, JAMA-J AM MED ASSOC, V260, P2926, DOI 10.1001/jama.260.19.2926; CATTERMOLE HEJ, 1987, ARCH DIS CHILD, V62, P302; CHAO TY, 1994, BONE MARROW TRANSPL, V14, P647; Cimon BCJ, 1995, J MYCOL MED, V5, P6; FFRENCH G, 1954, CAN MED ASSOC J, V71, P238; Hirotsu M, 2014, LARYNGOSCOPE, V124, pE347, DOI 10.1002/lary.24655; Ikegaya S, 2012, AM J MED SCI, V343, P419, DOI 10.1097/MAJ.0b013e31823f06d6; Inoue M, 2010, JPN J SOC LAB HEMATO, V11, pS81; Kaminami KNK, 2011, RINSHO KETSUEKI, V52, P1749; Kates MMPJB, 1988, LAB MED, V19, P6; KOBZA K, 1977, BRIT MED J, V1, P1640; Liapis K, 2011, CAN MED ASSOC J, V183, P1515, DOI 10.1503/cmaj.101947; Manabe A, 1997, Rinsho Ketsueki, V38, P669; MARSHALL BA, 1990, AM J CLIN PATHOL, V93, P526; Nadir E, 2005, NEW ENGL J MED, V353, pE9, DOI 10.1056/NEJMicm041054; Naidoo Y L, 2008, Br J Haematol, V143, P453, DOI 10.1111/j.1365-2141.2008.07299.x; OSSENKOPPELE GJ, 1988, NETH J MED, V33, P30; Pasqualotto AC, 2009, BRAZ J INFECT DIS, V13, P80, DOI 10.1590/S1413-86702009000100019; Peison B, 1992, N J Med, V89, P382; PORTNOY J, 1971, NEW ENGL J MED, V285, P1010, DOI 10.1056/NEJM197110282851807; ROSTI G, 1990, HAEMATOLOGICA, V75, P480; Saito N, 2005, NISSEKIIGAKU, V57, P140; SILVERMA.EM, 1973, AM J CLIN PATHOL, V60, P473	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-486X	1573-0832		MYCOPATHOLOGIA	Mycopathologia	AUG	2015	180	1-2					111	116		10.1007/s11046-015-9884-3		6	Mycology	Mycology	CN1FW	WOS:000358164600016		
J	Ohnuma, K; Hatano, R; Morimoto, C				Ohnuma, Kei; Hatano, Ryo; Morimoto, Chikao			DPP4 in anti-tumor immunity: going beyond the enzyme	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL FUNCTION; CD26; CANCER; IV	Effective anti-tumor immune therapy in solid tumors relies on the presence of effector T cells. Inhibition of the dipeptidylpeptidase DPP4 (CD26) enhances chemokine CXCL10-mediated infiltration of lymphocytes into the tumor parenchyma, which results in diminished tumor growth.	[Ohnuma, Kei; Hatano, Ryo; Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan	Ohnuma, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan.	morimoto@ims.u-tokyo.ac.jp					Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Shi Z, 2009, EUR J IMMUNOL, V39, P2106, DOI 10.1002/eji.200939314; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Davies S, 2015, BIOMED PHARMACOTHER, V71, P135, DOI 10.1016/j.biopha.2015.02.031; Hatano R, 2015, J IMMUNOL, V194, P960, DOI 10.4049/jimmunol.1402143; Herrmann H, 2014, BLOOD, V123, P3951, DOI 10.1182/blood-2013-10-536078; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					791	792		10.1038/ni.3210		2	Immunology	Immunology	CN3BT	WOS:000358299200002		
J	Nakayama, M; Ishida, M; Ogihara, M; Hanaoka, K; Tamura, M; Kanai, H; Tonozuka, Y; Marshall, MR				Nakayama, Masaaki; Ishida, Mari; Ogihara, Masahiko; Hanaoka, Kazushige; Tamura, Masahito; Kanai, Hidetoshi; Tonozuka, Yukio; Marshall, Mark R.			Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: A multi-centre survey of Japanese patients	NEPHROLOGY			English	Article						employment; haemodialysis; income; peritoneal dialysis; working hours	FACTORS AFFECTING EMPLOYMENT; SF-36 HEALTH SURVEY; HEMODIALYSIS-PATIENTS; WORK	AimPatient socialization and preservation of socioeconomic status are important patient-centred outcomes for those who start dialysis, and retention of employment is a key enabler. This study examined the influence of dialysis inception and modality upon these outcomes in a contemporary Japanese cohort. MethodsWe conducted a survey of prevalent chronic dialysis patients from 5 dialysis centres in Japan. All patients who had been on peritoneal dialysis (PD) since dialysis inception were recruited, and matched with a sample of those on in-centre haemodialysis (ICHD). We assessed patients' current social functioning (Short Form 36 Health Survey), and evaluated changes to patient employment status, annual income, and general health condition from the pre-dialysis period to the current time. ResultsA total of 179 patients were studied (102 PD and 77 ICHD). There were no differences in social functioning by modality. Among them, 113 were employed in the pre-dialysis period with no difference by modality. Of these, 22% became unemployed after dialysis inception, with a corresponding decline in average working hours and annual income. The odds of unemployment after dialysis inception were 5.02 fold higher in those on ICHD compared to those on PD, after adjustment for covariates. There were no changes for those who were already unemployed in the pre-dialysis period. ConclusionsEmployment status is significantly hampered by dialysis inception, although PD was associated with superior retention of employment and greater income compared to ICHD. This supports a positive role for PD in preservation of socioeconomic status and potentially other patient-centred outcomes. Summary at a Glance This study looked at the socioeconomic outcomes in patients who are started on renal replacement therapy in Japan. It also compared the effect that differing dialysis modality has on these outcomes and suggested a superior effect of peritoneal dialysis.	[Nakayama, Masaaki] Fukushima Med Univ, Dept Hypertens & Nephrol, Sch Med, Fukushima, Japan; [Ishida, Mari] Kitasaito Hosp, Nephrol, Asahikawa, Hokkaido, Japan; [Ogihara, Masahiko] Ogihara Hinyouki Me No Clin, Nephrol, Fukushima, Japan; [Hanaoka, Kazushige] Tokyo Jikei Univ, Nephrol, Sch Med, Tokyo, Japan; [Tamura, Masahito] Univ Occupat & Environm Hlth, Nephrol, Fukuoka, Japan; [Kanai, Hidetoshi] Kokura Mem Hosp, Nephrol, Fukuoka, Japan; [Tonozuka, Yukio] Baxter Ltd, Clin Dev & Med Afairs, Tokyo, Japan; [Marshall, Mark R.] Baxter Healthcare Asia Pacific, Med Affairs, Auckland, New Zealand	Nakayama, M (reprint author), Fukushima Univ, Sch Med, Dept Hypertens & Nephrol, Hikarigaoka 1, Fukushima, Fukushima 9601295, Japan.	masanaka@fmu.ac.jp			Baxter Healthcare Japan	MN, MI, MO, HK, KH, and MT have no conflicts of interest to declare. YT is an employee of Baxter Healthcare Japan, and MM is an employee of Baxter Healthcare Asia-Pacific. Funding for this study was provided by Baxter Healthcare Japan. We acknowledge the help of Anders Tranaeus in reviewing the manuscript, and the assistance of Naoki Hoshi and Koki Kabu in statistical analysis.	GUTMAN RA, 1981, NEW ENGL J MED, V304, P309, DOI 10.1056/NEJM198102053040601; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Muehrer RJ, 2011, CLIN J AM SOC NEPHRO, V6, P489, DOI 10.2215/CJN.02550310; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Liem YS, 2007, VALUE HEALTH, V10, P390, DOI 10.1111/j.1524-4733.2007.00193.x; Jaber BL, 2010, AM J KIDNEY DIS, V56, P531, DOI 10.1053/j.ajkd.2010.04.019; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Curtin RB, 1996, AM J KIDNEY DIS, V27, P533, DOI 10.1016/S0272-6386(96)90164-X; Fukuhara S, 2004, MANUAL SF 36V2 JAPAN; HOLLEY JL, 1994, AM J KIDNEY DIS, V23, P681; IFUDU O, 1994, AM J KIDNEY DIS, V23, P394; Kutner N, 2008, CLIN J AM SOC NEPHRO, V3, P111, DOI 10.2215/CJN.02990707; KUTNER NG, 1991, AM J NEPHROL, V11, P334, DOI 10.1159/000168333; Molsted S, 2004, SCAND J UROL NEPHROL, V38, P174, DOI 10.1080/00365590310020015; Rasgon S, 1997, Adv Ren Replace Ther, V4, P152; THEORELL T, 1991, J INTERN MED, V230, P501; vansManen JG, 2001, PERITON DIALYSIS INT, V21, P595	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	AUG	2015	20	8					523	530		10.1111/nep.12482		8	Urology & Nephrology	Urology & Nephrology	CN5ED	WOS:000358451700003		
J	Tanaka, N; Babazono, T; Takagi, M; Yoshida, N; Toya, K; Nyumura, I; Hanai, K; Uchigata, Y				Tanaka, Nobue; Babazono, Tetsuya; Takagi, Michino; Yoshida, Naoshi; Toya, Kiwako; Nyumura, Izumi; Hanai, Ko; Uchigata, Yasuko			Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients	NEPHROLOGY			English	Article						albuminuria; diabetes; diabetic nephropathy; estimated glomerular filtration rate	CHRONIC KIDNEY-DISEASE; JAPANESE PATIENTS; FUNCTION DECLINE; PIMA-INDIANS; ALL-CAUSE; MORTALITY; MELLITUS; RISK; NEPHROPATHY; PROGRESSION	AimThe first clinical manifestation of diabetic kidney disease is usually the development of microalbuminuria. However, recent studies have focused on diabetic patients with reduced glomerular filtration rate (GFR) without albuminuria. To evaluate the association of albuminuria and GFR with renal outcomes, we performed an observational study. MethodsA total of 3231 type 2 diabetic patients were included in this study between 2003 and 2005. There were 1249 women and the mean age was 5912 years. The renal endpoints were defined as the initiation of renal replacement therapy (RRT) or 50% reduction from the baseline of estimated GFR (eGFR). ResultsAt baseline, 669 (20.7%) patients had eGFR <60mL/min per 1.73m(2) and 1134 (35.1%) had albuminuria. During the mean follow-up period of 5.91.6 years, 107 patients initiated RRT. A 50% reduction of eGFR from the baseline value was found in 279 patients. None of the normoalbuminuric subjects with or without reduced eGFR required RRT during the observational period (P<0.01). Compared to normoalbuminuria patients with eGFR 60mL/min per 1.73m(2) at baseline, the group of normoalbuminuria patients with reduced eGFR had a 2.5-fold risk of developing the renal endpoints, (95% confidence interval (CI): 1.0-6.3, P=0.053). Patients with microalbuminuria with eGFR 60mL/min per 1.73m(2) at baseline had a 5.0-fold risk of developing the evaluated renal endpoints (95% CI: 2.8-8.8, P<0.001). ConclusionAlbuminuria was a significant predictor for the evaluated renal endpoints, but the impact of eGFR is likely to be less than that of albuminuria. Summary at a Glance This paper examines renal outcomes (as defined by initiation of renal replacement therapy or 50% reduction in eGFR) in over 3000 Japanese patients followed-up for nearly 6 years, demonstrating low progression to ESKD in the absence of albuminuria, but an elevated risk of mortality. This is an interesting study highlighting the prognostic importance of albuminuria in a Japanese population.	[Tanaka, Nobue; Babazono, Tetsuya; Takagi, Michino; Yoshida, Naoshi; Toya, Kiwako; Nyumura, Izumi; Hanai, Ko; Uchigata, Yasuko] Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Tokyo 1628666, Japan	Tanaka, N (reprint author), Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	nobuetan.dmc@twmu.ac.jp					ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Penno G, 2011, J HYPERTENS, V29, P1802, DOI 10.1097/HJH.0b013e3283495cd6; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Pavkov ME, 2012, CLIN J AM SOC NEPHRO, V7, P78, DOI 10.2215/CJN.07610711; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Hotta N, 2010, J DIABETES INVEST, V1, P66, DOI 10.1111/j.2040-1124.2010.00019.x; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Babazono T, 2009, DIABETES CARE, V32, P1518, DOI 10.2337/dc08-2151; Wada T, 2014, CLIN EXP NEPHROL, V18, P613, DOI 10.1007/s10157-013-0879-4; Ito H, 2010, NEPHROL DIAL TRANSPL, V25, P1161, DOI 10.1093/ndt/gfp579; Whaley-Connell A, 2012, AM J MED, V125, P661, DOI 10.1016/j.amjmed.2011.11.026; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Berhane AM, 2011, CLIN J AM SOC NEPHRO, V6, P2444, DOI 10.2215/CJN.00580111; Levey AS, 2003, ANN INTERN MED, V139, P137; Rigalleau V, 2007, DIABETES CARE, V30, P2034, DOI 10.2337/dc07-0140; Chaturvedi N, 2001, KIDNEY INT, V60, P219, DOI 10.1046/j.1523-1755.2001.00789.x; KUNZELMAN CL, 1989, KIDNEY INT, V35, P681, DOI 10.1038/ki.1989.39; Nag S, 2007, DIABETIC MED, V24, P10, DOI 10.1111/j.1464-5491.2007.02023.x; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Toyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071810; Wirta O, 2000, NEPHRON, V84, P236, DOI 10.1159/000045583	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	AUG	2015	20	8					531	538		10.1111/nep.12446		8	Urology & Nephrology	Urology & Nephrology	CN5ED	WOS:000358451700004		
J	Tashiro, S; Shinozaki, M; Mukaino, M; Renault-Mihara, F; Toyama, Y; Liu, MG; Nakamura, M; Okano, H				Tashiro, Syoichi; Shinozaki, Munehisa; Mukaino, Masahiko; Renault-Mihara, Francois; Toyama, Yoshiaki; Liu, Meigen; Nakamura, Masaya; Okano, Hideyuki			BDNF Induced by Treadmill Training Contributes to the Suppression of Spasticity and Allodynia After Spinal Cord Injury via Upregulation of KCC2	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain-derived neurotrophic factor; KCC2; phospholipase C; spinal cord injury; spasticity; allodynia	POTASSIUM-CHLORIDE COTRANSPORTER; RAT-CORTICAL-NEURONS; NEUROTROPHIC FACTOR; DORSAL-HORN; NEUROPATHIC PAIN; DOWN-REGULATION; GABAERGIC INHIBITION; FUNCTIONAL RECOVERY; LOCOMOTOR RECOVERY; EXPRESSION	Background. Spasticity and allodynia are major sequelae that affect the quality of life and daily activities of spinal cord injury (SCI) patients. Although rehabilitation ameliorates spasticity and allodynia, the molecular mechanisms involved in these processes remain elusive. Objective. To investigate the molecular mechanisms by which rehabilitation ameliorates spasticity and allodynia after SCI in rats. Methods. The expression levels of brain-derived neurotrophic factor (BDNF) and potassium-chloride cotransporter-2 (KCC2), as well as the localization of KCC2, were examined in the lumbar enlargements of untrained and treadmill-trained thoracic SCI model rats. Spasticity and allodynia were determined via behavioral and electrophysiological analyses. The effects of BDNF on spasticity, allodynia, and KCC2 activation were determined by inhibition of BDNF signaling via intrathecal administration of TrkB-IgG. The effects of SCI and training on the expression levels of functional phospholipase C- in the lumbar enlargement were also examined. Results. Treadmill training after SCI upregulated endogenous BDNF expression and posttranslational modification of KCC2 in the lumbar enlargement significantly. There were also significant correlations between increased KCC2 expression and ameliorated spasticity and allodynia. Administration of TrkB-IgG abrogated the training-induced upregulation of KCC2 and beneficial effects on spasticity and allodynia. The expression level of functional phospholipase C- was reduced significantly after SCI, which may have contributed to the change in the function of BDNF, whereby it did not trigger short-term downregulation or induce long-term upregulation of KCC2 expression secondary to training. Conclusions. BDNF-mediated restoration of KCC2 expression underlies the suppression of spasticity and allodynia caused by rehabilitation.	[Tashiro, Syoichi; Liu, Meigen] Keio Univ, Dept Rehabil Med, Sch Med, Tokyo 1608582, Japan; [Shinozaki, Munehisa; Renault-Mihara, Francois; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Tokyo 1608582, Japan; [Mukaino, Masahiko] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1608582, Japan	Okano, H (reprint author), Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Okano, Hideyuki/J-5973-2013		Japan Science and Technology-California Institute for Regenerative Medicine collaborative program; Japan Society for the Promotion of Science (SPS); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Project for Realization of Regenerative Medicine; MEXT; Keio Gijuku Academic by Comprehensive Brain Science Network from MEXT; General Insurance Association of Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the following organizations: the Japan Science and Technology-California Institute for Regenerative Medicine collaborative program; the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (SPS) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Project for Realization of Regenerative Medicine; the Support for Core Institutes for iPS Cell Research from MEXT; the Keio Gijuku Academic by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from MEXT; and the General Insurance Association of Japan.	Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Arion D, 2011, ARCH GEN PSYCHIAT, V68, P21, DOI 10.1001/archgenpsychiatry.2010.114; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; GIBSON SJ, 1984, J NEUROSCI, V4, P3101; Romero MI, 2000, J NEUROSCI, V20, P4435; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Berryman ER, 2009, J MUSCULOSKEL NEURON, V9, P89; Wu JF, 2013, J NEUROSCI, V33, P12447, DOI 10.1523/JNEUROSCI.0846-13.2013; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Martinez M, 2013, J NEUROPHYSIOL, V109, P2909, DOI 10.1152/jn.01044.2012; Morgado C, 2008, NEUROSCI LETT, V438, P102, DOI 10.1016/j.neulet.2008.04.032; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Nabekura J, 2002, J NEUROSCI, V22, P4412; Carmona MA, 2006, CEREB CORTEX, V16, P47, DOI 10.1093/cercor/bhi083; Lu Y, 2008, J PHYSIOL-LONDON, V586, P5701, DOI 10.1113/jphysiol.2008.152348; Renault-Mihara F, 2011, EMBO MOL MED, V3, P682, DOI 10.1002/emmm.201100179; Morawietz C, 2013, ARCH PHYS MED REHAB, V94, P2297, DOI 10.1016/j.apmr.2013.06.023; Alluin O, 2011, J NEUROTRAUM, V28, P1963, DOI 10.1089/neu.2011.1840; Lever I, 2003, EUR J NEUROSCI, V18, P1169, DOI 10.1046/j.1460-9568.2003.02848.x; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Lee JK, 2005, EXP NEUROL, V196, P430, DOI 10.1016/j.expneurol.2005.08.018; Rivera C, 1999, NATURE, V397, P251; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; Brown AK, 2011, SPINAL CORD, V49, P623, DOI 10.1038/sc.2010.167; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; Di Loreto S, 2009, J CELL PHYSIOL, V219, P334, DOI 10.1002/jcp.21674; Drew GM, 2004, PAIN, V109, P379, DOI 10.1016/j.pain.2004.02.007; Endo T, 2009, BIOCHEM BIOPH RES CO, V381, P339, DOI 10.1016/j.bbrc.2009.02.043; Furmaga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034844; Gajewska-Wozniak O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065937; GAO BX, 1995, J NEUROPHYSIOL, V74, P113; Garrison MK, 2011, EXP NEUROL, V227, P104, DOI 10.1016/j.expneurol.2010.09.019; Johnson WL, 2012, J NEUROSCI METH, V206, P65, DOI 10.1016/j.jneumeth.2012.02.008; Kitamura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027706; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130; WIDMER HR, 1993, J NEUROCHEM, V60, P2111, DOI 10.1111/j.1471-4159.1993.tb03496.x; Ziemlinska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088833	68	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	AUG	2015	29	7					677	689		10.1177/1545968314562110		13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CN3GS	WOS:000358314200009		
J	Chen, C; Takahashi, T; Nakagawa, S; Inoue, T; Kusumi, I				Chen, Chong; Takahashi, Taiki; Nakagawa, Shin; Inoue, Takeshi; Kusumi, Ichiro			Reinforcement learning in depression: A review of computational research	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Review						Anhedonia; Computational psychiatry; Depression; Dopamine; Incentive salience; Learning rate; 'Liking'; Model-free; Model-based; Motivation; Prediction error; Reinforcement learning; Reward sensitivity; Stress; 'Wanting'	DEEP BRAIN-STIMULATION; TREATMENT-RESISTANT DEPRESSION; VENTRAL TEGMENTAL AREA; TRANSCRANIAL MAGNETIC STIMULATION; O-METHYLTRANSFERASE COMT; MEDIAL PREFRONTAL CORTEX; ERROR-RELATED NEGATIVITY; DORSAL RAPHE NUCLEUS; VESICULAR NEUROTRANSMITTER TRANSPORTERS; BEHAVIORAL ACTIVATION TREATMENTS	Despite being considered primarily a mood disorder, major depressive disorder (MDD) is characterized by cognitive and decision making deficits. Recent research has employed computational models of reinforcement learning (RL) to address these deficits. The computational approach has the advantage in making explicit predictions about learning and behavior, specifying the process parameters of RL, differentiating between model-free and model-based RL, and the computational model-based functional magnetic resonance imaging and electroencephalography. With these merits there has been an emerging field of computational psychiatry and here we review specific studies that focused on MDD. Considerable evidence suggests that MDD is associated with impaired brain signals of reward prediction error and expected value ('wanting'), decreased reward sensitivity ('liking') and/or learning (be it model-free or model-based), etc., although the causality remains unclear. These parameters may serve as valuable intermediate phenotypes of MDD, linking general clinical symptoms to underlying molecular dysfunctions. We believe future computational research at clinical, systems, and cellular/molecular/genetic levels will propel us toward a better understanding of the disease. (C) 2015 Elsevier Ltd. All rights reserved.	[Chen, Chong; Nakagawa, Shin; Inoue, Takeshi; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido 0608638, Japan; [Takahashi, Taiki] Hokkaido Univ, Dept Behav Sci, Ctr Expt Res Social Sci, Sapporo, Hokkaido 0600810, Japan	Chen, C (reprint author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	cchen@med.hokudai.ac.jp	Chen, Chong/F-7448-2015	Chen, Chong/0000-0002-3189-7397	Ministry of Education, Culture, Sports, Science and Technology of Japan [23118001]	The authors thank three anonymous reviewers for their thoughtful comments and suggestions to improve the earlier manuscript. The authors are grateful to Peter Dayan, Kent C. Berridge, Minori Koga, and Yukiko Ogura for their valuable discussions and/or comments. The authors also thank Alexandre Y. Dombrovski for answering questions about their research. The research reported in this paper was supported by a grant from the Grant-in-Aid for Scientific Research (Global COE and on Innovative Areas, 23118001; Adolescent Mind and Self-Regulation) to T.T. from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aggarwal M, 2012, EUR J NEUROSCI, V35, P1115, DOI 10.1111/j.1460-9568.2012.08055.x; Ainsworth K, 1998, PSYCHOPHARMACOLOGY, V140, P470, DOI 10.1007/s002130050791; Alexander WH, 2010, NEURAL COMPUT, V22, P1511, DOI 10.1162/neco.2010.08-09-1080; American Psychiatric Association, 2014, DIAGN STAT MAN MENT; Amsterdam JD, 2012, J AFFECT DISORDERS, V141, P425, DOI 10.1016/j.jad.2012.03.007; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Hamani C, 2012, BIOL PSYCHIAT, V71, P30, DOI 10.1016/j.biopsych.2011.08.025; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Chase HW, 2010, PSYCHOL MED, V40, P433, DOI 10.1017/S0033291709990468; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Forbes EE, 2012, J CHILD PSYCHOL PSYC, V53, P3, DOI 10.1111/j.1469-7610.2011.02477.x; Polter AM, 2014, EUR J NEUROSCI, V39, P1179, DOI 10.1111/ejn.12490; Treadway MT, 2013, CURR DIR PSYCHOL SCI, V22, P244, DOI 10.1177/0963721412474460; Bershad AK, 2015, PSYCHONEUROENDOCRINO, V52, P281, DOI 10.1016/j.psyneuen.2014.12.004; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Kumar P, 2008, BRAIN, V131, P2084, DOI 10.1093/brain/awn136; Bahi A, 2014, PHYSIOL BEHAV, V135, P119, DOI 10.1016/j.physbeh.2014.06.003; Kato M, 2013, CNS DRUGS, V27, pS11, DOI 10.1007/s40263-012-0029-7; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Dombrovski AY, 2013, JAMA PSYCHIAT, V70, P1020, DOI 10.1001/jamapsychiatry.2013.75; Walsh MM, 2012, NEUROSCI BIOBEHAV R, V36, P1870, DOI 10.1016/j.neubiorev.2012.05.008; Finberg JPM, 2014, PHARMACOL THERAPEUT, V143, P133, DOI 10.1016/j.pharmthera.2014.02.010; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Dombrovski AY, 2011, BIOL PSYCHIAT, V70, P138, DOI 10.1016/j.biopsych.2010.12.025; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Rive MM, 2013, NEUROSCI BIOBEHAV R, V37, P2529, DOI 10.1016/j.neubiorev.2013.07.018; Franco-Chaves JA, 2013, J AFFECT DISORDERS, V149, P319, DOI 10.1016/j.jad.2013.02.003; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Riesel A, 2012, PSYCHOPHYSIOLOGY, V49, P239, DOI 10.1111/j.1469-8986.2011.01298.x; Morgan JK, 2013, NEUROBIOL DIS, V52, P66, DOI 10.1016/j.nbd.2012.03.039; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Winter C, 2007, BEHAV BRAIN RES, V184, P133, DOI 10.1016/j.bbr.2007.07.002; Bergfeld IO, 2013, BRAIN STIMUL, V6, P532, DOI 10.1016/j.brs.2013.01.003; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Parker G, 2002, AM J PSYCHIAT, V159, P1470, DOI 10.1176/appi.ajp.159.9.1470; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; Garcia-Gutierrez MS, 2010, BRIT J PHARMACOL, V160, P1773, DOI 10.1111/j.1476-5381.2010.00819.x; Neimat JS, 2008, AM J PSYCHIAT, V165, P687, DOI 10.1176/appi.ajp.2008.07081298; Vrieze E, 2013, BIOL PSYCHIAT, V73, P639, DOI 10.1016/j.biopsych.2012.10.014; Wayment HK, 2001, J NEUROSCI, V21, P35; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; KARHUNEN T, 1995, NEUROSCI LETT, V187, P57, DOI 10.1016/0304-3940(95)11337-V; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Puigdemont D, 2012, INT J NEUROPSYCHOPH, V15, P121, DOI 10.1017/S1461145711001088; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Akiskal HS, 2005, J AFFECT DISORDERS, V84, P209, DOI 10.1016/j.jad.2004.05.004; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Dayan P, 2009, NEURAL NETWORKS, V22, P213, DOI 10.1016/j.neunet.2009.03.004; Sherdell L, 2012, J ABNORM PSYCHOL, V121, P51, DOI 10.1037/a0024945; Bali A, 2015, NEUROSCI BIOBEHAV R, V51, P138, DOI 10.1016/j.neubiorev.2014.12.018; Novick AM, 2011, BRAIN RES BULL, V86, P123, DOI 10.1016/j.brainresbull.2011.06.009; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037//0003-066X.35.2.151; SCHULDINER S, 1995, PHYSIOL REV, V75, P369; Liljeholm M, 2012, TRENDS COGN SCI, V16, P467, DOI 10.1016/j.tics.2012.07.007; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Sharp C, 2012, BIOL PSYCHIAT, V72, P87, DOI 10.1016/j.biopsych.2012.02.029; Rogoz Z, 2013, PHARMACOL REP, V65, P1535; Fan Y, 2013, SYNAPSE, V67, P300, DOI 10.1002/syn.21641; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; Kennedy SH, 2011, AM J PSYCHIAT, V168, P502, DOI 10.1176/appi.ajp.2010.10081187; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Steele JD, 2007, BRAIN, V130, P2367, DOI 10.1093/brain/awm150; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Blier P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0536; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Chiuccariello L, 2014, NEUROPSYCHOPHARMACOL, V39, P973, DOI 10.1038/npp.2013.297; Walsh JJ, 2014, NEUROSCIENCE, V282, P101, DOI 10.1016/j.neuroscience.2014.06.006; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Maddox WT, 2014, CORTEX, V58, P186, DOI 10.1016/j.cortex.2014.06.013; Downar J, 2014, BIOL PSYCHIAT, V76, P176, DOI 10.1016/j.biopsych.2013.10.026; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Chatham CH, 2014, NEURON, V81, P930, DOI 10.1016/j.neuron.2014.01.002; Smittenaar P, 2013, NEURON, V80, P914, DOI 10.1016/j.neuron.2013.08.009; Vaidyanathan U, 2012, PSYCHOL MED, V42, P447, DOI 10.1017/S0033291711001528; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; Zhang WN, 2013, J AFFECT DISORDERS, V151, P531, DOI 10.1016/j.jad.2013.06.039; Gazit T, 2015, NEUROPHARMACOLOGY, V91, P135, DOI 10.1016/j.neuropharm.2014.12.003; Chamberlain SR, 2013, J PSYCHOPHARMACOL, V27, P694, DOI 10.1177/0269881113480988; Costa VD, 2015, J NEUROSCI, V35, P2407, DOI 10.1523/JNEUROSCI.1989-14.2015; Han RK, 2012, PHYSICA A, V391, P6568, DOI 10.1016/j.physa.2012.07.012; Berlim MT, 2013, PSYCHOL MED, V43, P2245, DOI 10.1017/S0033291712002802; Sharot T, 2012, CURR BIOL, V22, P1477, DOI 10.1016/j.cub.2012.05.053; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Burokas A, 2014, J NEUROCHEM, V130, P126, DOI 10.1111/jnc.12716; Jackson F, 2015, EMOTION, V15, P12, DOI 10.1037/emo0000020; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; Rea E, 2014, BRAIN STIMUL, V7, P21, DOI 10.1016/j.brs.2013.09.002; Wright BM, 2013, PHARMACOTHERAPY, V33, P344, DOI 10.1002/phar.1204; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Sinclair D, 2014, PSYCHOPHARMACOLOGY, V231, P1581, DOI 10.1007/s00213-013-3415-z; Santiago RM, 2014, BEHAV BRAIN RES, V259, P70, DOI 10.1016/j.bbr.2013.10.035; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; de Wit S, 2012, J NEUROSCI, V32, P12066, DOI 10.1523/JNEUROSCI.1088-12.2012; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Dzirasa K, 2012, ANN NY ACAD SCI, V1265, P36, DOI 10.1111/j.1749-6632.2012.06669.x; Veerakumar A, 2014, BIOL PSYCHIAT, V76, P203, DOI 10.1016/j.biopsych.2013.12.009; Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Trew JL, 2011, CLIN PSYCHOL REV, V31, P1156, DOI 10.1016/j.cpr.2011.07.007; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI [10.1196/annals.1432.036, 10.1196/annals.11432.036]; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037//0003-066X.49.8.709; Haber SN, 2014, NEUROSCIENCE, V282, P248, DOI 10.1016/j.neuroscience.2014.10.008; Schmuckermair C, 2013, NEUROPSYCHOPHARMACOL, V38, P1234, DOI 10.1038/npp.2013.21; Yetnikoff L, 2014, NEUROSCIENCE, V282, P23, DOI 10.1016/j.neuroscience.2014.04.010; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Paulus MP, 2012, TRENDS COGN SCI, V16, P476, DOI 10.1016/j.tics.2012.07.009; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Gorzalka BB, 2011, PROG NEURO-PSYCHOPH, V35, P1575, DOI 10.1016/j.pnpbp.2010.11.021; Cassano P, 2004, DEPRESS ANXIETY, V20, P131, DOI 10.1002/da.20038; Gersner R, 2010, BIOL PSYCHIAT, V67, P125, DOI 10.1016/j.biopsych.2009.09.015; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; Chowdhury R, 2013, NAT NEUROSCI, V16, P648, DOI 10.1038/nn.3364; Laasonen-Balk T, 1999, PSYCHOPHARMACOLOGY, V144, P282, DOI 10.1007/s002130051005; Robinson OJ, 2013, P NATL ACAD SCI USA, V110, P4129, DOI 10.1073/pnas.1213923110; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; Li Y, 2015, BEHAV BRAIN RES, V279, P100, DOI 10.1016/j.bbr.2014.11.016; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Garrison J, 2013, NEUROSCI BIOBEHAV R, V37, P1297, DOI 10.1016/j.neubiorev.2013.03.023; Chase HW, 2015, COGN AFFECT BEHAV NE, V15, P435, DOI 10.3758/s13415-015-0338-7; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dombrovski AY, 2010, AM J PSYCHIAT, V167, P699, DOI 10.1176/appi.ajp.2009.09030407; Forbes EE, 2010, COGN AFFECT BEHAV NE, V10, P107, DOI 10.3758/CABN.10.1.107; Gaynes BN, 2014, J CLIN PSYCHIAT, V75, P477, DOI 10.4088/JCP.13r08815; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Moraga-Amaro R, 2014, BEHAV BRAIN RES, V274, P186, DOI 10.1016/j.bbr.2014.07.055; Schilstrom B, 2011, SYNAPSE, V65, P357, DOI 10.1002/syn.20853; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Kennedy SE, 2006, ARCH GEN PSYCHIAT, V63, P1199, DOI 10.1001/archpsyc.63.11.1199; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Antypa N, 2013, NEUROSCI BIOBEHAV R, V37, P1597, DOI 10.1016/j.neubiorev.2013.06.006; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Haber SN, 2014, NEURON, V83, P1019, DOI 10.1016/j.neuron.2014.08.031; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Friedman A, 2009, NEUROPSYCHOPHARMACOL, V34, P1057, DOI 10.1038/npp.2008.177; Favier M, 2014, MOVEMENT DISORD, V29, P912, DOI 10.1002/mds.25837; Deakin JFW, 2013, J PSYCHOPHARMACOL, V27, P1084, DOI 10.1177/0269881113503508; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Takahashi T, 2008, NEUROENDOCRINOL LETT, V29, P351; WILLNER P, 1991, PSYCHOBIOLOGY, V19, P79; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8984.2005.00270.x; Zubieta JK, 2003, ARCH GEN PSYCHIAT, V60, P1145, DOI 10.1001/archpsyc.60.11.1145; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Agrawal A, 2012, ARCH GEN PSYCHIAT, V69, P732, DOI 10.1001/archgenpsychiatry.2011.2273; Otto AR, 2013, P NATL ACAD SCI USA, V110, P20941, DOI 10.1073/pnas.1312011110; Schwabe L, 2013, HIPPOCAMPUS, V23, P1035, DOI 10.1002/hipo.22175; Thase ME, 2009, NEUROPSYCHOPHARMACOL, V34, P2633, DOI 10.1038/npp.2009.100; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Hill MN, 2008, J NEUROCHEM, V106, P2322, DOI 10.1111/j.1471-4159.2008.05567.x; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Radenbach C, 2015, PSYCHONEUROENDOCRINO, V53, P268, DOI 10.1016/j.psyneuen.2014.12.017; Valverde O, 2012, NEUROSCIENCE, V204, P193, DOI 10.1016/j.neuroscience.2011.09.031; Kanter JW, 2010, CLIN PSYCHOL REV, V30, P608, DOI 10.1016/j.cpr.2010.04.001; McDannald MA, 2014, NEUROBIOL LEARN MEM, V108, P22, DOI 10.1016/j.nlm.2013.06.003; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Lutz PE, 2013, TRENDS NEUROSCI, V36, P195, DOI 10.1016/j.tins.2012.11.002; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; Stephan KE, 2014, CURR OPIN NEUROBIOL, V25, P85, DOI 10.1016/j.conb.2013.12.007; McNeely HE, 2008, J NERV MENT DIS, V196, P405, DOI 10.1097/NMD.0b013e3181710927; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Bogdan R, 2013, NEUROBIOL DIS, V52, P12, DOI 10.1016/j.nbd.2012.05.007; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Ullsperger M, 2014, PHYSIOL REV, V94, P35, DOI 10.1152/physrev.00041.2012; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037//0033-295X.109.4.679; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Van't Veer A, 2013, PSYCHOPHARMACOLOGY, V229, P435, DOI 10.1007/s00213-013-3195-5; Kerestes R, 2014, NEUROIMAGE-CLIN, V4, P209, DOI 10.1016/j.nicl.2013.11.009; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Berton O, 2012, SCIENCE, V338, P75, DOI 10.1126/science.1222940; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Belzung C, 2014, PHARMACOL BIOCHEM BE, V122, P144, DOI 10.1016/j.pbb.2014.04.002; Bress JN, 2013, PSYCHOPHYSIOLOGY, V50, P74, DOI 10.1111/j.1469-8986.2012.01485.x; Berlim MT, 2014, PSYCHOL MED, V44, P225, DOI 10.1017/S0033291713000512; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; O'Doherty JP, 2011, ANN NY ACAD SCI, V1239, P118, DOI 10.1111/j.1749-6632.2011.06290.x; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Domschke K, 2008, EUR NEUROPSYCHOPHARM, V18, P751, DOI 10.1016/j.euroneuro.2008.05.003; Starcke K, 2012, NEUROSCI BIOBEHAV R, V36, P1228, DOI 10.1016/j.neubiorev.2012.02.003; Tye KM, 2014, NEURON, V83, P1259, DOI 10.1016/j.neuron.2014.08.022; Lee D, 2013, NEURON, V78, P233, DOI 10.1016/j.neuron.2013.04.008; Huys QJM, 2011, NEURAL NETWORKS, V24, P544, DOI 10.1016/j.neunet.2011.03.001; Bornstein AM, 2012, EUR J NEUROSCI, V35, P1011, DOI 10.1111/j.1460-9568.2011.07920.x; DICKINSON A, 1985, Q J EXP PSYCHOL-B, V37, P397; Quelhas AC, 2008, CLIN PSYCHOL PSYCHOT, V15, P352, DOI 10.1002/cpp.593; Chernoloz O, 2012, J PSYCHIATR NEUROSCI, V37, P113, DOI 10.1503/jpn.110038; Aouizerate B, 2009, J NEUROSURG, V111, P775, DOI 10.3171/2009.2.JNS0881; Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; Balleine B.W., 2010, NEUROPSYCHOPHARMACOL, V5, P48; Bannon MJ, 2005, TOXICOL APPL PHARM, V204, P355, DOI 10.1016/j.taap.2004.08.013; Baskin-Sommers A.R., 2015, INT J PSYCHOPHYSIOL; Beck AT, 2009, DEPRESSION: CAUSES AND TREATMENT, SECOND EDITION, P1; Belujon P, 2014, BIOL PSYCHIAT, V76, P927, DOI 10.1016/j.biopsych.2014.04.014; Belzung C, 2015, CURR OPIN NEUROBIOL, V30, P24, DOI 10.1016/j.conb.2014.08.013; Berg B.A., 2014, EUR J NEUROSCI; Berridge K. C., 2014, NEUROECONOMICS DECIS, P335; Blanco NJ, 2013, COGNITION, V129, P563, DOI 10.1016/j.cognition.2013.08.018; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Brunswick DJ, 2003, AM J PSYCHIAT, V160, P1836, DOI 10.1176/appi.ajp.160.10.1836; Burnett FE, 1999, J AFFECT DISORDERS, V53, P263, DOI 10.1016/S0165-0327(98)00127-X; Buschman TJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0471; Caldarone BJ, 2015, EUR J PHARMACOL, V753, P51, DOI 10.1016/j.ejphar.2014.10.063; Castro D.C., 2014, PHYSL BEHAV; Chaudhry FA, 2008, ANNU REV PHARMACOL, V48, P277, DOI 10.1146/annurev.pharmtox.46.120604.141146; Chen C., 2014, J NEUROPHYSIOL; Cohen MX, 2007, SOC COGN AFFECT NEUR, V2, P20, DOI 10.1093/scan/nsl021; Cusin C, 2013, J CLIN PSYCHIAT, V74, pE636, DOI 10.4088/JCP.12m08093; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Daw N.D., 2013, NEUROECONOMICS DECIS, V2nd, P393; Daw N.D., 2013, NEUROECONOMICS DECIS, P299; Daw N.D., 2013, NEUROECONOMICS, V2nd, P283; Dillon DG, 2014, SOC COGN AFFECT NEUR, V9, P1576, DOI 10.1093/scan/nst155; Dombrovski A.Y., 2014, PSYCHOL MED; Duncan Jeremy, 2012, Drug Discov Ther, V6, P112; Dunlop B.W., 2010, DOPAMINE HDB, P572; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Friedel E., 2014, EUR ARCH PSYCHIAT CL; Friedman A, 2008, J MOL NEUROSCI, V34, P201, DOI 10.1007/s12031-007-9016-8; Friedman A, 2012, EUR NEUROPSYCHOPHARM, V22, P64, DOI 10.1016/j.euroneuro.2011.04.005; Gerfen C.R., 2011, ANNU REV NEUROSCI, V34, P441; Gershon AA, 2007, BIOL PSYCHIAT, V61, P145, DOI 10.1016/j.biopsych.2006.05.031; Gillies GE, 2014, NEUROSCIENCE, V282, P69, DOI 10.1016/j.neuroscience.2014.05.033; Glimcher P. W., 2013, NEUROECONOMICS DECIS; Gotlib IH, 2014, HDB DEPRESSION; Gottesman II, 2003, AM J PSYCHIAT, V160, P636; Hamani C, 2014, NEUROBIOL DIS, V71, P205, DOI 10.1016/j.nbd.2014.08.007; Hasler G, 2012, NEUROSCI BIOBEHAV R, V36, P64, DOI 10.1016/j.neubiorev.2011.04.011; Hirvonen J, 2011, J PSYCHOPHARMACOL, V25, P1329, DOI 10.1177/0269881110376691; Howlett Jonathon R, 2013, Front Psychiatry, V4, P143, DOI 10.3389/fpsyt.2013.00143; Hsiao MC, 2013, PSYCHIAT RES-NEUROIM, V211, P72, DOI 10.1016/j.pscychresns.2012.06.004; Huettel SA, 2012, NEUROIMAGE, V62, P1152, DOI 10.1016/j.neuroimage.2011.08.113; Huys Quentin Jm, 2013, Biol Mood Anxiety Disord, V3, P12, DOI 10.1186/2045-5380-3-12; Inoue T, 2010, PROG NEURO-PSYCHOPH, V34, P1446, DOI 10.1016/j.pnpbp.2010.07.035; Kahneman D., 2011, THINKING FAST SLOW; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAPUR S, 1992, BIOL PSYCHIAT, V32, P1, DOI 10.1016/0006-3223(92)90137-O; Knutson B, 2015, BIOL PSYCHIAT, V77, P418, DOI 10.1016/j.biopsych.2014.12.022; Kocabas NA, 2012, CNS NEUROL DISORD-DR, V11, P264; Kruk-Slomka M, 2015, BEHAV BRAIN RES, V284, P24, DOI 10.1016/j.bbr.2015.01.051; Lam RW, 1996, COMPR PSYCHIAT, V37, P375, DOI 10.1016/S0010-440X(96)90020-6; Lammers CH, 2000, MOL PSYCHIATR, V5, P378, DOI 10.1038/sj.mp.4000754; LANDAUER TK, 1969, PSYCHOL REV, V76, P82, DOI 10.1037/h0026746; Larsen T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0473; Leentjens AFG, 2011, DRUGS, V71, P273, DOI 10.2165/11585380-000000000-00000; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Maj J, 1999, POL J PHARMACOL, V51, P471; Malone J, 2009, BIOL PSYCHIAT, V65, P267; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Markman KD, 1996, SOC COGNITION, V14, P292, DOI 10.1521/soco.1996.14.4.292; Markman KD, 2006, J SOC CLIN PSYCHOL, V25, P210, DOI 10.1521/jscp.2006.25.2.210; Markou A, 2013, NEUROSCI BIOBEHAV R, V37, P2149, DOI 10.1016/j.neubiorev.2013.08.007; Martinez-Aran A., 2015, EUR NEUROPSYCHOPHARM; McIntyre RS, 2014, J AFFECT DISORDERS, V156, P1, DOI 10.1016/j.jad.2013.10.043; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Mueller E.M., 2015, DEPRESS ANXIETY; Must A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00732; Nakahara H, 2014, CURR OPIN NEUROBIOL, V25, P123, DOI 10.1016/j.conb.2014.01.001; Naranjo CA, 2001, PROG NEURO-PSYCHOPH, V25, P781, DOI 10.1016/S0278-5846(01)00156-7; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Papassotiropoulos A., 2015, TRENDS COGN SCI; PAPP M, 1994, PSYCHOPHARMACOLOGY, V114, P309, DOI 10.1007/BF02244853; Pearson-Fuhrhop KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093772; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Proudfit G. H., 2014, PSYCHOPHYSIOLOGY; Quitkin FM, 2003, AM J PSYCHIAT, V160, P798, DOI 10.1176/appi.ajp.160.4.798-b; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Ragland JD, 2009, SCHIZOPHRENIA BULL, V35, P197, DOI 10.1093/schbul/sbn134; Rangel A, 2013, NEUROECONOMICS DECIS, V2, P125; Richard JM, 2013, NEUROSCI BIOBEHAV R, V37, P1919, DOI 10.1016/j.neubiorev.2012.12.008; Riva-Posse P, 2014, BIOL PSYCHIAT, V76, P963, DOI 10.1016/j.biopsych.2014.03.029; Roy M, 2014, NAT NEUROSCI, V17, P1607, DOI 10.1038/nn.3832; Sacher J, 2015, NEUROPSYCHOPHARMACOL, V40, P429, DOI 10.1038/npp.2014.190; Savica R, 2014, NEUROLOGY, V83, P758, DOI 10.1212/WNL.0000000000000719; Schott Björn H, 2010, Front Psychiatry, V1, P142, DOI 10.3389/fpsyt.2010.00142; Schwartz K, 2003, BRAIN RES, V965, P174, DOI 10.1016/S0006-8993(02)04167-7; Seo H, 2014, SCIENCE, V346, P340, DOI 10.1126/science.1256254; Sesack S R, 1998, Adv Pharmacol, V42, P171; SHIMP CP, 1976, J EXP ANAL BEHAV, V26, P487, DOI 10.1901/jeab.1976.26-487; Sole B, 2015, EUR NEUROPSYCHOPHARM; Spasojevic N, 2012, NEUROENDOCRINOL LETT, V33, P631; Stewart JW, 2007, J CLIN PSYCHIAT, V68, P25; Stewart JW, 2009, NEUROPSYCHOPHARMACOL, V34, P2625, DOI 10.1038/npp.2009.99; Sutton R., 1998, REINFORCEMENT LEARNI; Takahashi T, 2011, NEUROENDOCRINOL LETT, V32, P400; Takahashi T., 2013, APPL MATH, V4, P876; Takahashi T, 2007, NEUROENDOCRINOL LETT, V28, P17; Takahashi T, 2004, NEUROREPORT, V15, P2145, DOI 10.1097/00001756-200409150-00029; Takahashi T, 2008, NEUROENDOCRINOL LETT, V29, P451; Takahashi T, 2011, NEUROENDOCRINOL LETT, V32, P221; Takahashi T., 2009, J NEUROSCI PSYCHOL E, V2, P75; Takahashi T, 2010, NEUROENDOCRINOL LETT, V31, P616; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Turner P, 2014, J PSYCHOPHARMACOL, V28, P85, DOI 10.1177/0269881113507640; van Heeringen K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00824; Watkins ER, 2014, J ABNORM PSYCHOL, V123, P24, DOI 10.1037/a0035540; Wiecki T.V., 2015, CLIN PSYCHOL SCI; WILLIAMS BA, 1991, J EXP ANAL BEHAV, V56, P455, DOI 10.1901/jeab.1991.56-455; Wilson RC, 2014, NEURON, V81, P267, DOI 10.1016/j.neuron.2013.11.005; Worbe Y., 2015, INT J NEUROPSYCHOPHA; Yang YK, 2008, PSYCHIAT RES-NEUROIM, V162, P230, DOI 10.1016/j.pscychresns.2007.08.008; Zhang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000437	351	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	AUG	2015	55						247	267		10.1016/j.neubiorev.2015.05.005		21	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CN2SA	WOS:000358271000019		
J	Rosario, FJ; Kanai, Y; Powell, TL; Jansson, T				Rosario, Fredrick J.; Kanai, Yoshikatsu; Powell, Theresa L.; Jansson, Thomas			Increased placental nutrient transport in a novel mouse model of maternal obesity with fetal overgrowth	OBESITY			English	Article							AMINO-ACID TRANSPORTER; HIGH-FAT DIET; INSULIN-RESISTANCE; TROPHOBLAST CELLS; PREGNANCY; GLUCOSE; EXPRESSION; SYSTEM; WOMEN; MICE	ObjectiveTo identify possible mechanisms linking obesity in pregnancy to increased fetal adiposity and growth, a unique mouse model of maternal obesity associated with fetal overgrowth was developed, and the hypothesis that maternal obesity causes up-regulation of placental nutrient transporter expression and activity was tested. MethodsC57BL/6J female mice were fed a control (C) or a high-fat/high-sugar (HF/HS) pelleted diet supplemented by ad libitum access to sucrose (20%) solution, mated, and studied at embryonic day 18.5. ResultsHF/HS diet increased maternal fat mass by 2.2-fold (P<0.01) and resulted in glucose intolerance with normal fasting glucose. Maternal circulating insulin, leptin, and cholesterol were increased (P<0.05) whereas total and high-molecular-weight adiponectin was decreased (P<0.05). HF/HS diet increased fetal weight (+18%, P=0.0005). In trophoblast plasma membranes (TPM) isolated from placentas of HF/HS-fed animals, protein expression of glucose transporter (GLUT) 1 and 3, sodium-coupled neutral amino acid transporter (SNAT) 2, and large neutral amino acid transporter 1 (LAT1) was increased. TPM System A and L amino acid transporter activity was increased in the HF/HS group. ConclusionsUp-regulation of specific placental nutrient transporter isoforms may constitute a mechanism underlying fetal overgrowth in maternal obesity.	[Rosario, Fredrick J.; Jansson, Thomas] Univ Texas Hlth Sci Ctr San Antonio, Dept OB GYN, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA; [Rosario, Fredrick J.] Univ Colorado Anschutz Med Campus, Div Basic Reprod Sci, Dept OB GYN, Aurora, CO USA; [Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, Osaka, Japan; [Powell, Theresa L.; Jansson, Thomas] Univ Colorado Anschutz Med Campus, Dept Pediat, Sect Neonatol, Aurora, CO USA	Rosario, FJ (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Dept OB GYN, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA.	fredrick.joseph@ucdenver.edu			NIH [OD016724]	This study was supported by grants from NIH (OD016724).	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Nien JK, 2007, J PERINAT MED, V35, P522, DOI 10.1515/JPM.2007.123; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Dilworth MR, 2013, PLACENTA, V34, pS34, DOI 10.1016/j.placenta.2012.10.011; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Gilbert PA, 2008, NUTR REV, V66, P203, DOI 10.1111/j.1753-4887.2008.00025.x; Zhang L, 2011, DOMEST ANIM ENDOCRIN, V40, P30, DOI 10.1016/j.domaniend.2010.08.004; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; Jansson T, 2002, DIABETES, V51, P2214, DOI 10.2337/diabetes.51.7.2214; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Retnakaran R, 2008, DIABETES CARE, V31, P2026, DOI 10.2337/dc08-0972; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Jansson N, 2008, AM J CLIN NUTR, V87, P1743; Norris SL, 2005, AM J PREV MED, V28, P126, DOI 10.1016/j.amepre.2004.08.006; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Kusinski LC, 2010, PLACENTA, V31, P53, DOI 10.1016/j.placenta.2009.11.006; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jansson N, 2003, J CLIN ENDOCR METAB, V88, P1205, DOI 10.1210/jc.2002-021332; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Ganguly A, 2012, ENDOCRINOLOGY, V153, P3995, DOI 10.1210/en.2011-1973; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; JANSSON T, 1993, J CLIN ENDOCR METAB, V77, P1554, DOI 10.1210/jc.77.6.1554; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Masuyama H, 2012, AM J PHYSIOL-ENDOC M, V303, pE293, DOI 10.1152/ajpendo.00167.2012; Mazzucco MB, 2013, J ENDOCRINOL, V217, P303, DOI 10.1530/JOE-13-0021; McGowan CA, 2012, EUR J CLIN NUTR, V66, P906, DOI 10.1038/ejcn.2012.15; Ogden CL, 2012, NCHS DATA BRIEF, V82, P1; Pedersen J, 1954, ENDOCRINOLOGY, V16, P330; Prendergast CH, 1999, PLACENTA, V20, P591, DOI 10.1053/plac.1999.0419; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914	39	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	AUG	2015	23	8					1663	1670		10.1002/oby.21165		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CN3JG	WOS:000358321300021		
J	Hoyois, W; Lee, WJ; Chen, SC; Kasama, K; Hur, KY; Lakdawala, M; Wong, SKH; Chen, A; Lomanto, D; Wang, W; Lee, MH; Sung, TC				Hoyois, William; Lee, Wei-Jei; Chen, Shu-Chun; Kasama, Kazunori; Hur, Kyung Yul; Lakdawala, Muffazal; Wong, Simon K-H; Chen, Anton; Lomanto, Davide; Wang, Weu; Lee, Ming-Hsien; Sung, Tien-Chou			PRE-OP BIO-DEMOGRAPHIC PROFILE OF PATIENTS ENROLLED IN A LARGE SCALE INTERNATIONAL DIATETIC SURGERY STUDY	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Hoyois, William; Lee, Wei-Jei; Chen, Shu-Chun] Min Sheng Gen Hosp, Taipei, Taiwan; [Kasama, Kazunori] Yotsuya Med Cube, Tokyo, Japan; [Hur, Kyung Yul] Soonchunhyang Univ Hosp, Asan, Chungcheongnam, South Korea; [Lakdawala, Muffazal] Saifee Hosp, Bombay, Maharashtra, India; [Wong, Simon K-H] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Chen, Anton] Khoo Teck Puat Hosp, Singapore, Singapore; [Lomanto, Davide] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Wang, Weu] Taipei Med Univ Hosp, Taipei, Taiwan; [Lee, Ming-Hsien] China Med Univ Hosp, Taichung, Taiwan; [Sung, Tien-Chou] Chiayi Christian Hosp, Chiayi, Taiwan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				TOP5-2	1307	1308				2	Surgery	Surgery	CN1GM	WOS:000358166600003		
J	Yamaguchi, T; Lee, WJ; Hur, KY; Lakadawala, M; Kasama, K; Wong, SKH; Tani, M; Tani, T				Yamaguchi, Tsuyoshi; Lee, Wei-Jei; Hur, Kyung Yul; Lakadawala, Muffazal; Kasama, Kazunori; Wong, Simon K. H.; Tani, Masaji; Tani, Tohru			GASTROINTESTINAL METABOLIC SURGERY FOR THE TREATMENT OF DIABETIC PATIENTS: A MULTI-INSTITUTIONAL INTERNATIONAL STUDY-3 YEAR OUTCOMES	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Yamaguchi, Tsuyoshi; Tani, Masaji; Tani, Tohru] Shiga Univ Med Sci, Shiga, Japan; [Lee, Wei-Jei] Min Sheng Gen Hosp, Taoyuan, Taiwan; [Hur, Kyung Yul] Soonchunhyang Univ Hosp, Asan, Chungcheongnam, South Korea; [Lakadawala, Muffazal] Saifee Hosp, Bombay, Maharashtra, India; [Kasama, Kazunori] Yotsuya Med Cube, Tokyo, Japan; [Wong, Simon K. H.] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				TOP5-4	1308	1308				1	Surgery	Surgery	CN1GM	WOS:000358166600005		
J	Hashimoto, K; Kasama, K; Seki, Y; Sakaguchi, Y; Kusumoto, T; Ikejiri, K				Hashimoto, Kenkichi; Kasama, Kazunori; Seki, Yosuke; Sakaguchi, Yoshihisa; Kusumoto, Tetsuya; Ikejiri, Kouji			BARIATRIC SURGERY IN OBESE TYPE 1 DIABETIC PATIEnts	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Hashimoto, Kenkichi; Kasama, Kazunori; Seki, Yosuke] Yotsuya Med Cube, Fukuoka, Japan; [Sakaguchi, Yoshihisa; Kusumoto, Tetsuya; Ikejiri, Kouji] Natl Kyushu Med Ctr, Fukuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				OP5-1	1320	1320				1	Surgery	Surgery	CN1GM	WOS:000358166600041		
J	Yamaguchi, T; Lee, WJ; Ser, KH; Chen, JC; Wu, CC; Hsieh, MJ; Tsou, JJ; Chen, SC; Tani, M; Tani, T				Yamaguchi, Tsuyoshi; Lee, Wei-Jei; Ser, Kong-Han; Chen, Jung-Chien; Wu, Chun-Chi; Hsieh, Mei-Jen; Tsou, Jun-Juin; Chen, Shu-Chun; Tani, Masaji; Tani, Tohru			"CANDY CANE" ROUX SYNDROME AFTER ROUX-EN Y BYPASS : REPORT OF A CASE	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Yamaguchi, Tsuyoshi; Tani, Masaji] Shiga Univ Med Sci, Shiga, Japan; [Lee, Wei-Jei; Ser, Kong-Han; Chen, Jung-Chien; Wu, Chun-Chi; Hsieh, Mei-Jen; Tsou, Jun-Juin; Chen, Shu-Chun] Min Sheng Gen Hosp, Tokyo, Japan; [Tani, Tohru] Biomed Innovat Ctr, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				VP2-1	1324	1324				1	Surgery	Surgery	CN1GM	WOS:000358166600055		
J	Endo, Y; Ohta, M; Kawasaki, T; Watanabe, K; Takayama, H; Uchida, H; Yada, K; Iwashita, Y; Inomata, M; Kitano, S				Endo, Yuichi; Ohta, Masayuki; Kawasaki, Takahide; Watanabe, Kiminori; Takayama, Hiroomi; Uchida, Hiroki; Yada, Kazuhiro; Iwashita, Yukio; Inomata, Masafumi; Kitano, Seigo			CHANGES IN THE GASTROESOPHAGEAL REFLUX DISEASE AND HIATAL HERNIA AFTER 5 YEAR FOLLOW-UP FOR LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Endo, Yuichi; Ohta, Masayuki; Kawasaki, Takahide; Watanabe, Kiminori; Takayama, Hiroomi; Uchida, Hiroki; Yada, Kazuhiro; Iwashita, Yukio; Inomata, Masafumi; Kitano, Seigo] Oita Univ, Fac Med, Oita, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				PP1-1	1326	1327				2	Surgery	Surgery	CN1GM	WOS:000358166600065		
J	Kikkawa, E; Seki, Y; Kasama, K; Sonoda, K; Nakazato, T				Kikkawa, Eri; Seki, Yosuke; Kasama, Kazunori; Sonoda, Kazuko; Nakazato, Tetsuya			DIETARY SATISFACTION AND FOOD TOLERANCE AFTER BARIATRIC SURGERY	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Kikkawa, Eri; Seki, Yosuke; Kasama, Kazunori; Sonoda, Kazuko; Nakazato, Tetsuya] Yotsuya Med Cube, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				PP7-4	1337	1337				1	Surgery	Surgery	CN1GM	WOS:000358166600101		
J	Sonoda, K; Seki, Y; Kasama, K; Kikkawa, E; Yotsuya, TN				Sonoda, Kazuko; Seki, Yousuke; Kasama, Kazunori; Kikkawa, Eri; Yotsuya, Tetsuya Nakazato			ROLE OF THE BARIATRIC NURSE/COORDINATOR IN BARIATRIC SURGERY IN JAPAN	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Sonoda, Kazuko; Seki, Yousuke; Kasama, Kazunori; Kikkawa, Eri; Yotsuya, Tetsuya Nakazato] Med Cube, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				PP7-5	1337	1337				1	Surgery	Surgery	CN1GM	WOS:000358166600102		
J	Ohta, M; Kawasaki, T; Watanabe, K; Takayama, H; Uchida, H; Yada, K; Iwashita, Y; Inomata, M; Kitano, S				Ohta, Masayuki; Kawasaki, Takahide; Watanabe, Kiminori; Takayama, Hiroomi; Uchida, Hiroki; Yada, Kazuhiro; Iwashita, Yukio; Inomata, Masafumi; Kitano, Seigo			TECHNIQUES AND RESULTS OF COMBINATION METHOD OF LAPAROSCOPIC SLEEVE GASTRECTOMY WITH CHOLECYSTECTOMY	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Ohta, Masayuki; Kawasaki, Takahide; Watanabe, Kiminori; Takayama, Hiroomi; Uchida, Hiroki; Yada, Kazuhiro; Iwashita, Yukio; Inomata, Masafumi; Kitano, Seigo] Oita Univ, Fac Med, Oita 87011, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				PP11-1	1342	1343				2	Surgery	Surgery	CN1GM	WOS:000358166600119		
J	Endo, Y; Ohta, M; Kawasaki, T; Watanabe, K; Watanabe, H; Iwashita, Y; Yada, K; Uchida, H; Inomata, M; Kitano, S				Endo, Yuichi; Ohta, Masayuki; Kawasaki, Takahide; Watanabe, Kiminori; Watanabe, Hiroomi; Iwashita, Yukio; Yada, Kazuhiro; Uchida, Hiroki; Inomata, Masafumi; Kitano, Seigo			LAPAROSCOPIC SLEEVE GASTRECTOMY FOR JAPANESE OBESE PATIENTS	OBESITY SURGERY			English	Meeting Abstract	International-Federation-for-the-Surgery-of-Obesity / Metabolic-Disorders-Asia-Pacific-Chapter (IFSO-APC) Meeting	APR 09-11, 2015	Goyang, SOUTH KOREA	Int Federat Surg Obes, Metab Disorders Asia Pacific Chapter					[Endo, Yuichi] Oita Univ, Fac Med, Gastroenterol & Pediat Surg, Oita, Japan; [Ohta, Masayuki; Kawasaki, Takahide; Watanabe, Kiminori; Watanabe, Hiroomi; Iwashita, Yukio; Yada, Kazuhiro; Uchida, Hiroki; Inomata, Masafumi] Oita Univ, Fac Med, Oita, Japan; [Kitano, Seigo] Oita Univ, Oita, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8				PP13-11	1347	1348				2	Surgery	Surgery	CN1GM	WOS:000358166600137		
J	Kawada, T				Kawada, Tomoyuki			Types of Bariatric Surgery and Fat Reduction by Ultrasound Evaluation	OBESITY SURGERY			English	Letter							VISCERAL FAT		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					TORNAGHI G, 1994, INT J OBESITY, V18, P771; ARMELLINI F, 1993, INT J OBESITY, V17, P209; Kawada T, 2014, J HEPATOL, V61, P1188, DOI 10.1016/j.jhep.2014.08.011; Mizrahi I, 2015, OBES SURG, V25, P959, DOI 10.1007/s11695-014-1495-4; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; VANDERKOOY K, 1993, INT J OBESITY, V17, P187	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0960-8923	1708-0428		OBES SURG	Obes. Surg.	AUG	2015	25	8					1498	1498		10.1007/s11695-015-1760-1		1	Surgery	Surgery	CN1GM	WOS:000358166600168		
J	Liang, IC; Shimada, N; Tanaka, Y; Nagaoka, N; Moriyama, M; Yoshida, T; Ohno-Matsui, K				Liang, I-Chia; Shimada, Noriaki; Tanaka, Yuichiro; Nagaoka, Natsuko; Moriyama, Muka; Yoshida, Takeshi; Ohno-Matsui, Kyoko			Comparison of Clinical Features in Highly Myopic Eyes with and without a Dome-Shaped Macula	OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SWEPT-SOURCE OCT; SPECTRAL-DOMAIN; CHOROIDAL THICKNESS; DETACHMENT	Purpose: To compare the clinical features of highly myopic eyes with a dome-shaped macula (DSM) with those without a DSM and to identify the funduscopic clues to suspect the presence of DSM. Design: Retrospective case series. Patients: A total of 586 patients (1118 eyes) with high myopia (refractive error < -8 diopters [D] or axial length >= 26.5 mm) who had optical coherence tomography (OCT) examinations through the central fovea at our High Myopia Clinic between February 2012 and November 2013. Methods: Vertical and horizontal OCT scans across the central fovea were retrospectively analyzed. A DSM was defined by the presence of an inward bulge of >50 mu m in the vertical OCT image. Fundus photographs also were analyzed to identify the funduscopic clues to suspect the presence of DSM. Main Outcome Measures: The rate of DSM in 1118 highly myopic eyes. The rate of DSM in highly myopic eyes with macular complications. Funduscopic features to suggest the presence of DSM. Results: Among the 1118 eyes, 225 (20.1%) had a DSM. A DSM was present in both vertical and horizontal OCT sections in 20% of eyes, along only the vertical section in 77% of eyes, and in only the horizontal section in 2% of eyes. The results of multiple regression analyses showed that serous retinal detachment and foveal and extrafoveal retinoschisis were significantly associated with the presence of DSM and that choroidal neovascularization was not. Ophthalmoscopically, 91.4% of the eyes with the appearance of a horizontal ridge connecting the optic disc and the fovea had a DSM. Conclusions: A DSM is found in as many as 20% of highly myopic individuals. Horizontal ridges connecting the optic disc and the fovea might be an important clue to suspect the presence of a DSM on the basis of fundus photographs. (C) 2015 by the American Academy of Ophthalmology	[Liang, I-Chia; Shimada, Noriaki; Tanaka, Yuichiro; Nagaoka, Natsuko; Moriyama, Muka; Yoshida, Takeshi; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo 1138510, Japan; [Liang, I-Chia] Cathay Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	Ohno-Matsui, K (reprint author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	k.ohno.oph@tmd.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25670727]	Supported in part by Research Grant 25670727 from the Japan Society for the Promotion of Science, Tokyo, Japan. The funding organization had no role in the design or conduct of this research.	Matsuo Y, 2013, INVEST OPHTH VIS SCI, V54, P7630, DOI 10.1167/iovs.13-13135; Ohno-Matsui K, 2014, OPHTHALMOLOGY, V121, P1798, DOI 10.1016/j.ophtha.2014.03.035; Tamura Nazuki, 2014, Clin Ophthalmol, V8, P83, DOI 10.2147/OPTH.S54903; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Imamura Y, 2011, AM J OPHTHALMOL, V151, P297, DOI 10.1016/j.ajo.2010.08.014; Caillaux V, 2013, AM J OPHTHALMOL, V156, P958, DOI 10.1016/j.ajo.2013.06.032; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Gaucher D, 2008, AM J OPHTHALMOL, V145, P909, DOI 10.1016/j.ajo.2008.01.012; Battaglia Parodi Maurizio, 2015, Eur J Ophthalmol, V25, P180, DOI 10.5301/ejo.5000531; Chebil A, 2014, J FR OPHTALMOL, V37, P237, DOI 10.1016/j.jfo.2013.10.002; Cheour M, 2013, J FR OPHTALMOL, V36, pE145, DOI 10.1016/j.jfo.2012.10.014; Chinskey ND, 2013, OPHTHAL SURG LAS IM, V44, P593, DOI 10.3928/23258160-20131010-01; Coco RM, 2012, OPHTHALMOLOGICA, V228, P7, DOI 10.1159/000336910; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Dirani Ali, 2014, Clin Ophthalmol, V8, P999, DOI 10.2147/OPTH.S62267; Ellabban AA, 2014, AM J OPHTHALMOL, V158, P1062, DOI 10.1016/j.ajo.2014.08.006; Ellabban AA, 2012, AM J OPHTHALMOL, V3, p578e8; Errera MH, 2014, GRAEF ARCH CLIN EXP, V252, P499, DOI 10.1007/s00417-013-2561-7; Ohsugi H, 2014, AM J OPHTHALMOL, V158, P162, DOI 10.1016/j.ajo.2014.02.054; Shin MK, 2014, OSLI RETINA, V45, P253, DOI 10.3928/23258160-20140501-03; Tan CSH, 2015, BRIT J OPHTHALMOL, V99, P354, DOI 10.1136/bjophthalmol-2014-305331; Tan CS, 2015, OSLI RETINA, V46, P172, DOI 10.3928/23258160-20150213-23; Tokoro T, 1998, ATLAS POSTERIOR FUND, P5; Viola F, 2015, AM J OPHTHALMOL, V159, P44, DOI 10.1016/j.ajo.2014.09.026	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	AUG	2015	122	8					1591	1600		10.1016/j.ophtha.2015.04.012		10	Ophthalmology	Ophthalmology	CN3JV	WOS:000358322900018		
J	Nagai, K; Matsushita, T; Matsuzaki, T; Takayama, K; Matsumoto, T; Kuroda, R; Kurosaka, M				Nagai, K.; Matsushita, T.; Matsuzaki, T.; Takayama, K.; Matsumoto, T.; Kuroda, R.; Kurosaka, M.			Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes	OSTEOARTHRITIS AND CARTILAGE			English	Article						Sirtuin; SIRT6; Chondrocyte; Senescence; DNA damage; Telomere dysfunction	OSTEOARTHRITIC ARTICULAR-CARTILAGE; GENE-EXPRESSION; HISTONE DEACETYLASE; HUMAN FIBROBLASTS; II COLLAGEN; LIFE-SPAN; CELLS; INHIBITORS; APOPTOSIS; PROTEIN	Objective: SIRT6, a member of the sirtuin family of nicotinamide adenine dinucleotide (NAD(+))-dependent protein deacetylases, has been implicated as a key factor in aging-related diseases. However, the role of SIRT6 in chondrocytes has not been fully explored. The purpose of this study was to examine the role of SIRT6 in human chondrocytes by inhibiting SIRT6 in vitro. Design: First, the localization of SIRT6 and proliferation cell nuclear antigen (PCNA) in human cartilages was examined by immunohistochemistry. Next, SIRT6 was depleted by RNA interference (RNAi), and the effect of SIRT6 depletion on changes in gene expression, protein levels, proliferation, and senescence in human chondrocytes was assessed. Furthermore, to detect DNA damage and telomere dysfunction, gamma H2AX foci and telomere dysfunction-induced foci (TIFs) were examined using immunofluorescence microscopy. The protein levels of two mediators for DNA damage induced-senescence, p16 and p21, were examined by western blotting. Results: Immunohistochemical analysis showed SIRT6 was preferentially expressed in the superficial zone chondrocytes and PCNA-positive cluster-forming chondrocytes in the osteoarthritic cartilage tissue samples. Real-time PCR analysis showed that matrix metalloproteinase 1 (MMP-1) and MMP-13 mRNA were significantly increased by SIRT6 inhibition. Moreover, SIRT6 inhibition significantly reduced proliferation and increased senescence associated beta-galactosidase (SA-beta-Gal)-positive chondrocytes; it also led to increased p16 levels. Immunofluorescence microscopy showed that gH2AX foci and TIFs were increased by SIRT6 inhibition. Conclusion: Depletion of SIRT6 in human chondrocytes caused increased DNA damage and telomere dysfunction, and subsequent premature senescence. These findings suggest that SIRT6 plays an important role in the regulation of senescence of human chondrocytes. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Nagai, K.; Matsushita, T.; Matsuzaki, T.; Takayama, K.; Matsumoto, T.; Kuroda, R.; Kurosaka, M.] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan	Matsushita, T (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kant_kantona@yahoo.co.jp; matsushi@kobe-u.ac.jp; tokiomatsuzaki@yahoo.co.jp; kojitakayama1978@gmail.com; matsun@m4.dion.ne.jp; kurodar@med.kobe-u.ac.jp; kurosaka@med.kobe-u.ac.jp					Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; Kim HA, 2000, J RHEUMATOL, V27, P455; Takayama K, 2009, ARTHRITIS RHEUM, V60, P2731, DOI 10.1002/art.24864; Sharma A, 2013, J BIOL CHEM, V288, P18439, DOI 10.1074/jbc.M112.405928; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Little CB, 2009, ARTHRITIS RHEUM, V60, P3723, DOI 10.1002/art.25002; Aigner T, 2006, ADV DRUG DELIVER REV, V58, P128, DOI 10.1016/j.addr.2006.01.020; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Imai S, 2000, NATURE, V403, P795; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Wu W, 2002, ARTHRITIS RHEUM, V46, P2087, DOI 10.1002/art.10428; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; McCord RA, 2009, AGING-US, V1, P109; Kevorkian L, 2004, ARTHRITIS RHEUM, V50, P131, DOI 10.1002/art.11433; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Hashimoto S, 2009, ARTHRITIS RHEUM, V60, P2340, DOI 10.1002/art.24706; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; DILEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Kouri JB, 1996, OSTEOARTHR CARTILAGE, V4, P111, DOI 10.1016/S1063-4584(05)80320-6; Matsuzaki T, 2013, ANN RHEUM DIS; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022	47	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	AUG	2015	23	8					1412	1420		10.1016/j.joca.2015.03.024		9	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CN4XU	WOS:000358434600022		
J	Matsumoto, T; Hashimura, M; Takayama, K; Ishida, K; Kawakami, Y; Matsuzaki, T; Nakano, N; Matsushita, T; Kuroda, R; Kurosaka, M				Matsumoto, T.; Hashimura, M.; Takayama, K.; Ishida, K.; Kawakami, Y.; Matsuzaki, T.; Nakano, N.; Matsushita, T.; Kuroda, R.; Kurosaka, M.			A radiographic analysis of alignment of the lower extremities - initiation and progression of varus-type knee osteoarthritis (vol 23, pg 217, 2015)	OSTEOARTHRITIS AND CARTILAGE			English	Correction									[Matsumoto, T.; Takayama, K.; Kawakami, Y.; Matsuzaki, T.; Nakano, N.; Matsushita, T.; Kuroda, R.; Kurosaka, M.] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 6500017, Japan; [Hashimura, M.] Yasue Orthopaed Clin, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Ishida, K.] Kobe Kaisei Hosp, Dept Orthopaed Surg, Kobe, Hyogo, Japan	Matsumoto, T (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	matsun@m4.dion.ne.jp; m-hasshi@gaia.eonet.ne.jp; kojitakayama78@yahoo.co.jp; wavedreamer17@yahoo.co.jp; yohei_kawakami@hotmail.com; tokiomatsuzaki@yahoo.co.jp; naokix1981@yahoo.co.jp; matsushi@med.kobe-u.ac.jp; kurodar@med.kobe-u.ac.jp; kurosaka@med.kobe-u.ac.jp					Matsumoto T, 2015, OSTEOARTHR CARTILAGE, V23, P217, DOI 10.1016/j.joca.2014.11.015	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	AUG	2015	23	8					1432	1433		10.1016/j.joca.2015.04.017		2	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CN4XU	WOS:000358434600024		
J	Kobayashi, K; Ando, M; Saito, Y; Kondo, K; Omura, G; Shinozaki-Ushiku, A; Fukayama, M; Asakage, T; Yamasoba, T				Kobayashi, Kenya; Ando, Mizuo; Saito, Yuki; Kondo, Kenji; Omura, Go; Shinozaki-Ushiku, Aya; Fukayama, Masashi; Asakage, Takahiro; Yamasoba, Tatsuya			Nerve Growth Factor Signals as Possible Pathogenic Biomarkers for Perineural Invasion in Adenoid Cystic Carcinoma	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						adenoid cystic carcinoma; NGF; TrkA; perineural invasion; Myb	HUMAN PANCREATIC-CANCER; SALIVARY-GLANDS; FACTOR RECEPTORS; MYB EXPRESSION; BREAST; CELLS; HEAD; NECK; PROGRESSION; PATHWAYS	Objective The molecular mechanisms underlying perineural invasion (PNI)a characteristic pathological feature of adenoid cystic carcinoma (ACC)remain largely unclear. Recently, nerve growth factor (NGF) has been implicated in perineural invasion in certain malignancies. Overexpression of Myb related to the MYB-NFIB fusion gene in ACC has also been correlated with perineural invasion and survival. However, this concept is controversial. The aim of this study was to examine the expression of NGF together with its receptors, tropomyosin receptor kinase A (TrkA) and p75NRT, and Myb in ACC and assess their relationship with perineural invasion and survival. Study Design Case series with chart review. Setting The University of Tokyo Hospital. Subjects and Methods We retrospectively analyzed 37 patients with ACC surgically treated from 1991 to 2011. We examined expression levels of NGF, TrkA, p75NRT, and Myb in the ACC specimens and their correlations with PNI and prognosis. Results NGF, TrkA, p75NRT, and Myb overexpression rates were 65%, 65%, 30%, and 62%, respectively. Pearson product-moment correlation coefficient revealed a strong correlation between NGF/TrkA immunostaining and PNI (NGF: r = 0.68, P < .0001; TrkA: r = 0.53, P = .0007). Moreover, NGF overexpression was significantly associated with worse 8-year local control rate (27% vs 80%, P = .005). However, p75NRT and Myb expression was related to neither perineural invasion nor survival. Conclusion Our findings demonstrated that NGF and TrkA overexpression, but not Myb and p75NRT overexpression, may contribute to PNI and thus cause local recurrence in patients with ACC.	[Kobayashi, Kenya; Ando, Mizuo; Saito, Yuki; Kondo, Kenji; Omura, Go; Asakage, Takahiro; Yamasoba, Tatsuya] Tokyo Univ Hosp, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Kobayashi, Kenya] Natl Canc Ctr, Dept Head & Neck Oncol, Tokyo, Japan; [Shinozaki-Ushiku, Aya; Fukayama, Masashi] Tokyo Univ Hosp, Dept Pathol, Tokyo 1138655, Japan	Kobayashi, K (reprint author), Tokyo Univ Hosp, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kenyajp@hotmail.com					Agarwal JP, 2008, ORAL ONCOL, V44, P986, DOI 10.1016/j.oraloncology.2008.01.004; Barrett AW, 2009, ORAL ONCOL, V45, P936, DOI 10.1016/j.oraloncology.2009.07.001; Liebig C, 2009, CANCER, V115, P3379, DOI 10.1002/cncr.24396; West RB, 2011, AM J SURG PATHOL, V35, P92, DOI 10.1097/PAS.0b013e3182002777; Zhu ZW, 2001, CLIN CANCER RES, V7, P105; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Moody SA, 2000, AM J OTOL, V21, P582; Chen AM, 2006, INT J RADIAT ONCOL, V66, P152, DOI 10.1016/j.ijrobp.2006.04.014; Mendenhall WM, 2004, HEAD NECK-J SCI SPEC, V26, P154, DOI 10.1002/hed.10380; Mitani Y, 2010, CLIN CANCER RES, V16, P4722, DOI 10.1158/1078-0432.CCR-10-0463; Naesse EP, 2013, EUR J ORAL SCI, V121, P13, DOI 10.1111/eos.12008; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Zhu ZW, 1999, J CLIN ONCOL, V17, P2419; Brill LB, 2011, MODERN PATHOL, V24, P1169, DOI 10.1038/modpathol.2011.86; Davidson B, 2004, BREAST CANCER RES TR, V83, P119, DOI 10.1023/B:BREA.0000010704.17479.8a; Dang CX, 2006, J GASTROEN HEPATOL, V21, P850, DOI 10.1111/j.1440-1746.2006.04074.x; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; FRANKENTHALER RA, 1991, ARCH OTOLARYNGOL, V117, P1251; Barnes L, 2005, WHO CLASSIFICATION H; BYERS RM, 1973, AM J SURG, V126, P458, DOI 10.1016/S0002-9610(73)80030-3; DESCHRYVERKECSKEMETI K, 1987, ARCH PATHOL LAB MED, V111, P833; Hao Li, 2010, Int J Oral Sci, V2, P35, DOI 10.4248/IJOS10005; Huang MX, 1997, INT J ORAL MAX SURG, V26, P435, DOI 10.1016/S0901-5027(97)80008-2; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Okada Y, 2004, CLIN EXP METASTAS, V21, P285, DOI 10.1023/B:CLIN.0000046131.24625.54; SHINGAKI S, 1986, J MAXILLOFAC SURG, V14, P53, DOI 10.1016/S0301-0503(86)80259-4; Wang L, 2006, J ORAL MAXIL SURG, V64, P636, DOI 10.1016/j.joms.2005.12.011; Yamamoto Miyuki, 1992, Arteriosclerosis and Thrombosis, V67, P642	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	AUG	2015	153	2					218	224		10.1177/0194599815584762		7	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CN4FW	WOS:000358387000011		
J	Nishio, N; Fujimoto, Y; Fujii, M; Saito, K; Hiramatsu, M; Maruo, T; Iwami, K; Kamei, Y; Yagi, S; Takahashi, M; Hayashi, Y; Ando, A; Nakashima, T				Nishio, Naoki; Fujimoto, Yasushi; Fujii, Masazumi; Saito, Kiyoshi; Hiramatsu, Mariko; Maruo, Takashi; Iwami, Kenichiro; Kamei, Yuzuru; Yagi, Shunjiro; Takahashi, Masakatsu; Hayashi, Yuichiro; Ando, Atsushi; Nakashima, Tsutomu			Craniofacial Resection for T4 Maxillary Sinus Carcinoma: Managing Cases with Involvement of the Skull Base	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						craniofacial resection; maxillary sinus carcinoma; cavernous sinus; skull base; surgical strategy	SQUAMOUS-CELL CARCINOMA; ADVANCED SINONASAL MALIGNANCIES; HEALTH SURVEY SF-36; PARANASAL SINUSES; NASAL CAVITY; CONCURRENT CHEMORADIOTHERAPY; CISPLATIN INFUSION; RADIATION-THERAPY; CANCER; TUMORS	Objective The objective of this study was to clarify the outcomes of craniofacial resection for locally advanced maxillary sinus carcinoma classified as T4 and to present methods for managing cases involving the skull base. Study Design Case series with chart review. Setting Tertiary university hospital. Subjects and Methods We performed anterolateral craniofacial resection in en bloc fashion for locally advanced maxillary sinus carcinoma at stage T4. Participants comprised 40 patients with T4 maxillary sinus carcinoma treated between 1992 and 2011. Surgical outcomes were analyzed retrospectively. Results Forty patients with stage T4a (n = 26) or stage T4b (n = 14) were included in this study. Five-year overall and disease-free survival rates for the 40 patients with T4 maxillary sinus carcinoma were 62.7% and 52.6%, respectively. Cavernous sinus involvement correlated significantly with worse prognosis (P = .012). In 35 cases without cavernous sinus involvement, previous treatment (P = .017) and positive margins (P = .019) correlated significantly with worse prognosis, and 5-year overall and disease-free survival rates were 72.4% and 55.3%, respectively. Conclusion This study only included cases of locally advanced maxillary sinus carcinoma classified as T4. Considering the advanced stage, our study suggests relatively favorable outcomes and the importance of managing the cavernous sinus in en bloc resections of malignant skull base tumors. Craniofacial resection in en bloc fashion achieved good survival rates.	[Nishio, Naoki; Fujimoto, Yasushi; Hiramatsu, Mariko; Maruo, Takashi; Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4668550, Japan; [Fujii, Masazumi] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Saito, Kiyoshi; Iwami, Kenichiro] Fukushima Med Univ, Dept Neurosurg, Fukushima, Japan; [Kamei, Yuzuru; Yagi, Shunjiro] Nagoya Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Nagoya, Aichi 4668550, Japan; [Takahashi, Masakatsu] Kariya Gen Hosp, Dept Otorhinolaryngol, Kariya, Aichi, Japan; [Hayashi, Yuichiro] Nagoya Univ, Dept Commun, Nagoya, Aichi 4668550, Japan; [Ando, Atsushi] Chubu Rosai Hosp, Dept Otorhinolaryngol, Japan Labor Hlth & Welf, Nagoya, Aichi, Japan	Nishio, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	naokin@med.nagoya-u.ac.jp	Nakashima, Tsutomu/B-8259-2012	Nakashima, Tsutomu/0000-0003-3930-9120	National Cancer Center Research and Development Fund [23-A-26]; JSPS	Funding source: National Cancer Center Research and Development Fund (23-A-26), JSPS Grant-in-Aid for Research Activity Start-up. Request for proof reading.	ALVAREZ I, 1995, AM J OTOLARYNG, V16, P109, DOI 10.1016/0196-0709(95)90041-1; Turner JH, 2012, HEAD NECK-J SCI SPEC, V34, P877, DOI 10.1002/hed.21830; Homma A, 2009, CANCER, V115, P4705, DOI 10.1002/cncr.24515; KETCHAM AS, 1963, AM J SURG, V106, P698; Resto VA, 2008, HEAD NECK-J SCI SPEC, V30, P222, DOI 10.1002/hed.20681; Hanna E, 2009, ARCH OTOLARYNGOL, V135, P1219, DOI 10.1001/archoto.2009.173; Patel SG, 2003, CANCER, V98, P1179, DOI 10.1002/cncr.11630; Kim GE, 1999, AM J OTOLARYNG, V20, P383; Dulguerov P, 2001, CANCER, V92, P3012, DOI 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E; Bilsky MH, 2005, NEUROSURGERY, V57, P339, DOI 10.1227/01.NEU.0000176648.06547.15; Katz TS, 2002, HEAD NECK-J SCI SPEC, V24, P821, DOI 10.1002/hed.10143; Nicolai P, 2008, AM J RHINOL, V22, P308, DOI 10.2500/ajr.2008.22.3170; Harbo G, 1997, ACTA ONCOL, V36, P45; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mock U, 2004, INT J RADIAT ONCOL, V58, P147, DOI 10.1016/S0360-3016(03)01452-4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ganly I, 2005, HEAD NECK-J SCI SPEC, V27, P445, DOI 10.1002/hed.20166; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Fukumitsu N, 2012, INT J RADIAT ONCOL, V83, P704, DOI 10.1016/j.ijrobp.2011.07.032; Kang JH, 2012, J ORAL MAXIL SURG, V70, P1717, DOI 10.1016/j.joms.2011.06.221; Samant S, 2004, ARCH OTOLARYNGOL, V130, P948, DOI 10.1001/archotol.130.8.948; Cantu G, 2010, SKULL BASE-INTERD AP, V20, P55, DOI 10.1055/s-0029-1234021; Duthoy W, 2005, CANCER, V104, P71, DOI 10.1002/cncr.21100; Ganly I, 2011, CANCER-AM CANCER SOC, V117, P563, DOI 10.1002/cncr.25390; Grant R N, 1970, Prog Clin Cancer, V4, P34; JIANG GL, 1991, RADIOTHER ONCOL, V21, P193, DOI 10.1016/0167-8140(91)90037-H; Nishimura G, 2009, AURIS NASUS LARYNX, V36, P547, DOI 10.1016/j.anl.2008.11.002; Parsons JT, 1995, OTOLARYNG CLIN N AM, V28, P1259; Saito K, 1999, HEAD NECK-J SCI SPEC, V21, P734, DOI 10.1002/(SICI)1097-0347(199912)21:8<734::AID-HED9>3.3.CO;2-O; Sakashita T, 2009, SKULL BASE-INTERD AP, V19, P127, DOI 10.1055/s-0028-1096201; Sanghvi S, 2013, LARYNGOSCOPE, V124, P76; SHAH JP, 1987, AM J SURG, V154, P352, DOI 10.1016/0002-9610(89)90003-2; Shiga K, 2007, OTOLARYNG HEAD NECK, V136, P1003, DOI 10.1016/j.otohns.2006.12.018; Terada N, 2003, LARYNGOSCOPE, V113, P729, DOI 10.1097/00005537-200304000-00026; Weber DC, 2006, RADIOTHER ONCOL, V81, P243, DOI 10.1016/j.radonc.2006.09.009	35	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	AUG	2015	153	2					231	238		10.1177/0194599815586770		8	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CN4FW	WOS:000358387000013		
J	Mukaida, T; Sone, M; Yoshida, T; Kato, K; Teranishi, M; Naganawa, S; Nakashima, T				Mukaida, Tohru; Sone, Michihiko; Yoshida, Tadao; Kato, Ken; Teranishi, Masaaki; Naganawa, Shinji; Nakashima, Tsutomu			Magnetic Resonance Imaging Evaluation of Endolymphatic Hydrops in Cases With Otosclerosis	OTOLOGY & NEUROTOLOGY			English	Article							MENIERES-DISEASE; COCHLEAR OTOSCLEROSIS; CLINICAL-SIGNIFICANCE; COMPLICATIONS; VISUALIZATION; SURGERY	Objective Endolymphatic hydrops (EH) has been reported in cases with otosclerosis, and preoperative EH could be a risk factor for inner ear disturbances after stapes surgery. Visualization of EH has recently become possible using magnetic resonance imaging (MRI) with contrast agents. This study investigated the presence of EH on MRI in ears with clinical otosclerosis. Study design Retrospective case series. Setting University hospital. Patients 27 ears of 15 cases diagnosed with otosclerosis. Intervention Ears were evaluated by 3-T MRI performed 4 hours after intravenous injection of gadolinium. The degree of EH in the vestibule and cochlea was classified into three grades (none, mild, and significant). Imaging data were compared with clinical findings for all ears. Main Outcome Measures Imaging and clinical findings. Results Varying degrees of cochlear EH and vestibular EH were observed in 20 and 15 ears, respectively. Episodes of acute sensorineural hearing loss with rotatory vertigo occurred in four ears that showed severe EH in the cochleae and vestibules. Severe EH, however, was also observed in ears without such symptoms. Conclusions The presence of EH in ears with otosclerosis was clearly visualized in the present patient series. Such MRI evaluation could provide useful information for managing symptoms related to EH.	[Mukaida, Tohru] Toyota Mem Hosp, Dept Otorhinolaryngol, Toyota, Japan; [Sone, Michihiko; Yoshida, Tadao; Kato, Ken; Teranishi, Masaaki] Nagoya Univ, Dept Otorhinolaryngol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Naganawa, Shinji] Nagoya Univ, Dept Radiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Nakashima, Tsutomu] Natl Ctr Geriatr & Gerontol, Dept Otorhinolaryngol, Obu, Japan	Sone, M (reprint author), Nagoya Univ, Dept Otorhinolaryngol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	michsone@med.nagoya-u.ac.jp	Nakashima, Tsutomu/B-8259-2012; Naganawa, Shinji/I-1572-2012; Yoshida, Tadao/I-1619-2012	Nakashima, Tsutomu/0000-0003-3930-9120; Naganawa, Shinji/0000-0002-0214-613X; 			Sugiura M, 2008, AURIS NASUS LARYNX, V35, P269, DOI 10.1016/j.anl.2007.04.004; Nakashima T, 2009, ACTA OTO-LARYNGOL, V129, P5, DOI 10.1080/00016480902729827; Nakashima T, 2007, LARYNGOSCOPE, V117, P415, DOI 10.1097/MLG.0b013e31802c300c; Merchant SN, 2005, OTOL NEUROTOL, V26, P74, DOI 10.1097/00129492-200501000-00013; Katayama N, 2010, ACTA OTO-LARYNGOL, V130, P917, DOI 10.3109/00016480903573187; [Anonymous], 1995, OTOLARYNGOL HEAD NEC, V113, P186; Naganawa S, 2014, JPN J RADIOL, V32, P191, DOI 10.1007/s11604-014-0290-4; Ayache D, 2007, ADV OTO-RHINO-LARYNG, V65, P308, DOI 10.1159/000098850; Doherty JK, 2004, OTOL NEUROTOL, V25, P457, DOI 10.1097/00129492-200407000-00010; FRANKLIN DJ, 1990, AM J OTOL, V11, P135; Kato M, 2011, OTOL NEUROTOL, V32, P1480, DOI 10.1097/MAO.0b013e318235568d; LISTON SL, 1984, LARYNGOSCOPE, V94, P1003; Mutlu C, 1998, EUR ARCH OTO-RHINO-L, V255, P189, DOI 10.1007/s004050050041; Naganawa S, 2012, MAGN RESON MED SCI, V11, P213; Nakashima T, 2009, ACTA OTO-LARYNGOL, V129, P9, DOI 10.1080/00016480902729801; Rangheard AS, 2001, AM J NEURORADIOL, V22, P1171; SHEA JJ, 1994, AM J OTOL, V15, P348; Sone M, 2013, OTOL NEUROTOL, V34, P1559, DOI 10.1097/MAO.0b013e3182a44476; Virk JS, 2013, OTOL NEUROTOL, V34, pE55, DOI 10.1097/MAO.0b013e318298ac96; Yamamoto M, 2009, AUDIOL NEURO-OTOL, V15, P254; YOON TH, 1990, OTOLARYNG HEAD NECK, V103, P107	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	AUG	2015	36	7					1146	1150		10.1097/MAO.0000000000000685		5	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CN4OK	WOS:000358409500003		
J	Maeda, Y; Fukushima, K; Kariya, S; Orita, Y; Nishizaki, K				Maeda, Yukihide; Fukushima, Kunihiro; Kariya, Shin; Orita, Yorihisa; Nishizaki, Kazunori			Dexamethasone Regulates Cochlear Expression of Deafness-associated Proteins Myelin Protein Zero and Heat Shock Protein 70, as Revealed by iTRAQ Proteomics	OTOLOGY & NEUROTOLOGY			English	Article							SENSORINEURAL HEARING-LOSS; NITRIC-OXIDE PRODUCTION; INTRATYMPANIC DEXAMETHASONE; CORTICOSTEROID-THERAPY; GUINEA-PIG; MPZ GENE; IN-VIVO; GLUCOCORTICOIDS; OTOTOXICITY; MUTATION	Aim Using proteomics, we aimed to identify the proteins differentially regulated by dexamethasone in the mouse cochlea based on mass-spectrometry data. Background Glucocorticoid therapy is widely used for many forms of sensorineural hearing loss; however, the molecular mechanism of its action in the cochlea remains poorly understood. Methods Dexamethasone or control saline was intratympanically applied to the cochleae of mice. Twelve hours after application, proteins differentially regulated by dexamethasone in the cochlea were analyzed by isobaric Tag for Relative and Absolute Quantitation (iTRAQ)-mass spectrometry. Next, dexamethasone-dependent regulation of these proteins was verified in the cochleae of mice with noise-induced hearing loss (NIHL) and systemic administration of dexamethasone by western blotting. Immunolocalizations of these proteins were examined in cochleae with NIHL. Results A total of 247 proteins with a greater than 95% confidence interval of protein identification were found, and 11 differentially expressed proteins by dexamethasone were identified by the iTRAQ-mass spectrometry. One protein, myelin protein zero (Mpz), was upregulated (1.870 +/- 0.201-fold change, p < 0.01) at 6 hours post-systemic dexamethasone and noise exposure in a mouse model of NIHL. Heat shock protein 70 (Hsp70) was downregulated (0.511 +/- 0.274-fold change, p < 0.05) at 12 hours post-systemic dexamethasone. Immunohistochemistry confirmed Mpz localization to the efferent and afferent processes of the spiral neurons, whereas Hsp70 showed a more ubiquitous expression pattern in the cochlea. Conclusion Both Mpz and Hsp70 have been reported to be closely associated with sensorineural hearing loss in humans. Dexamethasone significantly modulated the expression levels of these proteins in the cochleae of mice.	[Maeda, Yukihide; Fukushima, Kunihiro; Kariya, Shin; Orita, Yorihisa; Nishizaki, Kazunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama 7008558, Japan	Maeda, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	maedayj@yahoo.co.jp			Japanese Ministry of Health, Labour and Welfare [H23-NANCHI-IPPAN-021]; Japanese Ministry of Education, Culture, Sports, Science and Technology [KAKEN 22591880, 25462640]	This research was funded by grants from the Japanese Ministry of Health, Labour and Welfare (H23-NANCHI-IPPAN-021) and the Japanese Ministry of Education, Culture, Sports, Science and Technology (KAKEN 22591880 and 25462640).	Starr A, 2003, BRAIN, V126, P1604, DOI 10.1093/brain/awg156; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585; Zuchner S, 2004, NEUROMUSCULAR DISORD, V14, P147, DOI 10.1016/j.nmd.2003.10.003; Trune DR, 2012, ANAT REC, V295, P1928, DOI 10.1002/ar.22576; Hayashi R, 2004, EUR J PHARMACOL, V500, P51, DOI 10.1016/j.ejphar.2004.07.011; Daldal A, 2007, OTOLARYNG HEAD NECK, V137, P747, DOI 10.1016/j.otohns.2007.05.068; Nagashima R, 2006, BRAIN RES, V1117, P101, DOI 10.1016/j.brainres.2006.07.113; Grewal AS, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-19; Takemura K, 2004, HEARING RES, V196, P58, DOI 10.1016/j.heares.2004.06.003; Blass S, 2001, ARTHRITIS RHEUM, V44, P761; Desarnaud F, 2000, BRAIN RES, V865, P12, DOI 10.1016/S0006-8993(00)02130-2; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Haynes DS, 2007, LARYNGOSCOPE, V117, P3, DOI 10.1097/01.mlg.0000245058.11866.15; Yang J, 2008, ACTA OTO-LARYNGOL, V128, P496, DOI 10.1080/00016480701558906; Rauch SD, 2011, JAMA-J AM MED ASSOC, V305, P2071, DOI 10.1001/jama.2011.679; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; Bonaguri C, 2007, AUTOIMMUNITY, V40, P73, DOI 10.1080/08916930601119377; CHEN H, 1995, GENOMICS, V27, P389, DOI 10.1006/geno.1995.1068; Darville LNF, 2013, J PROTEOME RES, V12, P3620, DOI 10.1021/pr4001338; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Gong SS, 2002, ANN OTO RHINOL LARYN, V111, P275; Gong WT, 2012, JARO-J ASSOC RES OTO, V13, P29; Gratton MA, 2011, HEARING RES, V277, P211, DOI 10.1016/j.heares.2010.12.014; Himeno C, 2002, HEARING RES, V167, P61, DOI 10.1016/S0378-5955(02)00345-3; Hong SM, 2009, OTOLARYNG HEAD NECK, V141, P579, DOI 10.1016/j.otohns.2009.08.009; Ikezono T, 2001, BBA-MOL BASIS DIS, V1535, P258, DOI 10.1016/S0925-4439(00)00101-0; IMAI E, 1993, J BIOL CHEM, V268, P5353; Kabzinska D, 2007, AM J MED GENET A, V143A, P2196, DOI 10.1002/ajmg.a.31908; Kakehata S, 2011, AUDIOL NEURO-OTOL, V16, P191, DOI 10.1159/000320269; Maeda Y, 2012, ACTA OTO-LARYNGOL, V132, P4, DOI 10.3109/00016489.2011.619571; Maeda Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058775; Morawski K, 2009, OTOL NEUROTOL, V30, P851, DOI 10.1097/MAO.0b013e3181b12296; Moriyama M, 2007, ACTA OTO-LARYNGOL, V127, P676, DOI 10.1080/00016480600987859; Morizane I, 2005, NEUROSCI LETT, V391, P62, DOI 10.1016/j.neulet.2005.08.038; PARK YS, 1994, ANN OTO RHINOL LARYN, V103, P896; Shi XR, 2003, BRAIN RES, V967, P1, DOI 10.1016/S00066-8993(02)04090-8; Tabuchi K, 2010, CURR NEUROPHARMACOL, V8, P128, DOI 10.2174/157015910791233123; Tabuchi K, 2006, OTOL NEUROTOL, V27, P1176, DOI 10.1097/01.mao.0000226313.82069.3f; Usami S, 2003, EUR J HUM GENET, V11, P744, DOI 10.1038/sj.ejhg.5201043; Usami S, 2008, NEUROSCIENCE, V154, P22, DOI 10.1016/j.neuroscience.2008.03.018; Watanabe K, 2000, HEARING RES, V145, P149, DOI 10.1016/S0378-5955(00)00086-1	41	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	AUG	2015	36	7					1255	1265		10.1097/MAO.0000000000000748		11	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CN4OK	WOS:000358409500018		
J	Matsubayashi, M; Kanamori, K; Sadahiro, M; Tokoro, M; Abe, N; Haritani, M; Shibahara, T				Matsubayashi, Makoto; Kanamori, Kenta; Sadahiro, Masayuki; Tokoro, Masaharu; Abe, Niichiro; Haritani, Makoto; Shibahara, Tomoyuki			First molecular identification of Entamoeba polecki in a piglet in Japan and implications for aggravation of ileitis by coinfection with Lawsonia intracellularis	PARASITOLOGY RESEARCH			English	Article						Entamoeba polecki; Lawsonia intracellularis; Pathogenicity; Piglets	RIBOSOMAL-RNA GENES; PROLIFERATIVE ENTEROPATHY; INTESTINAL PROTOZOA; HISTOLYTICA; DISPAR; ASSAY; PIGS	Parasitic Entamoeba spp. are found in many vertebrate species including humans, as well as many livestock including pigs. In pigs, three Entamoeba spp., E. suis, and E. polecki and E. histolytica as zoonotic species, have been identified, but their pathogenicity has not been fully characterized. Here, we report the bacteriological, virological, and histopathological examination of three piglets with chronic diarrhea. Two animals appeared to be additionally infected with Lawsonia intracellularis, which caused a characteristic proliferative ileitis. In the piglet infected with Entamoeba spp., the trophozoites (approximately 10-15 mu m with one nucleus in their cytoplasm) invaded into the lamina propria and the disease was worsened by the formation of ulcers and pseudomembranes. Genetic analysis identified the parasite as E. polecki (99.5 % identity). Although E. polecki in humans or animals might be less pathogenic in the case of a single infection, coinfections with other pathogens including L. intracellularis may increase the severity of the disease.	[Matsubayashi, Makoto; Haritani, Makoto; Shibahara, Tomoyuki] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Kanamori, Kenta; Sadahiro, Masayuki] Chubu Livestock Dis Diagnost Ctr, Shimada, Shizuoka 4270007, Japan; [Tokoro, Masaharu] Kanazawa Univ, Grad Sch Med Sci, Dept Parasitol, Kanazawa, Ishikawa 9208640, Japan; [Abe, Niichiro] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Tennoji Ku, Osaka 5430026, Japan	Shibahara, T (reprint author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	tshiba@affrc.go.jp					Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; Lawson GHK, 2000, J COMP PATHOL, V122, P77, DOI 10.1053/jcpa.1999.0347; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Kawashima K, 1996, J COMP PATHOL, V114, P315, DOI 10.1016/S0021-9975(96)80053-3; McOrist S, 2005, VET J, V170, P8, DOI 10.1016/j.tvjl.2004.04.008; CLARK CG, 1991, MOL BIOCHEM PARASIT, V49, P297, DOI 10.1016/0166-6851(91)90073-F; Clark CG, 2006, INT J SYST EVOL MICR, V56, P2235, DOI 10.1099/ijs.0.64208; CLARK CG, 1995, J EUKARYOT MICROBIOL, V42, P590, DOI 10.1111/j.1550-7408.1995.tb05912.x; DESOWITZ RS, 1986, ANN TROP MED PARASIT, V80, P399; Evangelopoulos A, 2000, ANN TROP MED PARASIT, V94, P233, DOI 10.1080/00034980050006401; Garcia LS, 1997, DIAGNOSTIC MED PARAS; He GZ, 2012, PARASITOL RES, V111, P939, DOI 10.1007/s00436-012-2841-x; Matsubayashi M, 2014, PARASITOL RES, V113, P3023, DOI 10.1007/s00436-014-3965-y; NOBLE GA, 1952, J PARASITOL, V38, P571, DOI 10.2307/3273985; Prophet EB, 1992, LAB METHODS HISTOTEC, P132; Schuster FL, 2004, VET PARASITOL, V126, P91, DOI 10.1016/j.vetpar.2004.09.019; Shimizu C, 2010, J COMP PATHOL, V143, P303, DOI 10.1016/j.jcpa.2010.03.005; Solaymani-Mohammadi S, 2004, J WILDLIFE DIS, V40, P801; TACHIBANA H, 1991, J INFECT DIS, V164, P825; Uga S, 2000, VET PARASITOL, V94, P27, DOI 10.1016/S0304-4017(00)00338-1; Verweij JJ, 2001, J CLIN MICROBIOL, V39, P1644, DOI 10.1128/JCM.39.4.1644-1646.2001; Verweij JJ, 2003, J CLIN MICROBIOL, V41, P5041, DOI 10.1128/JCM.41.11.5041-5045.2003	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	AUG	2015	114	8					3069	3073		10.1007/s00436-015-4509-9		5	Parasitology	Parasitology	CN4OV	WOS:000358410600029		
J	Abe, N; Matsubara, K; Tamukai, K; Miwa, Y; Takami, K				Abe, Niichiro; Matsubara, Katsuki; Tamukai, Kenichi; Miwa, Yasutsugu; Takami, Kazutoshi			Molecular evidence of Sarcocystis species in captive snakes in Japan	PARASITOLOGY RESEARCH			English	Article						Sarcocystis zuoi; Captive snakes; Molecular identification; 18S ribosomal RNA gene	LIFE-CYCLE; SP-N; RATTUS-NORVEGICUS; COCCIDIA; HOST; SARCOSPORIDIA; TRANSMISSION; APICOMPLEXA; VIPER; SPP.	Sarcocystis nesbitti, using snakes as the definitive host, is a causative agent of acute human muscular sarcocystosis in Malaysia. Therefore, it is important to explore the distribution and prevalence of S. nesbitti in snakes. Nevertheless, epizootiological information of S. nesbitti in snakes remains insufficient because few surveys have assessed Sarcocystis infection in snakes in endemic countries. In Japan, snakes are popular exotic pet animals that are imported from overseas, but the degree of Sarcocystis infection in them remains unclear. The possibility exists that muscular sarcocystosis by S. nesbitti occurs in contact with captive snakes in non-endemic countries. For a total of 125 snake faecal samples from 67 snake species collected at animal hospitals, pet shops and a zoo, this study investigated the presence of Sarcocystis using polymerase chain reaction (PCR) for the 18S ribosomal RNA gene (18S rDNA). Four (3.2 %) faecal samples were positive by PCR. Phylogenetic analysis of the 18S rDNA sequences obtained from four amplification products revealed one isolate from a beauty snake (Elaphe taeniura), Sarcocystis zuoi, which uses rat snakes as the definitive host. The isolate from a Macklot's python (Liasis mackloti) was closely related with unidentified Sarcocystis sp. from reticulated pythons in Malaysia. The remaining two isolates from tree boas (Corallus spp.) were closely related with Sarcocystis lacertae, Sarcocystis gallotiae and unidentified Sarcocystis sp. from smooth snakes, Tenerife lizards and European shrews, respectively. This report is the first of a study examining the distribution of Sarcocystis species in captive snakes in Japan.	[Abe, Niichiro] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Tennoji Ku, Osaka 5430026, Japan; [Matsubara, Katsuki] Banquet Anim Hosp, Setagaya Ku, Tokyo 1540001, Japan; [Tamukai, Kenichi] Den En Chofu Anim Hosp, Ota Ku, Tokyo 1450071, Japan; [Miwa, Yasutsugu] Miwa Exot Anim Hosp, Toshima Ku, Tokyo 1700003, Japan; [Takami, Kazutoshi] Osaka Municipal Tennoji Zool Gardens, Tennoji Ku, Osaka 5430063, Japan	Abe, N (reprint author), Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Tennoji Ku, 8-34 Tojo Cho, Osaka 5430026, Japan.	ni-abe@city.osaka.lg.jp			Japan Society for the Promotion of Sciences (JSPS) [26460818]	This study was supported by a Grant-in-Aid for Scientific Research (C) (26460818) from the Japan Society for the Promotion of Sciences (JSPS).	AbuBaker S, 2013, EMERG INFECT DIS, V19, P1989; Odening K, 1998, SYST PARASITOL, V41, P209, DOI 10.1023/A:1006090232343; Slapeta JR, 2003, MOL PHYLOGENET EVOL, V27, P464, DOI 10.1016/S1055-7903(03)00018-6; MATUSCHKA FR, 1987, PARASITOL RES, V74, P88, DOI 10.1007/BF00534938; Fayer R, 2015, CLIN MICROBIOL REV, V28, P295, DOI 10.1128/CMR.00113-14; BEAVER PC, 1981, J PARASITOL, V67, P241, DOI 10.2307/3280645; BLEDSOE B, 1980, J PROTOZOOL, V27, P93; ENZEROTH R, 1985, ARCH PROTISTENKD, V129, P19; Esposito DH, 2015, CLIN INFECT DIS, V59, P1401; HAFNER U, 1984, Z PARASITENKD, V70, P715, DOI 10.1007/BF00927123; Hu JJ, 2012, J PARASITOL, V98, P550, DOI 10.1645/GE-2831.1; JAKEL T, 1995, J PARASITOL, V81, P626, DOI 10.2307/3283863; Lau YL, 2014, AM J TROP MED HYG, V90, P361, DOI 10.4269/ajtmh.12-0678; Lau YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-257; LINDSAY DS, 1992, J HELMINTHOL SOC W, V59, P9; MATUSCHKA FR, 1986, J PARASITOL, V72, P226, DOI 10.2307/3281596; MATUSCHKA F-R, 1987, Parasitology Research, V73, P33, DOI 10.1007/BF00536333; Morsy K, 2012, PARASITOL RES, V110, P355, DOI 10.1007/s00436-011-2496-z; MUNDAY BL, 1980, J WILDLIFE DIS, V16, P83; Slapeta JR, 1999, PARASITOL RES, V85, P758, DOI 10.1007/s004360050627; Slapeta JR, 2001, INT J PARASITOL, V31, P413, DOI 10.1016/S0020-7519(01)00127-8; Tian M, 2012, VET PARASITOL, V183, P373, DOI 10.1016/j.vetpar.2011.07.034; Volf J, 1999, FOLIA PARASIT, V46, P257	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	AUG	2015	114	8					3175	3179		10.1007/s00436-015-4564-2		5	Parasitology	Parasitology	CN4OV	WOS:000358410600043		
J	Shimada, S; Watanabe, T; Sato, S				Shimada, Shuichiro; Watanabe, Toru; Sato, Seiichi			A Patient with Kawasaki Disease Following Influenza Vaccinations	PEDIATRIC INFECTIOUS DISEASE JOURNAL			English	Letter									[Shimada, Shuichiro; Watanabe, Toru; Sato, Seiichi] Niigata City Gen Hosp, Dept Pediat, Niigata, Japan	Watanabe, T (reprint author), Niigata City Gen Hosp, Dept Pediat, Niigata, Japan.	twata@hosp.niigata.niigata.jp					Zafrir Y, 2009, JCR-J CLIN RHEUMATOL, V15, P269, DOI 10.1097/RHU.0b013e3181b56177; Watanabe T, 2011, PEDIATR NEPHROL, V26, P795, DOI 10.1007/s00467-010-1722-8; Schmoeller D, 2009, PEDIATR INFECT DIS J, V28, P1037, DOI 10.1097/INF.0b013e3181bbc571; Miron D, 2003, CLIN RHEUMATOL, V22, P461, DOI 10.1007/s10067-003-0785-3; Sundel RP, 2011, TXB PEDIAT RHEUMATOL, P505	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0891-3668	1532-0987		PEDIATR INFECT DIS J	Pediatr. Infect. Dis. J.	AUG	2015	34	8					913	913		10.1097/INF.0000000000000713		1	Immunology; Infectious Diseases; Pediatrics	Immunology; Infectious Diseases; Pediatrics	CN4PE	WOS:000358411500027		
J	Hatanaka, R; Gusev, O; Cornette, R; Shimura, S; Kikuta, S; Okada, J; Okuda, T; Kikawada, T				Hatanaka, Rie; Gusev, Oleg; Cornette, Richard; Shimura, Sachiko; Kikuta, Shingo; Okada, Jun; Okuda, Takashi; Kikawada, Takahiro			Diversity of the expression profiles of late embryogenesis abundant (LEA) protein encoding genes in the anhydrobiotic midge Polypedilum vanderplanki	PLANTA			English	Article						Anhydrobiosis; Desiccation tolerance; Gene expression; Late embryogenesis abundant (LEA) protein; Polypedilum vanderplanki; Subcellular localization	ARABIDOPSIS-THALIANA; MODEL PEPTIDES; IDENTIFICATION; TREHALOSE; EVOLUTION; STRESS; PLANTS	Main conclusion In the anhydrobiotic midge Polypedilum vanderplanki , LEA family proteins are likely to play distinct temporal and spatial roles in the larvae throughout the process of desiccation and rehydration. The larvae of the anhydrobiotic midge, P. vanderplanki, which can tolerate almost complete desiccation, accumulate late embryogenesis abundant (LEA) proteins in response to drying. Using complete genome data of the midge, we have identified 27 PvLea1-like genes based on the similarity to previously characterized PvLea1 gene belonging to group 3 LEA proteins. Generally, group 3 LEA proteins are characterized by several repetitions of an 11-mer motif. However, some PvLea genes lack the canonical motif in their sequences. We performed the detailed characterization of all 27 PvLea genes in terms of biochemical and biophysical properties and conserved motifs. The motif analysis among their amino acid sequences revealed that all 27 PvLEA proteins have at least one of two types of motifs (motif 1: G AKDTTKEKLGE AKDATAEKLG or motif 2: KD ILExAKDKLxD AKDAVKEKL), indicating the presence of at least two repeated 11-mer LEA motifs. Most of PvLEA proteins were localized to the cytosol. We also performed quantitative real-time PCR of all 27 PvLea genes in detail during the process of desiccation and rehydration. The expression of these genes was upregulated at the beginning of dehydration, the latter phase of the desiccation process and on rehydration process. These data suggested that each LEA protein is likely to play distinct temporal and spatial roles in the larvae throughout the process of desiccation and rehydration.	[Hatanaka, Rie; Gusev, Oleg; Cornette, Richard; Shimura, Sachiko; Kikuta, Shingo; Okada, Jun; Okuda, Takashi; Kikawada, Takahiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Gusev, Oleg] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Gusev, Oleg] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, ISS Sci Project Off, Tsukuba, Ibaraki, Japan; [Kikuta, Shingo] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn BASE, Tokyo, Japan	Kikawada, T (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	kikawada@affrc.go.jp	Gusev, Oleg/D-9383-2011; Kikuta, Shingo/J-5219-2013; Kikawada, Takahiro/A-1289-2010	Kikuta, Shingo/0000-0002-3925-576X; Kikawada, Takahiro/0000-0002-2329-9282	MEXT/JSPS KAKENHI, Japan [12JJ10847, 23780055, 25128712, 25128714, 60414900]; Russian Government; Russian Foundation for Basic Research [14-04-01657_A]; Ministry of Education of Russia [N 14.584.21.0002]	We extend our gratitude to the Federal Ministry of Environment of Nigeria for permitting research on P. vanderplanki. We thank Y. Saito, T. Shiratori, Y. Kikuzato and A. Saito for technical assistance. This work was supported in part by Grants-in-Aids from MEXT/JSPS KAKENHI (Grant Numbers 12JJ10847 for RH; 23780055 for RC; 25128712, 25128714 and 60414900 for TK), Japan; subsidy of the Russian Government to support the Program of competitive growth of Kazan Federal University among world class academic centers and universities and Russian Foundation for Basic Research No 14-04-01657_A and Ministry of Education of Russia Subsidy N 14.584.21.0002 for international cooperation.	Hatanaka R, 2013, INSECT BIOCHEM MOLEC, V43, P1055, DOI 10.1016/j.ibmb.2013.08.004; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Deng C, 2010, P NATL ACAD SCI USA, V107, P21593, DOI 10.1073/pnas.1007883107; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Lynch M, 2000, GENETICS, V154, P459; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; INGLE J, 1975, PLANT PHYSIOL, V55, P496, DOI 10.1104/pp.55.3.496; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Oliver MJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-89; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Cornette R, 2011, IUBMB LIFE, V63, P419, DOI 10.1002/iub.463; Furuki T, 2012, BBA-PROTEINS PROTEOM, V1824, P891, DOI 10.1016/j.bbapap.2012.04.013; Furuki T, 2011, BIOCHEMISTRY-US, V50, P7093, DOI 10.1021/bi200719s; Gusev O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5784; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; HINTON HE, 1951, P ZOOL SOC LOND, V121, P371; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Mitsumasu K, 2010, FEBS J, V277, P4215, DOI 10.1111/j.1742-4658.2010.07811.x	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	AUG	2015	242	2					451	459		10.1007/s00425-015-2284-6		9	Plant Sciences	Plant Sciences	CN1GZ	WOS:000358168000009		
J	Thiebot, JB; Demay, J; Marteau, C; Weimerskirch, H				Thiebot, Jean-Baptiste; Demay, Jeremie; Marteau, Cedric; Weimerskirch, Henri			The rime of the modern mariner: evidence for capture of yellow-nosed albatross from Amsterdam Island in Indian Ocean longline fisheries	POLAR BIOLOGY			English	Article						Seabird; Bycatch; Thalassarche carteri; Indian Ocean Tuna Commission; Non-breeding period; Sub-lethal effects	SEABIRD BYCATCH; SOUTHERN-OCEAN; MORTALITY; MANAGEMENT; IMPACT	Commercial fisheries currently pose a serious threat at sea to the conservation of a number of pelagic seabirds. However, these interactions are complex, and reports on population-specific bycatch in the high seas are scarce. Here we report the case of an Indian yellow-nosed albatross Thalassarche carteri re-sighted on Amsterdam Island after an apparent capture by an Indonesian long-liner, as indicated by a message attached to the bird. This record demonstrates that Amsterdam birds may interact with long-liners indeed, at least during winter, and that such interactions are not systematically lethal. We suggest that bycatch sub-lethal effects should be investigated at colonies with high risks of individual capture at sea.	[Thiebot, Jean-Baptiste; Demay, Jeremie; Weimerskirch, Henri] CNRS, UMR 7372, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Thiebot, Jean-Baptiste; Demay, Jeremie; Weimerskirch, Henri] Univ La Rochelle, F-79360 Villiers En Bois, France; [Thiebot, Jean-Baptiste; Marteau, Cedric] TAAF, Reserve Nat Natl Terres Australes Francaises, St Denis 97410, Reunion	Thiebot, JB (reprint author), Natl Inst Polar Res, 10-3 Midoricho, Tachikawa, Tokyo 1908518, Japan.	jbthiebot@gmail.com			Institut Polaire Francais Paul-Emile Victor (IPEV) [109]; Terres Australes et Antarctiques Francaises (TAAF); Zone Atelier Antarctique (INSU-CNRS)	We are grateful to three anonymous reviewers for their constructive comments. Fieldwork was supported financially and logistically by the Institut Polaire Francais Paul-Emile Victor (IPEV, Program No. 109: resp. H. Weimerskirch), the Terres Australes et Antarctiques Francaises (TAAF), and the Zone Atelier Antarctique (INSU-CNRS).	Weimerskirch H, 2004, POLAR BIOL, V27, P374, DOI 10.1007/s00300-004-0600-x; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Delord K, 2014, MAR POLICY, V48, P1, DOI 10.1016/j.marpol.2014.02.019; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Huang HW, 2010, FISH RES, V106, P261, DOI 10.1016/j.fishres.2010.08.005; Phillips RA, 2010, BIOL CONSERV, V143, P501, DOI 10.1016/j.biocon.2009.11.020; WEIMERSKIRCH H, 1985, EMU, V85, P22; Association Amicale des Missions Australes et Polaires Francaises, 1998, TROIS NAUFR TROIS IL; Barbraud C, 2011, KERGUELEN PLATEAU MA, P287; BirdLife International, 2015, SPEC FACTSH THAL CAR; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; IOTC, 2015, COMPL WORKSH COLL RE; Lebreton JD, 2013, BIRD CONSERV INT, V23, P25, DOI 10.1017/S0959270912000299; Nel D.C., 1999, CCAMLR Science, V6, P85; Otley H, 2007, POLAR BIOL, V30, P359, DOI 10.1007/s00300-006-0192-8; Petersen SL, 2009, AFR J MAR SCI, V31, P191, DOI 10.2989/AJMS.2009.31.2.7.879; Rolland V, 2009, BIOL CONSERV, V142, P1084, DOI 10.1016/j.biocon.2008.12.030; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Weimerskirch H, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P84	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4060	1432-2056		POLAR BIOL	Polar Biol.	AUG	2015	38	8					1297	1300		10.1007/s00300-015-1680-5		4	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CM9PQ	WOS:000358041600017		
J	Aoyama, M; Koda, T; Miyata, K; Nishio, T; Nishioka, A				Aoyama, Masataka; Koda, Tomonori; Miyata, Ken; Nishio, Taichi; Nishioka, Akihiro			Mechanical and Thermal Properties of Potassium Salts of Poly(ethylene-co-ethylacrylate): Polyolefin Ionomers in the Absence of Acid Groups	POLYMER ENGINEERING AND SCIENCE			English	Article							ETHYLENE IONOMERS; MELT RHEOLOGY	The thermal and mechanical properties of ionomers prepared by partial saponification of poly(ethylene-co-ethylacrylate) (EEA) with potassium were investigated by using differential scanning calorimetry (DSC) and dynamic mechanical analysis (DMA). The Vicat softening temperature (VST) and bending modulus were also evaluated. Molecular design of the present EEA-based ionomers eliminates acid groups, which affect ionic aggregates for conventional ionomers. The DSC results showed that the melting enthalpy and main crystallization temperature decreased as the ion content increased, whereas on the other hand, the crystal melting temperature at about 360 K did not depend on the ion content, and a secondary exo-thermal peak was observed in the cooling process. The variance of the VST increased as the crystallinity decreased. The temperature-dependent curves of DMA data of the EEA-based potassium ionomers with a higher ion content showed elastic plateau even at temperatures above their crystal melting points. Our results indicate the existence of strong cross-linking mediated by ion aggregates. The quadratic increase of stiffness as a function of ion content, increasing VST with decreasing crystallinity, and elastic plateau of temperature-dependent moduli above crystal melting temperature are significant characteristics of the EEA-based potassium ionomers, which contain ionic aggregations without acid group presence. (C) 2014 Society of Plastics Engineers	[Aoyama, Masataka] Du Pont Mitsui Polychem Co Ltd, Minato Ku, Tokyo 1057117, Japan; [Aoyama, Masataka; Koda, Tomonori; Miyata, Ken; Nishio, Taichi; Nishioka, Akihiro] Yamagata Univ, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Nishioka, A (reprint author), Yamagata Univ, Dept Polymer Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	nishioka@yz.yamagata-u.ac.jp			JSPS KAKENHI [23680072]	Contract grant sponsor: JSPS KAKENHI; contract grant number: 23680072.	YARUSSO DJ, 1983, MACROMOLECULES, V16, P1871, DOI 10.1021/ma00246a013; MARX CL, 1974, J MACROMOL SCI PHYS, VB  9, P19, DOI 10.1080/00222347408204538; Vanhoorne P, 1996, MACROMOLECULES, V29, P598, DOI 10.1021/ma951143m; HIRASAWA E, 1991, J APPL POLYM SCI, V42, P351, DOI 10.1002/app.1991.070420207; Eisenberg A., 1977, POLYM PHYS, V2; Eisenberg A., 1990, MACROMOLECULES, V23, P4089; Holliday L, 1975, IONIC POLYM; Kalista SJ, 2013, POLYM CHEM-UK, V4, P4910, DOI 10.1039/c3py00095h; Kosaka Y., 1969, KOBUNSHI, V18, P386; LONGWORT.R, 1968, NATURE, V218, P85, DOI 10.1038/218085a0; MacKnight W. J., 1974, J POLYM SCI POLYM S, V45, P113; MacKnight W.J., 1968, POLYM ENG SCI, V8, P267, DOI 10.1002/pen.760080406; Mark H.F., 1986, ENCY POLYM SCI ENG, V2nd, P487; Morris B.A., 2003, SPE ANTEC, V61, P3157; Nishioka A, 2001, POLYMER, V42, P7907, DOI 10.1016/S0032-3861(01)00268-3; Nishioka A, 2005, NIHON REOROJI GAKK, V33, P199, DOI 10.1678/rheology.33.199; Rees R.W., 1965, POLYMER PREPRINTS, V6, P296; Rees R.W., 1965, POLYMER PREPRINTS, V6, P287; Statz R.J., 1988, POLYM PREPRINTS, V29, P435; Wang H., 1996, U.S. Patent, Patent No. [5,569,722, 5569722]; WUNDERLI.B, 1967, J POLYM SCI A2, V5, P987, DOI 10.1002/pol.1967.160050514; Yano S., 2003, IONOMER ION CONTAINI, P184	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-3888	1548-2634		POLYM ENG SCI	Polym. Eng. Sci.	AUG	2015	55	8					1843	1848		10.1002/pen.24023		6	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CN1RM	WOS:000358197700015		
J	Saikusa, K; Shimoyama, S; Asano, Y; Nagadoi, A; Sato, M; Kurumizaka, H; Nishimura, Y; Akashi, S				Saikusa, Kazumi; Shimoyama, Singo; Asano, Yuuki; Nagadoi, Aritaka; Sato, Mamoru; Kurumizaka, Hitoshi; Nishimura, Yoshifumi; Akashi, Satoko			Charge-neutralization effect of the tail regions on the histone H2A/H2B dimer structure	PROTEIN SCIENCE			English	Article						histone H2A; H2B dimer; acetylation; deimination; electrospray ionization; ion mobility-mass spectrometry	IONIZATION MASS-SPECTROMETRY; ION MOBILITY; ELECTROSPRAY-IONIZATION; ARGININE METHYLATION; DEIMINATION; CHAPERONES; ACTIVATION; RESOLUTION; COMPLEXES	It is well known that various modifications of histone tails play important roles in the regulation of transcription initiation. In this study, some lysine (Lys) and arginine (Arg) residues were acetylated and deiminated, respectively, in the histone H2A/H2B dimer, and charge-neutralization effects on the dimer structure were studied by native mass spectrometry. Given that both acetylation and deimination neutralize the positive charges of basic amino acid residues, it had been expected that these modifications would correspondingly affect the gas-phase behavior of the histone H2A/H2B dimer. Contrary to this expectation, it was found that Arg deimination led to greater difficulty of dissociation of the dimer by gas-phase collision, whereas acetylation of Lys residues did not cause such a drastic change in the dimer stability. In contrast, ion mobility-mass spectrometry (IM-MS) experiments showed that arrival times in the mobility cell both of acetylated and of deiminated dimer ions changed little from those of the unmodified dimer ions, indicating that the sizes of the dimer ions did not change by modification. Charge neutralization of Arg, basicity of which is higher than Lys, might have triggered some alteration of the dimer structure that cannot be found in IM-MS but can be detected by collision in the gas phase.	[Saikusa, Kazumi; Shimoyama, Singo; Asano, Yuuki; Nagadoi, Aritaka; Sato, Mamoru; Nishimura, Yoshifumi; Akashi, Satoko] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Akashi, S (reprint author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	akashi@tsurumi.yokohama-cu.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology, Japan [26505009]; Sumitomo Foundation	Grant sponsors: Platform for Drug Discovery, Informatics, and Structural Life Science (to H.K., Y.N., and S.A.) and Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant number: 26505009 (to S.A.); Grant sponsor: Sumitomo Foundation (to S.A.).	De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Testa L, 2011, ANAL CHEM, V83, P6459, DOI 10.1021/ac201740z; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Akashi S, 2009, ANAL CHEM, V81, P2218, DOI 10.1021/ac802354j; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Luger K, 1997, NATURE, V389, P251; Kaltashov IA, 2005, ANAL CHEM, V77, P5370, DOI 10.1021/ac050511; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Giles K, 2011, RAPID COMMUN MASS SP, V25, P1559, DOI 10.1002/rcm.5013; Saikusa K, 2013, ANALYST, V138, P1441, DOI 10.1039/c2an35878f; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Downard KM, 2011, FEBS J, V278, P4044, DOI 10.1111/j.1742-4658.2011.08309.x; Hunter EP, 2000, 69 NIST, P20899; Lide D. R., 1991, HDB CHEM PHYS; Saikusa K, 2013, ANAL CHEM, V85, P4165, DOI 10.1021/ac400395j; Saikusa K, 2015, ANAL CHEM, V87, P2220, DOI 10.1021/ac503689w; Shimoyama S, 2010, J MASS SPECTROM, V45, P900, DOI 10.1002/jms.1778; Varge-Weisz P, 2005, PROGRESS MOL SUBCELL, P1, DOI 10.1145/1101499.1101513	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	AUG	2015	24	8			SI		1224	1231		10.1002/pro.2673		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN1JQ	WOS:000358176100006		
J	Okumura, Y; Tachimori, H; Matsumoto, T; Nishi, D				Okumura, Yasuyuki; Tachimori, Hisateru; Matsumoto, Toshihiko; Nishi, Daisuke			Exposure to psychotropic medications prior to overdose: a case-control study	PSYCHOPHARMACOLOGY			English	Article						Drug poisoning; Acute poisoning; Drug dependence; Deliberate self-harm; Parasuicide; Suicide; Benzodiazepines; Psychotropic medications	INTENTIONAL DRUG OVERDOSE; REPETITION; HOSPITALS; SUICIDE; OSLO	Little is known about psychotropic medication prescriptions prior to drug overdose. We aimed to examine the possible associations between the risk of overdose and exposures to various psychotropic medications. We conducted a matched case-control study of 3 groups of patients aged 12-74 years, using a large-scale health insurance claims database in Japan (population 1.2 million). A total of 351 cases with drug poisoning were compared with two control groups without overdose: 1755 patients with any treatment (general controls) and those with depression (high-risk controls). Current, past, and nonusers were patients most recently exposed to psychotropic medications a parts per thousand currency sign90 days, 91-180 days, and a parts per thousand yen180 days before the index date. Current sedative-hypnotic use was associated with an increased odds of overdose relative to general control nonusers (odds ratio [OR], 21.5; 95 % confidence interval [CI], 9.7-47.8) and high-risk control nonusers (OR, 2.6; 95 % CI, 1.9-3.5). In the comparison of cases and high-risk controls, the ORs for overdose were higher among excessive dosage users than among usual dosage users (OR, 4.3; 95 % CI, 3.0-6.1), among barbiturate users than among benzodiazepine/Z-drug only users (OR, 4.5; 95 % CI, 2.3-8.7), and among multiple provider episodes than among single provider episodes (OR, 4.4; 95 % CI, 1.7-11.0). Psychiatrists prescribed more than 77 % of potentially questionable prescriptions. These results highlight the need for psychiatrists to monitor prescribed medications and balance the benefits and risks of pharmacological treatments.	[Okumura, Yasuyuki] Assoc Hlth Econ Res & Social Insurance & Welf, Inst Hlth Econ & Policy, Res Dept, Tokyo, Japan; [Tachimori, Hisateru; Nishi, Daisuke] Natl Ctr Neurol & Psychiat, Dept Mental Hlth Adm, Natl Inst Mental Hlth, Tokyo, Japan; [Matsumoto, Toshihiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Ctr Suicide Prevent, Dept Drug Dependence Res, Tokyo, Japan	Okumura, Y (reprint author), Assoc Hlth Econ Res & Social Insurance & Welf, Inst Hlth Econ & Policy, Res Dept, Tokyo, Japan.	yokumura@blue.zero.jp			Japan Society for the Promotion of Science [26870914]	The funding for the analysis and writing this article was provided by a Grant-in-Aid for Young Scientists (B) (No.: 26870914) by the Japan Society for the Promotion of Science. The authors are grateful to Ms. Makiko Kaneko for the dataset preparation from the JMDC database. We also would like to express our appreciation to Editage for providing editorial assistance.	Alfresa Pharma, 2013, IM TOFR TABL; Xiang YX, 2012, AM J EMERG MED, V30, P293, DOI 10.1016/j.ajem.2010.11.031; Reith DM, 2003, AUST NZ J PSYCHIAT, V37, P212; Sundararajan V, 2007, MED CARE, V45, P1210; Sarchiapone M, 2011, INT J ENV RES PUB HE, V8, P4550, DOI 10.3390/ijerph8124550; Islambulchilar M, 2009, HUM EXP TOXICOL, V28, P185, DOI 10.1177/0960327108099679; Heyerdahl F, 2009, BRIT J PSYCHIAT, V194, P73, DOI 10.1192/bjp.bp.107.048322; Corcoran P, 2013, NEUROPSYCHIATRY-LOND, V3, P285, DOI 10.2217/NPY.13.23; Griffin E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005557; Harvard Initiative for Global Health Institute for Health Metrics and Evaluation at the University of Washington Johns Hopkins University University of Queensland and World Health Organization, 2008, GLOB BURD DIS INJ RI; HENRY JA, 1995, BRIT MED J, V310, P221; Hirata K, 1998, JPN J HOSP PHARM, V24, P340; Hovda KE, 2008, CLIN TOXICOL, V46, P35, DOI 10.1080/15563650601185969; Inagaki A, 2012, JPN CLIN PSYCHOPHARM, V15, P1403; Inagaki A, 2006, JPN J CLIN PSYCHOPHA, V9, P1859; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Matsumoto T, 2012, JPN J ALCOHOL DRUG D, V47, P317; Oh SH, 2011, AM J EMERG MED, V29, P908, DOI 10.1016/j.ajem.2011.03.015; Okumura Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001857; Okumura Y, 2012, GEN HOSP PSYCHIAT, V34, P681, DOI 10.1016/j.genhosppsych.2012.07.009; Schwake L, 2009, INTENS CARE MED, V35, P266, DOI 10.1007/s00134-008-1250-1; Shih HI, 2013, PSYCHOPHARMACOLOGY, V229, P665, DOI 10.1007/s00213-013-3127-4; Shionogi, 2013, CHLORPR WINT; Statistics Bureau, 2013, POP EST 2012 TABL 1; Takeda Pharmaceutical Company, 2012, DIAZ CERC TABL; Tournier M, 2009, EUR ARCH PSY CLIN N, V259, P86, DOI 10.1007/s00406-008-0839-2; Urabe A, 2012, TODAYS DRUG THERAPY; Urban M, 2013, NEUROENDOCRINOL LETT, V34, P25; Varnik A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-61	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	AUG	2015	232	16					3101	3109		10.1007/s00213-015-3952-8		9	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CN4QF	WOS:000358414400020		
J	Nakanishi, N; Long, NV				Nakanishi, Noritsugu; Ngo Van Long			The Distributional and Allocative Impacts of Virtual Labor Mobility across Time Zones through Communication Networks	REVIEW OF INTERNATIONAL ECONOMICS			English	Article							CAPITAL UTILIZATION; TRADE; LOCATION; TASKS; GOODS	Using a specific-factors' model, with two goods (a shift-working good and a non-shift-working good), three factors (capital specific to shift-working, land specific to non-shift-working and labor) and two countries (Home and Foreign), which are located in different time zones, we highlight the impact of trade in labor services via communication networks on factor prices and production patterns. If two countries are identical in size, then under free trade in labor services, all workers work only in their local daytime, and night shift in each country is performed by imported labor services supplied by residents of the other country in their local daytime. Night-time wage becomes the same as daytime wage (a wage equalization result). Other factor prices are also equalized. In both countries, capital rental rate increases, while land rent decreases. However, if two countries are different in size, trade in labor services does not equalize wages: in the large country, wages for night-shift workers are higher than daytime wages and some residents work at night; in the small country, daytime wages become higher than night-time wages and no one works at night, and night-shift work is done by imported labor services from the large country. Land rent in the small country decreases. Land rent in the large country may or may not decrease, but it is always higher than in the small country. Capital rental rates in both countries are equalized and increase.	[Nakanishi, Noritsugu] Kobe Univ, Grad Sch Econ, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ngo Van Long] McGill Univ, Dept Econ, Montreal, PQ H3A 2T7, Canada	Nakanishi, N (reprint author), Kobe Univ, Grad Sch Econ, Nada Ku, Rokkodai Cho 2-1, Kobe, Hyogo 6578501, Japan.	nakanishi@econ.kobe-u.ac.jp; ngo.long@mcgill.ca			Japan Society for the Promotion of Science [22243024]	Nakanishi: Graduate School of Economics, Kobe University, Rokkodai-cho 2-1, Nada-ku, Kobe 657-8501, Japan. Tel: +81-78-803-6837 (Office direct); E-mail: nakanishi@econ.kobe-u.ac.jp. Long: Department of Economics, McGill University, Montreal H3A 2T7, Canada. E-mail: ngo.long@mcgill.ca. The authors are grateful to an anonymous referee for useful comments and suggestions. Noritsugu Nakanishi acknowledges the financial support of the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (A), No. 22243024].	Antras P, 2005, AM ECON REV, V95, P1054, DOI 10.1257/0002828054825600; Feenstra RC, 1998, J ECON PERSPECT, V12, P31; Grossman GA, 2008, AM ECON REV, V98, P1978, DOI 10.1257/aer.98.5.1978; Head K, 2009, EUR ECON REV, V53, P429, DOI 10.1016/j.euroecorev.2008.08.001; Baldwin R, 2014, J INT ECON, V92, P51, DOI 10.1016/j.jinteco.2013.10.002; BETANCOURT R, 1985, REV ECON STUD, V52, P311, DOI 10.2307/2297624; BETANCOURT R, 1984, SOUTH ECON J, V50, P734, DOI 10.2307/1057988; Cairncross F, 2001, DEATH DISTANCE; Christen E., 2012, 201214 U INNSBRUCK; Dettmer B., 2011, 2011003 JENA; DORNBUSCH R, 1980, Q J ECON, V95, P203, DOI 10.2307/1885496; Feenstra R. C., 2010, OFFSHORING GLOBAL EC; Grossman GM, 2012, ECONOMETRICA, V80, P593, DOI 10.3982/ECTA8700; Hanson G. H., 1996, POLITICAL EC TRADE P; Harris R. G., 1995, CANADIAN J EC, V26, P755; Helpman E., 1998, GEN PURPOSE TECHNOLO; Jones R. W., 1990, POLITICAL EC INT TRA; Jones R. W., 1996, INT REV ECON FINANC, V5, P113, DOI 10.1016/S1059-0560(96)90039-8; Jones R. W., 1971, TRADE BALANCE PAYMEN; Kikuchi T, 2005, CAN J ECON, V38, P870, DOI 10.1111/j.0008-4085.2005.00306.x; Kikuchi T., 2006, EC B, V6, P1; Kikuchi T, 2003, CAN J ECON, V36, P155, DOI 10.1111/1540-5982.00008; Kikuchi T, 2010, INT REV ECON FINANC, V19, P75, DOI 10.1016/j.iref.2009.02.004; Kikuchi T., 2005, Q REV EC FINANCE, V45, P18, DOI 10.1016/j.qref.2004.02.002; Kikuchi T, 2009, REV INT ECON, V17, P961, DOI 10.1111/j.1467-9396.2009.00811.x; Kikuchi T, 2011, PAC ECON REV, V16, P553, DOI 10.1111/j.1468-0106.2011.00564.x; Kikuchi T, 2013, REV DEV ECON, V17, P699, DOI 10.1111/rode.12060; Kohler Wilhelm, 2001, N AM J ECON FINANC, V12, P31, DOI 10.1016/S1062-9408(00)00043-7; Long N. V., 2005, N AM J ECON FINANC, V16, P137; Marjit S., 2007, INT REV ECON FINANC, V16, P153, DOI 10.1016/j.iref.2005.08.002; Matsuoka Y, 2010, INT REV ECON FINANC, V19, P769, DOI 10.1016/j.iref.2010.05.001; Rajan R. S., 2008, 117 AISAN DEV BANK; Stein E, 2007, J INT ECON, V71, P96, DOI 10.1016/j.jinteco.2006.01.003; Tomasik R, 2013, REV WORLD ECON, V149, P321, DOI 10.1007/s10290-013-0147-4; Wachter RM, 2006, NEW ENGL J MED, V354, P661, DOI 10.1056/NEJMp058258	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-7576	1467-9396		REV INT ECON	Rev. Int. Econ.	AUG	2015	23	3					638	662		10.1111/roie.12185		25	Economics	Business & Economics	CN1KJ	WOS:000358178400010		
J	Kaneko, T; Kim, SW; Toda, A; Uematsu, K; Ishigaki, T; Toda, K; Sato, M; Koide, J; Toda, M; Kudo, Y; Masaki, T; Yoon, DH				Kaneko, Tatsuro; Kim, Sun Woog; Toda, Ayano; Uematsu, Kazuyoshi; Ishigaki, Tadashi; Toda, Kenji; Sato, Mineo; Koide, Junko; Toda, Masako; Kudo, Yoshiaki; Masaki, Takaki; Yoon, Dea Ho			Synthesis of YVO4 Nano Particles by Novel Room Temperature Synthesis Method	SCIENCE OF ADVANCED MATERIALS			English	Article						Water; Room Temperature Synthesis; Nano Particles; Reaction Mechanism	SOLID-STATE REACTION; MECHANOCHEMISTRY; MECHANISM	Yttrium orthovanadate, YVO4 was prepared using a novel water assisted room temperature solid state reaction method, consisting of simply mixing of Y2O3 and V2O5 at room temperature with the addition of a small amount of water. Nano-scale spherical particles of YVO4 approximately 10-100 nm in diameter were obtained.	[Kaneko, Tatsuro; Kim, Sun Woog; Toda, Ayano; Ishigaki, Tadashi; Toda, Kenji] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Uematsu, Kazuyoshi; Sato, Mineo] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan; [Koide, Junko; Toda, Masako; Kudo, Yoshiaki] N Luminescence Corp, Niigata 9502102, Japan; [Masaki, Takaki; Yoon, Dea Ho] Sungkyunkwan Univ, Sch Interdisciplinary Program Photovolta Syst Eng, Suwon 440746, South Korea; [Yoon, Dea Ho] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 400746, Kyunggi Do, South Korea	Toda, K (reprint author), Niigata Univ, Grad Sch Sci & Technol, 8050 Ikarashi 2 Nocho, Niigata 9502181, Japan.	ktoda@eng.niigata-u.ac.jp; dhyoon@skku.edu	KIM, Sun Woog/O-5366-2015				Urakaev FK, 2000, POWDER TECHNOL, V107, P93, DOI 10.1016/S0032-5910(99)00175-8; SHARP JH, 1966, J AM CERAM SOC, V49, P379, DOI 10.1111/j.1151-2916.1966.tb13289.x; PALILLA FC, 1966, APPL OPTICS, V5, P1467, DOI 10.1364/AO.5.001467; CARTER RE, 1961, J AM CERAM SOC, V44, P116, DOI 10.1111/j.1151-2916.1961.tb13724.x; Boldyrev VV, 2000, J MATER SYNTH PROCES, V8, P121, DOI 10.1023/A:1011347706721; Fernandez-Bertran JF, 1999, PURE APPL CHEM, V71, P581, DOI 10.1351/pac199971040581; Levine K., 1964, APPL PHYS LETT, V5, P118; Nakajima T, 2009, APPL SURF SCI, V255, P9787, DOI 10.1016/j.apsusc.2009.04.070; OCONNOR JR, 1967, T METALL SOC AIME, V239, P362; Sestak J., 1971, THERMOCHIM ACTA, V3, P1, DOI DOI 10.1016/0040-6031(71)85051-7; Stephen H., 1963, SOLUBILITIES INORGAN, V1; Toda A., 2009, 216 ECS M VIENN AUST; Toda K., 2009, Japanese Unexamined Patent, Patent No. [2011-16670, 201116670]	13	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1947-2935	1947-2943		SCI ADV MATER	Sci. Adv. Mater.	AUG	2015	7	8					1502	1505		10.1166/sam.2015.2364		4	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CN2RK	WOS:000358269400011		
J	Ye, ZH; Chen, OY; Zhang, RJ; Nakao, A; Fan, DF; Zhang, T; Gu, ZY; Tao, HY; Sun, XJ				Ye, Zhouheng; Chen, Ouyang; Zhang, Rongjia; Nakao, Atsunori; Fan, Danfeng; Zhang, Ting; Gu, Zhengyong; Tao, Hengyi; Sun, Xuejun			METHANE ATTENUATES HEPATIC ISCHEMIA/REPERFUSION INJURY IN RATS THROUGH ANTIAPOPTOTIC, ANTI-INFLAMMATORY, AND ANTIOXIDATIVE ACTIONS	SHOCK			English	Article						Methane; hepatic I/R injury; apoptosis; oxidation; inflammation	REPERFUSION INJURY; ISCHEMIA; INFLAMMATION; INHIBITION; TRANSIT	Hepatic ischemia/reperfusion (I/R) injury, which occurs in various diseases, introduces severe tissue damage and liver dysfunction. However, no promising therapies for such a significant condition currently exist. Methane has been suggested to exert a protective effect against intestinal I/R injury. In this study, we introduced methane to treat hepatic I/R injury to show its promising protective effect. Also, intraperitoneal injection with methane-rich saline, which could have potential clinical applications, was applied as a new method. Partial liver warm ischemia was applied in Sprague-Dawley rats for 60 min followed by succedent reperfusion. In the test for effective dosage, methane-rich saline was administrated intraperitoneally to the rats at doses of 1, 5, 20, or 40 mL/kg at onset of reperfusion. In the test for protective effect, rats received methane-rich saline intraperitoneally at a dose of 10 mL/kg before the initiation of reperfusion. We found that methane-rich saline significantly decreased serum alanine aminotransferase, aspartate aminotransferase activity, and the occurrence of necrosis. Moreover, methane-rich saline reduced the amount of caspase-3 and the number of apoptotic cells. In addition, methane-rich saline increased the level of superoxide dismutase and decreased the level of malondialdehyde and 8-hydroxyguanosine. Furthermore, research indicated that methane-rich saline markedly decreased gene expression and content of tumor necrosis factor- and interleukin-6. Also, reduced CD68-positive cells showed decreased inflammatory cells in the liver. Our results suggest that methane protects the liver against I/R injury through antiapoptotic, antioxidative, and anti-inflammatory actions.	[Ye, Zhouheng; Zhang, Rongjia; Fan, Danfeng; Zhang, Ting; Gu, Zhengyong; Sun, Xuejun] Second Mil Med Univ, Dept Navy Aeromed, Shanghai, Peoples R China; [Chen, Ouyang] Second Mil Med Univ, Grad Management Unit, Shanghai, Peoples R China; [Nakao, Atsunori] Hyogo Coll Med, Dept Emergency Disaster & Crit Care, Nishinomiya, Hyogo 6638501, Japan; [Tao, Hengyi] Nantong Univ, Dept Naut Med, Nantong, Jiangsu, Peoples R China	Sun, XJ (reprint author), Second Mil Med Univ, Shanghai, Peoples R China.	taohengyi@hotmail.com; sunxjk@hotmail.com	sun, xuejun/A-5561-2010	sun, xuejun/0000-0003-2387-5531	National Nature Science Foundation of China [81371316]	This study was supported by the National Nature Science Foundation of China (grant no. 81371316).	Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Cour M, 2011, EUR HEART J, V32, P226, DOI 10.1093/eurheartj/ehq112; Roccarina D, 2010, AM J GASTROENTEROL, V105, P1250, DOI 10.1038/ajg.2009.744; Li CX, 2014, ANN SURG, V260, P317, DOI 10.1097/SLA.0000000000000429; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Pimentel M, 2006, AM J PHYSIOL-GASTR L, V290, pG1089, DOI 10.1152/ajpgi.00574.2004; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9; Attaluri A, 2010, AM J GASTROENTEROL, V105, P1407, DOI 10.1038/ajg.2009.655; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Fiore AM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009162; Jahng J, 2012, NEUROGASTROENT MOTIL, V24, P185, DOI 10.1111/j.1365-2982.2011.01819.x; Boros M, 2012, CRIT CARE MED, V40, P1269, DOI 10.1097/CCM.0b013e31823dae05; DOUGHERT.RW, 1967, P SOC EXP BIOL MED, V124, P1155; Hartmann P, 2014, J SURG RES, V189, P32, DOI 10.1016/j.jss.2013.12.025; Hori Tomohide, 2014, World J Hepatol, V6, P72, DOI 10.4254/wjh.v6.i2.72; Pimentel M, 2003, DIGEST DIS SCI, V48, P86, DOI 10.1023/A:1021738515885; Wang C-R, 2002, CHINESE J APPL ECOLO, V13, P1707	21	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2015	44	2					181	187		10.1097/SHK.0000000000000385		7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CM9RQ	WOS:000358047000013		
J	Higuchi, T; Abe, M; Mizuno, M; Yamazaki, T; Suzuki, H; Moriuchi, M; Oikawa, O; Okawa, E; Ando, H; Okada, K				Higuchi, Terumi; Abe, Masanori; Mizuno, Mari; Yamazaki, Toshio; Suzuki, Hiroko; Moriuchi, Masari; Oikawa, Osamu; Okawa, Erina; Ando, Hideyuki; Okada, Kazuyoshi			Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysis	SLEEP MEDICINE			English	Article						Hemodialysis; N-terminal pro-B-type natriuretic peptide; Oxidative stress; Restless legs syndrome; 8-Hydroxy-2 '-deoxyguanosine	CHRONIC KIDNEY-DISEASE; ATHEROSCLEROSIS MIA SYNDROME; CHRONIC-RENAL-FAILURE; QUALITY-OF-LIFE; DIALYSIS PATIENTS; GENERAL-POPULATION; SLEEP DISORDERS; RISK-FACTORS; NT-PROBNP; ERYTHROPOIETIN RESPONSIVENESS	Background: Restless legs syndrome (RLS) is a common comorbidity in patients undergoing hemodialysis, but clinical factors predictive of RLS risk and severity have not been identified. The aims of this multicenter cross-sectional study were to document RLS prevalence and severity in patients undergoing hemodialysis and to identify associated risk factors. Methods: One-hundred and fifty-nine stable patients on maintenance hemodialysis were enrolled (113 men, 46 women; mean age: 68 +/- 11 years; mean duration of dialysis: 54 +/- 60 months). Diagnosis of RLS was based on the criteria proposed by the International Restless Legs Syndrome Study Group (IRLSSG), and RLS severity was assessed using the IRLSSG Severity Scale. Potential factors associated with RLS and IRLSSG Severity Scale score were assessed by univariate and multivariate regression analyses. Results: RLS affected 22% of the study population. The RLS subgroup had a significantly longer duration of hemodialysis and higher cardiothoracic ratio compared to the non-RLS subgroup. The RLS subgroup also had significantly higher serum levels of high-sensitivity C-reactive protein, interleukin-6, ferritin, N-terminal pro-B-type natriuretic peptide, and 8-hydroxy-2'-deoxyguanosine (8-OHdG), and a significantly lower transferrin saturation level compared to the non-RLS subgroup, suggesting a chronic inflammatory state and associated oxidative stress in comorbid patients. Serum 8-OHdG level was an independent risk factor for high IRLSSG Severity Scale score. Conclusion: This study confirms the high prevalence of RLS among hemodialysis patients and identifies the oxidative stress marker serum 8-OHdG as a significant independent predictor of RLS severity. Further studies are needed to identify detailed risk factors and the pathophysiological role of oxidative stress in RLS. (C) 2015 Elsevier B.V. All rights reserved.	[Higuchi, Terumi; Yamazaki, Toshio; Okawa, Erina] Keiai Hosp, Dept Nephrol, Tokyo 1730036, Japan; [Abe, Masanori; Suzuki, Hiroko; Moriuchi, Masari; Oikawa, Osamu; Okada, Kazuyoshi] Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Dept Internal Med, Tokyo 1738610, Japan; [Mizuno, Mari] Keiai Clin, Dept Nephrol, Tokyo 1730036, Japan; [Ando, Hideyuki] Keiai Hosp, Dept Cardiol, Tokyo 1730036, Japan	Abe, M (reprint author), Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Dept Internal Med,Itabashi Ku, 30-1 Oyaguchi Kami Chou, Tokyo 1738610, Japan.	abe.masanori@nihon-u.ac.jp					Abe M, 2011, CLIN NEPHROL, V75, P49, DOI 10.2379/CNP75049; Abe M, 2011, INT J ARTIF ORGANS, V34, P16, DOI 10.5301/IJAO.2011.6314; Unruh ML, 2004, AM J KIDNEY DIS, V43, P900, DOI 10.1053/j.ajkd.2004.01.013; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Nilsson PM, 2001, J INTERN MED, V250, P521, DOI 10.1046/j.1365-2796.2001.00913.x; Walters AS, 2009, SLEEP, V32, P589; Takaki J, 2003, AM J KIDNEY DIS, V41, P833, DOI 10.1016/S0272-6386(03)00031-3; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Kalantar-Zadeh K, 2004, AM J CLIN NUTR, V80, P299; Molnar MZ, 2005, AM J KIDNEY DIS, V45, P388, DOI 10.1053/j.ajkd.2004.10.007; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1053/S0272-6386(03)01005-9; Merlino G, 2006, NEPHROL DIAL TRANSPL, V21, P184, DOI 10.1093/ndt/gfi144; MONTPLAISIR J, 1986, CLIN NEUROPHARMACOL, V9, P456, DOI 10.1097/00002826-198610000-00006; Phillips B, 2000, ARCH INTERN MED, V160, P2137, DOI 10.1001/archinte.160.14.2137; Berger K, 2004, ARCH INTERN MED, V164, P196, DOI 10.1001/archinte.164.2.196; Lopes LA, 2005, DIABETES CARE, V28, P2633, DOI 10.2337/diacare.28.11.2633; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Winkelmann J, 2002, MOVEMENT DISORD, V17, P1072, DOI 10.1002/mds.10231; La Manna G, 2011, NEPHROL DIAL TRANSPL, V26, P1976, DOI 10.1093/ndt/gfq681; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Araujo SMHA, 2010, SLEEP MED, V11, P785, DOI 10.1016/j.sleep.2010.02.011; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Yamada K, 2008, AM J CLIN NUTR, V87, P106; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; Mucsi I, 2004, NEPHROL DIAL TRANSPL, V19, P1815, DOI 10.1093/ndt/gfh130; Aritake-Okada S, 2011, SLEEP MED, V12, P1031, DOI 10.1016/j.sleep.2011.06.014; Bagdanov M, 2000, FREE RADIC BIOL MED, V29, P652; Benz RL, 1999, AM J KIDNEY DIS, V34, P1089, DOI 10.1016/S0272-6386(99)70015-6; Chiu YL, 2009, NEPHROL DIAL TRANSPL, V24, P247, DOI 10.1093/ndt/gfn439; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gigil GL, 2004, SLEEP MED, V5, P309; Oh HJ, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000241; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kavanagh D, 2004, AM J KIDNEY DIS, V43, P763, DOI 10.1053/j.ajkd.2004.01.007; Kawauchi A, 2006, CLIN NEPHROL, V66, P440; Kim JM, 2008, J CLIN NEUROL, V4, P153, DOI 10.3988/jcn.2008.4.4.153; Locatelli F, 2013, BLOOD PURIFICAT, V35, P216, DOI 10.1159/000347076; Maruyama Y, 2007, NEPHROL DIAL TRANSPL, V22, P1407, DOI 10.1093/ndt/gfl789; Merlino G, 2007, NEUROL SCI, V28, P37; Merlino G, 2010, MOVEMENT DISORD, V25, P1019, DOI 10.1002/mds.23010; Miranda M, 2001, REV MED CHILE, V129, P179; Mucsi Istvan, 2005, Nephrology Dialysis Transplantation, V20, P571, DOI 10.1093/ndt/gfh654; Pizza F, 2012, ACTA NEUROL SCAND, V125, P403, DOI 10.1111/j.1600-0404.2011.01581.x; Reuter SE, 2009, NEPHROL DIAL TRANSPL, V24, P990, DOI 10.1093/ndt/gfn588; Sande FM, 2006, BLOOD PURIFICAT, V24, P335; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Shafi T, 2014, AM J KIDNEY DIS, V64, P443, DOI 10.1053/j.ajkd.2014.03.015; Siddiqui S, 2005, NEPHRON CLIN PRACT, V101, P155, DOI 10.1159/000087073; Tarng DG, 2000, AM J KIDNEY DIS, V36, P934, DOI 10.1053/ajkd.2000.19086; Winjelman JW, 1996, AM J KIDNEY DIS, V28, P372; Winkelmann J, 2001, SLEEP MED, V2, P57, DOI 10.1016/S1389-9457(00)00025-3	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	AUG	2015	16	8					941	948		10.1016/j.sleep.2015.03.025		8	Clinical Neurology	Neurosciences & Neurology	CN0EO	WOS:000358087000008		
J	Sasai-Sakuma, T; Inoue, Y				Sasai-Sakuma, Taeko; Inoue, Yuichi			Differences in electroencephalographic findings among categories of narcolepsy-spectrum disorders	SLEEP MEDICINE			English	Article						Narcolepsy; Idiopathic hypersomnia; Electroencephalogram; HLA DRB1*1501/DQB1*0602; Nocturnal polysomnography	SLEEP LATENCY TEST; REM-SLEEP; IDIOPATHIC HYPERSOMNIA; CEREBROSPINAL-FLUID; DAYTIME SLEEPINESS; BEHAVIOR DISORDER; TEST MSLT; CATAPLEXY; HYPOCRETIN; DIAGNOSIS	Objective: To clarify the differences in quantitative electroencephalographic (EEG) measures and their relation to clinical symptoms among narcolepsy-spectrum disorders. Methods: The enrolled patients were: 28 with narcolepsy with cataplexy (NA-CA); 16 with NA without cataplexy (NA w/o CA) and HLA-DRB1*1501/DQB1*0602 positive (NA w/o CA HLA+); 22 with NA w/o CA and HLA negative (NA w/o CA HLA-); and 22 with idiopathic hypersomnia without long sleep time (IHS w/o LST). Nocturnal polysomnography (n-PSG) and quantitative EEG evaluation, as well as the Multiple Sleep Latency test (MSLT), were conducted for all patients. Results: Patients with NA-CA or NA w/o CA HLA+ showed lower alpha power, higher delta and theta power during wakefulness, and higher alpha and beta power during rapid eye movement (REM) sleep, compared to those with NA w/o CA HLA- or IHS w/o LST. The former two groups also showed lower sleep efficiency and a higher rate of positivity of REM-related symptoms than the other two groups. Conclusions: In narcolepsy, the presence of cataplexy and HLA positivity are associated with EEG slowing during wakefulness and increased fast EEG activity during REM sleep, REM-related symptoms and disrupted nocturnal sleep in narcolepsy. (C) 2015 Elsevier B.V. All rights reserved.	[Sasai-Sakuma, Taeko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Sasai-Sakuma, Taeko] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Div Biomed Lab Sci, Dept Life Sci & Bioinformat, Tokyo, Japan; [Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan	Sasai-Sakuma, T (reprint author), Tokyo Med Univ, Dept Somnol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	taeko_ssi@yahoo.co.jp			Hisamitsu Pharmaceutical co., Inc.	Dr Sasai-Sakuma has reported no conflict of interest. Dr Inoue has received a consultancy fee from Hisamitsu Pharmaceutical co., Inc., expert testimony from Nippon Boehringer Ingelheim Co., Ltd., Philips Respironics GK, Alfresa Pharma Corporation, Takeda Pharmaceutical Company Limited, MSD K.K., Pacific Medico Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., and Mitsubishi Tanabe Pharma Corporation, and payment for lectures from Philips Respironics GK, Takeda Pharmaceutical Company Limited, GlaxoSmithKline K.K., Astellas Pharma Inc., Sanofi-Aventis K.K., Yoshitomiyakuhin Corporation, Otsuka Pharmaceutical Co., Ltd., and Eisai Co., Ltd.	AASM, 2005, INT CALSSIFICATION S, V2nd; Flemons WW, 1999, SLEEP, V22, P667; Andlauer O, 2013, JAMA NEUROL, V6, P1; Frauscher B, 2011, J SLEEP RES, V20, P514, DOI 10.1111/j.1365-2869.2011.00906.x; Mamelak M, 2009, PROG NEUROBIOL, V89, P193, DOI 10.1016/j.pneurobio.2009.07.004; Knudsen S, 2010, SLEEP, V33, P169; Aldrich MS, 1997, SLEEP, V20, P620; CARSKADON MA, 1986, SLEEP, V9, P519; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Danker-Hopfe H, 2009, J SLEEP RES, V18, P74, DOI 10.1111/j.1365-2869.2008.00700.x; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; Iranzo A, 2010, SLEEP MED, V11, P534, DOI 10.1016/j.sleep.2010.03.006; Khatami R, 2007, SLEEP, V30, P980; Sorensen GL, 2013, SLEEP, V36, P1173, DOI 10.5665/sleep.2880; Andlauer O, 2012, SLEEP, V35, P1247, DOI 10.5665/sleep.2080; Khatami R, 2008, SLEEP, V31, P859; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Mukai J, 2003, J SLEEP RES, V12, P63, DOI 10.1046/j.1365-2869.2003.00331.x; Roth T, 2013, J CLIN SLEEP MED, V9, P955, DOI 10.5664/jcsm.3004; Billiard M, 2007, SLEEP MED REV, V11, P377, DOI 10.1016/j.smrv.2007.04.001; Augustine K, 2002, ST HEAL T, V85, P31; Bastianini S, 2012, J SLEEP RES, V21, P185, DOI 10.1111/j.1365-2869.2011.00945.x; Bonnet M, 1992, SLEEP, V15, P173; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; Bruck D, 1996, J NEUROL NEUROSUR PS, V60, P576, DOI 10.1136/jnnp.60.5.576; Hohjoh H, 2001, TISSUE ANTIGENS, V57, P230, DOI 10.1034/j.1399-0039.2001.057003230.x; Huang YS, 2006, SLEEP MED, V7, P454, DOI 10.1016/j.sleep.2006.05.009; Jeong JH, 2007, J KOREAN MED SCI, V22, P127; Jimenez-Correa U, 2009, ARQ NEURO-PSIQUIAT, V67, P995, DOI 10.1590/S0004-282X2009000600006; JOHNS MW, 1991, SLEEP, V14, P540; Komada Y, 2005, PSYCHIAT CLIN NEUROS, V59, P194, DOI 10.1111/j.1440-1819.2005.01357.x; Krahn LE, 2002, SLEEP, V25, P733; Martinez-Rodriguez JE, 2007, MED CLIN-BARCELONA, V128, P361, DOI 10.1157/13099970; Massicotte-Marquez J, 2005, ANN NEUROL, V57, P277, DOI 10.1002/ana.20373; BONNET M, 1993, SLEEP, V16, P748; Planelles D, 1997, EUR J IMMUNOGENET, V24, P409, DOI 10.1046/j.1365-2370.1997.d01-115.x; Rechtschaffen A., 1968, MANUAL STANDARDIZED; ROSENTHAL LD, 1990, GEN HOSP PSYCHIAT, V12, P191, DOI 10.1016/0163-8343(90)90078-Q; Rovere H, 2008, ARQ NEURO-PSIQUIAT, V66, P163, DOI 10.1590/S0004-282X2008000200004; Sasai T, 2009, SLEEP MED, V10, P961, DOI 10.1016/j.sleep.2008.12.007; Seneviratne U, 2005, ANN ACAD MED SINGAP, V34, P90; Sturzenegger C, 2004, J SLEEP RES, V13, P395, DOI 10.1111/j.1365-2869.2004.00422.x; Takei Y, 2012, CLIN NEUROPHYSIOL, V123, P137, DOI 10.1016/j.clinph.2011.05.024; UCHIDA S, 1992, SLEEP, V15, P352; Vassalli A, 2013, BRAIN, V136, P1592, DOI 10.1093/brain/awt069; Zachariev Z, 1999, Folia Med (Plovdiv), V41, P5	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	AUG	2015	16	8					999	1005		10.1016/j.sleep.2015.01.022		7	Clinical Neurology	Neurosciences & Neurology	CN0EO	WOS:000358087000018		
J	Ikemoto-Uezumi, M; Uezumi, A; Tsuchida, K; Fukada, S; Yamamoto, H; Yamamoto, N; Shiomi, K; Hashimoto, N				Ikemoto-Uezumi, Madoka; Uezumi, Akiyoshi; Tsuchida, Kunihiro; Fukada, So-ichiro; Yamamoto, Hiroshi; Yamamoto, Naoki; Shiomi, Kosuke; Hashimoto, Naohiro			Pro-Insulin-Like Growth Factor-II Ameliorates Age-Related Inefficient Regenerative Response by Orchestrating Self-Reinforcement Mechanism of Muscle Regeneration	STEM CELLS			English	Article						Aging; Skeletal muscle; Regeneration; Pro-insulin-like growth factor-II	QUIESCENT SATELLITE CELLS; ADULT SKELETAL-MUSCLE; STEM-CELLS; MESENCHYMAL PROGENITORS; YOUNG; MICE; POPULATION; RENEWAL; TRANSPLANTATION; REJUVENATION	Sarcopenia, age-related muscle weakness, increases the frequency of falls and fractures in elderly people, which can trigger severe muscle injury. Rapid and successful recovery from muscle injury is essential not to cause further frailty and loss of independence. In fact, we showed insufficient muscle regeneration in aged mice. Although the number of satellite cells, muscle stem cells, decreases with age, the remaining satellite cells maintain the myogenic capacity equivalent to young mice. Transplantation of young green fluorescent protein (GFP)-Tg mice-derived satellite cells into young and aged mice revealed that age-related deterioration of the muscle environment contributes to the decline in regenerative capacity of satellite cells. Thus, extrinsic changes rather than intrinsic changes in satellite cells appear to be a major determinant of inefficient muscle regeneration with age. Comprehensive protein expression analysis identified a decrease in insulin-like growth factor-II (IGF-II) level in regenerating muscle of aged mice. We found that pro- and big-IGF-II but not mature IGF-II specifically express during muscle regeneration and the expressions are not only delayed but also decreased in absolute quantity with age. Supplementation of pro-IGF-II in aged mice ameliorated the inefficient regenerative response by promoting proliferation of satellite cells, angiogenesis, and suppressing adipogenic differentiation of platelet derived growth factor receptor (PDGFR)alpha(+) mesenchymal progenitors. We further revealed that pro-IGF-II but not mature IGF-II specifically inhibits the pathological adipogenesis of PDGFR alpha(+) cells. Together, these results uncovered a distinctive pro-IGF-II-mediated self-reinforcement mechanism of muscle regeneration and suggest that supplementation of pro-IGF-II could be one of the most effective therapeutic approaches for muscle injury in elderly people.	[Ikemoto-Uezumi, Madoka; Shiomi, Kosuke; Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Regenerat Med, Oobu, Aichi 4748511, Japan; [Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Toyoake, Aichi, Japan; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan; [Yamamoto, Hiroshi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Kobe, Hyogo, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Joint Res Lab, Lab Mol Biol & Histochem, Toyoake, Aichi, Japan	Ikemoto-Uezumi, M (reprint author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Regenerat Med, 7-430 Morioka, Oobu, Aichi 4748511, Japan.	mikemo-to@ncgg.go.jp; nao@ncgg.go.jp			JSPS KAKENHI [18890246, 20790242]; National Center for Geriatrics and Gerontology (NCGG), Japan	This work was supported by JSPS KAKENHI Grants 18890246, 20790242, and The Research Funding for Longevity Sciences (23-6) from National Center for Geriatrics and Gerontology (NCGG), Japan.	Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Brooks NE, 2009, J PHYSIOL SCI, V59, P465, DOI 10.1007/s12576-009-0058-2; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Araki E, 1997, BIOCHEM BIOPH RES CO, V238, P492, DOI 10.1006/bbrc.1997.7328; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Ikemoto M, 2007, MOL THER, V15, P2178, DOI 10.1038/sj.mt.6300295; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Greenall SA, 2013, J BIOL CHEM, V288, P59, DOI 10.1074/jbc.M112.432013; Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; BOLDRIN L, 2014, STEM CELL RES, V14, P20; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082; Grounds Miranda D, 2014, Bioarchitecture, V4, P81, DOI 10.4161/bioa.29668; Lee Antonio S J, 2013, Bioarchitecture, V3, P25, DOI 10.4161/bioa.24966; Morali OG, 2000, DEV BIOL, V227, P133, DOI 10.1006/dbio.2000.9875; Ogawa R, 2015, DEVELOPMENT, V142, P51, DOI 10.1242/dev.112557; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	AUG	2015	33	8					2456	2468		10.1002/stem.2045		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CN1UP	WOS:000358206000009		
J	Shirai, Y; Shiba, H; Sakamoto, T; Horiuchi, T; Haruki, K; Fujiwara, Y; Futagawa, Y; Ohashi, T; Yanaga, K				Shirai, Yoshihiro; Shiba, Hiroaki; Sakamoto, Taro; Horiuchi, Takashi; Haruki, Koichiro; Fujiwara, Yuki; Futagawa, Yasuro; Ohashi, Toya; Yanaga, Katsuhiko			Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection	SURGERY			English	Article							HEPATOCELLULAR-CARCINOMA; SURGICAL RESECTION; PROGNOSTIC VALUE; GROWTH-FACTORS; SOLID TUMORS; CANCER; INFLAMMATION; CELLS; METAANALYSIS; CYTOKINES	Background. Inflammation plays a crucial role in tumor growth, metastasis, and survival. The preoperative platelet-to-lymphocyte ratio (PLR) has been reported as a significant prognostic indicators in several digestive malignancies. Our objective was to evaluate whether preoperative PLR is a prognostic index in resected pancreatic ductal adenocarcinoma. Methods. Data from 131 patients who underwent pancreatic resection for pancreatic ductal adenocarcinoma were available from a prospectively maintained database. The patients were divided into groups according to a preoperative PLR of <150 or >= 150. Survival data were analyzed. Results. In univariate and multivariate analyses, a preoperative PLR of >= 150 was a significant and independent risk factor for cancer recurrence and poor survival, respectively (disease-free survival [DFS]; P=.0014, P =.047; OS, P <=.01each). Similarly, lymph node metastasis, and moderate or poor differentiation were independent risk factors for cancer recurrence, whereas tumor diameter, positive surgical margin, and moderate or poor differentiation were independent risk factors for poor patient survival (P <= .05 each). Conclusion. The preoperative PLR in patients with pancreatic ductal adenocarcinoma was an independent predictor in DES and overall survival after elective resection. Measurement of the PLR may help decision making in the postoperative management of patients with pancreatic ductal adenocarcinoma.	[Shirai, Yoshihiro; Shiba, Hiroaki; Sakamoto, Taro; Horiuchi, Takashi; Haruki, Koichiro; Fujiwara, Yuki; Futagawa, Yasuro; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo 1058461, Japan; [Shirai, Yoshihiro; Horiuchi, Takashi; Ohashi, Toya] Jikei Univ, Sch Med, Div Gene Therapy, Res Ctr Med Sci, Tokyo 1058461, Japan	Shirai, Y (reprint author), Jikei Univ, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	shirai@jikei.ac.jp					American Society of Anesthesiologists, ASA PHYS STAT CLASS; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Bilimoria KY, 2007, ANN SURG, V246, P173, DOI 10.1097/SLA.0b013e3180691579; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Han SS, 2006, PANCREAS, V32, P271, DOI 10.1097/01.mpa.0000202953.87740.93; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/01.SLA.0000018565.87010.B8; Dutta S, 2011, WORLD J SURG, V35, P1861, DOI 10.1007/s00268-011-1130-7; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Ebrahimi B, 2004, CANCER, V101, P2727, DOI 10.1002/cncr.20672; Dranoff G, 2005, CLIN CANCER RES, V11, P8226, DOI 10.1158/1078-0432.CCR-05-2035; Garcea G, 2011, WORLD J SURG, V35, P868, DOI 10.1007/s00268-011-0984-z; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-00007; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Alexakis N, 2004, BRIT J SURG, V91, P1410, DOI 10.1002/bjs.4794; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Aliustaoglu M, 2010, MED ONCOL, V27, P1060, DOI 10.1007/s12032-009-9335-4; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Goubran HA, 2014, SEMIN ONCOL, V41, P359, DOI 10.1053/j.seminoncol.2014.04.006; Lee YL, 2013, TRANSFUSION, V53, P1918, DOI 10.1111/trf.12068; Bastida A, 1987, INT J CANCER, V39, P760; DISTEFANO JF, 1990, AM J MED SCI, V300, P9, DOI 10.1097/00000441-199007000-00003; He WZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0439-x; Japanese Pancreas Society, 2009, GEN RUL STUD PANCR C; Martin HL, 2014, INTERN MED J, V44, P676, DOI 10.1111/imj.12453; Okabayashi T, 2014, WORLD J SURG, V38, P2986, DOI 10.1007/s00268-014-2703-z; Paramanathan A, 2014, SURG ONCOL, V23, P31, DOI 10.1016/j.suronc.2013.12.001; Placke T, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19367; Xiao WK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-117	41	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2015	158	2					360	365		10.1016/j.surg.2015.03.043		6	Surgery	Surgery	CN0MU	WOS:000358108500006		
J	Kohama, K; Yamashita, H; Aoyama-Ishikawa, M; Takahashi, T; Billiar, TR; Nishimura, T; Kotani, J; Nakao, A				Kohama, Keisuke; Yamashita, Hayato; Aoyama-Ishikawa, Michiko; Takahashi, Toru; Billiar, Timothy R.; Nishimura, Takeshi; Kotani, Joji; Nakao, Atsunori			Hydrogen inhalation protects against acute lung injury induced by hemorrhagic shock and resuscitation	SURGERY			English	Article							ISCHEMIA/REPERFUSION INJURY; MEDICAL GAS; RAT MODEL; DYSFUNCTION; MECHANISMS; EXPRESSION; GRAFTS; KINASE; MICE	Introduction. Hemorrhagic shock followed by fluid resuscitation (HS/R) triggers an inflammatory response and causes pulmonary inflammation that can lead to acute lung injury (ALI). Hydrogen, a therapeutic gas, has potent cytoprotective, antiinflammatory, and antioxidant effects. This study examined the effects of inhaled hydrogen on ALI caused by HS/R. Methods. Rats were subjected to hemorrhagic shock by withdrawing blood to lower blood pressure followed by resuscitation with shed blood and saline to restore blood pressure. After HS/R, the rats were maintained in a control gas of similar composition to room air or exposed to 1.3% hydrogen. Results. HS/R induced ALL as demonstrated by significantly impaired gas exchange, congestion, edema, cellular infiltration, and hemorrhage in the lungs. Hydrogen inhalation mitigated lung injury after HS/R, as indicated by significantly improved gas exchange and reduced cellular infiltration and hemorrhage. Hydrogen inhalation did not affect hemodynamic status during HS/R Exposure to 1.3% hydrogen significantly attenuated the upregulation of the messenger RNAs for several proinflammatory mediators induced by HS/R Lipid peroxidation was reduced significantly in the presence of hydrogen, indicating antioxidant effects. Conclusion. Hydrogen, administered through inhalation, may exert potent therapeutic effects against ALI induced by HS/R and attenuate the activation of inflammatory cascades.	[Kohama, Keisuke; Nishimura, Takeshi; Kotani, Joji; Nakao, Atsunori] Hyogo Coll Med, Dept Emergency Disaster & Crit Care Med, Nishinomiya, Hyogo 6638501, Japan; [Yamashita, Hayato; Aoyama-Ishikawa, Michiko] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan; [Takahashi, Toru] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Okayama, Japan; [Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Nakao, A (reprint author), 1-1 Mukogawa, Nishinomiya, Hyogo, Japan.	qq-nakao@hyo-med.ac.jp			JSPS KAKENHI [25462840]	Supported by JSPS KAKENHI Grant Number #25462840.	Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Kohama K, 2014, J CLIN BIOCHEM NUTR, V54, P116, DOI 10.3164/jcbn.13-90; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037; Buchholz BM, 2011, TRANSPLANTATION, V92, P985, DOI 10.1097/TP.0b013e318230159d; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Jarrar D, 1999, INT J MOL MED, V4, P575; Kohmoto J, 2006, SURGERY, V140, P179, DOI 10.1016/j.surg.2006.03.004; Rushing GD, 2008, ANN SURG, V247, P929, DOI 10.1097/SLA.0b013e31816757f7; LeTulzo Y, 1997, J CLIN INVEST, V99, P1516, DOI 10.1172/JCI119314; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; TRACEY KJ, 1993, CRIT CARE MED, V21, pS415; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Kawamura T, 2010, TRANSPLANTATION, V90, P1344, DOI 10.1097/TP.0b013e3181fe1357; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hayashida K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003459; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Huang CS, 2010, CRIT CARE, V14, DOI 10.1186/cc9389; Itoh T, 2003, J NEUROCHEM, V85, P1500, DOI 10.1046/j.1471-4159.2003.01795.x; Kang Ki-Mun, 2011, Med Gas Res, V1, P11, DOI 10.1186/2045-9912-1-11; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Nakao A, 2006, J PHARMACOL EXP THER, V319, P1265, DOI 10.1124/jpet.106.108654; Sato H, 2005, SHOCK, V24, P488, DOI 10.1097/01.shk.0000176594.64626.7f	25	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2015	158	2					399	407		10.1016/j.surg.2015.03.038		9	Surgery	Surgery	CN0MU	WOS:000358108500012		
J	Sakamoto, Y				Sakamoto, Yujiro			Spatial relationship between the palatopharyngeus and the superior constrictor of the pharynx	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Palatopharyngeus; Superior constrictor; Salpingopharyngeus; Levator veli palatini; Stylopharyngeus; Human gross anatomy	MORPHOLOGIC CHARACTERISTICS; MUSCLE; PALATE	The palatopharyngeus and the superior constrictor act during swallowing. However, because they overlap one another, their morphologies have been controversial. This study examined these muscles to clarify their configuration and interrelationships. The attachments and the fiber arrangement of the superior constrictor and the palatopharyngeus were gross anatomically examined in 28 Japanese cadavers. The most superior fibers of the superior constrictor arose from the palate and interfused with the lateral fibers of the palatopharyngeus. Consequently, their origins and insertions were arranged in a continuous line, respectively, and these flat muscles formed a sheet. The palatopharyngeus rotated 90 degrees, from the origin to the insertion, about its long axis, and its superior and inferior surfaces turned into internal and external, respectively. Its lateral fibers passed on the internal surface of the superior constrictor, and these two muscles were inserted into the pharyngeal raphe with an overlap, indicating that the muscular sheet was folded back. Its medial fibers consisted of two layers at the origin and were interdigitated with the insertion of the levator veli palatini. The superior layer was joined by the salpingopharyngeus and dispersed into the pharyngeal wall. The inferior one was joined by the stylopharyngeus and descended along the palatopharyngeal arch to be inserted into the thyroid cartilage and the epiglottis. These two muscles formed a sheet that was partially folded back. It is suggested that the superior constrictor and the lateral fibers cooperate as sphincters, and the medial fibers and the stylopharyngeus as elevators.	Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Basic Sci Oral Hlth Care, Bunkyo Ku, Tokyo 1138549, Japan	Sakamoto, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Basic Sci Oral Hlth Care, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	y.sakamoto.bsoh@tmd.ac.jp					Cho JH, 2013, LARYNGOSCOPE, V123, P2900, DOI 10.1002/lary.24067; Bergman RA, 1988, COMPENDIUM HUMAN ANA; Blount RF, 1953, MORRIS HUMAN ANATOMY, P1292; Choi DY, 2014, DYSPHAGIA, V29, P722, DOI 10.1007/s00455-014-9568-z; DuBrul EL, 1988, SICHER DUBRULS ORAL; Fleischhauer K, 1985, BENNINGHOFF MAKROSKO, P133; Harrington R, 1944, J SPEECH DISORD, V9, P325; Hwang K, 2009, J CRANIOFAC SURG, V20, P1591, DOI 10.1097/SCS.0b013e3181b0dbb2; Leonhardt H, 1987, RAUBER KOPSCH ANATOM, V2, P239; McMyn J. K., 1940, JOUR LARYNGOL AND OTOL, V55, P1; Okuda S, 2008, DYSPHAGIA, V23, P258, DOI 10.1007/s00455-007-9133-0; Passavant G, 1869, VIRCH ARCH PATHOL AN, V46, P1, DOI 10.1007/BF01930785; Sakamoto Y, 2009, SURG RADIOL ANAT, V31, P755, DOI 10.1007/s00276-009-0516-9; Sinclair DC, 1972, CUNNINGHAMS TXB ANAT, V11th, P259; Standring S, 2005, GRAYS ANATOMY, V39th, P439; Sumida K, 2012, CLIN ANAT, V25, P314, DOI 10.1002/ca.21233; Thane GD, 1894, QUAINS ELEMENTS ANAT, V10th, P199; Townshend RH, 1940, J LARYNGOL OTOL, V55, P154, DOI 10.1017/S0022215100005338; Tsumori N, 2007, DYSPHAGIA, V22, P122, DOI 10.1007/s00455-006-9063-2; Whillis J, 1930, J ANAT, V65, P92; Wyburn GM, 1972, CUNNINGHAMS TXB ANAT, V11th, P469	21	1	1	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	AUG	2015	37	6					649	655		10.1007/s00276-015-1444-5		7	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CN1IV	WOS:000358173400010		
J	Uchino, A; Saito, N; Kohyama, S				Uchino, Akira; Saito, Naoko; Kohyama, Shinya			Agenesis of the internal carotid artery with paraclinoid-supraclinoid anastomosis and basilar artery-posterior communicating artery anastomosis diagnosed by magnetic resonance angiography	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Agenesis; Arterial circle; Cerebral arterial variation; Internal carotid artery; Magnetic resonance angiography	CONGENITAL ABSENCE; HYPOPITUITARISM	The several types of agenesis of the internal carotid artery (ICA) are classified based on the aplastic segment of the ICA and types of collateral circulation. On magnetic resonance angiography, we incidentally found an extremely rare case in which the patient had 2 types of collateral circulation-anastomosis between the paraclinoid and supraclinoid segments of the contralateral ICA and anastomosis between the tip of the basilar artery and the posterior communicating artery. This is the first report of a case of ICA agenesis with 2 such types of collateral circulation.	[Uchino, Akira; Saito, Naoko] Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, Hidaka, Saitama 3501298, Japan; [Kohyama, Shinya] Saitama Med Univ, Int Med Ctr, Dept Intravasc Neurosurg, Hidaka, Japan	Uchino, A (reprint author), Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	auchino@saitama-med.ac.jp					QUINT DJ, 1989, AM J NEURORADIOL, V10, P435; Moon WJ, 2002, NEURORADIOLOGY, V44, P138, DOI 10.1007/s002340100678; Mellado JM, 2001, NEURORADIOLOGY, V43, P237; Kiritsi O, 2012, SURG RADIOL ANAT, V34, P475, DOI 10.1007/s00276-011-0901-z; Fitzgerald RT, 2012, PEDIATR RADIOL, V42, P1333, DOI 10.1007/s00247-012-2455-6; Gunnal SA, 2014, NEUROL RES INT, V2014; Khan A, 2012, PEDIATR NEUROL, V47, P68, DOI 10.1016/j.pediatrneurol.2012.04.003; Lie TA, 1968, CONGENIT ANOM, P16; Meder JF, 1997, SURG RADIOL ANAT, V19, P385, DOI 10.1007/BF01628506; Suyama K, 2009, J CLIN NEUROSCI, V16, P585, DOI 10.1016/j.jocn.2008.06.001; Takahashi S, 2010, NEUROVASCULAR IMAGIN, P12; Uchino A, 2002, EUR RADIOL, V12, P2339, DOI 10.1007/s00330-001-1262-5	12	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	AUG	2015	37	6					685	687		10.1007/s00276-014-1388-1		3	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CN1IV	WOS:000358173400014		
J	Nishimura, K; Fukuyama, N; Yamashita, M; Sumiyoshi, T; Yamamoto, Y; Yamada, K; Tomioka, K				Nishimura, Katsumi; Fukuyama, Naoshi; Yamashita, Mitsuaki; Sumiyoshi, Takaaki; Yamamoto, Yasutomo; Yamada, Ken-ichi; Tomioka, Kiyoshi			Cyclic Model for the Asymmetric Conjugate Addition of Organolithiums with Enoates	SYNTHESIS-STUTTGART			English	Article						chiral ligand; asymmetric synthesis; organolithiums; conjugate addition; cascade reaction	CHIRAL LIGAND; ALPHA,BETA-UNSATURATED ALDIMINE; MICHAEL CYCLIZATION; TANDEM REACTION; ESTER ENOLATE; LITHIUM; REAGENTS; DERIVATIVES; DIETHER; ACID	The chiral diether ligand controlled asymmetric conjugate addition of organolithiums to nona-2,7-dienedioates preferentially proceeds via the s-cis conformation with coordination of the carbonyl oxygen atom to the lithium to give a lithium E-enolate intermediate. Subsequent intramolecular conjugate addition of the enolate also proceeds via a cyclic transition state involving the lithium and the s-cis-enoate, resulting in trans,trans-trisubstituted cyclohexanes with high enantiomeric excesses and yields.	[Nishimura, Katsumi; Fukuyama, Naoshi; Yamashita, Mitsuaki; Sumiyoshi, Takaaki; Yamada, Ken-ichi; Tomioka, Kiyoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Yasutomo; Tomioka, Kiyoshi] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kodo, Kyotanabe 6100395, Japan	Nishimura, K (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	ktomioka@dwc.doshisha.ac.jp			JSPS; MEXT	We thank JSPS and MEXT for financial support.	Christoffers J, 2007, SYNTHESIS-STUTTGART, P1279, DOI 10.1055/s-2007-966005; HEATHCOCK CH, 1980, J ORG CHEM, V45, P1066, DOI 10.1021/jo01294a030; Harada S, 2013, TETRAHEDRON, V69, P3264, DOI 10.1016/j.tet.2013.02.035; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Valleix F, 2005, TETRAHEDRON, V61, P7420, DOI 10.1016/j.tet.2005.05.070; Beddow JE, 2007, ORG BIOMOL CHEM, V5, P2812, DOI 10.1039/b707689d; Yamada K, 2012, J ORG CHEM, V77, P5775, DOI 10.1021/jo300944f; Asano Y, 2001, TETRAHEDRON LETT, V42, P8493, DOI 10.1016/S0040-4039(01)01823-8; Yamada K, 2009, ORG LETT, V11, P1631, DOI 10.1021/ol9003564; IRELAND RE, 1976, J AM CHEM SOC, V98, P2868, DOI 10.1021/ja00426a033; Yamamoto Y, 2010, TETRAHEDRON, V66, P2470, DOI 10.1016/j.tet.2010.01.072; Harada S, 2012, J ORG CHEM, V77, P7212, DOI 10.1021/jo301495a; Davies SG, 2011, TETRAHEDRON-ASYMMETR, V22, P1035, DOI 10.1016/j.tetasy.2011.06.008; Tomioka K, 2001, J ORG CHEM, V66, P7051, DOI 10.1021/jo015766b; Shindo M, 1998, J ORG CHEM, V63, P9351, DOI 10.1021/jo9813181; SAITO S, 1989, J AM CHEM SOC, V111, P4533, DOI 10.1021/ja00194a078; Doi H, 2003, J AM CHEM SOC, V125, P2886, DOI 10.1021/ja029633z; Yamashita M, 2004, J AM CHEM SOC, V126, P1954, DOI 10.1021/ja031760n; TOMIOKA K, 1989, J AM CHEM SOC, V111, P8266, DOI 10.1021/ja00203a032; Krause N, 2001, SYNTHESIS-STUTTGART, P171; Yasuhara T, 2003, ORG LETT, V5, P1123, DOI 10.1021/ol0341905; Sakai T, 2006, TETRAHEDRON, V62, P8351, DOI 10.1016/j.tet.2006.06.040; Asano Y, 1997, TETRAHEDRON LETT, V38, P8973, DOI 10.1016/S0040-4039(97)10366-5; ASAO N, 1990, TETRAHEDRON, V46, P4563, DOI 10.1016/S0040-4020(01)85581-2; Borner C, 2001, TETRAHEDRON LETT, V42, P327, DOI 10.1016/S0040-4039(00)01940-7; Borner C, 2001, EUR J ORG CHEM, P2435; Cardillo G, 2001, ORG LETT, V3, P1165, DOI 10.1021/ol015616n; COREY EJ, 1985, TETRAHEDRON LETT, V26, P5025, DOI 10.1016/S0040-4039(01)80843-1; Dambacher J, 2004, TETRAHEDRON, V60, P2097, DOI 10.1016/j.tet.2003.12.049; Davies G., 2005, ORG BIOMOL CHEM, V3, P1284; Davies SG, 2004, CHEM COMMUN, P1128, DOI 10.1039/b401293c; Feringa B. L, 2002, MODERN ORGANOCOPPER, DOI DOI 10.1002/3527600086.CH7; Inoue H, 2002, J ORG CHEM, V67, P5864, DOI 10.1021/jo025725v; Kanai M., 2000, CATALYTIC ASYMMETRIC, P569; KLIMKO PG, 1992, J ORG CHEM, V57, P1733, DOI 10.1021/jo00032a026; Nagaoka Y, 1999, ORG LETT, V1, P1467, DOI 10.1021/ol991024h; Nishimura K., 2015, TETRAHEDRON IN PRESS, DOI [10.1016/j.tet.2015.03.014, DOI 10.1016/J.TET.2015.03.014]; Nishimura K, 2001, ANGEW CHEM INT EDIT, V40, P440, DOI 10.1002/1521-3773(20010119)40:2<440::AID-ANIE440>3.3.CO;2-1; Nishimura K, 2002, J ORG CHEM, V67, P431, DOI 10.1021/jo015879v; Nishimura K, 1997, J AM CHEM SOC, V119, P12974, DOI 10.1021/ja9729950; Ono M, 2001, J ORG CHEM, V66, P8199, DOI 10.1021/jo016090n; Randl S, 2001, CHEM COMMUN, P1796, DOI 10.1039/b106558k; SAITO S, 1992, SYNLETT, P241; SHIDA N, 1992, J ORG CHEM, V57, P5049, DOI 10.1021/jo00045a003; SHIDA N, 1994, J ORG CHEM, V59, P4068, DOI 10.1021/jo00094a013; Sibi M. P., 2000, TETRAHEDRON, V56, P8033; SUZUKI I, 1993, J AM CHEM SOC, V115, P10139, DOI 10.1021/ja00075a032; TOMIOKA K, 1990, SYNTHESIS-STUTTGART, P541; Tomioka K., 2012, COMPREHENSIVE CHIRAL, V4, P122; Tomioka K., 2004, COMPREHENSIVE ASYMME, P109; Uchiyama M, 2007, J AM CHEM SOC, V129, P13360, DOI 10.1021/ja070123k; Urones JG, 1997, TETRAHEDRON-ASYMMETR, V8, P2683, DOI 10.1016/S0957-4166(97)00340-6; UYEHARA T, 1992, J ORG CHEM, V57, P3139, DOI 10.1021/jo00037a034; Yamamoto Y., 2007, ORG LETT, V11, P2007; Yamataka H., 2004, CHEM ORGANOLITHIUM 1; YOSHII E, 1995, SYNLETT, P568	56	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	AUG	2015	47	15					2256	2264		10.1055/s-0034-1380702		9	Chemistry, Organic	Chemistry	CN3EW	WOS:000358308300011		
J	Sugiura, M; Ishikawa, W; Kuboyama, Y; Nakajima, M				Sugiura, Masaharu; Ishikawa, Wakoto; Kuboyama, Yukinobu; Nakajima, Makoto			Conjugate Addition of Diboron Catalyzed by O-Monoacyltartaric Acids	SYNTHESIS-STUTTGART			English	Article						organocatalysts; conjugate addition; diboron	ASYMMETRIC BETA-BORATION; ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; N-HETEROCYCLIC CARBENES; AMINO BORONATE ESTERS; ENANTIOSELECTIVE SYNTHESIS; TARTARIC ACID; CHIRAL DIOLS; ENONES; HYDROBORATION; ALDEHYDES	O-3,5-Di(adamantan-1-yl)benzoyltartaric acid catalyzes the conjugate addition of bis(neopentyl glycolato)diboron to ,-unsaturated ketones with good enantioselectivity. The addition of magnesium sulfate as a dehydrating agent and benzoic acid as a co-catalyst was found to be effective.	[Sugiura, Masaharu; Ishikawa, Wakoto; Kuboyama, Yukinobu; Nakajima, Makoto] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan	Sugiura, M (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	msugiura@kumamoto-u.ac.jp			JSPS KAKENHI Grant [23590009, 26460010]	This work was partially supported by JSPS KAKENHI Grant Numbers 23590009 and 26460010.	Beenen MA, 2008, J AM CHEM SOC, V130, P6910, DOI 10.1021/ja800829y; Chen IH, 2010, ORG LETT, V12, P4098, DOI 10.1021/ol101691p; Wu H, 2012, J AM CHEM SOC, V134, P8277, DOI 10.1021/ja302929d; Turner HM, 2011, ORG LETT, V13, P5796, DOI 10.1021/ol202391r; Sandrock DL, 2010, J AM CHEM SOC, V132, P17108, DOI 10.1021/ja108949w; Kobayashi S, 2012, ANGEW CHEM INT EDIT, V51, P12763, DOI 10.1002/anie.201207343; Kodama T, 2011, ORG LETT, V13, P6316, DOI 10.1021/ol2028702; Bonet A, 2010, ANGEW CHEM INT EDIT, V49, P5130, DOI 10.1002/anie.201001198; Lee KS, 2009, J AM CHEM SOC, V131, P7253, DOI 10.1021/ja902889s; Wu TR, 2007, J AM CHEM SOC, V129, P4908, DOI 10.1021/ja0713734; Kabalka GW, 2002, TETRAHEDRON LETT, V43, P2323, DOI 10.1016/S0040-4039(02)00261-7; Zhao L, 2012, ORG LETT, V14, P5780, DOI 10.1021/ol302839d; Pelz NF, 2004, J AM CHEM SOC, V126, P16328, DOI 10.1021/ja044167u; Lou S, 2007, J AM CHEM SOC, V129, P15398, DOI 10.1021/ja075204v; Toribatake K, 2013, TETRAHEDRON, V69, P3551, DOI 10.1016/j.tet.2013.02.086; Radomkit S, 2014, ANGEW CHEM INT EDIT, V53, P3387, DOI 10.1002/anie.201309982; Mantilli L, 2010, CHEMCATCHEM, V2, P501, DOI 10.1002/cctc.201000008; Lillo V, 2009, ORGANOMETALLICS, V28, P659, DOI 10.1021/om800946k; Sole C, 2012, CHEM COMMUN, V48, P3769, DOI 10.1039/c2cc00020b; Lundy BJ, 2011, ORG LETT, V13, P4958, DOI 10.1021/ol2020847; Hirano K, 2007, ORG LETT, V9, P5031, DOI 10.1021/ol702254g; Lee JE, 2008, ANGEW CHEM INT EDIT, V47, P145, DOI 10.1002/anie.200703699; Ibrahem I, 2012, CHEM-EUR J, V18, P5175, DOI 10.1002/chem.201103572; KABALKA GW, 1989, TETRAHEDRON LETT, V30, P1483, DOI 10.1016/S0040-4039(00)99497-8; O'Brien JM, 2010, J AM CHEM SOC, V132, P10630, DOI 10.1021/ja104777u; Lee YM, 2009, J AM CHEM SOC, V131, P3160, DOI 10.1021/ja809382c; Ito H, 2000, TETRAHEDRON LETT, V41, P6821, DOI 10.1016/S0040-4039(00)01161-8; Ito H, 2007, J AM CHEM SOC, V129, P14856, DOI 10.1021/ja076634o; Molander GA, 2013, ADV SYNTH CATAL, V355, P3037, DOI 10.1002/adsc.201300640; Chen IH, 2009, J AM CHEM SOC, V131, P11664, DOI 10.1021/ja9045839; Le PQ, 2012, ORG LETT, V14, P6104, DOI 10.1021/ol3030605; Lillo V, 2009, ORG BIOMOL CHEM, V7, P4674, DOI 10.1039/b909341a; Wu TR, 2005, J AM CHEM SOC, V127, P3244, DOI 10.1021/ja043001q; Hong K, 2013, J AM CHEM SOC, V135, P9252, DOI 10.1021/ja402569j; Carroll AM, 2005, ADV SYNTH CATAL, V347, P609, DOI 10.1002/adsc.200404232; Barnett D. S., 2009, ANGEW CHEM INT EDIT, V48, P8672; Bishop JA, 2009, ANGEW CHEM INT EDIT, V48, P4337, DOI 10.1002/anie.200901023; Bonet A, 2012, ORG BIOMOL CHEM, V10, P6621, DOI 10.1039/c2ob26079d; BROWN HC, 1986, TETRAHEDRON, V42, P5505, DOI 10.1016/S0040-4020(01)88152-7; Cheon CH, 2010, ORG LETT, V12, P2476, DOI 10.1021/ol100233t; Chinnusamy T., 2014, COMPREHENSIVE ORGANI, V7, P692; Grimblat N, 2014, J ORG CHEM, V79, P6754, DOI 10.1021/jo5012398; Luan Y, 2015, J AM CHEM SOC, V137, P3233, DOI 10.1021/jacs.5b00757; Moquist PN, 2010, ANGEW CHEM INT EDIT, V49, P7096, DOI 10.1002/anie.201003469; Nguyen TS, 2015, TETRAHEDRON LETT, V56, P3337, DOI 10.1016/j.tetlet.2015.01.166; Pubill-Ulldemolins C, 2012, CHEM-EUR J, V18, P1121, DOI 10.1002/chem.201102209; Pubill-Ulldemolins C, 2012, ORG BIOMOL CHEM, V10, P9677, DOI 10.1039/c2ob26899j; Shiomi T, 2009, CHEM COMMUN, P5987, DOI 10.1039/b915759j; Sugiura M, 2014, ORG LETT, V16, P5172, DOI 10.1021/ol502526y; Sugiura M, 2010, CHEM COMMUN, V46, P7799, DOI 10.1039/c0cc03076g; Zhang C, 2013, ORG LETT, V15, P3416, DOI 10.1021/ol401468v; Zhang SS, 2013, SYNLETT, V24, P437, DOI 10.1055/s-0032-1318145	52	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	AUG	2015	47	15					2265	2269		10.1055/s-0034-1378835		5	Chemistry, Organic	Chemistry	CN3EW	WOS:000358308300012		
J	Takahashi, A; Kuroki, K; Maenaka, K				Takahashi, Ami; Kuroki, Kimiko; Maenaka, Katsumi			THE IMMUNOSUPPRESSIVE EFFECT OF HLA-G2/G6 HOMODIMER IN COLLAGEN-INDUCED ARTHRITIS MICE	TISSUE ANTIGENS			English	Meeting Abstract									[Takahashi, Ami; Kuroki, Kimiko; Maenaka, Katsumi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 060, Japan		am.i.25049014@gmail.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	AUG	2015	86	2					78	78				1	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CN2NF	WOS:000358257700010		
J	Ezeakile, M; Portik-Dobos, V; Horuzsko, DD; Kapoor, R; Maenaka, K; Zayas, CF; Mulloy, LL; Horuzsko, A				Ezeakile, Maureen; Portik-Dobos, Vera; Horuzsko, Daniel D.; Kapoor, Rajan; Maenaka, Katsumi; Zayas, Carlos F.; Mulloy, Laura L.; Horuzsko, Anatolij			MECHANISMS REPROGRAMMING B CELLS BY HLA-G AND THEIR SIGNATURE IN KIDNEY TRANSPLANT PATIENTS	TISSUE ANTIGENS			English	Meeting Abstract									[Ezeakile, Maureen; Portik-Dobos, Vera; Horuzsko, Daniel D.; Kapoor, Rajan; Zayas, Carlos F.; Mulloy, Laura L.; Horuzsko, Anatolij] Georgia Regents Univ, Med Coll Georgia, Augusta, GA USA; [Maenaka, Katsumi] Hokkaido Univ, Sapporo, Hokkaido, Japan		ahoruzsko@gru.edu						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	AUG	2015	86	2					90	91				2	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CN2NF	WOS:000358257700040		
J	Sobata, R; Matsumoto, C; Uchida, S; Suzuki, Y; Satake, M; Tadokoro, K				Sobata, R.; Matsumoto, C.; Uchida, S.; Suzuki, Y.; Satake, M.; Tadokoro, K.			Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1	VOX SANGUINIS			English	Article						HTLV-1; leucocyte reduction; proviral load; transfusion; transfusion-transmitted infection	CELL LEUKEMIA-VIRUS; I HTLV-I; MILK-BORNE TRANSMISSION; BLOOD-TRANSFUSION; COMMON MARMOSET; CARRIER MOTHERS; PROVIRUS LOAD; BREAST-MILK; COMPONENTS; ANTIBODY	Background and ObjectivesThe risk of transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) after prestorage leucocyte reduction (LR) remains unknown, as the proviral load in the blood component that would cause TT-HTLV-1 is undetermined. On the basis of the distribution of HTLV-1 proviral load among HTLV-1-sero-positive blood donors, we attempted to estimate the proviral load for transfusion-related infectivity. We also discuss the effectiveness of LR in preventing TT-HTLV-1. Materials and MethodsThe HTLV-1 proviral load in 300 HTLV-1-sero-positive blood donors was determined by real-time polymerase chain reaction analysis. The proviral load required for transfusion-related infectivity was estimated using historical TT-HTLV-1 frequency data from a retrospective study on patients who had received blood from HTLV-1-sero-positive blood donors and the distribution pattern of HTLV-1 proviral load among blood donors. ResultsHTLV-1 proviral loads ranged between <001 and 250 copies per 100 leucocytes. Historical data showed TT-HTLV-1 frequency to be 80%. Assuming that 80% of the 300 sero-positive samples are infectious, it is estimated that the transfer of 9x10(4)cells containing the HTLV-1 provirus is required to establish TT-HTLV-1. ConclusionThe residual number of HTLV-1-infected cells after LR is substantially lower than the viral load necessary for TT-HTLV-1. LR therefore appears to be effective in minimizing the incidence of TT-HTLV-1.	[Sobata, R.; Matsumoto, C.; Uchida, S.; Satake, M.; Tadokoro, K.] Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Tokyo 1358521, Japan; [Suzuki, Y.] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan	Sobata, R (reprint author), Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Infect Dis Res Dept,Koto Ku, 2-1-67 Tatsumi, Tokyo 1358521, Japan.	r-sobata@jrc.or.jp					Akino M, 2000, JPN J T MED, V46, P521; ANDO Y, 1989, JPN J CANCER RES, V80, P405; ANDO Y, 1986, JPN J CANCER RES, V77, P974; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; BOWDEN RA, 1995, BLOOD, V86, P3598; King KE, 2004, TRANSFUSION, V44, P25, DOI 10.1046/j.0041-1132.2004.00609.x; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; KLEINMAN S, 1993, TRANSFUSION, V33, P14, DOI 10.1046/j.1537-2995.1993.33193142303.x; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Kannian P, 2012, J VIROL, V86, P3757, DOI 10.1128/JVI.06900-11; OSAME M, 1986, LANCET, V1, P1031; MURPHY EL, 1989, ANN INTERN MED, V111, P555; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Satake M, 2012, J MED VIROL, V84, P327, DOI 10.1002/jmv.23181; UCHIYAMA T, 1977, BLOOD, V50, P481; SULLIVAN MT, 1991, ARCH INTERN MED, V151, P2043; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Satake M, 2007, TRANSFUSION, V47, P1197, DOI 10.1111/j.1537-2995.2007.01276.x; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; MANNS A, 1992, INT J CANCER, V51, P886, DOI 10.1002/ijc.2910510609; Hisada M, 2005, J INFECT DIS, V191, P1383, DOI 10.1086/429094; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; Watanabe T, 1997, INT J HEMATOL, V66, P257; OKOCHI K, 1984, VOX SANG, V46, P245; Yamaguchi K, 2002, INT J HEMATOL, V76, P240; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Nicot C, 2005, AM J HEMATOL, V78, P232, DOI 10.1002/ajh.20307; desThe G, 1993, AIDS RES HUM RETROV, V9, P381; Dzik WH, 2001, ROSSIS PRINCIPLES TR, V3rd, P271; Hewitt PE, 2013, TRANSFUSION, V53, P2168, DOI 10.1111/trf.12105; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Hino S, 1996, J ACQ IMMUN DEF SYND, V13, pS199, DOI 10.1097/00042560-199600001-00030; Houldsworth A, 2014, J MED VIROL, V86, P162, DOI 10.1002/jmv.23726; KATAOKA R, 1990, BLOOD, V76, P1657; KHABBAZ RF, 1992, NEW ENGL J MED, V326, P375, DOI 10.1056/NEJM199202063260604; KINOSHITA K, 1985, JPN J CANCER RES, V76, P1147; KINOSHITA K, 1987, JPN J CANCER RES, V78, P674; MATSUMOTO C, 1990, J VIROL, V64, P5290; Mazda T, 2011, ISBT SCI SER, V6, P404; MORISHIMA Y, 1986, VOX SANG, V50, P212; Murphy EL, 2004, J INFECT DIS, V190, P504, DOI 10.1086/422398; Naito Y, 2009, JPN J TRANSFUS CELL, V55, P287; OKOCHI K, 1986, AIDS RES HUM RETROV, V2, pS157; Pennington J, 2002, BLOOD, V100, P677, DOI 10.1182/blood.V100.2.677; TAJIMA K, 1982, GANN, V73, P893; McFarland J, 1997, NEW ENGL J MED, V337, P1861; Yamada Yasuaki, 2011, Rinsho Ketsueki, V52, P1765; YAMANOUCHI K, 1985, JPN J CANCER RES, V76, P481	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	AUG	2015	109	2					122	128		10.1111/vox.12263		7	Hematology	Hematology	CN0TD	WOS:000358125600003		
J	Onodera, T; Tsuneyama, H; Ogasawara, K; Isa, K; Satake, M; Tadokoro, K; Uchikawa, M				Onodera, T.; Tsuneyama, H.; Ogasawara, K.; Isa, K.; Satake, M.; Tadokoro, K.; Uchikawa, M.			A novel DO null allele with a c.268C > T (p.Gln90Stop) mutation in Japanese	VOX SANGUINIS			English	Article						Dombrock blood group; DO null allele; Gy(a-)	PHENOTYPE; DOB	The Dombrock blood group system consists of two antithetical antigens, Do(a) (DO1) and Do(b) (DO2), and seven high-prevalence antigens, Gy(a) (DO3), Hy (DO4), Jo(a) (DO5), DOYA (DO6), DOMR (DO7), DOLG (DO8) and DOLC (DO9). Do(a)/Do(b) polymorphism is associated with c.793A>G (p.Asn265Asp) in exon 2 of the DO (ART4) gene, and the corresponding alleles are named DO*01 and DO*02. The rare Do(null) or Gy(a-) phenotype lacks all Dombrock antigens, and the DO null alleles vary with both DO*01 and DO*02 backgrounds. We report a novel DO null allele, which has a c.268C>T (p.Gln90Stop) nonsense mutation with a DO*02 background identified from four unrelated Gy(a-) Japanese individuals.	[Onodera, T.; Tsuneyama, H.; Uchikawa, M.] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan; [Ogasawara, K.; Isa, K.; Satake, M.; Tadokoro, K.] Japanese Red Cross Cent Blood Inst, Tokyo, Japan	Ogasawara, K (reprint author), Japanese Red Cross Cent Blood Inst, Koto Ku, 2-1-67 Tatsumi, Tokyo 1358521, Japan.	k-ogasawara@jrc.or.jp					Gubin AN, 2000, BLOOD, V96, P2621; Daniels G, 2013, HUMAN BLOOD GROUPS, P376; Lucien N, 2002, BLOOD, V100, P1063, DOI 10.1182/blood-2001-12-0298; MOLTHAN L, 1973, VOX SANG, V24, P382; OKUBO Y, 1986, TRANSFUSION, V26, P214, DOI 10.1046/j.1537-2995.1986.26286152921.x; Rios M, 2001, TRANSFUSION, V41, P1405, DOI 10.1046/j.1537-2995.2001.41111405.x; Rios M, 2002, BRIT J HAEMATOL, V117, P765, DOI 10.1046/j.1365-2141.2002.03524.x; SWANSON J, 1967, TRANSFUSION, V7, P304; SWANSON J, 1965, NATURE, V206, P313, DOI 10.1038/206313a0; Takahashi M, 2014, 62 ANN M JAP SOC T S, V60, P275; Westhoff C, 2007, TRANSFUSION, V47, P1356, DOI 10.1111/j.1537-2995.2007.01279.x	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	AUG	2015	109	2					191	193		10.1111/vox.12260		3	Hematology	Hematology	CN0TD	WOS:000358125600012		
J	Zhou, J; Jiang, H; Kikuchi, H				Zhou, Jie; Jiang, Hao; Kikuchi, Hisakazu			Performance of Uniform Concentric Circular Arrays in a Three-Dimensional Spatial Fading Channel Model	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Uniform concentric circular arrays; Multiple-input multiple-output; Three-dimensional multi-path channel; Electromagnetic vector sensor	VECTOR-SENSOR; MOBILE RADIO	In this paper, the performance of uniform concentric circular arrays (UCCA) for multiple-input multiple-output (MIMO) receiver in a three-dimensional (3D) multi-path channel is investigated. Firstly, the analytical expressions for antenna spatial fading correlation and electromagnetic vector sensor (EVS) at each element are derived, where the UCCA configuration for MIMO receiver is considered. Then the effect of the angular parameters associated with the mean azimuth of arrival, azimuth spread, mean elevation of arrival, and elevation spread on the system performance is presented. The numerical and simulation results indicate that the excellent performance of the proposed UCCA MIMO antenna array system. In addition, comparisons between our theoretical results of the UCCA-EVS antenna array with previous ULA and UCA antenna array show that the analysis is accurate and applicable to depict the 3D spatial fading channel model.	[Zhou, Jie; Jiang, Hao] Nanjing Univ Informat Sci & Technol, Dept Jiangsu, Key Lab Meteorol Observat & Informat Proc, Nanjing 210044, Jiangsu, Peoples R China; [Zhou, Jie; Kikuchi, Hisakazu] Niigata Univ, Dept Elect & Elect Engn, Niigata 9502181, Japan	Zhou, J (reprint author), Nanjing Univ Informat Sci & Technol, Dept Jiangsu, Key Lab Meteorol Observat & Informat Proc, Nanjing 210044, Jiangsu, Peoples R China.	zhoujie45@hotmail.com; haojiang89@sina.com			National Nature Science Foundation of China [61372128, 61471153]; Scientific and Technological Support Project (Industry) of Jiangsu Province [14KJA510001]; priority academic program development of the Jiangsu higher education institutions	We thank Professor Fumiyuki Adachi, Department of Electrical and Electronic Engineering, Tohoku University, Japan, for helping us complete this study successfully. This research was supported by the National Nature Science Foundation of China (No. 61372128 and 61471153), the Scientific and Technological Support Project (Industry) of Jiangsu Province (No. 14KJA510001), and a project funded by the priority academic program development of the Jiangsu higher education institutions. We would also like to thank the anonymous reviewers for their constructive comments, which greatly helped improve the paper.	Kuchar A, 2000, IEEE T ANTENN PROPAG, V48, P137, DOI 10.1109/8.833062; Chan SC, 2007, IEEE T SIGNAL PROCES, V55, P165, DOI 10.1109/TSP.2006.882109; Chen HH, 2007, IEEE T CIRCUITS-I, V54, P1938, DOI 10.1109/TCSI.2007.904648; Kim JK, 2011, IEEE INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS (ICCE 2011), P423; Fuhl J, 1997, IEEE T ANTENN PROPAG, V45, P672, DOI 10.1109/8.564093; Mammasis K, 2009, IEEE T WIREL COMMUN, V8, P2046, DOI 10.1109/TWC.2009.080505; Kalliola K, 2002, IEEE T VEH TECHNOL, V51, P823, DOI 10.1109/TVT.2002.800639; NEHORAI A, 1994, IEEE T SIGNAL PROCES, V42, P376, DOI 10.1109/78.275610; Zhou J, 2014, IET COMMUN, V8, P1, DOI 10.1049/iet-com.2013.0275; SALZ J, 1994, IEEE T VEH TECHNOL, V43, P1049, DOI 10.1109/25.330168; Yong SK, 2005, IEEE T WIREL COMMUN, V4, P2856, DOI 10.1109/TWC.2005.858335; Andrews MR, 2001, NATURE, V409, P316, DOI 10.1038/35053015; Wong KT, 2011, IEEE T SIGNAL PROCES, V59, P160, DOI 10.1109/TSP.2010.2084085; Durrani S., 2004, P MIKON 04 MAY, P493; Foschini G. J., 1998, WIRELESS PERS COMMUN, V6, P495; Fulghum T, 1998, IEEE VTC P, P489; Jakes W.C., 1974, MICROWAVE MOBILE COM; Lee JM, 2009, ICE-GIC: 2009 INTERNATIONAL IEEE CONSUMER ELECTRONICS SOCIETY'S GAMES INNOVATIONS CONFERENCE, P1; Lee JM, 2011, GRAD TEXTS MATH, V202, P1, DOI 10.1007/978-1-4419-7940-7; Shui D., 2000, IEEE T COMMUN, V48, P502, DOI DOI 10.1109/26.837052; Tafvizi H.R., 2011, IEEE VEH TECHN C SAN, P1; Yong S.K., 1994, IEEE INT S ANT PROP	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	AUG	2015	83	4					2949	2963		10.1007/s11277-015-2575-z		15	Telecommunications	Telecommunications	CN1BM	WOS:000358150600027		
J	Blanke, A; Busse, S; Machida, R				Blanke, Alexander; Buesse, Sebastian; Machida, Ryuichiro			Coding characters from different life stages for phylogenetic reconstruction: a case study on dragonfly adults and larvae, including a description of the larval head anatomy of Epiophlebia superstes (Odonata: Epiophlebiidae)	ZOOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						Anisoptera; Anisozygoptera; character coding; convergence; Epiophlebia; head anatomy; larva; microCT; multistate; muscles; Zygoptera	MORPHOLOGICAL CHARACTERS; CLADISTIC-ANALYSIS; INSECTA ODONATA; TRUE LARVA; ANISOPTERA; COLEOPTERA; CLASSIFICATION; IDENTIFICATION; LIBELLULIDAE; CONVERGENCE	The exclusive use of characters coding for specific life stages may bias tree reconstruction. If characters from several life stages are coded, the type of coding becomes important. Here, we simulate the influence on tree reconstruction of morphological characters of Odonata larvae incorporated into a data matrix based on the adult body under different coding schemes. For testing purposes, our analysis is focused on a well-supported hypothesis: the relationships of the suborders Zygoptera, Anisozygoptera', and Anisoptera. We studied the cephalic morphology of Epiophlebia, a key taxon among Odonata, and compared it with representatives of Zygoptera and Anisoptera in order to complement the data matrix. Odonate larvae are characterized by a peculiar morphology, such as the specific head form, mouthpart configuration, ridge configuration, cephalic musculature, and leg and gill morphology. Four coding strategies were used to incorporate the larval data: artificial coding (AC), treating larvae as independent terminal taxa; non-multistate coding (NMC), preferring the adult life stage; multistate coding (MC); and coding larval and adult characters separately (SC) within the same taxon. As expected, larvae are monophyletic' in the AC strategy, but with anisopteran and zygopteran larvae as sister groups. Excluding larvae in the NMC approach leads to strong support for both monophyletic Odonata and Epiprocta, whereas MC erodes phylogenetic signal completely. This is an obvious result of the larval morphology leading to many multistate characters. SC results in the strongest support for Odonata, and Epiprocta receives the same support as with NMC. Our results show the deleterious effects of larval morphology on tree reconstruction when multistate coding is applied. Coding larval characters separately is still the best approach in a phylogenetic framework.(c) 2015 The Linnean Society of London	[Blanke, Alexander; Machida, Ryuichiro] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan; [Buesse, Sebastian] Univ Cambridge, Univ Museum Zool, Dept Zool, Cambridge CB2 3EJ, England	Blanke, A (reprint author), Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan.	blanke@uni-bonn.de			German Academic Exchange Service (DAAD); Japanese Society for the Promotion of Science (JSPS) [P14071]	We thank K. Yoshizawa for the collection of Epiophlebia superstes, and D. N. Shah and R. D. Tachamo Shah for the loan of Epiophlebia laidlawi. Morphological investigation was possible through SR-mu CT investigations at the Swiss Light Source, Villigen, Switzerland (proposal IDs 20080794 & 20100088), as well as at the Deutsches Elektronen Synchrotron (DESY) in Hamburg, Germany, (ID I-20090102). S. B. is supported by a fellowship within the postdoctoral programme of the German Academic Exchange Service (DAAD). Thomas Hornschemeyer is thanked for his generous support to S. B. A. B. was supported by a fellowship of the Japanese Society for the Promotion of Science (JSPS fellowship P14071). Bernhard Misof is thanked for his valuable comments on an earlier version of this manuscript and for his unrelenting support of A. B.	Amans P., 1881, REV SCI NATURELLES 2, V1, P63; Blanke A, 2013, SYST ENTOMOL, V38, P474, DOI 10.1111/syen.12012; TANAKA Y, 1980, J EXP BIOL, V88, P1; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; Dijkstra KDB, 2013, ZOOTAXA, V3703, P36; Blanke A, 2013, SYST BIOL, V62, P250, DOI 10.1093/sysbio/sys091; Pohl H, 2010, MICROSC RES TECHNIQ, V73, P1073, DOI 10.1002/jemt.20835; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Bybee SM, 2008, CLADISTICS, V24, P477, DOI 10.1111/j.1096-0031.2007.00191.x; Pass Guenther, 2006, Arthropod Systematics & Phylogeny, V64, P165; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Bitsch C, 2004, ZOOL SCR, V33, P511, DOI 10.1111/j.0300-3256.2004.00162.x; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; Fleck Guenther, 2011, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V4, P83; Tomaszewska KW, 2005, ANN ZOOL, V55, P1; Pass G, 2000, ANNU REV ENTOMOL, V45, P495, DOI 10.1146/annurev.ento.45.1.495; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Bitsch C, 2000, ZOOL SCR, V29, P131, DOI 10.1046/j.1463-6409.2000.00036.x; Lawrence JF, 2011, ANN ZOOL, V61, P1, DOI 10.3161/000345411X576725; Busse S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-237; Marvaldi AE, 1997, CLADISTICS, V13, P285, DOI 10.1006/clad.1997.0049; DUPORTE EM, 1957, ANNU REV ENTOMOL, V2, P55, DOI 10.1146/annurev.en.02.010157.000415; Asahina S. A, 1954, MORPHOLOGICAL STUDY; Ballare EF, 2011, INT J ODONATOL, V14, P137, DOI 10.1080/13887890.2011.579538; Beckmann F, 2008, P SOC PHOTO-OPT INS, V7078, DOI 10.1117/12.794617; Beutel RG, 1999, SYST ENTOMOL, V24, P171, DOI 10.1046/j.1365-3113.1999.00075.x; BEUTEL RG, 1993, SYST ENTOMOL, V18, P127, DOI 10.1111/j.1365-3113.1993.tb00658.x; Bininda-Emonds ORP, 1998, BIOL J LINN SOC, V64, P101; Blanke A, 2013, ORG DIVERS EVOL, V13, P55, DOI 10.1007/s13127-012-0097-z; Brazeau MD, 2011, BIOL J LINN SOC, V104, P489, DOI 10.1111/j.1095-8312.2011.01755.x; Busse S, SCI REPORTS IN PRESS; CARLE FL, 1994, P ENTOMOL SOC WASH, V96, P147; Corbet P. S., 1962, BIOL DRAGONFLIES; Davis RB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-252; DuPorte EM, 1946, J MORPHOL, V79, P371; Emden FLV, 1957, ANNU REV ENTOMOL, V2, P91; Fleck G, 2006, ANN SOC ENTOMOL FR, V42, P91; Fleck G, 2012, ZOOTAXA, P80; Fleck G, 2008, ORG DIVERS EVOL, V8, P1, DOI 10.1016/j.ode.2006.08.003; Fleck G, 2008, J ZOOL SYST EVOL RES, V46, P310, DOI 10.1111/j.1439-0469.2008.00474.x; Forey P.L., 2000, HOMOLOGY SYSTEMATICS, V58, P54; Holland BR, 2010, SYST BIOL, V59, P433, DOI 10.1093/sysbio/syq023; Lee DC, 1999, CLADISTICS, V15, P373, DOI 10.1111/j.1096-0031.1999.tb00273.x; Lohmann Heinrich, 1996, Entomologische Zeitschrift, V106, P209; Needham J.G., 1955, MANUAL DRAGONFLIES N; Nel Andre, 1993, Martinia Numero Hors-Serie, V3, P1; OGRADY RT, 1987, SYST ZOOL, V36, P268, DOI 10.2307/2413066; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Rehn AC, 2003, SYST ENTOMOL, V28, P181, DOI 10.1046/j.1365-3113.2003.00210.x; Seifert G., 1995, ENTOMOLOGISCHES PRAK; SHORT J. R. T., 1955, TRANS ROY ENT SOC LONDON, V106, P197; Snodgrass R. E., 1947, SMITHSONIAN MISC COLL, V107, P1; Snodgrass R.E., 1935, PRINCIPLES INSECT MO; Stampanoni M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.140105; Staniczek AH, 2000, ZOOL ANZ, V239, P147; Staniczek AH., 2001, THESIS EBERHARD KARL; Strenger A, 1952, ZOOL JB, V72, P469; Takizawa H, 1976, JAPAN J ENTOMOLOGY, V44, P444; Tillyard R.J., 1917, BIOL DRAGONFLIES ODO; Trueman J. W. H., 1996, Odonatologica, V25, P59; vonsKeler S., 1963, ENTOMOLOGISCHES WORT; Wootton R.J., 1991, Advances in Odonatology, V5, P153; ZHANG ZQ, 1995, CAN J ZOOL, V73, P96, DOI 10.1139/z95-012	64	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4082	1096-3642		ZOOL J LINN SOC-LOND	Zool. J. Linn. Soc.	AUG	2015	174	4					718	732		10.1111/zoj.12258		15	Zoology	Zoology	CN4CJ	WOS:000358376200004		
J	Yamamoto, S; Yamamoto, Y; Kitajima, O; Maeda, T; Suzuki, T				Yamamoto, S.; Yamamoto, Y.; Kitajima, O.; Maeda, T.; Suzuki, T.			Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							ORBICULARIS OCULI; ROCURONIUM; PHARMACOKINETICS; PHARMACODYNAMICS; REVERSIBILITY; VECURONIUM; DIAPHRAGM; CISATRACURIUM; RELAXATION; INFUSION	BackgroundNeuromuscular monitoring using the corrugator supercilii muscle is associated with a number of challenges. The aim of this study was to assess reversal of a rocuronium-induced neuromuscular blockade with sugammadex according to monitoring either using the corrugator supercilii muscle or the adductor pollicis muscle. We hypothesized that a larger dose of sugammadex would be required to obtain a train-of-four (TOF) ratio of 1.0 with the corrugator supercilii muscle than with the adductor pollicis muscle. MethodsForty patients aged 20-60years and 40 patients aged 70years were enrolled. After induction of anesthesia, we recorded the corrugator supercilii muscle response to facial nerve stimulation and the adductor pollicis muscle response to ulnar nerve stimulation using acceleromyography. All patients received 1mg/kg rocuronium. When the first twitch (T1) of TOF recovered to 10% of control values at the corrugator supercilii, rocuronium infusion was commenced to maintain a T1 of 10% of the control at the corrugator supercilii. Immediately after discontinuation of rocuronium infusion, 2mg/kg or 4mg/kg of sugammadex was administered. The time for recovery to a TOF ratio of 1.0 and the number of patients not reaching a TOF ratio of 1.0 by 5min at each dose and muscle was recorded. ResultsWhen neuromuscular block at the corrugator supercilii was maintained at a T1 of 10% of control, that at the adductor pollicis was deep (post-tetanic count 5). Sugammadex 4mg/kg completely antagonized neuromuscular block at both muscles within 5min. The time to a TOF ratio of 1.0 at the adductor pollicis was significantly longer in the group 70years than the group 20-60years (mean (SD): 178 (42.8)s vs. 120 (9.4)s, P<0.0001). In contrast, 2mg/kg sugammadex reversed neuromuscular blockade at the corrugator supercilii but not at the adductor pollicis, with 10 patients in the group 20-60years and 8 patients in the group 70years requiring an additional sugammadex (P<0.05 vs. 4mg/kg sugammadex). ConclusionSugammadex 4mg/kg was required to reverse a moderate rocuronium-induced neuromuscular block when the corrugator supercilii muscle is used for monitoring.	[Yamamoto, S.; Yamamoto, Y.; Kitajima, O.; Maeda, T.; Suzuki, T.] Nihon Univ, Sch Med, Dept Anesthesiol, Tokyo, Japan	Suzuki, T (reprint author), Nihon Univ, Sch Med, Dept Anesthesiol, Itabashi Ku, 30-1 Oyaguchi Kami Cho, Tokyo, Japan.	suzuki.takahiro@nihon-u.ac.jp					Eikermann M, 2006, ANESTH ANALG, V102, P937, DOI 10.1213/01.ane.0000195233.80166.14; Goodmurphy CW, 1999, CLIN ANAT, V12, P1, DOI 10.1002/(SICI)1098-2353(1999)12:1<1::AID-CA1>3.0.CO;2-J; Plaud B, 2001, ANESTHESIOLOGY, V95, P96, DOI 10.1097/00000542-200107000-00019; BEVAN DR, 1993, CAN J ANAESTH, V40, P127; Suzuki T, 2006, BRIT J ANAESTH, V96, P44, DOI 10.1093/bja/aei273; Epemolu O, 2003, ANESTHESIOLOGY, V99, P632, DOI 10.1097/00000542-200309000-00018; Jones RK, 2008, ANESTHESIOLOGY, V109, P816, DOI 10.1097/ALN.0b013e31818a3fee; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095; Eikermann M, 2007, AM J RESP CRIT CARE, V175, P9, DOI 10.1164/rccm.200512-1862OC; MATTEO RS, 1993, ANESTH ANALG, V77, P1193; Duvaldestin P, 2010, ANESTH ANALG, V110, P74, DOI 10.1213/ANE.0b013e3181c3be3c; Hemmerling TM, 2003, CAN J ANAESTH, V50, P779; PLAUD B, 1995, CLIN PHARMACOL THER, V58, P185, DOI 10.1016/0009-9236(95)90196-5; Yoshida F, 2012, ACTA ANAESTH SCAND, V56, P83, DOI 10.1111/j.1399-6576.2011.02589.x; Sorgenfrei IF, 2006, ANESTHESIOLOGY, V104, P667, DOI 10.1097/00000542-200604000-00009; Claudius C, 2008, ANESTHESIOLOGY, V108, P1117, DOI 10.1097/ALN.0b013e318173f62f; Dinenno FA, 2001, J PHYSIOL-LONDON, V531, P573, DOI 10.1111/j.1469-7793.2001.0573i.x; DONATI F, 1990, ANESTHESIOLOGY, V73, P870, DOI 10.1097/00000542-199011000-00013; Hemmerling TM, 2000, BRIT J ANAESTH, V85, P856, DOI 10.1093/bja/85.6.856; Jellish WS, 2000, ANESTH ANALG, V91, P1250; Kirov K, 2007, BRIT J ANAESTH, V98, P611, DOI 10.1093/bja/aem048; Lee HJ, 2009, BRIT J ANAESTH, V102, P869, DOI 10.1093/bja/aep064; Sorooshian SS, 1996, ANESTHESIOLOGY, V84, P1083, DOI 10.1097/00000542-199605000-00010; Suzuki T, 2011, BRIT J ANAESTH, V106, P823, DOI 10.1093/bja/aer098; Suzuki T, 2009, ACTA ANAESTH SCAND, V53, P1336, DOI 10.1111/j.1399-6576.2009.02073.x; Yun S, 2014, PLAST RECONSTR SURG, V133, p455E, DOI 10.1097/PRS.0000000000000052	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	AUG	2015	59	7					892	901		10.1111/aas.12549		10	Anesthesiology	Anesthesiology	CM8RN	WOS:000357969800008		
J	Miyazaki, T				Miyazaki, Takafumi			A remark on Jesmanowicz' conjecture for the non-coprimality case	ACTA MATHEMATICA SINICA-ENGLISH SERIES			English	Article						Diophantine equation; Pythagorean numbers; Jesmanowicz' conjecture	PYTHAGOREAN TRIPLES	Let a, b, c be relatively prime positive integers such that a (2) + b (2) = c (2). JeA > manowicz' conjecture on Pythagorean numbers states that for any positive integer N, the Diophantine equation (aN) (x) + (bN) (y) = (cN) (z) has no positive solution (x, y, z) other than x = y = z = 2. In this paper, we prove this conjecture for the case that a or b is a power of 2.	Nihon Univ, Coll Sci & Technol, Dept Math, Chiyoda Ku, Tokyo 1018308, Japan	Miyazaki, T (reprint author), Nihon Univ, Coll Sci & Technol, Dept Math, Chiyoda Ku, 1-8-14 Kanda Surugadai, Tokyo 1018308, Japan.	miyazaki-takafumi@math.cst.nihon-u.ac.jp			 [25484]	Supported by Grant in Aid for JSPS Fellows (Grant No. 25484)	Miyazaki T, 2013, J NUMBER THEORY, V133, P583, DOI 10.1016/j.jnt.2012.08.018; Deng MJ, 1998, B AUST MATH SOC, V57, P515; Le MH, 1999, B AUST MATH SOC, V59, P477; Terai N, 2014, J NUMBER THEORY, V141, P316, DOI 10.1016/j.jnt.2014.02.009; Deng MJ, 2014, B AUST MATH SOC, V89, P316, DOI 10.1017/S000497271300066X; Bennett MA, 2010, INT J NUMBER THEORY, V6, P311, DOI 10.1142/S1793042110002971; Gyory K, 1998, ACTA ARITH, V83, P87; Jesmanowicz L., 1955, WIADOM MAT, V1, P196; Lu W. T., 1959, ACTA SCI NATUR U SZE, V2, P39; Miyazaki T, 2014, J NUMBER THEORY, V141, P184, DOI 10.1016/j.jnt.2014.01.011; Sierpinski W., 1955, WIADOM MAT, V1, P194; Tang M, 2014, TAIWAN J MATH, V18, P925; Tang M, 2013, B AUST MATH SOC, V88, P486, DOI 10.1017/S0004972713000038; Yang ZJ, 2012, B AUST MATH SOC, V86, P348, DOI 10.1017/S000497271100342X	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1439-8516	1439-7617		ACTA MATH SIN	Acta. Math. Sin.-English Ser.	AUG	2015	31	8					1255	1260		10.1007/s10114-015-4491-2		6	Mathematics, Applied; Mathematics	Mathematics	CM4GE	WOS:000357641800003		
J	Saito, KS; Sato, M; Tanaka, R				Saito, Kichi-Suke; Sato, Masahiro; Tanaka, Ryotaro			When does the equality J(X*) = J(X) hold for a two-dimensional Banach space X?	ACTA MATHEMATICA SINICA-ENGLISH SERIES			English	Article						James constant; symmetric absolute norms; piecewise linear functions	LORENTZ SEQUENCE-SPACES; NEUMANN-JORDAN CONSTANT; ABSOLUTE NORMS; DIRECT SUMS; SMOOTHNESS; JAMES; C-2	In this paper, we consider the following problem about the James constant: When does the equality J(X*) = J(X) hold for a Banach space X? It is known that the James constant of a Banach space does not coincide with that of its dual space in general. In fact, we already have counterexamples of two-dimensional normed spaces that are equipped with either symmetric or absolute norms. However, we show that if the norm on a two-dimensional space X is both symmetric and absolute, then the equality J(X*) = J(X) holds. This provides a global answer to the problem in the two-dimensional case.	[Saito, Kichi-Suke] Niigata Univ, Fac Sci, Dept Math, Niigata 9502181, Japan; [Sato, Masahiro; Tanaka, Ryotaro] Niigata Univ, Grad Sch Sci & Technol, Dept Math Sci, Niigata 9502181, Japan	Saito, KS (reprint author), Niigata Univ, Fac Sci, Dept Math, Niigata 9502181, Japan.	saito@math.sc.niigata-u.ac.jp; f13a058a@mail.cc.niigata-u.ac.jp; ryotarotanaka@m.sc.niigata-u.ac.jp					Takahashi Y, 2002, J INEQUAL APPL, V7, P179, DOI 10.1080/10255830290019762; Duncan J, 1973, NUMERICAL RANGES 2; Grzaslewicz R, 1988, C MATH, V56, P147; Kato M, 2001, J MATH ANAL APPL, V258, P457, DOI 10.1006/jmaa.2000.7367; Kato M, 2001, STUD MATH, V144, P275, DOI 10.4064/sm144-3-5; Komuro N, 2011, APPL MATH COMPUT, V217, P10035, DOI 10.1016/j.amc.2011.04.079; Komuro N, 2010, J MATH ANAL APPL, V370, P101, DOI 10.1016/j.jmaa.2010.04.016; Komuro N., 2013, P 7 INT C NONL AN CO, P255; GAO J, 1990, J AUST MATH SOC A, V48, P101; Mitani KI, 2005, MATH INEQUAL APPL, V8, P147; Mitani KI, 2008, J MATH ANAL APPL, V343, P310, DOI 10.1016/j.jmaa.2008.01.033; Mitani KI, 2003, J CONVEX ANAL, V10, P89; Mitani K-I, JAMES CONSTANT UNPUB; Mitani KI, 2009, NONLINEAR ANAL-THEOR, V71, P5238, DOI 10.1016/j.na.2009.04.007; Saejung S, 2006, J INEQUAL APPL, V2006; Saito K-S, 2003, J NONLINEAR CONVEX A, V4, P399; Saito KS, 2000, J MATH ANAL APPL, V244, P515, DOI 10.1006/jmaa.2000.6727; Saito KS, 2000, J MATH ANAL APPL, V252, P879, DOI 10.1006/jmaa.2000.7139	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1439-8516	1439-7617		ACTA MATH SIN	Acta. Math. Sin.-English Ser.	AUG	2015	31	8					1303	1314		10.1007/s10114-015-4539-3		12	Mathematics, Applied; Mathematics	Mathematics	CM4GE	WOS:000357641800007		
J	Kobayashi, A; Teruya, K; Matsuura, Y; Shirai, T; Nakamura, Y; Yamada, M; Mizusawa, H; Mohri, S; Kitamoto, T				Kobayashi, Atsushi; Teruya, Kenta; Matsuura, Yuichi; Shirai, Tsuyoshi; Nakamura, Yoshikazu; Yamada, Masahito; Mizusawa, Hidehiro; Mohri, Shirou; Kitamoto, Tetsuyuki			The influence of PRNP polymorphisms on human prion disease susceptibility: an update	ACTA NEUROPATHOLOGICA			English	Review						Creutzfeldt-Jakob disease; Prion; PRNP; Polymorphism	CREUTZFELDT-JAKOB-DISEASE; PROTEASE-SENSITIVE PRIONOPATHY; TRANSMISSION PROPERTIES; WILD-TYPE; BLOOD-TRANSFUSION; STRAIN VARIATION; VARIANT CJD; CODON 129; E200K MUTATION; NMR STRUCTURE	Two normally occurring polymorphisms of the human PRNP gene, methionine (M)/valine (V) at codon 129 and glutamic acid (E)/lysine (K) at codon 219, can affect the susceptibility to prion diseases. It has long been recognized that 129M/M homozygotes are overrepresented in sporadic Creutzfeldt-Jakob disease (CJD) patients and variant CJD patients, whereas 219E/K heterozygotes are absent in sporadic CJD patients. In addition to these pioneering findings, recent progress in experimental transmission studies and worldwide surveillance of prion diseases have identified novel relationships between the PRNP polymorphisms and the prion disease susceptibility. For example, although 219E/K heterozygosity confers resistance against the development of sporadic CJD, this genotype is not entirely protective against acquired forms (iatrogenic CJD and variant CJD) or genetic forms (genetic CJD and Gerstmann-Straussler-Scheinker syndrome) of prion diseases. In addition, 129M/V heterozygotes predispose to genetic CJD caused by a pathogenic PRNP mutation at codon 180. These findings show that the effects of the PRNP polymorphisms may be more complicated than previously thought. This review aims to summarize recent advances in our knowledge about the influence of the PRNP polymorphisms on the prion disease susceptibility.	[Kobayashi, Atsushi; Mohri, Shirou; Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Teruya, Kenta] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kita Ku, Kyoto 6038334, Japan; [Matsuura, Yuichi] Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Dept Comp Biosci, Nagahama 5260829, Japan; [Nakamura, Yoshikazu] Jichi Med Univ, Dept Publ Hlth, Shimotsuke 3290498, Japan; [Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa 9208640, Japan; [Mizusawa, Hidehiro] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878511, Japan; [Kobayashi, Atsushi] Hokkaido Univ, Grad Sch Vet Med, Lab Comparat Pathol, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Kitamoto, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kobayashi@vetmed.hokudai.ac.jp; kitamoto@med.tohoku.ac.jp			Ministry of Health, Labor and Welfare of Japan; JSPS; Platform for Drug Design, Informatics, and Structural Lifescience (PDIS); MEXT	We thank members of the Creutzfeldt-Jakob Disease Surveillance Committee in Japan, Creutzfeldt-Jakob disease specialists in the prefectures, and Creutzfeldt-Jakob disease patients and families for providing important clinical information. We thank Y. Ishikawa, H. Kudo, M. Yamamoto, and A. Yamazaki for their excellent technical assistance, and B. Bell for critical review of the manuscript. This study was supported by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan (A.K., Y.N., M.Y., H.M., S.M. and T.K.), Grants-in-Aid for Scientific Research from JSPS (A.K. and T.K.), the Platform for Drug Design, Informatics, and Structural Lifescience (PDIS) (T.S.), a grant from MEXT for the Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University (T.K.), and a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (T.K.).	Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Brandel JP, 2003, LANCET, V362, P128, DOI 10.1016/S0140-6736(03)13867-6; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Mead S, 2009, NEW ENGL J MED, V361, P2056, DOI 10.1056/NEJMoa0809716; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; Ironside JW, 2012, FOLIA NEUROPATHOL, V50, P50; Wadsworth JDF, 2008, P NATL ACAD SCI USA, V105, P3885, DOI 10.1073/pnas.0800190105; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; LAPLANCHE JL, 1994, NEUROLOGY, V44, P2347; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Wadsworth JDF, 2008, PHILOS T R SOC B, V363, P3747, DOI 10.1098/rstb.2008.0069; Watts JC, 2012, P NATL ACAD SCI USA, V109, P3498, DOI 10.1073/pnas.1121556109; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Moda F, 2012, BRAIN PATHOL, V22, P662, DOI 10.1111/j.1750-3639.2012.00572.x; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; SALVATORE M, 1994, HUM GENET, V94, P375; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; Mitrova E, 2002, ACTA VIROL, V46, P31; Yamada M, 1999, NEUROLOGY, V53, P181; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Biljan I, 2011, J MOL BIOL, V412, P660, DOI 10.1016/j.jmb.2011.07.067; Biljan I, 2012, BIOCHEM J, V446, P243, DOI 10.1042/BJ20111940; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; Collinge J, 1991, LANCET, V337, P1141; DELISLE MB, 1993, REV NEUROL, V149, P524; DEVILLEMEUR TB, 1994, NEUROPATH APPL NEURO, V20, P111; Diack AB, 2014, PRION, V8, P286, DOI 10.4161/pri.29237; Diack AB, 2014, EMERG INFECT DIS, V20, P1969, DOI 10.3201/eid2012.140214; DOHURA K, 1991, NATURE, V353, P801, DOI 10.1038/353801b0; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; Gambetti P, 2011, J MOL NEUROSCI, V45, P422, DOI 10.1007/s12031-011-9543-1; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Hainfellner JA, 1999, ANN NEUROL, V45, P812; Hamaguchi T, 2013, J NEUROL NEUROSUR PS, V84, P1171, DOI 10.1136/jnnp-2012-304850; Health Protection Agency, 2007, 1 HLTH PROT AG; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; KITAMOTO T, 1994, PHILOS T ROY SOC B, V343, P391, DOI 10.1098/rstb.1994.0034; Kobayashi A, 2010, J VIROL, V84, P3230, DOI 10.1128/JVI.02387-09; Kobayashi Atsushi, 2013, Acta Neuropathol Commun, V1, P74, DOI 10.1186/2051-5960-1-74; Kobayashi A, 2009, PRION, V3, P27; Kobayashi Atsushi, 2014, Acta Neuropathol Commun, V2, P32, DOI 10.1186/2051-5960-2-32; Kobayashi A, 2009, NEUROPATHOLOGY, V29, P619, DOI 10.1111/j.1440-1789.2008.00973.x; Kobayashi A, 2015, J VIROL, V89, P3939, DOI 10.1128/JVI.03183-14; Kobayashi A, 2015, BRAIN PATHOL, DOI [10.1111/bpa.12264, DOI 10.1111/BPA.12264]; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Lukic A, 2010, ARCH NEUROL-CHICAGO, V67, P1021, DOI 10.1001/archneurol.2010.184; Noguchi-Shinohara M, 2007, NEUROLOGY, V69, P360, DOI 10.1212/01.wnl.0000266624.63387.4a; Notari S, 2014, EMERG INFECT DIS, V20, P2006, DOI 10.3201/eid2012.140548; Dorandeu A, 1998, BRAIN PATHOL, V8, P531; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Petraroli R, 1996, AM J HUM GENET, V58, P888; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Qina T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004968; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Shirai T, 2014, STRUCTURE, V22, P560, DOI 10.1016/j.str.2013.12.019; Silvestrini MC, 1997, NAT MED, V3, P521, DOI 10.1038/nm0597-521; Soldevila Marta, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9157; Takeuchi A, 2013, J BIOL CHEM, V288, P21659, DOI 10.1074/jbc.M113.470328; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Xiao XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058786; Yamada M, 2009, NEUROPATHOLOGY, V29, P609, DOI 10.1111/j.1440-1789.2008.00987.x; Young K, 1997, MOL BRAIN RES, V44, P147, DOI 10.1016/S0169-328X(96)00251-3; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	86	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	AUG	2015	130	2					159	170		10.1007/s00401-015-1447-7		12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CM9JS	WOS:000358025300001		
J	Tacik, P; DeTure, M; Lin, WL; Contreras, MS; Wojtas, A; Hinkle, K; Fujioka, S; Baker, M; Walton, R; Carlomagno, Y; Brown, P; Strongosky, A; Kouri, N; Murray, M; Petrucelli, L; Josephs, K; Rademakers, R; Ross, O; Wszolek, Z; Dickson, D				Tacik, Pawel; DeTure, Michael; Lin, Wen-Lang; Sanchez Contreras, Monica; Wojtas, Aleksandra; Hinkle, Kelly M.; Fujioka, Shinsuke; Baker, Matthew C.; Walton, Ronald L.; Carlomagno, Yari; Brown, Patricia H.; Strongosky, Audrey J.; Kouri, Naomi; Murray, Melissa E.; Petrucelli, Leonard; Josephs, Keith A.; Rademakers, Rosa; Ross, Owen A.; Wszolek, Zbigniew K.; Dickson, Dennis W.			A novel tau mutation, p.K317N, causes globular glial tauopathy	ACTA NEUROPATHOLOGICA			English	Article						FTDP-17; Globular glial tauopathy (GGT); Hereditary tauopathies; Tau biochemistry; Tau gene (MAPT)	PROGRESSIVE SUPRANUCLEAR PALSY; ARGYROPHILIC GRAIN DISEASE; MOTOR-NEURON DISEASE; SPORADIC 4-REPEAT TAUOPATHY; CORTICOBASAL DEGENERATION; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; WHITE-MATTER; PICKS-DISEASE; PROTEIN-TAU	Globular glial tauopathies (GGTs) are 4-repeat tauopathies neuropathologically characterized by tau-positive, globular glial inclusions, including both globular oligodendroglial inclusions and globular astrocytic inclusions. No mutations have been found in 25 of the 30 GGT cases reported in the literature who have been screened for mutations in microtubule associated protein tau (MAPT). In this report, six patients with GGT (four with subtype III and two with subtype I) were screened for MAPT mutations. They included 4 men and 2 women with a mean age at death of 73 years (55-83 years) and mean age at symptomatic onset of 66 years (50-77 years). Disease duration ranged from 5 to 14 years. All were homozygous for the MAPT H1 haplotype. Three patients had a positive family history of dementia, and a novel MAPT mutation (c.951G > C, p.K317N) was identified in one of them, a patient with subtype III. Recombinant tau protein bearing the lysine-to-asparagine substitution at amino acid residue 317 was used to assess functional significance of the variant on microtubule assembly and tau filament formation. Recombinant p.K317N tau had reduced ability to promote tubulin polymerization. Recombinant 3R and 4R tau bearing the p.K317N mutation showed decreased 3R tau and increased 4R tau filament assembly. These results strongly suggest that the p.K317N variant is pathogenic. Sequencing of MAPT should be considered in patients with GGT and a family history of dementia or movement disorder. Since several individuals in our series had a positive family history but no MAPT mutation, genetic factors other than MAPT may play a role in disease pathogenesis.	[Tacik, Pawel; Fujioka, Shinsuke; Strongosky, Audrey J.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL USA; [DeTure, Michael; Lin, Wen-Lang; Sanchez Contreras, Monica; Wojtas, Aleksandra; Hinkle, Kelly M.; Baker, Matthew C.; Walton, Ronald L.; Carlomagno, Yari; Brown, Patricia H.; Kouri, Naomi; Murray, Melissa E.; Petrucelli, Leonard; Rademakers, Rosa; Ross, Owen A.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Josephs, Keith A.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Fujioka, Shinsuke] Fukuoka Univ, Dept Neurol, Fukuoka 81401, Japan	Dickson, D (reprint author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	dickson.dennis@mayo.edu			NIH [P50 NS072187, R01 NS078086, R01 NS080882, R01 NS065782, R01 AG026251, P50 AG16574, R01 DC010367, R01 AG037491, R01 DC012519, P50 AG016574, R01 NS089544-1]; Max Kade Foundation; ALS Therapy Alliance; Consortium for Frontotemporal Degeneration Research; Alzheimer's Association; Mayo Clinic Foundation; BrightFocus Foundation; Susan Bass Bolch Foundation	This study was supported by the NIH P50 NS072187 (DWD, ZKW, OAR, RR, AJS), the Max Kade Foundation (PT), NIH R01 NS078086 (OAR), NIH R01 NS080882 (RR), NIH R01 NS065782 (RR), NIH R01 AG026251 (RR), NIH P50 AG16574 (RR), the ALS Therapy Alliance (RR), the Consortium for Frontotemporal Degeneration Research (RR), the NIH R01 DC010367 (KAJ), the NIH R01 AG037491 (KAJ), the NIH R01 DC012519 (KAJ), and the Alzheimer's Association (KAJ), the Mayo Clinic Foundation (LP), the NIH P50 AG016574 (LP), the NIH R01 NS089544-1 (LP), the BrightFocus Foundation (LP), the gift from Carl Edward Bolch, Jr., and Susan Bass Bolch Foundation (SF, ZKW). We are grateful to all patients, family members, and caregivers who agreed to brain donation; without their donation these studies would have been impossible. We also acknowledge expert technical assistance of Linda Rousseau and Virginia Phillips for histology and Monica Castanedes-Casey for immunohistochemistry.	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; GOEDERT M, 1989, EMBO J, V8, P393; Josephs KA, 2003, MOVEMENT DISORD, V18, P1018, DOI 10.1002/mds.10488; Komori T, 1998, ACTA NEUROPATHOL, V96, P401; Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Togo T, 2002, BRAIN PATHOL, V12, P45; Kovacs GG, 2008, J NEUROPATH EXP NEUR, V67, P963, DOI 10.1097/NEN.0b013e318187a80f; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Zarranz JJ, 2005, NEUROLOGY, V64, P1578, DOI 10.1212/01.WNL.0000160116.65034.12; Josephs KA, 2012, BRAIN, V135, P1522, DOI 10.1093/brain/aws032; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; Togo T, 2002, J NEUROPATH EXP NEUR, V61, P547; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Santa-Maria I, 2006, J ALZHEIMERS DIS, V9, P279; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; FEANY MB, 1995, AM J PATHOL, V146, P1388; Alafuzoff I, 2006, J NEUROPATH EXP NEUR, V65, P740; Kouri N, 2011, BRAIN, V134, P3264, DOI 10.1093/brain/awr234; MIRRA SS, 1994, J NEUROPATH EXP NEUR, V53, P303, DOI 10.1097/00005072-199405000-00012; Josephs KA, 2006, J NEUROPATH EXP NEUR, V65, P396, DOI 10.1097/01.jnen.0000218446.38158.61; Ahmed Z, 2013, ACTA NEUROPATHOL, V126, P537, DOI 10.1007/s00401-013-1171-0; Fu YJ, 2010, ACTA NEUROPATHOL, V120, P21, DOI 10.1007/s00401-010-0649-2; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Dugger BN, 2014, J NEUROPATH EXP NEUR, V73, P72, DOI [10.1097/NEN.0000000000000030, 10.1097/NEN.0000000000000028]; Ahmed Z, 2011, ACTA NEUROPATHOL, V122, P415, DOI 10.1007/s00401-011-0857-4; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Kouri N, 2014, ACTA NEUROPATHOL, V127, P271, DOI 10.1007/s00401-013-1193-7; Tolnay M, 1997, ACTA NEUROPATHOL, V94, P353; BRAAK H, 1987, NEUROSCI LETT, V76, P124, DOI 10.1016/0304-3940(87)90204-7; Rosso SM, 2002, ANN NEUROL, V51, P373, DOI 10.1002/ana.10140; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Buee L, 1999, BRAIN PATHOL, V9, P681; van Herpen E, 2003, ANN NEUROL, V54, P573, DOI 10.1002/ana.10721; DUYCKAERTS C, 1990, J NEUROL SCI, V97, P295, DOI 10.1016/0022-510X(90)90226-D; Bigio EH, 2001, J NEUROPATH EXP NEUR, V60, P328; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; Ferrer I, 2003, ACTA NEUROPATHOL, V106, P419, DOI 10.1007/s00401-003-0756-4; Gelpi E, 2013, ACTA NEUROPATHOL, V126, P155, DOI 10.1007/s00401-013-1131-8; Ghetti B, 2011, NEURODEGENERATION MO, P110; Giaccone G, 2008, NEUROPATH APPL NEURO, V34, P468, DOI 10.1111/j.1365-2990.2007.00927.x; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Molina JA, 1998, EUR NEUROL, V40, P71, DOI 10.1159/000007961; Piao YS, 2005, ACTA NEUROPATHOL, V110, P600, DOI 10.1007/s00401-005-1086-5; Powers JM, 2003, ACTA NEUROPATHOL, V106, P181, DOI 10.1007/s00401-003-0719-9; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07	50	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	AUG	2015	130	2					199	214		10.1007/s00401-015-1425-0		16	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CM9JS	WOS:000358025300004		
J	Preisner, A; Albrecht, S; Cui, QL; Hucke, S; Ghelman, J; Hartmann, C; Taketo, M; Antel, J; Klotz, L; Kuhlmann, T				Preisner, Anna; Albrecht, Stefanie; Cui, Qiao-Ling; Hucke, Stephanie; Ghelman, Julia; Hartmann, Christine; Taketo, Makoto Mark; Antel, Jack; Klotz, Luisa; Kuhlmann, Tanja			Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination	ACTA NEUROPATHOLOGICA			English	Article						Multiple sclerosis; Oligodendrocytes; Remyelination; Indometacin; beta-Catenin; GSK3 beta	MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PROGENITOR CELLS; CATENIN SIGNALING PATHWAY; COLORECTAL-CANCER CELLS; BETA-CATENIN; BRAIN-INJURY; DEMYELINATION; CNS; GENE	Multiple sclerosis is the most frequent demyelinating disease in the CNS that is characterized by inflammatory demyelinating lesions and axonal loss, the morphological correlate of permanent clinical disability. Remyelination does occur, but is limited especially in chronic disease stages. Despite effective immunomodulatory therapies that reduce the number of relapses the progressive disease phase cannot be prevented. Therefore, promotion of neuroprotective and repair mechanisms, such as remyelination, represents an attractive additional treatment strategy. A number of pathways have been identified that may contribute to impaired remyelination in MS lesions, among them the Wnt/beta-catenin pathway. Here, we demonstrate that indometacin, a non-steroidal anti-inflammatory drug (NSAID) that has been also shown to modulate the Wnt/beta-catenin pathway in colorectal cancer cells promotes differentiation of primary human and murine oligodendrocytes, myelination of cerebellar slice cultures and remyelination in cuprizone-induced demyelination. Our in vitro experiments using GSK3 beta inhibitors, luciferase reporter assays and oligodendrocytes expressing a mutant, dominant stable beta-catenin indicate that the mechanism of action of indometacin depends on GSK3 beta activity and beta-catenin phosphorylation. Indometacin might represent a promising treatment option to enhance endogenous remyelination in MS patients.	[Preisner, Anna; Albrecht, Stefanie; Ghelman, Julia; Kuhlmann, Tanja] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Cui, Qiao-Ling; Antel, Jack] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Hucke, Stephanie; Klotz, Luisa] Univ Hosp Munster, Dept Neurol, D-48149 Munster, Germany; [Hartmann, Christine] Univ Hosp Munster, Inst Expt Musculoskeletal Med, D-48149 Munster, Germany; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Kuhlmann, T (reprint author), Univ Hosp Munster, Inst Neuropathol, Pottkamp 2, D-48149 Munster, Germany.	tanja.kuhlmann@ukmuenster.de			German Research Foundation [SFB-TR128-B7, Ku1477/6-1]; Interdisciplinary Clinical Research Center, Munster (IZKF) [KuT3/006/11]; Hertie Foundation [P1130073]	This study was supported by grants from the German Research Foundation (SFB-TR128-B7; Ku1477/6-1), the Interdisciplinary Clinical Research Center, Munster (IZKF; KuT3/006/11) and the Hertie Foundation (P1130073) to TK.	Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Dai ZM, 2014, J NEUROSCI, V34, P8467, DOI 10.1523/JNEUROSCI.0311-14.2014; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Chew LJ, 2011, J NEUROSCI, V31, P13921, DOI 10.1523/JNEUROSCI.3343-11.2011; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Dihlmann S, 2001, ONCOGENE, V20, P645, DOI 10.1038/sj.onc.1204123; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Chen JT, 2008, ANN NEUROL, V63, P254, DOI 10.1002/ana.21302; Cui QL, 2012, STEM CELLS DEV, V21, P1831, DOI 10.1089/scd.2011.0494; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Atkins Harold, 2009, V549, P231, DOI 10.1007/978-1-60327-931-4_16; BLAKEMOR.WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; Chen J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00007; Dihlmann S, 2003, MOL CANCER THER, V2, P509; Guo Q, 2009, MOL CELL BIOCHEM, V330, P71, DOI 10.1007/s11010-009-0102-9; Hawcroft G, 2002, CARCINOGENESIS, V23, P107, DOI 10.1093/carcin/23.1.107; JUNG M, 1994, J NEUROSCI RES, V37, P182, DOI 10.1002/jnr.490370204; Manrique-Hoyos N, 2012, ANN NEUROL, V71, P227, DOI 10.1002/ana.22681; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	AUG	2015	130	2					247	261		10.1007/s00401-015-1426-z		15	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CM9JS	WOS:000358025300007		
J	Matsubara, S; Baba, Y; Takahashi, H				Matsubara, Shigeki; Baba, Yosuke; Takahashi, Hironori			Preventing a Bakri balloon from sliding out during "holding the cervix": "fishing for the balloon shaft" technique (Matsubara)	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							POSTPARTUM HEMORRHAGE; INTRAUTERINE BALLOON; CESAREAN-SECTION; PLACENTA PREVIA		[Matsubara, Shigeki; Baba, Yosuke; Takahashi, Hironori] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P120, DOI 10.1111/aogs.12241; Gronvall M, 2013, ACTA OBSTET GYN SCAN, V92, P433, DOI 10.1111/j.1600-0412.2012.01531.x; Matsubara S, 2014, ARCH GYNECOL OBSTET, V290, P613, DOI 10.1007/s00404-014-3380-8; Matsubara S, 2011, ACTA OBSTET GYN SCAN, V90, P1454, DOI 10.1111/j.1600-0412.2011.01233.x; Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P314, DOI 10.1111/aogs.12282	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	AUG	2015	94	8					910	911		10.1111/aogs.12585		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CM8WR	WOS:000357983900016		
J	Fusato, Y; Itagaki, T; Oguro, M; Sakai, S				Fusato, Yusuke; Itagaki, Tomoyuki; Oguro, Michio; Sakai, Satoki			Effect of change in floral openness with floral age on floral display and reproduction in Gentiana	ACTA OECOLOGICA-INTERNATIONAL JOURNAL OF ECOLOGY			English	Article						Floral age; Floral display; Floral openness; Pollination; Seed production	COLOR-CHANGE; POLLINATION ECOLOGY; INFLORESCENCE ARCHITECTURE; SOUTHERN AFRICA; BEE BEHAVIOR; PLANT SIZE; SUCCESS; FLOWERS; BORAGINACEAE; GEITONOGAMY	Some plant species have flowers that open widely and then close slowly over time, resulting in changes in the width of the corolla opening. We examined the adaptive significance of retaining flowers with relatively closed corollas using Gentiana triflora var. japonica, a perennial species with petal movement, in Hakkoda, northern Japan. Under open pollination, floral openness changed with floral age. It increased from days 1-3 after the flower initially opened and decreased thereafter until floral senescence. Hand-pollinated flowers showed a significant reduction in floral openness compared with unpollinated flowers, suggesting that a floral openness reflects its demand for pollination. Pollinators visited inflorescences with many flowers irrespective of their openness, suggesting that the reduction in floral openness does not affect the attractiveness of the inflorescences to pollinators. Within inflorescences, pollinators visited less-pollinated flowers with wider floral openness more frequently and more-pollinated flowers with lower floral openness less frequently, possibly because of the time cost of entering flowers with low openness. This strategy appears adaptive because if all flowers maintain wide floral openness irrespective of their pollination demand, pollinators may visit more-pollinated flowers in an inflorescence and may leave the inflorescence without visiting less-pollinated flowers. Reduction of openness of more-pollinated flowers fits a strategy of enhancing effective pollination within inflorescences. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Fusato, Yusuke; Itagaki, Tomoyuki; Oguro, Michio; Sakai, Satoki] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Sakai, S (reprint author), Tohoku Univ, Grad Sch Life Sci, Aoba 6-3, Sendai, Miyagi 9808578, Japan.	satoki@m.tohoku.ac.jp					Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Ishii HS, 2008, OECOLOGIA, V156, P341, DOI 10.1007/s00442-008-0991-4; WEISS MR, 1991, NATURE, V354, P227, DOI 10.1038/354227a0; Strobl C, 2009, R J, V1, P14; STRUCK M, 1994, BOTHALIA, V24, P77; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; Jones CE, 1999, AM J BOT, V86, P273, DOI 10.2307/2656943; DEJONG TJ, 1993, TRENDS ECOL EVOL, V8, P321, DOI 10.1016/0169-5347(93)90239-L; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Ida TY, 2003, AM J BOT, V90, P1751, DOI 10.3732/ajb.90.12.1751; GOLDBLATT P, 1995, ANN MO BOT GARD, V82, P517, DOI 10.2307/2399833; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; Jordan CY, 2006, AM NAT, V167, P496, DOI 10.1086/501142; Breiman L., 2001, MACH LEARN, V45; Brostrom G., 2011, GLMMML GEN LINEAR MO; Bynum MR, 2001, AM J BOT, V88, P1088, DOI 10.2307/2657092; CASPER BB, 1984, EVOLUTION, V38, P128, DOI 10.2307/2408552; COSTELLOE BH, 1988, OHIO J SCI, V88, P132; DELPH LF, 1989, EVOLUTION, V43, P1252, DOI 10.2307/2409360; Frund J, 2011, ECOL LETT, V14, P896, DOI 10.1111/j.1461-0248.2011.01654.x; GEBER MA, 1985, ECOLOGY, V66, P762; Gori D.F., 1983, P31; GORI DF, 1989, EVOLUTION, V43, P870, DOI 10.2307/2409314; He Y. P., 2006, PLANT SYST EVOL, V256, P17, DOI [10.1007/s00606-005-0345-1, DOI 10.1007/S00606-005-0345-1]; Kato S, 2008, BOTANY, V86, P337, DOI 10.1139/B07-131; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Kozuharova E., 2004, ANN U SOFIA, V94, P39; Kozuharova E., 2002, ANN U DESOFIA ST K O, V93, P57; Kozuharova E., 2001, ANN U SOFIA, V92, P69; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036; Morinaga SI, 2009, POPUL ECOL, V51, P187, DOI 10.1007/s10144-008-0097-1; Mu JP, 2010, ARCT ANTARCT ALP RES, V42, P219, DOI 10.1657/1938-4246-42.2.219; Njesenbaum R.A., 1999, AM MIDL NAT, V141, P59; Oberrath R, 1999, OECOLOGIA, V121, P383, DOI 10.1007/s004420050943; Ohashi K, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P274, DOI 10.1017/CBO9780511542268.015; PETANIDOU T, 1995, NEW PHYTOL, V129, P155, DOI 10.1111/j.1469-8137.1995.tb03019.x; PETANIDOU T, 1995, ACTA BOT NEERL, V44, P55; Petanidou T, 1998, NORD J BOT, V18, P537, DOI 10.1111/j.1756-1051.1998.tb01534.x; PYKE GH, 1982, CAN J ZOOL, V60, P417, DOI 10.1139/z82-057; R Development Core Team, 2014, R LANG ENV STAT COMP; ROBERTSON AW, 1992, BIOL J LINN SOC, V46, P333, DOI 10.1111/j.1095-8312.1992.tb00868.x; SCHAAL B A, 1980, Southwestern Naturalist, V25, P280, DOI 10.2307/3671260; Simons P, 1992, ACTION PLANT MOVEMEN; Smith G.F., 1998, MESEMBS OF THE WORLD; Snow A.A., 1996, FLORAL BIOL STUDIES, P191; STIRTON C H, 1983, Bothalia, V14, P1003; Strobl C., 2007, BMC BIOINFORMA, V8; Strobl C., 2008, BMC BIOINFORMA, V9; Vaughton G, 1998, OECOLOGIA, V115, P93, DOI 10.1007/s004420050495; von Hase A., 2005, PLANT ECOL, V184, P75; Weiss MR, 1997, ISRAEL J PLANT SCI, V45, P185	52	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	1146-609X	1873-6238		ACTA OECOL	Acta Oecol.-Int. J. Ecol.	AUG	2015	67						17	23		10.1016/j.actao.2015.05.006		7	Ecology	Environmental Sciences & Ecology	CN0GS	WOS:000358092700003		
J	Saito, MU; Koike, F				Saito, Masayuki U.; Koike, Fumito			Trait-dependent changes in assemblages of mid-sized and large mammals along an Asian urban gradient	ACTA OECOLOGICA-INTERNATIONAL JOURNAL OF ECOLOGY			English	Article						City; Mammal community; Species trait; Trait-based approach; Urban ecology; Urban mammal	URBANIZATION; FOREST; POPULATIONS; PREDICTORS; LANDSCAPE; ECOLOGY; HABITAT; AREA	To plan a management strategy for the urban mammal community, it is necessary to understand the mechanisms by which many mammalian species are eliminated from the urban ecosystem. We analyzed ecological traits of assemblages of mid-sized and large mammals in the Tokyo Metropolitan Area to determine the key traits necessary for inhabiting urban landscapes. Using a cluster analysis, we roughly classified camera-trapped mammals in 10 quadrats, each nearly 5 km x 5 km, into assemblage types. In terms of its species composition, the assemblages in the more urbanized landscapes were a subset of the assemblages in more forested landscapes, except for domestic cats, which were much more common in the urban landscapes. To explain the species occurrence in each quadrat, we applied a generalized linear model with four ecological traits (i.e., body weight, annual reproductive capacity, food habit, and tree-climbing ability) and an environmental force (i.e., urban area) used as covariates. We found that a high annual reproductive capacity and an omnivorous food habit were the most critical traits enabling a species to live in urbanized landscapes. Species with low reproductive capacity were found in forested landscapes and were absent from landscapes with intermediate to high levels of urbanization. Herbivorous species, however, occurred in intermediate landscapes but not in urban landscapes. These key ecological traits can thus be used to predict the species composition of a mammalian assemblage, and they can also be used to devise appropriate strategies for managing species in urban environments. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Saito, Masayuki U.; Koike, Fumito] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Saito, MU (reprint author), Tokyo Univ Agr & Technol, Fac Agr, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	saito.ume@gmail.com			Japan Society for the Promotion of Science Global COE (Centers of Excellence) Program "Global eco-risk Management from Asian Viewpoints"; Joint Research Program C of the Research Institute of Environment and Information Sciences, Yokohama National University	We thank the administrative offices of Uchiura-yama Forest Park, Ichihara Citizens' Forest, Nagaike Park, Oyamadairi Park, Oyamada Park, Shikinomori Park, and Mitsuike Park; Ichihara Municipal Board of Education; Chiba City Government; Yokohama City Government; and Tokyo Metropolitan Government for permitting the field surveys and offering advice on carrying them out. We also thank Mr. Osamu Kurashima for helpful comments on the manuscript. This study was supported in part by the Japan Society for the Promotion of Science Global COE (Centers of Excellence) Program "Global eco-risk Management from Asian Viewpoints" and Joint Research Program C of the Research Institute of Environment and Information Sciences, Yokohama National University.	ABE H., 2008, GUIDE MAMMALS JAPAN; Tanaka R, 2011, ECOL RES, V26, P27, DOI 10.1007/s11284-010-0749-4; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Randa LA, 2006, J MAMMAL, V87, P1154, DOI 10.1644/05-MAMM-A-224R2.1; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Saito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065464; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McDonald RI, 2008, FRONT ECOL ENVIRON, V6, P99, DOI 10.1890/070038; HARRIS S, 1987, J APPL ECOL, V24, P75, DOI 10.2307/2403788; Koike F, 2001, J VEG SCI, V12, P327, DOI 10.2307/3236846; Keuling O, 2008, EUR J WILDLIFE RES, V54, P403, DOI 10.1007/s10344-007-0157-4; Asada M., 2009, JPN REP CHIBA BIODIV, V1, P21; Barton K., 2013, MUMIN MULTIMODEL INF; Bjerke T, 2004, ANTHROZOOS, V17, P109; Burnham K. P., 2002, MODEL SELECTION MULT; Curtis Paul D., 2010, P201; Flux JEC, 2007, NEW ZEAL J ZOOL, V34, P289; Fuller T.K., 2009, URBAN CARNIVORES ECO, P13; Gehrt S.D., 2009, URBAN CARNIVORES ECO, P79; Huang JG, 2007, LANDSCAPE URBAN PLAN, V82, P184, DOI 10.1016/j.landurbplan.2007.02.010; Jaccard P, 1912, NEW PHYTOL, V11, P37, DOI DOI 10.1111/J.1469-8137.1912.TB05611.X; Kaneko K., 2008, J JPN I LANDSC ARCHI, V71, P859; Kase C, 2011, MAMM STUDY, V36, P127; Machida City, 2012, CITY PLANN MACH CIT; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; Ministry of the Environment, 2004, 6 7 NAT SURV NAT ENV; Ministry of the Environment, 2004, 6 NAT SURV NAT ENV R; Miyawaki A., 1976, B I ENV SCI TECH YOK, V2, P95; National Institute for Environmental Studies, 2012, INV SPEC JAP; Nilon Charles H., 1997, Urban Ecosystems, V1, P247, DOI 10.1023/A:1018539914706; Ohdachi S.D., 2009, WILD MAMM JAP; R Development Core Team, 2013, R LANG ENV STAT COMP; Saito M, 2009, ACTA THERIOL, V54, P363, DOI 10.4098/j.at.0001-7051.061.2008; Simonova D, 2008, PERSPECT PLANT ECOL, V10, P89, DOI 10.1016/j.ppees.2007.11.003; Sneath PHA, 1973, NUMERICAL TAXONOMY P; Summerville KS, 2006, ECOL APPL, V16, P891, DOI 10.1890/1051-0761(2006)016[0891:STAPOL]2.0.CO;2; United Nations, 2011, POP DISTR URB INT MI; Uraguchi K, 2009, POPUL ECOL, V51, P271, DOI 10.1007/s10144-008-0125-1; Wells K, 2014, BIODIVERS CONSERV, V23, P2289, DOI 10.1007/s10531-014-0723-5; Wells K, 2012, ANIM CONSERV, V15, P626, DOI 10.1111/j.1469-1795.2012.00560.x	45	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	1146-609X	1873-6238		ACTA OECOL	Acta Oecol.-Int. J. Ecol.	AUG	2015	67						34	39		10.1016/j.actao.2015.06.002		6	Ecology	Environmental Sciences & Ecology	CN0GS	WOS:000358092700005		
J	Yabuuchi, H; Matsuo, Y; Kamitani, T; Jinnnouchi, M; Yonezawa, M; Yamasaki, Y; Nagao, M; Kawanami, S; Okamoto, T; Sasaki, M; Honda, H				Yabuuchi, Hidetake; Matsuo, Yoshio; Kamitani, Takeshi; Jinnnouchi, Mikako; Yonezawa, Masato; Yamasaki, Yuzo; Nagao, Michinobu; Kawanami, Satoshi; Okamoto, Tatsuro; Sasaki, Masayuki; Honda, Hiroshi			Detectability of T1a lung cancer on digital chest radiographs: an observer-performance comparison among 2-megapixel general-purpose, 2-megapixel medical-purpose, and 3-megapixel medical-purpose liquid-crystal display (LCD) monitors	ACTA RADIOLOGICA			English	Article						Liquid crystal; observer performance; pulmonary nodule; digital radiography; lung cancer	RAY TUBE MONITORS; THIN-SECTION CT; PROGNOSTIC-FACTORS; PULMONARY NODULES; ADENOCARCINOMA; RESOLUTION; LUMINANCE; SYSTEMS; SIZE	Background: There has been no comparison of detectability of small lung cancer between general and medical LCD monitors or no comparison of detectability of small lung cancer between solid and part-solid nodules. Purpose: To compare the detectabilities of T1a lung cancer on chest radiographs on three LCD monitor types: 2-megapixel (MP) for general purpose (General), 2-MP for medical purpose (Medical), and 3-MP-Medical. Material and Methods: Radiographs from forty patients with T1aN0M0 primary lung cancer (27 solid nodules, 13 part-solid nodules) and 60 patients with no abnormalities on both chest X-ray and computed tomography (CT) were consecutively collected. Five readers assessed 100 cases for each monitor. The observations were analyzed using receiver operating characteristic (ROC) analysis. A jackknife method was used for statistical analysis. A P value of <0.05 was considered significant. Results: The average AUC for all T1a lung cancer nodule detection using the 2-MP-General, 2-MP-Medical, and 3-MP-Medical LCD monitors were 0.86, 0.89, and 0.89, respectively; there were no significant differences among them. The average AUC for part-solid nodule detection using a 2-MP-General, 2-MP-Medical, and 3-MP-Medical LCD monitors were 0.77, 0.86, and 0.89, respectively. There were significant differences between the 2-MP-General and 2-MP-Medical LCD monitors (P = 0.043) and between the 2-MP-General and 3-MP-Medical LCD monitors (P = 0.027). There was no significant difference between the 2-MP-Medical and 3-MP-Medical LCD monitors. The average AUC for solid nodule detection using a 2-MP-General, 2-MP-Medical, and 3-MP-Medical LCD monitors were 0.90, 0.90, and 0.88, respectively; there were no significant differences among them. The mean AUC values for all and part-solid nodules of the low-experienced readers were significantly lower than those of the high-experienced readers with the 2 M-GP color LCD monitor (P < 0.05). Conclusion: Detectability of part-solid nodules using a general-purpose LCD monitor was significantly lower than those using medical-purpose LCD monitors.	[Yabuuchi, Hidetake; Sasaki, Masayuki] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 8128582, Japan; [Matsuo, Yoshio; Kamitani, Takeshi; Jinnnouchi, Mikako; Yonezawa, Masato; Yamasaki, Yuzo; Nagao, Michinobu; Kawanami, Satoshi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan; [Okamoto, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Yabuuchi, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	h-yabu@med.kyushu-u.ac.jp					Henschke CI, 2002, AM J ROENTGENOL, V178, P1053; Samei E, 2005, MED PHYS, V32, P1205, DOI 10.1118/1.1861159; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Tsubamoto M, 2002, RADIOLOGY, V224, P139, DOI 10.1148/radiol.2241001445; Hirsch FR, 2001, CLIN CANCER RES, V7, P5; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Badano A, 2004, RADIOGRAPHICS, V24, P879, DOI 10.1148/rg.243035133; Flieder DB, 2005, CHEST, V128, P2304, DOI 10.1378/chest.128.4.2304; Gondoy MCB, 2009, RADIOLOGY, V253, P606; Goo JM, 2004, RADIOLOGY, V232, P762, DOI 10.1148/radiol.2323030628; Herron JM, 2000, RADIOLOGY, V215, P169; Hwang SA, 2003, KOREAN J RADIOL, V4, P153; METZ CE, 1989, INVEST RADIOL, V24, P234, DOI 10.1097/00004424-198903000-00012; Metz Charles E, 2008, Radiol Phys Technol, V1, P2, DOI 10.1007/s12194-007-0002-1; Park CM, 2008, EUR J RADIOL, V66, P13, DOI 10.1016/j.ejrad.2007.05.023; Samei E, 2005, ASSESSMENT DISPLAY P; Usami H, 2006, EUR RADIOL, V16, P726, DOI 10.1007/s00330-005-0030-3; Yin JD, 2011, EUR J RADIOL, V80, pE153, DOI 10.1016/j.ejrad.2010.06.006; Yokose T, 2000, LUNG CANCER-J IASLC, V29, P179, DOI 10.1016/S0169-5002(00)00103-3	19	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	AUG	2015	56	8					943	949		10.1177/0284185114544244		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM7TX	WOS:000357900500006		
J	Takatsu, Y; Okada, T; Miyati, T; Koyama, T				Takatsu, Yasuo; Okada, Tsutomu; Miyati, Tosiaki; Koyama, Takashi			Magnetic resonance imaging relaxation times of female reproductive organs	ACTA RADIOLOGICA			English	Article						Reproductive organs; magnetic resonance imaging; pelvis; relaxation time; luteal phase	NORMAL MENSTRUAL-CYCLE; T-1; MR; CARTILAGE; UTERUS; PELVIS	Background: Relaxation time of female reproductive organs affects the tissue contrast of magnetic resonance image (MRI), and is used for quantitative analysis. Purpose: To evaluate the relaxation times of normal female reproductive organs in the luteal phase of the menstrual cycle. Material and Methods: On a 1.5-T MRI, relaxation times were measured in pelvic tissues (endometrium, junctional zone, myometrium, follicle, and stroma) of 32 female healthy volunteers (33.5 +/- 6.8 years). The Look-Locker sequence was used to measure T1 relaxation times. Furthermore, a multiple spin-echo method with 32 different echo times was used to measure T2 relaxation times. The images were obtained in the luteal phase of each volunteer's menstrual cycle. Results: The measured relaxation times (means +/- standard deviations) were as follows: endometrium (T1, 1703 +/- 147 ms; T2, 214 +/- 35 ms), junctional zone (T1, 1168 +/- 63 ms; T2, 72 +/- 12 ms), myometrium (T1, 1314 +/- 103 ms; T2, 138 +/- 20 ms), follicle (T1, 2267 +/- 249 ms; T2, 603 +/- 68 ms), and stroma (T1, 1481 +/- 129 ms; T2, 126 +/- 29 ms). Conclusion: Reliable MRI measurements of T1 and T2 relaxation times of normal female reproductive organs in the luteal phase of the menstrual cycle are useful as references to recognize the normal value.	[Takatsu, Yasuo] Osaka Red Cross Hosp, Dept Radiol, Osaka 5438555, Japan; [Takatsu, Yasuo; Miyati, Tosiaki] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Okada, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Koyama, Takashi] Kurashiki Cent Hosp, Dept Diagnost Radiol, Okayama, Japan	Takatsu, Y (reprint author), Osaka Red Cross Hosp, Dept Radiol, Tennouji Ku, 5-30 Fudegasaki, Osaka 5438555, Japan.	pcblue2@yahoo.co.jp					Adrian P, 1988, MAGN RESON MED, V7, P23; Kataoka M, 2005, RADIOLOGY, V235, P124, DOI 10.1148/radiol.2351031283; Shah NJ, 2001, NEUROIMAGE, V14, P1175, DOI 10.1006/nimg.2001.0886; Nakai A, 2003, J MAGN RESON IMAGING, V18, P726, DOI 10.1002/jmri.10415; Messroghli DR, 2004, MAGNET RESON MED, V52, P141, DOI [10.1002/mrm.20110, 10.1002/mm.20110]; Glaser C, 2006, MAGN RESON MED, V56, P527, DOI 10.1002/mrm.21005; HAYNOR DR, 1986, RADIOLOGY, V161, P459; Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Kido A, 2007, J MAGN RESON IMAGING, V26, P695, DOI 10.1002/jmri.21061; POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512; Bazelaire C, 2004, RADIOLOGY, V230, P652; Deichmann R, 1999, MAGNET RESON MED, V42, P206, DOI 10.1002/(SICI)1522-2594(199907)42:1<206::AID-MRM28>3.0.CO;2-Q; Henderson E, 1999, MAGN RESON IMAGING, V17, P1163, DOI 10.1016/S0730-725X(99)00025-9; Hoad CL, 2006, J MAGN RESON IMAGING, V24, P1350, DOI 10.1002/jmri.20784; Hoad CL, 2005, AM J OBSTET GYNECOL, V192, P648, DOI 10.1016/j.ajog.2004.07.032; Kataoka M, 2007, J MAGN RESON IMAGING, V25, P527, DOI 10.1002/jmri.20842; Look D. C., 1970, Review of Scientific Instruments, V41, DOI 10.1063/1.1684482; Nichols MB, 2008, J MAGN RESON IMAGING, V27, P224, DOI 10.1002/jmri.21243; VARPULA M, 1993, EUR J RADIOL, V16, P90, DOI 10.1016/0720-048X(93)90003-6	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	AUG	2015	56	8					997	1001		10.1177/0284185114542367		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM7TX	WOS:000357900500013		
J	Yanagisawa, T; Kurosaki, H; Oda, H; Tagawa, M				Yanagisawa, T.; Kurosaki, H.; Oda, H.; Tagawa, M.			Ground-based optical observation system for LEO objects	ADVANCES IN SPACE RESEARCH			English	Article						Space debris; Optical observation; Space-situation awareness	SPACE DEBRIS; GEO	We propose a ground-based optical observation system for monitoring LEO objects, which uses numerous optical sensors to cover a vast region of the sky. Its potential in terms of detection and orbital determination were examined. About 30 cm LEO objects at 1000 km altitude are detectable using an 18 cm telescope, a CCD camera and the analysis software developed. Simulations and a test observation showed that two longitudinally separate observation sites with arrays of optical sensors can identify the same objects from numerous data sets and determine their orbits precisely. The proposed system may complement or replace the current radar observation system for monitoring LEO objects, like space-situation awareness, in the near future. (C) 2015 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Yanagisawa, T.; Kurosaki, H.; Oda, H.] Japan Aerosp Explorat Agcy, Chofu, Tokyo 1828522, Japan; [Tagawa, M.] Kyushu Univ, Nishi Ku, Fukuoka 8190395, Japan	Yanagisawa, T (reprint author), Japan Aerosp Explorat Agcy, Innovat Technol Res Ctr, 7-44-1 Jindaiji Higashi Machi, Chofu, Tokyo 1828522, Japan.	yanagisawa.toshifumi@jaxa.jp					Agapov V., 2010, P 2010 AMOS TECHN C; Christiansen EL, 2001, INT J IMPACT ENG, V26, P93, DOI 10.1016/S0734-743X(01)00070-7; Bennett J.C., 2014, P 2014 AMOS TECHN C; Chun F.K., 2014, P 2014 AMOS TECHN C; Hoots F., 1980, 3 SPAC; Klinkrad H., 2006, S-P BOOKS ASTRONAUT, P5, DOI 10.1007/3-540-37674-7_2; Liou JC, 2006, SCIENCE, V311, P340, DOI 10.1126/science1121337; Mulrooney M., 2007, ORBITAL DEBRIS Q NEW, V11, P4; Schildknecht T, 2004, ADV SPACE RES, V34, P901, DOI 10.1016/j.asr.2003.01.009; Seitzer P., 2010, P 2010 AMOS TECHN C; Yanagisawa T., 2012, T JSASS AEROSP TECH, V10, pPr 29; Yanagisawa T, 2002, T JPN SOC AERONAUT S, V44, P190, DOI 10.2322/tjsass.44.190; Yanagisawa T, 2005, PUBL ASTRON SOC JPN, V57, P399; Zimmer P.C., 2014, P 2014 AMOS TECHN C	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	AUG 1	2015	56	3					414	420		10.1016/j.asr.2015.01.019		7	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	CM7VS	WOS:000357905200006		
J	Nakamura, M; Kitazawa, Y; Matsumoto, H; Okudaira, O; Hanada, T; Sakurai, A; Funakoshi, K; Yasaka, T; Hasegawa, S; Kobayashi, M				Nakamura, Maki; Kitazawa, Yukihito; Matsumoto, Haruhisa; Okudaira, Osamu; Hanada, Toshiya; Sakurai, Akira; Funakoshi, Kunihiro; Yasaka, Tetsuo; Hasegawa, Sunao; Kobayashi, Masanori			Development of in-situ micro-debris measurement system	ADVANCES IN SPACE RESEARCH			English	Article						Space debris; Meteoroid; Sensor		The in-situ debris environment awareness system has been developed. The objective of the system is to measure small debris (between 100 mu m and several cm) in orbit. The orbital distribution and the size distribution of the debris are not well understood. The size distribution is difficult to measure from the ground, although the size distribution is very important for the risk evaluation of the impact of debris on spacecraft. The in-situ measurement of the size distribution is useful for: (1) verification of meteoroid and debris environment models, (2) verification of meteoroid and debris environment evolution models, (3) real time detection of unexpected events, such as explosions and/or collisions on an orbit. This paper reports the development study of the in-situ debris measurement system and shows demonstration experiments and their results to describe the performance of the micro-debris sensor system. The sensor system for monitoring micro-debris with sizes ranging from 100 mu m to a few mm must have a large detection area, while the constraints of space deployment require that these systems be low in mass, low in power, robust and have low telemetry requirements. For this reason, we have been developing a simple trans-film sensor. Thin and conductive stripes (copper) are formed with fine pitch (100 mu m) on a thin film of nonconductive material (12.5-mu m thick polyimide). A hypervelocity micro-particle impact is detected when one or more stripes are severed by perforation of the film. We designed a debris detector specialized for measuring the micro-debris size and collision rate. We then manufactured and calibrated the detector. (C) 2015 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Nakamura, Maki] Tokyo Inst Technol, Tokyo 1528550, Japan; [Kitazawa, Yukihito] IHI Corp, Tokyo 1358710, Japan; [Kitazawa, Yukihito; Matsumoto, Haruhisa; Okudaira, Osamu] Japan Aerosp Explorat Agcy JAXA, Tsukuba, Ibaraki 3058505, Japan; [Kitazawa, Yukihito; Hasegawa, Sunao] Japan Aerosp Explorat Agcy ISAS JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Hanada, Toshiya] Kyushu Univ, Fukuoka 8128581, Japan; [Sakurai, Akira; Funakoshi, Kunihiro; Yasaka, Tetsuo] Inst Q Shu Pioneers Space Inc iQPS, Fukuoka 8100001, Japan; [Kobayashi, Masanori] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan	Nakamura, M (reprint author), Tokyo Inst Technol, Tokyo 1528550, Japan.	nakamura.m.bd@m.titech.ac.jp			Space Plasma Laboratory, ISAS, JAXA	The experiments were conducted and supported by the Space Plasma Laboratory, ISAS, JAXA.	[Anonymous], 2008, ORBITAL DEBRIS Q JUL, V12; [Anonymous], 2009, JERG2144HB001; Christiansen E.L., 2006, IAC06B6305; Fukushige S., 2007, IHI ENG REV, V40; Goldsworthy BJ, 2002, ADV SPACE RES, V29, P1139, DOI 10.1016/S0273-1177(02)00129-1; Horz F, 1995, INT J IMPACT ENG, V17, P419, DOI 10.1016/0734-743X(95)99867-Q; Ishizawa J., 2013, P 12 INT S MAT SPAC; Kitazawa Y., 2009, 28 INT S SPAC TECHN; Klinkrad H., 2006, S-P BOOKS ASTRONAUT, P5, DOI 10.1007/3-540-37674-7_2; Matsumoto H., 2009, J SPACE TECHNOL SCI, V24; Neish Michael J., 2001, P 3 EUR C SPAC DEBR, P19; Uetsuhara M., 2011, AEROSP TECHNOL, V10, P67	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	AUG 1	2015	56	3					436	448		10.1016/j.asr.2015.04.009		13	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	CM7VS	WOS:000357905200009		
J	Zolla, V; Nizamutdinova, IT; Scharf, B; Clement, CC; Maejima, D; Akl, T; Nagai, T; Luciani, P; Leroux, JC; Halin, C; Stukes, S; Tiwari, S; Casadevall, A; Jacobs, WR; Entenberg, D; Zawieja, DC; Condeelis, J; Fooksman, DR; Gashev, AA; Santambrogio, L				Zolla, Valerio; Nizamutdinova, Irina Tsoy; Scharf, Brian; Clement, Cristina C.; Maejima, Daisuke; Akl, Tony; Nagai, Takashi; Luciani, Paola; Leroux, Jean-Christophe; Halin, Cornelia; Stukes, Sabriya; Tiwari, Sangeeta; Casadevall, Arturo; Jacobs, William R., Jr.; Entenberg, David; Zawieja, David C.; Condeelis, John; Fooksman, David R.; Gashev, Anatoliy A.; Santambrogio, Laura			Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance	AGING CELL			English	Article						aging; mass spectrometry; oxidative stress; proteomics; lymphatics	MESENTERIC LYMPHATICS; CONTRACTILE ACTIVITY; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS; RAT; VESSELS; MUSCLE; FLOW; HYPERPERMEABILITY; ANTIGEN	The role of lymphatic vessels is to transport fluid, soluble molecules, and immune cells to the draining lymph nodes. Here, we analyze how the aging process affects the functionality of the lymphatic collectors and the dynamics of lymph flow. Ultrastructural, biochemical, and proteomic analysis indicates a loss of matrix proteins, and smooth muscle cells in aged collectors resulting in a decrease in contraction frequency, systolic lymph flow velocity, and pumping activity, as measured in vivo in lymphatic collectors. Functionally, this impairment also translated into a reduced ability for in vivo bacterial transport as determined by time-lapse microscopy. Ultrastructural and proteomic analysis also indicates a decrease in the thickness of the endothelial cell glycocalyx and loss of gap junction proteins in aged lymph collectors. Redox proteomic analysis mapped an aging-related increase in the glycation and carboxylation of lymphatic's endothelial cell and matrix proteins. Functionally, these modifications translate into apparent hyperpermeability of the lymphatics with pathogen escaping from the collectors into the surrounding tissue and a decreased ability to control tissue fluid homeostasis. Altogether, our data provide a mechanistic analysis of how the anatomical and biochemical changes, occurring in aged lymphatic vessels, compromise lymph flow, tissue fluid homeostasis, and pathogen transport.	[Zolla, Valerio; Scharf, Brian; Clement, Cristina C.; Fooksman, David R.; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Nizamutdinova, Irina Tsoy; Maejima, Daisuke; Nagai, Takashi; Zawieja, David C.; Gashev, Anatoliy A.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76501 USA; [Maejima, Daisuke; Nagai, Takashi] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 390, Japan; [Akl, Tony] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Luciani, Paola; Leroux, Jean-Christophe; Halin, Cornelia] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Stukes, Sabriya; Tiwari, Sangeeta; Casadevall, Arturo; Jacobs, William R., Jr.; Fooksman, David R.; Santambrogio, Laura] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Entenberg, David; Condeelis, John] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Entenberg, David; Condeelis, John] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Santambrogio, L (reprint author), Albert Einstein Coll Med, Dept Pathol, Forchheimer Bldg Room 140, Bronx, NY 10461 USA.	laura.santambrogio@einstein.yu.edu	Leroux, Jean-Christophe/N-4202-2015	Leroux, Jean-Christophe/0000-0001-5601-1292	HU Medical Institute; NIH [AG-030578, HL096552, AI072529, 5R01AI033774, 5R37AI033142, 5R01AI052733, CA100324]; Texas A&M University Health Science Center College of Medicine; Department of Medical Physiology; PhD program in Genetics and cell Biology at the University of Tuscia, Department of Ecology and Biology (DEB), Viterbo, Italy;  [NIH-AG045223];  [NIH-AI 26170];  [HL-094269]	The work was supported by the following grants: NIH-AG045223 to LS; NIH-AI 26170 and HU Medical Institute to WRJ; NIH AG-030578, HL-094269, and Texas A&M University Health Science Center College of Medicine and Department of Medical Physiology to AG; NIH HL096552 to DCZ; NIH AI072529 to DEB; NIH 5R01AI033774, 5R37AI033142, and 5R01AI052733 to AC; and CA100324 to JC. VZ is supported by the PhD program in Genetics and cell Biology at the University of Tuscia, Department of Ecology and Biology (DEB), Viterbo, Italy.	Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; Tharakan B, 2012, SHOCK, V37, P306, DOI 10.1097/SHK.0b013e318240b564; Entenberg D, 2011, NAT PROTOC, V6, P1500, DOI 10.1038/nprot.2011.376; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Nagai T, 2011, MICROCIRCULATION, V18, P463, DOI 10.1111/j.1549-8719.2011.00107.x; BENOIT JN, 1989, AM J PHYSIOL, V257, pH2059; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Scharf B, 2013, CHEM BIOL, V20, P922, DOI 10.1016/j.chembiol.2013.06.006; MCHALE NG, 1976, J PHYSIOL-LONDON, V261, P255; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Clement CC, 2011, TRENDS IMMUNOL, V32, P6, DOI 10.1016/j.it.2010.10.004; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Michel CC, 2004, J PHYSIOL-LONDON, V557, P701, DOI 10.1113/jphysiol.2004.06311; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; Davis MJ, 2011, AM J PHYSIOL-HEART C, V301, pH48, DOI 10.1152/ajpheart.00133.2011; Gashev AA, 2008, ANN NY ACAD SCI, V1131, P100, DOI 10.1196/annals.1413.009; Muthuchamy M, 2003, FASEB J, V17, P920, DOI 10.1096/fj.02-0626fje; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Akl TJ, 2011, AM J PHYSIOL-HEART C, V301, pH1828, DOI 10.1152/ajpheart.00538.2011; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Childs EW, 2007, AM J PHYSIOL-HEART C, V292, pH3179, DOI 10.1152/ajpheart.01337.2006; Bridenbaugh EA, 2013, LYMPHAT RES BIOL, V11, P35, DOI 10.1089/lrb.2012.0025; Bridenbaugh EA, 2013, LYMPHAT RES BIOL, V11, P155, DOI 10.1089/lrb.2013.0023; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Clement CC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00424; Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje; Davis MJ, 2008, AM J PHYSIOL-HEART C, V295, pH587, DOI 10.1152/ajpheart.01029.2007; Fang JF, 2010, SHOCK, V34, P291, DOI 10.1097/SHK.0b013e3181ceef5e; GASHEV A A, 1991, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V77, P63; Krouwer VJ, 2012, VASC CELL, V28, P12; LEAK LV, 1966, AM J ANAT, V118, P785, DOI 10.1002/aja.1001180308; Liese J, 2013, CELL MICROBIOL, V15, P891, DOI 10.1111/cmi.12085; MAZZONI MC, 1987, BLOOD VESSELS, V24, P304; Meng Z, 2007, PROTEOM CLIN APPL, V1, P747, DOI 10.1002/prca.200700243; MISLIN H, 1961, EXPERIENTIA, V17, P29, DOI 10.1007/BF02157935; OHHASHI T, 1980, AM J PHYSIOL, V239, pH88; Sardiu ME, 2010, NAT BIOTECHNOL, V28, P40, DOI 10.1038/nbt0110-40; SKALAK TC, 1984, MICROVASC RES, V28, P95, DOI 10.1016/0026-2862(84)90032-3; Thangaswamy S, 2012, LYMPHAT RES BIOL, V10, P53, DOI 10.1089/lrb.2011.0022; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; ZAWIEJA DC, 1993, LYMPHOLOGY, V26, P135; ZAWIEJA DC, 1991, AM J PHYSIOL, V260, pH1935	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9718	1474-9726		AGING CELL	Aging Cell	AUG	2015	14	4					582	594		10.1111/acel.12330		13	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	CM8IC	WOS:000357941900008		
J	Yamakoshi, K; Katano, S; Iida, M; Kimura, H; Okuma, A; Ikemoto-Uezumi, M; Ohtani, N; Hara, E; Maruyama, M				Yamakoshi, Kimi; Katano, Satoshi; Iida, Mayu; Kimura, Hiromi; Okuma, Atsushi; Ikemoto-Uezumi, Madoka; Ohtani, Naoko; Hara, Eiji; Maruyama, Mitsuo			Dysregulation of the Bmi-1/p16(Ink4a) pathway provokes an aging-associated decline of submandibular gland function	AGING CELL			English	Article						aging; Bmi-1; homeostasis; p16(Ink4a); stem; progenitor cells; submandibular gland	P16(INK4A) TUMOR-SUPPRESSOR; HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; INK4A-ARF LOCUS; SALIVARY-GLANDS; SENESCENT CELLS; BMI-1; EXPRESSION; GENE; PROLIFERATION	Bmi-1 prevents stem cell aging, at least partly, by blocking expression of the cyclin-dependent kinase inhibitor p16(Ink4a). Therefore, dysregulation of the Bmi-1/p16(Ink4a) pathway is considered key to the loss of tissue homeostasis and development of associated degenerative diseases during aging. However, because Bmi-1 knockout (KO) mice die within 20weeks after birth, it is difficult to determine exactly where and when dysregulation of the Bmi-1/p16(Ink4a) pathway occurs during aging in vivo. Using real-time in vivo imaging of p16(Ink4a) expression in Bmi-1-KO mice, we uncovered a novel function of the Bmi-1/p16(Ink4a) pathway in controlling homeostasis of the submandibular glands (SMGs), which secrete saliva into the oral cavity. This pathway is dysregulated during aging in vivo, leading to induction of p16(Ink4a) expression and subsequent declined SMG function. These findings will advance our understanding of the molecular mechanisms underlying the aging-related decline of SMG function and associated salivary gland hypofunction, which is particularly problematic among the elderly.	[Yamakoshi, Kimi; Katano, Satoshi; Iida, Mayu; Kimura, Hiromi; Maruyama, Mitsuo] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi 4748511, Japan; [Okuma, Atsushi; Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan; [Ikemoto-Uezumi, Madoka] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Regenerat Med, Obu, Aichi 4748511, Japan; [Ohtani, Naoko] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan	Yamakoshi, K (reprint author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi 4748511, Japan.	kyama@ncgg.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Prize Foundation; Takeda Science Foundation; Japan Foundation for Aging and Health; Toyoaki Scholarship Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japan Prize Foundation; the Takeda Science Foundation; Japan Foundation for Aging and Health; and Toyoaki Scholarship Foundation.	Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Yeh CK, 1998, AGING-CLIN EXP RES, V10, P421; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Biehs B, 2013, NAT CELL BIOL, V15, P846, DOI 10.1038/ncb2766; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Feng JL, 2009, RADIOTHER ONCOL, V92, P466, DOI 10.1016/j.radonc.2009.06.023; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Jacobs JJL, 1999, NATURE, V397, P164; Sreebny LM, 2000, INT DENT J, V50, P140; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; PEDERSEN W, 1985, J DENT RES, V64, P822, DOI 10.1177/00220345850640050801; Hara E, 1996, MOL CELL BIOL, V16, P859; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; EPSTEIN JB, 1980, J CLIN MICROBIOL, V12, P475; SCOTT J, 1977, ARCH ORAL BIOL, V22, P221, DOI 10.1016/0003-9969(77)90158-3; Das B, 2009, J HISTOCHEM CYTOCHEM, V57, P383; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lenander-Lumikari M, 2000, Adv Dent Res, V14, P40; Liu Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003199; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Olsen JG, 1997, J GERONTOL A-BIOL, V52, pB152; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; van dersMaarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3; VREUGDENHIL AP, 1982, HISTOCHEM J, V14, P767, DOI 10.1007/BF01033626; Young JA, 1978, MORPHOLOGY SALIVARY	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9718	1474-9726		AGING CELL	Aging Cell	AUG	2015	14	4					616	624		10.1111/acel.12337		9	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	CM8IC	WOS:000357941900011		
J	Takebayashi, S; Tanaka, H; Hino, S; Nakatsu, Y; Igata, T; Sakamoto, A; Narita, M; Nakao, M				Takebayashi, Shin-ichiro; Tanaka, Hiroshi; Hino, Shinjiro; Nakatsu, Yuko; Igata, Tomoka; Sakamoto, Akihisa; Narita, Masashi; Nakao, Mitsuyoshi			Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells	AGING CELL			English	Article						gene regulation; glycolysis; metabolic remodeling; oncogene-induced senescence; oxidative phosphorylation; retinoblastoma protein	CELLULAR SENESCENCE; HISTONE DEACETYLASE; REPRESS TRANSCRIPTION; CHROMATIN-STRUCTURE; TUMOR-SUPPRESSOR; STEM-CELLS; METABOLISM; CANCER; RB; DIFFERENTIATION	Metabolism is closely linked with cellular state and biological processes, but the mechanisms controlling metabolic properties in different contexts remain unclear. Cellular senescence is an irreversible growth arrest induced by various stresses, which exhibits active secretory and metabolic phenotypes. Here, we show that retinoblastoma protein (RB) plays a critical role in promoting the metabolic flow by activating both glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) in cells that have undergone oncogene-induced senescence (OIS). A combination of real-time metabolic monitoring, and metabolome and gene expression analyses showed that OIS-induced fibroblasts developed an accelerated metabolic flow. The loss of RB downregulated a series of glycolytic genes and simultaneously reduced metabolites produced from the glycolytic pathway, indicating that RB upregulates glycolytic genes in OIS cells. Importantly, both mitochondrial OXPHOS and glycolytic activities were abolished in RB-depleted or downstream glycolytic enzyme-depleted OIS cells, suggesting that RB-mediated glycolytic activation induces a metabolic flux into the OXPHOS pathway. Collectively, our findings reveal that RB essentially functions in metabolic remodeling and the maintenance of the active energy production in OIS cells.	[Takebayashi, Shin-ichiro; Tanaka, Hiroshi; Hino, Shinjiro; Nakatsu, Yuko; Igata, Tomoka; Sakamoto, Akihisa; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan; [Takebayashi, Shin-ichiro; Nakao, Mitsuyoshi] Kumamoto Univ, Program Leading Grad Sch HIGO Hlth life Sci Inter, Kumamoto 8600811, Japan; [Narita, Masashi] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Nakao, Mitsuyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Nakao, M (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	mnakao@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency (CREST); Takeda Science Foundation; Program for Leading Graduate Schools 'HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program'; Kumamoto University; University of Cambridge; Cancer Research UK; Hutchison Whampoa	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M. Nakao and S. T.), the Japan Science and Technology Agency (CREST), the Takeda Science Foundation (M. Nakao), by the Program for Leading Graduate Schools 'HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program', Kumamoto University (M. Nakao and S. T.), and by the University of Cambridge, Cancer Research UK, Hutchison Whampoa (M. Narita).	Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Magnaghi-Jaulin L, 1998, NATURE, V391, P601; Reynolds MR, 2014, ONCOGENE, V33, P556, DOI 10.1038/onc.2012.635; Colombo SL, 2011, P NATL ACAD SCI USA, V108, P21069, DOI 10.1073/pnas.1117500108; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Quijano C, 2012, CELL CYCLE, V11, P1383, DOI [10.4161/cc.19800, 10.4161/cc.11.7.19800]; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-62; Talluri S, 2012, CELL CYCLE, V11, P3189, DOI 10.4161/cc.21263; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Hirosue A, 2012, AGING CELL, V11, P553, DOI 10.1111/j.1474-9726.2012.00809.x; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Brehm A, 1998, NATURE, V391, P597; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Hino S, 2013, J HUM GENET, V58, P410, DOI 10.1038/jhg.2013.57; López-Otín Carlos, 2013, Cell, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Noe V, 1998, ONCOGENE, V16, P1931, DOI 10.1038/sj.onc.1201718; Takahashi C, 2012, CANCER SCI, V103, P1182, DOI 10.1111/j.1349-7006.2012.02284.x; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9718	1474-9726		AGING CELL	Aging Cell	AUG	2015	14	4					689	697		10.1111/acel.12351		9	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	CM8IC	WOS:000357941900018		
J	Shimokawa, I; Komatsu, T; Hayashi, N; Kim, SE; Kawata, T; Park, S; Hayashi, H; Yamaza, H; Chiba, T; Mori, R				Shimokawa, Isao; Komatsu, Toshimitsu; Hayashi, Nobutaka; Kim, Sang-Eun; Kawata, Takuya; Park, Seongjoon; Hayashi, Hiroko; Yamaza, Haruyoshi; Chiba, Takuya; Mori, Ryoichi			The life-extending effect of dietary restriction requires Foxo3 in mice	AGING CELL			English	Article						cancer; dietary restriction; Foxo; lifespan; longevity; mouse	C-ELEGANS; LONGEVITY; DAF-16	Forkhead box O (Foxo) transcription factors may be involved in the salutary effect of dietary restriction (DR). This study examined the role of Foxo3 in lifespan extension and cancer suppression in DR mice. Wild-type (WT) and Foxo3-knockout heterozygous ((+/-)) and homozygous ((-/-)) mice were subjected to a 30% DR regimen initiated at 12weeks of age. Control mice were fed adlibitum (AL) throughout the study. In contrast to WT mice, DR did not significantly extend the lifespan of Foxo3(+/-) or Foxo3(-/-) mice. However, DR reduced the prevalence of tumors at death in WT, Foxo3(+/-), and Foxo3(-/-) mice. These results indicate the necessity of Foxo3 for lifespan extension but not cancer suppression by DR. The findings in Foxo3(+/-) mice contrast with those in Foxo1(+/-) mice reported previously by our laboratory suggest differential regulation of cancer and lifespan by DR via Foxo1 and Foxo3.	[Shimokawa, Isao] Nagasaki Univ, Sch Med, Dept Pathol, Nagasaki 8528523, Japan; [Shimokawa, Isao] Grad Sch Biomed Sci, Nagasaki 8528523, Japan	Shimokawa, I (reprint author), Nagasaki Univ, Sch Med, Dept Pathol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	shimo@nagasaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15390128, 16790226, 20790260]; JSPS Asian CORE Program	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (15390128, 16790226, and 20790260) and the JSPS Asian CORE Program.	Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.13.029; WEINDRUCH R, 1988, RETARDATION AGING DI; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9718	1474-9726		AGING CELL	Aging Cell	AUG	2015	14	4					707	709		10.1111/acel.12340		3	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	CM8IC	WOS:000357941900022		
J	Kibria, ASMG; Inoue, M; Nath, TK				Kibria, Abu Saleh Md. Golam; Inoue, Makoto; Nath, Tapan Kumar			Analysing the land uses of forest-dwelling indigenous people in the Chittagong Hill Tracts, Bangladesh	AGROFORESTRY SYSTEMS			English	Article						Indigenous people; Unclassed state forest; Land uses; Sustainability	SHIFTING CULTIVATION; AGROFORESTRY; COMMUNITY; BIODIVERSITY; MANAGEMENT	Unsustainable land use systems in the Chittagong Hill Tracts (CHT) have damaged the environment and enhanced vulnerability of indigenous people. Promoting improved land use in degraded and abandoned shifting cultivation areas has been widely suggested for better livelihoods and environmental conservation. This article analysed four major land uses, agroforestry, fruit orchards, shifting cultivation and village common forest (VCF), in the CHT by correlating them with local perceptions. Traditionally, the indigenous people of the CHT are dependent on shifting cultivation and VCF for their livelihood. Agroforestry and orchards are newly introduced land uses in the CHT area. This analysis is performed by using the Strength, Weakness, Opportunity and Threat (SWOT) approach in combination with the Analytic Hierarchy Process (AHP). The introduction of agroforestry and fruit orchards influenced marginalised indigenous people to reduce the shifting cultivation area. However, potential weaknesses and threats were associated with shifting cultivation, agroforestry and fruit orchards. Except for shifting cultivation, the positive factors of other land uses outweighed the negative ones. The AHP results indicate that while adopting a land use, the respondents prioritised economic benefits (75 % preference) over social (17 %) and environmental aspects (8 %). Considering these three factors, people ranked four land uses in the order of orchards > agroforestry > VCF > shifting cultivation. This suggests that future land use planning in the CHT cannot secure sustainability by mere trade-offs among the three sustainability factors (social, economic, environmental). Instead, if the activities for achieving social and environmental benefits of a project can be employed to create benefits in terms of income or savings (money/effort/time), they will be well accepted by the marginalised rural communities.	[Kibria, Abu Saleh Md. Golam; Inoue, Makoto] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Nath, Tapan Kumar] Univ Nottingham, Fac Sci, Semenyih 43500, Selangor Darul, Malaysia	Kibria, ASMG (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	kibria.asmg@gmail.com; mkinoue@fr.a.u-tokyo.ac.jp; tapan.nath@nottingham.edu.my					Adnan S, 2011, ALIENATION LANDS IND; Simon S, 2010, AGRON SUSTAIN DEV, V30, P139, DOI 10.1051/agro/2009013; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Rasul G, 2004, APPL GEOGR, V24, P217, DOI 10.1016/j.apgeog.2004.03.004; Dewi S, 2013, LAND USE POLICY, V30, P38, DOI 10.1016/j.landusepol.2012.02.006; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Borggaard OK, 2003, AMBIO, V32, P118, DOI 10.1639/0044-7447(2003)032[0118:SAOSCI]2.0.CO;2; Gafur A, 2003, J HYDROL, V274, P30, DOI 10.1016/S0022-1694(02)00351-7; Boroushaki S, 2008, COMPUT GEOSCI-UK, V34, P399, DOI 10.1016/j.cageo.2007.04.003; BROWN MW, 1992, ENVIRON ENTOMOL, V21, P485; Fischer A, 2000, BIODIVERS CONSERV, V9, P739, DOI 10.1023/A:1008939425511; Garity DP, 2004, AGROFORESTRY ACHIEVE, V61, P5; Halim S, 2007, BRIDGING GAP POLICIE, P41; Jashimuddin M, 2012, OPEN J FOR, V2, P121; Kurttila M., 2000, Forest Policy and Economics, V1, P41, DOI 10.1016/S1389-9341(99)00004-0; Mantel S, 2006, NAT WORKSH HELD RANG; McNeely JA, 2004, AGROFOREST SYST, V61-2, P155, DOI 10.1023/B:AGFO.0000028996.92553.ea; Nath TK, 2005, J FOR RES-JPN, V10, P443, DOI 10.1007/s10310-005-0171-x; Nath TK, 2009, INT FOREST REV, V11, P394; Rahman SA, 2012, AGROFOREST SYST, V84, P141, DOI 10.1007/s10457-011-9422-3; Rao RV, 2007, SPRINGER SER ADV MAN, P1, DOI 10.1007/978-1-84628-819-7; Rasul G, 2007, ENVIRON CONSERV, V34, P153, DOI 10.1017/s0376892907003888; Rasul G, 2003, LAND DEGRAD DEV, V14, P495, DOI 10.1002/ldr.570; Rasul G, 2006, AGR SYST, V91, P29, DOI 10.1016/j.agsy.2006.01.006; Rasul G, 2006, POLITICAL ECOLOGY DE; Rist Stephan, 2006, Environment Development and Sustainability, V8, P467, DOI 10.1007/s10668-006-9050-7; Roy RD, 2002, FARMING PRACTICES SU, P135; Saaty T. L., 2001, MODELS METHODS CONCE; Saaty TL, 1980, ANAL HIERARCHY PROCE; Saaty Thomas L, 2008, International Journal of Services Science, V1, DOI 10.1504/IJSSCI.2008.017590; Saaty TL, 1993, CENTRAL EUROPEAN J O, V2, P119; Saha PS, 2010, DHARITRI OCCASIONAL; Shoaib JU, 2000, DEV SUSTAINABLE CULT; SU (Shensu University), 2012, WEB BAS SOFTW; Sunderlin W., 2008, EXCLUSION OWNERSHIP	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4366	1572-9680		AGROFOREST SYST	Agrofor. Syst.	AUG	2015	89	4					663	676		10.1007/s10457-015-9803-0		14	Agronomy; Forestry	Agriculture; Forestry	CM4HU	WOS:000357646200008		
J	Sugimoto, M; Sahara, S; Ichikawa, H; Kagami, T; Uotani, T; Furuta, T				Sugimoto, M.; Sahara, S.; Ichikawa, H.; Kagami, T.; Uotani, T.; Furuta, T.			High Helicobacter pylori cure rate with sitafloxacin-based triple therapy	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							3RD-LINE REGIMEN; ACID-SECRETION; RESCUE THERAPY; ERADICATION; INFECTION; RESISTANCE; CLARITHROMYCIN; AMOXICILLIN; RABEPRAZOLE; JAPAN	BackgroundBacterial resistance of Helicobacter pylori to antibiotics is increasing and it often leads to failure of antibiotic treatment. A new sitafloxacin-based triple therapy was developed to counter this situation; the fluoroquinolone sitafloxacin has a low minimum inhibitory concentration for H. pylori. AimTo investigate the efficacy in Japanese patients of sitafloxacin-based triple therapy and document its efficacy in relation to anti-microbial susceptibility. MethodsWe investigated the efficacy of a 1-week sitafloxicin-based regimen of rabeprazole 10mg four times daily (q.d.s.), metronidazole 250mg twice daily (b.d.) and sitafloxacin 100mg b.d. in 180 H.pylori-positive Japanese patients (first-line treatment: n=45, second-line; n=41, third-line: n=94). At 8weeks, patients were given the C-13-urea breath test to assess eradication status. ResultsEradication rate was 92.2% [95% confidence interval (CI): 87.3-95.7%, 166/180] in intention-to-treat analysis. Although the eradication rate was higher in patients treated with first-line therapy [45/45 (100%, 95% CI: 83.4-100%)] than in those with second- [38/41 (92.7%, 80.1-98.5%)] or third-line therapy [83/94 (88.3%, 80.0-94.0%)], no significant differences were noted with respect to the number of previous therapy attempts (P=0.054). Eradication rates in patients infected with sensitive- and resistant strains to metronidazole were 96.6% (28/29) and 96.3% (77/80) (P=0.941), respectively, while rates were 98.4% (60/61) in sitafloxacin-sensitive and 50.0% (1/2) in sitafloxacin resistant strains (P<0.001). ConclusionSitofloxacin-based triple therapy with metronidazole b.d. and rabeprazole q.d.s. achieved an eradication rate exceeding 88%, irrespective of eradication history, CYP2C19 genotype, or metronidazole resistance status.	[Sugimoto, M.; Sahara, S.; Ichikawa, H.; Kagami, T.; Uotani, T.] Hamamatsu Univ Sch Med, Dept Med 1, Shizuoka, Japan; [Sugimoto, M.] Shiga Univ Med Sci Hosp, Div Digest Endoscopy, Otsu, Shiga 5202192, Japan; [Furuta, T.] Hamamatsu Univ Sch Med, Clin Res Ctr, Shizuoka, Japan	Sugimoto, M (reprint author), Shiga Univ Med Sci Hosp, Div Digest Endoscopy, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	sugimo@belle.shiga-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22790640, 24590912]	A grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22790640 and 24590912).	Adamek RJ, 1997, AM J GASTROENTEROL, V92, P1949; CLAYTON CL, 1992, J CLIN MICROBIOL, V30, P192; HUNT RH, 1993, AM J GASTROENTEROL, V88, P481; Perna F, 2007, DIGEST LIVER DIS, V39, P1001, DOI 10.1016/j.dld.2007.06.016; Appelbaum PC, 2000, INT J ANTIMICROB AG, V16, P5, DOI 10.1016/S0924-8579(00)00192-8; Hirata Y, 2012, INT J ANTIMICROB AG, V39, P352, DOI 10.1016/j.ijantimicag.2011.12.002; Lee HJ, 2013, J INFECT DIS, V208, P1123, DOI 10.1093/infdis/jit287; GRAYSON ML, 1989, EUR J CLIN MICROBIOL, V8, P888, DOI 10.1007/BF01963775; Furuta T, 2007, CLIN PHARMACOL THER, V81, P521, DOI 10.1038/sj.clpt.6100043; Kawai T, 2008, J GASTROEN HEPATOL, V23, pS171, DOI 10.1111/j.1440-1746.2008.05408.x; Sugimoto M, 2014, HELICOBACTER, V19, P312, DOI 10.1111/hel.12128; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Sanchez JEG, 2000, J ANTIMICROB CHEMOTH, V46, P283, DOI 10.1093/jac/46.2.283; Sugimoto M, 2004, CLIN PHARMACOL THER, V76, P290, DOI 10.1016/j.clpt.2004.06.008; Zhanel GG, 2002, DRUGS, V62, P13, DOI 10.2165/00003495-200262010-00002; Bontems P, 2011, J PEDIATR GASTR NUTR, V53, P646, DOI 10.1097/MPG.0b013e318229c769; Cammarota G, 2000, ALIMENT PHARM THERAP, V14, P1339, DOI 10.1046/j.1365-2036.2000.00846.x; Liou JM, 2011, ANTIMICROB AGENTS CH, V55, P1123, DOI 10.1128/AAC.01131-10; Sugimoto M, 2007, HELICOBACTER, V12, P317, DOI 10.1111/j.1523-5378.2007.00508.x; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Sugimoto M, 2012, ALIMENT PHARM THER, V36, P627, DOI 10.1111/apt.12014; Shirai N, 2007, EUR J CLIN PHARMACOL, V63, P743, DOI 10.1007/s00228-007-0302-8; Asaka M, 2001, HELICOBACTER, V6, P254, DOI 10.1046/j.1523-5378.2001.00037.x; Furuta T, 2013, J GASTROEN HEPATOL, V2, P506; Furuta T, 2014, J GASTROEN HEPATOL, V29, P487, DOI 10.1111/jgh.12442; Furuta T, 2000, CLIN PHARMACOL THER, V67, P684, DOI 10.1067/mcp.2000.106826; Furuta T, 2014, INTERNAL MED, V53, P571, DOI 10.2169/internalmedicine.53.1677; Kawakami E, 2006, WORLD J GASTROENTERO, V12, P5544; Matsumoto Y, 2005, DIGEST LIVER DIS, V37, P821, DOI 10.1016/j.dld.2005.06.002; Matsuzaki J, 2012, ANTIMICROB AGENTS CH, V56, P1643, DOI 10.1128/AAC.05941-11; Murakami K, 2009, ANTIMICROB AGENTS CH, V53, P3097, DOI 10.1128/AAC.01552-08; Murakami K, 2003, ALIMENT PHARM THERAP, V17, P119, DOI 10.1046/j.0269-2813.2003.01401.x; Murakami K, 2002, ALIMENT PHARM THERAP, V16, P1933, DOI 10.1046/j.0269-2813.2002.01368.x; Murakami K, 2013, J GASTROENTEROL, V48, P1128, DOI 10.1007/s00535-012-0731-8; Sharara AI, 2006, HELICOBACTER, V11, P231, DOI 10.1111/j.1523-5378.2006.00416.x; Suzuki H, 2009, ANTIMICROB AGENTS CH, V53, P1720, DOI 10.1128/AAC.00049-09; Yamade M, 2011, J GASTROEN HEPATOL, V26, P1457, DOI 10.1111/j.1440-1746.2011.06815.x	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	AUG	2015	42	4					477	483		10.1111/apt.13280		7	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CM7TU	WOS:000357900200009		
J	Miyata, K; Yamamoto, H; Ogawa, Y				Miyata, Kakuko; Yamamoto, Hitoshi; Ogawa, Yuki			What Affects the Spiral of Silence and the Hard Core on Twitter? An Analysis of the Nuclear Power Issue in Japan	AMERICAN BEHAVIORAL SCIENTIST			English	Article						Spiral of Silence; Twitter; selective exposure; machine learning	WILLINGNESS; OPINION; ONLINE	We test the Spiral of Silence theory about Internet use in Japanese Internet society. We looked at Twitter and analyzed whether the Spiral of Silence theory would hold for it. Twitter's speed and scope of information dissemination is fast and extremely wide ranging. For these reasons, Twitter is an appropriate field for analyzing the influences of the Internet on the formation of public opinion. By integrating social investigation and behavioral log analysis, we test a model that incorporates an individual's attitudes (measured via a questionnaire) and an individual's communication network structure and actual communication behavior (measured via behavior log analysis). The results from our analysis show a positive correlation between individuals' perception that their opinion represents the majority view and the number of times they have spoken out. Moreover, while homogeneity of opinions of a personal network on Twitter influenced speaking out by a majority group, homogeneity of opinions does not influence speaking out by a minority group.	[Miyata, Kakuko] Meijigakuin Univ, Tokyo, Japan; [Yamamoto, Hitoshi; Ogawa, Yuki] Rissho Univ, Tokyo, Japan	Yamamoto, H (reprint author), Rissho Univ, Fac Business Adm, 3-2-16 Osaki Shinagawa Ku, Tokyo 1418602, Japan.	hitoshi@ris.ac.jp					Sriram B, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P841, DOI 10.1145/1835449.1835643; Yun GW, 2011, J COMPUT-MEDIAT COMM, V16, P201, DOI 10.1111/j.1083-6101.2010.01533.x; Scheufele DA, 2000, INT J PUBLIC OPIN R, V12, P3, DOI 10.1093/ijpor/12.1.3; Golbeck J, 2014, SOC NETWORKS, V36, P177, DOI 10.1016/j.socnet.2013.07.004; BREIMAN L., 2001, MACH LEARN, V45, P1, DOI DOI 10.1023/A:1010933404324; Glynn CJ, 1997, PUBLIC OPIN QUART, V61, P452, DOI 10.1086/297808; Hampton K. N., 2014, SOCIAL MEDIA SPIRAL; Hayes A. F., 2011, COMMUN RES, V40, P439; Kobayashi T., 2012, COMMUNICATION METHOD, V6, P126; McDonald DG, 2001, COMMUN RES, V28, P139, DOI 10.1177/009365001028002001; Mutz Diana C., 1989, INT J PUBLIC OPINION, V1, P3, DOI 10.1093/ijpor/1.1.3; NOELLENE.E, 1974, J COMMUN, V24, P43, DOI 10.1111/j.1460-2466.1974.tb00367.x; Noelle-Neumann E, 1993, SPIRAL SILENCE PUBLI; Pang B., 2002, P ACL 02 C EMP METH, V10, P79, DOI DOI 10.3115/1118693.1118704; Price V, 2006, COMMUN THEOR, V16, P47, DOI 10.1111/j.1468-2885.2006.00005.x; Rao D, 2010, P 2 INT WORKSH SEARC, P37, DOI 10.1145/1871985.1871993; SALMON CT, 1990, JOURNALISM QUART, V67, P567; Shamir J, 1997, JOURNALISM MASS COMM, V74, P602; TAYLOR DG, 1982, PUBLIC OPIN QUART, V46, P311, DOI 10.1086/268729; Turney P. D., 2002, P 40 ANN M ASS COMP, P417, DOI DOI 10.3115/1073083.1073153; Yasuno S., 2001, ANN M WORLD ASS PUBL	21	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0002-7642	1552-3381		AM BEHAV SCI	Am. Behav. Sci.	AUG	2015	59	9			SI		1129	1141		10.1177/0002764215580618		13	Psychology, Clinical; Social Sciences, Interdisciplinary	Psychology; Social Sciences - Other Topics	CM8JW	WOS:000357947500006		
J	Okayama, D; Suzuki, T; Shiga, T; Minami, Y; Tsuruoka, S; Hagiwara, N				Okayama, Dai; Suzuki, Tsuyoshi; Shiga, Tsuyoshi; Minami, Yuichiro; Tsuruoka, Shuichi; Hagiwara, Nobuhisa			Blood Urea Nitrogen/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis	AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS			English	Article							TRIAL; DYSFUNCTION; NITROGEN	Introduction Arginine vasopressin-stimulated reabsorption of urea occurs in the collecting duct via increased expression of the urea transporter. Objective The aim of this study was to evaluate whether the blood urea nitrogen/creatinine (BUN/Cr) ratio is useful for predicting tolvaptan response in patients with decompensated heart failure (HF). Methods Among 71 consecutive patients with HF who received oral tolvaptan between 2010 and 2014, we retrospectively studied 33 patients with decompensated HF without any mechanical circulatory assistance or inotropic support who had already been treated with loop diuretics. A responder to tolvaptan was defined as an individual who experienced a a parts per thousand yen30 % increase in their respective 24-h urine volume. Results Among the 33 patients, 21 met the criteria of a responder. The area under the receiver operating characteristic curves of BUN/Cr and BUN were 0.790 and 0.714, respectively, and the respective cut-off values for responders to tolvaptan were 23.8 and 49.0. BUN/Cr and BUN retained their significant relationships with the responder status (odds ratio for BUN/Cr > 23.8: 20.9; 95 % confidence interval [CI] 2.7-531.1; p = 0.002; odds ratio for BUN a parts per thousand yen49: 7.7; 95 % CI 1.4-65.8; p = 0.02). Conclusion Our results suggest that high BUN/Cr may be a predictor of response to tolvaptan in decompensated HF patients. A prospective study with a large sample size is required to confirm this preliminary finding.	[Okayama, Dai; Suzuki, Tsuyoshi; Shiga, Tsuyoshi; Minami, Yuichiro; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, Tokyo 1628666, Japan; [Tsuruoka, Shuichi] Nippon Med Sch, Dept Nephrol, Bunkyo Ku, Tokyo 1138602, Japan	Shiga, T (reprint author), Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	mshiga@hij.twmu.ac.jp					Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Gheorghiade M, 2006, AM J MED, V119, P3, DOI 10.1016/j.amjmed.2006.09.011; Brisco MA, 2013, CIRC-HEART FAIL, V6, P233, DOI 10.1161/CIRCHEARTFAILURE.112.968230; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; FRANCIS GS, 1990, CIRCULATION, V82, P1724; Edwards RM, 2001, J PHARMACOL EXP THER, V298, P1001; Imamura T, 2013, CIRC J, V77, P1208, DOI 10.1253/circj.CJ-12-1328; Lindenfeld J, 2011, J AM COLL CARDIOL, V58, P383, DOI 10.1016/j.jacc.2011.01.054; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS19, DOI 10.1007/s10557-011-6303-y; Pitt B, 2011, EUR J HEART FAIL, V13, P1261, DOI 10.1093/eurjhf/hfr150; Sands JM, 2003, ANNU REV PHYSIOL, V65, P543, DOI 10.1146/annurev.physiol.65.092101.142638; Sato E, 2014, INT HEART J, V55, P533; Valania Gregory, 2011, Curr Heart Fail Rep, V8, P198, DOI 10.1007/s11897-010-0035-3	13	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1175-3277	1179-187X		AM J CARDIOVASC DRUG	Am. J. Cardiovasc. Drugs	AUG	2015	15	4					289	293		10.1007/s40256-015-0121-8		5	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CN0DP	WOS:000358083700009		
J	Tsutaya, T; Ishida, H; Yoneda, M				Tsutaya, Takumi; Ishida, Hajime; Yoneda, Minoru			Weaning age in an expanding population: stable carbon and nitrogen isotope analysis of infant feeding practices in the Okhotsk culture (5th-13th centuries AD) in Northern Japan	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Article						breastfeeding; fertility; Hokkaido; hunter-gatherer-fisher; complementary food	NONMETRIC CRANIAL VARIATION; MITOCHONDRIAL-DNA ANALYSIS; INDIVIDUAL AMINO-ACIDS; EARLY-CHILDHOOD DIET; BONE-COLLAGEN; HUNTER-GATHERERS; ANCIENT DNA; GENE FLOW; HOKKAIDO; RATIOS	Objective: The Okhotsk people were sedentary hunter-gatherer-fishers who lived and prospered in Sakhalin, Hokkaido, and the Kurile Islands during the 5th to 13th centuries AD. They expanded rapidly along the northeastern coast of Hokkaido. We reconstructed infant feeding practices of the Moyoro population of the Okhotsk culture in eastern Hokkaido, Japan. Methods: Stable isotope ratios in 58 subadult human skeletons were measured. Results: The results suggest that complementary foods with a relatively low carbon isotope ratio were consumed during and after weaning, as observed in ethnographic descriptions of northern human populations such as the Ainu and isotopically suggested in ancient northern hunter-gatherer-fisher populations. Nitrogen isotope ratios of subadults showed that the age at the end of weaning in the Moyoro population was 1.8 (1.4-2.2 in 95% credible interval) years, which is earlier than that in other northern hunter-gatherer-fisher populations. Conclusions: Because weaning age is one of the most important determinants of fertility, a shorter breastfeeding period suggests increased fertility. Furthermore, better nutrition would further promote the population increase, and thus populations of the Okhotsk culture could expand into new regions. These findings are consistent with recent emerging evidence of great contributions of the Okhotsk to the formation of later Ainu populations and culture. Am J Phys Anthropol 157:544-555, 2015. (c) 2015 Wiley Periodicals, Inc.	[Tsutaya, Takumi; Yoneda, Minoru] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Ishida, Hajime] Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Nishihara, Okinawa 9030215, Japan; [Yoneda, Minoru] Univ Tokyo, Univ Museum, Tokyo 1130033, Japan	Tsutaya, T (reprint author), Univ Tokyo, Univ Museum, Lab Radiocarbon Dating, Hongo 7-3-1,Bunkyo, Tokyo 1130033, Japan.	127309@ib.k.u-tokyo.ac.jp			Japan Society for the Promotion of Science [17107006, 18500769, 20370095, 20255007, 24242030, 24-785]	Grant sponsor: Grants-in-Aid for Scientific Research (KAKENHI; Japan Society for the Promotion of Science); Grant numbers: 17107006, 18500769, 20370095, 20255007, 24242030, 24-785.	Abashiri City Board of Education, 2009, SHIS MOYOR KAID; Adami S, 2008, CALCIFIED TISSUE INT, V83, P388, DOI 10.1007/s00223-008-9184-8; Amano T., 2003, ZOKU JOMON OKHOTSK B, P110; Amano T., 1979, B I STUDY N EURASIAN, V12, P75; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; RELETHFORD JH, 1990, HUM BIOL, V62, P5; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Eerkens JW, 2011, J ARCHAEOL SCI, V38, P3101, DOI 10.1016/j.jas.2011.07.010; ELLISON PT, 1994, ANNU REV ANTHROPOL, V23, P255, DOI 10.1146/annurev.anthro.23.1.255; Valeggia C, 2009, AM J HUM BIOL, V21, P559, DOI 10.1002/ajhb.20907; Sellen DW, 2001, J NUTR, V131, P2707; Kohler TA, 2014, P NATL ACAD SCI USA, V111, P10101, DOI 10.1073/pnas.1404367111; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; HOWELL N, 1986, ANNU REV ANTHROPOL, V15, P219; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Naito YI, 2013, J ARCHAEOL SCI, V40, P2913, DOI 10.1016/j.jas.2013.03.012; SEALY J, 1995, ANTIQUITY, V69, P290; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Masuda R, 2001, ZOOL SCI, V18, P741, DOI 10.2108/zsj.18.741; Naito YI, 2010, AM J PHYS ANTHROPOL, V143, P31, DOI 10.1002/ajpa.21287; BONGAARTS J, 1980, SCIENCE, V208, P564, DOI 10.1126/science.7367878; Cordain L, 2000, AM J CLIN NUTR, V71, P682; Eriksson G, 2004, J ANTHROPOL ARCHAEOL, V23, P135, DOI 10.1016/j.jaa.2003.12.005; Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Marlowe FW, 2001, CURR ANTHROPOL, V42, P755, DOI 10.1086/323820; BARRY H, 1971, ETHNOLOGY, V10, P466; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; Chamberlain A, 2009, HUM BIOL, V81, P275, DOI 10.3378/027.081.0309; Jinam T, 2012, J HUM GENET, V57, P787, DOI 10.1038/jhg.2012.114; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; Clayton F, 2006, AM J PHYS ANTHROPOL, V129, P311, DOI 10.1002/ajpa.20248; Sato T, 2009, ANTHROPOL SCI, V117, P171, DOI 10.1537/ase081202; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Wilmoth JR, 2000, EXP GERONTOL, V35, P1111, DOI 10.1016/S0531-5565(00)00194-7; Hanihara T, 2010, AM J HUM BIOL, V22, P163, DOI 10.1002/ajhb.20969; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Oxenham MF, 2008, AM J PHYS ANTHROPOL, V135, P64, DOI 10.1002/ajpa.20709; Bird IL, 1880, UNBEATEN TRACKS JAPA; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bongaarts J, 1983, FERTILITY BIOL BEHAV; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; Burt NM, 2015, J ARCHAEOL SCI, V53, P277, DOI 10.1016/j.jas.2014.10.019; Burt NM, 2013, AM J PHYS ANTHROPOL, V152, P407, DOI 10.1002/ajpa.22370; Chiri M, 1976, CHIRI MASHIHO CHOSAK, V1, P1; CHISHOLM B, 1992, PACIFIC NORTHEAST ASIA IN PREHISTORY, P69; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dodo Y, 2013, ANTHR SCI JAPANESE S, V121, P1; Dupras TL, 2001, AM J PHYS ANTHROPOL, V115, P204, DOI 10.1002/ajpa.1075; Eerkens JW, 2013, AM J PHYS ANTHROPOL, V152, P471, DOI 10.1002/ajpa.22384; Ellison PT, 1995, BREASTFEEDING BIOCUL, P305; Fagre T., 1993, PREHISTORIC HUMAN BO, P121; FAO, 2008, FATS FATT AC HUM NUT; Fogel ML, 1989, ANN REPORT DIRECTOR, V88, P111; Ford CS., 1945, COMP STUDY HUMAN REP; Gardner KS, 2011, SCA SOC CALIFORNIA A, V25, P1; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; HAWKES K, 1995, CURR ANTHROPOL, V36, P688, DOI 10.1086/204420; Heller CA, 1967, ALASKA DIETARY SURVE; Hilger MI, 1971, TOGETHER AINU VANISH; Howcroft R, 2014, J ANTHROPOL ARCHAEOL, V34, P42, DOI 10.1016/j.jaa.2014.01.001; Hudson MJ, 2004, J ANTHROPOL ARCHAEOL, V23, P290, DOI 10.1016/j.jaa.2004.05.002; Humphrey LT, 2014, ANN HUM BIOL, V41, P348, DOI 10.3109/03014460.2014.923939; Ishida H, 1996, ANTHROPOL SCI, V104, P233; ITO S, 1965, Okajimas Folia Anat Jpn, V40, P679; JOHANSSON SR, 1986, AM J PHYS ANTHROPOL, V71, P233, DOI 10.1002/ajpa.1330710211; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Kasai T., 1943, KARAFUTO AINU NO MIN; KATZENBERG MA, 1993, AM J PHYS ANTHROPOL, V90, P267, DOI 10.1002/ajpa.1330900302; Kiyono K., 1969, NIHON KAIZUKA NO KEN; KNODEL J, 1968, POP STUD-J DEMOG, V22, P297, DOI 10.1080/00324728.1968.10404941; Kodama S., 1948, MOYORO KAIDUKA; Komai K, 1964, OKHOTSK KAI ENGAN SH; Komesu A, 2008, ANTHROPOL SCI, V116, P33, DOI 10.1537/ase.070323; Kudaka M, 2013, ANTHROPOL SCI, V121, P49, DOI 10.1537/ase.121125; Lewis ME, 2007, CAM S BIO EVOL ANTHR, V50, P1; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Minagawa M., 2001, B NATL MUSEUM JAPANE, V86, P333; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Nagaoka T, 2012, ANTHROPOL SCI, V120, P103, DOI 10.1537/ase.1107311; Naito YI, 2010, RADIOCARBON, V52, P671; Nishimoto T, 1978, BUSSHITSU BUNKA, V31, P1; Nitsch EK, 2011, AM J PHYS ANTHROPOL, V146, P619, DOI 10.1002/ajpa.21623; O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110; Ohnuki-Tierney E, 1974, AINU NW COAST SO SAK; Ohyi H, 1978, B I STUDY N EURASIAN, V12, P93; Ohyi H, 1988, KOKOGAKU SOKO CHU, P455; Ohyi H, 1975, PREHISTORIC MARITIME, P123; Okada A, 1998, ARCTIC ANTHROPOL, V35, P340; Ono H., 1996, KODAI BUNKA, V48, P281; Parfitt AM, 2002, BONE, V30, P807, DOI 10.1016/S8756-3282(02)00735-4; Pennington RL, 1996, AM J PHYS ANTHROPOL, V99, P259, DOI 10.1002/(SICI)1096-8644(199602)99:2<259::AID-AJPA4>3.0.CO;2-U; POTTER RG, 1975, SOC FORCES, V54, P36, DOI 10.2307/2576076; R Core Team, 2014, R LANG ENV STAT COMP; Sato T, 2007, J HUM GENET, V52, P618, DOI 10.1007/s10038-007-0164-z; SATTENSPIEL L, 1983, AM ANTIQUITY, V48, P489, DOI 10.2307/280557; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schurr MR, 2005, AM J PHYS ANTHROPOL, V126, P278, DOI 10.1002/ajpa.20034; Trussell J., 1979, NATURAL FERTILITY PA, P29; Tsutaya T, 2014, ANTHROPOL SCI, V122, P89, DOI 10.1537/ase.140604; Tsutaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072327; Tsutaya T, 2013, J ARCHAEOL SCI, V40, P3914, DOI 10.1016/j.jas.2013.05.015; Tsutaya T., 2015, YEARB PHYS ANTHROPOL, V156, P2; Turner BL, 2007, INT J OSTEOARCHAEOL, V17, P1, DOI 10.1002/oa.862; Ubelaker D.H., 1999, HUMAN SKELETAL REMAI; Ushiro H, 1991, ANN REP HIST MUSEUM, V19, P23; vansKlinken G. J., 1999, J ARCHAEOL SCI, V26, P687; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Waters-Rist AL, 2011, AM J PHYS ANTHROPOL, V146, P225, DOI 10.1002/ajpa.21568; WHO USAID UNICEF AED FANTA UC Davis, 2008, IND ASS INF YOUNG 1; Wood J., 1988, NATURAL HUMAN FERTIL, P39; Wood JW., 1994, DYNAMICS HUMAN REPRO; Yamaura K, 1998, ARCTIC ANTHROPOL, V35, P321; Yamaura K, 1999, AINU SPIRIT NO PEOPL, P39; Yoneda M, 2004, J ARCHAEOL SCI, V31, P97, DOI 10.1016/S0305-4403(03)00103-1; Yoneda M, 2002, NO ABORIGINAL WORLD, P94; Yonemura K, 1935, JINRUIGAKU ZASSHI, V50, P47	127	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	AUG	2015	157	4					544	555		10.1002/ajpa.22740		12	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CM8ON	WOS:000357961600003		
J	Rodriguez-Vazquez, JF; Verdugo-Lopez, S; Abe, H; Murakami, G				Francisco Rodriguez-Vazquez, Jose; Verdugo-Lopez, Samuel; Abe, Hiroshi; Murakami, Gen			The Origin of the Variations of the Hyoid Apparatus in Human	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						hyoid apparatus; Reichert's cartilage; styloid process; hyoid bone; eagle's syndrome	ELONGATED STYLOID PROCESS; STYLOHYOID CHAIN OSSIFICATION; EAGLES-SYNDROME; HUMAN EMBRYOS; GLOSSOPHARYNGEAL NEURALGIA; PANORAMIC RADIOGRAPHS; LIGAMENT; CALCIFICATION; COMPLEX; MORPHOLOGY	Currently, theories based on acquired calcification of the stylohyoid ligament are believed to be a pathogenesis of syndromes associated with the hyoid apparatus (HA) and its variations. We studied the development of the HA from Reichert ' s cartilage using serial sections of 25 human embryos and 45 fetuses. We ensured a fact that, at the initial stage, the HA appeared as two independent cartilage segments, that is, the cranial or styloid segment and the caudal or hyoid segment of Reichert's cartilage, those are connected by a mesenchymal structure. However, between 8 and 10 weeks of development, the mesenchymal connection was lost. We hypothesize that this disconnection is likely to be one of the major factors to make a descent of the hyoid bone in evolution. The stylohyoid ligament was not observed. The variations of the HA, should be considered variations of the development of Reicherts cartilage. If these variations are maintained in the adult, are likely to explain a major symptom associated with Eagle's syndrome. Anat Rec, 298:1395-1407, 2015. (c) 2015 Wiley Periodicals, Inc.	[Francisco Rodriguez-Vazquez, Jose; Verdugo-Lopez, Samuel] Univ Complutense, Fac Med, Inst Embryol, Dept Anat & Human Embryol, E-28040 Madrid, Spain; [Abe, Hiroshi] Akita Univ, Sch Med, Dept Anat, Akita 010, Japan; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan	Rodriguez-Vazquez, JF (reprint author), Univ Complutense, Fac Med, Dept Anat & Embriol Humanas, E-28040 Madrid, Spain.	jfrodvaz@ucm.es		Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492			Alpoz E, 2014, SURG RADIOL ANAT, V36, P39, DOI 10.1007/s00276-013-1137-x; MONTALBETTI L, 1995, CEPHALALGIA, V15, P80, DOI 10.1046/j.1468-2982.1995.015002080.x; Lieberman DE, 2001, ARCH ORAL BIOL, V46, P117, DOI 10.1016/S0003-9969(00)00108-4; Fusco DJ, 2012, ACTA NEUROCHIR, V154, P1119, DOI 10.1007/s00701-012-1385-2; Fini G, 2000, J CRANIO MAXILL SURG, V28, P123, DOI 10.1054/jcms.2000.0128; Loeser LH, 1942, ARCHIV OTOLARYNGOL, V36, P198; EAGLE WW, 1949, ARCH OTOLARYNGOL, V49, P490; EAGLE WW, 1948, ARCH OTOLARYNGOL, V47, P630; KAUFMAN SM, 1970, ARCHIV OTOLARYNGOL, V91, P460; CAMARDA AJ, 1989, ORAL SURG ORAL MED O, V67, P508, DOI 10.1016/0030-4220(89)90264-8; PETERS G, 1994, Z SAUGETIERKD, V59, P87; Gozil R, 2001, ANN ANAT, V183, P527, DOI 10.1016/S0940-9602(01)80060-1; O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817; Barney A, 2012, PHILOS T R SOC B, V367, P88, DOI 10.1098/rstb.2011.0259; Arnould G, 1969, Rev Otoneuroophtalmol, V41, P190; AUBIN A, 1954, Ann Otolaryngol, V71, P948; BADDOUR HM, 1978, ORAL SURG ORAL MED O, V46, P486, DOI 10.1016/0030-4220(78)90378-X; Balasubramanian S., 1964, BR DENT J, V116, P108; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Bensoussan Y, 2014, HEAD NECK-J SCI SPEC, V36, P136; Blomgren K, 1999, J LARYNGOL OTOL, V113, P854; CAMARDA AJ, 1989, ORAL SURG ORAL MED O, V67, P515, DOI 10.1016/0030-4220(89)90265-X; Carlson BM., 2009, EMBRIOLOGIA HUMANA B; Corliss CE., 1979, EMBRIOLOGIA HUMANA B; CORRELL RW, 1979, ORAL SURG ORAL MED O, V48, P286, DOI 10.1016/0030-4220(79)90025-2; Diewert V M, 1985, Prog Clin Biol Res, V187, P57; Dwight T, 1907, ANN SURG, V46, P721, DOI 10.1097/00000658-190711000-00010; EAGLE WW, 1958, ARCHIV OTOLARYNGOL, V67, P172; Fanibunda K, 1997, DENTOMAXILLOFAC RAD, V26, P249, DOI 10.1038/sj.dmfr.4600246; FERRARIO VF, 1990, ORAL SURG ORAL MED O, V69, P524, DOI 10.1016/0030-4220(90)90390-E; FROMMER J, 1974, ORAL SURG ORAL MED O, V38, P659, DOI 10.1016/0030-4220(74)90382-X; Furbringer M., 1922, ABHANDLUNGEN HEIDE B, V11, P1; Goldstein GR, 1973, J PROSTHET DENT, V30, P30; GOODMAN RS, 1981, ARCH OTOLARYNGOL, V107, P129; GRAF CJ, 1959, J NEUROSURG, V16, P448, DOI 10.3171/jns.1959.16.4.0448; Hamilton WI, 1975, EMBRIOLOGIA HUMANA, V4th; Katori Y, 2013, CLIN ANAT, V26, P204, DOI 10.1002/ca.22088; Kay DJ, 2001, AM J OTOLARYNG, V22, P358, DOI 10.1053/ajot.2001.26497; Koebke J, 1976, Laryngol Rhinol Otol (Stuttg), V55, P913; Krennmair G, 2003, CRANIO, V21, P31; Larsen JW, 2003, EMBRIOLOGIA HUMANA, V3rd; LAVINE MH, 1968, ORAL SURG ORAL MED O, V25, P55, DOI 10.1016/0030-4220(68)90197-7; Lieberman P., 1971, LINGUIST INQ, V2, P203; LYKAKI G, 1988, ANAT ANZEIGER, V166, P187; MacDonald-Jankowski DS, 2001, DENTOMAXILLOFAC RAD, V30, P35, DOI 10.1038/sj.dmfr.4600574; Merida-Velasco JR, 2006, J ANAT, V208, P649, DOI 10.1111/j.1469-7580.2006.00570.x; Rodriguez-Vazquez JF, 2006, J ANAT, V208, P179, DOI 10.1111/j.1469-7580.2006.00524.x; MONSOUR PA, 1986, ORAL SURG ORAL MED O, V61, P522, DOI 10.1016/0030-4220(86)90399-3; Moore KL, 2013, EMBRIOLOGIA CLIN, V9th; NAKANO T, 1988, ANAT ANZEIGER, V167, P105; Nishimura T, 2003, PRIMATES, V44, P41, DOI 10.1007/s10329-002-0005-9; O'Rahilly R, 1996, HUMAN EMBRYOLOGY TER; OCARROLL MK, 1984, ORAL SURG ORAL MED O, V58, P617; Olivier E, 1923, LAPPAREI HYOIDIEN SO; Ommell KAH, 1998, ORAL SURG ORAL MED O, V85, P226; Öztaş Bengi, 2012, J Investig Clin Dent, V3, P30, DOI 10.1111/j.2041-1626.2011.00081.x; Patni V M, 1986, J Indian Dent Assoc, V58, P227; PORRATH S, 1969, AMER J ROENTGENOL RA, V105, P63; Rodriguez-Vazquez JF, 2005, J ANAT, V207, P165, DOI 10.1111/j.1469-7580.2005.00441.x; Rodriguez-Vazquez JF, 2009, J ANAT, V215, P292, DOI 10.1111/j.1469-7580.2009.01105.x; RodriguezVazquez JF, 1997, ANAT REC, V249, P249, DOI 10.1002/(SICI)1097-0185(199710)249:2<249::AID-AR12>3.0.CO;2-O; Rodríguez Vázquez J F, 1992, Anat Rec, V233, P453; Rodriguez-Vazquez JF, 2013, CLIN ANAT, V26, P944, DOI 10.1002/ca.22275; Rodriguez-Vazquez JF, 2011, J ANAT, V219, P143, DOI 10.1111/j.1469-7580.2011.01387.x; Ruprecht A, 1988, Dentomaxillofac Radiol, V17, P61; Sadler TW, 2001, LANGMAN EMBRIOLOGIA; Satyapal KS, 2000, SURG RADIOL ANAT, V22, P211, DOI 10.1007/s00276-000-0211-3; Shenoi P M, 1972, J Laryngol Otol, V86, P1203, DOI 10.1017/S0022215100076428; Sperber GH, 2010, CRANIOFACIAL EMBRYOG; Steinman EP., 1970, ARCH OTOLARYNGOL, V91, P75; Sundmaker W H, 1989, Ear Nose Throat J, V68, P561; Weissengruber GE, 2002, J ANAT, V201, P195, DOI 10.1046/j.1469-7580.2002.00088.x	72	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	AUG	2015	298	8					1395	1407		10.1002/ar.23166		13	Anatomy & Morphology	Anatomy & Morphology	CM7QQ	WOS:000357890900003		
J	Kihara, M				Kihara, Minoru			Pepsin-like protease activity and the gastric digestion within ex vivo Pacific bluefin tuna Thunnus orientalis stomachs, as a gastric digestion model	ANIMAL FEED SCIENCE AND TECHNOLOGY			English	Article						Artificial digestion; Ex vivo; Motility; Pepsin; Pacific bluefin tuna Thunnus orientalis; Stomach	FRACTIONATED FISH HYDROLYSATE; IN-VITRO DIGESTIBILITY; ATLANTIC SALMON; GADUS-MORHUA; GROWTH; TRACT; DIETS; BIOACCESSIBILITY; DISTENSION; ABSORPTION	Isolated whole stomachs of farmed Pacific bluefin tuna Thunnus orientalis were externally batch-cultured in cell culture medium at 24 degrees C for 8 h. This was done in order to confirm that gastric function was maintained during incubation (Exp. 1) so that the effectiveness of the ex vivo technique outlined in the present study in serving as an artificial method of gastric digestion could be determined (Exp. 2). During experiment 1, fresh or cold-stored stomachs (48 h on ice) were intra-gastrically infused with a saline solution (control group) or a skipjack tuna broth stimulant (infusion group). Pepsin-like protease activities within the gastric effluent of each study group were compared. In both control and infusion groups, fresh stomachs demonstrated higher pepsin-like protease activity. Within fresh stomachs, protease activity subsequent to stimulant infusion was significantly greater than it was in the control group. In cold-stored stomachs, however, no difference was observed in the protease activities of control and infusion groups. According to the results, fresh stomachs respond to luminal stimuli. Furthermore, fresh stomachs exhibited motility during incubation while cold-stored stomachs did not. Mucosal layers within fresh stomachs indicated histological normality subsequent to incubation. In experiment 2, both fresh and cold-stored stomachs were filled with a diet consisting of boiled fish paste. After a period of 8 h, dry matter loss of diet was significantly greater within fresh stomachs than it was in cold-stored stomachs. The level of pepsin-like protease activity within fresh stomachs was also higher than levels observed within cold-stored stomachs during the incubation period. These results suggest that fresh stomachs obtained from bluefin tuna maintained functionality ex vivo and that the technique outlined in the present study could be used effectively in the evaluation of bluefin tuna gastric digestion. (C) 2015 Elsevier B.V. All rights reserved.	Tokai Univ, Dept Marine Biol & Sci, Minami Ku, Sapporo, Hokkaido 0058601, Japan	Kihara, M (reprint author), Tokai Univ, Dept Marine Biol & Sci, Minami Ku, Minamisawa 5-1-1-1, Sapporo, Hokkaido 0058601, Japan.	m-kihara@tokai.ac.jp			Research and Study Program of Tokai University Educational System General Research Organization	The author would like to express his gratitude to Amami Fish Farm Co., Ltd. Frozen surimi and skipjack tuna broth were kindly provided by the Central Research Institute of Maruha Nichiro Corporation and Nakajima Ekisu Co., Ltd. The author would also like to thank Takashi Kusano and Norio Ishiguro for their support of this study. The author is very grateful to Drs. Walsh and Mommsen who advised on the culture conditions for fish stomach. The experiment was greatly assisted from the members of the author's laboratory. A part of this study was supported by the Research and Study Program of Tokai University Educational System General Research Organization.	Aksnes A, 2006, AQUACULTURE, V261, P318, DOI 10.1016/j.aquaculture.2006.07.026; Aksnes A, 2006, AQUACULTURE, V261, P1102, DOI 10.1016/j.aquaculture.2006.07.038; Lim SJ, 2011, AQUACULTURE, V313, P165, DOI 10.1016/j.aquaculture.2011.01.007; Kousoulaki K, 2009, AQUACULTURE, V289, P74, DOI 10.1016/j.aquaculture.2008.12.034; Ortega N, 2009, J AGR FOOD CHEM, V57, P5743, DOI 10.1021/jf900591q; Bassompierre M, 1998, AQUACULT INT, V6, P47, DOI 10.1023/A:1009269703297; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Failla ML, 2008, ASIA PAC J CLIN NUTR, V17, P200; Morrison CM, 1999, J FISH BIOL, V54, P597, DOI 10.1006/jfbi.1998.0890; Buddington RK, 2004, COMP BIOCHEM PHYS A, V139, P261, DOI 10.1016/j.cbpb.2004.09.007; BOISEN S, 1991, Nutrition Research Reviews, V4, P141, DOI 10.1079/NRR19910012; Cao XJ, 2009, ANAT HISTOL EMBRYOL, V38, P254, DOI 10.1111/j.1439-0264.2009.00932.x; Diaz-Lopez M, 1998, COMP BIOCHEM PHYS B, V121, P369, DOI 10.1016/S0305-0491(98)10123-2; GILDBERG A, 1988, COMP BIOCHEM PHYS B, V91, P425, DOI 10.1016/0305-0491(88)90002-8; GOLDMAN H, 1968, ARCH PATHOL, V85, P580; Grans A, 2011, ENCY FISH PHYSL GENO, V2, P1292; GROVE DJ, 1992, J EXP BIOL, V163, P33; GROVE DJ, 1992, J EXP BIOL, V163, P49; Igarashi K, 2005, TRACE NUTR RES, V22, P121; Jackson S, 1987, FUNCT ECOL, V1, P287, DOI 10.2307/2389433; Kihara M, 2011, COMP BIOCHEM PHYS A, V158, P444, DOI 10.1016/j.cbpa.2010.11.027; Kihara M., 2012, AQUACULT SCI, V60, P285; Kusano T., 2010, Nippon Suisan Gakkaishi, V76, P978, DOI 10.2331/suisan.76.978; Martinez-Llorens S, 2009, AQUACULT NUTR, V15, P320, DOI 10.1111/j.1365-2095.2008.00597.x; Martinez-Montano E, 2010, AQUACULTURE, V299, P134, DOI 10.1016/j.aquaculture.2009.12.003; Ministry of Agriculture Forestry and Fisheries Japan, 2013, REP MIN AGR FOR FISH; MURRAY HM, 1994, CAN J ZOOL, V72, P1191, DOI 10.1139/z94-160; Olsson C, 2011, FISH PHYSIOL, V30, P319, DOI 10.1016/S1546-5098(10)03008-6; Rungruangsak-Torrissen K, 2002, J SCI FOOD AGR, V82, P644, DOI 10.1002/jsfa.1089; Tacon A.G.J., 1985, P119; Tonheim SK, 2007, AQUACULTURE, V262, P426, DOI 10.1016/j.aquaculture.2006.10.030; Zertuche-Gonzalez J. A., 2008, MARINE SCI ASSESSMEN	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0377-8401	1873-2216		ANIM FEED SCI TECH	Anim. Feed Sci. Technol.	AUG	2015	206						87	99		10.1016/j.anifeedsci.2015.05.009		13	Agriculture, Dairy & Animal Science	Agriculture	CM7VF	WOS:000357903900010		
J	Abe, Y				Abe, Yoshihiro			Effective resistances for supercritical percolation clusters in boxes	ANNALES DE L INSTITUT HENRI POINCARE-PROBABILITES ET STATISTIQUES			English	Article						Effective resistances; Simple random walks; Cover times; Gaussian free fields; Supercritical percolation	QUENCHED INVARIANCE-PRINCIPLES; ORDER LARGE DEVIATIONS; SIMPLE RANDOM-WALK; COVER TIMES; FLOWS; PROFILE; ENERGY; MODELS; POTTS; Z(2)	Let C-n be the largest open cluster for supercritical Bernoulli bond percolation in [-n, n](d) boolean AND z(d) with d >= 2. We obtain a sharp estimate for the effective resistance on C-n. As an application we show that the cover time for the simple random walk on C-n is comparable to n(d) (log n)(2). Noting that the cover time for the simple random walk on [-n, n](d) boolean AND z(d) is of order n(d) log n for d >= 3 (and of order n(2)(log n)(2) for d = 2), this gives a quantitative difference between the two random walks for d >= 3.	Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Abe, Y (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	yosihiro@kurims.kyoto-u.ac.jp			JSPS Research Fellowships	Supported by JSPS Research Fellowships.	Abe Y, 2014, KYOTO J MATH, V54, P555, DOI 10.1215/21562261-2693442; Angel O, 2006, ELECTRON J PROBAB, V11, P655; Barlow MT, 2004, ANN PROBAB, V32, P3024, DOI 10.1214/009117904000000748; Antal P, 1996, ANN PROBAB, V24, P1036; Berger N, 2007, PROBAB THEORY REL, V137, P83, DOI 10.1007/s00440-006-0498-z; GRIMMETT GR, 1993, PROBAB THEORY REL, V96, P33, DOI 10.1007/BF01195881; Mathieu P, 2007, P R SOC A, V463, P2287, DOI 10.1098/rspa.2007.1876; Benjamini I, 2003, PROBAB THEORY REL, V125, P408, DOI 10.1007/s00440-002-0246-y; Ding J, 2012, ANN MATH, V175, P1409, DOI 10.4007/annals.2012.175.3.8; MATTHEWS P, 1988, ANN PROBAB, V16, P189, DOI 10.1214/aop/1176991894; Chen XX, 2010, SCI CHINA MATH, V53, P1971, DOI 10.1007/s11425-010-4064-x; Mathieu P, 2004, ANN PROBAB, V32, P100; Barlow MT, 2012, ANN I H POINCARE-PR, V48, P922, DOI 10.1214/12-AIHP481; Sidoravicius V, 2004, PROBAB THEORY REL, V129, P219, DOI 10.1007/s00440-004-0336-0; Liggett TM, 1997, ANN PROBAB, V25, P71; Benjamini I, 2005, COMBINATORICA, V25, P645, DOI 10.1007/s00493-005-0040-4; Benjamini I, 1998, ANN PROBAB, V26, P1198; Boivin D, 2013, J STAT PHYS, V150, P235, DOI 10.1007/s10955-012-0685-5; Chandra AK, 1997, COMPUT COMPLEX, V6, P312; CHAYES JT, 1986, COMMUN MATH PHYS, V105, P133, DOI 10.1007/BF01212346; Chen Z.-Q., QUENCHED INVARIANCE; Couronne O, 2004, STOCH PROC APPL, V113, P81, DOI 10.1016/j.spa.2004.03.010; Doyle P. G., 1984, RANDOM WALKS ELECT N, V22; GRIMMETT G, 1984, Z WAHRSCHEINLICHKEIT, V66, P335, DOI 10.1007/BF00533701; Haggstrom O, 1998, ANN PROBAB, V26, P1212; Hoffman C, 2000, RANDOM STRUCT ALGOR, V16, P143, DOI 10.1002/(SICI)1098-2418(200003)16:2<143::AID-RSA2>3.0.CO;2-U; Hoffman C, 2001, POTENTIAL ANAL, V14, P375, DOI 10.1023/A:1011216004099; Kesten H., 1982, PROBABILITY STAT; Kozma G., COMMUNICATION; Kumagai T., 2014, LECT NOTES MATH, V2101; Levin D., 1999, P CORTONA WORKSH RAN, P264; LEVIN D. A., 2009, MARKOV CHAINS MIXING; Lyons R., PROBABILITY TR UNPUB; Pete G, 2008, ELECTRON COMMUN PROB, V13, P377; Pisztora A, 1996, PROBAB THEORY REL, V104, P427	35	0	0	INST MATHEMATICAL STATISTICS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	0246-0203			ANN I H POINCARE-PR	Ann. Inst. Henri Poincare-Probab. Stat.	AUG	2015	51	3					935	946		10.1214/14-AIHP604		12	Statistics & Probability	Mathematics	CN0IQ	WOS:000358097700007		
J	Walts, AE; Hiroshima, K; Marchevsky, AM				Walts, Ann E.; Hiroshima, Kenzo; Marchevsky, Alberto M.			Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Desmoglein 3; p40; Thymoma; Thymic carcinoma; Squamous carcinoma	SQUAMOUS-CELL CARCINOMA; HUMAN LUNG-CANCER; PARANEOPLASTIC PEMPHIGUS; EXPRESSION; THYMOMA; ADENOCARCINOMA; CLASSIFICATION; P63; AUTOANTIGEN; ANTIBODIES	The potential usefulness of the squamous markers p40 and desmoglein 3 (DSG-3) for the diagnosis and staging of selected thymic lesions is uncertain. We investigated their expression and distribution pattern in 66 thymomas, 12 thymic squamous carcinomas, 6 undifferentiated thymic carcinomas, 5 hyperplastic thymi, and 5 normal thymi. p40 nuclear and DSG-3 cytoplasmic/membranous immunoreactivity in greater than or equal to 10% of thymic epithelial cells was interpreted as positive, and DSG-3 distribution pattern was classified as organotypic and nonorganotypic. All nonneoplastic thymic tissues, 100% of thymic squamous carcinomas, 97% of thymomas, and 50% of undifferentiated thymic carcinomas were positive for p40. Expression of p40 in almost all thymomas and in 50% of undifferentiated carcinomas that lacked squamous features suggests that p40 is not a good marker for the diagnosis of thymic squamous carcinoma. All normal and hyperplastic thymi, 51.5% of thymomas, and 0% of thymic squamous carcinomas expressed DSG-3 in an organotypic pattern, and 13.6% of thymomas and 83% of thymic squamous carcinomas were DSG-3 positive in a nonorganotypic pattern. Findings suggest that nonorganotypic DSG-3 expression favors the diagnosis of squamous cell carcinoma over thymoma. In 26 (60.5%) of the 43 cases where neoplastic and nonneoplastic thymus were present on the same slide, the presence/absence or distribution pattern of DSG-3 immunoreactivity was different in the 2 components, suggesting that this marker can be helpful in staging thymomas with incomplete encapsulation. The presence of DSG-3-positive and DSG-3-negative thymomas raises the possibility that these tumors may originate from 2 different types of thymic epithelial cells. (C) 2015 Elsevier Inc. All rights reserved.	[Walts, Ann E.; Marchevsky, Alberto M.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Hiroshima, Kenzo] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Yachiyo, Japan	Walts, AE (reprint author), Cedars Sinai Med Ctr, Dept Pathol & Lab Med, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	walts@cshs.org; hiroshima.kenzo@twmu.ac.jp; alberto.marchevsky@cshs.org					Agackiran Y, 2012, APPL IMMUNOHISTO M M, V20, P350, DOI 10.1097/PAI.0b013e318245c730; BEUTNER EH, 1964, P SOC EXP BIOL MED, V117, P505; Cui T, 2012, J CLIN PATHOL, V65, P1100, DOI 10.1136/jclinpath-2011-200630; Nobre AR, 2013, ACTA CYTOL, V57, P1, DOI 10.1159/000345245; Savci-Heijink CD, 2009, AM J PATHOL, V174, P1629, DOI 10.2353/ajpath.2009.080778; Suster S, 2005, SEMIN DIAGN PATHOL, V22, P188, DOI 10.1053/j.semdp.2006.02.004; Gomez-Morales M, 2013, HISTOPATHOLOGY, V63, P103, DOI 10.1111/his.12126; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1710, DOI 10.1097/JTO.0b013e31821e8cff; Brown L, 2014, ONCOGENE, V33, P2363, DOI 10.1038/onc.2013.186; Weiss D, 2015, ACTA DERM-VENEREOL, V95, P559, DOI 10.2340/00015555-2023; Wada N, 2011, J INVEST DERMATOL, V131, P410, DOI 10.1038/jid.2010.330; Brown AF, 2013, ARCH PATHOL LAB MED, V137, P1274, DOI 10.5858/arpa.2012-0635-OA; Wang J, 2005, BRIT J DERMATOL, V153, P558, DOI 10.1111/j.1365-2133.2005.06599.x; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Dotto J, 2007, AM J CLIN PATHOL, V127, P415, DOI 10.1309/2GAYKPDDM85P2VEW; Barbetakis N, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-83; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Hayashi Atsushi, 2013, J Clin Exp Hematop, V53, P9; Marchevsky AM, 2014, PATHOLOGY OF THE MEDIASTINUM, P1; Memar OM, 1996, J INVEST DERMATOL, V106, P261, DOI 10.1111/1523-1747.ep12340663; Mouquet H, 2008, TISSUE ANTIGENS, V71, P464, DOI [10.1111/j.1399-0039.2008.01020.x, 10.1111/d.1399-0039.2008.01020.x]; Muller-Hermelink HK, 2004, WHO CLASSIFICATION T, P146; Roden AC, 2013, EUR J CARDIO-THORAC, V43, P1131, DOI 10.1093/ejcts/ezs529; Saaber F, 2015, PATHOL RES PRACT, V211, P208, DOI 10.1016/j.prp.2014.10.008; SUDA T, 1990, J IMMUNOL, V144, P1783; Tacha D, 2014, ARCH PATHOL LAB MED, V138, P1358, DOI 10.5858/arpa.2013-0342-OA; Tacha D, 2012, APPL IMMUNOHISTO M M, V20, P201, DOI 10.1097/PAI.0b013e31823d7f0e; Takeshita K, 2000, INTERNAL MED, V39, P742, DOI 10.2169/internalmedicine.39.742; Tatsumori T, 2014, APPL IMMUNOHISTO M M, V22, P377, DOI 10.1097/PAI.0b013e3182980544; Yoshida M, 2013, SURG TODAY, V43, P806, DOI 10.1007/s00595-012-0272-z	30	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	AUG	2015	19	4					216	220		10.1016/j.anndiagpath.2015.04.006		5	Pathology	Pathology	CM9KO	WOS:000358027500006		
J	Peckova, K; Martinek, P; Ohe, C; Kuroda, N; Bulimbasic, S; Mundo, EC; Montiel, DP; Lopez, JI; Daum, O; Rotterova, P; Kokoskova, B; Dubova, M; Pivovarcikova, K; Bauleth, K; Grossmann, P; Hora, M; Kalusova, K; Davidson, W; Slouka, D; Miroslav, S; Buzrla, P; Hynek, M; Michal, M; Hes, O				Peckova, Kvetoslava; Martinek, Petr; Ohe, Chisato; Kuroda, Naoto; Bulimbasic, Stela; Condom Mundo, Enric; Perez Montiel, Delia; Lopez, Jose I.; Daum, Ondrej; Rotterova, Pavia; Kokoskova, Bohuslava; Dubova, Magdalena; Pivovarcikova, Kristyna; Bauleth, Kevin; Grossmann, Petr; Hora, Milan; Kalusova, Kristyna; Davidson, Whitney; Slouka, David; Miroslav, Sulc; Buzrla, Petr; Hynek, Mirka; Michal, Michal; Hes, Ondrej			Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Kidney; Chromophobe renal cell carcinoma; Neuroendocrine differentiation; Immunohistochemisty; Chromosomal numerical aberrations; aCGH	DIAGNOSTIC PITFALL; DIFFERENTIATION; TUMORS; OSTEOSARCOMA; CHROMOSOMES; ARRANGEMENT; ONCOCYTOMA; METAPLASIA; LOSSES; SYSTEM	Chromophobe renal cell carcinoma (CRCC) with neuroendocrine differentiation (CRCCND) has only recently been described. Eighteen cases of CRCC with morphologic features suggestive of neuroendocrine differentiation were selected from among 624 CRCCs in our registry. The tissues were fixed in neutral formalin, embedded in paraffin, cut into 4- to 5-mu m-thick sections, and stained with hematoxylin and eosin. As CRCC with neuroendocrine features, tumors with following morphology were suggested: (1) trabecular/palisading/ribbon-like, gyriform, insular, glandular, and solid pattern; (2) uniform polygonal cells formed in small islets; and (3) cribriform pattern in combination with palisading. Selected cases were further analyzed using immunohistochemistry, electron microscopy, array comparative genomic hybridization, and fluorescence in situ hybridization. Cases were classified as CRCCND or CRCC with neuroendocrine-like features (CRCCND-L) based on the immunohistochemical expression of neuroendocrine markers: CRCCND, 4 cases, age range 49 to 79 years, size ranged from 2.2 to 22 cm, and CRCCND-L, 14 cases, age range 34 to 74 years, size range 3.8 to 16.5 cm. Follow-up information was available for 11 of 18 patients aged 0.5 to 12 years. Two of 4 CRCCNDs showed aggressive clinical course with metastatic spreading. Chromophobe renal cell carcinomas with neuroendocrine differentiation were focally positive for CD56 (4/4), synaptophysin (4/4), chromogranin A (1/4), and neuron-specific enolase (3/4). All 14 CRCCND-Ls were mostly negative or very weakly focally positive for some of the aforementioned markers. All 18 tumors were positive for cytokeratin 7 and CD117. Ultrastructural analysis showed poorly preserved neuroendocrine granules only in 2 of 4 analyzed CRCCNDs. Losses of chromosomes 1, 2, 6, and 10 were found in all analyzable CRCCNDs, whereas multiple losses (chromosomes 1, 2, 6, 10, 13, 17, and 21) and gains (chromosomes 4, 11, 12, 14, 15, 16, 19, and 20) were found in CRCCND-L. (c) 2015 Elsevier Inc. All rights reserved.	[Peckova, Kvetoslava; Martinek, Petr; Daum, Ondrej; Rotterova, Pavia; Kokoskova, Bohuslava; Dubova, Magdalena; Pivovarcikova, Kristyna; Bauleth, Kevin; Grossmann, Petr; Michal, Michal; Hes, Ondrej] Charles Univ Prague, Fac Med, Dept Pathol, Plzen 30460, Czech Republic; [Peckova, Kvetoslava; Martinek, Petr; Daum, Ondrej; Rotterova, Pavia; Kokoskova, Bohuslava; Dubova, Magdalena; Pivovarcikova, Kristyna; Bauleth, Kevin; Grossmann, Petr; Hora, Milan; Kalusova, Kristyna; Slouka, David; Hynek, Mirka; Michal, Michal; Hes, Ondrej] Charles Univ Hosp Plzen, Plzen, Czech Republic; [Ohe, Chisato] Kansai Med Univ, Hirakata Hosp, Dept Diagnost Pathol, Osaka, Japan; [Kuroda, Naoto] Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan; [Bulimbasic, Stela] Univ Hosp Dubrava, Dept Pathol, Zagreb, Croatia; [Condom Mundo, Enric] Bellvitge Univ Hosp, Dept Pathol, Barcelona, Spain; [Perez Montiel, Delia] Inst Natl Cancerol, Dept Pathol, Mexico City, DF, Mexico; [Lopez, Jose I.] Cruces Univ Hosp, Dept Pathol, Baracaldo, Spain; [Hora, Milan; Kalusova, Kristyna] Charles Univ Prague, Fac Med, Dept Urol, Plzen 30460, Czech Republic; [Davidson, Whitney] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Slouka, David] Charles Univ Prague, Fac Med, Dept Otorhinolaryngol, Plzen 30460, Czech Republic; [Miroslav, Sulc] Biopt Lab Chomutov, Chomutov, Czech Republic; [Buzrla, Petr] Univ Hosp Ostrava, Dept Pathol, Ostrava, Czech Republic; [Hynek, Mirka] Fac Med, Dept Radiol, Plzen, Czech Republic; [Hes, Ondrej] Charles Univ Prague, Fac Med, Biomed Ctr, Plzen 30460, Czech Republic	Hes, O (reprint author), Charles Univ Prague, Fac Med, Dept Pathol, Alej Svobody 80, Plzen 30460, Czech Republic.	hes@medima.cz			Charles University Research Fund [P36]; European Regional Development Fund [CZ.1.05/2.1.00/03.0076]	The study was supported by the Charles University Research Fund (project no. P36) and by the project CZ.1.05/2.1.00/03.0076 from European Regional Development Fund.	Anila KR, 2012, INT J SURG PATHOL, V20, P416, DOI 10.1177/1066896911429298; Sperga M, 2013, VIRCHOWS ARCH, V463, P563, DOI 10.1007/s00428-013-1457-6; Brunelli M, 2005, MODERN PATHOL, V18, P161, DOI 10.1038/modpathol.3800286; Kuroda N, 2013, MED MOL MORPHOL, V46, P49, DOI 10.1007/s00795-012-0007-7; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; THOENES W, 1988, J PATHOL, V155, P277, DOI 10.1002/path.1711550402; Vieira J, 2010, GENE CHROMOSOME CANC, V49, P935, DOI 10.1002/gcc.20805; Akhtar M, 1997, AM J SURG PATHOL, V21, P1188, DOI 10.1097/00000478-199710000-00009; Caplin ME, 2015, ANN ONCOL, V2; Dittus CFC, 2004, J COMMUNITY SUPPORT, V12, P71; Dundr P, 2007, PATHOL RES PRACT, V203, P593, DOI 10.1016/j.prp.2007.05.005; Eble JN, 2004, WHO CLASSIFICATION; Gunawan B, 1999, CANCER GENET CYTOGEN, V110, P57, DOI 10.1016/S0165-4608(98)00185-X; Hes O, 2005, VIRCHOWS ARCH, V446, P383, DOI 10.1007/s00428-004-1187-x; Husain A, 2014, ANAL QUANT CYTOL, V36, P235; Itoh T, 2002, AM J SURG PATHOL, V26, P1358, DOI 10.1097/01.PAS.0000029062.55439.A7; Kuroda N, 2005, HISTOPATHOLOGY, V46, P712, DOI 10.1111/j.1365-2559.2005.02032.x; Kuroda N, 2011, PATHOL INT, V61, P552, DOI 10.1111/j.1440-1827.2011.02689.x; Kuroda N, 2013, HISTOL HISTOPATHOL, V28, P15; La Rosa S, 2014, ENDOCR PATHOL, V25, P193, DOI 10.1007/s12022-014-9316-9; Magro G, 2005, VIRCHOWS ARCH, V447, P894, DOI 10.1007/s00428-005-0026-z; Michal M, 1998, Ann Diagn Pathol, V2, P149, DOI 10.1016/S1092-9134(98)80001-4; Ohe C, 2014, HUM PATHOL CASE REP, V1, P31; Parada DD, 2008, APMIS, V116, P859, DOI 10.1111/j.1600-0463.2008.01004.x; Petersson F, 2010, INT J CLIN EXP PATHO, V3, P534; Quiroga-Garza G, 2009, ARCH PATHOL LAB MED, V133, P1857, DOI 10.1043/1543-2165-133.11.1857; Tan MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-196	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	AUG	2015	19	4					261	268		10.1016/j.anndiagpath.2015.05.001		8	Pathology	Pathology	CM9KO	WOS:000358027500014		
J	Saito, C; Ishikawa, K; Nakamura, K; Fujita, A; Shimizu, M; Fukushima, N; Nishino, H; Ichimura, K				Saito, Chizu; Ishikawa, Kotaro; Nakamura, Ken-ichi; Fujita, Akifumi; Shimizu, Michio; Fukushima, Noriyoshi; Nishino, Hiroshi; Ichimura, Keiichi			A Melanocytic Lesion Extending From the Right Ear to the Nasopharynx in a Pediatric Patient: A Case Report	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						blue nevus; malignant melanoma; middle ear; inner ear; pharynx; melanocyte	MUCOSAL MALIGNANT-MELANOMA; MIDDLE-EAR; UPDATE	Background: Blue nevus is a benign dermal melanocyte tumor that mainly arises from the skin. We report an extremely rare case of blue nevus in a pediatric patient with extensive progression from the middle ear and inner ear to the nasopharynx through the Eustachian tube. Case Report: A 2-year-old girl with blue tympanum was referred to our department. Computed tomography scans and magnetic resonance imaging were performed, followed by a tissue biopsy and histopathologic evaluations. Radiologic examinations revealed that the lesion had progressed beyond the middle ear into the inner ear and the nasopharynx through the Eustachian tube. Subsequent histopathologic examinations indicated dermal dendritic melanocytic proliferations, but no evidence of malignancy. Based on the clinical and histopathologic findings, we concluded that the lesion was consistent with blue nevus. Discussion: Blue nevus is a relatively common skin lesion. However, no prior reports have described the extension of blue nevus from the auditory organ to the nasopharynx in a pediatric patient. Despite the benign nature of the lesion, the patient experienced profound hearing loss in the affected ear, which necessitates continued monitoring as the lesion may expand with patient growth.	[Saito, Chizu; Ishikawa, Kotaro; Nakamura, Ken-ichi; Nishino, Hiroshi; Ichimura, Keiichi] Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shimotsuke, Tochigi, Japan; [Ishikawa, Kotaro] Natl Rehabil Ctr Persons Disabil, Dept Otolaryngol, Tokorozawa, Saitama 3598555, Japan; [Fujita, Akifumi] Jichi Med Univ, Sch Med, Dept Radiol, Shimotsuke, Tochigi, Japan; [Shimizu, Michio] Saitama Med Univ, Int Med Ctr, Dept Pathol, Saitama, Japan; [Fukushima, Noriyoshi] Jichi Med Univ Hosp, Dept Diagnost Pathol, Shimotsuke, Tochigi, Japan; [Ichimura, Keiichi] Ishibashi Gen Hosp, Dept Otolaryngol, Shimotsuke, Tochigi, Japan	Ishikawa, K (reprint author), Natl Rehabil Ctr Persons Disabil, Dept Med Treatment 2, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	ishikawa-kotaro@rehab.go.jp					Zembowicz A, 2004, AM J SURG PATHOL, V28, P31, DOI 10.1097/00000478-200401000-00002; Zembowicz A, 2004, HISTOPATHOLOGY, V45, P433, DOI 10.1111/j.1365-2559.2004.01975.x; Murali R, 2009, ADV ANAT PATHOL, V16, P365, DOI 10.1097/PAP.0b013e3181bb6b53; Patel SG, 2002, HEAD NECK-J SCI SPEC, V24, P247, DOI 10.1002/hed.10019; Ishihara K, 2008, INT J CLIN ONCOL, V13, P33, DOI 10.1007/s10147-007-0751-1; BABIN RW, 1976, ANN OTO RHINOL LARYN, V85, P387; Curry JM, 2007, OTOLARYNG HEAD NECK, V136, P856, DOI 10.1016/j.otohns.2006.10.010; Halaban R., 2003, FITZPATRICKS DERMATO, P127; Kojima C, 1997, Nihon Jibiinkoka Gakkai Kaiho, V100, P655; Newton Bishop JA., 2010, ROOKS TXB DERMATOLOG, P25; Peters G, 2012, OTOL NEUROTOL, V33, P239, DOI 10.1097/MAO.0b013e3182423191; SHERMAN IW, 1991, J LARYNGOL OTOL, V105, P1061, DOI 10.1017/S0022215100118195; WATANABE M, 1987, Otolaryngology (Tokyo), V59, P659; Wen-Sen L, 2012, INDIAN J DERMATOL VE, V78, P376	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	AUG	2015	124	8					609	613		10.1177/0003489415573071		5	Otorhinolaryngology	Otorhinolaryngology	CM8NG	WOS:000357957900004		
J	Imataki, O; Kubo, H; Hamasaki, Y; Oku, M; Kida, J; Uemura, M				Imataki, Osamu; Kubo, Hiroyuki; Hamasaki, Yukiko; Oku, Maki; Kida, Jun-ichiro; Uemura, Makiko			Anti-CD30 Antibody-Induced Radiation Recall Reaction: A Collateral Target for Activated Lymphocytes	ANNALS OF PHARMACOTHERAPY			English	Letter									[Imataki, Osamu; Kubo, Hiroyuki; Hamasaki, Yukiko; Oku, Maki; Kida, Jun-ichiro; Uemura, Makiko] Kagawa Univ, Kagawa, Japan	Imataki, O (reprint author), Kagawa Univ, Kagawa, Japan.						Azria D, 2005, CANCER TREAT REV, V31, P555, DOI 10.1016/j.ctrv.2005.07.008; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1060-0280	1542-6270		ANN PHARMACOTHER	Ann. Pharmacother.	AUG	2015	49	8					947	948		10.1177/1060028015589169		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM9JD	WOS:000358023800010		
J	Kawashima, H; Itoh, A; Ohno, E; Itoh, Y; Ebata, T; Nagino, M; Goto, H; Hirooka, Y				Kawashima, Hiroki; Itoh, Akihiro; Ohno, Eizaburo; Itoh, Yuya; Ebata, Tomoki; Nagino, Masato; Goto, Hidemi; Hirooka, Yoshiki			Preoperative Endoscopic Nasobiliary Drainage in Patients With Suspected Hilar Cholangiocarcinoma; Better Than Endoscopic or Percutaneous Biliary Drainage? Reply	ANNALS OF SURGERY			English	Letter									[Kawashima, Hiroki; Itoh, Akihiro; Itoh, Yuya; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Ohno, Eizaburo; Hirooka, Yoshiki] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan; [Ebata, Tomoki; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan	Kawashima, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan.		KAWASHIMA, Hiroki/I-7285-2014				Kloek JJ, 2010, J GASTROINTEST SURG, V14, P119, DOI 10.1007/s11605-009-1009-1; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Hwang S, 2012, WORLD J SURG, V36, P379, DOI 10.1007/s00268-011-1364-4; Gerhards MF, 2000, EUR J SURG ONCOL, V26, P480, DOI 10.1053/ejso.1999.0926; Rerknimitr R, 2004, J CLIN GASTROENTEROL, V38, P518, DOI 10.1097/01.mcg.0000123204.36471.be; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Takahashi Y, 2010, BRIT J SURG, V97, P1860, DOI 10.1002/bjs.7228; ten Hoopen-Neumann H, 1999, DIGEST SURG, V16, P209	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	AUG	2015	262	2					e55	U17				4	Surgery	Surgery	CM8KJ	WOS:000357949100016		
J	Baer, AN; DeMarco, MM; Shiboski, SC; Lam, MY; Challacombe, S; Daniels, TE; Dong, Y; Greenspan, JS; Kirkham, BW; Lanfranchi, HE; Schiodt, M; Srinivasan, M; Umehara, H; Vivino, FB; Vollenweider, CF; Zhao, Y; Criswell, LA; Shiboski, CH				Baer, Alan N.; DeMarco, Mara McAdams; Shiboski, Stephen C.; Lam, Mi Y.; Challacombe, Stephen; Daniels, Troy E.; Dong, Yi; Greenspan, John S.; Kirkham, Bruce W.; Lanfranchi, Hector E.; Schiodt, Morten; Srinivasan, Muthiah; Umehara, Hisanori; Vivino, Frederick B.; Vollenweider, Cristina F.; Zhao, Yan; Criswell, Lindsey A.; Shiboski, Caroline H.		Sjogren's Int Collaborative	The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome	ANNALS OF THE RHEUMATIC DISEASES			English	Article							CLASSIFICATION CRITERIA; SYNDROME REGISTRY; AUTOANTIBODIES; RO60; AUTOANTIGENS; RECOGNITION; POPULATION; FRAGMENTS; LA/SSB	Objective To determine whether the Sjogren's syndrome B (SSB)-positive/Sjogren's syndrome A (SSA)-negative antibody profile is associated with key phenotypic features of SS. Methods Among registrants in the Sjogren's International Collaborative Clinical Alliance (SICCA) with possible or established SS, we compared anti-SSA/anti-SSB reactivity profiles against concurrent phenotypic features. We fitted logistic regression models to explore the association between anti-SSA/anti-SSB reactivity profile and each key SS phenotypic feature, controlling for potential confounders. Results Among 3297 participants, 2061 (63%) had negative anti-SSA/anti-SSB, 1162 (35%) had anti-SSA with or without anti-SSB, and 74 (2%) anti-SSB alone. Key SS phenotypic features were more prevalent and had measures indicative of greater disease activity in those participants with anti-SSA, either alone or with anti-SSB, than in those with anti-SSB alone or negative SSA/SSB serology. These between-group differences were highly significant and not explained by confounding by age, race/ethnicity or gender. Participants with anti-SSB alone were comparable to those with negative SSA/SSB serology in their association with these key phenotypic features. Among SICCA participants classified with SS on the basis of the American-European Consensus Group or American College of Rheumatology criteria, only 2% required the anti-SSB-alone test result to meet these criteria. Conclusions The presence of anti-SSB, without anti-SSA antibodies, had no significant association with SS phenotypic features, relative to seronegative participants. The solitary presence of anti-SSB antibodies does not provide any more support than negative serology for the diagnosis of SS. This serological profile should thus be interpreted cautiously in clinical practice and potentially eliminated from future classification criteria.	[Baer, Alan N.; DeMarco, Mara McAdams] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA; [Shiboski, Stephen C.; Lam, Mi Y.; Daniels, Troy E.; Greenspan, John S.; Criswell, Lindsey A.; Shiboski, Caroline H.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Challacombe, Stephen; Kirkham, Bruce W.] Kings Coll London, London WC2R 2LS, England; [Dong, Yi; Zhao, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lanfranchi, Hector E.; Vollenweider, Cristina F.] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Lanfranchi, Hector E.; Vollenweider, Cristina F.] German Hosp, Buenos Aires, DF, Argentina; [Schiodt, Morten] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Srinivasan, Muthiah] Aravind Eye Care Syst, Madurai, Tamil Nadu, India; [Umehara, Hisanori] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan; [Vivino, Frederick B.] Penn Presbyterian Med Ctr, Philadelphia, PA USA; [Vivino, Frederick B.] Univ Penn, Philadelphia, PA 19104 USA	Baer, AN (reprint author), Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21224 USA.	alanbaer@jhmi.edu	Hamann, Steffen/E-2090-2013	Hamann, Steffen/0000-0003-4318-2716	NIH/NIDCR [NO1-DE-32636]; Jerome L. Greene Foundation; Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center	This work was supported by a contract from the NIH/NIDCR NO1-DE-32636, the Jerome L. Greene Foundation and the Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center.	Nagaraju K, 2001, ARTHRITIS RHEUM, V44, P2376, DOI 10.1002/1529-0131(200110)44:10<2376::AID-ART402>3.0.CO;2-E; Daniels TE, 2009, ARTHRIT RHEUM-ARTHR, V61, P711, DOI 10.1002/art.24397; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6af; Kurien BT, 2012, CLIN EXP RHEUMATOL, V30, P886; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Garberg H, 2005, SCAND J RHEUMATOL, V34, P49, DOI 10.1080/03009740510017940; Malladi AS, 2012, ARTHRIT CARE RES, V64, P911, DOI 10.1002/acr.21610; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Bournia VK, 2012, J AUTOIMMUN, V39, P15, DOI 10.1016/j.jaut.2012.03.001; Fauchais AL, 2010, AUTOIMMUN REV, V9, P595, DOI 10.1016/j.autrev.2010.05.004; Danda D, 2014, ARTHRITIS RHEUMATOL, V66, pS1111; Desplat-Jego S, 2007, ANN NY ACAD SCI, V1109, P245, DOI 10.1196/annals.1398.030; GAITHER KK, 1987, J CLIN INVEST, V79, P841, DOI 10.1172/JCI112892; Gerli R, 1997, BRIT J RHEUMATOL, V36, P969; Hanly JG, 2010, J IMMUNOL METHODS, V352, P147, DOI 10.1016/j.jim.2009.10.003; HORSFALL AC, 1992, J AUTOIMMUN, V5, P479, DOI 10.1016/0896-8411(92)90007-D; Infantino M, 2013, CLIN DEV IMMUNOL, V2013; Metskula K, 2006, IMMUNOL LETT, V106, P14, DOI 10.1016/j.imlet.2006.03.005; Peene I, 2002, ANN RHEUM DIS, V61, P1090, DOI 10.1136/ard.61.12.1090; Schachna L, 2002, ARTHRITIS RHEUM, V46, P1873, DOI 10.1002/art.10407; Touloupi E, 2005, CLIN EXP IMMUNOL, V142, P172, DOI 10.1111/j.1365-2249.2005.02892.x; Wahren M, 1996, J AUTOIMMUN, V9, P537, DOI 10.1006/jaut.1996.0072	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	AUG	2015	74	8					1557	1561		10.1136/annrheumdis-2014-206683		5	Rheumatology	Rheumatology	CM4VQ	WOS:000357683600024		
J	Yamamoto, M; Awakawa, T; Takahashi, H				Yamamoto, Motohisa; Awakawa, Teruhito; Takahashi, Hiroki			Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years	ANNALS OF THE RHEUMATIC DISEASES			English	Letter									[Yamamoto, Motohisa; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Div Rheumatol & Clin Immunol, Sapporo, Hokkaido 0608543, Japan; [Awakawa, Teruhito] Sapporo Dohkohkai Hosp, Dept Internal Med & Gastroenterol, Sapporo, Hokkaido, Japan	Yamamoto, M (reprint author), Sapporo Med Univ, Sch Med, Div Rheumatol & Clin Immunol, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan.	mocha@cocoa.plala.or.jp					Carruthers MN, 2015, ANN RHEUM DIS, V74, P1171, DOI 10.1136/annrheumdis-2014-206605; Yamamoto M, 2014, NAT REV RHEUMATOL, V10, P148, DOI 10.1038/nrrheum.2013.183; Umehara H, 2011, MOD RHEUMATOL, V2012, P21, DOI DOI 10.1007/S10165-011-0571-Z; Yamamoto M, 2015, MOD RHEUMATOL, V25, P199, DOI 10.3109/14397595.2014.950036	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	AUG	2015	74	8					E46	U23		10.1136/annrheumdis-2015-207640		2	Rheumatology	Rheumatology	CM4VQ	WOS:000357683600009		
J	Liu, JZ; Liu, B; Guo, GZ; Jing, YK; Zhao, GS				Liu, Jianzhen; Liu, Bo; Guo, Guangzhu; Jing, Yongkui; Zhao, Guisen			Discovery of novel androgen receptor antagonists: a hybrid approach of pharmacophore-based and docking-based virtual screening	ANTI-CANCER DRUGS			English	Article						androgen receptor; antagonist; prostate cancer; virtual screening	RESISTANT PROSTATE-CANCER; TUMOR LNCAP CELLS; ANTIANDROGEN; LIGANDS; GALAHAD; BINDING; DESIGN	Androgen receptor (AR) is an attractive target for the treatment of prostate cancer. An integrated pharmacophore-based and docking-based virtual screening approach was applied to identify novel AR antagonists with a distinct scaffold. The candidate compounds were evaluated for their abilities to inhibit prostate cancer cell proliferation and AR target gene prostate-specific antigen gene expression as well as the binding affinity to AR. A potent lead compound, T3, was discovered with the ability to inhibit prostate-specific antigen expression, with a similar binding affinity to AR, and with antiproliferative effects on AR-positive prostate cancer cells similar to that of MDV3100.	[Liu, Jianzhen; Liu, Bo; Guo, Guangzhu; Zhao, Guisen] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China; Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Jing, Yongkui] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Zhao, GS (reprint author), Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China.	guisenzhao@sdu.edu.cn			National Natural Science Foundation of China [21272140]	This work was supported by the National Natural Science Foundation of China (No. 21272140). We really appreciate the convenience afforded by the Institute of Immunopharmacology and Immunotherapy in the School of Pharmaceutical Sciences at Shandong University for biological evaluation.	Ishioka T, 2003, BIOORG MED CHEM LETT, V13, P2655, DOI 10.1016/S0960-894X(03)00575-4; Yin DH, 2003, MOL PHARMACOL, V63, P211, DOI 10.1124/mol.63.1.211; Salvati ME, 2005, BIOORG MED CHEM LETT, V15, P271, DOI 10.1016/j.bmcl.2004.10.085; Hu LY, 2007, BIOORG MED CHEM LETT, V17, P5693, DOI 10.1016/j.bmcl.2007.07.059; Jung ME, 2010, J MED CHEM, V53, P2779, DOI 10.1021/jm901488g; Bohl CE, 2008, BIOORG MED CHEM LETT, V18, P5567, DOI 10.1016/j.bmcl.2008.09.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richmond NJ, 2006, J COMPUT AID MOL DES, V20, P567, DOI 10.1007/s10822-006-9082-y; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Shen HC, 2009, CANCER CELL, V15, P461, DOI 10.1016/j.ccr.2009.05.005; Bohl CE, 2004, J MED CHEM, V47, P3765, DOI 10.1021/jm0499007; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Joseph James D, 2013, Cancer Discov, V3, P1020, DOI 10.1158/2159-8290.CD-13-0226; Kim W, 2012, CURR TREAT OPTION ON, V13, P189, DOI 10.1007/s11864-012-0188-2; Kinoyama I, 2005, CHEM PHARM BULL, V53, P402, DOI 10.1248/cpb.53.402; Shen HC, 2012, MOL ENDOCRINOL, V26, P1836, DOI 10.1210/me.2012-1222; Shepphird JK, 2006, J COMPUT AID MOL DES, V20, P763, DOI 10.1007/s10822-006-9070-2; Soderholm AA, 2008, J CHEM INF MODEL, V48, P1882, DOI 10.1021/ci800149w; Wakabayashi KI, 2008, BIOORGAN MED CHEM, V16, P6799, DOI 10.1016/j.bmc.2008.05.063; Zhou JM, 2009, J MED CHEM, V52, P5546, DOI 10.1021/jm801218k	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4973	1473-5741		ANTI-CANCER DRUG	Anti-Cancer Drugs	AUG	2015	26	7					747	753		10.1097/CAD.0000000000000245		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CL9SP	WOS:000357318700007		
J	Sakaguchi, M; Shimodaira, S; Ishida, S; Amemiya, M; Honda, S; Sugahara, Y; Oyama, F; Kawakita, M				Sakaguchi, Masayoshi; Shimodaira, Satoru; Ishida, Shin-nosuke; Amemiya, Miko; Honda, Shotaro; Sugahara, Yasusato; Oyama, Fumitaka; Kawakita, Masao			Identification of GH15 Family Thermophilic Archaeal Trehalases That Function within a Narrow Acidic-pH Range	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							STRUCTURE-GUIDED CONSENSUS; ESCHERICHIA-COLI; THERMOPLASMA-VOLCANIUM; TREHALOSE METABOLISM; ASPERGILLUS-AWAMORI; HIGH OSMOLARITY; GLUCOAMYLASE; PURIFICATION; ENZYME; MUTAGENESIS	Two glucoamylase-like genes, TVN1315 and Ta0286, from the archaea Thermoplasma volcanium and T. acidophilum, respectively, were expressed in Escherichia coli. The gene products, TVN1315 and Ta0286, were identified as archaeal trehalases. These trehalases belong to the CAZy database family GH15, although they have putative (alpha/alpha)(6) barrel catalytic domain structures similar to those of GH37 and GH65 family trehalases from other organisms. These newly identified trehalases function within a narrow range of acidic pH values (pH 3.2 to 4.0) and at high temperatures (50 to 60 degrees C), and these enzymes display Km values for trehalose higher than those observed for typical trehalases. These enzymes were inhibited by validamycin A; however, the inhibition constants (K-i) were higher than those of other trehalases. Three TVN1315 mutants, corresponding to E408Q, E571Q, and E408Q/E571Q mutations, showed reduced activity, suggesting that these two glutamic acid residues are involved in trehalase catalysis in a manner similar to that of glucoamylase. To date, TVN1315 and Ta0286 are the first archaeal trehalases to be identified, and this is the first report of the heterologous expression of GH15 family trehalases. The identification of these trehalases could extend our understanding of the relationships between the structure and function of GH15 family enzymes as well as glycoside hydrolase family enzymes; additionally, these enzymes provide insight into archaeal trehalose metabolism.	[Sakaguchi, Masayoshi; Shimodaira, Satoru; Ishida, Shin-nosuke; Amemiya, Miko; Honda, Shotaro; Sugahara, Yasusato; Oyama, Fumitaka; Kawakita, Masao] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo, Japan; [Kawakita, Masao] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 113, Japan	Sakaguchi, M (reprint author), Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo, Japan.	bt11532@ns.kogakuin.ac.jp			Strategic Research Foundation Grant-aided Project for Private Universities of the Ministry of Education, Culture, Sport, Science and Technology, Japan (MEXT) [S1411005]	This study was supported in part by a grant from the Strategic Research Foundation Grant-aided Project for Private Universities of the Ministry of Education, Culture, Sport, Science and Technology, Japan (MEXT) (S1411005).	Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; MITTENBUHLER K, 1988, J BIOL CHEM, V263, P8537; FRANDSEN TP, 1994, BIOCHEMISTRY-US, V33, P13808, DOI 10.1021/bi00250a035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MULLER J, 1992, J PLANT PHYSIOL, V140, P8; Ruepp A, 2000, NATURE, V407, P508; Li H, 2012, J BIOSCI BIOENG, V113, P224, DOI 10.1016/j.jbiosc.2011.09.018; Kouril T, 2008, ARCH MICROBIOL, V190, P355, DOI 10.1007/s00203-008-0377-3; Qu QH, 2004, J BIOL CHEM, V279, P47890, DOI 10.1074/jbc.M404955200; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Vazquez-Figueroa E, 2008, PROTEIN ENG DES SEL, V21, P673, DOI 10.1093/protein/gzn048; DIXON M, 1953, BIOCHEM J, V55, P170; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Martins LO, 1997, APPL ENVIRON MICROB, V63, P896; APP H, 1989, J BIOL CHEM, V264, P17583; ASANO N, 1987, J ANTIBIOT, V40, P526; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Barraza Aarón, 2013, Plant Signal Behav, V8, pe24778, DOI 10.4161/psb.24778; BOOS W, 1987, J BIOL CHEM, V262, P13212; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; DESTRUELLE M, 1995, YEAST, V11, P1015, DOI 10.1002/yea.320111103; Dror A, 2014, APPL ENVIRON MICROB, V80, P1515, DOI 10.1128/AEM.03371-13; Elbein AD, 2003, GLYCOBIOLOGY, V13, P17; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Guirao-Abad JP, 2013, INT MICROBIOL, V16, P217; HARRIS EMS, 1993, BIOCHEMISTRY-US, V32, P1618, DOI 10.1021/bi00057a028; Horlacher R, 1996, J BACTERIOL, V178, P6250; Iwasa T, 1970, Jpn J Antibiot, V23, P595; Jorge CD, 2007, EXTREMOPHILES, V11, P115, DOI 10.1007/s00792-006-0021-6; Kawashima T, 1999, P JPN ACAD B-PHYS, V75, P213, DOI 10.2183/pjab.75.213; Kawashima T, 2000, P NATL ACAD SCI USA, V97, P14257, DOI 10.1073/pnas.97.26.14257; KILLICK KA, 1983, ARCH BIOCHEM BIOPHYS, V222, P561, DOI 10.1016/0003-9861(83)90554-4; NWAKA S, 1995, J BIOL CHEM, V270, P10193, DOI 10.1074/jbc.270.17.10193; OHNISHI H, 1994, J BIOL CHEM, V269, P3503; OHNISHI H, 1992, EUR J BIOCHEM, V207, P413, DOI 10.1111/j.1432-1033.1992.tb17064.x; TOURINHODOSSANTOS CF, 1994, BRAZ J MED BIOL RES, V27, P627; RIBY J, 1985, COMP BIOCHEM PHYS B, V82, P821, DOI 10.1016/0305-0491(85)90530-9; Sakaguchi M, 2014, AMB EXPRESS, V4, DOI 10.1186/2191-0855-4-5; SALLEH HM, 1990, FEBS LETT, V262, P359, DOI 10.1016/0014-5793(90)80229-C; Sambrook J, 2012, MOLECULAR CLONING A; Sharma A, 2012, EXTREMOPHILES, V16, P1, DOI 10.1007/s00792-011-0402-3; Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200; SIERKS MR, 1990, PROTEIN ENG, V3, P193, DOI 10.1093/protein/3.3.193; TERRA WR, 1978, BIOCHIM BIOPHYS ACTA, V524, P131, DOI 10.1016/0005-2744(78)90111-0; Uhland K, 2000, J BIOL CHEM, V275, P23439, DOI 10.1074/jbc.M002793200; Zaparty M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061354	52	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	AUG	2015	81	15					4920	4931		10.1128/AEM.00956-15		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CM4QC	WOS:000357668600006		
J	Hata, A; Katayama, H; Kitajima, M; Furumai, H				Hata, Akihiko; Katayama, Hiroyuki; Kitajima, Masaaki; Furumai, Hiroaki			Wastewater Analysis Indicates that Genetically Diverse Astroviruses, Including Strains Belonging to Novel Clades MLB and VA, Are Circulating within Japanese Populations	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							MOLECULAR CHARACTERIZATION; ACUTE GASTROENTERITIS; ENTERIC VIRUSES; CHILDREN; INFECTION; NOROVIRUS; SAMPLES; PCR; EPIDEMIOLOGY; QUANTITATION	Human astroviruses (HAstVs) are a common etiological agent of infantile gastroenteritis. Recent studies revealed that novel astrovirus (AstV) strains of the MLB clade (MLB-AstVs) and VA clade (VA-AstVs), which are genetically distinct from the classic HAstVs, are circulating in the human population. In the present study, we quantified classic HAstVs as well as carried out a genetic analysis of classic and novel HAstVs in wastewater in Japan. The concentration of classic HAstVs in the influent water samples ranged from 104 to 105 copies per liter, and the amount removed by wastewater treatment was determined to be 2.4 +/- 0.3 log(10). Four types of classic HAstV strains (HAstV types 1, 2, 5, and 4/8) as well as novel AstV strains belonging to the MLB-2, VA-1, and VA-2 clades were identified using reverse transcription-PCR (RT-PCR) assays, including assays newly developed for the detection of strains of the MLB and VA clades, followed by cloning and nucleotide sequencing. Our results suggest that genetically diverse AstV strains are circulating among the human population in Japan. The newly developed (semi) nested RT-PCR assays for these novel AstV clades are useful to identify and characterize the novel AstVs in environmental waters.	[Hata, Akihiko] Kyoto Univ, Res Ctr Environm Qual Management, Shiga, Japan; [Katayama, Hiroyuki; Furumai, Hiroaki] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Tokyo, Japan; [Kitajima, Masaaki] Singapore MIT Alliance Res & Technol, Ctr Environm Sensing & Modeling, Singapore, Singapore	Hata, A (reprint author), Kyoto Univ, Res Ctr Environm Qual Management, Shiga, Japan.	hata.akihiko.33c@st.kyoto-u.ac.jp			Core Research for Evolutional Science and Technology (CREST)	This work was supported by Core Research for Evolutional Science and Technology (CREST).	Ahmed SF, 2011, EMERG INFECT DIS, V17, P2391, DOI 10.3201/eid1712.110909; Andreasi MSA, 2008, MEM I OSWALDO CRUZ, V103, P741, DOI 10.1590/S0074-02762008000700020; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Gofti-Laroche L, 2003, J CLIN VIROL, V27, P74, DOI 10.1016/S1386-6532(02)00130-0; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Victoria M, 2009, J VIROL METHODS, V156, P73, DOI 10.1016/j.jviromet.2008.11.003; Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Bertrand I, 2012, J APPL MICROBIOL, V112, P1059, DOI 10.1111/j.1365-2672.2012.05267.x; Rezaeinejad S, 2014, WATER RES, V58, P122, DOI 10.1016/j.watres.2014.03.051; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; Zhang Z, 2006, J VIROL METHODS, V134, P190, DOI 10.1016/j.jviromet.2006.01.009; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Rodriguez-Diaz J, 2009, APPL ENVIRON MICROB, V75, P387, DOI 10.1128/AEM.02045-08; El-Senousy WM, 2007, APPL ENVIRON MICROB, V73, P164, DOI 10.1128/AEM.01748-06; Clark B, 2004, CURR OPIN INFECT DIS, V17, P461, DOI 10.1097/00001432-200410000-00011; Mustafa H, 2000, J CLIN MICROBIOL, V38, P1058; De Grazia S, 2013, EPIDEMIOL INFECT, V141, P524, DOI 10.1017/S0950268812000945; Chu DKW, 2010, J GEN VIROL, V91, P2457, DOI 10.1099/vir.0.022764-0; Smits SL, 2010, J CLIN MICROBIOL, V48, P3416, DOI 10.1128/JCM.01164-10; Silva PA, 2006, ARCH VIROL, V151, P1405, DOI 10.1007/s00705-005-0704-9; Mendez-Toss M, 2000, J GEN VIROL, V81, P2891; Tran A, 2010, J CLIN MICROBIOL, V48, P1943, DOI 10.1128/JCM.02181-09; Hata A, 2013, J APPL MICROBIOL, V114, P545, DOI 10.1111/jam.12051; Aw TG, 2011, J APPL MICROBIOL, V110, P903, DOI 10.1111/j.1365-2672.2011.04947.x; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Chan-it W, 2010, JPN J INFECT DIS, V63, P302; Dai YC, 2010, ARCH VIROL, V155, P977, DOI 10.1007/s00705-010-0664-6; Dey SK, 2010, J TROP PEDIATRICS, V56, P205, DOI 10.1093/tropej/fmp082; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Gentry J, 2009, J VIROL METHODS, V156, P59, DOI 10.1016/j.jviromet.2008.11.001; Guix S, 2005, LETT APPL MICROBIOL, V41, P103, DOI 10.1111/j.1472-765X.2005.01759.x; Hata A, 2014, J VIROL METHODS, V200, P29, DOI 10.1016/j.jviromet.2014.01.023; Holtz L. R., 2011, PLOS ONE, V6, P12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitajima M., 2008, ENV ENG RES, V45, P361; Kitajima M, 2010, APPL ENVIRON MICROB, V76, P2461, DOI 10.1128/AEM.02739-09; Matsumoto T, 2013, GENOME ANNOUNC, V1; Nadan S, 2003, APPL ENVIRON MICROB, V69, P747, DOI 10.1128/AEM.69.2.747-753.2003; RISCO C, 1995, J GEN VIROL, V76, P2075, DOI 10.1099/0022-1317-76-8-2075; Scarcella C., 2009, EUROSURVEILLANCE, V23, P14; Wang YX, 2013, EMERG INFECT DIS, V19, P1333, DOI 10.3201/eid1908.121863; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Yang BY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-38; Yokoi H, 2001, Kansenshogaku Zasshi, V75, P263; Yokoi Hajime, 2009, Kansenshogaku Zasshi, V83, P120	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	AUG	2015	81	15					4932	4939		10.1128/AEM.00563-15		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CM4QC	WOS:000357668600007		
J	Yamazaki, K				Yamazaki, Kazutoshi			Contraction Options and Optimal Multiple-Stopping in Spectrally Negative Levy Models	APPLIED MATHEMATICS AND OPTIMIZATION			English	Article						Optimal multiple-stopping; Spectrally negative Levy processes; Real options	OPTIMAL CAPITAL STRUCTURE; STOCHASTIC GAME DRIVEN; ENDOGENOUS BANKRUPTCY; AMERICAN; PRINCIPLES; SMOOTH; PRICES; FIT	This paper studies the optimal multiple-stopping problem arising in the context of the timing option to withdraw from a project in stages. The profits are driven by a general spectrally negative L,vy process. This allows the model to incorporate sudden declines of the project values, generalizing greatly the classical geometric Brownian motion model. We solve the one-stage case as well as the extension to the multiple-stage case. The optimal stopping times are of threshold-type and the value function admits an expression in terms of the scale function. A series of numerical experiments are conducted to verify the optimality and to evaluate the efficiency of the algorithm.	Kansai Univ, Dept Math, Fac Engn Sci, Suita, Osaka 5648680, Japan	Yamazaki, K (reprint author), Kansai Univ, Dept Math, Fac Engn Sci, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	kyamazak@kansai-u.ac.jp			MEXT KAKENHI [22710143, 26800092]; JSPS KAKENHI [23310103]; Inamori foundation; Kansai University	The author thanks the anonymous referee for his/her thorough reviews and insightful comments that help improve the presentation of the paper. K. Yamazaki is in part supported by MEXT KAKENHI grant numbers 22710143 and 26800092, JSPS KAKENHI Grant Number 23310103, the Inamori foundation research grant, and the Kansai University subsidy for supporting young scholars 2014.	Avram F, 2004, ANN APPL PROBAB, V14, P215; Alili L, 2005, ANN APPL PROBAB, V15, P2062, DOI 10.1214/105051605000000377; DEATON A, 1992, REV ECON STUD, V59, P1, DOI 10.2307/2297923; Egami M, 2013, STOCHASTICS, V85, P111, DOI 10.1080/17442508.2011.653566; Kuznetsov A, 2012, ANN APPL PROBAB, V22, P1101, DOI 10.1214/11-AAP787; Kyprianou AE, 2007, FINANC STOCH, V11, P131, DOI 10.1007/s00780-006-0028-y; Egami M, 2013, STOCH PROC APPL, V123, P347, DOI 10.1016/j.spa.2012.09.008; Egami M, 2014, J COMPUT APPL MATH, V264, P1, DOI 10.1016/j.cam.2013.12.044; Asmussen S, 2004, STOCH PROC APPL, V109, P79, DOI 10.1016/j.spa.2003.07.005; Carmona R, 2008, MATH FINANC, V18, P239, DOI 10.1111/j.1467-9965.2007.00331.x; Mordecki E, 2002, FINANC STOCH, V6, P473, DOI 10.1007/s007800200070; Leland HE, 1996, J FINANC, V51, P987, DOI 10.2307/2329229; Carmona R, 2008, MATH OPER RES, V33, P446, DOI 10.1287/moor.1070.0301; Leung T, 2013, QUANT FINANC, V13, P137, DOI 10.1080/14697688.2012.730624; Feldmann A, 1998, PERFORM EVALUATION, V31, P245, DOI 10.1016/S0166-5316(97)00003-5; Asmussen S., 2007, J COMPUT FINANC, V11, P79; Avram F, 2007, ANN APPL PROBAB, V17, P156, DOI 10.1214/105051606000000709; Baurdoux E, 2008, ELECTRON J PROBAB, V13, P173; Baurdoux EJ, 2009, THEOR PROBAB APPL+, V53, P481, DOI 10.1137/S0040585X97983778; Bertoin J., 1997, ANN APPL PROBAB, V7, P156; Boyarchenko S., 2006, CONTRIBUTIONS THEORE, V6, P1; Boyarchenko S, 2007, STUD ECON THEORY, V27, P1, DOI 10.1007/978-3-540-73746-9; Chan T, 2011, PROBAB THEORY REL, V150, P691, DOI 10.1007/s00440-010-0289-4; Dixit A., 1996, INVESTMENT UNCERTAIN; Egami M, 2014, ADV APPL PROBAB, V46, P139; Hernandez-Hernandez D., STOCHASTIC PROCESS A; KUZNETSOV A., 2013, SPRINGER LECT NOTES, V2061, P97; Kyprianou AE, 2006, UNIVERSITEXT, P1; LELAND HE, 1994, J FINANC, V49, P1213, DOI 10.2307/2329184; Oksendal B., 2005, APPL STOCHASTIC CONT; Peskir G., 2006, LECT MATH; Protter P E, 2005, STOCHASTIC INTEGRATI; Surya BA, 2008, J APPL PROBAB, V45, P135, DOI 10.1239/jap/1208358957; Yamazaki K., 2013, ARXIV13035163; YANG SR, 1992, AM J AGR ECON, V74, P706, DOI 10.2307/1242584	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-4616	1432-0606		APPL MATH OPT	Appl. Math. Optim.	AUG	2015	72	1					147	185		10.1007/s00245-014-9274-0		39	Mathematics, Applied	Mathematics	CN1JO	WOS:000358175800006		
J	Selvaraj, S; Ohga, H; Nyuji, M; Kitano, H; Nagano, N; Yamaguchi, A; Matsuyama, M				Selvaraj, Sethu; Ohga, Hirofumi; Nyuji, Mitsuo; Kitano, Hajime; Nagano, Naoki; Yamaguchi, Akihiko; Matsuyama, Michiya			Effects of synthetic kisspeptin peptides and GnRH analogue on oocyte growth and circulating sex steroids in prepubertal female chub mackerel (Scomber japonicus)	AQUACULTURE RESEARCH			English	Article						chub mackerel; Kiss1-15; Kiss2-12; GnRHa; oocyte growth	GONADOTROPIN-RELEASING-HORMONE; METASTASIS-SUPPRESSOR GENE; COUPLED RECEPTOR GPR54; GONADAL DEVELOPMENT; OVARIAN-FOLLICLES; SCOMBROID FISH; PLASMA-CONCENTRATIONS; EXPRESSION PROFILES; MATURATION; PITUITARY	In recent years, kisspeptin peptides, encoded by kiss genes have been used to manipulate reproductive processes in farmed animals, including fish. Our previous studies demonstrated that the chub mackerel brain expresses kiss1 and kiss2 and intramuscular injection of synthetic Kiss1 pentadecapeptide (Kiss1-15) but not Kiss2 dodecapeptide (Kiss2-12) accelerates spermatogenesis in prepubertal male chub mackerel (Scomber japonicus). In the present study, we evaluated their effects in prepubertal female chub mackerel. The gonadosomatic index (GSI) values of experimental fish did not show any significant changes. Condition factor (CF) values increased significantly in Kiss1-15 treated fish, in comparison with control and GnRH analogue (GnRHa) injected fish. Histologically, only perinucleolar oocytes were found in all experimental fish. However, Kiss and GnRHa treated fish showed a significant increase in the perinucleolar oocyte diameter, in comparison with the control fish. Gene expression analyses revealed decreased expression of gnrh1 in the telencephalon-preoptic region of the brain of Kiss2-12 and GnRHa injected fish, in comparison with control fish. In contrast, GnRHa injected fish exhibited higher levels of fsh in the pituitary, with no changes in the levels of lh among different treatments. Levels of circulating sex steroids, testosterone, and estradiol-17 were significantly higher in Kiss1-15 injected fish, in comparison with control fish. These results indicate that synthetic kisspeptin peptides and GnRHa can induce oocyte growth in prepubertal female chub mackerel.	[Selvaraj, Sethu; Ohga, Hirofumi; Yamaguchi, Akihiko; Matsuyama, Michiya] Kyushu Univ, Dept Bioresource Sci, Marine Biol Lab, Fac Agr, Fukuoka 8128581, Japan; [Nyuji, Mitsuo] Natl Res Inst Aquaculture, Watarai Dist, Mie, Japan; [Kitano, Hajime; Nagano, Naoki] Kyushu Univ, Fac Agr, Fisheries Res Inst Karatsu, Dept Joint Res, Saga, Japan	Matsuyama, M (reprint author), Kyushu Univ, Dept Bioresource Sci, Marine Biol Lab, Fac Agr, Fukuoka 8128581, Japan.	rinya_m@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS [PU13010]	This research was funded by a Grant-in-Aid for Scientific research from the Japan Society for the Promotion of Science (JSPS) to MM. The first author SS is supported by the JSPS postdoctoral fellowship (PU13010). The authors declare that they have no competing interests.	Adachi H., 2013, 10 AFAF CAA4 2013 AP, P544; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Ohta K, 2008, MAR BIOL, V153, P843, DOI 10.1007/s00227-007-0856-0; Grone BP, 2010, GEN COMP ENDOCR, V169, P98, DOI 10.1016/j.ygcen.2010.07.018; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1; Chang JP, 2012, GEN COMP ENDOCR, V179, P38, DOI 10.1016/j.ygcen.2012.07.028; Mendiola D, 2008, AQUAC RES, V39, P1122, DOI 10.1111/j.1365-2109.2008.01959.x; Shiraishi T, 2008, FISHERIES SCI, V74, P764, DOI 10.1111/j.1444-2906.2008.01587.x; Beck BH, 2012, COMP BIOCHEM PHYS A, V162, P265, DOI 10.1016/j.cbpa.2012.03.019; Ohga H, 2013, GEN COMP ENDOCR, V193, P130, DOI 10.1016/j.ygcen.2013.07.016; Selvaraj S, 2012, AQUACULTURE, V356, P200, DOI 10.1016/j.aquaculture.2012.05.015; Okubo K, 2008, ACTA PHYSIOL, V193, P3, DOI 10.1111/j.1748-1716.2008.01832.x; Selvaraj S, 2013, ZOOL SCI, V30, P446, DOI 10.2108/zsj.30.446; Pasquier J, 2011, GEN COMP ENDOCR, V173, P216, DOI 10.1016/j.ygcen.2011.05.019; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Miura C, 2007, BIOL REPROD, V77, P822, DOI 10.1095/biolreprod.107.061408; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; Nyuji M, 2012, ZOOL SCI, V29, P623, DOI 10.2108/zsj.29.623; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Shiraishi T, 2005, FISHERIES SCI, V71, P531, DOI 10.1111/j.1444-2906.2005.00997.x; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Lokman PM, 1998, FISH PHYSIOL BIOCHEM, V19, P325, DOI 10.1023/A:1007719414295; Nyuji M, 2012, FISH PHYSIOL BIOCHEM, V38, P883, DOI 10.1007/s10695-011-9576-y; Selvaraj S, 2010, GEN COMP ENDOCR, V169, P28, DOI 10.1016/j.ygcen.2010.07.011; Nocillado JN, 2013, GEN COMP ENDOCR, V191, P168, DOI 10.1016/j.ygcen.2013.06.005; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Selvaraj S, 2009, ZOOL SCI, V26, P828, DOI 10.2108/zsj.26.828; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Parhar I, 2012, PROG NEUROBIOL, V98, P176, DOI 10.1016/j.pneurobio.2012.05.011; Selvaraj S, 2013, COMP BIOCHEM PHYS A, V166, P228, DOI 10.1016/j.cbpa.2013.06.007; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Lee JH, 1996, J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017; Bullough W. S., 1942, JOUR ENDOCRINOL, V3, P211, DOI 10.1677/joe.0.0030211; Caraty A, 2012, DOMEST ANIM ENDOCRIN, V43, P95, DOI 10.1016/j.domaniend.2012.03.002; Forsgren KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098772; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Higashino T, 2003, FISH PHYSIOL BIOCHEM, V28, P343, DOI 10.1023/B:FISH.0000030580.95994.77; Kadokawa H, 2008, J ENDOCRINOL, V196, P331, DOI 10.1677/JOE-07-0504; Kanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062776; LIN HR, 1991, AQUACULTURE, V96, P87, DOI 10.1016/0044-8486(91)90141-S; Matsubara M., 2005, AQUACULTURE, V243, P393; Matsuyama M, 2005, ZOOL SCI, V22, P101, DOI 10.2108/zsj.22.101; Murata S., 2005, AQUA SCI, V53, P319; Nyuji M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107292; Nyuji M, 2011, FISHERIES SCI, V77, P731, DOI 10.1007/s12562-011-0380-5; Ohga H., 2013, 10 AFAF CAA4 2013 AP, P265; Ohga H, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-71; Ohta K., 2012, J EXP ZOOL PART A, P1; Okamura H, 2013, ANIM SCI J, V84, P369, DOI 10.1111/asj.12056; Scott AP, 1999, J FISH BIOL, V55, P316, DOI 10.1006/jfbi.1999.0999; Selvaraj S, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-64; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	AUG	2015	46	8					1866	1877		10.1111/are.12342		12	Fisheries	Fisheries	CM6SM	WOS:000357820100008		
J	Mitsuyama, S; Abe, F; Kimura, M; Yoshida, M; Higuchi, T				Mitsuyama, Shinji; Abe, Fumihito; Kimura, Masaaki; Yoshida, Masami; Higuchi, Tetsuya			Association between leptin gene expression in subcutaneous adipose tissue and circulating leptin levels in obese patients with psoriasis	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						Leptin; Obesity; Psoriasis; Subcutaneous adipose tissue	DISEASE	Numerous reports have shown that psoriasis is associated with obesity and leptin. However, few reports are available on the association between serum leptin levels and leptin gene expression in SAT of psoriasis patients. To clarify this point, we examined serum leptin levels and expression levels of leptin messenger RNA (mRNA) in subcutaneous adipose tissue (SAT) of psoriasis patients. 17 psoriasis vulgaris patients and 6 non-obese control patients who underwent skin surgery were enrolled in this study. We measured serum leptin levels. SAT samples in psoriasis patients were taken from beneath the lesional psoriatic skin at the time of skin biopsy. Leptin mRNA expression in SAT was measured using quantitative real-time reverse transcription polymerase chain reaction (real-time RT-PCR) amplification. Leptin mRNA expression showed a positive correlation with serum leptin levels and BMI. We classified psoriasis patients into two groups according to BMI: the group of non-obese psoriasis patients (BMI < 25, n = 7), and the group of obese psoriasis patients (BMI a parts per thousand yen 25, n = 10). PASI score, serum leptin levels and Leptin mRNA expression in SAT were significantly higher in the obese psoriasis patients than in the non-obese psoriasis patients. Leptin mRNA expression in SAT was correlated with circulating levels of leptin, the severity of psoriasis, and obesity in psoriasis patients. Serum leptin levels and leptin mRNA expression levels in SAT of non-obese psoriasis patients were not significantly different from those of non-obese controls. The altered secretion of leptin by SAT may be related to the severity of psoriasis.	[Mitsuyama, Shinji; Abe, Fumihito; Kimura, Masaaki; Yoshida, Masami; Higuchi, Tetsuya] Toho Univ, Sch Med, Dept Dermatol, Sakura Med Ctr, Sakura, Chiba 2850841, Japan	Higuchi, T (reprint author), Toho Univ, Sch Med, Dept Dermatol, Sakura Med Ctr, 564-1 Shimoshizu, Sakura, Chiba 2850841, Japan.	higuchit@sakura.med.toho-u.ac.jp					Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Johnston A, 2008, BRIT J DERMATOL, V159, P342, DOI 10.1111/j.1365-2133.2008.08655.x; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Cerman AA, 2008, BRIT J DERMATOL, V159, P820, DOI 10.1111/j.1365-2133.2008.08742.x; Zha JM, 2009, ENDOCR J, V56, P935, DOI 10.1507/endocrj.K09E-091; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Bremmer S, 2010, J AM ACAD DERMATOL, V63, P1058, DOI 10.1016/j.jaad.2009.09.053; Armstrong AW, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.26; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Gerkowicz A, 2012, FOLIA HISTOCHEM CYTO, V50, P155, DOI 10.5603/FHC.2012.0025; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Takahashi H, 2010, J DERMATOL SCI, V59, P143, DOI 10.1016/j.jdermsci.2010.06.004; Xue K, 2013, EXP DERMATOL, V22, P406, DOI 10.1111/exd.12162	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	AUG	2015	307	6					539	544		10.1007/s00403-015-1581-z		6	Dermatology	Dermatology	CN0TO	WOS:000358126800009		
J	Wu, XH; Tang, SH; Jin, Y; Zhang, Y; Hattori, M; Wang, XJ; Zhang, HL; Wang, ZG				Wu, Xiuhong; Tang, Shuhan; Jin, Yan; Zhang, Yan; Hattori, Masao; Wang, Xijun; Zhang, Hailong; Wang, Zhigang			New analytical method for the study of metabolism of swertiamarin in rats after oral administration by UPLC-TOF-MS following DNPH derivatization	BIOMEDICAL CHROMATOGRAPHY			English	Article						swertiamarin; metabolism; erythrocentaurin; derivatization	HUMAN INTESTINAL BACTERIA; GLYCOSIDES	The metabolism of swertiamarin in vivo was studied by LC-MS following 2,4-dinitrophenylhydrazine derivatization. The ionization efficiency of the main metabolite erythrocentaurin was greatly enhanced by the new analytical method developed, and erythrocentaurin was successfully detected for the first time in rat plasma after oral administration of swertiamarin. Methyl 4-formylbenzoate was used as the internal standard to quantify erythrocentaurin in rat plasma in negative mode by UPLC-TOF-MS, and it was found that erythrocentaurin reached the maximum mean plasma concentration of 425.8 +/- 127.6ng/mL at about 2h after oral administration of swertiamarin at a dose of 200mg/kg. A metabolic pathway of swertiamarin to erythrocentaurin was proposed. Swertiamarin is first hydrolyzed by bacterial -glucusidase to give the aglycone, which is readily converted to erythrocentaurin. The monoterpene compound swertiamarin was found to be metabolized to dihydroisocoumarin and alkaloid compounds in vivo, which may be responsible for the pharmacological effect of swertiamarin. The results may shed light on the clinical efficacy of swertiamarin and the new analytical method may assist in studies for the metabolism of other natural iridoids and secoiridoids in vivo. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Wu, Xiuhong; Wang, Xijun; Wang, Zhigang] Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Natl TCM Key Lab Serum Pharmacochem, Harbin 150040, Peoples R China; [Tang, Shuhan; Hattori, Masao; Wang, Zhigang] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan; [Tang, Shuhan; Jin, Yan; Zhang, Yan] Harbin Children Hosp, Harbin, Peoples R China; [Zhang, Hailong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian 710061, Shaanxi, Peoples R China	Wang, ZG (reprint author), Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Natl TCM Key Lab Serum Pharmacochem, Heping Rd 24, Harbin 150040, Peoples R China.	wangzhigang0513@vip.163.com			National Natural Science Foundation of China [81102896, 81373931]; Innovative Talent Supporting Plan of Heilongjiang University of Chinese Medicine [2010RCD06, 2010RCD07]; Fundamental Research Funds for the Central Universities, China	This study was financially supported by National Natural Science Foundation of China (grant nos 81102896, 81373931), by the Innovative Talent Supporting Plan of Heilongjiang University of Chinese Medicine (grant nos 2010RCD06, 2010RCD07) and by the Fundamental Research Funds for the Central Universities, China.	Honda A, 2009, J LIPID RES, V50, P350, DOI 10.1194/jlr.D800040-JLR200; [Anonymous], 2006, INSTRUCTION MANUAL J, P397; Kumarasamy Y, 2003, PHYTOMEDICINE, V10, P344, DOI 10.1078/094471103322004857; YAMAHARA J, 1991, J ETHNOPHARMACOL, V33, P31, DOI 10.1016/0378-8741(91)90157-9; Santa T, 2011, BIOMED CHROMATOGR, V25, P1, DOI 10.1002/bmc.1548; Higgins CA, 2009, BIOCONJUGATE CHEM, V20, P1737, DOI 10.1021/bc900122g; BHATTACHARYA SK, 1976, J PHARM SCI, V65, P1547, DOI 10.1002/jps.2600651037; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Vaidya H, 2013, PHYTOTHER RES, V27, P624, DOI 10.1002/ptr.4763; Higashi T, 2007, J CHROMATOGR B, V848, P188, DOI 10.1016/j.jchromb.2006.10.036; DENISE CE, 2008, J NAT PRODUCTS, V71, P1082; EL-SEDAWY A, 1989, Planta Medica, V55, P147, DOI 10.1055/s-2006-961909; HATTORI M, 1990, PHYTOTHER RES, V4, P66, DOI 10.1002/ptr.2650040207; KAWATA Y, 1991, PLANTA MED, V57, P536, DOI 10.1055/s-2006-960201; Liu J, 2013, CHEM PHARM BULL, V61, P655, DOI 10.1248/cpb.c13-00160; Wang S-S, 2013, BIOMEDICAL CHROMATOG, V28, P939; Wang ZG, 2012, J ASIAN NAT PROD RES, V14, P176, DOI 10.1080/10286020.2011.631132; Zeng WL, 2013, BIOMED CHROMATOGR, V27, P1129, DOI 10.1002/bmc.2917; Zwiener C., 2002, Analytical and Bioanalytical Chemistry, V372, P615	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	AUG	2015	29	8					1184	1189		10.1002/bmc.3406		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CM8ZO	WOS:000357994000006		
J	Yamaguchi, R; Kawata, J; Yamamoto, T; Ishimaru, Y; Sakamoto, A; Ono, T; Narahara, S; Sugiuchi, H; Hirose, E; Yamaguchi, Y				Yamaguchi, Rui; Kawata, Jin; Yamamoto, Toshitaka; Ishimaru, Yasuji; Sakamoto, Arisa; Ono, Tomomichi; Narahara, Shinji; Sugiuchi, Hiroyuki; Hirose, Eiji; Yamaguchi, Yasuo			Mechanism of interferon-gamma production by monocytes stimulated with myeloperoxidase and neutrophil extracellular traps	BLOOD CELLS MOLECULES AND DISEASES			English	Article						Interferon-gamma; Myeloperoxidase; Neutrophil elastase; Mannose receptor; p38 Mitogen-activated protein kinase	PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; ADAPTIVE IMMUNITY; MAP KINASE; SERINE PROTEASES; IFN-GAMMA; CELLS; ACTIVATION; INNATE	Neutrophil extracellular traps (NETs) have an important role in antimicrobial innate immunity and release substances that may modulate the immune response. We investigated the effects of soluble factors from NETs and neutrophil granule proteins on human monocyte function by using the Transwell system to prevent cell-cell contact. NET formation was induced by exposing human neutrophils to phorbol myristate acetate (PMA). When monocytes were incubated with PMA alone, expression of interleukin (IL)-4, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha mRNA was upregulated, but IL-10, IL-12, and interferon (IFN)-gamma mRNA were not detected. Incubation of monocytes with NETs enhanced the expression of IL-10 and IFN-gamma mRNA, but not IL-12 mRNA. Myeloperoxidase stimulated IFN-gamma production by monocytes in a dose-dependent manner. Both a nuclear factor-kappaB inhibitor (PDTC) and an intracellular calcium antagonist (TMB-8) prevented upregulation of IFNgamma production. Neither a combined p38alpha and p38beta inhibitor (SB203580) nor an extracellular signalregulated kinase inhibitor (PD98059) suppressed IFN-gamma production. Interestingly, a combined p38gamma and p38delta inhibitor (BIRB796) significantly decreased IFN-gamma production. These findings suggest that myeloperoxidase induces IFN-gamma production by monocytes via p38gamma/delta mitogen-activated protein kinase. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaguchi, Rui; Kawata, Jin; Yamamoto, Toshitaka; Ishimaru, Yasuji; Sakamoto, Arisa; Ono, Tomomichi; Narahara, Shinji; Sugiuchi, Hiroyuki; Hirose, Eiji; Yamaguchi, Yasuo] Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kumamoto 8615598, Japan	Yamaguchi, Y (reprint author), Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kitaku Izumi Machi 325, Kumamoto 8615598, Japan.	yamaguti@kumamoto-hsu.ac.jp			Kumamoto Health Science University special fellowship grant [24-A-02]	This study was supported by a Kumamoto Health Science University special fellowship grant (No. 24-A-02).	Abu-Soud HM, 2014, J INORG BIOCHEM, V140, P245, DOI 10.1016/j.jinorgbio.2014.06.018; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Meyer-Hoffert U, 2011, CURR OPIN HEMATOL, V18, P19, DOI 10.1097/MOH.0b013e32834115d1; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; KING CL, 1989, P NATL ACAD SCI USA, V86, P10085, DOI 10.1073/pnas.86.24.10085; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Bradley LM, 1996, J IMMUNOL, V157, P1350; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Hwang YP, 2011, TOXICOL LETT, V203, P9, DOI 10.1016/j.toxlet.2011.02.013; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Bank U, 2001, J LEUKOCYTE BIOL, V69, P197; Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; BERRIH S, 1985, J IMMUNOL, V135, P1165; Cook NL, 2012, FREE RADICAL BIO MED, V52, P951, DOI 10.1016/j.freeradbiomed.2011.12.001; Druszczynska M., 2013, CLIN DEV IMMUNOL, V2013; GOLDBERG M, 1990, J CLIN INVEST, V85, P563, DOI 10.1172/JCI114473; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064182; KOHNO S, 1993, MICROBIOL IMMUNOL, V37, P207; Kurosaka K, 1998, J IMMUNOL, V161, P6245; Lin TC, 2005, ANESTH ANALG, V100, P1554, DOI 10.1213/01.ANE.000015-1307.92060.84; McGreal EP, 2010, BBA-MOL BASIS DIS, V1802, P649, DOI 10.1016/j.bbadis.2010.04.005; Parker H., 2012, J LEUKOCYTE BIOL, V91, P69; Paulnock DM, 2000, J LEUKOCYTE BIOL, V67, P677; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; SHEPHERD VL, 1990, AM J RESP CELL MOL, V2, P335; Singh UP, 2003, J INTERF CYTOK RES, V23, P591, DOI 10.1089/107999003322485099; STRIETER RM, 1989, AM J RESP CELL MOL, V1, P57; Tahara E, 2009, CANCER BIOL THER, V8, P801, DOI 10.4161/cbt.8.9.8186; Talc P.P., 2001, J CLIN INVEST, V107, P7	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1079-9796	1096-0961		BLOOD CELL MOL DIS	Blood Cells Mol. Dis.	AUG	2015	55	2					127	133		10.1016/j.bcmd.2015.05.012		7	Hematology	Hematology	CM7XD	WOS:000357908900007		
J	Sano, H; Ohki, K; Park, MJ; Shiba, N; Hara, Y; Sotomatsu, M; Tomizawa, D; Taga, T; Kiyokawa, N; Tawa, A; Horibe, K; Adachi, S; Hayashi, Y				Sano, Hitoshi; Ohki, Kentaro; Park, Myoung-ja; Shiba, Norio; Hara, Yusuke; Sotomatsu, Manabu; Tomizawa, Daisuke; Taga, Takashi; Kiyokawa, Nobutaka; Tawa, Akio; Horibe, Keizo; Adachi, Souichi; Hayashi, Yasuhide			CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8;21)	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						CSF3R; CALR; myeloid disorder; children	STIMULATING FACTOR-RECEPTOR; CHRONIC NEUTROPHILIC LEUKEMIA; SEVERE CONGENITAL NEUTROPENIA; COOPERATIVE-STUDY GROUP; MYELOPROLIFERATIVE NEOPLASMS; ENDOPLASMIC-RETICULUM; CYTOPLASMIC DOMAIN; ATYPICAL CML; CALRETICULIN; GENE	Mutations in the colony-stimulating factor 3 receptor (CSF3R) and calreticulin (CALR) genes have been reported in a proportion of adults with myeloproliferative disease. However, little is known about CSF3R or CALR mutations in paediatric myeloid disorders. We analysed CSF3R exons 14 and 17, and CALR exon 9, using direct sequencing in samples of paediatric acute myeloid leukaemia (AML; n=521), juvenile myelomonocytic leukaemia (JMML; n=40), myelodysplastic syndrome (MDS; n=20) and essential thrombocythaemia (ET; n=21). CSF3R mutations were found in 10 (192%) of 521 patients with AML; two in exon 14 (both missense mutations resulting in p.T618I) and eight in exon 17 (three frameshift mutations: p.S715X, p.Q774R, and p.S783Q; and five novel missense mutations: p.Q754K, p.R769H, p.L777F, p.T781I, and S795R). All of the patients with mutations in CSF3R exon 17 had chromosomal translocations, including four with t(8;21). At the time of reporting, seven of these ten patients are alive; three have died, due to side effects of chemotherapy. No CSF3R mutations were found in cases of MDS, JMML or ET. The only mutation found in the CALR gene was a frameshift (p.L367 fs) in one ET patient. We discuss the potential impact of these findings for the leukaemogenesis and clinical features of paediatric myeloid disorders.	[Sano, Hitoshi; Ohki, Kentaro; Park, Myoung-ja; Shiba, Norio; Hara, Yusuke; Sotomatsu, Manabu; Hayashi, Yasuhide] Gunma Childrens Med Ctr, Dept Haematol Oncol, Shibukawa, Gunma 3778577, Japan; [Shiba, Norio; Hara, Yusuke] Gunma Univ, Grad Sch Med, Dept Paediat, Maebashi, Gumma 371, Japan; [Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Div Leukaemia & Lymphoma, Childrens Canc Ctr, Tokyo, Japan; [Taga, Takashi] Shiga Univ Med Sci, Dept Paediat, Otsu, Shiga, Japan; [Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Paediat Haematol & Oncol Res, Tokyo, Japan; [Tawa, Akio] Natl Hosp Org Osaka Natl Hosp, Dept Paediat, Osaka, Japan; [Horibe, Keizo] Natl Hosp Org Nagoya Med Ctr, Dept Paediat, Nagoya, Aichi, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan	Hayashi, Y (reprint author), Gunma Childrens Med Ctr, Dept Haematol Oncol, 779 Shimohakoda, Shibukawa, Gunma 3778577, Japan.	hayashiy-tky@umin.ac.jp		Tomizawa, Daisuke/0000-0003-1520-7007	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Kawano Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	This work was supported by a grant for Cancer Research and a grant for Research on Children and Families from the Ministry of Health, Labour and Welfare of Japan, a Grant-in-Aid for Scientific Research and Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a research grant for Gunma Prefectural Hospitals and from the Kawano Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics. We thank Ms. Y. Hoshino for technical assistance and all participating doctors and patients who were involved in AML-05 and other studies.	Gotlib J, 2013, BLOOD, V122, P1707, DOI 10.1182/blood-2013-05-500959; Rhoades KL, 2000, BLOOD, V96, P2108; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Tefferi A, 2014, LEUKEMIA, V28, P1407, DOI [10.1038/leu.2014.35, 10.1038/Ieu.2014.35]; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; DONG F, 1993, MOL CELL BIOL, V13, P7774; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Fleischman AG, 2013, BLOOD, V122, P3628, DOI 10.1182/blood-2013-06-509976; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Giona F, 2014, BLOOD, V123, P3677, DOI 10.1182/blood-2014-04-572040; Hermans MHA, 1998, BLOOD, V92, P32; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hunter MG, 2000, BLOOD, V95, P2132; Mitsui T, 2003, BLOOD, V101, P2990, DOI 10.1182/blood.V101.8.2990; Sano H, 2013, INT J HEMATOL, V98, P437, DOI 10.1007/s12185-013-1409-6; Shiba N, 2013, GENE CHROMOSOME CANC, V52, P683, DOI 10.1002/gcc.22064; Shimada A, 2008, PEDIATR BLOOD CANCER, V50, P264, DOI 10.1002/pbc.21318; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	AUG	2015	170	3					391	397		10.1111/bjh.13439		7	Hematology	Hematology	CM9DS	WOS:000358007400010		
J	Kataoka, K; Nakamura, K; Mizusawa, J; Fukuda, H; Igaki, H; Ozawa, S; Hayashi, K; Kato, K; Kitagawa, Y; Ando, N				Kataoka, K.; Nakamura, K.; Mizusawa, J.; Fukuda, H.; Igaki, H.; Ozawa, S.; Hayashi, K.; Kato, K.; Kitagawa, Y.; Ando, N.			Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer	BRITISH JOURNAL OF SURGERY			English	Article							LYMPH-NODE DISSECTION; THORACIC ESOPHAGUS; OPERATIVE MORTALITY; SURGEON VOLUME; CARCINOMA; ENGLAND; COHORT	BackgroundVariations in institutional practice may contribute to different outcomes of cancer treatment. The impact of interinstitutional heterogeneity on outcomes between hospitals after oesophagectomy has not been examined previously using data from surgical clinical trials. MethodsThe data from two phase III trials for oesophageal cancer were used. Japan Clinical Oncology Group (JCOG) 9204 involved oesophagectomy (92-OP) versus oesophagectomy plus postoperative chemotherapy (92-POST), with accrual from 1992 to 1997. JCOG9907 involved postoperative chemotherapy (99-POST) versus preoperative chemotherapy (99-PRE), with accrual from 2000 to 2006. Hospitals contributing fewer than three patients were excluded. The influence of time and preoperative chemotherapy on interinstitutional heterogeneity related to postoperative complications and 5-year overall survival were evaluated by comparisons within and between these trial groups. Heterogeneity was estimated by a mixed-effects model after adjusting for age, sex, performance status, location of the primary tumour and clinical stage. ResultsTwelve hospitals in 92-OP (114 patients), 13 in 92-POST (114), 19 in 99-POST (158) and 18 in 99-PRE (154) were eligible. There was considerable heterogeneity in predicted postoperative complications in both groups in JCOG9204 (median 313 (range 150-682) per cent), and in 99-PRE (352 (226-466) per cent) but not in 99-POST (277 (277-277) per cent) from JCOG9907. A similar pattern was seen for predicted overall survival (92-POST: 664 (range 641-689) per cent; 99-PRE: 559 (540-597) per cent; 99-POST: 444 (444-444) per cent). ConclusionInterinstitutional heterogeneity regarding complications and survival after oesophagectomy is a problem that merits wider consideration. Heterogeneity is still a problem in surgical RCTs	[Kataoka, K.; Nakamura, K.; Mizusawa, J.; Fukuda, H.] Natl Canc Ctr, Ctr Res Adm & Support, JCOG Data Ctr, Operat Off, Tokyo 1040045, Japan; [Igaki, H.] Natl Canc Ctr, Oesophageal Surg Div, Tokyo, Japan; [Kato, K.] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Hayashi, K.] Tokyo Womens Med Univ, Dept Chemotherapy & Palliat Care, Tokyo, Japan; [Kitagawa, Y.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Ozawa, S.] Tokai Univ, Sch Med, Dept Gastrointestinal Surg, Isehara, Kanagawa 25911, Japan; [Ando, N.] Int Goodwill Hosp, Yokohama, Kanagawa, Japan	Kataoka, K (reprint author), Natl Canc Ctr, Ctr Res Adm & Support, JCOG Operat Off, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kozokataoka@hotmail.co.jp					Al-Sarira AA, 2007, BRIT J SURG, V94, P585, DOI 10.1002/bjs.5805; Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Gruen RL, 2009, CA-CANCER J CLIN, V59, P192, DOI 10.3322/caac.20018; Derogar M, 2013, J CLIN ONCOL, V31, P551, DOI 10.1200/JCO.2012.46.1517; Wouters MWJM, 2009, ANN SURG ONCOL, V16, P1789, DOI 10.1245/s10434-009-0458-9; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; McCulloch P, 2003, BMJ-BRIT MED J, V327, P1192, DOI 10.1136/bmj.327.7425.1192; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Hollenbeck BK, 2007, J CLIN ONCOL, V25, P91, DOI 10.1200/JCO.2006.07.2454; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; BABA M, 1994, ANN SURG, V219, P310, DOI 10.1097/00000658-199403000-00012; Bachmann MO, 2002, BRIT J SURG, V89, P914, DOI 10.1046/j.1365-2168.2002.02135.x; Forshaw MJ, 2006, ANN ROY COLL SURG, V88, P566, DOI 10.1308/003588406X130624; Fujita H, 2010, DIS ESOPHAGUS, V23, P145, DOI 10.1111/j.1442-2050.2009.00986.x; Legrand C, 2006, CLIN TRIALS, V3, P10, DOI 10.1191/1740774506cn132oa; MATSUBARA T, 1994, J THORAC CARDIOV SUR, V107, P1073; Yamaguchi T, 2002, STAT METHODS MED RES, V11, P221, DOI 10.1191/0962280202sm284ra; Yamaguchi T, 1999, STAT MED, V18, P1961	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	AUG	2015	102	9					1088	1096		10.1002/bjs.9839		9	Surgery	Surgery	CM7PG	WOS:000357886600010		
J	Muto, M; Baghdadi, M; Maekawa, R; Wada, H; Seino, K				Muto, Masato; Baghdadi, Muhammad; Maekawa, Ryuji; Wada, Haruka; Seino, Ken-ichiro			Myeloid molecular characteristics of human gamma delta T cells support their acquisition of tumor antigen-presenting capacity	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						gamma delta T cells; Zoledronate; Antigen-presenting capacity; CD36; C/EBP alpha; Myeloid	DENDRITIC CELLS; MULTIPLE-MYELOMA; APOPTOTIC CELLS; IMMUNOTHERAPY; LYMPHOCYTES; RESPONSES; CANCER; ALPHA; PHAGOCYTOSIS; STIMULATION	Human T cells expressing gamma delta T cell receptor have a potential to show antigen-presenting cell-like phenotype and function upon their activation. However, the mechanisms that underlie the alterations in human gamma delta T cells remain largely unclear. In this study, we have investigated the molecular characteristics of human gamma delta T cells related to their acquisition of antigen-presenting capacity in comparison with activated alpha beta T cells. We found that activated gamma delta but not alpha beta T cells upregulated cell surface expression of a scavenger receptor, CD36, which seemed to be mediated by signaling through mitogen-activated protein kinase and/or NF-kappa B pathways. Confocal microscopical analysis revealed that activated gamma delta T cells can phagocytose protein antigens. Activated gamma delta T cells could induce tumor antigen-specific CD8(+) T cells using both apoptotic and live tumor cells as antigen resources. Furthermore, we detected that C/EBP alpha, a critical transcription factor for the development of myeloid-lineage cells, is expressed much higher in gamma delta T cells than in alpha beta T cells. These results unveiled the molecular mechanisms for the elicitation of antigen-presenting functions in gamma delta T cells and would also help designing new approaches for gamma delta T cell-mediated human cancer immunotherapy.	[Muto, Masato; Baghdadi, Muhammad; Wada, Haruka; Seino, Ken-ichiro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Muto, Masato; Maekawa, Ryuji] MEDINET Co Ltd, Medinet Med Inst, Tokyo, Japan	Seino, K (reprint author), Hokkaido Univ, Inst Med Genet, Kita15 Nishi7, Sapporo, Hokkaido 0600815, Japan.	seino@igm.hokudai.ac.jp			MEDINET Co., Ltd.	This work was supported in part by research funding from MEDINET Co., Ltd.	Altvater B, 2012, CANCER IMMUNOL IMMUN, V61, P385, DOI 10.1007/s00262-011-1111-6; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Wu Y, 2009, J IMMUNOL, V183, P5622, DOI 10.4049/jimmunol.0901772; Nicol AJ, 2011, BRIT J CANCER, V105, P778, DOI 10.1038/bjc.2011.293; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Abe Y, 2009, EXP HEMATOL, V37, P956, DOI 10.1016/j.exphem.2009.04.008; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Ardeshna KM, 2000, BLOOD, V96, P1039; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kunzmann V, 2000, BLOOD, V96, P384; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Himoudi N, 2012, J IMMUNOL, V188, P1708, DOI 10.4049/jimmunol.1102654; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Qiao LP, 2008, J BIOL CHEM, V283, P8788, DOI 10.1074/jbc.M800055200; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Hao SG, 2007, J LEUKOCYTE BIOL, V82, P829, DOI 10.1189/jlb.0407249; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Hollis A, 2012, CHEMBIOCHEM, V13, P302, DOI 10.1002/cbic.201100652; Kabelitz D, 2004, INT J CANCER, V112, P727, DOI 10.1002/ijc.20445; Landmeier S, 2009, J IMMUNOTHER, V32, P310, DOI 10.1097/CJI.0b013e31819b7c30; Lubick K, 2006, J LEUKOCYTE BIOL, V79, P1268, DOI 10.1189/jlb.1005616; Meuter S, 2010, P NATL ACAD SCI USA, V107, P8730, DOI 10.1073/pnas.1002769107; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Umeshappa CS, 2009, J IMMUNOL, V182, P193; Wada I, 2014, CANCER MED-US, V3, P362, DOI 10.1002/cam4.196	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	AUG	2015	64	8					941	949		10.1007/s00262-015-1700-x		9	Oncology; Immunology	Oncology; Immunology	CN0ER	WOS:000358087400002		
J	Maeda, Y; Yoshimura, K; Matsui, H; Shindo, Y; Tamesa, T; Tokumitsu, Y; Hashimoto, N; Tokuhisa, Y; Sakamoto, K; Sakai, K; Suehiro, Y; Hinoda, Y; Tamada, K; Yoshino, S; Hazama, S; Oka, M				Maeda, Yoshinari; Yoshimura, Kiyoshi; Matsui, Hiroto; Shindo, Yoshitaro; Tamesa, Takao; Tokumitsu, Yukio; Hashimoto, Noriaki; Tokuhisa, Yoshihiro; Sakamoto, Kazuhiko; Sakai, Kouhei; Suehiro, Yutaka; Hinoda, Yuji; Tamada, Koji; Yoshino, Shigefumi; Hazama, Shoichi; Oka, Masaaki			Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Hepatocellular carcinoma; Heat-shock protein 70; Dendritic cell; Immunotherapy; Electroporation	ANTIGEN-PRESENTING CELLS; HEAT-SHOCK PROTEINS; ADOPTIVE IMMUNOTHERAPY; RECURRENCE; CANCER; HSP70; EXPRESSION; RESECTION; FAMILY; TUMORS	We previously reported overexpression of heat-shock protein (HSP) 70 in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) using proteomic profiling and immunohistochemical staining (IHS). This suggested that HSP70 could be a molecular target for treatment of HCC. Twelve patients with HCV-related HCC were enrolled in a phase 1 clinical trial. Dendritic cells (DCs) transfected with HSP70 mRNA (HSP70-DCs) induced by electroporation were injected intradermally. Patients were treated three times every 3 weeks. The number of HSP70-DCs injected was 1 x 10(7) as the lowest dose, then 2 x 10(7) as the medium dose, and then 3 x 10(7) as the highest dose. Immunological analyses were performed. No adverse effects of grade III/IV, except one grade III liver abscess at the 3 x 10(7) dose, were observed. Thus, we added three more patients to confirm whether 3 x 10(7) is an appropriate dose. Eventually, we chose 3 x 10(7) as the recommended dose of DCs. Complete response (CR) without any recurrence occurred in two patients, stable disease in five, and progression of disease in five. The two patients with CR have had no recurrence for 44 and 33 months, respectively. IHS in one patient who underwent partial hepatectomy showed infiltration of CD8+ T cells and granzyme B in tumors, indicating that the dominant immune effector cells were cytotoxic T lymphocytes with tumor-killing activity. This study demonstrated that HSP70-DCs therapy is both safe and feasible in patients with HCV-related HCC. Further clinical trials should be considered.	[Maeda, Yoshinari; Yoshimura, Kiyoshi; Matsui, Hiroto; Shindo, Yoshitaro; Tamesa, Takao; Tokumitsu, Yukio; Hashimoto, Noriaki; Tokuhisa, Yoshihiro; Sakamoto, Kazuhiko; Yoshino, Shigefumi; Hazama, Shoichi; Oka, Masaaki] Yamaguchi Univ, Dept Digest Surg & Surg Oncol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Sakai, Kouhei; Suehiro, Yutaka; Hinoda, Yuji] Yamaguchi Univ, Dept Oncol & Lab Med, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Tamada, Koji] Yamaguchi Univ, Dept Immunol & Cell Signaling Anal, Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Maeda, Y (reprint author), Yamaguchi Univ, Dept Digest Surg & Surg Oncol, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	y.maeda@kousei-h.jp; 2geka-1@yamaguchi-u.ac.jp			KAKEN [20591612]	This study was funded by KAKEN 20591612. We thank Ms. Akiko Sano, Ms. Kaori Kaneyasu, and Ms. Yuko Yanai for their excellent technical assistance.	Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Liao XS, 2004, MOL THER, V9, P757, DOI 10.1016/j.ymthe.2004.02.011; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Chuma M, 2003, HEPATOLOGY, V37, P198, DOI 10.1053/jhep.2003.50022; Ohishi W, 2003, SCAND J GASTROENTERO, V38, P894, DOI 10.1080/00365520310004434; Elsner L, 2007, J IMMUNOL, V179, P5523; Unitt E, 2006, J HEPATOL, V45, P246, DOI 10.1016/j.jhep.2005.12.027; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Tada F, 2012, INT J ONCOL, V41, P1601, DOI 10.3892/ijo.2012.1626; Palmer DH, 2009, HEPATOLOGY, V49, P124, DOI 10.1002/hep.22626; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Ikai I, 2005, HEPATOL RES, V32, P163, DOI 10.1016/j.hepres.2005.04.005; Thomas MB, 2005, J CLIN ONCOL, V23, P8093, DOI 10.1200/JCO.2004.00.1537; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; Binder RJ, 2009, J IMMUNOL, V182, P6844, DOI 10.4049/jimmunol.0900026; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Ciocca DR, 2012, CURR MOL MED, V12, P1183; Iizuka N, 2004, LANCET, V364, P1837, DOI 10.1016/S0140-6736(04)17455-2; Itoh Y, 2002, ONCOL REP, V9, P331; Litzow MR, 2006, CYTOTHERAPY, V8, P290, DOI 10.1080/14653240600735743; Olin Michael R, 2014, J Immunother Cancer, V2, P4, DOI 10.1186/2051-1426-2-4; Takashima M, 2003, PROTEOMICS, V3, P2487, DOI 10.1002/pmic.200300621; Tan A, 2010, ONCOLOGY-BASEL, V78, P161, DOI 10.1159/000315577; Xie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042879; Yoshida S, 2009, ANTICANCER RES, V29, P539	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	AUG	2015	64	8					1047	1056		10.1007/s00262-015-1709-1		10	Oncology; Immunology	Oncology; Immunology	CN0ER	WOS:000358087400011		
J	Ho, WS; Khor, CS; Hashim, H; Lim, JS; Ashina, S; Herran, DS				Ho, Wai Shin; Khor, Cheng Seong; Hashim, Haslenda; Lim, Jeng Shiun; Ashina, Suichi; Herran, Diego Silva			Optimal operation of a distributed energy generation system for a sustainable palm oil-based eco-community	CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY			English	Article						Distributed energy generation system; Palm oil mill; Biomass energy; Biogas energy; Energy storage; Load shifting	CASCADE ANALYSIS ESCA; OPTIMAL-DESIGN; INTEGRATED BIOMASS; ELECTRIC SYSTEM; OPTIMIZATION; DISPATCH; CHINA; MODEL	The palm oil industry potentially can be environmentally sustainable through utilizing the vast availability of biomass residues from palm oil mills as renewable energy sources. This work addresses the optimal operation of a combined bioenergy and solar PV distributed energy generation system to meet the electricity and heat demands of an eco-community comprising a palm oil mill and its surrounding residential community. A multiperiod mixed-integer linear programming planning and scheduling model is formulated on an hourly basis that optimally selects the power generation mix from among available biomass, biogas, and solar energy resources with consideration for energy storage and load shifting. A multiscenario approach is employed that considers scenarios in the form of many possible weather conditions and various energy profiles under varying mill operation modes and residential electricity consumption. The proposed approach is demonstrated on a realistic case study for a palm oil mill in the Iskandar Malaysia economic development region. The computational results indicate that biomass-based resource is the preferred renewable energy to be implemented due to the high cost associated with solar PV. As well, load shifting and energy storage can be feasibly deployed for demand peak shaving particularly for solar PV systems.	[Ho, Wai Shin; Hashim, Haslenda; Lim, Jeng Shiun] Univ Teknol Malaysia, Proc Syst Engn Ctr PROSPECT, Fac Chem Engn, Skudai 81310, Johor, Malaysia; [Khor, Cheng Seong] Univ Teknol PETRONAS, Dept Chem Engn, Tronoh 31750, Perak, Malaysia; [Ashina, Suichi; Herran, Diego Silva] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058056, Japan	Hashim, H (reprint author), Univ Teknol Malaysia, Proc Syst Engn Ctr PROSPECT, Fac Chem Engn, Skudai 81310, Johor, Malaysia.	khorchengseong@gmail.com; haslenda@cheme.utm.my			Malaysian Ministry of Higher Education (MOHE); University Teknologi Malaysia (UTM) [Q.J130000.2525.01H52]; Japan International Cooperation Agency (JICA)	The authors are grateful for the financial support to complete this work provided by the Malaysian Ministry of Higher Education (MOHE) and University Teknologi Malaysia (UTM) under the GUP Research Grant of Vote Number Q.J130000.2525.01H52 and the Japan International Cooperation Agency (JICA) under the Science and Technology Research Partnership for Sustainable Development (SATREPS) scheme for the project "Development of Low Carbon Society Scenarios for Asian Regions''.	Ho WS, 2012, APPL ENERG, V99, P309, DOI 10.1016/j.apenergy.2012.04.016; Hashim H, 2014, ENERGY, V75, P31, DOI 10.1016/j.energy.2014.04.086; Liu P, 2010, AICHE J, V56, P1218, DOI 10.1002/aic.12058; Ho WS, 2013, CLEAN TECHNOL ENVIR, V15, P433, DOI 10.1007/s10098-013-0617-3; Liu P, 2010, ENERG POLICY, V38, P4224, DOI 10.1016/j.enpol.2010.03.051; Mehleri ED, 2012, ENERGY, V44, P96, DOI 10.1016/j.energy.2012.02.009; Ho WS, 2014, CLEAN TECHNOL ENVIR, V16, P957, DOI 10.1007/s10098-013-0700-9; Ho WS, 2014, RENEW ENERG, V69, P190, DOI 10.1016/j.renene.2014.02.053; Hansen SB, 2012, BIORESOURCE TECHNOL, V104, P358, DOI 10.1016/j.biortech.2011.10.069; Bazmi AA, 2011, RENEW SUST ENERG REV, V15, P574, DOI 10.1016/j.rser.2010.09.031; Ren HB, 2010, APPL ENERG, V87, P1001, DOI 10.1016/j.apenergy.2009.09.023; MULVEY JM, 1995, OPER RES, V43, P264, DOI 10.1287/opre.43.2.264; Nemet A, 2012, CLEAN TECHNOL ENVIR, V14, P453, DOI 10.1007/s10098-012-0457-6; Gupta A, 2011, RENEW ENERG, V36, P466, DOI 10.1016/j.renene.2009.04.035; Herran DS, 2012, APPL ENERG, V91, P130, DOI 10.1016/j.apenergy.2011.09.022; Pruitt KA, 2013, APPL ENERG, V102, P386, DOI 10.1016/j.apenergy.2012.07.030; Gupta A, 2011, RENEW ENERG, V36, P459, DOI 10.1016/j.renene.2010.06.035; Kasivisvanathan H, 2012, CHEM ENG J, V200, P694, DOI 10.1016/j.cej.2012.05.113; Ren HB, 2012, APPL ENERG, V91, P156, DOI 10.1016/j.apenergy.2011.08.044; Gupta A, 2011, RENEW ENERG, V36, P474, DOI 10.1016/j.renene.2009.04.036; Yang HX, 2009, APPL ENERG, V86, P163, DOI 10.1016/j.apenergy.2008.03.008; Evald A, 2005, RENEWABLE ENERGY RES; Foo DCY, 2013, ENERGY, V55, P68, DOI 10.1016/j.energy.2013.01.045; Ho WS, 2014, DESALIN WATER TREAT, V52, P1202, DOI 10.1080/19443994.2013.826785; Ho WS, 2014, INT J ELEC POWER, V54, P481, DOI 10.1016/j.ijepes.2013.07.007; Shin HW, 2012, GLOBAL J TECHNOL OPT, V3, P36; Steward D, 2009, LIFECYCLE COST ANAL; U.S. Energy Information Administration (EIA), 2010, UPD CAP COST EST EL; Yun HT, 2011, P INT C SMART GRID C, V12; Zhou Z, 2013, COMPUT CHEM ENG, V48, P165, DOI 10.1016/j.compchemeng.2012.08.013	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1618-954X	1618-9558		CLEAN TECHNOL ENVIR	Clean Technol. Environ. Policy	AUG	2015	17	6					1597	1617		10.1007/s10098-014-0893-6		21	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CN0GE	WOS:000358091300019		
J	Sakaguchi, I; Inoue, Y; Nakamura, S; Kojima, Y; Sasai, R; Sawada, K; Suzuki, K; Takenaka, C; Katayama, A				Sakaguchi, Iwao; Inoue, Yasushi; Nakamura, Shinichiro; Kojima, Yoshihiro; Sasai, Ryo; Sawada, Kayo; Suzuki, Kenji; Takenaka, Chisato; Katayama, Arata			Assessment of soil remediation technologies by comparing health risk reduction and potential impacts using unified index, disability-adjusted life years	CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY			English	Article						Soil remediation technology; Disability-adjusted life years; Health risk reduction; Environmental impact	CONTAMINATED SITE; CYCLE; SUSTAINABILITY	The assessment methodology of soil remediation technologies including citizen's opinions about environmental policy was developed to enable direct comparison between the resident health risk reduction by carrying out remediation (decreased primary risk) and the potential impacts of chemicals emitted during the remediation on national health, social assets, and primary production (secondary risk). Both risks were quantified with an unified index, disability-adjusted life years (DALYs), by employing life cycle costing (LCC), economic input-output life cycle assessment (EIO-LCA), and life cycle impact assessment (LCIA) database. Four remediation technologies were considered: excavation-disposal, high temperature thermal desorption (HTTD), biopile, and landfarming. There was almost no difference in the decreased primary risk among the four technologies, apart from landfarming, which had the smallest decreased primary risk. The secondary risk of the biological technologies (biopile, landfarming) was smaller than that of the physical and chemical technologies (excavation-disposal, HTTD). The ratio of the decreased primary risk to the secondary risk was largest in case of landfarming, which indicated that landfarming was most effective. The sum of the residual primary risks and secondary risk was small in the biological technologies, indicating that the biological technologies had smaller environmental impacts. Indexing both of decreased primary risk and secondary risk with DALYs enables non-experts who prioritize resident's health to assess the soil remediation technologies and would facilitate the decision making in the selection of remediation technologies.	[Sakaguchi, Iwao; Inoue, Yasushi; Kojima, Yoshihiro; Sawada, Kayo; Suzuki, Kenji; Katayama, Arata] Nagoya Univ, Div Environm Res, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nakamura, Shinichiro] Waseda Univ, Grad Sch Econ, Shinjuku Ku, Tokyo 1698050, Japan; [Sasai, Ryo] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Dept Phys & Mat Sci, Matsue, Shimane 6908504, Japan; [Takenaka, Chisato] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Katayama, A (reprint author), Nagoya Univ, Div Environm Res, EcoTopia Sci Inst, Chikusa Ku, F3-4 670 Furo Cho, Nagoya, Aichi 4648603, Japan.	a-katayama@esi.nagoya-u.ac.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [HC-09-2510-3]; EcoTopia Science Institute Director's Discretionary Fund of Nagoya University; Japan Science and Technology Agency (JST)	The authors would like to thank Mrs. Chisa Hiyama for her help in collecting and organizing data, and Mrs. Nana Watanabe for her help in calculating risk using the CalTOX model. This study was supported in part by a Grant-in-aid (Hazardous Chemicals) from the Ministry of Agriculture, Forestry, and Fisheries of Japan (HC-09-2510-3), and by the EcoTopia Science Institute Director's Discretionary Fund of Nagoya University (A Harmonization of the Environment in Asian Countries by the Consensus of Environmental Standard) during 2008-2012. This study was also partially supported by Core Research for Evolutionary Science and Technology (CREST) Program "Sustainable Groundwater Management Systems under Enhanced Geo-Thermal Energy Usage'' of Japan Science and Technology Agency (JST).	Inoue Y, 2011, J HAZARD MATER, V192, P1234, DOI 10.1016/j.jhazmat.2011.06.029; Bare JC, 2014, CLEAN TECHNOL ENVIR, V16, P681, DOI 10.1007/s10098-013-0685-4; Lemming G, 2012, J ENVIRON MANAGE, V112, P392, DOI 10.1016/j.jenvman.2012.08.002; Laurent A, 2011, INT J LIFE CYCLE ASS, V16, P728, DOI 10.1007/s11367-011-0285-7; Ryberg M, 2014, CLEAN TECHNOL ENVIR, V16, P329, DOI 10.1007/s10098-013-0629-z; Donnarumma L, 2009, J ENVIRON SCI HEAL B, V44, P449, DOI 10.1080/03601230902935113; Inoue Y, 2004, J MATER CYCLES WASTE, V6, P48, DOI 10.1007/s10163-003-0107-5; Itsubo N, 2010, LIME2 ENV IMPACT ASS; Kondo H, 2003, ANN REP TOKYO METR I, V54, P132; Laurent A, 2011, INT J LIFE CYCLE ASS, V16, P401, DOI 10.1007/s11367-011-0278-6; Lesage P, 2007, INT J LIFE CYCLE ASS, V12, P391, DOI 10.1065/lca2006.10.279.1; Ministry of Agriculutre Forestry and Fisheries in Japan, 2000, WORLD AGR CENS 2000, V9; Ohtani R, 1981, B HYOGO PREF AGR CEN, V29, P59; Otobe Y, 1998, B HOKKAIDO CENTRAL A, V75, P21; Reza B, 2014, CLEAN TECHNOL ENVIR, V16, P251, DOI 10.1007/s10098-013-0615-5; Seike N, 2010, SEIKE N; U.S. Environmental Protection Agency, 2012, INT RISK INF SYST; World Health Organization (WHO), 2009, INV IPCS OTH WHO PES; Yasutaka T, 2008, ENV SCI, V21, P291	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1618-954X	1618-9558		CLEAN TECHNOL ENVIR	Clean Technol. Environ. Policy	AUG	2015	17	6					1663	1670		10.1007/s10098-014-0871-z		8	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CN0GE	WOS:000358091300023		
J	Koyama, K; Ohba, T; Haro, H; Nakao, A				Koyama, K.; Ohba, T.; Haro, H.; Nakao, A.			Positive association between serum thymic stromal lymphopoietin and anti-citrullinated peptide antibodies in patients with rheumatoid arthritis	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						ACPA; rheumatoid arthritis; serum; thymic stromal lymphopoietin	RADIOGRAPHIC PROGRESSION; DENDRITIC CELLS; TSLP; EXPRESSION; RESPONSES; DISEASE	Thymic stromal lymphopoietin (TSLP) has been suggested recently to play an important role in the pathophysiology of rheumatoid arthritis (RA). However, there is little information on serum TSLP concentrations in RA and its clinical significance. The present study investigated whether serum TSLP concentrations were affected in patients with RA. Using an enzyme-linked immunosorbent assay (ELISA), we measured TSLP concentrations in the serum obtained from 100 patients with RA, 60 patients with osteoarthritis (OA) and 34 healthy volunteers. We also investigated the correlation between serum TSLP concentrations and clinical parameters of disease activity in RA [disease activity score using 28 joint counts (DAS28)-C-reactive protein (CRP), DAS28-erythrocyte sedimentation rate (ESR), Clinical Disease Activity Index (CDAI]), patient's/-physician's Visual Analogue Scale (VAS), swollen joints count, tender joints count, CRP, ESR and matrix metalloproteinase-3 (MMP-3) concentrations]. In addition, we investigated the correlation between serum TSLP concentrations and anti-citrullinated peptide antibody (ACPA) and serum tumour necrosis factor (TNF)-. Serum TSLP levels in patients with RA were significantly higher than those in patients with OA and in healthy volunteers. Interestingly, serum TSLP concentrations were correlated significantly with ACPA titres, but not with other clinical parameters. There was a significant increase in serum TSLP concentrations in patients with RA, which was correlated positively with serum ACPA titres. These findings suggest that in patients with RA, TSLP may play a role in ACPA production by B cells.	[Koyama, K.; Ohba, T.; Haro, H.] Univ Yamanashi, Fac Med, Dept Orthopaed Surg, Yamanashi 4093898, Japan; [Nakao, A.] Univ Yamanashi, Fac Med, Dept Immunol, Yamanashi 4093898, Japan	Koyama, K (reprint author), Univ Yamanashi, Fac Med, Dept Orthopaed Surg, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	kkoyama@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Volpe E, 2014, J ALLERGY CLIN IMMUN, V134, P373, DOI 10.1016/j.jaci.2014.04.022; Leandro MJ, 2013, J RHEUMATOL, V40, P1247, DOI 10.3899/jrheum.130677; Zhang F, 2011, CLIN EXP IMMUNOL, V164, P256, DOI 10.1111/j.1365-2249.2011.04328.x; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Alysandratos KD, 2010, ANN ALLERG ASTHMA IM, V105, P403, DOI 10.1016/j.anai.2010.09.017; Koyama K, 2007, BIOCHEM BIOPH RES CO, V357, P99, DOI 10.1016/j.bbrc.2007.03.081; Shiozawa K, 2012, J RHEUMATOL, V39, P694, DOI 10.3899/jrheum.111152; Moret FM, 2014, ARTHRITIS RHEUMATOL, V66, P1176, DOI 10.1002/art.38338; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Hartgring SAY, 2011, ARTHRITIS RHEUM-US, V63, P1878, DOI 10.1002/art.30336; Messer L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2648; Modi S, 2013, CLIN EXP IMMUNOL, V173, P8, DOI 10.1111/cei.12114; Mouterde G, 2011, ANN RHEUM DIS, V70, P1251, DOI 10.1136/ard.2010.144402; Takeuchi T, 2011, ANN RHEUM DIS, V70, P1208, DOI 10.1136/ard.2011.153023; VansVenrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	AUG	2015	181	2					239	243		10.1111/cei.12632		5	Immunology	Immunology	CM9CL	WOS:000358003700005		
J	Uemoto, S; Ozawa, K; Kaido, T; Mori, A; Fujimoto, Y; Ogawa, K				Uemoto, S.; Ozawa, K.; Kaido, T.; Mori, A.; Fujimoto, Y.; Ogawa, K.			Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8(+) central memory and effector T cells for better clinical outcomes in liver transplant recipients	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						CD8(+) central memory T cells and CCR7(-) subsets; initial encounter with alloantigen; initial priming of IL-12R1; living donor liver transplantation; Tac; GC or Tac; MMF regimen	MYCOPHENOLATE-MOFETIL; CLONAL EXPANSION; 3RD SIGNAL; ANTIGENIC-STIMULATION; ALLOGRAFT-REJECTION; NAIVE; DIFFERENTIATION; IL-12; ACTIVATION; GENERATION	This study aimed to investigate the role of initial priming of interleukin (IL)-12 receptor beta-1 in CD8(+)central memory T cells (initial IL-12RT(CM) priming) and CCR7-negative subsets (CNS) in effector cell expansion and clinical outcome after living donor liver transplantation (LDLT). One hundred and six patients who underwent LDLT were classified into the following three groups according to hierarchical clustering of CD8(+)CD45 isoforms before LDLT: I, naive-dominant; II, effector memory-dominant; and III, effector-dominant. The pre-existing CD8(+)effector cells (T-E) and activated immune status increased progressively from group I to group II to group III. Groups I, II and III received tacrolimus (Tac)/glucocorticoid (GC) regimens. Eighteen group III recipients received Tac/mycophenolate mofetil (MMF) and were defined as group IV. Initial IL-12RT(CM) priming was slightly, moderately and markedly decreased in droups I, II, and III, respectively. Initial priming of IL-12R1 in CNS was decreased markedly in the three groups with marked decreases of T-E, perforin and interferon (IFN)-; all parameters were restored by up-regulation of IL-12R1(+)T(CM) through the self-renewal of T-CM. The lag time required until coupled up-regulation of IL-12R1 of T-CM and CNS to above baseline was 12, 20 and 32 days in groups I, II and III, respectively. Inferior clinical outcomes were associated with increasing lag time. In contrast, the initial priming of IL-12R1 in T-CM and CNS remained above baseline in group IV due to MMF-mediated increase of IL-12R1. Early coupled up-regulation of T-CM and CNS leads to efficient T-E differentiation and optimal clinical outcomes.	[Uemoto, S.; Kaido, T.; Mori, A.; Fujimoto, Y.; Ogawa, K.] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan; [Ozawa, K.] Hepat Dis Res Inst, Kyoto 6050981, Japan	Ozawa, K (reprint author), Hepat Dis Res Inst, Higashiyama Ku, Honmachi 15Chyome 754-1, Kyoto 6050981, Japan.	kanzou@vesta.ocn.ne.jp			Ministry of Education, Science and Culture of Japan [21659300, 20249058]	This work was funded in part by grants (numbers 21659300 and 20249058) from the Scientific Research Fund of the Ministry of Education, Science and Culture of Japan. We thank members of the Department of Surgery of Kyoto University Medical School for their assistance in this work.	Curtsinger JM, 1999, J IMMUNOL, V162, P3256; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423; Kaech SM, 2001, NAT IMMUNOL, V2, P415; KRAMS SM, 1995, TRANSPLANTATION, V59, P621; Fearon DT, 2006, IMMUNOL REV, V211, P104, DOI 10.1111/j.0105-2896.2006.00390.x; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Carr JM, 2006, P NATL ACAD SCI USA, V103, P19454, DOI 10.1073/pnas.0609706104; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Klintmalm GB, 2011, LIVER TRANSPLANT, V17, P1394, DOI 10.1002/lt.22417; Chang J, 2004, J IMMUNOL, V172, P2818; Schmidt CS, 2002, J IMMUNOL, V168, P5521; Bannard O, 2009, EUR J IMMUNOL, V39, P2083, DOI 10.1002/eji.200939555; Cicinnati VR, 2007, ALIMENT PHARM THERAP, V26, P1195, DOI 10.1111/j.1365-2036.2007.03466.x; Egawa H, 2010, CLIN EXP IMMUNOL, V160, P420, DOI 10.1111/j.1365-2249.2010.04117.x; Egawa H, 2007, LIVER TRANSPLANT, V13, P1262, DOI 10.1002/lt.21232; Everitt BS, 2001, CLUSTER ANAL, P55; Hori T, 2010, SURGERY, V147, P840, DOI 10.1016/j.surg.2009.11.022; Kobayashi H, 2003, TRANSPLANTATION, V75, P529, DOI 10.1097/01.TP.0000048377.59350.E4; Krams SM, 1998, SEMIN LIVER DIS, V18, P153, DOI 10.1055/s-2007-1007151; Martinez OM, 2005, LIVER TRANSPLANT, V11, P370, DOI 10.1002/lt.20406; Mele TS, 2000, IMMUNOPHARMACOLOGY, V47, P215, DOI 10.1016/S0162-3109(00)00190-9; Nashan B, 2009, LIVER TRANSPLANT, V15, P136, DOI 10.1002/lt.21657; Takada Y, 2010, TRANSL RES, V156, P68, DOI 10.1016/j.trsl.2010.06.002; Tanaka K, 2006, LIVER TRANSPLANT, V12, P792, DOI 10.1002/lt.20705; Tanaka K, 2003, LIVING DONOR LIVER T; Uemoto S, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/718386; Valenzuela J, 2002, J IMMUNOL, V169, P6842; Yu AS, 2001, CAN J GASTROENTEROL, V15, P729	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	AUG	2015	181	2					373	384		10.1111/cei.12588		12	Immunology	Immunology	CM9CL	WOS:000358003700019		
J	Noda, S; Otsuji, T; Baba, M; Yoshida, T; Kageyama, S; Okamoto, K; Okada, Y; Kawauchi, A; Onishi, H; Hira, D; Morita, SY; Terada, T				Noda, Satoshi; Otsuji, Takashi; Baba, Masato; Yoshida, Tetsuya; Kageyama, Susumu; Okamoto, Keisei; Okada, Yusaku; Kawauchi, Akihiro; Onishi, Hiroyuki; Hira, Daiki; Morita, Shin-ya; Terada, Tomohiro			Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma	CLINICAL GENITOURINARY CANCER			English	Article						Individualized pharmacotherpy; Kidney cancer; Pharmacokinetics; Tolerability; Tyrosine kinase inhibitor	TYROSINE KINASE INHIBITOR; ANTITUMOR-ACTIVITY; JAPANESE PATIENTS; LUNG-CANCER; PHARMACOKINETICS; EXPOSURE; SAFETY; TUMORS; POLYMORPHISM; ERLOTINIB	The benefit of pharmacokinetic assessment of sunitinib remains unknown. We reported that patients with total sunitinib (sunitinib + its active metabolite SU12662) >= 100 ng/mL showed high incidence of Grade >= 3 toxicities and worsening clinical outcomes. Thus, pharmacokinetic assessment of sunitinib could be helpful for dose optimization. Background: Sunitinib has been approved for the treatment of metastatic renal cell carcinoma (RCC). Sunitinib pharmacokinetics shows a large interpatient variability. Patients and Methods: A retrospective, observational clinical study of 21 patients with RCC was performed. Sunitinib was administered for 4 weeks of a 6-week cycle for the first cycle. We evaluated the association of sunitinib-induced toxicities and clinical outcomes with the trough total sunitinib concentration in a steady state during the first cycle. Results: The median total sunitinib concentration was 91.8 ng/mL (range, 49.8-205 ng/mL). There was an association between total sunitinib concentration and the severity of thrombocytopenia, anorexia, and fatigue. Patients with >= 100 ng/mL total sunitinib (n = 8), compared with patients with < 100 ng/mL (n = 13), had a greater incidence of Grade >= 3 toxicities (6 patients [75.0%] vs. 3 patients [23.1%]). Patients with < 100 ng/mL total sunitinib had significantly longer time to treatment failure (TTF) and progression-free survival (PFS) time than patients with >= 100 ng/mL (median TTF, 590 vs. 71 days; P = .04; median PFS, 748 vs. 238 days; P = .02). Conclusion: Results of this study suggest that therapeutic drug monitoring of sunitinib could be useful for avoiding severe toxicities. Dose reduction might be needed, especially when the total sunitinib concentration is >= 100 ng/mL, to avoid unnecessary early discontinuation of treatment.	[Noda, Satoshi; Hira, Daiki; Morita, Shin-ya; Terada, Tomohiro] Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga 5202192, Japan; [Otsuji, Takashi] Shiga Med Ctr Adults, Dept Pharm, Moriyama, Shiga, Japan; [Baba, Masato; Yoshida, Tetsuya; Kageyama, Susumu; Okamoto, Keisei; Okada, Yusaku; Kawauchi, Akihiro] Shiga Univ Med Sci Hosp, Dept Urol, Otsu, Shiga 5202192, Japan; [Onishi, Hiroyuki] Shiga Med Ctr Adults, Dept Urol, Moriyama, Shiga, Japan	Terada, T (reprint author), Shiga Univ Med Sci Hosp, Dept Pharm, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	teradat@belle.shiga-med.ac.jp		Morita, Shin-ya/0000-0003-4079-707X; Kageyama, Susumu/0000-0001-7150-647X	Japanese Ministry of Education, Culture, Sports, Science, and Technology [22390029]	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 22390029) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Boyle HJ, 2012, EUR RESPIR J, V40, P1300, DOI 10.1183/09031936.00048212; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P147, DOI 10.2165/00003088-200544020-00002; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Hu SY, 2009, CLIN CANCER RES, V15, P6062, DOI 10.1158/1078-0432.CCR-09-0048; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Hamada A, 2012, PHARMACOGENOMICS, V13, P615, DOI [10.2217/pgs.11.176, 10.2217/PGS.11.176]; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Mizuno T, 2010, ANN ONCOL, V21, P1382, DOI 10.1093/annonc/mdq150; Britten CD, 2008, CANCER CHEMOTH PHARM, V61, P515, DOI 10.1007/s00280-007-0498-4; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; de Wit D, 2014, CANCER CHEMOTH PHARM, V73, P87, DOI 10.1007/s00280-013-2322-7; Feyerabend S, 2009, UROL INT, V82, P246, DOI 10.1159/000200809; Flaig T, 2009, INVEST NEW DRUG, V27, P83, DOI 10.1007/s10637-008-9146-z; Guilhot F, 2012, HAEMATOL-HEMATOL J, V97, P731, DOI 10.3324/haematol.2011.045666; Kim HR, 2013, CANCER CHEMOTH PHARM, V72, P825, DOI 10.1007/s00280-013-2258-y; Mizuno T, 2012, DRUG METAB PHARMACOK, V27, P631, DOI 10.2133/dmpk.DMPK-12-RG-026; Mizuno T, 2014, THER DRUG MONIT, V36, P310, DOI 10.1097/FTD.0000000000000025; Noda Satoshi, 2012, Case Rep Oncol, V5, P627, DOI 10.1159/000345694; Sugiyama Y, 2007, DRUG METAB PHARMACOK, V22, P199, DOI 10.2133/dmpk.22.199	27	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1558-7673	1938-0682		CLIN GENITOURIN CANC	Clin. Genitourin. Cancer	AUG	2015	13	4					350	358		10.1016/j.clgc.2015.01.007		9	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CM7NF	WOS:000357880000036		
J	Fujimoto, N; Kubo, T; Tomisaki, I				Fujimoto, Naohiro; Kubo, Tatsuhiko; Tomisaki, Ikko			Cessation of Primary Androgen Deprivation Therapy for Men With Localized Prostate Cancer	CLINICAL GENITOURINARY CANCER			English	Article						Androgen deprivation; Localized cancer; Cessation; Prostate; PSA recurrence	RADICAL PROSTATECTOMY; BLOCKADE; RADIOTHERAPY; STATISTICS; PATTERNS; TRENDS; RISK	In a retrospective study, we analyzed the clinical outcomes after cessation of primary androgen deprivation therapy (ADT) for localized prostate cancer. Prostate-specific antigen (PSA) recurrence was observed in 10 of 34 men (29.4%), with the median follow-up of 37 months after ADT cessation. The 5-year PSA progression-free rate was 66.2%. Neither clinical progression nor prostate cancer death was observed. Introduction: Substantial numbers of men with localized prostate cancer undergo long-term primary androgen deprivation therapy (ADT). Whether long-term ADT is required for patients with localized prostate cancer, especially elderly men, remains unknown. In the present study, we explored the possibility of ADT cessation after a favorable response to primary ADT in patients with localized prostate cancer. Patients and Methods: We retrospectively reviewed men with localized prostate cancer who had achieved a good initial response to primary ADT and stopped it thereafter. Prostate-specific antigen (PSA) recurrence was defined as 2 consecutive increases > 4 ng/mL. A total of 34 patients (age, 62-89 years) were followed up for > 24 months after ADT cessation. Results: The ADT duration and follow-up period after ADT cessation was 10 to 162 months (median, 33.5 months) and 24 to 95 months (median, 37 months), respectively. PSA recurrence was observed in 10 of 34 patients (29.4%), and the 5-year PSA progression-free rate was 66.2%. PSA recurrence was observed in 100% (6 of 6) and 14.3% (4 of 28) of men who had received ADT for < 16 months and > 16 months, respectively. ADT was reinstated in 5 patients after PSA recurrence; and their PSA levels declined rapidly, and no clinical progression was observed. The 5-year overall and disease-specific survival rate was 65.1% and 100%, respectively. Conclusion: ADT can be stopped for men with localized prostate cancer, especially elderly men, after a favorable response to primary ADT.	[Fujimoto, Naohiro; Tomisaki, Ikko] Univ Occupat & Environm Hlth, Sch Med, Dept Urol, Kitakyushu, Fukuoka 8078555, Japan; [Kubo, Tatsuhiko] Univ Occupat & Environm Hlth, Sch Med, Dept Publ Hlth, Kitakyushu, Fukuoka 8078555, Japan	Fujimoto, N (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Urol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	n-fuji@med.uoeh-u.ac.jp					Akaza H, 2006, CANCER SCI, V97, P243, DOI 10.1111/j.1349-7006.2006.00180.x; Alibhai SMH, 2006, CRIT REV ONCOL HEMAT, V60, P201, DOI 10.1016/j.critrevonc.2006.06.006; Cooperberg MR, 2003, J NATL CANCER I, V95, P981; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Akaza H, 2006, BJU INT, V98, P573, DOI 10.1111/j.1464-410X.2006.06349.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Cheung AS, 2013, ANDROLOGY-US, V1, P583, DOI 10.1111/j.2047-2927.2013.00093.x; Kawakami J, 2006, CANCER, V106, P1708, DOI 10.1002/cncr.21799; Fujimoto H, 2005, INT J UROL, V12, P46; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; Fujimoto N, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-7; Guise Theresa A, 2007, Rev Urol, V9, P163; Kurek R, 1999, EUR UROL, V35, P27, DOI 10.1159/000052304; Labrie F, 2002, UROLOGY, V60, P115, DOI 10.1016/S0090-4295(02)01639-4; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V301, P38; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595	20	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1558-7673	1938-0682		CLIN GENITOURIN CANC	Clin. Genitourin. Cancer	AUG	2015	13	4					359	363		10.1016/j.clgc.2015.02.013		5	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CM7NF	WOS:000357880000037		
J	Takahashi, M; Kusuhara, Y; Mori, H; Komori, M; Kagawa, J; Fukawa, T; Yamamoto, Y; Yamaguchi, K; Fukumori, T; Kanayama, H				Takahashi, Masayuki; Kusuhara, Yoshito; Mori, Hidehisa; Komori, Masatsugu; Kagawa, Junichiro; Fukawa, Tomoya; Yamamoto, Yasuyo; Yamaguchi, Kunihisa; Fukumori, Tomoharu; Kanayama, Hiroomi			Long-Term Administration of Docetaxel Over 70 Cycles for Castration-Resistant Prostate Cancer	CLINICAL GENITOURINARY CANCER			English	Article						ARD6563; Chemotherapy; CRPC; Long survival; Metastatic	MITOXANTRONE PLUS PREDNISONE; PHASE-II TRIAL; JAPAN; CHEMOTHERAPY; ESTRAMUSTINE; MULTICENTER; THERAPY; PLACEBO; MEN	Docetaxel is recommended as the first-line chemotherapy in patients with castration-refractory prostate cancer. Usually, 10 cycles of docetaxel is administered, however, the efficacy and the safety with more than 10 cycles of docetaxel have not been fully reported. We report on 2 patients who received at least 70 cycles of docetaxel including the combination therapy and survived more than 6 years. Considering the possible survival benefit of the long-term administration of docetaxel in selected patients, the timing to switch from docetaxel to the new drugs such as abiraterone acetate, enzalutamide, and cabazitaxel might be more complex. (C) 2015 Elsevier Inc. All rights reserved.	[Takahashi, Masayuki; Kusuhara, Yoshito; Mori, Hidehisa; Komori, Masatsugu; Kagawa, Junichiro; Fukawa, Tomoya; Yamamoto, Yasuyo; Yamaguchi, Kunihisa; Fukumori, Tomoharu; Kanayama, Hiroomi] Univ Tokushima, Grad Sch, Dept Urol, Inst Hlth Biosci, Tokushima 7708503, Japan	Takahashi, M (reprint author), Univ Tokushima, Grad Sch, Dept Urol, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	takahashi.masayuki@tokushima-u.ac.jp					Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Sonpavde G, 2012, ANN ONCOL, V23, P1803, DOI 10.1093/annonc/mdr555; Beer TM, 2008, CANCER, V112, P326, DOI 10.1002/cncr.23163; Naito S, 2008, JPN J CLIN ONCOL, V38, P365, DOI 10.1093/jjco/hyn029; Soga N, 2009, INT J CLIN ONCOL, V14, P130, DOI 10.1007/s10147-008-0814-y; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Fujimoto H, 2005, INT J UROL, V12, P46; Kawahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048186; Miyake H, 2013, UROL ONCOL-SEMIN ORI, V31, P733, DOI 10.1016/j.urolonc.2011.06.006; Nishimura K, 2013, INT J CLIN ONCOL, V18, P306, DOI 10.1007/s10147-012-0380-1; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pond GR, 2012, EUR UROL, V61, P363, DOI 10.1016/j.eururo.2011.06.034	12	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1558-7673	1938-0682		CLIN GENITOURIN CANC	Clin. Genitourin. Cancer	AUG	2015	13	4					E337	E340		10.1016/j.clgc.2015.01.012		4	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CM7NF	WOS:000357880000023		
J	Tanabe, K; Yoshida, S; Koga, F; Inoue, M; Kobayashi, S; Ishioka, J; Tamura, T; Sugawara, E; Saito, K; Akashi, T; Fujii, Y; Kihara, K				Tanabe, Kenji; Yoshida, Soichiro; Koga, Fumitaka; Inoue, Masaharu; Kobayashi, Shuichiro; Ishioka, Junichiro; Tamura, Tomoki; Sugawara, Emiko; Saito, Kazutaka; Akashi, Takumi; Fujii, Yasuhisa; Kihara, Kazunori			High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol	CLINICAL GENITOURINARY CANCER			English	Article						Chemoradiotherapy; Ki-67 antigen; Organ preservation; Prognosis; Urinary bladder neoplasms	THERAPY ONCOLOGY GROUP; APPARENT DIFFUSION-COEFFICIENT; SELECTIVE ORGAN PRESERVATION; COMBINED-MODALITY THERAPY; RADIATION-THERAPY; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; TRIMODALITY THERAPY; LABELING INDEX; CELL-CARCINOMA	Reportedly, in bladder cancer patients, higher Ki-67 expression status is associated with poorer clinical outcomes after radical cystectomy. The current study demonstrated the application of induction chemoradiotherapy (CRT) may give survival benefits to muscle-invasive bladder cancer (MIBC) patients with high Ki-67 labeling index (LI). Favorable CRT response could potentially contribute to improved survival outcomes in MIBC patients with high Ki-67 LI. Purpose: To evaluate associations of Ki-67 expression with oncologic outcomes in muscle-invasive bladder cancer (MIBC) patients treated with chemoradiotherapy (CRT)-based bladder-sparing protocol. Materials and Methods: Between 1998 and 2011, 190 consecutive MIBC patients were treated with CRT-based bladder-sparing protocol. After transurethral resection of the bladder tumor, the patients underwent induction CRT (40 Gy with concurrent cisplatin) followed by partial cystectomy for bladder preservation or radical cystectomy (RC). Included in this study were 94 patients who were histologically diagnosed with urothelial carcinoma and whose tumor tissues before CRT were available for immunohistochemical evaluation of Ki-67 expression status. Results: After induction CRT, 16 (17%) and 53 (56%) patients underwent partial cystectomy and RC, respectively, while the remaining 25 (27%) did not undergo cystectomy. Successful bladder preservation was achieved in 34 patients (36%). Higher Ki-67 labeling index (LI) independently predicted CRT response clinically and pathologically. Among the clinicopathologic variables available before CRT and cystectomy, high Ki-67 LI (>= 20%) was independently associated with better cancer-specific survival (CSS) (5-year CSS rate, 78% vs. 46% for low Ki-67 LI; P = .019). The difference in CSS according to Ki-67 expression status was more remarkable in patients with cT3 disease (5-year CSS rate, 72% vs. 29%; P = .0098). Conclusion: High Ki-67 expression predicts favorable CSS in MIBC patients treated with CRT-based bladder-sparing protocol. MIBC patients with high Ki-67 expression status might benefit from CRT-based multimodal approaches in terms of prognosis and quality of life as a result of bladder preservation.	[Tanabe, Kenji; Yoshida, Soichiro; Inoue, Masaharu; Kobayashi, Shuichiro; Ishioka, Junichiro; Saito, Kazutaka; Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Tokyo 1138519, Japan; [Tamura, Tomoki; Sugawara, Emiko; Akashi, Takumi] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol, Tokyo 1138519, Japan; [Koga, Fumitaka] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo, Japan	Yoshida, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	s-yoshida.uro@tmd.ac.jp					Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; James ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106; Coen JJ, 2013, INT J RADIAT ONCOL, V86, P311, DOI 10.1016/j.ijrobp.2013.01.020; Matsumoto H, 2004, JPN J CLIN ONCOL, V34, P124, DOI 10.1093/jjco/hyh026; Kobayashi S, 2014, J MAGN RESON IMAGING, V39, P172, DOI 10.1002/jmri.24148; Shipley WU, 1998, J CLIN ONCOL, V16, P3576; Kachnic LA, 1997, J CLIN ONCOL, V15, P1022; Chen RC, 2013, J NATL COMPR CANC NE, V11, P952; Yoshida S, 2013, EUR RADIOL, V23, P2206, DOI 10.1007/s00330-013-2805-2; Margulis V, 2006, CLIN CANCER RES, V12, P7369, DOI 10.1158/1078-0432.CCR-06-1472; RaybaudDiogene H, 1997, J CLIN ONCOL, V15, P1030; Quintero A, 2006, J CLIN PATHOL, V59, P83, DOI 10.1136/jcp.2004.022939; David KA, 2007, J UROLOGY, V178, P451, DOI 10.1016/j.juro.2007.03.101; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Mitin T, 2013, CURR UROL REP, V14, P109, DOI 10.1007/s11934-012-0301-x; Huddart RA, 2010, BJU INT, V106, P753, DOI 10.1111/j.1464-410X.2010.09537.x; Morinaga S, 2005, J SURG ONCOL, V92, P331, DOI 10.1002/jso.20309; HOUSSET M, 1993, J CLIN ONCOL, V11, P2150; Margulis V, 2009, JNCI-J NATL CANCER I, V101, P114, DOI 10.1093/jnci/djn451; Eisenberg MS, 2010, J UROLOGY, V184, P2264, DOI 10.1016/j.juro.2010.08.007; Yoshida S, 2012, INT J RADIAT ONCOL, V83, pE21, DOI 10.1016/j.ijrobp.2011.11.065; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; Tester W, 1996, J CLIN ONCOL, V14, P119; Smith ZL, 2013, BJU INT, V112, P13, DOI 10.1111/j.1464-410X.2012.11762.x; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Coppin CML, 1996, J CLIN ONCOL, V14, P2901; Gimotty PA, 2005, J CLIN ONCOL, V23, P8048, DOI 10.1200/JCO.2005.02.0735; Koga F, 2009, BJU INT, V104, P189, DOI 10.1111/j.1464-410X.2008.08297.x; Koga F, 2012, INT J UROL, V19, P388, DOI 10.1111/j.1442-2042.2012.02974.x; Koga F, 2008, UROLOGY, V72, P384, DOI 10.1016/j.urology.2008.03.017; Koga F, 2012, BJU INT, V109, P860, DOI 10.1111/j.1464-410X.2011.10425.x; Nakano T, 1997, CANCER, V79, P513, DOI 10.1002/(SICI)1097-0142(19970201)79:3<513::AID-CNCR13>3.3.CO;2-Z; Paramasivan S, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-78; Rodel C, 2000, INT J RADIAT ONCOL, V46, P1213, DOI 10.1016/S0360-3016(99)00544-1; Sandler HM, 2010, EXPERT REV ANTICANC, V10, P895, DOI [10.1586/era.10.34, 10.1586/ERA.10.34]; Shipley WU, 2003, CANCER, V97, P2115, DOI 10.1002/cncr.11282; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stein JP, 2001, J CLIN ONCOL, V19, P666; Abol-Enein H, 2005, EUR UROL, V48, P202, DOI 10.1016/j.eururo.2005.04.006	40	1	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1558-7673	1938-0682		CLIN GENITOURIN CANC	Clin. Genitourin. Cancer	AUG	2015	13	4					E243	E251		10.1016/j.clgc.2015.03.002		9	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CM7NF	WOS:000357880000008		
J	Kono, M; Yamashita, H; Kubota, K; Kano, T; Mimori, A				Kono, Masanori; Yamashita, Hiroyuki; Kubota, Kazuo; Kano, Toshikazu; Mimori, Akio			FDG PET Imaging in Pneumocystis Pneumonia	CLINICAL NUCLEAR MEDICINE			English	Editorial Material							JIROVECI PNEUMONIA; BONE-SCINTIGRAPHY; INFECTION; DIAGNOSIS	A 69-year-old woman with rheumatoid arthritis and pleuritis presented with dyspnea. On admission, she was afebrile and had an oxygen saturation of 97% on ambient air. Chest radiography and CT revealed only subtle ground-glass opacities. However, FDG PET revealed pathological uptake in both lungs. A diagnosis of Pneumocystis pneumonia was made based on a positive beta-d-glucan assay and polymerase chain reaction amplification of Pneumocystis jirovecii from the sputum. Posttreatment FDG PET revealed resolution of the previously noted uptake. This case illustrates that FDG PET can be used to diagnose Pneumocystis pneumonia when the CT findings are equivocal.	[Kono, Masanori; Yamashita, Hiroyuki; Kano, Toshikazu; Mimori, Akio] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Dept Radiol, Tokyo 1628655, Japan; [Kubota, Kazuo] Natl Ctr Global Hlth & Med, Div Nucl Med, Dept Radiol, Tokyo 1628655, Japan	Kono, M (reprint author), Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mkouno-tky@umin.ac.jp					Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Kanne JP, 2012, AM J ROENTGENOL, V198, pW555, DOI 10.2214/AJR.11.7329; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/ERI.10.42]; Bollee G, 2007, CHEST, V132, P1305, DOI 10.1378/chest.07-0223; Matsumura Y, 2012, CLIN MICROBIOL INFEC, V18, P591, DOI 10.1111/j.1469-0691.2011.03605.x; Chamroonrat W, 2010, CLIN NUCL MED, V35, P542, DOI 10.1097/RLU.0b013e3181e05d54; Chamroonrat W, 2013, CLIN NUCL MED, V38, P285, DOI 10.1097/RLU.0b013e3182815fb6; Hidalgo A, 2002, EUR RADIOL, V13, P1179; Sajan SM, 2005, CLIN NUCL MED, V30, P763; Song L, 2014, CLIN NUCL MED, V39, P996, DOI 10.1097/RLU.0000000000000484; Win Z, 2005, CLIN NUCL MED, V30, P690, DOI 10.1097/01.rlu.0000178784.58278.36	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	AUG	2015	40	8					679	681		10.1097/RLU.0000000000000831		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9QJ	WOS:000358043600015		
J	Satoh, Y; Koizumi, K; Nambu, A; Araki, T				Satoh, Yoko; Koizumi, Kiyoshi; Nambu, Atsushi; Araki, Tsutomu			A Case of Massive Bone Metastases From Lung Cancer Detected Only by 18F-FDG PET/CT	CLINICAL NUCLEAR MEDICINE			English	Editorial Material							FDG-PET; SCINTIGRAPHY	A 74-year-old man was diagnosed with small cell lung carcinoma in the left upper lobe. F-18-FDG PET/CT showed multifocal strong abnormal uptakes in the axial skeleton and those of the primary lung tumor. CT failed to demonstrate the bony abnormalities. A subsequent Tc-99m-MDP bone scintigraphy was also almost negative. It is important to note that bone metastasis may be undetectable by both CT and bone scintigraphy even if it is massive.	[Satoh, Yoko] Kofu Neurosurg Hosp, PET Ctr, Kofu, Yamanashi 4000805, Japan; [Koizumi, Kiyoshi] Tokyo Med Univ, Hachioji Med Ctr, Dept Radiol, Tokyo 1608402, Japan; [Nambu, Atsushi] Teikyo Univ, Sch Med, Dept Radiol, Teikyo Univ Hosp, Tokyo 173, Japan; [Araki, Tsutomu] Yamanashi Univ, Dept Radiol, Chuo City, Yamanashi, Japan	Satoh, Y (reprint author), Kofu Neurosurg Hosp, PET Ctr, Sakaori 1-16-18, Kofu, Yamanashi 4000805, Japan.	pecampecam@yahoo.co.jp					Abe K, 2005, ANN NUCL MED, V19, P573, DOI 10.1007/BF02985050; Bury T, 1998, EUR J NUCL MED, V25, P1244, DOI 10.1007/s002590050291; Nakamoto Y, 2005, RADIOLOGY, V237, P627, DOI 10.1148/radiol.2372031994; Cheran SK, 2004, LUNG CANCER-J IASLC, V44, P317, DOI 10.1016/j.lungcan.2003.11.008; CHARKES ND, 1979, J NUCL MED, V20, P794; Cheng X, 2011, ACTA RADIOL, V52, P779, DOI 10.1258/ar.2011.110115; Min JW, 2009, J KOREAN MED SCI, V24, P275, DOI 10.3346/jkms.2009.24.2.275; Nosaki T, 1989, Rinsho Hoshasen, V34, P991	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	AUG	2015	40	8					E411	E414		10.1097/RLU.0000000000000836		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9QM	WOS:000358043900005		
J	Okubo, T; Hagiwara, A; Kitano, H; Takahashi, S; Tsuchida, A				Okubo, Tsuneo; Hagiwara, Akira; Kitano, Hiromi; Takahashi, Shinya; Tsuchida, Akira			Drying dissipative patterns of aqueous solution of poly(methacrylic acid) and its salt neutralized half	COLLOID AND POLYMER SCIENCE			English	Article						Poly(methacrylic acid) (HPMA); Laurel crown pattern; Drying pattern; Broad ring pattern; Hygroscopic polymer	COLLOIDAL SILICA SPHERES; 1.2 MU-M; COVER GLASS; DIAMETER SUSPENSIONS; WATCH GLASS; POLY(RIBOADENYLIC ACID); POTASSIUM-SALTS; DIFFERENT SIZES; SEDIMENTATION; CRYSTALLIZATION	Drying patterns of poly(methacrylic acid) (HPMA) and its salt neutralized half with sodium hydroxide (NaHPMA) were studied on a cover glass, a watch glass, and a glass dish. The patterns of HPMA and NaHPMA are compared with the previous observation of sodium salt of poly(methacrylic acid), NaPMA (Okubo et al. Colloid Polym Sci 287:1155-1165, 2009). HPMA and especially NaHPMA are hygroscopic, and only the macroscopic patterns were observed. However, microscopic patterns were not observed clearly especially for NaHPMA in the room atmosphere. The hygroscopy of the dried films was in the order NaPMA < HPMA < NaHPMA. Broad rings of HPMA formed only at the outside edge irrespective of polymer concentration. Simplified laurel crown-like patterns appeared on a cover glass, which supports the strong solute-substrate affinity. On the other hand, the broad ring size of NaHPMA decreased sharply at the lower polymer concentrations than the critical concentration, m*. The results of NaHPMA support that both the inter-solutes and solute-substrate affinity are rather weak, and the pattern size was determined with the excluded volume effects. Sharpness parameter, S, of the broad rings was in the order HPMA > NaHPMA > NaPMA. The magnitude of S values of NaPMA was similar to that of poly(ethylene glycol) (PEG). HPMA, NaHPMA, and NaPMA were grouped into E, A, and A, respectively, among six groups of solutes A to F.	[Okubo, Tsuneo] Inst Colloidal Org, Uji, Kyoto 6110012, Japan; [Hagiwara, Akira; Kitano, Hiromi] Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Toyama 9308555, Japan; [Takahashi, Shinya; Tsuchida, Akira] Gifu Univ, Dept Appl Chem, Fac Engn, Gifu 5011193, Japan	Okubo, T (reprint author), Inst Colloidal Org, Hatoyama 3-1-112, Uji, Kyoto 6110012, Japan.	okubotsu@ybb.ne.jp					Maenosono S, 1999, LANGMUIR, V15, P957, DOI 10.1021/la980702q; Okubo T, 2009, COLLOID POLYM SCI, V287, P351, DOI 10.1007/s00396-008-1947-2; Okubo T, 2008, COLLOID POLYM SCI, V286, P385, DOI 10.1007/s00396-007-1778-6; Okubo T, 2014, COLLOID POLYM SCI, V292, P1419, DOI 10.1007/s00396-014-3200-5; Yamaguchi T, 2005, COLLOID POLYM SCI, V283, P1123, DOI 10.1007/s00396-004-1258-1; Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9; Okubo T, 2009, COLLOID POLYM SCI, V287, P645, DOI 10.1007/s00396-009-2021-4; Okubo T, 2011, COLLOID SURFACE B, V87, P11, DOI 10.1016/j.colsurfb.2011.03.022; Okubo T, 2008, COLLOID POLYM SCI, V286, P941, DOI 10.1007/s00396-008-1852-8; Nikoobakht B, 2000, J PHYS CHEM B, V104, P8635, DOI 10.1021/jp001287p; Okubo T, 2008, COLLOID POLYM SCI, V286, P1123, DOI 10.1007/s00396-008-1874-2; Ung T, 2001, J PHYS CHEM B, V105, P3441, DOI 10.1021/jp003500n; Ball P, 1999, PATTERN FORMATION NA; Gribbin G, 1999, EVERYONES GUIDE SCI; Ida T, 2008, J APPL CRYSTALLOGR, V41, P393, DOI 10.1107/S0021889807067659; Nakaya U, 1947, MEMOIRS TORAHIKO TER; Nicolis G., 1977, SELF ORG NONEQUILIBR; Ohara PC, 1997, ANGEW CHEM, V109, P1120, DOI 10.1002/ange.19971091011; Okubo T, 2005, COLLOID POLYM SCI, V283, P1; Okubo T, 2008, COLLOID POLYM SCI, V286, P1411, DOI 10.1007/s00396-008-1912-0; Okubo T, 2006, MOL COLLOIDAL ELECTR, P573; Okubo T, 2009, COLLOID POLYM SCI, V287, P167, DOI 10.1007/s00396-008-1960-5; Okubo T, 2006, COLLOID POLYM SCI, V284, P1191, DOI 10.1007/s00396-006-1511-x; Okubo T, 2011, COLLOID POLYM SCI, V289, P1729, DOI 10.1007/s00396-011-2495-8; Okubo T, 2011, COLLOID SURFACE B, V87, P439, DOI 10.1016/j.colsurfb.2011.06.006; Okubo T, 2008, NANOPARTICLES SYNTHE, P256; Okubo T, 2008, COLLOID POLYM SCI, V286, P1307, DOI 10.1007/s00396-008-1898-7; Okubo T, 2007, COLLOID POLYM SCI, V285, P1257, DOI 10.1007/s00396-007-1681-1; Okubo T, 2006, COLLOID POLYM SCI, V285, P331, DOI 10.1007/s00396-006-1576-6; Okubo T, 2004, COLLOID POLYM SCI, V282, P230, DOI 10.1007/s00396-003-0899-9; Okubo T, 2007, COLLOID POLYM SCI, V285, P1495, DOI 10.1007/s00396-007-1715-8; Okubo T, 2007, COLLOID POLYM SCI, V285, P967, DOI 10.1007/s00396-007-1642-8; Okubo T, 2009, COLLOID POLYM SCI, V287, P1155, DOI 10.1007/s00396-009-2075-3; Okubo T, 2006, COLLOID POLYM SCI, V285, P339, DOI 10.1007/S00396-006-1577-5; Okubo T, 2006, COLLOID POLYM SCI, V285, P225, DOI 10.1007/s00396-006-1555-y; Okubo T, 2010, COLLOID POLYM SCI, V288, P981, DOI 10.1007/s00396-010-2218-6; Okubo T, 2001, BEAUTIFUL WORLD COLL; Okubo T, 2010, COLLOID POLYM SCI, V288, P1435, DOI 10.1007/s00396-010-2281-z; Okubo T, 2005, LANGMUIR, V21, P9889, DOI 10.1021/la050692a; Okubo T, 2010, MACROMOL SYMP, V288, P67, DOI 10.1002/masy.201050209; Okubo T, 2006, COLLOID POLYM SCI, V284, P1395, DOI 10.1007/s00396-006-1509-4; Okubo T, 2006, COLLOID POLYM SCI, V284, P396, DOI 10.1007/s00396-005-1397-z; Okubo T, 2004, COLLOID POLYM SCI, V282, P486, DOI 10.1007/s00396-003-0972-4; Okubo T, 2009, COLLOID POLYM SCI, V287, P933, DOI 10.1007/s00396-009-2049-5; Terada T, 1935, P IMPER ACAD TOKYO, V11, P214; Terada T, 1934, SCI PAP I PHYS CHEM, V23, P173; Terada T, 1934, SCI PAP I PHYS CHEM, V27, P75; Vanderhoff JW, 1973, J POLYM SCI POLYM S, V41, P155	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	AUG	2015	293	8					2137	2146		10.1007/s00396-015-3602-z		10	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CM9UM	WOS:000358054500001		
J	Kodama, S; Zhang, X; Yoshie, N				Kodama, Shunsuke; Zhang, Xin; Yoshie, Naoko			Formation of nanostructured thin films of immiscible polymer blends by directional crystallization onto a crystallizable organic solvent	COLLOID AND POLYMER SCIENCE			English	Article						Nanopatterning; Poly(L-lactic acid); Epitaxial crystallization; Self-assembly; Non-equilibrium solidification	EPITAXIAL CRYSTALLIZATION; DIBLOCK COPOLYMERS; ORIENTATION; MICRODOMAIN; SURFACES; FIELDS	We show that epitaxial crystallization on a crystallizable solvent is a valuable method for achieving well-ordered nanoscale patterning in thin films of crystalline/amorphous immiscible polymer blends. Nanoscale patterning was achieved by cooling a hot solution of poly(l-lactic acid) (PLLA) and polystyrene (PS) in hexamethylbenzene (HMB) to a temperature below the melting temperature of HMB. Crystallization of HMB induced deposition of the polymers, directional crystallization of PLLA, and freezing of the progress of the phase segregation almost simultaneously, allowing the development of nanoscale well-oriented lamellar patterns. We compare the patterns formed in thin films of PLLA/PS immiscible blends with those formed in thin films of PLLA/poly(vinyl acetate) miscible blends and discuss the mechanism underlying the formation of ordered structures in immiscible blends in crystallizable solvents.	[Kodama, Shunsuke; Zhang, Xin; Yoshie, Naoko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Yoshie, N (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	yoshie@iis.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25600023]	This work was partially supported by a Grant-in-Aid for Scientific Research (No. 25600023) from the Japan Society for the Promotion of Science.	WITTMANN JC, 1983, J POLYM SCI POL PHYS, V21, P2495, DOI 10.1002/pol.1983.180211207; Ho RM, 2003, MACROMOLECULES, V36, P9085, DOI 10.1021/ma0347868; Boltau M, 1998, NATURE, V391, P877; Cartier L, 2000, POLYMER, V41, P8909, DOI 10.1016/S0032-3861(00)00234-2; Li SM, 1999, MACROMOLECULES, V32, P4454, DOI 10.1021/ma990117b; Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109; Osuji C, 2004, MACROMOLECULES, V37, P9903, DOI 10.1021/ma0483064; Walheim S, 1997, MACROMOLECULES, V30, P4995, DOI 10.1021/ma9619288; Ejima H, 2007, MACROMOLECULES, V40, P6445, DOI 10.1021/ma0711543; WITTMANN JC, 1990, PROG POLYM SCI, V15, P909, DOI 10.1016/0079-6700(90)90025-V; Nagpal U, 2011, ACS NANO, V5, P5673, DOI 10.1021/nn201335v; Bodycomb J, 1999, MACROMOLECULES, V32, P2075, DOI 10.1021/ma981538g; Morkved TL, 1996, SCIENCE, V273, P931, DOI 10.1126/science.273.5277.931; Byun M, 2008, MACROMOLECULES, V41, P9312, DOI 10.1021/ma801864n; Fang L, 2012, LANGMUIR, V28, P10280; Fang LA, 2010, MACROMOLECULES, V43, P9747, DOI 10.1021/ma1017082; Germack DS, 2013, ACS NANO, V7, P1990, DOI 10.1021/nn303765t; Rosa D, 2000, MACROMOLECULES, V33, P4871; Rosa D, 2000, NATURE, V405, P433; Villar MA, 2002, POLYMER, V43, P5139, DOI 10.1016/S0032-3861(02)00388-9; Wu KH, 2006, LANGMUIR, V22, P8029, DOI 10.1021/la060418w	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	AUG	2015	293	8					2165	2169		10.1007/s00396-015-3593-9		5	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CM9UM	WOS:000358054500004		
J	Yusof, NH; Noguchi, K; Fukuhara, L; Yamamoto, Y; Kawahara, S				Yusof, Nurul Hayati; Noguchi, Kenshi; Fukuhara, Lina; Yamamoto, Yoshimasa; Kawahara, Seiichi			Preparation and properties of natural rubber with filler nanomatrix structure	COLLOID AND POLYMER SCIENCE			English	Article						Natural rubber; Filler nanomatrix; Silica nanoparticle; TEM; Mechanical properties		Natural rubber with filler nanomatrix structure was prepared by forming chemical linkages between natural rubber particles and filler nanoparticles. The filler nanomatrix structure was formed by graft copolymerization of vinyltriethoxysilane (VTES) onto natural rubber particles in the latex stage followed by casting of the latex to prepare an as-cast film. The silica nanoparticles were produced during the graft copolymerization through hydrolysis and condensation, i.e., sol-gel reaction; hence, they linked to the natural rubber particles. The nanomatrix structure was observed by transmission electron microscopy, in which the natural rubber particles of about 1 mu m in diameter were well dispersed in the filler nanomatrix. Tensile properties were significantly improved by forming filler nanomatrix structure. The loss modulus and loss tangent of the natural rubber with the filler nanomatrix structure were almost independent of deformation frequency in the rubbery plateau region, which was explained to be due to the energetic elasticity and entropic elasticity characteristic of the nanomatrix structure.	[Yusof, Nurul Hayati; Noguchi, Kenshi; Kawahara, Seiichi] Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan; [Yusof, Nurul Hayati] Malaysian Rubber Board, RRIM Res Stn, Sg Buloh 47000, Selangor, Malaysia; [Fukuhara, Lina; Yamamoto, Yoshimasa] Tokyo Natl Coll Technol, Dept Chem Sci & Engn, Hachioji, Tokyo 1930997, Japan	Kawahara, S (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan.	kawahara@mst.nagaokaut.ac.jp			Japan Society for the Promotion of Science [26620176, 25288098]; JST-JICA SATREPS	This work was supported in part by a Grant-in-Aid (26620176) for Challenging Exploratory Research and Grant-in-Aid (25288098) for Scientific Research (B) from Japan Society for the Promotion of Science and JST-JICA SATREPS.	Pukkate N, 2007, EUR POLYM J, V43, P3208, DOI 10.1016/j.eurpolymj.2007.04.037; Brechet Y, 2001, ADV ENG MATER, V3, P571, DOI 10.1002/1527-2648(200108)3:8<571::AID-ADEM571>3.0.CO;2-M; EDWARDS DC, 1990, J MATER SCI, V25, P4175, DOI 10.1007/BF00581070; Brandrup J, 1998, POLYM HDB; Deepalekshmi P, 2014, NONLINEAR VISCOELAST; Ferry JD, 1980, VISCOELASTIC PROPERT; Isono Y, 2013, NIHON REOROJI GAKK, V41, P137; Ivanov Y, 2001, POLYMER COMPOSITE MA, V90; James EM, 2007, PHYS PROPERTIES POLY, P455; Joseph CS, 1996, POLYMERIC MAT ENCY, P699; Kawahara S, 2011, POLYM ADVAN TECHNOL, V22, P2665, DOI 10.1002/pat.1803; Kawahara S, 2014, NIHON REOROJI GAKK, V42, P79; Kawahara S, 2014, POLYMER, V55, P5024, DOI 10.1016/j.polymer.2014.07.026; Kawahara S, 2008, MACROMOLECULES, V41, P4510, DOI 10.1021/ma7028538; Kosugi K, 2012, COLLOID POLYM SCI, V290, P1457, DOI 10.1007/s00396-012-2703-1; Lawrence EN, 1994, MECH PROPERTIES POLY, V2nd; Maghami S, 2011, 180 TECH M RUBB DIV; Meng-Jiao W, 1998, RUBBER CHEM TECHNOL, V71, P520; Robert AD, 1998, NAT RUBBER SCI TECH; ROLAND CM, 1989, RUBBER CHEM TECHNOL, V62, P896, DOI 10.5254/1.3536282; Sam C, 2014, PHYS REV LETT, V113; Tinker AJ, 1998, BLENDS NAT RUBBER	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	AUG	2015	293	8					2249	2256		10.1007/s00396-015-3615-7		8	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CM9UM	WOS:000358054500013		
J	Wang, GW; Uyama, H				Wang, Guowei; Uyama, Hiroshi			Reactive poly(ethylene-co-vinyl alcohol) monoliths with tunable pore morphology for enzyme immobilization	COLLOID AND POLYMER SCIENCE			English	Article						Poly(ethylene-co-vinyl alcohol); Thermally induced phase separation; Monolith; Immobilized enzyme	INDUCED PHASE-SEPARATION; LARGE SURFACE-AREA; EFFICIENT SEPARATION; COUPLING REACTIONS; SMALL MOLECULES; CHITOSAN BEADS; POLYMER; UREASE; NANOPARTICLES; FABRICATION	Poly(ethylene-co-vinyl alcohol) (EVOH) monoliths were fabricated from two kinds of EVOH with different ethylene contents by thermally induced phase separation (TIPS) technique using a mixed solvent of isopropanol (IPA) and water. The pore and skeleton sizes could be controlled by changing the fabrication parameters such as the concentration of the polymer, the ratio of IPA and water, and the cooling temperature. The EVOH monoliths possessed relatively high specific surface area and uniform mesopore structure. Furthermore, the monolith was applied for a support matrix of enzyme immobilization. The monolith was successfully activated by carbonyldiimidazole and subsequently reacted with urease. The good reusability of the urease-immobilized monolith was demonstrated. The present EVOH monoliths have good hydrophilicity and reactive hydroxyl groups; therefore, it possesses large potential for various bio-related applications such as enzyme immobilization and protein purification.	[Wang, Guowei; Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Uyama, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	uyama@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [25288090]; Project for Creating Start-ups from Advanced Research and Technology, MEXT	This study is financially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25288090) and a Project for Creating Start-ups from Advanced Research and Technology, MEXT.	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tomasic V, 2007, CATAL TODAY, V119, P106, DOI 10.1016/j.cattod.2006.08.047; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451; Li YC, 2013, COLLOID SURFACE B, V102, P53, DOI 10.1016/j.colsurfb.2012.08.054; Pierre SJ, 2006, ADV MATER, V18, P1822, DOI 10.1002/adma.200600293; Gonzalez-Benito J, 2006, POLYMER, V47, P3065, DOI 10.1016/j.polymer.2006.02.086; Wang GW, 2015, J COLLOID INTERF SCI, V451, P184, DOI 10.1016/j.jcis.2015.03.061; KRAJEWSKA B, 1990, J CHEM TECHNOL BIOT, V48, P337; Bencina M, 2005, J CHROMATOGR A, V1065, P83, DOI 10.1016/j.chroma.2004.10.006; Xin YR, 2012, POLYMER, V53, P2847, DOI 10.1016/j.polymer.2012.04.029; CHANEY AL, 1962, CLIN CHEM, V8, P130; Urban J, 2010, ANAL CHEM, V82, P1621, DOI 10.1021/ac100008n; Wang GW, 2015, RSC ADV, V5, P25777, DOI 10.1039/c5ra03585f; Wan Y, 2007, CHEM REV, V107, P2821, DOI 10.1021/cr068020s; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Okada K, 2011, CHEM COMMUN, V47, P7422, DOI 10.1039/c1cc12402a; Lv R, 2006, J MEMBRANE SCI, V281, P700, DOI 10.1016/j.memsci.2006.04.042; Kayastha AM, 2001, APPL BIOCHEM BIOTECH, V96, P41, DOI 10.1385/ABAB:96:1-3:041; Kato M, 2005, ANAL CHEM, V77, P1813, DOI 10.1021/ac048388u; Lubbad SH, 2011, J CHROMATOGR A, V1218, P8897, DOI 10.1016/j.chroma.2011.03.003; Koci P, 2007, CATAL TODAY, V119, P64, DOI 10.1016/j.cattod.2006.08.014; Svec F, 2006, ELECTROPHORESIS, V27, P947, DOI 10.1002/elps.200500661; Li W, 2013, CHEM COMMUN, V49, P943, DOI 10.1039/c2cc36964h; Lee WY, 2000, ANAL CHIM ACTA, V404, P195, DOI 10.1016/S0003-2670(99)00699-6; Urban J, 2010, J CHROMATOGR A, V1217, P8212, DOI 10.1016/j.chroma.2010.10.100; Kundu D, 2014, REACT FUNCT POLYM, V79, P8, DOI 10.1016/j.reactfunctpolym.2014.03.002; Modak A, 2011, GREEN CHEM, V13, P1317, DOI 10.1039/c1gc15045f; BETHELL GS, 1979, J BIOL CHEM, V254, P2572; Chandra D, 2007, CHEM MATER, V19, P6290, DOI 10.1021/cm702259q; Chang TM, 1966, ASAIO T, V12, P13; Chen JP, 1999, BIOPROCESS ENG, V21, P323, DOI 10.1007/s004490050683; Han WJ, 2014, POLYM DEGRAD STABIL, V109, P362, DOI 10.1016/j.polymdegradstab.2014.05.032; Langley PJ, 1999, CHEM SOC REV, V28, P279, DOI 10.1039/a704290f; Park SB, 2013, POLYMER, V54, P6114, DOI 10.1016/j.polymer.2013.09.014; Shalini J, 2014, BIOSENS BIOELECTRON, V56, P64, DOI 10.1016/j.bios.2013.11.071; Shinya Y, 2014, POLYMER, V55, P3212; Sun XX, 2013, POLYM J, V45, P1101, DOI 10.1038/pj.2013.18; Xin YR, 2012, CHEM LETT, V41, P1509, DOI 10.1246/cl.2012.1509	38	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	AUG	2015	293	8					2429	2435		10.1007/s00396-015-3637-1		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CM9UM	WOS:000358054500030		
J	Yoshida, E				Yoshida, Eri			Enhanced permeability of Rhodamine B into bilayers comprised of amphiphilic random block copolymers by incorporation of ionic segments in the hydrophobic chains	COLLOID AND POLYMER SCIENCE			English	Article						Permeability; Rhodamine B; Bilayers; Amphiphilic random block copolymers; 3-Sulfopropyl methacrylate potassium salt; Hydrophobic phases; Pore formation; Photopolymerization-induced self-assembly	RANDOM-MATHACRYLIC ACID); GIANT VESICLES; RADICAL POLYMERIZATION; MORPHOLOGY CONTROL; THIN BILAYERS; TRANSPORT; METHACRYLATE; MEMBRANE; PERMEATION; CHANNEL	The permeability of Rhodamine B (Rh) into bilayers comprised of amphiphilic block copolymers was explored using ionic segments incorporated in the hydrophobic chains. The amphiphilic block copolymer consisting of a hydrophilic poly(methacrylic acid) block and a hydrophobic poly(methyl methacrylate-random-methacrylic acid) block containing 0.2 mol% units of the 3-sulfopropyl methacrylate potassium salt (SpMA) produced giant vesicles by photopolymerization-induced self-assembly in an aqueous methanol solution. The spherical vesicles were transformed into films as the SpMA ratio increased. The SpMA units incorporated in the hydrophobic chains enhanced the Rh permeability into the bilayer, whereas the vesicles without SpMA units captured no Rh molecules. However, the Rh was released from the hydrophobic phases in the isolation process of the bilayers by repeated sedimentation-redispersion. The permeability enhancement was attributed to the pore formation in the bilayers by the capture and release of the Rh by the SpMA units in the hydrophobic phases.	Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Elston T, 1998, NATURE, V391, P510; Yoshida E, 2015, COLLOID POLYM SCI, V293, P249, DOI 10.1007/s00396-014-3403-9; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1835, DOI 10.1007/s00396-015-3577-9; Paula S, 1996, BIOPHYS J, V70, P339; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; Kim K, 2014, NANO LETT, V14, P7051, DOI 10.1021/nl5034446; Randles EG, 2013, LANGMUIR, V29, P1490, DOI 10.1021/la303526k; Kandasamy YS, 2015, ORG BIOMOL CHEM, V13, P2652, DOI 10.1039/c4ob02382j; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1841, DOI 10.1007/s00396-015-3600-1; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; Arteta MY, 2014, J PHYS CHEM B, V118, P12892, DOI 10.1021/jp506510s; HAMILTON RT, 1990, J PHYS CHEM-US, V94, P2560, DOI 10.1021/j100369a063; HAMILTON RT, 1990, J MEMBRANE SCI, V54, P259, DOI 10.1016/S0376-7388(00)80613-4; HIGAKI K, 1988, PHARMACEUT RES, V5, P309, DOI 10.1023/A:1015982805718; Runas KA, 2015, SOFT MATTER, V11, P499, DOI 10.1039/c4sm01478b; Steyern FV, 1996, J HISTOCHEM CYTOCHEM, V44, P267; STRZELBICKI J, 1982, J MEMBRANE SCI, V10, P35, DOI 10.1016/S0376-7388(00)82185-7; Tse ECM, 2015, ANAL CHEM, V87, P2403, DOI 10.1021/ac5043544; Yoshida E, 2009, COLLOID POLYM SCI, V287, P767, DOI 10.1007/s00396-009-2023-2; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1275, DOI 10.1007/s00396-015-3519-6; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2012, ISPN POLYM SCI, DOI 10.5402/2012/102186; Yoshida E, 2013, OPEN J POLYM CHEM, V3, P16; Yoshida E, 2015, SUPRAMOL CHEM, V27, P274, DOI 10.1080/10610278.2014.959014; Yoshida E, 2015, COLLOID POLYM SCI, V293, P649, DOI 10.1007/s00396-014-3482-7	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	AUG	2015	293	8					2437	2443		10.1007/s00396-015-3679-4		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CM9UM	WOS:000358054500031		
J	Fukushima, D; Sk, UH; Sakamoto, Y; Nakase, I; Kojima, C				Fukushima, Daichi; Sk, Ugir Hossain; Sakamoto, Yasuhiro; Nakase, Ikuhiko; Kojima, Chie			Dual stimuli-sensitive dendrimers: Photothermogenic gold nanoparticle-loaded thermo-responsive elastin-mimetic dendrimers	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Gold nanoparticle; Elastin; Dendrimer; Thermosensitive; Photosensitive; Photothermal therapy	BIOMEDICAL APPLICATIONS; PAMAM DENDRIMERS; DRUG-DELIVERY; CATALYSIS; THERAPY; SURFACE; HEAT	Dendrimers are synthetic macromolecules with unique structures that can work as nanoplatforms for both photothermogenic gold nanoparticles (AuNPs) and thermosensitive elastin-like peptides (ELPs) with valine-proline-glycine-valine-glycine (VPGVG) repeats. In this study, photothermogenic AuNPs were loaded into thermo-responsive elastin-mimetic dendrimers (dendrimers conjugating ELPs at their periphery) to produce dual stimuli-sensitive nanoparticles. Polyamidoamine G4 dendrimers were modified with acetylated VPGVG and (VPGVG)2, and the resulting materials were named ELP1-den and ELP2-den, respectively. The AuNPs were prepared by the reduction of Au ions using a dendrimer-nanotemplated method. The AuNP-loaded elastin-mimetic dendrimers exhibited photothermal properties. ELP1-den and ELP2-den showed similar temperature-dependent changes in their conformations. Phase transitions were observed at around 55 degrees C and 35 degrees C for the AuNP-loaded ELP1-den and AuNP-loaded ELP2-den, respectively, but not for the corresponding PEGylated dendrimer. In contrast to the AuNP-loaded PEGylated dendrimer, AuNP-loaded ELP2-den readily associated with cells and induced efficient photocytotoxicity at 37 degrees C. The cell association and the photocytotoxicity properties of AuNP-loaded ELP2-den could be controlled by temperature. These results therefore suggest that dual stimuli-sensitive dendrimer nanoparticles of this type could be used for photothermal therapy. (c) 2015 Elsevier B.V. All rights reserved.	[Fukushima, Daichi; Kojima, Chie] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998570, Japan; [Sk, Ugir Hossain; Sakamoto, Yasuhiro; Nakase, Ikuhiko] Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, Sakai, Osaka 5998570, Japan	Kojima, C (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.	kojima@chem.osakafu-u.ac.jp			Tokuyama Science Foundation; Takeda Science Foundation	We are grateful to Mr. Kotaro Irie for his help in peptide synthesis. This work was supported by the Tokuyama Science Foundation. U.H.S. gratefully acknowledges financial assistance from the Takeda Science Foundation for awarding a fellowship.	Llevot A, 2012, CHEM SOC REV, V41, P242, DOI 10.1039/c1cs15080d; Bronstein LM, 2011, CHEM REV, V111, P5301, DOI 10.1021/cr2000724; Chen HJ, 2013, CHEM SOC REV, V42, P2679, DOI 10.1039/c2cs35367a; Lemieux V, 2010, CHEM COMMUN, V46, P3071, DOI 10.1039/b923280j; Umeda Y, 2010, BIOCONJUGATE CHEM, V21, P1559, DOI 10.1021/bc1001399; Haba Y, 2007, LANGMUIR, V23, P5243, DOI 10.1021/la0700826; Haba Y, 2004, J AM CHEM SOC, V126, P12760, DOI 10.1021/ja047755g; Peng C, 2012, BIOMATERIALS, V33, P1107, DOI 10.1016/j.biomaterials.2011.10.052; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; URRY DW, 1985, BIOCHEM BIOPH RES CO, V130, P50, DOI 10.1016/0006-291X(85)90380-8; Urry DW, 2010, ADV DRUG DELIVER REV, V62, P1404, DOI 10.1016/j.addr.2010.07.001; Kono K, 2001, ADV DRUG DELIVER REV, V53, P307, DOI 10.1016/S0169-409X(01)00204-6; Kojima C, 2014, BIOPOLYMERS, V101, P603, DOI 10.1002/bip.22425; Govorov AO, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70017-8; Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Kojima C, 2013, BIOPOLYMERS, V100, P714, DOI 10.1002/bip.22276; Garacia-Martinez J. C., 2004, J AM CHEM SOC, V126, P16170; Kim YG, 2004, CHEM MATER, V16, P167, DOI 10.1021/cm034932o; Kojima C, 2014, CHEM LETT, V43, P975, DOI 10.1246/cl.140124; Kono K, 2014, RSC ADV, V4, P27811, DOI 10.1039/c4ra03947e; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Li XJ, 2013, BIOCONJUGATE CHEM, V24, P282, DOI 10.1021/bc300190v; Murugan E, 2010, J POLYM SCI POL CHEM, V48, P2525, DOI 10.1002/pola.24028; Panzarini E., 2011, INT J PHOTOENERGY, V2011; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	AUG 1	2015	132						155	160		10.1016/j.colsurfb.2015.05.012		6	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CN0HF	WOS:000358094000019		
J	Hiruta, Y; Nagumo, Y; Suzuki, Y; Funatsu, T; Ishikawa, Y; Kanazawa, H				Hiruta, Yuki; Nagumo, Yuhei; Suzuki, Yuichi; Funatsu, Takaaki; Ishikawa, Yuki; Kanazawa, Hideko			The effects of anionic electrolytes and human serum albumin on the LCST of poly(N-isopropylacrylamide)-based temperature-responsive copolymers	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						LCST; Poly(N-isopropylacrylamide); Temperature-responsive; Hofmeister series; Human serum albumin	POLY N-ISOPROPYLACRYLAMIDE; WATER; PNIPAM; SALT	Poly(N-isopropylacrylamide) (PNIPAm) is one of the most widely studied temperature-responsive polymers among those that have been applied to biomaterials science and technology. Here, we investigated the importance of interactions between PNIPAm-based copolymers and biological factors. The effects of a series of major anionic electrolytes in biological environments and of human serum albumin (HSA) on the lower critical solution temperature (LCST) of homo-PNIPAm and PNIPAm copolymers were studied, using either a hydrophobic monomer or a cationic monomer. We synthesized P(NIPAm-co-BMA3%) with butyl methacrylate (BMA) as a hydrophobic monomer and P(NIPAm-co-DMAPAm2%) with N,N-dimethylaminopropyl acrylamide (DMAPAm) as a cationic monomer. The LCST of PNIPAm and P(NIPAm-co-DMAPAm2%) decreased with increasing salt concentrations, and the effects of anions on each polymer corresponded to the Hofmeister series. The LCST of P(NIPAm-co-DMAPAm2%) was greatly affected by anionic electrolytes compared with those of homo-PNIPAm and P(NIPAm-co-BMA3%). While the LCST of homo-PNIPAm was not affected by HSA, the LCST of P(NIPAm-co-DMAPAm2%) decreased non-linearly with increasing HSA concentrations. These effects were due to the electrostatic interactions between the positively charged polymer chains and the negatively charged HSA, as well as the stabilization of polymer aggregations with HSA. Under physiological buffer conditions, the LCST of P(NIPAm-co-DMAPAm2%) was not significantly affected by the HSA concentration. These results indicated that depending on the types of copolymers used for biological applications, it is necessary to take into account the effect of biological media while designing polymers. (c) 2015 Elsevier B.V. All rights reserved.	[Hiruta, Yuki; Nagumo, Yuhei; Suzuki, Yuichi; Funatsu, Takaaki; Ishikawa, Yuki; Kanazawa, Hideko] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan	Kanazawa, H (reprint author), Keio Univ, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	kanazawa-hd@pha.keio.ac.jp			Japan Society for the Promotion of Science (JSPS) [25893232]	This study was supported in part by a Grant-in-Aid for Research Activity Start-Up (Grant No. 25893232) from the Japan Society for the Promotion of Science (JSPS).	Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002; Hiruta Y, 2014, ACS MACRO LETT, V3, P281, DOI 10.1021/mz5000569; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Jochum FD, 2009, MACROMOLECULES, V42, P7854, DOI 10.1021/ma901295f; SCHILD HG, 1990, J PHYS CHEM-US, V94, P4352, DOI 10.1021/j100373a088; Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031; Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k; FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016; Zhang YJ, 2005, J AM CHEM SOC, V127, P14505, DOI 10.1021/ja0546424; Henderson IM, 2014, J POLYM SCI POL PHYS, V52, P507, DOI 10.1002/polb.23444; Du HB, 2010, J PHYS CHEM B, V114, P16594, DOI 10.1021/jp105652c; Obiweluozor FO, 2014, MACROMOL CHEM PHYS, V215, P1077, DOI 10.1002/macp.201300778; Suwa K, 1998, COLLOID POLYM SCI, V276, P529, DOI 10.1007/s003960050276; Zhang Y, 2007, J PHYS CHEM C, V111, P8916, DOI 10.1021/jp0690603; Ayano E, 2014, ANAL SCI, V30, P167; BAE YH, 1991, PHARMACEUT RES, V8, P531, DOI 10.1023/A:1015871732706; Heskins M.a.G.J.E., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; Hiruta Y, 2015, SENSOR ACTUAT B-CHEM, V207, P724, DOI 10.1016/j.snb.2014.10.065; Ju XJ, 2009, POLYMER, V50, P922, DOI 10.1016/j.polymer.2008.12.022; Krylov S.N., 2000, ANAL CHEM, V72, P111, DOI 10.1021/a1000014c; Lopez-Leon T, 2007, CHEMPHYSCHEM, V8, P148, DOI 10.1002/cphc.200600521; Roy D, 2008, CHEM COMMUN, P2477, DOI 10.1039/b802293c; TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P42, DOI 10.1021/bc00019a006	25	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	AUG 1	2015	132						299	304		10.1016/j.colsurfb.2015.05.032		6	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CN0HF	WOS:000358094000036		
J	Bursi, OS; Feng, MQ; Wu, ZS				Bursi, Oreste S.; Feng, Maria Q.; Wu, Zhishen			Special Issue: Health Monitoring of Structures Introduction	COMPUTER-AIDED CIVIL AND INFRASTRUCTURE ENGINEERING			English	Editorial Material									[Bursi, Oreste S.] Univ Trento, Trento, Italy; [Feng, Maria Q.] Columbia Univ, New York, NY USA; [Wu, Zhishen] Ibaraki Univ, Hitachi, Ibaraki, Japan	Bursi, OS (reprint author), Univ Trento, Trento, Italy.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1093-9687	1467-8667		COMPUT-AIDED CIV INF	Comput.-Aided Civil Infrastruct. Eng.	AUG	2015	30	8			SI		601	601		10.1111/mice.12155		1	Computer Science, Interdisciplinary Applications; Construction & Building Technology; Engineering, Civil; Transportation Science & Technology	Computer Science; Construction & Building Technology; Engineering; Transportation	CM9RB	WOS:000358045500001		
J	Kobayashi, Y; Okura, H; Kume, T; Miyamoto, Y; Yamada, R; Kobayashi, Y; Fukuhara, K; Koyama, T; Neishi, Y; Yoshida, K				Kobayashi, Yuhei; Okura, Hiroyuki; Kume, Teruyoshi; Miyamoto, Yoshinori; Yamada, Ryotaro; Kobayashi, Yukari; Fukuhara, Kenzo; Koyama, Terumasa; Neishi, Yoji; Yoshida, Kiyoshi			Direct relationship of local C-reactive protein production and lipid pool characterized by integrated backscatter intravascular ultrasound: a preliminary observation	CORONARY ARTERY DISEASE			English	Article						intravascular ultrasound; percutaneous coronary intervention; translesional high-sensitivity C-reactive protein	PERCUTANEOUS CORONARY INTERVENTION; ANGINA-PECTORIS; PLAQUE CHARACTERISTICS; MYOCARDIAL-INFARCTION; VULNERABLE PLAQUE; STATIN THERAPY; ARTERIAL; DISEASE; MHZ; ATHEROSCLEROSIS	BackgroundLocal production of C-reactive protein (CRP) in human coronary arterial plaque was reported as a possible marker for local inflammation and vulnerable plaque. Integrated backscatter intravascular ultrasound (IB-IVUS) plaque tissue characterization may detect vulnerable plaque with high local plaque inflammation. Thus, the aim of this study was to clarify the relationship between IB-IVUS-based plaque characteristics and local high-sensitivity C-reactive protein (hs-CRP) production in stable and unstable plaque.Methods and resultsEighteen patients (nine unstable angina/non-ST-segment elevation myocardial infarction and nine stable angina) were prospectively enrolled. Using the microcatheter, blood samples from the proximal and distal sites of the culprit lesion were obtained to measure local CRP production. Translesional hs-CRP was defined as distal hs-CRP minus proximal hs-CRP of the culprit lesion. Gray-scale and IB-IVUS analyses were carried out at the target lesion. The translesional hs-CRP level tended to be higher in the unstable angina group than in the stable angina group (0.0260.033 vs. 0.003 +/- 0.007mg/dl, P=0.050). Gray-scale IVUS-derived indices did not correlate with translesional hs-CRP. However, % lipid pool area by IB-IVUS correlated positively (r=0.54, P=0.02) and % fibrosis area correlated negatively with the translesional hs-CRP level (r=-0.52, P=0.03).ConclusionLipid pool area detected by IB-IVUS is correlated positively with the translesional hs-CRP level.	[Kobayashi, Yuhei; Okura, Hiroyuki; Kume, Teruyoshi; Yamada, Ryotaro; Kobayashi, Yukari; Fukuhara, Kenzo; Koyama, Terumasa; Neishi, Yoji; Yoshida, Kiyoshi] Kawasaki Med Univ, Div Cardiovasc Med, Kurashiki, Okayama, Japan; [Miyamoto, Yoshinori] Ota Mem Hosp, Div Cardiovasc Med, Fukuyama, Hiroshima, Japan	Kobayashi, Y (reprint author), Stanford Univ, Med Ctr, Div Cardiovasc Med, 300 Pasteur Dr,Room H3554, Stanford, CA 94305 USA.	yuhei@stanford.edu					Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Mintz GS, 1996, CIRCULATION, V94, P35; Vancraeynest D, 2011, J AM COLL CARDIOL, V57, P1961, DOI 10.1016/j.jacc.2011.02.018; Ridker PM, 2001, CIRCULATION, V103, P1813; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Danenberg HD, 2003, CIRCULATION, V108, P512, DOI 10.1161/01.CIR.0000085568.13915.1E; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7; LOCKWOOD GR, 1991, ULTRASOUND MED BIOL, V17, P653, DOI 10.1016/0301-5629(91)90096-F; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Brugaletta S, 2014, CIRC J, V78, P1531, DOI 10.1253/circj.CJ-14-0496; Miyamoto Y, 2011, JACC-CARDIOVASC IMAG, V4, P638, DOI 10.1016/j.jcmg.2011.03.014; Ishikawa T, 2003, AM J CARDIOL, V91, P287, DOI 10.1016/S0002-9149(02)03156-9; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Yamada R, 2013, J CARDIOL, V61, P149, DOI 10.1016/j.jjcc.2012.10.008; Yamada R, 2010, CIRC-CARDIOVASC INTE, V3, P484, DOI 10.1161/CIRCINTERVENTIONS.109.928911; Kawamoto T, 2007, J AM COLL CARDIOL, V50, P1635, DOI 10.1016/j.jacc.2007.05.050; Zwaka TP, 2001, CIRCULATION, V103, P1194; VANDERWAL AC, 1994, CIRCULATION, V89, P36; Bridal SL, 1997, ULTRASOUND MED BIOL, V23, P215, DOI 10.1016/S0301-5629(96)00201-3; Imai K, 2008, AM HEART J, V156, P713, DOI 10.1016/j.ahj.2008.04.011; Imai K, 2009, J CARDIOL, V53, P388, DOI 10.1016/j.jjcc.2009.01.005; Inoue T, 2005, J AM COLL CARDIOL, V46, P239, DOI 10.1016/j.jacc.2005.04.029; Maehama T, 2010, J CARDIOL, V56, P118, DOI 10.1016/j.jjcc.2010.03.006; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Okura H, 2001, J AM COLL CARDIOL, V38, P2001, DOI 10.1016/S0735-1097(01)01642-4; Okura H, 2007, INTERNAL MED, V46, P1337, DOI 10.2169/internalmedicine.46.0021; Tanindi Asli, 2011, Open Cardiovasc Med J, V5, P110, DOI 10.2174/1874192401105010110; Yamada R, 2010, CIRC J, V74, P1658, DOI 10.1253/circj.CJ-09-0992	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	AUG	2015	26	5					425	431		10.1097/MCA.0000000000000250		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM4GA	WOS:000357641400010		
J	Yamada, R; Yoshida, K; Okura, H				Yamada, Ryotaro; Yoshida, Kiyoshi; Okura, Hiroyuki			Progression of cardiac allograft vasculopathy detected by optical coherence tomography	CORONARY ARTERY DISEASE			English	Editorial Material							HEART		[Yamada, Ryotaro; Okura, Hiroyuki] Kawasaki Med Univ, Dept Cardiol, Kurashiki, Okayama 7010192, Japan; [Yoshida, Kiyoshi] Sakakibara Heart Inst Okayama, Dept Cardiol, Okayama, Japan	Okura, H (reprint author), Kawasaki Med Univ, Dept Cardiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hokura@fides.dti.ne.jp					Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014; Hou JB, 2012, JACC-CARDIOVASC IMAG, V5, P662, DOI 10.1016/j.jcmg.2012.01.018	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	AUG	2015	26	5					459	460		10.1097/MCA.0000000000000234		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CM4GA	WOS:000357641400015		
J	Alvarez, B; Escalona, Z; Uenishi, H; Toki, D; Revilla, C; Yuste, M; del Moral, MG; Alonso, F; Ezquerra, A; Dominguez, J				Alvarez, B.; Escalona, Z.; Uenishi, H.; Toki, D.; Revilla, C.; Yuste, M.; Gomez del Moral, M.; Alonso, F.; Ezquerra, A.; Dominguez, J.			Molecular and functional characterization of porcine Siglec-3/CD33 and analysis of its expression in blood and tissues	DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY			English	Article						Siglec-3; CD33; Monoclonal antibody; Swine; Myeloid cells; Monocyte	PLASMACYTOID DENDRITIC CELLS; LEUKEMIC MYELOID CELLS; INHIBITORY RECEPTOR; IMMUNE-SYSTEM; IN-VITRO; CD33; MONOCYTES; SIGLECS; SIALOADHESIN; SURFACE	A cDNA clone encoding a 380 a-a type 1 transmembrane protein with homology to human Siglec-3/ CD33 was obtained from a swine small intestine library. An analysis of protein sequence identified two immunoglobulin-like domains, a transmembrane region, and a carboxi-terminal tail with two tyrosine-based signalling motifs. Binding assays of Siglec-3 transfected CHO cells to polyacrylamide glycoconjugates showed a preference for alpha 2-6-linked sialic acids. Using mAbs raised against a fragment containing the two Ig-like domains, porcine Siglec-3 was found to be expressed on monocytes and granulocytes, and their bone marrow precursors. It was also detected in lymph node, splenic and alveolar macrophages. MAbs immunoprecipitated, from granulocyte lysates, a protein of 51-60 kDa under both non-reducing and reducing conditions. MAbs were also used to analyse functional activity of Siglec-3 on bone marrow and blood cells. Engagement of Siglec-3 by mAb had no apparent effect on cell proliferation or cytokine production. (C) 2015 Elsevier Ltd. All rights reserved.	[Alvarez, B.; Escalona, Z.; Revilla, C.; Yuste, M.; Alonso, F.; Ezquerra, A.; Dominguez, J.] INIA, Dept Biotechnol, Inst Nacl Invest & Tecnol Agr & Alimentaria, Madrid 28040, Spain; [Uenishi, H.] NIAS, Tsukuba, Ibaraki 3058602, Japan; [Toki, D.] Inst Japan Assoc Technoinnovat Agr Forestry & Fis, Tsukuba, Ibaraki 3050854, Japan; [Gomez del Moral, M.] Univ Complutense Madrid, Fac Med, Dept Biol Celular & Inmunol, E-28040 Madrid, Spain	Dominguez, J (reprint author), INIA, Dept Biotechnol, Ctra Coruna Km 7-5, Madrid 28040, Spain.	juncal@inia.es	Ezquerra, Angel/I-3440-2012; Dominguez, Javier/I-1210-2015		Spanish Ministry of Science and Innovation (MICINN) [AGL2009-09729]; Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan [AGB1002]; MICINN	This work was supported by grants AGL2009-09729 from the Spanish Ministry of Science and Innovation (MICINN) and AGL2012-31556 from the Spanish Ministry of Economy and Competitiveness, and AGB1002 from the Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan. PhD studies of Zoraida Escalona were supported by a doctoral fellowship from MICINN. We thank Paloma Martinez de la Riva and Elena Ramos for technical assistance assistance.	Alvarez B, 2008, VET RES, V39, DOI 10.1051/vetres:2007051; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Ulyanova T, 1999, EUR J IMMUNOL, V29, P3440, DOI 10.1002/(SICI)1521-4141(199911)29:11<3440::AID-IMMU3440>3.0.CO;2-C; Angata T, 2006, MOL DIVERS, V10, P555, DOI 10.1007/s11030-006-9029-1; FREEMAN SD, 1995, BLOOD, V85, P2005; Ezquerra A, 2009, DEV COMP IMMUNOL, V33, P284, DOI 10.1016/j.dci.2008.06.002; Perez C, 2007, DEV COMP IMMUNOL, V31, P296, DOI 10.1016/j.dci.2006.06.002; Uenishi H, 2007, NUCLEIC ACIDS RES, V35, pD650, DOI 10.1093/nar/gkl954; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-200509-3842; Poderoso T, 2011, VACCINE, V29, P4813, DOI 10.1016/j.vaccine.2011.04.076; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Paul SP, 2000, BLOOD, V96, P483; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Chamorro S, 2005, IMMUNOLOGY, V114, P63, DOI 10.1111/j.1365-2567.2004.01994.x; Garnache-Ottou F, 2005, BLOOD, V105, P1256, DOI 10.1182/blood-2004-06-2416; Veillette A, 2009, IMMUNOL REV, V232, P229, DOI 10.1111/j.1600-065X.2009.00824.x; ANDREWS RG, 1983, BLOOD, V62, P124; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Brinkman-Vand der Linden E.C.M., 2003, MOL CELL BIOL, V23, P4199; Chamorro S, 2004, IMMUNOBIOLOGY, V209, P57, DOI 10.1016/j.imbio.2004.02.002; Cornish AL, 1998, BLOOD, V92, P2123; Cravens PD, 2007, SCAND J IMMUNOL, V65, P514, DOI 10.1111/j.1365-3083.2007.01933.x; Escalona Z, 2014, DEV COMP IMMUNOL, V44, P206, DOI 10.1016/j.dci.2013.12.013; Escalona Z, 2015, DEV COMP IMMUNOL, V48, P116, DOI 10.1016/j.dci.2014.09.011; Ferlazzo G, 2000, EUR J IMMUNOL, V30, P827, DOI 10.1002/1521-4141(200003)30:3<827::AID-IMMU827>3.0.CO;2-1; Ishida A, 2008, PROTEOMICS, V8, P3342, DOI 10.1002/pmic.200800039; MAGYAR A, 1995, VET IMMUNOL IMMUNOP, V47, P273, DOI 10.1016/0165-2427(94)05369-4; Mingari MC, 2001, IMMUNOL REV, V181, P260, DOI 10.1034/j.1600-065X.2001.1810122.x; Moreno S, 2013, DEV COMP IMMUNOL, V39, P207, DOI 10.1016/j.dci.2012.11.010; Mussa T, 2011, VIROLOGY, V420, P125, DOI 10.1016/j.virol.2011.09.001; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; Perez C, 2007, J IMMUNOL METHODS, V321, P70, DOI 10.1016/j.jim.2007.01.003; Sigrist C.J., 2009, NUCLEIC ACIDS RES, V38, pD161, DOI DOI 10.1093/NAR/GKP885; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vitale C, 1999, P NATL ACAD SCI USA, V96, P15091, DOI 10.1073/pnas.96.26.15091	44	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0145-305X	1879-0089		DEV COMP IMMUNOL	Dev. Comp. Immunol.	AUG	2015	51	2					238	250		10.1016/j.dci.2015.04.002		13	Immunology; Zoology	Immunology; Zoology	CM7XU	WOS:000357910600003		
J	Ozaki, S; Mizukami, Y; Kawahara, E				Ozaki, Satoru; Mizukami, Yuji; Kawahara, Ei			Cytologic Features of Nipple Adenoma: A Report of Four Cases of Adenoma of the Nipple	DIAGNOSTIC CYTOPATHOLOGY			English	Article						case report; cytology; breast; adenoma; nipple	FLORID PAPILLOMATOSIS; EROSIVE ADENOMATOSIS; MAMMARY-CARCINOMA; DIAGNOSIS	We report four cases of adenoma of the nipple, a rare benign epithelial benign tumor occurring under the nipple and areola. Clinically, erosion findings of the nipple require discrimination from Paget's disease. In addition, a mass found in the nipple warrants discrimination from ductal carcinoma. Two cases underwent aspiration biopsy cytology and the other underwent tumor imprint cytology, respectively, revealing a large number of epithelial cell populations in the necrotic background material. These large cell clusters had a papillary or sheet structure and exhibited decreased cell cohesiveness at the cluster part. In addition, small clusters and solitary epithelial cells were also present. Furthermore, a two-cell pattern comprising both duct epithelial and myoepithelial cells was observed in the cell clusters. Two other cases underwent nipple brush cytology, revealing a few small papillary clusters with isolated epithelial cells in the hemorrhagic background. The clusters appeared as benign duct proliferative lesions such as papilloma, papillomatosis, and adenosis. An accurate diagnosis warrants the recognition of regular nuclei with bland chromatin and myoepithelial cells and the identification of the lesion location. (C) 2015 Wiley Periodicals, Inc.	[Ozaki, Satoru; Mizukami, Yuji; Kawahara, Ei] Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa 9208642, Japan	Ozaki, S (reprint author), Kanazawa Univ, Dept Clin Lab Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9208642, Japan.	s-ozaki@med.kanazawau.ac.jp	Kawahara, Ei/C-3233-2015				BHAGAVAN BS, 1973, HUM PATHOL, V4, P289, DOI 10.1016/S0046-8177(73)80015-2; DIAZ NM, 1992, MODERN PATHOL, V5, P179; DIsBonito M, 2014, ONCOL LETT, V7, P1839; GUDJONSD.A, 1971, ACTA PATH MICRO IM A, VA 79, P676; Gupta RK, 2004, DIAGN CYTOPATHOL, V31, P432, DOI 10.1002/dc.20168; Kijima Yuko, 2006, Breast Cancer, V13, P95, DOI 10.2325/jbcs.13.95; Koss LG, 1984, ASPIRATION BIOPSY CY, Vxv, P502; MAZZARA PF, 1989, ACTA CYTOL, V33, P188; PERZIN KH, 1972, CANCER, V29, P996, DOI 10.1002/1097-0142(197204)29:4<996::AID-CNCR2820290447>3.0.CO;2-H; ROSEN PP, 1986, AM J SURG PATHOL, V10, P87, DOI 10.1097/00000478-198602000-00002; Rosen PP, 2009, ROSENS BREAST PATHOL, V3rd, P114; SMITH EJ, 1970, ARCH DERMATOL, V102, P330, DOI 10.1001/archderm.102.3.330; STORMBY N, 1984, ACTA CYTOL, V28, P729	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	AUG	2015	43	8					664	668		10.1002/dc.23292		5	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CM8RF	WOS:000357969000015		
